{"Environment": ["During 2021, we appointed the newly created role of chief impact officer, who will drive our strategy and execution related to DEI as well as sustainability, environmental, social, and governance (\u201cESG\u201d), and philanthropy.", "Our vision for a healthier world begins with our employees, who strive to bring our mission to life every day.", "In response to the COVID-19 pandemic, our priority has been, and continues to be, protecting the health and safety of our employees.", "Controlled Substances: We are subject to the operating and security standards of the Drug Enforcement Administration (\u201cDEA\u201d), the U.S.", "Failure to comply with applicable laws, regulations, and government guidance, including but not limited to those involving the regulation of controlled substances, the federal Anti- Kickback Statute, and others, could subject us to federal or state government investigations or qui tam actions, and to liability for damages and civil and criminal penalties, including the loss of licenses or our ability to participate in Medicare, Medicaid and other federal and state healthcare programs, or pursue government contracts.", "Additionally, our operations are subject to regulations under various federal, state, local and foreign laws concerning the environment, including laws addressing the discharge of pollutants into the air and water, the management and disposal of hazardous substances and wastes, and the cleanup of contaminated sites, as discussed in more detail below.", "We could incur substantial costs, including cleanup costs, fines and civil or criminal sanctions, and third-party damage or personal injury claims, if in the future we were to violate or become liable under environmental laws.", "We are committed to maintaining compliance with all environmental laws applicable to our operations, products and services and to reducing our environmental impact across all aspects of our business.", "We meet this commitment through an environmental strategy and sustainability program.", "Although there is no assurance that existing or future environmental laws applicable to our operations or products will not have a material adverse impact on our operations or financial condition, we do not currently anticipate material capital expenditures for environmental matters.", "Other than the expected  expenditures  that  may  be  required  in  connection  with  our  legacy  chemical  distribution  operations,  we  do  not  anticipate  making  substantial  capital expenditures either for environmental issues or to comply with environmental laws, regulations, or government guidance in the future.", "The amount of our capital expenditures for environmental compliance was not material in 2021 and is not expected to be material in the next year.", "We sold our chemical distribution operations in 1987 and retained responsibility for certain environmental obligations.", "Compliance with climate-related laws may be further complicated by disparate regulatory approaches in various jurisdictions.", "New or expanded climate-related laws could impose substantial costs on us.", "Until the timing and extent of climate-related laws are clarified, we cannot predict their potential effect on our capital expenditures or our results of operations.", "Climate Change Regulation: Governments in the U.S. and abroad are considering new or expanded laws to address climate change.", "We experience costly legal disputes, government actions and adverse publicity regarding our role in distributing controlled substances such as opioids.", "We might experience increased costs to distribute controlled substances such as opioids.", "negatively  impact  our  profit  margins  and  the  profit  margins  of  our  customers,  delay  the  introduction  or  implementation  of  our  new  products,  or  otherwise negatively  impact  our business and expose the Company to litigation  and regulatory  investigations.  For example,  we are subject  to many environmental  and hazardous  materials  regulations,  including  those  relating  to  radiation-emitting  equipment  operated  at  U.S.  Oncology  Network  practices.  Additionally,  we  are subject to various routine agency (e.g., Drug Enforcement Administration (\u201cDEA\u201d), the U.S.", "We are subject to extensive and frequently changing local, state and federal laws and regulations relating to healthcare fraud, waste and abuse.", "We might lose our ability to purchase, compound, store or distribute pharmaceuticals and controlled substances.", "For example, we are required to hold valid DEA and state-level registrations and licenses, meet various security and operating standards and comply with the Controlled Substances Act and its accompanying regulations governing the sale, marketing, packaging, holding, distribution, and disposal of controlled substances.", "For example, the COVID-19 pandemic has disrupted the global economy and exacerbated uncertainties inherent in estimates, judgments and assumptions used in our forecasts and impairment assessments.", "These risks are increased by the COVID-19 pandemic.", "We might be adversely impacted by the Brexit withdrawal of the United Kingdom from the European Union.", "We  might  be  adversely  impacted  by  events  outside  of  our  control,  such  as  widespread  public  health  issues,  natural  disasters,  political  events  and  other catastrophic events.", "We may be adversely affected by global climate change or by legal, regulatory or market responses to such change.", "The effects could impair, for example, the availability and cost of certain products, commodities and energy (including utilities), which in turn may impact our ability to procure goods or services required for the operation of our business at the quantities and levels we require.", "We bear losses incurred as a result of, for example, physical damage to or destruction of our facilities (such as distribution or fulfillment centers), loss or spoilage of inventory, and business interruption due to weather events that may be attributable to climate change.", "The long-term effects of climate change are difficult to predict and may be widespread.", "During the second quarter of 2021, we also implemented on-site workplace temperature screening as we continue to adapt our health and safety practices in response to the COVID-19 pandemic.", "These amounts are equivalent to our LIFO reserves.", "In conjunction with the preparation of the accompanying financial statements, we considered matters related to ongoing controlled substances claims to which we are a party.", "During 2021, we appointed the newly created role of chief impact officer, who will drive our strategy and execution related to DEI as well as sustainability, environmental, social, and governance (\u201cESG\u201d), and philanthropy.", "Our vision for a healthier world begins with our employees, who strive to bring our mission to life every day.", "In response to the COVID-19 pandemic, our priority has been, and continues to be, protecting the health and safety of our employees.", "Controlled Substances: We are subject to the operating and security standards of the Drug Enforcement Administration (\u201cDEA\u201d), the U.S.", "Failure to comply with applicable laws, regulations, and government guidance, including but not limited to those involving the regulation of controlled substances, the federal Anti- Kickback Statute, and others, could subject us to federal or state government investigations or qui tam actions, and to liability for damages and civil and criminal penalties, including the loss of licenses or our ability to participate in Medicare, Medicaid and other federal and state healthcare programs, or pursue government contracts.", "Additionally, our operations are subject to regulations under various federal, state, local and foreign laws concerning the environment, including laws addressing the discharge of pollutants into the air and water, the management and disposal of hazardous substances and wastes, and the cleanup of contaminated sites, as discussed in more detail below.", "We could incur substantial costs, including cleanup costs, fines and civil or criminal sanctions, and third-party damage or personal injury claims, if in the future we were to violate or become liable under environmental laws.", "We are committed to maintaining compliance with all environmental laws applicable to our operations, products and services and to reducing our environmental impact across all aspects of our business.", "We meet this commitment through an environmental strategy and sustainability program.", "Although there is no assurance that existing or future environmental laws applicable to our operations or products will not have a material adverse impact on our operations or financial condition, we do not currently anticipate material capital expenditures for environmental matters.", "Other than the expected  expenditures  that  may  be  required  in  connection  with  our  legacy  chemical  distribution  operations,  we  do  not  anticipate  making  substantial  capital expenditures either for environmental issues or to comply with environmental laws, regulations, or government guidance in the future.", "The amount of our capital expenditures for environmental compliance was not material in 2021 and is not expected to be material in the next year.", "We sold our chemical distribution operations in 1987 and retained responsibility for certain environmental obligations.", "Compliance with climate-related laws may be further complicated by disparate regulatory approaches in various jurisdictions.", "New or expanded climate-related laws could impose substantial costs on us.", "Until the timing and extent of climate-related laws are clarified, we cannot predict their potential effect on our capital expenditures or our results of operations.", "Climate Change Regulation: Governments in the U.S. and abroad are considering new or expanded laws to address climate change.", "We experience costly legal disputes, government actions and adverse publicity regarding our role in distributing controlled substances such as opioids.", "We might experience increased costs to distribute controlled substances such as opioids.", "negatively  impact  our  profit  margins  and  the  profit  margins  of  our  customers,  delay  the  introduction  or  implementation  of  our  new  products,  or  otherwise negatively  impact  our business and expose the Company to litigation  and regulatory  investigations.  For example,  we are subject  to many environmental  and hazardous  materials  regulations,  including  those  relating  to  radiation-emitting  equipment  operated  at  U.S.  Oncology  Network  practices.  Additionally,  we  are subject to various routine agency (e.g., Drug Enforcement Administration (\u201cDEA\u201d), the U.S.", "We are subject to extensive and frequently changing local, state and federal laws and regulations relating to healthcare fraud, waste and abuse.", "We might lose our ability to purchase, compound, store or distribute pharmaceuticals and controlled substances.", "For example, we are required to hold valid DEA and state-level registrations and licenses, meet various security and operating standards and comply with the Controlled Substances Act and its accompanying regulations governing the sale, marketing, packaging, holding, distribution, and disposal of controlled substances.", "For example, the COVID-19 pandemic has disrupted the global economy and exacerbated uncertainties inherent in estimates, judgments and assumptions used in our forecasts and impairment assessments.", "These risks are increased by the COVID-19 pandemic.", "We might be adversely impacted by the Brexit withdrawal of the United Kingdom from the European Union.", "We  might  be  adversely  impacted  by  events  outside  of  our  control,  such  as  widespread  public  health  issues,  natural  disasters,  political  events  and  other catastrophic events.", "We may be adversely affected by global climate change or by legal, regulatory or market responses to such change.", "The effects could impair, for example, the availability and cost of certain products, commodities and energy (including utilities), which in turn may impact our ability to procure goods or services required for the operation of our business at the quantities and levels we require.", "We bear losses incurred as a result of, for example, physical damage to or destruction of our facilities (such as distribution or fulfillment centers), loss or spoilage of inventory, and business interruption due to weather events that may be attributable to climate change.", "The long-term effects of climate change are difficult to predict and may be widespread.", "During the second quarter of 2021, we also implemented on-site workplace temperature screening as we continue to adapt our health and safety practices in response to the COVID-19 pandemic.", "These amounts are equivalent to our LIFO reserves.", "In conjunction with the preparation of the accompanying financial statements, we considered matters related to ongoing controlled substances claims to which we are a party.", "During 2021, we appointed the newly created role of chief impact officer, who will drive our strategy and execution related to DEI as well as sustainability, environmental, social, and governance (\u201cESG\u201d), and philanthropy.", "Our vision for a healthier world begins with our employees, who strive to bring our mission to life every day.", "In response to the COVID-19 pandemic, our priority has been, and continues to be, protecting the health and safety of our employees.", "Controlled Substances: We are subject to the operating and security standards of the Drug Enforcement Administration (\u201cDEA\u201d), the U.S.", "Failure to comply with applicable laws, regulations, and government guidance, including but not limited to those involving the regulation of controlled substances, the federal Anti- Kickback Statute, and others, could subject us to federal or state government investigations or qui tam actions, and to liability for damages and civil and criminal penalties, including the loss of licenses or our ability to participate in Medicare, Medicaid and other federal and state healthcare programs, or pursue government contracts.", "Additionally, our operations are subject to regulations under various federal, state, local and foreign laws concerning the environment, including laws addressing the discharge of pollutants into the air and water, the management and disposal of hazardous substances and wastes, and the cleanup of contaminated sites, as discussed in more detail below.", "We could incur substantial costs, including cleanup costs, fines and civil or criminal sanctions, and third-party damage or personal injury claims, if in the future we were to violate or become liable under environmental laws.", "We are committed to maintaining compliance with all environmental laws applicable to our operations, products and services and to reducing our environmental impact across all aspects of our business.", "We meet this commitment through an environmental strategy and sustainability program.", "Although there is no assurance that existing or future environmental laws applicable to our operations or products will not have a material adverse impact on our operations or financial condition, we do not currently anticipate material capital expenditures for environmental matters.", "Other than the expected  expenditures  that  may  be  required  in  connection  with  our  legacy  chemical  distribution  operations,  we  do  not  anticipate  making  substantial  capital expenditures either for environmental issues or to comply with environmental laws, regulations, or government guidance in the future.", "The amount of our capital expenditures for environmental compliance was not material in 2021 and is not expected to be material in the next year.", "We sold our chemical distribution operations in 1987 and retained responsibility for certain environmental obligations.", "Compliance with climate-related laws may be further complicated by disparate regulatory approaches in various jurisdictions.", "New or expanded climate-related laws could impose substantial costs on us.", "Until the timing and extent of climate-related laws are clarified, we cannot predict their potential effect on our capital expenditures or our results of operations.", "Climate Change Regulation: Governments in the U.S. and abroad are considering new or expanded laws to address climate change.", "We experience costly legal disputes, government actions and adverse publicity regarding our role in distributing controlled substances such as opioids.", "We might experience increased costs to distribute controlled substances such as opioids.", "negatively  impact  our  profit  margins  and  the  profit  margins  of  our  customers,  delay  the  introduction  or  implementation  of  our  new  products,  or  otherwise negatively  impact  our business and expose the Company to litigation  and regulatory  investigations.  For example,  we are subject  to many environmental  and hazardous  materials  regulations,  including  those  relating  to  radiation-emitting  equipment  operated  at  U.S.  Oncology  Network  practices.  Additionally,  we  are subject to various routine agency (e.g., Drug Enforcement Administration (\u201cDEA\u201d), the U.S.", "We are subject to extensive and frequently changing local, state and federal laws and regulations relating to healthcare fraud, waste and abuse.", "We might lose our ability to purchase, compound, store or distribute pharmaceuticals and controlled substances.", "For example, we are required to hold valid DEA and state-level registrations and licenses, meet various security and operating standards and comply with the Controlled Substances Act and its accompanying regulations governing the sale, marketing, packaging, holding, distribution, and disposal of controlled substances.", "For example, the COVID-19 pandemic has disrupted the global economy and exacerbated uncertainties inherent in estimates, judgments and assumptions used in our forecasts and impairment assessments.", "These risks are increased by the COVID-19 pandemic.", "We might be adversely impacted by the Brexit withdrawal of the United Kingdom from the European Union.", "We  might  be  adversely  impacted  by  events  outside  of  our  control,  such  as  widespread  public  health  issues,  natural  disasters,  political  events  and  other catastrophic events.", "We may be adversely affected by global climate change or by legal, regulatory or market responses to such change.", "The effects could impair, for example, the availability and cost of certain products, commodities and energy (including utilities), which in turn may impact our ability to procure goods or services required for the operation of our business at the quantities and levels we require.", "We bear losses incurred as a result of, for example, physical damage to or destruction of our facilities (such as distribution or fulfillment centers), loss or spoilage of inventory, and business interruption due to weather events that may be attributable to climate change.", "The long-term effects of climate change are difficult to predict and may be widespread.", "During the second quarter of 2021, we also implemented on-site workplace temperature screening as we continue to adapt our health and safety practices in response to the COVID-19 pandemic.", "These amounts are equivalent to our LIFO reserves.", "In conjunction with the preparation of the accompanying financial statements, we considered matters related to ongoing controlled substances claims to which we are a party.", "During 2021, we appointed the newly created role of chief impact officer, who will drive our strategy and execution related to DEI as well as sustainability, environmental, social, and governance (\u201cESG\u201d), and philanthropy.", "Our vision for a healthier world begins with our employees, who strive to bring our mission to life every day.", "In response to the COVID-19 pandemic, our priority has been, and continues to be, protecting the health and safety of our employees.", "Controlled Substances: We are subject to the operating and security standards of the Drug Enforcement Administration (\u201cDEA\u201d), the U.S.", "Failure to comply with applicable laws, regulations, and government guidance, including but not limited to those involving the regulation of controlled substances, the federal Anti- Kickback Statute, and others, could subject us to federal or state government investigations or qui tam actions, and to liability for damages and civil and criminal penalties, including the loss of licenses or our ability to participate in Medicare, Medicaid and other federal and state healthcare programs, or pursue government contracts.", "Additionally, our operations are subject to regulations under various federal, state, local and foreign laws concerning the environment, including laws addressing the discharge of pollutants into the air and water, the management and disposal of hazardous substances and wastes, and the cleanup of contaminated sites, as discussed in more detail below.", "We could incur substantial costs, including cleanup costs, fines and civil or criminal sanctions, and third-party damage or personal injury claims, if in the future we were to violate or become liable under environmental laws.", "We are committed to maintaining compliance with all environmental laws applicable to our operations, products and services and to reducing our environmental impact across all aspects of our business.", "We meet this commitment through an environmental strategy and sustainability program.", "Although there is no assurance that existing or future environmental laws applicable to our operations or products will not have a material adverse impact on our operations or financial condition, we do not currently anticipate material capital expenditures for environmental matters.", "Other than the expected  expenditures  that  may  be  required  in  connection  with  our  legacy  chemical  distribution  operations,  we  do  not  anticipate  making  substantial  capital expenditures either for environmental issues or to comply with environmental laws, regulations, or government guidance in the future.", "The amount of our capital expenditures for environmental compliance was not material in 2021 and is not expected to be material in the next year.", "We sold our chemical distribution operations in 1987 and retained responsibility for certain environmental obligations.", "Compliance with climate-related laws may be further complicated by disparate regulatory approaches in various jurisdictions.", "New or expanded climate-related laws could impose substantial costs on us.", "Until the timing and extent of climate-related laws are clarified, we cannot predict their potential effect on our capital expenditures or our results of operations.", "Climate Change Regulation: Governments in the U.S. and abroad are considering new or expanded laws to address climate change.", "We experience costly legal disputes, government actions and adverse publicity regarding our role in distributing controlled substances such as opioids.", "We might experience increased costs to distribute controlled substances such as opioids.", "negatively  impact  our  profit  margins  and  the  profit  margins  of  our  customers,  delay  the  introduction  or  implementation  of  our  new  products,  or  otherwise negatively  impact  our business and expose the Company to litigation  and regulatory  investigations.  For example,  we are subject  to many environmental  and hazardous  materials  regulations,  including  those  relating  to  radiation-emitting  equipment  operated  at  U.S.  Oncology  Network  practices.  Additionally,  we  are subject to various routine agency (e.g., Drug Enforcement Administration (\u201cDEA\u201d), the U.S.", "We are subject to extensive and frequently changing local, state and federal laws and regulations relating to healthcare fraud, waste and abuse.", "We might lose our ability to purchase, compound, store or distribute pharmaceuticals and controlled substances.", "For example, we are required to hold valid DEA and state-level registrations and licenses, meet various security and operating standards and comply with the Controlled Substances Act and its accompanying regulations governing the sale, marketing, packaging, holding, distribution, and disposal of controlled substances.", "For example, the COVID-19 pandemic has disrupted the global economy and exacerbated uncertainties inherent in estimates, judgments and assumptions used in our forecasts and impairment assessments.", "These risks are increased by the COVID-19 pandemic.", "We might be adversely impacted by the Brexit withdrawal of the United Kingdom from the European Union.", "We  might  be  adversely  impacted  by  events  outside  of  our  control,  such  as  widespread  public  health  issues,  natural  disasters,  political  events  and  other catastrophic events.", "We may be adversely affected by global climate change or by legal, regulatory or market responses to such change.", "The effects could impair, for example, the availability and cost of certain products, commodities and energy (including utilities), which in turn may impact our ability to procure goods or services required for the operation of our business at the quantities and levels we require.", "We bear losses incurred as a result of, for example, physical damage to or destruction of our facilities (such as distribution or fulfillment centers), loss or spoilage of inventory, and business interruption due to weather events that may be attributable to climate change.", "The long-term effects of climate change are difficult to predict and may be widespread.", "During the second quarter of 2021, we also implemented on-site workplace temperature screening as we continue to adapt our health and safety practices in response to the COVID-19 pandemic.", "These amounts are equivalent to our LIFO reserves.", "In conjunction with the preparation of the accompanying financial statements, we considered matters related to ongoing controlled substances claims to which we are a party.", "During 2021, we appointed the newly created role of chief impact officer, who will drive our strategy and execution related to DEI as well as sustainability, environmental, social, and governance (\u201cESG\u201d), and philanthropy.", "Our vision for a healthier world begins with our employees, who strive to bring our mission to life every day.", "In response to the COVID-19 pandemic, our priority has been, and continues to be, protecting the health and safety of our employees.", "Controlled Substances: We are subject to the operating and security standards of the Drug Enforcement Administration (\u201cDEA\u201d), the U.S.", "Failure to comply with applicable laws, regulations, and government guidance, including but not limited to those involving the regulation of controlled substances, the federal Anti- Kickback Statute, and others, could subject us to federal or state government investigations or qui tam actions, and to liability for damages and civil and criminal penalties, including the loss of licenses or our ability to participate in Medicare, Medicaid and other federal and state healthcare programs, or pursue government contracts.", "Additionally, our operations are subject to regulations under various federal, state, local and foreign laws concerning the environment, including laws addressing the discharge of pollutants into the air and water, the management and disposal of hazardous substances and wastes, and the cleanup of contaminated sites, as discussed in more detail below.", "We could incur substantial costs, including cleanup costs, fines and civil or criminal sanctions, and third-party damage or personal injury claims, if in the future we were to violate or become liable under environmental laws.", "We are committed to maintaining compliance with all environmental laws applicable to our operations, products and services and to reducing our environmental impact across all aspects of our business.", "We meet this commitment through an environmental strategy and sustainability program.", "Although there is no assurance that existing or future environmental laws applicable to our operations or products will not have a material adverse impact on our operations or financial condition, we do not currently anticipate material capital expenditures for environmental matters.", "Other than the expected  expenditures  that  may  be  required  in  connection  with  our  legacy  chemical  distribution  operations,  we  do  not  anticipate  making  substantial  capital expenditures either for environmental issues or to comply with environmental laws, regulations, or government guidance in the future.", "The amount of our capital expenditures for environmental compliance was not material in 2021 and is not expected to be material in the next year.", "We sold our chemical distribution operations in 1987 and retained responsibility for certain environmental obligations.", "Compliance with climate-related laws may be further complicated by disparate regulatory approaches in various jurisdictions.", "New or expanded climate-related laws could impose substantial costs on us.", "Until the timing and extent of climate-related laws are clarified, we cannot predict their potential effect on our capital expenditures or our results of operations.", "Climate Change Regulation: Governments in the U.S. and abroad are considering new or expanded laws to address climate change.", "We experience costly legal disputes, government actions and adverse publicity regarding our role in distributing controlled substances such as opioids.", "We might experience increased costs to distribute controlled substances such as opioids.", "negatively  impact  our  profit  margins  and  the  profit  margins  of  our  customers,  delay  the  introduction  or  implementation  of  our  new  products,  or  otherwise negatively  impact  our business and expose the Company to litigation  and regulatory  investigations.  For example,  we are subject  to many environmental  and hazardous  materials  regulations,  including  those  relating  to  radiation-emitting  equipment  operated  at  U.S.  Oncology  Network  practices.  Additionally,  we  are subject to various routine agency (e.g., Drug Enforcement Administration (\u201cDEA\u201d), the U.S.", "We are subject to extensive and frequently changing local, state and federal laws and regulations relating to healthcare fraud, waste and abuse.", "We might lose our ability to purchase, compound, store or distribute pharmaceuticals and controlled substances.", "For example, we are required to hold valid DEA and state-level registrations and licenses, meet various security and operating standards and comply with the Controlled Substances Act and its accompanying regulations governing the sale, marketing, packaging, holding, distribution, and disposal of controlled substances.", "For example, the COVID-19 pandemic has disrupted the global economy and exacerbated uncertainties inherent in estimates, judgments and assumptions used in our forecasts and impairment assessments.", "These risks are increased by the COVID-19 pandemic.", "We might be adversely impacted by the Brexit withdrawal of the United Kingdom from the European Union.", "We  might  be  adversely  impacted  by  events  outside  of  our  control,  such  as  widespread  public  health  issues,  natural  disasters,  political  events  and  other catastrophic events.", "We may be adversely affected by global climate change or by legal, regulatory or market responses to such change.", "The effects could impair, for example, the availability and cost of certain products, commodities and energy (including utilities), which in turn may impact our ability to procure goods or services required for the operation of our business at the quantities and levels we require.", "We bear losses incurred as a result of, for example, physical damage to or destruction of our facilities (such as distribution or fulfillment centers), loss or spoilage of inventory, and business interruption due to weather events that may be attributable to climate change.", "The long-term effects of climate change are difficult to predict and may be widespread.", "During the second quarter of 2021, we also implemented on-site workplace temperature screening as we continue to adapt our health and safety practices in response to the COVID-19 pandemic.", "These amounts are equivalent to our LIFO reserves.", "In conjunction with the preparation of the accompanying financial statements, we considered matters related to ongoing controlled substances claims to which we are a party.", "During 2021, we appointed the newly created role of chief impact officer, who will drive our strategy and execution related to DEI as well as sustainability, environmental, social, and governance (\u201cESG\u201d), and philanthropy.", "Our vision for a healthier world begins with our employees, who strive to bring our mission to life every day.", "In response to the COVID-19 pandemic, our priority has been, and continues to be, protecting the health and safety of our employees.", "Controlled Substances: We are subject to the operating and security standards of the Drug Enforcement Administration (\u201cDEA\u201d), the U.S.", "Failure to comply with applicable laws, regulations, and government guidance, including but not limited to those involving the regulation of controlled substances, the federal Anti- Kickback Statute, and others, could subject us to federal or state government investigations or qui tam actions, and to liability for damages and civil and criminal penalties, including the loss of licenses or our ability to participate in Medicare, Medicaid and other federal and state healthcare programs, or pursue government contracts.", "Additionally, our operations are subject to regulations under various federal, state, local and foreign laws concerning the environment, including laws addressing the discharge of pollutants into the air and water, the management and disposal of hazardous substances and wastes, and the cleanup of contaminated sites, as discussed in more detail below.", "We could incur substantial costs, including cleanup costs, fines and civil or criminal sanctions, and third-party damage or personal injury claims, if in the future we were to violate or become liable under environmental laws.", "We are committed to maintaining compliance with all environmental laws applicable to our operations, products and services and to reducing our environmental impact across all aspects of our business.", "We meet this commitment through an environmental strategy and sustainability program.", "Although there is no assurance that existing or future environmental laws applicable to our operations or products will not have a material adverse impact on our operations or financial condition, we do not currently anticipate material capital expenditures for environmental matters.", "Other than the expected  expenditures  that  may  be  required  in  connection  with  our  legacy  chemical  distribution  operations,  we  do  not  anticipate  making  substantial  capital expenditures either for environmental issues or to comply with environmental laws, regulations, or government guidance in the future.", "The amount of our capital expenditures for environmental compliance was not material in 2021 and is not expected to be material in the next year.", "We sold our chemical distribution operations in 1987 and retained responsibility for certain environmental obligations.", "Compliance with climate-related laws may be further complicated by disparate regulatory approaches in various jurisdictions.", "New or expanded climate-related laws could impose substantial costs on us.", "Until the timing and extent of climate-related laws are clarified, we cannot predict their potential effect on our capital expenditures or our results of operations.", "Climate Change Regulation: Governments in the U.S. and abroad are considering new or expanded laws to address climate change.", "We experience costly legal disputes, government actions and adverse publicity regarding our role in distributing controlled substances such as opioids.", "We might experience increased costs to distribute controlled substances such as opioids.", "negatively  impact  our  profit  margins  and  the  profit  margins  of  our  customers,  delay  the  introduction  or  implementation  of  our  new  products,  or  otherwise negatively  impact  our business and expose the Company to litigation  and regulatory  investigations.  For example,  we are subject  to many environmental  and hazardous  materials  regulations,  including  those  relating  to  radiation-emitting  equipment  operated  at  U.S.  Oncology  Network  practices.  Additionally,  we  are subject to various routine agency (e.g., Drug Enforcement Administration (\u201cDEA\u201d), the U.S.", "We are subject to extensive and frequently changing local, state and federal laws and regulations relating to healthcare fraud, waste and abuse.", "We might lose our ability to purchase, compound, store or distribute pharmaceuticals and controlled substances.", "For example, we are required to hold valid DEA and state-level registrations and licenses, meet various security and operating standards and comply with the Controlled Substances Act and its accompanying regulations governing the sale, marketing, packaging, holding, distribution, and disposal of controlled substances.", "For example, the COVID-19 pandemic has disrupted the global economy and exacerbated uncertainties inherent in estimates, judgments and assumptions used in our forecasts and impairment assessments.", "These risks are increased by the COVID-19 pandemic.", "We might be adversely impacted by the Brexit withdrawal of the United Kingdom from the European Union.", "We  might  be  adversely  impacted  by  events  outside  of  our  control,  such  as  widespread  public  health  issues,  natural  disasters,  political  events  and  other catastrophic events.", "We may be adversely affected by global climate change or by legal, regulatory or market responses to such change.", "The effects could impair, for example, the availability and cost of certain products, commodities and energy (including utilities), which in turn may impact our ability to procure goods or services required for the operation of our business at the quantities and levels we require.", "We bear losses incurred as a result of, for example, physical damage to or destruction of our facilities (such as distribution or fulfillment centers), loss or spoilage of inventory, and business interruption due to weather events that may be attributable to climate change.", "The long-term effects of climate change are difficult to predict and may be widespread.", "During the second quarter of 2021, we also implemented on-site workplace temperature screening as we continue to adapt our health and safety practices in response to the COVID-19 pandemic.", "These amounts are equivalent to our LIFO reserves.", "In conjunction with the preparation of the accompanying financial statements, we considered matters related to ongoing controlled substances claims to which we are a party.", "During 2021, we appointed the newly created role of chief impact officer, who will drive our strategy and execution related to DEI as well as sustainability, environmental, social, and governance (\u201cESG\u201d), and philanthropy.", "Our vision for a healthier world begins with our employees, who strive to bring our mission to life every day.", "In response to the COVID-19 pandemic, our priority has been, and continues to be, protecting the health and safety of our employees.", "Controlled Substances: We are subject to the operating and security standards of the Drug Enforcement Administration (\u201cDEA\u201d), the U.S.", "Failure to comply with applicable laws, regulations, and government guidance, including but not limited to those involving the regulation of controlled substances, the federal Anti- Kickback Statute, and others, could subject us to federal or state government investigations or qui tam actions, and to liability for damages and civil and criminal penalties, including the loss of licenses or our ability to participate in Medicare, Medicaid and other federal and state healthcare programs, or pursue government contracts.", "Additionally, our operations are subject to regulations under various federal, state, local and foreign laws concerning the environment, including laws addressing the discharge of pollutants into the air and water, the management and disposal of hazardous substances and wastes, and the cleanup of contaminated sites, as discussed in more detail below.", "We could incur substantial costs, including cleanup costs, fines and civil or criminal sanctions, and third-party damage or personal injury claims, if in the future we were to violate or become liable under environmental laws.", "We are committed to maintaining compliance with all environmental laws applicable to our operations, products and services and to reducing our environmental impact across all aspects of our business.", "We meet this commitment through an environmental strategy and sustainability program.", "Although there is no assurance that existing or future environmental laws applicable to our operations or products will not have a material adverse impact on our operations or financial condition, we do not currently anticipate material capital expenditures for environmental matters.", "Other than the expected  expenditures  that  may  be  required  in  connection  with  our  legacy  chemical  distribution  operations,  we  do  not  anticipate  making  substantial  capital expenditures either for environmental issues or to comply with environmental laws, regulations, or government guidance in the future.", "The amount of our capital expenditures for environmental compliance was not material in 2021 and is not expected to be material in the next year.", "We sold our chemical distribution operations in 1987 and retained responsibility for certain environmental obligations.", "Compliance with climate-related laws may be further complicated by disparate regulatory approaches in various jurisdictions.", "New or expanded climate-related laws could impose substantial costs on us.", "Until the timing and extent of climate-related laws are clarified, we cannot predict their potential effect on our capital expenditures or our results of operations.", "Climate Change Regulation: Governments in the U.S. and abroad are considering new or expanded laws to address climate change.", "We experience costly legal disputes, government actions and adverse publicity regarding our role in distributing controlled substances such as opioids.", "We might experience increased costs to distribute controlled substances such as opioids.", "negatively  impact  our  profit  margins  and  the  profit  margins  of  our  customers,  delay  the  introduction  or  implementation  of  our  new  products,  or  otherwise negatively  impact  our business and expose the Company to litigation  and regulatory  investigations.  For example,  we are subject  to many environmental  and hazardous  materials  regulations,  including  those  relating  to  radiation-emitting  equipment  operated  at  U.S.  Oncology  Network  practices.  Additionally,  we  are subject to various routine agency (e.g., Drug Enforcement Administration (\u201cDEA\u201d), the U.S.", "We are subject to extensive and frequently changing local, state and federal laws and regulations relating to healthcare fraud, waste and abuse.", "We might lose our ability to purchase, compound, store or distribute pharmaceuticals and controlled substances.", "For example, we are required to hold valid DEA and state-level registrations and licenses, meet various security and operating standards and comply with the Controlled Substances Act and its accompanying regulations governing the sale, marketing, packaging, holding, distribution, and disposal of controlled substances.", "For example, the COVID-19 pandemic has disrupted the global economy and exacerbated uncertainties inherent in estimates, judgments and assumptions used in our forecasts and impairment assessments.", "These risks are increased by the COVID-19 pandemic.", "We might be adversely impacted by the Brexit withdrawal of the United Kingdom from the European Union.", "We  might  be  adversely  impacted  by  events  outside  of  our  control,  such  as  widespread  public  health  issues,  natural  disasters,  political  events  and  other catastrophic events.", "We may be adversely affected by global climate change or by legal, regulatory or market responses to such change.", "The effects could impair, for example, the availability and cost of certain products, commodities and energy (including utilities), which in turn may impact our ability to procure goods or services required for the operation of our business at the quantities and levels we require.", "We bear losses incurred as a result of, for example, physical damage to or destruction of our facilities (such as distribution or fulfillment centers), loss or spoilage of inventory, and business interruption due to weather events that may be attributable to climate change.", "The long-term effects of climate change are difficult to predict and may be widespread.", "During the second quarter of 2021, we also implemented on-site workplace temperature screening as we continue to adapt our health and safety practices in response to the COVID-19 pandemic.", "These amounts are equivalent to our LIFO reserves.", "In conjunction with the preparation of the accompanying financial statements, we considered matters related to ongoing controlled substances claims to which we are a party.", "During 2021, we appointed the newly created role of chief impact officer, who will drive our strategy and execution related to DEI as well as sustainability, environmental, social, and governance (\u201cESG\u201d), and philanthropy.", "Our vision for a healthier world begins with our employees, who strive to bring our mission to life every day.", "In response to the COVID-19 pandemic, our priority has been, and continues to be, protecting the health and safety of our employees.", "Controlled Substances: We are subject to the operating and security standards of the Drug Enforcement Administration (\u201cDEA\u201d), the U.S.", "Failure to comply with applicable laws, regulations, and government guidance, including but not limited to those involving the regulation of controlled substances, the federal Anti- Kickback Statute, and others, could subject us to federal or state government investigations or qui tam actions, and to liability for damages and civil and criminal penalties, including the loss of licenses or our ability to participate in Medicare, Medicaid and other federal and state healthcare programs, or pursue government contracts.", "Additionally, our operations are subject to regulations under various federal, state, local and foreign laws concerning the environment, including laws addressing the discharge of pollutants into the air and water, the management and disposal of hazardous substances and wastes, and the cleanup of contaminated sites, as discussed in more detail below.", "We could incur substantial costs, including cleanup costs, fines and civil or criminal sanctions, and third-party damage or personal injury claims, if in the future we were to violate or become liable under environmental laws.", "We are committed to maintaining compliance with all environmental laws applicable to our operations, products and services and to reducing our environmental impact across all aspects of our business.", "We meet this commitment through an environmental strategy and sustainability program.", "Although there is no assurance that existing or future environmental laws applicable to our operations or products will not have a material adverse impact on our operations or financial condition, we do not currently anticipate material capital expenditures for environmental matters.", "Other than the expected  expenditures  that  may  be  required  in  connection  with  our  legacy  chemical  distribution  operations,  we  do  not  anticipate  making  substantial  capital expenditures either for environmental issues or to comply with environmental laws, regulations, or government guidance in the future.", "The amount of our capital expenditures for environmental compliance was not material in 2021 and is not expected to be material in the next year.", "We sold our chemical distribution operations in 1987 and retained responsibility for certain environmental obligations.", "Compliance with climate-related laws may be further complicated by disparate regulatory approaches in various jurisdictions.", "New or expanded climate-related laws could impose substantial costs on us.", "Until the timing and extent of climate-related laws are clarified, we cannot predict their potential effect on our capital expenditures or our results of operations.", "Climate Change Regulation: Governments in the U.S. and abroad are considering new or expanded laws to address climate change.", "We experience costly legal disputes, government actions and adverse publicity regarding our role in distributing controlled substances such as opioids.", "We might experience increased costs to distribute controlled substances such as opioids.", "negatively  impact  our  profit  margins  and  the  profit  margins  of  our  customers,  delay  the  introduction  or  implementation  of  our  new  products,  or  otherwise negatively  impact  our business and expose the Company to litigation  and regulatory  investigations.  For example,  we are subject  to many environmental  and hazardous  materials  regulations,  including  those  relating  to  radiation-emitting  equipment  operated  at  U.S.  Oncology  Network  practices.  Additionally,  we  are subject to various routine agency (e.g., Drug Enforcement Administration (\u201cDEA\u201d), the U.S.", "We are subject to extensive and frequently changing local, state and federal laws and regulations relating to healthcare fraud, waste and abuse.", "We might lose our ability to purchase, compound, store or distribute pharmaceuticals and controlled substances.", "For example, we are required to hold valid DEA and state-level registrations and licenses, meet various security and operating standards and comply with the Controlled Substances Act and its accompanying regulations governing the sale, marketing, packaging, holding, distribution, and disposal of controlled substances.", "For example, the COVID-19 pandemic has disrupted the global economy and exacerbated uncertainties inherent in estimates, judgments and assumptions used in our forecasts and impairment assessments.", "These risks are increased by the COVID-19 pandemic.", "We might be adversely impacted by the Brexit withdrawal of the United Kingdom from the European Union.", "We  might  be  adversely  impacted  by  events  outside  of  our  control,  such  as  widespread  public  health  issues,  natural  disasters,  political  events  and  other catastrophic events.", "We may be adversely affected by global climate change or by legal, regulatory or market responses to such change.", "The effects could impair, for example, the availability and cost of certain products, commodities and energy (including utilities), which in turn may impact our ability to procure goods or services required for the operation of our business at the quantities and levels we require.", "We bear losses incurred as a result of, for example, physical damage to or destruction of our facilities (such as distribution or fulfillment centers), loss or spoilage of inventory, and business interruption due to weather events that may be attributable to climate change.", "The long-term effects of climate change are difficult to predict and may be widespread.", "During the second quarter of 2021, we also implemented on-site workplace temperature screening as we continue to adapt our health and safety practices in response to the COVID-19 pandemic.", "These amounts are equivalent to our LIFO reserves.", "In conjunction with the preparation of the accompanying financial statements, we considered matters related to ongoing controlled substances claims to which we are a party.", "During 2021, we appointed the newly created role of chief impact officer, who will drive our strategy and execution related to DEI as well as sustainability, environmental, social, and governance (\u201cESG\u201d), and philanthropy.", "Our vision for a healthier world begins with our employees, who strive to bring our mission to life every day.", "In response to the COVID-19 pandemic, our priority has been, and continues to be, protecting the health and safety of our employees.", "Controlled Substances: We are subject to the operating and security standards of the Drug Enforcement Administration (\u201cDEA\u201d), the U.S.", "Failure to comply with applicable laws, regulations, and government guidance, including but not limited to those involving the regulation of controlled substances, the federal Anti- Kickback Statute, and others, could subject us to federal or state government investigations or qui tam actions, and to liability for damages and civil and criminal penalties, including the loss of licenses or our ability to participate in Medicare, Medicaid and other federal and state healthcare programs, or pursue government contracts.", "Additionally, our operations are subject to regulations under various federal, state, local and foreign laws concerning the environment, including laws addressing the discharge of pollutants into the air and water, the management and disposal of hazardous substances and wastes, and the cleanup of contaminated sites, as discussed in more detail below.", "We could incur substantial costs, including cleanup costs, fines and civil or criminal sanctions, and third-party damage or personal injury claims, if in the future we were to violate or become liable under environmental laws.", "We are committed to maintaining compliance with all environmental laws applicable to our operations, products and services and to reducing our environmental impact across all aspects of our business.", "We meet this commitment through an environmental strategy and sustainability program.", "Although there is no assurance that existing or future environmental laws applicable to our operations or products will not have a material adverse impact on our operations or financial condition, we do not currently anticipate material capital expenditures for environmental matters.", "Other than the expected  expenditures  that  may  be  required  in  connection  with  our  legacy  chemical  distribution  operations,  we  do  not  anticipate  making  substantial  capital expenditures either for environmental issues or to comply with environmental laws, regulations, or government guidance in the future.", "The amount of our capital expenditures for environmental compliance was not material in 2021 and is not expected to be material in the next year.", "We sold our chemical distribution operations in 1987 and retained responsibility for certain environmental obligations.", "Compliance with climate-related laws may be further complicated by disparate regulatory approaches in various jurisdictions.", "New or expanded climate-related laws could impose substantial costs on us.", "Until the timing and extent of climate-related laws are clarified, we cannot predict their potential effect on our capital expenditures or our results of operations.", "Climate Change Regulation: Governments in the U.S. and abroad are considering new or expanded laws to address climate change.", "We experience costly legal disputes, government actions and adverse publicity regarding our role in distributing controlled substances such as opioids.", "We might experience increased costs to distribute controlled substances such as opioids.", "negatively  impact  our  profit  margins  and  the  profit  margins  of  our  customers,  delay  the  introduction  or  implementation  of  our  new  products,  or  otherwise negatively  impact  our business and expose the Company to litigation  and regulatory  investigations.  For example,  we are subject  to many environmental  and hazardous  materials  regulations,  including  those  relating  to  radiation-emitting  equipment  operated  at  U.S.  Oncology  Network  practices.  Additionally,  we  are subject to various routine agency (e.g., Drug Enforcement Administration (\u201cDEA\u201d), the U.S.", "We are subject to extensive and frequently changing local, state and federal laws and regulations relating to healthcare fraud, waste and abuse.", "We might lose our ability to purchase, compound, store or distribute pharmaceuticals and controlled substances.", "For example, we are required to hold valid DEA and state-level registrations and licenses, meet various security and operating standards and comply with the Controlled Substances Act and its accompanying regulations governing the sale, marketing, packaging, holding, distribution, and disposal of controlled substances.", "For example, the COVID-19 pandemic has disrupted the global economy and exacerbated uncertainties inherent in estimates, judgments and assumptions used in our forecasts and impairment assessments.", "These risks are increased by the COVID-19 pandemic.", "We might be adversely impacted by the Brexit withdrawal of the United Kingdom from the European Union.", "We  might  be  adversely  impacted  by  events  outside  of  our  control,  such  as  widespread  public  health  issues,  natural  disasters,  political  events  and  other catastrophic events.", "We may be adversely affected by global climate change or by legal, regulatory or market responses to such change.", "The effects could impair, for example, the availability and cost of certain products, commodities and energy (including utilities), which in turn may impact our ability to procure goods or services required for the operation of our business at the quantities and levels we require.", "We bear losses incurred as a result of, for example, physical damage to or destruction of our facilities (such as distribution or fulfillment centers), loss or spoilage of inventory, and business interruption due to weather events that may be attributable to climate change.", "The long-term effects of climate change are difficult to predict and may be widespread.", "During the second quarter of 2021, we also implemented on-site workplace temperature screening as we continue to adapt our health and safety practices in response to the COVID-19 pandemic.", "These amounts are equivalent to our LIFO reserves.", "In conjunction with the preparation of the accompanying financial statements, we considered matters related to ongoing controlled substances claims to which we are a party.", "During 2021, we appointed the newly created role of chief impact officer, who will drive our strategy and execution related to DEI as well as sustainability, environmental, social, and governance (\u201cESG\u201d), and philanthropy.", "Our vision for a healthier world begins with our employees, who strive to bring our mission to life every day.", "In response to the COVID-19 pandemic, our priority has been, and continues to be, protecting the health and safety of our employees.", "Controlled Substances: We are subject to the operating and security standards of the Drug Enforcement Administration (\u201cDEA\u201d), the U.S.", "Failure to comply with applicable laws, regulations, and government guidance, including but not limited to those involving the regulation of controlled substances, the federal Anti- Kickback Statute, and others, could subject us to federal or state government investigations or qui tam actions, and to liability for damages and civil and criminal penalties, including the loss of licenses or our ability to participate in Medicare, Medicaid and other federal and state healthcare programs, or pursue government contracts.", "Additionally, our operations are subject to regulations under various federal, state, local and foreign laws concerning the environment, including laws addressing the discharge of pollutants into the air and water, the management and disposal of hazardous substances and wastes, and the cleanup of contaminated sites, as discussed in more detail below.", "We could incur substantial costs, including cleanup costs, fines and civil or criminal sanctions, and third-party damage or personal injury claims, if in the future we were to violate or become liable under environmental laws.", "We are committed to maintaining compliance with all environmental laws applicable to our operations, products and services and to reducing our environmental impact across all aspects of our business.", "We meet this commitment through an environmental strategy and sustainability program.", "Although there is no assurance that existing or future environmental laws applicable to our operations or products will not have a material adverse impact on our operations or financial condition, we do not currently anticipate material capital expenditures for environmental matters.", "Other than the expected  expenditures  that  may  be  required  in  connection  with  our  legacy  chemical  distribution  operations,  we  do  not  anticipate  making  substantial  capital expenditures either for environmental issues or to comply with environmental laws, regulations, or government guidance in the future.", "The amount of our capital expenditures for environmental compliance was not material in 2021 and is not expected to be material in the next year.", "We sold our chemical distribution operations in 1987 and retained responsibility for certain environmental obligations.", "Compliance with climate-related laws may be further complicated by disparate regulatory approaches in various jurisdictions.", "New or expanded climate-related laws could impose substantial costs on us.", "Until the timing and extent of climate-related laws are clarified, we cannot predict their potential effect on our capital expenditures or our results of operations.", "Climate Change Regulation: Governments in the U.S. and abroad are considering new or expanded laws to address climate change.", "We experience costly legal disputes, government actions and adverse publicity regarding our role in distributing controlled substances such as opioids.", "We might experience increased costs to distribute controlled substances such as opioids.", "negatively  impact  our  profit  margins  and  the  profit  margins  of  our  customers,  delay  the  introduction  or  implementation  of  our  new  products,  or  otherwise negatively  impact  our business and expose the Company to litigation  and regulatory  investigations.  For example,  we are subject  to many environmental  and hazardous  materials  regulations,  including  those  relating  to  radiation-emitting  equipment  operated  at  U.S.  Oncology  Network  practices.  Additionally,  we  are subject to various routine agency (e.g., Drug Enforcement Administration (\u201cDEA\u201d), the U.S.", "We are subject to extensive and frequently changing local, state and federal laws and regulations relating to healthcare fraud, waste and abuse.", "We might lose our ability to purchase, compound, store or distribute pharmaceuticals and controlled substances.", "For example, we are required to hold valid DEA and state-level registrations and licenses, meet various security and operating standards and comply with the Controlled Substances Act and its accompanying regulations governing the sale, marketing, packaging, holding, distribution, and disposal of controlled substances.", "For example, the COVID-19 pandemic has disrupted the global economy and exacerbated uncertainties inherent in estimates, judgments and assumptions used in our forecasts and impairment assessments.", "These risks are increased by the COVID-19 pandemic.", "We might be adversely impacted by the Brexit withdrawal of the United Kingdom from the European Union.", "We  might  be  adversely  impacted  by  events  outside  of  our  control,  such  as  widespread  public  health  issues,  natural  disasters,  political  events  and  other catastrophic events.", "We may be adversely affected by global climate change or by legal, regulatory or market responses to such change.", "The effects could impair, for example, the availability and cost of certain products, commodities and energy (including utilities), which in turn may impact our ability to procure goods or services required for the operation of our business at the quantities and levels we require.", "We bear losses incurred as a result of, for example, physical damage to or destruction of our facilities (such as distribution or fulfillment centers), loss or spoilage of inventory, and business interruption due to weather events that may be attributable to climate change.", "The long-term effects of climate change are difficult to predict and may be widespread.", "During the second quarter of 2021, we also implemented on-site workplace temperature screening as we continue to adapt our health and safety practices in response to the COVID-19 pandemic.", "These amounts are equivalent to our LIFO reserves.", "In conjunction with the preparation of the accompanying financial statements, we considered matters related to ongoing controlled substances claims to which we are a party.", "During 2021, we appointed the newly created role of chief impact officer, who will drive our strategy and execution related to DEI as well as sustainability, environmental, social, and governance (\u201cESG\u201d), and philanthropy.", "Our vision for a healthier world begins with our employees, who strive to bring our mission to life every day.", "In response to the COVID-19 pandemic, our priority has been, and continues to be, protecting the health and safety of our employees.", "Controlled Substances: We are subject to the operating and security standards of the Drug Enforcement Administration (\u201cDEA\u201d), the U.S.", "Failure to comply with applicable laws, regulations, and government guidance, including but not limited to those involving the regulation of controlled substances, the federal Anti- Kickback Statute, and others, could subject us to federal or state government investigations or qui tam actions, and to liability for damages and civil and criminal penalties, including the loss of licenses or our ability to participate in Medicare, Medicaid and other federal and state healthcare programs, or pursue government contracts.", "Additionally, our operations are subject to regulations under various federal, state, local and foreign laws concerning the environment, including laws addressing the discharge of pollutants into the air and water, the management and disposal of hazardous substances and wastes, and the cleanup of contaminated sites, as discussed in more detail below.", "We could incur substantial costs, including cleanup costs, fines and civil or criminal sanctions, and third-party damage or personal injury claims, if in the future we were to violate or become liable under environmental laws.", "We are committed to maintaining compliance with all environmental laws applicable to our operations, products and services and to reducing our environmental impact across all aspects of our business.", "We meet this commitment through an environmental strategy and sustainability program.", "Although there is no assurance that existing or future environmental laws applicable to our operations or products will not have a material adverse impact on our operations or financial condition, we do not currently anticipate material capital expenditures for environmental matters.", "Other than the expected  expenditures  that  may  be  required  in  connection  with  our  legacy  chemical  distribution  operations,  we  do  not  anticipate  making  substantial  capital expenditures either for environmental issues or to comply with environmental laws, regulations, or government guidance in the future.", "The amount of our capital expenditures for environmental compliance was not material in 2021 and is not expected to be material in the next year.", "We sold our chemical distribution operations in 1987 and retained responsibility for certain environmental obligations.", "Compliance with climate-related laws may be further complicated by disparate regulatory approaches in various jurisdictions.", "New or expanded climate-related laws could impose substantial costs on us.", "Until the timing and extent of climate-related laws are clarified, we cannot predict their potential effect on our capital expenditures or our results of operations.", "Climate Change Regulation: Governments in the U.S. and abroad are considering new or expanded laws to address climate change.", "We experience costly legal disputes, government actions and adverse publicity regarding our role in distributing controlled substances such as opioids.", "We might experience increased costs to distribute controlled substances such as opioids.", "negatively  impact  our  profit  margins  and  the  profit  margins  of  our  customers,  delay  the  introduction  or  implementation  of  our  new  products,  or  otherwise negatively  impact  our business and expose the Company to litigation  and regulatory  investigations.  For example,  we are subject  to many environmental  and hazardous  materials  regulations,  including  those  relating  to  radiation-emitting  equipment  operated  at  U.S.  Oncology  Network  practices.  Additionally,  we  are subject to various routine agency (e.g., Drug Enforcement Administration (\u201cDEA\u201d), the U.S.", "We are subject to extensive and frequently changing local, state and federal laws and regulations relating to healthcare fraud, waste and abuse.", "We might lose our ability to purchase, compound, store or distribute pharmaceuticals and controlled substances.", "For example, we are required to hold valid DEA and state-level registrations and licenses, meet various security and operating standards and comply with the Controlled Substances Act and its accompanying regulations governing the sale, marketing, packaging, holding, distribution, and disposal of controlled substances.", "For example, the COVID-19 pandemic has disrupted the global economy and exacerbated uncertainties inherent in estimates, judgments and assumptions used in our forecasts and impairment assessments.", "These risks are increased by the COVID-19 pandemic.", "We might be adversely impacted by the Brexit withdrawal of the United Kingdom from the European Union.", "We  might  be  adversely  impacted  by  events  outside  of  our  control,  such  as  widespread  public  health  issues,  natural  disasters,  political  events  and  other catastrophic events.", "We may be adversely affected by global climate change or by legal, regulatory or market responses to such change.", "The effects could impair, for example, the availability and cost of certain products, commodities and energy (including utilities), which in turn may impact our ability to procure goods or services required for the operation of our business at the quantities and levels we require.", "We bear losses incurred as a result of, for example, physical damage to or destruction of our facilities (such as distribution or fulfillment centers), loss or spoilage of inventory, and business interruption due to weather events that may be attributable to climate change.", "The long-term effects of climate change are difficult to predict and may be widespread.", "During the second quarter of 2021, we also implemented on-site workplace temperature screening as we continue to adapt our health and safety practices in response to the COVID-19 pandemic.", "These amounts are equivalent to our LIFO reserves.", "In conjunction with the preparation of the accompanying financial statements, we considered matters related to ongoing controlled substances claims to which we are a party."], "Social": ["Together, we work across the healthcare delivery system to connect pharmacies, providers, payers, and biopharma for next-generation patient access and adherence solutions that help people get the medicine they need to live healthier lives.", "Unless otherwise noted, all references in this document to a particular year shall mean the", "On March 10, 2020, we completed the separation of our interest in the Change Healthcare JV through a split- off transaction.", "This transaction reduced our investment in the Change Healthcare JV to zero.", "Change Healthcare: Our equity ownership interest in Change Healthcare JV, a joint venture, has been accounted for using the equity method of accounting.", "for our innovations and obtain copyright protection for our original works of authorship, when such protection is advantageous.", "Through these efforts, we have developed a portfolio of patents and copyrights in the U.S. and worldwide.", "In addition, we have registered or applied to register certain trademarks and service marks in the U.S. and in foreign countries.", "We cannot guarantee that our intellectual property portfolio will be sufficient to deter misappropriation, theft, or misuse of our technology, nor that we can successfully enjoin infringers.", "We periodically receive notices alleging that our products or services infringe on third party patents and other intellectual property rights.", "While the outcome of any litigation or dispute is inherently uncertain, we do not believe that the resolution of any of these infringement notices would have a material adverse impact on our results of operation.", "These values and behaviors help make McKesson unique.", "We offer financial assistance programs for higher education opportunities that support employees\u2019 career growth at the company.", "To provide compensation that is focused on attracting and retaining talent with the skills and experience necessary for a specific role, our compensation program is built on a set of quantifiable factors defined by our guiding principles of internal fairness, market competitiveness, and pay for performance.", "We operate in several countries and our benefits offerings vary accordingly.", "We offer health and wellness benefits to advance the physical, mental, and social well-being of our people, savings programs to help prepare them for retirement, and flexible work arrangements, among other  benefits  offerings,  when  possible.  In  response  to  the  COVID-19  pandemic,  we  offered  extended  medical  benefits  covering  COVID-19  related  visits, treatment and testing, expanded telehealth options, emergency paid time off (\u201cPTO\u201d), and a platform for employees to donate their regular PTO to co-workers who were  more  impacted  by  COVID-19.", "We have received monetary penalties and/or licensing sanctions pursuant to these requirements and future allegations of noncompliance could result in an inability to obtain, maintain or renew permits, licenses or other regulatory approvals needed for the operation of our businesses.", "As a result of ongoing, advanced discussions with state attorneys general and plaintiffs\u2019 representatives regarding a framework to resolve the claims of governmental entities, and our assessment of certain other opioid-related claims, we have reached a stage at which a broad settlement of opioid claims by governmental entities is probable and recorded a charge of $8.1 billion for the year ended March 31, 2021 within \u201cClaims and litigation charges, net\u201d in our Consolidated Statement of Operations in this Annual Report on Form 10-K.", "Because of the many uncertainties associated with any potential settlement arrangement or other resolution of opioid-related litigation, including the uncertainty of the scope of participation by plaintiffs in any potential settlement, we are not able to reasonably estimate the upper or lower ends of the range of ultimate possible loss for all opioid-related litigation matters.", "The adverse outcome of legal proceedings might also involve significant  expense,  management  time  and  distraction,  and risk  of loss that  can be difficult  to predict  or quantify.  In addition  to this litigation,  legislative  or regulatory measures related to the distribution of controlled substances such as prescription opioids could affect our business in ways that we may not be able to predict.", "For example, some states have passed legislation that could require us to pay taxes or assessments on the distribution of opioid medications in those states and other states have considered similar legislation.", "We are subject to government audits,  investigations  and  oversight  proceedings.  Government  agencies  routinely  review  and  audit  government  contractors  to  determine  whether  they  are complying with contractual and legal requirements.", "If we fail to comply with these requirements, or we fail an audit, we may be subject to various sanctions such as monetary damages, criminal and civil penalties, termination of contracts and suspension or debarment from government contract work.", "These requirements complicate our business and increase our compliance burden and material non-compliance could harm our reputation.", "affecting  Medicare,  Medicaid,  other  government  healthcare  programs,  and  government  contracts.  Our  relationships  with  pharmaceutical  and  medical  surgical product manufacturers and healthcare providers, as well as our provision of products and services to government entities, subject our business to laws, regulation, and government guidance on fraud and abuse.", "Many of these laws are vague or indefinite and have not been interpreted by the courts and, as such, may be interpreted or applied by a prosecutorial, regulatory, or judicial authority in a manner that could require us to make changes in our operations.", "Americans and changed the way healthcare is financed by both governmental and private payers.", "There are also further efforts to broaden healthcare coverage.", "Provincial governments in Canada that provide partial funding for the purchase of pharmaceuticals and independently regulate the sale and reimbursement of drugs have sought to reduce the costs of publicly funded health programs.", "Some European governments  have  implemented  or  are  considering  austerity  measures  to  reduce  healthcare  spending.  These  measures  exert  pressure  on  the  pricing  and reimbursement timelines for pharmaceuticals and may cause our customers to purchase fewer of our products and services or influence us to reduce prices.", "There is substantial uncertainty about the likelihood, timing and results of these health reform efforts.", "We also have record- keeping  and  other  obligations  under  the  E.U.  Falsified  Medicines  Directive.  Pedigree  tracking  laws  such  as  these  increase  our  compliance  burden  and  our pharmaceutical distribution costs.", "For example, under the Health Insurance Portability and Accountability Act of 1996 (\u201cHIPAA\u201d) we must maintain administrative, physical  and  technological  safeguards  to  protect  individually  identifiable  health  information  (\u201cprotected  health  information\u201d)  and  ensure  the  confidentiality, integrity, and availability of electronic protected health information.", "We are subject to significant compliance obligations under privacy laws such as the General Data Protection Regulation (\u201cGDPR\u201d) in the European Union, the Personal Information Protection and Electronic Documents Act (\u201cPIPEDA\u201d) in Canada, and the California Consumer Protection Act (\u201cCCPA\u201d).", "We are subject to privacy  and  data  protection  compliance  audits  or  investigations  by  various  government  agencies.  Failure  to  comply  with  these  laws  subjects  us  to  potential regulatory enforcement activity, fines, private litigation including class actions, and other costs.", "We also have contractual obligations to customers that might be breached if we fail to comply with privacy laws.", "Our efforts to comply with privacy laws complicate our operations and add to our compliance costs.", "storage and hosting of sensitive information, including protected health information and other types of personal information, confidential financial information, proprietary information, and other sensitive information relating to our customers, company and workforce.", "costs.  Environmental  costs  and  accruals,  including  that  related  to  our  legacy  chemical  distribution  operations,  presently  are  not  material  to our  operations  or financial position.", "Our ten largest customers comprised approximately 32%, and CVS was approximately 19%, of total trade accounts receivable at March 31, 2021.", "We also have agreements with GPOs, each of which functions as a purchasing agent on behalf of member  hospitals,  pharmacies  and other healthcare  providers,  as well as with government  entities  and agencies.  The accounts receivable balances are with individual members of the GPOs, and therefore no significant concentration of credit risk exists.", "Substantially all of these revenues and accounts receivable are included in our U.S.", "distribution arrangements with pharmaceutical manufacturers that include an inflation-based compensation component whereby we benefit when the manufacturers increase their prices as we sell our existing inventory at the new higher prices.", "Forward-looking  statements  involve  risks  and  uncertainties  that  could  cause  actual  results  to  differ  materially  from  those  projected,  anticipated,  or  implied.", "Except to the extent required by federal securities laws, we undertake no obligation to publicly release the result of any revisions to any forward-looking statements to reflect events or circumstances after the date the statements are made, or to reflect the occurrence of unanticipated events.", "Some of our distribution arrangements with the manufacturers provides us compensation based on a percentage of our purchases.", "We experience costly and disruptive legal disputes.", "Despite valid defenses that we assert, legal disputes are often costly, time-consuming, distracting to management and disruptive to normal business operations.", "The outcome of legal disputes is difficult to predict.", "Outcomes can occur that are not justified by the evidence or existing law.", "The uncertainty and expense associated with unresolved legal disputes might harm our business and reputation even if the matter is favorably resolved.", "Accordingly, any legal dispute might have a materially adverse impact on our reputation, our business operations and our financial position or results of operations.", "We might experience losses not covered by insurance.", "supplies, the provision of ancillary services, the conduct of our payer businesses and the provision of products that assist clinical decision-making and relate to patient medical histories and treatment plans.", "Although we seek to maintain adequate insurance coverage,  such  as  property  insurance  for  inventory  and  professional  and  general  liability  insurance,  coverages  on  acceptable  terms  might  be  unavailable,  or coverages might not cover our losses.", "We generally seek to limit our contractual exposure, but limitations of liability or indemnity provisions in our contracts may not be enforceable or adequately protect us from liability.", "Uninsured losses might have a materially adverse impact on our business operations and our financial position or results of operations.", "We regularly are named as a defendant in similar, new cases.", "Many of these cases raise novel theories of liability.", "Any proceedings can have unexpected outcomes that are not justified by evidence or existing law.", "It is not uncommon for claims to be resolved over many years.", "Although the Company has valid defenses and is vigorously defending itself, some proceedings have been and others may be resolved by negotiated outcome.", "Our reputation has been and may continue to be impacted by publicity regarding the litigation and related allegations.", "The adverse outcome of legal proceedings might have a materially adverse impact on our business operations and our financial position or results of operations.", "For example, some states have passed legislation that could require us to pay taxes or assessments on the distribution of opioid medications in those states and other states have considered similar legislation.", "Liabilities for taxes or assessments or other costs of compliance under any such laws might have a materially adverse impact on our reputation, business operations, and our financial position or results of operations.", "We are subject to extensive, complex and challenging healthcare and other laws.", "Any noncompliance by us with applicable laws or the failure to maintain, renew or obtain necessary permits and licenses could lead to litigation and might have a materially adverse impact on our business operations and our financial position or results of operations.", "Local, state and federal governments continue to strengthen their position and scrutiny over practices involving or allegedly involving fraud, waste and abuse affecting Medicare, Medicaid and other government healthcare programs.", "Our relationships with pharmaceutical and medical surgical product manufacturers and healthcare providers, as well as our provision of products and services to government entities, subject our business to laws and regulations on fraud and abuse, which among other things: (1) prohibit persons from soliciting, offering, receiving or paying any remuneration in order to induce the referral of a patient for treatment  or  to  induce  the  ordering  or  purchasing  of  items  or  services  that  are  in  any  way  paid  for  by  Medicare,  Medicaid  or  other  government-sponsored healthcare programs; (2) impose many restrictions upon referring physicians and providers of designated health services under Medicare and Medicaid programs; and (3) prohibit the knowing submission of a false or fraudulent claim for payment to, and knowing retention of an overpayment by, a federal healthcare program such  as  Medicare  and  Medicaid.  Many  of  these  laws,  regulations,  and  government  guidance,  including  those  relating  to  marketing  incentives,  are  vague  or indefinite and have not been interpreted by the courts.", "The laws may be interpreted or applied by a prosecutorial, regulatory, or judicial authority in a manner that could require us to make changes in our operations.", "Failures to comply with applicable laws subject us to federal or state government investigations or qui tam actions, and to liability for damages and civil and criminal penalties, including the loss of licenses or our ability to participate in Medicare, Medicaid and other federal and state healthcare programs.", "These sanctions might have a materially adverse impact on our business operations and our financial position or results of operations.", "Noncompliance with these requirements has resulted in monetary penalties and/or licensing sanctions.", "For example, under a January 2017 agreement with the DEA and Department of Justice we paid $150 million to settle potential administrative and civil claims about our practices for reporting suspicious orders of controlled substances and the DEA suspended, on a staggered basis for limited periods of time, our registrations to distribute certain controlled substances from four distribution centers.", "Pedigree tracking laws increase our compliance burden and our pharmaceutical distribution costs.", "Pedigree tracking laws such as these increase our compliance burden and our pharmaceutical distribution costs, and they might have a materially adverse impact on our business operations and our financial position or results of operations.", "Privacy and data protection laws increase our compliance burden.", "example,  under  the  Health  Insurance  Portability  and  Accountability  Act  of  1996  (\u201cHIPAA\u201d)  we  must  maintain  administrative,  physical  and  technological safeguards  to  protect  individually  identifiable  health  information  (\u201cprotected  health  information\u201d)  and  ensure  the  confidentiality,  integrity  and  availability  of electronic protected health information.", "Failure to comply with these laws subjects us to potential regulatory enforcement activity, fines, private litigation including class actions, and other costs.", "We also have contractual obligations to customers that might be breached if we fail to comply with privacy laws.", "Our efforts to comply with privacy laws complicates our operations and adds to our compliance costs.", "A significant privacy breach or failure  to  comply  with  privacy  laws  might  have  a  materially  adverse  impact  on  our  reputation,  business  operations  and  our  financial  position  or  results  of operations.", "Anti-bribery and anti-corruption laws increase our compliance burden.", "Bribery Act unless the organization can establish the defense of having implemented adequate procedures to prevent bribery.", "Our failure to comply with these laws might subject us to civil and criminal penalties that might have a materially adverse impact on our reputation, business operations and our financial position or results of operations.", "We are subject to a variety of privacy and data protection laws that change frequently and have requirements that vary from jurisdiction to jurisdiction.", "We  are  subject  to  laws  prohibiting  improper  payments  and  bribery,  including  the  U.S.  Foreign  Corrupt  Practices  Act,  the  U.K.  Bribery  Act  and  similar", "We might record significant charges from impairment to goodwill, intangibles and other assets or investments.", "In addition, we periodically review our intangible and other long-lived assets for impairment when events or changes in circumstances, such as a divestiture, indicate the carrying value may not be recoverable.", "Factors that may be considered a change in circumstances indicating that  the  carrying  value  of  our  intangible  and  other  long-lived  assets  may  not  be  recoverable  include  slower  growth  rates,  the  loss  of  a  significant  customer, burdensome new laws or divestiture of a business or asset for less than its carrying value.", "There are inherent uncertainties in management\u2019s estimates, judgments and assumptions used in assessing recoverability of goodwill, intangible and other long-lived assets.", "We may be required to record a significant charge to earnings in our consolidated financial statements during the period in which any impairment of our goodwill or intangible and other long-lived assets is determined, which might have a materially adverse impact on our business operations and our financial position or results of operations.", "storage and hosting of sensitive information, including protected health information and other types of personal information, confidential financial information, proprietary information, and other sensitive information relating to our customers, company and workforce.", "If our software and technology services are alleged to have contributed to faulty clinical decisions or injury to patients, we might be subject to claims or litigation by users of our software or services or their patients.", "Any of these types of errors or failures might have a materially adverse impact on our reputation, business operations and our financial position or results of operations.", "We  are  required  under  U.S.  Generally  Accepted  Accounting  Principles  (\u201cGAAP\u201d)  to  test  our  goodwill  for  impairment  annually  or  more  frequently  if", "We might be impeded in providing customers online services and data access.", "Any such problems might have a materially adverse impact on our business operations and our financial position or results of operations.", "Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.", "we may require financing that may not be available on acceptable terms.", "Any of these risks could adversely affect our ability to achieve the anticipated benefits of an acquisition and might have a materially adverse impact on our business operations and our financial position or results of operations.", "Exclusive forum provisions in our Bylaws could limit our stockholders\u2019 ability to choose their preferred judicial forum for disputes with us or our directors, officers or employees.", "Current and former stockholders are deemed to have consented to the personal jurisdiction of the Delaware Courts in connection with any action to enforce that exclusive forum provision and to service of process in any such action.", "To the extent that these provisions of the bylaws limit a current or former stockholder\u2019s ability to select a judicial forum other than the Delaware Courts, they might discourage the specified legal actions, might cause current or former stockholders to incur additional litigation-related expenses and might result in outcomes unfavorable to current or former stockholders.", "A court might determine that these provisions of the bylaws are inapplicable or unenforceable in any particular action, in which case we may incur additional litigation related expenses in such action, and the action may result in outcomes unfavorable to us, which could have a materially adverse impact on our reputation, our business operations and our financial position or results of operations.", "We might be adversely impacted by delays or other difficulties with divestitures.", "After the disposition, we might experience greater dissynergies than expected, and the impact of the divestiture on our revenue or profit might be larger than we expected.", "We might have difficulties with pre-closing conditions such as regulatory and governmental approvals, which could delay or prevent the divestiture.", "We might have financial exposure in a divested business, such as through minority equity ownership, financial  or  performance  guarantees,  indemnities  or  other  obligations,  such  that  conditions  outside  of  our  control  might  negate  the  expected  benefits  of  the disposition.", "Any of these risks could adversely affect our ability to achieve the anticipated benefits of a divestiture and might have a materially adverse impact on our business operations and our financial position or results of operations.", "We might not realize the expected tax treatment from our split-off of Change Healthcare.", "If Change does not honor its obligations to indemnify the Company, or if the Transactions fail to qualify for the intended tax-free treatment for reasons not related to a disqualifying action by Change or SpinCo, the resulting tax to the Company could have a significant adverse effect on our financial position or results of operations.", "outsourced service providers, and we might not realize expected cost savings or other benefits.", "For example, our ability to use outsourcing resources in certain jurisdictions might be limited by legislative action or customer contracts, with the result that the work must be performed at greater expense or we may be subject to sanctions for non-compliance.", "Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.", "We might encounter difficulties attracting and retaining customers to our retail locations due to their unfamiliarity with our brands or our inexperience with local market  preferences.  Competition  from  our  retail  pharmacy  operations  might  strain  relationships  with  our  retail  pharmacy  customers.  Consolidation  of  retail pharmacies with third party payers, expansion of large retail pharmacy networks, reductions in reimbursement rates, shifts in the mix of branded and generic pharmaceutical sales, and exclusion from preferred pharmacy networks can impair our retail pharmacy sales and profitability.", "We might be harmed by large customer purchase reductions, payment defaults or contract non-renewal.", "March 31, 2021, sales to our largest customer represented approximately 21% of our consolidated revenues and approximately 19% of our trade receivables, and those of our ten largest customers combined accounted for approximately 51% of our consolidated revenues and approximately 32% of our trade receivables.", "A material  default  in  payment,  reduction  in  purchases,  or  the  loss  of  business  from  a  large  customer  might  have  a  materially  adverse  impact  on  our  business operations and our financial position or results of operations.", "Our contracts with government entities involve future funding and compliance risks.", "Our government contracts might not be renewed or might be terminated for convenience with little or no prior notice.", "Government contracts typically expose us to higher potential liability than do other types of contracts.", "We are subject to government audits, investigations and oversight proceedings.", "If we fail to comply with these requirements, or we fail an audit, we are subject to various sanctions such as monetary damages, criminal and civil penalties, termination of contracts and suspension or debarment from government contract work.", "These requirements complicate our business and increase our compliance burden.", "We also provide supplies used for vaccine administration in the Federal COVID-19 Response.", "Our participation in such programs exposes us to various uncertainties.", "Because of these risks and uncertainties our operating results may be materially higher or lower than our projections.", "Certain distribution agreements with manufacturers include pharmaceutical price inflation as a component of our compensation, and we cannot  control  the  frequency  or  magnitude  of  pharmaceutical  price  changes.  We  might  be  unable  to  renew  pharmaceutical  distribution  agreements  with manufacturers in a timely and favorable manner.", "Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.", "We  derive  a  significant  portion  of  our  revenue  from,  and  have  a  significant  portion  of  our  accounts  receivable  with,  a  small  number  of  customers.  At", "Our contracts with government entities are subject to risks such as lack of funding and compliance  with unique requirements.", "We might infringe intellectual property rights or our intellectual property protections might be inadequate.", "If a court were to hold that we infringed other\u2019s rights, we might be required to pay substantial damages, develop non-infringing products or services, obtain a license, stop selling or using the infringing products or services, or incur other sanctions.", "We rely on trade secret, patent, copyright and  trademark  laws,  nondisclosure  obligations  and  other  contractual  provisions  and  technical  measures  to  protect  our  proprietary  rights  in  our  products  and solutions.  We  might  initiate  costly  and  time-consuming  litigation  to  protect  our  trade  secrets,  to  enforce  our  patent,  copyright  and  trademark  rights  and  to determine the scope and validity of the proprietary rights of others.", "Our intellectual property protection efforts might be inadequate to protect our rights.", "Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.", "Competition among potential employers might result in increased salaries, benefits or other employee-related costs, or in our failure to recruit and retain employees.", "Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.", "We might be adversely impacted by healthcare reform such as changes in pricing and reimbursement models.", "healthcare industry and related government programs are changing.", "profit margins for us and our customers and impose new legal requirements on healthcare providers.", "the way healthcare is financed by both governmental and private payers.", "drugs have sought to reduce the costs of publicly funded health programs.", "These measures exert pressure on the pricing and reimbursement timelines for pharmaceuticals and may cause our customers to purchase fewer of our products and services or influence us to reduce prices.", "adverse impact on our business operations and our financial position or results of operations.", "Consolidation might increase counter-party credit risk because credit purchases increase for fewer market participants.", "Any of these changes or disruptions might have a materially adverse impact on our business operations and our financial position or results of operations.", "We might be adversely impacted as a result of our distribution of generic pharmaceuticals.", "Generic drug manufacturers often offer a generic version of branded pharmaceuticals while they challenge the validity or enforceability branded pharmaceutical patents.", "The patent holder might assert infringement claims against us for distributing those generic versions and the generic drug manufactures may not fully indemnify us against such claims.", "These risks, as well as changes in the availability,  pricing  volatility,  reimbursement  rates  for  generic  drugs,  or significant  changes  in  the  nature,  frequency  or magnitude  of  generic  pharmaceutical launches, might have a materially adverse impact on our business operations and our financial position or results of operations.", "We might be adversely impacted by an economic slowdown or recession.", "Any economic slowdown or recession might have a materially adverse impact on our business operations and our financial position or results of operations.", "Disruption or other changes in capital and credit markets might impede access to credit and increase borrowing costs for us and our customers and suppliers and might impair the financial soundness of our customers and suppliers.", "activity by financial institutions, or decreased liquidity and increased costs in the commercial paper market, might adversely affect our borrowing ability and cost of borrowing.", "We generally sell our products and services under short-term unsecured credit arrangements.", "An adverse change in general economic conditions or access to capital might cause our customers to reduce their purchases from us, or delay or fail paying amounts owed to us.", "Suppliers might be unable to make payments due to us for fees, returned products or incentives.", "Interest rate increases or changes in capital market conditions might impede our or our customers\u2019 or suppliers\u2019 ability or cost to obtain credit.", "Any of these risks might have a material adverse impact on our business operations and our financial position or results of operations.", "Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.", "We might be adversely impacted by tax legislation or challenges to our tax positions.", "Tax laws might change in ways that adversely affect our tax positions, effective tax rate and cash flow.", "The tax laws are extremely complex and subject to varying interpretations.", "We are subject to tax examinations in various jurisdictions that might assess additional tax liabilities against us.", "Our tax reporting positions might be challenged by relevant tax authorities, we might incur significant expense in our efforts to defend those challenges, and we might be unsuccessful in those efforts.", "Developments in examinations and challenges might materially change our provision for taxes in the affected periods and might differ materially from our historical tax accruals.", "Any of these risks might have a materially adverse impact on our business operations, our cash flows and our financial position or results of operations.", "For example, we might experience volatility in exchange rates and interest rates and changes in laws regulating our U.K. operations.", "Customers might reduce purchases due to the uncertainty caused by Brexit.", "Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.", "We might be adversely impacted by fluctuations in foreign currency exchange rates.", "exchange rates could reduce our revenues, increase our costs or otherwise adversely affect our financial results reported in U.S. dollars.", "For example, we are exposed to transactional currency exchange risk due to our import and export of products that are purchased or sold in currencies other than the U.S. dollar.", "We also  have  currency  exchange  risk  due  to  intercompany  loans  denominated  in  various  currencies.  The  COVID-19  pandemic  has  affected  and  might  increase currency exchange rate volatility.", "We may from time to time enter into foreign currency contracts, foreign currency borrowings or other techniques intended to hedge  a  portion  of our  foreign  currency  exchange  rate  risks.  These  hedging  activities  may  not  completely  offset  the  adverse  financial  effects  of  unfavorable movements in foreign currency exchange rates during the time the hedges are in place.", "Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.", "We are subject to the tax laws in the U.S. at the federal, state and local government levels and to the tax laws of many other jurisdictions in which we operate", "We conduct our business in various currencies,  including  the U.S. dollar, euro, British pound sterling  and Canadian dollar.  Changes in foreign  currency", "Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.", "We might be adversely impacted by changes in accounting standards.", "It is possible that future accounting standards may require changes to the accounting treatment in our consolidated financial statements and may require us to make significant changes to our financial systems.", "Such changes might have a materially adverse impact on our financial position or results of operations.", "Our consolidated financial statements are subject to the application of U.S.", "Disclosure of an environmental proceeding where a governmental agency is a party generally is included only if we expect monetary sanctions in the proceeding to exceed $1 million, unless otherwise material.", "There are no family relationships between any of the executive officers or directors of the Company.", "We declared regular cash dividends of $1.67 and $1.62 per share in the years ended March 31, 2021 and 2020, respectively.", "discretion of the Board and will depend upon our future earnings, financial condition, capital requirements, and other factors.", "Dividends: In  July  2020,  our  quarterly  dividend  was  raised  from  $0.41  to  $0.42  per  common  share  for  dividends  declared  on  or  after  such  date  by  the", "We anticipate that we will continue to pay quarterly cash dividends in the future.", "In accordance with our accounting policy, we allocate any excess of share repurchase price over par value between additional paid-in capital and retained earnings.", "Accordingly, our retained earnings and additional paid-in capital were reduced by $472 million and $70 million, respectively, during 2019.", "In 2019, we retired 5.0 million or $542 million of our treasury shares previously repurchased.", "This discussion and analysis should be read in conjunction with the consolidated financial statements and accompanying financial notes in Item 8 of Part II of this Annual Report on Form 10-K.", "Our fiscal year begins on April 1 and ends on March 31.", "Unless otherwise noted, all references to a particular year shall mean our fiscal year.", "Our organizational structure also includes Corporate, which consists of income and expenses associated with administrative functions and projects, and the results of certain investments.", "We evaluate the performance of our operating segments on a number of measures, including revenues and operating profit before interest expense and income taxes.", "The following summarizes our four reportable segments and the changes made to our reporting structure commencing in the second quarter of 2021.", "\u2022 Coronavirus disease 2019 (\u201cCOVID-19\u201d) impacted our results of operations for the year ended March 31, 2021.", "The recovery from the COVID- 19 pandemic continued to fluctuate throughout our fiscal year.", "\u2022 We expanded our existing contractual relationship with the Centers for Disease Control and Prevention (\u201cCDC\u201d) through an amendment to our existing Vaccines for Children Program contract to support the U.S. government as a centralized distributor of COVID-19 vaccines and ancillary supplies needed to administer vaccines.", "\u2022 In  December  2020,  we  began  distributing  certain  COVID-19  vaccines  under  the  direction  of  the  CDC.  Through  the  end  of  the  fiscal  year,  we  had distributed approximately 100 million of COVID-19 vaccine doses.", "\u2022 Revenues of $238.2 billion, reflects a 3% increase from the prior year primarily in our U.S.", "\u2022 Diluted loss per common share from continuing operations attributable to McKesson Corporation in 2021 of $28.26 reflects the aforementioned items, net of any respective tax impacts, and a lower share count compared to the prior year driven largely by the separation of our investment in Change Healthcare JV on March 10, 2020;", "The full extent to which COVID-19 will impact us depends on many factors and future developments, which are described at the end of this COVID-19 section.", "We continue to evaluate the nature and extent of the impacts COVID-19 has on our business and operations.", "We provided further support including additional emergency leave and an internal paid time off donation platform for employees impacted by COVID-19.", "These responses were initially put in place during our fourth quarter of 2020.", "policies did not have a material effect on our internal control over financial reporting during the year ended March 31, 2021.", "We also took various actions to mitigate the impact of COVID-19 on our results from operations through cost-containment and payroll-related expenses.", "We support the U.S. government as a centralized distributor of COVID-19 vaccines and ancillary supplies needed to administer vaccines.", "We make no decisions on where products are to be distributed nor how the products are allocated between the various provider sites and ultimately administered to the individuals receiving a vaccine.", "We utilize our expertise and capabilities to support the CDC\u2019s efforts to vaccinate everyone in the U.S. who wants to receive a COVID-19 vaccine.", "The Pfizer Vaccine, which is ultra-frozen, is not being distributed by McKesson, although we are providing ancillary supplies needed for its administration.", "custom freezers and refrigerators to safely store and process millions of vaccine doses.", "The capital expenditures we made during 2021 to prepare for vaccine and ancillary supply kit distribution were not material to our financial condition or liquidity.", "In December 2020, we began distributing the Moderna Vaccine in the U.S. and in March 2021, we began distributing the Janssen Vaccine.", "Subsequently, during the first quarter, we had lower pharmaceutical volumes, specialty drug volumes, and patient care visits that negatively impacted our consolidated revenues and income (loss) from continuing operations before income taxes for the year ended March 31, 2021.", "Additionally, increased costs for certain PPE compressed our margins.", "During the year ended March 31, 2021, we recorded charges totaling $136 million in cost of sales on certain PPE and other related products due to inventory impairments and excess inventory in our Medical-Surgical Solutions segment.", "Although market price volatility and changes to anticipated customer demand may require additional write-downs in future periods, we are taking measures to mitigate such risk.", "We collaborated closely with the federal government and other healthcare stakeholders to source more critical PPE to the U.S.", "We have deferred certain employer payroll taxes and continue to monitor the potential impact of other tax legislation changes as result of the CARES Act, including refundable payroll tax credits on certain qualified wages.", "We anticipate changes due to the CARES Act in the timing of certain cash flows, with no material impact to our financial results for the year ended March 31, 2021.", "The CA Act did not have a material impact on our financial condition, results of operations, or liquidity for the year ended March 31, 2021 nor do we currently expect a material impact on our future financial results.", "We are monitoring our customers closely for changes to their timing of payments or ability to pay amounts owed to us as a result of COVID-19 pandemic impacts to their businesses.", "We remain well-capitalized with access to liquidity from our revolving credit facility.", "Long- term debt markets and commercial paper markets, our primary sources of capital after cash flow from operations, have remained open and accessible to us during the COVID-19 pandemic.", "At March 31, 2021, we were in compliance with all debt covenants, and believe we have the ability to continue to meet our debt covenants in the future.", "Our consolidated balance sheets and ability to maintain financial liquidity remains strong.", "We have experienced no material impacts to our liquidity or net", "We face numerous uncertainties in estimating the direct and indirect effects of COVID-19 on our future business operations, financial condition, results of operations, and liquidity.", "Due to several rapidly changing variables related to the COVID-19 pandemic, estimations of future economic trends and the timing of when stability will  return  remains  challenging.  Additionally,  we  periodically  review  our  intangible  and  other  long-lived  assets  for  impairment  when  events  or  changes  in circumstances indicate  the carrying value may not be recoverable.  Key assumptions and estimates  about future values in our impairment assessments can be affected by a variety of factors, including the impacts of the global pandemic on industry and economic trends as well as on our business strategy and internal forecasts.", "We continue to be involved in discussions with the objective of achieving broad resolution of opioid- related claims of states, their political subdivisions and other government entities (\u201cgovernmental entities\u201d).", "We are in ongoing, advanced discussions with state attorneys general and plaintiffs\u2019 representatives regarding a framework under which, in order to resolve the claims of governmental entities, the three largest U.S. pharmaceutical distributors would pay up to approximately $21.0 billion over a period of 18 years, with up to approximately $8.0 billion to be paid by us, of which more than 90% is anticipated to be used to remediate the opioids crisis.", "As a result of that conclusion, and our assessment of certain other opioid- related claims, we recorded a charge of $8.1 billion for the year ended March 31, 2021 within \u201cClaims and litigation charges, net\u201d in our Consolidated Statement of Operations, related to our share of the settlement framework described above, as well as other opioid-related claims.", "Because of the many uncertainties associated with any potential settlement arrangement or other resolution of opioid-related litigation, including the uncertainty of the scope of participation by plaintiffs in any potential settlement, we are not able to reasonably estimate the upper or lower ends of the range of ultimate possible loss for all opioid-related litigation matters.", "We believe that we have valid defenses to the claims pending against us and, absent an acceptable settlement, intend to vigorously defend against all such claims.  An  adverse  judgment  or  negotiated  resolution  in  any  of  these  matters  could  have  a  material  adverse  impact  on  our  financial  position,  cash  flows  or liquidity, or results of operations.", "The law adopting the excise tax made clear that the OSA would apply only to opioid sales on or before December 31, 2018.", "The excise tax applies only to the first sale occurring in New York, and thus may not apply to sales from our distribution centers in New York to New York customers.", "Unless the appellate court\u2019s decision is overturned, the OSA will be reinstated for calendar years 2017 and 2018 (but not beyond those years), and, subject to any further legal challenge, we will have to pay our ratable share of the annual surcharge for those two years.", "During the second quarter of 2021, we reflected an estimated liability of $50 million for the OSA surcharge in our accompanying consolidated financial statements on the assumption that the appellate court\u2019s decision will stand.", "The higher LIFO credits in 2020 compared to 2019 is primarily driven by higher generic deflation.", "\u2022 Claims and litigation charges, net: These charges include adjustments for estimated probable settlements related to our controlled substance monitoring and reporting, and opioid-related claims, as well as any applicable income items or credit adjustments due to subsequent changes in estimates.", "We have reclassified prior period amounts to conform to the current period presentation.", "\u2022 Goodwill impairments charges: We perform an impairment test on goodwill balances annually in the third quarter and more frequently if indicators for potential impairment exist.", "The resulting goodwill impairment charges are reflected within this line item. \u2022 Restructuring, impairment, and related charges: Restructuring charges that are incurred for programs in which we change our operations, the scope of a business undertaken by our business units, or the manner in which that business is conducted as well as long-lived asset impairments.", "\u2022 SDG&A reflects charges of $58 million to remeasure assets and liabilities held for sale to fair value less costs to sell related to the completed contribution of the majority of our German pharmaceutical wholesale business to create a joint venture with WBA in which we have a 30% ownership interest within our International segment.", "As a result, we were required to perform a goodwill impairment test for these reporting units and recorded a goodwill impairment charge in our European RP reporting unit of $69 million during the second quarter of 2021.", "As of the testing date, other risks, expenses, and future developments, such as additional government actions, increased regulatory uncertainty, and material changes in key market assumptions limit our ability to estimate projected cash flows, which could adversely affect the fair value of various reporting units in future periods, including our McKesson Canada reporting unit within our International segment and our RxCrossroads reporting unit within our RxTS segment, where the risk of a material goodwill impairment is higher than other reporting units.", "\u2022 Restructuring, impairment, and related charges, net includes long-lived asset impairment charges of $112 million, primarily for our United Kingdom (\u201cU.K.\u201d)  business  (mainly  pharmacy  licenses)  and  Rexall  Health  retail  business  (\u201cRexall  Health\u201d)  (mainly  customer  relationships)  within  our International segment, and the remaining $156 million primarily represents employee severance and exit-related costs related to our 2019 restructuring initiatives, as further discussed below; and", "\u2022 Total operating expenses includes higher SDG&A due to our business acquisitions and to support business growth, as well as our technology initiatives, partially offset by favorable effects of foreign currency exchange fluctuations.", "\u2022 SDG&A includes opioid-related costs of $114 million, primarily related to litigation expenses, and increased expenses due to our business acquisitions and to support growth, partially offset by a gain from an escrow settlement of $97 million representing certain indemnity and other claims related to our 2017 acquisition of Rexall Health and a credit of $90 million for the derecognition of a liability related to the tax receivable agreement (\u201cTRA\u201d) payable to the shareholders of Change Healthcare, Inc. (\u201cChange\u201d);", "\u2022 Restructuring,  impairment,  and  related  charges,  net  primarily  includes  employee  severance  and  exit-related  costs  of  $352  million  for  our  2019 restructuring initiatives, as further discussed below and long-lived asset impairment charges of $245 million primarily for our U.K. business (mainly pharmacy licenses) within our International segment driven by additional government reimbursement reductions and competitive pressures in the U.K.", "We evaluate goodwill for impairment on an annual basis as of October 1, and at an interim date, if indicators of potential impairment exist.", "This change was not material to our consolidated financial statements as it did not delay, accelerate, or avoid any potential goodwill impairment charge.", "We expect to incur total charges of approximately $180 million to $280 million for this initiative, consisting primarily of exit related costs, accelerated depreciation and amortization of long-lived assets, and asset impairments.", "We expect to incur total charges of approximately $85 million to $90 million, of which $57 million of charges were recorded to date.", "This initiative was substantially complete in 2021 and remaining costs we expect to record under this initiative are not material.", "The relocation was substantially complete in January 2021 and remaining costs we expect to record under this initiative, primarily relating to lease costs, are not material.", "This primarily reflects mark-to-market gains on our investments in certain U.S. growth stage companies in the healthcare industry and realized gains on the exit of some of these investments as further described in Financial Note 17, \u201cFair Value Measurements,\u201d to the accompanying consolidated financial statements  included  in  this  Annual  Report  on  Form  10-K.  In  future  periods,  fair  value  adjustments  recognized  in  our  operating  results  for  these  types  of investments may be adversely impacted by market volatility.", "Other income, net also increased year over year due to pension settlement charges of $122 million recognized in 2020 related to our previously approved termination of the frozen U.S. defined benefit pension plan.", "In connection with the pension plan termination, we purchased annuity contracts from an insurer that will pay and administer the future pension benefits of the remaining participants.", "Excluding the impairment and transaction-related items described below, our proportionate share of loss from our investment in Change Healthcare JV for the years ended March 31, 2020 and 2019 was $119 million and $194 million, respectively, which primarily includes transaction and integration expenses incurred by the joint venture and basis differences between the joint venture and McKesson including amortization of fair value adjustments.", "During the first quarter of 2020 and for the year ended March 31, 2019, we owned approximately 70% of this joint venture.", "The proceeds from the concurrent offering of other securities were also used by Change  to  acquire  certain  securities  of  Change  Healthcare  JV.  As  a  result,  McKesson\u2019s  equity  interest  in  Change  Healthcare  JV  was  reduced  from  70%  to approximately 58.5%, which was used to recognize our proportionate share in net loss from Change Healthcare JV, commencing in the second quarter of 2020.", "As a result of the ownership dilution to 58.5% from 70%, we recognized a dilution loss of approximately $246 million in the second quarter of 2020.", "Additionally, our proportionate share of income or loss from this investment was subsequently reduced as immaterial settlements of stock option exercises occurred after the IPO and further diluted our ownership.", "Equity Earnings and Charges from Investment in Change Healthcare Joint Venture Until the separation of our investment in Change Healthcare JV on March 10, 2020, we accounted for this investment using the equity method of accounting.", "In the second quarter of 2020, we recorded an other-than-temporary-impairment (\u201cOTTI\u201d) charge of $1.2 billion to our investment in Change Healthcare JV,", "Following the Split-off, we do not beneficially own any of Change\u2019s outstanding securities.", "In connection with this transaction, we recognized a net gain for financial reporting purposes of $414 million during the fourth quarter of 2020, which was largely driven by the reversal of a related deferred tax liability.", "The receipt of any payments under the TRA is dependent upon Change benefiting from this depreciation or amortization in future tax return filings, which creates uncertainty over the amount, timing and probability of the gain recognized.", "As such, we accounted for the TRA as a gain contingency, with no receivable recognized as of March 31, 2021 nor 2020.", "Interest expense decreased in 2020 compared to the prior year primarily due to a decrease in the issuance of commercial paper, partially offset by a decrease in interest income from our derivative contracts.", "Our reported income tax (benefit) expense rates were (13.8%), 1.6%, and 58.4% in 2021, 2020, and 2019, respectively.", "after-tax), which was intended to generally be a tax-free split-off for U.S. federal income tax purposes, and unfavorably impacted by charges of $275 million (pre- tax and after-tax) to remeasure assets and liabilities held for sale to fair value less costs to sell related to the completed contribution of the majority of our German pharmaceutical wholesale business to create a joint venture with WBA.", "goodwill of our European RP and European PD reporting units within the International segment, given that these charges are generally not deductible for tax purposes.", "Our income tax expense, deferred tax assets and liabilities, and uncertain tax liabilities reflect management\u2019s best assessment of estimated current and future taxes to be paid.", "We believe that we have made adequate provision for all income tax uncertainties.", "In connection with the exchange offer, on March 9, 2020, we distributed all 176.0 million outstanding shares of common stock of SpinCo to participating", "Income Tax (Benefit) Expense We recorded income tax (benefit) expense of ($695 million), $18 million, and $356 million for the years ended March 31, 2021, 2020, and 2019, respectively.", "Our reported income tax expense rate for 2019 was unfavorably impacted by charges of $1.8 billion (pre-tax and after-tax) to impair the carrying value of", "Significant judgments and estimates are required in determining the consolidated income tax provision and evaluating income tax uncertainties.", "Noncontrolling interests with redemption  features, such as put rights, that are not solely within our control are considered redeemable  noncontrolling  interests.  Redeemable  noncontrolling interests are presented outside of McKesson Corporation stockholders\u2019 equity (deficit) on our consolidated balance sheet.", "Diluted earnings (loss) per common share attributable to McKesson Corporation was $(28.26), $4.95, and $0.17 for the years ended March 31, 2021,  2020,  and  2019,  respectively.  Net  loss  per  diluted  share  for  the  year  ended  March  31,  2021  is  calculated  by  excluding  dilutive  securities  from  the denominator  due to their antidilutive  effects.  Additionally,  our 2021, 2020, and 2019 diluted  earnings (loss) per share  reflect  the cumulative  effects  of share repurchases.", "Weighted-average diluted common shares outstanding is impacted by the exercise and settlement of share-based awards and the cumulative effect of share repurchases, including the impact of shares exchanged as part of the split-off from our investment in Change Healthcare JV, as discussed above.", "(1) Segment operating profit (loss) includes gross profit, net of operating expenses, as well as other income (expense), net, for our reportable segments.", "For retrospective periods presented, operating loss for Other reflects equity earnings and charges from our equity method investment in Change Healthcare JV, which we split-off in the fourth quarter of 2020.", "Pharmaceutical segment includes a charge of $50 million for the year ended March 31, 2021 related to our estimated liability under the OSA.", "(3) Operating loss for our International segment for the years ended March 31, 2021 and 2020 includes charges of $58 million and $275 million, respectively, to remeasure to fair value the assets and liabilities of our German pharmaceutical wholesale business which was contributed to a joint venture with WBA.", "This segment\u2019s operating loss for the years ended March 31, 2021 and 2019 includes goodwill impairment charges of $69 million and $1.8 billion, respectively, as well as long-lived asset impairment charges for the  years ended March 31, 2021,  2020, and 2019  of $115  million,  $112  million,  and $245  million,  respectively, primarily  related to  our retail  pharmacy businesses in Canada and Europe.", "(4) Operating profit for our Medical-Surgical Solutions segment for the year ended March 31, 2021 includes charges totaling $136 million on certain PPE and other related products due to inventory impairments and excess inventory.", "(5) Operating profit for our RxTS segment for the year ended March 31, 2019 includes a gain of $56 million from the divestiture of an equity investment.", "(6) Operating loss for Other for the year ended March 31, 2020 includes an OTTI charge of $1.2 billion and a dilution loss of $246 million related to our investment in Change Healthcare JV, partially offset by a net gain of $414 million related to the completed separation of our interest in Change Healthcare JV during the fourth quarter of 2020.", "(7) Corporate expenses, net for the year ended March 31, 2021 includes a charge of $8.1 billion related to our estimated liability for opioid-related claims, net gains of $133 million  from  our  equity  investments,  and a net  gain  of $131  million  recorded  in  connection  with  insurance  proceeds  received  from  the  settlement  of  the  shareholder derivative action related to our controlled substances monitoring program.", "This was partially offset by a decrease in LIFO credits of $214 million, a charge of $50 million recorded in 2021 related to our estimated liability under the OSA, net impacts from COVID-19, including a less severe cough, cold, and flu season, as well as increased costs for strategic growth initiatives.", "Operating profit and operating profit margin were unfavorably impacted by customer mix and a decrease in net cash proceeds received of $180 million representing our share of antitrust legal settlements.", "recorded to remeasure to fair value the assets and liabilities of our German pharmaceutical wholesale business which was contributed to a joint venture with WBA, of  which  $58  million  and  $275  million  was  reflected  for  the  years  ended  March  31,  2021  and  2020,  respectively.  This  was  partially  offset  by  a  goodwill impairment charge of $69 million recorded in the second quarter of 2021 related to our European retail pharmacy business.", "This was partially offset  by  the  fair  value  remeasurement  charges  in  2020  described  above  and  a  gain  from  an  escrow  settlement  of  $97  million  in  2019  related  to  our  2017 acquisition of Rexall Health.", "Additionally,  operating  profit  was favorable  year over year  due to lower  operating  expenses, including a decrease in our provision for bad debts.", "primary care business and lower restructuring charges, partially offset by the remeasurement of assets and liabilities to fair value related to a divestiture that was completed in 2020 and higher operating expenses, including an increase in our provision for bad debts.", "and existing customers, integration costs incurred in 2019 for our acquisition of RxCrossroads that closed during the fourth quarter of 2018, partially offset by a gain of $56 million from the divestiture of an equity investment in 2019.", "investment in Change Healthcare JV, partially offset by a net gain of $414 million related to the completed separation of our interest in Change Healthcare JV during the fourth quarter of 2020.", "Operating loss for Other also includes our proportionate share of loss from Change Healthcare JV of $119 million and $194 million for the years ended March 31, 2020 and 2019, respectively.", "connection with insurance proceeds received from the settlement of the shareholder derivative action related to our controlled substances monitoring program.", "Corporate expenses, net, for 2020 includes pension settlement charges of $122 million, an opioid claim settlement charge of $82 million, and net settlement gains of $26 million recognized from our derivative contracts.", "claim settlement charge mentioned above, as well as higher costs for technology initiatives, partially offset by net settlement gains recognized in 2020 from our derivative contracts.", "Other Operating  loss  for  Other  for  the  year  ended  March  31,  2020  includes  an  OTTI charge  of  $1.2  billion  and  a  dilution  loss  of  $246  million  related  to  our", "Corporate 2021 vs. 2020 Corporate expenses, net increased for the year ended March 31, 2021 compared to the prior year due to a charge of $8.1 billion related to our estimated", "We conduct our business worldwide in local currencies including Euro, British pound sterling, and Canadian dollar.", "As a result, the comparability of our results reported in U.S. dollars can be affected by changes in foreign currency exchange rates.", "In discussing our operating results, we may use the term \u201cforeign currency exchange fluctuations,\u201d which refers to the effect of changes in foreign currency exchange rates used to convert the local currency results of our operations in foreign countries where the functional currency is not the U.S. dollar.", "We present this information to provide a framework for assessing how our business performed excluding the effect of foreign currency exchange rate fluctuations.", "In computing the foreign currency exchange fluctuations, we translate our current year results of our operations in foreign countries recorded in local currencies into U.S dollars by applying their respective average foreign currency exchange rates of the corresponding prior year periods, and we subsequently compare those results to the previously reported results of the comparable prior year periods reported in U.S. dollars.", "estimate was made and if different estimates that we reasonably could have used in the current period, or changes in the accounting estimate that are reasonably likely to occur from period to period, could have a material impact on our financial condition or results from operations.", "Below are the estimates that we believe are  critical  to  the  understanding  of  our  operating  results  and  financial  condition.  Other  accounting  policies  are  described  in  Financial  Note  1,  \u201cSignificant Accounting  Policies,\u201d  to  the  consolidated  financial  statements  appearing  in  this  Annual  Report  on  Form  10-K.  Because  of  the  uncertainty  inherent  in  such estimates, actual results may differ from these estimates.", "Other customer financing primarily relates to guarantees provided to our customers, or their creditors, regarding the repurchase of inventories.", "We also provide financing to certain customers related to the purchase of pharmacies, which serve as collateral for the loans.", "We estimate the receivables for which we do not  expect  full  collection  based  on  historical  collection  rates  and  specific  knowledge  regarding  the  current  creditworthiness  of  our  customers  and  record  an allowance in our consolidated financial statements for these amounts.", "Management reviews these factors quarterly to determine if any adjustments are needed to the allowance.", "Sales to our largest customer, CVS Health Corporation (\u201cCVS\u201d), accounted for approximately 21% of our total consolidated revenues in 2021 and comprised approximately 19% of total trade accounts receivable at March 31, 2021.", "As a result, our sales and credit concentration is significant.", "The accounts receivables balances are with individual members of the GPOs, and therefore no significant concentration of credit risk exists.", "A material default in payment, a material reduction in purchases from these or any other large customers, or the loss of a large customer or GPO could have a material adverse impact on our financial position, results of operations, and liquidity.", "We believe the reserves maintained and expenses recorded in 2021 are appropriate and consistent in the context of historical methodologies employed, as well as assessment of trends currently available.", "The selected 0.1% hypothetical change does not reflect what could be considered the best or worst-case scenarios.", "Our LIFO valuation amount includes both pharmaceutical and non-pharmaceutical products.", "We recognized LIFO credits of $38 million, $252 million, and $210 million, respectively, in 2021, 2020, and 2019 in our Consolidated Statements of Operations.", "A LIFO charge is recognized when the net effect of price increases on pharmaceutical and non-pharmaceutical products held in inventory exceeds the impact of price declines, including the effect  of branded pharmaceutical  products  that have lost market  exclusivity.  A LIFO credit  is recognized  when the net effect  of price  declines exceeds the impact of price increases on pharmaceutical and non-pharmaceutical products held in inventory.", "Excluding LIFO reserves, our inventory reserves as of March 31, 2021 and 2020 were $263 million and $96 million, respectively.", "The increase was primarily due to 2021 charges totaling $136 million on certain PPE and other related products due to inventory impairments and excess inventory within our Medical-Surgical Solutions segment.", "In 2021, 2020 and, 2019, our provision for bad debts", "At March 31, 2021 and 2020, total inventories, net were $19.2 billion and $16.7 billion, respectively, in our Consolidated Balance Sheets.", "Any purchase consideration in excess of the estimated fair values of the net assets acquired is recorded as goodwill.", "that is a form or variation of the income approach, whereby a forecast of future cash flows attributable to the asset are discounted to present value using a risk- adjusted discount rate.", "We perform an impairment test on goodwill balances annually in the third quarter and more frequently if indicators for potential impairment exist.", "equal to the amount of excess carrying value above the estimated fair value, if any, but not to exceed the amount of goodwill allocated to the reporting unit.", "we estimate fair value by comparing the business to similar businesses, or guideline companies whose securities are actively traded in public markets.", "Under the income approach, we use a discounted cash flow (\u201cDCF\u201d) model in which cash flows anticipated over several periods, plus a terminal value at the end of that time horizon, are discounted to their present value using an appropriate rate that is commensurate with the risk inherent within the reporting unit.", "Goodwill  and  Long-Lived  Assets: As  a  result  of  acquiring  businesses,  we  have  $9.5  billion  and  $9.4  billion  of  goodwill  at  March  31,  2021  and  2020,", "To estimate the fair value of our reporting units, we generally use a combination of the market approach and the income approach.", "Judgments made in determining an estimate of fair value may materially impact our results of operations.", "Included in the estimate of the weighted-average cost of capital is the assumption of an unsystematic risk premium to address incremental uncertainty related to the reporting units\u2019 future cash flow projections.", "An increase in the unsystematic risk premium increases the discount rate.", "Pharmaceutical  Distribution  reporting  units  in  our  International  segment,  exceeded  their  carrying  values.  The  impairment  testing  performed  in  2020  did  not indicate  any  material  impairment  of  goodwill.  The  segment  change  in  the  second  quarter  of  2021  prompted  changes  in  multiple  reporting  units  across  the Company.", "We recorded a goodwill impairment charge of $69 million in 2021 as the estimated fair value of the Europe Retail Pharmacy reporting unit was lower than its reassigned carrying value based on changes in the composition of the Europe Retail Pharmacy reporting unit within the International segment.", "At March 31, 2021, the  balance  of goodwill for the  reporting  units  in Europe  was approximately  nil  and the  remaining  balance  of goodwill  in the International segment primarily relates to one of our reporting units in Canada.", "Other risks, expenses and future developments, such as additional government actions, increased regulatory uncertainty, and material changes in key market assumptions that we were unable to anticipate as of the testing date may require us to further revise the projected cash flows, which could adversely affect the fair value of our other reporting units in future periods.", "We review intangible assets for impairment at an asset group level whenever events or changes in circumstances indicate that the carrying value of the assets may not be recoverable.", "Determination of recoverability of intangible assets is based on the lowest level of identifiable estimated future undiscounted cash flows resulting from use of the asset and its eventual disposition.", "Measurement of any impairment loss is based on the excess of the carrying value of the asset group over its fair value.", "Assumptions and estimates about future values and remaining useful lives of our purchased intangible assets are complex and subjective.", "When the decline in value is deemed to be other than temporary, an impairment is recognized to the extent that the fair value is less than the carrying value of the investment.", "We consider various factors in determining whether a loss in value of an investment is other than temporary including: the length of time and the extent to which the fair value has been below cost, the financial condition of the investees, and our intent and ability to retain the investment for a period of time sufficient to allow for recovery of value.", "Any significant changes in assumptions or judgments in assessing impairments could result in an impairment charge.", "We generally recognize employee severance costs when payments are probable and amounts are estimable.  Costs related  to contracts without future benefit or contract termination  are recognized  at the earlier of the contract termination  or  the  cease-use  dates.  Other  exit-related  costs  are  recognized  as  incurred.  In  connection  with  these  restructuring  actions,  we  also  assess  the recoverability of long-lived assets used in the business, and as a result, we may recognize accelerated depreciation and amortization reflecting shortened useful lives of the underlying assets.", "paid.  We  are  subject  to  income  taxes  in  the  U.S.  and  numerous  foreign  jurisdictions.  Significant  judgments  and  estimates  are  required  in  determining  the consolidated income tax provision and in evaluating income tax uncertainties and include those used to conclude on the tax-free nature of the separation of the Change Healthcare JV and the unrecognized tax position related to opioid-related litigation and claims, which remains unfinalized, and which may differ from the actual amounts of tax benefit recognized.", "We review our tax positions at the end of each quarter and adjust the balances as new information becomes available.", "to recover our deferred tax assets, we consider all available positive and negative evidence including our past operating results, the existence of cumulative net operating losses in the most recent years, and our forecast of future taxable income.", "In estimating future taxable income, we develop assumptions including the amount of future federal, state and foreign pre-tax operating income, the reversal of temporary differences, and the implementation of feasible and prudent tax planning strategies.", "These assumptions require significant judgment about the forecasts of future taxable income and are consistent with the plans and estimates we use to manage the underlying businesses.", "additional taxes and related interest will be due.", "If our current estimate of tax and interest liabilities is less than the ultimate settlement, an additional charge to income tax expense may result.", "If our current estimate of tax and interest liabilities is more than the ultimate settlement, a reduction to income tax expense may be recognized.", "investigations  relating  to  laws  and  regulations  and  other  matters  arising  out  of  the  normal  conduct  of  our  business.  When  a  loss  is  considered  probable  and reasonably estimable, we record a liability in the amount of our best estimate for the ultimate loss.", "When a material loss is reasonably possible or probable but a reasonable estimate cannot be made, disclosure of the proceeding is provided.", "Deferred income taxes arise from temporary differences between the tax and financial statement recognition of revenue and expense.", "Changes in tax laws and rates could also affect recorded deferred tax assets and liabilities in the future.", "We recognize liabilities for tax and related interest for issues in the U.S. and other tax jurisdictions based on our estimate of whether, and the extent to which,", "As discussed above, development of a meaningful estimate of loss or a range of potential loss is complex when the outcome is directly dependent on future negotiations with or decisions by third parties, such as regulatory agencies, the court system and other interested parties.", "As a result of ongoing, advanced discussions with state attorneys general and plaintiffs\u2019 representatives regarding a framework to resolve the claims of governmental  entities,  and  our  assessment  of  certain  other  opioid-related  claims,  we  have  reached  a  stage  at  which  a  broad  settlement  of  opioid  claims  by governmental entities is probable and recorded a charge of $8.1 billion for the year ended March 31, 2021 within \u201cClaims and litigation charges, net\u201d in our Consolidated Statement of Operations in this report.", "Because of the many uncertainties associated with any potential settlement arrangement or other resolution of opioid-related litigation, including the uncertainty of the scope of participation by plaintiffs in any potential settlement, we are not able to reasonably estimate the upper or lower ends of the range of ultimate possible loss for all opioid-related litigation matters.", "While we are not able to predict the outcome or reasonably estimate a range of possible losses in these matters, an adverse judgment or negotiated resolution in any of these matters could have a material adverse effect on our results of operations, consolidated financial position, cash flows or liquidity.", "facilities and commercial paper program, will be sufficient to fund our short-term and long-term capital expenditures, working capital, and other cash requirements.", "We continue to monitor its impact on demand within parts of our business, as well as trends potentially impacting the timing or ability for some of our customers to pay amounts owed to us.", "We remain well-capitalized with access to liquidity from our $4.0 billion revolving credit facility.", "Additionally, long-term debt markets and commercial paper markets, our primary sources of capital after cash flow from operations, have remained open and accessible to us during the COVID-19 pandemic.", "We have seen continued improvement in conditions in the debt markets and commercial paper markets as the Federal Reserve has taken steps to stabilize the markets.", "At March 31, 2021, we were in compliance with all debt covenants, and believe we have the ability to continue to meet our debt covenants in the future.", "Cash flows from operations can be significantly impacted by factors such as the timing of receipts from customers and payments to vendors.", "Operating activities for the year ended March 31, 2021 were affected by net income adjusted for non-cash items, including the pre-tax $8.1 billion (after-tax $6.8 billion) non-cash charge related to our estimated liability for opioid-related claims, an increase in inventory of $2.3 billion and an increase in drafts and accounts payable of $1.3 billion driven by higher inventory stock levels to meet increased volume demand as part of our inventory management, as well as a decrease in receivables of $1.1 billion driven by timing, higher sales recognized at the end of March 2020, and higher collections in our fourth quarter of 2021.", "value remeasurement charges of $58 million related to the contribution of our German pharmaceutical wholesale business to a joint venture with WBA.", "Additionally, we made a cash payment of $114 million from the executive benefit retirement plan in 2020.", "Investing activities for the year ended March 31, 2021 also includes net cash proceeds of $400 million from sales of businesses and investments, including $286 million in exchange for the contribution of our German pharmaceutical wholesale business to a joint venture with WBA.", "Cash used for other financing activities generally includes payments to noncontrolling interests and activity from our finance leases.", "We received cash from long-term debt issuances of $1.1 billion and made repayments on long-term debt of $1.1 billion in 2019.", "The timing of any repurchases and the actual number of shares repurchased will depend on a variety of factors, including our stock price, corporate and regulatory requirements, restrictions under our debt obligations, and other market and economic conditions.", "In accordance with our accounting policy, we allocate any excess of share repurchase price over par value between additional paid-in capital and retained earnings.", "Accordingly, our retained earnings and additional paid-in capital were reduced by $472 million and $70 million during 2019, respectively.", "outstanding shares of SpinCo common stock, which held all of the Company\u2019s interests in the Change Healthcare JV, to participating holders of the Company\u2019s common  stock  in  exchange  for  15.4  million  shares  of  McKesson  stock,  which  are  now  held  as  treasury  stock  on  our  consolidated  balance  sheet.  Following consummation of the exchange offer, on March 10, 2020, SpinCo merged with and into Change and each share of SpinCo common stock was converted into one share of Change common stock, par value $0.001 per share, with cash being paid in lieu of fractional shares of Change common stock.", "give us the ability to meet our financing needs for the foreseeable future.", "However, there can be no assurance that an increase in volatility or disruption in the global capital and credit markets will not impair our liquidity or increase our costs of borrowing.", "As described within the \u201cTrends and Uncertainties\u201d section above,  the  COVID-19  pandemic  continues  to  develop  rapidly.  We  continue  to  monitor  its  impact  on  demand  within  parts  of  our  business,  as  well  as  trends potentially impacting the timing or ability for some of our customers to pay amounts owed to us.", "(2) This ratio describes the relationship and changes within our capital resources, and is computed as total debt divided by the sum of total debt and McKesson stockholders\u2019 equity (deficit), which excludes noncontrolling and redeemable noncontrolling interests and accumulated other comprehensive loss. (3) Ratio is computed as net income (loss) attributable to McKesson Corporation for the last four quarters, divided by a five-quarter average of McKesson stockholders\u2019 equity (deficit), which excludes noncontrolling and redeemable noncontrolling interests.", "In 2019, we retired 5.0 million or $542 million of the Company\u2019s treasury shares previously repurchased.", "In connection with the Split-off, we distributed all 176.0 million", "Deposits with financial institutions are primarily denominated in U.S. dollars and the functional currencies of our foreign subsidiaries, including Euro, British pound sterling, and Canadian dollars.", "We mitigate the risk of our short-term investment portfolio by depositing funds with reputable financial institutions and monitoring risk profiles and investment strategies of money market funds. outside of the U.S., respectively.", "Our primary intent is to utilize this cash for foreign operations for an indefinite period of time.", "Although the vast majority of cash held outside the U.S. is available for repatriation, doing so could subject us to foreign withholding taxes and state income taxes.", "The COVID-19 pandemic has potential to increase the variations in our working capital, which we continue to monitor closely. partially offset by an increase in drafts and accounts payable and a decrease in receivables.", "Our unfavorable return on McKesson\u2019s stockholder\u2019s equity (deficit) as of March 31, 2021 was also driven by net loss for the year.", "Net loss for the year ended March 31, 2021 includes an after-tax non-cash charge of $6.8 billion related to our estimated liability for opioid-related claims, as discussed in \u201cTrends  and  Uncertainties\u201d of  this  Financial  Review  and  Financial  Note  19,  \u201cCommitments  and  Contingent  Liabilities,\u201d  to  the  accompanying  consolidated financial statements included in this Annual Report on Form 10\u2011K.", "Our debt to capital ratio increased for 2020 primarily due to a decrease in stockholders\u2019 equity driven by the Split-off of our interest in Change Healthcare JV and share repurchases.", "We anticipate that we will continue to pay quarterly cash dividends in the future.", "However, the payment and amount of future dividends remain within the discretion of the Board and will depend upon our future earnings, financial condition,  capital  requirements,  and  other  factors.  In  2021,  2020,  and  2019,  we  paid  total  cash  dividends  of  $276  million,  $294  million,  and  $292  million, respectively.  Additionally,  as  required  under  the  Domination  Agreement,  we  are  obligated  to  pay  an  annual  recurring  compensation  amount  of  \u20ac0.83  per McKesson Europe share (effective January 1, 2015) to the noncontrolling shareholders of McKesson Europe.", "Cash equivalents, which are readily convertible to known amounts of cash, are carried at fair value.", "Our cash and cash equivalents balance as of March 31, 2021 and 2020 included approximately $2.3 billion and $1.7 billion of cash held by our subsidiaries", "On  July  29,  2020,  we  raised  our  quarterly  dividend  from  $0.41  to  $0.42  per  common  share  for  dividends  declared  on  or  after  such  date  by  the  Board.", "(3) Includes our estimated benefit payments for the unfunded benefit plans and minimum funding requirements for the pension plans. (4) Primarily represents interest that will become due on our fixed rate long-term debt obligations.", "These obligations primarily relate to inventory purchases and capital commitments. (6) Includes agreements under which we have guaranteed the repurchase of our customers\u2019 inventory and our customers\u2019 debt in the event these customers are unable to meet their obligations to those financial institutions.", "The ultimate amount and timing of any future cash settlements related to these items cannot be predicted with reasonable certainty.", "and are mostly related to our customer contracts and to meet the security requirements for statutory licenses and permits, court and fiduciary obligations, and our workers\u2019 compensation and automotive liability programs.", "The exercise of the Put Right will reduce the balance of redeemable noncontrolling interests.", "During 2021, we paid $49 million to purchase 1.8 million shares of McKesson Europe through exercises of the Put Right by the noncontrolling shareholders.", "Our banks and insurance companies have issued $146 million of standby letters of credit and surety bonds at March 31, 2021.", "redemption value is the Put Amount adjusted for exchange rate fluctuations each period.", "In future periods, unfavorable foreign currency exchange rate fluctuations between the Euro and the U.S. dollar could adversely impact the carrying value of our redeemable noncontrolling interests and require an adjustment to increase the balance of our redeemable noncontrolling interests to its maximum redemption value.", "On April 12, 2021, we received the Stuttgart Court of Appeals\u2019 final ruling confirming the original put value of \u20ac22.99 per share and the annual recurring compensation of \u20ac0.83 per McKesson Europe share.", "Funds necessary for future debt maturities and our other cash requirements are expected to be met by existing cash balances, cash flow from operations, existing credit sources, and other capital market transactions.", "The effect of a hypothetical 50 bp increase in the underlying interest rate on our cash and cash equivalents, net of short-term borrowings and variable rate debt, would have resulted in a favorable impact to earnings in 2021 and 2020 of approximately $17 million and $6 million, respectively.", "The balance of redeemable noncontrolling interests is reported at the greater of its carrying value or its maximum redemption value at each reporting date.", "Additionally,  we  are  obligated  to  pay  an  annual  recurring  compensation  of  \u20ac0.83  per  McKesson  Europe  share  (the  \u201cCompensation  Amount\u201d)  to  the", "Interest rate risk: Our long-term debt bears interest predominately at fixed rates, whereas our short-term borrowings are at variable interest rates.", "Our cash and cash equivalents balances earn interest at variable rates.", "At March 31, 2021 and 2020, we had $6.3 billion and $4.0 billion, respectively, in cash", "Changes in foreign currency exchange rates could have a material adverse impact on our financial results that are reported in U.S. dollars.", "We are also exposed to foreign exchange rate risk related to our foreign subsidiaries, including intercompany loans denominated in non-functional currencies.", "These programs reduce but do not entirely eliminate foreign exchange risk.", "fair value of our foreign exchange contracts by approximately $267 million and $435 million, respectively.", "Foreign exchange risk: We conduct our business worldwide in U.S. dollars and the functional currencies of our foreign subsidiaries, including Euro, British", "We have certain foreign exchange rate risk programs that use foreign currency forward contracts and cross-currency swaps.", "Based on this assessment, our management has concluded that our internal control over financial reporting was effective as of March 31, 2021.", "In our opinion, the financial statements referred to above present fairly, in all material respects, the financial position of the Company as of March 31, 2021 and 2020, and the results of its operations and its cash flows for each of the three years in the period ended March 31, 2021, in conformity with accounting principles generally accepted in the United States of America.", "Also, in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of March 31, 2021, based on criteria established in Internal Control \u2014 Integrated Framework (2013) issued by COSO.", "Our responsibility is to express an opinion on these financial statements and an opinion on the Company\u2019s internal control over financial reporting based  on  our  audits.  We  are  a  public  accounting  firm  registered  with  the  Public  Company  Accounting  Oversight  Board  (United  States)  (\u201cPCAOB\u201d)  and  are required  to  be  independent  with  respect  to  the  Company  in  accordance  with  the  U.S.  federal  securities  laws  and  the  applicable  rules  and  regulations  of  the Securities and Exchange Commission and the PCAOB.", "We conducted our audits in accordance with the standards of the PCAOB.", "Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.", "Our audits of the financial statements included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures to respond to those risks.", "Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements.", "Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk.", "Our audits also included performing such other procedures as we considered necessary in the circumstances.", "We believe that our audits provide a reasonable basis for our opinions.", "The critical audit matters communicated below are matters arising from the current-period audit of the financial statements that were communicated or required to be communicated to the audit committee and that (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments.", "The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.", "The Company also performs an assessment of loss contingencies where a loss is reasonably possible.", "We identified the potential broad settlement of opioid claims as a critical audit matter because of the significant judgment and challenges auditing management\u2019s determination  of  whether  such  loss  is  probable  and  reasonably  estimable.  Specifically,  auditing  management\u2019s  determination  and  disclosure  of  whether  the contingent loss arising from the potential broad settlement of opioid claims is probable, and the related measurement of such loss, is subjective and requires significant judgment given that the potential loss is based upon settlement terms that have not yet been finalized.", "\u2022 We tested the effectiveness of internal controls related to the potential broad settlement of opioid claims, and approval of the accounting treatment and related disclosures based on the most recent facts and circumstances.", "In addition, we inspected responses to inquiry letters sent to both internal and external legal counsel as it relates to the status of discussions with plaintiffs\u2019 counsel and the Company\u2019s intent regarding the framework for a potential broad settlement of opioid claims.", "\u2022 We evaluated management\u2019s analysis of the potential broad settlement of opioid claims, including the methodology used by management to determine the probability of such loss.", "We also evaluated the methodology used by management to estimate the most likely loss to be incurred by the Company as a result of a potential broad settlement of opioid claims.", "\u2022 We performed public domain searches for evidence contrary to management\u2019s analysis.", "\u2022 We evaluated any events subsequent to March 31, 2021 that might impact our evaluation of the potential broad settlement of opioid claims. \u2022 We obtained written representations from executives and internal counsel of the Company. \u2022 We examined proposed terms related to the potential broad settlement framework. \u2022 We evaluated the Company\u2019s related disclosures for consistency with our testing.", "The net amount recognized by management is measured as the largest amount of tax benefit that is greater than 50 percent likely of being realized.", "We identified the Company\u2019s uncertain tax position related to the charge for the potential broad settlement of opioid claims as a critical audit matter because of the challenges in auditing management\u2019s estimate of the amount of income tax benefit that qualifies for recognition.", "Our audit procedures related to the Company's uncertain tax position associated with a potential broad settlement of opioid claims included the following, among others: \u2022 We tested the effectiveness of internal controls related to the Company\u2019s assessment of the technical merits of its tax position, including the Company\u2019s assessment as to the amount of benefit that is more likely than not to be realized. \u2022 With  the  assistance  of  our  tax  specialists,  we  evaluated  the  facts,  evidence  and  the  Company\u2019s  related  income  tax  analysis  for  the  charge  related  to  the potential broad settlement of opioid claims, including assumptions used by management to measure the related recognized and unrecognized tax benefits. \u2022 We inquired of the Company\u2019s internal and external legal counsel to understand the basis for the Company\u2019s conclusion that a portion of the potential broad settlement of opioid claims would be deductible based on the most recent discussions with plaintiffs\u2019 counsel.", "\u2022 We  compared  management's  income  tax  assessment  of  this  matter  to  the  treatment  of  other  recorded  opioid  charges  to  evaluate  the  consistency  of  the Company\u2019s judgments related to the uncertain tax position. \u2022 We evaluated any events subsequent to March 31, 2021 that might impact our evaluation of the Company\u2019s uncertain tax position related to the charge for the potential broad settlement of opioid claims.", "\u2022 We obtained written representations from executives and internal counsel of the Company. \u2022 We examined proposed terms related to the potential broad settlement framework.", "\u2022 We evaluated the Company\u2019s related disclosures for consistency with our testing and also searched for contradictory evidence by reading disclosures from peer companies, who are also party to the potential broad settlement of opioid claims.", "We identified the estimation of the fair value of the McKesson Canada reporting unit used to evaluate the recoverability of goodwill as a critical audit matter because of the challenges auditing significant judgments used in the selection of a discount rate, including the unsystematic risk premium.", "In particular, the fair value estimate is sensitive to the unsystematic risk premium assumption, which is affected by expected risk of changes in the Canadian business and regulatory environments.", "Auditing management\u2019s selected discount rate required a high degree of auditor judgment and an increased extent of effort, including the need to involve more senior members of the team and our fair value specialists.", "Our audit procedures related to the Company\u2019s selection of a discount rate, including consideration of the unsystematic risk premium, for the McKesson Canada reporting unit included the following, among others: \u2022 We tested the effectiveness of internal controls related to management\u2019s goodwill impairment evaluation, including those related to the selection of a discount rate and consideration of an unsystematic risk premium. \u2022 We  evaluated  management\u2019s  ability  to  accurately  forecast  operating  results  for  the  McKesson  Canada  reporting  unit  by  comparing  actual  results  to management\u2019s historical forecasts, in order to consider the reasonableness and adequacy of management\u2019s selected unsystematic risk premium. \u2022 As part of our assessment of the unsystematic risk premium, we evaluated the reasonableness of strategic plans expected to be implemented during the forecast period by comparing the forecasts to:", "\u2022 With the assistance of our fair value specialists, we evaluated the reasonableness of the discount rate, including the unsystematic risk premium, by developing a range of independent estimates, testing the mathematical accuracy of the calculation and comparing to the discount rate selected by management.", "We have served as the Company\u2019s auditor since 1968.", "The Company consolidates VIEs when it is determined that it is the primary beneficiary of the VIE.", "Investments in business entities in which the Company does not have control but has the ability to exercise significant influence over operating and financial policies, are accounted for using the equity method.", "Actual amounts could differ from those estimated amounts.", "These legislative acts are not expected to have a material impact on the Company\u2019s consolidated financial results.", "The Company considers itself to control an entity if it is the majority owner of or has voting control over such entity.", "GAAP requires that the Company make estimates and assumptions that", "If a loss in value has occurred that is deemed to be other-than-temporary, an impairment loss is recorded.", "economic environment, customer credit ratings or bankruptcies, as well as reasonable and supportable forecasts.", "We are exposed to credit losses on accounts receivable balances.", "As a result, the Company\u2019s sales and credit concentration is significant.", "The accounts receivables balances are with individual members of the GPOs, and therefore no significant concentration of credit risk exists.", "This credit risk is mitigated by the size and diversity of the Company\u2019s customer base as well as its geographic dispersion.", "These amounts are equivalent to the Company\u2019s LIFO reserves.", "A LIFO credit is recognized when the net effect of price declines exceeds the impact of price increases on pharmaceutical and non-pharmaceutical products held in inventory.", "The increase was primarily due to charges in 2021 totaling $136 million on certain personal protective equipment and other related products due to inventory impairments and excess inventory within our Medical-Surgical Solutions segment.", "When the net realizable value of a disposal group increases during a period, a gain can be recognized to the extent that it does not increase the value of the disposal group beyond its original carrying value when the disposal group was reclassified as held for sale.", "Depreciation and amortization begins when an asset is placed in service and ready for its intended use.", "The use of alternative assumptions and estimates could affect the fair values and change the impairment determinations.", "Measurement of any impairment loss is based on the excess of the carrying value of the asset group over its estimated fair market value.", "customer in an amount that reflects the consideration to which the entity expects to be entitled for that good or service.", "Revenue is recognized when control of goods is transferred to the customer which occurs upon the Company\u2019s delivery to the customer or upon customer  pick-up.", "The ultimate outcome of any outstanding claims may be different than the Company\u2019s estimate.", "If a derivative is designated as a fair value hedge, the changes in the fair value of the derivative and of the hedged item attributable to the hedged risk are recognized in earnings.", "The cumulative changes in fair value are reclassified to the same line as the hedged item in the Consolidated Statements of Operations when the hedged item affects earnings.", "Noncontrolling interests with redemption features, such as put rights, that are not solely within the Company\u2019s control are considered redeemable noncontrolling interests.", "When a loss is considered probable and reasonably estimable, the Company records a liability in the amount of its best estimate for the ultimate loss.", "When a material loss is reasonably possible or probable, but a reasonable estimate cannot be made, disclosure of the proceeding is provided.", "As discussed above, development of a meaningful estimate of loss or a range of potential loss is complex when the outcome is directly dependent on negotiations with or decisions by third parties, such as regulatory agencies, the court system, and other interested parties.", "Any purchase consideration in excess of the estimated fair values of the net assets acquired is recorded as goodwill.", "Restructuring Charges: Employee severance costs are generally recognized when payments are probable and amounts are reasonably estimable.", "The forward-looking model requires the Company to consider historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount in estimating credit losses.", "The adoption of this amended guidance is not expected to have a material impact on the Company\u2019s consolidated financial statements or disclosures.", "accounting policy has been to disclose any intervening events of the joint venture in the lag period that could materially affect its consolidated financial statements.", "McKesson had the ability to adjust the manner in which certain depreciation or amortization deductions are allocated among Change and McKesson.", "This creates uncertainty over the amount, timing, and probability of the gain recognized.", "Any such change is not expected to have a material impact on the Company\u2019s consolidated financial statements.", "This initiative was substantially complete in 2021 and remaining costs the Company expects to record under this initiative are not material.", "This set of initiatives was substantially complete by the end of 2020 and charges in 2021 were not material.", "Goodwill recognized for business acquisitions is generally not expected to be deductible for tax purposes.", "share-based awards that will ultimately vest primarily based on historical experience.", "The estimated forfeiture rate established upon grant is re-assessed throughout the requisite service period and is adjusted when actual forfeitures occur.", "The actual forfeitures in future reporting periods could be higher or lower than current estimates.", "PSUs have a requisite service period of generally three years.", "Compensation expense for the share-based awards is recognized for the portion of awards ultimately expected to vest.", "The number of vested PSUs is assessed at the end of a", "All  outstanding  PeRSU awards  have  completed  the  performance  period  and  are  now classified  and  accounted  for  as RSUs.", "portion of the awards that is ultimately expected to vest.", "Once the fair value of an employee stock option is determined, current accounting practices do not permit it to be changed, even if the estimates used are different from actual.", "The Company believes this market-based input provides a reasonable estimate of its future stock price movements and is consistent with employee stock option valuation considerations.", "These amounts have not been significant for all the years presented.", "Substantially all its foreign net operating losses have indefinite lives.", "The decrease in unrecognized tax benefits in 2020  compared  to  2019  is  primarily  attributable  to  the  favorable  resolution  of  an  outstanding  California  tax  refund  claim  which  decreased  unrecognized  tax benefits by $91 million.", "2017 Tax Act, the repatriation of cash to the U.S. is generally no longer taxable for federal income tax purposes.", "The Company may remit foreign earnings to the U.S. to the extent it is tax efficient to do so.", "It does not expect the tax impact from remitting these earnings to be material.", "The exercise of the Put Right will reduce the balance of redeemable noncontrolling interests.", "The adoption of this guidance did not have a material impact on the Company\u2019s consolidated statements of operations and cash flows.", "The Company\u2019s lease agreements do not contain any material residual value guarantees or material restrictive covenants.", "Operating lease liabilities are recognized based on the present value of the future lease payments over the lease term, discounted at the Company\u2019s incremental borrowing rate as the implicit rate in the lease is not readily determinable for most of the Company\u2019s leases.", "As a practical expedient, short-term leases with an initial term of 12 months or less are excluded from the Consolidated Balance Sheets and charges from these leases are expensed as incurred.", "Fair value estimates result from a complex series of judgments about future events and uncertainties and rely heavily on estimates and assumptions that have been deemed reasonable by management as of the measurement date.", "The unsystematic risk premium is an input factor used in calculating the discount rate that specifically addresses uncertainty related to the reporting unit\u2019s future cash flow projections.", "The risk of successfully achieving certain business initiatives was the primary factor in the use of a higher discount rate.", "and, from time-to-time, future unsecured and unsubordinated indebtedness outstanding.", "As a result of absorbing this risk, the leases provide the Company with the power to direct the operations of the leased properties and the obligation to absorb losses or the right to receive benefits of the entity.", "Consolidated VIEs do not have a material impact on the Company\u2019s Consolidated Statements of Operations and Cash Flows.", "their economic performance and thus is not considered the primary beneficiary of the entities.", "The pension obligation in Germany is unfunded with the exception of the contractual trust arrangement used to fund pensions of McKesson Europe\u2019s Management Board.", "actuarial  losses  exceeding  10%  of  the  greater  of  the  projected  benefit  obligation  or  the  market  value  of  assets  are  amortized  straight-line  over  the  average remaining future service period of active employees.", "Pension obligations for its unfunded plans are based on the recommendations of independent actuaries.", "The difference between actual inflation and assumed inflation in our U.K. pension plans resulted in a gain of $23 million.", "corporate bonds rated AA or better whose maturities are aligned with the expected benefit payments of its plans.", "Plan assets of the non-U.S. plans are broadly invested in a manner appropriate to the nature and duration of the expected future retirement benefits payable under the plans.", "Assets are properly diversified to avoid excessive reliance on any particular asset, issuer, or group of undertakings so as to avoid accumulations of risk in the portfolio as a whole.", "practical expedient are not leveled within the fair value hierarchy and are included as a reconciling item to total investments.", "Actions taken by other participating employers may lead to adverse changes in the financial condition of a multiemployer benefit plan and the Company\u2019s withdrawal liability and contributions may increase.", "It does not use derivatives for trading or speculative purposes.", "Eligible employees may contribute to the RSP up to 75% of", "In the normal course of business, the Company is exposed to interest rate and foreign currency exchange rate fluctuations.", "These forward contracts and cross-currency swaps are generally used to offset the potential income statement effects from intercompany loans and other obligations denominated in non-functional currencies.", "These programs reduce but do not entirely eliminate foreign currency exchange rate risk.", "To the extent foreign currency-denominated notes designated as net investment hedges are ineffective, changes in carrying value attributable to the change in spot rates are recorded in earnings.", "To the extent cross-currency swaps designated as hedges are ineffective, changes in carrying value attributable to the change in spot rates are recorded in earnings.", "Changes in fair values representing hedge ineffectiveness are recognized in current earnings.", "The settlement loss on the swaps was not material and will be amortized on a straight-line basis as interest expense over the five-year life of the 2025 Notes.", "Gains or losses from these contracts are largely offset by changes in the value of the underlying intercompany obligations.", "Changes in the fair value for contracts not designated as hedges are recorded directly in earnings.", "The carrying value of all other cash equivalents approximates their fair value due to their relatively short-term nature.", "These inputs are considered Level 2 under the fair value measurements and disclosure guidance and may not be representative of actual values that could have been realized or that will be realized in the future.", "If the carrying amount of an asset group is not recoverable, an impairment charge is recorded to reduce the carrying amount by the excess over its fair value.", "repurchase of its customers\u2019 inventory or its customers\u2019 debt in the event these customers are unable to meet their obligations to those financial institutions.", "For the Company\u2019s inventory repurchase agreements, among other requirements, inventories must be in resalable condition and any repurchase would be at a discount.", "The majority of the Company\u2019s customers\u2019 debt guarantees are secured by certain assets of the customer.", "The Company\u2019s long-term debt is also recorded at cost.", "The carrying value and fair value of the Company\u2019s long-term debt was as follows:", "Long-lived Assets The Company utilizes multiple approaches including the DCF model and market approaches for estimating the fair value of intangible assets.", "infringe a third party\u2019s intellectual property rights.", "Where appropriate, obligations for such indemnifications are recorded as liabilities.", "Accrued warranty costs were not material to the Consolidated Balance Sheets.", "Significant developments in those matters are described below.", "Company  is  unable  to  determine  that  a  loss  is  probable,  or  to  reasonably  estimate  the  amount  of  loss  or  a  range  of  loss,  for  a  claim  because  of  the  limited information  available  and  the  potential  effects  of future  events  and  decisions  by third  parties,  such  as  courts  and  regulators,  that  will  determine  the  ultimate resolution of the claim.", "It is not uncommon for claims to remain unresolved over many years.", "The Company reviews loss contingencies at least quarterly to determine whether the likelihood of loss has changed and whether it can make a reasonable estimate of the loss or range of loss.", "When the Company determines that a loss from a claim is probable and reasonably estimable, it records a liability for an estimated amount.", "The Company also provides disclosure when it is reasonably possible that a loss may be incurred or when it is reasonably possible that the amount of a loss will exceed its recorded liability.", "Warranties In the normal course of business, the Company provides certain warranties and indemnification protection for its products and services.", "These two West Virginia plaintiffs are not expected to participate in any broader multistate resolution of opioid-related claims.", "The Cherokee Nation is not expected to participate in any broader multistate resolution of opioid-related claims.", "Those non-participating governmental entities would be entitled to pursue their claims against the Company and other defendants.", "The Company believes that it has valid defenses to the claims pending against it, and it intends to vigorously defend against all such claims if acceptable settlement terms are not achieved.", "The Company believes it has valid legal defenses in these matters and intends to mount a vigorous defense.", "The Company has not concluded a loss is probable in any of these matters; nor is the amount of any loss reasonably estimable.", "An adverse judgment or negotiated resolution in any of these matters could have a material adverse impact on the Company\u2019s financial position, cash flows or liquidity, or results of operations.", "AIG and ACE are seeking declarations that they have no duty to defend or indemnify McKesson in the thousands of lawsuits pending in federal and state courts related to opioids.", "Discussions with attorneys general and other parties continue.", "If the negotiating parties agree on terms under the framework for a broad resolution of claims of", "Plaintiffs\u2019 moved for summary judgment on the same day.", "subpoenas and requests in a cooperative, thorough and timely manner.", "These responses sometimes require time and effort and can result in considerable costs being incurred by the Company.", "Such subpoenas and requests can lead to the assertion of claims or the commencement of civil or criminal legal proceedings against the Company and other members of the health care industry, as well as to settlements of claims against the Company.", "The Company responds to these requests in the ordinary course of business.", "The law adopting the excise tax made clear that the OSA does not apply to sales or distributions occurring after December 31, 2018.", "It is not certain at this point in time what proportion of this estimated liability will be borne by the Company.", "However, it is possible that the ultimate costs of these matters may exceed or be less than the reserves.", "Due to the complex nature of the tax laws, it is not possible to estimate the outcome of these matters.", "improper actions to delay or prevent generic drugs from entering the market.", "The quarterly results of operations are not necessarily indicative of the results that may be expected for the entire year.", "effectiveness of the Company\u2019s \u201cdisclosure controls and procedures\u201d (as such term is defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) as of the end of the period  covered  by  this  report  and  have  concluded  that  our  disclosure  controls  and  procedures  are  effective  based  on  their  evaluation  of  these  controls  and procedures as required by paragraph (b) of Exchange Act Rules 13a-15 or 15d-15.", "Rules 13a-15 or 15d-15 that occurred during our fourth quarter of 2021 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.", "caption  \u201cInvestors  -  Corporate  Governance.\u201d  The  Company\u2019s  Corporate  Governance  Guidelines  and  Charters  for  the  Audit,  Compensation  and  Governance Committees can also be found on our website under the same caption.", "Information  about the Code of Conduct applicable  to all employees, officers  and directors can be found on our website, www.mckesson.com, under the", "Information with respect to this item is incorporated by reference from the discussion under the heading \u201cExecutive Compensation\u201d in our Proxy Statement.", "Such non-employee director award is fully vested on the date of the grant.", "subject to and qualified in their entirety by reference to our amended and restated certificate of incorporation, our amended and restated by- laws  and  the  Delaware  General  Corporation  Law  (\u201cDGCL\u201d).  Copies  of  our  amended  and  restated  certificate  of  incorporation  and  our amended and restated by-laws have been filed with the Securities and Exchange Commission (the \u201cSEC\u201d) and are incorporated by reference herein. 100,000,000 shares are preferred stock, par value $0.01 per share.", "We may amend from time to time our amended and restated certificate of incorporation to increase the number of authorized shares of Common Stock and/or preferred stock.", "Any such amendment would require the approval of the holders of a majority of our shares entitled to vote.", "All of our outstanding shares of Common Stock are fully paid and non- assessable.", "Stock are entitled to receive ratably dividends out of assets legally available therefor at such times and in such amounts as our board of directors may from time to time determine.", "ratably in our assets that are legally available for distribution, after payment of all debts, other liabilities and any liquidation preferences of outstanding preferred stock.", "amended and restated certificate of incorporation does not provide for cumulative voting in the election of directors.", "Upon liquidation, dissolution or winding up of our affairs, the holders of Common Stock are entitled to share", "Holders of our Common Stock have no conversion, redemption, preemptive or similar", "Each outstanding share of Common Stock is entitled to one vote on all matters submitted to a vote of stockholders.", "Anti-Takeover Effects of Provisions of Our Amended and Restated Certificate of Incorporation and Our Amended and Restated By- Laws deemed to have an anti-takeover effect and may delay, deter or prevent a tender offer or takeover attempt that a stockholder might consider in its best interest, including those attempts that might result in a premium over the market price for the shares held by stockholders.", "Our amended and restated by-laws provide that special meetings of holders of Common Stock may be called only by our Chair, Chief Executive Officer or a majority of our board of directors for any purpose at any time.", "Holders of Common Stock owning at least 15% of the outstanding shares of Common Stock for at least one year are permitted to submit a special meeting request in accordance with the procedures described in our amended and restated by-laws.", "In general, notice of intent to nominate a director or raise business at such meetings must be received by us not less than 90 nor more than 120 days prior to the date of the  annual meeting and must contain certain specified  information concerning the person to be nominated or the matters to be brought before the meeting and concerning the stockholder submitting the proposal.", "may be amended by a vote of a majority of our board of directors and by the affirmative vote of a majority of the shares of the corporation entitled  to  vote  thereon.  Our  amended  and  restated  certificate  of  incorporation  and  our  amended  and  restated  by-laws  provide  that  our amended and restated by-laws may be amended by a vote of a majority of our board of directors.", "In addition, our amended and restated by- laws provide that our amended and restated by-laws may be amended by the affirmative vote of a majority of the shares of the corporation entitled to vote thereon.", "Current and former stockholders are deemed to have consented to the personal jurisdiction of the Delaware Courts in connection with any action to enforce that exclusive forum provision and to service of process in any such action.", "We  are  subject  to  the  \u201cbusiness  combination\u201d  statute  of  the  DGCL.  In  general,  such  statute  prohibits  a  publicly  held  Delaware", "The statute could prohibit or delay mergers or other takeover or change in control attempts with respect to us and, accordingly, may discourage attempts to acquire us.", "stock could decrease the amount available for distribution to holders of our Common Stock or could adversely affect the rights and powers, including voting rights, of such holders.", "The issuance of preferred stock could have the effect of delaying or preventing a change in control of us.", "Such limitation does not, however, affect the liability of a director (1) for any breach of the director\u2019s duty of loyalty to us or our stockholders, (2) for acts or omissions not in good faith or that involve intentional misconduct or a knowing violation of law, (3) in respect of certain unlawful dividend payments or stock redemptions or purchases and (4) for any transaction from which the director derives an improper personal benefit.", "The effect of this provision is to eliminate our rights and the rights of our stockholders (through stockholders\u2019 derivative suits) to recover monetary damages against a director for breach of the fiduciary duty of care as a director (including breaches resulting from negligent or grossly negligent behavior) except in the situations described in clauses (1) through (4) above.", "This provision does not limit or eliminate our rights or the rights of our stockholders to seek non-monetary relief such as an injunction or rescission in the event of a breach of a director\u2019s duty of care.", "In addition, our directors and officers have indemnification protection.", "principal amount of 0.625% Notes due 2021 and \u20ac600,000,000 aggregate principal amount of 1.500% Notes due 2025, and on February 12, 2018, we issued \u20ac500,000,000 aggregate principal amount of 1.625% Notes due 2026.", "existing and future unsecured and unsubordinated indebtedness from time to time outstanding.", "EQ Shareowner Services acts as transfer agent and registrar of our Common Stock.", "Our Common Stock is listed on the New York Stock Exchange under the symbol \u201cMCK\u201d.", "On  February  17,  2017,  we  issued  \u00a3450,000,000  aggregate  principal  amount  of  3.125%  Notes  due  2029,  \u20ac600,000,000  aggregate", "Securities\u201d), our senior subordinated debt (\u201cSenior Subordinated Debt Securities\u201d), our subordinated debt (\u201cSubordinated Debt Securities\u201d) or our  junior  subordinated  debt  (\u201cJunior  Subordinated  Debt  Securities\u201d  and,  together  with  the  Senior  Subordinated  Debt  Securities  and  the Subordinated Debt Securities, the \u201cSubordinated Securities\u201d).  The Indenture does not limit the amount of debt securities that we may issue.", "It provides that we may issue debt securities up to the principal amount that we may authorize and may be in any currency or currency unit designated  by  us.  Except  for  the  limitations  on  consolidation,  merger  and  sale  of  all  or  substantially  all  of  our  assets  contained  in  the Indenture, the terms of the Indenture do not contain any covenants or other provisions designed to afford holders of any debt securities protection with respect to our operations, financial condition or transactions involving us.", "any person unless (a) we will be the continuing corporation or (b) the successor corporation or person formed by such consolidation or into which we are merged or to which our assets substantially as an entirety are transferred or leased is a corporation, limited liability company or limited partnership organized or existing under the laws of the United States, any state of the United States or the District of Columbia and, if such entity is not a corporation, a co-obligor of the debt securities is a corporation organized or existing under any such laws, and such successor corporation or person, including such co-obligor, if any, expressly assumes our obligations on the debt securities and under the Indenture.", "In addition, we cannot effect such a transaction unless immediately after giving effect to such transaction, no default or Event of Default under the Indenture shall have occurred and be continuing.", "Subject to certain exceptions, when the person to whom our assets are transferred or leased has assumed our obligations under the debt securities and the Indenture, we shall be discharged from all our obligations under the debt securities and the Indenture, except in limited circumstances.", "unless the transaction or change of control were structured to include a merger or consolidation or transfer or lease of all or substantially all of our assets.", "We cannot consolidate or merge with or into, or transfer or lease all or substantially all of our assets to,", "\u2022 any  other  Event  of  Default  provided  in  the  applicable  resolution  of  our  board  of  directors  or  the  officers\u2019  certificate  or supplemental Indenture under which we issue such series of debt securities.", "The Indenture imposes limitations on suits brought by holders of debt securities against us.", "officer knows of any default by us in the performance, observance or fulfillment of any condition or covenant of the Indenture.", "We and the Trustee may not, however, without the consent of the holder of each outstanding debt security affected thereby:", "The Indenture provides that we and the Trustee may enter into supplemental indentures without the", "value of the assets subject to such transaction, as determined by our Board of Directors, or (b) the present value of the remaining obligations of the lessee for net rental payments during the term of any lease discounted at the rate of interest set forth or implicit in the terms of such lease or, if not practicable to determine such rate, the weighted average interest rate per annum borne by the debt securities of each series outstanding pursuant to the Indenture and subject to limitations on sale and lease-back transaction covenants, compounded semi-annually in either case as determined by our principal accounting or financial officer.", "located,  and  substantially  all  the  operations  of  which  are  conducted,  in  the  United  States  of  America  whose  financial  statements  are consolidated with our financial statements in accordance with accounting principles generally accepted in the United States of America.", "Consolidated  Subsidiaries  incurred  after  the  date  of  issuance  of  the  notes  and  secured  by  liens  not  permitted  by  the  limitation  on  liens provisions, and (2) Attributable Debt of ours and our Consolidated Subsidiaries in respect of every sale and lease-back transaction entered into after the date of the issuance of the notes, other than leases permitted by the limitation on sale and lease-back provisions.", "accordance with accounting principles generally accepted in the United States of America.", "Subsidiaries pursuant to which we or any of our Subsidiaries sells, conveys or otherwise transfers to (1) a Receivables Subsidiary (in the case of a transfer by us or any of our Subsidiaries) or (2) any other person (in the case of a transfer by a Receivables Subsidiary), or grants a security interest in, any accounts receivable (whether now existing or arising in the future) or inventory of us or any of our Subsidiaries, and any assets related thereto including, without limitation, all collateral securing such accounts receivable, all contracts and all guarantees or other  obligations  in  respect  of  such  accounts  receivable  or  inventory,  proceeds  of  such  accounts  receivable  and  other  assets  which  are customarily transferred or in respect of which security interests are customarily granted in connection with asset securitization transactions involving accounts receivable or inventory.", "financing of accounts receivable or inventory (a) no portion of the Indebtedness or any other obligations (contingent or otherwise) of which (1)  is  guaranteed  by  us  or  any  Subsidiary  of  ours  (excluding  guarantees  of  obligations  (other  than  the  principal  of,  and  interest  on, Indebtedness) pursuant to representations, warranties, covenants and indemnities entered into in the ordinary course of business in connection with  a  Qualified  Receivables  Transaction),  (2)  is  recourse  or  obligates  us  or  any  Subsidiary  of  ours  in  any  way  other  than  pursuant  to representations,  warranties,  covenants  and  indemnities  entered  into  in  the  ordinary  course  of  business  in  connection  with  a  Qualified Receivables Transaction or (3) subjects any property or asset of ours or any Subsidiary of ours (other than accounts receivable or inventory and related assets as provided in the definition of \u201cQualified Receivables Transaction\u201d), directly or indirectly, contingently or otherwise, to the satisfaction thereof, other than pursuant to representations, warranties, covenants and indemnities entered into in the ordinary course of business in connection with a Qualified Receivables Transaction, (b) with which neither we nor any Subsidiary of ours has any material contract, agreement, arrangement or understanding other than on terms customary for securitization of receivables or inventory and (c) with which neither we nor any Subsidiary of ours has any obligations to maintain or preserve such Subsidiary\u2019s financial condition or cause such Subsidiary to achieve certain levels of operating results.", "Limitation  on  Liens.  We  covenant  that,  so  long  as  any  of  the  Notes  remain  outstanding,  we  will  not,  and  will  not  permit  any", "Indebtedness which is secured by a lien which would otherwise be subject to the foregoing restrictions; provided that after giving effect thereto the Exempted Debt then outstanding at such time does not exceed 10% of our total assets on a consolidated basis.", "than three years, by us or any Consolidated Subsidiary of any assets are prohibited unless (a) we or such Consolidated Subsidiary would be entitled to incur Indebtedness secured by a lien on the assets to be leased in an amount at least equal to the Attributable Debt in respect of such transaction without equally and ratably securing the notes, or (b) the proceeds of the sale of the assets to be leased are at least equal to their fair market value (as determined by our Board of Directors) and the proceeds are applied to the purchase or acquisition, or, in the case of real property, the construction, of assets or to the retirement of Indebtedness.", "The foregoing limitation will not apply, if at the time we or any Consolidated Subsidiary enters into such sale and lease-back transaction, and after giving effect thereto, Exempted Debt does not exceed 10% of our total assets on a consolidated basis.", "time, or in part, from time to time, at our option, for cash, at a redemption price that includes accrued and unpaid interest and a make-whole premium, as specified in the Indenture and the applicable Officer\u2019s Certificate.", "York  Stock  Exchange  under  the  symbol  \u201cMCK25.\u201d  Our  2026  Notes  are  listed  on  the  New  York  Stock  Exchange  under  the  symbol \u201cMCK26.\u201d Our 2029 Notes are listed on the New York Stock Exchange under the symbol \u201cMCK29.\u201d", "This Statement of Terms and Conditions is intended to meet the requirements of Code Section 409A and any regulations and rules promulgated thereunder.", "In the event of any inconsistency between this Statement of Terms and Conditions and the Plan, the Plan shall govern.", "Capitalized terms not otherwise defined in this Statement of Terms and Conditions shall have the meaning set forth in the Plan.", "With respect to  annual  Restricted  Stock  Unit  Awards  granted  to  Outside  Directors  under  the  Plan,  such  awards  shall  be  subject  to  the  following  terms,  conditions  and restrictions.", "The Administrator administering the Plan has authority to determine the Outside Directors to whom, and the time or", "additional Restricted Stock Units, which will be subject to all of the terms and conditions of the underlying Restricted Stock Unit Award.", "The number of such additional Restricted Stock Units shall be calculated by dividing (a) the aggregate amount or value of the dividends paid with respect to that number of Shares equal to the number of Restricted Stock Units credited as of the record date for such dividend by (b) the Fair Market Value per Share on the payment date for such dividend.", "Any fractional Shares resulting from the accumulation of dividend equivalents shall be paid in cash.", "Dividend equivalents in respect of Restricted Stock Units, if granted in tandem with such Units, will be converted into", "Neither an Outside Director nor any person entitled to exercise an Outside Director\u2019s rights in the event of the Outside", "this Statement of Terms and Conditions, or under a Restricted Stock Unit Agreement, shall be conclusive and binding on all persons.", "is providing the consents herein on a purely voluntary basis.", "Nothing herein contained shall affect an Outside Director\u2019s right, if any, to participate in and receive benefits", "Each Outside Director shall agree to make appropriate arrangements with the Corporation for satisfaction of any applicable federal,", "The Corporation will hold and use the Data only as long as is necessary to implement, administer and manage the", "illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.", "Agreements shall be governed by the laws of the State of Delaware.", "The provisions in this Statement of Terms and Conditions are severable and if any one or more provisions are determined to be", "This Statement of Terms and Conditions and the Restricted Stock Unit Agreements shall be binding upon and inure to the benefit of", "This Statement of Terms and Conditions is intended to meet the requirements of Code Section 409A and any regulations and rules promulgated thereunder.", "In the event of any inconsistency between this Statement of Terms and Conditions and the Plan, the Plan shall govern.", "Capitalized terms not otherwise defined in this Statement of Terms and Conditions shall have the meaning set forth in the Plan.", "With respect to  annual  Restricted  Stock  Unit  Awards  granted  to  Outside  Directors  under  the  Plan,  such  awards  shall  be  subject  to  the  following  terms,  conditions  and restrictions.", "The Administrator administering the Plan has authority to determine the Outside Directors to whom, and the time or", "Neither an Outside Director nor any person entitled to exercise an Outside Director\u2019s rights in the event of the Outside", "this Statement of Terms and Conditions, or under a Restricted Stock Unit Agreement, shall be conclusive and binding on all persons.", "is providing the consents herein on a purely voluntary basis.", "Nothing herein contained shall affect an Outside Director\u2019s right, if any, to participate in and receive benefits", "Each Outside Director shall agree to make appropriate arrangements with the Corporation for satisfaction of any applicable federal,", "The Corporation will hold and use the Data only as long as is necessary to implement, administer and manage the", "illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.", "Agreements shall be governed by the laws of the State of Delaware.", "The provisions in this Statement of Terms and Conditions are severable and if any one or more provisions are determined to be", "This Statement of Terms and Conditions and the Restricted Stock Unit Agreements shall be binding upon and inure to the benefit of", "In the event of any inconsistency between this Statement of Terms and Conditions and the Plan, the Plan shall govern.", "Capitalized terms not otherwise defined in this Statement of Terms and Conditions shall have the meaning set forth in the Plan.", "The Option is also subject to the terms and conditions of the Plan.", "In no event shall the Corporation be required to issue fractional Shares.", "An Option granted under the Plan shall be evidenced by an Option Agreement setting forth the terms and conditions of the", "The Exercise Price of an Option, as specified in the Option Agreement, shall be equal to or greater than the Fair Market Value of", "Period, the Option Period shall end on the date of such termination of employment and the Option shall thereupon not be exercisable to any extent whatsoever.", "Term Disability, the vesting schedule of the Participant\u2019s Option shall be accelerated, the Option shall become fully exercisable and the Option Period shall end on the earlier of (i) three years after the date of the Participant\u2019s termination of employment and (ii) the Expiration Date.", "Retirement, (i) the Option shall be exercisable only to the extent that it was exercisable at the time of such retirement and (ii) the Option Period for that portion of the Option designated as a Non Statutory Stock Option shall end on the earlier of (a) three years after the date of such retirement and (b) the Expiration Date.", "of  the  Participant's  Option,  then  the  Option  shall  continue  to  remain  outstanding  until  the  earlier  of  (i)  such  time  as  the  Participant  subsequently  terminates employment and (ii) the Expiration Date.", "number of Shares as to which the Option is so exercised.", "thereunder shall be transferable by the Participant by operation of law or otherwise, other than by will or the laws of descent and distribution.", "have any of the rights of a stockholder with respect to the Shares subject to an Option except to the extent that a book entry has been entered in the records of the Corporation\u2019s transfer agent with respect to such Shares upon the exercise of an Option.", "Neither a Participant nor any person entitled to exercise a Participant\u2019s rights in the event of the Participant\u2019s death shall", "Stock dividends paid with respect to Restricted Stock during the Restriction Period shall be treated as Restricted Stock which shall be subject to the same restrictions as the original award for the duration of the Restriction Period.", "If the Participant does not have a brokerage account of record, then an appropriate book entry recording the Participant\u2019s interest in the unrestricted Shares shall be entered on the records of the Corporation\u2019s transfer agent.", "Cash dividends paid with respect to Restricted Stock during the Restriction Period shall be credited on behalf of the Participant to a", "Election to Recognize Gross Income in the Year of Grant.", "The Administrator reserves the right to impose a restriction on the sale of Shares that the Participant receives upon", "Neither a Participant nor any person entitled to exercise a Participant\u2019s rights in the event of the Participant\u2019s death shall", "The Administrator reserves the right to impose a restriction on the sale of Shares that the Participant receives upon", "Following the end of the performance period, the Compensation Committee shall determine the extent to which the criteria have been achieved and shall authorize the grant and issuance of Shares in respect of the Performance Stock Unit Award.", "The performance period of a Performance Stock Unit Award shall be greater than one year,", "Unless otherwise determined by the Compensation Committee in its sole discretion, Dividend Equivalents shall not be", "A Participant shall not be permitted to sell, transfer, pledge, assign or encumber all or any portion of a Performance Stock Unit", "Neither a Participant nor any person entitled to exercise a Participant\u2019s rights in the event of the Participant\u2019s death shall", "The Administrator reserves the right to impose a restriction on the sale of Shares that the Participant", "addition, any Award of Restricted Stock or Restricted Stock Units as to which the restrictions have not lapsed shall immediately and automatically be forfeited, Performance Stock Unit Awards shall immediately and automatically be forfeited and any such Shares of Restricted Stock shall be returned to the Corporation and all of the rights of the Participant to such Awards and the underlying Shares shall immediately terminate.", "Any outstanding Option shall immediately and automatically terminate, be forfeited and shall cease to be exercisable, without limitation.", "determination shall be conclusive and binding on all interested persons.", "a manner that is valid and enforceable and that comes closest to the business objectives intended by such invalid or unenforceable provision, without invalidating or rendering unenforceable the remaining provisions of this Section VI.", "under an Award Agreement, shall be conclusive and binding on all interested persons.", "Participation in the Plan shall not create a right to further employment with the Participant\u2019s employer (the", "In making grants to Participants in foreign countries, the Administrator has the full discretion to", "All decisions of the Administrator administering the Plan upon any questions arising under the Plan or", "Nothing herein contained shall affect a Participant\u2019s right to participate in and receive benefits from and in", "Regardless  of any  action  the  Corporation  or  the  Employer  takes  with  respect  to  any  federal,  state  or  local  income  tax,  social", "Calculation of the number of Shares to be withheld shall be made based on the closing price of the Common Stock on the New York Stock Exchange on the date that the amount of tax to be withheld is determined.", "With respect to an Award other than an Option, if adequate arrangements to satisfy the obligations with regard to all Tax-Related Items are not made by the Participant with the Corporation and/or the Employer prior to the relevant taxable event, the Corporation will satisfy such obligations as provided above in clause (3) of this paragraph.", "The Administrator shall be authorized to establish such rules, forms and procedures as it deems necessary to implement the foregoing.", "In accepting the grant, the Participant acknowledges that:", "jurisdiction may have different data privacy laws and protections than the United States.", "In the latter case, the Participant understands and acknowledges that the Corporation\u2019s legal basis for the processing of the Participant\u2019s Data would be compliance with the relevant  laws  or  regulations  or  the  pursuit  by  the  Corporation  of  respective  legitimate  interests  not  outweighed  by  the  Participant\u2019s  interests,  rights  or freedoms.", "When the Corporation no longer needs the Participant\u2019s Data for any of the above purposes, the Participant understands the Corporation will remove it from its systems.", "providing the consents herein on a purely voluntary basis.", "illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.", "If the Participant has received this Statement of Terms and Conditions or any other document related to the Plan translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control.", "The provisions in this Statement of Terms and Conditions are severable and if any one or more provisions are determined to be", "The Participant acknowledges that the Participant is proficient in the English language and, accordingly, understands the provisions of", "The Corporation will hold and use the Data only as long as is necessary to implement, administer and manage the", "Participation in the Plan is voluntary and the Participant is", "In the event of any inconsistency between this Statement of Terms and Conditions and the Plan, the Plan shall govern.", "Capitalized terms not otherwise defined in this Statement of Terms and Conditions shall have the meaning set forth in the Plan.", "The Option is also subject to the terms and conditions of the Plan.", "In no event shall the Corporation be required to issue fractional Shares.", "An Option granted under the Plan shall be evidenced by an Option Agreement setting forth the terms and conditions of the", "The Exercise Price of an Option, as specified in the Option Agreement, shall be equal to or greater than the Fair Market Value of", "Period, the Option Period shall end on the date of such termination of employment and the Option shall thereupon not be exercisable to any extent whatsoever.", "Term Disability, the vesting schedule of the Participant\u2019s Option shall be accelerated, the Option shall become fully exercisable and the Option Period shall end on the earlier of (i) three years after the date of the Participant\u2019s termination of employment and (ii) the Expiration Date.", "Retirement, (i) the Option shall be exercisable only to the extent that it was exercisable at the time of such retirement and (ii) the Option Period for that portion of the Option designated as a Nonstatutory Stock Option shall end on the earlier of (a) three years after the date of such retirement and (b) the Expiration Date.", "of  the  Participant's  Option,  then  the  Option  shall  continue  to  remain  outstanding  until  the  earlier  of  (i)  such  time  as  the  Participant  subsequently  terminates employment and (ii) the Expiration Date.", "number of Shares as to which the Option is so exercised.", "thereunder shall be transferable by the Participant by operation of law or otherwise, other than by will or the laws of descent and distribution.", "have any of the rights of a stockholder with respect to the Shares subject to an Option except to the extent that a book entry has been entered in the records of the Corporation\u2019s transfer agent with respect to such Shares upon the exercise of an Option.", "Neither a Participant nor any person entitled to exercise a Participant\u2019s rights in the event of the Participant\u2019s death shall", "Stock dividends paid with respect to Restricted Stock during the Restriction Period shall be treated as Restricted Stock which shall be subject to the same restrictions as the original award for the duration of the Restriction Period.", "If the Participant does not have a brokerage account of record, then an appropriate book entry recording the Participant\u2019s interest in the unrestricted Shares shall be entered on the records of the Corporation\u2019s transfer agent.", "Cash dividends paid with respect to Restricted Stock during the Restriction Period shall be credited on behalf of the Participant to a", "Election to Recognize Gross Income in the Year of Grant.", "The Administrator reserves the right to impose a restriction on the sale of Shares that the Participant receives upon", "Neither a Participant nor any person entitled to exercise a Participant\u2019s rights in the event of the Participant\u2019s death shall", "The Administrator reserves the right to impose a restriction on the sale of Shares that the Participant receives upon", "The performance period of a Performance Stock Unit Award shall be greater than one year,", "Unless otherwise determined by the Compensation Committee in its sole discretion, Dividend Equivalents shall not be", "A Participant shall not be permitted to sell, transfer, pledge, assign or encumber all or any portion of a Performance Stock Unit", "Neither a Participant nor any person entitled to exercise a Participant\u2019s rights in the event of the Participant\u2019s death shall", "The Administrator reserves the right to impose a restriction on the sale of Shares that the Participant", "addition, any Award of Restricted Stock or Restricted Stock Units as to which the restrictions have not lapsed shall immediately and automatically be forfeited, Performance Stock Unit Awards shall immediately and automatically be forfeited and any such Shares of Restricted Stock shall be returned to the Corporation and all of the rights of the Participant to such Awards and the underlying Shares shall immediately terminate.", "Any outstanding Option shall immediately and automatically terminate, be forfeited and shall cease to be exercisable, without limitation.", "determination shall be conclusive and binding on all interested persons.", "a manner that is valid and enforceable and that comes closest to the business objectives intended by such invalid or unenforceable provision, without invalidating or rendering unenforceable the remaining provisions of this Section VI.", "under an Award Agreement, shall be conclusive and binding on all interested persons.", "Participation in the Plan shall not create a right to further employment with the Participant\u2019s employer (the", "In making grants to Participants in foreign countries, the Administrator has the full discretion to", "All decisions of the Administrator administering the Plan upon any questions arising under the Plan or", "Nothing herein contained shall affect a Participant\u2019s right to participate in and receive benefits from and in", "Regardless  of any  action  the  Corporation  or  the  Employer  takes  with  respect  to  any  federal,  state  or  local  income  tax,  social", "Calculation of the number of Shares to be withheld shall be made based on the closing price of the Common Stock on the New York Stock Exchange on the date that the amount of tax to be withheld is determined.", "With respect to an Award other than an Option, if adequate arrangements to satisfy the obligations with regard to all Tax-Related Items are not made by the Participant with the Corporation and/or the Employer prior to the relevant taxable event, the Corporation will satisfy such obligations as provided above in clause (3) of this paragraph.", "The Administrator shall be authorized to establish such rules, forms and procedures as it deems necessary to implement the foregoing.", "In accepting the grant, the Participant acknowledges that:", "jurisdiction may have different data privacy laws and protections than the United States.", "In the latter case, the Participant understands and acknowledges that the Corporation\u2019s legal basis for the processing of the Participant\u2019s Data would be compliance with the relevant  laws  or  regulations  or  the  pursuit  by  the  Corporation  of  respective  legitimate  interests  not  outweighed  by  the  Participant\u2019s  interests,  rights  or freedoms.", "When the Corporation no longer needs the Participant\u2019s Data for any of the above purposes, the Participant understands the Corporation will remove it from its systems.", "providing the consents herein on a purely voluntary basis.", "illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.", "If the Participant has received this Statement of Terms and Conditions or any other document related to the Plan translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control.", "The provisions in this Statement of Terms and Conditions are severable and if any one or more provisions are determined to be", "The Participant acknowledges that the Participant is proficient in the English language and, accordingly, understands the provisions of", "The Corporation will hold and use the Data only as long as is necessary to implement, administer and manage the", "Participation in the Plan is voluntary and the Participant is", "In the event of any inconsistency between this Statement of Terms and Conditions and the Plan, the Plan shall govern.", "Capitalized terms not otherwise defined in this Statement of Terms and Conditions shall have the meaning set forth in the Plan.", "The Option is also subject to the terms and conditions of the Plan.", "In no event shall the Corporation be required to issue fractional Shares.", "An Option granted under the Plan shall be evidenced by an Option Agreement setting forth the terms and conditions of the", "The Exercise Price of an Option, as specified in the Option Agreement, shall be equal to or greater than the Fair Market Value of", "Period, the Option Period shall end on the date of such termination of employment and the Option shall thereupon not be exercisable to any extent whatsoever.", "Term Disability, the vesting schedule of the Participant\u2019s Option shall be accelerated, the Option shall become fully exercisable and the Option Period shall end on the earlier of (i) three years after the date of the Participant\u2019s termination of employment and (ii) the Expiration Date.", "Retirement, (i) the Option shall be exercisable only to the extent that it was exercisable at the time of such retirement and (ii) the Option Period for that portion of the Option designated as a Non Statutory Stock Option shall end on the earlier of (a) three years after the date of such retirement and (b) the Expiration Date.", "of  the  Participant's  Option,  then  the  Option  shall  continue  to  remain  outstanding  until  the  earlier  of  (i)  such  time  as  the  Participant  subsequently  terminates employment and (ii) the Expiration Date.", "number of Shares as to which the Option is so exercised.", "thereunder shall be transferable by the Participant by operation of law or otherwise, other than by will or the laws of descent and distribution.", "have any of the rights of a stockholder with respect to the Shares subject to an Option except to the extent that a book entry has been entered in the records of the Corporation\u2019s transfer agent with respect to such Shares upon the exercise of an Option.", "Neither a Participant nor any person entitled to exercise a Participant\u2019s rights in the event of the Participant\u2019s death shall", "Stock dividends paid with respect to Restricted Stock during the Restriction Period shall be treated as Restricted Stock which shall be subject to the same restrictions as the original award for the duration of the Restriction Period.", "If the Participant does not have a brokerage account of record, then an appropriate book entry recording the Participant\u2019s interest in the unrestricted Shares shall be entered on the records of the Corporation\u2019s transfer agent.", "Cash dividends paid with respect to Restricted Stock during the Restriction Period shall be credited on behalf of the Participant to a", "Election to Recognize Gross Income in the Year of Grant.", "Neither a Participant nor any person entitled to exercise a Participant\u2019s rights in the event of the Participant\u2019s death shall", "Following the end of the performance period, the Compensation Committee shall determine the extent to which the criteria have been achieved and shall authorize the grant and issuance of Shares in respect of the Performance Stock Unit Award.", "The performance period of a Performance Stock Unit Award shall be greater than one year,", "addition, any Award of Restricted Stock or Restricted Stock Units as to which the restrictions have not lapsed shall immediately and automatically be forfeited, Performance Stock Unit Awards shall immediately and automatically be forfeited and any such Shares of Restricted Stock shall be returned to the Corporation and all of the rights of the Participant to such Awards and the underlying Shares shall immediately terminate.", "Unless otherwise determined by the Compensation Committee in its sole discretion, Dividend Equivalents shall not be", "A Participant shall not be permitted to sell, transfer, pledge, assign or encumber all or any portion of a Performance Stock Unit", "Neither a Participant nor any person entitled to exercise a Participant\u2019s rights in the event of the Participant\u2019s death shall", "Any outstanding Option shall immediately and automatically terminate, be forfeited and shall cease to be exercisable, without limitation.", "determination shall be conclusive and binding on all interested persons.", "a manner that is valid and enforceable and that comes closest to the business objectives intended by such invalid or unenforceable provision, without invalidating or rendering unenforceable the remaining provisions of this Section VI.", "Participation in the Plan shall not create a right to further employment with the Participant\u2019s employer (the", "In making grants to Participants in foreign countries, the Administrator has the full discretion to", "under an Award Agreement, shall be conclusive and binding on all interested persons.", "Calculation of the number of Shares to be withheld shall be made based on the closing price of the Common Stock on the New York Stock Exchange on the date that the amount of tax to be withheld is determined.", "With respect to an Award other than an Option, if adequate arrangements to satisfy the obligations with regard to all Tax-Related Items are not made by the Participant with the Corporation and/or the Employer prior to the relevant taxable event, the Corporation will satisfy such obligations as provided above in clause (3) of this paragraph.", "All decisions of the Administrator administering the Plan upon any questions arising under the Plan or", "Nothing herein contained shall affect a Participant\u2019s right to participate in and receive benefits from and in", "Regardless  of any  action  the  Corporation  or  the  Employer  takes  with  respect  to  any  federal,  state  or  local  income  tax,  social", "The Administrator shall be authorized to establish such rules, forms and procedures as it deems necessary to implement the foregoing.", "In accepting the grant, the Participant acknowledges that:", "jurisdiction may have different data privacy laws and protections than the United States.", "In the latter case, the Participant understands and acknowledges that the Corporation\u2019s legal basis for the processing of the Participant\u2019s Data would be compliance with the relevant  laws  or  regulations  or  the  pursuit  by  the  Corporation  of  respective  legitimate  interests  not  outweighed  by  the  Participant\u2019s  interests,  rights  or freedoms.", "When the Corporation no longer needs the Participant\u2019s Data for any of the above purposes, the Participant understands the Corporation will remove it from its systems.", "providing the consents herein on a purely voluntary basis.", "The Corporation will hold and use the Data only as long as is necessary to implement, administer and manage the", "Participation in the Plan is voluntary and the Participant is", "illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.", "If the Participant has received this Statement of Terms and Conditions or any other document related to the Plan translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control.", "The provisions in this Statement of Terms and Conditions are severable and if any one or more provisions are determined to be", "The Participant acknowledges that the Participant is proficient in the English language and, accordingly, understands the provisions of", "In the event of any inconsistency between this Award Agreement and the Plan, the Plan shall govern.", "Capitalized terms not otherwise defined in this Award Agreement shall have the meaning set forth in the Plan.", "determine the extent to which the performance goals have been achieved, and shall determine the number of PSUs that have been earned.", "Once the Compensation Committee has determined the number of PSUs that have been earned pursuant to the", "Dividend equivalents shall be credited in respect of the One-Year RSU Award.", "The restrictions applicable to the RSU Award shall lapse with respect to 100% of the underlying Shares on the third", "Dividend equivalents shall be credited in respect of the RSU Award granted under this Section III.", "If the Participant ceases to be a bona fide employee of the Corporation or any Affiliate (except as otherwise", "otherwise  forfeited  pursuant  to  the  terms  of  the  Plan  and  this  Award  Agreement  shall  be  paid  to  the  Participant  as  soon  as  reasonably  practicable  after  the restrictions lapse.", "Performance  Stock  Units and  Restricted  Stock  Units,  to  the  extent  the  restrictions  have  not  lapsed,  shall  immediately  and  automatically  be", "determination shall be conclusive and binding on all interested persons.", "a manner that is valid and enforceable and that comes closest to the business objectives intended by such invalid or unenforceable provision, without invalidating or rendering unenforceable the remaining provisions of this Section IV.", "Compensation Committee reserves the right to impose a restriction on the sale of Shares that the Participant receives upon the settlement of the Performance Stock Units and Restricted Stock Units granted hereunder, unless the Participant has satisfied the ownership targets applicable to the Participant as provided in such policy.", "Neither the Participant nor any person entitled to exercise the Participant\u2019s rights in the event of the Participant\u2019s death", "Participation in the Plan shall not create a right to further employment with the Participant\u2019s employer (the", "under this Award Agreement, shall be conclusive and binding on all interested persons.", "Calculation of the number of Shares to be withheld shall be made based on the closing price of the Common Stock on the New York Stock Exchange on the date that the amount of tax to be withheld is determined.", "If adequate arrangements to satisfy the obligations with regard to all Tax-Related Items are not made by the Participant with the Corporation and/or the Employer prior to the relevant taxable event, the Corporation will satisfy such obligations as provided above in clause (iii) of this paragraph.", "The Administrator has the full discretion to deviate from this Award Agreement in order to adjust the Awards", "All decisions of the Administrator administering the Plan upon any questions arising under the Plan or", "Nothing herein contained shall affect the Participant\u2019s right to participate in and receive benefits from and in", "Regardless  of any  action  the  Corporation  or  the  Employer  takes  with  respect  to  any  federal,  state  or  local  income  tax,  social", "The Administrator shall be authorized to establish such rules, forms and procedures as it deems necessary to implement the foregoing.", "In accepting the grant, the Participant acknowledges that:", "providing the consents herein on a purely voluntary basis.", "The Corporation will hold and use the Data only as long as is necessary to implement, administer and manage the", "Participation in the Plan is voluntary and the Participant is", "unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.", "English and if the meaning of the translated version is different than the English version, the English version will control.", "Award, the terms of which are set forth herein and in the Plan.", "The provisions in this Award Agreement are severable and if any one or more provisions are determined to be illegal or otherwise", "Below is a list of documents that are made available to you in connection with this Notice.", "PLEASE BE SURE TO READ THESE DOCUMENTS BECAUSE THEY CONTAIN IMPORTANT INFORMATION SPECIFIC TO THIS GRANT OF RSUs.", "By signing below, I acknowledge that: 1.    I agree to receive copies of the stockholder information, including copies of any annual report, proxy and Form 10-K, from the Investor Resources section of", "Below is a list of documents that are made available to you in connection with this Notice.", "PLEASE BE SURE TO READ THESE DOCUMENTS BECAUSE THEY CONTAIN IMPORTANT INFORMATION SPECIFIC TO THIS GRANT OF RSUs.", "I consent to receiving electronically a copy of the documents set forth above and attachments to this Notice; and 5.", "I accept ALL the terms and conditions as set forth in the Plan and ST&Cs applicable to this grant of RSUs.", "Your  PSUs  will  be  earned  subject  to  the  Company\u2019s  attainment  of  performance  goals  that  have  been  pre-established  by  the  Compensation  Committee  (the \u201cCommittee\u201d) of the Company\u2019s Board of Directors.", "Below is a list of documents that are made available to you in connection with this Notice.", "PLEASE BE SURE TO READ THESE DOCUMENTS BECAUSE THEY CONTAIN IMPORTANT INFORMATION SPECIFIC TO THIS GRANT OF PSUs.", "I consent to receiving electronically a copy of the documents set forth above and attachments to this Notice; and 12.", "I should consult with a tax advisor prior to accepting this grant of PSUs or taking any other action with respect to this grant of PSUs; and 14.", "I accept ALL the terms and conditions as set forth in the Plan and ST&Cs applicable to this grant of PSUs.", "We consent to the incorporation by reference in McKesson Corporation Registration Statement Nos. 333-249817, 333-163642, 333-190847, 333-190848, and 333- 213488 on Form S-8, and Registration Statement No. 333-236808 on Form S-3, of our report dated May 12, 2021, relating to the consolidated financial statements and consolidated financial statement schedule of McKesson Corporation and subsidiaries, and the effectiveness of McKesson Corporation\u2019s internal control over financial reporting appearing in this Annual Report on Form 10-K of McKesson Corporation for the year ended March 31, 2021.", "I have reviewed this annual report on Form 10-K of McKesson Corporation;", "The registrant\u2019s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant\u2019s auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):", "I have reviewed this annual report on Form 10-K of McKesson Corporation;", "The registrant\u2019s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant\u2019s auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):", "Together, we work across the healthcare delivery system to connect pharmacies, providers, payers, and biopharma for next-generation patient access and adherence solutions that help people get the medicine they need to live healthier lives.", "Unless otherwise noted, all references in this document to a particular year shall mean the", "On March 10, 2020, we completed the separation of our interest in the Change Healthcare JV through a split- off transaction.", "This transaction reduced our investment in the Change Healthcare JV to zero.", "Change Healthcare: Our equity ownership interest in Change Healthcare JV, a joint venture, has been accounted for using the equity method of accounting.", "for our innovations and obtain copyright protection for our original works of authorship, when such protection is advantageous.", "Through these efforts, we have developed a portfolio of patents and copyrights in the U.S. and worldwide.", "In addition, we have registered or applied to register certain trademarks and service marks in the U.S. and in foreign countries.", "We cannot guarantee that our intellectual property portfolio will be sufficient to deter misappropriation, theft, or misuse of our technology, nor that we can successfully enjoin infringers.", "We periodically receive notices alleging that our products or services infringe on third party patents and other intellectual property rights.", "While the outcome of any litigation or dispute is inherently uncertain, we do not believe that the resolution of any of these infringement notices would have a material adverse impact on our results of operation.", "These values and behaviors help make McKesson unique.", "We offer financial assistance programs for higher education opportunities that support employees\u2019 career growth at the company.", "To provide compensation that is focused on attracting and retaining talent with the skills and experience necessary for a specific role, our compensation program is built on a set of quantifiable factors defined by our guiding principles of internal fairness, market competitiveness, and pay for performance.", "We operate in several countries and our benefits offerings vary accordingly.", "We offer health and wellness benefits to advance the physical, mental, and social well-being of our people, savings programs to help prepare them for retirement, and flexible work arrangements, among other  benefits  offerings,  when  possible.  In  response  to  the  COVID-19  pandemic,  we  offered  extended  medical  benefits  covering  COVID-19  related  visits, treatment and testing, expanded telehealth options, emergency paid time off (\u201cPTO\u201d), and a platform for employees to donate their regular PTO to co-workers who were  more  impacted  by  COVID-19.", "We have received monetary penalties and/or licensing sanctions pursuant to these requirements and future allegations of noncompliance could result in an inability to obtain, maintain or renew permits, licenses or other regulatory approvals needed for the operation of our businesses.", "As a result of ongoing, advanced discussions with state attorneys general and plaintiffs\u2019 representatives regarding a framework to resolve the claims of governmental entities, and our assessment of certain other opioid-related claims, we have reached a stage at which a broad settlement of opioid claims by governmental entities is probable and recorded a charge of $8.1 billion for the year ended March 31, 2021 within \u201cClaims and litigation charges, net\u201d in our Consolidated Statement of Operations in this Annual Report on Form 10-K.", "Because of the many uncertainties associated with any potential settlement arrangement or other resolution of opioid-related litigation, including the uncertainty of the scope of participation by plaintiffs in any potential settlement, we are not able to reasonably estimate the upper or lower ends of the range of ultimate possible loss for all opioid-related litigation matters.", "The adverse outcome of legal proceedings might also involve significant  expense,  management  time  and  distraction,  and risk  of loss that  can be difficult  to predict  or quantify.  In addition  to this litigation,  legislative  or regulatory measures related to the distribution of controlled substances such as prescription opioids could affect our business in ways that we may not be able to predict.", "For example, some states have passed legislation that could require us to pay taxes or assessments on the distribution of opioid medications in those states and other states have considered similar legislation.", "We are subject to government audits,  investigations  and  oversight  proceedings.  Government  agencies  routinely  review  and  audit  government  contractors  to  determine  whether  they  are complying with contractual and legal requirements.", "If we fail to comply with these requirements, or we fail an audit, we may be subject to various sanctions such as monetary damages, criminal and civil penalties, termination of contracts and suspension or debarment from government contract work.", "These requirements complicate our business and increase our compliance burden and material non-compliance could harm our reputation.", "affecting  Medicare,  Medicaid,  other  government  healthcare  programs,  and  government  contracts.  Our  relationships  with  pharmaceutical  and  medical  surgical product manufacturers and healthcare providers, as well as our provision of products and services to government entities, subject our business to laws, regulation, and government guidance on fraud and abuse.", "Many of these laws are vague or indefinite and have not been interpreted by the courts and, as such, may be interpreted or applied by a prosecutorial, regulatory, or judicial authority in a manner that could require us to make changes in our operations.", "Americans and changed the way healthcare is financed by both governmental and private payers.", "There are also further efforts to broaden healthcare coverage.", "Provincial governments in Canada that provide partial funding for the purchase of pharmaceuticals and independently regulate the sale and reimbursement of drugs have sought to reduce the costs of publicly funded health programs.", "Some European governments  have  implemented  or  are  considering  austerity  measures  to  reduce  healthcare  spending.  These  measures  exert  pressure  on  the  pricing  and reimbursement timelines for pharmaceuticals and may cause our customers to purchase fewer of our products and services or influence us to reduce prices.", "There is substantial uncertainty about the likelihood, timing and results of these health reform efforts.", "We also have record- keeping  and  other  obligations  under  the  E.U.  Falsified  Medicines  Directive.  Pedigree  tracking  laws  such  as  these  increase  our  compliance  burden  and  our pharmaceutical distribution costs.", "For example, under the Health Insurance Portability and Accountability Act of 1996 (\u201cHIPAA\u201d) we must maintain administrative, physical  and  technological  safeguards  to  protect  individually  identifiable  health  information  (\u201cprotected  health  information\u201d)  and  ensure  the  confidentiality, integrity, and availability of electronic protected health information.", "We are subject to significant compliance obligations under privacy laws such as the General Data Protection Regulation (\u201cGDPR\u201d) in the European Union, the Personal Information Protection and Electronic Documents Act (\u201cPIPEDA\u201d) in Canada, and the California Consumer Protection Act (\u201cCCPA\u201d).", "We are subject to privacy  and  data  protection  compliance  audits  or  investigations  by  various  government  agencies.  Failure  to  comply  with  these  laws  subjects  us  to  potential regulatory enforcement activity, fines, private litigation including class actions, and other costs.", "We also have contractual obligations to customers that might be breached if we fail to comply with privacy laws.", "Our efforts to comply with privacy laws complicate our operations and add to our compliance costs.", "storage and hosting of sensitive information, including protected health information and other types of personal information, confidential financial information, proprietary information, and other sensitive information relating to our customers, company and workforce.", "costs.  Environmental  costs  and  accruals,  including  that  related  to  our  legacy  chemical  distribution  operations,  presently  are  not  material  to our  operations  or financial position.", "Our ten largest customers comprised approximately 32%, and CVS was approximately 19%, of total trade accounts receivable at March 31, 2021.", "We also have agreements with GPOs, each of which functions as a purchasing agent on behalf of member  hospitals,  pharmacies  and other healthcare  providers,  as well as with government  entities  and agencies.  The accounts receivable balances are with individual members of the GPOs, and therefore no significant concentration of credit risk exists.", "Substantially all of these revenues and accounts receivable are included in our U.S.", "distribution arrangements with pharmaceutical manufacturers that include an inflation-based compensation component whereby we benefit when the manufacturers increase their prices as we sell our existing inventory at the new higher prices.", "Forward-looking  statements  involve  risks  and  uncertainties  that  could  cause  actual  results  to  differ  materially  from  those  projected,  anticipated,  or  implied.", "Except to the extent required by federal securities laws, we undertake no obligation to publicly release the result of any revisions to any forward-looking statements to reflect events or circumstances after the date the statements are made, or to reflect the occurrence of unanticipated events.", "Some of our distribution arrangements with the manufacturers provides us compensation based on a percentage of our purchases.", "We experience costly and disruptive legal disputes.", "Despite valid defenses that we assert, legal disputes are often costly, time-consuming, distracting to management and disruptive to normal business operations.", "The outcome of legal disputes is difficult to predict.", "Outcomes can occur that are not justified by the evidence or existing law.", "The uncertainty and expense associated with unresolved legal disputes might harm our business and reputation even if the matter is favorably resolved.", "Accordingly, any legal dispute might have a materially adverse impact on our reputation, our business operations and our financial position or results of operations.", "We might experience losses not covered by insurance.", "supplies, the provision of ancillary services, the conduct of our payer businesses and the provision of products that assist clinical decision-making and relate to patient medical histories and treatment plans.", "Although we seek to maintain adequate insurance coverage,  such  as  property  insurance  for  inventory  and  professional  and  general  liability  insurance,  coverages  on  acceptable  terms  might  be  unavailable,  or coverages might not cover our losses.", "We generally seek to limit our contractual exposure, but limitations of liability or indemnity provisions in our contracts may not be enforceable or adequately protect us from liability.", "Uninsured losses might have a materially adverse impact on our business operations and our financial position or results of operations.", "We regularly are named as a defendant in similar, new cases.", "Many of these cases raise novel theories of liability.", "Any proceedings can have unexpected outcomes that are not justified by evidence or existing law.", "It is not uncommon for claims to be resolved over many years.", "Although the Company has valid defenses and is vigorously defending itself, some proceedings have been and others may be resolved by negotiated outcome.", "Our reputation has been and may continue to be impacted by publicity regarding the litigation and related allegations.", "The adverse outcome of legal proceedings might have a materially adverse impact on our business operations and our financial position or results of operations.", "For example, some states have passed legislation that could require us to pay taxes or assessments on the distribution of opioid medications in those states and other states have considered similar legislation.", "Liabilities for taxes or assessments or other costs of compliance under any such laws might have a materially adverse impact on our reputation, business operations, and our financial position or results of operations.", "We are subject to extensive, complex and challenging healthcare and other laws.", "Any noncompliance by us with applicable laws or the failure to maintain, renew or obtain necessary permits and licenses could lead to litigation and might have a materially adverse impact on our business operations and our financial position or results of operations.", "Local, state and federal governments continue to strengthen their position and scrutiny over practices involving or allegedly involving fraud, waste and abuse affecting Medicare, Medicaid and other government healthcare programs.", "Our relationships with pharmaceutical and medical surgical product manufacturers and healthcare providers, as well as our provision of products and services to government entities, subject our business to laws and regulations on fraud and abuse, which among other things: (1) prohibit persons from soliciting, offering, receiving or paying any remuneration in order to induce the referral of a patient for treatment  or  to  induce  the  ordering  or  purchasing  of  items  or  services  that  are  in  any  way  paid  for  by  Medicare,  Medicaid  or  other  government-sponsored healthcare programs; (2) impose many restrictions upon referring physicians and providers of designated health services under Medicare and Medicaid programs; and (3) prohibit the knowing submission of a false or fraudulent claim for payment to, and knowing retention of an overpayment by, a federal healthcare program such  as  Medicare  and  Medicaid.  Many  of  these  laws,  regulations,  and  government  guidance,  including  those  relating  to  marketing  incentives,  are  vague  or indefinite and have not been interpreted by the courts.", "The laws may be interpreted or applied by a prosecutorial, regulatory, or judicial authority in a manner that could require us to make changes in our operations.", "Failures to comply with applicable laws subject us to federal or state government investigations or qui tam actions, and to liability for damages and civil and criminal penalties, including the loss of licenses or our ability to participate in Medicare, Medicaid and other federal and state healthcare programs.", "These sanctions might have a materially adverse impact on our business operations and our financial position or results of operations.", "Noncompliance with these requirements has resulted in monetary penalties and/or licensing sanctions.", "For example, under a January 2017 agreement with the DEA and Department of Justice we paid $150 million to settle potential administrative and civil claims about our practices for reporting suspicious orders of controlled substances and the DEA suspended, on a staggered basis for limited periods of time, our registrations to distribute certain controlled substances from four distribution centers.", "Pedigree tracking laws increase our compliance burden and our pharmaceutical distribution costs.", "Pedigree tracking laws such as these increase our compliance burden and our pharmaceutical distribution costs, and they might have a materially adverse impact on our business operations and our financial position or results of operations.", "Privacy and data protection laws increase our compliance burden.", "example,  under  the  Health  Insurance  Portability  and  Accountability  Act  of  1996  (\u201cHIPAA\u201d)  we  must  maintain  administrative,  physical  and  technological safeguards  to  protect  individually  identifiable  health  information  (\u201cprotected  health  information\u201d)  and  ensure  the  confidentiality,  integrity  and  availability  of electronic protected health information.", "Failure to comply with these laws subjects us to potential regulatory enforcement activity, fines, private litigation including class actions, and other costs.", "We also have contractual obligations to customers that might be breached if we fail to comply with privacy laws.", "Our efforts to comply with privacy laws complicates our operations and adds to our compliance costs.", "A significant privacy breach or failure  to  comply  with  privacy  laws  might  have  a  materially  adverse  impact  on  our  reputation,  business  operations  and  our  financial  position  or  results  of operations.", "Anti-bribery and anti-corruption laws increase our compliance burden.", "Bribery Act unless the organization can establish the defense of having implemented adequate procedures to prevent bribery.", "Our failure to comply with these laws might subject us to civil and criminal penalties that might have a materially adverse impact on our reputation, business operations and our financial position or results of operations.", "We are subject to a variety of privacy and data protection laws that change frequently and have requirements that vary from jurisdiction to jurisdiction.", "We  are  subject  to  laws  prohibiting  improper  payments  and  bribery,  including  the  U.S.  Foreign  Corrupt  Practices  Act,  the  U.K.  Bribery  Act  and  similar", "We might record significant charges from impairment to goodwill, intangibles and other assets or investments.", "In addition, we periodically review our intangible and other long-lived assets for impairment when events or changes in circumstances, such as a divestiture, indicate the carrying value may not be recoverable.", "Factors that may be considered a change in circumstances indicating that  the  carrying  value  of  our  intangible  and  other  long-lived  assets  may  not  be  recoverable  include  slower  growth  rates,  the  loss  of  a  significant  customer, burdensome new laws or divestiture of a business or asset for less than its carrying value.", "There are inherent uncertainties in management\u2019s estimates, judgments and assumptions used in assessing recoverability of goodwill, intangible and other long-lived assets.", "We may be required to record a significant charge to earnings in our consolidated financial statements during the period in which any impairment of our goodwill or intangible and other long-lived assets is determined, which might have a materially adverse impact on our business operations and our financial position or results of operations.", "storage and hosting of sensitive information, including protected health information and other types of personal information, confidential financial information, proprietary information, and other sensitive information relating to our customers, company and workforce.", "If our software and technology services are alleged to have contributed to faulty clinical decisions or injury to patients, we might be subject to claims or litigation by users of our software or services or their patients.", "Any of these types of errors or failures might have a materially adverse impact on our reputation, business operations and our financial position or results of operations.", "We  are  required  under  U.S.  Generally  Accepted  Accounting  Principles  (\u201cGAAP\u201d)  to  test  our  goodwill  for  impairment  annually  or  more  frequently  if", "We might be impeded in providing customers online services and data access.", "Any such problems might have a materially adverse impact on our business operations and our financial position or results of operations.", "Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.", "we may require financing that may not be available on acceptable terms.", "Any of these risks could adversely affect our ability to achieve the anticipated benefits of an acquisition and might have a materially adverse impact on our business operations and our financial position or results of operations.", "Exclusive forum provisions in our Bylaws could limit our stockholders\u2019 ability to choose their preferred judicial forum for disputes with us or our directors, officers or employees.", "Current and former stockholders are deemed to have consented to the personal jurisdiction of the Delaware Courts in connection with any action to enforce that exclusive forum provision and to service of process in any such action.", "To the extent that these provisions of the bylaws limit a current or former stockholder\u2019s ability to select a judicial forum other than the Delaware Courts, they might discourage the specified legal actions, might cause current or former stockholders to incur additional litigation-related expenses and might result in outcomes unfavorable to current or former stockholders.", "A court might determine that these provisions of the bylaws are inapplicable or unenforceable in any particular action, in which case we may incur additional litigation related expenses in such action, and the action may result in outcomes unfavorable to us, which could have a materially adverse impact on our reputation, our business operations and our financial position or results of operations.", "We might be adversely impacted by delays or other difficulties with divestitures.", "After the disposition, we might experience greater dissynergies than expected, and the impact of the divestiture on our revenue or profit might be larger than we expected.", "We might have difficulties with pre-closing conditions such as regulatory and governmental approvals, which could delay or prevent the divestiture.", "We might have financial exposure in a divested business, such as through minority equity ownership, financial  or  performance  guarantees,  indemnities  or  other  obligations,  such  that  conditions  outside  of  our  control  might  negate  the  expected  benefits  of  the disposition.", "Any of these risks could adversely affect our ability to achieve the anticipated benefits of a divestiture and might have a materially adverse impact on our business operations and our financial position or results of operations.", "We might not realize the expected tax treatment from our split-off of Change Healthcare.", "If Change does not honor its obligations to indemnify the Company, or if the Transactions fail to qualify for the intended tax-free treatment for reasons not related to a disqualifying action by Change or SpinCo, the resulting tax to the Company could have a significant adverse effect on our financial position or results of operations.", "outsourced service providers, and we might not realize expected cost savings or other benefits.", "For example, our ability to use outsourcing resources in certain jurisdictions might be limited by legislative action or customer contracts, with the result that the work must be performed at greater expense or we may be subject to sanctions for non-compliance.", "Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.", "We might encounter difficulties attracting and retaining customers to our retail locations due to their unfamiliarity with our brands or our inexperience with local market  preferences.  Competition  from  our  retail  pharmacy  operations  might  strain  relationships  with  our  retail  pharmacy  customers.  Consolidation  of  retail pharmacies with third party payers, expansion of large retail pharmacy networks, reductions in reimbursement rates, shifts in the mix of branded and generic pharmaceutical sales, and exclusion from preferred pharmacy networks can impair our retail pharmacy sales and profitability.", "We might be harmed by large customer purchase reductions, payment defaults or contract non-renewal.", "March 31, 2021, sales to our largest customer represented approximately 21% of our consolidated revenues and approximately 19% of our trade receivables, and those of our ten largest customers combined accounted for approximately 51% of our consolidated revenues and approximately 32% of our trade receivables.", "A material  default  in  payment,  reduction  in  purchases,  or  the  loss  of  business  from  a  large  customer  might  have  a  materially  adverse  impact  on  our  business operations and our financial position or results of operations.", "Our contracts with government entities involve future funding and compliance risks.", "Our government contracts might not be renewed or might be terminated for convenience with little or no prior notice.", "Government contracts typically expose us to higher potential liability than do other types of contracts.", "We are subject to government audits, investigations and oversight proceedings.", "If we fail to comply with these requirements, or we fail an audit, we are subject to various sanctions such as monetary damages, criminal and civil penalties, termination of contracts and suspension or debarment from government contract work.", "These requirements complicate our business and increase our compliance burden.", "We also provide supplies used for vaccine administration in the Federal COVID-19 Response.", "Our participation in such programs exposes us to various uncertainties.", "Because of these risks and uncertainties our operating results may be materially higher or lower than our projections.", "Certain distribution agreements with manufacturers include pharmaceutical price inflation as a component of our compensation, and we cannot  control  the  frequency  or  magnitude  of  pharmaceutical  price  changes.  We  might  be  unable  to  renew  pharmaceutical  distribution  agreements  with manufacturers in a timely and favorable manner.", "Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.", "We  derive  a  significant  portion  of  our  revenue  from,  and  have  a  significant  portion  of  our  accounts  receivable  with,  a  small  number  of  customers.  At", "Our contracts with government entities are subject to risks such as lack of funding and compliance  with unique requirements.", "We might infringe intellectual property rights or our intellectual property protections might be inadequate.", "If a court were to hold that we infringed other\u2019s rights, we might be required to pay substantial damages, develop non-infringing products or services, obtain a license, stop selling or using the infringing products or services, or incur other sanctions.", "We rely on trade secret, patent, copyright and  trademark  laws,  nondisclosure  obligations  and  other  contractual  provisions  and  technical  measures  to  protect  our  proprietary  rights  in  our  products  and solutions.  We  might  initiate  costly  and  time-consuming  litigation  to  protect  our  trade  secrets,  to  enforce  our  patent,  copyright  and  trademark  rights  and  to determine the scope and validity of the proprietary rights of others.", "Our intellectual property protection efforts might be inadequate to protect our rights.", "Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.", "Competition among potential employers might result in increased salaries, benefits or other employee-related costs, or in our failure to recruit and retain employees.", "Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.", "We might be adversely impacted by healthcare reform such as changes in pricing and reimbursement models.", "healthcare industry and related government programs are changing.", "profit margins for us and our customers and impose new legal requirements on healthcare providers.", "the way healthcare is financed by both governmental and private payers.", "drugs have sought to reduce the costs of publicly funded health programs.", "These measures exert pressure on the pricing and reimbursement timelines for pharmaceuticals and may cause our customers to purchase fewer of our products and services or influence us to reduce prices.", "adverse impact on our business operations and our financial position or results of operations.", "Consolidation might increase counter-party credit risk because credit purchases increase for fewer market participants.", "Any of these changes or disruptions might have a materially adverse impact on our business operations and our financial position or results of operations.", "We might be adversely impacted as a result of our distribution of generic pharmaceuticals.", "Generic drug manufacturers often offer a generic version of branded pharmaceuticals while they challenge the validity or enforceability branded pharmaceutical patents.", "The patent holder might assert infringement claims against us for distributing those generic versions and the generic drug manufactures may not fully indemnify us against such claims.", "These risks, as well as changes in the availability,  pricing  volatility,  reimbursement  rates  for  generic  drugs,  or significant  changes  in  the  nature,  frequency  or magnitude  of  generic  pharmaceutical launches, might have a materially adverse impact on our business operations and our financial position or results of operations.", "We might be adversely impacted by an economic slowdown or recession.", "Any economic slowdown or recession might have a materially adverse impact on our business operations and our financial position or results of operations.", "Disruption or other changes in capital and credit markets might impede access to credit and increase borrowing costs for us and our customers and suppliers and might impair the financial soundness of our customers and suppliers.", "activity by financial institutions, or decreased liquidity and increased costs in the commercial paper market, might adversely affect our borrowing ability and cost of borrowing.", "We generally sell our products and services under short-term unsecured credit arrangements.", "An adverse change in general economic conditions or access to capital might cause our customers to reduce their purchases from us, or delay or fail paying amounts owed to us.", "Suppliers might be unable to make payments due to us for fees, returned products or incentives.", "Interest rate increases or changes in capital market conditions might impede our or our customers\u2019 or suppliers\u2019 ability or cost to obtain credit.", "Any of these risks might have a material adverse impact on our business operations and our financial position or results of operations.", "Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.", "We might be adversely impacted by tax legislation or challenges to our tax positions.", "Tax laws might change in ways that adversely affect our tax positions, effective tax rate and cash flow.", "The tax laws are extremely complex and subject to varying interpretations.", "We are subject to tax examinations in various jurisdictions that might assess additional tax liabilities against us.", "Our tax reporting positions might be challenged by relevant tax authorities, we might incur significant expense in our efforts to defend those challenges, and we might be unsuccessful in those efforts.", "Developments in examinations and challenges might materially change our provision for taxes in the affected periods and might differ materially from our historical tax accruals.", "Any of these risks might have a materially adverse impact on our business operations, our cash flows and our financial position or results of operations.", "For example, we might experience volatility in exchange rates and interest rates and changes in laws regulating our U.K. operations.", "Customers might reduce purchases due to the uncertainty caused by Brexit.", "Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.", "We might be adversely impacted by fluctuations in foreign currency exchange rates.", "exchange rates could reduce our revenues, increase our costs or otherwise adversely affect our financial results reported in U.S. dollars.", "For example, we are exposed to transactional currency exchange risk due to our import and export of products that are purchased or sold in currencies other than the U.S. dollar.", "We also  have  currency  exchange  risk  due  to  intercompany  loans  denominated  in  various  currencies.  The  COVID-19  pandemic  has  affected  and  might  increase currency exchange rate volatility.", "We may from time to time enter into foreign currency contracts, foreign currency borrowings or other techniques intended to hedge  a  portion  of our  foreign  currency  exchange  rate  risks.  These  hedging  activities  may  not  completely  offset  the  adverse  financial  effects  of  unfavorable movements in foreign currency exchange rates during the time the hedges are in place.", "Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.", "We are subject to the tax laws in the U.S. at the federal, state and local government levels and to the tax laws of many other jurisdictions in which we operate", "We conduct our business in various currencies,  including  the U.S. dollar, euro, British pound sterling  and Canadian dollar.  Changes in foreign  currency", "Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.", "We might be adversely impacted by changes in accounting standards.", "It is possible that future accounting standards may require changes to the accounting treatment in our consolidated financial statements and may require us to make significant changes to our financial systems.", "Such changes might have a materially adverse impact on our financial position or results of operations.", "Our consolidated financial statements are subject to the application of U.S.", "Disclosure of an environmental proceeding where a governmental agency is a party generally is included only if we expect monetary sanctions in the proceeding to exceed $1 million, unless otherwise material.", "There are no family relationships between any of the executive officers or directors of the Company.", "We declared regular cash dividends of $1.67 and $1.62 per share in the years ended March 31, 2021 and 2020, respectively.", "discretion of the Board and will depend upon our future earnings, financial condition, capital requirements, and other factors.", "Dividends: In  July  2020,  our  quarterly  dividend  was  raised  from  $0.41  to  $0.42  per  common  share  for  dividends  declared  on  or  after  such  date  by  the", "We anticipate that we will continue to pay quarterly cash dividends in the future.", "In accordance with our accounting policy, we allocate any excess of share repurchase price over par value between additional paid-in capital and retained earnings.", "Accordingly, our retained earnings and additional paid-in capital were reduced by $472 million and $70 million, respectively, during 2019.", "In 2019, we retired 5.0 million or $542 million of our treasury shares previously repurchased.", "This discussion and analysis should be read in conjunction with the consolidated financial statements and accompanying financial notes in Item 8 of Part II of this Annual Report on Form 10-K.", "Our fiscal year begins on April 1 and ends on March 31.", "Unless otherwise noted, all references to a particular year shall mean our fiscal year.", "Our organizational structure also includes Corporate, which consists of income and expenses associated with administrative functions and projects, and the results of certain investments.", "We evaluate the performance of our operating segments on a number of measures, including revenues and operating profit before interest expense and income taxes.", "The following summarizes our four reportable segments and the changes made to our reporting structure commencing in the second quarter of 2021.", "\u2022 Coronavirus disease 2019 (\u201cCOVID-19\u201d) impacted our results of operations for the year ended March 31, 2021.", "The recovery from the COVID- 19 pandemic continued to fluctuate throughout our fiscal year.", "\u2022 We expanded our existing contractual relationship with the Centers for Disease Control and Prevention (\u201cCDC\u201d) through an amendment to our existing Vaccines for Children Program contract to support the U.S. government as a centralized distributor of COVID-19 vaccines and ancillary supplies needed to administer vaccines.", "\u2022 In  December  2020,  we  began  distributing  certain  COVID-19  vaccines  under  the  direction  of  the  CDC.  Through  the  end  of  the  fiscal  year,  we  had distributed approximately 100 million of COVID-19 vaccine doses.", "\u2022 Revenues of $238.2 billion, reflects a 3% increase from the prior year primarily in our U.S.", "\u2022 Diluted loss per common share from continuing operations attributable to McKesson Corporation in 2021 of $28.26 reflects the aforementioned items, net of any respective tax impacts, and a lower share count compared to the prior year driven largely by the separation of our investment in Change Healthcare JV on March 10, 2020;", "The full extent to which COVID-19 will impact us depends on many factors and future developments, which are described at the end of this COVID-19 section.", "We continue to evaluate the nature and extent of the impacts COVID-19 has on our business and operations.", "We provided further support including additional emergency leave and an internal paid time off donation platform for employees impacted by COVID-19.", "These responses were initially put in place during our fourth quarter of 2020.", "policies did not have a material effect on our internal control over financial reporting during the year ended March 31, 2021.", "We also took various actions to mitigate the impact of COVID-19 on our results from operations through cost-containment and payroll-related expenses.", "We support the U.S. government as a centralized distributor of COVID-19 vaccines and ancillary supplies needed to administer vaccines.", "We make no decisions on where products are to be distributed nor how the products are allocated between the various provider sites and ultimately administered to the individuals receiving a vaccine.", "We utilize our expertise and capabilities to support the CDC\u2019s efforts to vaccinate everyone in the U.S. who wants to receive a COVID-19 vaccine.", "The Pfizer Vaccine, which is ultra-frozen, is not being distributed by McKesson, although we are providing ancillary supplies needed for its administration.", "custom freezers and refrigerators to safely store and process millions of vaccine doses.", "The capital expenditures we made during 2021 to prepare for vaccine and ancillary supply kit distribution were not material to our financial condition or liquidity.", "In December 2020, we began distributing the Moderna Vaccine in the U.S. and in March 2021, we began distributing the Janssen Vaccine.", "Subsequently, during the first quarter, we had lower pharmaceutical volumes, specialty drug volumes, and patient care visits that negatively impacted our consolidated revenues and income (loss) from continuing operations before income taxes for the year ended March 31, 2021.", "Additionally, increased costs for certain PPE compressed our margins.", "During the year ended March 31, 2021, we recorded charges totaling $136 million in cost of sales on certain PPE and other related products due to inventory impairments and excess inventory in our Medical-Surgical Solutions segment.", "Although market price volatility and changes to anticipated customer demand may require additional write-downs in future periods, we are taking measures to mitigate such risk.", "We collaborated closely with the federal government and other healthcare stakeholders to source more critical PPE to the U.S.", "We have deferred certain employer payroll taxes and continue to monitor the potential impact of other tax legislation changes as result of the CARES Act, including refundable payroll tax credits on certain qualified wages.", "We anticipate changes due to the CARES Act in the timing of certain cash flows, with no material impact to our financial results for the year ended March 31, 2021.", "The CA Act did not have a material impact on our financial condition, results of operations, or liquidity for the year ended March 31, 2021 nor do we currently expect a material impact on our future financial results.", "We are monitoring our customers closely for changes to their timing of payments or ability to pay amounts owed to us as a result of COVID-19 pandemic impacts to their businesses.", "We remain well-capitalized with access to liquidity from our revolving credit facility.", "Long- term debt markets and commercial paper markets, our primary sources of capital after cash flow from operations, have remained open and accessible to us during the COVID-19 pandemic.", "At March 31, 2021, we were in compliance with all debt covenants, and believe we have the ability to continue to meet our debt covenants in the future.", "Our consolidated balance sheets and ability to maintain financial liquidity remains strong.", "We have experienced no material impacts to our liquidity or net", "We face numerous uncertainties in estimating the direct and indirect effects of COVID-19 on our future business operations, financial condition, results of operations, and liquidity.", "Due to several rapidly changing variables related to the COVID-19 pandemic, estimations of future economic trends and the timing of when stability will  return  remains  challenging.  Additionally,  we  periodically  review  our  intangible  and  other  long-lived  assets  for  impairment  when  events  or  changes  in circumstances indicate  the carrying value may not be recoverable.  Key assumptions and estimates  about future values in our impairment assessments can be affected by a variety of factors, including the impacts of the global pandemic on industry and economic trends as well as on our business strategy and internal forecasts.", "We continue to be involved in discussions with the objective of achieving broad resolution of opioid- related claims of states, their political subdivisions and other government entities (\u201cgovernmental entities\u201d).", "We are in ongoing, advanced discussions with state attorneys general and plaintiffs\u2019 representatives regarding a framework under which, in order to resolve the claims of governmental entities, the three largest U.S. pharmaceutical distributors would pay up to approximately $21.0 billion over a period of 18 years, with up to approximately $8.0 billion to be paid by us, of which more than 90% is anticipated to be used to remediate the opioids crisis.", "As a result of that conclusion, and our assessment of certain other opioid- related claims, we recorded a charge of $8.1 billion for the year ended March 31, 2021 within \u201cClaims and litigation charges, net\u201d in our Consolidated Statement of Operations, related to our share of the settlement framework described above, as well as other opioid-related claims.", "Because of the many uncertainties associated with any potential settlement arrangement or other resolution of opioid-related litigation, including the uncertainty of the scope of participation by plaintiffs in any potential settlement, we are not able to reasonably estimate the upper or lower ends of the range of ultimate possible loss for all opioid-related litigation matters.", "We believe that we have valid defenses to the claims pending against us and, absent an acceptable settlement, intend to vigorously defend against all such claims.  An  adverse  judgment  or  negotiated  resolution  in  any  of  these  matters  could  have  a  material  adverse  impact  on  our  financial  position,  cash  flows  or liquidity, or results of operations.", "The law adopting the excise tax made clear that the OSA would apply only to opioid sales on or before December 31, 2018.", "The excise tax applies only to the first sale occurring in New York, and thus may not apply to sales from our distribution centers in New York to New York customers.", "Unless the appellate court\u2019s decision is overturned, the OSA will be reinstated for calendar years 2017 and 2018 (but not beyond those years), and, subject to any further legal challenge, we will have to pay our ratable share of the annual surcharge for those two years.", "During the second quarter of 2021, we reflected an estimated liability of $50 million for the OSA surcharge in our accompanying consolidated financial statements on the assumption that the appellate court\u2019s decision will stand.", "The higher LIFO credits in 2020 compared to 2019 is primarily driven by higher generic deflation.", "\u2022 Claims and litigation charges, net: These charges include adjustments for estimated probable settlements related to our controlled substance monitoring and reporting, and opioid-related claims, as well as any applicable income items or credit adjustments due to subsequent changes in estimates.", "We have reclassified prior period amounts to conform to the current period presentation.", "\u2022 Goodwill impairments charges: We perform an impairment test on goodwill balances annually in the third quarter and more frequently if indicators for potential impairment exist.", "The resulting goodwill impairment charges are reflected within this line item. \u2022 Restructuring, impairment, and related charges: Restructuring charges that are incurred for programs in which we change our operations, the scope of a business undertaken by our business units, or the manner in which that business is conducted as well as long-lived asset impairments.", "\u2022 SDG&A reflects charges of $58 million to remeasure assets and liabilities held for sale to fair value less costs to sell related to the completed contribution of the majority of our German pharmaceutical wholesale business to create a joint venture with WBA in which we have a 30% ownership interest within our International segment.", "As a result, we were required to perform a goodwill impairment test for these reporting units and recorded a goodwill impairment charge in our European RP reporting unit of $69 million during the second quarter of 2021.", "As of the testing date, other risks, expenses, and future developments, such as additional government actions, increased regulatory uncertainty, and material changes in key market assumptions limit our ability to estimate projected cash flows, which could adversely affect the fair value of various reporting units in future periods, including our McKesson Canada reporting unit within our International segment and our RxCrossroads reporting unit within our RxTS segment, where the risk of a material goodwill impairment is higher than other reporting units.", "\u2022 Restructuring, impairment, and related charges, net includes long-lived asset impairment charges of $112 million, primarily for our United Kingdom (\u201cU.K.\u201d)  business  (mainly  pharmacy  licenses)  and  Rexall  Health  retail  business  (\u201cRexall  Health\u201d)  (mainly  customer  relationships)  within  our International segment, and the remaining $156 million primarily represents employee severance and exit-related costs related to our 2019 restructuring initiatives, as further discussed below; and", "\u2022 Total operating expenses includes higher SDG&A due to our business acquisitions and to support business growth, as well as our technology initiatives, partially offset by favorable effects of foreign currency exchange fluctuations.", "\u2022 SDG&A includes opioid-related costs of $114 million, primarily related to litigation expenses, and increased expenses due to our business acquisitions and to support growth, partially offset by a gain from an escrow settlement of $97 million representing certain indemnity and other claims related to our 2017 acquisition of Rexall Health and a credit of $90 million for the derecognition of a liability related to the tax receivable agreement (\u201cTRA\u201d) payable to the shareholders of Change Healthcare, Inc. (\u201cChange\u201d);", "\u2022 Restructuring,  impairment,  and  related  charges,  net  primarily  includes  employee  severance  and  exit-related  costs  of  $352  million  for  our  2019 restructuring initiatives, as further discussed below and long-lived asset impairment charges of $245 million primarily for our U.K. business (mainly pharmacy licenses) within our International segment driven by additional government reimbursement reductions and competitive pressures in the U.K.", "We evaluate goodwill for impairment on an annual basis as of October 1, and at an interim date, if indicators of potential impairment exist.", "This change was not material to our consolidated financial statements as it did not delay, accelerate, or avoid any potential goodwill impairment charge.", "We expect to incur total charges of approximately $180 million to $280 million for this initiative, consisting primarily of exit related costs, accelerated depreciation and amortization of long-lived assets, and asset impairments.", "We expect to incur total charges of approximately $85 million to $90 million, of which $57 million of charges were recorded to date.", "This initiative was substantially complete in 2021 and remaining costs we expect to record under this initiative are not material.", "The relocation was substantially complete in January 2021 and remaining costs we expect to record under this initiative, primarily relating to lease costs, are not material.", "This primarily reflects mark-to-market gains on our investments in certain U.S. growth stage companies in the healthcare industry and realized gains on the exit of some of these investments as further described in Financial Note 17, \u201cFair Value Measurements,\u201d to the accompanying consolidated financial statements  included  in  this  Annual  Report  on  Form  10-K.  In  future  periods,  fair  value  adjustments  recognized  in  our  operating  results  for  these  types  of investments may be adversely impacted by market volatility.", "Other income, net also increased year over year due to pension settlement charges of $122 million recognized in 2020 related to our previously approved termination of the frozen U.S. defined benefit pension plan.", "In connection with the pension plan termination, we purchased annuity contracts from an insurer that will pay and administer the future pension benefits of the remaining participants.", "Excluding the impairment and transaction-related items described below, our proportionate share of loss from our investment in Change Healthcare JV for the years ended March 31, 2020 and 2019 was $119 million and $194 million, respectively, which primarily includes transaction and integration expenses incurred by the joint venture and basis differences between the joint venture and McKesson including amortization of fair value adjustments.", "During the first quarter of 2020 and for the year ended March 31, 2019, we owned approximately 70% of this joint venture.", "The proceeds from the concurrent offering of other securities were also used by Change  to  acquire  certain  securities  of  Change  Healthcare  JV.  As  a  result,  McKesson\u2019s  equity  interest  in  Change  Healthcare  JV  was  reduced  from  70%  to approximately 58.5%, which was used to recognize our proportionate share in net loss from Change Healthcare JV, commencing in the second quarter of 2020.", "As a result of the ownership dilution to 58.5% from 70%, we recognized a dilution loss of approximately $246 million in the second quarter of 2020.", "Additionally, our proportionate share of income or loss from this investment was subsequently reduced as immaterial settlements of stock option exercises occurred after the IPO and further diluted our ownership.", "Equity Earnings and Charges from Investment in Change Healthcare Joint Venture Until the separation of our investment in Change Healthcare JV on March 10, 2020, we accounted for this investment using the equity method of accounting.", "In the second quarter of 2020, we recorded an other-than-temporary-impairment (\u201cOTTI\u201d) charge of $1.2 billion to our investment in Change Healthcare JV,", "Following the Split-off, we do not beneficially own any of Change\u2019s outstanding securities.", "In connection with this transaction, we recognized a net gain for financial reporting purposes of $414 million during the fourth quarter of 2020, which was largely driven by the reversal of a related deferred tax liability.", "The receipt of any payments under the TRA is dependent upon Change benefiting from this depreciation or amortization in future tax return filings, which creates uncertainty over the amount, timing and probability of the gain recognized.", "As such, we accounted for the TRA as a gain contingency, with no receivable recognized as of March 31, 2021 nor 2020.", "Interest expense decreased in 2020 compared to the prior year primarily due to a decrease in the issuance of commercial paper, partially offset by a decrease in interest income from our derivative contracts.", "Our reported income tax (benefit) expense rates were (13.8%), 1.6%, and 58.4% in 2021, 2020, and 2019, respectively.", "after-tax), which was intended to generally be a tax-free split-off for U.S. federal income tax purposes, and unfavorably impacted by charges of $275 million (pre- tax and after-tax) to remeasure assets and liabilities held for sale to fair value less costs to sell related to the completed contribution of the majority of our German pharmaceutical wholesale business to create a joint venture with WBA.", "goodwill of our European RP and European PD reporting units within the International segment, given that these charges are generally not deductible for tax purposes.", "Our income tax expense, deferred tax assets and liabilities, and uncertain tax liabilities reflect management\u2019s best assessment of estimated current and future taxes to be paid.", "We believe that we have made adequate provision for all income tax uncertainties.", "In connection with the exchange offer, on March 9, 2020, we distributed all 176.0 million outstanding shares of common stock of SpinCo to participating", "Income Tax (Benefit) Expense We recorded income tax (benefit) expense of ($695 million), $18 million, and $356 million for the years ended March 31, 2021, 2020, and 2019, respectively.", "Our reported income tax expense rate for 2019 was unfavorably impacted by charges of $1.8 billion (pre-tax and after-tax) to impair the carrying value of", "Significant judgments and estimates are required in determining the consolidated income tax provision and evaluating income tax uncertainties.", "Noncontrolling interests with redemption  features, such as put rights, that are not solely within our control are considered redeemable  noncontrolling  interests.  Redeemable  noncontrolling interests are presented outside of McKesson Corporation stockholders\u2019 equity (deficit) on our consolidated balance sheet.", "Diluted earnings (loss) per common share attributable to McKesson Corporation was $(28.26), $4.95, and $0.17 for the years ended March 31, 2021,  2020,  and  2019,  respectively.  Net  loss  per  diluted  share  for  the  year  ended  March  31,  2021  is  calculated  by  excluding  dilutive  securities  from  the denominator  due to their antidilutive  effects.  Additionally,  our 2021, 2020, and 2019 diluted  earnings (loss) per share  reflect  the cumulative  effects  of share repurchases.", "Weighted-average diluted common shares outstanding is impacted by the exercise and settlement of share-based awards and the cumulative effect of share repurchases, including the impact of shares exchanged as part of the split-off from our investment in Change Healthcare JV, as discussed above.", "(1) Segment operating profit (loss) includes gross profit, net of operating expenses, as well as other income (expense), net, for our reportable segments.", "For retrospective periods presented, operating loss for Other reflects equity earnings and charges from our equity method investment in Change Healthcare JV, which we split-off in the fourth quarter of 2020.", "Pharmaceutical segment includes a charge of $50 million for the year ended March 31, 2021 related to our estimated liability under the OSA.", "(3) Operating loss for our International segment for the years ended March 31, 2021 and 2020 includes charges of $58 million and $275 million, respectively, to remeasure to fair value the assets and liabilities of our German pharmaceutical wholesale business which was contributed to a joint venture with WBA.", "This segment\u2019s operating loss for the years ended March 31, 2021 and 2019 includes goodwill impairment charges of $69 million and $1.8 billion, respectively, as well as long-lived asset impairment charges for the  years ended March 31, 2021,  2020, and 2019  of $115  million,  $112  million,  and $245  million,  respectively, primarily  related to  our retail  pharmacy businesses in Canada and Europe.", "(4) Operating profit for our Medical-Surgical Solutions segment for the year ended March 31, 2021 includes charges totaling $136 million on certain PPE and other related products due to inventory impairments and excess inventory.", "(5) Operating profit for our RxTS segment for the year ended March 31, 2019 includes a gain of $56 million from the divestiture of an equity investment.", "(6) Operating loss for Other for the year ended March 31, 2020 includes an OTTI charge of $1.2 billion and a dilution loss of $246 million related to our investment in Change Healthcare JV, partially offset by a net gain of $414 million related to the completed separation of our interest in Change Healthcare JV during the fourth quarter of 2020.", "(7) Corporate expenses, net for the year ended March 31, 2021 includes a charge of $8.1 billion related to our estimated liability for opioid-related claims, net gains of $133 million  from  our  equity  investments,  and a net  gain  of $131  million  recorded  in  connection  with  insurance  proceeds  received  from  the  settlement  of  the  shareholder derivative action related to our controlled substances monitoring program.", "This was partially offset by a decrease in LIFO credits of $214 million, a charge of $50 million recorded in 2021 related to our estimated liability under the OSA, net impacts from COVID-19, including a less severe cough, cold, and flu season, as well as increased costs for strategic growth initiatives.", "Operating profit and operating profit margin were unfavorably impacted by customer mix and a decrease in net cash proceeds received of $180 million representing our share of antitrust legal settlements.", "recorded to remeasure to fair value the assets and liabilities of our German pharmaceutical wholesale business which was contributed to a joint venture with WBA, of  which  $58  million  and  $275  million  was  reflected  for  the  years  ended  March  31,  2021  and  2020,  respectively.  This  was  partially  offset  by  a  goodwill impairment charge of $69 million recorded in the second quarter of 2021 related to our European retail pharmacy business.", "This was partially offset  by  the  fair  value  remeasurement  charges  in  2020  described  above  and  a  gain  from  an  escrow  settlement  of  $97  million  in  2019  related  to  our  2017 acquisition of Rexall Health.", "Additionally,  operating  profit  was favorable  year over year  due to lower  operating  expenses, including a decrease in our provision for bad debts.", "primary care business and lower restructuring charges, partially offset by the remeasurement of assets and liabilities to fair value related to a divestiture that was completed in 2020 and higher operating expenses, including an increase in our provision for bad debts.", "and existing customers, integration costs incurred in 2019 for our acquisition of RxCrossroads that closed during the fourth quarter of 2018, partially offset by a gain of $56 million from the divestiture of an equity investment in 2019.", "investment in Change Healthcare JV, partially offset by a net gain of $414 million related to the completed separation of our interest in Change Healthcare JV during the fourth quarter of 2020.", "Operating loss for Other also includes our proportionate share of loss from Change Healthcare JV of $119 million and $194 million for the years ended March 31, 2020 and 2019, respectively.", "connection with insurance proceeds received from the settlement of the shareholder derivative action related to our controlled substances monitoring program.", "Corporate expenses, net, for 2020 includes pension settlement charges of $122 million, an opioid claim settlement charge of $82 million, and net settlement gains of $26 million recognized from our derivative contracts.", "claim settlement charge mentioned above, as well as higher costs for technology initiatives, partially offset by net settlement gains recognized in 2020 from our derivative contracts.", "Other Operating  loss  for  Other  for  the  year  ended  March  31,  2020  includes  an  OTTI charge  of  $1.2  billion  and  a  dilution  loss  of  $246  million  related  to  our", "Corporate 2021 vs. 2020 Corporate expenses, net increased for the year ended March 31, 2021 compared to the prior year due to a charge of $8.1 billion related to our estimated", "We conduct our business worldwide in local currencies including Euro, British pound sterling, and Canadian dollar.", "As a result, the comparability of our results reported in U.S. dollars can be affected by changes in foreign currency exchange rates.", "In discussing our operating results, we may use the term \u201cforeign currency exchange fluctuations,\u201d which refers to the effect of changes in foreign currency exchange rates used to convert the local currency results of our operations in foreign countries where the functional currency is not the U.S. dollar.", "We present this information to provide a framework for assessing how our business performed excluding the effect of foreign currency exchange rate fluctuations.", "In computing the foreign currency exchange fluctuations, we translate our current year results of our operations in foreign countries recorded in local currencies into U.S dollars by applying their respective average foreign currency exchange rates of the corresponding prior year periods, and we subsequently compare those results to the previously reported results of the comparable prior year periods reported in U.S. dollars.", "estimate was made and if different estimates that we reasonably could have used in the current period, or changes in the accounting estimate that are reasonably likely to occur from period to period, could have a material impact on our financial condition or results from operations.", "Below are the estimates that we believe are  critical  to  the  understanding  of  our  operating  results  and  financial  condition.  Other  accounting  policies  are  described  in  Financial  Note  1,  \u201cSignificant Accounting  Policies,\u201d  to  the  consolidated  financial  statements  appearing  in  this  Annual  Report  on  Form  10-K.  Because  of  the  uncertainty  inherent  in  such estimates, actual results may differ from these estimates.", "Other customer financing primarily relates to guarantees provided to our customers, or their creditors, regarding the repurchase of inventories.", "We also provide financing to certain customers related to the purchase of pharmacies, which serve as collateral for the loans.", "We estimate the receivables for which we do not  expect  full  collection  based  on  historical  collection  rates  and  specific  knowledge  regarding  the  current  creditworthiness  of  our  customers  and  record  an allowance in our consolidated financial statements for these amounts.", "Management reviews these factors quarterly to determine if any adjustments are needed to the allowance.", "Sales to our largest customer, CVS Health Corporation (\u201cCVS\u201d), accounted for approximately 21% of our total consolidated revenues in 2021 and comprised approximately 19% of total trade accounts receivable at March 31, 2021.", "As a result, our sales and credit concentration is significant.", "The accounts receivables balances are with individual members of the GPOs, and therefore no significant concentration of credit risk exists.", "A material default in payment, a material reduction in purchases from these or any other large customers, or the loss of a large customer or GPO could have a material adverse impact on our financial position, results of operations, and liquidity.", "We believe the reserves maintained and expenses recorded in 2021 are appropriate and consistent in the context of historical methodologies employed, as well as assessment of trends currently available.", "The selected 0.1% hypothetical change does not reflect what could be considered the best or worst-case scenarios.", "Our LIFO valuation amount includes both pharmaceutical and non-pharmaceutical products.", "We recognized LIFO credits of $38 million, $252 million, and $210 million, respectively, in 2021, 2020, and 2019 in our Consolidated Statements of Operations.", "A LIFO charge is recognized when the net effect of price increases on pharmaceutical and non-pharmaceutical products held in inventory exceeds the impact of price declines, including the effect  of branded pharmaceutical  products  that have lost market  exclusivity.  A LIFO credit  is recognized  when the net effect  of price  declines exceeds the impact of price increases on pharmaceutical and non-pharmaceutical products held in inventory.", "Excluding LIFO reserves, our inventory reserves as of March 31, 2021 and 2020 were $263 million and $96 million, respectively.", "The increase was primarily due to 2021 charges totaling $136 million on certain PPE and other related products due to inventory impairments and excess inventory within our Medical-Surgical Solutions segment.", "In 2021, 2020 and, 2019, our provision for bad debts", "At March 31, 2021 and 2020, total inventories, net were $19.2 billion and $16.7 billion, respectively, in our Consolidated Balance Sheets.", "Any purchase consideration in excess of the estimated fair values of the net assets acquired is recorded as goodwill.", "that is a form or variation of the income approach, whereby a forecast of future cash flows attributable to the asset are discounted to present value using a risk- adjusted discount rate.", "We perform an impairment test on goodwill balances annually in the third quarter and more frequently if indicators for potential impairment exist.", "equal to the amount of excess carrying value above the estimated fair value, if any, but not to exceed the amount of goodwill allocated to the reporting unit.", "we estimate fair value by comparing the business to similar businesses, or guideline companies whose securities are actively traded in public markets.", "Under the income approach, we use a discounted cash flow (\u201cDCF\u201d) model in which cash flows anticipated over several periods, plus a terminal value at the end of that time horizon, are discounted to their present value using an appropriate rate that is commensurate with the risk inherent within the reporting unit.", "Goodwill  and  Long-Lived  Assets: As  a  result  of  acquiring  businesses,  we  have  $9.5  billion  and  $9.4  billion  of  goodwill  at  March  31,  2021  and  2020,", "To estimate the fair value of our reporting units, we generally use a combination of the market approach and the income approach.", "Judgments made in determining an estimate of fair value may materially impact our results of operations.", "Included in the estimate of the weighted-average cost of capital is the assumption of an unsystematic risk premium to address incremental uncertainty related to the reporting units\u2019 future cash flow projections.", "An increase in the unsystematic risk premium increases the discount rate.", "Pharmaceutical  Distribution  reporting  units  in  our  International  segment,  exceeded  their  carrying  values.  The  impairment  testing  performed  in  2020  did  not indicate  any  material  impairment  of  goodwill.  The  segment  change  in  the  second  quarter  of  2021  prompted  changes  in  multiple  reporting  units  across  the Company.", "We recorded a goodwill impairment charge of $69 million in 2021 as the estimated fair value of the Europe Retail Pharmacy reporting unit was lower than its reassigned carrying value based on changes in the composition of the Europe Retail Pharmacy reporting unit within the International segment.", "At March 31, 2021, the  balance  of goodwill for the  reporting  units  in Europe  was approximately  nil  and the  remaining  balance  of goodwill  in the International segment primarily relates to one of our reporting units in Canada.", "Other risks, expenses and future developments, such as additional government actions, increased regulatory uncertainty, and material changes in key market assumptions that we were unable to anticipate as of the testing date may require us to further revise the projected cash flows, which could adversely affect the fair value of our other reporting units in future periods.", "We review intangible assets for impairment at an asset group level whenever events or changes in circumstances indicate that the carrying value of the assets may not be recoverable.", "Determination of recoverability of intangible assets is based on the lowest level of identifiable estimated future undiscounted cash flows resulting from use of the asset and its eventual disposition.", "Measurement of any impairment loss is based on the excess of the carrying value of the asset group over its fair value.", "Assumptions and estimates about future values and remaining useful lives of our purchased intangible assets are complex and subjective.", "When the decline in value is deemed to be other than temporary, an impairment is recognized to the extent that the fair value is less than the carrying value of the investment.", "We consider various factors in determining whether a loss in value of an investment is other than temporary including: the length of time and the extent to which the fair value has been below cost, the financial condition of the investees, and our intent and ability to retain the investment for a period of time sufficient to allow for recovery of value.", "Any significant changes in assumptions or judgments in assessing impairments could result in an impairment charge.", "We generally recognize employee severance costs when payments are probable and amounts are estimable.  Costs related  to contracts without future benefit or contract termination  are recognized  at the earlier of the contract termination  or  the  cease-use  dates.  Other  exit-related  costs  are  recognized  as  incurred.  In  connection  with  these  restructuring  actions,  we  also  assess  the recoverability of long-lived assets used in the business, and as a result, we may recognize accelerated depreciation and amortization reflecting shortened useful lives of the underlying assets.", "paid.  We  are  subject  to  income  taxes  in  the  U.S.  and  numerous  foreign  jurisdictions.  Significant  judgments  and  estimates  are  required  in  determining  the consolidated income tax provision and in evaluating income tax uncertainties and include those used to conclude on the tax-free nature of the separation of the Change Healthcare JV and the unrecognized tax position related to opioid-related litigation and claims, which remains unfinalized, and which may differ from the actual amounts of tax benefit recognized.", "We review our tax positions at the end of each quarter and adjust the balances as new information becomes available.", "to recover our deferred tax assets, we consider all available positive and negative evidence including our past operating results, the existence of cumulative net operating losses in the most recent years, and our forecast of future taxable income.", "In estimating future taxable income, we develop assumptions including the amount of future federal, state and foreign pre-tax operating income, the reversal of temporary differences, and the implementation of feasible and prudent tax planning strategies.", "These assumptions require significant judgment about the forecasts of future taxable income and are consistent with the plans and estimates we use to manage the underlying businesses.", "additional taxes and related interest will be due.", "If our current estimate of tax and interest liabilities is less than the ultimate settlement, an additional charge to income tax expense may result.", "If our current estimate of tax and interest liabilities is more than the ultimate settlement, a reduction to income tax expense may be recognized.", "investigations  relating  to  laws  and  regulations  and  other  matters  arising  out  of  the  normal  conduct  of  our  business.  When  a  loss  is  considered  probable  and reasonably estimable, we record a liability in the amount of our best estimate for the ultimate loss.", "When a material loss is reasonably possible or probable but a reasonable estimate cannot be made, disclosure of the proceeding is provided.", "Deferred income taxes arise from temporary differences between the tax and financial statement recognition of revenue and expense.", "Changes in tax laws and rates could also affect recorded deferred tax assets and liabilities in the future.", "We recognize liabilities for tax and related interest for issues in the U.S. and other tax jurisdictions based on our estimate of whether, and the extent to which,", "As discussed above, development of a meaningful estimate of loss or a range of potential loss is complex when the outcome is directly dependent on future negotiations with or decisions by third parties, such as regulatory agencies, the court system and other interested parties.", "As a result of ongoing, advanced discussions with state attorneys general and plaintiffs\u2019 representatives regarding a framework to resolve the claims of governmental  entities,  and  our  assessment  of  certain  other  opioid-related  claims,  we  have  reached  a  stage  at  which  a  broad  settlement  of  opioid  claims  by governmental entities is probable and recorded a charge of $8.1 billion for the year ended March 31, 2021 within \u201cClaims and litigation charges, net\u201d in our Consolidated Statement of Operations in this report.", "Because of the many uncertainties associated with any potential settlement arrangement or other resolution of opioid-related litigation, including the uncertainty of the scope of participation by plaintiffs in any potential settlement, we are not able to reasonably estimate the upper or lower ends of the range of ultimate possible loss for all opioid-related litigation matters.", "While we are not able to predict the outcome or reasonably estimate a range of possible losses in these matters, an adverse judgment or negotiated resolution in any of these matters could have a material adverse effect on our results of operations, consolidated financial position, cash flows or liquidity.", "facilities and commercial paper program, will be sufficient to fund our short-term and long-term capital expenditures, working capital, and other cash requirements.", "We continue to monitor its impact on demand within parts of our business, as well as trends potentially impacting the timing or ability for some of our customers to pay amounts owed to us.", "We remain well-capitalized with access to liquidity from our $4.0 billion revolving credit facility.", "Additionally, long-term debt markets and commercial paper markets, our primary sources of capital after cash flow from operations, have remained open and accessible to us during the COVID-19 pandemic.", "We have seen continued improvement in conditions in the debt markets and commercial paper markets as the Federal Reserve has taken steps to stabilize the markets.", "At March 31, 2021, we were in compliance with all debt covenants, and believe we have the ability to continue to meet our debt covenants in the future.", "Cash flows from operations can be significantly impacted by factors such as the timing of receipts from customers and payments to vendors.", "Operating activities for the year ended March 31, 2021 were affected by net income adjusted for non-cash items, including the pre-tax $8.1 billion (after-tax $6.8 billion) non-cash charge related to our estimated liability for opioid-related claims, an increase in inventory of $2.3 billion and an increase in drafts and accounts payable of $1.3 billion driven by higher inventory stock levels to meet increased volume demand as part of our inventory management, as well as a decrease in receivables of $1.1 billion driven by timing, higher sales recognized at the end of March 2020, and higher collections in our fourth quarter of 2021.", "value remeasurement charges of $58 million related to the contribution of our German pharmaceutical wholesale business to a joint venture with WBA.", "Additionally, we made a cash payment of $114 million from the executive benefit retirement plan in 2020.", "Investing activities for the year ended March 31, 2021 also includes net cash proceeds of $400 million from sales of businesses and investments, including $286 million in exchange for the contribution of our German pharmaceutical wholesale business to a joint venture with WBA.", "Cash used for other financing activities generally includes payments to noncontrolling interests and activity from our finance leases.", "We received cash from long-term debt issuances of $1.1 billion and made repayments on long-term debt of $1.1 billion in 2019.", "The timing of any repurchases and the actual number of shares repurchased will depend on a variety of factors, including our stock price, corporate and regulatory requirements, restrictions under our debt obligations, and other market and economic conditions.", "In accordance with our accounting policy, we allocate any excess of share repurchase price over par value between additional paid-in capital and retained earnings.", "Accordingly, our retained earnings and additional paid-in capital were reduced by $472 million and $70 million during 2019, respectively.", "outstanding shares of SpinCo common stock, which held all of the Company\u2019s interests in the Change Healthcare JV, to participating holders of the Company\u2019s common  stock  in  exchange  for  15.4  million  shares  of  McKesson  stock,  which  are  now  held  as  treasury  stock  on  our  consolidated  balance  sheet.  Following consummation of the exchange offer, on March 10, 2020, SpinCo merged with and into Change and each share of SpinCo common stock was converted into one share of Change common stock, par value $0.001 per share, with cash being paid in lieu of fractional shares of Change common stock.", "give us the ability to meet our financing needs for the foreseeable future.", "However, there can be no assurance that an increase in volatility or disruption in the global capital and credit markets will not impair our liquidity or increase our costs of borrowing.", "As described within the \u201cTrends and Uncertainties\u201d section above,  the  COVID-19  pandemic  continues  to  develop  rapidly.  We  continue  to  monitor  its  impact  on  demand  within  parts  of  our  business,  as  well  as  trends potentially impacting the timing or ability for some of our customers to pay amounts owed to us.", "(2) This ratio describes the relationship and changes within our capital resources, and is computed as total debt divided by the sum of total debt and McKesson stockholders\u2019 equity (deficit), which excludes noncontrolling and redeemable noncontrolling interests and accumulated other comprehensive loss. (3) Ratio is computed as net income (loss) attributable to McKesson Corporation for the last four quarters, divided by a five-quarter average of McKesson stockholders\u2019 equity (deficit), which excludes noncontrolling and redeemable noncontrolling interests.", "In 2019, we retired 5.0 million or $542 million of the Company\u2019s treasury shares previously repurchased.", "In connection with the Split-off, we distributed all 176.0 million", "Deposits with financial institutions are primarily denominated in U.S. dollars and the functional currencies of our foreign subsidiaries, including Euro, British pound sterling, and Canadian dollars.", "We mitigate the risk of our short-term investment portfolio by depositing funds with reputable financial institutions and monitoring risk profiles and investment strategies of money market funds. outside of the U.S., respectively.", "Our primary intent is to utilize this cash for foreign operations for an indefinite period of time.", "Although the vast majority of cash held outside the U.S. is available for repatriation, doing so could subject us to foreign withholding taxes and state income taxes.", "The COVID-19 pandemic has potential to increase the variations in our working capital, which we continue to monitor closely. partially offset by an increase in drafts and accounts payable and a decrease in receivables.", "Our unfavorable return on McKesson\u2019s stockholder\u2019s equity (deficit) as of March 31, 2021 was also driven by net loss for the year.", "Net loss for the year ended March 31, 2021 includes an after-tax non-cash charge of $6.8 billion related to our estimated liability for opioid-related claims, as discussed in \u201cTrends  and  Uncertainties\u201d of  this  Financial  Review  and  Financial  Note  19,  \u201cCommitments  and  Contingent  Liabilities,\u201d  to  the  accompanying  consolidated financial statements included in this Annual Report on Form 10\u2011K.", "Our debt to capital ratio increased for 2020 primarily due to a decrease in stockholders\u2019 equity driven by the Split-off of our interest in Change Healthcare JV and share repurchases.", "We anticipate that we will continue to pay quarterly cash dividends in the future.", "However, the payment and amount of future dividends remain within the discretion of the Board and will depend upon our future earnings, financial condition,  capital  requirements,  and  other  factors.  In  2021,  2020,  and  2019,  we  paid  total  cash  dividends  of  $276  million,  $294  million,  and  $292  million, respectively.  Additionally,  as  required  under  the  Domination  Agreement,  we  are  obligated  to  pay  an  annual  recurring  compensation  amount  of  \u20ac0.83  per McKesson Europe share (effective January 1, 2015) to the noncontrolling shareholders of McKesson Europe.", "Cash equivalents, which are readily convertible to known amounts of cash, are carried at fair value.", "Our cash and cash equivalents balance as of March 31, 2021 and 2020 included approximately $2.3 billion and $1.7 billion of cash held by our subsidiaries", "On  July  29,  2020,  we  raised  our  quarterly  dividend  from  $0.41  to  $0.42  per  common  share  for  dividends  declared  on  or  after  such  date  by  the  Board.", "(3) Includes our estimated benefit payments for the unfunded benefit plans and minimum funding requirements for the pension plans. (4) Primarily represents interest that will become due on our fixed rate long-term debt obligations.", "These obligations primarily relate to inventory purchases and capital commitments. (6) Includes agreements under which we have guaranteed the repurchase of our customers\u2019 inventory and our customers\u2019 debt in the event these customers are unable to meet their obligations to those financial institutions.", "The ultimate amount and timing of any future cash settlements related to these items cannot be predicted with reasonable certainty.", "and are mostly related to our customer contracts and to meet the security requirements for statutory licenses and permits, court and fiduciary obligations, and our workers\u2019 compensation and automotive liability programs.", "The exercise of the Put Right will reduce the balance of redeemable noncontrolling interests.", "During 2021, we paid $49 million to purchase 1.8 million shares of McKesson Europe through exercises of the Put Right by the noncontrolling shareholders.", "Our banks and insurance companies have issued $146 million of standby letters of credit and surety bonds at March 31, 2021.", "redemption value is the Put Amount adjusted for exchange rate fluctuations each period.", "In future periods, unfavorable foreign currency exchange rate fluctuations between the Euro and the U.S. dollar could adversely impact the carrying value of our redeemable noncontrolling interests and require an adjustment to increase the balance of our redeemable noncontrolling interests to its maximum redemption value.", "On April 12, 2021, we received the Stuttgart Court of Appeals\u2019 final ruling confirming the original put value of \u20ac22.99 per share and the annual recurring compensation of \u20ac0.83 per McKesson Europe share.", "Funds necessary for future debt maturities and our other cash requirements are expected to be met by existing cash balances, cash flow from operations, existing credit sources, and other capital market transactions.", "The effect of a hypothetical 50 bp increase in the underlying interest rate on our cash and cash equivalents, net of short-term borrowings and variable rate debt, would have resulted in a favorable impact to earnings in 2021 and 2020 of approximately $17 million and $6 million, respectively.", "The balance of redeemable noncontrolling interests is reported at the greater of its carrying value or its maximum redemption value at each reporting date.", "Additionally,  we  are  obligated  to  pay  an  annual  recurring  compensation  of  \u20ac0.83  per  McKesson  Europe  share  (the  \u201cCompensation  Amount\u201d)  to  the", "Interest rate risk: Our long-term debt bears interest predominately at fixed rates, whereas our short-term borrowings are at variable interest rates.", "Our cash and cash equivalents balances earn interest at variable rates.", "At March 31, 2021 and 2020, we had $6.3 billion and $4.0 billion, respectively, in cash", "Changes in foreign currency exchange rates could have a material adverse impact on our financial results that are reported in U.S. dollars.", "We are also exposed to foreign exchange rate risk related to our foreign subsidiaries, including intercompany loans denominated in non-functional currencies.", "These programs reduce but do not entirely eliminate foreign exchange risk.", "fair value of our foreign exchange contracts by approximately $267 million and $435 million, respectively.", "Foreign exchange risk: We conduct our business worldwide in U.S. dollars and the functional currencies of our foreign subsidiaries, including Euro, British", "We have certain foreign exchange rate risk programs that use foreign currency forward contracts and cross-currency swaps.", "Based on this assessment, our management has concluded that our internal control over financial reporting was effective as of March 31, 2021.", "In our opinion, the financial statements referred to above present fairly, in all material respects, the financial position of the Company as of March 31, 2021 and 2020, and the results of its operations and its cash flows for each of the three years in the period ended March 31, 2021, in conformity with accounting principles generally accepted in the United States of America.", "Also, in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of March 31, 2021, based on criteria established in Internal Control \u2014 Integrated Framework (2013) issued by COSO.", "Our responsibility is to express an opinion on these financial statements and an opinion on the Company\u2019s internal control over financial reporting based  on  our  audits.  We  are  a  public  accounting  firm  registered  with  the  Public  Company  Accounting  Oversight  Board  (United  States)  (\u201cPCAOB\u201d)  and  are required  to  be  independent  with  respect  to  the  Company  in  accordance  with  the  U.S.  federal  securities  laws  and  the  applicable  rules  and  regulations  of  the Securities and Exchange Commission and the PCAOB.", "We conducted our audits in accordance with the standards of the PCAOB.", "Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.", "Our audits of the financial statements included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures to respond to those risks.", "Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements.", "Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk.", "Our audits also included performing such other procedures as we considered necessary in the circumstances.", "We believe that our audits provide a reasonable basis for our opinions.", "The critical audit matters communicated below are matters arising from the current-period audit of the financial statements that were communicated or required to be communicated to the audit committee and that (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments.", "The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.", "The Company also performs an assessment of loss contingencies where a loss is reasonably possible.", "We identified the potential broad settlement of opioid claims as a critical audit matter because of the significant judgment and challenges auditing management\u2019s determination  of  whether  such  loss  is  probable  and  reasonably  estimable.  Specifically,  auditing  management\u2019s  determination  and  disclosure  of  whether  the contingent loss arising from the potential broad settlement of opioid claims is probable, and the related measurement of such loss, is subjective and requires significant judgment given that the potential loss is based upon settlement terms that have not yet been finalized.", "\u2022 We tested the effectiveness of internal controls related to the potential broad settlement of opioid claims, and approval of the accounting treatment and related disclosures based on the most recent facts and circumstances.", "In addition, we inspected responses to inquiry letters sent to both internal and external legal counsel as it relates to the status of discussions with plaintiffs\u2019 counsel and the Company\u2019s intent regarding the framework for a potential broad settlement of opioid claims.", "\u2022 We evaluated management\u2019s analysis of the potential broad settlement of opioid claims, including the methodology used by management to determine the probability of such loss.", "We also evaluated the methodology used by management to estimate the most likely loss to be incurred by the Company as a result of a potential broad settlement of opioid claims.", "\u2022 We performed public domain searches for evidence contrary to management\u2019s analysis.", "\u2022 We evaluated any events subsequent to March 31, 2021 that might impact our evaluation of the potential broad settlement of opioid claims. \u2022 We obtained written representations from executives and internal counsel of the Company. \u2022 We examined proposed terms related to the potential broad settlement framework. \u2022 We evaluated the Company\u2019s related disclosures for consistency with our testing.", "The net amount recognized by management is measured as the largest amount of tax benefit that is greater than 50 percent likely of being realized.", "We identified the Company\u2019s uncertain tax position related to the charge for the potential broad settlement of opioid claims as a critical audit matter because of the challenges in auditing management\u2019s estimate of the amount of income tax benefit that qualifies for recognition.", "Our audit procedures related to the Company's uncertain tax position associated with a potential broad settlement of opioid claims included the following, among others: \u2022 We tested the effectiveness of internal controls related to the Company\u2019s assessment of the technical merits of its tax position, including the Company\u2019s assessment as to the amount of benefit that is more likely than not to be realized. \u2022 With  the  assistance  of  our  tax  specialists,  we  evaluated  the  facts,  evidence  and  the  Company\u2019s  related  income  tax  analysis  for  the  charge  related  to  the potential broad settlement of opioid claims, including assumptions used by management to measure the related recognized and unrecognized tax benefits. \u2022 We inquired of the Company\u2019s internal and external legal counsel to understand the basis for the Company\u2019s conclusion that a portion of the potential broad settlement of opioid claims would be deductible based on the most recent discussions with plaintiffs\u2019 counsel.", "\u2022 We  compared  management's  income  tax  assessment  of  this  matter  to  the  treatment  of  other  recorded  opioid  charges  to  evaluate  the  consistency  of  the Company\u2019s judgments related to the uncertain tax position. \u2022 We evaluated any events subsequent to March 31, 2021 that might impact our evaluation of the Company\u2019s uncertain tax position related to the charge for the potential broad settlement of opioid claims.", "\u2022 We obtained written representations from executives and internal counsel of the Company. \u2022 We examined proposed terms related to the potential broad settlement framework.", "\u2022 We evaluated the Company\u2019s related disclosures for consistency with our testing and also searched for contradictory evidence by reading disclosures from peer companies, who are also party to the potential broad settlement of opioid claims.", "We identified the estimation of the fair value of the McKesson Canada reporting unit used to evaluate the recoverability of goodwill as a critical audit matter because of the challenges auditing significant judgments used in the selection of a discount rate, including the unsystematic risk premium.", "In particular, the fair value estimate is sensitive to the unsystematic risk premium assumption, which is affected by expected risk of changes in the Canadian business and regulatory environments.", "Auditing management\u2019s selected discount rate required a high degree of auditor judgment and an increased extent of effort, including the need to involve more senior members of the team and our fair value specialists.", "Our audit procedures related to the Company\u2019s selection of a discount rate, including consideration of the unsystematic risk premium, for the McKesson Canada reporting unit included the following, among others: \u2022 We tested the effectiveness of internal controls related to management\u2019s goodwill impairment evaluation, including those related to the selection of a discount rate and consideration of an unsystematic risk premium. \u2022 We  evaluated  management\u2019s  ability  to  accurately  forecast  operating  results  for  the  McKesson  Canada  reporting  unit  by  comparing  actual  results  to management\u2019s historical forecasts, in order to consider the reasonableness and adequacy of management\u2019s selected unsystematic risk premium. \u2022 As part of our assessment of the unsystematic risk premium, we evaluated the reasonableness of strategic plans expected to be implemented during the forecast period by comparing the forecasts to:", "\u2022 With the assistance of our fair value specialists, we evaluated the reasonableness of the discount rate, including the unsystematic risk premium, by developing a range of independent estimates, testing the mathematical accuracy of the calculation and comparing to the discount rate selected by management.", "We have served as the Company\u2019s auditor since 1968.", "The Company consolidates VIEs when it is determined that it is the primary beneficiary of the VIE.", "Investments in business entities in which the Company does not have control but has the ability to exercise significant influence over operating and financial policies, are accounted for using the equity method.", "Actual amounts could differ from those estimated amounts.", "These legislative acts are not expected to have a material impact on the Company\u2019s consolidated financial results.", "The Company considers itself to control an entity if it is the majority owner of or has voting control over such entity.", "GAAP requires that the Company make estimates and assumptions that", "If a loss in value has occurred that is deemed to be other-than-temporary, an impairment loss is recorded.", "economic environment, customer credit ratings or bankruptcies, as well as reasonable and supportable forecasts.", "We are exposed to credit losses on accounts receivable balances.", "As a result, the Company\u2019s sales and credit concentration is significant.", "The accounts receivables balances are with individual members of the GPOs, and therefore no significant concentration of credit risk exists.", "This credit risk is mitigated by the size and diversity of the Company\u2019s customer base as well as its geographic dispersion.", "These amounts are equivalent to the Company\u2019s LIFO reserves.", "A LIFO credit is recognized when the net effect of price declines exceeds the impact of price increases on pharmaceutical and non-pharmaceutical products held in inventory.", "The increase was primarily due to charges in 2021 totaling $136 million on certain personal protective equipment and other related products due to inventory impairments and excess inventory within our Medical-Surgical Solutions segment.", "When the net realizable value of a disposal group increases during a period, a gain can be recognized to the extent that it does not increase the value of the disposal group beyond its original carrying value when the disposal group was reclassified as held for sale.", "Depreciation and amortization begins when an asset is placed in service and ready for its intended use.", "The use of alternative assumptions and estimates could affect the fair values and change the impairment determinations.", "Measurement of any impairment loss is based on the excess of the carrying value of the asset group over its estimated fair market value.", "customer in an amount that reflects the consideration to which the entity expects to be entitled for that good or service.", "Revenue is recognized when control of goods is transferred to the customer which occurs upon the Company\u2019s delivery to the customer or upon customer  pick-up.", "The ultimate outcome of any outstanding claims may be different than the Company\u2019s estimate.", "If a derivative is designated as a fair value hedge, the changes in the fair value of the derivative and of the hedged item attributable to the hedged risk are recognized in earnings.", "The cumulative changes in fair value are reclassified to the same line as the hedged item in the Consolidated Statements of Operations when the hedged item affects earnings.", "Noncontrolling interests with redemption features, such as put rights, that are not solely within the Company\u2019s control are considered redeemable noncontrolling interests.", "When a loss is considered probable and reasonably estimable, the Company records a liability in the amount of its best estimate for the ultimate loss.", "When a material loss is reasonably possible or probable, but a reasonable estimate cannot be made, disclosure of the proceeding is provided.", "As discussed above, development of a meaningful estimate of loss or a range of potential loss is complex when the outcome is directly dependent on negotiations with or decisions by third parties, such as regulatory agencies, the court system, and other interested parties.", "Any purchase consideration in excess of the estimated fair values of the net assets acquired is recorded as goodwill.", "Restructuring Charges: Employee severance costs are generally recognized when payments are probable and amounts are reasonably estimable.", "The forward-looking model requires the Company to consider historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount in estimating credit losses.", "The adoption of this amended guidance is not expected to have a material impact on the Company\u2019s consolidated financial statements or disclosures.", "accounting policy has been to disclose any intervening events of the joint venture in the lag period that could materially affect its consolidated financial statements.", "McKesson had the ability to adjust the manner in which certain depreciation or amortization deductions are allocated among Change and McKesson.", "This creates uncertainty over the amount, timing, and probability of the gain recognized.", "Any such change is not expected to have a material impact on the Company\u2019s consolidated financial statements.", "This initiative was substantially complete in 2021 and remaining costs the Company expects to record under this initiative are not material.", "This set of initiatives was substantially complete by the end of 2020 and charges in 2021 were not material.", "Goodwill recognized for business acquisitions is generally not expected to be deductible for tax purposes.", "share-based awards that will ultimately vest primarily based on historical experience.", "The estimated forfeiture rate established upon grant is re-assessed throughout the requisite service period and is adjusted when actual forfeitures occur.", "The actual forfeitures in future reporting periods could be higher or lower than current estimates.", "PSUs have a requisite service period of generally three years.", "Compensation expense for the share-based awards is recognized for the portion of awards ultimately expected to vest.", "The number of vested PSUs is assessed at the end of a", "All  outstanding  PeRSU awards  have  completed  the  performance  period  and  are  now classified  and  accounted  for  as RSUs.", "portion of the awards that is ultimately expected to vest.", "Once the fair value of an employee stock option is determined, current accounting practices do not permit it to be changed, even if the estimates used are different from actual.", "The Company believes this market-based input provides a reasonable estimate of its future stock price movements and is consistent with employee stock option valuation considerations.", "These amounts have not been significant for all the years presented.", "Substantially all its foreign net operating losses have indefinite lives.", "The decrease in unrecognized tax benefits in 2020  compared  to  2019  is  primarily  attributable  to  the  favorable  resolution  of  an  outstanding  California  tax  refund  claim  which  decreased  unrecognized  tax benefits by $91 million.", "2017 Tax Act, the repatriation of cash to the U.S. is generally no longer taxable for federal income tax purposes.", "The Company may remit foreign earnings to the U.S. to the extent it is tax efficient to do so.", "It does not expect the tax impact from remitting these earnings to be material.", "The exercise of the Put Right will reduce the balance of redeemable noncontrolling interests.", "The adoption of this guidance did not have a material impact on the Company\u2019s consolidated statements of operations and cash flows.", "The Company\u2019s lease agreements do not contain any material residual value guarantees or material restrictive covenants.", "Operating lease liabilities are recognized based on the present value of the future lease payments over the lease term, discounted at the Company\u2019s incremental borrowing rate as the implicit rate in the lease is not readily determinable for most of the Company\u2019s leases.", "As a practical expedient, short-term leases with an initial term of 12 months or less are excluded from the Consolidated Balance Sheets and charges from these leases are expensed as incurred.", "Fair value estimates result from a complex series of judgments about future events and uncertainties and rely heavily on estimates and assumptions that have been deemed reasonable by management as of the measurement date.", "The unsystematic risk premium is an input factor used in calculating the discount rate that specifically addresses uncertainty related to the reporting unit\u2019s future cash flow projections.", "The risk of successfully achieving certain business initiatives was the primary factor in the use of a higher discount rate.", "and, from time-to-time, future unsecured and unsubordinated indebtedness outstanding.", "As a result of absorbing this risk, the leases provide the Company with the power to direct the operations of the leased properties and the obligation to absorb losses or the right to receive benefits of the entity.", "Consolidated VIEs do not have a material impact on the Company\u2019s Consolidated Statements of Operations and Cash Flows.", "their economic performance and thus is not considered the primary beneficiary of the entities.", "The pension obligation in Germany is unfunded with the exception of the contractual trust arrangement used to fund pensions of McKesson Europe\u2019s Management Board.", "actuarial  losses  exceeding  10%  of  the  greater  of  the  projected  benefit  obligation  or  the  market  value  of  assets  are  amortized  straight-line  over  the  average remaining future service period of active employees.", "Pension obligations for its unfunded plans are based on the recommendations of independent actuaries.", "The difference between actual inflation and assumed inflation in our U.K. pension plans resulted in a gain of $23 million.", "corporate bonds rated AA or better whose maturities are aligned with the expected benefit payments of its plans.", "Plan assets of the non-U.S. plans are broadly invested in a manner appropriate to the nature and duration of the expected future retirement benefits payable under the plans.", "Assets are properly diversified to avoid excessive reliance on any particular asset, issuer, or group of undertakings so as to avoid accumulations of risk in the portfolio as a whole.", "practical expedient are not leveled within the fair value hierarchy and are included as a reconciling item to total investments.", "Actions taken by other participating employers may lead to adverse changes in the financial condition of a multiemployer benefit plan and the Company\u2019s withdrawal liability and contributions may increase.", "It does not use derivatives for trading or speculative purposes.", "Eligible employees may contribute to the RSP up to 75% of", "In the normal course of business, the Company is exposed to interest rate and foreign currency exchange rate fluctuations.", "These forward contracts and cross-currency swaps are generally used to offset the potential income statement effects from intercompany loans and other obligations denominated in non-functional currencies.", "These programs reduce but do not entirely eliminate foreign currency exchange rate risk.", "To the extent foreign currency-denominated notes designated as net investment hedges are ineffective, changes in carrying value attributable to the change in spot rates are recorded in earnings.", "To the extent cross-currency swaps designated as hedges are ineffective, changes in carrying value attributable to the change in spot rates are recorded in earnings.", "Changes in fair values representing hedge ineffectiveness are recognized in current earnings.", "The settlement loss on the swaps was not material and will be amortized on a straight-line basis as interest expense over the five-year life of the 2025 Notes.", "Gains or losses from these contracts are largely offset by changes in the value of the underlying intercompany obligations.", "Changes in the fair value for contracts not designated as hedges are recorded directly in earnings.", "The carrying value of all other cash equivalents approximates their fair value due to their relatively short-term nature.", "These inputs are considered Level 2 under the fair value measurements and disclosure guidance and may not be representative of actual values that could have been realized or that will be realized in the future.", "If the carrying amount of an asset group is not recoverable, an impairment charge is recorded to reduce the carrying amount by the excess over its fair value.", "repurchase of its customers\u2019 inventory or its customers\u2019 debt in the event these customers are unable to meet their obligations to those financial institutions.", "For the Company\u2019s inventory repurchase agreements, among other requirements, inventories must be in resalable condition and any repurchase would be at a discount.", "The majority of the Company\u2019s customers\u2019 debt guarantees are secured by certain assets of the customer.", "The Company\u2019s long-term debt is also recorded at cost.", "The carrying value and fair value of the Company\u2019s long-term debt was as follows:", "Long-lived Assets The Company utilizes multiple approaches including the DCF model and market approaches for estimating the fair value of intangible assets.", "infringe a third party\u2019s intellectual property rights.", "Where appropriate, obligations for such indemnifications are recorded as liabilities.", "Accrued warranty costs were not material to the Consolidated Balance Sheets.", "Significant developments in those matters are described below.", "Company  is  unable  to  determine  that  a  loss  is  probable,  or  to  reasonably  estimate  the  amount  of  loss  or  a  range  of  loss,  for  a  claim  because  of  the  limited information  available  and  the  potential  effects  of future  events  and  decisions  by third  parties,  such  as  courts  and  regulators,  that  will  determine  the  ultimate resolution of the claim.", "It is not uncommon for claims to remain unresolved over many years.", "The Company reviews loss contingencies at least quarterly to determine whether the likelihood of loss has changed and whether it can make a reasonable estimate of the loss or range of loss.", "When the Company determines that a loss from a claim is probable and reasonably estimable, it records a liability for an estimated amount.", "The Company also provides disclosure when it is reasonably possible that a loss may be incurred or when it is reasonably possible that the amount of a loss will exceed its recorded liability.", "Warranties In the normal course of business, the Company provides certain warranties and indemnification protection for its products and services.", "These two West Virginia plaintiffs are not expected to participate in any broader multistate resolution of opioid-related claims.", "The Cherokee Nation is not expected to participate in any broader multistate resolution of opioid-related claims.", "Those non-participating governmental entities would be entitled to pursue their claims against the Company and other defendants.", "The Company believes that it has valid defenses to the claims pending against it, and it intends to vigorously defend against all such claims if acceptable settlement terms are not achieved.", "The Company believes it has valid legal defenses in these matters and intends to mount a vigorous defense.", "The Company has not concluded a loss is probable in any of these matters; nor is the amount of any loss reasonably estimable.", "An adverse judgment or negotiated resolution in any of these matters could have a material adverse impact on the Company\u2019s financial position, cash flows or liquidity, or results of operations.", "AIG and ACE are seeking declarations that they have no duty to defend or indemnify McKesson in the thousands of lawsuits pending in federal and state courts related to opioids.", "Discussions with attorneys general and other parties continue.", "If the negotiating parties agree on terms under the framework for a broad resolution of claims of", "Plaintiffs\u2019 moved for summary judgment on the same day.", "subpoenas and requests in a cooperative, thorough and timely manner.", "These responses sometimes require time and effort and can result in considerable costs being incurred by the Company.", "Such subpoenas and requests can lead to the assertion of claims or the commencement of civil or criminal legal proceedings against the Company and other members of the health care industry, as well as to settlements of claims against the Company.", "The Company responds to these requests in the ordinary course of business.", "The law adopting the excise tax made clear that the OSA does not apply to sales or distributions occurring after December 31, 2018.", "It is not certain at this point in time what proportion of this estimated liability will be borne by the Company.", "However, it is possible that the ultimate costs of these matters may exceed or be less than the reserves.", "Due to the complex nature of the tax laws, it is not possible to estimate the outcome of these matters.", "improper actions to delay or prevent generic drugs from entering the market.", "The quarterly results of operations are not necessarily indicative of the results that may be expected for the entire year.", "effectiveness of the Company\u2019s \u201cdisclosure controls and procedures\u201d (as such term is defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) as of the end of the period  covered  by  this  report  and  have  concluded  that  our  disclosure  controls  and  procedures  are  effective  based  on  their  evaluation  of  these  controls  and procedures as required by paragraph (b) of Exchange Act Rules 13a-15 or 15d-15.", "Rules 13a-15 or 15d-15 that occurred during our fourth quarter of 2021 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.", "caption  \u201cInvestors  -  Corporate  Governance.\u201d  The  Company\u2019s  Corporate  Governance  Guidelines  and  Charters  for  the  Audit,  Compensation  and  Governance Committees can also be found on our website under the same caption.", "Information  about the Code of Conduct applicable  to all employees, officers  and directors can be found on our website, www.mckesson.com, under the", "Information with respect to this item is incorporated by reference from the discussion under the heading \u201cExecutive Compensation\u201d in our Proxy Statement.", "Such non-employee director award is fully vested on the date of the grant.", "subject to and qualified in their entirety by reference to our amended and restated certificate of incorporation, our amended and restated by- laws  and  the  Delaware  General  Corporation  Law  (\u201cDGCL\u201d).  Copies  of  our  amended  and  restated  certificate  of  incorporation  and  our amended and restated by-laws have been filed with the Securities and Exchange Commission (the \u201cSEC\u201d) and are incorporated by reference herein. 100,000,000 shares are preferred stock, par value $0.01 per share.", "We may amend from time to time our amended and restated certificate of incorporation to increase the number of authorized shares of Common Stock and/or preferred stock.", "Any such amendment would require the approval of the holders of a majority of our shares entitled to vote.", "All of our outstanding shares of Common Stock are fully paid and non- assessable.", "Stock are entitled to receive ratably dividends out of assets legally available therefor at such times and in such amounts as our board of directors may from time to time determine.", "ratably in our assets that are legally available for distribution, after payment of all debts, other liabilities and any liquidation preferences of outstanding preferred stock.", "amended and restated certificate of incorporation does not provide for cumulative voting in the election of directors.", "Upon liquidation, dissolution or winding up of our affairs, the holders of Common Stock are entitled to share", "Holders of our Common Stock have no conversion, redemption, preemptive or similar", "Each outstanding share of Common Stock is entitled to one vote on all matters submitted to a vote of stockholders.", "Anti-Takeover Effects of Provisions of Our Amended and Restated Certificate of Incorporation and Our Amended and Restated By- Laws deemed to have an anti-takeover effect and may delay, deter or prevent a tender offer or takeover attempt that a stockholder might consider in its best interest, including those attempts that might result in a premium over the market price for the shares held by stockholders.", "Our amended and restated by-laws provide that special meetings of holders of Common Stock may be called only by our Chair, Chief Executive Officer or a majority of our board of directors for any purpose at any time.", "Holders of Common Stock owning at least 15% of the outstanding shares of Common Stock for at least one year are permitted to submit a special meeting request in accordance with the procedures described in our amended and restated by-laws.", "In general, notice of intent to nominate a director or raise business at such meetings must be received by us not less than 90 nor more than 120 days prior to the date of the  annual meeting and must contain certain specified  information concerning the person to be nominated or the matters to be brought before the meeting and concerning the stockholder submitting the proposal.", "may be amended by a vote of a majority of our board of directors and by the affirmative vote of a majority of the shares of the corporation entitled  to  vote  thereon.  Our  amended  and  restated  certificate  of  incorporation  and  our  amended  and  restated  by-laws  provide  that  our amended and restated by-laws may be amended by a vote of a majority of our board of directors.", "In addition, our amended and restated by- laws provide that our amended and restated by-laws may be amended by the affirmative vote of a majority of the shares of the corporation entitled to vote thereon.", "Current and former stockholders are deemed to have consented to the personal jurisdiction of the Delaware Courts in connection with any action to enforce that exclusive forum provision and to service of process in any such action.", "We  are  subject  to  the  \u201cbusiness  combination\u201d  statute  of  the  DGCL.  In  general,  such  statute  prohibits  a  publicly  held  Delaware", "The statute could prohibit or delay mergers or other takeover or change in control attempts with respect to us and, accordingly, may discourage attempts to acquire us.", "stock could decrease the amount available for distribution to holders of our Common Stock or could adversely affect the rights and powers, including voting rights, of such holders.", "The issuance of preferred stock could have the effect of delaying or preventing a change in control of us.", "Such limitation does not, however, affect the liability of a director (1) for any breach of the director\u2019s duty of loyalty to us or our stockholders, (2) for acts or omissions not in good faith or that involve intentional misconduct or a knowing violation of law, (3) in respect of certain unlawful dividend payments or stock redemptions or purchases and (4) for any transaction from which the director derives an improper personal benefit.", "The effect of this provision is to eliminate our rights and the rights of our stockholders (through stockholders\u2019 derivative suits) to recover monetary damages against a director for breach of the fiduciary duty of care as a director (including breaches resulting from negligent or grossly negligent behavior) except in the situations described in clauses (1) through (4) above.", "This provision does not limit or eliminate our rights or the rights of our stockholders to seek non-monetary relief such as an injunction or rescission in the event of a breach of a director\u2019s duty of care.", "In addition, our directors and officers have indemnification protection.", "principal amount of 0.625% Notes due 2021 and \u20ac600,000,000 aggregate principal amount of 1.500% Notes due 2025, and on February 12, 2018, we issued \u20ac500,000,000 aggregate principal amount of 1.625% Notes due 2026.", "existing and future unsecured and unsubordinated indebtedness from time to time outstanding.", "EQ Shareowner Services acts as transfer agent and registrar of our Common Stock.", "Our Common Stock is listed on the New York Stock Exchange under the symbol \u201cMCK\u201d.", "On  February  17,  2017,  we  issued  \u00a3450,000,000  aggregate  principal  amount  of  3.125%  Notes  due  2029,  \u20ac600,000,000  aggregate", "Securities\u201d), our senior subordinated debt (\u201cSenior Subordinated Debt Securities\u201d), our subordinated debt (\u201cSubordinated Debt Securities\u201d) or our  junior  subordinated  debt  (\u201cJunior  Subordinated  Debt  Securities\u201d  and,  together  with  the  Senior  Subordinated  Debt  Securities  and  the Subordinated Debt Securities, the \u201cSubordinated Securities\u201d).  The Indenture does not limit the amount of debt securities that we may issue.", "It provides that we may issue debt securities up to the principal amount that we may authorize and may be in any currency or currency unit designated  by  us.  Except  for  the  limitations  on  consolidation,  merger  and  sale  of  all  or  substantially  all  of  our  assets  contained  in  the Indenture, the terms of the Indenture do not contain any covenants or other provisions designed to afford holders of any debt securities protection with respect to our operations, financial condition or transactions involving us.", "any person unless (a) we will be the continuing corporation or (b) the successor corporation or person formed by such consolidation or into which we are merged or to which our assets substantially as an entirety are transferred or leased is a corporation, limited liability company or limited partnership organized or existing under the laws of the United States, any state of the United States or the District of Columbia and, if such entity is not a corporation, a co-obligor of the debt securities is a corporation organized or existing under any such laws, and such successor corporation or person, including such co-obligor, if any, expressly assumes our obligations on the debt securities and under the Indenture.", "In addition, we cannot effect such a transaction unless immediately after giving effect to such transaction, no default or Event of Default under the Indenture shall have occurred and be continuing.", "Subject to certain exceptions, when the person to whom our assets are transferred or leased has assumed our obligations under the debt securities and the Indenture, we shall be discharged from all our obligations under the debt securities and the Indenture, except in limited circumstances.", "unless the transaction or change of control were structured to include a merger or consolidation or transfer or lease of all or substantially all of our assets.", "We cannot consolidate or merge with or into, or transfer or lease all or substantially all of our assets to,", "\u2022 any  other  Event  of  Default  provided  in  the  applicable  resolution  of  our  board  of  directors  or  the  officers\u2019  certificate  or supplemental Indenture under which we issue such series of debt securities.", "The Indenture imposes limitations on suits brought by holders of debt securities against us.", "officer knows of any default by us in the performance, observance or fulfillment of any condition or covenant of the Indenture.", "We and the Trustee may not, however, without the consent of the holder of each outstanding debt security affected thereby:", "The Indenture provides that we and the Trustee may enter into supplemental indentures without the", "value of the assets subject to such transaction, as determined by our Board of Directors, or (b) the present value of the remaining obligations of the lessee for net rental payments during the term of any lease discounted at the rate of interest set forth or implicit in the terms of such lease or, if not practicable to determine such rate, the weighted average interest rate per annum borne by the debt securities of each series outstanding pursuant to the Indenture and subject to limitations on sale and lease-back transaction covenants, compounded semi-annually in either case as determined by our principal accounting or financial officer.", "located,  and  substantially  all  the  operations  of  which  are  conducted,  in  the  United  States  of  America  whose  financial  statements  are consolidated with our financial statements in accordance with accounting principles generally accepted in the United States of America.", "Consolidated  Subsidiaries  incurred  after  the  date  of  issuance  of  the  notes  and  secured  by  liens  not  permitted  by  the  limitation  on  liens provisions, and (2) Attributable Debt of ours and our Consolidated Subsidiaries in respect of every sale and lease-back transaction entered into after the date of the issuance of the notes, other than leases permitted by the limitation on sale and lease-back provisions.", "accordance with accounting principles generally accepted in the United States of America.", "Subsidiaries pursuant to which we or any of our Subsidiaries sells, conveys or otherwise transfers to (1) a Receivables Subsidiary (in the case of a transfer by us or any of our Subsidiaries) or (2) any other person (in the case of a transfer by a Receivables Subsidiary), or grants a security interest in, any accounts receivable (whether now existing or arising in the future) or inventory of us or any of our Subsidiaries, and any assets related thereto including, without limitation, all collateral securing such accounts receivable, all contracts and all guarantees or other  obligations  in  respect  of  such  accounts  receivable  or  inventory,  proceeds  of  such  accounts  receivable  and  other  assets  which  are customarily transferred or in respect of which security interests are customarily granted in connection with asset securitization transactions involving accounts receivable or inventory.", "financing of accounts receivable or inventory (a) no portion of the Indebtedness or any other obligations (contingent or otherwise) of which (1)  is  guaranteed  by  us  or  any  Subsidiary  of  ours  (excluding  guarantees  of  obligations  (other  than  the  principal  of,  and  interest  on, Indebtedness) pursuant to representations, warranties, covenants and indemnities entered into in the ordinary course of business in connection with  a  Qualified  Receivables  Transaction),  (2)  is  recourse  or  obligates  us  or  any  Subsidiary  of  ours  in  any  way  other  than  pursuant  to representations,  warranties,  covenants  and  indemnities  entered  into  in  the  ordinary  course  of  business  in  connection  with  a  Qualified Receivables Transaction or (3) subjects any property or asset of ours or any Subsidiary of ours (other than accounts receivable or inventory and related assets as provided in the definition of \u201cQualified Receivables Transaction\u201d), directly or indirectly, contingently or otherwise, to the satisfaction thereof, other than pursuant to representations, warranties, covenants and indemnities entered into in the ordinary course of business in connection with a Qualified Receivables Transaction, (b) with which neither we nor any Subsidiary of ours has any material contract, agreement, arrangement or understanding other than on terms customary for securitization of receivables or inventory and (c) with which neither we nor any Subsidiary of ours has any obligations to maintain or preserve such Subsidiary\u2019s financial condition or cause such Subsidiary to achieve certain levels of operating results.", "Limitation  on  Liens.  We  covenant  that,  so  long  as  any  of  the  Notes  remain  outstanding,  we  will  not,  and  will  not  permit  any", "Indebtedness which is secured by a lien which would otherwise be subject to the foregoing restrictions; provided that after giving effect thereto the Exempted Debt then outstanding at such time does not exceed 10% of our total assets on a consolidated basis.", "than three years, by us or any Consolidated Subsidiary of any assets are prohibited unless (a) we or such Consolidated Subsidiary would be entitled to incur Indebtedness secured by a lien on the assets to be leased in an amount at least equal to the Attributable Debt in respect of such transaction without equally and ratably securing the notes, or (b) the proceeds of the sale of the assets to be leased are at least equal to their fair market value (as determined by our Board of Directors) and the proceeds are applied to the purchase or acquisition, or, in the case of real property, the construction, of assets or to the retirement of Indebtedness.", "The foregoing limitation will not apply, if at the time we or any Consolidated Subsidiary enters into such sale and lease-back transaction, and after giving effect thereto, Exempted Debt does not exceed 10% of our total assets on a consolidated basis.", "time, or in part, from time to time, at our option, for cash, at a redemption price that includes accrued and unpaid interest and a make-whole premium, as specified in the Indenture and the applicable Officer\u2019s Certificate.", "York  Stock  Exchange  under  the  symbol  \u201cMCK25.\u201d  Our  2026  Notes  are  listed  on  the  New  York  Stock  Exchange  under  the  symbol \u201cMCK26.\u201d Our 2029 Notes are listed on the New York Stock Exchange under the symbol \u201cMCK29.\u201d", "This Statement of Terms and Conditions is intended to meet the requirements of Code Section 409A and any regulations and rules promulgated thereunder.", "In the event of any inconsistency between this Statement of Terms and Conditions and the Plan, the Plan shall govern.", "Capitalized terms not otherwise defined in this Statement of Terms and Conditions shall have the meaning set forth in the Plan.", "With respect to  annual  Restricted  Stock  Unit  Awards  granted  to  Outside  Directors  under  the  Plan,  such  awards  shall  be  subject  to  the  following  terms,  conditions  and restrictions.", "The Administrator administering the Plan has authority to determine the Outside Directors to whom, and the time or", "additional Restricted Stock Units, which will be subject to all of the terms and conditions of the underlying Restricted Stock Unit Award.", "The number of such additional Restricted Stock Units shall be calculated by dividing (a) the aggregate amount or value of the dividends paid with respect to that number of Shares equal to the number of Restricted Stock Units credited as of the record date for such dividend by (b) the Fair Market Value per Share on the payment date for such dividend.", "Any fractional Shares resulting from the accumulation of dividend equivalents shall be paid in cash.", "Dividend equivalents in respect of Restricted Stock Units, if granted in tandem with such Units, will be converted into", "Neither an Outside Director nor any person entitled to exercise an Outside Director\u2019s rights in the event of the Outside", "this Statement of Terms and Conditions, or under a Restricted Stock Unit Agreement, shall be conclusive and binding on all persons.", "is providing the consents herein on a purely voluntary basis.", "Nothing herein contained shall affect an Outside Director\u2019s right, if any, to participate in and receive benefits", "Each Outside Director shall agree to make appropriate arrangements with the Corporation for satisfaction of any applicable federal,", "The Corporation will hold and use the Data only as long as is necessary to implement, administer and manage the", "illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.", "Agreements shall be governed by the laws of the State of Delaware.", "The provisions in this Statement of Terms and Conditions are severable and if any one or more provisions are determined to be", "This Statement of Terms and Conditions and the Restricted Stock Unit Agreements shall be binding upon and inure to the benefit of", "This Statement of Terms and Conditions is intended to meet the requirements of Code Section 409A and any regulations and rules promulgated thereunder.", "In the event of any inconsistency between this Statement of Terms and Conditions and the Plan, the Plan shall govern.", "Capitalized terms not otherwise defined in this Statement of Terms and Conditions shall have the meaning set forth in the Plan.", "With respect to  annual  Restricted  Stock  Unit  Awards  granted  to  Outside  Directors  under  the  Plan,  such  awards  shall  be  subject  to  the  following  terms,  conditions  and restrictions.", "The Administrator administering the Plan has authority to determine the Outside Directors to whom, and the time or", "Neither an Outside Director nor any person entitled to exercise an Outside Director\u2019s rights in the event of the Outside", "this Statement of Terms and Conditions, or under a Restricted Stock Unit Agreement, shall be conclusive and binding on all persons.", "is providing the consents herein on a purely voluntary basis.", "Nothing herein contained shall affect an Outside Director\u2019s right, if any, to participate in and receive benefits", "Each Outside Director shall agree to make appropriate arrangements with the Corporation for satisfaction of any applicable federal,", "The Corporation will hold and use the Data only as long as is necessary to implement, administer and manage the", "illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.", "Agreements shall be governed by the laws of the State of Delaware.", "The provisions in this Statement of Terms and Conditions are severable and if any one or more provisions are determined to be", "This Statement of Terms and Conditions and the Restricted Stock Unit Agreements shall be binding upon and inure to the benefit of", "In the event of any inconsistency between this Statement of Terms and Conditions and the Plan, the Plan shall govern.", "Capitalized terms not otherwise defined in this Statement of Terms and Conditions shall have the meaning set forth in the Plan.", "The Option is also subject to the terms and conditions of the Plan.", "In no event shall the Corporation be required to issue fractional Shares.", "An Option granted under the Plan shall be evidenced by an Option Agreement setting forth the terms and conditions of the", "The Exercise Price of an Option, as specified in the Option Agreement, shall be equal to or greater than the Fair Market Value of", "Period, the Option Period shall end on the date of such termination of employment and the Option shall thereupon not be exercisable to any extent whatsoever.", "Term Disability, the vesting schedule of the Participant\u2019s Option shall be accelerated, the Option shall become fully exercisable and the Option Period shall end on the earlier of (i) three years after the date of the Participant\u2019s termination of employment and (ii) the Expiration Date.", "Retirement, (i) the Option shall be exercisable only to the extent that it was exercisable at the time of such retirement and (ii) the Option Period for that portion of the Option designated as a Non Statutory Stock Option shall end on the earlier of (a) three years after the date of such retirement and (b) the Expiration Date.", "of  the  Participant's  Option,  then  the  Option  shall  continue  to  remain  outstanding  until  the  earlier  of  (i)  such  time  as  the  Participant  subsequently  terminates employment and (ii) the Expiration Date.", "number of Shares as to which the Option is so exercised.", "thereunder shall be transferable by the Participant by operation of law or otherwise, other than by will or the laws of descent and distribution.", "have any of the rights of a stockholder with respect to the Shares subject to an Option except to the extent that a book entry has been entered in the records of the Corporation\u2019s transfer agent with respect to such Shares upon the exercise of an Option.", "Neither a Participant nor any person entitled to exercise a Participant\u2019s rights in the event of the Participant\u2019s death shall", "Stock dividends paid with respect to Restricted Stock during the Restriction Period shall be treated as Restricted Stock which shall be subject to the same restrictions as the original award for the duration of the Restriction Period.", "If the Participant does not have a brokerage account of record, then an appropriate book entry recording the Participant\u2019s interest in the unrestricted Shares shall be entered on the records of the Corporation\u2019s transfer agent.", "Cash dividends paid with respect to Restricted Stock during the Restriction Period shall be credited on behalf of the Participant to a", "Election to Recognize Gross Income in the Year of Grant.", "The Administrator reserves the right to impose a restriction on the sale of Shares that the Participant receives upon", "Neither a Participant nor any person entitled to exercise a Participant\u2019s rights in the event of the Participant\u2019s death shall", "The Administrator reserves the right to impose a restriction on the sale of Shares that the Participant receives upon", "Following the end of the performance period, the Compensation Committee shall determine the extent to which the criteria have been achieved and shall authorize the grant and issuance of Shares in respect of the Performance Stock Unit Award.", "The performance period of a Performance Stock Unit Award shall be greater than one year,", "Unless otherwise determined by the Compensation Committee in its sole discretion, Dividend Equivalents shall not be", "A Participant shall not be permitted to sell, transfer, pledge, assign or encumber all or any portion of a Performance Stock Unit", "Neither a Participant nor any person entitled to exercise a Participant\u2019s rights in the event of the Participant\u2019s death shall", "The Administrator reserves the right to impose a restriction on the sale of Shares that the Participant", "addition, any Award of Restricted Stock or Restricted Stock Units as to which the restrictions have not lapsed shall immediately and automatically be forfeited, Performance Stock Unit Awards shall immediately and automatically be forfeited and any such Shares of Restricted Stock shall be returned to the Corporation and all of the rights of the Participant to such Awards and the underlying Shares shall immediately terminate.", "Any outstanding Option shall immediately and automatically terminate, be forfeited and shall cease to be exercisable, without limitation.", "determination shall be conclusive and binding on all interested persons.", "a manner that is valid and enforceable and that comes closest to the business objectives intended by such invalid or unenforceable provision, without invalidating or rendering unenforceable the remaining provisions of this Section VI.", "under an Award Agreement, shall be conclusive and binding on all interested persons.", "Participation in the Plan shall not create a right to further employment with the Participant\u2019s employer (the", "In making grants to Participants in foreign countries, the Administrator has the full discretion to", "All decisions of the Administrator administering the Plan upon any questions arising under the Plan or", "Nothing herein contained shall affect a Participant\u2019s right to participate in and receive benefits from and in", "Regardless  of any  action  the  Corporation  or  the  Employer  takes  with  respect  to  any  federal,  state  or  local  income  tax,  social", "Calculation of the number of Shares to be withheld shall be made based on the closing price of the Common Stock on the New York Stock Exchange on the date that the amount of tax to be withheld is determined.", "With respect to an Award other than an Option, if adequate arrangements to satisfy the obligations with regard to all Tax-Related Items are not made by the Participant with the Corporation and/or the Employer prior to the relevant taxable event, the Corporation will satisfy such obligations as provided above in clause (3) of this paragraph.", "The Administrator shall be authorized to establish such rules, forms and procedures as it deems necessary to implement the foregoing.", "In accepting the grant, the Participant acknowledges that:", "jurisdiction may have different data privacy laws and protections than the United States.", "In the latter case, the Participant understands and acknowledges that the Corporation\u2019s legal basis for the processing of the Participant\u2019s Data would be compliance with the relevant  laws  or  regulations  or  the  pursuit  by  the  Corporation  of  respective  legitimate  interests  not  outweighed  by  the  Participant\u2019s  interests,  rights  or freedoms.", "When the Corporation no longer needs the Participant\u2019s Data for any of the above purposes, the Participant understands the Corporation will remove it from its systems.", "providing the consents herein on a purely voluntary basis.", "illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.", "If the Participant has received this Statement of Terms and Conditions or any other document related to the Plan translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control.", "The provisions in this Statement of Terms and Conditions are severable and if any one or more provisions are determined to be", "The Participant acknowledges that the Participant is proficient in the English language and, accordingly, understands the provisions of", "The Corporation will hold and use the Data only as long as is necessary to implement, administer and manage the", "Participation in the Plan is voluntary and the Participant is", "In the event of any inconsistency between this Statement of Terms and Conditions and the Plan, the Plan shall govern.", "Capitalized terms not otherwise defined in this Statement of Terms and Conditions shall have the meaning set forth in the Plan.", "The Option is also subject to the terms and conditions of the Plan.", "In no event shall the Corporation be required to issue fractional Shares.", "An Option granted under the Plan shall be evidenced by an Option Agreement setting forth the terms and conditions of the", "The Exercise Price of an Option, as specified in the Option Agreement, shall be equal to or greater than the Fair Market Value of", "Period, the Option Period shall end on the date of such termination of employment and the Option shall thereupon not be exercisable to any extent whatsoever.", "Term Disability, the vesting schedule of the Participant\u2019s Option shall be accelerated, the Option shall become fully exercisable and the Option Period shall end on the earlier of (i) three years after the date of the Participant\u2019s termination of employment and (ii) the Expiration Date.", "Retirement, (i) the Option shall be exercisable only to the extent that it was exercisable at the time of such retirement and (ii) the Option Period for that portion of the Option designated as a Nonstatutory Stock Option shall end on the earlier of (a) three years after the date of such retirement and (b) the Expiration Date.", "of  the  Participant's  Option,  then  the  Option  shall  continue  to  remain  outstanding  until  the  earlier  of  (i)  such  time  as  the  Participant  subsequently  terminates employment and (ii) the Expiration Date.", "number of Shares as to which the Option is so exercised.", "thereunder shall be transferable by the Participant by operation of law or otherwise, other than by will or the laws of descent and distribution.", "have any of the rights of a stockholder with respect to the Shares subject to an Option except to the extent that a book entry has been entered in the records of the Corporation\u2019s transfer agent with respect to such Shares upon the exercise of an Option.", "Neither a Participant nor any person entitled to exercise a Participant\u2019s rights in the event of the Participant\u2019s death shall", "Stock dividends paid with respect to Restricted Stock during the Restriction Period shall be treated as Restricted Stock which shall be subject to the same restrictions as the original award for the duration of the Restriction Period.", "If the Participant does not have a brokerage account of record, then an appropriate book entry recording the Participant\u2019s interest in the unrestricted Shares shall be entered on the records of the Corporation\u2019s transfer agent.", "Cash dividends paid with respect to Restricted Stock during the Restriction Period shall be credited on behalf of the Participant to a", "Election to Recognize Gross Income in the Year of Grant.", "The Administrator reserves the right to impose a restriction on the sale of Shares that the Participant receives upon", "Neither a Participant nor any person entitled to exercise a Participant\u2019s rights in the event of the Participant\u2019s death shall", "The Administrator reserves the right to impose a restriction on the sale of Shares that the Participant receives upon", "The performance period of a Performance Stock Unit Award shall be greater than one year,", "Unless otherwise determined by the Compensation Committee in its sole discretion, Dividend Equivalents shall not be", "A Participant shall not be permitted to sell, transfer, pledge, assign or encumber all or any portion of a Performance Stock Unit", "Neither a Participant nor any person entitled to exercise a Participant\u2019s rights in the event of the Participant\u2019s death shall", "The Administrator reserves the right to impose a restriction on the sale of Shares that the Participant", "addition, any Award of Restricted Stock or Restricted Stock Units as to which the restrictions have not lapsed shall immediately and automatically be forfeited, Performance Stock Unit Awards shall immediately and automatically be forfeited and any such Shares of Restricted Stock shall be returned to the Corporation and all of the rights of the Participant to such Awards and the underlying Shares shall immediately terminate.", "Any outstanding Option shall immediately and automatically terminate, be forfeited and shall cease to be exercisable, without limitation.", "determination shall be conclusive and binding on all interested persons.", "a manner that is valid and enforceable and that comes closest to the business objectives intended by such invalid or unenforceable provision, without invalidating or rendering unenforceable the remaining provisions of this Section VI.", "under an Award Agreement, shall be conclusive and binding on all interested persons.", "Participation in the Plan shall not create a right to further employment with the Participant\u2019s employer (the", "In making grants to Participants in foreign countries, the Administrator has the full discretion to", "All decisions of the Administrator administering the Plan upon any questions arising under the Plan or", "Nothing herein contained shall affect a Participant\u2019s right to participate in and receive benefits from and in", "Regardless  of any  action  the  Corporation  or  the  Employer  takes  with  respect  to  any  federal,  state  or  local  income  tax,  social", "Calculation of the number of Shares to be withheld shall be made based on the closing price of the Common Stock on the New York Stock Exchange on the date that the amount of tax to be withheld is determined.", "With respect to an Award other than an Option, if adequate arrangements to satisfy the obligations with regard to all Tax-Related Items are not made by the Participant with the Corporation and/or the Employer prior to the relevant taxable event, the Corporation will satisfy such obligations as provided above in clause (3) of this paragraph.", "The Administrator shall be authorized to establish such rules, forms and procedures as it deems necessary to implement the foregoing.", "In accepting the grant, the Participant acknowledges that:", "jurisdiction may have different data privacy laws and protections than the United States.", "In the latter case, the Participant understands and acknowledges that the Corporation\u2019s legal basis for the processing of the Participant\u2019s Data would be compliance with the relevant  laws  or  regulations  or  the  pursuit  by  the  Corporation  of  respective  legitimate  interests  not  outweighed  by  the  Participant\u2019s  interests,  rights  or freedoms.", "When the Corporation no longer needs the Participant\u2019s Data for any of the above purposes, the Participant understands the Corporation will remove it from its systems.", "providing the consents herein on a purely voluntary basis.", "illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.", "If the Participant has received this Statement of Terms and Conditions or any other document related to the Plan translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control.", "The provisions in this Statement of Terms and Conditions are severable and if any one or more provisions are determined to be", "The Participant acknowledges that the Participant is proficient in the English language and, accordingly, understands the provisions of", "The Corporation will hold and use the Data only as long as is necessary to implement, administer and manage the", "Participation in the Plan is voluntary and the Participant is", "In the event of any inconsistency between this Statement of Terms and Conditions and the Plan, the Plan shall govern.", "Capitalized terms not otherwise defined in this Statement of Terms and Conditions shall have the meaning set forth in the Plan.", "The Option is also subject to the terms and conditions of the Plan.", "In no event shall the Corporation be required to issue fractional Shares.", "An Option granted under the Plan shall be evidenced by an Option Agreement setting forth the terms and conditions of the", "The Exercise Price of an Option, as specified in the Option Agreement, shall be equal to or greater than the Fair Market Value of", "Period, the Option Period shall end on the date of such termination of employment and the Option shall thereupon not be exercisable to any extent whatsoever.", "Term Disability, the vesting schedule of the Participant\u2019s Option shall be accelerated, the Option shall become fully exercisable and the Option Period shall end on the earlier of (i) three years after the date of the Participant\u2019s termination of employment and (ii) the Expiration Date.", "Retirement, (i) the Option shall be exercisable only to the extent that it was exercisable at the time of such retirement and (ii) the Option Period for that portion of the Option designated as a Non Statutory Stock Option shall end on the earlier of (a) three years after the date of such retirement and (b) the Expiration Date.", "of  the  Participant's  Option,  then  the  Option  shall  continue  to  remain  outstanding  until  the  earlier  of  (i)  such  time  as  the  Participant  subsequently  terminates employment and (ii) the Expiration Date.", "number of Shares as to which the Option is so exercised.", "thereunder shall be transferable by the Participant by operation of law or otherwise, other than by will or the laws of descent and distribution.", "have any of the rights of a stockholder with respect to the Shares subject to an Option except to the extent that a book entry has been entered in the records of the Corporation\u2019s transfer agent with respect to such Shares upon the exercise of an Option.", "Neither a Participant nor any person entitled to exercise a Participant\u2019s rights in the event of the Participant\u2019s death shall", "Stock dividends paid with respect to Restricted Stock during the Restriction Period shall be treated as Restricted Stock which shall be subject to the same restrictions as the original award for the duration of the Restriction Period.", "If the Participant does not have a brokerage account of record, then an appropriate book entry recording the Participant\u2019s interest in the unrestricted Shares shall be entered on the records of the Corporation\u2019s transfer agent.", "Cash dividends paid with respect to Restricted Stock during the Restriction Period shall be credited on behalf of the Participant to a", "Election to Recognize Gross Income in the Year of Grant.", "Neither a Participant nor any person entitled to exercise a Participant\u2019s rights in the event of the Participant\u2019s death shall", "Following the end of the performance period, the Compensation Committee shall determine the extent to which the criteria have been achieved and shall authorize the grant and issuance of Shares in respect of the Performance Stock Unit Award.", "The performance period of a Performance Stock Unit Award shall be greater than one year,", "addition, any Award of Restricted Stock or Restricted Stock Units as to which the restrictions have not lapsed shall immediately and automatically be forfeited, Performance Stock Unit Awards shall immediately and automatically be forfeited and any such Shares of Restricted Stock shall be returned to the Corporation and all of the rights of the Participant to such Awards and the underlying Shares shall immediately terminate.", "Unless otherwise determined by the Compensation Committee in its sole discretion, Dividend Equivalents shall not be", "A Participant shall not be permitted to sell, transfer, pledge, assign or encumber all or any portion of a Performance Stock Unit", "Neither a Participant nor any person entitled to exercise a Participant\u2019s rights in the event of the Participant\u2019s death shall", "Any outstanding Option shall immediately and automatically terminate, be forfeited and shall cease to be exercisable, without limitation.", "determination shall be conclusive and binding on all interested persons.", "a manner that is valid and enforceable and that comes closest to the business objectives intended by such invalid or unenforceable provision, without invalidating or rendering unenforceable the remaining provisions of this Section VI.", "Participation in the Plan shall not create a right to further employment with the Participant\u2019s employer (the", "In making grants to Participants in foreign countries, the Administrator has the full discretion to", "under an Award Agreement, shall be conclusive and binding on all interested persons.", "Calculation of the number of Shares to be withheld shall be made based on the closing price of the Common Stock on the New York Stock Exchange on the date that the amount of tax to be withheld is determined.", "With respect to an Award other than an Option, if adequate arrangements to satisfy the obligations with regard to all Tax-Related Items are not made by the Participant with the Corporation and/or the Employer prior to the relevant taxable event, the Corporation will satisfy such obligations as provided above in clause (3) of this paragraph.", "All decisions of the Administrator administering the Plan upon any questions arising under the Plan or", "Nothing herein contained shall affect a Participant\u2019s right to participate in and receive benefits from and in", "Regardless  of any  action  the  Corporation  or  the  Employer  takes  with  respect  to  any  federal,  state  or  local  income  tax,  social", "The Administrator shall be authorized to establish such rules, forms and procedures as it deems necessary to implement the foregoing.", "In accepting the grant, the Participant acknowledges that:", "jurisdiction may have different data privacy laws and protections than the United States.", "In the latter case, the Participant understands and acknowledges that the Corporation\u2019s legal basis for the processing of the Participant\u2019s Data would be compliance with the relevant  laws  or  regulations  or  the  pursuit  by  the  Corporation  of  respective  legitimate  interests  not  outweighed  by  the  Participant\u2019s  interests,  rights  or freedoms.", "When the Corporation no longer needs the Participant\u2019s Data for any of the above purposes, the Participant understands the Corporation will remove it from its systems.", "providing the consents herein on a purely voluntary basis.", "The Corporation will hold and use the Data only as long as is necessary to implement, administer and manage the", "Participation in the Plan is voluntary and the Participant is", "illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.", "If the Participant has received this Statement of Terms and Conditions or any other document related to the Plan translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control.", "The provisions in this Statement of Terms and Conditions are severable and if any one or more provisions are determined to be", "The Participant acknowledges that the Participant is proficient in the English language and, accordingly, understands the provisions of", "In the event of any inconsistency between this Award Agreement and the Plan, the Plan shall govern.", "Capitalized terms not otherwise defined in this Award Agreement shall have the meaning set forth in the Plan.", "determine the extent to which the performance goals have been achieved, and shall determine the number of PSUs that have been earned.", "Once the Compensation Committee has determined the number of PSUs that have been earned pursuant to the", "Dividend equivalents shall be credited in respect of the One-Year RSU Award.", "The restrictions applicable to the RSU Award shall lapse with respect to 100% of the underlying Shares on the third", "Dividend equivalents shall be credited in respect of the RSU Award granted under this Section III.", "If the Participant ceases to be a bona fide employee of the Corporation or any Affiliate (except as otherwise", "otherwise  forfeited  pursuant  to  the  terms  of  the  Plan  and  this  Award  Agreement  shall  be  paid  to  the  Participant  as  soon  as  reasonably  practicable  after  the restrictions lapse.", "Performance  Stock  Units and  Restricted  Stock  Units,  to  the  extent  the  restrictions  have  not  lapsed,  shall  immediately  and  automatically  be", "determination shall be conclusive and binding on all interested persons.", "a manner that is valid and enforceable and that comes closest to the business objectives intended by such invalid or unenforceable provision, without invalidating or rendering unenforceable the remaining provisions of this Section IV.", "Compensation Committee reserves the right to impose a restriction on the sale of Shares that the Participant receives upon the settlement of the Performance Stock Units and Restricted Stock Units granted hereunder, unless the Participant has satisfied the ownership targets applicable to the Participant as provided in such policy.", "Neither the Participant nor any person entitled to exercise the Participant\u2019s rights in the event of the Participant\u2019s death", "Participation in the Plan shall not create a right to further employment with the Participant\u2019s employer (the", "under this Award Agreement, shall be conclusive and binding on all interested persons.", "Calculation of the number of Shares to be withheld shall be made based on the closing price of the Common Stock on the New York Stock Exchange on the date that the amount of tax to be withheld is determined.", "If adequate arrangements to satisfy the obligations with regard to all Tax-Related Items are not made by the Participant with the Corporation and/or the Employer prior to the relevant taxable event, the Corporation will satisfy such obligations as provided above in clause (iii) of this paragraph.", "The Administrator has the full discretion to deviate from this Award Agreement in order to adjust the Awards", "All decisions of the Administrator administering the Plan upon any questions arising under the Plan or", "Nothing herein contained shall affect the Participant\u2019s right to participate in and receive benefits from and in", "Regardless  of any  action  the  Corporation  or  the  Employer  takes  with  respect  to  any  federal,  state  or  local  income  tax,  social", "The Administrator shall be authorized to establish such rules, forms and procedures as it deems necessary to implement the foregoing.", "In accepting the grant, the Participant acknowledges that:", "providing the consents herein on a purely voluntary basis.", "The Corporation will hold and use the Data only as long as is necessary to implement, administer and manage the", "Participation in the Plan is voluntary and the Participant is", "unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.", "English and if the meaning of the translated version is different than the English version, the English version will control.", "Award, the terms of which are set forth herein and in the Plan.", "The provisions in this Award Agreement are severable and if any one or more provisions are determined to be illegal or otherwise", "Below is a list of documents that are made available to you in connection with this Notice.", "PLEASE BE SURE TO READ THESE DOCUMENTS BECAUSE THEY CONTAIN IMPORTANT INFORMATION SPECIFIC TO THIS GRANT OF RSUs.", "By signing below, I acknowledge that: 1.    I agree to receive copies of the stockholder information, including copies of any annual report, proxy and Form 10-K, from the Investor Resources section of", "Below is a list of documents that are made available to you in connection with this Notice.", "PLEASE BE SURE TO READ THESE DOCUMENTS BECAUSE THEY CONTAIN IMPORTANT INFORMATION SPECIFIC TO THIS GRANT OF RSUs.", "I consent to receiving electronically a copy of the documents set forth above and attachments to this Notice; and 5.", "I accept ALL the terms and conditions as set forth in the Plan and ST&Cs applicable to this grant of RSUs.", "Your  PSUs  will  be  earned  subject  to  the  Company\u2019s  attainment  of  performance  goals  that  have  been  pre-established  by  the  Compensation  Committee  (the \u201cCommittee\u201d) of the Company\u2019s Board of Directors.", "Below is a list of documents that are made available to you in connection with this Notice.", "PLEASE BE SURE TO READ THESE DOCUMENTS BECAUSE THEY CONTAIN IMPORTANT INFORMATION SPECIFIC TO THIS GRANT OF PSUs.", "I consent to receiving electronically a copy of the documents set forth above and attachments to this Notice; and 12.", "I should consult with a tax advisor prior to accepting this grant of PSUs or taking any other action with respect to this grant of PSUs; and 14.", "I accept ALL the terms and conditions as set forth in the Plan and ST&Cs applicable to this grant of PSUs.", "We consent to the incorporation by reference in McKesson Corporation Registration Statement Nos. 333-249817, 333-163642, 333-190847, 333-190848, and 333- 213488 on Form S-8, and Registration Statement No. 333-236808 on Form S-3, of our report dated May 12, 2021, relating to the consolidated financial statements and consolidated financial statement schedule of McKesson Corporation and subsidiaries, and the effectiveness of McKesson Corporation\u2019s internal control over financial reporting appearing in this Annual Report on Form 10-K of McKesson Corporation for the year ended March 31, 2021.", "I have reviewed this annual report on Form 10-K of McKesson Corporation;", "The registrant\u2019s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant\u2019s auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):", "I have reviewed this annual report on Form 10-K of McKesson Corporation;", "The registrant\u2019s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant\u2019s auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):", "Together, we work across the healthcare delivery system to connect pharmacies, providers, payers, and biopharma for next-generation patient access and adherence solutions that help people get the medicine they need to live healthier lives.", "Unless otherwise noted, all references in this document to a particular year shall mean the", "On March 10, 2020, we completed the separation of our interest in the Change Healthcare JV through a split- off transaction.", "This transaction reduced our investment in the Change Healthcare JV to zero.", "Change Healthcare: Our equity ownership interest in Change Healthcare JV, a joint venture, has been accounted for using the equity method of accounting.", "for our innovations and obtain copyright protection for our original works of authorship, when such protection is advantageous.", "Through these efforts, we have developed a portfolio of patents and copyrights in the U.S. and worldwide.", "In addition, we have registered or applied to register certain trademarks and service marks in the U.S. and in foreign countries.", "We cannot guarantee that our intellectual property portfolio will be sufficient to deter misappropriation, theft, or misuse of our technology, nor that we can successfully enjoin infringers.", "We periodically receive notices alleging that our products or services infringe on third party patents and other intellectual property rights.", "While the outcome of any litigation or dispute is inherently uncertain, we do not believe that the resolution of any of these infringement notices would have a material adverse impact on our results of operation.", "These values and behaviors help make McKesson unique.", "We offer financial assistance programs for higher education opportunities that support employees\u2019 career growth at the company.", "To provide compensation that is focused on attracting and retaining talent with the skills and experience necessary for a specific role, our compensation program is built on a set of quantifiable factors defined by our guiding principles of internal fairness, market competitiveness, and pay for performance.", "We operate in several countries and our benefits offerings vary accordingly.", "We offer health and wellness benefits to advance the physical, mental, and social well-being of our people, savings programs to help prepare them for retirement, and flexible work arrangements, among other  benefits  offerings,  when  possible.  In  response  to  the  COVID-19  pandemic,  we  offered  extended  medical  benefits  covering  COVID-19  related  visits, treatment and testing, expanded telehealth options, emergency paid time off (\u201cPTO\u201d), and a platform for employees to donate their regular PTO to co-workers who were  more  impacted  by  COVID-19.", "We have received monetary penalties and/or licensing sanctions pursuant to these requirements and future allegations of noncompliance could result in an inability to obtain, maintain or renew permits, licenses or other regulatory approvals needed for the operation of our businesses.", "As a result of ongoing, advanced discussions with state attorneys general and plaintiffs\u2019 representatives regarding a framework to resolve the claims of governmental entities, and our assessment of certain other opioid-related claims, we have reached a stage at which a broad settlement of opioid claims by governmental entities is probable and recorded a charge of $8.1 billion for the year ended March 31, 2021 within \u201cClaims and litigation charges, net\u201d in our Consolidated Statement of Operations in this Annual Report on Form 10-K.", "Because of the many uncertainties associated with any potential settlement arrangement or other resolution of opioid-related litigation, including the uncertainty of the scope of participation by plaintiffs in any potential settlement, we are not able to reasonably estimate the upper or lower ends of the range of ultimate possible loss for all opioid-related litigation matters.", "The adverse outcome of legal proceedings might also involve significant  expense,  management  time  and  distraction,  and risk  of loss that  can be difficult  to predict  or quantify.  In addition  to this litigation,  legislative  or regulatory measures related to the distribution of controlled substances such as prescription opioids could affect our business in ways that we may not be able to predict.", "For example, some states have passed legislation that could require us to pay taxes or assessments on the distribution of opioid medications in those states and other states have considered similar legislation.", "We are subject to government audits,  investigations  and  oversight  proceedings.  Government  agencies  routinely  review  and  audit  government  contractors  to  determine  whether  they  are complying with contractual and legal requirements.", "If we fail to comply with these requirements, or we fail an audit, we may be subject to various sanctions such as monetary damages, criminal and civil penalties, termination of contracts and suspension or debarment from government contract work.", "These requirements complicate our business and increase our compliance burden and material non-compliance could harm our reputation.", "affecting  Medicare,  Medicaid,  other  government  healthcare  programs,  and  government  contracts.  Our  relationships  with  pharmaceutical  and  medical  surgical product manufacturers and healthcare providers, as well as our provision of products and services to government entities, subject our business to laws, regulation, and government guidance on fraud and abuse.", "Many of these laws are vague or indefinite and have not been interpreted by the courts and, as such, may be interpreted or applied by a prosecutorial, regulatory, or judicial authority in a manner that could require us to make changes in our operations.", "Americans and changed the way healthcare is financed by both governmental and private payers.", "There are also further efforts to broaden healthcare coverage.", "Provincial governments in Canada that provide partial funding for the purchase of pharmaceuticals and independently regulate the sale and reimbursement of drugs have sought to reduce the costs of publicly funded health programs.", "Some European governments  have  implemented  or  are  considering  austerity  measures  to  reduce  healthcare  spending.  These  measures  exert  pressure  on  the  pricing  and reimbursement timelines for pharmaceuticals and may cause our customers to purchase fewer of our products and services or influence us to reduce prices.", "There is substantial uncertainty about the likelihood, timing and results of these health reform efforts.", "We also have record- keeping  and  other  obligations  under  the  E.U.  Falsified  Medicines  Directive.  Pedigree  tracking  laws  such  as  these  increase  our  compliance  burden  and  our pharmaceutical distribution costs.", "For example, under the Health Insurance Portability and Accountability Act of 1996 (\u201cHIPAA\u201d) we must maintain administrative, physical  and  technological  safeguards  to  protect  individually  identifiable  health  information  (\u201cprotected  health  information\u201d)  and  ensure  the  confidentiality, integrity, and availability of electronic protected health information.", "We are subject to significant compliance obligations under privacy laws such as the General Data Protection Regulation (\u201cGDPR\u201d) in the European Union, the Personal Information Protection and Electronic Documents Act (\u201cPIPEDA\u201d) in Canada, and the California Consumer Protection Act (\u201cCCPA\u201d).", "We are subject to privacy  and  data  protection  compliance  audits  or  investigations  by  various  government  agencies.  Failure  to  comply  with  these  laws  subjects  us  to  potential regulatory enforcement activity, fines, private litigation including class actions, and other costs.", "We also have contractual obligations to customers that might be breached if we fail to comply with privacy laws.", "Our efforts to comply with privacy laws complicate our operations and add to our compliance costs.", "storage and hosting of sensitive information, including protected health information and other types of personal information, confidential financial information, proprietary information, and other sensitive information relating to our customers, company and workforce.", "costs.  Environmental  costs  and  accruals,  including  that  related  to  our  legacy  chemical  distribution  operations,  presently  are  not  material  to our  operations  or financial position.", "Our ten largest customers comprised approximately 32%, and CVS was approximately 19%, of total trade accounts receivable at March 31, 2021.", "We also have agreements with GPOs, each of which functions as a purchasing agent on behalf of member  hospitals,  pharmacies  and other healthcare  providers,  as well as with government  entities  and agencies.  The accounts receivable balances are with individual members of the GPOs, and therefore no significant concentration of credit risk exists.", "Substantially all of these revenues and accounts receivable are included in our U.S.", "distribution arrangements with pharmaceutical manufacturers that include an inflation-based compensation component whereby we benefit when the manufacturers increase their prices as we sell our existing inventory at the new higher prices.", "Forward-looking  statements  involve  risks  and  uncertainties  that  could  cause  actual  results  to  differ  materially  from  those  projected,  anticipated,  or  implied.", "Except to the extent required by federal securities laws, we undertake no obligation to publicly release the result of any revisions to any forward-looking statements to reflect events or circumstances after the date the statements are made, or to reflect the occurrence of unanticipated events.", "Some of our distribution arrangements with the manufacturers provides us compensation based on a percentage of our purchases.", "We experience costly and disruptive legal disputes.", "Despite valid defenses that we assert, legal disputes are often costly, time-consuming, distracting to management and disruptive to normal business operations.", "The outcome of legal disputes is difficult to predict.", "Outcomes can occur that are not justified by the evidence or existing law.", "The uncertainty and expense associated with unresolved legal disputes might harm our business and reputation even if the matter is favorably resolved.", "Accordingly, any legal dispute might have a materially adverse impact on our reputation, our business operations and our financial position or results of operations.", "We might experience losses not covered by insurance.", "supplies, the provision of ancillary services, the conduct of our payer businesses and the provision of products that assist clinical decision-making and relate to patient medical histories and treatment plans.", "Although we seek to maintain adequate insurance coverage,  such  as  property  insurance  for  inventory  and  professional  and  general  liability  insurance,  coverages  on  acceptable  terms  might  be  unavailable,  or coverages might not cover our losses.", "We generally seek to limit our contractual exposure, but limitations of liability or indemnity provisions in our contracts may not be enforceable or adequately protect us from liability.", "Uninsured losses might have a materially adverse impact on our business operations and our financial position or results of operations.", "We regularly are named as a defendant in similar, new cases.", "Many of these cases raise novel theories of liability.", "Any proceedings can have unexpected outcomes that are not justified by evidence or existing law.", "It is not uncommon for claims to be resolved over many years.", "Although the Company has valid defenses and is vigorously defending itself, some proceedings have been and others may be resolved by negotiated outcome.", "Our reputation has been and may continue to be impacted by publicity regarding the litigation and related allegations.", "The adverse outcome of legal proceedings might have a materially adverse impact on our business operations and our financial position or results of operations.", "For example, some states have passed legislation that could require us to pay taxes or assessments on the distribution of opioid medications in those states and other states have considered similar legislation.", "Liabilities for taxes or assessments or other costs of compliance under any such laws might have a materially adverse impact on our reputation, business operations, and our financial position or results of operations.", "We are subject to extensive, complex and challenging healthcare and other laws.", "Any noncompliance by us with applicable laws or the failure to maintain, renew or obtain necessary permits and licenses could lead to litigation and might have a materially adverse impact on our business operations and our financial position or results of operations.", "Local, state and federal governments continue to strengthen their position and scrutiny over practices involving or allegedly involving fraud, waste and abuse affecting Medicare, Medicaid and other government healthcare programs.", "Our relationships with pharmaceutical and medical surgical product manufacturers and healthcare providers, as well as our provision of products and services to government entities, subject our business to laws and regulations on fraud and abuse, which among other things: (1) prohibit persons from soliciting, offering, receiving or paying any remuneration in order to induce the referral of a patient for treatment  or  to  induce  the  ordering  or  purchasing  of  items  or  services  that  are  in  any  way  paid  for  by  Medicare,  Medicaid  or  other  government-sponsored healthcare programs; (2) impose many restrictions upon referring physicians and providers of designated health services under Medicare and Medicaid programs; and (3) prohibit the knowing submission of a false or fraudulent claim for payment to, and knowing retention of an overpayment by, a federal healthcare program such  as  Medicare  and  Medicaid.  Many  of  these  laws,  regulations,  and  government  guidance,  including  those  relating  to  marketing  incentives,  are  vague  or indefinite and have not been interpreted by the courts.", "The laws may be interpreted or applied by a prosecutorial, regulatory, or judicial authority in a manner that could require us to make changes in our operations.", "Failures to comply with applicable laws subject us to federal or state government investigations or qui tam actions, and to liability for damages and civil and criminal penalties, including the loss of licenses or our ability to participate in Medicare, Medicaid and other federal and state healthcare programs.", "These sanctions might have a materially adverse impact on our business operations and our financial position or results of operations.", "Noncompliance with these requirements has resulted in monetary penalties and/or licensing sanctions.", "For example, under a January 2017 agreement with the DEA and Department of Justice we paid $150 million to settle potential administrative and civil claims about our practices for reporting suspicious orders of controlled substances and the DEA suspended, on a staggered basis for limited periods of time, our registrations to distribute certain controlled substances from four distribution centers.", "Pedigree tracking laws increase our compliance burden and our pharmaceutical distribution costs.", "Pedigree tracking laws such as these increase our compliance burden and our pharmaceutical distribution costs, and they might have a materially adverse impact on our business operations and our financial position or results of operations.", "Privacy and data protection laws increase our compliance burden.", "example,  under  the  Health  Insurance  Portability  and  Accountability  Act  of  1996  (\u201cHIPAA\u201d)  we  must  maintain  administrative,  physical  and  technological safeguards  to  protect  individually  identifiable  health  information  (\u201cprotected  health  information\u201d)  and  ensure  the  confidentiality,  integrity  and  availability  of electronic protected health information.", "Failure to comply with these laws subjects us to potential regulatory enforcement activity, fines, private litigation including class actions, and other costs.", "We also have contractual obligations to customers that might be breached if we fail to comply with privacy laws.", "Our efforts to comply with privacy laws complicates our operations and adds to our compliance costs.", "A significant privacy breach or failure  to  comply  with  privacy  laws  might  have  a  materially  adverse  impact  on  our  reputation,  business  operations  and  our  financial  position  or  results  of operations.", "Anti-bribery and anti-corruption laws increase our compliance burden.", "Bribery Act unless the organization can establish the defense of having implemented adequate procedures to prevent bribery.", "Our failure to comply with these laws might subject us to civil and criminal penalties that might have a materially adverse impact on our reputation, business operations and our financial position or results of operations.", "We are subject to a variety of privacy and data protection laws that change frequently and have requirements that vary from jurisdiction to jurisdiction.", "We  are  subject  to  laws  prohibiting  improper  payments  and  bribery,  including  the  U.S.  Foreign  Corrupt  Practices  Act,  the  U.K.  Bribery  Act  and  similar", "We might record significant charges from impairment to goodwill, intangibles and other assets or investments.", "In addition, we periodically review our intangible and other long-lived assets for impairment when events or changes in circumstances, such as a divestiture, indicate the carrying value may not be recoverable.", "Factors that may be considered a change in circumstances indicating that  the  carrying  value  of  our  intangible  and  other  long-lived  assets  may  not  be  recoverable  include  slower  growth  rates,  the  loss  of  a  significant  customer, burdensome new laws or divestiture of a business or asset for less than its carrying value.", "There are inherent uncertainties in management\u2019s estimates, judgments and assumptions used in assessing recoverability of goodwill, intangible and other long-lived assets.", "We may be required to record a significant charge to earnings in our consolidated financial statements during the period in which any impairment of our goodwill or intangible and other long-lived assets is determined, which might have a materially adverse impact on our business operations and our financial position or results of operations.", "storage and hosting of sensitive information, including protected health information and other types of personal information, confidential financial information, proprietary information, and other sensitive information relating to our customers, company and workforce.", "If our software and technology services are alleged to have contributed to faulty clinical decisions or injury to patients, we might be subject to claims or litigation by users of our software or services or their patients.", "Any of these types of errors or failures might have a materially adverse impact on our reputation, business operations and our financial position or results of operations.", "We  are  required  under  U.S.  Generally  Accepted  Accounting  Principles  (\u201cGAAP\u201d)  to  test  our  goodwill  for  impairment  annually  or  more  frequently  if", "We might be impeded in providing customers online services and data access.", "Any such problems might have a materially adverse impact on our business operations and our financial position or results of operations.", "Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.", "we may require financing that may not be available on acceptable terms.", "Any of these risks could adversely affect our ability to achieve the anticipated benefits of an acquisition and might have a materially adverse impact on our business operations and our financial position or results of operations.", "Exclusive forum provisions in our Bylaws could limit our stockholders\u2019 ability to choose their preferred judicial forum for disputes with us or our directors, officers or employees.", "Current and former stockholders are deemed to have consented to the personal jurisdiction of the Delaware Courts in connection with any action to enforce that exclusive forum provision and to service of process in any such action.", "To the extent that these provisions of the bylaws limit a current or former stockholder\u2019s ability to select a judicial forum other than the Delaware Courts, they might discourage the specified legal actions, might cause current or former stockholders to incur additional litigation-related expenses and might result in outcomes unfavorable to current or former stockholders.", "A court might determine that these provisions of the bylaws are inapplicable or unenforceable in any particular action, in which case we may incur additional litigation related expenses in such action, and the action may result in outcomes unfavorable to us, which could have a materially adverse impact on our reputation, our business operations and our financial position or results of operations.", "We might be adversely impacted by delays or other difficulties with divestitures.", "After the disposition, we might experience greater dissynergies than expected, and the impact of the divestiture on our revenue or profit might be larger than we expected.", "We might have difficulties with pre-closing conditions such as regulatory and governmental approvals, which could delay or prevent the divestiture.", "We might have financial exposure in a divested business, such as through minority equity ownership, financial  or  performance  guarantees,  indemnities  or  other  obligations,  such  that  conditions  outside  of  our  control  might  negate  the  expected  benefits  of  the disposition.", "Any of these risks could adversely affect our ability to achieve the anticipated benefits of a divestiture and might have a materially adverse impact on our business operations and our financial position or results of operations.", "We might not realize the expected tax treatment from our split-off of Change Healthcare.", "If Change does not honor its obligations to indemnify the Company, or if the Transactions fail to qualify for the intended tax-free treatment for reasons not related to a disqualifying action by Change or SpinCo, the resulting tax to the Company could have a significant adverse effect on our financial position or results of operations.", "outsourced service providers, and we might not realize expected cost savings or other benefits.", "For example, our ability to use outsourcing resources in certain jurisdictions might be limited by legislative action or customer contracts, with the result that the work must be performed at greater expense or we may be subject to sanctions for non-compliance.", "Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.", "We might encounter difficulties attracting and retaining customers to our retail locations due to their unfamiliarity with our brands or our inexperience with local market  preferences.  Competition  from  our  retail  pharmacy  operations  might  strain  relationships  with  our  retail  pharmacy  customers.  Consolidation  of  retail pharmacies with third party payers, expansion of large retail pharmacy networks, reductions in reimbursement rates, shifts in the mix of branded and generic pharmaceutical sales, and exclusion from preferred pharmacy networks can impair our retail pharmacy sales and profitability.", "We might be harmed by large customer purchase reductions, payment defaults or contract non-renewal.", "March 31, 2021, sales to our largest customer represented approximately 21% of our consolidated revenues and approximately 19% of our trade receivables, and those of our ten largest customers combined accounted for approximately 51% of our consolidated revenues and approximately 32% of our trade receivables.", "A material  default  in  payment,  reduction  in  purchases,  or  the  loss  of  business  from  a  large  customer  might  have  a  materially  adverse  impact  on  our  business operations and our financial position or results of operations.", "Our contracts with government entities involve future funding and compliance risks.", "Our government contracts might not be renewed or might be terminated for convenience with little or no prior notice.", "Government contracts typically expose us to higher potential liability than do other types of contracts.", "We are subject to government audits, investigations and oversight proceedings.", "If we fail to comply with these requirements, or we fail an audit, we are subject to various sanctions such as monetary damages, criminal and civil penalties, termination of contracts and suspension or debarment from government contract work.", "These requirements complicate our business and increase our compliance burden.", "We also provide supplies used for vaccine administration in the Federal COVID-19 Response.", "Our participation in such programs exposes us to various uncertainties.", "Because of these risks and uncertainties our operating results may be materially higher or lower than our projections.", "Certain distribution agreements with manufacturers include pharmaceutical price inflation as a component of our compensation, and we cannot  control  the  frequency  or  magnitude  of  pharmaceutical  price  changes.  We  might  be  unable  to  renew  pharmaceutical  distribution  agreements  with manufacturers in a timely and favorable manner.", "Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.", "We  derive  a  significant  portion  of  our  revenue  from,  and  have  a  significant  portion  of  our  accounts  receivable  with,  a  small  number  of  customers.  At", "Our contracts with government entities are subject to risks such as lack of funding and compliance  with unique requirements.", "We might infringe intellectual property rights or our intellectual property protections might be inadequate.", "If a court were to hold that we infringed other\u2019s rights, we might be required to pay substantial damages, develop non-infringing products or services, obtain a license, stop selling or using the infringing products or services, or incur other sanctions.", "We rely on trade secret, patent, copyright and  trademark  laws,  nondisclosure  obligations  and  other  contractual  provisions  and  technical  measures  to  protect  our  proprietary  rights  in  our  products  and solutions.  We  might  initiate  costly  and  time-consuming  litigation  to  protect  our  trade  secrets,  to  enforce  our  patent,  copyright  and  trademark  rights  and  to determine the scope and validity of the proprietary rights of others.", "Our intellectual property protection efforts might be inadequate to protect our rights.", "Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.", "Competition among potential employers might result in increased salaries, benefits or other employee-related costs, or in our failure to recruit and retain employees.", "Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.", "We might be adversely impacted by healthcare reform such as changes in pricing and reimbursement models.", "healthcare industry and related government programs are changing.", "profit margins for us and our customers and impose new legal requirements on healthcare providers.", "the way healthcare is financed by both governmental and private payers.", "drugs have sought to reduce the costs of publicly funded health programs.", "These measures exert pressure on the pricing and reimbursement timelines for pharmaceuticals and may cause our customers to purchase fewer of our products and services or influence us to reduce prices.", "adverse impact on our business operations and our financial position or results of operations.", "Consolidation might increase counter-party credit risk because credit purchases increase for fewer market participants.", "Any of these changes or disruptions might have a materially adverse impact on our business operations and our financial position or results of operations.", "We might be adversely impacted as a result of our distribution of generic pharmaceuticals.", "Generic drug manufacturers often offer a generic version of branded pharmaceuticals while they challenge the validity or enforceability branded pharmaceutical patents.", "The patent holder might assert infringement claims against us for distributing those generic versions and the generic drug manufactures may not fully indemnify us against such claims.", "These risks, as well as changes in the availability,  pricing  volatility,  reimbursement  rates  for  generic  drugs,  or significant  changes  in  the  nature,  frequency  or magnitude  of  generic  pharmaceutical launches, might have a materially adverse impact on our business operations and our financial position or results of operations.", "We might be adversely impacted by an economic slowdown or recession.", "Any economic slowdown or recession might have a materially adverse impact on our business operations and our financial position or results of operations.", "Disruption or other changes in capital and credit markets might impede access to credit and increase borrowing costs for us and our customers and suppliers and might impair the financial soundness of our customers and suppliers.", "activity by financial institutions, or decreased liquidity and increased costs in the commercial paper market, might adversely affect our borrowing ability and cost of borrowing.", "We generally sell our products and services under short-term unsecured credit arrangements.", "An adverse change in general economic conditions or access to capital might cause our customers to reduce their purchases from us, or delay or fail paying amounts owed to us.", "Suppliers might be unable to make payments due to us for fees, returned products or incentives.", "Interest rate increases or changes in capital market conditions might impede our or our customers\u2019 or suppliers\u2019 ability or cost to obtain credit.", "Any of these risks might have a material adverse impact on our business operations and our financial position or results of operations.", "Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.", "We might be adversely impacted by tax legislation or challenges to our tax positions.", "Tax laws might change in ways that adversely affect our tax positions, effective tax rate and cash flow.", "The tax laws are extremely complex and subject to varying interpretations.", "We are subject to tax examinations in various jurisdictions that might assess additional tax liabilities against us.", "Our tax reporting positions might be challenged by relevant tax authorities, we might incur significant expense in our efforts to defend those challenges, and we might be unsuccessful in those efforts.", "Developments in examinations and challenges might materially change our provision for taxes in the affected periods and might differ materially from our historical tax accruals.", "Any of these risks might have a materially adverse impact on our business operations, our cash flows and our financial position or results of operations.", "For example, we might experience volatility in exchange rates and interest rates and changes in laws regulating our U.K. operations.", "Customers might reduce purchases due to the uncertainty caused by Brexit.", "Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.", "We might be adversely impacted by fluctuations in foreign currency exchange rates.", "exchange rates could reduce our revenues, increase our costs or otherwise adversely affect our financial results reported in U.S. dollars.", "For example, we are exposed to transactional currency exchange risk due to our import and export of products that are purchased or sold in currencies other than the U.S. dollar.", "We also  have  currency  exchange  risk  due  to  intercompany  loans  denominated  in  various  currencies.  The  COVID-19  pandemic  has  affected  and  might  increase currency exchange rate volatility.", "We may from time to time enter into foreign currency contracts, foreign currency borrowings or other techniques intended to hedge  a  portion  of our  foreign  currency  exchange  rate  risks.  These  hedging  activities  may  not  completely  offset  the  adverse  financial  effects  of  unfavorable movements in foreign currency exchange rates during the time the hedges are in place.", "Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.", "We are subject to the tax laws in the U.S. at the federal, state and local government levels and to the tax laws of many other jurisdictions in which we operate", "We conduct our business in various currencies,  including  the U.S. dollar, euro, British pound sterling  and Canadian dollar.  Changes in foreign  currency", "Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.", "We might be adversely impacted by changes in accounting standards.", "It is possible that future accounting standards may require changes to the accounting treatment in our consolidated financial statements and may require us to make significant changes to our financial systems.", "Such changes might have a materially adverse impact on our financial position or results of operations.", "Our consolidated financial statements are subject to the application of U.S.", "Disclosure of an environmental proceeding where a governmental agency is a party generally is included only if we expect monetary sanctions in the proceeding to exceed $1 million, unless otherwise material.", "There are no family relationships between any of the executive officers or directors of the Company.", "We declared regular cash dividends of $1.67 and $1.62 per share in the years ended March 31, 2021 and 2020, respectively.", "discretion of the Board and will depend upon our future earnings, financial condition, capital requirements, and other factors.", "Dividends: In  July  2020,  our  quarterly  dividend  was  raised  from  $0.41  to  $0.42  per  common  share  for  dividends  declared  on  or  after  such  date  by  the", "We anticipate that we will continue to pay quarterly cash dividends in the future.", "In accordance with our accounting policy, we allocate any excess of share repurchase price over par value between additional paid-in capital and retained earnings.", "Accordingly, our retained earnings and additional paid-in capital were reduced by $472 million and $70 million, respectively, during 2019.", "In 2019, we retired 5.0 million or $542 million of our treasury shares previously repurchased.", "This discussion and analysis should be read in conjunction with the consolidated financial statements and accompanying financial notes in Item 8 of Part II of this Annual Report on Form 10-K.", "Our fiscal year begins on April 1 and ends on March 31.", "Unless otherwise noted, all references to a particular year shall mean our fiscal year.", "Our organizational structure also includes Corporate, which consists of income and expenses associated with administrative functions and projects, and the results of certain investments.", "We evaluate the performance of our operating segments on a number of measures, including revenues and operating profit before interest expense and income taxes.", "The following summarizes our four reportable segments and the changes made to our reporting structure commencing in the second quarter of 2021.", "\u2022 Coronavirus disease 2019 (\u201cCOVID-19\u201d) impacted our results of operations for the year ended March 31, 2021.", "The recovery from the COVID- 19 pandemic continued to fluctuate throughout our fiscal year.", "\u2022 We expanded our existing contractual relationship with the Centers for Disease Control and Prevention (\u201cCDC\u201d) through an amendment to our existing Vaccines for Children Program contract to support the U.S. government as a centralized distributor of COVID-19 vaccines and ancillary supplies needed to administer vaccines.", "\u2022 In  December  2020,  we  began  distributing  certain  COVID-19  vaccines  under  the  direction  of  the  CDC.  Through  the  end  of  the  fiscal  year,  we  had distributed approximately 100 million of COVID-19 vaccine doses.", "\u2022 Revenues of $238.2 billion, reflects a 3% increase from the prior year primarily in our U.S.", "\u2022 Diluted loss per common share from continuing operations attributable to McKesson Corporation in 2021 of $28.26 reflects the aforementioned items, net of any respective tax impacts, and a lower share count compared to the prior year driven largely by the separation of our investment in Change Healthcare JV on March 10, 2020;", "The full extent to which COVID-19 will impact us depends on many factors and future developments, which are described at the end of this COVID-19 section.", "We continue to evaluate the nature and extent of the impacts COVID-19 has on our business and operations.", "We provided further support including additional emergency leave and an internal paid time off donation platform for employees impacted by COVID-19.", "These responses were initially put in place during our fourth quarter of 2020.", "policies did not have a material effect on our internal control over financial reporting during the year ended March 31, 2021.", "We also took various actions to mitigate the impact of COVID-19 on our results from operations through cost-containment and payroll-related expenses.", "We support the U.S. government as a centralized distributor of COVID-19 vaccines and ancillary supplies needed to administer vaccines.", "We make no decisions on where products are to be distributed nor how the products are allocated between the various provider sites and ultimately administered to the individuals receiving a vaccine.", "We utilize our expertise and capabilities to support the CDC\u2019s efforts to vaccinate everyone in the U.S. who wants to receive a COVID-19 vaccine.", "The Pfizer Vaccine, which is ultra-frozen, is not being distributed by McKesson, although we are providing ancillary supplies needed for its administration.", "custom freezers and refrigerators to safely store and process millions of vaccine doses.", "The capital expenditures we made during 2021 to prepare for vaccine and ancillary supply kit distribution were not material to our financial condition or liquidity.", "In December 2020, we began distributing the Moderna Vaccine in the U.S. and in March 2021, we began distributing the Janssen Vaccine.", "Subsequently, during the first quarter, we had lower pharmaceutical volumes, specialty drug volumes, and patient care visits that negatively impacted our consolidated revenues and income (loss) from continuing operations before income taxes for the year ended March 31, 2021.", "Additionally, increased costs for certain PPE compressed our margins.", "During the year ended March 31, 2021, we recorded charges totaling $136 million in cost of sales on certain PPE and other related products due to inventory impairments and excess inventory in our Medical-Surgical Solutions segment.", "Although market price volatility and changes to anticipated customer demand may require additional write-downs in future periods, we are taking measures to mitigate such risk.", "We collaborated closely with the federal government and other healthcare stakeholders to source more critical PPE to the U.S.", "We have deferred certain employer payroll taxes and continue to monitor the potential impact of other tax legislation changes as result of the CARES Act, including refundable payroll tax credits on certain qualified wages.", "We anticipate changes due to the CARES Act in the timing of certain cash flows, with no material impact to our financial results for the year ended March 31, 2021.", "The CA Act did not have a material impact on our financial condition, results of operations, or liquidity for the year ended March 31, 2021 nor do we currently expect a material impact on our future financial results.", "We are monitoring our customers closely for changes to their timing of payments or ability to pay amounts owed to us as a result of COVID-19 pandemic impacts to their businesses.", "We remain well-capitalized with access to liquidity from our revolving credit facility.", "Long- term debt markets and commercial paper markets, our primary sources of capital after cash flow from operations, have remained open and accessible to us during the COVID-19 pandemic.", "At March 31, 2021, we were in compliance with all debt covenants, and believe we have the ability to continue to meet our debt covenants in the future.", "Our consolidated balance sheets and ability to maintain financial liquidity remains strong.", "We have experienced no material impacts to our liquidity or net", "We face numerous uncertainties in estimating the direct and indirect effects of COVID-19 on our future business operations, financial condition, results of operations, and liquidity.", "Due to several rapidly changing variables related to the COVID-19 pandemic, estimations of future economic trends and the timing of when stability will  return  remains  challenging.  Additionally,  we  periodically  review  our  intangible  and  other  long-lived  assets  for  impairment  when  events  or  changes  in circumstances indicate  the carrying value may not be recoverable.  Key assumptions and estimates  about future values in our impairment assessments can be affected by a variety of factors, including the impacts of the global pandemic on industry and economic trends as well as on our business strategy and internal forecasts.", "We continue to be involved in discussions with the objective of achieving broad resolution of opioid- related claims of states, their political subdivisions and other government entities (\u201cgovernmental entities\u201d).", "We are in ongoing, advanced discussions with state attorneys general and plaintiffs\u2019 representatives regarding a framework under which, in order to resolve the claims of governmental entities, the three largest U.S. pharmaceutical distributors would pay up to approximately $21.0 billion over a period of 18 years, with up to approximately $8.0 billion to be paid by us, of which more than 90% is anticipated to be used to remediate the opioids crisis.", "As a result of that conclusion, and our assessment of certain other opioid- related claims, we recorded a charge of $8.1 billion for the year ended March 31, 2021 within \u201cClaims and litigation charges, net\u201d in our Consolidated Statement of Operations, related to our share of the settlement framework described above, as well as other opioid-related claims.", "Because of the many uncertainties associated with any potential settlement arrangement or other resolution of opioid-related litigation, including the uncertainty of the scope of participation by plaintiffs in any potential settlement, we are not able to reasonably estimate the upper or lower ends of the range of ultimate possible loss for all opioid-related litigation matters.", "We believe that we have valid defenses to the claims pending against us and, absent an acceptable settlement, intend to vigorously defend against all such claims.  An  adverse  judgment  or  negotiated  resolution  in  any  of  these  matters  could  have  a  material  adverse  impact  on  our  financial  position,  cash  flows  or liquidity, or results of operations.", "The law adopting the excise tax made clear that the OSA would apply only to opioid sales on or before December 31, 2018.", "The excise tax applies only to the first sale occurring in New York, and thus may not apply to sales from our distribution centers in New York to New York customers.", "Unless the appellate court\u2019s decision is overturned, the OSA will be reinstated for calendar years 2017 and 2018 (but not beyond those years), and, subject to any further legal challenge, we will have to pay our ratable share of the annual surcharge for those two years.", "During the second quarter of 2021, we reflected an estimated liability of $50 million for the OSA surcharge in our accompanying consolidated financial statements on the assumption that the appellate court\u2019s decision will stand.", "The higher LIFO credits in 2020 compared to 2019 is primarily driven by higher generic deflation.", "\u2022 Claims and litigation charges, net: These charges include adjustments for estimated probable settlements related to our controlled substance monitoring and reporting, and opioid-related claims, as well as any applicable income items or credit adjustments due to subsequent changes in estimates.", "We have reclassified prior period amounts to conform to the current period presentation.", "\u2022 Goodwill impairments charges: We perform an impairment test on goodwill balances annually in the third quarter and more frequently if indicators for potential impairment exist.", "The resulting goodwill impairment charges are reflected within this line item. \u2022 Restructuring, impairment, and related charges: Restructuring charges that are incurred for programs in which we change our operations, the scope of a business undertaken by our business units, or the manner in which that business is conducted as well as long-lived asset impairments.", "\u2022 SDG&A reflects charges of $58 million to remeasure assets and liabilities held for sale to fair value less costs to sell related to the completed contribution of the majority of our German pharmaceutical wholesale business to create a joint venture with WBA in which we have a 30% ownership interest within our International segment.", "As a result, we were required to perform a goodwill impairment test for these reporting units and recorded a goodwill impairment charge in our European RP reporting unit of $69 million during the second quarter of 2021.", "As of the testing date, other risks, expenses, and future developments, such as additional government actions, increased regulatory uncertainty, and material changes in key market assumptions limit our ability to estimate projected cash flows, which could adversely affect the fair value of various reporting units in future periods, including our McKesson Canada reporting unit within our International segment and our RxCrossroads reporting unit within our RxTS segment, where the risk of a material goodwill impairment is higher than other reporting units.", "\u2022 Restructuring, impairment, and related charges, net includes long-lived asset impairment charges of $112 million, primarily for our United Kingdom (\u201cU.K.\u201d)  business  (mainly  pharmacy  licenses)  and  Rexall  Health  retail  business  (\u201cRexall  Health\u201d)  (mainly  customer  relationships)  within  our International segment, and the remaining $156 million primarily represents employee severance and exit-related costs related to our 2019 restructuring initiatives, as further discussed below; and", "\u2022 Total operating expenses includes higher SDG&A due to our business acquisitions and to support business growth, as well as our technology initiatives, partially offset by favorable effects of foreign currency exchange fluctuations.", "\u2022 SDG&A includes opioid-related costs of $114 million, primarily related to litigation expenses, and increased expenses due to our business acquisitions and to support growth, partially offset by a gain from an escrow settlement of $97 million representing certain indemnity and other claims related to our 2017 acquisition of Rexall Health and a credit of $90 million for the derecognition of a liability related to the tax receivable agreement (\u201cTRA\u201d) payable to the shareholders of Change Healthcare, Inc. (\u201cChange\u201d);", "\u2022 Restructuring,  impairment,  and  related  charges,  net  primarily  includes  employee  severance  and  exit-related  costs  of  $352  million  for  our  2019 restructuring initiatives, as further discussed below and long-lived asset impairment charges of $245 million primarily for our U.K. business (mainly pharmacy licenses) within our International segment driven by additional government reimbursement reductions and competitive pressures in the U.K.", "We evaluate goodwill for impairment on an annual basis as of October 1, and at an interim date, if indicators of potential impairment exist.", "This change was not material to our consolidated financial statements as it did not delay, accelerate, or avoid any potential goodwill impairment charge.", "We expect to incur total charges of approximately $180 million to $280 million for this initiative, consisting primarily of exit related costs, accelerated depreciation and amortization of long-lived assets, and asset impairments.", "We expect to incur total charges of approximately $85 million to $90 million, of which $57 million of charges were recorded to date.", "This initiative was substantially complete in 2021 and remaining costs we expect to record under this initiative are not material.", "The relocation was substantially complete in January 2021 and remaining costs we expect to record under this initiative, primarily relating to lease costs, are not material.", "This primarily reflects mark-to-market gains on our investments in certain U.S. growth stage companies in the healthcare industry and realized gains on the exit of some of these investments as further described in Financial Note 17, \u201cFair Value Measurements,\u201d to the accompanying consolidated financial statements  included  in  this  Annual  Report  on  Form  10-K.  In  future  periods,  fair  value  adjustments  recognized  in  our  operating  results  for  these  types  of investments may be adversely impacted by market volatility.", "Other income, net also increased year over year due to pension settlement charges of $122 million recognized in 2020 related to our previously approved termination of the frozen U.S. defined benefit pension plan.", "In connection with the pension plan termination, we purchased annuity contracts from an insurer that will pay and administer the future pension benefits of the remaining participants.", "Excluding the impairment and transaction-related items described below, our proportionate share of loss from our investment in Change Healthcare JV for the years ended March 31, 2020 and 2019 was $119 million and $194 million, respectively, which primarily includes transaction and integration expenses incurred by the joint venture and basis differences between the joint venture and McKesson including amortization of fair value adjustments.", "During the first quarter of 2020 and for the year ended March 31, 2019, we owned approximately 70% of this joint venture.", "The proceeds from the concurrent offering of other securities were also used by Change  to  acquire  certain  securities  of  Change  Healthcare  JV.  As  a  result,  McKesson\u2019s  equity  interest  in  Change  Healthcare  JV  was  reduced  from  70%  to approximately 58.5%, which was used to recognize our proportionate share in net loss from Change Healthcare JV, commencing in the second quarter of 2020.", "As a result of the ownership dilution to 58.5% from 70%, we recognized a dilution loss of approximately $246 million in the second quarter of 2020.", "Additionally, our proportionate share of income or loss from this investment was subsequently reduced as immaterial settlements of stock option exercises occurred after the IPO and further diluted our ownership.", "Equity Earnings and Charges from Investment in Change Healthcare Joint Venture Until the separation of our investment in Change Healthcare JV on March 10, 2020, we accounted for this investment using the equity method of accounting.", "In the second quarter of 2020, we recorded an other-than-temporary-impairment (\u201cOTTI\u201d) charge of $1.2 billion to our investment in Change Healthcare JV,", "Following the Split-off, we do not beneficially own any of Change\u2019s outstanding securities.", "In connection with this transaction, we recognized a net gain for financial reporting purposes of $414 million during the fourth quarter of 2020, which was largely driven by the reversal of a related deferred tax liability.", "The receipt of any payments under the TRA is dependent upon Change benefiting from this depreciation or amortization in future tax return filings, which creates uncertainty over the amount, timing and probability of the gain recognized.", "As such, we accounted for the TRA as a gain contingency, with no receivable recognized as of March 31, 2021 nor 2020.", "Interest expense decreased in 2020 compared to the prior year primarily due to a decrease in the issuance of commercial paper, partially offset by a decrease in interest income from our derivative contracts.", "Our reported income tax (benefit) expense rates were (13.8%), 1.6%, and 58.4% in 2021, 2020, and 2019, respectively.", "after-tax), which was intended to generally be a tax-free split-off for U.S. federal income tax purposes, and unfavorably impacted by charges of $275 million (pre- tax and after-tax) to remeasure assets and liabilities held for sale to fair value less costs to sell related to the completed contribution of the majority of our German pharmaceutical wholesale business to create a joint venture with WBA.", "goodwill of our European RP and European PD reporting units within the International segment, given that these charges are generally not deductible for tax purposes.", "Our income tax expense, deferred tax assets and liabilities, and uncertain tax liabilities reflect management\u2019s best assessment of estimated current and future taxes to be paid.", "We believe that we have made adequate provision for all income tax uncertainties.", "In connection with the exchange offer, on March 9, 2020, we distributed all 176.0 million outstanding shares of common stock of SpinCo to participating", "Income Tax (Benefit) Expense We recorded income tax (benefit) expense of ($695 million), $18 million, and $356 million for the years ended March 31, 2021, 2020, and 2019, respectively.", "Our reported income tax expense rate for 2019 was unfavorably impacted by charges of $1.8 billion (pre-tax and after-tax) to impair the carrying value of", "Significant judgments and estimates are required in determining the consolidated income tax provision and evaluating income tax uncertainties.", "Noncontrolling interests with redemption  features, such as put rights, that are not solely within our control are considered redeemable  noncontrolling  interests.  Redeemable  noncontrolling interests are presented outside of McKesson Corporation stockholders\u2019 equity (deficit) on our consolidated balance sheet.", "Diluted earnings (loss) per common share attributable to McKesson Corporation was $(28.26), $4.95, and $0.17 for the years ended March 31, 2021,  2020,  and  2019,  respectively.  Net  loss  per  diluted  share  for  the  year  ended  March  31,  2021  is  calculated  by  excluding  dilutive  securities  from  the denominator  due to their antidilutive  effects.  Additionally,  our 2021, 2020, and 2019 diluted  earnings (loss) per share  reflect  the cumulative  effects  of share repurchases.", "Weighted-average diluted common shares outstanding is impacted by the exercise and settlement of share-based awards and the cumulative effect of share repurchases, including the impact of shares exchanged as part of the split-off from our investment in Change Healthcare JV, as discussed above.", "(1) Segment operating profit (loss) includes gross profit, net of operating expenses, as well as other income (expense), net, for our reportable segments.", "For retrospective periods presented, operating loss for Other reflects equity earnings and charges from our equity method investment in Change Healthcare JV, which we split-off in the fourth quarter of 2020.", "Pharmaceutical segment includes a charge of $50 million for the year ended March 31, 2021 related to our estimated liability under the OSA.", "(3) Operating loss for our International segment for the years ended March 31, 2021 and 2020 includes charges of $58 million and $275 million, respectively, to remeasure to fair value the assets and liabilities of our German pharmaceutical wholesale business which was contributed to a joint venture with WBA.", "This segment\u2019s operating loss for the years ended March 31, 2021 and 2019 includes goodwill impairment charges of $69 million and $1.8 billion, respectively, as well as long-lived asset impairment charges for the  years ended March 31, 2021,  2020, and 2019  of $115  million,  $112  million,  and $245  million,  respectively, primarily  related to  our retail  pharmacy businesses in Canada and Europe.", "(4) Operating profit for our Medical-Surgical Solutions segment for the year ended March 31, 2021 includes charges totaling $136 million on certain PPE and other related products due to inventory impairments and excess inventory.", "(5) Operating profit for our RxTS segment for the year ended March 31, 2019 includes a gain of $56 million from the divestiture of an equity investment.", "(6) Operating loss for Other for the year ended March 31, 2020 includes an OTTI charge of $1.2 billion and a dilution loss of $246 million related to our investment in Change Healthcare JV, partially offset by a net gain of $414 million related to the completed separation of our interest in Change Healthcare JV during the fourth quarter of 2020.", "(7) Corporate expenses, net for the year ended March 31, 2021 includes a charge of $8.1 billion related to our estimated liability for opioid-related claims, net gains of $133 million  from  our  equity  investments,  and a net  gain  of $131  million  recorded  in  connection  with  insurance  proceeds  received  from  the  settlement  of  the  shareholder derivative action related to our controlled substances monitoring program.", "This was partially offset by a decrease in LIFO credits of $214 million, a charge of $50 million recorded in 2021 related to our estimated liability under the OSA, net impacts from COVID-19, including a less severe cough, cold, and flu season, as well as increased costs for strategic growth initiatives.", "Operating profit and operating profit margin were unfavorably impacted by customer mix and a decrease in net cash proceeds received of $180 million representing our share of antitrust legal settlements.", "recorded to remeasure to fair value the assets and liabilities of our German pharmaceutical wholesale business which was contributed to a joint venture with WBA, of  which  $58  million  and  $275  million  was  reflected  for  the  years  ended  March  31,  2021  and  2020,  respectively.  This  was  partially  offset  by  a  goodwill impairment charge of $69 million recorded in the second quarter of 2021 related to our European retail pharmacy business.", "This was partially offset  by  the  fair  value  remeasurement  charges  in  2020  described  above  and  a  gain  from  an  escrow  settlement  of  $97  million  in  2019  related  to  our  2017 acquisition of Rexall Health.", "Additionally,  operating  profit  was favorable  year over year  due to lower  operating  expenses, including a decrease in our provision for bad debts.", "primary care business and lower restructuring charges, partially offset by the remeasurement of assets and liabilities to fair value related to a divestiture that was completed in 2020 and higher operating expenses, including an increase in our provision for bad debts.", "and existing customers, integration costs incurred in 2019 for our acquisition of RxCrossroads that closed during the fourth quarter of 2018, partially offset by a gain of $56 million from the divestiture of an equity investment in 2019.", "investment in Change Healthcare JV, partially offset by a net gain of $414 million related to the completed separation of our interest in Change Healthcare JV during the fourth quarter of 2020.", "Operating loss for Other also includes our proportionate share of loss from Change Healthcare JV of $119 million and $194 million for the years ended March 31, 2020 and 2019, respectively.", "connection with insurance proceeds received from the settlement of the shareholder derivative action related to our controlled substances monitoring program.", "Corporate expenses, net, for 2020 includes pension settlement charges of $122 million, an opioid claim settlement charge of $82 million, and net settlement gains of $26 million recognized from our derivative contracts.", "claim settlement charge mentioned above, as well as higher costs for technology initiatives, partially offset by net settlement gains recognized in 2020 from our derivative contracts.", "Other Operating  loss  for  Other  for  the  year  ended  March  31,  2020  includes  an  OTTI charge  of  $1.2  billion  and  a  dilution  loss  of  $246  million  related  to  our", "Corporate 2021 vs. 2020 Corporate expenses, net increased for the year ended March 31, 2021 compared to the prior year due to a charge of $8.1 billion related to our estimated", "We conduct our business worldwide in local currencies including Euro, British pound sterling, and Canadian dollar.", "As a result, the comparability of our results reported in U.S. dollars can be affected by changes in foreign currency exchange rates.", "In discussing our operating results, we may use the term \u201cforeign currency exchange fluctuations,\u201d which refers to the effect of changes in foreign currency exchange rates used to convert the local currency results of our operations in foreign countries where the functional currency is not the U.S. dollar.", "We present this information to provide a framework for assessing how our business performed excluding the effect of foreign currency exchange rate fluctuations.", "In computing the foreign currency exchange fluctuations, we translate our current year results of our operations in foreign countries recorded in local currencies into U.S dollars by applying their respective average foreign currency exchange rates of the corresponding prior year periods, and we subsequently compare those results to the previously reported results of the comparable prior year periods reported in U.S. dollars.", "estimate was made and if different estimates that we reasonably could have used in the current period, or changes in the accounting estimate that are reasonably likely to occur from period to period, could have a material impact on our financial condition or results from operations.", "Below are the estimates that we believe are  critical  to  the  understanding  of  our  operating  results  and  financial  condition.  Other  accounting  policies  are  described  in  Financial  Note  1,  \u201cSignificant Accounting  Policies,\u201d  to  the  consolidated  financial  statements  appearing  in  this  Annual  Report  on  Form  10-K.  Because  of  the  uncertainty  inherent  in  such estimates, actual results may differ from these estimates.", "Other customer financing primarily relates to guarantees provided to our customers, or their creditors, regarding the repurchase of inventories.", "We also provide financing to certain customers related to the purchase of pharmacies, which serve as collateral for the loans.", "We estimate the receivables for which we do not  expect  full  collection  based  on  historical  collection  rates  and  specific  knowledge  regarding  the  current  creditworthiness  of  our  customers  and  record  an allowance in our consolidated financial statements for these amounts.", "Management reviews these factors quarterly to determine if any adjustments are needed to the allowance.", "Sales to our largest customer, CVS Health Corporation (\u201cCVS\u201d), accounted for approximately 21% of our total consolidated revenues in 2021 and comprised approximately 19% of total trade accounts receivable at March 31, 2021.", "As a result, our sales and credit concentration is significant.", "The accounts receivables balances are with individual members of the GPOs, and therefore no significant concentration of credit risk exists.", "A material default in payment, a material reduction in purchases from these or any other large customers, or the loss of a large customer or GPO could have a material adverse impact on our financial position, results of operations, and liquidity.", "We believe the reserves maintained and expenses recorded in 2021 are appropriate and consistent in the context of historical methodologies employed, as well as assessment of trends currently available.", "The selected 0.1% hypothetical change does not reflect what could be considered the best or worst-case scenarios.", "Our LIFO valuation amount includes both pharmaceutical and non-pharmaceutical products.", "We recognized LIFO credits of $38 million, $252 million, and $210 million, respectively, in 2021, 2020, and 2019 in our Consolidated Statements of Operations.", "A LIFO charge is recognized when the net effect of price increases on pharmaceutical and non-pharmaceutical products held in inventory exceeds the impact of price declines, including the effect  of branded pharmaceutical  products  that have lost market  exclusivity.  A LIFO credit  is recognized  when the net effect  of price  declines exceeds the impact of price increases on pharmaceutical and non-pharmaceutical products held in inventory.", "Excluding LIFO reserves, our inventory reserves as of March 31, 2021 and 2020 were $263 million and $96 million, respectively.", "The increase was primarily due to 2021 charges totaling $136 million on certain PPE and other related products due to inventory impairments and excess inventory within our Medical-Surgical Solutions segment.", "In 2021, 2020 and, 2019, our provision for bad debts", "At March 31, 2021 and 2020, total inventories, net were $19.2 billion and $16.7 billion, respectively, in our Consolidated Balance Sheets.", "Any purchase consideration in excess of the estimated fair values of the net assets acquired is recorded as goodwill.", "that is a form or variation of the income approach, whereby a forecast of future cash flows attributable to the asset are discounted to present value using a risk- adjusted discount rate.", "We perform an impairment test on goodwill balances annually in the third quarter and more frequently if indicators for potential impairment exist.", "equal to the amount of excess carrying value above the estimated fair value, if any, but not to exceed the amount of goodwill allocated to the reporting unit.", "we estimate fair value by comparing the business to similar businesses, or guideline companies whose securities are actively traded in public markets.", "Under the income approach, we use a discounted cash flow (\u201cDCF\u201d) model in which cash flows anticipated over several periods, plus a terminal value at the end of that time horizon, are discounted to their present value using an appropriate rate that is commensurate with the risk inherent within the reporting unit.", "Goodwill  and  Long-Lived  Assets: As  a  result  of  acquiring  businesses,  we  have  $9.5  billion  and  $9.4  billion  of  goodwill  at  March  31,  2021  and  2020,", "To estimate the fair value of our reporting units, we generally use a combination of the market approach and the income approach.", "Judgments made in determining an estimate of fair value may materially impact our results of operations.", "Included in the estimate of the weighted-average cost of capital is the assumption of an unsystematic risk premium to address incremental uncertainty related to the reporting units\u2019 future cash flow projections.", "An increase in the unsystematic risk premium increases the discount rate.", "Pharmaceutical  Distribution  reporting  units  in  our  International  segment,  exceeded  their  carrying  values.  The  impairment  testing  performed  in  2020  did  not indicate  any  material  impairment  of  goodwill.  The  segment  change  in  the  second  quarter  of  2021  prompted  changes  in  multiple  reporting  units  across  the Company.", "We recorded a goodwill impairment charge of $69 million in 2021 as the estimated fair value of the Europe Retail Pharmacy reporting unit was lower than its reassigned carrying value based on changes in the composition of the Europe Retail Pharmacy reporting unit within the International segment.", "At March 31, 2021, the  balance  of goodwill for the  reporting  units  in Europe  was approximately  nil  and the  remaining  balance  of goodwill  in the International segment primarily relates to one of our reporting units in Canada.", "Other risks, expenses and future developments, such as additional government actions, increased regulatory uncertainty, and material changes in key market assumptions that we were unable to anticipate as of the testing date may require us to further revise the projected cash flows, which could adversely affect the fair value of our other reporting units in future periods.", "We review intangible assets for impairment at an asset group level whenever events or changes in circumstances indicate that the carrying value of the assets may not be recoverable.", "Determination of recoverability of intangible assets is based on the lowest level of identifiable estimated future undiscounted cash flows resulting from use of the asset and its eventual disposition.", "Measurement of any impairment loss is based on the excess of the carrying value of the asset group over its fair value.", "Assumptions and estimates about future values and remaining useful lives of our purchased intangible assets are complex and subjective.", "When the decline in value is deemed to be other than temporary, an impairment is recognized to the extent that the fair value is less than the carrying value of the investment.", "We consider various factors in determining whether a loss in value of an investment is other than temporary including: the length of time and the extent to which the fair value has been below cost, the financial condition of the investees, and our intent and ability to retain the investment for a period of time sufficient to allow for recovery of value.", "Any significant changes in assumptions or judgments in assessing impairments could result in an impairment charge.", "We generally recognize employee severance costs when payments are probable and amounts are estimable.  Costs related  to contracts without future benefit or contract termination  are recognized  at the earlier of the contract termination  or  the  cease-use  dates.  Other  exit-related  costs  are  recognized  as  incurred.  In  connection  with  these  restructuring  actions,  we  also  assess  the recoverability of long-lived assets used in the business, and as a result, we may recognize accelerated depreciation and amortization reflecting shortened useful lives of the underlying assets.", "paid.  We  are  subject  to  income  taxes  in  the  U.S.  and  numerous  foreign  jurisdictions.  Significant  judgments  and  estimates  are  required  in  determining  the consolidated income tax provision and in evaluating income tax uncertainties and include those used to conclude on the tax-free nature of the separation of the Change Healthcare JV and the unrecognized tax position related to opioid-related litigation and claims, which remains unfinalized, and which may differ from the actual amounts of tax benefit recognized.", "We review our tax positions at the end of each quarter and adjust the balances as new information becomes available.", "to recover our deferred tax assets, we consider all available positive and negative evidence including our past operating results, the existence of cumulative net operating losses in the most recent years, and our forecast of future taxable income.", "In estimating future taxable income, we develop assumptions including the amount of future federal, state and foreign pre-tax operating income, the reversal of temporary differences, and the implementation of feasible and prudent tax planning strategies.", "These assumptions require significant judgment about the forecasts of future taxable income and are consistent with the plans and estimates we use to manage the underlying businesses.", "additional taxes and related interest will be due.", "If our current estimate of tax and interest liabilities is less than the ultimate settlement, an additional charge to income tax expense may result.", "If our current estimate of tax and interest liabilities is more than the ultimate settlement, a reduction to income tax expense may be recognized.", "investigations  relating  to  laws  and  regulations  and  other  matters  arising  out  of  the  normal  conduct  of  our  business.  When  a  loss  is  considered  probable  and reasonably estimable, we record a liability in the amount of our best estimate for the ultimate loss.", "When a material loss is reasonably possible or probable but a reasonable estimate cannot be made, disclosure of the proceeding is provided.", "Deferred income taxes arise from temporary differences between the tax and financial statement recognition of revenue and expense.", "Changes in tax laws and rates could also affect recorded deferred tax assets and liabilities in the future.", "We recognize liabilities for tax and related interest for issues in the U.S. and other tax jurisdictions based on our estimate of whether, and the extent to which,", "As discussed above, development of a meaningful estimate of loss or a range of potential loss is complex when the outcome is directly dependent on future negotiations with or decisions by third parties, such as regulatory agencies, the court system and other interested parties.", "As a result of ongoing, advanced discussions with state attorneys general and plaintiffs\u2019 representatives regarding a framework to resolve the claims of governmental  entities,  and  our  assessment  of  certain  other  opioid-related  claims,  we  have  reached  a  stage  at  which  a  broad  settlement  of  opioid  claims  by governmental entities is probable and recorded a charge of $8.1 billion for the year ended March 31, 2021 within \u201cClaims and litigation charges, net\u201d in our Consolidated Statement of Operations in this report.", "Because of the many uncertainties associated with any potential settlement arrangement or other resolution of opioid-related litigation, including the uncertainty of the scope of participation by plaintiffs in any potential settlement, we are not able to reasonably estimate the upper or lower ends of the range of ultimate possible loss for all opioid-related litigation matters.", "While we are not able to predict the outcome or reasonably estimate a range of possible losses in these matters, an adverse judgment or negotiated resolution in any of these matters could have a material adverse effect on our results of operations, consolidated financial position, cash flows or liquidity.", "facilities and commercial paper program, will be sufficient to fund our short-term and long-term capital expenditures, working capital, and other cash requirements.", "We continue to monitor its impact on demand within parts of our business, as well as trends potentially impacting the timing or ability for some of our customers to pay amounts owed to us.", "We remain well-capitalized with access to liquidity from our $4.0 billion revolving credit facility.", "Additionally, long-term debt markets and commercial paper markets, our primary sources of capital after cash flow from operations, have remained open and accessible to us during the COVID-19 pandemic.", "We have seen continued improvement in conditions in the debt markets and commercial paper markets as the Federal Reserve has taken steps to stabilize the markets.", "At March 31, 2021, we were in compliance with all debt covenants, and believe we have the ability to continue to meet our debt covenants in the future.", "Cash flows from operations can be significantly impacted by factors such as the timing of receipts from customers and payments to vendors.", "Operating activities for the year ended March 31, 2021 were affected by net income adjusted for non-cash items, including the pre-tax $8.1 billion (after-tax $6.8 billion) non-cash charge related to our estimated liability for opioid-related claims, an increase in inventory of $2.3 billion and an increase in drafts and accounts payable of $1.3 billion driven by higher inventory stock levels to meet increased volume demand as part of our inventory management, as well as a decrease in receivables of $1.1 billion driven by timing, higher sales recognized at the end of March 2020, and higher collections in our fourth quarter of 2021.", "value remeasurement charges of $58 million related to the contribution of our German pharmaceutical wholesale business to a joint venture with WBA.", "Additionally, we made a cash payment of $114 million from the executive benefit retirement plan in 2020.", "Investing activities for the year ended March 31, 2021 also includes net cash proceeds of $400 million from sales of businesses and investments, including $286 million in exchange for the contribution of our German pharmaceutical wholesale business to a joint venture with WBA.", "Cash used for other financing activities generally includes payments to noncontrolling interests and activity from our finance leases.", "We received cash from long-term debt issuances of $1.1 billion and made repayments on long-term debt of $1.1 billion in 2019.", "The timing of any repurchases and the actual number of shares repurchased will depend on a variety of factors, including our stock price, corporate and regulatory requirements, restrictions under our debt obligations, and other market and economic conditions.", "In accordance with our accounting policy, we allocate any excess of share repurchase price over par value between additional paid-in capital and retained earnings.", "Accordingly, our retained earnings and additional paid-in capital were reduced by $472 million and $70 million during 2019, respectively.", "outstanding shares of SpinCo common stock, which held all of the Company\u2019s interests in the Change Healthcare JV, to participating holders of the Company\u2019s common  stock  in  exchange  for  15.4  million  shares  of  McKesson  stock,  which  are  now  held  as  treasury  stock  on  our  consolidated  balance  sheet.  Following consummation of the exchange offer, on March 10, 2020, SpinCo merged with and into Change and each share of SpinCo common stock was converted into one share of Change common stock, par value $0.001 per share, with cash being paid in lieu of fractional shares of Change common stock.", "give us the ability to meet our financing needs for the foreseeable future.", "However, there can be no assurance that an increase in volatility or disruption in the global capital and credit markets will not impair our liquidity or increase our costs of borrowing.", "As described within the \u201cTrends and Uncertainties\u201d section above,  the  COVID-19  pandemic  continues  to  develop  rapidly.  We  continue  to  monitor  its  impact  on  demand  within  parts  of  our  business,  as  well  as  trends potentially impacting the timing or ability for some of our customers to pay amounts owed to us.", "(2) This ratio describes the relationship and changes within our capital resources, and is computed as total debt divided by the sum of total debt and McKesson stockholders\u2019 equity (deficit), which excludes noncontrolling and redeemable noncontrolling interests and accumulated other comprehensive loss. (3) Ratio is computed as net income (loss) attributable to McKesson Corporation for the last four quarters, divided by a five-quarter average of McKesson stockholders\u2019 equity (deficit), which excludes noncontrolling and redeemable noncontrolling interests.", "In 2019, we retired 5.0 million or $542 million of the Company\u2019s treasury shares previously repurchased.", "In connection with the Split-off, we distributed all 176.0 million", "Deposits with financial institutions are primarily denominated in U.S. dollars and the functional currencies of our foreign subsidiaries, including Euro, British pound sterling, and Canadian dollars.", "We mitigate the risk of our short-term investment portfolio by depositing funds with reputable financial institutions and monitoring risk profiles and investment strategies of money market funds. outside of the U.S., respectively.", "Our primary intent is to utilize this cash for foreign operations for an indefinite period of time.", "Although the vast majority of cash held outside the U.S. is available for repatriation, doing so could subject us to foreign withholding taxes and state income taxes.", "The COVID-19 pandemic has potential to increase the variations in our working capital, which we continue to monitor closely. partially offset by an increase in drafts and accounts payable and a decrease in receivables.", "Our unfavorable return on McKesson\u2019s stockholder\u2019s equity (deficit) as of March 31, 2021 was also driven by net loss for the year.", "Net loss for the year ended March 31, 2021 includes an after-tax non-cash charge of $6.8 billion related to our estimated liability for opioid-related claims, as discussed in \u201cTrends  and  Uncertainties\u201d of  this  Financial  Review  and  Financial  Note  19,  \u201cCommitments  and  Contingent  Liabilities,\u201d  to  the  accompanying  consolidated financial statements included in this Annual Report on Form 10\u2011K.", "Our debt to capital ratio increased for 2020 primarily due to a decrease in stockholders\u2019 equity driven by the Split-off of our interest in Change Healthcare JV and share repurchases.", "We anticipate that we will continue to pay quarterly cash dividends in the future.", "However, the payment and amount of future dividends remain within the discretion of the Board and will depend upon our future earnings, financial condition,  capital  requirements,  and  other  factors.  In  2021,  2020,  and  2019,  we  paid  total  cash  dividends  of  $276  million,  $294  million,  and  $292  million, respectively.  Additionally,  as  required  under  the  Domination  Agreement,  we  are  obligated  to  pay  an  annual  recurring  compensation  amount  of  \u20ac0.83  per McKesson Europe share (effective January 1, 2015) to the noncontrolling shareholders of McKesson Europe.", "Cash equivalents, which are readily convertible to known amounts of cash, are carried at fair value.", "Our cash and cash equivalents balance as of March 31, 2021 and 2020 included approximately $2.3 billion and $1.7 billion of cash held by our subsidiaries", "On  July  29,  2020,  we  raised  our  quarterly  dividend  from  $0.41  to  $0.42  per  common  share  for  dividends  declared  on  or  after  such  date  by  the  Board.", "(3) Includes our estimated benefit payments for the unfunded benefit plans and minimum funding requirements for the pension plans. (4) Primarily represents interest that will become due on our fixed rate long-term debt obligations.", "These obligations primarily relate to inventory purchases and capital commitments. (6) Includes agreements under which we have guaranteed the repurchase of our customers\u2019 inventory and our customers\u2019 debt in the event these customers are unable to meet their obligations to those financial institutions.", "The ultimate amount and timing of any future cash settlements related to these items cannot be predicted with reasonable certainty.", "and are mostly related to our customer contracts and to meet the security requirements for statutory licenses and permits, court and fiduciary obligations, and our workers\u2019 compensation and automotive liability programs.", "The exercise of the Put Right will reduce the balance of redeemable noncontrolling interests.", "During 2021, we paid $49 million to purchase 1.8 million shares of McKesson Europe through exercises of the Put Right by the noncontrolling shareholders.", "Our banks and insurance companies have issued $146 million of standby letters of credit and surety bonds at March 31, 2021.", "redemption value is the Put Amount adjusted for exchange rate fluctuations each period.", "In future periods, unfavorable foreign currency exchange rate fluctuations between the Euro and the U.S. dollar could adversely impact the carrying value of our redeemable noncontrolling interests and require an adjustment to increase the balance of our redeemable noncontrolling interests to its maximum redemption value.", "On April 12, 2021, we received the Stuttgart Court of Appeals\u2019 final ruling confirming the original put value of \u20ac22.99 per share and the annual recurring compensation of \u20ac0.83 per McKesson Europe share.", "Funds necessary for future debt maturities and our other cash requirements are expected to be met by existing cash balances, cash flow from operations, existing credit sources, and other capital market transactions.", "The effect of a hypothetical 50 bp increase in the underlying interest rate on our cash and cash equivalents, net of short-term borrowings and variable rate debt, would have resulted in a favorable impact to earnings in 2021 and 2020 of approximately $17 million and $6 million, respectively.", "The balance of redeemable noncontrolling interests is reported at the greater of its carrying value or its maximum redemption value at each reporting date.", "Additionally,  we  are  obligated  to  pay  an  annual  recurring  compensation  of  \u20ac0.83  per  McKesson  Europe  share  (the  \u201cCompensation  Amount\u201d)  to  the", "Interest rate risk: Our long-term debt bears interest predominately at fixed rates, whereas our short-term borrowings are at variable interest rates.", "Our cash and cash equivalents balances earn interest at variable rates.", "At March 31, 2021 and 2020, we had $6.3 billion and $4.0 billion, respectively, in cash", "Changes in foreign currency exchange rates could have a material adverse impact on our financial results that are reported in U.S. dollars.", "We are also exposed to foreign exchange rate risk related to our foreign subsidiaries, including intercompany loans denominated in non-functional currencies.", "These programs reduce but do not entirely eliminate foreign exchange risk.", "fair value of our foreign exchange contracts by approximately $267 million and $435 million, respectively.", "Foreign exchange risk: We conduct our business worldwide in U.S. dollars and the functional currencies of our foreign subsidiaries, including Euro, British", "We have certain foreign exchange rate risk programs that use foreign currency forward contracts and cross-currency swaps.", "Based on this assessment, our management has concluded that our internal control over financial reporting was effective as of March 31, 2021.", "In our opinion, the financial statements referred to above present fairly, in all material respects, the financial position of the Company as of March 31, 2021 and 2020, and the results of its operations and its cash flows for each of the three years in the period ended March 31, 2021, in conformity with accounting principles generally accepted in the United States of America.", "Also, in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of March 31, 2021, based on criteria established in Internal Control \u2014 Integrated Framework (2013) issued by COSO.", "Our responsibility is to express an opinion on these financial statements and an opinion on the Company\u2019s internal control over financial reporting based  on  our  audits.  We  are  a  public  accounting  firm  registered  with  the  Public  Company  Accounting  Oversight  Board  (United  States)  (\u201cPCAOB\u201d)  and  are required  to  be  independent  with  respect  to  the  Company  in  accordance  with  the  U.S.  federal  securities  laws  and  the  applicable  rules  and  regulations  of  the Securities and Exchange Commission and the PCAOB.", "We conducted our audits in accordance with the standards of the PCAOB.", "Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.", "Our audits of the financial statements included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures to respond to those risks.", "Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements.", "Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk.", "Our audits also included performing such other procedures as we considered necessary in the circumstances.", "We believe that our audits provide a reasonable basis for our opinions.", "The critical audit matters communicated below are matters arising from the current-period audit of the financial statements that were communicated or required to be communicated to the audit committee and that (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments.", "The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.", "The Company also performs an assessment of loss contingencies where a loss is reasonably possible.", "We identified the potential broad settlement of opioid claims as a critical audit matter because of the significant judgment and challenges auditing management\u2019s determination  of  whether  such  loss  is  probable  and  reasonably  estimable.  Specifically,  auditing  management\u2019s  determination  and  disclosure  of  whether  the contingent loss arising from the potential broad settlement of opioid claims is probable, and the related measurement of such loss, is subjective and requires significant judgment given that the potential loss is based upon settlement terms that have not yet been finalized.", "\u2022 We tested the effectiveness of internal controls related to the potential broad settlement of opioid claims, and approval of the accounting treatment and related disclosures based on the most recent facts and circumstances.", "In addition, we inspected responses to inquiry letters sent to both internal and external legal counsel as it relates to the status of discussions with plaintiffs\u2019 counsel and the Company\u2019s intent regarding the framework for a potential broad settlement of opioid claims.", "\u2022 We evaluated management\u2019s analysis of the potential broad settlement of opioid claims, including the methodology used by management to determine the probability of such loss.", "We also evaluated the methodology used by management to estimate the most likely loss to be incurred by the Company as a result of a potential broad settlement of opioid claims.", "\u2022 We performed public domain searches for evidence contrary to management\u2019s analysis.", "\u2022 We evaluated any events subsequent to March 31, 2021 that might impact our evaluation of the potential broad settlement of opioid claims. \u2022 We obtained written representations from executives and internal counsel of the Company. \u2022 We examined proposed terms related to the potential broad settlement framework. \u2022 We evaluated the Company\u2019s related disclosures for consistency with our testing.", "The net amount recognized by management is measured as the largest amount of tax benefit that is greater than 50 percent likely of being realized.", "We identified the Company\u2019s uncertain tax position related to the charge for the potential broad settlement of opioid claims as a critical audit matter because of the challenges in auditing management\u2019s estimate of the amount of income tax benefit that qualifies for recognition.", "Our audit procedures related to the Company's uncertain tax position associated with a potential broad settlement of opioid claims included the following, among others: \u2022 We tested the effectiveness of internal controls related to the Company\u2019s assessment of the technical merits of its tax position, including the Company\u2019s assessment as to the amount of benefit that is more likely than not to be realized. \u2022 With  the  assistance  of  our  tax  specialists,  we  evaluated  the  facts,  evidence  and  the  Company\u2019s  related  income  tax  analysis  for  the  charge  related  to  the potential broad settlement of opioid claims, including assumptions used by management to measure the related recognized and unrecognized tax benefits. \u2022 We inquired of the Company\u2019s internal and external legal counsel to understand the basis for the Company\u2019s conclusion that a portion of the potential broad settlement of opioid claims would be deductible based on the most recent discussions with plaintiffs\u2019 counsel.", "\u2022 We  compared  management's  income  tax  assessment  of  this  matter  to  the  treatment  of  other  recorded  opioid  charges  to  evaluate  the  consistency  of  the Company\u2019s judgments related to the uncertain tax position. \u2022 We evaluated any events subsequent to March 31, 2021 that might impact our evaluation of the Company\u2019s uncertain tax position related to the charge for the potential broad settlement of opioid claims.", "\u2022 We obtained written representations from executives and internal counsel of the Company. \u2022 We examined proposed terms related to the potential broad settlement framework.", "\u2022 We evaluated the Company\u2019s related disclosures for consistency with our testing and also searched for contradictory evidence by reading disclosures from peer companies, who are also party to the potential broad settlement of opioid claims.", "We identified the estimation of the fair value of the McKesson Canada reporting unit used to evaluate the recoverability of goodwill as a critical audit matter because of the challenges auditing significant judgments used in the selection of a discount rate, including the unsystematic risk premium.", "In particular, the fair value estimate is sensitive to the unsystematic risk premium assumption, which is affected by expected risk of changes in the Canadian business and regulatory environments.", "Auditing management\u2019s selected discount rate required a high degree of auditor judgment and an increased extent of effort, including the need to involve more senior members of the team and our fair value specialists.", "Our audit procedures related to the Company\u2019s selection of a discount rate, including consideration of the unsystematic risk premium, for the McKesson Canada reporting unit included the following, among others: \u2022 We tested the effectiveness of internal controls related to management\u2019s goodwill impairment evaluation, including those related to the selection of a discount rate and consideration of an unsystematic risk premium. \u2022 We  evaluated  management\u2019s  ability  to  accurately  forecast  operating  results  for  the  McKesson  Canada  reporting  unit  by  comparing  actual  results  to management\u2019s historical forecasts, in order to consider the reasonableness and adequacy of management\u2019s selected unsystematic risk premium. \u2022 As part of our assessment of the unsystematic risk premium, we evaluated the reasonableness of strategic plans expected to be implemented during the forecast period by comparing the forecasts to:", "\u2022 With the assistance of our fair value specialists, we evaluated the reasonableness of the discount rate, including the unsystematic risk premium, by developing a range of independent estimates, testing the mathematical accuracy of the calculation and comparing to the discount rate selected by management.", "We have served as the Company\u2019s auditor since 1968.", "The Company consolidates VIEs when it is determined that it is the primary beneficiary of the VIE.", "Investments in business entities in which the Company does not have control but has the ability to exercise significant influence over operating and financial policies, are accounted for using the equity method.", "Actual amounts could differ from those estimated amounts.", "These legislative acts are not expected to have a material impact on the Company\u2019s consolidated financial results.", "The Company considers itself to control an entity if it is the majority owner of or has voting control over such entity.", "GAAP requires that the Company make estimates and assumptions that", "If a loss in value has occurred that is deemed to be other-than-temporary, an impairment loss is recorded.", "economic environment, customer credit ratings or bankruptcies, as well as reasonable and supportable forecasts.", "We are exposed to credit losses on accounts receivable balances.", "As a result, the Company\u2019s sales and credit concentration is significant.", "The accounts receivables balances are with individual members of the GPOs, and therefore no significant concentration of credit risk exists.", "This credit risk is mitigated by the size and diversity of the Company\u2019s customer base as well as its geographic dispersion.", "These amounts are equivalent to the Company\u2019s LIFO reserves.", "A LIFO credit is recognized when the net effect of price declines exceeds the impact of price increases on pharmaceutical and non-pharmaceutical products held in inventory.", "The increase was primarily due to charges in 2021 totaling $136 million on certain personal protective equipment and other related products due to inventory impairments and excess inventory within our Medical-Surgical Solutions segment.", "When the net realizable value of a disposal group increases during a period, a gain can be recognized to the extent that it does not increase the value of the disposal group beyond its original carrying value when the disposal group was reclassified as held for sale.", "Depreciation and amortization begins when an asset is placed in service and ready for its intended use.", "The use of alternative assumptions and estimates could affect the fair values and change the impairment determinations.", "Measurement of any impairment loss is based on the excess of the carrying value of the asset group over its estimated fair market value.", "customer in an amount that reflects the consideration to which the entity expects to be entitled for that good or service.", "Revenue is recognized when control of goods is transferred to the customer which occurs upon the Company\u2019s delivery to the customer or upon customer  pick-up.", "The ultimate outcome of any outstanding claims may be different than the Company\u2019s estimate.", "If a derivative is designated as a fair value hedge, the changes in the fair value of the derivative and of the hedged item attributable to the hedged risk are recognized in earnings.", "The cumulative changes in fair value are reclassified to the same line as the hedged item in the Consolidated Statements of Operations when the hedged item affects earnings.", "Noncontrolling interests with redemption features, such as put rights, that are not solely within the Company\u2019s control are considered redeemable noncontrolling interests.", "When a loss is considered probable and reasonably estimable, the Company records a liability in the amount of its best estimate for the ultimate loss.", "When a material loss is reasonably possible or probable, but a reasonable estimate cannot be made, disclosure of the proceeding is provided.", "As discussed above, development of a meaningful estimate of loss or a range of potential loss is complex when the outcome is directly dependent on negotiations with or decisions by third parties, such as regulatory agencies, the court system, and other interested parties.", "Any purchase consideration in excess of the estimated fair values of the net assets acquired is recorded as goodwill.", "Restructuring Charges: Employee severance costs are generally recognized when payments are probable and amounts are reasonably estimable.", "The forward-looking model requires the Company to consider historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount in estimating credit losses.", "The adoption of this amended guidance is not expected to have a material impact on the Company\u2019s consolidated financial statements or disclosures.", "accounting policy has been to disclose any intervening events of the joint venture in the lag period that could materially affect its consolidated financial statements.", "McKesson had the ability to adjust the manner in which certain depreciation or amortization deductions are allocated among Change and McKesson.", "This creates uncertainty over the amount, timing, and probability of the gain recognized.", "Any such change is not expected to have a material impact on the Company\u2019s consolidated financial statements.", "This initiative was substantially complete in 2021 and remaining costs the Company expects to record under this initiative are not material.", "This set of initiatives was substantially complete by the end of 2020 and charges in 2021 were not material.", "Goodwill recognized for business acquisitions is generally not expected to be deductible for tax purposes.", "share-based awards that will ultimately vest primarily based on historical experience.", "The estimated forfeiture rate established upon grant is re-assessed throughout the requisite service period and is adjusted when actual forfeitures occur.", "The actual forfeitures in future reporting periods could be higher or lower than current estimates.", "PSUs have a requisite service period of generally three years.", "Compensation expense for the share-based awards is recognized for the portion of awards ultimately expected to vest.", "The number of vested PSUs is assessed at the end of a", "All  outstanding  PeRSU awards  have  completed  the  performance  period  and  are  now classified  and  accounted  for  as RSUs.", "portion of the awards that is ultimately expected to vest.", "Once the fair value of an employee stock option is determined, current accounting practices do not permit it to be changed, even if the estimates used are different from actual.", "The Company believes this market-based input provides a reasonable estimate of its future stock price movements and is consistent with employee stock option valuation considerations.", "These amounts have not been significant for all the years presented.", "Substantially all its foreign net operating losses have indefinite lives.", "The decrease in unrecognized tax benefits in 2020  compared  to  2019  is  primarily  attributable  to  the  favorable  resolution  of  an  outstanding  California  tax  refund  claim  which  decreased  unrecognized  tax benefits by $91 million.", "2017 Tax Act, the repatriation of cash to the U.S. is generally no longer taxable for federal income tax purposes.", "The Company may remit foreign earnings to the U.S. to the extent it is tax efficient to do so.", "It does not expect the tax impact from remitting these earnings to be material.", "The exercise of the Put Right will reduce the balance of redeemable noncontrolling interests.", "The adoption of this guidance did not have a material impact on the Company\u2019s consolidated statements of operations and cash flows.", "The Company\u2019s lease agreements do not contain any material residual value guarantees or material restrictive covenants.", "Operating lease liabilities are recognized based on the present value of the future lease payments over the lease term, discounted at the Company\u2019s incremental borrowing rate as the implicit rate in the lease is not readily determinable for most of the Company\u2019s leases.", "As a practical expedient, short-term leases with an initial term of 12 months or less are excluded from the Consolidated Balance Sheets and charges from these leases are expensed as incurred.", "Fair value estimates result from a complex series of judgments about future events and uncertainties and rely heavily on estimates and assumptions that have been deemed reasonable by management as of the measurement date.", "The unsystematic risk premium is an input factor used in calculating the discount rate that specifically addresses uncertainty related to the reporting unit\u2019s future cash flow projections.", "The risk of successfully achieving certain business initiatives was the primary factor in the use of a higher discount rate.", "and, from time-to-time, future unsecured and unsubordinated indebtedness outstanding.", "As a result of absorbing this risk, the leases provide the Company with the power to direct the operations of the leased properties and the obligation to absorb losses or the right to receive benefits of the entity.", "Consolidated VIEs do not have a material impact on the Company\u2019s Consolidated Statements of Operations and Cash Flows.", "their economic performance and thus is not considered the primary beneficiary of the entities.", "The pension obligation in Germany is unfunded with the exception of the contractual trust arrangement used to fund pensions of McKesson Europe\u2019s Management Board.", "actuarial  losses  exceeding  10%  of  the  greater  of  the  projected  benefit  obligation  or  the  market  value  of  assets  are  amortized  straight-line  over  the  average remaining future service period of active employees.", "Pension obligations for its unfunded plans are based on the recommendations of independent actuaries.", "The difference between actual inflation and assumed inflation in our U.K. pension plans resulted in a gain of $23 million.", "corporate bonds rated AA or better whose maturities are aligned with the expected benefit payments of its plans.", "Plan assets of the non-U.S. plans are broadly invested in a manner appropriate to the nature and duration of the expected future retirement benefits payable under the plans.", "Assets are properly diversified to avoid excessive reliance on any particular asset, issuer, or group of undertakings so as to avoid accumulations of risk in the portfolio as a whole.", "practical expedient are not leveled within the fair value hierarchy and are included as a reconciling item to total investments.", "Actions taken by other participating employers may lead to adverse changes in the financial condition of a multiemployer benefit plan and the Company\u2019s withdrawal liability and contributions may increase.", "It does not use derivatives for trading or speculative purposes.", "Eligible employees may contribute to the RSP up to 75% of", "In the normal course of business, the Company is exposed to interest rate and foreign currency exchange rate fluctuations.", "These forward contracts and cross-currency swaps are generally used to offset the potential income statement effects from intercompany loans and other obligations denominated in non-functional currencies.", "These programs reduce but do not entirely eliminate foreign currency exchange rate risk.", "To the extent foreign currency-denominated notes designated as net investment hedges are ineffective, changes in carrying value attributable to the change in spot rates are recorded in earnings.", "To the extent cross-currency swaps designated as hedges are ineffective, changes in carrying value attributable to the change in spot rates are recorded in earnings.", "Changes in fair values representing hedge ineffectiveness are recognized in current earnings.", "The settlement loss on the swaps was not material and will be amortized on a straight-line basis as interest expense over the five-year life of the 2025 Notes.", "Gains or losses from these contracts are largely offset by changes in the value of the underlying intercompany obligations.", "Changes in the fair value for contracts not designated as hedges are recorded directly in earnings.", "The carrying value of all other cash equivalents approximates their fair value due to their relatively short-term nature.", "These inputs are considered Level 2 under the fair value measurements and disclosure guidance and may not be representative of actual values that could have been realized or that will be realized in the future.", "If the carrying amount of an asset group is not recoverable, an impairment charge is recorded to reduce the carrying amount by the excess over its fair value.", "repurchase of its customers\u2019 inventory or its customers\u2019 debt in the event these customers are unable to meet their obligations to those financial institutions.", "For the Company\u2019s inventory repurchase agreements, among other requirements, inventories must be in resalable condition and any repurchase would be at a discount.", "The majority of the Company\u2019s customers\u2019 debt guarantees are secured by certain assets of the customer.", "The Company\u2019s long-term debt is also recorded at cost.", "The carrying value and fair value of the Company\u2019s long-term debt was as follows:", "Long-lived Assets The Company utilizes multiple approaches including the DCF model and market approaches for estimating the fair value of intangible assets.", "infringe a third party\u2019s intellectual property rights.", "Where appropriate, obligations for such indemnifications are recorded as liabilities.", "Accrued warranty costs were not material to the Consolidated Balance Sheets.", "Significant developments in those matters are described below.", "Company  is  unable  to  determine  that  a  loss  is  probable,  or  to  reasonably  estimate  the  amount  of  loss  or  a  range  of  loss,  for  a  claim  because  of  the  limited information  available  and  the  potential  effects  of future  events  and  decisions  by third  parties,  such  as  courts  and  regulators,  that  will  determine  the  ultimate resolution of the claim.", "It is not uncommon for claims to remain unresolved over many years.", "The Company reviews loss contingencies at least quarterly to determine whether the likelihood of loss has changed and whether it can make a reasonable estimate of the loss or range of loss.", "When the Company determines that a loss from a claim is probable and reasonably estimable, it records a liability for an estimated amount.", "The Company also provides disclosure when it is reasonably possible that a loss may be incurred or when it is reasonably possible that the amount of a loss will exceed its recorded liability.", "Warranties In the normal course of business, the Company provides certain warranties and indemnification protection for its products and services.", "These two West Virginia plaintiffs are not expected to participate in any broader multistate resolution of opioid-related claims.", "The Cherokee Nation is not expected to participate in any broader multistate resolution of opioid-related claims.", "Those non-participating governmental entities would be entitled to pursue their claims against the Company and other defendants.", "The Company believes that it has valid defenses to the claims pending against it, and it intends to vigorously defend against all such claims if acceptable settlement terms are not achieved.", "The Company believes it has valid legal defenses in these matters and intends to mount a vigorous defense.", "The Company has not concluded a loss is probable in any of these matters; nor is the amount of any loss reasonably estimable.", "An adverse judgment or negotiated resolution in any of these matters could have a material adverse impact on the Company\u2019s financial position, cash flows or liquidity, or results of operations.", "AIG and ACE are seeking declarations that they have no duty to defend or indemnify McKesson in the thousands of lawsuits pending in federal and state courts related to opioids.", "Discussions with attorneys general and other parties continue.", "If the negotiating parties agree on terms under the framework for a broad resolution of claims of", "Plaintiffs\u2019 moved for summary judgment on the same day.", "subpoenas and requests in a cooperative, thorough and timely manner.", "These responses sometimes require time and effort and can result in considerable costs being incurred by the Company.", "Such subpoenas and requests can lead to the assertion of claims or the commencement of civil or criminal legal proceedings against the Company and other members of the health care industry, as well as to settlements of claims against the Company.", "The Company responds to these requests in the ordinary course of business.", "The law adopting the excise tax made clear that the OSA does not apply to sales or distributions occurring after December 31, 2018.", "It is not certain at this point in time what proportion of this estimated liability will be borne by the Company.", "However, it is possible that the ultimate costs of these matters may exceed or be less than the reserves.", "Due to the complex nature of the tax laws, it is not possible to estimate the outcome of these matters.", "improper actions to delay or prevent generic drugs from entering the market.", "The quarterly results of operations are not necessarily indicative of the results that may be expected for the entire year.", "effectiveness of the Company\u2019s \u201cdisclosure controls and procedures\u201d (as such term is defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) as of the end of the period  covered  by  this  report  and  have  concluded  that  our  disclosure  controls  and  procedures  are  effective  based  on  their  evaluation  of  these  controls  and procedures as required by paragraph (b) of Exchange Act Rules 13a-15 or 15d-15.", "Rules 13a-15 or 15d-15 that occurred during our fourth quarter of 2021 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.", "caption  \u201cInvestors  -  Corporate  Governance.\u201d  The  Company\u2019s  Corporate  Governance  Guidelines  and  Charters  for  the  Audit,  Compensation  and  Governance Committees can also be found on our website under the same caption.", "Information  about the Code of Conduct applicable  to all employees, officers  and directors can be found on our website, www.mckesson.com, under the", "Information with respect to this item is incorporated by reference from the discussion under the heading \u201cExecutive Compensation\u201d in our Proxy Statement.", "Such non-employee director award is fully vested on the date of the grant.", "subject to and qualified in their entirety by reference to our amended and restated certificate of incorporation, our amended and restated by- laws  and  the  Delaware  General  Corporation  Law  (\u201cDGCL\u201d).  Copies  of  our  amended  and  restated  certificate  of  incorporation  and  our amended and restated by-laws have been filed with the Securities and Exchange Commission (the \u201cSEC\u201d) and are incorporated by reference herein. 100,000,000 shares are preferred stock, par value $0.01 per share.", "We may amend from time to time our amended and restated certificate of incorporation to increase the number of authorized shares of Common Stock and/or preferred stock.", "Any such amendment would require the approval of the holders of a majority of our shares entitled to vote.", "All of our outstanding shares of Common Stock are fully paid and non- assessable.", "Stock are entitled to receive ratably dividends out of assets legally available therefor at such times and in such amounts as our board of directors may from time to time determine.", "ratably in our assets that are legally available for distribution, after payment of all debts, other liabilities and any liquidation preferences of outstanding preferred stock.", "amended and restated certificate of incorporation does not provide for cumulative voting in the election of directors.", "Upon liquidation, dissolution or winding up of our affairs, the holders of Common Stock are entitled to share", "Holders of our Common Stock have no conversion, redemption, preemptive or similar", "Each outstanding share of Common Stock is entitled to one vote on all matters submitted to a vote of stockholders.", "Anti-Takeover Effects of Provisions of Our Amended and Restated Certificate of Incorporation and Our Amended and Restated By- Laws deemed to have an anti-takeover effect and may delay, deter or prevent a tender offer or takeover attempt that a stockholder might consider in its best interest, including those attempts that might result in a premium over the market price for the shares held by stockholders.", "Our amended and restated by-laws provide that special meetings of holders of Common Stock may be called only by our Chair, Chief Executive Officer or a majority of our board of directors for any purpose at any time.", "Holders of Common Stock owning at least 15% of the outstanding shares of Common Stock for at least one year are permitted to submit a special meeting request in accordance with the procedures described in our amended and restated by-laws.", "In general, notice of intent to nominate a director or raise business at such meetings must be received by us not less than 90 nor more than 120 days prior to the date of the  annual meeting and must contain certain specified  information concerning the person to be nominated or the matters to be brought before the meeting and concerning the stockholder submitting the proposal.", "may be amended by a vote of a majority of our board of directors and by the affirmative vote of a majority of the shares of the corporation entitled  to  vote  thereon.  Our  amended  and  restated  certificate  of  incorporation  and  our  amended  and  restated  by-laws  provide  that  our amended and restated by-laws may be amended by a vote of a majority of our board of directors.", "In addition, our amended and restated by- laws provide that our amended and restated by-laws may be amended by the affirmative vote of a majority of the shares of the corporation entitled to vote thereon.", "Current and former stockholders are deemed to have consented to the personal jurisdiction of the Delaware Courts in connection with any action to enforce that exclusive forum provision and to service of process in any such action.", "We  are  subject  to  the  \u201cbusiness  combination\u201d  statute  of  the  DGCL.  In  general,  such  statute  prohibits  a  publicly  held  Delaware", "The statute could prohibit or delay mergers or other takeover or change in control attempts with respect to us and, accordingly, may discourage attempts to acquire us.", "stock could decrease the amount available for distribution to holders of our Common Stock or could adversely affect the rights and powers, including voting rights, of such holders.", "The issuance of preferred stock could have the effect of delaying or preventing a change in control of us.", "Such limitation does not, however, affect the liability of a director (1) for any breach of the director\u2019s duty of loyalty to us or our stockholders, (2) for acts or omissions not in good faith or that involve intentional misconduct or a knowing violation of law, (3) in respect of certain unlawful dividend payments or stock redemptions or purchases and (4) for any transaction from which the director derives an improper personal benefit.", "The effect of this provision is to eliminate our rights and the rights of our stockholders (through stockholders\u2019 derivative suits) to recover monetary damages against a director for breach of the fiduciary duty of care as a director (including breaches resulting from negligent or grossly negligent behavior) except in the situations described in clauses (1) through (4) above.", "This provision does not limit or eliminate our rights or the rights of our stockholders to seek non-monetary relief such as an injunction or rescission in the event of a breach of a director\u2019s duty of care.", "In addition, our directors and officers have indemnification protection.", "principal amount of 0.625% Notes due 2021 and \u20ac600,000,000 aggregate principal amount of 1.500% Notes due 2025, and on February 12, 2018, we issued \u20ac500,000,000 aggregate principal amount of 1.625% Notes due 2026.", "existing and future unsecured and unsubordinated indebtedness from time to time outstanding.", "EQ Shareowner Services acts as transfer agent and registrar of our Common Stock.", "Our Common Stock is listed on the New York Stock Exchange under the symbol \u201cMCK\u201d.", "On  February  17,  2017,  we  issued  \u00a3450,000,000  aggregate  principal  amount  of  3.125%  Notes  due  2029,  \u20ac600,000,000  aggregate", "Securities\u201d), our senior subordinated debt (\u201cSenior Subordinated Debt Securities\u201d), our subordinated debt (\u201cSubordinated Debt Securities\u201d) or our  junior  subordinated  debt  (\u201cJunior  Subordinated  Debt  Securities\u201d  and,  together  with  the  Senior  Subordinated  Debt  Securities  and  the Subordinated Debt Securities, the \u201cSubordinated Securities\u201d).  The Indenture does not limit the amount of debt securities that we may issue.", "It provides that we may issue debt securities up to the principal amount that we may authorize and may be in any currency or currency unit designated  by  us.  Except  for  the  limitations  on  consolidation,  merger  and  sale  of  all  or  substantially  all  of  our  assets  contained  in  the Indenture, the terms of the Indenture do not contain any covenants or other provisions designed to afford holders of any debt securities protection with respect to our operations, financial condition or transactions involving us.", "any person unless (a) we will be the continuing corporation or (b) the successor corporation or person formed by such consolidation or into which we are merged or to which our assets substantially as an entirety are transferred or leased is a corporation, limited liability company or limited partnership organized or existing under the laws of the United States, any state of the United States or the District of Columbia and, if such entity is not a corporation, a co-obligor of the debt securities is a corporation organized or existing under any such laws, and such successor corporation or person, including such co-obligor, if any, expressly assumes our obligations on the debt securities and under the Indenture.", "In addition, we cannot effect such a transaction unless immediately after giving effect to such transaction, no default or Event of Default under the Indenture shall have occurred and be continuing.", "Subject to certain exceptions, when the person to whom our assets are transferred or leased has assumed our obligations under the debt securities and the Indenture, we shall be discharged from all our obligations under the debt securities and the Indenture, except in limited circumstances.", "unless the transaction or change of control were structured to include a merger or consolidation or transfer or lease of all or substantially all of our assets.", "We cannot consolidate or merge with or into, or transfer or lease all or substantially all of our assets to,", "\u2022 any  other  Event  of  Default  provided  in  the  applicable  resolution  of  our  board  of  directors  or  the  officers\u2019  certificate  or supplemental Indenture under which we issue such series of debt securities.", "The Indenture imposes limitations on suits brought by holders of debt securities against us.", "officer knows of any default by us in the performance, observance or fulfillment of any condition or covenant of the Indenture.", "We and the Trustee may not, however, without the consent of the holder of each outstanding debt security affected thereby:", "The Indenture provides that we and the Trustee may enter into supplemental indentures without the", "value of the assets subject to such transaction, as determined by our Board of Directors, or (b) the present value of the remaining obligations of the lessee for net rental payments during the term of any lease discounted at the rate of interest set forth or implicit in the terms of such lease or, if not practicable to determine such rate, the weighted average interest rate per annum borne by the debt securities of each series outstanding pursuant to the Indenture and subject to limitations on sale and lease-back transaction covenants, compounded semi-annually in either case as determined by our principal accounting or financial officer.", "located,  and  substantially  all  the  operations  of  which  are  conducted,  in  the  United  States  of  America  whose  financial  statements  are consolidated with our financial statements in accordance with accounting principles generally accepted in the United States of America.", "Consolidated  Subsidiaries  incurred  after  the  date  of  issuance  of  the  notes  and  secured  by  liens  not  permitted  by  the  limitation  on  liens provisions, and (2) Attributable Debt of ours and our Consolidated Subsidiaries in respect of every sale and lease-back transaction entered into after the date of the issuance of the notes, other than leases permitted by the limitation on sale and lease-back provisions.", "accordance with accounting principles generally accepted in the United States of America.", "Subsidiaries pursuant to which we or any of our Subsidiaries sells, conveys or otherwise transfers to (1) a Receivables Subsidiary (in the case of a transfer by us or any of our Subsidiaries) or (2) any other person (in the case of a transfer by a Receivables Subsidiary), or grants a security interest in, any accounts receivable (whether now existing or arising in the future) or inventory of us or any of our Subsidiaries, and any assets related thereto including, without limitation, all collateral securing such accounts receivable, all contracts and all guarantees or other  obligations  in  respect  of  such  accounts  receivable  or  inventory,  proceeds  of  such  accounts  receivable  and  other  assets  which  are customarily transferred or in respect of which security interests are customarily granted in connection with asset securitization transactions involving accounts receivable or inventory.", "financing of accounts receivable or inventory (a) no portion of the Indebtedness or any other obligations (contingent or otherwise) of which (1)  is  guaranteed  by  us  or  any  Subsidiary  of  ours  (excluding  guarantees  of  obligations  (other  than  the  principal  of,  and  interest  on, Indebtedness) pursuant to representations, warranties, covenants and indemnities entered into in the ordinary course of business in connection with  a  Qualified  Receivables  Transaction),  (2)  is  recourse  or  obligates  us  or  any  Subsidiary  of  ours  in  any  way  other  than  pursuant  to representations,  warranties,  covenants  and  indemnities  entered  into  in  the  ordinary  course  of  business  in  connection  with  a  Qualified Receivables Transaction or (3) subjects any property or asset of ours or any Subsidiary of ours (other than accounts receivable or inventory and related assets as provided in the definition of \u201cQualified Receivables Transaction\u201d), directly or indirectly, contingently or otherwise, to the satisfaction thereof, other than pursuant to representations, warranties, covenants and indemnities entered into in the ordinary course of business in connection with a Qualified Receivables Transaction, (b) with which neither we nor any Subsidiary of ours has any material contract, agreement, arrangement or understanding other than on terms customary for securitization of receivables or inventory and (c) with which neither we nor any Subsidiary of ours has any obligations to maintain or preserve such Subsidiary\u2019s financial condition or cause such Subsidiary to achieve certain levels of operating results.", "Limitation  on  Liens.  We  covenant  that,  so  long  as  any  of  the  Notes  remain  outstanding,  we  will  not,  and  will  not  permit  any", "Indebtedness which is secured by a lien which would otherwise be subject to the foregoing restrictions; provided that after giving effect thereto the Exempted Debt then outstanding at such time does not exceed 10% of our total assets on a consolidated basis.", "than three years, by us or any Consolidated Subsidiary of any assets are prohibited unless (a) we or such Consolidated Subsidiary would be entitled to incur Indebtedness secured by a lien on the assets to be leased in an amount at least equal to the Attributable Debt in respect of such transaction without equally and ratably securing the notes, or (b) the proceeds of the sale of the assets to be leased are at least equal to their fair market value (as determined by our Board of Directors) and the proceeds are applied to the purchase or acquisition, or, in the case of real property, the construction, of assets or to the retirement of Indebtedness.", "The foregoing limitation will not apply, if at the time we or any Consolidated Subsidiary enters into such sale and lease-back transaction, and after giving effect thereto, Exempted Debt does not exceed 10% of our total assets on a consolidated basis.", "time, or in part, from time to time, at our option, for cash, at a redemption price that includes accrued and unpaid interest and a make-whole premium, as specified in the Indenture and the applicable Officer\u2019s Certificate.", "York  Stock  Exchange  under  the  symbol  \u201cMCK25.\u201d  Our  2026  Notes  are  listed  on  the  New  York  Stock  Exchange  under  the  symbol \u201cMCK26.\u201d Our 2029 Notes are listed on the New York Stock Exchange under the symbol \u201cMCK29.\u201d", "This Statement of Terms and Conditions is intended to meet the requirements of Code Section 409A and any regulations and rules promulgated thereunder.", "In the event of any inconsistency between this Statement of Terms and Conditions and the Plan, the Plan shall govern.", "Capitalized terms not otherwise defined in this Statement of Terms and Conditions shall have the meaning set forth in the Plan.", "With respect to  annual  Restricted  Stock  Unit  Awards  granted  to  Outside  Directors  under  the  Plan,  such  awards  shall  be  subject  to  the  following  terms,  conditions  and restrictions.", "The Administrator administering the Plan has authority to determine the Outside Directors to whom, and the time or", "additional Restricted Stock Units, which will be subject to all of the terms and conditions of the underlying Restricted Stock Unit Award.", "The number of such additional Restricted Stock Units shall be calculated by dividing (a) the aggregate amount or value of the dividends paid with respect to that number of Shares equal to the number of Restricted Stock Units credited as of the record date for such dividend by (b) the Fair Market Value per Share on the payment date for such dividend.", "Any fractional Shares resulting from the accumulation of dividend equivalents shall be paid in cash.", "Dividend equivalents in respect of Restricted Stock Units, if granted in tandem with such Units, will be converted into", "Neither an Outside Director nor any person entitled to exercise an Outside Director\u2019s rights in the event of the Outside", "this Statement of Terms and Conditions, or under a Restricted Stock Unit Agreement, shall be conclusive and binding on all persons.", "is providing the consents herein on a purely voluntary basis.", "Nothing herein contained shall affect an Outside Director\u2019s right, if any, to participate in and receive benefits", "Each Outside Director shall agree to make appropriate arrangements with the Corporation for satisfaction of any applicable federal,", "The Corporation will hold and use the Data only as long as is necessary to implement, administer and manage the", "illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.", "Agreements shall be governed by the laws of the State of Delaware.", "The provisions in this Statement of Terms and Conditions are severable and if any one or more provisions are determined to be", "This Statement of Terms and Conditions and the Restricted Stock Unit Agreements shall be binding upon and inure to the benefit of", "This Statement of Terms and Conditions is intended to meet the requirements of Code Section 409A and any regulations and rules promulgated thereunder.", "In the event of any inconsistency between this Statement of Terms and Conditions and the Plan, the Plan shall govern.", "Capitalized terms not otherwise defined in this Statement of Terms and Conditions shall have the meaning set forth in the Plan.", "With respect to  annual  Restricted  Stock  Unit  Awards  granted  to  Outside  Directors  under  the  Plan,  such  awards  shall  be  subject  to  the  following  terms,  conditions  and restrictions.", "The Administrator administering the Plan has authority to determine the Outside Directors to whom, and the time or", "Neither an Outside Director nor any person entitled to exercise an Outside Director\u2019s rights in the event of the Outside", "this Statement of Terms and Conditions, or under a Restricted Stock Unit Agreement, shall be conclusive and binding on all persons.", "is providing the consents herein on a purely voluntary basis.", "Nothing herein contained shall affect an Outside Director\u2019s right, if any, to participate in and receive benefits", "Each Outside Director shall agree to make appropriate arrangements with the Corporation for satisfaction of any applicable federal,", "The Corporation will hold and use the Data only as long as is necessary to implement, administer and manage the", "illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.", "Agreements shall be governed by the laws of the State of Delaware.", "The provisions in this Statement of Terms and Conditions are severable and if any one or more provisions are determined to be", "This Statement of Terms and Conditions and the Restricted Stock Unit Agreements shall be binding upon and inure to the benefit of", "In the event of any inconsistency between this Statement of Terms and Conditions and the Plan, the Plan shall govern.", "Capitalized terms not otherwise defined in this Statement of Terms and Conditions shall have the meaning set forth in the Plan.", "The Option is also subject to the terms and conditions of the Plan.", "In no event shall the Corporation be required to issue fractional Shares.", "An Option granted under the Plan shall be evidenced by an Option Agreement setting forth the terms and conditions of the", "The Exercise Price of an Option, as specified in the Option Agreement, shall be equal to or greater than the Fair Market Value of", "Period, the Option Period shall end on the date of such termination of employment and the Option shall thereupon not be exercisable to any extent whatsoever.", "Term Disability, the vesting schedule of the Participant\u2019s Option shall be accelerated, the Option shall become fully exercisable and the Option Period shall end on the earlier of (i) three years after the date of the Participant\u2019s termination of employment and (ii) the Expiration Date.", "Retirement, (i) the Option shall be exercisable only to the extent that it was exercisable at the time of such retirement and (ii) the Option Period for that portion of the Option designated as a Non Statutory Stock Option shall end on the earlier of (a) three years after the date of such retirement and (b) the Expiration Date.", "of  the  Participant's  Option,  then  the  Option  shall  continue  to  remain  outstanding  until  the  earlier  of  (i)  such  time  as  the  Participant  subsequently  terminates employment and (ii) the Expiration Date.", "number of Shares as to which the Option is so exercised.", "thereunder shall be transferable by the Participant by operation of law or otherwise, other than by will or the laws of descent and distribution.", "have any of the rights of a stockholder with respect to the Shares subject to an Option except to the extent that a book entry has been entered in the records of the Corporation\u2019s transfer agent with respect to such Shares upon the exercise of an Option.", "Neither a Participant nor any person entitled to exercise a Participant\u2019s rights in the event of the Participant\u2019s death shall", "Stock dividends paid with respect to Restricted Stock during the Restriction Period shall be treated as Restricted Stock which shall be subject to the same restrictions as the original award for the duration of the Restriction Period.", "If the Participant does not have a brokerage account of record, then an appropriate book entry recording the Participant\u2019s interest in the unrestricted Shares shall be entered on the records of the Corporation\u2019s transfer agent.", "Cash dividends paid with respect to Restricted Stock during the Restriction Period shall be credited on behalf of the Participant to a", "Election to Recognize Gross Income in the Year of Grant.", "The Administrator reserves the right to impose a restriction on the sale of Shares that the Participant receives upon", "Neither a Participant nor any person entitled to exercise a Participant\u2019s rights in the event of the Participant\u2019s death shall", "The Administrator reserves the right to impose a restriction on the sale of Shares that the Participant receives upon", "Following the end of the performance period, the Compensation Committee shall determine the extent to which the criteria have been achieved and shall authorize the grant and issuance of Shares in respect of the Performance Stock Unit Award.", "The performance period of a Performance Stock Unit Award shall be greater than one year,", "Unless otherwise determined by the Compensation Committee in its sole discretion, Dividend Equivalents shall not be", "A Participant shall not be permitted to sell, transfer, pledge, assign or encumber all or any portion of a Performance Stock Unit", "Neither a Participant nor any person entitled to exercise a Participant\u2019s rights in the event of the Participant\u2019s death shall", "The Administrator reserves the right to impose a restriction on the sale of Shares that the Participant", "addition, any Award of Restricted Stock or Restricted Stock Units as to which the restrictions have not lapsed shall immediately and automatically be forfeited, Performance Stock Unit Awards shall immediately and automatically be forfeited and any such Shares of Restricted Stock shall be returned to the Corporation and all of the rights of the Participant to such Awards and the underlying Shares shall immediately terminate.", "Any outstanding Option shall immediately and automatically terminate, be forfeited and shall cease to be exercisable, without limitation.", "determination shall be conclusive and binding on all interested persons.", "a manner that is valid and enforceable and that comes closest to the business objectives intended by such invalid or unenforceable provision, without invalidating or rendering unenforceable the remaining provisions of this Section VI.", "under an Award Agreement, shall be conclusive and binding on all interested persons.", "Participation in the Plan shall not create a right to further employment with the Participant\u2019s employer (the", "In making grants to Participants in foreign countries, the Administrator has the full discretion to", "All decisions of the Administrator administering the Plan upon any questions arising under the Plan or", "Nothing herein contained shall affect a Participant\u2019s right to participate in and receive benefits from and in", "Regardless  of any  action  the  Corporation  or  the  Employer  takes  with  respect  to  any  federal,  state  or  local  income  tax,  social", "Calculation of the number of Shares to be withheld shall be made based on the closing price of the Common Stock on the New York Stock Exchange on the date that the amount of tax to be withheld is determined.", "With respect to an Award other than an Option, if adequate arrangements to satisfy the obligations with regard to all Tax-Related Items are not made by the Participant with the Corporation and/or the Employer prior to the relevant taxable event, the Corporation will satisfy such obligations as provided above in clause (3) of this paragraph.", "The Administrator shall be authorized to establish such rules, forms and procedures as it deems necessary to implement the foregoing.", "In accepting the grant, the Participant acknowledges that:", "jurisdiction may have different data privacy laws and protections than the United States.", "In the latter case, the Participant understands and acknowledges that the Corporation\u2019s legal basis for the processing of the Participant\u2019s Data would be compliance with the relevant  laws  or  regulations  or  the  pursuit  by  the  Corporation  of  respective  legitimate  interests  not  outweighed  by  the  Participant\u2019s  interests,  rights  or freedoms.", "When the Corporation no longer needs the Participant\u2019s Data for any of the above purposes, the Participant understands the Corporation will remove it from its systems.", "providing the consents herein on a purely voluntary basis.", "illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.", "If the Participant has received this Statement of Terms and Conditions or any other document related to the Plan translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control.", "The provisions in this Statement of Terms and Conditions are severable and if any one or more provisions are determined to be", "The Participant acknowledges that the Participant is proficient in the English language and, accordingly, understands the provisions of", "The Corporation will hold and use the Data only as long as is necessary to implement, administer and manage the", "Participation in the Plan is voluntary and the Participant is", "In the event of any inconsistency between this Statement of Terms and Conditions and the Plan, the Plan shall govern.", "Capitalized terms not otherwise defined in this Statement of Terms and Conditions shall have the meaning set forth in the Plan.", "The Option is also subject to the terms and conditions of the Plan.", "In no event shall the Corporation be required to issue fractional Shares.", "An Option granted under the Plan shall be evidenced by an Option Agreement setting forth the terms and conditions of the", "The Exercise Price of an Option, as specified in the Option Agreement, shall be equal to or greater than the Fair Market Value of", "Period, the Option Period shall end on the date of such termination of employment and the Option shall thereupon not be exercisable to any extent whatsoever.", "Term Disability, the vesting schedule of the Participant\u2019s Option shall be accelerated, the Option shall become fully exercisable and the Option Period shall end on the earlier of (i) three years after the date of the Participant\u2019s termination of employment and (ii) the Expiration Date.", "Retirement, (i) the Option shall be exercisable only to the extent that it was exercisable at the time of such retirement and (ii) the Option Period for that portion of the Option designated as a Nonstatutory Stock Option shall end on the earlier of (a) three years after the date of such retirement and (b) the Expiration Date.", "of  the  Participant's  Option,  then  the  Option  shall  continue  to  remain  outstanding  until  the  earlier  of  (i)  such  time  as  the  Participant  subsequently  terminates employment and (ii) the Expiration Date.", "number of Shares as to which the Option is so exercised.", "thereunder shall be transferable by the Participant by operation of law or otherwise, other than by will or the laws of descent and distribution.", "have any of the rights of a stockholder with respect to the Shares subject to an Option except to the extent that a book entry has been entered in the records of the Corporation\u2019s transfer agent with respect to such Shares upon the exercise of an Option.", "Neither a Participant nor any person entitled to exercise a Participant\u2019s rights in the event of the Participant\u2019s death shall", "Stock dividends paid with respect to Restricted Stock during the Restriction Period shall be treated as Restricted Stock which shall be subject to the same restrictions as the original award for the duration of the Restriction Period.", "If the Participant does not have a brokerage account of record, then an appropriate book entry recording the Participant\u2019s interest in the unrestricted Shares shall be entered on the records of the Corporation\u2019s transfer agent.", "Cash dividends paid with respect to Restricted Stock during the Restriction Period shall be credited on behalf of the Participant to a", "Election to Recognize Gross Income in the Year of Grant.", "The Administrator reserves the right to impose a restriction on the sale of Shares that the Participant receives upon", "Neither a Participant nor any person entitled to exercise a Participant\u2019s rights in the event of the Participant\u2019s death shall", "The Administrator reserves the right to impose a restriction on the sale of Shares that the Participant receives upon", "The performance period of a Performance Stock Unit Award shall be greater than one year,", "Unless otherwise determined by the Compensation Committee in its sole discretion, Dividend Equivalents shall not be", "A Participant shall not be permitted to sell, transfer, pledge, assign or encumber all or any portion of a Performance Stock Unit", "Neither a Participant nor any person entitled to exercise a Participant\u2019s rights in the event of the Participant\u2019s death shall", "The Administrator reserves the right to impose a restriction on the sale of Shares that the Participant", "addition, any Award of Restricted Stock or Restricted Stock Units as to which the restrictions have not lapsed shall immediately and automatically be forfeited, Performance Stock Unit Awards shall immediately and automatically be forfeited and any such Shares of Restricted Stock shall be returned to the Corporation and all of the rights of the Participant to such Awards and the underlying Shares shall immediately terminate.", "Any outstanding Option shall immediately and automatically terminate, be forfeited and shall cease to be exercisable, without limitation.", "determination shall be conclusive and binding on all interested persons.", "a manner that is valid and enforceable and that comes closest to the business objectives intended by such invalid or unenforceable provision, without invalidating or rendering unenforceable the remaining provisions of this Section VI.", "under an Award Agreement, shall be conclusive and binding on all interested persons.", "Participation in the Plan shall not create a right to further employment with the Participant\u2019s employer (the", "In making grants to Participants in foreign countries, the Administrator has the full discretion to", "All decisions of the Administrator administering the Plan upon any questions arising under the Plan or", "Nothing herein contained shall affect a Participant\u2019s right to participate in and receive benefits from and in", "Regardless  of any  action  the  Corporation  or  the  Employer  takes  with  respect  to  any  federal,  state  or  local  income  tax,  social", "Calculation of the number of Shares to be withheld shall be made based on the closing price of the Common Stock on the New York Stock Exchange on the date that the amount of tax to be withheld is determined.", "With respect to an Award other than an Option, if adequate arrangements to satisfy the obligations with regard to all Tax-Related Items are not made by the Participant with the Corporation and/or the Employer prior to the relevant taxable event, the Corporation will satisfy such obligations as provided above in clause (3) of this paragraph.", "The Administrator shall be authorized to establish such rules, forms and procedures as it deems necessary to implement the foregoing.", "In accepting the grant, the Participant acknowledges that:", "jurisdiction may have different data privacy laws and protections than the United States.", "In the latter case, the Participant understands and acknowledges that the Corporation\u2019s legal basis for the processing of the Participant\u2019s Data would be compliance with the relevant  laws  or  regulations  or  the  pursuit  by  the  Corporation  of  respective  legitimate  interests  not  outweighed  by  the  Participant\u2019s  interests,  rights  or freedoms.", "When the Corporation no longer needs the Participant\u2019s Data for any of the above purposes, the Participant understands the Corporation will remove it from its systems.", "providing the consents herein on a purely voluntary basis.", "illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.", "If the Participant has received this Statement of Terms and Conditions or any other document related to the Plan translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control.", "The provisions in this Statement of Terms and Conditions are severable and if any one or more provisions are determined to be", "The Participant acknowledges that the Participant is proficient in the English language and, accordingly, understands the provisions of", "The Corporation will hold and use the Data only as long as is necessary to implement, administer and manage the", "Participation in the Plan is voluntary and the Participant is", "In the event of any inconsistency between this Statement of Terms and Conditions and the Plan, the Plan shall govern.", "Capitalized terms not otherwise defined in this Statement of Terms and Conditions shall have the meaning set forth in the Plan.", "The Option is also subject to the terms and conditions of the Plan.", "In no event shall the Corporation be required to issue fractional Shares.", "An Option granted under the Plan shall be evidenced by an Option Agreement setting forth the terms and conditions of the", "The Exercise Price of an Option, as specified in the Option Agreement, shall be equal to or greater than the Fair Market Value of", "Period, the Option Period shall end on the date of such termination of employment and the Option shall thereupon not be exercisable to any extent whatsoever.", "Term Disability, the vesting schedule of the Participant\u2019s Option shall be accelerated, the Option shall become fully exercisable and the Option Period shall end on the earlier of (i) three years after the date of the Participant\u2019s termination of employment and (ii) the Expiration Date.", "Retirement, (i) the Option shall be exercisable only to the extent that it was exercisable at the time of such retirement and (ii) the Option Period for that portion of the Option designated as a Non Statutory Stock Option shall end on the earlier of (a) three years after the date of such retirement and (b) the Expiration Date.", "of  the  Participant's  Option,  then  the  Option  shall  continue  to  remain  outstanding  until  the  earlier  of  (i)  such  time  as  the  Participant  subsequently  terminates employment and (ii) the Expiration Date.", "number of Shares as to which the Option is so exercised.", "thereunder shall be transferable by the Participant by operation of law or otherwise, other than by will or the laws of descent and distribution.", "have any of the rights of a stockholder with respect to the Shares subject to an Option except to the extent that a book entry has been entered in the records of the Corporation\u2019s transfer agent with respect to such Shares upon the exercise of an Option.", "Neither a Participant nor any person entitled to exercise a Participant\u2019s rights in the event of the Participant\u2019s death shall", "Stock dividends paid with respect to Restricted Stock during the Restriction Period shall be treated as Restricted Stock which shall be subject to the same restrictions as the original award for the duration of the Restriction Period.", "If the Participant does not have a brokerage account of record, then an appropriate book entry recording the Participant\u2019s interest in the unrestricted Shares shall be entered on the records of the Corporation\u2019s transfer agent.", "Cash dividends paid with respect to Restricted Stock during the Restriction Period shall be credited on behalf of the Participant to a", "Election to Recognize Gross Income in the Year of Grant.", "Neither a Participant nor any person entitled to exercise a Participant\u2019s rights in the event of the Participant\u2019s death shall", "Following the end of the performance period, the Compensation Committee shall determine the extent to which the criteria have been achieved and shall authorize the grant and issuance of Shares in respect of the Performance Stock Unit Award.", "The performance period of a Performance Stock Unit Award shall be greater than one year,", "addition, any Award of Restricted Stock or Restricted Stock Units as to which the restrictions have not lapsed shall immediately and automatically be forfeited, Performance Stock Unit Awards shall immediately and automatically be forfeited and any such Shares of Restricted Stock shall be returned to the Corporation and all of the rights of the Participant to such Awards and the underlying Shares shall immediately terminate.", "Unless otherwise determined by the Compensation Committee in its sole discretion, Dividend Equivalents shall not be", "A Participant shall not be permitted to sell, transfer, pledge, assign or encumber all or any portion of a Performance Stock Unit", "Neither a Participant nor any person entitled to exercise a Participant\u2019s rights in the event of the Participant\u2019s death shall", "Any outstanding Option shall immediately and automatically terminate, be forfeited and shall cease to be exercisable, without limitation.", "determination shall be conclusive and binding on all interested persons.", "a manner that is valid and enforceable and that comes closest to the business objectives intended by such invalid or unenforceable provision, without invalidating or rendering unenforceable the remaining provisions of this Section VI.", "Participation in the Plan shall not create a right to further employment with the Participant\u2019s employer (the", "In making grants to Participants in foreign countries, the Administrator has the full discretion to", "under an Award Agreement, shall be conclusive and binding on all interested persons.", "Calculation of the number of Shares to be withheld shall be made based on the closing price of the Common Stock on the New York Stock Exchange on the date that the amount of tax to be withheld is determined.", "With respect to an Award other than an Option, if adequate arrangements to satisfy the obligations with regard to all Tax-Related Items are not made by the Participant with the Corporation and/or the Employer prior to the relevant taxable event, the Corporation will satisfy such obligations as provided above in clause (3) of this paragraph.", "All decisions of the Administrator administering the Plan upon any questions arising under the Plan or", "Nothing herein contained shall affect a Participant\u2019s right to participate in and receive benefits from and in", "Regardless  of any  action  the  Corporation  or  the  Employer  takes  with  respect  to  any  federal,  state  or  local  income  tax,  social", "The Administrator shall be authorized to establish such rules, forms and procedures as it deems necessary to implement the foregoing.", "In accepting the grant, the Participant acknowledges that:", "jurisdiction may have different data privacy laws and protections than the United States.", "In the latter case, the Participant understands and acknowledges that the Corporation\u2019s legal basis for the processing of the Participant\u2019s Data would be compliance with the relevant  laws  or  regulations  or  the  pursuit  by  the  Corporation  of  respective  legitimate  interests  not  outweighed  by  the  Participant\u2019s  interests,  rights  or freedoms.", "When the Corporation no longer needs the Participant\u2019s Data for any of the above purposes, the Participant understands the Corporation will remove it from its systems.", "providing the consents herein on a purely voluntary basis.", "The Corporation will hold and use the Data only as long as is necessary to implement, administer and manage the", "Participation in the Plan is voluntary and the Participant is", "illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.", "If the Participant has received this Statement of Terms and Conditions or any other document related to the Plan translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control.", "The provisions in this Statement of Terms and Conditions are severable and if any one or more provisions are determined to be", "The Participant acknowledges that the Participant is proficient in the English language and, accordingly, understands the provisions of", "In the event of any inconsistency between this Award Agreement and the Plan, the Plan shall govern.", "Capitalized terms not otherwise defined in this Award Agreement shall have the meaning set forth in the Plan.", "determine the extent to which the performance goals have been achieved, and shall determine the number of PSUs that have been earned.", "Once the Compensation Committee has determined the number of PSUs that have been earned pursuant to the", "Dividend equivalents shall be credited in respect of the One-Year RSU Award.", "The restrictions applicable to the RSU Award shall lapse with respect to 100% of the underlying Shares on the third", "Dividend equivalents shall be credited in respect of the RSU Award granted under this Section III.", "If the Participant ceases to be a bona fide employee of the Corporation or any Affiliate (except as otherwise", "otherwise  forfeited  pursuant  to  the  terms  of  the  Plan  and  this  Award  Agreement  shall  be  paid  to  the  Participant  as  soon  as  reasonably  practicable  after  the restrictions lapse.", "Performance  Stock  Units and  Restricted  Stock  Units,  to  the  extent  the  restrictions  have  not  lapsed,  shall  immediately  and  automatically  be", "determination shall be conclusive and binding on all interested persons.", "a manner that is valid and enforceable and that comes closest to the business objectives intended by such invalid or unenforceable provision, without invalidating or rendering unenforceable the remaining provisions of this Section IV.", "Compensation Committee reserves the right to impose a restriction on the sale of Shares that the Participant receives upon the settlement of the Performance Stock Units and Restricted Stock Units granted hereunder, unless the Participant has satisfied the ownership targets applicable to the Participant as provided in such policy.", "Neither the Participant nor any person entitled to exercise the Participant\u2019s rights in the event of the Participant\u2019s death", "Participation in the Plan shall not create a right to further employment with the Participant\u2019s employer (the", "under this Award Agreement, shall be conclusive and binding on all interested persons.", "Calculation of the number of Shares to be withheld shall be made based on the closing price of the Common Stock on the New York Stock Exchange on the date that the amount of tax to be withheld is determined.", "If adequate arrangements to satisfy the obligations with regard to all Tax-Related Items are not made by the Participant with the Corporation and/or the Employer prior to the relevant taxable event, the Corporation will satisfy such obligations as provided above in clause (iii) of this paragraph.", "The Administrator has the full discretion to deviate from this Award Agreement in order to adjust the Awards", "All decisions of the Administrator administering the Plan upon any questions arising under the Plan or", "Nothing herein contained shall affect the Participant\u2019s right to participate in and receive benefits from and in", "Regardless  of any  action  the  Corporation  or  the  Employer  takes  with  respect  to  any  federal,  state  or  local  income  tax,  social", "The Administrator shall be authorized to establish such rules, forms and procedures as it deems necessary to implement the foregoing.", "In accepting the grant, the Participant acknowledges that:", "providing the consents herein on a purely voluntary basis.", "The Corporation will hold and use the Data only as long as is necessary to implement, administer and manage the", "Participation in the Plan is voluntary and the Participant is", "unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.", "English and if the meaning of the translated version is different than the English version, the English version will control.", "Award, the terms of which are set forth herein and in the Plan.", "The provisions in this Award Agreement are severable and if any one or more provisions are determined to be illegal or otherwise", "Below is a list of documents that are made available to you in connection with this Notice.", "PLEASE BE SURE TO READ THESE DOCUMENTS BECAUSE THEY CONTAIN IMPORTANT INFORMATION SPECIFIC TO THIS GRANT OF RSUs.", "By signing below, I acknowledge that: 1.    I agree to receive copies of the stockholder information, including copies of any annual report, proxy and Form 10-K, from the Investor Resources section of", "Below is a list of documents that are made available to you in connection with this Notice.", "PLEASE BE SURE TO READ THESE DOCUMENTS BECAUSE THEY CONTAIN IMPORTANT INFORMATION SPECIFIC TO THIS GRANT OF RSUs.", "I consent to receiving electronically a copy of the documents set forth above and attachments to this Notice; and 5.", "I accept ALL the terms and conditions as set forth in the Plan and ST&Cs applicable to this grant of RSUs.", "Your  PSUs  will  be  earned  subject  to  the  Company\u2019s  attainment  of  performance  goals  that  have  been  pre-established  by  the  Compensation  Committee  (the \u201cCommittee\u201d) of the Company\u2019s Board of Directors.", "Below is a list of documents that are made available to you in connection with this Notice.", "PLEASE BE SURE TO READ THESE DOCUMENTS BECAUSE THEY CONTAIN IMPORTANT INFORMATION SPECIFIC TO THIS GRANT OF PSUs.", "I consent to receiving electronically a copy of the documents set forth above and attachments to this Notice; and 12.", "I should consult with a tax advisor prior to accepting this grant of PSUs or taking any other action with respect to this grant of PSUs; and 14.", "I accept ALL the terms and conditions as set forth in the Plan and ST&Cs applicable to this grant of PSUs.", "We consent to the incorporation by reference in McKesson Corporation Registration Statement Nos. 333-249817, 333-163642, 333-190847, 333-190848, and 333- 213488 on Form S-8, and Registration Statement No. 333-236808 on Form S-3, of our report dated May 12, 2021, relating to the consolidated financial statements and consolidated financial statement schedule of McKesson Corporation and subsidiaries, and the effectiveness of McKesson Corporation\u2019s internal control over financial reporting appearing in this Annual Report on Form 10-K of McKesson Corporation for the year ended March 31, 2021.", "I have reviewed this annual report on Form 10-K of McKesson Corporation;", "The registrant\u2019s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant\u2019s auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):", "I have reviewed this annual report on Form 10-K of McKesson Corporation;", "The registrant\u2019s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant\u2019s auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):", "Together, we work across the healthcare delivery system to connect pharmacies, providers, payers, and biopharma for next-generation patient access and adherence solutions that help people get the medicine they need to live healthier lives.", "Unless otherwise noted, all references in this document to a particular year shall mean the", "On March 10, 2020, we completed the separation of our interest in the Change Healthcare JV through a split- off transaction.", "This transaction reduced our investment in the Change Healthcare JV to zero.", "Change Healthcare: Our equity ownership interest in Change Healthcare JV, a joint venture, has been accounted for using the equity method of accounting.", "for our innovations and obtain copyright protection for our original works of authorship, when such protection is advantageous.", "Through these efforts, we have developed a portfolio of patents and copyrights in the U.S. and worldwide.", "In addition, we have registered or applied to register certain trademarks and service marks in the U.S. and in foreign countries.", "We cannot guarantee that our intellectual property portfolio will be sufficient to deter misappropriation, theft, or misuse of our technology, nor that we can successfully enjoin infringers.", "We periodically receive notices alleging that our products or services infringe on third party patents and other intellectual property rights.", "While the outcome of any litigation or dispute is inherently uncertain, we do not believe that the resolution of any of these infringement notices would have a material adverse impact on our results of operation.", "These values and behaviors help make McKesson unique.", "We offer financial assistance programs for higher education opportunities that support employees\u2019 career growth at the company.", "To provide compensation that is focused on attracting and retaining talent with the skills and experience necessary for a specific role, our compensation program is built on a set of quantifiable factors defined by our guiding principles of internal fairness, market competitiveness, and pay for performance.", "We operate in several countries and our benefits offerings vary accordingly.", "We offer health and wellness benefits to advance the physical, mental, and social well-being of our people, savings programs to help prepare them for retirement, and flexible work arrangements, among other  benefits  offerings,  when  possible.  In  response  to  the  COVID-19  pandemic,  we  offered  extended  medical  benefits  covering  COVID-19  related  visits, treatment and testing, expanded telehealth options, emergency paid time off (\u201cPTO\u201d), and a platform for employees to donate their regular PTO to co-workers who were  more  impacted  by  COVID-19.", "We have received monetary penalties and/or licensing sanctions pursuant to these requirements and future allegations of noncompliance could result in an inability to obtain, maintain or renew permits, licenses or other regulatory approvals needed for the operation of our businesses.", "As a result of ongoing, advanced discussions with state attorneys general and plaintiffs\u2019 representatives regarding a framework to resolve the claims of governmental entities, and our assessment of certain other opioid-related claims, we have reached a stage at which a broad settlement of opioid claims by governmental entities is probable and recorded a charge of $8.1 billion for the year ended March 31, 2021 within \u201cClaims and litigation charges, net\u201d in our Consolidated Statement of Operations in this Annual Report on Form 10-K.", "Because of the many uncertainties associated with any potential settlement arrangement or other resolution of opioid-related litigation, including the uncertainty of the scope of participation by plaintiffs in any potential settlement, we are not able to reasonably estimate the upper or lower ends of the range of ultimate possible loss for all opioid-related litigation matters.", "The adverse outcome of legal proceedings might also involve significant  expense,  management  time  and  distraction,  and risk  of loss that  can be difficult  to predict  or quantify.  In addition  to this litigation,  legislative  or regulatory measures related to the distribution of controlled substances such as prescription opioids could affect our business in ways that we may not be able to predict.", "For example, some states have passed legislation that could require us to pay taxes or assessments on the distribution of opioid medications in those states and other states have considered similar legislation.", "We are subject to government audits,  investigations  and  oversight  proceedings.  Government  agencies  routinely  review  and  audit  government  contractors  to  determine  whether  they  are complying with contractual and legal requirements.", "If we fail to comply with these requirements, or we fail an audit, we may be subject to various sanctions such as monetary damages, criminal and civil penalties, termination of contracts and suspension or debarment from government contract work.", "These requirements complicate our business and increase our compliance burden and material non-compliance could harm our reputation.", "affecting  Medicare,  Medicaid,  other  government  healthcare  programs,  and  government  contracts.  Our  relationships  with  pharmaceutical  and  medical  surgical product manufacturers and healthcare providers, as well as our provision of products and services to government entities, subject our business to laws, regulation, and government guidance on fraud and abuse.", "Many of these laws are vague or indefinite and have not been interpreted by the courts and, as such, may be interpreted or applied by a prosecutorial, regulatory, or judicial authority in a manner that could require us to make changes in our operations.", "Americans and changed the way healthcare is financed by both governmental and private payers.", "There are also further efforts to broaden healthcare coverage.", "Provincial governments in Canada that provide partial funding for the purchase of pharmaceuticals and independently regulate the sale and reimbursement of drugs have sought to reduce the costs of publicly funded health programs.", "Some European governments  have  implemented  or  are  considering  austerity  measures  to  reduce  healthcare  spending.  These  measures  exert  pressure  on  the  pricing  and reimbursement timelines for pharmaceuticals and may cause our customers to purchase fewer of our products and services or influence us to reduce prices.", "There is substantial uncertainty about the likelihood, timing and results of these health reform efforts.", "We also have record- keeping  and  other  obligations  under  the  E.U.  Falsified  Medicines  Directive.  Pedigree  tracking  laws  such  as  these  increase  our  compliance  burden  and  our pharmaceutical distribution costs.", "For example, under the Health Insurance Portability and Accountability Act of 1996 (\u201cHIPAA\u201d) we must maintain administrative, physical  and  technological  safeguards  to  protect  individually  identifiable  health  information  (\u201cprotected  health  information\u201d)  and  ensure  the  confidentiality, integrity, and availability of electronic protected health information.", "We are subject to significant compliance obligations under privacy laws such as the General Data Protection Regulation (\u201cGDPR\u201d) in the European Union, the Personal Information Protection and Electronic Documents Act (\u201cPIPEDA\u201d) in Canada, and the California Consumer Protection Act (\u201cCCPA\u201d).", "We are subject to privacy  and  data  protection  compliance  audits  or  investigations  by  various  government  agencies.  Failure  to  comply  with  these  laws  subjects  us  to  potential regulatory enforcement activity, fines, private litigation including class actions, and other costs.", "We also have contractual obligations to customers that might be breached if we fail to comply with privacy laws.", "Our efforts to comply with privacy laws complicate our operations and add to our compliance costs.", "storage and hosting of sensitive information, including protected health information and other types of personal information, confidential financial information, proprietary information, and other sensitive information relating to our customers, company and workforce.", "costs.  Environmental  costs  and  accruals,  including  that  related  to  our  legacy  chemical  distribution  operations,  presently  are  not  material  to our  operations  or financial position.", "Our ten largest customers comprised approximately 32%, and CVS was approximately 19%, of total trade accounts receivable at March 31, 2021.", "We also have agreements with GPOs, each of which functions as a purchasing agent on behalf of member  hospitals,  pharmacies  and other healthcare  providers,  as well as with government  entities  and agencies.  The accounts receivable balances are with individual members of the GPOs, and therefore no significant concentration of credit risk exists.", "Substantially all of these revenues and accounts receivable are included in our U.S.", "distribution arrangements with pharmaceutical manufacturers that include an inflation-based compensation component whereby we benefit when the manufacturers increase their prices as we sell our existing inventory at the new higher prices.", "Forward-looking  statements  involve  risks  and  uncertainties  that  could  cause  actual  results  to  differ  materially  from  those  projected,  anticipated,  or  implied.", "Except to the extent required by federal securities laws, we undertake no obligation to publicly release the result of any revisions to any forward-looking statements to reflect events or circumstances after the date the statements are made, or to reflect the occurrence of unanticipated events.", "Some of our distribution arrangements with the manufacturers provides us compensation based on a percentage of our purchases.", "We experience costly and disruptive legal disputes.", "Despite valid defenses that we assert, legal disputes are often costly, time-consuming, distracting to management and disruptive to normal business operations.", "The outcome of legal disputes is difficult to predict.", "Outcomes can occur that are not justified by the evidence or existing law.", "The uncertainty and expense associated with unresolved legal disputes might harm our business and reputation even if the matter is favorably resolved.", "Accordingly, any legal dispute might have a materially adverse impact on our reputation, our business operations and our financial position or results of operations.", "We might experience losses not covered by insurance.", "supplies, the provision of ancillary services, the conduct of our payer businesses and the provision of products that assist clinical decision-making and relate to patient medical histories and treatment plans.", "Although we seek to maintain adequate insurance coverage,  such  as  property  insurance  for  inventory  and  professional  and  general  liability  insurance,  coverages  on  acceptable  terms  might  be  unavailable,  or coverages might not cover our losses.", "We generally seek to limit our contractual exposure, but limitations of liability or indemnity provisions in our contracts may not be enforceable or adequately protect us from liability.", "Uninsured losses might have a materially adverse impact on our business operations and our financial position or results of operations.", "We regularly are named as a defendant in similar, new cases.", "Many of these cases raise novel theories of liability.", "Any proceedings can have unexpected outcomes that are not justified by evidence or existing law.", "It is not uncommon for claims to be resolved over many years.", "Although the Company has valid defenses and is vigorously defending itself, some proceedings have been and others may be resolved by negotiated outcome.", "Our reputation has been and may continue to be impacted by publicity regarding the litigation and related allegations.", "The adverse outcome of legal proceedings might have a materially adverse impact on our business operations and our financial position or results of operations.", "For example, some states have passed legislation that could require us to pay taxes or assessments on the distribution of opioid medications in those states and other states have considered similar legislation.", "Liabilities for taxes or assessments or other costs of compliance under any such laws might have a materially adverse impact on our reputation, business operations, and our financial position or results of operations.", "We are subject to extensive, complex and challenging healthcare and other laws.", "Any noncompliance by us with applicable laws or the failure to maintain, renew or obtain necessary permits and licenses could lead to litigation and might have a materially adverse impact on our business operations and our financial position or results of operations.", "Local, state and federal governments continue to strengthen their position and scrutiny over practices involving or allegedly involving fraud, waste and abuse affecting Medicare, Medicaid and other government healthcare programs.", "Our relationships with pharmaceutical and medical surgical product manufacturers and healthcare providers, as well as our provision of products and services to government entities, subject our business to laws and regulations on fraud and abuse, which among other things: (1) prohibit persons from soliciting, offering, receiving or paying any remuneration in order to induce the referral of a patient for treatment  or  to  induce  the  ordering  or  purchasing  of  items  or  services  that  are  in  any  way  paid  for  by  Medicare,  Medicaid  or  other  government-sponsored healthcare programs; (2) impose many restrictions upon referring physicians and providers of designated health services under Medicare and Medicaid programs; and (3) prohibit the knowing submission of a false or fraudulent claim for payment to, and knowing retention of an overpayment by, a federal healthcare program such  as  Medicare  and  Medicaid.  Many  of  these  laws,  regulations,  and  government  guidance,  including  those  relating  to  marketing  incentives,  are  vague  or indefinite and have not been interpreted by the courts.", "The laws may be interpreted or applied by a prosecutorial, regulatory, or judicial authority in a manner that could require us to make changes in our operations.", "Failures to comply with applicable laws subject us to federal or state government investigations or qui tam actions, and to liability for damages and civil and criminal penalties, including the loss of licenses or our ability to participate in Medicare, Medicaid and other federal and state healthcare programs.", "These sanctions might have a materially adverse impact on our business operations and our financial position or results of operations.", "Noncompliance with these requirements has resulted in monetary penalties and/or licensing sanctions.", "For example, under a January 2017 agreement with the DEA and Department of Justice we paid $150 million to settle potential administrative and civil claims about our practices for reporting suspicious orders of controlled substances and the DEA suspended, on a staggered basis for limited periods of time, our registrations to distribute certain controlled substances from four distribution centers.", "Pedigree tracking laws increase our compliance burden and our pharmaceutical distribution costs.", "Pedigree tracking laws such as these increase our compliance burden and our pharmaceutical distribution costs, and they might have a materially adverse impact on our business operations and our financial position or results of operations.", "Privacy and data protection laws increase our compliance burden.", "example,  under  the  Health  Insurance  Portability  and  Accountability  Act  of  1996  (\u201cHIPAA\u201d)  we  must  maintain  administrative,  physical  and  technological safeguards  to  protect  individually  identifiable  health  information  (\u201cprotected  health  information\u201d)  and  ensure  the  confidentiality,  integrity  and  availability  of electronic protected health information.", "Failure to comply with these laws subjects us to potential regulatory enforcement activity, fines, private litigation including class actions, and other costs.", "We also have contractual obligations to customers that might be breached if we fail to comply with privacy laws.", "Our efforts to comply with privacy laws complicates our operations and adds to our compliance costs.", "A significant privacy breach or failure  to  comply  with  privacy  laws  might  have  a  materially  adverse  impact  on  our  reputation,  business  operations  and  our  financial  position  or  results  of operations.", "Anti-bribery and anti-corruption laws increase our compliance burden.", "Bribery Act unless the organization can establish the defense of having implemented adequate procedures to prevent bribery.", "Our failure to comply with these laws might subject us to civil and criminal penalties that might have a materially adverse impact on our reputation, business operations and our financial position or results of operations.", "We are subject to a variety of privacy and data protection laws that change frequently and have requirements that vary from jurisdiction to jurisdiction.", "We  are  subject  to  laws  prohibiting  improper  payments  and  bribery,  including  the  U.S.  Foreign  Corrupt  Practices  Act,  the  U.K.  Bribery  Act  and  similar", "We might record significant charges from impairment to goodwill, intangibles and other assets or investments.", "In addition, we periodically review our intangible and other long-lived assets for impairment when events or changes in circumstances, such as a divestiture, indicate the carrying value may not be recoverable.", "Factors that may be considered a change in circumstances indicating that  the  carrying  value  of  our  intangible  and  other  long-lived  assets  may  not  be  recoverable  include  slower  growth  rates,  the  loss  of  a  significant  customer, burdensome new laws or divestiture of a business or asset for less than its carrying value.", "There are inherent uncertainties in management\u2019s estimates, judgments and assumptions used in assessing recoverability of goodwill, intangible and other long-lived assets.", "We may be required to record a significant charge to earnings in our consolidated financial statements during the period in which any impairment of our goodwill or intangible and other long-lived assets is determined, which might have a materially adverse impact on our business operations and our financial position or results of operations.", "storage and hosting of sensitive information, including protected health information and other types of personal information, confidential financial information, proprietary information, and other sensitive information relating to our customers, company and workforce.", "If our software and technology services are alleged to have contributed to faulty clinical decisions or injury to patients, we might be subject to claims or litigation by users of our software or services or their patients.", "Any of these types of errors or failures might have a materially adverse impact on our reputation, business operations and our financial position or results of operations.", "We  are  required  under  U.S.  Generally  Accepted  Accounting  Principles  (\u201cGAAP\u201d)  to  test  our  goodwill  for  impairment  annually  or  more  frequently  if", "We might be impeded in providing customers online services and data access.", "Any such problems might have a materially adverse impact on our business operations and our financial position or results of operations.", "Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.", "we may require financing that may not be available on acceptable terms.", "Any of these risks could adversely affect our ability to achieve the anticipated benefits of an acquisition and might have a materially adverse impact on our business operations and our financial position or results of operations.", "Exclusive forum provisions in our Bylaws could limit our stockholders\u2019 ability to choose their preferred judicial forum for disputes with us or our directors, officers or employees.", "Current and former stockholders are deemed to have consented to the personal jurisdiction of the Delaware Courts in connection with any action to enforce that exclusive forum provision and to service of process in any such action.", "To the extent that these provisions of the bylaws limit a current or former stockholder\u2019s ability to select a judicial forum other than the Delaware Courts, they might discourage the specified legal actions, might cause current or former stockholders to incur additional litigation-related expenses and might result in outcomes unfavorable to current or former stockholders.", "A court might determine that these provisions of the bylaws are inapplicable or unenforceable in any particular action, in which case we may incur additional litigation related expenses in such action, and the action may result in outcomes unfavorable to us, which could have a materially adverse impact on our reputation, our business operations and our financial position or results of operations.", "We might be adversely impacted by delays or other difficulties with divestitures.", "After the disposition, we might experience greater dissynergies than expected, and the impact of the divestiture on our revenue or profit might be larger than we expected.", "We might have difficulties with pre-closing conditions such as regulatory and governmental approvals, which could delay or prevent the divestiture.", "We might have financial exposure in a divested business, such as through minority equity ownership, financial  or  performance  guarantees,  indemnities  or  other  obligations,  such  that  conditions  outside  of  our  control  might  negate  the  expected  benefits  of  the disposition.", "Any of these risks could adversely affect our ability to achieve the anticipated benefits of a divestiture and might have a materially adverse impact on our business operations and our financial position or results of operations.", "We might not realize the expected tax treatment from our split-off of Change Healthcare.", "If Change does not honor its obligations to indemnify the Company, or if the Transactions fail to qualify for the intended tax-free treatment for reasons not related to a disqualifying action by Change or SpinCo, the resulting tax to the Company could have a significant adverse effect on our financial position or results of operations.", "outsourced service providers, and we might not realize expected cost savings or other benefits.", "For example, our ability to use outsourcing resources in certain jurisdictions might be limited by legislative action or customer contracts, with the result that the work must be performed at greater expense or we may be subject to sanctions for non-compliance.", "Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.", "We might encounter difficulties attracting and retaining customers to our retail locations due to their unfamiliarity with our brands or our inexperience with local market  preferences.  Competition  from  our  retail  pharmacy  operations  might  strain  relationships  with  our  retail  pharmacy  customers.  Consolidation  of  retail pharmacies with third party payers, expansion of large retail pharmacy networks, reductions in reimbursement rates, shifts in the mix of branded and generic pharmaceutical sales, and exclusion from preferred pharmacy networks can impair our retail pharmacy sales and profitability.", "We might be harmed by large customer purchase reductions, payment defaults or contract non-renewal.", "March 31, 2021, sales to our largest customer represented approximately 21% of our consolidated revenues and approximately 19% of our trade receivables, and those of our ten largest customers combined accounted for approximately 51% of our consolidated revenues and approximately 32% of our trade receivables.", "A material  default  in  payment,  reduction  in  purchases,  or  the  loss  of  business  from  a  large  customer  might  have  a  materially  adverse  impact  on  our  business operations and our financial position or results of operations.", "Our contracts with government entities involve future funding and compliance risks.", "Our government contracts might not be renewed or might be terminated for convenience with little or no prior notice.", "Government contracts typically expose us to higher potential liability than do other types of contracts.", "We are subject to government audits, investigations and oversight proceedings.", "If we fail to comply with these requirements, or we fail an audit, we are subject to various sanctions such as monetary damages, criminal and civil penalties, termination of contracts and suspension or debarment from government contract work.", "These requirements complicate our business and increase our compliance burden.", "We also provide supplies used for vaccine administration in the Federal COVID-19 Response.", "Our participation in such programs exposes us to various uncertainties.", "Because of these risks and uncertainties our operating results may be materially higher or lower than our projections.", "Certain distribution agreements with manufacturers include pharmaceutical price inflation as a component of our compensation, and we cannot  control  the  frequency  or  magnitude  of  pharmaceutical  price  changes.  We  might  be  unable  to  renew  pharmaceutical  distribution  agreements  with manufacturers in a timely and favorable manner.", "Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.", "We  derive  a  significant  portion  of  our  revenue  from,  and  have  a  significant  portion  of  our  accounts  receivable  with,  a  small  number  of  customers.  At", "Our contracts with government entities are subject to risks such as lack of funding and compliance  with unique requirements.", "We might infringe intellectual property rights or our intellectual property protections might be inadequate.", "If a court were to hold that we infringed other\u2019s rights, we might be required to pay substantial damages, develop non-infringing products or services, obtain a license, stop selling or using the infringing products or services, or incur other sanctions.", "We rely on trade secret, patent, copyright and  trademark  laws,  nondisclosure  obligations  and  other  contractual  provisions  and  technical  measures  to  protect  our  proprietary  rights  in  our  products  and solutions.  We  might  initiate  costly  and  time-consuming  litigation  to  protect  our  trade  secrets,  to  enforce  our  patent,  copyright  and  trademark  rights  and  to determine the scope and validity of the proprietary rights of others.", "Our intellectual property protection efforts might be inadequate to protect our rights.", "Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.", "Competition among potential employers might result in increased salaries, benefits or other employee-related costs, or in our failure to recruit and retain employees.", "Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.", "We might be adversely impacted by healthcare reform such as changes in pricing and reimbursement models.", "healthcare industry and related government programs are changing.", "profit margins for us and our customers and impose new legal requirements on healthcare providers.", "the way healthcare is financed by both governmental and private payers.", "drugs have sought to reduce the costs of publicly funded health programs.", "These measures exert pressure on the pricing and reimbursement timelines for pharmaceuticals and may cause our customers to purchase fewer of our products and services or influence us to reduce prices.", "adverse impact on our business operations and our financial position or results of operations.", "Consolidation might increase counter-party credit risk because credit purchases increase for fewer market participants.", "Any of these changes or disruptions might have a materially adverse impact on our business operations and our financial position or results of operations.", "We might be adversely impacted as a result of our distribution of generic pharmaceuticals.", "Generic drug manufacturers often offer a generic version of branded pharmaceuticals while they challenge the validity or enforceability branded pharmaceutical patents.", "The patent holder might assert infringement claims against us for distributing those generic versions and the generic drug manufactures may not fully indemnify us against such claims.", "These risks, as well as changes in the availability,  pricing  volatility,  reimbursement  rates  for  generic  drugs,  or significant  changes  in  the  nature,  frequency  or magnitude  of  generic  pharmaceutical launches, might have a materially adverse impact on our business operations and our financial position or results of operations.", "We might be adversely impacted by an economic slowdown or recession.", "Any economic slowdown or recession might have a materially adverse impact on our business operations and our financial position or results of operations.", "Disruption or other changes in capital and credit markets might impede access to credit and increase borrowing costs for us and our customers and suppliers and might impair the financial soundness of our customers and suppliers.", "activity by financial institutions, or decreased liquidity and increased costs in the commercial paper market, might adversely affect our borrowing ability and cost of borrowing.", "We generally sell our products and services under short-term unsecured credit arrangements.", "An adverse change in general economic conditions or access to capital might cause our customers to reduce their purchases from us, or delay or fail paying amounts owed to us.", "Suppliers might be unable to make payments due to us for fees, returned products or incentives.", "Interest rate increases or changes in capital market conditions might impede our or our customers\u2019 or suppliers\u2019 ability or cost to obtain credit.", "Any of these risks might have a material adverse impact on our business operations and our financial position or results of operations.", "Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.", "We might be adversely impacted by tax legislation or challenges to our tax positions.", "Tax laws might change in ways that adversely affect our tax positions, effective tax rate and cash flow.", "The tax laws are extremely complex and subject to varying interpretations.", "We are subject to tax examinations in various jurisdictions that might assess additional tax liabilities against us.", "Our tax reporting positions might be challenged by relevant tax authorities, we might incur significant expense in our efforts to defend those challenges, and we might be unsuccessful in those efforts.", "Developments in examinations and challenges might materially change our provision for taxes in the affected periods and might differ materially from our historical tax accruals.", "Any of these risks might have a materially adverse impact on our business operations, our cash flows and our financial position or results of operations.", "For example, we might experience volatility in exchange rates and interest rates and changes in laws regulating our U.K. operations.", "Customers might reduce purchases due to the uncertainty caused by Brexit.", "Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.", "We might be adversely impacted by fluctuations in foreign currency exchange rates.", "exchange rates could reduce our revenues, increase our costs or otherwise adversely affect our financial results reported in U.S. dollars.", "For example, we are exposed to transactional currency exchange risk due to our import and export of products that are purchased or sold in currencies other than the U.S. dollar.", "We also  have  currency  exchange  risk  due  to  intercompany  loans  denominated  in  various  currencies.  The  COVID-19  pandemic  has  affected  and  might  increase currency exchange rate volatility.", "We may from time to time enter into foreign currency contracts, foreign currency borrowings or other techniques intended to hedge  a  portion  of our  foreign  currency  exchange  rate  risks.  These  hedging  activities  may  not  completely  offset  the  adverse  financial  effects  of  unfavorable movements in foreign currency exchange rates during the time the hedges are in place.", "Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.", "We are subject to the tax laws in the U.S. at the federal, state and local government levels and to the tax laws of many other jurisdictions in which we operate", "We conduct our business in various currencies,  including  the U.S. dollar, euro, British pound sterling  and Canadian dollar.  Changes in foreign  currency", "Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.", "We might be adversely impacted by changes in accounting standards.", "It is possible that future accounting standards may require changes to the accounting treatment in our consolidated financial statements and may require us to make significant changes to our financial systems.", "Such changes might have a materially adverse impact on our financial position or results of operations.", "Our consolidated financial statements are subject to the application of U.S.", "Disclosure of an environmental proceeding where a governmental agency is a party generally is included only if we expect monetary sanctions in the proceeding to exceed $1 million, unless otherwise material.", "There are no family relationships between any of the executive officers or directors of the Company.", "We declared regular cash dividends of $1.67 and $1.62 per share in the years ended March 31, 2021 and 2020, respectively.", "discretion of the Board and will depend upon our future earnings, financial condition, capital requirements, and other factors.", "Dividends: In  July  2020,  our  quarterly  dividend  was  raised  from  $0.41  to  $0.42  per  common  share  for  dividends  declared  on  or  after  such  date  by  the", "We anticipate that we will continue to pay quarterly cash dividends in the future.", "In accordance with our accounting policy, we allocate any excess of share repurchase price over par value between additional paid-in capital and retained earnings.", "Accordingly, our retained earnings and additional paid-in capital were reduced by $472 million and $70 million, respectively, during 2019.", "In 2019, we retired 5.0 million or $542 million of our treasury shares previously repurchased.", "This discussion and analysis should be read in conjunction with the consolidated financial statements and accompanying financial notes in Item 8 of Part II of this Annual Report on Form 10-K.", "Our fiscal year begins on April 1 and ends on March 31.", "Unless otherwise noted, all references to a particular year shall mean our fiscal year.", "Our organizational structure also includes Corporate, which consists of income and expenses associated with administrative functions and projects, and the results of certain investments.", "We evaluate the performance of our operating segments on a number of measures, including revenues and operating profit before interest expense and income taxes.", "The following summarizes our four reportable segments and the changes made to our reporting structure commencing in the second quarter of 2021.", "\u2022 Coronavirus disease 2019 (\u201cCOVID-19\u201d) impacted our results of operations for the year ended March 31, 2021.", "The recovery from the COVID- 19 pandemic continued to fluctuate throughout our fiscal year.", "\u2022 We expanded our existing contractual relationship with the Centers for Disease Control and Prevention (\u201cCDC\u201d) through an amendment to our existing Vaccines for Children Program contract to support the U.S. government as a centralized distributor of COVID-19 vaccines and ancillary supplies needed to administer vaccines.", "\u2022 In  December  2020,  we  began  distributing  certain  COVID-19  vaccines  under  the  direction  of  the  CDC.  Through  the  end  of  the  fiscal  year,  we  had distributed approximately 100 million of COVID-19 vaccine doses.", "\u2022 Revenues of $238.2 billion, reflects a 3% increase from the prior year primarily in our U.S.", "\u2022 Diluted loss per common share from continuing operations attributable to McKesson Corporation in 2021 of $28.26 reflects the aforementioned items, net of any respective tax impacts, and a lower share count compared to the prior year driven largely by the separation of our investment in Change Healthcare JV on March 10, 2020;", "The full extent to which COVID-19 will impact us depends on many factors and future developments, which are described at the end of this COVID-19 section.", "We continue to evaluate the nature and extent of the impacts COVID-19 has on our business and operations.", "We provided further support including additional emergency leave and an internal paid time off donation platform for employees impacted by COVID-19.", "These responses were initially put in place during our fourth quarter of 2020.", "policies did not have a material effect on our internal control over financial reporting during the year ended March 31, 2021.", "We also took various actions to mitigate the impact of COVID-19 on our results from operations through cost-containment and payroll-related expenses.", "We support the U.S. government as a centralized distributor of COVID-19 vaccines and ancillary supplies needed to administer vaccines.", "We make no decisions on where products are to be distributed nor how the products are allocated between the various provider sites and ultimately administered to the individuals receiving a vaccine.", "We utilize our expertise and capabilities to support the CDC\u2019s efforts to vaccinate everyone in the U.S. who wants to receive a COVID-19 vaccine.", "The Pfizer Vaccine, which is ultra-frozen, is not being distributed by McKesson, although we are providing ancillary supplies needed for its administration.", "custom freezers and refrigerators to safely store and process millions of vaccine doses.", "The capital expenditures we made during 2021 to prepare for vaccine and ancillary supply kit distribution were not material to our financial condition or liquidity.", "In December 2020, we began distributing the Moderna Vaccine in the U.S. and in March 2021, we began distributing the Janssen Vaccine.", "Subsequently, during the first quarter, we had lower pharmaceutical volumes, specialty drug volumes, and patient care visits that negatively impacted our consolidated revenues and income (loss) from continuing operations before income taxes for the year ended March 31, 2021.", "Additionally, increased costs for certain PPE compressed our margins.", "During the year ended March 31, 2021, we recorded charges totaling $136 million in cost of sales on certain PPE and other related products due to inventory impairments and excess inventory in our Medical-Surgical Solutions segment.", "Although market price volatility and changes to anticipated customer demand may require additional write-downs in future periods, we are taking measures to mitigate such risk.", "We collaborated closely with the federal government and other healthcare stakeholders to source more critical PPE to the U.S.", "We have deferred certain employer payroll taxes and continue to monitor the potential impact of other tax legislation changes as result of the CARES Act, including refundable payroll tax credits on certain qualified wages.", "We anticipate changes due to the CARES Act in the timing of certain cash flows, with no material impact to our financial results for the year ended March 31, 2021.", "The CA Act did not have a material impact on our financial condition, results of operations, or liquidity for the year ended March 31, 2021 nor do we currently expect a material impact on our future financial results.", "We are monitoring our customers closely for changes to their timing of payments or ability to pay amounts owed to us as a result of COVID-19 pandemic impacts to their businesses.", "We remain well-capitalized with access to liquidity from our revolving credit facility.", "Long- term debt markets and commercial paper markets, our primary sources of capital after cash flow from operations, have remained open and accessible to us during the COVID-19 pandemic.", "At March 31, 2021, we were in compliance with all debt covenants, and believe we have the ability to continue to meet our debt covenants in the future.", "Our consolidated balance sheets and ability to maintain financial liquidity remains strong.", "We have experienced no material impacts to our liquidity or net", "We face numerous uncertainties in estimating the direct and indirect effects of COVID-19 on our future business operations, financial condition, results of operations, and liquidity.", "Due to several rapidly changing variables related to the COVID-19 pandemic, estimations of future economic trends and the timing of when stability will  return  remains  challenging.  Additionally,  we  periodically  review  our  intangible  and  other  long-lived  assets  for  impairment  when  events  or  changes  in circumstances indicate  the carrying value may not be recoverable.  Key assumptions and estimates  about future values in our impairment assessments can be affected by a variety of factors, including the impacts of the global pandemic on industry and economic trends as well as on our business strategy and internal forecasts.", "We continue to be involved in discussions with the objective of achieving broad resolution of opioid- related claims of states, their political subdivisions and other government entities (\u201cgovernmental entities\u201d).", "We are in ongoing, advanced discussions with state attorneys general and plaintiffs\u2019 representatives regarding a framework under which, in order to resolve the claims of governmental entities, the three largest U.S. pharmaceutical distributors would pay up to approximately $21.0 billion over a period of 18 years, with up to approximately $8.0 billion to be paid by us, of which more than 90% is anticipated to be used to remediate the opioids crisis.", "As a result of that conclusion, and our assessment of certain other opioid- related claims, we recorded a charge of $8.1 billion for the year ended March 31, 2021 within \u201cClaims and litigation charges, net\u201d in our Consolidated Statement of Operations, related to our share of the settlement framework described above, as well as other opioid-related claims.", "Because of the many uncertainties associated with any potential settlement arrangement or other resolution of opioid-related litigation, including the uncertainty of the scope of participation by plaintiffs in any potential settlement, we are not able to reasonably estimate the upper or lower ends of the range of ultimate possible loss for all opioid-related litigation matters.", "We believe that we have valid defenses to the claims pending against us and, absent an acceptable settlement, intend to vigorously defend against all such claims.  An  adverse  judgment  or  negotiated  resolution  in  any  of  these  matters  could  have  a  material  adverse  impact  on  our  financial  position,  cash  flows  or liquidity, or results of operations.", "The law adopting the excise tax made clear that the OSA would apply only to opioid sales on or before December 31, 2018.", "The excise tax applies only to the first sale occurring in New York, and thus may not apply to sales from our distribution centers in New York to New York customers.", "Unless the appellate court\u2019s decision is overturned, the OSA will be reinstated for calendar years 2017 and 2018 (but not beyond those years), and, subject to any further legal challenge, we will have to pay our ratable share of the annual surcharge for those two years.", "During the second quarter of 2021, we reflected an estimated liability of $50 million for the OSA surcharge in our accompanying consolidated financial statements on the assumption that the appellate court\u2019s decision will stand.", "The higher LIFO credits in 2020 compared to 2019 is primarily driven by higher generic deflation.", "\u2022 Claims and litigation charges, net: These charges include adjustments for estimated probable settlements related to our controlled substance monitoring and reporting, and opioid-related claims, as well as any applicable income items or credit adjustments due to subsequent changes in estimates.", "We have reclassified prior period amounts to conform to the current period presentation.", "\u2022 Goodwill impairments charges: We perform an impairment test on goodwill balances annually in the third quarter and more frequently if indicators for potential impairment exist.", "The resulting goodwill impairment charges are reflected within this line item. \u2022 Restructuring, impairment, and related charges: Restructuring charges that are incurred for programs in which we change our operations, the scope of a business undertaken by our business units, or the manner in which that business is conducted as well as long-lived asset impairments.", "\u2022 SDG&A reflects charges of $58 million to remeasure assets and liabilities held for sale to fair value less costs to sell related to the completed contribution of the majority of our German pharmaceutical wholesale business to create a joint venture with WBA in which we have a 30% ownership interest within our International segment.", "As a result, we were required to perform a goodwill impairment test for these reporting units and recorded a goodwill impairment charge in our European RP reporting unit of $69 million during the second quarter of 2021.", "As of the testing date, other risks, expenses, and future developments, such as additional government actions, increased regulatory uncertainty, and material changes in key market assumptions limit our ability to estimate projected cash flows, which could adversely affect the fair value of various reporting units in future periods, including our McKesson Canada reporting unit within our International segment and our RxCrossroads reporting unit within our RxTS segment, where the risk of a material goodwill impairment is higher than other reporting units.", "\u2022 Restructuring, impairment, and related charges, net includes long-lived asset impairment charges of $112 million, primarily for our United Kingdom (\u201cU.K.\u201d)  business  (mainly  pharmacy  licenses)  and  Rexall  Health  retail  business  (\u201cRexall  Health\u201d)  (mainly  customer  relationships)  within  our International segment, and the remaining $156 million primarily represents employee severance and exit-related costs related to our 2019 restructuring initiatives, as further discussed below; and", "\u2022 Total operating expenses includes higher SDG&A due to our business acquisitions and to support business growth, as well as our technology initiatives, partially offset by favorable effects of foreign currency exchange fluctuations.", "\u2022 SDG&A includes opioid-related costs of $114 million, primarily related to litigation expenses, and increased expenses due to our business acquisitions and to support growth, partially offset by a gain from an escrow settlement of $97 million representing certain indemnity and other claims related to our 2017 acquisition of Rexall Health and a credit of $90 million for the derecognition of a liability related to the tax receivable agreement (\u201cTRA\u201d) payable to the shareholders of Change Healthcare, Inc. (\u201cChange\u201d);", "\u2022 Restructuring,  impairment,  and  related  charges,  net  primarily  includes  employee  severance  and  exit-related  costs  of  $352  million  for  our  2019 restructuring initiatives, as further discussed below and long-lived asset impairment charges of $245 million primarily for our U.K. business (mainly pharmacy licenses) within our International segment driven by additional government reimbursement reductions and competitive pressures in the U.K.", "We evaluate goodwill for impairment on an annual basis as of October 1, and at an interim date, if indicators of potential impairment exist.", "This change was not material to our consolidated financial statements as it did not delay, accelerate, or avoid any potential goodwill impairment charge.", "We expect to incur total charges of approximately $180 million to $280 million for this initiative, consisting primarily of exit related costs, accelerated depreciation and amortization of long-lived assets, and asset impairments.", "We expect to incur total charges of approximately $85 million to $90 million, of which $57 million of charges were recorded to date.", "This initiative was substantially complete in 2021 and remaining costs we expect to record under this initiative are not material.", "The relocation was substantially complete in January 2021 and remaining costs we expect to record under this initiative, primarily relating to lease costs, are not material.", "This primarily reflects mark-to-market gains on our investments in certain U.S. growth stage companies in the healthcare industry and realized gains on the exit of some of these investments as further described in Financial Note 17, \u201cFair Value Measurements,\u201d to the accompanying consolidated financial statements  included  in  this  Annual  Report  on  Form  10-K.  In  future  periods,  fair  value  adjustments  recognized  in  our  operating  results  for  these  types  of investments may be adversely impacted by market volatility.", "Other income, net also increased year over year due to pension settlement charges of $122 million recognized in 2020 related to our previously approved termination of the frozen U.S. defined benefit pension plan.", "In connection with the pension plan termination, we purchased annuity contracts from an insurer that will pay and administer the future pension benefits of the remaining participants.", "Excluding the impairment and transaction-related items described below, our proportionate share of loss from our investment in Change Healthcare JV for the years ended March 31, 2020 and 2019 was $119 million and $194 million, respectively, which primarily includes transaction and integration expenses incurred by the joint venture and basis differences between the joint venture and McKesson including amortization of fair value adjustments.", "During the first quarter of 2020 and for the year ended March 31, 2019, we owned approximately 70% of this joint venture.", "The proceeds from the concurrent offering of other securities were also used by Change  to  acquire  certain  securities  of  Change  Healthcare  JV.  As  a  result,  McKesson\u2019s  equity  interest  in  Change  Healthcare  JV  was  reduced  from  70%  to approximately 58.5%, which was used to recognize our proportionate share in net loss from Change Healthcare JV, commencing in the second quarter of 2020.", "As a result of the ownership dilution to 58.5% from 70%, we recognized a dilution loss of approximately $246 million in the second quarter of 2020.", "Additionally, our proportionate share of income or loss from this investment was subsequently reduced as immaterial settlements of stock option exercises occurred after the IPO and further diluted our ownership.", "Equity Earnings and Charges from Investment in Change Healthcare Joint Venture Until the separation of our investment in Change Healthcare JV on March 10, 2020, we accounted for this investment using the equity method of accounting.", "In the second quarter of 2020, we recorded an other-than-temporary-impairment (\u201cOTTI\u201d) charge of $1.2 billion to our investment in Change Healthcare JV,", "Following the Split-off, we do not beneficially own any of Change\u2019s outstanding securities.", "In connection with this transaction, we recognized a net gain for financial reporting purposes of $414 million during the fourth quarter of 2020, which was largely driven by the reversal of a related deferred tax liability.", "The receipt of any payments under the TRA is dependent upon Change benefiting from this depreciation or amortization in future tax return filings, which creates uncertainty over the amount, timing and probability of the gain recognized.", "As such, we accounted for the TRA as a gain contingency, with no receivable recognized as of March 31, 2021 nor 2020.", "Interest expense decreased in 2020 compared to the prior year primarily due to a decrease in the issuance of commercial paper, partially offset by a decrease in interest income from our derivative contracts.", "Our reported income tax (benefit) expense rates were (13.8%), 1.6%, and 58.4% in 2021, 2020, and 2019, respectively.", "after-tax), which was intended to generally be a tax-free split-off for U.S. federal income tax purposes, and unfavorably impacted by charges of $275 million (pre- tax and after-tax) to remeasure assets and liabilities held for sale to fair value less costs to sell related to the completed contribution of the majority of our German pharmaceutical wholesale business to create a joint venture with WBA.", "goodwill of our European RP and European PD reporting units within the International segment, given that these charges are generally not deductible for tax purposes.", "Our income tax expense, deferred tax assets and liabilities, and uncertain tax liabilities reflect management\u2019s best assessment of estimated current and future taxes to be paid.", "We believe that we have made adequate provision for all income tax uncertainties.", "In connection with the exchange offer, on March 9, 2020, we distributed all 176.0 million outstanding shares of common stock of SpinCo to participating", "Income Tax (Benefit) Expense We recorded income tax (benefit) expense of ($695 million), $18 million, and $356 million for the years ended March 31, 2021, 2020, and 2019, respectively.", "Our reported income tax expense rate for 2019 was unfavorably impacted by charges of $1.8 billion (pre-tax and after-tax) to impair the carrying value of", "Significant judgments and estimates are required in determining the consolidated income tax provision and evaluating income tax uncertainties.", "Noncontrolling interests with redemption  features, such as put rights, that are not solely within our control are considered redeemable  noncontrolling  interests.  Redeemable  noncontrolling interests are presented outside of McKesson Corporation stockholders\u2019 equity (deficit) on our consolidated balance sheet.", "Diluted earnings (loss) per common share attributable to McKesson Corporation was $(28.26), $4.95, and $0.17 for the years ended March 31, 2021,  2020,  and  2019,  respectively.  Net  loss  per  diluted  share  for  the  year  ended  March  31,  2021  is  calculated  by  excluding  dilutive  securities  from  the denominator  due to their antidilutive  effects.  Additionally,  our 2021, 2020, and 2019 diluted  earnings (loss) per share  reflect  the cumulative  effects  of share repurchases.", "Weighted-average diluted common shares outstanding is impacted by the exercise and settlement of share-based awards and the cumulative effect of share repurchases, including the impact of shares exchanged as part of the split-off from our investment in Change Healthcare JV, as discussed above.", "(1) Segment operating profit (loss) includes gross profit, net of operating expenses, as well as other income (expense), net, for our reportable segments.", "For retrospective periods presented, operating loss for Other reflects equity earnings and charges from our equity method investment in Change Healthcare JV, which we split-off in the fourth quarter of 2020.", "Pharmaceutical segment includes a charge of $50 million for the year ended March 31, 2021 related to our estimated liability under the OSA.", "(3) Operating loss for our International segment for the years ended March 31, 2021 and 2020 includes charges of $58 million and $275 million, respectively, to remeasure to fair value the assets and liabilities of our German pharmaceutical wholesale business which was contributed to a joint venture with WBA.", "This segment\u2019s operating loss for the years ended March 31, 2021 and 2019 includes goodwill impairment charges of $69 million and $1.8 billion, respectively, as well as long-lived asset impairment charges for the  years ended March 31, 2021,  2020, and 2019  of $115  million,  $112  million,  and $245  million,  respectively, primarily  related to  our retail  pharmacy businesses in Canada and Europe.", "(4) Operating profit for our Medical-Surgical Solutions segment for the year ended March 31, 2021 includes charges totaling $136 million on certain PPE and other related products due to inventory impairments and excess inventory.", "(5) Operating profit for our RxTS segment for the year ended March 31, 2019 includes a gain of $56 million from the divestiture of an equity investment.", "(6) Operating loss for Other for the year ended March 31, 2020 includes an OTTI charge of $1.2 billion and a dilution loss of $246 million related to our investment in Change Healthcare JV, partially offset by a net gain of $414 million related to the completed separation of our interest in Change Healthcare JV during the fourth quarter of 2020.", "(7) Corporate expenses, net for the year ended March 31, 2021 includes a charge of $8.1 billion related to our estimated liability for opioid-related claims, net gains of $133 million  from  our  equity  investments,  and a net  gain  of $131  million  recorded  in  connection  with  insurance  proceeds  received  from  the  settlement  of  the  shareholder derivative action related to our controlled substances monitoring program.", "This was partially offset by a decrease in LIFO credits of $214 million, a charge of $50 million recorded in 2021 related to our estimated liability under the OSA, net impacts from COVID-19, including a less severe cough, cold, and flu season, as well as increased costs for strategic growth initiatives.", "Operating profit and operating profit margin were unfavorably impacted by customer mix and a decrease in net cash proceeds received of $180 million representing our share of antitrust legal settlements.", "recorded to remeasure to fair value the assets and liabilities of our German pharmaceutical wholesale business which was contributed to a joint venture with WBA, of  which  $58  million  and  $275  million  was  reflected  for  the  years  ended  March  31,  2021  and  2020,  respectively.  This  was  partially  offset  by  a  goodwill impairment charge of $69 million recorded in the second quarter of 2021 related to our European retail pharmacy business.", "This was partially offset  by  the  fair  value  remeasurement  charges  in  2020  described  above  and  a  gain  from  an  escrow  settlement  of  $97  million  in  2019  related  to  our  2017 acquisition of Rexall Health.", "Additionally,  operating  profit  was favorable  year over year  due to lower  operating  expenses, including a decrease in our provision for bad debts.", "primary care business and lower restructuring charges, partially offset by the remeasurement of assets and liabilities to fair value related to a divestiture that was completed in 2020 and higher operating expenses, including an increase in our provision for bad debts.", "and existing customers, integration costs incurred in 2019 for our acquisition of RxCrossroads that closed during the fourth quarter of 2018, partially offset by a gain of $56 million from the divestiture of an equity investment in 2019.", "investment in Change Healthcare JV, partially offset by a net gain of $414 million related to the completed separation of our interest in Change Healthcare JV during the fourth quarter of 2020.", "Operating loss for Other also includes our proportionate share of loss from Change Healthcare JV of $119 million and $194 million for the years ended March 31, 2020 and 2019, respectively.", "connection with insurance proceeds received from the settlement of the shareholder derivative action related to our controlled substances monitoring program.", "Corporate expenses, net, for 2020 includes pension settlement charges of $122 million, an opioid claim settlement charge of $82 million, and net settlement gains of $26 million recognized from our derivative contracts.", "claim settlement charge mentioned above, as well as higher costs for technology initiatives, partially offset by net settlement gains recognized in 2020 from our derivative contracts.", "Other Operating  loss  for  Other  for  the  year  ended  March  31,  2020  includes  an  OTTI charge  of  $1.2  billion  and  a  dilution  loss  of  $246  million  related  to  our", "Corporate 2021 vs. 2020 Corporate expenses, net increased for the year ended March 31, 2021 compared to the prior year due to a charge of $8.1 billion related to our estimated", "We conduct our business worldwide in local currencies including Euro, British pound sterling, and Canadian dollar.", "As a result, the comparability of our results reported in U.S. dollars can be affected by changes in foreign currency exchange rates.", "In discussing our operating results, we may use the term \u201cforeign currency exchange fluctuations,\u201d which refers to the effect of changes in foreign currency exchange rates used to convert the local currency results of our operations in foreign countries where the functional currency is not the U.S. dollar.", "We present this information to provide a framework for assessing how our business performed excluding the effect of foreign currency exchange rate fluctuations.", "In computing the foreign currency exchange fluctuations, we translate our current year results of our operations in foreign countries recorded in local currencies into U.S dollars by applying their respective average foreign currency exchange rates of the corresponding prior year periods, and we subsequently compare those results to the previously reported results of the comparable prior year periods reported in U.S. dollars.", "estimate was made and if different estimates that we reasonably could have used in the current period, or changes in the accounting estimate that are reasonably likely to occur from period to period, could have a material impact on our financial condition or results from operations.", "Below are the estimates that we believe are  critical  to  the  understanding  of  our  operating  results  and  financial  condition.  Other  accounting  policies  are  described  in  Financial  Note  1,  \u201cSignificant Accounting  Policies,\u201d  to  the  consolidated  financial  statements  appearing  in  this  Annual  Report  on  Form  10-K.  Because  of  the  uncertainty  inherent  in  such estimates, actual results may differ from these estimates.", "Other customer financing primarily relates to guarantees provided to our customers, or their creditors, regarding the repurchase of inventories.", "We also provide financing to certain customers related to the purchase of pharmacies, which serve as collateral for the loans.", "We estimate the receivables for which we do not  expect  full  collection  based  on  historical  collection  rates  and  specific  knowledge  regarding  the  current  creditworthiness  of  our  customers  and  record  an allowance in our consolidated financial statements for these amounts.", "Management reviews these factors quarterly to determine if any adjustments are needed to the allowance.", "Sales to our largest customer, CVS Health Corporation (\u201cCVS\u201d), accounted for approximately 21% of our total consolidated revenues in 2021 and comprised approximately 19% of total trade accounts receivable at March 31, 2021.", "As a result, our sales and credit concentration is significant.", "The accounts receivables balances are with individual members of the GPOs, and therefore no significant concentration of credit risk exists.", "A material default in payment, a material reduction in purchases from these or any other large customers, or the loss of a large customer or GPO could have a material adverse impact on our financial position, results of operations, and liquidity.", "We believe the reserves maintained and expenses recorded in 2021 are appropriate and consistent in the context of historical methodologies employed, as well as assessment of trends currently available.", "The selected 0.1% hypothetical change does not reflect what could be considered the best or worst-case scenarios.", "Our LIFO valuation amount includes both pharmaceutical and non-pharmaceutical products.", "We recognized LIFO credits of $38 million, $252 million, and $210 million, respectively, in 2021, 2020, and 2019 in our Consolidated Statements of Operations.", "A LIFO charge is recognized when the net effect of price increases on pharmaceutical and non-pharmaceutical products held in inventory exceeds the impact of price declines, including the effect  of branded pharmaceutical  products  that have lost market  exclusivity.  A LIFO credit  is recognized  when the net effect  of price  declines exceeds the impact of price increases on pharmaceutical and non-pharmaceutical products held in inventory.", "Excluding LIFO reserves, our inventory reserves as of March 31, 2021 and 2020 were $263 million and $96 million, respectively.", "The increase was primarily due to 2021 charges totaling $136 million on certain PPE and other related products due to inventory impairments and excess inventory within our Medical-Surgical Solutions segment.", "In 2021, 2020 and, 2019, our provision for bad debts", "At March 31, 2021 and 2020, total inventories, net were $19.2 billion and $16.7 billion, respectively, in our Consolidated Balance Sheets.", "Any purchase consideration in excess of the estimated fair values of the net assets acquired is recorded as goodwill.", "that is a form or variation of the income approach, whereby a forecast of future cash flows attributable to the asset are discounted to present value using a risk- adjusted discount rate.", "We perform an impairment test on goodwill balances annually in the third quarter and more frequently if indicators for potential impairment exist.", "equal to the amount of excess carrying value above the estimated fair value, if any, but not to exceed the amount of goodwill allocated to the reporting unit.", "we estimate fair value by comparing the business to similar businesses, or guideline companies whose securities are actively traded in public markets.", "Under the income approach, we use a discounted cash flow (\u201cDCF\u201d) model in which cash flows anticipated over several periods, plus a terminal value at the end of that time horizon, are discounted to their present value using an appropriate rate that is commensurate with the risk inherent within the reporting unit.", "Goodwill  and  Long-Lived  Assets: As  a  result  of  acquiring  businesses,  we  have  $9.5  billion  and  $9.4  billion  of  goodwill  at  March  31,  2021  and  2020,", "To estimate the fair value of our reporting units, we generally use a combination of the market approach and the income approach.", "Judgments made in determining an estimate of fair value may materially impact our results of operations.", "Included in the estimate of the weighted-average cost of capital is the assumption of an unsystematic risk premium to address incremental uncertainty related to the reporting units\u2019 future cash flow projections.", "An increase in the unsystematic risk premium increases the discount rate.", "Pharmaceutical  Distribution  reporting  units  in  our  International  segment,  exceeded  their  carrying  values.  The  impairment  testing  performed  in  2020  did  not indicate  any  material  impairment  of  goodwill.  The  segment  change  in  the  second  quarter  of  2021  prompted  changes  in  multiple  reporting  units  across  the Company.", "We recorded a goodwill impairment charge of $69 million in 2021 as the estimated fair value of the Europe Retail Pharmacy reporting unit was lower than its reassigned carrying value based on changes in the composition of the Europe Retail Pharmacy reporting unit within the International segment.", "At March 31, 2021, the  balance  of goodwill for the  reporting  units  in Europe  was approximately  nil  and the  remaining  balance  of goodwill  in the International segment primarily relates to one of our reporting units in Canada.", "Other risks, expenses and future developments, such as additional government actions, increased regulatory uncertainty, and material changes in key market assumptions that we were unable to anticipate as of the testing date may require us to further revise the projected cash flows, which could adversely affect the fair value of our other reporting units in future periods.", "We review intangible assets for impairment at an asset group level whenever events or changes in circumstances indicate that the carrying value of the assets may not be recoverable.", "Determination of recoverability of intangible assets is based on the lowest level of identifiable estimated future undiscounted cash flows resulting from use of the asset and its eventual disposition.", "Measurement of any impairment loss is based on the excess of the carrying value of the asset group over its fair value.", "Assumptions and estimates about future values and remaining useful lives of our purchased intangible assets are complex and subjective.", "When the decline in value is deemed to be other than temporary, an impairment is recognized to the extent that the fair value is less than the carrying value of the investment.", "We consider various factors in determining whether a loss in value of an investment is other than temporary including: the length of time and the extent to which the fair value has been below cost, the financial condition of the investees, and our intent and ability to retain the investment for a period of time sufficient to allow for recovery of value.", "Any significant changes in assumptions or judgments in assessing impairments could result in an impairment charge.", "We generally recognize employee severance costs when payments are probable and amounts are estimable.  Costs related  to contracts without future benefit or contract termination  are recognized  at the earlier of the contract termination  or  the  cease-use  dates.  Other  exit-related  costs  are  recognized  as  incurred.  In  connection  with  these  restructuring  actions,  we  also  assess  the recoverability of long-lived assets used in the business, and as a result, we may recognize accelerated depreciation and amortization reflecting shortened useful lives of the underlying assets.", "paid.  We  are  subject  to  income  taxes  in  the  U.S.  and  numerous  foreign  jurisdictions.  Significant  judgments  and  estimates  are  required  in  determining  the consolidated income tax provision and in evaluating income tax uncertainties and include those used to conclude on the tax-free nature of the separation of the Change Healthcare JV and the unrecognized tax position related to opioid-related litigation and claims, which remains unfinalized, and which may differ from the actual amounts of tax benefit recognized.", "We review our tax positions at the end of each quarter and adjust the balances as new information becomes available.", "to recover our deferred tax assets, we consider all available positive and negative evidence including our past operating results, the existence of cumulative net operating losses in the most recent years, and our forecast of future taxable income.", "In estimating future taxable income, we develop assumptions including the amount of future federal, state and foreign pre-tax operating income, the reversal of temporary differences, and the implementation of feasible and prudent tax planning strategies.", "These assumptions require significant judgment about the forecasts of future taxable income and are consistent with the plans and estimates we use to manage the underlying businesses.", "additional taxes and related interest will be due.", "If our current estimate of tax and interest liabilities is less than the ultimate settlement, an additional charge to income tax expense may result.", "If our current estimate of tax and interest liabilities is more than the ultimate settlement, a reduction to income tax expense may be recognized.", "investigations  relating  to  laws  and  regulations  and  other  matters  arising  out  of  the  normal  conduct  of  our  business.  When  a  loss  is  considered  probable  and reasonably estimable, we record a liability in the amount of our best estimate for the ultimate loss.", "When a material loss is reasonably possible or probable but a reasonable estimate cannot be made, disclosure of the proceeding is provided.", "Deferred income taxes arise from temporary differences between the tax and financial statement recognition of revenue and expense.", "Changes in tax laws and rates could also affect recorded deferred tax assets and liabilities in the future.", "We recognize liabilities for tax and related interest for issues in the U.S. and other tax jurisdictions based on our estimate of whether, and the extent to which,", "As discussed above, development of a meaningful estimate of loss or a range of potential loss is complex when the outcome is directly dependent on future negotiations with or decisions by third parties, such as regulatory agencies, the court system and other interested parties.", "As a result of ongoing, advanced discussions with state attorneys general and plaintiffs\u2019 representatives regarding a framework to resolve the claims of governmental  entities,  and  our  assessment  of  certain  other  opioid-related  claims,  we  have  reached  a  stage  at  which  a  broad  settlement  of  opioid  claims  by governmental entities is probable and recorded a charge of $8.1 billion for the year ended March 31, 2021 within \u201cClaims and litigation charges, net\u201d in our Consolidated Statement of Operations in this report.", "Because of the many uncertainties associated with any potential settlement arrangement or other resolution of opioid-related litigation, including the uncertainty of the scope of participation by plaintiffs in any potential settlement, we are not able to reasonably estimate the upper or lower ends of the range of ultimate possible loss for all opioid-related litigation matters.", "While we are not able to predict the outcome or reasonably estimate a range of possible losses in these matters, an adverse judgment or negotiated resolution in any of these matters could have a material adverse effect on our results of operations, consolidated financial position, cash flows or liquidity.", "facilities and commercial paper program, will be sufficient to fund our short-term and long-term capital expenditures, working capital, and other cash requirements.", "We continue to monitor its impact on demand within parts of our business, as well as trends potentially impacting the timing or ability for some of our customers to pay amounts owed to us.", "We remain well-capitalized with access to liquidity from our $4.0 billion revolving credit facility.", "Additionally, long-term debt markets and commercial paper markets, our primary sources of capital after cash flow from operations, have remained open and accessible to us during the COVID-19 pandemic.", "We have seen continued improvement in conditions in the debt markets and commercial paper markets as the Federal Reserve has taken steps to stabilize the markets.", "At March 31, 2021, we were in compliance with all debt covenants, and believe we have the ability to continue to meet our debt covenants in the future.", "Cash flows from operations can be significantly impacted by factors such as the timing of receipts from customers and payments to vendors.", "Operating activities for the year ended March 31, 2021 were affected by net income adjusted for non-cash items, including the pre-tax $8.1 billion (after-tax $6.8 billion) non-cash charge related to our estimated liability for opioid-related claims, an increase in inventory of $2.3 billion and an increase in drafts and accounts payable of $1.3 billion driven by higher inventory stock levels to meet increased volume demand as part of our inventory management, as well as a decrease in receivables of $1.1 billion driven by timing, higher sales recognized at the end of March 2020, and higher collections in our fourth quarter of 2021.", "value remeasurement charges of $58 million related to the contribution of our German pharmaceutical wholesale business to a joint venture with WBA.", "Additionally, we made a cash payment of $114 million from the executive benefit retirement plan in 2020.", "Investing activities for the year ended March 31, 2021 also includes net cash proceeds of $400 million from sales of businesses and investments, including $286 million in exchange for the contribution of our German pharmaceutical wholesale business to a joint venture with WBA.", "Cash used for other financing activities generally includes payments to noncontrolling interests and activity from our finance leases.", "We received cash from long-term debt issuances of $1.1 billion and made repayments on long-term debt of $1.1 billion in 2019.", "The timing of any repurchases and the actual number of shares repurchased will depend on a variety of factors, including our stock price, corporate and regulatory requirements, restrictions under our debt obligations, and other market and economic conditions.", "In accordance with our accounting policy, we allocate any excess of share repurchase price over par value between additional paid-in capital and retained earnings.", "Accordingly, our retained earnings and additional paid-in capital were reduced by $472 million and $70 million during 2019, respectively.", "outstanding shares of SpinCo common stock, which held all of the Company\u2019s interests in the Change Healthcare JV, to participating holders of the Company\u2019s common  stock  in  exchange  for  15.4  million  shares  of  McKesson  stock,  which  are  now  held  as  treasury  stock  on  our  consolidated  balance  sheet.  Following consummation of the exchange offer, on March 10, 2020, SpinCo merged with and into Change and each share of SpinCo common stock was converted into one share of Change common stock, par value $0.001 per share, with cash being paid in lieu of fractional shares of Change common stock.", "give us the ability to meet our financing needs for the foreseeable future.", "However, there can be no assurance that an increase in volatility or disruption in the global capital and credit markets will not impair our liquidity or increase our costs of borrowing.", "As described within the \u201cTrends and Uncertainties\u201d section above,  the  COVID-19  pandemic  continues  to  develop  rapidly.  We  continue  to  monitor  its  impact  on  demand  within  parts  of  our  business,  as  well  as  trends potentially impacting the timing or ability for some of our customers to pay amounts owed to us.", "(2) This ratio describes the relationship and changes within our capital resources, and is computed as total debt divided by the sum of total debt and McKesson stockholders\u2019 equity (deficit), which excludes noncontrolling and redeemable noncontrolling interests and accumulated other comprehensive loss. (3) Ratio is computed as net income (loss) attributable to McKesson Corporation for the last four quarters, divided by a five-quarter average of McKesson stockholders\u2019 equity (deficit), which excludes noncontrolling and redeemable noncontrolling interests.", "In 2019, we retired 5.0 million or $542 million of the Company\u2019s treasury shares previously repurchased.", "In connection with the Split-off, we distributed all 176.0 million", "Deposits with financial institutions are primarily denominated in U.S. dollars and the functional currencies of our foreign subsidiaries, including Euro, British pound sterling, and Canadian dollars.", "We mitigate the risk of our short-term investment portfolio by depositing funds with reputable financial institutions and monitoring risk profiles and investment strategies of money market funds. outside of the U.S., respectively.", "Our primary intent is to utilize this cash for foreign operations for an indefinite period of time.", "Although the vast majority of cash held outside the U.S. is available for repatriation, doing so could subject us to foreign withholding taxes and state income taxes.", "The COVID-19 pandemic has potential to increase the variations in our working capital, which we continue to monitor closely. partially offset by an increase in drafts and accounts payable and a decrease in receivables.", "Our unfavorable return on McKesson\u2019s stockholder\u2019s equity (deficit) as of March 31, 2021 was also driven by net loss for the year.", "Net loss for the year ended March 31, 2021 includes an after-tax non-cash charge of $6.8 billion related to our estimated liability for opioid-related claims, as discussed in \u201cTrends  and  Uncertainties\u201d of  this  Financial  Review  and  Financial  Note  19,  \u201cCommitments  and  Contingent  Liabilities,\u201d  to  the  accompanying  consolidated financial statements included in this Annual Report on Form 10\u2011K.", "Our debt to capital ratio increased for 2020 primarily due to a decrease in stockholders\u2019 equity driven by the Split-off of our interest in Change Healthcare JV and share repurchases.", "We anticipate that we will continue to pay quarterly cash dividends in the future.", "However, the payment and amount of future dividends remain within the discretion of the Board and will depend upon our future earnings, financial condition,  capital  requirements,  and  other  factors.  In  2021,  2020,  and  2019,  we  paid  total  cash  dividends  of  $276  million,  $294  million,  and  $292  million, respectively.  Additionally,  as  required  under  the  Domination  Agreement,  we  are  obligated  to  pay  an  annual  recurring  compensation  amount  of  \u20ac0.83  per McKesson Europe share (effective January 1, 2015) to the noncontrolling shareholders of McKesson Europe.", "Cash equivalents, which are readily convertible to known amounts of cash, are carried at fair value.", "Our cash and cash equivalents balance as of March 31, 2021 and 2020 included approximately $2.3 billion and $1.7 billion of cash held by our subsidiaries", "On  July  29,  2020,  we  raised  our  quarterly  dividend  from  $0.41  to  $0.42  per  common  share  for  dividends  declared  on  or  after  such  date  by  the  Board.", "(3) Includes our estimated benefit payments for the unfunded benefit plans and minimum funding requirements for the pension plans. (4) Primarily represents interest that will become due on our fixed rate long-term debt obligations.", "These obligations primarily relate to inventory purchases and capital commitments. (6) Includes agreements under which we have guaranteed the repurchase of our customers\u2019 inventory and our customers\u2019 debt in the event these customers are unable to meet their obligations to those financial institutions.", "The ultimate amount and timing of any future cash settlements related to these items cannot be predicted with reasonable certainty.", "and are mostly related to our customer contracts and to meet the security requirements for statutory licenses and permits, court and fiduciary obligations, and our workers\u2019 compensation and automotive liability programs.", "The exercise of the Put Right will reduce the balance of redeemable noncontrolling interests.", "During 2021, we paid $49 million to purchase 1.8 million shares of McKesson Europe through exercises of the Put Right by the noncontrolling shareholders.", "Our banks and insurance companies have issued $146 million of standby letters of credit and surety bonds at March 31, 2021.", "redemption value is the Put Amount adjusted for exchange rate fluctuations each period.", "In future periods, unfavorable foreign currency exchange rate fluctuations between the Euro and the U.S. dollar could adversely impact the carrying value of our redeemable noncontrolling interests and require an adjustment to increase the balance of our redeemable noncontrolling interests to its maximum redemption value.", "On April 12, 2021, we received the Stuttgart Court of Appeals\u2019 final ruling confirming the original put value of \u20ac22.99 per share and the annual recurring compensation of \u20ac0.83 per McKesson Europe share.", "Funds necessary for future debt maturities and our other cash requirements are expected to be met by existing cash balances, cash flow from operations, existing credit sources, and other capital market transactions.", "The effect of a hypothetical 50 bp increase in the underlying interest rate on our cash and cash equivalents, net of short-term borrowings and variable rate debt, would have resulted in a favorable impact to earnings in 2021 and 2020 of approximately $17 million and $6 million, respectively.", "The balance of redeemable noncontrolling interests is reported at the greater of its carrying value or its maximum redemption value at each reporting date.", "Additionally,  we  are  obligated  to  pay  an  annual  recurring  compensation  of  \u20ac0.83  per  McKesson  Europe  share  (the  \u201cCompensation  Amount\u201d)  to  the", "Interest rate risk: Our long-term debt bears interest predominately at fixed rates, whereas our short-term borrowings are at variable interest rates.", "Our cash and cash equivalents balances earn interest at variable rates.", "At March 31, 2021 and 2020, we had $6.3 billion and $4.0 billion, respectively, in cash", "Changes in foreign currency exchange rates could have a material adverse impact on our financial results that are reported in U.S. dollars.", "We are also exposed to foreign exchange rate risk related to our foreign subsidiaries, including intercompany loans denominated in non-functional currencies.", "These programs reduce but do not entirely eliminate foreign exchange risk.", "fair value of our foreign exchange contracts by approximately $267 million and $435 million, respectively.", "Foreign exchange risk: We conduct our business worldwide in U.S. dollars and the functional currencies of our foreign subsidiaries, including Euro, British", "We have certain foreign exchange rate risk programs that use foreign currency forward contracts and cross-currency swaps.", "Based on this assessment, our management has concluded that our internal control over financial reporting was effective as of March 31, 2021.", "In our opinion, the financial statements referred to above present fairly, in all material respects, the financial position of the Company as of March 31, 2021 and 2020, and the results of its operations and its cash flows for each of the three years in the period ended March 31, 2021, in conformity with accounting principles generally accepted in the United States of America.", "Also, in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of March 31, 2021, based on criteria established in Internal Control \u2014 Integrated Framework (2013) issued by COSO.", "Our responsibility is to express an opinion on these financial statements and an opinion on the Company\u2019s internal control over financial reporting based  on  our  audits.  We  are  a  public  accounting  firm  registered  with  the  Public  Company  Accounting  Oversight  Board  (United  States)  (\u201cPCAOB\u201d)  and  are required  to  be  independent  with  respect  to  the  Company  in  accordance  with  the  U.S.  federal  securities  laws  and  the  applicable  rules  and  regulations  of  the Securities and Exchange Commission and the PCAOB.", "We conducted our audits in accordance with the standards of the PCAOB.", "Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.", "Our audits of the financial statements included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures to respond to those risks.", "Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements.", "Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk.", "Our audits also included performing such other procedures as we considered necessary in the circumstances.", "We believe that our audits provide a reasonable basis for our opinions.", "The critical audit matters communicated below are matters arising from the current-period audit of the financial statements that were communicated or required to be communicated to the audit committee and that (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments.", "The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.", "The Company also performs an assessment of loss contingencies where a loss is reasonably possible.", "We identified the potential broad settlement of opioid claims as a critical audit matter because of the significant judgment and challenges auditing management\u2019s determination  of  whether  such  loss  is  probable  and  reasonably  estimable.  Specifically,  auditing  management\u2019s  determination  and  disclosure  of  whether  the contingent loss arising from the potential broad settlement of opioid claims is probable, and the related measurement of such loss, is subjective and requires significant judgment given that the potential loss is based upon settlement terms that have not yet been finalized.", "\u2022 We tested the effectiveness of internal controls related to the potential broad settlement of opioid claims, and approval of the accounting treatment and related disclosures based on the most recent facts and circumstances.", "In addition, we inspected responses to inquiry letters sent to both internal and external legal counsel as it relates to the status of discussions with plaintiffs\u2019 counsel and the Company\u2019s intent regarding the framework for a potential broad settlement of opioid claims.", "\u2022 We evaluated management\u2019s analysis of the potential broad settlement of opioid claims, including the methodology used by management to determine the probability of such loss.", "We also evaluated the methodology used by management to estimate the most likely loss to be incurred by the Company as a result of a potential broad settlement of opioid claims.", "\u2022 We performed public domain searches for evidence contrary to management\u2019s analysis.", "\u2022 We evaluated any events subsequent to March 31, 2021 that might impact our evaluation of the potential broad settlement of opioid claims. \u2022 We obtained written representations from executives and internal counsel of the Company. \u2022 We examined proposed terms related to the potential broad settlement framework. \u2022 We evaluated the Company\u2019s related disclosures for consistency with our testing.", "The net amount recognized by management is measured as the largest amount of tax benefit that is greater than 50 percent likely of being realized.", "We identified the Company\u2019s uncertain tax position related to the charge for the potential broad settlement of opioid claims as a critical audit matter because of the challenges in auditing management\u2019s estimate of the amount of income tax benefit that qualifies for recognition.", "Our audit procedures related to the Company's uncertain tax position associated with a potential broad settlement of opioid claims included the following, among others: \u2022 We tested the effectiveness of internal controls related to the Company\u2019s assessment of the technical merits of its tax position, including the Company\u2019s assessment as to the amount of benefit that is more likely than not to be realized. \u2022 With  the  assistance  of  our  tax  specialists,  we  evaluated  the  facts,  evidence  and  the  Company\u2019s  related  income  tax  analysis  for  the  charge  related  to  the potential broad settlement of opioid claims, including assumptions used by management to measure the related recognized and unrecognized tax benefits. \u2022 We inquired of the Company\u2019s internal and external legal counsel to understand the basis for the Company\u2019s conclusion that a portion of the potential broad settlement of opioid claims would be deductible based on the most recent discussions with plaintiffs\u2019 counsel.", "\u2022 We  compared  management's  income  tax  assessment  of  this  matter  to  the  treatment  of  other  recorded  opioid  charges  to  evaluate  the  consistency  of  the Company\u2019s judgments related to the uncertain tax position. \u2022 We evaluated any events subsequent to March 31, 2021 that might impact our evaluation of the Company\u2019s uncertain tax position related to the charge for the potential broad settlement of opioid claims.", "\u2022 We obtained written representations from executives and internal counsel of the Company. \u2022 We examined proposed terms related to the potential broad settlement framework.", "\u2022 We evaluated the Company\u2019s related disclosures for consistency with our testing and also searched for contradictory evidence by reading disclosures from peer companies, who are also party to the potential broad settlement of opioid claims.", "We identified the estimation of the fair value of the McKesson Canada reporting unit used to evaluate the recoverability of goodwill as a critical audit matter because of the challenges auditing significant judgments used in the selection of a discount rate, including the unsystematic risk premium.", "In particular, the fair value estimate is sensitive to the unsystematic risk premium assumption, which is affected by expected risk of changes in the Canadian business and regulatory environments.", "Auditing management\u2019s selected discount rate required a high degree of auditor judgment and an increased extent of effort, including the need to involve more senior members of the team and our fair value specialists.", "Our audit procedures related to the Company\u2019s selection of a discount rate, including consideration of the unsystematic risk premium, for the McKesson Canada reporting unit included the following, among others: \u2022 We tested the effectiveness of internal controls related to management\u2019s goodwill impairment evaluation, including those related to the selection of a discount rate and consideration of an unsystematic risk premium. \u2022 We  evaluated  management\u2019s  ability  to  accurately  forecast  operating  results  for  the  McKesson  Canada  reporting  unit  by  comparing  actual  results  to management\u2019s historical forecasts, in order to consider the reasonableness and adequacy of management\u2019s selected unsystematic risk premium. \u2022 As part of our assessment of the unsystematic risk premium, we evaluated the reasonableness of strategic plans expected to be implemented during the forecast period by comparing the forecasts to:", "\u2022 With the assistance of our fair value specialists, we evaluated the reasonableness of the discount rate, including the unsystematic risk premium, by developing a range of independent estimates, testing the mathematical accuracy of the calculation and comparing to the discount rate selected by management.", "We have served as the Company\u2019s auditor since 1968.", "The Company consolidates VIEs when it is determined that it is the primary beneficiary of the VIE.", "Investments in business entities in which the Company does not have control but has the ability to exercise significant influence over operating and financial policies, are accounted for using the equity method.", "Actual amounts could differ from those estimated amounts.", "These legislative acts are not expected to have a material impact on the Company\u2019s consolidated financial results.", "The Company considers itself to control an entity if it is the majority owner of or has voting control over such entity.", "GAAP requires that the Company make estimates and assumptions that", "If a loss in value has occurred that is deemed to be other-than-temporary, an impairment loss is recorded.", "economic environment, customer credit ratings or bankruptcies, as well as reasonable and supportable forecasts.", "We are exposed to credit losses on accounts receivable balances.", "As a result, the Company\u2019s sales and credit concentration is significant.", "The accounts receivables balances are with individual members of the GPOs, and therefore no significant concentration of credit risk exists.", "This credit risk is mitigated by the size and diversity of the Company\u2019s customer base as well as its geographic dispersion.", "These amounts are equivalent to the Company\u2019s LIFO reserves.", "A LIFO credit is recognized when the net effect of price declines exceeds the impact of price increases on pharmaceutical and non-pharmaceutical products held in inventory.", "The increase was primarily due to charges in 2021 totaling $136 million on certain personal protective equipment and other related products due to inventory impairments and excess inventory within our Medical-Surgical Solutions segment.", "When the net realizable value of a disposal group increases during a period, a gain can be recognized to the extent that it does not increase the value of the disposal group beyond its original carrying value when the disposal group was reclassified as held for sale.", "Depreciation and amortization begins when an asset is placed in service and ready for its intended use.", "The use of alternative assumptions and estimates could affect the fair values and change the impairment determinations.", "Measurement of any impairment loss is based on the excess of the carrying value of the asset group over its estimated fair market value.", "customer in an amount that reflects the consideration to which the entity expects to be entitled for that good or service.", "Revenue is recognized when control of goods is transferred to the customer which occurs upon the Company\u2019s delivery to the customer or upon customer  pick-up.", "The ultimate outcome of any outstanding claims may be different than the Company\u2019s estimate.", "If a derivative is designated as a fair value hedge, the changes in the fair value of the derivative and of the hedged item attributable to the hedged risk are recognized in earnings.", "The cumulative changes in fair value are reclassified to the same line as the hedged item in the Consolidated Statements of Operations when the hedged item affects earnings.", "Noncontrolling interests with redemption features, such as put rights, that are not solely within the Company\u2019s control are considered redeemable noncontrolling interests.", "When a loss is considered probable and reasonably estimable, the Company records a liability in the amount of its best estimate for the ultimate loss.", "When a material loss is reasonably possible or probable, but a reasonable estimate cannot be made, disclosure of the proceeding is provided.", "As discussed above, development of a meaningful estimate of loss or a range of potential loss is complex when the outcome is directly dependent on negotiations with or decisions by third parties, such as regulatory agencies, the court system, and other interested parties.", "Any purchase consideration in excess of the estimated fair values of the net assets acquired is recorded as goodwill.", "Restructuring Charges: Employee severance costs are generally recognized when payments are probable and amounts are reasonably estimable.", "The forward-looking model requires the Company to consider historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount in estimating credit losses.", "The adoption of this amended guidance is not expected to have a material impact on the Company\u2019s consolidated financial statements or disclosures.", "accounting policy has been to disclose any intervening events of the joint venture in the lag period that could materially affect its consolidated financial statements.", "McKesson had the ability to adjust the manner in which certain depreciation or amortization deductions are allocated among Change and McKesson.", "This creates uncertainty over the amount, timing, and probability of the gain recognized.", "Any such change is not expected to have a material impact on the Company\u2019s consolidated financial statements.", "This initiative was substantially complete in 2021 and remaining costs the Company expects to record under this initiative are not material.", "This set of initiatives was substantially complete by the end of 2020 and charges in 2021 were not material.", "Goodwill recognized for business acquisitions is generally not expected to be deductible for tax purposes.", "share-based awards that will ultimately vest primarily based on historical experience.", "The estimated forfeiture rate established upon grant is re-assessed throughout the requisite service period and is adjusted when actual forfeitures occur.", "The actual forfeitures in future reporting periods could be higher or lower than current estimates.", "PSUs have a requisite service period of generally three years.", "Compensation expense for the share-based awards is recognized for the portion of awards ultimately expected to vest.", "The number of vested PSUs is assessed at the end of a", "All  outstanding  PeRSU awards  have  completed  the  performance  period  and  are  now classified  and  accounted  for  as RSUs.", "portion of the awards that is ultimately expected to vest.", "Once the fair value of an employee stock option is determined, current accounting practices do not permit it to be changed, even if the estimates used are different from actual.", "The Company believes this market-based input provides a reasonable estimate of its future stock price movements and is consistent with employee stock option valuation considerations.", "These amounts have not been significant for all the years presented.", "Substantially all its foreign net operating losses have indefinite lives.", "The decrease in unrecognized tax benefits in 2020  compared  to  2019  is  primarily  attributable  to  the  favorable  resolution  of  an  outstanding  California  tax  refund  claim  which  decreased  unrecognized  tax benefits by $91 million.", "2017 Tax Act, the repatriation of cash to the U.S. is generally no longer taxable for federal income tax purposes.", "The Company may remit foreign earnings to the U.S. to the extent it is tax efficient to do so.", "It does not expect the tax impact from remitting these earnings to be material.", "The exercise of the Put Right will reduce the balance of redeemable noncontrolling interests.", "The adoption of this guidance did not have a material impact on the Company\u2019s consolidated statements of operations and cash flows.", "The Company\u2019s lease agreements do not contain any material residual value guarantees or material restrictive covenants.", "Operating lease liabilities are recognized based on the present value of the future lease payments over the lease term, discounted at the Company\u2019s incremental borrowing rate as the implicit rate in the lease is not readily determinable for most of the Company\u2019s leases.", "As a practical expedient, short-term leases with an initial term of 12 months or less are excluded from the Consolidated Balance Sheets and charges from these leases are expensed as incurred.", "Fair value estimates result from a complex series of judgments about future events and uncertainties and rely heavily on estimates and assumptions that have been deemed reasonable by management as of the measurement date.", "The unsystematic risk premium is an input factor used in calculating the discount rate that specifically addresses uncertainty related to the reporting unit\u2019s future cash flow projections.", "The risk of successfully achieving certain business initiatives was the primary factor in the use of a higher discount rate.", "and, from time-to-time, future unsecured and unsubordinated indebtedness outstanding.", "As a result of absorbing this risk, the leases provide the Company with the power to direct the operations of the leased properties and the obligation to absorb losses or the right to receive benefits of the entity.", "Consolidated VIEs do not have a material impact on the Company\u2019s Consolidated Statements of Operations and Cash Flows.", "their economic performance and thus is not considered the primary beneficiary of the entities.", "The pension obligation in Germany is unfunded with the exception of the contractual trust arrangement used to fund pensions of McKesson Europe\u2019s Management Board.", "actuarial  losses  exceeding  10%  of  the  greater  of  the  projected  benefit  obligation  or  the  market  value  of  assets  are  amortized  straight-line  over  the  average remaining future service period of active employees.", "Pension obligations for its unfunded plans are based on the recommendations of independent actuaries.", "The difference between actual inflation and assumed inflation in our U.K. pension plans resulted in a gain of $23 million.", "corporate bonds rated AA or better whose maturities are aligned with the expected benefit payments of its plans.", "Plan assets of the non-U.S. plans are broadly invested in a manner appropriate to the nature and duration of the expected future retirement benefits payable under the plans.", "Assets are properly diversified to avoid excessive reliance on any particular asset, issuer, or group of undertakings so as to avoid accumulations of risk in the portfolio as a whole.", "practical expedient are not leveled within the fair value hierarchy and are included as a reconciling item to total investments.", "Actions taken by other participating employers may lead to adverse changes in the financial condition of a multiemployer benefit plan and the Company\u2019s withdrawal liability and contributions may increase.", "It does not use derivatives for trading or speculative purposes.", "Eligible employees may contribute to the RSP up to 75% of", "In the normal course of business, the Company is exposed to interest rate and foreign currency exchange rate fluctuations.", "These forward contracts and cross-currency swaps are generally used to offset the potential income statement effects from intercompany loans and other obligations denominated in non-functional currencies.", "These programs reduce but do not entirely eliminate foreign currency exchange rate risk.", "To the extent foreign currency-denominated notes designated as net investment hedges are ineffective, changes in carrying value attributable to the change in spot rates are recorded in earnings.", "To the extent cross-currency swaps designated as hedges are ineffective, changes in carrying value attributable to the change in spot rates are recorded in earnings.", "Changes in fair values representing hedge ineffectiveness are recognized in current earnings.", "The settlement loss on the swaps was not material and will be amortized on a straight-line basis as interest expense over the five-year life of the 2025 Notes.", "Gains or losses from these contracts are largely offset by changes in the value of the underlying intercompany obligations.", "Changes in the fair value for contracts not designated as hedges are recorded directly in earnings.", "The carrying value of all other cash equivalents approximates their fair value due to their relatively short-term nature.", "These inputs are considered Level 2 under the fair value measurements and disclosure guidance and may not be representative of actual values that could have been realized or that will be realized in the future.", "If the carrying amount of an asset group is not recoverable, an impairment charge is recorded to reduce the carrying amount by the excess over its fair value.", "repurchase of its customers\u2019 inventory or its customers\u2019 debt in the event these customers are unable to meet their obligations to those financial institutions.", "For the Company\u2019s inventory repurchase agreements, among other requirements, inventories must be in resalable condition and any repurchase would be at a discount.", "The majority of the Company\u2019s customers\u2019 debt guarantees are secured by certain assets of the customer.", "The Company\u2019s long-term debt is also recorded at cost.", "The carrying value and fair value of the Company\u2019s long-term debt was as follows:", "Long-lived Assets The Company utilizes multiple approaches including the DCF model and market approaches for estimating the fair value of intangible assets.", "infringe a third party\u2019s intellectual property rights.", "Where appropriate, obligations for such indemnifications are recorded as liabilities.", "Accrued warranty costs were not material to the Consolidated Balance Sheets.", "Significant developments in those matters are described below.", "Company  is  unable  to  determine  that  a  loss  is  probable,  or  to  reasonably  estimate  the  amount  of  loss  or  a  range  of  loss,  for  a  claim  because  of  the  limited information  available  and  the  potential  effects  of future  events  and  decisions  by third  parties,  such  as  courts  and  regulators,  that  will  determine  the  ultimate resolution of the claim.", "It is not uncommon for claims to remain unresolved over many years.", "The Company reviews loss contingencies at least quarterly to determine whether the likelihood of loss has changed and whether it can make a reasonable estimate of the loss or range of loss.", "When the Company determines that a loss from a claim is probable and reasonably estimable, it records a liability for an estimated amount.", "The Company also provides disclosure when it is reasonably possible that a loss may be incurred or when it is reasonably possible that the amount of a loss will exceed its recorded liability.", "Warranties In the normal course of business, the Company provides certain warranties and indemnification protection for its products and services.", "These two West Virginia plaintiffs are not expected to participate in any broader multistate resolution of opioid-related claims.", "The Cherokee Nation is not expected to participate in any broader multistate resolution of opioid-related claims.", "Those non-participating governmental entities would be entitled to pursue their claims against the Company and other defendants.", "The Company believes that it has valid defenses to the claims pending against it, and it intends to vigorously defend against all such claims if acceptable settlement terms are not achieved.", "The Company believes it has valid legal defenses in these matters and intends to mount a vigorous defense.", "The Company has not concluded a loss is probable in any of these matters; nor is the amount of any loss reasonably estimable.", "An adverse judgment or negotiated resolution in any of these matters could have a material adverse impact on the Company\u2019s financial position, cash flows or liquidity, or results of operations.", "AIG and ACE are seeking declarations that they have no duty to defend or indemnify McKesson in the thousands of lawsuits pending in federal and state courts related to opioids.", "Discussions with attorneys general and other parties continue.", "If the negotiating parties agree on terms under the framework for a broad resolution of claims of", "Plaintiffs\u2019 moved for summary judgment on the same day.", "subpoenas and requests in a cooperative, thorough and timely manner.", "These responses sometimes require time and effort and can result in considerable costs being incurred by the Company.", "Such subpoenas and requests can lead to the assertion of claims or the commencement of civil or criminal legal proceedings against the Company and other members of the health care industry, as well as to settlements of claims against the Company.", "The Company responds to these requests in the ordinary course of business.", "The law adopting the excise tax made clear that the OSA does not apply to sales or distributions occurring after December 31, 2018.", "It is not certain at this point in time what proportion of this estimated liability will be borne by the Company.", "However, it is possible that the ultimate costs of these matters may exceed or be less than the reserves.", "Due to the complex nature of the tax laws, it is not possible to estimate the outcome of these matters.", "improper actions to delay or prevent generic drugs from entering the market.", "The quarterly results of operations are not necessarily indicative of the results that may be expected for the entire year.", "effectiveness of the Company\u2019s \u201cdisclosure controls and procedures\u201d (as such term is defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) as of the end of the period  covered  by  this  report  and  have  concluded  that  our  disclosure  controls  and  procedures  are  effective  based  on  their  evaluation  of  these  controls  and procedures as required by paragraph (b) of Exchange Act Rules 13a-15 or 15d-15.", "Rules 13a-15 or 15d-15 that occurred during our fourth quarter of 2021 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.", "caption  \u201cInvestors  -  Corporate  Governance.\u201d  The  Company\u2019s  Corporate  Governance  Guidelines  and  Charters  for  the  Audit,  Compensation  and  Governance Committees can also be found on our website under the same caption.", "Information  about the Code of Conduct applicable  to all employees, officers  and directors can be found on our website, www.mckesson.com, under the", "Information with respect to this item is incorporated by reference from the discussion under the heading \u201cExecutive Compensation\u201d in our Proxy Statement.", "Such non-employee director award is fully vested on the date of the grant.", "subject to and qualified in their entirety by reference to our amended and restated certificate of incorporation, our amended and restated by- laws  and  the  Delaware  General  Corporation  Law  (\u201cDGCL\u201d).  Copies  of  our  amended  and  restated  certificate  of  incorporation  and  our amended and restated by-laws have been filed with the Securities and Exchange Commission (the \u201cSEC\u201d) and are incorporated by reference herein. 100,000,000 shares are preferred stock, par value $0.01 per share.", "We may amend from time to time our amended and restated certificate of incorporation to increase the number of authorized shares of Common Stock and/or preferred stock.", "Any such amendment would require the approval of the holders of a majority of our shares entitled to vote.", "All of our outstanding shares of Common Stock are fully paid and non- assessable.", "Stock are entitled to receive ratably dividends out of assets legally available therefor at such times and in such amounts as our board of directors may from time to time determine.", "ratably in our assets that are legally available for distribution, after payment of all debts, other liabilities and any liquidation preferences of outstanding preferred stock.", "amended and restated certificate of incorporation does not provide for cumulative voting in the election of directors.", "Upon liquidation, dissolution or winding up of our affairs, the holders of Common Stock are entitled to share", "Holders of our Common Stock have no conversion, redemption, preemptive or similar", "Each outstanding share of Common Stock is entitled to one vote on all matters submitted to a vote of stockholders.", "Anti-Takeover Effects of Provisions of Our Amended and Restated Certificate of Incorporation and Our Amended and Restated By- Laws deemed to have an anti-takeover effect and may delay, deter or prevent a tender offer or takeover attempt that a stockholder might consider in its best interest, including those attempts that might result in a premium over the market price for the shares held by stockholders.", "Our amended and restated by-laws provide that special meetings of holders of Common Stock may be called only by our Chair, Chief Executive Officer or a majority of our board of directors for any purpose at any time.", "Holders of Common Stock owning at least 15% of the outstanding shares of Common Stock for at least one year are permitted to submit a special meeting request in accordance with the procedures described in our amended and restated by-laws.", "In general, notice of intent to nominate a director or raise business at such meetings must be received by us not less than 90 nor more than 120 days prior to the date of the  annual meeting and must contain certain specified  information concerning the person to be nominated or the matters to be brought before the meeting and concerning the stockholder submitting the proposal.", "may be amended by a vote of a majority of our board of directors and by the affirmative vote of a majority of the shares of the corporation entitled  to  vote  thereon.  Our  amended  and  restated  certificate  of  incorporation  and  our  amended  and  restated  by-laws  provide  that  our amended and restated by-laws may be amended by a vote of a majority of our board of directors.", "In addition, our amended and restated by- laws provide that our amended and restated by-laws may be amended by the affirmative vote of a majority of the shares of the corporation entitled to vote thereon.", "Current and former stockholders are deemed to have consented to the personal jurisdiction of the Delaware Courts in connection with any action to enforce that exclusive forum provision and to service of process in any such action.", "We  are  subject  to  the  \u201cbusiness  combination\u201d  statute  of  the  DGCL.  In  general,  such  statute  prohibits  a  publicly  held  Delaware", "The statute could prohibit or delay mergers or other takeover or change in control attempts with respect to us and, accordingly, may discourage attempts to acquire us.", "stock could decrease the amount available for distribution to holders of our Common Stock or could adversely affect the rights and powers, including voting rights, of such holders.", "The issuance of preferred stock could have the effect of delaying or preventing a change in control of us.", "Such limitation does not, however, affect the liability of a director (1) for any breach of the director\u2019s duty of loyalty to us or our stockholders, (2) for acts or omissions not in good faith or that involve intentional misconduct or a knowing violation of law, (3) in respect of certain unlawful dividend payments or stock redemptions or purchases and (4) for any transaction from which the director derives an improper personal benefit.", "The effect of this provision is to eliminate our rights and the rights of our stockholders (through stockholders\u2019 derivative suits) to recover monetary damages against a director for breach of the fiduciary duty of care as a director (including breaches resulting from negligent or grossly negligent behavior) except in the situations described in clauses (1) through (4) above.", "This provision does not limit or eliminate our rights or the rights of our stockholders to seek non-monetary relief such as an injunction or rescission in the event of a breach of a director\u2019s duty of care.", "In addition, our directors and officers have indemnification protection.", "principal amount of 0.625% Notes due 2021 and \u20ac600,000,000 aggregate principal amount of 1.500% Notes due 2025, and on February 12, 2018, we issued \u20ac500,000,000 aggregate principal amount of 1.625% Notes due 2026.", "existing and future unsecured and unsubordinated indebtedness from time to time outstanding.", "EQ Shareowner Services acts as transfer agent and registrar of our Common Stock.", "Our Common Stock is listed on the New York Stock Exchange under the symbol \u201cMCK\u201d.", "On  February  17,  2017,  we  issued  \u00a3450,000,000  aggregate  principal  amount  of  3.125%  Notes  due  2029,  \u20ac600,000,000  aggregate", "Securities\u201d), our senior subordinated debt (\u201cSenior Subordinated Debt Securities\u201d), our subordinated debt (\u201cSubordinated Debt Securities\u201d) or our  junior  subordinated  debt  (\u201cJunior  Subordinated  Debt  Securities\u201d  and,  together  with  the  Senior  Subordinated  Debt  Securities  and  the Subordinated Debt Securities, the \u201cSubordinated Securities\u201d).  The Indenture does not limit the amount of debt securities that we may issue.", "It provides that we may issue debt securities up to the principal amount that we may authorize and may be in any currency or currency unit designated  by  us.  Except  for  the  limitations  on  consolidation,  merger  and  sale  of  all  or  substantially  all  of  our  assets  contained  in  the Indenture, the terms of the Indenture do not contain any covenants or other provisions designed to afford holders of any debt securities protection with respect to our operations, financial condition or transactions involving us.", "any person unless (a) we will be the continuing corporation or (b) the successor corporation or person formed by such consolidation or into which we are merged or to which our assets substantially as an entirety are transferred or leased is a corporation, limited liability company or limited partnership organized or existing under the laws of the United States, any state of the United States or the District of Columbia and, if such entity is not a corporation, a co-obligor of the debt securities is a corporation organized or existing under any such laws, and such successor corporation or person, including such co-obligor, if any, expressly assumes our obligations on the debt securities and under the Indenture.", "In addition, we cannot effect such a transaction unless immediately after giving effect to such transaction, no default or Event of Default under the Indenture shall have occurred and be continuing.", "Subject to certain exceptions, when the person to whom our assets are transferred or leased has assumed our obligations under the debt securities and the Indenture, we shall be discharged from all our obligations under the debt securities and the Indenture, except in limited circumstances.", "unless the transaction or change of control were structured to include a merger or consolidation or transfer or lease of all or substantially all of our assets.", "We cannot consolidate or merge with or into, or transfer or lease all or substantially all of our assets to,", "\u2022 any  other  Event  of  Default  provided  in  the  applicable  resolution  of  our  board  of  directors  or  the  officers\u2019  certificate  or supplemental Indenture under which we issue such series of debt securities.", "The Indenture imposes limitations on suits brought by holders of debt securities against us.", "officer knows of any default by us in the performance, observance or fulfillment of any condition or covenant of the Indenture.", "We and the Trustee may not, however, without the consent of the holder of each outstanding debt security affected thereby:", "The Indenture provides that we and the Trustee may enter into supplemental indentures without the", "value of the assets subject to such transaction, as determined by our Board of Directors, or (b) the present value of the remaining obligations of the lessee for net rental payments during the term of any lease discounted at the rate of interest set forth or implicit in the terms of such lease or, if not practicable to determine such rate, the weighted average interest rate per annum borne by the debt securities of each series outstanding pursuant to the Indenture and subject to limitations on sale and lease-back transaction covenants, compounded semi-annually in either case as determined by our principal accounting or financial officer.", "located,  and  substantially  all  the  operations  of  which  are  conducted,  in  the  United  States  of  America  whose  financial  statements  are consolidated with our financial statements in accordance with accounting principles generally accepted in the United States of America.", "Consolidated  Subsidiaries  incurred  after  the  date  of  issuance  of  the  notes  and  secured  by  liens  not  permitted  by  the  limitation  on  liens provisions, and (2) Attributable Debt of ours and our Consolidated Subsidiaries in respect of every sale and lease-back transaction entered into after the date of the issuance of the notes, other than leases permitted by the limitation on sale and lease-back provisions.", "accordance with accounting principles generally accepted in the United States of America.", "Subsidiaries pursuant to which we or any of our Subsidiaries sells, conveys or otherwise transfers to (1) a Receivables Subsidiary (in the case of a transfer by us or any of our Subsidiaries) or (2) any other person (in the case of a transfer by a Receivables Subsidiary), or grants a security interest in, any accounts receivable (whether now existing or arising in the future) or inventory of us or any of our Subsidiaries, and any assets related thereto including, without limitation, all collateral securing such accounts receivable, all contracts and all guarantees or other  obligations  in  respect  of  such  accounts  receivable  or  inventory,  proceeds  of  such  accounts  receivable  and  other  assets  which  are customarily transferred or in respect of which security interests are customarily granted in connection with asset securitization transactions involving accounts receivable or inventory.", "financing of accounts receivable or inventory (a) no portion of the Indebtedness or any other obligations (contingent or otherwise) of which (1)  is  guaranteed  by  us  or  any  Subsidiary  of  ours  (excluding  guarantees  of  obligations  (other  than  the  principal  of,  and  interest  on, Indebtedness) pursuant to representations, warranties, covenants and indemnities entered into in the ordinary course of business in connection with  a  Qualified  Receivables  Transaction),  (2)  is  recourse  or  obligates  us  or  any  Subsidiary  of  ours  in  any  way  other  than  pursuant  to representations,  warranties,  covenants  and  indemnities  entered  into  in  the  ordinary  course  of  business  in  connection  with  a  Qualified Receivables Transaction or (3) subjects any property or asset of ours or any Subsidiary of ours (other than accounts receivable or inventory and related assets as provided in the definition of \u201cQualified Receivables Transaction\u201d), directly or indirectly, contingently or otherwise, to the satisfaction thereof, other than pursuant to representations, warranties, covenants and indemnities entered into in the ordinary course of business in connection with a Qualified Receivables Transaction, (b) with which neither we nor any Subsidiary of ours has any material contract, agreement, arrangement or understanding other than on terms customary for securitization of receivables or inventory and (c) with which neither we nor any Subsidiary of ours has any obligations to maintain or preserve such Subsidiary\u2019s financial condition or cause such Subsidiary to achieve certain levels of operating results.", "Limitation  on  Liens.  We  covenant  that,  so  long  as  any  of  the  Notes  remain  outstanding,  we  will  not,  and  will  not  permit  any", "Indebtedness which is secured by a lien which would otherwise be subject to the foregoing restrictions; provided that after giving effect thereto the Exempted Debt then outstanding at such time does not exceed 10% of our total assets on a consolidated basis.", "than three years, by us or any Consolidated Subsidiary of any assets are prohibited unless (a) we or such Consolidated Subsidiary would be entitled to incur Indebtedness secured by a lien on the assets to be leased in an amount at least equal to the Attributable Debt in respect of such transaction without equally and ratably securing the notes, or (b) the proceeds of the sale of the assets to be leased are at least equal to their fair market value (as determined by our Board of Directors) and the proceeds are applied to the purchase or acquisition, or, in the case of real property, the construction, of assets or to the retirement of Indebtedness.", "The foregoing limitation will not apply, if at the time we or any Consolidated Subsidiary enters into such sale and lease-back transaction, and after giving effect thereto, Exempted Debt does not exceed 10% of our total assets on a consolidated basis.", "time, or in part, from time to time, at our option, for cash, at a redemption price that includes accrued and unpaid interest and a make-whole premium, as specified in the Indenture and the applicable Officer\u2019s Certificate.", "York  Stock  Exchange  under  the  symbol  \u201cMCK25.\u201d  Our  2026  Notes  are  listed  on  the  New  York  Stock  Exchange  under  the  symbol \u201cMCK26.\u201d Our 2029 Notes are listed on the New York Stock Exchange under the symbol \u201cMCK29.\u201d", "This Statement of Terms and Conditions is intended to meet the requirements of Code Section 409A and any regulations and rules promulgated thereunder.", "In the event of any inconsistency between this Statement of Terms and Conditions and the Plan, the Plan shall govern.", "Capitalized terms not otherwise defined in this Statement of Terms and Conditions shall have the meaning set forth in the Plan.", "With respect to  annual  Restricted  Stock  Unit  Awards  granted  to  Outside  Directors  under  the  Plan,  such  awards  shall  be  subject  to  the  following  terms,  conditions  and restrictions.", "The Administrator administering the Plan has authority to determine the Outside Directors to whom, and the time or", "additional Restricted Stock Units, which will be subject to all of the terms and conditions of the underlying Restricted Stock Unit Award.", "The number of such additional Restricted Stock Units shall be calculated by dividing (a) the aggregate amount or value of the dividends paid with respect to that number of Shares equal to the number of Restricted Stock Units credited as of the record date for such dividend by (b) the Fair Market Value per Share on the payment date for such dividend.", "Any fractional Shares resulting from the accumulation of dividend equivalents shall be paid in cash.", "Dividend equivalents in respect of Restricted Stock Units, if granted in tandem with such Units, will be converted into", "Neither an Outside Director nor any person entitled to exercise an Outside Director\u2019s rights in the event of the Outside", "this Statement of Terms and Conditions, or under a Restricted Stock Unit Agreement, shall be conclusive and binding on all persons.", "is providing the consents herein on a purely voluntary basis.", "Nothing herein contained shall affect an Outside Director\u2019s right, if any, to participate in and receive benefits", "Each Outside Director shall agree to make appropriate arrangements with the Corporation for satisfaction of any applicable federal,", "The Corporation will hold and use the Data only as long as is necessary to implement, administer and manage the", "illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.", "Agreements shall be governed by the laws of the State of Delaware.", "The provisions in this Statement of Terms and Conditions are severable and if any one or more provisions are determined to be", "This Statement of Terms and Conditions and the Restricted Stock Unit Agreements shall be binding upon and inure to the benefit of", "This Statement of Terms and Conditions is intended to meet the requirements of Code Section 409A and any regulations and rules promulgated thereunder.", "In the event of any inconsistency between this Statement of Terms and Conditions and the Plan, the Plan shall govern.", "Capitalized terms not otherwise defined in this Statement of Terms and Conditions shall have the meaning set forth in the Plan.", "With respect to  annual  Restricted  Stock  Unit  Awards  granted  to  Outside  Directors  under  the  Plan,  such  awards  shall  be  subject  to  the  following  terms,  conditions  and restrictions.", "The Administrator administering the Plan has authority to determine the Outside Directors to whom, and the time or", "Neither an Outside Director nor any person entitled to exercise an Outside Director\u2019s rights in the event of the Outside", "this Statement of Terms and Conditions, or under a Restricted Stock Unit Agreement, shall be conclusive and binding on all persons.", "is providing the consents herein on a purely voluntary basis.", "Nothing herein contained shall affect an Outside Director\u2019s right, if any, to participate in and receive benefits", "Each Outside Director shall agree to make appropriate arrangements with the Corporation for satisfaction of any applicable federal,", "The Corporation will hold and use the Data only as long as is necessary to implement, administer and manage the", "illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.", "Agreements shall be governed by the laws of the State of Delaware.", "The provisions in this Statement of Terms and Conditions are severable and if any one or more provisions are determined to be", "This Statement of Terms and Conditions and the Restricted Stock Unit Agreements shall be binding upon and inure to the benefit of", "In the event of any inconsistency between this Statement of Terms and Conditions and the Plan, the Plan shall govern.", "Capitalized terms not otherwise defined in this Statement of Terms and Conditions shall have the meaning set forth in the Plan.", "The Option is also subject to the terms and conditions of the Plan.", "In no event shall the Corporation be required to issue fractional Shares.", "An Option granted under the Plan shall be evidenced by an Option Agreement setting forth the terms and conditions of the", "The Exercise Price of an Option, as specified in the Option Agreement, shall be equal to or greater than the Fair Market Value of", "Period, the Option Period shall end on the date of such termination of employment and the Option shall thereupon not be exercisable to any extent whatsoever.", "Term Disability, the vesting schedule of the Participant\u2019s Option shall be accelerated, the Option shall become fully exercisable and the Option Period shall end on the earlier of (i) three years after the date of the Participant\u2019s termination of employment and (ii) the Expiration Date.", "Retirement, (i) the Option shall be exercisable only to the extent that it was exercisable at the time of such retirement and (ii) the Option Period for that portion of the Option designated as a Non Statutory Stock Option shall end on the earlier of (a) three years after the date of such retirement and (b) the Expiration Date.", "of  the  Participant's  Option,  then  the  Option  shall  continue  to  remain  outstanding  until  the  earlier  of  (i)  such  time  as  the  Participant  subsequently  terminates employment and (ii) the Expiration Date.", "number of Shares as to which the Option is so exercised.", "thereunder shall be transferable by the Participant by operation of law or otherwise, other than by will or the laws of descent and distribution.", "have any of the rights of a stockholder with respect to the Shares subject to an Option except to the extent that a book entry has been entered in the records of the Corporation\u2019s transfer agent with respect to such Shares upon the exercise of an Option.", "Neither a Participant nor any person entitled to exercise a Participant\u2019s rights in the event of the Participant\u2019s death shall", "Stock dividends paid with respect to Restricted Stock during the Restriction Period shall be treated as Restricted Stock which shall be subject to the same restrictions as the original award for the duration of the Restriction Period.", "If the Participant does not have a brokerage account of record, then an appropriate book entry recording the Participant\u2019s interest in the unrestricted Shares shall be entered on the records of the Corporation\u2019s transfer agent.", "Cash dividends paid with respect to Restricted Stock during the Restriction Period shall be credited on behalf of the Participant to a", "Election to Recognize Gross Income in the Year of Grant.", "The Administrator reserves the right to impose a restriction on the sale of Shares that the Participant receives upon", "Neither a Participant nor any person entitled to exercise a Participant\u2019s rights in the event of the Participant\u2019s death shall", "The Administrator reserves the right to impose a restriction on the sale of Shares that the Participant receives upon", "Following the end of the performance period, the Compensation Committee shall determine the extent to which the criteria have been achieved and shall authorize the grant and issuance of Shares in respect of the Performance Stock Unit Award.", "The performance period of a Performance Stock Unit Award shall be greater than one year,", "Unless otherwise determined by the Compensation Committee in its sole discretion, Dividend Equivalents shall not be", "A Participant shall not be permitted to sell, transfer, pledge, assign or encumber all or any portion of a Performance Stock Unit", "Neither a Participant nor any person entitled to exercise a Participant\u2019s rights in the event of the Participant\u2019s death shall", "The Administrator reserves the right to impose a restriction on the sale of Shares that the Participant", "addition, any Award of Restricted Stock or Restricted Stock Units as to which the restrictions have not lapsed shall immediately and automatically be forfeited, Performance Stock Unit Awards shall immediately and automatically be forfeited and any such Shares of Restricted Stock shall be returned to the Corporation and all of the rights of the Participant to such Awards and the underlying Shares shall immediately terminate.", "Any outstanding Option shall immediately and automatically terminate, be forfeited and shall cease to be exercisable, without limitation.", "determination shall be conclusive and binding on all interested persons.", "a manner that is valid and enforceable and that comes closest to the business objectives intended by such invalid or unenforceable provision, without invalidating or rendering unenforceable the remaining provisions of this Section VI.", "under an Award Agreement, shall be conclusive and binding on all interested persons.", "Participation in the Plan shall not create a right to further employment with the Participant\u2019s employer (the", "In making grants to Participants in foreign countries, the Administrator has the full discretion to", "All decisions of the Administrator administering the Plan upon any questions arising under the Plan or", "Nothing herein contained shall affect a Participant\u2019s right to participate in and receive benefits from and in", "Regardless  of any  action  the  Corporation  or  the  Employer  takes  with  respect  to  any  federal,  state  or  local  income  tax,  social", "Calculation of the number of Shares to be withheld shall be made based on the closing price of the Common Stock on the New York Stock Exchange on the date that the amount of tax to be withheld is determined.", "With respect to an Award other than an Option, if adequate arrangements to satisfy the obligations with regard to all Tax-Related Items are not made by the Participant with the Corporation and/or the Employer prior to the relevant taxable event, the Corporation will satisfy such obligations as provided above in clause (3) of this paragraph.", "The Administrator shall be authorized to establish such rules, forms and procedures as it deems necessary to implement the foregoing.", "In accepting the grant, the Participant acknowledges that:", "jurisdiction may have different data privacy laws and protections than the United States.", "In the latter case, the Participant understands and acknowledges that the Corporation\u2019s legal basis for the processing of the Participant\u2019s Data would be compliance with the relevant  laws  or  regulations  or  the  pursuit  by  the  Corporation  of  respective  legitimate  interests  not  outweighed  by  the  Participant\u2019s  interests,  rights  or freedoms.", "When the Corporation no longer needs the Participant\u2019s Data for any of the above purposes, the Participant understands the Corporation will remove it from its systems.", "providing the consents herein on a purely voluntary basis.", "illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.", "If the Participant has received this Statement of Terms and Conditions or any other document related to the Plan translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control.", "The provisions in this Statement of Terms and Conditions are severable and if any one or more provisions are determined to be", "The Participant acknowledges that the Participant is proficient in the English language and, accordingly, understands the provisions of", "The Corporation will hold and use the Data only as long as is necessary to implement, administer and manage the", "Participation in the Plan is voluntary and the Participant is", "In the event of any inconsistency between this Statement of Terms and Conditions and the Plan, the Plan shall govern.", "Capitalized terms not otherwise defined in this Statement of Terms and Conditions shall have the meaning set forth in the Plan.", "The Option is also subject to the terms and conditions of the Plan.", "In no event shall the Corporation be required to issue fractional Shares.", "An Option granted under the Plan shall be evidenced by an Option Agreement setting forth the terms and conditions of the", "The Exercise Price of an Option, as specified in the Option Agreement, shall be equal to or greater than the Fair Market Value of", "Period, the Option Period shall end on the date of such termination of employment and the Option shall thereupon not be exercisable to any extent whatsoever.", "Term Disability, the vesting schedule of the Participant\u2019s Option shall be accelerated, the Option shall become fully exercisable and the Option Period shall end on the earlier of (i) three years after the date of the Participant\u2019s termination of employment and (ii) the Expiration Date.", "Retirement, (i) the Option shall be exercisable only to the extent that it was exercisable at the time of such retirement and (ii) the Option Period for that portion of the Option designated as a Nonstatutory Stock Option shall end on the earlier of (a) three years after the date of such retirement and (b) the Expiration Date.", "of  the  Participant's  Option,  then  the  Option  shall  continue  to  remain  outstanding  until  the  earlier  of  (i)  such  time  as  the  Participant  subsequently  terminates employment and (ii) the Expiration Date.", "number of Shares as to which the Option is so exercised.", "thereunder shall be transferable by the Participant by operation of law or otherwise, other than by will or the laws of descent and distribution.", "have any of the rights of a stockholder with respect to the Shares subject to an Option except to the extent that a book entry has been entered in the records of the Corporation\u2019s transfer agent with respect to such Shares upon the exercise of an Option.", "Neither a Participant nor any person entitled to exercise a Participant\u2019s rights in the event of the Participant\u2019s death shall", "Stock dividends paid with respect to Restricted Stock during the Restriction Period shall be treated as Restricted Stock which shall be subject to the same restrictions as the original award for the duration of the Restriction Period.", "If the Participant does not have a brokerage account of record, then an appropriate book entry recording the Participant\u2019s interest in the unrestricted Shares shall be entered on the records of the Corporation\u2019s transfer agent.", "Cash dividends paid with respect to Restricted Stock during the Restriction Period shall be credited on behalf of the Participant to a", "Election to Recognize Gross Income in the Year of Grant.", "The Administrator reserves the right to impose a restriction on the sale of Shares that the Participant receives upon", "Neither a Participant nor any person entitled to exercise a Participant\u2019s rights in the event of the Participant\u2019s death shall", "The Administrator reserves the right to impose a restriction on the sale of Shares that the Participant receives upon", "The performance period of a Performance Stock Unit Award shall be greater than one year,", "Unless otherwise determined by the Compensation Committee in its sole discretion, Dividend Equivalents shall not be", "A Participant shall not be permitted to sell, transfer, pledge, assign or encumber all or any portion of a Performance Stock Unit", "Neither a Participant nor any person entitled to exercise a Participant\u2019s rights in the event of the Participant\u2019s death shall", "The Administrator reserves the right to impose a restriction on the sale of Shares that the Participant", "addition, any Award of Restricted Stock or Restricted Stock Units as to which the restrictions have not lapsed shall immediately and automatically be forfeited, Performance Stock Unit Awards shall immediately and automatically be forfeited and any such Shares of Restricted Stock shall be returned to the Corporation and all of the rights of the Participant to such Awards and the underlying Shares shall immediately terminate.", "Any outstanding Option shall immediately and automatically terminate, be forfeited and shall cease to be exercisable, without limitation.", "determination shall be conclusive and binding on all interested persons.", "a manner that is valid and enforceable and that comes closest to the business objectives intended by such invalid or unenforceable provision, without invalidating or rendering unenforceable the remaining provisions of this Section VI.", "under an Award Agreement, shall be conclusive and binding on all interested persons.", "Participation in the Plan shall not create a right to further employment with the Participant\u2019s employer (the", "In making grants to Participants in foreign countries, the Administrator has the full discretion to", "All decisions of the Administrator administering the Plan upon any questions arising under the Plan or", "Nothing herein contained shall affect a Participant\u2019s right to participate in and receive benefits from and in", "Regardless  of any  action  the  Corporation  or  the  Employer  takes  with  respect  to  any  federal,  state  or  local  income  tax,  social", "Calculation of the number of Shares to be withheld shall be made based on the closing price of the Common Stock on the New York Stock Exchange on the date that the amount of tax to be withheld is determined.", "With respect to an Award other than an Option, if adequate arrangements to satisfy the obligations with regard to all Tax-Related Items are not made by the Participant with the Corporation and/or the Employer prior to the relevant taxable event, the Corporation will satisfy such obligations as provided above in clause (3) of this paragraph.", "The Administrator shall be authorized to establish such rules, forms and procedures as it deems necessary to implement the foregoing.", "In accepting the grant, the Participant acknowledges that:", "jurisdiction may have different data privacy laws and protections than the United States.", "In the latter case, the Participant understands and acknowledges that the Corporation\u2019s legal basis for the processing of the Participant\u2019s Data would be compliance with the relevant  laws  or  regulations  or  the  pursuit  by  the  Corporation  of  respective  legitimate  interests  not  outweighed  by  the  Participant\u2019s  interests,  rights  or freedoms.", "When the Corporation no longer needs the Participant\u2019s Data for any of the above purposes, the Participant understands the Corporation will remove it from its systems.", "providing the consents herein on a purely voluntary basis.", "illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.", "If the Participant has received this Statement of Terms and Conditions or any other document related to the Plan translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control.", "The provisions in this Statement of Terms and Conditions are severable and if any one or more provisions are determined to be", "The Participant acknowledges that the Participant is proficient in the English language and, accordingly, understands the provisions of", "The Corporation will hold and use the Data only as long as is necessary to implement, administer and manage the", "Participation in the Plan is voluntary and the Participant is", "In the event of any inconsistency between this Statement of Terms and Conditions and the Plan, the Plan shall govern.", "Capitalized terms not otherwise defined in this Statement of Terms and Conditions shall have the meaning set forth in the Plan.", "The Option is also subject to the terms and conditions of the Plan.", "In no event shall the Corporation be required to issue fractional Shares.", "An Option granted under the Plan shall be evidenced by an Option Agreement setting forth the terms and conditions of the", "The Exercise Price of an Option, as specified in the Option Agreement, shall be equal to or greater than the Fair Market Value of", "Period, the Option Period shall end on the date of such termination of employment and the Option shall thereupon not be exercisable to any extent whatsoever.", "Term Disability, the vesting schedule of the Participant\u2019s Option shall be accelerated, the Option shall become fully exercisable and the Option Period shall end on the earlier of (i) three years after the date of the Participant\u2019s termination of employment and (ii) the Expiration Date.", "Retirement, (i) the Option shall be exercisable only to the extent that it was exercisable at the time of such retirement and (ii) the Option Period for that portion of the Option designated as a Non Statutory Stock Option shall end on the earlier of (a) three years after the date of such retirement and (b) the Expiration Date.", "of  the  Participant's  Option,  then  the  Option  shall  continue  to  remain  outstanding  until  the  earlier  of  (i)  such  time  as  the  Participant  subsequently  terminates employment and (ii) the Expiration Date.", "number of Shares as to which the Option is so exercised.", "thereunder shall be transferable by the Participant by operation of law or otherwise, other than by will or the laws of descent and distribution.", "have any of the rights of a stockholder with respect to the Shares subject to an Option except to the extent that a book entry has been entered in the records of the Corporation\u2019s transfer agent with respect to such Shares upon the exercise of an Option.", "Neither a Participant nor any person entitled to exercise a Participant\u2019s rights in the event of the Participant\u2019s death shall", "Stock dividends paid with respect to Restricted Stock during the Restriction Period shall be treated as Restricted Stock which shall be subject to the same restrictions as the original award for the duration of the Restriction Period.", "If the Participant does not have a brokerage account of record, then an appropriate book entry recording the Participant\u2019s interest in the unrestricted Shares shall be entered on the records of the Corporation\u2019s transfer agent.", "Cash dividends paid with respect to Restricted Stock during the Restriction Period shall be credited on behalf of the Participant to a", "Election to Recognize Gross Income in the Year of Grant.", "Neither a Participant nor any person entitled to exercise a Participant\u2019s rights in the event of the Participant\u2019s death shall", "Following the end of the performance period, the Compensation Committee shall determine the extent to which the criteria have been achieved and shall authorize the grant and issuance of Shares in respect of the Performance Stock Unit Award.", "The performance period of a Performance Stock Unit Award shall be greater than one year,", "addition, any Award of Restricted Stock or Restricted Stock Units as to which the restrictions have not lapsed shall immediately and automatically be forfeited, Performance Stock Unit Awards shall immediately and automatically be forfeited and any such Shares of Restricted Stock shall be returned to the Corporation and all of the rights of the Participant to such Awards and the underlying Shares shall immediately terminate.", "Unless otherwise determined by the Compensation Committee in its sole discretion, Dividend Equivalents shall not be", "A Participant shall not be permitted to sell, transfer, pledge, assign or encumber all or any portion of a Performance Stock Unit", "Neither a Participant nor any person entitled to exercise a Participant\u2019s rights in the event of the Participant\u2019s death shall", "Any outstanding Option shall immediately and automatically terminate, be forfeited and shall cease to be exercisable, without limitation.", "determination shall be conclusive and binding on all interested persons.", "a manner that is valid and enforceable and that comes closest to the business objectives intended by such invalid or unenforceable provision, without invalidating or rendering unenforceable the remaining provisions of this Section VI.", "Participation in the Plan shall not create a right to further employment with the Participant\u2019s employer (the", "In making grants to Participants in foreign countries, the Administrator has the full discretion to", "under an Award Agreement, shall be conclusive and binding on all interested persons.", "Calculation of the number of Shares to be withheld shall be made based on the closing price of the Common Stock on the New York Stock Exchange on the date that the amount of tax to be withheld is determined.", "With respect to an Award other than an Option, if adequate arrangements to satisfy the obligations with regard to all Tax-Related Items are not made by the Participant with the Corporation and/or the Employer prior to the relevant taxable event, the Corporation will satisfy such obligations as provided above in clause (3) of this paragraph.", "All decisions of the Administrator administering the Plan upon any questions arising under the Plan or", "Nothing herein contained shall affect a Participant\u2019s right to participate in and receive benefits from and in", "Regardless  of any  action  the  Corporation  or  the  Employer  takes  with  respect  to  any  federal,  state  or  local  income  tax,  social", "The Administrator shall be authorized to establish such rules, forms and procedures as it deems necessary to implement the foregoing.", "In accepting the grant, the Participant acknowledges that:", "jurisdiction may have different data privacy laws and protections than the United States.", "In the latter case, the Participant understands and acknowledges that the Corporation\u2019s legal basis for the processing of the Participant\u2019s Data would be compliance with the relevant  laws  or  regulations  or  the  pursuit  by  the  Corporation  of  respective  legitimate  interests  not  outweighed  by  the  Participant\u2019s  interests,  rights  or freedoms.", "When the Corporation no longer needs the Participant\u2019s Data for any of the above purposes, the Participant understands the Corporation will remove it from its systems.", "providing the consents herein on a purely voluntary basis.", "The Corporation will hold and use the Data only as long as is necessary to implement, administer and manage the", "Participation in the Plan is voluntary and the Participant is", "illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.", "If the Participant has received this Statement of Terms and Conditions or any other document related to the Plan translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control.", "The provisions in this Statement of Terms and Conditions are severable and if any one or more provisions are determined to be", "The Participant acknowledges that the Participant is proficient in the English language and, accordingly, understands the provisions of", "In the event of any inconsistency between this Award Agreement and the Plan, the Plan shall govern.", "Capitalized terms not otherwise defined in this Award Agreement shall have the meaning set forth in the Plan.", "determine the extent to which the performance goals have been achieved, and shall determine the number of PSUs that have been earned.", "Once the Compensation Committee has determined the number of PSUs that have been earned pursuant to the", "Dividend equivalents shall be credited in respect of the One-Year RSU Award.", "The restrictions applicable to the RSU Award shall lapse with respect to 100% of the underlying Shares on the third", "Dividend equivalents shall be credited in respect of the RSU Award granted under this Section III.", "If the Participant ceases to be a bona fide employee of the Corporation or any Affiliate (except as otherwise", "otherwise  forfeited  pursuant  to  the  terms  of  the  Plan  and  this  Award  Agreement  shall  be  paid  to  the  Participant  as  soon  as  reasonably  practicable  after  the restrictions lapse.", "Performance  Stock  Units and  Restricted  Stock  Units,  to  the  extent  the  restrictions  have  not  lapsed,  shall  immediately  and  automatically  be", "determination shall be conclusive and binding on all interested persons.", "a manner that is valid and enforceable and that comes closest to the business objectives intended by such invalid or unenforceable provision, without invalidating or rendering unenforceable the remaining provisions of this Section IV.", "Compensation Committee reserves the right to impose a restriction on the sale of Shares that the Participant receives upon the settlement of the Performance Stock Units and Restricted Stock Units granted hereunder, unless the Participant has satisfied the ownership targets applicable to the Participant as provided in such policy.", "Neither the Participant nor any person entitled to exercise the Participant\u2019s rights in the event of the Participant\u2019s death", "Participation in the Plan shall not create a right to further employment with the Participant\u2019s employer (the", "under this Award Agreement, shall be conclusive and binding on all interested persons.", "Calculation of the number of Shares to be withheld shall be made based on the closing price of the Common Stock on the New York Stock Exchange on the date that the amount of tax to be withheld is determined.", "If adequate arrangements to satisfy the obligations with regard to all Tax-Related Items are not made by the Participant with the Corporation and/or the Employer prior to the relevant taxable event, the Corporation will satisfy such obligations as provided above in clause (iii) of this paragraph.", "The Administrator has the full discretion to deviate from this Award Agreement in order to adjust the Awards", "All decisions of the Administrator administering the Plan upon any questions arising under the Plan or", "Nothing herein contained shall affect the Participant\u2019s right to participate in and receive benefits from and in", "Regardless  of any  action  the  Corporation  or  the  Employer  takes  with  respect  to  any  federal,  state  or  local  income  tax,  social", "The Administrator shall be authorized to establish such rules, forms and procedures as it deems necessary to implement the foregoing.", "In accepting the grant, the Participant acknowledges that:", "providing the consents herein on a purely voluntary basis.", "The Corporation will hold and use the Data only as long as is necessary to implement, administer and manage the", "Participation in the Plan is voluntary and the Participant is", "unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.", "English and if the meaning of the translated version is different than the English version, the English version will control.", "Award, the terms of which are set forth herein and in the Plan.", "The provisions in this Award Agreement are severable and if any one or more provisions are determined to be illegal or otherwise", "Below is a list of documents that are made available to you in connection with this Notice.", "PLEASE BE SURE TO READ THESE DOCUMENTS BECAUSE THEY CONTAIN IMPORTANT INFORMATION SPECIFIC TO THIS GRANT OF RSUs.", "By signing below, I acknowledge that: 1.    I agree to receive copies of the stockholder information, including copies of any annual report, proxy and Form 10-K, from the Investor Resources section of", "Below is a list of documents that are made available to you in connection with this Notice.", "PLEASE BE SURE TO READ THESE DOCUMENTS BECAUSE THEY CONTAIN IMPORTANT INFORMATION SPECIFIC TO THIS GRANT OF RSUs.", "I consent to receiving electronically a copy of the documents set forth above and attachments to this Notice; and 5.", "I accept ALL the terms and conditions as set forth in the Plan and ST&Cs applicable to this grant of RSUs.", "Your  PSUs  will  be  earned  subject  to  the  Company\u2019s  attainment  of  performance  goals  that  have  been  pre-established  by  the  Compensation  Committee  (the \u201cCommittee\u201d) of the Company\u2019s Board of Directors.", "Below is a list of documents that are made available to you in connection with this Notice.", "PLEASE BE SURE TO READ THESE DOCUMENTS BECAUSE THEY CONTAIN IMPORTANT INFORMATION SPECIFIC TO THIS GRANT OF PSUs.", "I consent to receiving electronically a copy of the documents set forth above and attachments to this Notice; and 12.", "I should consult with a tax advisor prior to accepting this grant of PSUs or taking any other action with respect to this grant of PSUs; and 14.", "I accept ALL the terms and conditions as set forth in the Plan and ST&Cs applicable to this grant of PSUs.", "We consent to the incorporation by reference in McKesson Corporation Registration Statement Nos. 333-249817, 333-163642, 333-190847, 333-190848, and 333- 213488 on Form S-8, and Registration Statement No. 333-236808 on Form S-3, of our report dated May 12, 2021, relating to the consolidated financial statements and consolidated financial statement schedule of McKesson Corporation and subsidiaries, and the effectiveness of McKesson Corporation\u2019s internal control over financial reporting appearing in this Annual Report on Form 10-K of McKesson Corporation for the year ended March 31, 2021.", "I have reviewed this annual report on Form 10-K of McKesson Corporation;", "The registrant\u2019s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant\u2019s auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):", "I have reviewed this annual report on Form 10-K of McKesson Corporation;", "The registrant\u2019s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant\u2019s auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):", "Together, we work across the healthcare delivery system to connect pharmacies, providers, payers, and biopharma for next-generation patient access and adherence solutions that help people get the medicine they need to live healthier lives.", "Unless otherwise noted, all references in this document to a particular year shall mean the", "On March 10, 2020, we completed the separation of our interest in the Change Healthcare JV through a split- off transaction.", "This transaction reduced our investment in the Change Healthcare JV to zero.", "Change Healthcare: Our equity ownership interest in Change Healthcare JV, a joint venture, has been accounted for using the equity method of accounting.", "for our innovations and obtain copyright protection for our original works of authorship, when such protection is advantageous.", "Through these efforts, we have developed a portfolio of patents and copyrights in the U.S. and worldwide.", "In addition, we have registered or applied to register certain trademarks and service marks in the U.S. and in foreign countries.", "We cannot guarantee that our intellectual property portfolio will be sufficient to deter misappropriation, theft, or misuse of our technology, nor that we can successfully enjoin infringers.", "We periodically receive notices alleging that our products or services infringe on third party patents and other intellectual property rights.", "While the outcome of any litigation or dispute is inherently uncertain, we do not believe that the resolution of any of these infringement notices would have a material adverse impact on our results of operation.", "These values and behaviors help make McKesson unique.", "We offer financial assistance programs for higher education opportunities that support employees\u2019 career growth at the company.", "To provide compensation that is focused on attracting and retaining talent with the skills and experience necessary for a specific role, our compensation program is built on a set of quantifiable factors defined by our guiding principles of internal fairness, market competitiveness, and pay for performance.", "We operate in several countries and our benefits offerings vary accordingly.", "We offer health and wellness benefits to advance the physical, mental, and social well-being of our people, savings programs to help prepare them for retirement, and flexible work arrangements, among other  benefits  offerings,  when  possible.  In  response  to  the  COVID-19  pandemic,  we  offered  extended  medical  benefits  covering  COVID-19  related  visits, treatment and testing, expanded telehealth options, emergency paid time off (\u201cPTO\u201d), and a platform for employees to donate their regular PTO to co-workers who were  more  impacted  by  COVID-19.", "We have received monetary penalties and/or licensing sanctions pursuant to these requirements and future allegations of noncompliance could result in an inability to obtain, maintain or renew permits, licenses or other regulatory approvals needed for the operation of our businesses.", "As a result of ongoing, advanced discussions with state attorneys general and plaintiffs\u2019 representatives regarding a framework to resolve the claims of governmental entities, and our assessment of certain other opioid-related claims, we have reached a stage at which a broad settlement of opioid claims by governmental entities is probable and recorded a charge of $8.1 billion for the year ended March 31, 2021 within \u201cClaims and litigation charges, net\u201d in our Consolidated Statement of Operations in this Annual Report on Form 10-K.", "Because of the many uncertainties associated with any potential settlement arrangement or other resolution of opioid-related litigation, including the uncertainty of the scope of participation by plaintiffs in any potential settlement, we are not able to reasonably estimate the upper or lower ends of the range of ultimate possible loss for all opioid-related litigation matters.", "The adverse outcome of legal proceedings might also involve significant  expense,  management  time  and  distraction,  and risk  of loss that  can be difficult  to predict  or quantify.  In addition  to this litigation,  legislative  or regulatory measures related to the distribution of controlled substances such as prescription opioids could affect our business in ways that we may not be able to predict.", "For example, some states have passed legislation that could require us to pay taxes or assessments on the distribution of opioid medications in those states and other states have considered similar legislation.", "We are subject to government audits,  investigations  and  oversight  proceedings.  Government  agencies  routinely  review  and  audit  government  contractors  to  determine  whether  they  are complying with contractual and legal requirements.", "If we fail to comply with these requirements, or we fail an audit, we may be subject to various sanctions such as monetary damages, criminal and civil penalties, termination of contracts and suspension or debarment from government contract work.", "These requirements complicate our business and increase our compliance burden and material non-compliance could harm our reputation.", "affecting  Medicare,  Medicaid,  other  government  healthcare  programs,  and  government  contracts.  Our  relationships  with  pharmaceutical  and  medical  surgical product manufacturers and healthcare providers, as well as our provision of products and services to government entities, subject our business to laws, regulation, and government guidance on fraud and abuse.", "Many of these laws are vague or indefinite and have not been interpreted by the courts and, as such, may be interpreted or applied by a prosecutorial, regulatory, or judicial authority in a manner that could require us to make changes in our operations.", "Americans and changed the way healthcare is financed by both governmental and private payers.", "There are also further efforts to broaden healthcare coverage.", "Provincial governments in Canada that provide partial funding for the purchase of pharmaceuticals and independently regulate the sale and reimbursement of drugs have sought to reduce the costs of publicly funded health programs.", "Some European governments  have  implemented  or  are  considering  austerity  measures  to  reduce  healthcare  spending.  These  measures  exert  pressure  on  the  pricing  and reimbursement timelines for pharmaceuticals and may cause our customers to purchase fewer of our products and services or influence us to reduce prices.", "There is substantial uncertainty about the likelihood, timing and results of these health reform efforts.", "We also have record- keeping  and  other  obligations  under  the  E.U.  Falsified  Medicines  Directive.  Pedigree  tracking  laws  such  as  these  increase  our  compliance  burden  and  our pharmaceutical distribution costs.", "For example, under the Health Insurance Portability and Accountability Act of 1996 (\u201cHIPAA\u201d) we must maintain administrative, physical  and  technological  safeguards  to  protect  individually  identifiable  health  information  (\u201cprotected  health  information\u201d)  and  ensure  the  confidentiality, integrity, and availability of electronic protected health information.", "We are subject to significant compliance obligations under privacy laws such as the General Data Protection Regulation (\u201cGDPR\u201d) in the European Union, the Personal Information Protection and Electronic Documents Act (\u201cPIPEDA\u201d) in Canada, and the California Consumer Protection Act (\u201cCCPA\u201d).", "We are subject to privacy  and  data  protection  compliance  audits  or  investigations  by  various  government  agencies.  Failure  to  comply  with  these  laws  subjects  us  to  potential regulatory enforcement activity, fines, private litigation including class actions, and other costs.", "We also have contractual obligations to customers that might be breached if we fail to comply with privacy laws.", "Our efforts to comply with privacy laws complicate our operations and add to our compliance costs.", "storage and hosting of sensitive information, including protected health information and other types of personal information, confidential financial information, proprietary information, and other sensitive information relating to our customers, company and workforce.", "costs.  Environmental  costs  and  accruals,  including  that  related  to  our  legacy  chemical  distribution  operations,  presently  are  not  material  to our  operations  or financial position.", "Our ten largest customers comprised approximately 32%, and CVS was approximately 19%, of total trade accounts receivable at March 31, 2021.", "We also have agreements with GPOs, each of which functions as a purchasing agent on behalf of member  hospitals,  pharmacies  and other healthcare  providers,  as well as with government  entities  and agencies.  The accounts receivable balances are with individual members of the GPOs, and therefore no significant concentration of credit risk exists.", "Substantially all of these revenues and accounts receivable are included in our U.S.", "distribution arrangements with pharmaceutical manufacturers that include an inflation-based compensation component whereby we benefit when the manufacturers increase their prices as we sell our existing inventory at the new higher prices.", "Forward-looking  statements  involve  risks  and  uncertainties  that  could  cause  actual  results  to  differ  materially  from  those  projected,  anticipated,  or  implied.", "Except to the extent required by federal securities laws, we undertake no obligation to publicly release the result of any revisions to any forward-looking statements to reflect events or circumstances after the date the statements are made, or to reflect the occurrence of unanticipated events.", "Some of our distribution arrangements with the manufacturers provides us compensation based on a percentage of our purchases.", "We experience costly and disruptive legal disputes.", "Despite valid defenses that we assert, legal disputes are often costly, time-consuming, distracting to management and disruptive to normal business operations.", "The outcome of legal disputes is difficult to predict.", "Outcomes can occur that are not justified by the evidence or existing law.", "The uncertainty and expense associated with unresolved legal disputes might harm our business and reputation even if the matter is favorably resolved.", "Accordingly, any legal dispute might have a materially adverse impact on our reputation, our business operations and our financial position or results of operations.", "We might experience losses not covered by insurance.", "supplies, the provision of ancillary services, the conduct of our payer businesses and the provision of products that assist clinical decision-making and relate to patient medical histories and treatment plans.", "Although we seek to maintain adequate insurance coverage,  such  as  property  insurance  for  inventory  and  professional  and  general  liability  insurance,  coverages  on  acceptable  terms  might  be  unavailable,  or coverages might not cover our losses.", "We generally seek to limit our contractual exposure, but limitations of liability or indemnity provisions in our contracts may not be enforceable or adequately protect us from liability.", "Uninsured losses might have a materially adverse impact on our business operations and our financial position or results of operations.", "We regularly are named as a defendant in similar, new cases.", "Many of these cases raise novel theories of liability.", "Any proceedings can have unexpected outcomes that are not justified by evidence or existing law.", "It is not uncommon for claims to be resolved over many years.", "Although the Company has valid defenses and is vigorously defending itself, some proceedings have been and others may be resolved by negotiated outcome.", "Our reputation has been and may continue to be impacted by publicity regarding the litigation and related allegations.", "The adverse outcome of legal proceedings might have a materially adverse impact on our business operations and our financial position or results of operations.", "For example, some states have passed legislation that could require us to pay taxes or assessments on the distribution of opioid medications in those states and other states have considered similar legislation.", "Liabilities for taxes or assessments or other costs of compliance under any such laws might have a materially adverse impact on our reputation, business operations, and our financial position or results of operations.", "We are subject to extensive, complex and challenging healthcare and other laws.", "Any noncompliance by us with applicable laws or the failure to maintain, renew or obtain necessary permits and licenses could lead to litigation and might have a materially adverse impact on our business operations and our financial position or results of operations.", "Local, state and federal governments continue to strengthen their position and scrutiny over practices involving or allegedly involving fraud, waste and abuse affecting Medicare, Medicaid and other government healthcare programs.", "Our relationships with pharmaceutical and medical surgical product manufacturers and healthcare providers, as well as our provision of products and services to government entities, subject our business to laws and regulations on fraud and abuse, which among other things: (1) prohibit persons from soliciting, offering, receiving or paying any remuneration in order to induce the referral of a patient for treatment  or  to  induce  the  ordering  or  purchasing  of  items  or  services  that  are  in  any  way  paid  for  by  Medicare,  Medicaid  or  other  government-sponsored healthcare programs; (2) impose many restrictions upon referring physicians and providers of designated health services under Medicare and Medicaid programs; and (3) prohibit the knowing submission of a false or fraudulent claim for payment to, and knowing retention of an overpayment by, a federal healthcare program such  as  Medicare  and  Medicaid.  Many  of  these  laws,  regulations,  and  government  guidance,  including  those  relating  to  marketing  incentives,  are  vague  or indefinite and have not been interpreted by the courts.", "The laws may be interpreted or applied by a prosecutorial, regulatory, or judicial authority in a manner that could require us to make changes in our operations.", "Failures to comply with applicable laws subject us to federal or state government investigations or qui tam actions, and to liability for damages and civil and criminal penalties, including the loss of licenses or our ability to participate in Medicare, Medicaid and other federal and state healthcare programs.", "These sanctions might have a materially adverse impact on our business operations and our financial position or results of operations.", "Noncompliance with these requirements has resulted in monetary penalties and/or licensing sanctions.", "For example, under a January 2017 agreement with the DEA and Department of Justice we paid $150 million to settle potential administrative and civil claims about our practices for reporting suspicious orders of controlled substances and the DEA suspended, on a staggered basis for limited periods of time, our registrations to distribute certain controlled substances from four distribution centers.", "Pedigree tracking laws increase our compliance burden and our pharmaceutical distribution costs.", "Pedigree tracking laws such as these increase our compliance burden and our pharmaceutical distribution costs, and they might have a materially adverse impact on our business operations and our financial position or results of operations.", "Privacy and data protection laws increase our compliance burden.", "example,  under  the  Health  Insurance  Portability  and  Accountability  Act  of  1996  (\u201cHIPAA\u201d)  we  must  maintain  administrative,  physical  and  technological safeguards  to  protect  individually  identifiable  health  information  (\u201cprotected  health  information\u201d)  and  ensure  the  confidentiality,  integrity  and  availability  of electronic protected health information.", "Failure to comply with these laws subjects us to potential regulatory enforcement activity, fines, private litigation including class actions, and other costs.", "We also have contractual obligations to customers that might be breached if we fail to comply with privacy laws.", "Our efforts to comply with privacy laws complicates our operations and adds to our compliance costs.", "A significant privacy breach or failure  to  comply  with  privacy  laws  might  have  a  materially  adverse  impact  on  our  reputation,  business  operations  and  our  financial  position  or  results  of operations.", "Anti-bribery and anti-corruption laws increase our compliance burden.", "Bribery Act unless the organization can establish the defense of having implemented adequate procedures to prevent bribery.", "Our failure to comply with these laws might subject us to civil and criminal penalties that might have a materially adverse impact on our reputation, business operations and our financial position or results of operations.", "We are subject to a variety of privacy and data protection laws that change frequently and have requirements that vary from jurisdiction to jurisdiction.", "We  are  subject  to  laws  prohibiting  improper  payments  and  bribery,  including  the  U.S.  Foreign  Corrupt  Practices  Act,  the  U.K.  Bribery  Act  and  similar", "We might record significant charges from impairment to goodwill, intangibles and other assets or investments.", "In addition, we periodically review our intangible and other long-lived assets for impairment when events or changes in circumstances, such as a divestiture, indicate the carrying value may not be recoverable.", "Factors that may be considered a change in circumstances indicating that  the  carrying  value  of  our  intangible  and  other  long-lived  assets  may  not  be  recoverable  include  slower  growth  rates,  the  loss  of  a  significant  customer, burdensome new laws or divestiture of a business or asset for less than its carrying value.", "There are inherent uncertainties in management\u2019s estimates, judgments and assumptions used in assessing recoverability of goodwill, intangible and other long-lived assets.", "We may be required to record a significant charge to earnings in our consolidated financial statements during the period in which any impairment of our goodwill or intangible and other long-lived assets is determined, which might have a materially adverse impact on our business operations and our financial position or results of operations.", "storage and hosting of sensitive information, including protected health information and other types of personal information, confidential financial information, proprietary information, and other sensitive information relating to our customers, company and workforce.", "If our software and technology services are alleged to have contributed to faulty clinical decisions or injury to patients, we might be subject to claims or litigation by users of our software or services or their patients.", "Any of these types of errors or failures might have a materially adverse impact on our reputation, business operations and our financial position or results of operations.", "We  are  required  under  U.S.  Generally  Accepted  Accounting  Principles  (\u201cGAAP\u201d)  to  test  our  goodwill  for  impairment  annually  or  more  frequently  if", "We might be impeded in providing customers online services and data access.", "Any such problems might have a materially adverse impact on our business operations and our financial position or results of operations.", "Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.", "we may require financing that may not be available on acceptable terms.", "Any of these risks could adversely affect our ability to achieve the anticipated benefits of an acquisition and might have a materially adverse impact on our business operations and our financial position or results of operations.", "Exclusive forum provisions in our Bylaws could limit our stockholders\u2019 ability to choose their preferred judicial forum for disputes with us or our directors, officers or employees.", "Current and former stockholders are deemed to have consented to the personal jurisdiction of the Delaware Courts in connection with any action to enforce that exclusive forum provision and to service of process in any such action.", "To the extent that these provisions of the bylaws limit a current or former stockholder\u2019s ability to select a judicial forum other than the Delaware Courts, they might discourage the specified legal actions, might cause current or former stockholders to incur additional litigation-related expenses and might result in outcomes unfavorable to current or former stockholders.", "A court might determine that these provisions of the bylaws are inapplicable or unenforceable in any particular action, in which case we may incur additional litigation related expenses in such action, and the action may result in outcomes unfavorable to us, which could have a materially adverse impact on our reputation, our business operations and our financial position or results of operations.", "We might be adversely impacted by delays or other difficulties with divestitures.", "After the disposition, we might experience greater dissynergies than expected, and the impact of the divestiture on our revenue or profit might be larger than we expected.", "We might have difficulties with pre-closing conditions such as regulatory and governmental approvals, which could delay or prevent the divestiture.", "We might have financial exposure in a divested business, such as through minority equity ownership, financial  or  performance  guarantees,  indemnities  or  other  obligations,  such  that  conditions  outside  of  our  control  might  negate  the  expected  benefits  of  the disposition.", "Any of these risks could adversely affect our ability to achieve the anticipated benefits of a divestiture and might have a materially adverse impact on our business operations and our financial position or results of operations.", "We might not realize the expected tax treatment from our split-off of Change Healthcare.", "If Change does not honor its obligations to indemnify the Company, or if the Transactions fail to qualify for the intended tax-free treatment for reasons not related to a disqualifying action by Change or SpinCo, the resulting tax to the Company could have a significant adverse effect on our financial position or results of operations.", "outsourced service providers, and we might not realize expected cost savings or other benefits.", "For example, our ability to use outsourcing resources in certain jurisdictions might be limited by legislative action or customer contracts, with the result that the work must be performed at greater expense or we may be subject to sanctions for non-compliance.", "Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.", "We might encounter difficulties attracting and retaining customers to our retail locations due to their unfamiliarity with our brands or our inexperience with local market  preferences.  Competition  from  our  retail  pharmacy  operations  might  strain  relationships  with  our  retail  pharmacy  customers.  Consolidation  of  retail pharmacies with third party payers, expansion of large retail pharmacy networks, reductions in reimbursement rates, shifts in the mix of branded and generic pharmaceutical sales, and exclusion from preferred pharmacy networks can impair our retail pharmacy sales and profitability.", "We might be harmed by large customer purchase reductions, payment defaults or contract non-renewal.", "March 31, 2021, sales to our largest customer represented approximately 21% of our consolidated revenues and approximately 19% of our trade receivables, and those of our ten largest customers combined accounted for approximately 51% of our consolidated revenues and approximately 32% of our trade receivables.", "A material  default  in  payment,  reduction  in  purchases,  or  the  loss  of  business  from  a  large  customer  might  have  a  materially  adverse  impact  on  our  business operations and our financial position or results of operations.", "Our contracts with government entities involve future funding and compliance risks.", "Our government contracts might not be renewed or might be terminated for convenience with little or no prior notice.", "Government contracts typically expose us to higher potential liability than do other types of contracts.", "We are subject to government audits, investigations and oversight proceedings.", "If we fail to comply with these requirements, or we fail an audit, we are subject to various sanctions such as monetary damages, criminal and civil penalties, termination of contracts and suspension or debarment from government contract work.", "These requirements complicate our business and increase our compliance burden.", "We also provide supplies used for vaccine administration in the Federal COVID-19 Response.", "Our participation in such programs exposes us to various uncertainties.", "Because of these risks and uncertainties our operating results may be materially higher or lower than our projections.", "Certain distribution agreements with manufacturers include pharmaceutical price inflation as a component of our compensation, and we cannot  control  the  frequency  or  magnitude  of  pharmaceutical  price  changes.  We  might  be  unable  to  renew  pharmaceutical  distribution  agreements  with manufacturers in a timely and favorable manner.", "Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.", "We  derive  a  significant  portion  of  our  revenue  from,  and  have  a  significant  portion  of  our  accounts  receivable  with,  a  small  number  of  customers.  At", "Our contracts with government entities are subject to risks such as lack of funding and compliance  with unique requirements.", "We might infringe intellectual property rights or our intellectual property protections might be inadequate.", "If a court were to hold that we infringed other\u2019s rights, we might be required to pay substantial damages, develop non-infringing products or services, obtain a license, stop selling or using the infringing products or services, or incur other sanctions.", "We rely on trade secret, patent, copyright and  trademark  laws,  nondisclosure  obligations  and  other  contractual  provisions  and  technical  measures  to  protect  our  proprietary  rights  in  our  products  and solutions.  We  might  initiate  costly  and  time-consuming  litigation  to  protect  our  trade  secrets,  to  enforce  our  patent,  copyright  and  trademark  rights  and  to determine the scope and validity of the proprietary rights of others.", "Our intellectual property protection efforts might be inadequate to protect our rights.", "Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.", "Competition among potential employers might result in increased salaries, benefits or other employee-related costs, or in our failure to recruit and retain employees.", "Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.", "We might be adversely impacted by healthcare reform such as changes in pricing and reimbursement models.", "healthcare industry and related government programs are changing.", "profit margins for us and our customers and impose new legal requirements on healthcare providers.", "the way healthcare is financed by both governmental and private payers.", "drugs have sought to reduce the costs of publicly funded health programs.", "These measures exert pressure on the pricing and reimbursement timelines for pharmaceuticals and may cause our customers to purchase fewer of our products and services or influence us to reduce prices.", "adverse impact on our business operations and our financial position or results of operations.", "Consolidation might increase counter-party credit risk because credit purchases increase for fewer market participants.", "Any of these changes or disruptions might have a materially adverse impact on our business operations and our financial position or results of operations.", "We might be adversely impacted as a result of our distribution of generic pharmaceuticals.", "Generic drug manufacturers often offer a generic version of branded pharmaceuticals while they challenge the validity or enforceability branded pharmaceutical patents.", "The patent holder might assert infringement claims against us for distributing those generic versions and the generic drug manufactures may not fully indemnify us against such claims.", "These risks, as well as changes in the availability,  pricing  volatility,  reimbursement  rates  for  generic  drugs,  or significant  changes  in  the  nature,  frequency  or magnitude  of  generic  pharmaceutical launches, might have a materially adverse impact on our business operations and our financial position or results of operations.", "We might be adversely impacted by an economic slowdown or recession.", "Any economic slowdown or recession might have a materially adverse impact on our business operations and our financial position or results of operations.", "Disruption or other changes in capital and credit markets might impede access to credit and increase borrowing costs for us and our customers and suppliers and might impair the financial soundness of our customers and suppliers.", "activity by financial institutions, or decreased liquidity and increased costs in the commercial paper market, might adversely affect our borrowing ability and cost of borrowing.", "We generally sell our products and services under short-term unsecured credit arrangements.", "An adverse change in general economic conditions or access to capital might cause our customers to reduce their purchases from us, or delay or fail paying amounts owed to us.", "Suppliers might be unable to make payments due to us for fees, returned products or incentives.", "Interest rate increases or changes in capital market conditions might impede our or our customers\u2019 or suppliers\u2019 ability or cost to obtain credit.", "Any of these risks might have a material adverse impact on our business operations and our financial position or results of operations.", "Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.", "We might be adversely impacted by tax legislation or challenges to our tax positions.", "Tax laws might change in ways that adversely affect our tax positions, effective tax rate and cash flow.", "The tax laws are extremely complex and subject to varying interpretations.", "We are subject to tax examinations in various jurisdictions that might assess additional tax liabilities against us.", "Our tax reporting positions might be challenged by relevant tax authorities, we might incur significant expense in our efforts to defend those challenges, and we might be unsuccessful in those efforts.", "Developments in examinations and challenges might materially change our provision for taxes in the affected periods and might differ materially from our historical tax accruals.", "Any of these risks might have a materially adverse impact on our business operations, our cash flows and our financial position or results of operations.", "For example, we might experience volatility in exchange rates and interest rates and changes in laws regulating our U.K. operations.", "Customers might reduce purchases due to the uncertainty caused by Brexit.", "Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.", "We might be adversely impacted by fluctuations in foreign currency exchange rates.", "exchange rates could reduce our revenues, increase our costs or otherwise adversely affect our financial results reported in U.S. dollars.", "For example, we are exposed to transactional currency exchange risk due to our import and export of products that are purchased or sold in currencies other than the U.S. dollar.", "We also  have  currency  exchange  risk  due  to  intercompany  loans  denominated  in  various  currencies.  The  COVID-19  pandemic  has  affected  and  might  increase currency exchange rate volatility.", "We may from time to time enter into foreign currency contracts, foreign currency borrowings or other techniques intended to hedge  a  portion  of our  foreign  currency  exchange  rate  risks.  These  hedging  activities  may  not  completely  offset  the  adverse  financial  effects  of  unfavorable movements in foreign currency exchange rates during the time the hedges are in place.", "Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.", "We are subject to the tax laws in the U.S. at the federal, state and local government levels and to the tax laws of many other jurisdictions in which we operate", "We conduct our business in various currencies,  including  the U.S. dollar, euro, British pound sterling  and Canadian dollar.  Changes in foreign  currency", "Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.", "We might be adversely impacted by changes in accounting standards.", "It is possible that future accounting standards may require changes to the accounting treatment in our consolidated financial statements and may require us to make significant changes to our financial systems.", "Such changes might have a materially adverse impact on our financial position or results of operations.", "Our consolidated financial statements are subject to the application of U.S.", "Disclosure of an environmental proceeding where a governmental agency is a party generally is included only if we expect monetary sanctions in the proceeding to exceed $1 million, unless otherwise material.", "There are no family relationships between any of the executive officers or directors of the Company.", "We declared regular cash dividends of $1.67 and $1.62 per share in the years ended March 31, 2021 and 2020, respectively.", "discretion of the Board and will depend upon our future earnings, financial condition, capital requirements, and other factors.", "Dividends: In  July  2020,  our  quarterly  dividend  was  raised  from  $0.41  to  $0.42  per  common  share  for  dividends  declared  on  or  after  such  date  by  the", "We anticipate that we will continue to pay quarterly cash dividends in the future.", "In accordance with our accounting policy, we allocate any excess of share repurchase price over par value between additional paid-in capital and retained earnings.", "Accordingly, our retained earnings and additional paid-in capital were reduced by $472 million and $70 million, respectively, during 2019.", "In 2019, we retired 5.0 million or $542 million of our treasury shares previously repurchased.", "This discussion and analysis should be read in conjunction with the consolidated financial statements and accompanying financial notes in Item 8 of Part II of this Annual Report on Form 10-K.", "Our fiscal year begins on April 1 and ends on March 31.", "Unless otherwise noted, all references to a particular year shall mean our fiscal year.", "Our organizational structure also includes Corporate, which consists of income and expenses associated with administrative functions and projects, and the results of certain investments.", "We evaluate the performance of our operating segments on a number of measures, including revenues and operating profit before interest expense and income taxes.", "The following summarizes our four reportable segments and the changes made to our reporting structure commencing in the second quarter of 2021.", "\u2022 Coronavirus disease 2019 (\u201cCOVID-19\u201d) impacted our results of operations for the year ended March 31, 2021.", "The recovery from the COVID- 19 pandemic continued to fluctuate throughout our fiscal year.", "\u2022 We expanded our existing contractual relationship with the Centers for Disease Control and Prevention (\u201cCDC\u201d) through an amendment to our existing Vaccines for Children Program contract to support the U.S. government as a centralized distributor of COVID-19 vaccines and ancillary supplies needed to administer vaccines.", "\u2022 In  December  2020,  we  began  distributing  certain  COVID-19  vaccines  under  the  direction  of  the  CDC.  Through  the  end  of  the  fiscal  year,  we  had distributed approximately 100 million of COVID-19 vaccine doses.", "\u2022 Revenues of $238.2 billion, reflects a 3% increase from the prior year primarily in our U.S.", "\u2022 Diluted loss per common share from continuing operations attributable to McKesson Corporation in 2021 of $28.26 reflects the aforementioned items, net of any respective tax impacts, and a lower share count compared to the prior year driven largely by the separation of our investment in Change Healthcare JV on March 10, 2020;", "The full extent to which COVID-19 will impact us depends on many factors and future developments, which are described at the end of this COVID-19 section.", "We continue to evaluate the nature and extent of the impacts COVID-19 has on our business and operations.", "We provided further support including additional emergency leave and an internal paid time off donation platform for employees impacted by COVID-19.", "These responses were initially put in place during our fourth quarter of 2020.", "policies did not have a material effect on our internal control over financial reporting during the year ended March 31, 2021.", "We also took various actions to mitigate the impact of COVID-19 on our results from operations through cost-containment and payroll-related expenses.", "We support the U.S. government as a centralized distributor of COVID-19 vaccines and ancillary supplies needed to administer vaccines.", "We make no decisions on where products are to be distributed nor how the products are allocated between the various provider sites and ultimately administered to the individuals receiving a vaccine.", "We utilize our expertise and capabilities to support the CDC\u2019s efforts to vaccinate everyone in the U.S. who wants to receive a COVID-19 vaccine.", "The Pfizer Vaccine, which is ultra-frozen, is not being distributed by McKesson, although we are providing ancillary supplies needed for its administration.", "custom freezers and refrigerators to safely store and process millions of vaccine doses.", "The capital expenditures we made during 2021 to prepare for vaccine and ancillary supply kit distribution were not material to our financial condition or liquidity.", "In December 2020, we began distributing the Moderna Vaccine in the U.S. and in March 2021, we began distributing the Janssen Vaccine.", "Subsequently, during the first quarter, we had lower pharmaceutical volumes, specialty drug volumes, and patient care visits that negatively impacted our consolidated revenues and income (loss) from continuing operations before income taxes for the year ended March 31, 2021.", "Additionally, increased costs for certain PPE compressed our margins.", "During the year ended March 31, 2021, we recorded charges totaling $136 million in cost of sales on certain PPE and other related products due to inventory impairments and excess inventory in our Medical-Surgical Solutions segment.", "Although market price volatility and changes to anticipated customer demand may require additional write-downs in future periods, we are taking measures to mitigate such risk.", "We collaborated closely with the federal government and other healthcare stakeholders to source more critical PPE to the U.S.", "We have deferred certain employer payroll taxes and continue to monitor the potential impact of other tax legislation changes as result of the CARES Act, including refundable payroll tax credits on certain qualified wages.", "We anticipate changes due to the CARES Act in the timing of certain cash flows, with no material impact to our financial results for the year ended March 31, 2021.", "The CA Act did not have a material impact on our financial condition, results of operations, or liquidity for the year ended March 31, 2021 nor do we currently expect a material impact on our future financial results.", "We are monitoring our customers closely for changes to their timing of payments or ability to pay amounts owed to us as a result of COVID-19 pandemic impacts to their businesses.", "We remain well-capitalized with access to liquidity from our revolving credit facility.", "Long- term debt markets and commercial paper markets, our primary sources of capital after cash flow from operations, have remained open and accessible to us during the COVID-19 pandemic.", "At March 31, 2021, we were in compliance with all debt covenants, and believe we have the ability to continue to meet our debt covenants in the future.", "Our consolidated balance sheets and ability to maintain financial liquidity remains strong.", "We have experienced no material impacts to our liquidity or net", "We face numerous uncertainties in estimating the direct and indirect effects of COVID-19 on our future business operations, financial condition, results of operations, and liquidity.", "Due to several rapidly changing variables related to the COVID-19 pandemic, estimations of future economic trends and the timing of when stability will  return  remains  challenging.  Additionally,  we  periodically  review  our  intangible  and  other  long-lived  assets  for  impairment  when  events  or  changes  in circumstances indicate  the carrying value may not be recoverable.  Key assumptions and estimates  about future values in our impairment assessments can be affected by a variety of factors, including the impacts of the global pandemic on industry and economic trends as well as on our business strategy and internal forecasts.", "We continue to be involved in discussions with the objective of achieving broad resolution of opioid- related claims of states, their political subdivisions and other government entities (\u201cgovernmental entities\u201d).", "We are in ongoing, advanced discussions with state attorneys general and plaintiffs\u2019 representatives regarding a framework under which, in order to resolve the claims of governmental entities, the three largest U.S. pharmaceutical distributors would pay up to approximately $21.0 billion over a period of 18 years, with up to approximately $8.0 billion to be paid by us, of which more than 90% is anticipated to be used to remediate the opioids crisis.", "As a result of that conclusion, and our assessment of certain other opioid- related claims, we recorded a charge of $8.1 billion for the year ended March 31, 2021 within \u201cClaims and litigation charges, net\u201d in our Consolidated Statement of Operations, related to our share of the settlement framework described above, as well as other opioid-related claims.", "Because of the many uncertainties associated with any potential settlement arrangement or other resolution of opioid-related litigation, including the uncertainty of the scope of participation by plaintiffs in any potential settlement, we are not able to reasonably estimate the upper or lower ends of the range of ultimate possible loss for all opioid-related litigation matters.", "We believe that we have valid defenses to the claims pending against us and, absent an acceptable settlement, intend to vigorously defend against all such claims.  An  adverse  judgment  or  negotiated  resolution  in  any  of  these  matters  could  have  a  material  adverse  impact  on  our  financial  position,  cash  flows  or liquidity, or results of operations.", "The law adopting the excise tax made clear that the OSA would apply only to opioid sales on or before December 31, 2018.", "The excise tax applies only to the first sale occurring in New York, and thus may not apply to sales from our distribution centers in New York to New York customers.", "Unless the appellate court\u2019s decision is overturned, the OSA will be reinstated for calendar years 2017 and 2018 (but not beyond those years), and, subject to any further legal challenge, we will have to pay our ratable share of the annual surcharge for those two years.", "During the second quarter of 2021, we reflected an estimated liability of $50 million for the OSA surcharge in our accompanying consolidated financial statements on the assumption that the appellate court\u2019s decision will stand.", "The higher LIFO credits in 2020 compared to 2019 is primarily driven by higher generic deflation.", "\u2022 Claims and litigation charges, net: These charges include adjustments for estimated probable settlements related to our controlled substance monitoring and reporting, and opioid-related claims, as well as any applicable income items or credit adjustments due to subsequent changes in estimates.", "We have reclassified prior period amounts to conform to the current period presentation.", "\u2022 Goodwill impairments charges: We perform an impairment test on goodwill balances annually in the third quarter and more frequently if indicators for potential impairment exist.", "The resulting goodwill impairment charges are reflected within this line item. \u2022 Restructuring, impairment, and related charges: Restructuring charges that are incurred for programs in which we change our operations, the scope of a business undertaken by our business units, or the manner in which that business is conducted as well as long-lived asset impairments.", "\u2022 SDG&A reflects charges of $58 million to remeasure assets and liabilities held for sale to fair value less costs to sell related to the completed contribution of the majority of our German pharmaceutical wholesale business to create a joint venture with WBA in which we have a 30% ownership interest within our International segment.", "As a result, we were required to perform a goodwill impairment test for these reporting units and recorded a goodwill impairment charge in our European RP reporting unit of $69 million during the second quarter of 2021.", "As of the testing date, other risks, expenses, and future developments, such as additional government actions, increased regulatory uncertainty, and material changes in key market assumptions limit our ability to estimate projected cash flows, which could adversely affect the fair value of various reporting units in future periods, including our McKesson Canada reporting unit within our International segment and our RxCrossroads reporting unit within our RxTS segment, where the risk of a material goodwill impairment is higher than other reporting units.", "\u2022 Restructuring, impairment, and related charges, net includes long-lived asset impairment charges of $112 million, primarily for our United Kingdom (\u201cU.K.\u201d)  business  (mainly  pharmacy  licenses)  and  Rexall  Health  retail  business  (\u201cRexall  Health\u201d)  (mainly  customer  relationships)  within  our International segment, and the remaining $156 million primarily represents employee severance and exit-related costs related to our 2019 restructuring initiatives, as further discussed below; and", "\u2022 Total operating expenses includes higher SDG&A due to our business acquisitions and to support business growth, as well as our technology initiatives, partially offset by favorable effects of foreign currency exchange fluctuations.", "\u2022 SDG&A includes opioid-related costs of $114 million, primarily related to litigation expenses, and increased expenses due to our business acquisitions and to support growth, partially offset by a gain from an escrow settlement of $97 million representing certain indemnity and other claims related to our 2017 acquisition of Rexall Health and a credit of $90 million for the derecognition of a liability related to the tax receivable agreement (\u201cTRA\u201d) payable to the shareholders of Change Healthcare, Inc. (\u201cChange\u201d);", "\u2022 Restructuring,  impairment,  and  related  charges,  net  primarily  includes  employee  severance  and  exit-related  costs  of  $352  million  for  our  2019 restructuring initiatives, as further discussed below and long-lived asset impairment charges of $245 million primarily for our U.K. business (mainly pharmacy licenses) within our International segment driven by additional government reimbursement reductions and competitive pressures in the U.K.", "We evaluate goodwill for impairment on an annual basis as of October 1, and at an interim date, if indicators of potential impairment exist.", "This change was not material to our consolidated financial statements as it did not delay, accelerate, or avoid any potential goodwill impairment charge.", "We expect to incur total charges of approximately $180 million to $280 million for this initiative, consisting primarily of exit related costs, accelerated depreciation and amortization of long-lived assets, and asset impairments.", "We expect to incur total charges of approximately $85 million to $90 million, of which $57 million of charges were recorded to date.", "This initiative was substantially complete in 2021 and remaining costs we expect to record under this initiative are not material.", "The relocation was substantially complete in January 2021 and remaining costs we expect to record under this initiative, primarily relating to lease costs, are not material.", "This primarily reflects mark-to-market gains on our investments in certain U.S. growth stage companies in the healthcare industry and realized gains on the exit of some of these investments as further described in Financial Note 17, \u201cFair Value Measurements,\u201d to the accompanying consolidated financial statements  included  in  this  Annual  Report  on  Form  10-K.  In  future  periods,  fair  value  adjustments  recognized  in  our  operating  results  for  these  types  of investments may be adversely impacted by market volatility.", "Other income, net also increased year over year due to pension settlement charges of $122 million recognized in 2020 related to our previously approved termination of the frozen U.S. defined benefit pension plan.", "In connection with the pension plan termination, we purchased annuity contracts from an insurer that will pay and administer the future pension benefits of the remaining participants.", "Excluding the impairment and transaction-related items described below, our proportionate share of loss from our investment in Change Healthcare JV for the years ended March 31, 2020 and 2019 was $119 million and $194 million, respectively, which primarily includes transaction and integration expenses incurred by the joint venture and basis differences between the joint venture and McKesson including amortization of fair value adjustments.", "During the first quarter of 2020 and for the year ended March 31, 2019, we owned approximately 70% of this joint venture.", "The proceeds from the concurrent offering of other securities were also used by Change  to  acquire  certain  securities  of  Change  Healthcare  JV.  As  a  result,  McKesson\u2019s  equity  interest  in  Change  Healthcare  JV  was  reduced  from  70%  to approximately 58.5%, which was used to recognize our proportionate share in net loss from Change Healthcare JV, commencing in the second quarter of 2020.", "As a result of the ownership dilution to 58.5% from 70%, we recognized a dilution loss of approximately $246 million in the second quarter of 2020.", "Additionally, our proportionate share of income or loss from this investment was subsequently reduced as immaterial settlements of stock option exercises occurred after the IPO and further diluted our ownership.", "Equity Earnings and Charges from Investment in Change Healthcare Joint Venture Until the separation of our investment in Change Healthcare JV on March 10, 2020, we accounted for this investment using the equity method of accounting.", "In the second quarter of 2020, we recorded an other-than-temporary-impairment (\u201cOTTI\u201d) charge of $1.2 billion to our investment in Change Healthcare JV,", "Following the Split-off, we do not beneficially own any of Change\u2019s outstanding securities.", "In connection with this transaction, we recognized a net gain for financial reporting purposes of $414 million during the fourth quarter of 2020, which was largely driven by the reversal of a related deferred tax liability.", "The receipt of any payments under the TRA is dependent upon Change benefiting from this depreciation or amortization in future tax return filings, which creates uncertainty over the amount, timing and probability of the gain recognized.", "As such, we accounted for the TRA as a gain contingency, with no receivable recognized as of March 31, 2021 nor 2020.", "Interest expense decreased in 2020 compared to the prior year primarily due to a decrease in the issuance of commercial paper, partially offset by a decrease in interest income from our derivative contracts.", "Our reported income tax (benefit) expense rates were (13.8%), 1.6%, and 58.4% in 2021, 2020, and 2019, respectively.", "after-tax), which was intended to generally be a tax-free split-off for U.S. federal income tax purposes, and unfavorably impacted by charges of $275 million (pre- tax and after-tax) to remeasure assets and liabilities held for sale to fair value less costs to sell related to the completed contribution of the majority of our German pharmaceutical wholesale business to create a joint venture with WBA.", "goodwill of our European RP and European PD reporting units within the International segment, given that these charges are generally not deductible for tax purposes.", "Our income tax expense, deferred tax assets and liabilities, and uncertain tax liabilities reflect management\u2019s best assessment of estimated current and future taxes to be paid.", "We believe that we have made adequate provision for all income tax uncertainties.", "In connection with the exchange offer, on March 9, 2020, we distributed all 176.0 million outstanding shares of common stock of SpinCo to participating", "Income Tax (Benefit) Expense We recorded income tax (benefit) expense of ($695 million), $18 million, and $356 million for the years ended March 31, 2021, 2020, and 2019, respectively.", "Our reported income tax expense rate for 2019 was unfavorably impacted by charges of $1.8 billion (pre-tax and after-tax) to impair the carrying value of", "Significant judgments and estimates are required in determining the consolidated income tax provision and evaluating income tax uncertainties.", "Noncontrolling interests with redemption  features, such as put rights, that are not solely within our control are considered redeemable  noncontrolling  interests.  Redeemable  noncontrolling interests are presented outside of McKesson Corporation stockholders\u2019 equity (deficit) on our consolidated balance sheet.", "Diluted earnings (loss) per common share attributable to McKesson Corporation was $(28.26), $4.95, and $0.17 for the years ended March 31, 2021,  2020,  and  2019,  respectively.  Net  loss  per  diluted  share  for  the  year  ended  March  31,  2021  is  calculated  by  excluding  dilutive  securities  from  the denominator  due to their antidilutive  effects.  Additionally,  our 2021, 2020, and 2019 diluted  earnings (loss) per share  reflect  the cumulative  effects  of share repurchases.", "Weighted-average diluted common shares outstanding is impacted by the exercise and settlement of share-based awards and the cumulative effect of share repurchases, including the impact of shares exchanged as part of the split-off from our investment in Change Healthcare JV, as discussed above.", "(1) Segment operating profit (loss) includes gross profit, net of operating expenses, as well as other income (expense), net, for our reportable segments.", "For retrospective periods presented, operating loss for Other reflects equity earnings and charges from our equity method investment in Change Healthcare JV, which we split-off in the fourth quarter of 2020.", "Pharmaceutical segment includes a charge of $50 million for the year ended March 31, 2021 related to our estimated liability under the OSA.", "(3) Operating loss for our International segment for the years ended March 31, 2021 and 2020 includes charges of $58 million and $275 million, respectively, to remeasure to fair value the assets and liabilities of our German pharmaceutical wholesale business which was contributed to a joint venture with WBA.", "This segment\u2019s operating loss for the years ended March 31, 2021 and 2019 includes goodwill impairment charges of $69 million and $1.8 billion, respectively, as well as long-lived asset impairment charges for the  years ended March 31, 2021,  2020, and 2019  of $115  million,  $112  million,  and $245  million,  respectively, primarily  related to  our retail  pharmacy businesses in Canada and Europe.", "(4) Operating profit for our Medical-Surgical Solutions segment for the year ended March 31, 2021 includes charges totaling $136 million on certain PPE and other related products due to inventory impairments and excess inventory.", "(5) Operating profit for our RxTS segment for the year ended March 31, 2019 includes a gain of $56 million from the divestiture of an equity investment.", "(6) Operating loss for Other for the year ended March 31, 2020 includes an OTTI charge of $1.2 billion and a dilution loss of $246 million related to our investment in Change Healthcare JV, partially offset by a net gain of $414 million related to the completed separation of our interest in Change Healthcare JV during the fourth quarter of 2020.", "(7) Corporate expenses, net for the year ended March 31, 2021 includes a charge of $8.1 billion related to our estimated liability for opioid-related claims, net gains of $133 million  from  our  equity  investments,  and a net  gain  of $131  million  recorded  in  connection  with  insurance  proceeds  received  from  the  settlement  of  the  shareholder derivative action related to our controlled substances monitoring program.", "This was partially offset by a decrease in LIFO credits of $214 million, a charge of $50 million recorded in 2021 related to our estimated liability under the OSA, net impacts from COVID-19, including a less severe cough, cold, and flu season, as well as increased costs for strategic growth initiatives.", "Operating profit and operating profit margin were unfavorably impacted by customer mix and a decrease in net cash proceeds received of $180 million representing our share of antitrust legal settlements.", "recorded to remeasure to fair value the assets and liabilities of our German pharmaceutical wholesale business which was contributed to a joint venture with WBA, of  which  $58  million  and  $275  million  was  reflected  for  the  years  ended  March  31,  2021  and  2020,  respectively.  This  was  partially  offset  by  a  goodwill impairment charge of $69 million recorded in the second quarter of 2021 related to our European retail pharmacy business.", "This was partially offset  by  the  fair  value  remeasurement  charges  in  2020  described  above  and  a  gain  from  an  escrow  settlement  of  $97  million  in  2019  related  to  our  2017 acquisition of Rexall Health.", "Additionally,  operating  profit  was favorable  year over year  due to lower  operating  expenses, including a decrease in our provision for bad debts.", "primary care business and lower restructuring charges, partially offset by the remeasurement of assets and liabilities to fair value related to a divestiture that was completed in 2020 and higher operating expenses, including an increase in our provision for bad debts.", "and existing customers, integration costs incurred in 2019 for our acquisition of RxCrossroads that closed during the fourth quarter of 2018, partially offset by a gain of $56 million from the divestiture of an equity investment in 2019.", "investment in Change Healthcare JV, partially offset by a net gain of $414 million related to the completed separation of our interest in Change Healthcare JV during the fourth quarter of 2020.", "Operating loss for Other also includes our proportionate share of loss from Change Healthcare JV of $119 million and $194 million for the years ended March 31, 2020 and 2019, respectively.", "connection with insurance proceeds received from the settlement of the shareholder derivative action related to our controlled substances monitoring program.", "Corporate expenses, net, for 2020 includes pension settlement charges of $122 million, an opioid claim settlement charge of $82 million, and net settlement gains of $26 million recognized from our derivative contracts.", "claim settlement charge mentioned above, as well as higher costs for technology initiatives, partially offset by net settlement gains recognized in 2020 from our derivative contracts.", "Other Operating  loss  for  Other  for  the  year  ended  March  31,  2020  includes  an  OTTI charge  of  $1.2  billion  and  a  dilution  loss  of  $246  million  related  to  our", "Corporate 2021 vs. 2020 Corporate expenses, net increased for the year ended March 31, 2021 compared to the prior year due to a charge of $8.1 billion related to our estimated", "We conduct our business worldwide in local currencies including Euro, British pound sterling, and Canadian dollar.", "As a result, the comparability of our results reported in U.S. dollars can be affected by changes in foreign currency exchange rates.", "In discussing our operating results, we may use the term \u201cforeign currency exchange fluctuations,\u201d which refers to the effect of changes in foreign currency exchange rates used to convert the local currency results of our operations in foreign countries where the functional currency is not the U.S. dollar.", "We present this information to provide a framework for assessing how our business performed excluding the effect of foreign currency exchange rate fluctuations.", "In computing the foreign currency exchange fluctuations, we translate our current year results of our operations in foreign countries recorded in local currencies into U.S dollars by applying their respective average foreign currency exchange rates of the corresponding prior year periods, and we subsequently compare those results to the previously reported results of the comparable prior year periods reported in U.S. dollars.", "estimate was made and if different estimates that we reasonably could have used in the current period, or changes in the accounting estimate that are reasonably likely to occur from period to period, could have a material impact on our financial condition or results from operations.", "Below are the estimates that we believe are  critical  to  the  understanding  of  our  operating  results  and  financial  condition.  Other  accounting  policies  are  described  in  Financial  Note  1,  \u201cSignificant Accounting  Policies,\u201d  to  the  consolidated  financial  statements  appearing  in  this  Annual  Report  on  Form  10-K.  Because  of  the  uncertainty  inherent  in  such estimates, actual results may differ from these estimates.", "Other customer financing primarily relates to guarantees provided to our customers, or their creditors, regarding the repurchase of inventories.", "We also provide financing to certain customers related to the purchase of pharmacies, which serve as collateral for the loans.", "We estimate the receivables for which we do not  expect  full  collection  based  on  historical  collection  rates  and  specific  knowledge  regarding  the  current  creditworthiness  of  our  customers  and  record  an allowance in our consolidated financial statements for these amounts.", "Management reviews these factors quarterly to determine if any adjustments are needed to the allowance.", "Sales to our largest customer, CVS Health Corporation (\u201cCVS\u201d), accounted for approximately 21% of our total consolidated revenues in 2021 and comprised approximately 19% of total trade accounts receivable at March 31, 2021.", "As a result, our sales and credit concentration is significant.", "The accounts receivables balances are with individual members of the GPOs, and therefore no significant concentration of credit risk exists.", "A material default in payment, a material reduction in purchases from these or any other large customers, or the loss of a large customer or GPO could have a material adverse impact on our financial position, results of operations, and liquidity.", "We believe the reserves maintained and expenses recorded in 2021 are appropriate and consistent in the context of historical methodologies employed, as well as assessment of trends currently available.", "The selected 0.1% hypothetical change does not reflect what could be considered the best or worst-case scenarios.", "Our LIFO valuation amount includes both pharmaceutical and non-pharmaceutical products.", "We recognized LIFO credits of $38 million, $252 million, and $210 million, respectively, in 2021, 2020, and 2019 in our Consolidated Statements of Operations.", "A LIFO charge is recognized when the net effect of price increases on pharmaceutical and non-pharmaceutical products held in inventory exceeds the impact of price declines, including the effect  of branded pharmaceutical  products  that have lost market  exclusivity.  A LIFO credit  is recognized  when the net effect  of price  declines exceeds the impact of price increases on pharmaceutical and non-pharmaceutical products held in inventory.", "Excluding LIFO reserves, our inventory reserves as of March 31, 2021 and 2020 were $263 million and $96 million, respectively.", "The increase was primarily due to 2021 charges totaling $136 million on certain PPE and other related products due to inventory impairments and excess inventory within our Medical-Surgical Solutions segment.", "In 2021, 2020 and, 2019, our provision for bad debts", "At March 31, 2021 and 2020, total inventories, net were $19.2 billion and $16.7 billion, respectively, in our Consolidated Balance Sheets.", "Any purchase consideration in excess of the estimated fair values of the net assets acquired is recorded as goodwill.", "that is a form or variation of the income approach, whereby a forecast of future cash flows attributable to the asset are discounted to present value using a risk- adjusted discount rate.", "We perform an impairment test on goodwill balances annually in the third quarter and more frequently if indicators for potential impairment exist.", "equal to the amount of excess carrying value above the estimated fair value, if any, but not to exceed the amount of goodwill allocated to the reporting unit.", "we estimate fair value by comparing the business to similar businesses, or guideline companies whose securities are actively traded in public markets.", "Under the income approach, we use a discounted cash flow (\u201cDCF\u201d) model in which cash flows anticipated over several periods, plus a terminal value at the end of that time horizon, are discounted to their present value using an appropriate rate that is commensurate with the risk inherent within the reporting unit.", "Goodwill  and  Long-Lived  Assets: As  a  result  of  acquiring  businesses,  we  have  $9.5  billion  and  $9.4  billion  of  goodwill  at  March  31,  2021  and  2020,", "To estimate the fair value of our reporting units, we generally use a combination of the market approach and the income approach.", "Judgments made in determining an estimate of fair value may materially impact our results of operations.", "Included in the estimate of the weighted-average cost of capital is the assumption of an unsystematic risk premium to address incremental uncertainty related to the reporting units\u2019 future cash flow projections.", "An increase in the unsystematic risk premium increases the discount rate.", "Pharmaceutical  Distribution  reporting  units  in  our  International  segment,  exceeded  their  carrying  values.  The  impairment  testing  performed  in  2020  did  not indicate  any  material  impairment  of  goodwill.  The  segment  change  in  the  second  quarter  of  2021  prompted  changes  in  multiple  reporting  units  across  the Company.", "We recorded a goodwill impairment charge of $69 million in 2021 as the estimated fair value of the Europe Retail Pharmacy reporting unit was lower than its reassigned carrying value based on changes in the composition of the Europe Retail Pharmacy reporting unit within the International segment.", "At March 31, 2021, the  balance  of goodwill for the  reporting  units  in Europe  was approximately  nil  and the  remaining  balance  of goodwill  in the International segment primarily relates to one of our reporting units in Canada.", "Other risks, expenses and future developments, such as additional government actions, increased regulatory uncertainty, and material changes in key market assumptions that we were unable to anticipate as of the testing date may require us to further revise the projected cash flows, which could adversely affect the fair value of our other reporting units in future periods.", "We review intangible assets for impairment at an asset group level whenever events or changes in circumstances indicate that the carrying value of the assets may not be recoverable.", "Determination of recoverability of intangible assets is based on the lowest level of identifiable estimated future undiscounted cash flows resulting from use of the asset and its eventual disposition.", "Measurement of any impairment loss is based on the excess of the carrying value of the asset group over its fair value.", "Assumptions and estimates about future values and remaining useful lives of our purchased intangible assets are complex and subjective.", "When the decline in value is deemed to be other than temporary, an impairment is recognized to the extent that the fair value is less than the carrying value of the investment.", "We consider various factors in determining whether a loss in value of an investment is other than temporary including: the length of time and the extent to which the fair value has been below cost, the financial condition of the investees, and our intent and ability to retain the investment for a period of time sufficient to allow for recovery of value.", "Any significant changes in assumptions or judgments in assessing impairments could result in an impairment charge.", "We generally recognize employee severance costs when payments are probable and amounts are estimable.  Costs related  to contracts without future benefit or contract termination  are recognized  at the earlier of the contract termination  or  the  cease-use  dates.  Other  exit-related  costs  are  recognized  as  incurred.  In  connection  with  these  restructuring  actions,  we  also  assess  the recoverability of long-lived assets used in the business, and as a result, we may recognize accelerated depreciation and amortization reflecting shortened useful lives of the underlying assets.", "paid.  We  are  subject  to  income  taxes  in  the  U.S.  and  numerous  foreign  jurisdictions.  Significant  judgments  and  estimates  are  required  in  determining  the consolidated income tax provision and in evaluating income tax uncertainties and include those used to conclude on the tax-free nature of the separation of the Change Healthcare JV and the unrecognized tax position related to opioid-related litigation and claims, which remains unfinalized, and which may differ from the actual amounts of tax benefit recognized.", "We review our tax positions at the end of each quarter and adjust the balances as new information becomes available.", "to recover our deferred tax assets, we consider all available positive and negative evidence including our past operating results, the existence of cumulative net operating losses in the most recent years, and our forecast of future taxable income.", "In estimating future taxable income, we develop assumptions including the amount of future federal, state and foreign pre-tax operating income, the reversal of temporary differences, and the implementation of feasible and prudent tax planning strategies.", "These assumptions require significant judgment about the forecasts of future taxable income and are consistent with the plans and estimates we use to manage the underlying businesses.", "additional taxes and related interest will be due.", "If our current estimate of tax and interest liabilities is less than the ultimate settlement, an additional charge to income tax expense may result.", "If our current estimate of tax and interest liabilities is more than the ultimate settlement, a reduction to income tax expense may be recognized.", "investigations  relating  to  laws  and  regulations  and  other  matters  arising  out  of  the  normal  conduct  of  our  business.  When  a  loss  is  considered  probable  and reasonably estimable, we record a liability in the amount of our best estimate for the ultimate loss.", "When a material loss is reasonably possible or probable but a reasonable estimate cannot be made, disclosure of the proceeding is provided.", "Deferred income taxes arise from temporary differences between the tax and financial statement recognition of revenue and expense.", "Changes in tax laws and rates could also affect recorded deferred tax assets and liabilities in the future.", "We recognize liabilities for tax and related interest for issues in the U.S. and other tax jurisdictions based on our estimate of whether, and the extent to which,", "As discussed above, development of a meaningful estimate of loss or a range of potential loss is complex when the outcome is directly dependent on future negotiations with or decisions by third parties, such as regulatory agencies, the court system and other interested parties.", "As a result of ongoing, advanced discussions with state attorneys general and plaintiffs\u2019 representatives regarding a framework to resolve the claims of governmental  entities,  and  our  assessment  of  certain  other  opioid-related  claims,  we  have  reached  a  stage  at  which  a  broad  settlement  of  opioid  claims  by governmental entities is probable and recorded a charge of $8.1 billion for the year ended March 31, 2021 within \u201cClaims and litigation charges, net\u201d in our Consolidated Statement of Operations in this report.", "Because of the many uncertainties associated with any potential settlement arrangement or other resolution of opioid-related litigation, including the uncertainty of the scope of participation by plaintiffs in any potential settlement, we are not able to reasonably estimate the upper or lower ends of the range of ultimate possible loss for all opioid-related litigation matters.", "While we are not able to predict the outcome or reasonably estimate a range of possible losses in these matters, an adverse judgment or negotiated resolution in any of these matters could have a material adverse effect on our results of operations, consolidated financial position, cash flows or liquidity.", "facilities and commercial paper program, will be sufficient to fund our short-term and long-term capital expenditures, working capital, and other cash requirements.", "We continue to monitor its impact on demand within parts of our business, as well as trends potentially impacting the timing or ability for some of our customers to pay amounts owed to us.", "We remain well-capitalized with access to liquidity from our $4.0 billion revolving credit facility.", "Additionally, long-term debt markets and commercial paper markets, our primary sources of capital after cash flow from operations, have remained open and accessible to us during the COVID-19 pandemic.", "We have seen continued improvement in conditions in the debt markets and commercial paper markets as the Federal Reserve has taken steps to stabilize the markets.", "At March 31, 2021, we were in compliance with all debt covenants, and believe we have the ability to continue to meet our debt covenants in the future.", "Cash flows from operations can be significantly impacted by factors such as the timing of receipts from customers and payments to vendors.", "Operating activities for the year ended March 31, 2021 were affected by net income adjusted for non-cash items, including the pre-tax $8.1 billion (after-tax $6.8 billion) non-cash charge related to our estimated liability for opioid-related claims, an increase in inventory of $2.3 billion and an increase in drafts and accounts payable of $1.3 billion driven by higher inventory stock levels to meet increased volume demand as part of our inventory management, as well as a decrease in receivables of $1.1 billion driven by timing, higher sales recognized at the end of March 2020, and higher collections in our fourth quarter of 2021.", "value remeasurement charges of $58 million related to the contribution of our German pharmaceutical wholesale business to a joint venture with WBA.", "Additionally, we made a cash payment of $114 million from the executive benefit retirement plan in 2020.", "Investing activities for the year ended March 31, 2021 also includes net cash proceeds of $400 million from sales of businesses and investments, including $286 million in exchange for the contribution of our German pharmaceutical wholesale business to a joint venture with WBA.", "Cash used for other financing activities generally includes payments to noncontrolling interests and activity from our finance leases.", "We received cash from long-term debt issuances of $1.1 billion and made repayments on long-term debt of $1.1 billion in 2019.", "The timing of any repurchases and the actual number of shares repurchased will depend on a variety of factors, including our stock price, corporate and regulatory requirements, restrictions under our debt obligations, and other market and economic conditions.", "In accordance with our accounting policy, we allocate any excess of share repurchase price over par value between additional paid-in capital and retained earnings.", "Accordingly, our retained earnings and additional paid-in capital were reduced by $472 million and $70 million during 2019, respectively.", "outstanding shares of SpinCo common stock, which held all of the Company\u2019s interests in the Change Healthcare JV, to participating holders of the Company\u2019s common  stock  in  exchange  for  15.4  million  shares  of  McKesson  stock,  which  are  now  held  as  treasury  stock  on  our  consolidated  balance  sheet.  Following consummation of the exchange offer, on March 10, 2020, SpinCo merged with and into Change and each share of SpinCo common stock was converted into one share of Change common stock, par value $0.001 per share, with cash being paid in lieu of fractional shares of Change common stock.", "give us the ability to meet our financing needs for the foreseeable future.", "However, there can be no assurance that an increase in volatility or disruption in the global capital and credit markets will not impair our liquidity or increase our costs of borrowing.", "As described within the \u201cTrends and Uncertainties\u201d section above,  the  COVID-19  pandemic  continues  to  develop  rapidly.  We  continue  to  monitor  its  impact  on  demand  within  parts  of  our  business,  as  well  as  trends potentially impacting the timing or ability for some of our customers to pay amounts owed to us.", "(2) This ratio describes the relationship and changes within our capital resources, and is computed as total debt divided by the sum of total debt and McKesson stockholders\u2019 equity (deficit), which excludes noncontrolling and redeemable noncontrolling interests and accumulated other comprehensive loss. (3) Ratio is computed as net income (loss) attributable to McKesson Corporation for the last four quarters, divided by a five-quarter average of McKesson stockholders\u2019 equity (deficit), which excludes noncontrolling and redeemable noncontrolling interests.", "In 2019, we retired 5.0 million or $542 million of the Company\u2019s treasury shares previously repurchased.", "In connection with the Split-off, we distributed all 176.0 million", "Deposits with financial institutions are primarily denominated in U.S. dollars and the functional currencies of our foreign subsidiaries, including Euro, British pound sterling, and Canadian dollars.", "We mitigate the risk of our short-term investment portfolio by depositing funds with reputable financial institutions and monitoring risk profiles and investment strategies of money market funds. outside of the U.S., respectively.", "Our primary intent is to utilize this cash for foreign operations for an indefinite period of time.", "Although the vast majority of cash held outside the U.S. is available for repatriation, doing so could subject us to foreign withholding taxes and state income taxes.", "The COVID-19 pandemic has potential to increase the variations in our working capital, which we continue to monitor closely. partially offset by an increase in drafts and accounts payable and a decrease in receivables.", "Our unfavorable return on McKesson\u2019s stockholder\u2019s equity (deficit) as of March 31, 2021 was also driven by net loss for the year.", "Net loss for the year ended March 31, 2021 includes an after-tax non-cash charge of $6.8 billion related to our estimated liability for opioid-related claims, as discussed in \u201cTrends  and  Uncertainties\u201d of  this  Financial  Review  and  Financial  Note  19,  \u201cCommitments  and  Contingent  Liabilities,\u201d  to  the  accompanying  consolidated financial statements included in this Annual Report on Form 10\u2011K.", "Our debt to capital ratio increased for 2020 primarily due to a decrease in stockholders\u2019 equity driven by the Split-off of our interest in Change Healthcare JV and share repurchases.", "We anticipate that we will continue to pay quarterly cash dividends in the future.", "However, the payment and amount of future dividends remain within the discretion of the Board and will depend upon our future earnings, financial condition,  capital  requirements,  and  other  factors.  In  2021,  2020,  and  2019,  we  paid  total  cash  dividends  of  $276  million,  $294  million,  and  $292  million, respectively.  Additionally,  as  required  under  the  Domination  Agreement,  we  are  obligated  to  pay  an  annual  recurring  compensation  amount  of  \u20ac0.83  per McKesson Europe share (effective January 1, 2015) to the noncontrolling shareholders of McKesson Europe.", "Cash equivalents, which are readily convertible to known amounts of cash, are carried at fair value.", "Our cash and cash equivalents balance as of March 31, 2021 and 2020 included approximately $2.3 billion and $1.7 billion of cash held by our subsidiaries", "On  July  29,  2020,  we  raised  our  quarterly  dividend  from  $0.41  to  $0.42  per  common  share  for  dividends  declared  on  or  after  such  date  by  the  Board.", "(3) Includes our estimated benefit payments for the unfunded benefit plans and minimum funding requirements for the pension plans. (4) Primarily represents interest that will become due on our fixed rate long-term debt obligations.", "These obligations primarily relate to inventory purchases and capital commitments. (6) Includes agreements under which we have guaranteed the repurchase of our customers\u2019 inventory and our customers\u2019 debt in the event these customers are unable to meet their obligations to those financial institutions.", "The ultimate amount and timing of any future cash settlements related to these items cannot be predicted with reasonable certainty.", "and are mostly related to our customer contracts and to meet the security requirements for statutory licenses and permits, court and fiduciary obligations, and our workers\u2019 compensation and automotive liability programs.", "The exercise of the Put Right will reduce the balance of redeemable noncontrolling interests.", "During 2021, we paid $49 million to purchase 1.8 million shares of McKesson Europe through exercises of the Put Right by the noncontrolling shareholders.", "Our banks and insurance companies have issued $146 million of standby letters of credit and surety bonds at March 31, 2021.", "redemption value is the Put Amount adjusted for exchange rate fluctuations each period.", "In future periods, unfavorable foreign currency exchange rate fluctuations between the Euro and the U.S. dollar could adversely impact the carrying value of our redeemable noncontrolling interests and require an adjustment to increase the balance of our redeemable noncontrolling interests to its maximum redemption value.", "On April 12, 2021, we received the Stuttgart Court of Appeals\u2019 final ruling confirming the original put value of \u20ac22.99 per share and the annual recurring compensation of \u20ac0.83 per McKesson Europe share.", "Funds necessary for future debt maturities and our other cash requirements are expected to be met by existing cash balances, cash flow from operations, existing credit sources, and other capital market transactions.", "The effect of a hypothetical 50 bp increase in the underlying interest rate on our cash and cash equivalents, net of short-term borrowings and variable rate debt, would have resulted in a favorable impact to earnings in 2021 and 2020 of approximately $17 million and $6 million, respectively.", "The balance of redeemable noncontrolling interests is reported at the greater of its carrying value or its maximum redemption value at each reporting date.", "Additionally,  we  are  obligated  to  pay  an  annual  recurring  compensation  of  \u20ac0.83  per  McKesson  Europe  share  (the  \u201cCompensation  Amount\u201d)  to  the", "Interest rate risk: Our long-term debt bears interest predominately at fixed rates, whereas our short-term borrowings are at variable interest rates.", "Our cash and cash equivalents balances earn interest at variable rates.", "At March 31, 2021 and 2020, we had $6.3 billion and $4.0 billion, respectively, in cash", "Changes in foreign currency exchange rates could have a material adverse impact on our financial results that are reported in U.S. dollars.", "We are also exposed to foreign exchange rate risk related to our foreign subsidiaries, including intercompany loans denominated in non-functional currencies.", "These programs reduce but do not entirely eliminate foreign exchange risk.", "fair value of our foreign exchange contracts by approximately $267 million and $435 million, respectively.", "Foreign exchange risk: We conduct our business worldwide in U.S. dollars and the functional currencies of our foreign subsidiaries, including Euro, British", "We have certain foreign exchange rate risk programs that use foreign currency forward contracts and cross-currency swaps.", "Based on this assessment, our management has concluded that our internal control over financial reporting was effective as of March 31, 2021.", "In our opinion, the financial statements referred to above present fairly, in all material respects, the financial position of the Company as of March 31, 2021 and 2020, and the results of its operations and its cash flows for each of the three years in the period ended March 31, 2021, in conformity with accounting principles generally accepted in the United States of America.", "Also, in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of March 31, 2021, based on criteria established in Internal Control \u2014 Integrated Framework (2013) issued by COSO.", "Our responsibility is to express an opinion on these financial statements and an opinion on the Company\u2019s internal control over financial reporting based  on  our  audits.  We  are  a  public  accounting  firm  registered  with  the  Public  Company  Accounting  Oversight  Board  (United  States)  (\u201cPCAOB\u201d)  and  are required  to  be  independent  with  respect  to  the  Company  in  accordance  with  the  U.S.  federal  securities  laws  and  the  applicable  rules  and  regulations  of  the Securities and Exchange Commission and the PCAOB.", "We conducted our audits in accordance with the standards of the PCAOB.", "Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.", "Our audits of the financial statements included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures to respond to those risks.", "Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements.", "Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk.", "Our audits also included performing such other procedures as we considered necessary in the circumstances.", "We believe that our audits provide a reasonable basis for our opinions.", "The critical audit matters communicated below are matters arising from the current-period audit of the financial statements that were communicated or required to be communicated to the audit committee and that (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments.", "The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.", "The Company also performs an assessment of loss contingencies where a loss is reasonably possible.", "We identified the potential broad settlement of opioid claims as a critical audit matter because of the significant judgment and challenges auditing management\u2019s determination  of  whether  such  loss  is  probable  and  reasonably  estimable.  Specifically,  auditing  management\u2019s  determination  and  disclosure  of  whether  the contingent loss arising from the potential broad settlement of opioid claims is probable, and the related measurement of such loss, is subjective and requires significant judgment given that the potential loss is based upon settlement terms that have not yet been finalized.", "\u2022 We tested the effectiveness of internal controls related to the potential broad settlement of opioid claims, and approval of the accounting treatment and related disclosures based on the most recent facts and circumstances.", "In addition, we inspected responses to inquiry letters sent to both internal and external legal counsel as it relates to the status of discussions with plaintiffs\u2019 counsel and the Company\u2019s intent regarding the framework for a potential broad settlement of opioid claims.", "\u2022 We evaluated management\u2019s analysis of the potential broad settlement of opioid claims, including the methodology used by management to determine the probability of such loss.", "We also evaluated the methodology used by management to estimate the most likely loss to be incurred by the Company as a result of a potential broad settlement of opioid claims.", "\u2022 We performed public domain searches for evidence contrary to management\u2019s analysis.", "\u2022 We evaluated any events subsequent to March 31, 2021 that might impact our evaluation of the potential broad settlement of opioid claims. \u2022 We obtained written representations from executives and internal counsel of the Company. \u2022 We examined proposed terms related to the potential broad settlement framework. \u2022 We evaluated the Company\u2019s related disclosures for consistency with our testing.", "The net amount recognized by management is measured as the largest amount of tax benefit that is greater than 50 percent likely of being realized.", "We identified the Company\u2019s uncertain tax position related to the charge for the potential broad settlement of opioid claims as a critical audit matter because of the challenges in auditing management\u2019s estimate of the amount of income tax benefit that qualifies for recognition.", "Our audit procedures related to the Company's uncertain tax position associated with a potential broad settlement of opioid claims included the following, among others: \u2022 We tested the effectiveness of internal controls related to the Company\u2019s assessment of the technical merits of its tax position, including the Company\u2019s assessment as to the amount of benefit that is more likely than not to be realized. \u2022 With  the  assistance  of  our  tax  specialists,  we  evaluated  the  facts,  evidence  and  the  Company\u2019s  related  income  tax  analysis  for  the  charge  related  to  the potential broad settlement of opioid claims, including assumptions used by management to measure the related recognized and unrecognized tax benefits. \u2022 We inquired of the Company\u2019s internal and external legal counsel to understand the basis for the Company\u2019s conclusion that a portion of the potential broad settlement of opioid claims would be deductible based on the most recent discussions with plaintiffs\u2019 counsel.", "\u2022 We  compared  management's  income  tax  assessment  of  this  matter  to  the  treatment  of  other  recorded  opioid  charges  to  evaluate  the  consistency  of  the Company\u2019s judgments related to the uncertain tax position. \u2022 We evaluated any events subsequent to March 31, 2021 that might impact our evaluation of the Company\u2019s uncertain tax position related to the charge for the potential broad settlement of opioid claims.", "\u2022 We obtained written representations from executives and internal counsel of the Company. \u2022 We examined proposed terms related to the potential broad settlement framework.", "\u2022 We evaluated the Company\u2019s related disclosures for consistency with our testing and also searched for contradictory evidence by reading disclosures from peer companies, who are also party to the potential broad settlement of opioid claims.", "We identified the estimation of the fair value of the McKesson Canada reporting unit used to evaluate the recoverability of goodwill as a critical audit matter because of the challenges auditing significant judgments used in the selection of a discount rate, including the unsystematic risk premium.", "In particular, the fair value estimate is sensitive to the unsystematic risk premium assumption, which is affected by expected risk of changes in the Canadian business and regulatory environments.", "Auditing management\u2019s selected discount rate required a high degree of auditor judgment and an increased extent of effort, including the need to involve more senior members of the team and our fair value specialists.", "Our audit procedures related to the Company\u2019s selection of a discount rate, including consideration of the unsystematic risk premium, for the McKesson Canada reporting unit included the following, among others: \u2022 We tested the effectiveness of internal controls related to management\u2019s goodwill impairment evaluation, including those related to the selection of a discount rate and consideration of an unsystematic risk premium. \u2022 We  evaluated  management\u2019s  ability  to  accurately  forecast  operating  results  for  the  McKesson  Canada  reporting  unit  by  comparing  actual  results  to management\u2019s historical forecasts, in order to consider the reasonableness and adequacy of management\u2019s selected unsystematic risk premium. \u2022 As part of our assessment of the unsystematic risk premium, we evaluated the reasonableness of strategic plans expected to be implemented during the forecast period by comparing the forecasts to:", "\u2022 With the assistance of our fair value specialists, we evaluated the reasonableness of the discount rate, including the unsystematic risk premium, by developing a range of independent estimates, testing the mathematical accuracy of the calculation and comparing to the discount rate selected by management.", "We have served as the Company\u2019s auditor since 1968.", "The Company consolidates VIEs when it is determined that it is the primary beneficiary of the VIE.", "Investments in business entities in which the Company does not have control but has the ability to exercise significant influence over operating and financial policies, are accounted for using the equity method.", "Actual amounts could differ from those estimated amounts.", "These legislative acts are not expected to have a material impact on the Company\u2019s consolidated financial results.", "The Company considers itself to control an entity if it is the majority owner of or has voting control over such entity.", "GAAP requires that the Company make estimates and assumptions that", "If a loss in value has occurred that is deemed to be other-than-temporary, an impairment loss is recorded.", "economic environment, customer credit ratings or bankruptcies, as well as reasonable and supportable forecasts.", "We are exposed to credit losses on accounts receivable balances.", "As a result, the Company\u2019s sales and credit concentration is significant.", "The accounts receivables balances are with individual members of the GPOs, and therefore no significant concentration of credit risk exists.", "This credit risk is mitigated by the size and diversity of the Company\u2019s customer base as well as its geographic dispersion.", "These amounts are equivalent to the Company\u2019s LIFO reserves.", "A LIFO credit is recognized when the net effect of price declines exceeds the impact of price increases on pharmaceutical and non-pharmaceutical products held in inventory.", "The increase was primarily due to charges in 2021 totaling $136 million on certain personal protective equipment and other related products due to inventory impairments and excess inventory within our Medical-Surgical Solutions segment.", "When the net realizable value of a disposal group increases during a period, a gain can be recognized to the extent that it does not increase the value of the disposal group beyond its original carrying value when the disposal group was reclassified as held for sale.", "Depreciation and amortization begins when an asset is placed in service and ready for its intended use.", "The use of alternative assumptions and estimates could affect the fair values and change the impairment determinations.", "Measurement of any impairment loss is based on the excess of the carrying value of the asset group over its estimated fair market value.", "customer in an amount that reflects the consideration to which the entity expects to be entitled for that good or service.", "Revenue is recognized when control of goods is transferred to the customer which occurs upon the Company\u2019s delivery to the customer or upon customer  pick-up.", "The ultimate outcome of any outstanding claims may be different than the Company\u2019s estimate.", "If a derivative is designated as a fair value hedge, the changes in the fair value of the derivative and of the hedged item attributable to the hedged risk are recognized in earnings.", "The cumulative changes in fair value are reclassified to the same line as the hedged item in the Consolidated Statements of Operations when the hedged item affects earnings.", "Noncontrolling interests with redemption features, such as put rights, that are not solely within the Company\u2019s control are considered redeemable noncontrolling interests.", "When a loss is considered probable and reasonably estimable, the Company records a liability in the amount of its best estimate for the ultimate loss.", "When a material loss is reasonably possible or probable, but a reasonable estimate cannot be made, disclosure of the proceeding is provided.", "As discussed above, development of a meaningful estimate of loss or a range of potential loss is complex when the outcome is directly dependent on negotiations with or decisions by third parties, such as regulatory agencies, the court system, and other interested parties.", "Any purchase consideration in excess of the estimated fair values of the net assets acquired is recorded as goodwill.", "Restructuring Charges: Employee severance costs are generally recognized when payments are probable and amounts are reasonably estimable.", "The forward-looking model requires the Company to consider historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount in estimating credit losses.", "The adoption of this amended guidance is not expected to have a material impact on the Company\u2019s consolidated financial statements or disclosures.", "accounting policy has been to disclose any intervening events of the joint venture in the lag period that could materially affect its consolidated financial statements.", "McKesson had the ability to adjust the manner in which certain depreciation or amortization deductions are allocated among Change and McKesson.", "This creates uncertainty over the amount, timing, and probability of the gain recognized.", "Any such change is not expected to have a material impact on the Company\u2019s consolidated financial statements.", "This initiative was substantially complete in 2021 and remaining costs the Company expects to record under this initiative are not material.", "This set of initiatives was substantially complete by the end of 2020 and charges in 2021 were not material.", "Goodwill recognized for business acquisitions is generally not expected to be deductible for tax purposes.", "share-based awards that will ultimately vest primarily based on historical experience.", "The estimated forfeiture rate established upon grant is re-assessed throughout the requisite service period and is adjusted when actual forfeitures occur.", "The actual forfeitures in future reporting periods could be higher or lower than current estimates.", "PSUs have a requisite service period of generally three years.", "Compensation expense for the share-based awards is recognized for the portion of awards ultimately expected to vest.", "The number of vested PSUs is assessed at the end of a", "All  outstanding  PeRSU awards  have  completed  the  performance  period  and  are  now classified  and  accounted  for  as RSUs.", "portion of the awards that is ultimately expected to vest.", "Once the fair value of an employee stock option is determined, current accounting practices do not permit it to be changed, even if the estimates used are different from actual.", "The Company believes this market-based input provides a reasonable estimate of its future stock price movements and is consistent with employee stock option valuation considerations.", "These amounts have not been significant for all the years presented.", "Substantially all its foreign net operating losses have indefinite lives.", "The decrease in unrecognized tax benefits in 2020  compared  to  2019  is  primarily  attributable  to  the  favorable  resolution  of  an  outstanding  California  tax  refund  claim  which  decreased  unrecognized  tax benefits by $91 million.", "2017 Tax Act, the repatriation of cash to the U.S. is generally no longer taxable for federal income tax purposes.", "The Company may remit foreign earnings to the U.S. to the extent it is tax efficient to do so.", "It does not expect the tax impact from remitting these earnings to be material.", "The exercise of the Put Right will reduce the balance of redeemable noncontrolling interests.", "The adoption of this guidance did not have a material impact on the Company\u2019s consolidated statements of operations and cash flows.", "The Company\u2019s lease agreements do not contain any material residual value guarantees or material restrictive covenants.", "Operating lease liabilities are recognized based on the present value of the future lease payments over the lease term, discounted at the Company\u2019s incremental borrowing rate as the implicit rate in the lease is not readily determinable for most of the Company\u2019s leases.", "As a practical expedient, short-term leases with an initial term of 12 months or less are excluded from the Consolidated Balance Sheets and charges from these leases are expensed as incurred.", "Fair value estimates result from a complex series of judgments about future events and uncertainties and rely heavily on estimates and assumptions that have been deemed reasonable by management as of the measurement date.", "The unsystematic risk premium is an input factor used in calculating the discount rate that specifically addresses uncertainty related to the reporting unit\u2019s future cash flow projections.", "The risk of successfully achieving certain business initiatives was the primary factor in the use of a higher discount rate.", "and, from time-to-time, future unsecured and unsubordinated indebtedness outstanding.", "As a result of absorbing this risk, the leases provide the Company with the power to direct the operations of the leased properties and the obligation to absorb losses or the right to receive benefits of the entity.", "Consolidated VIEs do not have a material impact on the Company\u2019s Consolidated Statements of Operations and Cash Flows.", "their economic performance and thus is not considered the primary beneficiary of the entities.", "The pension obligation in Germany is unfunded with the exception of the contractual trust arrangement used to fund pensions of McKesson Europe\u2019s Management Board.", "actuarial  losses  exceeding  10%  of  the  greater  of  the  projected  benefit  obligation  or  the  market  value  of  assets  are  amortized  straight-line  over  the  average remaining future service period of active employees.", "Pension obligations for its unfunded plans are based on the recommendations of independent actuaries.", "The difference between actual inflation and assumed inflation in our U.K. pension plans resulted in a gain of $23 million.", "corporate bonds rated AA or better whose maturities are aligned with the expected benefit payments of its plans.", "Plan assets of the non-U.S. plans are broadly invested in a manner appropriate to the nature and duration of the expected future retirement benefits payable under the plans.", "Assets are properly diversified to avoid excessive reliance on any particular asset, issuer, or group of undertakings so as to avoid accumulations of risk in the portfolio as a whole.", "practical expedient are not leveled within the fair value hierarchy and are included as a reconciling item to total investments.", "Actions taken by other participating employers may lead to adverse changes in the financial condition of a multiemployer benefit plan and the Company\u2019s withdrawal liability and contributions may increase.", "It does not use derivatives for trading or speculative purposes.", "Eligible employees may contribute to the RSP up to 75% of", "In the normal course of business, the Company is exposed to interest rate and foreign currency exchange rate fluctuations.", "These forward contracts and cross-currency swaps are generally used to offset the potential income statement effects from intercompany loans and other obligations denominated in non-functional currencies.", "These programs reduce but do not entirely eliminate foreign currency exchange rate risk.", "To the extent foreign currency-denominated notes designated as net investment hedges are ineffective, changes in carrying value attributable to the change in spot rates are recorded in earnings.", "To the extent cross-currency swaps designated as hedges are ineffective, changes in carrying value attributable to the change in spot rates are recorded in earnings.", "Changes in fair values representing hedge ineffectiveness are recognized in current earnings.", "The settlement loss on the swaps was not material and will be amortized on a straight-line basis as interest expense over the five-year life of the 2025 Notes.", "Gains or losses from these contracts are largely offset by changes in the value of the underlying intercompany obligations.", "Changes in the fair value for contracts not designated as hedges are recorded directly in earnings.", "The carrying value of all other cash equivalents approximates their fair value due to their relatively short-term nature.", "These inputs are considered Level 2 under the fair value measurements and disclosure guidance and may not be representative of actual values that could have been realized or that will be realized in the future.", "If the carrying amount of an asset group is not recoverable, an impairment charge is recorded to reduce the carrying amount by the excess over its fair value.", "repurchase of its customers\u2019 inventory or its customers\u2019 debt in the event these customers are unable to meet their obligations to those financial institutions.", "For the Company\u2019s inventory repurchase agreements, among other requirements, inventories must be in resalable condition and any repurchase would be at a discount.", "The majority of the Company\u2019s customers\u2019 debt guarantees are secured by certain assets of the customer.", "The Company\u2019s long-term debt is also recorded at cost.", "The carrying value and fair value of the Company\u2019s long-term debt was as follows:", "Long-lived Assets The Company utilizes multiple approaches including the DCF model and market approaches for estimating the fair value of intangible assets.", "infringe a third party\u2019s intellectual property rights.", "Where appropriate, obligations for such indemnifications are recorded as liabilities.", "Accrued warranty costs were not material to the Consolidated Balance Sheets.", "Significant developments in those matters are described below.", "Company  is  unable  to  determine  that  a  loss  is  probable,  or  to  reasonably  estimate  the  amount  of  loss  or  a  range  of  loss,  for  a  claim  because  of  the  limited information  available  and  the  potential  effects  of future  events  and  decisions  by third  parties,  such  as  courts  and  regulators,  that  will  determine  the  ultimate resolution of the claim.", "It is not uncommon for claims to remain unresolved over many years.", "The Company reviews loss contingencies at least quarterly to determine whether the likelihood of loss has changed and whether it can make a reasonable estimate of the loss or range of loss.", "When the Company determines that a loss from a claim is probable and reasonably estimable, it records a liability for an estimated amount.", "The Company also provides disclosure when it is reasonably possible that a loss may be incurred or when it is reasonably possible that the amount of a loss will exceed its recorded liability.", "Warranties In the normal course of business, the Company provides certain warranties and indemnification protection for its products and services.", "These two West Virginia plaintiffs are not expected to participate in any broader multistate resolution of opioid-related claims.", "The Cherokee Nation is not expected to participate in any broader multistate resolution of opioid-related claims.", "Those non-participating governmental entities would be entitled to pursue their claims against the Company and other defendants.", "The Company believes that it has valid defenses to the claims pending against it, and it intends to vigorously defend against all such claims if acceptable settlement terms are not achieved.", "The Company believes it has valid legal defenses in these matters and intends to mount a vigorous defense.", "The Company has not concluded a loss is probable in any of these matters; nor is the amount of any loss reasonably estimable.", "An adverse judgment or negotiated resolution in any of these matters could have a material adverse impact on the Company\u2019s financial position, cash flows or liquidity, or results of operations.", "AIG and ACE are seeking declarations that they have no duty to defend or indemnify McKesson in the thousands of lawsuits pending in federal and state courts related to opioids.", "Discussions with attorneys general and other parties continue.", "If the negotiating parties agree on terms under the framework for a broad resolution of claims of", "Plaintiffs\u2019 moved for summary judgment on the same day.", "subpoenas and requests in a cooperative, thorough and timely manner.", "These responses sometimes require time and effort and can result in considerable costs being incurred by the Company.", "Such subpoenas and requests can lead to the assertion of claims or the commencement of civil or criminal legal proceedings against the Company and other members of the health care industry, as well as to settlements of claims against the Company.", "The Company responds to these requests in the ordinary course of business.", "The law adopting the excise tax made clear that the OSA does not apply to sales or distributions occurring after December 31, 2018.", "It is not certain at this point in time what proportion of this estimated liability will be borne by the Company.", "However, it is possible that the ultimate costs of these matters may exceed or be less than the reserves.", "Due to the complex nature of the tax laws, it is not possible to estimate the outcome of these matters.", "improper actions to delay or prevent generic drugs from entering the market.", "The quarterly results of operations are not necessarily indicative of the results that may be expected for the entire year.", "effectiveness of the Company\u2019s \u201cdisclosure controls and procedures\u201d (as such term is defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) as of the end of the period  covered  by  this  report  and  have  concluded  that  our  disclosure  controls  and  procedures  are  effective  based  on  their  evaluation  of  these  controls  and procedures as required by paragraph (b) of Exchange Act Rules 13a-15 or 15d-15.", "Rules 13a-15 or 15d-15 that occurred during our fourth quarter of 2021 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.", "caption  \u201cInvestors  -  Corporate  Governance.\u201d  The  Company\u2019s  Corporate  Governance  Guidelines  and  Charters  for  the  Audit,  Compensation  and  Governance Committees can also be found on our website under the same caption.", "Information  about the Code of Conduct applicable  to all employees, officers  and directors can be found on our website, www.mckesson.com, under the", "Information with respect to this item is incorporated by reference from the discussion under the heading \u201cExecutive Compensation\u201d in our Proxy Statement.", "Such non-employee director award is fully vested on the date of the grant.", "subject to and qualified in their entirety by reference to our amended and restated certificate of incorporation, our amended and restated by- laws  and  the  Delaware  General  Corporation  Law  (\u201cDGCL\u201d).  Copies  of  our  amended  and  restated  certificate  of  incorporation  and  our amended and restated by-laws have been filed with the Securities and Exchange Commission (the \u201cSEC\u201d) and are incorporated by reference herein. 100,000,000 shares are preferred stock, par value $0.01 per share.", "We may amend from time to time our amended and restated certificate of incorporation to increase the number of authorized shares of Common Stock and/or preferred stock.", "Any such amendment would require the approval of the holders of a majority of our shares entitled to vote.", "All of our outstanding shares of Common Stock are fully paid and non- assessable.", "Stock are entitled to receive ratably dividends out of assets legally available therefor at such times and in such amounts as our board of directors may from time to time determine.", "ratably in our assets that are legally available for distribution, after payment of all debts, other liabilities and any liquidation preferences of outstanding preferred stock.", "amended and restated certificate of incorporation does not provide for cumulative voting in the election of directors.", "Upon liquidation, dissolution or winding up of our affairs, the holders of Common Stock are entitled to share", "Holders of our Common Stock have no conversion, redemption, preemptive or similar", "Each outstanding share of Common Stock is entitled to one vote on all matters submitted to a vote of stockholders.", "Anti-Takeover Effects of Provisions of Our Amended and Restated Certificate of Incorporation and Our Amended and Restated By- Laws deemed to have an anti-takeover effect and may delay, deter or prevent a tender offer or takeover attempt that a stockholder might consider in its best interest, including those attempts that might result in a premium over the market price for the shares held by stockholders.", "Our amended and restated by-laws provide that special meetings of holders of Common Stock may be called only by our Chair, Chief Executive Officer or a majority of our board of directors for any purpose at any time.", "Holders of Common Stock owning at least 15% of the outstanding shares of Common Stock for at least one year are permitted to submit a special meeting request in accordance with the procedures described in our amended and restated by-laws.", "In general, notice of intent to nominate a director or raise business at such meetings must be received by us not less than 90 nor more than 120 days prior to the date of the  annual meeting and must contain certain specified  information concerning the person to be nominated or the matters to be brought before the meeting and concerning the stockholder submitting the proposal.", "may be amended by a vote of a majority of our board of directors and by the affirmative vote of a majority of the shares of the corporation entitled  to  vote  thereon.  Our  amended  and  restated  certificate  of  incorporation  and  our  amended  and  restated  by-laws  provide  that  our amended and restated by-laws may be amended by a vote of a majority of our board of directors.", "In addition, our amended and restated by- laws provide that our amended and restated by-laws may be amended by the affirmative vote of a majority of the shares of the corporation entitled to vote thereon.", "Current and former stockholders are deemed to have consented to the personal jurisdiction of the Delaware Courts in connection with any action to enforce that exclusive forum provision and to service of process in any such action.", "We  are  subject  to  the  \u201cbusiness  combination\u201d  statute  of  the  DGCL.  In  general,  such  statute  prohibits  a  publicly  held  Delaware", "The statute could prohibit or delay mergers or other takeover or change in control attempts with respect to us and, accordingly, may discourage attempts to acquire us.", "stock could decrease the amount available for distribution to holders of our Common Stock or could adversely affect the rights and powers, including voting rights, of such holders.", "The issuance of preferred stock could have the effect of delaying or preventing a change in control of us.", "Such limitation does not, however, affect the liability of a director (1) for any breach of the director\u2019s duty of loyalty to us or our stockholders, (2) for acts or omissions not in good faith or that involve intentional misconduct or a knowing violation of law, (3) in respect of certain unlawful dividend payments or stock redemptions or purchases and (4) for any transaction from which the director derives an improper personal benefit.", "The effect of this provision is to eliminate our rights and the rights of our stockholders (through stockholders\u2019 derivative suits) to recover monetary damages against a director for breach of the fiduciary duty of care as a director (including breaches resulting from negligent or grossly negligent behavior) except in the situations described in clauses (1) through (4) above.", "This provision does not limit or eliminate our rights or the rights of our stockholders to seek non-monetary relief such as an injunction or rescission in the event of a breach of a director\u2019s duty of care.", "In addition, our directors and officers have indemnification protection.", "principal amount of 0.625% Notes due 2021 and \u20ac600,000,000 aggregate principal amount of 1.500% Notes due 2025, and on February 12, 2018, we issued \u20ac500,000,000 aggregate principal amount of 1.625% Notes due 2026.", "existing and future unsecured and unsubordinated indebtedness from time to time outstanding.", "EQ Shareowner Services acts as transfer agent and registrar of our Common Stock.", "Our Common Stock is listed on the New York Stock Exchange under the symbol \u201cMCK\u201d.", "On  February  17,  2017,  we  issued  \u00a3450,000,000  aggregate  principal  amount  of  3.125%  Notes  due  2029,  \u20ac600,000,000  aggregate", "Securities\u201d), our senior subordinated debt (\u201cSenior Subordinated Debt Securities\u201d), our subordinated debt (\u201cSubordinated Debt Securities\u201d) or our  junior  subordinated  debt  (\u201cJunior  Subordinated  Debt  Securities\u201d  and,  together  with  the  Senior  Subordinated  Debt  Securities  and  the Subordinated Debt Securities, the \u201cSubordinated Securities\u201d).  The Indenture does not limit the amount of debt securities that we may issue.", "It provides that we may issue debt securities up to the principal amount that we may authorize and may be in any currency or currency unit designated  by  us.  Except  for  the  limitations  on  consolidation,  merger  and  sale  of  all  or  substantially  all  of  our  assets  contained  in  the Indenture, the terms of the Indenture do not contain any covenants or other provisions designed to afford holders of any debt securities protection with respect to our operations, financial condition or transactions involving us.", "any person unless (a) we will be the continuing corporation or (b) the successor corporation or person formed by such consolidation or into which we are merged or to which our assets substantially as an entirety are transferred or leased is a corporation, limited liability company or limited partnership organized or existing under the laws of the United States, any state of the United States or the District of Columbia and, if such entity is not a corporation, a co-obligor of the debt securities is a corporation organized or existing under any such laws, and such successor corporation or person, including such co-obligor, if any, expressly assumes our obligations on the debt securities and under the Indenture.", "In addition, we cannot effect such a transaction unless immediately after giving effect to such transaction, no default or Event of Default under the Indenture shall have occurred and be continuing.", "Subject to certain exceptions, when the person to whom our assets are transferred or leased has assumed our obligations under the debt securities and the Indenture, we shall be discharged from all our obligations under the debt securities and the Indenture, except in limited circumstances.", "unless the transaction or change of control were structured to include a merger or consolidation or transfer or lease of all or substantially all of our assets.", "We cannot consolidate or merge with or into, or transfer or lease all or substantially all of our assets to,", "\u2022 any  other  Event  of  Default  provided  in  the  applicable  resolution  of  our  board  of  directors  or  the  officers\u2019  certificate  or supplemental Indenture under which we issue such series of debt securities.", "The Indenture imposes limitations on suits brought by holders of debt securities against us.", "officer knows of any default by us in the performance, observance or fulfillment of any condition or covenant of the Indenture.", "We and the Trustee may not, however, without the consent of the holder of each outstanding debt security affected thereby:", "The Indenture provides that we and the Trustee may enter into supplemental indentures without the", "value of the assets subject to such transaction, as determined by our Board of Directors, or (b) the present value of the remaining obligations of the lessee for net rental payments during the term of any lease discounted at the rate of interest set forth or implicit in the terms of such lease or, if not practicable to determine such rate, the weighted average interest rate per annum borne by the debt securities of each series outstanding pursuant to the Indenture and subject to limitations on sale and lease-back transaction covenants, compounded semi-annually in either case as determined by our principal accounting or financial officer.", "located,  and  substantially  all  the  operations  of  which  are  conducted,  in  the  United  States  of  America  whose  financial  statements  are consolidated with our financial statements in accordance with accounting principles generally accepted in the United States of America.", "Consolidated  Subsidiaries  incurred  after  the  date  of  issuance  of  the  notes  and  secured  by  liens  not  permitted  by  the  limitation  on  liens provisions, and (2) Attributable Debt of ours and our Consolidated Subsidiaries in respect of every sale and lease-back transaction entered into after the date of the issuance of the notes, other than leases permitted by the limitation on sale and lease-back provisions.", "accordance with accounting principles generally accepted in the United States of America.", "Subsidiaries pursuant to which we or any of our Subsidiaries sells, conveys or otherwise transfers to (1) a Receivables Subsidiary (in the case of a transfer by us or any of our Subsidiaries) or (2) any other person (in the case of a transfer by a Receivables Subsidiary), or grants a security interest in, any accounts receivable (whether now existing or arising in the future) or inventory of us or any of our Subsidiaries, and any assets related thereto including, without limitation, all collateral securing such accounts receivable, all contracts and all guarantees or other  obligations  in  respect  of  such  accounts  receivable  or  inventory,  proceeds  of  such  accounts  receivable  and  other  assets  which  are customarily transferred or in respect of which security interests are customarily granted in connection with asset securitization transactions involving accounts receivable or inventory.", "financing of accounts receivable or inventory (a) no portion of the Indebtedness or any other obligations (contingent or otherwise) of which (1)  is  guaranteed  by  us  or  any  Subsidiary  of  ours  (excluding  guarantees  of  obligations  (other  than  the  principal  of,  and  interest  on, Indebtedness) pursuant to representations, warranties, covenants and indemnities entered into in the ordinary course of business in connection with  a  Qualified  Receivables  Transaction),  (2)  is  recourse  or  obligates  us  or  any  Subsidiary  of  ours  in  any  way  other  than  pursuant  to representations,  warranties,  covenants  and  indemnities  entered  into  in  the  ordinary  course  of  business  in  connection  with  a  Qualified Receivables Transaction or (3) subjects any property or asset of ours or any Subsidiary of ours (other than accounts receivable or inventory and related assets as provided in the definition of \u201cQualified Receivables Transaction\u201d), directly or indirectly, contingently or otherwise, to the satisfaction thereof, other than pursuant to representations, warranties, covenants and indemnities entered into in the ordinary course of business in connection with a Qualified Receivables Transaction, (b) with which neither we nor any Subsidiary of ours has any material contract, agreement, arrangement or understanding other than on terms customary for securitization of receivables or inventory and (c) with which neither we nor any Subsidiary of ours has any obligations to maintain or preserve such Subsidiary\u2019s financial condition or cause such Subsidiary to achieve certain levels of operating results.", "Limitation  on  Liens.  We  covenant  that,  so  long  as  any  of  the  Notes  remain  outstanding,  we  will  not,  and  will  not  permit  any", "Indebtedness which is secured by a lien which would otherwise be subject to the foregoing restrictions; provided that after giving effect thereto the Exempted Debt then outstanding at such time does not exceed 10% of our total assets on a consolidated basis.", "than three years, by us or any Consolidated Subsidiary of any assets are prohibited unless (a) we or such Consolidated Subsidiary would be entitled to incur Indebtedness secured by a lien on the assets to be leased in an amount at least equal to the Attributable Debt in respect of such transaction without equally and ratably securing the notes, or (b) the proceeds of the sale of the assets to be leased are at least equal to their fair market value (as determined by our Board of Directors) and the proceeds are applied to the purchase or acquisition, or, in the case of real property, the construction, of assets or to the retirement of Indebtedness.", "The foregoing limitation will not apply, if at the time we or any Consolidated Subsidiary enters into such sale and lease-back transaction, and after giving effect thereto, Exempted Debt does not exceed 10% of our total assets on a consolidated basis.", "time, or in part, from time to time, at our option, for cash, at a redemption price that includes accrued and unpaid interest and a make-whole premium, as specified in the Indenture and the applicable Officer\u2019s Certificate.", "York  Stock  Exchange  under  the  symbol  \u201cMCK25.\u201d  Our  2026  Notes  are  listed  on  the  New  York  Stock  Exchange  under  the  symbol \u201cMCK26.\u201d Our 2029 Notes are listed on the New York Stock Exchange under the symbol \u201cMCK29.\u201d", "This Statement of Terms and Conditions is intended to meet the requirements of Code Section 409A and any regulations and rules promulgated thereunder.", "In the event of any inconsistency between this Statement of Terms and Conditions and the Plan, the Plan shall govern.", "Capitalized terms not otherwise defined in this Statement of Terms and Conditions shall have the meaning set forth in the Plan.", "With respect to  annual  Restricted  Stock  Unit  Awards  granted  to  Outside  Directors  under  the  Plan,  such  awards  shall  be  subject  to  the  following  terms,  conditions  and restrictions.", "The Administrator administering the Plan has authority to determine the Outside Directors to whom, and the time or", "additional Restricted Stock Units, which will be subject to all of the terms and conditions of the underlying Restricted Stock Unit Award.", "The number of such additional Restricted Stock Units shall be calculated by dividing (a) the aggregate amount or value of the dividends paid with respect to that number of Shares equal to the number of Restricted Stock Units credited as of the record date for such dividend by (b) the Fair Market Value per Share on the payment date for such dividend.", "Any fractional Shares resulting from the accumulation of dividend equivalents shall be paid in cash.", "Dividend equivalents in respect of Restricted Stock Units, if granted in tandem with such Units, will be converted into", "Neither an Outside Director nor any person entitled to exercise an Outside Director\u2019s rights in the event of the Outside", "this Statement of Terms and Conditions, or under a Restricted Stock Unit Agreement, shall be conclusive and binding on all persons.", "is providing the consents herein on a purely voluntary basis.", "Nothing herein contained shall affect an Outside Director\u2019s right, if any, to participate in and receive benefits", "Each Outside Director shall agree to make appropriate arrangements with the Corporation for satisfaction of any applicable federal,", "The Corporation will hold and use the Data only as long as is necessary to implement, administer and manage the", "illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.", "Agreements shall be governed by the laws of the State of Delaware.", "The provisions in this Statement of Terms and Conditions are severable and if any one or more provisions are determined to be", "This Statement of Terms and Conditions and the Restricted Stock Unit Agreements shall be binding upon and inure to the benefit of", "This Statement of Terms and Conditions is intended to meet the requirements of Code Section 409A and any regulations and rules promulgated thereunder.", "In the event of any inconsistency between this Statement of Terms and Conditions and the Plan, the Plan shall govern.", "Capitalized terms not otherwise defined in this Statement of Terms and Conditions shall have the meaning set forth in the Plan.", "With respect to  annual  Restricted  Stock  Unit  Awards  granted  to  Outside  Directors  under  the  Plan,  such  awards  shall  be  subject  to  the  following  terms,  conditions  and restrictions.", "The Administrator administering the Plan has authority to determine the Outside Directors to whom, and the time or", "Neither an Outside Director nor any person entitled to exercise an Outside Director\u2019s rights in the event of the Outside", "this Statement of Terms and Conditions, or under a Restricted Stock Unit Agreement, shall be conclusive and binding on all persons.", "is providing the consents herein on a purely voluntary basis.", "Nothing herein contained shall affect an Outside Director\u2019s right, if any, to participate in and receive benefits", "Each Outside Director shall agree to make appropriate arrangements with the Corporation for satisfaction of any applicable federal,", "The Corporation will hold and use the Data only as long as is necessary to implement, administer and manage the", "illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.", "Agreements shall be governed by the laws of the State of Delaware.", "The provisions in this Statement of Terms and Conditions are severable and if any one or more provisions are determined to be", "This Statement of Terms and Conditions and the Restricted Stock Unit Agreements shall be binding upon and inure to the benefit of", "In the event of any inconsistency between this Statement of Terms and Conditions and the Plan, the Plan shall govern.", "Capitalized terms not otherwise defined in this Statement of Terms and Conditions shall have the meaning set forth in the Plan.", "The Option is also subject to the terms and conditions of the Plan.", "In no event shall the Corporation be required to issue fractional Shares.", "An Option granted under the Plan shall be evidenced by an Option Agreement setting forth the terms and conditions of the", "The Exercise Price of an Option, as specified in the Option Agreement, shall be equal to or greater than the Fair Market Value of", "Period, the Option Period shall end on the date of such termination of employment and the Option shall thereupon not be exercisable to any extent whatsoever.", "Term Disability, the vesting schedule of the Participant\u2019s Option shall be accelerated, the Option shall become fully exercisable and the Option Period shall end on the earlier of (i) three years after the date of the Participant\u2019s termination of employment and (ii) the Expiration Date.", "Retirement, (i) the Option shall be exercisable only to the extent that it was exercisable at the time of such retirement and (ii) the Option Period for that portion of the Option designated as a Non Statutory Stock Option shall end on the earlier of (a) three years after the date of such retirement and (b) the Expiration Date.", "of  the  Participant's  Option,  then  the  Option  shall  continue  to  remain  outstanding  until  the  earlier  of  (i)  such  time  as  the  Participant  subsequently  terminates employment and (ii) the Expiration Date.", "number of Shares as to which the Option is so exercised.", "thereunder shall be transferable by the Participant by operation of law or otherwise, other than by will or the laws of descent and distribution.", "have any of the rights of a stockholder with respect to the Shares subject to an Option except to the extent that a book entry has been entered in the records of the Corporation\u2019s transfer agent with respect to such Shares upon the exercise of an Option.", "Neither a Participant nor any person entitled to exercise a Participant\u2019s rights in the event of the Participant\u2019s death shall", "Stock dividends paid with respect to Restricted Stock during the Restriction Period shall be treated as Restricted Stock which shall be subject to the same restrictions as the original award for the duration of the Restriction Period.", "If the Participant does not have a brokerage account of record, then an appropriate book entry recording the Participant\u2019s interest in the unrestricted Shares shall be entered on the records of the Corporation\u2019s transfer agent.", "Cash dividends paid with respect to Restricted Stock during the Restriction Period shall be credited on behalf of the Participant to a", "Election to Recognize Gross Income in the Year of Grant.", "The Administrator reserves the right to impose a restriction on the sale of Shares that the Participant receives upon", "Neither a Participant nor any person entitled to exercise a Participant\u2019s rights in the event of the Participant\u2019s death shall", "The Administrator reserves the right to impose a restriction on the sale of Shares that the Participant receives upon", "Following the end of the performance period, the Compensation Committee shall determine the extent to which the criteria have been achieved and shall authorize the grant and issuance of Shares in respect of the Performance Stock Unit Award.", "The performance period of a Performance Stock Unit Award shall be greater than one year,", "Unless otherwise determined by the Compensation Committee in its sole discretion, Dividend Equivalents shall not be", "A Participant shall not be permitted to sell, transfer, pledge, assign or encumber all or any portion of a Performance Stock Unit", "Neither a Participant nor any person entitled to exercise a Participant\u2019s rights in the event of the Participant\u2019s death shall", "The Administrator reserves the right to impose a restriction on the sale of Shares that the Participant", "addition, any Award of Restricted Stock or Restricted Stock Units as to which the restrictions have not lapsed shall immediately and automatically be forfeited, Performance Stock Unit Awards shall immediately and automatically be forfeited and any such Shares of Restricted Stock shall be returned to the Corporation and all of the rights of the Participant to such Awards and the underlying Shares shall immediately terminate.", "Any outstanding Option shall immediately and automatically terminate, be forfeited and shall cease to be exercisable, without limitation.", "determination shall be conclusive and binding on all interested persons.", "a manner that is valid and enforceable and that comes closest to the business objectives intended by such invalid or unenforceable provision, without invalidating or rendering unenforceable the remaining provisions of this Section VI.", "under an Award Agreement, shall be conclusive and binding on all interested persons.", "Participation in the Plan shall not create a right to further employment with the Participant\u2019s employer (the", "In making grants to Participants in foreign countries, the Administrator has the full discretion to", "All decisions of the Administrator administering the Plan upon any questions arising under the Plan or", "Nothing herein contained shall affect a Participant\u2019s right to participate in and receive benefits from and in", "Regardless  of any  action  the  Corporation  or  the  Employer  takes  with  respect  to  any  federal,  state  or  local  income  tax,  social", "Calculation of the number of Shares to be withheld shall be made based on the closing price of the Common Stock on the New York Stock Exchange on the date that the amount of tax to be withheld is determined.", "With respect to an Award other than an Option, if adequate arrangements to satisfy the obligations with regard to all Tax-Related Items are not made by the Participant with the Corporation and/or the Employer prior to the relevant taxable event, the Corporation will satisfy such obligations as provided above in clause (3) of this paragraph.", "The Administrator shall be authorized to establish such rules, forms and procedures as it deems necessary to implement the foregoing.", "In accepting the grant, the Participant acknowledges that:", "jurisdiction may have different data privacy laws and protections than the United States.", "In the latter case, the Participant understands and acknowledges that the Corporation\u2019s legal basis for the processing of the Participant\u2019s Data would be compliance with the relevant  laws  or  regulations  or  the  pursuit  by  the  Corporation  of  respective  legitimate  interests  not  outweighed  by  the  Participant\u2019s  interests,  rights  or freedoms.", "When the Corporation no longer needs the Participant\u2019s Data for any of the above purposes, the Participant understands the Corporation will remove it from its systems.", "providing the consents herein on a purely voluntary basis.", "illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.", "If the Participant has received this Statement of Terms and Conditions or any other document related to the Plan translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control.", "The provisions in this Statement of Terms and Conditions are severable and if any one or more provisions are determined to be", "The Participant acknowledges that the Participant is proficient in the English language and, accordingly, understands the provisions of", "The Corporation will hold and use the Data only as long as is necessary to implement, administer and manage the", "Participation in the Plan is voluntary and the Participant is", "In the event of any inconsistency between this Statement of Terms and Conditions and the Plan, the Plan shall govern.", "Capitalized terms not otherwise defined in this Statement of Terms and Conditions shall have the meaning set forth in the Plan.", "The Option is also subject to the terms and conditions of the Plan.", "In no event shall the Corporation be required to issue fractional Shares.", "An Option granted under the Plan shall be evidenced by an Option Agreement setting forth the terms and conditions of the", "The Exercise Price of an Option, as specified in the Option Agreement, shall be equal to or greater than the Fair Market Value of", "Period, the Option Period shall end on the date of such termination of employment and the Option shall thereupon not be exercisable to any extent whatsoever.", "Term Disability, the vesting schedule of the Participant\u2019s Option shall be accelerated, the Option shall become fully exercisable and the Option Period shall end on the earlier of (i) three years after the date of the Participant\u2019s termination of employment and (ii) the Expiration Date.", "Retirement, (i) the Option shall be exercisable only to the extent that it was exercisable at the time of such retirement and (ii) the Option Period for that portion of the Option designated as a Nonstatutory Stock Option shall end on the earlier of (a) three years after the date of such retirement and (b) the Expiration Date.", "of  the  Participant's  Option,  then  the  Option  shall  continue  to  remain  outstanding  until  the  earlier  of  (i)  such  time  as  the  Participant  subsequently  terminates employment and (ii) the Expiration Date.", "number of Shares as to which the Option is so exercised.", "thereunder shall be transferable by the Participant by operation of law or otherwise, other than by will or the laws of descent and distribution.", "have any of the rights of a stockholder with respect to the Shares subject to an Option except to the extent that a book entry has been entered in the records of the Corporation\u2019s transfer agent with respect to such Shares upon the exercise of an Option.", "Neither a Participant nor any person entitled to exercise a Participant\u2019s rights in the event of the Participant\u2019s death shall", "Stock dividends paid with respect to Restricted Stock during the Restriction Period shall be treated as Restricted Stock which shall be subject to the same restrictions as the original award for the duration of the Restriction Period.", "If the Participant does not have a brokerage account of record, then an appropriate book entry recording the Participant\u2019s interest in the unrestricted Shares shall be entered on the records of the Corporation\u2019s transfer agent.", "Cash dividends paid with respect to Restricted Stock during the Restriction Period shall be credited on behalf of the Participant to a", "Election to Recognize Gross Income in the Year of Grant.", "The Administrator reserves the right to impose a restriction on the sale of Shares that the Participant receives upon", "Neither a Participant nor any person entitled to exercise a Participant\u2019s rights in the event of the Participant\u2019s death shall", "The Administrator reserves the right to impose a restriction on the sale of Shares that the Participant receives upon", "The performance period of a Performance Stock Unit Award shall be greater than one year,", "Unless otherwise determined by the Compensation Committee in its sole discretion, Dividend Equivalents shall not be", "A Participant shall not be permitted to sell, transfer, pledge, assign or encumber all or any portion of a Performance Stock Unit", "Neither a Participant nor any person entitled to exercise a Participant\u2019s rights in the event of the Participant\u2019s death shall", "The Administrator reserves the right to impose a restriction on the sale of Shares that the Participant", "addition, any Award of Restricted Stock or Restricted Stock Units as to which the restrictions have not lapsed shall immediately and automatically be forfeited, Performance Stock Unit Awards shall immediately and automatically be forfeited and any such Shares of Restricted Stock shall be returned to the Corporation and all of the rights of the Participant to such Awards and the underlying Shares shall immediately terminate.", "Any outstanding Option shall immediately and automatically terminate, be forfeited and shall cease to be exercisable, without limitation.", "determination shall be conclusive and binding on all interested persons.", "a manner that is valid and enforceable and that comes closest to the business objectives intended by such invalid or unenforceable provision, without invalidating or rendering unenforceable the remaining provisions of this Section VI.", "under an Award Agreement, shall be conclusive and binding on all interested persons.", "Participation in the Plan shall not create a right to further employment with the Participant\u2019s employer (the", "In making grants to Participants in foreign countries, the Administrator has the full discretion to", "All decisions of the Administrator administering the Plan upon any questions arising under the Plan or", "Nothing herein contained shall affect a Participant\u2019s right to participate in and receive benefits from and in", "Regardless  of any  action  the  Corporation  or  the  Employer  takes  with  respect  to  any  federal,  state  or  local  income  tax,  social", "Calculation of the number of Shares to be withheld shall be made based on the closing price of the Common Stock on the New York Stock Exchange on the date that the amount of tax to be withheld is determined.", "With respect to an Award other than an Option, if adequate arrangements to satisfy the obligations with regard to all Tax-Related Items are not made by the Participant with the Corporation and/or the Employer prior to the relevant taxable event, the Corporation will satisfy such obligations as provided above in clause (3) of this paragraph.", "The Administrator shall be authorized to establish such rules, forms and procedures as it deems necessary to implement the foregoing.", "In accepting the grant, the Participant acknowledges that:", "jurisdiction may have different data privacy laws and protections than the United States.", "In the latter case, the Participant understands and acknowledges that the Corporation\u2019s legal basis for the processing of the Participant\u2019s Data would be compliance with the relevant  laws  or  regulations  or  the  pursuit  by  the  Corporation  of  respective  legitimate  interests  not  outweighed  by  the  Participant\u2019s  interests,  rights  or freedoms.", "When the Corporation no longer needs the Participant\u2019s Data for any of the above purposes, the Participant understands the Corporation will remove it from its systems.", "providing the consents herein on a purely voluntary basis.", "illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.", "If the Participant has received this Statement of Terms and Conditions or any other document related to the Plan translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control.", "The provisions in this Statement of Terms and Conditions are severable and if any one or more provisions are determined to be", "The Participant acknowledges that the Participant is proficient in the English language and, accordingly, understands the provisions of", "The Corporation will hold and use the Data only as long as is necessary to implement, administer and manage the", "Participation in the Plan is voluntary and the Participant is", "In the event of any inconsistency between this Statement of Terms and Conditions and the Plan, the Plan shall govern.", "Capitalized terms not otherwise defined in this Statement of Terms and Conditions shall have the meaning set forth in the Plan.", "The Option is also subject to the terms and conditions of the Plan.", "In no event shall the Corporation be required to issue fractional Shares.", "An Option granted under the Plan shall be evidenced by an Option Agreement setting forth the terms and conditions of the", "The Exercise Price of an Option, as specified in the Option Agreement, shall be equal to or greater than the Fair Market Value of", "Period, the Option Period shall end on the date of such termination of employment and the Option shall thereupon not be exercisable to any extent whatsoever.", "Term Disability, the vesting schedule of the Participant\u2019s Option shall be accelerated, the Option shall become fully exercisable and the Option Period shall end on the earlier of (i) three years after the date of the Participant\u2019s termination of employment and (ii) the Expiration Date.", "Retirement, (i) the Option shall be exercisable only to the extent that it was exercisable at the time of such retirement and (ii) the Option Period for that portion of the Option designated as a Non Statutory Stock Option shall end on the earlier of (a) three years after the date of such retirement and (b) the Expiration Date.", "of  the  Participant's  Option,  then  the  Option  shall  continue  to  remain  outstanding  until  the  earlier  of  (i)  such  time  as  the  Participant  subsequently  terminates employment and (ii) the Expiration Date.", "number of Shares as to which the Option is so exercised.", "thereunder shall be transferable by the Participant by operation of law or otherwise, other than by will or the laws of descent and distribution.", "have any of the rights of a stockholder with respect to the Shares subject to an Option except to the extent that a book entry has been entered in the records of the Corporation\u2019s transfer agent with respect to such Shares upon the exercise of an Option.", "Neither a Participant nor any person entitled to exercise a Participant\u2019s rights in the event of the Participant\u2019s death shall", "Stock dividends paid with respect to Restricted Stock during the Restriction Period shall be treated as Restricted Stock which shall be subject to the same restrictions as the original award for the duration of the Restriction Period.", "If the Participant does not have a brokerage account of record, then an appropriate book entry recording the Participant\u2019s interest in the unrestricted Shares shall be entered on the records of the Corporation\u2019s transfer agent.", "Cash dividends paid with respect to Restricted Stock during the Restriction Period shall be credited on behalf of the Participant to a", "Election to Recognize Gross Income in the Year of Grant.", "Neither a Participant nor any person entitled to exercise a Participant\u2019s rights in the event of the Participant\u2019s death shall", "Following the end of the performance period, the Compensation Committee shall determine the extent to which the criteria have been achieved and shall authorize the grant and issuance of Shares in respect of the Performance Stock Unit Award.", "The performance period of a Performance Stock Unit Award shall be greater than one year,", "addition, any Award of Restricted Stock or Restricted Stock Units as to which the restrictions have not lapsed shall immediately and automatically be forfeited, Performance Stock Unit Awards shall immediately and automatically be forfeited and any such Shares of Restricted Stock shall be returned to the Corporation and all of the rights of the Participant to such Awards and the underlying Shares shall immediately terminate.", "Unless otherwise determined by the Compensation Committee in its sole discretion, Dividend Equivalents shall not be", "A Participant shall not be permitted to sell, transfer, pledge, assign or encumber all or any portion of a Performance Stock Unit", "Neither a Participant nor any person entitled to exercise a Participant\u2019s rights in the event of the Participant\u2019s death shall", "Any outstanding Option shall immediately and automatically terminate, be forfeited and shall cease to be exercisable, without limitation.", "determination shall be conclusive and binding on all interested persons.", "a manner that is valid and enforceable and that comes closest to the business objectives intended by such invalid or unenforceable provision, without invalidating or rendering unenforceable the remaining provisions of this Section VI.", "Participation in the Plan shall not create a right to further employment with the Participant\u2019s employer (the", "In making grants to Participants in foreign countries, the Administrator has the full discretion to", "under an Award Agreement, shall be conclusive and binding on all interested persons.", "Calculation of the number of Shares to be withheld shall be made based on the closing price of the Common Stock on the New York Stock Exchange on the date that the amount of tax to be withheld is determined.", "With respect to an Award other than an Option, if adequate arrangements to satisfy the obligations with regard to all Tax-Related Items are not made by the Participant with the Corporation and/or the Employer prior to the relevant taxable event, the Corporation will satisfy such obligations as provided above in clause (3) of this paragraph.", "All decisions of the Administrator administering the Plan upon any questions arising under the Plan or", "Nothing herein contained shall affect a Participant\u2019s right to participate in and receive benefits from and in", "Regardless  of any  action  the  Corporation  or  the  Employer  takes  with  respect  to  any  federal,  state  or  local  income  tax,  social", "The Administrator shall be authorized to establish such rules, forms and procedures as it deems necessary to implement the foregoing.", "In accepting the grant, the Participant acknowledges that:", "jurisdiction may have different data privacy laws and protections than the United States.", "In the latter case, the Participant understands and acknowledges that the Corporation\u2019s legal basis for the processing of the Participant\u2019s Data would be compliance with the relevant  laws  or  regulations  or  the  pursuit  by  the  Corporation  of  respective  legitimate  interests  not  outweighed  by  the  Participant\u2019s  interests,  rights  or freedoms.", "When the Corporation no longer needs the Participant\u2019s Data for any of the above purposes, the Participant understands the Corporation will remove it from its systems.", "providing the consents herein on a purely voluntary basis.", "The Corporation will hold and use the Data only as long as is necessary to implement, administer and manage the", "Participation in the Plan is voluntary and the Participant is", "illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.", "If the Participant has received this Statement of Terms and Conditions or any other document related to the Plan translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control.", "The provisions in this Statement of Terms and Conditions are severable and if any one or more provisions are determined to be", "The Participant acknowledges that the Participant is proficient in the English language and, accordingly, understands the provisions of", "In the event of any inconsistency between this Award Agreement and the Plan, the Plan shall govern.", "Capitalized terms not otherwise defined in this Award Agreement shall have the meaning set forth in the Plan.", "determine the extent to which the performance goals have been achieved, and shall determine the number of PSUs that have been earned.", "Once the Compensation Committee has determined the number of PSUs that have been earned pursuant to the", "Dividend equivalents shall be credited in respect of the One-Year RSU Award.", "The restrictions applicable to the RSU Award shall lapse with respect to 100% of the underlying Shares on the third", "Dividend equivalents shall be credited in respect of the RSU Award granted under this Section III.", "If the Participant ceases to be a bona fide employee of the Corporation or any Affiliate (except as otherwise", "otherwise  forfeited  pursuant  to  the  terms  of  the  Plan  and  this  Award  Agreement  shall  be  paid  to  the  Participant  as  soon  as  reasonably  practicable  after  the restrictions lapse.", "Performance  Stock  Units and  Restricted  Stock  Units,  to  the  extent  the  restrictions  have  not  lapsed,  shall  immediately  and  automatically  be", "determination shall be conclusive and binding on all interested persons.", "a manner that is valid and enforceable and that comes closest to the business objectives intended by such invalid or unenforceable provision, without invalidating or rendering unenforceable the remaining provisions of this Section IV.", "Compensation Committee reserves the right to impose a restriction on the sale of Shares that the Participant receives upon the settlement of the Performance Stock Units and Restricted Stock Units granted hereunder, unless the Participant has satisfied the ownership targets applicable to the Participant as provided in such policy.", "Neither the Participant nor any person entitled to exercise the Participant\u2019s rights in the event of the Participant\u2019s death", "Participation in the Plan shall not create a right to further employment with the Participant\u2019s employer (the", "under this Award Agreement, shall be conclusive and binding on all interested persons.", "Calculation of the number of Shares to be withheld shall be made based on the closing price of the Common Stock on the New York Stock Exchange on the date that the amount of tax to be withheld is determined.", "If adequate arrangements to satisfy the obligations with regard to all Tax-Related Items are not made by the Participant with the Corporation and/or the Employer prior to the relevant taxable event, the Corporation will satisfy such obligations as provided above in clause (iii) of this paragraph.", "The Administrator has the full discretion to deviate from this Award Agreement in order to adjust the Awards", "All decisions of the Administrator administering the Plan upon any questions arising under the Plan or", "Nothing herein contained shall affect the Participant\u2019s right to participate in and receive benefits from and in", "Regardless  of any  action  the  Corporation  or  the  Employer  takes  with  respect  to  any  federal,  state  or  local  income  tax,  social", "The Administrator shall be authorized to establish such rules, forms and procedures as it deems necessary to implement the foregoing.", "In accepting the grant, the Participant acknowledges that:", "providing the consents herein on a purely voluntary basis.", "The Corporation will hold and use the Data only as long as is necessary to implement, administer and manage the", "Participation in the Plan is voluntary and the Participant is", "unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.", "English and if the meaning of the translated version is different than the English version, the English version will control.", "Award, the terms of which are set forth herein and in the Plan.", "The provisions in this Award Agreement are severable and if any one or more provisions are determined to be illegal or otherwise", "Below is a list of documents that are made available to you in connection with this Notice.", "PLEASE BE SURE TO READ THESE DOCUMENTS BECAUSE THEY CONTAIN IMPORTANT INFORMATION SPECIFIC TO THIS GRANT OF RSUs.", "By signing below, I acknowledge that: 1.    I agree to receive copies of the stockholder information, including copies of any annual report, proxy and Form 10-K, from the Investor Resources section of", "Below is a list of documents that are made available to you in connection with this Notice.", "PLEASE BE SURE TO READ THESE DOCUMENTS BECAUSE THEY CONTAIN IMPORTANT INFORMATION SPECIFIC TO THIS GRANT OF RSUs.", "I consent to receiving electronically a copy of the documents set forth above and attachments to this Notice; and 5.", "I accept ALL the terms and conditions as set forth in the Plan and ST&Cs applicable to this grant of RSUs.", "Your  PSUs  will  be  earned  subject  to  the  Company\u2019s  attainment  of  performance  goals  that  have  been  pre-established  by  the  Compensation  Committee  (the \u201cCommittee\u201d) of the Company\u2019s Board of Directors.", "Below is a list of documents that are made available to you in connection with this Notice.", "PLEASE BE SURE TO READ THESE DOCUMENTS BECAUSE THEY CONTAIN IMPORTANT INFORMATION SPECIFIC TO THIS GRANT OF PSUs.", "I consent to receiving electronically a copy of the documents set forth above and attachments to this Notice; and 12.", "I should consult with a tax advisor prior to accepting this grant of PSUs or taking any other action with respect to this grant of PSUs; and 14.", "I accept ALL the terms and conditions as set forth in the Plan and ST&Cs applicable to this grant of PSUs.", "We consent to the incorporation by reference in McKesson Corporation Registration Statement Nos. 333-249817, 333-163642, 333-190847, 333-190848, and 333- 213488 on Form S-8, and Registration Statement No. 333-236808 on Form S-3, of our report dated May 12, 2021, relating to the consolidated financial statements and consolidated financial statement schedule of McKesson Corporation and subsidiaries, and the effectiveness of McKesson Corporation\u2019s internal control over financial reporting appearing in this Annual Report on Form 10-K of McKesson Corporation for the year ended March 31, 2021.", "I have reviewed this annual report on Form 10-K of McKesson Corporation;", "The registrant\u2019s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant\u2019s auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):", "I have reviewed this annual report on Form 10-K of McKesson Corporation;", "The registrant\u2019s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant\u2019s auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):", "Together, we work across the healthcare delivery system to connect pharmacies, providers, payers, and biopharma for next-generation patient access and adherence solutions that help people get the medicine they need to live healthier lives.", "Unless otherwise noted, all references in this document to a particular year shall mean the", "On March 10, 2020, we completed the separation of our interest in the Change Healthcare JV through a split- off transaction.", "This transaction reduced our investment in the Change Healthcare JV to zero.", "Change Healthcare: Our equity ownership interest in Change Healthcare JV, a joint venture, has been accounted for using the equity method of accounting.", "for our innovations and obtain copyright protection for our original works of authorship, when such protection is advantageous.", "Through these efforts, we have developed a portfolio of patents and copyrights in the U.S. and worldwide.", "In addition, we have registered or applied to register certain trademarks and service marks in the U.S. and in foreign countries.", "We cannot guarantee that our intellectual property portfolio will be sufficient to deter misappropriation, theft, or misuse of our technology, nor that we can successfully enjoin infringers.", "We periodically receive notices alleging that our products or services infringe on third party patents and other intellectual property rights.", "While the outcome of any litigation or dispute is inherently uncertain, we do not believe that the resolution of any of these infringement notices would have a material adverse impact on our results of operation.", "These values and behaviors help make McKesson unique.", "We offer financial assistance programs for higher education opportunities that support employees\u2019 career growth at the company.", "To provide compensation that is focused on attracting and retaining talent with the skills and experience necessary for a specific role, our compensation program is built on a set of quantifiable factors defined by our guiding principles of internal fairness, market competitiveness, and pay for performance.", "We operate in several countries and our benefits offerings vary accordingly.", "We offer health and wellness benefits to advance the physical, mental, and social well-being of our people, savings programs to help prepare them for retirement, and flexible work arrangements, among other  benefits  offerings,  when  possible.  In  response  to  the  COVID-19  pandemic,  we  offered  extended  medical  benefits  covering  COVID-19  related  visits, treatment and testing, expanded telehealth options, emergency paid time off (\u201cPTO\u201d), and a platform for employees to donate their regular PTO to co-workers who were  more  impacted  by  COVID-19.", "We have received monetary penalties and/or licensing sanctions pursuant to these requirements and future allegations of noncompliance could result in an inability to obtain, maintain or renew permits, licenses or other regulatory approvals needed for the operation of our businesses.", "As a result of ongoing, advanced discussions with state attorneys general and plaintiffs\u2019 representatives regarding a framework to resolve the claims of governmental entities, and our assessment of certain other opioid-related claims, we have reached a stage at which a broad settlement of opioid claims by governmental entities is probable and recorded a charge of $8.1 billion for the year ended March 31, 2021 within \u201cClaims and litigation charges, net\u201d in our Consolidated Statement of Operations in this Annual Report on Form 10-K.", "Because of the many uncertainties associated with any potential settlement arrangement or other resolution of opioid-related litigation, including the uncertainty of the scope of participation by plaintiffs in any potential settlement, we are not able to reasonably estimate the upper or lower ends of the range of ultimate possible loss for all opioid-related litigation matters.", "The adverse outcome of legal proceedings might also involve significant  expense,  management  time  and  distraction,  and risk  of loss that  can be difficult  to predict  or quantify.  In addition  to this litigation,  legislative  or regulatory measures related to the distribution of controlled substances such as prescription opioids could affect our business in ways that we may not be able to predict.", "For example, some states have passed legislation that could require us to pay taxes or assessments on the distribution of opioid medications in those states and other states have considered similar legislation.", "We are subject to government audits,  investigations  and  oversight  proceedings.  Government  agencies  routinely  review  and  audit  government  contractors  to  determine  whether  they  are complying with contractual and legal requirements.", "If we fail to comply with these requirements, or we fail an audit, we may be subject to various sanctions such as monetary damages, criminal and civil penalties, termination of contracts and suspension or debarment from government contract work.", "These requirements complicate our business and increase our compliance burden and material non-compliance could harm our reputation.", "affecting  Medicare,  Medicaid,  other  government  healthcare  programs,  and  government  contracts.  Our  relationships  with  pharmaceutical  and  medical  surgical product manufacturers and healthcare providers, as well as our provision of products and services to government entities, subject our business to laws, regulation, and government guidance on fraud and abuse.", "Many of these laws are vague or indefinite and have not been interpreted by the courts and, as such, may be interpreted or applied by a prosecutorial, regulatory, or judicial authority in a manner that could require us to make changes in our operations.", "Americans and changed the way healthcare is financed by both governmental and private payers.", "There are also further efforts to broaden healthcare coverage.", "Provincial governments in Canada that provide partial funding for the purchase of pharmaceuticals and independently regulate the sale and reimbursement of drugs have sought to reduce the costs of publicly funded health programs.", "Some European governments  have  implemented  or  are  considering  austerity  measures  to  reduce  healthcare  spending.  These  measures  exert  pressure  on  the  pricing  and reimbursement timelines for pharmaceuticals and may cause our customers to purchase fewer of our products and services or influence us to reduce prices.", "There is substantial uncertainty about the likelihood, timing and results of these health reform efforts.", "We also have record- keeping  and  other  obligations  under  the  E.U.  Falsified  Medicines  Directive.  Pedigree  tracking  laws  such  as  these  increase  our  compliance  burden  and  our pharmaceutical distribution costs.", "For example, under the Health Insurance Portability and Accountability Act of 1996 (\u201cHIPAA\u201d) we must maintain administrative, physical  and  technological  safeguards  to  protect  individually  identifiable  health  information  (\u201cprotected  health  information\u201d)  and  ensure  the  confidentiality, integrity, and availability of electronic protected health information.", "We are subject to significant compliance obligations under privacy laws such as the General Data Protection Regulation (\u201cGDPR\u201d) in the European Union, the Personal Information Protection and Electronic Documents Act (\u201cPIPEDA\u201d) in Canada, and the California Consumer Protection Act (\u201cCCPA\u201d).", "We are subject to privacy  and  data  protection  compliance  audits  or  investigations  by  various  government  agencies.  Failure  to  comply  with  these  laws  subjects  us  to  potential regulatory enforcement activity, fines, private litigation including class actions, and other costs.", "We also have contractual obligations to customers that might be breached if we fail to comply with privacy laws.", "Our efforts to comply with privacy laws complicate our operations and add to our compliance costs.", "storage and hosting of sensitive information, including protected health information and other types of personal information, confidential financial information, proprietary information, and other sensitive information relating to our customers, company and workforce.", "costs.  Environmental  costs  and  accruals,  including  that  related  to  our  legacy  chemical  distribution  operations,  presently  are  not  material  to our  operations  or financial position.", "Our ten largest customers comprised approximately 32%, and CVS was approximately 19%, of total trade accounts receivable at March 31, 2021.", "We also have agreements with GPOs, each of which functions as a purchasing agent on behalf of member  hospitals,  pharmacies  and other healthcare  providers,  as well as with government  entities  and agencies.  The accounts receivable balances are with individual members of the GPOs, and therefore no significant concentration of credit risk exists.", "Substantially all of these revenues and accounts receivable are included in our U.S.", "distribution arrangements with pharmaceutical manufacturers that include an inflation-based compensation component whereby we benefit when the manufacturers increase their prices as we sell our existing inventory at the new higher prices.", "Forward-looking  statements  involve  risks  and  uncertainties  that  could  cause  actual  results  to  differ  materially  from  those  projected,  anticipated,  or  implied.", "Except to the extent required by federal securities laws, we undertake no obligation to publicly release the result of any revisions to any forward-looking statements to reflect events or circumstances after the date the statements are made, or to reflect the occurrence of unanticipated events.", "Some of our distribution arrangements with the manufacturers provides us compensation based on a percentage of our purchases.", "We experience costly and disruptive legal disputes.", "Despite valid defenses that we assert, legal disputes are often costly, time-consuming, distracting to management and disruptive to normal business operations.", "The outcome of legal disputes is difficult to predict.", "Outcomes can occur that are not justified by the evidence or existing law.", "The uncertainty and expense associated with unresolved legal disputes might harm our business and reputation even if the matter is favorably resolved.", "Accordingly, any legal dispute might have a materially adverse impact on our reputation, our business operations and our financial position or results of operations.", "We might experience losses not covered by insurance.", "supplies, the provision of ancillary services, the conduct of our payer businesses and the provision of products that assist clinical decision-making and relate to patient medical histories and treatment plans.", "Although we seek to maintain adequate insurance coverage,  such  as  property  insurance  for  inventory  and  professional  and  general  liability  insurance,  coverages  on  acceptable  terms  might  be  unavailable,  or coverages might not cover our losses.", "We generally seek to limit our contractual exposure, but limitations of liability or indemnity provisions in our contracts may not be enforceable or adequately protect us from liability.", "Uninsured losses might have a materially adverse impact on our business operations and our financial position or results of operations.", "We regularly are named as a defendant in similar, new cases.", "Many of these cases raise novel theories of liability.", "Any proceedings can have unexpected outcomes that are not justified by evidence or existing law.", "It is not uncommon for claims to be resolved over many years.", "Although the Company has valid defenses and is vigorously defending itself, some proceedings have been and others may be resolved by negotiated outcome.", "Our reputation has been and may continue to be impacted by publicity regarding the litigation and related allegations.", "The adverse outcome of legal proceedings might have a materially adverse impact on our business operations and our financial position or results of operations.", "For example, some states have passed legislation that could require us to pay taxes or assessments on the distribution of opioid medications in those states and other states have considered similar legislation.", "Liabilities for taxes or assessments or other costs of compliance under any such laws might have a materially adverse impact on our reputation, business operations, and our financial position or results of operations.", "We are subject to extensive, complex and challenging healthcare and other laws.", "Any noncompliance by us with applicable laws or the failure to maintain, renew or obtain necessary permits and licenses could lead to litigation and might have a materially adverse impact on our business operations and our financial position or results of operations.", "Local, state and federal governments continue to strengthen their position and scrutiny over practices involving or allegedly involving fraud, waste and abuse affecting Medicare, Medicaid and other government healthcare programs.", "Our relationships with pharmaceutical and medical surgical product manufacturers and healthcare providers, as well as our provision of products and services to government entities, subject our business to laws and regulations on fraud and abuse, which among other things: (1) prohibit persons from soliciting, offering, receiving or paying any remuneration in order to induce the referral of a patient for treatment  or  to  induce  the  ordering  or  purchasing  of  items  or  services  that  are  in  any  way  paid  for  by  Medicare,  Medicaid  or  other  government-sponsored healthcare programs; (2) impose many restrictions upon referring physicians and providers of designated health services under Medicare and Medicaid programs; and (3) prohibit the knowing submission of a false or fraudulent claim for payment to, and knowing retention of an overpayment by, a federal healthcare program such  as  Medicare  and  Medicaid.  Many  of  these  laws,  regulations,  and  government  guidance,  including  those  relating  to  marketing  incentives,  are  vague  or indefinite and have not been interpreted by the courts.", "The laws may be interpreted or applied by a prosecutorial, regulatory, or judicial authority in a manner that could require us to make changes in our operations.", "Failures to comply with applicable laws subject us to federal or state government investigations or qui tam actions, and to liability for damages and civil and criminal penalties, including the loss of licenses or our ability to participate in Medicare, Medicaid and other federal and state healthcare programs.", "These sanctions might have a materially adverse impact on our business operations and our financial position or results of operations.", "Noncompliance with these requirements has resulted in monetary penalties and/or licensing sanctions.", "For example, under a January 2017 agreement with the DEA and Department of Justice we paid $150 million to settle potential administrative and civil claims about our practices for reporting suspicious orders of controlled substances and the DEA suspended, on a staggered basis for limited periods of time, our registrations to distribute certain controlled substances from four distribution centers.", "Pedigree tracking laws increase our compliance burden and our pharmaceutical distribution costs.", "Pedigree tracking laws such as these increase our compliance burden and our pharmaceutical distribution costs, and they might have a materially adverse impact on our business operations and our financial position or results of operations.", "Privacy and data protection laws increase our compliance burden.", "example,  under  the  Health  Insurance  Portability  and  Accountability  Act  of  1996  (\u201cHIPAA\u201d)  we  must  maintain  administrative,  physical  and  technological safeguards  to  protect  individually  identifiable  health  information  (\u201cprotected  health  information\u201d)  and  ensure  the  confidentiality,  integrity  and  availability  of electronic protected health information.", "Failure to comply with these laws subjects us to potential regulatory enforcement activity, fines, private litigation including class actions, and other costs.", "We also have contractual obligations to customers that might be breached if we fail to comply with privacy laws.", "Our efforts to comply with privacy laws complicates our operations and adds to our compliance costs.", "A significant privacy breach or failure  to  comply  with  privacy  laws  might  have  a  materially  adverse  impact  on  our  reputation,  business  operations  and  our  financial  position  or  results  of operations.", "Anti-bribery and anti-corruption laws increase our compliance burden.", "Bribery Act unless the organization can establish the defense of having implemented adequate procedures to prevent bribery.", "Our failure to comply with these laws might subject us to civil and criminal penalties that might have a materially adverse impact on our reputation, business operations and our financial position or results of operations.", "We are subject to a variety of privacy and data protection laws that change frequently and have requirements that vary from jurisdiction to jurisdiction.", "We  are  subject  to  laws  prohibiting  improper  payments  and  bribery,  including  the  U.S.  Foreign  Corrupt  Practices  Act,  the  U.K.  Bribery  Act  and  similar", "We might record significant charges from impairment to goodwill, intangibles and other assets or investments.", "In addition, we periodically review our intangible and other long-lived assets for impairment when events or changes in circumstances, such as a divestiture, indicate the carrying value may not be recoverable.", "Factors that may be considered a change in circumstances indicating that  the  carrying  value  of  our  intangible  and  other  long-lived  assets  may  not  be  recoverable  include  slower  growth  rates,  the  loss  of  a  significant  customer, burdensome new laws or divestiture of a business or asset for less than its carrying value.", "There are inherent uncertainties in management\u2019s estimates, judgments and assumptions used in assessing recoverability of goodwill, intangible and other long-lived assets.", "We may be required to record a significant charge to earnings in our consolidated financial statements during the period in which any impairment of our goodwill or intangible and other long-lived assets is determined, which might have a materially adverse impact on our business operations and our financial position or results of operations.", "storage and hosting of sensitive information, including protected health information and other types of personal information, confidential financial information, proprietary information, and other sensitive information relating to our customers, company and workforce.", "If our software and technology services are alleged to have contributed to faulty clinical decisions or injury to patients, we might be subject to claims or litigation by users of our software or services or their patients.", "Any of these types of errors or failures might have a materially adverse impact on our reputation, business operations and our financial position or results of operations.", "We  are  required  under  U.S.  Generally  Accepted  Accounting  Principles  (\u201cGAAP\u201d)  to  test  our  goodwill  for  impairment  annually  or  more  frequently  if", "We might be impeded in providing customers online services and data access.", "Any such problems might have a materially adverse impact on our business operations and our financial position or results of operations.", "Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.", "we may require financing that may not be available on acceptable terms.", "Any of these risks could adversely affect our ability to achieve the anticipated benefits of an acquisition and might have a materially adverse impact on our business operations and our financial position or results of operations.", "Exclusive forum provisions in our Bylaws could limit our stockholders\u2019 ability to choose their preferred judicial forum for disputes with us or our directors, officers or employees.", "Current and former stockholders are deemed to have consented to the personal jurisdiction of the Delaware Courts in connection with any action to enforce that exclusive forum provision and to service of process in any such action.", "To the extent that these provisions of the bylaws limit a current or former stockholder\u2019s ability to select a judicial forum other than the Delaware Courts, they might discourage the specified legal actions, might cause current or former stockholders to incur additional litigation-related expenses and might result in outcomes unfavorable to current or former stockholders.", "A court might determine that these provisions of the bylaws are inapplicable or unenforceable in any particular action, in which case we may incur additional litigation related expenses in such action, and the action may result in outcomes unfavorable to us, which could have a materially adverse impact on our reputation, our business operations and our financial position or results of operations.", "We might be adversely impacted by delays or other difficulties with divestitures.", "After the disposition, we might experience greater dissynergies than expected, and the impact of the divestiture on our revenue or profit might be larger than we expected.", "We might have difficulties with pre-closing conditions such as regulatory and governmental approvals, which could delay or prevent the divestiture.", "We might have financial exposure in a divested business, such as through minority equity ownership, financial  or  performance  guarantees,  indemnities  or  other  obligations,  such  that  conditions  outside  of  our  control  might  negate  the  expected  benefits  of  the disposition.", "Any of these risks could adversely affect our ability to achieve the anticipated benefits of a divestiture and might have a materially adverse impact on our business operations and our financial position or results of operations.", "We might not realize the expected tax treatment from our split-off of Change Healthcare.", "If Change does not honor its obligations to indemnify the Company, or if the Transactions fail to qualify for the intended tax-free treatment for reasons not related to a disqualifying action by Change or SpinCo, the resulting tax to the Company could have a significant adverse effect on our financial position or results of operations.", "outsourced service providers, and we might not realize expected cost savings or other benefits.", "For example, our ability to use outsourcing resources in certain jurisdictions might be limited by legislative action or customer contracts, with the result that the work must be performed at greater expense or we may be subject to sanctions for non-compliance.", "Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.", "We might encounter difficulties attracting and retaining customers to our retail locations due to their unfamiliarity with our brands or our inexperience with local market  preferences.  Competition  from  our  retail  pharmacy  operations  might  strain  relationships  with  our  retail  pharmacy  customers.  Consolidation  of  retail pharmacies with third party payers, expansion of large retail pharmacy networks, reductions in reimbursement rates, shifts in the mix of branded and generic pharmaceutical sales, and exclusion from preferred pharmacy networks can impair our retail pharmacy sales and profitability.", "We might be harmed by large customer purchase reductions, payment defaults or contract non-renewal.", "March 31, 2021, sales to our largest customer represented approximately 21% of our consolidated revenues and approximately 19% of our trade receivables, and those of our ten largest customers combined accounted for approximately 51% of our consolidated revenues and approximately 32% of our trade receivables.", "A material  default  in  payment,  reduction  in  purchases,  or  the  loss  of  business  from  a  large  customer  might  have  a  materially  adverse  impact  on  our  business operations and our financial position or results of operations.", "Our contracts with government entities involve future funding and compliance risks.", "Our government contracts might not be renewed or might be terminated for convenience with little or no prior notice.", "Government contracts typically expose us to higher potential liability than do other types of contracts.", "We are subject to government audits, investigations and oversight proceedings.", "If we fail to comply with these requirements, or we fail an audit, we are subject to various sanctions such as monetary damages, criminal and civil penalties, termination of contracts and suspension or debarment from government contract work.", "These requirements complicate our business and increase our compliance burden.", "We also provide supplies used for vaccine administration in the Federal COVID-19 Response.", "Our participation in such programs exposes us to various uncertainties.", "Because of these risks and uncertainties our operating results may be materially higher or lower than our projections.", "Certain distribution agreements with manufacturers include pharmaceutical price inflation as a component of our compensation, and we cannot  control  the  frequency  or  magnitude  of  pharmaceutical  price  changes.  We  might  be  unable  to  renew  pharmaceutical  distribution  agreements  with manufacturers in a timely and favorable manner.", "Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.", "We  derive  a  significant  portion  of  our  revenue  from,  and  have  a  significant  portion  of  our  accounts  receivable  with,  a  small  number  of  customers.  At", "Our contracts with government entities are subject to risks such as lack of funding and compliance  with unique requirements.", "We might infringe intellectual property rights or our intellectual property protections might be inadequate.", "If a court were to hold that we infringed other\u2019s rights, we might be required to pay substantial damages, develop non-infringing products or services, obtain a license, stop selling or using the infringing products or services, or incur other sanctions.", "We rely on trade secret, patent, copyright and  trademark  laws,  nondisclosure  obligations  and  other  contractual  provisions  and  technical  measures  to  protect  our  proprietary  rights  in  our  products  and solutions.  We  might  initiate  costly  and  time-consuming  litigation  to  protect  our  trade  secrets,  to  enforce  our  patent,  copyright  and  trademark  rights  and  to determine the scope and validity of the proprietary rights of others.", "Our intellectual property protection efforts might be inadequate to protect our rights.", "Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.", "Competition among potential employers might result in increased salaries, benefits or other employee-related costs, or in our failure to recruit and retain employees.", "Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.", "We might be adversely impacted by healthcare reform such as changes in pricing and reimbursement models.", "healthcare industry and related government programs are changing.", "profit margins for us and our customers and impose new legal requirements on healthcare providers.", "the way healthcare is financed by both governmental and private payers.", "drugs have sought to reduce the costs of publicly funded health programs.", "These measures exert pressure on the pricing and reimbursement timelines for pharmaceuticals and may cause our customers to purchase fewer of our products and services or influence us to reduce prices.", "adverse impact on our business operations and our financial position or results of operations.", "Consolidation might increase counter-party credit risk because credit purchases increase for fewer market participants.", "Any of these changes or disruptions might have a materially adverse impact on our business operations and our financial position or results of operations.", "We might be adversely impacted as a result of our distribution of generic pharmaceuticals.", "Generic drug manufacturers often offer a generic version of branded pharmaceuticals while they challenge the validity or enforceability branded pharmaceutical patents.", "The patent holder might assert infringement claims against us for distributing those generic versions and the generic drug manufactures may not fully indemnify us against such claims.", "These risks, as well as changes in the availability,  pricing  volatility,  reimbursement  rates  for  generic  drugs,  or significant  changes  in  the  nature,  frequency  or magnitude  of  generic  pharmaceutical launches, might have a materially adverse impact on our business operations and our financial position or results of operations.", "We might be adversely impacted by an economic slowdown or recession.", "Any economic slowdown or recession might have a materially adverse impact on our business operations and our financial position or results of operations.", "Disruption or other changes in capital and credit markets might impede access to credit and increase borrowing costs for us and our customers and suppliers and might impair the financial soundness of our customers and suppliers.", "activity by financial institutions, or decreased liquidity and increased costs in the commercial paper market, might adversely affect our borrowing ability and cost of borrowing.", "We generally sell our products and services under short-term unsecured credit arrangements.", "An adverse change in general economic conditions or access to capital might cause our customers to reduce their purchases from us, or delay or fail paying amounts owed to us.", "Suppliers might be unable to make payments due to us for fees, returned products or incentives.", "Interest rate increases or changes in capital market conditions might impede our or our customers\u2019 or suppliers\u2019 ability or cost to obtain credit.", "Any of these risks might have a material adverse impact on our business operations and our financial position or results of operations.", "Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.", "We might be adversely impacted by tax legislation or challenges to our tax positions.", "Tax laws might change in ways that adversely affect our tax positions, effective tax rate and cash flow.", "The tax laws are extremely complex and subject to varying interpretations.", "We are subject to tax examinations in various jurisdictions that might assess additional tax liabilities against us.", "Our tax reporting positions might be challenged by relevant tax authorities, we might incur significant expense in our efforts to defend those challenges, and we might be unsuccessful in those efforts.", "Developments in examinations and challenges might materially change our provision for taxes in the affected periods and might differ materially from our historical tax accruals.", "Any of these risks might have a materially adverse impact on our business operations, our cash flows and our financial position or results of operations.", "For example, we might experience volatility in exchange rates and interest rates and changes in laws regulating our U.K. operations.", "Customers might reduce purchases due to the uncertainty caused by Brexit.", "Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.", "We might be adversely impacted by fluctuations in foreign currency exchange rates.", "exchange rates could reduce our revenues, increase our costs or otherwise adversely affect our financial results reported in U.S. dollars.", "For example, we are exposed to transactional currency exchange risk due to our import and export of products that are purchased or sold in currencies other than the U.S. dollar.", "We also  have  currency  exchange  risk  due  to  intercompany  loans  denominated  in  various  currencies.  The  COVID-19  pandemic  has  affected  and  might  increase currency exchange rate volatility.", "We may from time to time enter into foreign currency contracts, foreign currency borrowings or other techniques intended to hedge  a  portion  of our  foreign  currency  exchange  rate  risks.  These  hedging  activities  may  not  completely  offset  the  adverse  financial  effects  of  unfavorable movements in foreign currency exchange rates during the time the hedges are in place.", "Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.", "We are subject to the tax laws in the U.S. at the federal, state and local government levels and to the tax laws of many other jurisdictions in which we operate", "We conduct our business in various currencies,  including  the U.S. dollar, euro, British pound sterling  and Canadian dollar.  Changes in foreign  currency", "Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.", "We might be adversely impacted by changes in accounting standards.", "It is possible that future accounting standards may require changes to the accounting treatment in our consolidated financial statements and may require us to make significant changes to our financial systems.", "Such changes might have a materially adverse impact on our financial position or results of operations.", "Our consolidated financial statements are subject to the application of U.S.", "Disclosure of an environmental proceeding where a governmental agency is a party generally is included only if we expect monetary sanctions in the proceeding to exceed $1 million, unless otherwise material.", "There are no family relationships between any of the executive officers or directors of the Company.", "We declared regular cash dividends of $1.67 and $1.62 per share in the years ended March 31, 2021 and 2020, respectively.", "discretion of the Board and will depend upon our future earnings, financial condition, capital requirements, and other factors.", "Dividends: In  July  2020,  our  quarterly  dividend  was  raised  from  $0.41  to  $0.42  per  common  share  for  dividends  declared  on  or  after  such  date  by  the", "We anticipate that we will continue to pay quarterly cash dividends in the future.", "In accordance with our accounting policy, we allocate any excess of share repurchase price over par value between additional paid-in capital and retained earnings.", "Accordingly, our retained earnings and additional paid-in capital were reduced by $472 million and $70 million, respectively, during 2019.", "In 2019, we retired 5.0 million or $542 million of our treasury shares previously repurchased.", "This discussion and analysis should be read in conjunction with the consolidated financial statements and accompanying financial notes in Item 8 of Part II of this Annual Report on Form 10-K.", "Our fiscal year begins on April 1 and ends on March 31.", "Unless otherwise noted, all references to a particular year shall mean our fiscal year.", "Our organizational structure also includes Corporate, which consists of income and expenses associated with administrative functions and projects, and the results of certain investments.", "We evaluate the performance of our operating segments on a number of measures, including revenues and operating profit before interest expense and income taxes.", "The following summarizes our four reportable segments and the changes made to our reporting structure commencing in the second quarter of 2021.", "\u2022 Coronavirus disease 2019 (\u201cCOVID-19\u201d) impacted our results of operations for the year ended March 31, 2021.", "The recovery from the COVID- 19 pandemic continued to fluctuate throughout our fiscal year.", "\u2022 We expanded our existing contractual relationship with the Centers for Disease Control and Prevention (\u201cCDC\u201d) through an amendment to our existing Vaccines for Children Program contract to support the U.S. government as a centralized distributor of COVID-19 vaccines and ancillary supplies needed to administer vaccines.", "\u2022 In  December  2020,  we  began  distributing  certain  COVID-19  vaccines  under  the  direction  of  the  CDC.  Through  the  end  of  the  fiscal  year,  we  had distributed approximately 100 million of COVID-19 vaccine doses.", "\u2022 Revenues of $238.2 billion, reflects a 3% increase from the prior year primarily in our U.S.", "\u2022 Diluted loss per common share from continuing operations attributable to McKesson Corporation in 2021 of $28.26 reflects the aforementioned items, net of any respective tax impacts, and a lower share count compared to the prior year driven largely by the separation of our investment in Change Healthcare JV on March 10, 2020;", "The full extent to which COVID-19 will impact us depends on many factors and future developments, which are described at the end of this COVID-19 section.", "We continue to evaluate the nature and extent of the impacts COVID-19 has on our business and operations.", "We provided further support including additional emergency leave and an internal paid time off donation platform for employees impacted by COVID-19.", "These responses were initially put in place during our fourth quarter of 2020.", "policies did not have a material effect on our internal control over financial reporting during the year ended March 31, 2021.", "We also took various actions to mitigate the impact of COVID-19 on our results from operations through cost-containment and payroll-related expenses.", "We support the U.S. government as a centralized distributor of COVID-19 vaccines and ancillary supplies needed to administer vaccines.", "We make no decisions on where products are to be distributed nor how the products are allocated between the various provider sites and ultimately administered to the individuals receiving a vaccine.", "We utilize our expertise and capabilities to support the CDC\u2019s efforts to vaccinate everyone in the U.S. who wants to receive a COVID-19 vaccine.", "The Pfizer Vaccine, which is ultra-frozen, is not being distributed by McKesson, although we are providing ancillary supplies needed for its administration.", "custom freezers and refrigerators to safely store and process millions of vaccine doses.", "The capital expenditures we made during 2021 to prepare for vaccine and ancillary supply kit distribution were not material to our financial condition or liquidity.", "In December 2020, we began distributing the Moderna Vaccine in the U.S. and in March 2021, we began distributing the Janssen Vaccine.", "Subsequently, during the first quarter, we had lower pharmaceutical volumes, specialty drug volumes, and patient care visits that negatively impacted our consolidated revenues and income (loss) from continuing operations before income taxes for the year ended March 31, 2021.", "Additionally, increased costs for certain PPE compressed our margins.", "During the year ended March 31, 2021, we recorded charges totaling $136 million in cost of sales on certain PPE and other related products due to inventory impairments and excess inventory in our Medical-Surgical Solutions segment.", "Although market price volatility and changes to anticipated customer demand may require additional write-downs in future periods, we are taking measures to mitigate such risk.", "We collaborated closely with the federal government and other healthcare stakeholders to source more critical PPE to the U.S.", "We have deferred certain employer payroll taxes and continue to monitor the potential impact of other tax legislation changes as result of the CARES Act, including refundable payroll tax credits on certain qualified wages.", "We anticipate changes due to the CARES Act in the timing of certain cash flows, with no material impact to our financial results for the year ended March 31, 2021.", "The CA Act did not have a material impact on our financial condition, results of operations, or liquidity for the year ended March 31, 2021 nor do we currently expect a material impact on our future financial results.", "We are monitoring our customers closely for changes to their timing of payments or ability to pay amounts owed to us as a result of COVID-19 pandemic impacts to their businesses.", "We remain well-capitalized with access to liquidity from our revolving credit facility.", "Long- term debt markets and commercial paper markets, our primary sources of capital after cash flow from operations, have remained open and accessible to us during the COVID-19 pandemic.", "At March 31, 2021, we were in compliance with all debt covenants, and believe we have the ability to continue to meet our debt covenants in the future.", "Our consolidated balance sheets and ability to maintain financial liquidity remains strong.", "We have experienced no material impacts to our liquidity or net", "We face numerous uncertainties in estimating the direct and indirect effects of COVID-19 on our future business operations, financial condition, results of operations, and liquidity.", "Due to several rapidly changing variables related to the COVID-19 pandemic, estimations of future economic trends and the timing of when stability will  return  remains  challenging.  Additionally,  we  periodically  review  our  intangible  and  other  long-lived  assets  for  impairment  when  events  or  changes  in circumstances indicate  the carrying value may not be recoverable.  Key assumptions and estimates  about future values in our impairment assessments can be affected by a variety of factors, including the impacts of the global pandemic on industry and economic trends as well as on our business strategy and internal forecasts.", "We continue to be involved in discussions with the objective of achieving broad resolution of opioid- related claims of states, their political subdivisions and other government entities (\u201cgovernmental entities\u201d).", "We are in ongoing, advanced discussions with state attorneys general and plaintiffs\u2019 representatives regarding a framework under which, in order to resolve the claims of governmental entities, the three largest U.S. pharmaceutical distributors would pay up to approximately $21.0 billion over a period of 18 years, with up to approximately $8.0 billion to be paid by us, of which more than 90% is anticipated to be used to remediate the opioids crisis.", "As a result of that conclusion, and our assessment of certain other opioid- related claims, we recorded a charge of $8.1 billion for the year ended March 31, 2021 within \u201cClaims and litigation charges, net\u201d in our Consolidated Statement of Operations, related to our share of the settlement framework described above, as well as other opioid-related claims.", "Because of the many uncertainties associated with any potential settlement arrangement or other resolution of opioid-related litigation, including the uncertainty of the scope of participation by plaintiffs in any potential settlement, we are not able to reasonably estimate the upper or lower ends of the range of ultimate possible loss for all opioid-related litigation matters.", "We believe that we have valid defenses to the claims pending against us and, absent an acceptable settlement, intend to vigorously defend against all such claims.  An  adverse  judgment  or  negotiated  resolution  in  any  of  these  matters  could  have  a  material  adverse  impact  on  our  financial  position,  cash  flows  or liquidity, or results of operations.", "The law adopting the excise tax made clear that the OSA would apply only to opioid sales on or before December 31, 2018.", "The excise tax applies only to the first sale occurring in New York, and thus may not apply to sales from our distribution centers in New York to New York customers.", "Unless the appellate court\u2019s decision is overturned, the OSA will be reinstated for calendar years 2017 and 2018 (but not beyond those years), and, subject to any further legal challenge, we will have to pay our ratable share of the annual surcharge for those two years.", "During the second quarter of 2021, we reflected an estimated liability of $50 million for the OSA surcharge in our accompanying consolidated financial statements on the assumption that the appellate court\u2019s decision will stand.", "The higher LIFO credits in 2020 compared to 2019 is primarily driven by higher generic deflation.", "\u2022 Claims and litigation charges, net: These charges include adjustments for estimated probable settlements related to our controlled substance monitoring and reporting, and opioid-related claims, as well as any applicable income items or credit adjustments due to subsequent changes in estimates.", "We have reclassified prior period amounts to conform to the current period presentation.", "\u2022 Goodwill impairments charges: We perform an impairment test on goodwill balances annually in the third quarter and more frequently if indicators for potential impairment exist.", "The resulting goodwill impairment charges are reflected within this line item. \u2022 Restructuring, impairment, and related charges: Restructuring charges that are incurred for programs in which we change our operations, the scope of a business undertaken by our business units, or the manner in which that business is conducted as well as long-lived asset impairments.", "\u2022 SDG&A reflects charges of $58 million to remeasure assets and liabilities held for sale to fair value less costs to sell related to the completed contribution of the majority of our German pharmaceutical wholesale business to create a joint venture with WBA in which we have a 30% ownership interest within our International segment.", "As a result, we were required to perform a goodwill impairment test for these reporting units and recorded a goodwill impairment charge in our European RP reporting unit of $69 million during the second quarter of 2021.", "As of the testing date, other risks, expenses, and future developments, such as additional government actions, increased regulatory uncertainty, and material changes in key market assumptions limit our ability to estimate projected cash flows, which could adversely affect the fair value of various reporting units in future periods, including our McKesson Canada reporting unit within our International segment and our RxCrossroads reporting unit within our RxTS segment, where the risk of a material goodwill impairment is higher than other reporting units.", "\u2022 Restructuring, impairment, and related charges, net includes long-lived asset impairment charges of $112 million, primarily for our United Kingdom (\u201cU.K.\u201d)  business  (mainly  pharmacy  licenses)  and  Rexall  Health  retail  business  (\u201cRexall  Health\u201d)  (mainly  customer  relationships)  within  our International segment, and the remaining $156 million primarily represents employee severance and exit-related costs related to our 2019 restructuring initiatives, as further discussed below; and", "\u2022 Total operating expenses includes higher SDG&A due to our business acquisitions and to support business growth, as well as our technology initiatives, partially offset by favorable effects of foreign currency exchange fluctuations.", "\u2022 SDG&A includes opioid-related costs of $114 million, primarily related to litigation expenses, and increased expenses due to our business acquisitions and to support growth, partially offset by a gain from an escrow settlement of $97 million representing certain indemnity and other claims related to our 2017 acquisition of Rexall Health and a credit of $90 million for the derecognition of a liability related to the tax receivable agreement (\u201cTRA\u201d) payable to the shareholders of Change Healthcare, Inc. (\u201cChange\u201d);", "\u2022 Restructuring,  impairment,  and  related  charges,  net  primarily  includes  employee  severance  and  exit-related  costs  of  $352  million  for  our  2019 restructuring initiatives, as further discussed below and long-lived asset impairment charges of $245 million primarily for our U.K. business (mainly pharmacy licenses) within our International segment driven by additional government reimbursement reductions and competitive pressures in the U.K.", "We evaluate goodwill for impairment on an annual basis as of October 1, and at an interim date, if indicators of potential impairment exist.", "This change was not material to our consolidated financial statements as it did not delay, accelerate, or avoid any potential goodwill impairment charge.", "We expect to incur total charges of approximately $180 million to $280 million for this initiative, consisting primarily of exit related costs, accelerated depreciation and amortization of long-lived assets, and asset impairments.", "We expect to incur total charges of approximately $85 million to $90 million, of which $57 million of charges were recorded to date.", "This initiative was substantially complete in 2021 and remaining costs we expect to record under this initiative are not material.", "The relocation was substantially complete in January 2021 and remaining costs we expect to record under this initiative, primarily relating to lease costs, are not material.", "This primarily reflects mark-to-market gains on our investments in certain U.S. growth stage companies in the healthcare industry and realized gains on the exit of some of these investments as further described in Financial Note 17, \u201cFair Value Measurements,\u201d to the accompanying consolidated financial statements  included  in  this  Annual  Report  on  Form  10-K.  In  future  periods,  fair  value  adjustments  recognized  in  our  operating  results  for  these  types  of investments may be adversely impacted by market volatility.", "Other income, net also increased year over year due to pension settlement charges of $122 million recognized in 2020 related to our previously approved termination of the frozen U.S. defined benefit pension plan.", "In connection with the pension plan termination, we purchased annuity contracts from an insurer that will pay and administer the future pension benefits of the remaining participants.", "Excluding the impairment and transaction-related items described below, our proportionate share of loss from our investment in Change Healthcare JV for the years ended March 31, 2020 and 2019 was $119 million and $194 million, respectively, which primarily includes transaction and integration expenses incurred by the joint venture and basis differences between the joint venture and McKesson including amortization of fair value adjustments.", "During the first quarter of 2020 and for the year ended March 31, 2019, we owned approximately 70% of this joint venture.", "The proceeds from the concurrent offering of other securities were also used by Change  to  acquire  certain  securities  of  Change  Healthcare  JV.  As  a  result,  McKesson\u2019s  equity  interest  in  Change  Healthcare  JV  was  reduced  from  70%  to approximately 58.5%, which was used to recognize our proportionate share in net loss from Change Healthcare JV, commencing in the second quarter of 2020.", "As a result of the ownership dilution to 58.5% from 70%, we recognized a dilution loss of approximately $246 million in the second quarter of 2020.", "Additionally, our proportionate share of income or loss from this investment was subsequently reduced as immaterial settlements of stock option exercises occurred after the IPO and further diluted our ownership.", "Equity Earnings and Charges from Investment in Change Healthcare Joint Venture Until the separation of our investment in Change Healthcare JV on March 10, 2020, we accounted for this investment using the equity method of accounting.", "In the second quarter of 2020, we recorded an other-than-temporary-impairment (\u201cOTTI\u201d) charge of $1.2 billion to our investment in Change Healthcare JV,", "Following the Split-off, we do not beneficially own any of Change\u2019s outstanding securities.", "In connection with this transaction, we recognized a net gain for financial reporting purposes of $414 million during the fourth quarter of 2020, which was largely driven by the reversal of a related deferred tax liability.", "The receipt of any payments under the TRA is dependent upon Change benefiting from this depreciation or amortization in future tax return filings, which creates uncertainty over the amount, timing and probability of the gain recognized.", "As such, we accounted for the TRA as a gain contingency, with no receivable recognized as of March 31, 2021 nor 2020.", "Interest expense decreased in 2020 compared to the prior year primarily due to a decrease in the issuance of commercial paper, partially offset by a decrease in interest income from our derivative contracts.", "Our reported income tax (benefit) expense rates were (13.8%), 1.6%, and 58.4% in 2021, 2020, and 2019, respectively.", "after-tax), which was intended to generally be a tax-free split-off for U.S. federal income tax purposes, and unfavorably impacted by charges of $275 million (pre- tax and after-tax) to remeasure assets and liabilities held for sale to fair value less costs to sell related to the completed contribution of the majority of our German pharmaceutical wholesale business to create a joint venture with WBA.", "goodwill of our European RP and European PD reporting units within the International segment, given that these charges are generally not deductible for tax purposes.", "Our income tax expense, deferred tax assets and liabilities, and uncertain tax liabilities reflect management\u2019s best assessment of estimated current and future taxes to be paid.", "We believe that we have made adequate provision for all income tax uncertainties.", "In connection with the exchange offer, on March 9, 2020, we distributed all 176.0 million outstanding shares of common stock of SpinCo to participating", "Income Tax (Benefit) Expense We recorded income tax (benefit) expense of ($695 million), $18 million, and $356 million for the years ended March 31, 2021, 2020, and 2019, respectively.", "Our reported income tax expense rate for 2019 was unfavorably impacted by charges of $1.8 billion (pre-tax and after-tax) to impair the carrying value of", "Significant judgments and estimates are required in determining the consolidated income tax provision and evaluating income tax uncertainties.", "Noncontrolling interests with redemption  features, such as put rights, that are not solely within our control are considered redeemable  noncontrolling  interests.  Redeemable  noncontrolling interests are presented outside of McKesson Corporation stockholders\u2019 equity (deficit) on our consolidated balance sheet.", "Diluted earnings (loss) per common share attributable to McKesson Corporation was $(28.26), $4.95, and $0.17 for the years ended March 31, 2021,  2020,  and  2019,  respectively.  Net  loss  per  diluted  share  for  the  year  ended  March  31,  2021  is  calculated  by  excluding  dilutive  securities  from  the denominator  due to their antidilutive  effects.  Additionally,  our 2021, 2020, and 2019 diluted  earnings (loss) per share  reflect  the cumulative  effects  of share repurchases.", "Weighted-average diluted common shares outstanding is impacted by the exercise and settlement of share-based awards and the cumulative effect of share repurchases, including the impact of shares exchanged as part of the split-off from our investment in Change Healthcare JV, as discussed above.", "(1) Segment operating profit (loss) includes gross profit, net of operating expenses, as well as other income (expense), net, for our reportable segments.", "For retrospective periods presented, operating loss for Other reflects equity earnings and charges from our equity method investment in Change Healthcare JV, which we split-off in the fourth quarter of 2020.", "Pharmaceutical segment includes a charge of $50 million for the year ended March 31, 2021 related to our estimated liability under the OSA.", "(3) Operating loss for our International segment for the years ended March 31, 2021 and 2020 includes charges of $58 million and $275 million, respectively, to remeasure to fair value the assets and liabilities of our German pharmaceutical wholesale business which was contributed to a joint venture with WBA.", "This segment\u2019s operating loss for the years ended March 31, 2021 and 2019 includes goodwill impairment charges of $69 million and $1.8 billion, respectively, as well as long-lived asset impairment charges for the  years ended March 31, 2021,  2020, and 2019  of $115  million,  $112  million,  and $245  million,  respectively, primarily  related to  our retail  pharmacy businesses in Canada and Europe.", "(4) Operating profit for our Medical-Surgical Solutions segment for the year ended March 31, 2021 includes charges totaling $136 million on certain PPE and other related products due to inventory impairments and excess inventory.", "(5) Operating profit for our RxTS segment for the year ended March 31, 2019 includes a gain of $56 million from the divestiture of an equity investment.", "(6) Operating loss for Other for the year ended March 31, 2020 includes an OTTI charge of $1.2 billion and a dilution loss of $246 million related to our investment in Change Healthcare JV, partially offset by a net gain of $414 million related to the completed separation of our interest in Change Healthcare JV during the fourth quarter of 2020.", "(7) Corporate expenses, net for the year ended March 31, 2021 includes a charge of $8.1 billion related to our estimated liability for opioid-related claims, net gains of $133 million  from  our  equity  investments,  and a net  gain  of $131  million  recorded  in  connection  with  insurance  proceeds  received  from  the  settlement  of  the  shareholder derivative action related to our controlled substances monitoring program.", "This was partially offset by a decrease in LIFO credits of $214 million, a charge of $50 million recorded in 2021 related to our estimated liability under the OSA, net impacts from COVID-19, including a less severe cough, cold, and flu season, as well as increased costs for strategic growth initiatives.", "Operating profit and operating profit margin were unfavorably impacted by customer mix and a decrease in net cash proceeds received of $180 million representing our share of antitrust legal settlements.", "recorded to remeasure to fair value the assets and liabilities of our German pharmaceutical wholesale business which was contributed to a joint venture with WBA, of  which  $58  million  and  $275  million  was  reflected  for  the  years  ended  March  31,  2021  and  2020,  respectively.  This  was  partially  offset  by  a  goodwill impairment charge of $69 million recorded in the second quarter of 2021 related to our European retail pharmacy business.", "This was partially offset  by  the  fair  value  remeasurement  charges  in  2020  described  above  and  a  gain  from  an  escrow  settlement  of  $97  million  in  2019  related  to  our  2017 acquisition of Rexall Health.", "Additionally,  operating  profit  was favorable  year over year  due to lower  operating  expenses, including a decrease in our provision for bad debts.", "primary care business and lower restructuring charges, partially offset by the remeasurement of assets and liabilities to fair value related to a divestiture that was completed in 2020 and higher operating expenses, including an increase in our provision for bad debts.", "and existing customers, integration costs incurred in 2019 for our acquisition of RxCrossroads that closed during the fourth quarter of 2018, partially offset by a gain of $56 million from the divestiture of an equity investment in 2019.", "investment in Change Healthcare JV, partially offset by a net gain of $414 million related to the completed separation of our interest in Change Healthcare JV during the fourth quarter of 2020.", "Operating loss for Other also includes our proportionate share of loss from Change Healthcare JV of $119 million and $194 million for the years ended March 31, 2020 and 2019, respectively.", "connection with insurance proceeds received from the settlement of the shareholder derivative action related to our controlled substances monitoring program.", "Corporate expenses, net, for 2020 includes pension settlement charges of $122 million, an opioid claim settlement charge of $82 million, and net settlement gains of $26 million recognized from our derivative contracts.", "claim settlement charge mentioned above, as well as higher costs for technology initiatives, partially offset by net settlement gains recognized in 2020 from our derivative contracts.", "Other Operating  loss  for  Other  for  the  year  ended  March  31,  2020  includes  an  OTTI charge  of  $1.2  billion  and  a  dilution  loss  of  $246  million  related  to  our", "Corporate 2021 vs. 2020 Corporate expenses, net increased for the year ended March 31, 2021 compared to the prior year due to a charge of $8.1 billion related to our estimated", "We conduct our business worldwide in local currencies including Euro, British pound sterling, and Canadian dollar.", "As a result, the comparability of our results reported in U.S. dollars can be affected by changes in foreign currency exchange rates.", "In discussing our operating results, we may use the term \u201cforeign currency exchange fluctuations,\u201d which refers to the effect of changes in foreign currency exchange rates used to convert the local currency results of our operations in foreign countries where the functional currency is not the U.S. dollar.", "We present this information to provide a framework for assessing how our business performed excluding the effect of foreign currency exchange rate fluctuations.", "In computing the foreign currency exchange fluctuations, we translate our current year results of our operations in foreign countries recorded in local currencies into U.S dollars by applying their respective average foreign currency exchange rates of the corresponding prior year periods, and we subsequently compare those results to the previously reported results of the comparable prior year periods reported in U.S. dollars.", "estimate was made and if different estimates that we reasonably could have used in the current period, or changes in the accounting estimate that are reasonably likely to occur from period to period, could have a material impact on our financial condition or results from operations.", "Below are the estimates that we believe are  critical  to  the  understanding  of  our  operating  results  and  financial  condition.  Other  accounting  policies  are  described  in  Financial  Note  1,  \u201cSignificant Accounting  Policies,\u201d  to  the  consolidated  financial  statements  appearing  in  this  Annual  Report  on  Form  10-K.  Because  of  the  uncertainty  inherent  in  such estimates, actual results may differ from these estimates.", "Other customer financing primarily relates to guarantees provided to our customers, or their creditors, regarding the repurchase of inventories.", "We also provide financing to certain customers related to the purchase of pharmacies, which serve as collateral for the loans.", "We estimate the receivables for which we do not  expect  full  collection  based  on  historical  collection  rates  and  specific  knowledge  regarding  the  current  creditworthiness  of  our  customers  and  record  an allowance in our consolidated financial statements for these amounts.", "Management reviews these factors quarterly to determine if any adjustments are needed to the allowance.", "Sales to our largest customer, CVS Health Corporation (\u201cCVS\u201d), accounted for approximately 21% of our total consolidated revenues in 2021 and comprised approximately 19% of total trade accounts receivable at March 31, 2021.", "As a result, our sales and credit concentration is significant.", "The accounts receivables balances are with individual members of the GPOs, and therefore no significant concentration of credit risk exists.", "A material default in payment, a material reduction in purchases from these or any other large customers, or the loss of a large customer or GPO could have a material adverse impact on our financial position, results of operations, and liquidity.", "We believe the reserves maintained and expenses recorded in 2021 are appropriate and consistent in the context of historical methodologies employed, as well as assessment of trends currently available.", "The selected 0.1% hypothetical change does not reflect what could be considered the best or worst-case scenarios.", "Our LIFO valuation amount includes both pharmaceutical and non-pharmaceutical products.", "We recognized LIFO credits of $38 million, $252 million, and $210 million, respectively, in 2021, 2020, and 2019 in our Consolidated Statements of Operations.", "A LIFO charge is recognized when the net effect of price increases on pharmaceutical and non-pharmaceutical products held in inventory exceeds the impact of price declines, including the effect  of branded pharmaceutical  products  that have lost market  exclusivity.  A LIFO credit  is recognized  when the net effect  of price  declines exceeds the impact of price increases on pharmaceutical and non-pharmaceutical products held in inventory.", "Excluding LIFO reserves, our inventory reserves as of March 31, 2021 and 2020 were $263 million and $96 million, respectively.", "The increase was primarily due to 2021 charges totaling $136 million on certain PPE and other related products due to inventory impairments and excess inventory within our Medical-Surgical Solutions segment.", "In 2021, 2020 and, 2019, our provision for bad debts", "At March 31, 2021 and 2020, total inventories, net were $19.2 billion and $16.7 billion, respectively, in our Consolidated Balance Sheets.", "Any purchase consideration in excess of the estimated fair values of the net assets acquired is recorded as goodwill.", "that is a form or variation of the income approach, whereby a forecast of future cash flows attributable to the asset are discounted to present value using a risk- adjusted discount rate.", "We perform an impairment test on goodwill balances annually in the third quarter and more frequently if indicators for potential impairment exist.", "equal to the amount of excess carrying value above the estimated fair value, if any, but not to exceed the amount of goodwill allocated to the reporting unit.", "we estimate fair value by comparing the business to similar businesses, or guideline companies whose securities are actively traded in public markets.", "Under the income approach, we use a discounted cash flow (\u201cDCF\u201d) model in which cash flows anticipated over several periods, plus a terminal value at the end of that time horizon, are discounted to their present value using an appropriate rate that is commensurate with the risk inherent within the reporting unit.", "Goodwill  and  Long-Lived  Assets: As  a  result  of  acquiring  businesses,  we  have  $9.5  billion  and  $9.4  billion  of  goodwill  at  March  31,  2021  and  2020,", "To estimate the fair value of our reporting units, we generally use a combination of the market approach and the income approach.", "Judgments made in determining an estimate of fair value may materially impact our results of operations.", "Included in the estimate of the weighted-average cost of capital is the assumption of an unsystematic risk premium to address incremental uncertainty related to the reporting units\u2019 future cash flow projections.", "An increase in the unsystematic risk premium increases the discount rate.", "Pharmaceutical  Distribution  reporting  units  in  our  International  segment,  exceeded  their  carrying  values.  The  impairment  testing  performed  in  2020  did  not indicate  any  material  impairment  of  goodwill.  The  segment  change  in  the  second  quarter  of  2021  prompted  changes  in  multiple  reporting  units  across  the Company.", "We recorded a goodwill impairment charge of $69 million in 2021 as the estimated fair value of the Europe Retail Pharmacy reporting unit was lower than its reassigned carrying value based on changes in the composition of the Europe Retail Pharmacy reporting unit within the International segment.", "At March 31, 2021, the  balance  of goodwill for the  reporting  units  in Europe  was approximately  nil  and the  remaining  balance  of goodwill  in the International segment primarily relates to one of our reporting units in Canada.", "Other risks, expenses and future developments, such as additional government actions, increased regulatory uncertainty, and material changes in key market assumptions that we were unable to anticipate as of the testing date may require us to further revise the projected cash flows, which could adversely affect the fair value of our other reporting units in future periods.", "We review intangible assets for impairment at an asset group level whenever events or changes in circumstances indicate that the carrying value of the assets may not be recoverable.", "Determination of recoverability of intangible assets is based on the lowest level of identifiable estimated future undiscounted cash flows resulting from use of the asset and its eventual disposition.", "Measurement of any impairment loss is based on the excess of the carrying value of the asset group over its fair value.", "Assumptions and estimates about future values and remaining useful lives of our purchased intangible assets are complex and subjective.", "When the decline in value is deemed to be other than temporary, an impairment is recognized to the extent that the fair value is less than the carrying value of the investment.", "We consider various factors in determining whether a loss in value of an investment is other than temporary including: the length of time and the extent to which the fair value has been below cost, the financial condition of the investees, and our intent and ability to retain the investment for a period of time sufficient to allow for recovery of value.", "Any significant changes in assumptions or judgments in assessing impairments could result in an impairment charge.", "We generally recognize employee severance costs when payments are probable and amounts are estimable.  Costs related  to contracts without future benefit or contract termination  are recognized  at the earlier of the contract termination  or  the  cease-use  dates.  Other  exit-related  costs  are  recognized  as  incurred.  In  connection  with  these  restructuring  actions,  we  also  assess  the recoverability of long-lived assets used in the business, and as a result, we may recognize accelerated depreciation and amortization reflecting shortened useful lives of the underlying assets.", "paid.  We  are  subject  to  income  taxes  in  the  U.S.  and  numerous  foreign  jurisdictions.  Significant  judgments  and  estimates  are  required  in  determining  the consolidated income tax provision and in evaluating income tax uncertainties and include those used to conclude on the tax-free nature of the separation of the Change Healthcare JV and the unrecognized tax position related to opioid-related litigation and claims, which remains unfinalized, and which may differ from the actual amounts of tax benefit recognized.", "We review our tax positions at the end of each quarter and adjust the balances as new information becomes available.", "to recover our deferred tax assets, we consider all available positive and negative evidence including our past operating results, the existence of cumulative net operating losses in the most recent years, and our forecast of future taxable income.", "In estimating future taxable income, we develop assumptions including the amount of future federal, state and foreign pre-tax operating income, the reversal of temporary differences, and the implementation of feasible and prudent tax planning strategies.", "These assumptions require significant judgment about the forecasts of future taxable income and are consistent with the plans and estimates we use to manage the underlying businesses.", "additional taxes and related interest will be due.", "If our current estimate of tax and interest liabilities is less than the ultimate settlement, an additional charge to income tax expense may result.", "If our current estimate of tax and interest liabilities is more than the ultimate settlement, a reduction to income tax expense may be recognized.", "investigations  relating  to  laws  and  regulations  and  other  matters  arising  out  of  the  normal  conduct  of  our  business.  When  a  loss  is  considered  probable  and reasonably estimable, we record a liability in the amount of our best estimate for the ultimate loss.", "When a material loss is reasonably possible or probable but a reasonable estimate cannot be made, disclosure of the proceeding is provided.", "Deferred income taxes arise from temporary differences between the tax and financial statement recognition of revenue and expense.", "Changes in tax laws and rates could also affect recorded deferred tax assets and liabilities in the future.", "We recognize liabilities for tax and related interest for issues in the U.S. and other tax jurisdictions based on our estimate of whether, and the extent to which,", "As discussed above, development of a meaningful estimate of loss or a range of potential loss is complex when the outcome is directly dependent on future negotiations with or decisions by third parties, such as regulatory agencies, the court system and other interested parties.", "As a result of ongoing, advanced discussions with state attorneys general and plaintiffs\u2019 representatives regarding a framework to resolve the claims of governmental  entities,  and  our  assessment  of  certain  other  opioid-related  claims,  we  have  reached  a  stage  at  which  a  broad  settlement  of  opioid  claims  by governmental entities is probable and recorded a charge of $8.1 billion for the year ended March 31, 2021 within \u201cClaims and litigation charges, net\u201d in our Consolidated Statement of Operations in this report.", "Because of the many uncertainties associated with any potential settlement arrangement or other resolution of opioid-related litigation, including the uncertainty of the scope of participation by plaintiffs in any potential settlement, we are not able to reasonably estimate the upper or lower ends of the range of ultimate possible loss for all opioid-related litigation matters.", "While we are not able to predict the outcome or reasonably estimate a range of possible losses in these matters, an adverse judgment or negotiated resolution in any of these matters could have a material adverse effect on our results of operations, consolidated financial position, cash flows or liquidity.", "facilities and commercial paper program, will be sufficient to fund our short-term and long-term capital expenditures, working capital, and other cash requirements.", "We continue to monitor its impact on demand within parts of our business, as well as trends potentially impacting the timing or ability for some of our customers to pay amounts owed to us.", "We remain well-capitalized with access to liquidity from our $4.0 billion revolving credit facility.", "Additionally, long-term debt markets and commercial paper markets, our primary sources of capital after cash flow from operations, have remained open and accessible to us during the COVID-19 pandemic.", "We have seen continued improvement in conditions in the debt markets and commercial paper markets as the Federal Reserve has taken steps to stabilize the markets.", "At March 31, 2021, we were in compliance with all debt covenants, and believe we have the ability to continue to meet our debt covenants in the future.", "Cash flows from operations can be significantly impacted by factors such as the timing of receipts from customers and payments to vendors.", "Operating activities for the year ended March 31, 2021 were affected by net income adjusted for non-cash items, including the pre-tax $8.1 billion (after-tax $6.8 billion) non-cash charge related to our estimated liability for opioid-related claims, an increase in inventory of $2.3 billion and an increase in drafts and accounts payable of $1.3 billion driven by higher inventory stock levels to meet increased volume demand as part of our inventory management, as well as a decrease in receivables of $1.1 billion driven by timing, higher sales recognized at the end of March 2020, and higher collections in our fourth quarter of 2021.", "value remeasurement charges of $58 million related to the contribution of our German pharmaceutical wholesale business to a joint venture with WBA.", "Additionally, we made a cash payment of $114 million from the executive benefit retirement plan in 2020.", "Investing activities for the year ended March 31, 2021 also includes net cash proceeds of $400 million from sales of businesses and investments, including $286 million in exchange for the contribution of our German pharmaceutical wholesale business to a joint venture with WBA.", "Cash used for other financing activities generally includes payments to noncontrolling interests and activity from our finance leases.", "We received cash from long-term debt issuances of $1.1 billion and made repayments on long-term debt of $1.1 billion in 2019.", "The timing of any repurchases and the actual number of shares repurchased will depend on a variety of factors, including our stock price, corporate and regulatory requirements, restrictions under our debt obligations, and other market and economic conditions.", "In accordance with our accounting policy, we allocate any excess of share repurchase price over par value between additional paid-in capital and retained earnings.", "Accordingly, our retained earnings and additional paid-in capital were reduced by $472 million and $70 million during 2019, respectively.", "outstanding shares of SpinCo common stock, which held all of the Company\u2019s interests in the Change Healthcare JV, to participating holders of the Company\u2019s common  stock  in  exchange  for  15.4  million  shares  of  McKesson  stock,  which  are  now  held  as  treasury  stock  on  our  consolidated  balance  sheet.  Following consummation of the exchange offer, on March 10, 2020, SpinCo merged with and into Change and each share of SpinCo common stock was converted into one share of Change common stock, par value $0.001 per share, with cash being paid in lieu of fractional shares of Change common stock.", "give us the ability to meet our financing needs for the foreseeable future.", "However, there can be no assurance that an increase in volatility or disruption in the global capital and credit markets will not impair our liquidity or increase our costs of borrowing.", "As described within the \u201cTrends and Uncertainties\u201d section above,  the  COVID-19  pandemic  continues  to  develop  rapidly.  We  continue  to  monitor  its  impact  on  demand  within  parts  of  our  business,  as  well  as  trends potentially impacting the timing or ability for some of our customers to pay amounts owed to us.", "(2) This ratio describes the relationship and changes within our capital resources, and is computed as total debt divided by the sum of total debt and McKesson stockholders\u2019 equity (deficit), which excludes noncontrolling and redeemable noncontrolling interests and accumulated other comprehensive loss. (3) Ratio is computed as net income (loss) attributable to McKesson Corporation for the last four quarters, divided by a five-quarter average of McKesson stockholders\u2019 equity (deficit), which excludes noncontrolling and redeemable noncontrolling interests.", "In 2019, we retired 5.0 million or $542 million of the Company\u2019s treasury shares previously repurchased.", "In connection with the Split-off, we distributed all 176.0 million", "Deposits with financial institutions are primarily denominated in U.S. dollars and the functional currencies of our foreign subsidiaries, including Euro, British pound sterling, and Canadian dollars.", "We mitigate the risk of our short-term investment portfolio by depositing funds with reputable financial institutions and monitoring risk profiles and investment strategies of money market funds. outside of the U.S., respectively.", "Our primary intent is to utilize this cash for foreign operations for an indefinite period of time.", "Although the vast majority of cash held outside the U.S. is available for repatriation, doing so could subject us to foreign withholding taxes and state income taxes.", "The COVID-19 pandemic has potential to increase the variations in our working capital, which we continue to monitor closely. partially offset by an increase in drafts and accounts payable and a decrease in receivables.", "Our unfavorable return on McKesson\u2019s stockholder\u2019s equity (deficit) as of March 31, 2021 was also driven by net loss for the year.", "Net loss for the year ended March 31, 2021 includes an after-tax non-cash charge of $6.8 billion related to our estimated liability for opioid-related claims, as discussed in \u201cTrends  and  Uncertainties\u201d of  this  Financial  Review  and  Financial  Note  19,  \u201cCommitments  and  Contingent  Liabilities,\u201d  to  the  accompanying  consolidated financial statements included in this Annual Report on Form 10\u2011K.", "Our debt to capital ratio increased for 2020 primarily due to a decrease in stockholders\u2019 equity driven by the Split-off of our interest in Change Healthcare JV and share repurchases.", "We anticipate that we will continue to pay quarterly cash dividends in the future.", "However, the payment and amount of future dividends remain within the discretion of the Board and will depend upon our future earnings, financial condition,  capital  requirements,  and  other  factors.  In  2021,  2020,  and  2019,  we  paid  total  cash  dividends  of  $276  million,  $294  million,  and  $292  million, respectively.  Additionally,  as  required  under  the  Domination  Agreement,  we  are  obligated  to  pay  an  annual  recurring  compensation  amount  of  \u20ac0.83  per McKesson Europe share (effective January 1, 2015) to the noncontrolling shareholders of McKesson Europe.", "Cash equivalents, which are readily convertible to known amounts of cash, are carried at fair value.", "Our cash and cash equivalents balance as of March 31, 2021 and 2020 included approximately $2.3 billion and $1.7 billion of cash held by our subsidiaries", "On  July  29,  2020,  we  raised  our  quarterly  dividend  from  $0.41  to  $0.42  per  common  share  for  dividends  declared  on  or  after  such  date  by  the  Board.", "(3) Includes our estimated benefit payments for the unfunded benefit plans and minimum funding requirements for the pension plans. (4) Primarily represents interest that will become due on our fixed rate long-term debt obligations.", "These obligations primarily relate to inventory purchases and capital commitments. (6) Includes agreements under which we have guaranteed the repurchase of our customers\u2019 inventory and our customers\u2019 debt in the event these customers are unable to meet their obligations to those financial institutions.", "The ultimate amount and timing of any future cash settlements related to these items cannot be predicted with reasonable certainty.", "and are mostly related to our customer contracts and to meet the security requirements for statutory licenses and permits, court and fiduciary obligations, and our workers\u2019 compensation and automotive liability programs.", "The exercise of the Put Right will reduce the balance of redeemable noncontrolling interests.", "During 2021, we paid $49 million to purchase 1.8 million shares of McKesson Europe through exercises of the Put Right by the noncontrolling shareholders.", "Our banks and insurance companies have issued $146 million of standby letters of credit and surety bonds at March 31, 2021.", "redemption value is the Put Amount adjusted for exchange rate fluctuations each period.", "In future periods, unfavorable foreign currency exchange rate fluctuations between the Euro and the U.S. dollar could adversely impact the carrying value of our redeemable noncontrolling interests and require an adjustment to increase the balance of our redeemable noncontrolling interests to its maximum redemption value.", "On April 12, 2021, we received the Stuttgart Court of Appeals\u2019 final ruling confirming the original put value of \u20ac22.99 per share and the annual recurring compensation of \u20ac0.83 per McKesson Europe share.", "Funds necessary for future debt maturities and our other cash requirements are expected to be met by existing cash balances, cash flow from operations, existing credit sources, and other capital market transactions.", "The effect of a hypothetical 50 bp increase in the underlying interest rate on our cash and cash equivalents, net of short-term borrowings and variable rate debt, would have resulted in a favorable impact to earnings in 2021 and 2020 of approximately $17 million and $6 million, respectively.", "The balance of redeemable noncontrolling interests is reported at the greater of its carrying value or its maximum redemption value at each reporting date.", "Additionally,  we  are  obligated  to  pay  an  annual  recurring  compensation  of  \u20ac0.83  per  McKesson  Europe  share  (the  \u201cCompensation  Amount\u201d)  to  the", "Interest rate risk: Our long-term debt bears interest predominately at fixed rates, whereas our short-term borrowings are at variable interest rates.", "Our cash and cash equivalents balances earn interest at variable rates.", "At March 31, 2021 and 2020, we had $6.3 billion and $4.0 billion, respectively, in cash", "Changes in foreign currency exchange rates could have a material adverse impact on our financial results that are reported in U.S. dollars.", "We are also exposed to foreign exchange rate risk related to our foreign subsidiaries, including intercompany loans denominated in non-functional currencies.", "These programs reduce but do not entirely eliminate foreign exchange risk.", "fair value of our foreign exchange contracts by approximately $267 million and $435 million, respectively.", "Foreign exchange risk: We conduct our business worldwide in U.S. dollars and the functional currencies of our foreign subsidiaries, including Euro, British", "We have certain foreign exchange rate risk programs that use foreign currency forward contracts and cross-currency swaps.", "Based on this assessment, our management has concluded that our internal control over financial reporting was effective as of March 31, 2021.", "In our opinion, the financial statements referred to above present fairly, in all material respects, the financial position of the Company as of March 31, 2021 and 2020, and the results of its operations and its cash flows for each of the three years in the period ended March 31, 2021, in conformity with accounting principles generally accepted in the United States of America.", "Also, in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of March 31, 2021, based on criteria established in Internal Control \u2014 Integrated Framework (2013) issued by COSO.", "Our responsibility is to express an opinion on these financial statements and an opinion on the Company\u2019s internal control over financial reporting based  on  our  audits.  We  are  a  public  accounting  firm  registered  with  the  Public  Company  Accounting  Oversight  Board  (United  States)  (\u201cPCAOB\u201d)  and  are required  to  be  independent  with  respect  to  the  Company  in  accordance  with  the  U.S.  federal  securities  laws  and  the  applicable  rules  and  regulations  of  the Securities and Exchange Commission and the PCAOB.", "We conducted our audits in accordance with the standards of the PCAOB.", "Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.", "Our audits of the financial statements included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures to respond to those risks.", "Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements.", "Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk.", "Our audits also included performing such other procedures as we considered necessary in the circumstances.", "We believe that our audits provide a reasonable basis for our opinions.", "The critical audit matters communicated below are matters arising from the current-period audit of the financial statements that were communicated or required to be communicated to the audit committee and that (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments.", "The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.", "The Company also performs an assessment of loss contingencies where a loss is reasonably possible.", "We identified the potential broad settlement of opioid claims as a critical audit matter because of the significant judgment and challenges auditing management\u2019s determination  of  whether  such  loss  is  probable  and  reasonably  estimable.  Specifically,  auditing  management\u2019s  determination  and  disclosure  of  whether  the contingent loss arising from the potential broad settlement of opioid claims is probable, and the related measurement of such loss, is subjective and requires significant judgment given that the potential loss is based upon settlement terms that have not yet been finalized.", "\u2022 We tested the effectiveness of internal controls related to the potential broad settlement of opioid claims, and approval of the accounting treatment and related disclosures based on the most recent facts and circumstances.", "In addition, we inspected responses to inquiry letters sent to both internal and external legal counsel as it relates to the status of discussions with plaintiffs\u2019 counsel and the Company\u2019s intent regarding the framework for a potential broad settlement of opioid claims.", "\u2022 We evaluated management\u2019s analysis of the potential broad settlement of opioid claims, including the methodology used by management to determine the probability of such loss.", "We also evaluated the methodology used by management to estimate the most likely loss to be incurred by the Company as a result of a potential broad settlement of opioid claims.", "\u2022 We performed public domain searches for evidence contrary to management\u2019s analysis.", "\u2022 We evaluated any events subsequent to March 31, 2021 that might impact our evaluation of the potential broad settlement of opioid claims. \u2022 We obtained written representations from executives and internal counsel of the Company. \u2022 We examined proposed terms related to the potential broad settlement framework. \u2022 We evaluated the Company\u2019s related disclosures for consistency with our testing.", "The net amount recognized by management is measured as the largest amount of tax benefit that is greater than 50 percent likely of being realized.", "We identified the Company\u2019s uncertain tax position related to the charge for the potential broad settlement of opioid claims as a critical audit matter because of the challenges in auditing management\u2019s estimate of the amount of income tax benefit that qualifies for recognition.", "Our audit procedures related to the Company's uncertain tax position associated with a potential broad settlement of opioid claims included the following, among others: \u2022 We tested the effectiveness of internal controls related to the Company\u2019s assessment of the technical merits of its tax position, including the Company\u2019s assessment as to the amount of benefit that is more likely than not to be realized. \u2022 With  the  assistance  of  our  tax  specialists,  we  evaluated  the  facts,  evidence  and  the  Company\u2019s  related  income  tax  analysis  for  the  charge  related  to  the potential broad settlement of opioid claims, including assumptions used by management to measure the related recognized and unrecognized tax benefits. \u2022 We inquired of the Company\u2019s internal and external legal counsel to understand the basis for the Company\u2019s conclusion that a portion of the potential broad settlement of opioid claims would be deductible based on the most recent discussions with plaintiffs\u2019 counsel.", "\u2022 We  compared  management's  income  tax  assessment  of  this  matter  to  the  treatment  of  other  recorded  opioid  charges  to  evaluate  the  consistency  of  the Company\u2019s judgments related to the uncertain tax position. \u2022 We evaluated any events subsequent to March 31, 2021 that might impact our evaluation of the Company\u2019s uncertain tax position related to the charge for the potential broad settlement of opioid claims.", "\u2022 We obtained written representations from executives and internal counsel of the Company. \u2022 We examined proposed terms related to the potential broad settlement framework.", "\u2022 We evaluated the Company\u2019s related disclosures for consistency with our testing and also searched for contradictory evidence by reading disclosures from peer companies, who are also party to the potential broad settlement of opioid claims.", "We identified the estimation of the fair value of the McKesson Canada reporting unit used to evaluate the recoverability of goodwill as a critical audit matter because of the challenges auditing significant judgments used in the selection of a discount rate, including the unsystematic risk premium.", "In particular, the fair value estimate is sensitive to the unsystematic risk premium assumption, which is affected by expected risk of changes in the Canadian business and regulatory environments.", "Auditing management\u2019s selected discount rate required a high degree of auditor judgment and an increased extent of effort, including the need to involve more senior members of the team and our fair value specialists.", "Our audit procedures related to the Company\u2019s selection of a discount rate, including consideration of the unsystematic risk premium, for the McKesson Canada reporting unit included the following, among others: \u2022 We tested the effectiveness of internal controls related to management\u2019s goodwill impairment evaluation, including those related to the selection of a discount rate and consideration of an unsystematic risk premium. \u2022 We  evaluated  management\u2019s  ability  to  accurately  forecast  operating  results  for  the  McKesson  Canada  reporting  unit  by  comparing  actual  results  to management\u2019s historical forecasts, in order to consider the reasonableness and adequacy of management\u2019s selected unsystematic risk premium. \u2022 As part of our assessment of the unsystematic risk premium, we evaluated the reasonableness of strategic plans expected to be implemented during the forecast period by comparing the forecasts to:", "\u2022 With the assistance of our fair value specialists, we evaluated the reasonableness of the discount rate, including the unsystematic risk premium, by developing a range of independent estimates, testing the mathematical accuracy of the calculation and comparing to the discount rate selected by management.", "We have served as the Company\u2019s auditor since 1968.", "The Company consolidates VIEs when it is determined that it is the primary beneficiary of the VIE.", "Investments in business entities in which the Company does not have control but has the ability to exercise significant influence over operating and financial policies, are accounted for using the equity method.", "Actual amounts could differ from those estimated amounts.", "These legislative acts are not expected to have a material impact on the Company\u2019s consolidated financial results.", "The Company considers itself to control an entity if it is the majority owner of or has voting control over such entity.", "GAAP requires that the Company make estimates and assumptions that", "If a loss in value has occurred that is deemed to be other-than-temporary, an impairment loss is recorded.", "economic environment, customer credit ratings or bankruptcies, as well as reasonable and supportable forecasts.", "We are exposed to credit losses on accounts receivable balances.", "As a result, the Company\u2019s sales and credit concentration is significant.", "The accounts receivables balances are with individual members of the GPOs, and therefore no significant concentration of credit risk exists.", "This credit risk is mitigated by the size and diversity of the Company\u2019s customer base as well as its geographic dispersion.", "These amounts are equivalent to the Company\u2019s LIFO reserves.", "A LIFO credit is recognized when the net effect of price declines exceeds the impact of price increases on pharmaceutical and non-pharmaceutical products held in inventory.", "The increase was primarily due to charges in 2021 totaling $136 million on certain personal protective equipment and other related products due to inventory impairments and excess inventory within our Medical-Surgical Solutions segment.", "When the net realizable value of a disposal group increases during a period, a gain can be recognized to the extent that it does not increase the value of the disposal group beyond its original carrying value when the disposal group was reclassified as held for sale.", "Depreciation and amortization begins when an asset is placed in service and ready for its intended use.", "The use of alternative assumptions and estimates could affect the fair values and change the impairment determinations.", "Measurement of any impairment loss is based on the excess of the carrying value of the asset group over its estimated fair market value.", "customer in an amount that reflects the consideration to which the entity expects to be entitled for that good or service.", "Revenue is recognized when control of goods is transferred to the customer which occurs upon the Company\u2019s delivery to the customer or upon customer  pick-up.", "The ultimate outcome of any outstanding claims may be different than the Company\u2019s estimate.", "If a derivative is designated as a fair value hedge, the changes in the fair value of the derivative and of the hedged item attributable to the hedged risk are recognized in earnings.", "The cumulative changes in fair value are reclassified to the same line as the hedged item in the Consolidated Statements of Operations when the hedged item affects earnings.", "Noncontrolling interests with redemption features, such as put rights, that are not solely within the Company\u2019s control are considered redeemable noncontrolling interests.", "When a loss is considered probable and reasonably estimable, the Company records a liability in the amount of its best estimate for the ultimate loss.", "When a material loss is reasonably possible or probable, but a reasonable estimate cannot be made, disclosure of the proceeding is provided.", "As discussed above, development of a meaningful estimate of loss or a range of potential loss is complex when the outcome is directly dependent on negotiations with or decisions by third parties, such as regulatory agencies, the court system, and other interested parties.", "Any purchase consideration in excess of the estimated fair values of the net assets acquired is recorded as goodwill.", "Restructuring Charges: Employee severance costs are generally recognized when payments are probable and amounts are reasonably estimable.", "The forward-looking model requires the Company to consider historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount in estimating credit losses.", "The adoption of this amended guidance is not expected to have a material impact on the Company\u2019s consolidated financial statements or disclosures.", "accounting policy has been to disclose any intervening events of the joint venture in the lag period that could materially affect its consolidated financial statements.", "McKesson had the ability to adjust the manner in which certain depreciation or amortization deductions are allocated among Change and McKesson.", "This creates uncertainty over the amount, timing, and probability of the gain recognized.", "Any such change is not expected to have a material impact on the Company\u2019s consolidated financial statements.", "This initiative was substantially complete in 2021 and remaining costs the Company expects to record under this initiative are not material.", "This set of initiatives was substantially complete by the end of 2020 and charges in 2021 were not material.", "Goodwill recognized for business acquisitions is generally not expected to be deductible for tax purposes.", "share-based awards that will ultimately vest primarily based on historical experience.", "The estimated forfeiture rate established upon grant is re-assessed throughout the requisite service period and is adjusted when actual forfeitures occur.", "The actual forfeitures in future reporting periods could be higher or lower than current estimates.", "PSUs have a requisite service period of generally three years.", "Compensation expense for the share-based awards is recognized for the portion of awards ultimately expected to vest.", "The number of vested PSUs is assessed at the end of a", "All  outstanding  PeRSU awards  have  completed  the  performance  period  and  are  now classified  and  accounted  for  as RSUs.", "portion of the awards that is ultimately expected to vest.", "Once the fair value of an employee stock option is determined, current accounting practices do not permit it to be changed, even if the estimates used are different from actual.", "The Company believes this market-based input provides a reasonable estimate of its future stock price movements and is consistent with employee stock option valuation considerations.", "These amounts have not been significant for all the years presented.", "Substantially all its foreign net operating losses have indefinite lives.", "The decrease in unrecognized tax benefits in 2020  compared  to  2019  is  primarily  attributable  to  the  favorable  resolution  of  an  outstanding  California  tax  refund  claim  which  decreased  unrecognized  tax benefits by $91 million.", "2017 Tax Act, the repatriation of cash to the U.S. is generally no longer taxable for federal income tax purposes.", "The Company may remit foreign earnings to the U.S. to the extent it is tax efficient to do so.", "It does not expect the tax impact from remitting these earnings to be material.", "The exercise of the Put Right will reduce the balance of redeemable noncontrolling interests.", "The adoption of this guidance did not have a material impact on the Company\u2019s consolidated statements of operations and cash flows.", "The Company\u2019s lease agreements do not contain any material residual value guarantees or material restrictive covenants.", "Operating lease liabilities are recognized based on the present value of the future lease payments over the lease term, discounted at the Company\u2019s incremental borrowing rate as the implicit rate in the lease is not readily determinable for most of the Company\u2019s leases.", "As a practical expedient, short-term leases with an initial term of 12 months or less are excluded from the Consolidated Balance Sheets and charges from these leases are expensed as incurred.", "Fair value estimates result from a complex series of judgments about future events and uncertainties and rely heavily on estimates and assumptions that have been deemed reasonable by management as of the measurement date.", "The unsystematic risk premium is an input factor used in calculating the discount rate that specifically addresses uncertainty related to the reporting unit\u2019s future cash flow projections.", "The risk of successfully achieving certain business initiatives was the primary factor in the use of a higher discount rate.", "and, from time-to-time, future unsecured and unsubordinated indebtedness outstanding.", "As a result of absorbing this risk, the leases provide the Company with the power to direct the operations of the leased properties and the obligation to absorb losses or the right to receive benefits of the entity.", "Consolidated VIEs do not have a material impact on the Company\u2019s Consolidated Statements of Operations and Cash Flows.", "their economic performance and thus is not considered the primary beneficiary of the entities.", "The pension obligation in Germany is unfunded with the exception of the contractual trust arrangement used to fund pensions of McKesson Europe\u2019s Management Board.", "actuarial  losses  exceeding  10%  of  the  greater  of  the  projected  benefit  obligation  or  the  market  value  of  assets  are  amortized  straight-line  over  the  average remaining future service period of active employees.", "Pension obligations for its unfunded plans are based on the recommendations of independent actuaries.", "The difference between actual inflation and assumed inflation in our U.K. pension plans resulted in a gain of $23 million.", "corporate bonds rated AA or better whose maturities are aligned with the expected benefit payments of its plans.", "Plan assets of the non-U.S. plans are broadly invested in a manner appropriate to the nature and duration of the expected future retirement benefits payable under the plans.", "Assets are properly diversified to avoid excessive reliance on any particular asset, issuer, or group of undertakings so as to avoid accumulations of risk in the portfolio as a whole.", "practical expedient are not leveled within the fair value hierarchy and are included as a reconciling item to total investments.", "Actions taken by other participating employers may lead to adverse changes in the financial condition of a multiemployer benefit plan and the Company\u2019s withdrawal liability and contributions may increase.", "It does not use derivatives for trading or speculative purposes.", "Eligible employees may contribute to the RSP up to 75% of", "In the normal course of business, the Company is exposed to interest rate and foreign currency exchange rate fluctuations.", "These forward contracts and cross-currency swaps are generally used to offset the potential income statement effects from intercompany loans and other obligations denominated in non-functional currencies.", "These programs reduce but do not entirely eliminate foreign currency exchange rate risk.", "To the extent foreign currency-denominated notes designated as net investment hedges are ineffective, changes in carrying value attributable to the change in spot rates are recorded in earnings.", "To the extent cross-currency swaps designated as hedges are ineffective, changes in carrying value attributable to the change in spot rates are recorded in earnings.", "Changes in fair values representing hedge ineffectiveness are recognized in current earnings.", "The settlement loss on the swaps was not material and will be amortized on a straight-line basis as interest expense over the five-year life of the 2025 Notes.", "Gains or losses from these contracts are largely offset by changes in the value of the underlying intercompany obligations.", "Changes in the fair value for contracts not designated as hedges are recorded directly in earnings.", "The carrying value of all other cash equivalents approximates their fair value due to their relatively short-term nature.", "These inputs are considered Level 2 under the fair value measurements and disclosure guidance and may not be representative of actual values that could have been realized or that will be realized in the future.", "If the carrying amount of an asset group is not recoverable, an impairment charge is recorded to reduce the carrying amount by the excess over its fair value.", "repurchase of its customers\u2019 inventory or its customers\u2019 debt in the event these customers are unable to meet their obligations to those financial institutions.", "For the Company\u2019s inventory repurchase agreements, among other requirements, inventories must be in resalable condition and any repurchase would be at a discount.", "The majority of the Company\u2019s customers\u2019 debt guarantees are secured by certain assets of the customer.", "The Company\u2019s long-term debt is also recorded at cost.", "The carrying value and fair value of the Company\u2019s long-term debt was as follows:", "Long-lived Assets The Company utilizes multiple approaches including the DCF model and market approaches for estimating the fair value of intangible assets.", "infringe a third party\u2019s intellectual property rights.", "Where appropriate, obligations for such indemnifications are recorded as liabilities.", "Accrued warranty costs were not material to the Consolidated Balance Sheets.", "Significant developments in those matters are described below.", "Company  is  unable  to  determine  that  a  loss  is  probable,  or  to  reasonably  estimate  the  amount  of  loss  or  a  range  of  loss,  for  a  claim  because  of  the  limited information  available  and  the  potential  effects  of future  events  and  decisions  by third  parties,  such  as  courts  and  regulators,  that  will  determine  the  ultimate resolution of the claim.", "It is not uncommon for claims to remain unresolved over many years.", "The Company reviews loss contingencies at least quarterly to determine whether the likelihood of loss has changed and whether it can make a reasonable estimate of the loss or range of loss.", "When the Company determines that a loss from a claim is probable and reasonably estimable, it records a liability for an estimated amount.", "The Company also provides disclosure when it is reasonably possible that a loss may be incurred or when it is reasonably possible that the amount of a loss will exceed its recorded liability.", "Warranties In the normal course of business, the Company provides certain warranties and indemnification protection for its products and services.", "These two West Virginia plaintiffs are not expected to participate in any broader multistate resolution of opioid-related claims.", "The Cherokee Nation is not expected to participate in any broader multistate resolution of opioid-related claims.", "Those non-participating governmental entities would be entitled to pursue their claims against the Company and other defendants.", "The Company believes that it has valid defenses to the claims pending against it, and it intends to vigorously defend against all such claims if acceptable settlement terms are not achieved.", "The Company believes it has valid legal defenses in these matters and intends to mount a vigorous defense.", "The Company has not concluded a loss is probable in any of these matters; nor is the amount of any loss reasonably estimable.", "An adverse judgment or negotiated resolution in any of these matters could have a material adverse impact on the Company\u2019s financial position, cash flows or liquidity, or results of operations.", "AIG and ACE are seeking declarations that they have no duty to defend or indemnify McKesson in the thousands of lawsuits pending in federal and state courts related to opioids.", "Discussions with attorneys general and other parties continue.", "If the negotiating parties agree on terms under the framework for a broad resolution of claims of", "Plaintiffs\u2019 moved for summary judgment on the same day.", "subpoenas and requests in a cooperative, thorough and timely manner.", "These responses sometimes require time and effort and can result in considerable costs being incurred by the Company.", "Such subpoenas and requests can lead to the assertion of claims or the commencement of civil or criminal legal proceedings against the Company and other members of the health care industry, as well as to settlements of claims against the Company.", "The Company responds to these requests in the ordinary course of business.", "The law adopting the excise tax made clear that the OSA does not apply to sales or distributions occurring after December 31, 2018.", "It is not certain at this point in time what proportion of this estimated liability will be borne by the Company.", "However, it is possible that the ultimate costs of these matters may exceed or be less than the reserves.", "Due to the complex nature of the tax laws, it is not possible to estimate the outcome of these matters.", "improper actions to delay or prevent generic drugs from entering the market.", "The quarterly results of operations are not necessarily indicative of the results that may be expected for the entire year.", "effectiveness of the Company\u2019s \u201cdisclosure controls and procedures\u201d (as such term is defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) as of the end of the period  covered  by  this  report  and  have  concluded  that  our  disclosure  controls  and  procedures  are  effective  based  on  their  evaluation  of  these  controls  and procedures as required by paragraph (b) of Exchange Act Rules 13a-15 or 15d-15.", "Rules 13a-15 or 15d-15 that occurred during our fourth quarter of 2021 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.", "caption  \u201cInvestors  -  Corporate  Governance.\u201d  The  Company\u2019s  Corporate  Governance  Guidelines  and  Charters  for  the  Audit,  Compensation  and  Governance Committees can also be found on our website under the same caption.", "Information  about the Code of Conduct applicable  to all employees, officers  and directors can be found on our website, www.mckesson.com, under the", "Information with respect to this item is incorporated by reference from the discussion under the heading \u201cExecutive Compensation\u201d in our Proxy Statement.", "Such non-employee director award is fully vested on the date of the grant.", "subject to and qualified in their entirety by reference to our amended and restated certificate of incorporation, our amended and restated by- laws  and  the  Delaware  General  Corporation  Law  (\u201cDGCL\u201d).  Copies  of  our  amended  and  restated  certificate  of  incorporation  and  our amended and restated by-laws have been filed with the Securities and Exchange Commission (the \u201cSEC\u201d) and are incorporated by reference herein. 100,000,000 shares are preferred stock, par value $0.01 per share.", "We may amend from time to time our amended and restated certificate of incorporation to increase the number of authorized shares of Common Stock and/or preferred stock.", "Any such amendment would require the approval of the holders of a majority of our shares entitled to vote.", "All of our outstanding shares of Common Stock are fully paid and non- assessable.", "Stock are entitled to receive ratably dividends out of assets legally available therefor at such times and in such amounts as our board of directors may from time to time determine.", "ratably in our assets that are legally available for distribution, after payment of all debts, other liabilities and any liquidation preferences of outstanding preferred stock.", "amended and restated certificate of incorporation does not provide for cumulative voting in the election of directors.", "Upon liquidation, dissolution or winding up of our affairs, the holders of Common Stock are entitled to share", "Holders of our Common Stock have no conversion, redemption, preemptive or similar", "Each outstanding share of Common Stock is entitled to one vote on all matters submitted to a vote of stockholders.", "Anti-Takeover Effects of Provisions of Our Amended and Restated Certificate of Incorporation and Our Amended and Restated By- Laws deemed to have an anti-takeover effect and may delay, deter or prevent a tender offer or takeover attempt that a stockholder might consider in its best interest, including those attempts that might result in a premium over the market price for the shares held by stockholders.", "Our amended and restated by-laws provide that special meetings of holders of Common Stock may be called only by our Chair, Chief Executive Officer or a majority of our board of directors for any purpose at any time.", "Holders of Common Stock owning at least 15% of the outstanding shares of Common Stock for at least one year are permitted to submit a special meeting request in accordance with the procedures described in our amended and restated by-laws.", "In general, notice of intent to nominate a director or raise business at such meetings must be received by us not less than 90 nor more than 120 days prior to the date of the  annual meeting and must contain certain specified  information concerning the person to be nominated or the matters to be brought before the meeting and concerning the stockholder submitting the proposal.", "may be amended by a vote of a majority of our board of directors and by the affirmative vote of a majority of the shares of the corporation entitled  to  vote  thereon.  Our  amended  and  restated  certificate  of  incorporation  and  our  amended  and  restated  by-laws  provide  that  our amended and restated by-laws may be amended by a vote of a majority of our board of directors.", "In addition, our amended and restated by- laws provide that our amended and restated by-laws may be amended by the affirmative vote of a majority of the shares of the corporation entitled to vote thereon.", "Current and former stockholders are deemed to have consented to the personal jurisdiction of the Delaware Courts in connection with any action to enforce that exclusive forum provision and to service of process in any such action.", "We  are  subject  to  the  \u201cbusiness  combination\u201d  statute  of  the  DGCL.  In  general,  such  statute  prohibits  a  publicly  held  Delaware", "The statute could prohibit or delay mergers or other takeover or change in control attempts with respect to us and, accordingly, may discourage attempts to acquire us.", "stock could decrease the amount available for distribution to holders of our Common Stock or could adversely affect the rights and powers, including voting rights, of such holders.", "The issuance of preferred stock could have the effect of delaying or preventing a change in control of us.", "Such limitation does not, however, affect the liability of a director (1) for any breach of the director\u2019s duty of loyalty to us or our stockholders, (2) for acts or omissions not in good faith or that involve intentional misconduct or a knowing violation of law, (3) in respect of certain unlawful dividend payments or stock redemptions or purchases and (4) for any transaction from which the director derives an improper personal benefit.", "The effect of this provision is to eliminate our rights and the rights of our stockholders (through stockholders\u2019 derivative suits) to recover monetary damages against a director for breach of the fiduciary duty of care as a director (including breaches resulting from negligent or grossly negligent behavior) except in the situations described in clauses (1) through (4) above.", "This provision does not limit or eliminate our rights or the rights of our stockholders to seek non-monetary relief such as an injunction or rescission in the event of a breach of a director\u2019s duty of care.", "In addition, our directors and officers have indemnification protection.", "principal amount of 0.625% Notes due 2021 and \u20ac600,000,000 aggregate principal amount of 1.500% Notes due 2025, and on February 12, 2018, we issued \u20ac500,000,000 aggregate principal amount of 1.625% Notes due 2026.", "existing and future unsecured and unsubordinated indebtedness from time to time outstanding.", "EQ Shareowner Services acts as transfer agent and registrar of our Common Stock.", "Our Common Stock is listed on the New York Stock Exchange under the symbol \u201cMCK\u201d.", "On  February  17,  2017,  we  issued  \u00a3450,000,000  aggregate  principal  amount  of  3.125%  Notes  due  2029,  \u20ac600,000,000  aggregate", "Securities\u201d), our senior subordinated debt (\u201cSenior Subordinated Debt Securities\u201d), our subordinated debt (\u201cSubordinated Debt Securities\u201d) or our  junior  subordinated  debt  (\u201cJunior  Subordinated  Debt  Securities\u201d  and,  together  with  the  Senior  Subordinated  Debt  Securities  and  the Subordinated Debt Securities, the \u201cSubordinated Securities\u201d).  The Indenture does not limit the amount of debt securities that we may issue.", "It provides that we may issue debt securities up to the principal amount that we may authorize and may be in any currency or currency unit designated  by  us.  Except  for  the  limitations  on  consolidation,  merger  and  sale  of  all  or  substantially  all  of  our  assets  contained  in  the Indenture, the terms of the Indenture do not contain any covenants or other provisions designed to afford holders of any debt securities protection with respect to our operations, financial condition or transactions involving us.", "any person unless (a) we will be the continuing corporation or (b) the successor corporation or person formed by such consolidation or into which we are merged or to which our assets substantially as an entirety are transferred or leased is a corporation, limited liability company or limited partnership organized or existing under the laws of the United States, any state of the United States or the District of Columbia and, if such entity is not a corporation, a co-obligor of the debt securities is a corporation organized or existing under any such laws, and such successor corporation or person, including such co-obligor, if any, expressly assumes our obligations on the debt securities and under the Indenture.", "In addition, we cannot effect such a transaction unless immediately after giving effect to such transaction, no default or Event of Default under the Indenture shall have occurred and be continuing.", "Subject to certain exceptions, when the person to whom our assets are transferred or leased has assumed our obligations under the debt securities and the Indenture, we shall be discharged from all our obligations under the debt securities and the Indenture, except in limited circumstances.", "unless the transaction or change of control were structured to include a merger or consolidation or transfer or lease of all or substantially all of our assets.", "We cannot consolidate or merge with or into, or transfer or lease all or substantially all of our assets to,", "\u2022 any  other  Event  of  Default  provided  in  the  applicable  resolution  of  our  board  of  directors  or  the  officers\u2019  certificate  or supplemental Indenture under which we issue such series of debt securities.", "The Indenture imposes limitations on suits brought by holders of debt securities against us.", "officer knows of any default by us in the performance, observance or fulfillment of any condition or covenant of the Indenture.", "We and the Trustee may not, however, without the consent of the holder of each outstanding debt security affected thereby:", "The Indenture provides that we and the Trustee may enter into supplemental indentures without the", "value of the assets subject to such transaction, as determined by our Board of Directors, or (b) the present value of the remaining obligations of the lessee for net rental payments during the term of any lease discounted at the rate of interest set forth or implicit in the terms of such lease or, if not practicable to determine such rate, the weighted average interest rate per annum borne by the debt securities of each series outstanding pursuant to the Indenture and subject to limitations on sale and lease-back transaction covenants, compounded semi-annually in either case as determined by our principal accounting or financial officer.", "located,  and  substantially  all  the  operations  of  which  are  conducted,  in  the  United  States  of  America  whose  financial  statements  are consolidated with our financial statements in accordance with accounting principles generally accepted in the United States of America.", "Consolidated  Subsidiaries  incurred  after  the  date  of  issuance  of  the  notes  and  secured  by  liens  not  permitted  by  the  limitation  on  liens provisions, and (2) Attributable Debt of ours and our Consolidated Subsidiaries in respect of every sale and lease-back transaction entered into after the date of the issuance of the notes, other than leases permitted by the limitation on sale and lease-back provisions.", "accordance with accounting principles generally accepted in the United States of America.", "Subsidiaries pursuant to which we or any of our Subsidiaries sells, conveys or otherwise transfers to (1) a Receivables Subsidiary (in the case of a transfer by us or any of our Subsidiaries) or (2) any other person (in the case of a transfer by a Receivables Subsidiary), or grants a security interest in, any accounts receivable (whether now existing or arising in the future) or inventory of us or any of our Subsidiaries, and any assets related thereto including, without limitation, all collateral securing such accounts receivable, all contracts and all guarantees or other  obligations  in  respect  of  such  accounts  receivable  or  inventory,  proceeds  of  such  accounts  receivable  and  other  assets  which  are customarily transferred or in respect of which security interests are customarily granted in connection with asset securitization transactions involving accounts receivable or inventory.", "financing of accounts receivable or inventory (a) no portion of the Indebtedness or any other obligations (contingent or otherwise) of which (1)  is  guaranteed  by  us  or  any  Subsidiary  of  ours  (excluding  guarantees  of  obligations  (other  than  the  principal  of,  and  interest  on, Indebtedness) pursuant to representations, warranties, covenants and indemnities entered into in the ordinary course of business in connection with  a  Qualified  Receivables  Transaction),  (2)  is  recourse  or  obligates  us  or  any  Subsidiary  of  ours  in  any  way  other  than  pursuant  to representations,  warranties,  covenants  and  indemnities  entered  into  in  the  ordinary  course  of  business  in  connection  with  a  Qualified Receivables Transaction or (3) subjects any property or asset of ours or any Subsidiary of ours (other than accounts receivable or inventory and related assets as provided in the definition of \u201cQualified Receivables Transaction\u201d), directly or indirectly, contingently or otherwise, to the satisfaction thereof, other than pursuant to representations, warranties, covenants and indemnities entered into in the ordinary course of business in connection with a Qualified Receivables Transaction, (b) with which neither we nor any Subsidiary of ours has any material contract, agreement, arrangement or understanding other than on terms customary for securitization of receivables or inventory and (c) with which neither we nor any Subsidiary of ours has any obligations to maintain or preserve such Subsidiary\u2019s financial condition or cause such Subsidiary to achieve certain levels of operating results.", "Limitation  on  Liens.  We  covenant  that,  so  long  as  any  of  the  Notes  remain  outstanding,  we  will  not,  and  will  not  permit  any", "Indebtedness which is secured by a lien which would otherwise be subject to the foregoing restrictions; provided that after giving effect thereto the Exempted Debt then outstanding at such time does not exceed 10% of our total assets on a consolidated basis.", "than three years, by us or any Consolidated Subsidiary of any assets are prohibited unless (a) we or such Consolidated Subsidiary would be entitled to incur Indebtedness secured by a lien on the assets to be leased in an amount at least equal to the Attributable Debt in respect of such transaction without equally and ratably securing the notes, or (b) the proceeds of the sale of the assets to be leased are at least equal to their fair market value (as determined by our Board of Directors) and the proceeds are applied to the purchase or acquisition, or, in the case of real property, the construction, of assets or to the retirement of Indebtedness.", "The foregoing limitation will not apply, if at the time we or any Consolidated Subsidiary enters into such sale and lease-back transaction, and after giving effect thereto, Exempted Debt does not exceed 10% of our total assets on a consolidated basis.", "time, or in part, from time to time, at our option, for cash, at a redemption price that includes accrued and unpaid interest and a make-whole premium, as specified in the Indenture and the applicable Officer\u2019s Certificate.", "York  Stock  Exchange  under  the  symbol  \u201cMCK25.\u201d  Our  2026  Notes  are  listed  on  the  New  York  Stock  Exchange  under  the  symbol \u201cMCK26.\u201d Our 2029 Notes are listed on the New York Stock Exchange under the symbol \u201cMCK29.\u201d", "This Statement of Terms and Conditions is intended to meet the requirements of Code Section 409A and any regulations and rules promulgated thereunder.", "In the event of any inconsistency between this Statement of Terms and Conditions and the Plan, the Plan shall govern.", "Capitalized terms not otherwise defined in this Statement of Terms and Conditions shall have the meaning set forth in the Plan.", "With respect to  annual  Restricted  Stock  Unit  Awards  granted  to  Outside  Directors  under  the  Plan,  such  awards  shall  be  subject  to  the  following  terms,  conditions  and restrictions.", "The Administrator administering the Plan has authority to determine the Outside Directors to whom, and the time or", "additional Restricted Stock Units, which will be subject to all of the terms and conditions of the underlying Restricted Stock Unit Award.", "The number of such additional Restricted Stock Units shall be calculated by dividing (a) the aggregate amount or value of the dividends paid with respect to that number of Shares equal to the number of Restricted Stock Units credited as of the record date for such dividend by (b) the Fair Market Value per Share on the payment date for such dividend.", "Any fractional Shares resulting from the accumulation of dividend equivalents shall be paid in cash.", "Dividend equivalents in respect of Restricted Stock Units, if granted in tandem with such Units, will be converted into", "Neither an Outside Director nor any person entitled to exercise an Outside Director\u2019s rights in the event of the Outside", "this Statement of Terms and Conditions, or under a Restricted Stock Unit Agreement, shall be conclusive and binding on all persons.", "is providing the consents herein on a purely voluntary basis.", "Nothing herein contained shall affect an Outside Director\u2019s right, if any, to participate in and receive benefits", "Each Outside Director shall agree to make appropriate arrangements with the Corporation for satisfaction of any applicable federal,", "The Corporation will hold and use the Data only as long as is necessary to implement, administer and manage the", "illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.", "Agreements shall be governed by the laws of the State of Delaware.", "The provisions in this Statement of Terms and Conditions are severable and if any one or more provisions are determined to be", "This Statement of Terms and Conditions and the Restricted Stock Unit Agreements shall be binding upon and inure to the benefit of", "This Statement of Terms and Conditions is intended to meet the requirements of Code Section 409A and any regulations and rules promulgated thereunder.", "In the event of any inconsistency between this Statement of Terms and Conditions and the Plan, the Plan shall govern.", "Capitalized terms not otherwise defined in this Statement of Terms and Conditions shall have the meaning set forth in the Plan.", "With respect to  annual  Restricted  Stock  Unit  Awards  granted  to  Outside  Directors  under  the  Plan,  such  awards  shall  be  subject  to  the  following  terms,  conditions  and restrictions.", "The Administrator administering the Plan has authority to determine the Outside Directors to whom, and the time or", "Neither an Outside Director nor any person entitled to exercise an Outside Director\u2019s rights in the event of the Outside", "this Statement of Terms and Conditions, or under a Restricted Stock Unit Agreement, shall be conclusive and binding on all persons.", "is providing the consents herein on a purely voluntary basis.", "Nothing herein contained shall affect an Outside Director\u2019s right, if any, to participate in and receive benefits", "Each Outside Director shall agree to make appropriate arrangements with the Corporation for satisfaction of any applicable federal,", "The Corporation will hold and use the Data only as long as is necessary to implement, administer and manage the", "illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.", "Agreements shall be governed by the laws of the State of Delaware.", "The provisions in this Statement of Terms and Conditions are severable and if any one or more provisions are determined to be", "This Statement of Terms and Conditions and the Restricted Stock Unit Agreements shall be binding upon and inure to the benefit of", "In the event of any inconsistency between this Statement of Terms and Conditions and the Plan, the Plan shall govern.", "Capitalized terms not otherwise defined in this Statement of Terms and Conditions shall have the meaning set forth in the Plan.", "The Option is also subject to the terms and conditions of the Plan.", "In no event shall the Corporation be required to issue fractional Shares.", "An Option granted under the Plan shall be evidenced by an Option Agreement setting forth the terms and conditions of the", "The Exercise Price of an Option, as specified in the Option Agreement, shall be equal to or greater than the Fair Market Value of", "Period, the Option Period shall end on the date of such termination of employment and the Option shall thereupon not be exercisable to any extent whatsoever.", "Term Disability, the vesting schedule of the Participant\u2019s Option shall be accelerated, the Option shall become fully exercisable and the Option Period shall end on the earlier of (i) three years after the date of the Participant\u2019s termination of employment and (ii) the Expiration Date.", "Retirement, (i) the Option shall be exercisable only to the extent that it was exercisable at the time of such retirement and (ii) the Option Period for that portion of the Option designated as a Non Statutory Stock Option shall end on the earlier of (a) three years after the date of such retirement and (b) the Expiration Date.", "of  the  Participant's  Option,  then  the  Option  shall  continue  to  remain  outstanding  until  the  earlier  of  (i)  such  time  as  the  Participant  subsequently  terminates employment and (ii) the Expiration Date.", "number of Shares as to which the Option is so exercised.", "thereunder shall be transferable by the Participant by operation of law or otherwise, other than by will or the laws of descent and distribution.", "have any of the rights of a stockholder with respect to the Shares subject to an Option except to the extent that a book entry has been entered in the records of the Corporation\u2019s transfer agent with respect to such Shares upon the exercise of an Option.", "Neither a Participant nor any person entitled to exercise a Participant\u2019s rights in the event of the Participant\u2019s death shall", "Stock dividends paid with respect to Restricted Stock during the Restriction Period shall be treated as Restricted Stock which shall be subject to the same restrictions as the original award for the duration of the Restriction Period.", "If the Participant does not have a brokerage account of record, then an appropriate book entry recording the Participant\u2019s interest in the unrestricted Shares shall be entered on the records of the Corporation\u2019s transfer agent.", "Cash dividends paid with respect to Restricted Stock during the Restriction Period shall be credited on behalf of the Participant to a", "Election to Recognize Gross Income in the Year of Grant.", "The Administrator reserves the right to impose a restriction on the sale of Shares that the Participant receives upon", "Neither a Participant nor any person entitled to exercise a Participant\u2019s rights in the event of the Participant\u2019s death shall", "The Administrator reserves the right to impose a restriction on the sale of Shares that the Participant receives upon", "Following the end of the performance period, the Compensation Committee shall determine the extent to which the criteria have been achieved and shall authorize the grant and issuance of Shares in respect of the Performance Stock Unit Award.", "The performance period of a Performance Stock Unit Award shall be greater than one year,", "Unless otherwise determined by the Compensation Committee in its sole discretion, Dividend Equivalents shall not be", "A Participant shall not be permitted to sell, transfer, pledge, assign or encumber all or any portion of a Performance Stock Unit", "Neither a Participant nor any person entitled to exercise a Participant\u2019s rights in the event of the Participant\u2019s death shall", "The Administrator reserves the right to impose a restriction on the sale of Shares that the Participant", "addition, any Award of Restricted Stock or Restricted Stock Units as to which the restrictions have not lapsed shall immediately and automatically be forfeited, Performance Stock Unit Awards shall immediately and automatically be forfeited and any such Shares of Restricted Stock shall be returned to the Corporation and all of the rights of the Participant to such Awards and the underlying Shares shall immediately terminate.", "Any outstanding Option shall immediately and automatically terminate, be forfeited and shall cease to be exercisable, without limitation.", "determination shall be conclusive and binding on all interested persons.", "a manner that is valid and enforceable and that comes closest to the business objectives intended by such invalid or unenforceable provision, without invalidating or rendering unenforceable the remaining provisions of this Section VI.", "under an Award Agreement, shall be conclusive and binding on all interested persons.", "Participation in the Plan shall not create a right to further employment with the Participant\u2019s employer (the", "In making grants to Participants in foreign countries, the Administrator has the full discretion to", "All decisions of the Administrator administering the Plan upon any questions arising under the Plan or", "Nothing herein contained shall affect a Participant\u2019s right to participate in and receive benefits from and in", "Regardless  of any  action  the  Corporation  or  the  Employer  takes  with  respect  to  any  federal,  state  or  local  income  tax,  social", "Calculation of the number of Shares to be withheld shall be made based on the closing price of the Common Stock on the New York Stock Exchange on the date that the amount of tax to be withheld is determined.", "With respect to an Award other than an Option, if adequate arrangements to satisfy the obligations with regard to all Tax-Related Items are not made by the Participant with the Corporation and/or the Employer prior to the relevant taxable event, the Corporation will satisfy such obligations as provided above in clause (3) of this paragraph.", "The Administrator shall be authorized to establish such rules, forms and procedures as it deems necessary to implement the foregoing.", "In accepting the grant, the Participant acknowledges that:", "jurisdiction may have different data privacy laws and protections than the United States.", "In the latter case, the Participant understands and acknowledges that the Corporation\u2019s legal basis for the processing of the Participant\u2019s Data would be compliance with the relevant  laws  or  regulations  or  the  pursuit  by  the  Corporation  of  respective  legitimate  interests  not  outweighed  by  the  Participant\u2019s  interests,  rights  or freedoms.", "When the Corporation no longer needs the Participant\u2019s Data for any of the above purposes, the Participant understands the Corporation will remove it from its systems.", "providing the consents herein on a purely voluntary basis.", "illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.", "If the Participant has received this Statement of Terms and Conditions or any other document related to the Plan translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control.", "The provisions in this Statement of Terms and Conditions are severable and if any one or more provisions are determined to be", "The Participant acknowledges that the Participant is proficient in the English language and, accordingly, understands the provisions of", "The Corporation will hold and use the Data only as long as is necessary to implement, administer and manage the", "Participation in the Plan is voluntary and the Participant is", "In the event of any inconsistency between this Statement of Terms and Conditions and the Plan, the Plan shall govern.", "Capitalized terms not otherwise defined in this Statement of Terms and Conditions shall have the meaning set forth in the Plan.", "The Option is also subject to the terms and conditions of the Plan.", "In no event shall the Corporation be required to issue fractional Shares.", "An Option granted under the Plan shall be evidenced by an Option Agreement setting forth the terms and conditions of the", "The Exercise Price of an Option, as specified in the Option Agreement, shall be equal to or greater than the Fair Market Value of", "Period, the Option Period shall end on the date of such termination of employment and the Option shall thereupon not be exercisable to any extent whatsoever.", "Term Disability, the vesting schedule of the Participant\u2019s Option shall be accelerated, the Option shall become fully exercisable and the Option Period shall end on the earlier of (i) three years after the date of the Participant\u2019s termination of employment and (ii) the Expiration Date.", "Retirement, (i) the Option shall be exercisable only to the extent that it was exercisable at the time of such retirement and (ii) the Option Period for that portion of the Option designated as a Nonstatutory Stock Option shall end on the earlier of (a) three years after the date of such retirement and (b) the Expiration Date.", "of  the  Participant's  Option,  then  the  Option  shall  continue  to  remain  outstanding  until  the  earlier  of  (i)  such  time  as  the  Participant  subsequently  terminates employment and (ii) the Expiration Date.", "number of Shares as to which the Option is so exercised.", "thereunder shall be transferable by the Participant by operation of law or otherwise, other than by will or the laws of descent and distribution.", "have any of the rights of a stockholder with respect to the Shares subject to an Option except to the extent that a book entry has been entered in the records of the Corporation\u2019s transfer agent with respect to such Shares upon the exercise of an Option.", "Neither a Participant nor any person entitled to exercise a Participant\u2019s rights in the event of the Participant\u2019s death shall", "Stock dividends paid with respect to Restricted Stock during the Restriction Period shall be treated as Restricted Stock which shall be subject to the same restrictions as the original award for the duration of the Restriction Period.", "If the Participant does not have a brokerage account of record, then an appropriate book entry recording the Participant\u2019s interest in the unrestricted Shares shall be entered on the records of the Corporation\u2019s transfer agent.", "Cash dividends paid with respect to Restricted Stock during the Restriction Period shall be credited on behalf of the Participant to a", "Election to Recognize Gross Income in the Year of Grant.", "The Administrator reserves the right to impose a restriction on the sale of Shares that the Participant receives upon", "Neither a Participant nor any person entitled to exercise a Participant\u2019s rights in the event of the Participant\u2019s death shall", "The Administrator reserves the right to impose a restriction on the sale of Shares that the Participant receives upon", "The performance period of a Performance Stock Unit Award shall be greater than one year,", "Unless otherwise determined by the Compensation Committee in its sole discretion, Dividend Equivalents shall not be", "A Participant shall not be permitted to sell, transfer, pledge, assign or encumber all or any portion of a Performance Stock Unit", "Neither a Participant nor any person entitled to exercise a Participant\u2019s rights in the event of the Participant\u2019s death shall", "The Administrator reserves the right to impose a restriction on the sale of Shares that the Participant", "addition, any Award of Restricted Stock or Restricted Stock Units as to which the restrictions have not lapsed shall immediately and automatically be forfeited, Performance Stock Unit Awards shall immediately and automatically be forfeited and any such Shares of Restricted Stock shall be returned to the Corporation and all of the rights of the Participant to such Awards and the underlying Shares shall immediately terminate.", "Any outstanding Option shall immediately and automatically terminate, be forfeited and shall cease to be exercisable, without limitation.", "determination shall be conclusive and binding on all interested persons.", "a manner that is valid and enforceable and that comes closest to the business objectives intended by such invalid or unenforceable provision, without invalidating or rendering unenforceable the remaining provisions of this Section VI.", "under an Award Agreement, shall be conclusive and binding on all interested persons.", "Participation in the Plan shall not create a right to further employment with the Participant\u2019s employer (the", "In making grants to Participants in foreign countries, the Administrator has the full discretion to", "All decisions of the Administrator administering the Plan upon any questions arising under the Plan or", "Nothing herein contained shall affect a Participant\u2019s right to participate in and receive benefits from and in", "Regardless  of any  action  the  Corporation  or  the  Employer  takes  with  respect  to  any  federal,  state  or  local  income  tax,  social", "Calculation of the number of Shares to be withheld shall be made based on the closing price of the Common Stock on the New York Stock Exchange on the date that the amount of tax to be withheld is determined.", "With respect to an Award other than an Option, if adequate arrangements to satisfy the obligations with regard to all Tax-Related Items are not made by the Participant with the Corporation and/or the Employer prior to the relevant taxable event, the Corporation will satisfy such obligations as provided above in clause (3) of this paragraph.", "The Administrator shall be authorized to establish such rules, forms and procedures as it deems necessary to implement the foregoing.", "In accepting the grant, the Participant acknowledges that:", "jurisdiction may have different data privacy laws and protections than the United States.", "In the latter case, the Participant understands and acknowledges that the Corporation\u2019s legal basis for the processing of the Participant\u2019s Data would be compliance with the relevant  laws  or  regulations  or  the  pursuit  by  the  Corporation  of  respective  legitimate  interests  not  outweighed  by  the  Participant\u2019s  interests,  rights  or freedoms.", "When the Corporation no longer needs the Participant\u2019s Data for any of the above purposes, the Participant understands the Corporation will remove it from its systems.", "providing the consents herein on a purely voluntary basis.", "illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.", "If the Participant has received this Statement of Terms and Conditions or any other document related to the Plan translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control.", "The provisions in this Statement of Terms and Conditions are severable and if any one or more provisions are determined to be", "The Participant acknowledges that the Participant is proficient in the English language and, accordingly, understands the provisions of", "The Corporation will hold and use the Data only as long as is necessary to implement, administer and manage the", "Participation in the Plan is voluntary and the Participant is", "In the event of any inconsistency between this Statement of Terms and Conditions and the Plan, the Plan shall govern.", "Capitalized terms not otherwise defined in this Statement of Terms and Conditions shall have the meaning set forth in the Plan.", "The Option is also subject to the terms and conditions of the Plan.", "In no event shall the Corporation be required to issue fractional Shares.", "An Option granted under the Plan shall be evidenced by an Option Agreement setting forth the terms and conditions of the", "The Exercise Price of an Option, as specified in the Option Agreement, shall be equal to or greater than the Fair Market Value of", "Period, the Option Period shall end on the date of such termination of employment and the Option shall thereupon not be exercisable to any extent whatsoever.", "Term Disability, the vesting schedule of the Participant\u2019s Option shall be accelerated, the Option shall become fully exercisable and the Option Period shall end on the earlier of (i) three years after the date of the Participant\u2019s termination of employment and (ii) the Expiration Date.", "Retirement, (i) the Option shall be exercisable only to the extent that it was exercisable at the time of such retirement and (ii) the Option Period for that portion of the Option designated as a Non Statutory Stock Option shall end on the earlier of (a) three years after the date of such retirement and (b) the Expiration Date.", "of  the  Participant's  Option,  then  the  Option  shall  continue  to  remain  outstanding  until  the  earlier  of  (i)  such  time  as  the  Participant  subsequently  terminates employment and (ii) the Expiration Date.", "number of Shares as to which the Option is so exercised.", "thereunder shall be transferable by the Participant by operation of law or otherwise, other than by will or the laws of descent and distribution.", "have any of the rights of a stockholder with respect to the Shares subject to an Option except to the extent that a book entry has been entered in the records of the Corporation\u2019s transfer agent with respect to such Shares upon the exercise of an Option.", "Neither a Participant nor any person entitled to exercise a Participant\u2019s rights in the event of the Participant\u2019s death shall", "Stock dividends paid with respect to Restricted Stock during the Restriction Period shall be treated as Restricted Stock which shall be subject to the same restrictions as the original award for the duration of the Restriction Period.", "If the Participant does not have a brokerage account of record, then an appropriate book entry recording the Participant\u2019s interest in the unrestricted Shares shall be entered on the records of the Corporation\u2019s transfer agent.", "Cash dividends paid with respect to Restricted Stock during the Restriction Period shall be credited on behalf of the Participant to a", "Election to Recognize Gross Income in the Year of Grant.", "Neither a Participant nor any person entitled to exercise a Participant\u2019s rights in the event of the Participant\u2019s death shall", "Following the end of the performance period, the Compensation Committee shall determine the extent to which the criteria have been achieved and shall authorize the grant and issuance of Shares in respect of the Performance Stock Unit Award.", "The performance period of a Performance Stock Unit Award shall be greater than one year,", "addition, any Award of Restricted Stock or Restricted Stock Units as to which the restrictions have not lapsed shall immediately and automatically be forfeited, Performance Stock Unit Awards shall immediately and automatically be forfeited and any such Shares of Restricted Stock shall be returned to the Corporation and all of the rights of the Participant to such Awards and the underlying Shares shall immediately terminate.", "Unless otherwise determined by the Compensation Committee in its sole discretion, Dividend Equivalents shall not be", "A Participant shall not be permitted to sell, transfer, pledge, assign or encumber all or any portion of a Performance Stock Unit", "Neither a Participant nor any person entitled to exercise a Participant\u2019s rights in the event of the Participant\u2019s death shall", "Any outstanding Option shall immediately and automatically terminate, be forfeited and shall cease to be exercisable, without limitation.", "determination shall be conclusive and binding on all interested persons.", "a manner that is valid and enforceable and that comes closest to the business objectives intended by such invalid or unenforceable provision, without invalidating or rendering unenforceable the remaining provisions of this Section VI.", "Participation in the Plan shall not create a right to further employment with the Participant\u2019s employer (the", "In making grants to Participants in foreign countries, the Administrator has the full discretion to", "under an Award Agreement, shall be conclusive and binding on all interested persons.", "Calculation of the number of Shares to be withheld shall be made based on the closing price of the Common Stock on the New York Stock Exchange on the date that the amount of tax to be withheld is determined.", "With respect to an Award other than an Option, if adequate arrangements to satisfy the obligations with regard to all Tax-Related Items are not made by the Participant with the Corporation and/or the Employer prior to the relevant taxable event, the Corporation will satisfy such obligations as provided above in clause (3) of this paragraph.", "All decisions of the Administrator administering the Plan upon any questions arising under the Plan or", "Nothing herein contained shall affect a Participant\u2019s right to participate in and receive benefits from and in", "Regardless  of any  action  the  Corporation  or  the  Employer  takes  with  respect  to  any  federal,  state  or  local  income  tax,  social", "The Administrator shall be authorized to establish such rules, forms and procedures as it deems necessary to implement the foregoing.", "In accepting the grant, the Participant acknowledges that:", "jurisdiction may have different data privacy laws and protections than the United States.", "In the latter case, the Participant understands and acknowledges that the Corporation\u2019s legal basis for the processing of the Participant\u2019s Data would be compliance with the relevant  laws  or  regulations  or  the  pursuit  by  the  Corporation  of  respective  legitimate  interests  not  outweighed  by  the  Participant\u2019s  interests,  rights  or freedoms.", "When the Corporation no longer needs the Participant\u2019s Data for any of the above purposes, the Participant understands the Corporation will remove it from its systems.", "providing the consents herein on a purely voluntary basis.", "The Corporation will hold and use the Data only as long as is necessary to implement, administer and manage the", "Participation in the Plan is voluntary and the Participant is", "illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.", "If the Participant has received this Statement of Terms and Conditions or any other document related to the Plan translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control.", "The provisions in this Statement of Terms and Conditions are severable and if any one or more provisions are determined to be", "The Participant acknowledges that the Participant is proficient in the English language and, accordingly, understands the provisions of", "In the event of any inconsistency between this Award Agreement and the Plan, the Plan shall govern.", "Capitalized terms not otherwise defined in this Award Agreement shall have the meaning set forth in the Plan.", "determine the extent to which the performance goals have been achieved, and shall determine the number of PSUs that have been earned.", "Once the Compensation Committee has determined the number of PSUs that have been earned pursuant to the", "Dividend equivalents shall be credited in respect of the One-Year RSU Award.", "The restrictions applicable to the RSU Award shall lapse with respect to 100% of the underlying Shares on the third", "Dividend equivalents shall be credited in respect of the RSU Award granted under this Section III.", "If the Participant ceases to be a bona fide employee of the Corporation or any Affiliate (except as otherwise", "otherwise  forfeited  pursuant  to  the  terms  of  the  Plan  and  this  Award  Agreement  shall  be  paid  to  the  Participant  as  soon  as  reasonably  practicable  after  the restrictions lapse.", "Performance  Stock  Units and  Restricted  Stock  Units,  to  the  extent  the  restrictions  have  not  lapsed,  shall  immediately  and  automatically  be", "determination shall be conclusive and binding on all interested persons.", "a manner that is valid and enforceable and that comes closest to the business objectives intended by such invalid or unenforceable provision, without invalidating or rendering unenforceable the remaining provisions of this Section IV.", "Compensation Committee reserves the right to impose a restriction on the sale of Shares that the Participant receives upon the settlement of the Performance Stock Units and Restricted Stock Units granted hereunder, unless the Participant has satisfied the ownership targets applicable to the Participant as provided in such policy.", "Neither the Participant nor any person entitled to exercise the Participant\u2019s rights in the event of the Participant\u2019s death", "Participation in the Plan shall not create a right to further employment with the Participant\u2019s employer (the", "under this Award Agreement, shall be conclusive and binding on all interested persons.", "Calculation of the number of Shares to be withheld shall be made based on the closing price of the Common Stock on the New York Stock Exchange on the date that the amount of tax to be withheld is determined.", "If adequate arrangements to satisfy the obligations with regard to all Tax-Related Items are not made by the Participant with the Corporation and/or the Employer prior to the relevant taxable event, the Corporation will satisfy such obligations as provided above in clause (iii) of this paragraph.", "The Administrator has the full discretion to deviate from this Award Agreement in order to adjust the Awards", "All decisions of the Administrator administering the Plan upon any questions arising under the Plan or", "Nothing herein contained shall affect the Participant\u2019s right to participate in and receive benefits from and in", "Regardless  of any  action  the  Corporation  or  the  Employer  takes  with  respect  to  any  federal,  state  or  local  income  tax,  social", "The Administrator shall be authorized to establish such rules, forms and procedures as it deems necessary to implement the foregoing.", "In accepting the grant, the Participant acknowledges that:", "providing the consents herein on a purely voluntary basis.", "The Corporation will hold and use the Data only as long as is necessary to implement, administer and manage the", "Participation in the Plan is voluntary and the Participant is", "unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.", "English and if the meaning of the translated version is different than the English version, the English version will control.", "Award, the terms of which are set forth herein and in the Plan.", "The provisions in this Award Agreement are severable and if any one or more provisions are determined to be illegal or otherwise", "Below is a list of documents that are made available to you in connection with this Notice.", "PLEASE BE SURE TO READ THESE DOCUMENTS BECAUSE THEY CONTAIN IMPORTANT INFORMATION SPECIFIC TO THIS GRANT OF RSUs.", "By signing below, I acknowledge that: 1.    I agree to receive copies of the stockholder information, including copies of any annual report, proxy and Form 10-K, from the Investor Resources section of", "Below is a list of documents that are made available to you in connection with this Notice.", "PLEASE BE SURE TO READ THESE DOCUMENTS BECAUSE THEY CONTAIN IMPORTANT INFORMATION SPECIFIC TO THIS GRANT OF RSUs.", "I consent to receiving electronically a copy of the documents set forth above and attachments to this Notice; and 5.", "I accept ALL the terms and conditions as set forth in the Plan and ST&Cs applicable to this grant of RSUs.", "Your  PSUs  will  be  earned  subject  to  the  Company\u2019s  attainment  of  performance  goals  that  have  been  pre-established  by  the  Compensation  Committee  (the \u201cCommittee\u201d) of the Company\u2019s Board of Directors.", "Below is a list of documents that are made available to you in connection with this Notice.", "PLEASE BE SURE TO READ THESE DOCUMENTS BECAUSE THEY CONTAIN IMPORTANT INFORMATION SPECIFIC TO THIS GRANT OF PSUs.", "I consent to receiving electronically a copy of the documents set forth above and attachments to this Notice; and 12.", "I should consult with a tax advisor prior to accepting this grant of PSUs or taking any other action with respect to this grant of PSUs; and 14.", "I accept ALL the terms and conditions as set forth in the Plan and ST&Cs applicable to this grant of PSUs.", "We consent to the incorporation by reference in McKesson Corporation Registration Statement Nos. 333-249817, 333-163642, 333-190847, 333-190848, and 333- 213488 on Form S-8, and Registration Statement No. 333-236808 on Form S-3, of our report dated May 12, 2021, relating to the consolidated financial statements and consolidated financial statement schedule of McKesson Corporation and subsidiaries, and the effectiveness of McKesson Corporation\u2019s internal control over financial reporting appearing in this Annual Report on Form 10-K of McKesson Corporation for the year ended March 31, 2021.", "I have reviewed this annual report on Form 10-K of McKesson Corporation;", "The registrant\u2019s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant\u2019s auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):", "I have reviewed this annual report on Form 10-K of McKesson Corporation;", "The registrant\u2019s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant\u2019s auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):", "Together, we work across the healthcare delivery system to connect pharmacies, providers, payers, and biopharma for next-generation patient access and adherence solutions that help people get the medicine they need to live healthier lives.", "Unless otherwise noted, all references in this document to a particular year shall mean the", "On March 10, 2020, we completed the separation of our interest in the Change Healthcare JV through a split- off transaction.", "This transaction reduced our investment in the Change Healthcare JV to zero.", "Change Healthcare: Our equity ownership interest in Change Healthcare JV, a joint venture, has been accounted for using the equity method of accounting.", "for our innovations and obtain copyright protection for our original works of authorship, when such protection is advantageous.", "Through these efforts, we have developed a portfolio of patents and copyrights in the U.S. and worldwide.", "In addition, we have registered or applied to register certain trademarks and service marks in the U.S. and in foreign countries.", "We cannot guarantee that our intellectual property portfolio will be sufficient to deter misappropriation, theft, or misuse of our technology, nor that we can successfully enjoin infringers.", "We periodically receive notices alleging that our products or services infringe on third party patents and other intellectual property rights.", "While the outcome of any litigation or dispute is inherently uncertain, we do not believe that the resolution of any of these infringement notices would have a material adverse impact on our results of operation.", "These values and behaviors help make McKesson unique.", "We offer financial assistance programs for higher education opportunities that support employees\u2019 career growth at the company.", "To provide compensation that is focused on attracting and retaining talent with the skills and experience necessary for a specific role, our compensation program is built on a set of quantifiable factors defined by our guiding principles of internal fairness, market competitiveness, and pay for performance.", "We operate in several countries and our benefits offerings vary accordingly.", "We offer health and wellness benefits to advance the physical, mental, and social well-being of our people, savings programs to help prepare them for retirement, and flexible work arrangements, among other  benefits  offerings,  when  possible.  In  response  to  the  COVID-19  pandemic,  we  offered  extended  medical  benefits  covering  COVID-19  related  visits, treatment and testing, expanded telehealth options, emergency paid time off (\u201cPTO\u201d), and a platform for employees to donate their regular PTO to co-workers who were  more  impacted  by  COVID-19.", "We have received monetary penalties and/or licensing sanctions pursuant to these requirements and future allegations of noncompliance could result in an inability to obtain, maintain or renew permits, licenses or other regulatory approvals needed for the operation of our businesses.", "As a result of ongoing, advanced discussions with state attorneys general and plaintiffs\u2019 representatives regarding a framework to resolve the claims of governmental entities, and our assessment of certain other opioid-related claims, we have reached a stage at which a broad settlement of opioid claims by governmental entities is probable and recorded a charge of $8.1 billion for the year ended March 31, 2021 within \u201cClaims and litigation charges, net\u201d in our Consolidated Statement of Operations in this Annual Report on Form 10-K.", "Because of the many uncertainties associated with any potential settlement arrangement or other resolution of opioid-related litigation, including the uncertainty of the scope of participation by plaintiffs in any potential settlement, we are not able to reasonably estimate the upper or lower ends of the range of ultimate possible loss for all opioid-related litigation matters.", "The adverse outcome of legal proceedings might also involve significant  expense,  management  time  and  distraction,  and risk  of loss that  can be difficult  to predict  or quantify.  In addition  to this litigation,  legislative  or regulatory measures related to the distribution of controlled substances such as prescription opioids could affect our business in ways that we may not be able to predict.", "For example, some states have passed legislation that could require us to pay taxes or assessments on the distribution of opioid medications in those states and other states have considered similar legislation.", "We are subject to government audits,  investigations  and  oversight  proceedings.  Government  agencies  routinely  review  and  audit  government  contractors  to  determine  whether  they  are complying with contractual and legal requirements.", "If we fail to comply with these requirements, or we fail an audit, we may be subject to various sanctions such as monetary damages, criminal and civil penalties, termination of contracts and suspension or debarment from government contract work.", "These requirements complicate our business and increase our compliance burden and material non-compliance could harm our reputation.", "affecting  Medicare,  Medicaid,  other  government  healthcare  programs,  and  government  contracts.  Our  relationships  with  pharmaceutical  and  medical  surgical product manufacturers and healthcare providers, as well as our provision of products and services to government entities, subject our business to laws, regulation, and government guidance on fraud and abuse.", "Many of these laws are vague or indefinite and have not been interpreted by the courts and, as such, may be interpreted or applied by a prosecutorial, regulatory, or judicial authority in a manner that could require us to make changes in our operations.", "Americans and changed the way healthcare is financed by both governmental and private payers.", "There are also further efforts to broaden healthcare coverage.", "Provincial governments in Canada that provide partial funding for the purchase of pharmaceuticals and independently regulate the sale and reimbursement of drugs have sought to reduce the costs of publicly funded health programs.", "Some European governments  have  implemented  or  are  considering  austerity  measures  to  reduce  healthcare  spending.  These  measures  exert  pressure  on  the  pricing  and reimbursement timelines for pharmaceuticals and may cause our customers to purchase fewer of our products and services or influence us to reduce prices.", "There is substantial uncertainty about the likelihood, timing and results of these health reform efforts.", "We also have record- keeping  and  other  obligations  under  the  E.U.  Falsified  Medicines  Directive.  Pedigree  tracking  laws  such  as  these  increase  our  compliance  burden  and  our pharmaceutical distribution costs.", "For example, under the Health Insurance Portability and Accountability Act of 1996 (\u201cHIPAA\u201d) we must maintain administrative, physical  and  technological  safeguards  to  protect  individually  identifiable  health  information  (\u201cprotected  health  information\u201d)  and  ensure  the  confidentiality, integrity, and availability of electronic protected health information.", "We are subject to significant compliance obligations under privacy laws such as the General Data Protection Regulation (\u201cGDPR\u201d) in the European Union, the Personal Information Protection and Electronic Documents Act (\u201cPIPEDA\u201d) in Canada, and the California Consumer Protection Act (\u201cCCPA\u201d).", "We are subject to privacy  and  data  protection  compliance  audits  or  investigations  by  various  government  agencies.  Failure  to  comply  with  these  laws  subjects  us  to  potential regulatory enforcement activity, fines, private litigation including class actions, and other costs.", "We also have contractual obligations to customers that might be breached if we fail to comply with privacy laws.", "Our efforts to comply with privacy laws complicate our operations and add to our compliance costs.", "storage and hosting of sensitive information, including protected health information and other types of personal information, confidential financial information, proprietary information, and other sensitive information relating to our customers, company and workforce.", "costs.  Environmental  costs  and  accruals,  including  that  related  to  our  legacy  chemical  distribution  operations,  presently  are  not  material  to our  operations  or financial position.", "Our ten largest customers comprised approximately 32%, and CVS was approximately 19%, of total trade accounts receivable at March 31, 2021.", "We also have agreements with GPOs, each of which functions as a purchasing agent on behalf of member  hospitals,  pharmacies  and other healthcare  providers,  as well as with government  entities  and agencies.  The accounts receivable balances are with individual members of the GPOs, and therefore no significant concentration of credit risk exists.", "Substantially all of these revenues and accounts receivable are included in our U.S.", "distribution arrangements with pharmaceutical manufacturers that include an inflation-based compensation component whereby we benefit when the manufacturers increase their prices as we sell our existing inventory at the new higher prices.", "Forward-looking  statements  involve  risks  and  uncertainties  that  could  cause  actual  results  to  differ  materially  from  those  projected,  anticipated,  or  implied.", "Except to the extent required by federal securities laws, we undertake no obligation to publicly release the result of any revisions to any forward-looking statements to reflect events or circumstances after the date the statements are made, or to reflect the occurrence of unanticipated events.", "Some of our distribution arrangements with the manufacturers provides us compensation based on a percentage of our purchases.", "We experience costly and disruptive legal disputes.", "Despite valid defenses that we assert, legal disputes are often costly, time-consuming, distracting to management and disruptive to normal business operations.", "The outcome of legal disputes is difficult to predict.", "Outcomes can occur that are not justified by the evidence or existing law.", "The uncertainty and expense associated with unresolved legal disputes might harm our business and reputation even if the matter is favorably resolved.", "Accordingly, any legal dispute might have a materially adverse impact on our reputation, our business operations and our financial position or results of operations.", "We might experience losses not covered by insurance.", "supplies, the provision of ancillary services, the conduct of our payer businesses and the provision of products that assist clinical decision-making and relate to patient medical histories and treatment plans.", "Although we seek to maintain adequate insurance coverage,  such  as  property  insurance  for  inventory  and  professional  and  general  liability  insurance,  coverages  on  acceptable  terms  might  be  unavailable,  or coverages might not cover our losses.", "We generally seek to limit our contractual exposure, but limitations of liability or indemnity provisions in our contracts may not be enforceable or adequately protect us from liability.", "Uninsured losses might have a materially adverse impact on our business operations and our financial position or results of operations.", "We regularly are named as a defendant in similar, new cases.", "Many of these cases raise novel theories of liability.", "Any proceedings can have unexpected outcomes that are not justified by evidence or existing law.", "It is not uncommon for claims to be resolved over many years.", "Although the Company has valid defenses and is vigorously defending itself, some proceedings have been and others may be resolved by negotiated outcome.", "Our reputation has been and may continue to be impacted by publicity regarding the litigation and related allegations.", "The adverse outcome of legal proceedings might have a materially adverse impact on our business operations and our financial position or results of operations.", "For example, some states have passed legislation that could require us to pay taxes or assessments on the distribution of opioid medications in those states and other states have considered similar legislation.", "Liabilities for taxes or assessments or other costs of compliance under any such laws might have a materially adverse impact on our reputation, business operations, and our financial position or results of operations.", "We are subject to extensive, complex and challenging healthcare and other laws.", "Any noncompliance by us with applicable laws or the failure to maintain, renew or obtain necessary permits and licenses could lead to litigation and might have a materially adverse impact on our business operations and our financial position or results of operations.", "Local, state and federal governments continue to strengthen their position and scrutiny over practices involving or allegedly involving fraud, waste and abuse affecting Medicare, Medicaid and other government healthcare programs.", "Our relationships with pharmaceutical and medical surgical product manufacturers and healthcare providers, as well as our provision of products and services to government entities, subject our business to laws and regulations on fraud and abuse, which among other things: (1) prohibit persons from soliciting, offering, receiving or paying any remuneration in order to induce the referral of a patient for treatment  or  to  induce  the  ordering  or  purchasing  of  items  or  services  that  are  in  any  way  paid  for  by  Medicare,  Medicaid  or  other  government-sponsored healthcare programs; (2) impose many restrictions upon referring physicians and providers of designated health services under Medicare and Medicaid programs; and (3) prohibit the knowing submission of a false or fraudulent claim for payment to, and knowing retention of an overpayment by, a federal healthcare program such  as  Medicare  and  Medicaid.  Many  of  these  laws,  regulations,  and  government  guidance,  including  those  relating  to  marketing  incentives,  are  vague  or indefinite and have not been interpreted by the courts.", "The laws may be interpreted or applied by a prosecutorial, regulatory, or judicial authority in a manner that could require us to make changes in our operations.", "Failures to comply with applicable laws subject us to federal or state government investigations or qui tam actions, and to liability for damages and civil and criminal penalties, including the loss of licenses or our ability to participate in Medicare, Medicaid and other federal and state healthcare programs.", "These sanctions might have a materially adverse impact on our business operations and our financial position or results of operations.", "Noncompliance with these requirements has resulted in monetary penalties and/or licensing sanctions.", "For example, under a January 2017 agreement with the DEA and Department of Justice we paid $150 million to settle potential administrative and civil claims about our practices for reporting suspicious orders of controlled substances and the DEA suspended, on a staggered basis for limited periods of time, our registrations to distribute certain controlled substances from four distribution centers.", "Pedigree tracking laws increase our compliance burden and our pharmaceutical distribution costs.", "Pedigree tracking laws such as these increase our compliance burden and our pharmaceutical distribution costs, and they might have a materially adverse impact on our business operations and our financial position or results of operations.", "Privacy and data protection laws increase our compliance burden.", "example,  under  the  Health  Insurance  Portability  and  Accountability  Act  of  1996  (\u201cHIPAA\u201d)  we  must  maintain  administrative,  physical  and  technological safeguards  to  protect  individually  identifiable  health  information  (\u201cprotected  health  information\u201d)  and  ensure  the  confidentiality,  integrity  and  availability  of electronic protected health information.", "Failure to comply with these laws subjects us to potential regulatory enforcement activity, fines, private litigation including class actions, and other costs.", "We also have contractual obligations to customers that might be breached if we fail to comply with privacy laws.", "Our efforts to comply with privacy laws complicates our operations and adds to our compliance costs.", "A significant privacy breach or failure  to  comply  with  privacy  laws  might  have  a  materially  adverse  impact  on  our  reputation,  business  operations  and  our  financial  position  or  results  of operations.", "Anti-bribery and anti-corruption laws increase our compliance burden.", "Bribery Act unless the organization can establish the defense of having implemented adequate procedures to prevent bribery.", "Our failure to comply with these laws might subject us to civil and criminal penalties that might have a materially adverse impact on our reputation, business operations and our financial position or results of operations.", "We are subject to a variety of privacy and data protection laws that change frequently and have requirements that vary from jurisdiction to jurisdiction.", "We  are  subject  to  laws  prohibiting  improper  payments  and  bribery,  including  the  U.S.  Foreign  Corrupt  Practices  Act,  the  U.K.  Bribery  Act  and  similar", "We might record significant charges from impairment to goodwill, intangibles and other assets or investments.", "In addition, we periodically review our intangible and other long-lived assets for impairment when events or changes in circumstances, such as a divestiture, indicate the carrying value may not be recoverable.", "Factors that may be considered a change in circumstances indicating that  the  carrying  value  of  our  intangible  and  other  long-lived  assets  may  not  be  recoverable  include  slower  growth  rates,  the  loss  of  a  significant  customer, burdensome new laws or divestiture of a business or asset for less than its carrying value.", "There are inherent uncertainties in management\u2019s estimates, judgments and assumptions used in assessing recoverability of goodwill, intangible and other long-lived assets.", "We may be required to record a significant charge to earnings in our consolidated financial statements during the period in which any impairment of our goodwill or intangible and other long-lived assets is determined, which might have a materially adverse impact on our business operations and our financial position or results of operations.", "storage and hosting of sensitive information, including protected health information and other types of personal information, confidential financial information, proprietary information, and other sensitive information relating to our customers, company and workforce.", "If our software and technology services are alleged to have contributed to faulty clinical decisions or injury to patients, we might be subject to claims or litigation by users of our software or services or their patients.", "Any of these types of errors or failures might have a materially adverse impact on our reputation, business operations and our financial position or results of operations.", "We  are  required  under  U.S.  Generally  Accepted  Accounting  Principles  (\u201cGAAP\u201d)  to  test  our  goodwill  for  impairment  annually  or  more  frequently  if", "We might be impeded in providing customers online services and data access.", "Any such problems might have a materially adverse impact on our business operations and our financial position or results of operations.", "Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.", "we may require financing that may not be available on acceptable terms.", "Any of these risks could adversely affect our ability to achieve the anticipated benefits of an acquisition and might have a materially adverse impact on our business operations and our financial position or results of operations.", "Exclusive forum provisions in our Bylaws could limit our stockholders\u2019 ability to choose their preferred judicial forum for disputes with us or our directors, officers or employees.", "Current and former stockholders are deemed to have consented to the personal jurisdiction of the Delaware Courts in connection with any action to enforce that exclusive forum provision and to service of process in any such action.", "To the extent that these provisions of the bylaws limit a current or former stockholder\u2019s ability to select a judicial forum other than the Delaware Courts, they might discourage the specified legal actions, might cause current or former stockholders to incur additional litigation-related expenses and might result in outcomes unfavorable to current or former stockholders.", "A court might determine that these provisions of the bylaws are inapplicable or unenforceable in any particular action, in which case we may incur additional litigation related expenses in such action, and the action may result in outcomes unfavorable to us, which could have a materially adverse impact on our reputation, our business operations and our financial position or results of operations.", "We might be adversely impacted by delays or other difficulties with divestitures.", "After the disposition, we might experience greater dissynergies than expected, and the impact of the divestiture on our revenue or profit might be larger than we expected.", "We might have difficulties with pre-closing conditions such as regulatory and governmental approvals, which could delay or prevent the divestiture.", "We might have financial exposure in a divested business, such as through minority equity ownership, financial  or  performance  guarantees,  indemnities  or  other  obligations,  such  that  conditions  outside  of  our  control  might  negate  the  expected  benefits  of  the disposition.", "Any of these risks could adversely affect our ability to achieve the anticipated benefits of a divestiture and might have a materially adverse impact on our business operations and our financial position or results of operations.", "We might not realize the expected tax treatment from our split-off of Change Healthcare.", "If Change does not honor its obligations to indemnify the Company, or if the Transactions fail to qualify for the intended tax-free treatment for reasons not related to a disqualifying action by Change or SpinCo, the resulting tax to the Company could have a significant adverse effect on our financial position or results of operations.", "outsourced service providers, and we might not realize expected cost savings or other benefits.", "For example, our ability to use outsourcing resources in certain jurisdictions might be limited by legislative action or customer contracts, with the result that the work must be performed at greater expense or we may be subject to sanctions for non-compliance.", "Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.", "We might encounter difficulties attracting and retaining customers to our retail locations due to their unfamiliarity with our brands or our inexperience with local market  preferences.  Competition  from  our  retail  pharmacy  operations  might  strain  relationships  with  our  retail  pharmacy  customers.  Consolidation  of  retail pharmacies with third party payers, expansion of large retail pharmacy networks, reductions in reimbursement rates, shifts in the mix of branded and generic pharmaceutical sales, and exclusion from preferred pharmacy networks can impair our retail pharmacy sales and profitability.", "We might be harmed by large customer purchase reductions, payment defaults or contract non-renewal.", "March 31, 2021, sales to our largest customer represented approximately 21% of our consolidated revenues and approximately 19% of our trade receivables, and those of our ten largest customers combined accounted for approximately 51% of our consolidated revenues and approximately 32% of our trade receivables.", "A material  default  in  payment,  reduction  in  purchases,  or  the  loss  of  business  from  a  large  customer  might  have  a  materially  adverse  impact  on  our  business operations and our financial position or results of operations.", "Our contracts with government entities involve future funding and compliance risks.", "Our government contracts might not be renewed or might be terminated for convenience with little or no prior notice.", "Government contracts typically expose us to higher potential liability than do other types of contracts.", "We are subject to government audits, investigations and oversight proceedings.", "If we fail to comply with these requirements, or we fail an audit, we are subject to various sanctions such as monetary damages, criminal and civil penalties, termination of contracts and suspension or debarment from government contract work.", "These requirements complicate our business and increase our compliance burden.", "We also provide supplies used for vaccine administration in the Federal COVID-19 Response.", "Our participation in such programs exposes us to various uncertainties.", "Because of these risks and uncertainties our operating results may be materially higher or lower than our projections.", "Certain distribution agreements with manufacturers include pharmaceutical price inflation as a component of our compensation, and we cannot  control  the  frequency  or  magnitude  of  pharmaceutical  price  changes.  We  might  be  unable  to  renew  pharmaceutical  distribution  agreements  with manufacturers in a timely and favorable manner.", "Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.", "We  derive  a  significant  portion  of  our  revenue  from,  and  have  a  significant  portion  of  our  accounts  receivable  with,  a  small  number  of  customers.  At", "Our contracts with government entities are subject to risks such as lack of funding and compliance  with unique requirements.", "We might infringe intellectual property rights or our intellectual property protections might be inadequate.", "If a court were to hold that we infringed other\u2019s rights, we might be required to pay substantial damages, develop non-infringing products or services, obtain a license, stop selling or using the infringing products or services, or incur other sanctions.", "We rely on trade secret, patent, copyright and  trademark  laws,  nondisclosure  obligations  and  other  contractual  provisions  and  technical  measures  to  protect  our  proprietary  rights  in  our  products  and solutions.  We  might  initiate  costly  and  time-consuming  litigation  to  protect  our  trade  secrets,  to  enforce  our  patent,  copyright  and  trademark  rights  and  to determine the scope and validity of the proprietary rights of others.", "Our intellectual property protection efforts might be inadequate to protect our rights.", "Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.", "Competition among potential employers might result in increased salaries, benefits or other employee-related costs, or in our failure to recruit and retain employees.", "Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.", "We might be adversely impacted by healthcare reform such as changes in pricing and reimbursement models.", "healthcare industry and related government programs are changing.", "profit margins for us and our customers and impose new legal requirements on healthcare providers.", "the way healthcare is financed by both governmental and private payers.", "drugs have sought to reduce the costs of publicly funded health programs.", "These measures exert pressure on the pricing and reimbursement timelines for pharmaceuticals and may cause our customers to purchase fewer of our products and services or influence us to reduce prices.", "adverse impact on our business operations and our financial position or results of operations.", "Consolidation might increase counter-party credit risk because credit purchases increase for fewer market participants.", "Any of these changes or disruptions might have a materially adverse impact on our business operations and our financial position or results of operations.", "We might be adversely impacted as a result of our distribution of generic pharmaceuticals.", "Generic drug manufacturers often offer a generic version of branded pharmaceuticals while they challenge the validity or enforceability branded pharmaceutical patents.", "The patent holder might assert infringement claims against us for distributing those generic versions and the generic drug manufactures may not fully indemnify us against such claims.", "These risks, as well as changes in the availability,  pricing  volatility,  reimbursement  rates  for  generic  drugs,  or significant  changes  in  the  nature,  frequency  or magnitude  of  generic  pharmaceutical launches, might have a materially adverse impact on our business operations and our financial position or results of operations.", "We might be adversely impacted by an economic slowdown or recession.", "Any economic slowdown or recession might have a materially adverse impact on our business operations and our financial position or results of operations.", "Disruption or other changes in capital and credit markets might impede access to credit and increase borrowing costs for us and our customers and suppliers and might impair the financial soundness of our customers and suppliers.", "activity by financial institutions, or decreased liquidity and increased costs in the commercial paper market, might adversely affect our borrowing ability and cost of borrowing.", "We generally sell our products and services under short-term unsecured credit arrangements.", "An adverse change in general economic conditions or access to capital might cause our customers to reduce their purchases from us, or delay or fail paying amounts owed to us.", "Suppliers might be unable to make payments due to us for fees, returned products or incentives.", "Interest rate increases or changes in capital market conditions might impede our or our customers\u2019 or suppliers\u2019 ability or cost to obtain credit.", "Any of these risks might have a material adverse impact on our business operations and our financial position or results of operations.", "Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.", "We might be adversely impacted by tax legislation or challenges to our tax positions.", "Tax laws might change in ways that adversely affect our tax positions, effective tax rate and cash flow.", "The tax laws are extremely complex and subject to varying interpretations.", "We are subject to tax examinations in various jurisdictions that might assess additional tax liabilities against us.", "Our tax reporting positions might be challenged by relevant tax authorities, we might incur significant expense in our efforts to defend those challenges, and we might be unsuccessful in those efforts.", "Developments in examinations and challenges might materially change our provision for taxes in the affected periods and might differ materially from our historical tax accruals.", "Any of these risks might have a materially adverse impact on our business operations, our cash flows and our financial position or results of operations.", "For example, we might experience volatility in exchange rates and interest rates and changes in laws regulating our U.K. operations.", "Customers might reduce purchases due to the uncertainty caused by Brexit.", "Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.", "We might be adversely impacted by fluctuations in foreign currency exchange rates.", "exchange rates could reduce our revenues, increase our costs or otherwise adversely affect our financial results reported in U.S. dollars.", "For example, we are exposed to transactional currency exchange risk due to our import and export of products that are purchased or sold in currencies other than the U.S. dollar.", "We also  have  currency  exchange  risk  due  to  intercompany  loans  denominated  in  various  currencies.  The  COVID-19  pandemic  has  affected  and  might  increase currency exchange rate volatility.", "We may from time to time enter into foreign currency contracts, foreign currency borrowings or other techniques intended to hedge  a  portion  of our  foreign  currency  exchange  rate  risks.  These  hedging  activities  may  not  completely  offset  the  adverse  financial  effects  of  unfavorable movements in foreign currency exchange rates during the time the hedges are in place.", "Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.", "We are subject to the tax laws in the U.S. at the federal, state and local government levels and to the tax laws of many other jurisdictions in which we operate", "We conduct our business in various currencies,  including  the U.S. dollar, euro, British pound sterling  and Canadian dollar.  Changes in foreign  currency", "Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.", "We might be adversely impacted by changes in accounting standards.", "It is possible that future accounting standards may require changes to the accounting treatment in our consolidated financial statements and may require us to make significant changes to our financial systems.", "Such changes might have a materially adverse impact on our financial position or results of operations.", "Our consolidated financial statements are subject to the application of U.S.", "Disclosure of an environmental proceeding where a governmental agency is a party generally is included only if we expect monetary sanctions in the proceeding to exceed $1 million, unless otherwise material.", "There are no family relationships between any of the executive officers or directors of the Company.", "We declared regular cash dividends of $1.67 and $1.62 per share in the years ended March 31, 2021 and 2020, respectively.", "discretion of the Board and will depend upon our future earnings, financial condition, capital requirements, and other factors.", "Dividends: In  July  2020,  our  quarterly  dividend  was  raised  from  $0.41  to  $0.42  per  common  share  for  dividends  declared  on  or  after  such  date  by  the", "We anticipate that we will continue to pay quarterly cash dividends in the future.", "In accordance with our accounting policy, we allocate any excess of share repurchase price over par value between additional paid-in capital and retained earnings.", "Accordingly, our retained earnings and additional paid-in capital were reduced by $472 million and $70 million, respectively, during 2019.", "In 2019, we retired 5.0 million or $542 million of our treasury shares previously repurchased.", "This discussion and analysis should be read in conjunction with the consolidated financial statements and accompanying financial notes in Item 8 of Part II of this Annual Report on Form 10-K.", "Our fiscal year begins on April 1 and ends on March 31.", "Unless otherwise noted, all references to a particular year shall mean our fiscal year.", "Our organizational structure also includes Corporate, which consists of income and expenses associated with administrative functions and projects, and the results of certain investments.", "We evaluate the performance of our operating segments on a number of measures, including revenues and operating profit before interest expense and income taxes.", "The following summarizes our four reportable segments and the changes made to our reporting structure commencing in the second quarter of 2021.", "\u2022 Coronavirus disease 2019 (\u201cCOVID-19\u201d) impacted our results of operations for the year ended March 31, 2021.", "The recovery from the COVID- 19 pandemic continued to fluctuate throughout our fiscal year.", "\u2022 We expanded our existing contractual relationship with the Centers for Disease Control and Prevention (\u201cCDC\u201d) through an amendment to our existing Vaccines for Children Program contract to support the U.S. government as a centralized distributor of COVID-19 vaccines and ancillary supplies needed to administer vaccines.", "\u2022 In  December  2020,  we  began  distributing  certain  COVID-19  vaccines  under  the  direction  of  the  CDC.  Through  the  end  of  the  fiscal  year,  we  had distributed approximately 100 million of COVID-19 vaccine doses.", "\u2022 Revenues of $238.2 billion, reflects a 3% increase from the prior year primarily in our U.S.", "\u2022 Diluted loss per common share from continuing operations attributable to McKesson Corporation in 2021 of $28.26 reflects the aforementioned items, net of any respective tax impacts, and a lower share count compared to the prior year driven largely by the separation of our investment in Change Healthcare JV on March 10, 2020;", "The full extent to which COVID-19 will impact us depends on many factors and future developments, which are described at the end of this COVID-19 section.", "We continue to evaluate the nature and extent of the impacts COVID-19 has on our business and operations.", "We provided further support including additional emergency leave and an internal paid time off donation platform for employees impacted by COVID-19.", "These responses were initially put in place during our fourth quarter of 2020.", "policies did not have a material effect on our internal control over financial reporting during the year ended March 31, 2021.", "We also took various actions to mitigate the impact of COVID-19 on our results from operations through cost-containment and payroll-related expenses.", "We support the U.S. government as a centralized distributor of COVID-19 vaccines and ancillary supplies needed to administer vaccines.", "We make no decisions on where products are to be distributed nor how the products are allocated between the various provider sites and ultimately administered to the individuals receiving a vaccine.", "We utilize our expertise and capabilities to support the CDC\u2019s efforts to vaccinate everyone in the U.S. who wants to receive a COVID-19 vaccine.", "The Pfizer Vaccine, which is ultra-frozen, is not being distributed by McKesson, although we are providing ancillary supplies needed for its administration.", "custom freezers and refrigerators to safely store and process millions of vaccine doses.", "The capital expenditures we made during 2021 to prepare for vaccine and ancillary supply kit distribution were not material to our financial condition or liquidity.", "In December 2020, we began distributing the Moderna Vaccine in the U.S. and in March 2021, we began distributing the Janssen Vaccine.", "Subsequently, during the first quarter, we had lower pharmaceutical volumes, specialty drug volumes, and patient care visits that negatively impacted our consolidated revenues and income (loss) from continuing operations before income taxes for the year ended March 31, 2021.", "Additionally, increased costs for certain PPE compressed our margins.", "During the year ended March 31, 2021, we recorded charges totaling $136 million in cost of sales on certain PPE and other related products due to inventory impairments and excess inventory in our Medical-Surgical Solutions segment.", "Although market price volatility and changes to anticipated customer demand may require additional write-downs in future periods, we are taking measures to mitigate such risk.", "We collaborated closely with the federal government and other healthcare stakeholders to source more critical PPE to the U.S.", "We have deferred certain employer payroll taxes and continue to monitor the potential impact of other tax legislation changes as result of the CARES Act, including refundable payroll tax credits on certain qualified wages.", "We anticipate changes due to the CARES Act in the timing of certain cash flows, with no material impact to our financial results for the year ended March 31, 2021.", "The CA Act did not have a material impact on our financial condition, results of operations, or liquidity for the year ended March 31, 2021 nor do we currently expect a material impact on our future financial results.", "We are monitoring our customers closely for changes to their timing of payments or ability to pay amounts owed to us as a result of COVID-19 pandemic impacts to their businesses.", "We remain well-capitalized with access to liquidity from our revolving credit facility.", "Long- term debt markets and commercial paper markets, our primary sources of capital after cash flow from operations, have remained open and accessible to us during the COVID-19 pandemic.", "At March 31, 2021, we were in compliance with all debt covenants, and believe we have the ability to continue to meet our debt covenants in the future.", "Our consolidated balance sheets and ability to maintain financial liquidity remains strong.", "We have experienced no material impacts to our liquidity or net", "We face numerous uncertainties in estimating the direct and indirect effects of COVID-19 on our future business operations, financial condition, results of operations, and liquidity.", "Due to several rapidly changing variables related to the COVID-19 pandemic, estimations of future economic trends and the timing of when stability will  return  remains  challenging.  Additionally,  we  periodically  review  our  intangible  and  other  long-lived  assets  for  impairment  when  events  or  changes  in circumstances indicate  the carrying value may not be recoverable.  Key assumptions and estimates  about future values in our impairment assessments can be affected by a variety of factors, including the impacts of the global pandemic on industry and economic trends as well as on our business strategy and internal forecasts.", "We continue to be involved in discussions with the objective of achieving broad resolution of opioid- related claims of states, their political subdivisions and other government entities (\u201cgovernmental entities\u201d).", "We are in ongoing, advanced discussions with state attorneys general and plaintiffs\u2019 representatives regarding a framework under which, in order to resolve the claims of governmental entities, the three largest U.S. pharmaceutical distributors would pay up to approximately $21.0 billion over a period of 18 years, with up to approximately $8.0 billion to be paid by us, of which more than 90% is anticipated to be used to remediate the opioids crisis.", "As a result of that conclusion, and our assessment of certain other opioid- related claims, we recorded a charge of $8.1 billion for the year ended March 31, 2021 within \u201cClaims and litigation charges, net\u201d in our Consolidated Statement of Operations, related to our share of the settlement framework described above, as well as other opioid-related claims.", "Because of the many uncertainties associated with any potential settlement arrangement or other resolution of opioid-related litigation, including the uncertainty of the scope of participation by plaintiffs in any potential settlement, we are not able to reasonably estimate the upper or lower ends of the range of ultimate possible loss for all opioid-related litigation matters.", "We believe that we have valid defenses to the claims pending against us and, absent an acceptable settlement, intend to vigorously defend against all such claims.  An  adverse  judgment  or  negotiated  resolution  in  any  of  these  matters  could  have  a  material  adverse  impact  on  our  financial  position,  cash  flows  or liquidity, or results of operations.", "The law adopting the excise tax made clear that the OSA would apply only to opioid sales on or before December 31, 2018.", "The excise tax applies only to the first sale occurring in New York, and thus may not apply to sales from our distribution centers in New York to New York customers.", "Unless the appellate court\u2019s decision is overturned, the OSA will be reinstated for calendar years 2017 and 2018 (but not beyond those years), and, subject to any further legal challenge, we will have to pay our ratable share of the annual surcharge for those two years.", "During the second quarter of 2021, we reflected an estimated liability of $50 million for the OSA surcharge in our accompanying consolidated financial statements on the assumption that the appellate court\u2019s decision will stand.", "The higher LIFO credits in 2020 compared to 2019 is primarily driven by higher generic deflation.", "\u2022 Claims and litigation charges, net: These charges include adjustments for estimated probable settlements related to our controlled substance monitoring and reporting, and opioid-related claims, as well as any applicable income items or credit adjustments due to subsequent changes in estimates.", "We have reclassified prior period amounts to conform to the current period presentation.", "\u2022 Goodwill impairments charges: We perform an impairment test on goodwill balances annually in the third quarter and more frequently if indicators for potential impairment exist.", "The resulting goodwill impairment charges are reflected within this line item. \u2022 Restructuring, impairment, and related charges: Restructuring charges that are incurred for programs in which we change our operations, the scope of a business undertaken by our business units, or the manner in which that business is conducted as well as long-lived asset impairments.", "\u2022 SDG&A reflects charges of $58 million to remeasure assets and liabilities held for sale to fair value less costs to sell related to the completed contribution of the majority of our German pharmaceutical wholesale business to create a joint venture with WBA in which we have a 30% ownership interest within our International segment.", "As a result, we were required to perform a goodwill impairment test for these reporting units and recorded a goodwill impairment charge in our European RP reporting unit of $69 million during the second quarter of 2021.", "As of the testing date, other risks, expenses, and future developments, such as additional government actions, increased regulatory uncertainty, and material changes in key market assumptions limit our ability to estimate projected cash flows, which could adversely affect the fair value of various reporting units in future periods, including our McKesson Canada reporting unit within our International segment and our RxCrossroads reporting unit within our RxTS segment, where the risk of a material goodwill impairment is higher than other reporting units.", "\u2022 Restructuring, impairment, and related charges, net includes long-lived asset impairment charges of $112 million, primarily for our United Kingdom (\u201cU.K.\u201d)  business  (mainly  pharmacy  licenses)  and  Rexall  Health  retail  business  (\u201cRexall  Health\u201d)  (mainly  customer  relationships)  within  our International segment, and the remaining $156 million primarily represents employee severance and exit-related costs related to our 2019 restructuring initiatives, as further discussed below; and", "\u2022 Total operating expenses includes higher SDG&A due to our business acquisitions and to support business growth, as well as our technology initiatives, partially offset by favorable effects of foreign currency exchange fluctuations.", "\u2022 SDG&A includes opioid-related costs of $114 million, primarily related to litigation expenses, and increased expenses due to our business acquisitions and to support growth, partially offset by a gain from an escrow settlement of $97 million representing certain indemnity and other claims related to our 2017 acquisition of Rexall Health and a credit of $90 million for the derecognition of a liability related to the tax receivable agreement (\u201cTRA\u201d) payable to the shareholders of Change Healthcare, Inc. (\u201cChange\u201d);", "\u2022 Restructuring,  impairment,  and  related  charges,  net  primarily  includes  employee  severance  and  exit-related  costs  of  $352  million  for  our  2019 restructuring initiatives, as further discussed below and long-lived asset impairment charges of $245 million primarily for our U.K. business (mainly pharmacy licenses) within our International segment driven by additional government reimbursement reductions and competitive pressures in the U.K.", "We evaluate goodwill for impairment on an annual basis as of October 1, and at an interim date, if indicators of potential impairment exist.", "This change was not material to our consolidated financial statements as it did not delay, accelerate, or avoid any potential goodwill impairment charge.", "We expect to incur total charges of approximately $180 million to $280 million for this initiative, consisting primarily of exit related costs, accelerated depreciation and amortization of long-lived assets, and asset impairments.", "We expect to incur total charges of approximately $85 million to $90 million, of which $57 million of charges were recorded to date.", "This initiative was substantially complete in 2021 and remaining costs we expect to record under this initiative are not material.", "The relocation was substantially complete in January 2021 and remaining costs we expect to record under this initiative, primarily relating to lease costs, are not material.", "This primarily reflects mark-to-market gains on our investments in certain U.S. growth stage companies in the healthcare industry and realized gains on the exit of some of these investments as further described in Financial Note 17, \u201cFair Value Measurements,\u201d to the accompanying consolidated financial statements  included  in  this  Annual  Report  on  Form  10-K.  In  future  periods,  fair  value  adjustments  recognized  in  our  operating  results  for  these  types  of investments may be adversely impacted by market volatility.", "Other income, net also increased year over year due to pension settlement charges of $122 million recognized in 2020 related to our previously approved termination of the frozen U.S. defined benefit pension plan.", "In connection with the pension plan termination, we purchased annuity contracts from an insurer that will pay and administer the future pension benefits of the remaining participants.", "Excluding the impairment and transaction-related items described below, our proportionate share of loss from our investment in Change Healthcare JV for the years ended March 31, 2020 and 2019 was $119 million and $194 million, respectively, which primarily includes transaction and integration expenses incurred by the joint venture and basis differences between the joint venture and McKesson including amortization of fair value adjustments.", "During the first quarter of 2020 and for the year ended March 31, 2019, we owned approximately 70% of this joint venture.", "The proceeds from the concurrent offering of other securities were also used by Change  to  acquire  certain  securities  of  Change  Healthcare  JV.  As  a  result,  McKesson\u2019s  equity  interest  in  Change  Healthcare  JV  was  reduced  from  70%  to approximately 58.5%, which was used to recognize our proportionate share in net loss from Change Healthcare JV, commencing in the second quarter of 2020.", "As a result of the ownership dilution to 58.5% from 70%, we recognized a dilution loss of approximately $246 million in the second quarter of 2020.", "Additionally, our proportionate share of income or loss from this investment was subsequently reduced as immaterial settlements of stock option exercises occurred after the IPO and further diluted our ownership.", "Equity Earnings and Charges from Investment in Change Healthcare Joint Venture Until the separation of our investment in Change Healthcare JV on March 10, 2020, we accounted for this investment using the equity method of accounting.", "In the second quarter of 2020, we recorded an other-than-temporary-impairment (\u201cOTTI\u201d) charge of $1.2 billion to our investment in Change Healthcare JV,", "Following the Split-off, we do not beneficially own any of Change\u2019s outstanding securities.", "In connection with this transaction, we recognized a net gain for financial reporting purposes of $414 million during the fourth quarter of 2020, which was largely driven by the reversal of a related deferred tax liability.", "The receipt of any payments under the TRA is dependent upon Change benefiting from this depreciation or amortization in future tax return filings, which creates uncertainty over the amount, timing and probability of the gain recognized.", "As such, we accounted for the TRA as a gain contingency, with no receivable recognized as of March 31, 2021 nor 2020.", "Interest expense decreased in 2020 compared to the prior year primarily due to a decrease in the issuance of commercial paper, partially offset by a decrease in interest income from our derivative contracts.", "Our reported income tax (benefit) expense rates were (13.8%), 1.6%, and 58.4% in 2021, 2020, and 2019, respectively.", "after-tax), which was intended to generally be a tax-free split-off for U.S. federal income tax purposes, and unfavorably impacted by charges of $275 million (pre- tax and after-tax) to remeasure assets and liabilities held for sale to fair value less costs to sell related to the completed contribution of the majority of our German pharmaceutical wholesale business to create a joint venture with WBA.", "goodwill of our European RP and European PD reporting units within the International segment, given that these charges are generally not deductible for tax purposes.", "Our income tax expense, deferred tax assets and liabilities, and uncertain tax liabilities reflect management\u2019s best assessment of estimated current and future taxes to be paid.", "We believe that we have made adequate provision for all income tax uncertainties.", "In connection with the exchange offer, on March 9, 2020, we distributed all 176.0 million outstanding shares of common stock of SpinCo to participating", "Income Tax (Benefit) Expense We recorded income tax (benefit) expense of ($695 million), $18 million, and $356 million for the years ended March 31, 2021, 2020, and 2019, respectively.", "Our reported income tax expense rate for 2019 was unfavorably impacted by charges of $1.8 billion (pre-tax and after-tax) to impair the carrying value of", "Significant judgments and estimates are required in determining the consolidated income tax provision and evaluating income tax uncertainties.", "Noncontrolling interests with redemption  features, such as put rights, that are not solely within our control are considered redeemable  noncontrolling  interests.  Redeemable  noncontrolling interests are presented outside of McKesson Corporation stockholders\u2019 equity (deficit) on our consolidated balance sheet.", "Diluted earnings (loss) per common share attributable to McKesson Corporation was $(28.26), $4.95, and $0.17 for the years ended March 31, 2021,  2020,  and  2019,  respectively.  Net  loss  per  diluted  share  for  the  year  ended  March  31,  2021  is  calculated  by  excluding  dilutive  securities  from  the denominator  due to their antidilutive  effects.  Additionally,  our 2021, 2020, and 2019 diluted  earnings (loss) per share  reflect  the cumulative  effects  of share repurchases.", "Weighted-average diluted common shares outstanding is impacted by the exercise and settlement of share-based awards and the cumulative effect of share repurchases, including the impact of shares exchanged as part of the split-off from our investment in Change Healthcare JV, as discussed above.", "(1) Segment operating profit (loss) includes gross profit, net of operating expenses, as well as other income (expense), net, for our reportable segments.", "For retrospective periods presented, operating loss for Other reflects equity earnings and charges from our equity method investment in Change Healthcare JV, which we split-off in the fourth quarter of 2020.", "Pharmaceutical segment includes a charge of $50 million for the year ended March 31, 2021 related to our estimated liability under the OSA.", "(3) Operating loss for our International segment for the years ended March 31, 2021 and 2020 includes charges of $58 million and $275 million, respectively, to remeasure to fair value the assets and liabilities of our German pharmaceutical wholesale business which was contributed to a joint venture with WBA.", "This segment\u2019s operating loss for the years ended March 31, 2021 and 2019 includes goodwill impairment charges of $69 million and $1.8 billion, respectively, as well as long-lived asset impairment charges for the  years ended March 31, 2021,  2020, and 2019  of $115  million,  $112  million,  and $245  million,  respectively, primarily  related to  our retail  pharmacy businesses in Canada and Europe.", "(4) Operating profit for our Medical-Surgical Solutions segment for the year ended March 31, 2021 includes charges totaling $136 million on certain PPE and other related products due to inventory impairments and excess inventory.", "(5) Operating profit for our RxTS segment for the year ended March 31, 2019 includes a gain of $56 million from the divestiture of an equity investment.", "(6) Operating loss for Other for the year ended March 31, 2020 includes an OTTI charge of $1.2 billion and a dilution loss of $246 million related to our investment in Change Healthcare JV, partially offset by a net gain of $414 million related to the completed separation of our interest in Change Healthcare JV during the fourth quarter of 2020.", "(7) Corporate expenses, net for the year ended March 31, 2021 includes a charge of $8.1 billion related to our estimated liability for opioid-related claims, net gains of $133 million  from  our  equity  investments,  and a net  gain  of $131  million  recorded  in  connection  with  insurance  proceeds  received  from  the  settlement  of  the  shareholder derivative action related to our controlled substances monitoring program.", "This was partially offset by a decrease in LIFO credits of $214 million, a charge of $50 million recorded in 2021 related to our estimated liability under the OSA, net impacts from COVID-19, including a less severe cough, cold, and flu season, as well as increased costs for strategic growth initiatives.", "Operating profit and operating profit margin were unfavorably impacted by customer mix and a decrease in net cash proceeds received of $180 million representing our share of antitrust legal settlements.", "recorded to remeasure to fair value the assets and liabilities of our German pharmaceutical wholesale business which was contributed to a joint venture with WBA, of  which  $58  million  and  $275  million  was  reflected  for  the  years  ended  March  31,  2021  and  2020,  respectively.  This  was  partially  offset  by  a  goodwill impairment charge of $69 million recorded in the second quarter of 2021 related to our European retail pharmacy business.", "This was partially offset  by  the  fair  value  remeasurement  charges  in  2020  described  above  and  a  gain  from  an  escrow  settlement  of  $97  million  in  2019  related  to  our  2017 acquisition of Rexall Health.", "Additionally,  operating  profit  was favorable  year over year  due to lower  operating  expenses, including a decrease in our provision for bad debts.", "primary care business and lower restructuring charges, partially offset by the remeasurement of assets and liabilities to fair value related to a divestiture that was completed in 2020 and higher operating expenses, including an increase in our provision for bad debts.", "and existing customers, integration costs incurred in 2019 for our acquisition of RxCrossroads that closed during the fourth quarter of 2018, partially offset by a gain of $56 million from the divestiture of an equity investment in 2019.", "investment in Change Healthcare JV, partially offset by a net gain of $414 million related to the completed separation of our interest in Change Healthcare JV during the fourth quarter of 2020.", "Operating loss for Other also includes our proportionate share of loss from Change Healthcare JV of $119 million and $194 million for the years ended March 31, 2020 and 2019, respectively.", "connection with insurance proceeds received from the settlement of the shareholder derivative action related to our controlled substances monitoring program.", "Corporate expenses, net, for 2020 includes pension settlement charges of $122 million, an opioid claim settlement charge of $82 million, and net settlement gains of $26 million recognized from our derivative contracts.", "claim settlement charge mentioned above, as well as higher costs for technology initiatives, partially offset by net settlement gains recognized in 2020 from our derivative contracts.", "Other Operating  loss  for  Other  for  the  year  ended  March  31,  2020  includes  an  OTTI charge  of  $1.2  billion  and  a  dilution  loss  of  $246  million  related  to  our", "Corporate 2021 vs. 2020 Corporate expenses, net increased for the year ended March 31, 2021 compared to the prior year due to a charge of $8.1 billion related to our estimated", "We conduct our business worldwide in local currencies including Euro, British pound sterling, and Canadian dollar.", "As a result, the comparability of our results reported in U.S. dollars can be affected by changes in foreign currency exchange rates.", "In discussing our operating results, we may use the term \u201cforeign currency exchange fluctuations,\u201d which refers to the effect of changes in foreign currency exchange rates used to convert the local currency results of our operations in foreign countries where the functional currency is not the U.S. dollar.", "We present this information to provide a framework for assessing how our business performed excluding the effect of foreign currency exchange rate fluctuations.", "In computing the foreign currency exchange fluctuations, we translate our current year results of our operations in foreign countries recorded in local currencies into U.S dollars by applying their respective average foreign currency exchange rates of the corresponding prior year periods, and we subsequently compare those results to the previously reported results of the comparable prior year periods reported in U.S. dollars.", "estimate was made and if different estimates that we reasonably could have used in the current period, or changes in the accounting estimate that are reasonably likely to occur from period to period, could have a material impact on our financial condition or results from operations.", "Below are the estimates that we believe are  critical  to  the  understanding  of  our  operating  results  and  financial  condition.  Other  accounting  policies  are  described  in  Financial  Note  1,  \u201cSignificant Accounting  Policies,\u201d  to  the  consolidated  financial  statements  appearing  in  this  Annual  Report  on  Form  10-K.  Because  of  the  uncertainty  inherent  in  such estimates, actual results may differ from these estimates.", "Other customer financing primarily relates to guarantees provided to our customers, or their creditors, regarding the repurchase of inventories.", "We also provide financing to certain customers related to the purchase of pharmacies, which serve as collateral for the loans.", "We estimate the receivables for which we do not  expect  full  collection  based  on  historical  collection  rates  and  specific  knowledge  regarding  the  current  creditworthiness  of  our  customers  and  record  an allowance in our consolidated financial statements for these amounts.", "Management reviews these factors quarterly to determine if any adjustments are needed to the allowance.", "Sales to our largest customer, CVS Health Corporation (\u201cCVS\u201d), accounted for approximately 21% of our total consolidated revenues in 2021 and comprised approximately 19% of total trade accounts receivable at March 31, 2021.", "As a result, our sales and credit concentration is significant.", "The accounts receivables balances are with individual members of the GPOs, and therefore no significant concentration of credit risk exists.", "A material default in payment, a material reduction in purchases from these or any other large customers, or the loss of a large customer or GPO could have a material adverse impact on our financial position, results of operations, and liquidity.", "We believe the reserves maintained and expenses recorded in 2021 are appropriate and consistent in the context of historical methodologies employed, as well as assessment of trends currently available.", "The selected 0.1% hypothetical change does not reflect what could be considered the best or worst-case scenarios.", "Our LIFO valuation amount includes both pharmaceutical and non-pharmaceutical products.", "We recognized LIFO credits of $38 million, $252 million, and $210 million, respectively, in 2021, 2020, and 2019 in our Consolidated Statements of Operations.", "A LIFO charge is recognized when the net effect of price increases on pharmaceutical and non-pharmaceutical products held in inventory exceeds the impact of price declines, including the effect  of branded pharmaceutical  products  that have lost market  exclusivity.  A LIFO credit  is recognized  when the net effect  of price  declines exceeds the impact of price increases on pharmaceutical and non-pharmaceutical products held in inventory.", "Excluding LIFO reserves, our inventory reserves as of March 31, 2021 and 2020 were $263 million and $96 million, respectively.", "The increase was primarily due to 2021 charges totaling $136 million on certain PPE and other related products due to inventory impairments and excess inventory within our Medical-Surgical Solutions segment.", "In 2021, 2020 and, 2019, our provision for bad debts", "At March 31, 2021 and 2020, total inventories, net were $19.2 billion and $16.7 billion, respectively, in our Consolidated Balance Sheets.", "Any purchase consideration in excess of the estimated fair values of the net assets acquired is recorded as goodwill.", "that is a form or variation of the income approach, whereby a forecast of future cash flows attributable to the asset are discounted to present value using a risk- adjusted discount rate.", "We perform an impairment test on goodwill balances annually in the third quarter and more frequently if indicators for potential impairment exist.", "equal to the amount of excess carrying value above the estimated fair value, if any, but not to exceed the amount of goodwill allocated to the reporting unit.", "we estimate fair value by comparing the business to similar businesses, or guideline companies whose securities are actively traded in public markets.", "Under the income approach, we use a discounted cash flow (\u201cDCF\u201d) model in which cash flows anticipated over several periods, plus a terminal value at the end of that time horizon, are discounted to their present value using an appropriate rate that is commensurate with the risk inherent within the reporting unit.", "Goodwill  and  Long-Lived  Assets: As  a  result  of  acquiring  businesses,  we  have  $9.5  billion  and  $9.4  billion  of  goodwill  at  March  31,  2021  and  2020,", "To estimate the fair value of our reporting units, we generally use a combination of the market approach and the income approach.", "Judgments made in determining an estimate of fair value may materially impact our results of operations.", "Included in the estimate of the weighted-average cost of capital is the assumption of an unsystematic risk premium to address incremental uncertainty related to the reporting units\u2019 future cash flow projections.", "An increase in the unsystematic risk premium increases the discount rate.", "Pharmaceutical  Distribution  reporting  units  in  our  International  segment,  exceeded  their  carrying  values.  The  impairment  testing  performed  in  2020  did  not indicate  any  material  impairment  of  goodwill.  The  segment  change  in  the  second  quarter  of  2021  prompted  changes  in  multiple  reporting  units  across  the Company.", "We recorded a goodwill impairment charge of $69 million in 2021 as the estimated fair value of the Europe Retail Pharmacy reporting unit was lower than its reassigned carrying value based on changes in the composition of the Europe Retail Pharmacy reporting unit within the International segment.", "At March 31, 2021, the  balance  of goodwill for the  reporting  units  in Europe  was approximately  nil  and the  remaining  balance  of goodwill  in the International segment primarily relates to one of our reporting units in Canada.", "Other risks, expenses and future developments, such as additional government actions, increased regulatory uncertainty, and material changes in key market assumptions that we were unable to anticipate as of the testing date may require us to further revise the projected cash flows, which could adversely affect the fair value of our other reporting units in future periods.", "We review intangible assets for impairment at an asset group level whenever events or changes in circumstances indicate that the carrying value of the assets may not be recoverable.", "Determination of recoverability of intangible assets is based on the lowest level of identifiable estimated future undiscounted cash flows resulting from use of the asset and its eventual disposition.", "Measurement of any impairment loss is based on the excess of the carrying value of the asset group over its fair value.", "Assumptions and estimates about future values and remaining useful lives of our purchased intangible assets are complex and subjective.", "When the decline in value is deemed to be other than temporary, an impairment is recognized to the extent that the fair value is less than the carrying value of the investment.", "We consider various factors in determining whether a loss in value of an investment is other than temporary including: the length of time and the extent to which the fair value has been below cost, the financial condition of the investees, and our intent and ability to retain the investment for a period of time sufficient to allow for recovery of value.", "Any significant changes in assumptions or judgments in assessing impairments could result in an impairment charge.", "We generally recognize employee severance costs when payments are probable and amounts are estimable.  Costs related  to contracts without future benefit or contract termination  are recognized  at the earlier of the contract termination  or  the  cease-use  dates.  Other  exit-related  costs  are  recognized  as  incurred.  In  connection  with  these  restructuring  actions,  we  also  assess  the recoverability of long-lived assets used in the business, and as a result, we may recognize accelerated depreciation and amortization reflecting shortened useful lives of the underlying assets.", "paid.  We  are  subject  to  income  taxes  in  the  U.S.  and  numerous  foreign  jurisdictions.  Significant  judgments  and  estimates  are  required  in  determining  the consolidated income tax provision and in evaluating income tax uncertainties and include those used to conclude on the tax-free nature of the separation of the Change Healthcare JV and the unrecognized tax position related to opioid-related litigation and claims, which remains unfinalized, and which may differ from the actual amounts of tax benefit recognized.", "We review our tax positions at the end of each quarter and adjust the balances as new information becomes available.", "to recover our deferred tax assets, we consider all available positive and negative evidence including our past operating results, the existence of cumulative net operating losses in the most recent years, and our forecast of future taxable income.", "In estimating future taxable income, we develop assumptions including the amount of future federal, state and foreign pre-tax operating income, the reversal of temporary differences, and the implementation of feasible and prudent tax planning strategies.", "These assumptions require significant judgment about the forecasts of future taxable income and are consistent with the plans and estimates we use to manage the underlying businesses.", "additional taxes and related interest will be due.", "If our current estimate of tax and interest liabilities is less than the ultimate settlement, an additional charge to income tax expense may result.", "If our current estimate of tax and interest liabilities is more than the ultimate settlement, a reduction to income tax expense may be recognized.", "investigations  relating  to  laws  and  regulations  and  other  matters  arising  out  of  the  normal  conduct  of  our  business.  When  a  loss  is  considered  probable  and reasonably estimable, we record a liability in the amount of our best estimate for the ultimate loss.", "When a material loss is reasonably possible or probable but a reasonable estimate cannot be made, disclosure of the proceeding is provided.", "Deferred income taxes arise from temporary differences between the tax and financial statement recognition of revenue and expense.", "Changes in tax laws and rates could also affect recorded deferred tax assets and liabilities in the future.", "We recognize liabilities for tax and related interest for issues in the U.S. and other tax jurisdictions based on our estimate of whether, and the extent to which,", "As discussed above, development of a meaningful estimate of loss or a range of potential loss is complex when the outcome is directly dependent on future negotiations with or decisions by third parties, such as regulatory agencies, the court system and other interested parties.", "As a result of ongoing, advanced discussions with state attorneys general and plaintiffs\u2019 representatives regarding a framework to resolve the claims of governmental  entities,  and  our  assessment  of  certain  other  opioid-related  claims,  we  have  reached  a  stage  at  which  a  broad  settlement  of  opioid  claims  by governmental entities is probable and recorded a charge of $8.1 billion for the year ended March 31, 2021 within \u201cClaims and litigation charges, net\u201d in our Consolidated Statement of Operations in this report.", "Because of the many uncertainties associated with any potential settlement arrangement or other resolution of opioid-related litigation, including the uncertainty of the scope of participation by plaintiffs in any potential settlement, we are not able to reasonably estimate the upper or lower ends of the range of ultimate possible loss for all opioid-related litigation matters.", "While we are not able to predict the outcome or reasonably estimate a range of possible losses in these matters, an adverse judgment or negotiated resolution in any of these matters could have a material adverse effect on our results of operations, consolidated financial position, cash flows or liquidity.", "facilities and commercial paper program, will be sufficient to fund our short-term and long-term capital expenditures, working capital, and other cash requirements.", "We continue to monitor its impact on demand within parts of our business, as well as trends potentially impacting the timing or ability for some of our customers to pay amounts owed to us.", "We remain well-capitalized with access to liquidity from our $4.0 billion revolving credit facility.", "Additionally, long-term debt markets and commercial paper markets, our primary sources of capital after cash flow from operations, have remained open and accessible to us during the COVID-19 pandemic.", "We have seen continued improvement in conditions in the debt markets and commercial paper markets as the Federal Reserve has taken steps to stabilize the markets.", "At March 31, 2021, we were in compliance with all debt covenants, and believe we have the ability to continue to meet our debt covenants in the future.", "Cash flows from operations can be significantly impacted by factors such as the timing of receipts from customers and payments to vendors.", "Operating activities for the year ended March 31, 2021 were affected by net income adjusted for non-cash items, including the pre-tax $8.1 billion (after-tax $6.8 billion) non-cash charge related to our estimated liability for opioid-related claims, an increase in inventory of $2.3 billion and an increase in drafts and accounts payable of $1.3 billion driven by higher inventory stock levels to meet increased volume demand as part of our inventory management, as well as a decrease in receivables of $1.1 billion driven by timing, higher sales recognized at the end of March 2020, and higher collections in our fourth quarter of 2021.", "value remeasurement charges of $58 million related to the contribution of our German pharmaceutical wholesale business to a joint venture with WBA.", "Additionally, we made a cash payment of $114 million from the executive benefit retirement plan in 2020.", "Investing activities for the year ended March 31, 2021 also includes net cash proceeds of $400 million from sales of businesses and investments, including $286 million in exchange for the contribution of our German pharmaceutical wholesale business to a joint venture with WBA.", "Cash used for other financing activities generally includes payments to noncontrolling interests and activity from our finance leases.", "We received cash from long-term debt issuances of $1.1 billion and made repayments on long-term debt of $1.1 billion in 2019.", "The timing of any repurchases and the actual number of shares repurchased will depend on a variety of factors, including our stock price, corporate and regulatory requirements, restrictions under our debt obligations, and other market and economic conditions.", "In accordance with our accounting policy, we allocate any excess of share repurchase price over par value between additional paid-in capital and retained earnings.", "Accordingly, our retained earnings and additional paid-in capital were reduced by $472 million and $70 million during 2019, respectively.", "outstanding shares of SpinCo common stock, which held all of the Company\u2019s interests in the Change Healthcare JV, to participating holders of the Company\u2019s common  stock  in  exchange  for  15.4  million  shares  of  McKesson  stock,  which  are  now  held  as  treasury  stock  on  our  consolidated  balance  sheet.  Following consummation of the exchange offer, on March 10, 2020, SpinCo merged with and into Change and each share of SpinCo common stock was converted into one share of Change common stock, par value $0.001 per share, with cash being paid in lieu of fractional shares of Change common stock.", "give us the ability to meet our financing needs for the foreseeable future.", "However, there can be no assurance that an increase in volatility or disruption in the global capital and credit markets will not impair our liquidity or increase our costs of borrowing.", "As described within the \u201cTrends and Uncertainties\u201d section above,  the  COVID-19  pandemic  continues  to  develop  rapidly.  We  continue  to  monitor  its  impact  on  demand  within  parts  of  our  business,  as  well  as  trends potentially impacting the timing or ability for some of our customers to pay amounts owed to us.", "(2) This ratio describes the relationship and changes within our capital resources, and is computed as total debt divided by the sum of total debt and McKesson stockholders\u2019 equity (deficit), which excludes noncontrolling and redeemable noncontrolling interests and accumulated other comprehensive loss. (3) Ratio is computed as net income (loss) attributable to McKesson Corporation for the last four quarters, divided by a five-quarter average of McKesson stockholders\u2019 equity (deficit), which excludes noncontrolling and redeemable noncontrolling interests.", "In 2019, we retired 5.0 million or $542 million of the Company\u2019s treasury shares previously repurchased.", "In connection with the Split-off, we distributed all 176.0 million", "Deposits with financial institutions are primarily denominated in U.S. dollars and the functional currencies of our foreign subsidiaries, including Euro, British pound sterling, and Canadian dollars.", "We mitigate the risk of our short-term investment portfolio by depositing funds with reputable financial institutions and monitoring risk profiles and investment strategies of money market funds. outside of the U.S., respectively.", "Our primary intent is to utilize this cash for foreign operations for an indefinite period of time.", "Although the vast majority of cash held outside the U.S. is available for repatriation, doing so could subject us to foreign withholding taxes and state income taxes.", "The COVID-19 pandemic has potential to increase the variations in our working capital, which we continue to monitor closely. partially offset by an increase in drafts and accounts payable and a decrease in receivables.", "Our unfavorable return on McKesson\u2019s stockholder\u2019s equity (deficit) as of March 31, 2021 was also driven by net loss for the year.", "Net loss for the year ended March 31, 2021 includes an after-tax non-cash charge of $6.8 billion related to our estimated liability for opioid-related claims, as discussed in \u201cTrends  and  Uncertainties\u201d of  this  Financial  Review  and  Financial  Note  19,  \u201cCommitments  and  Contingent  Liabilities,\u201d  to  the  accompanying  consolidated financial statements included in this Annual Report on Form 10\u2011K.", "Our debt to capital ratio increased for 2020 primarily due to a decrease in stockholders\u2019 equity driven by the Split-off of our interest in Change Healthcare JV and share repurchases.", "We anticipate that we will continue to pay quarterly cash dividends in the future.", "However, the payment and amount of future dividends remain within the discretion of the Board and will depend upon our future earnings, financial condition,  capital  requirements,  and  other  factors.  In  2021,  2020,  and  2019,  we  paid  total  cash  dividends  of  $276  million,  $294  million,  and  $292  million, respectively.  Additionally,  as  required  under  the  Domination  Agreement,  we  are  obligated  to  pay  an  annual  recurring  compensation  amount  of  \u20ac0.83  per McKesson Europe share (effective January 1, 2015) to the noncontrolling shareholders of McKesson Europe.", "Cash equivalents, which are readily convertible to known amounts of cash, are carried at fair value.", "Our cash and cash equivalents balance as of March 31, 2021 and 2020 included approximately $2.3 billion and $1.7 billion of cash held by our subsidiaries", "On  July  29,  2020,  we  raised  our  quarterly  dividend  from  $0.41  to  $0.42  per  common  share  for  dividends  declared  on  or  after  such  date  by  the  Board.", "(3) Includes our estimated benefit payments for the unfunded benefit plans and minimum funding requirements for the pension plans. (4) Primarily represents interest that will become due on our fixed rate long-term debt obligations.", "These obligations primarily relate to inventory purchases and capital commitments. (6) Includes agreements under which we have guaranteed the repurchase of our customers\u2019 inventory and our customers\u2019 debt in the event these customers are unable to meet their obligations to those financial institutions.", "The ultimate amount and timing of any future cash settlements related to these items cannot be predicted with reasonable certainty.", "and are mostly related to our customer contracts and to meet the security requirements for statutory licenses and permits, court and fiduciary obligations, and our workers\u2019 compensation and automotive liability programs.", "The exercise of the Put Right will reduce the balance of redeemable noncontrolling interests.", "During 2021, we paid $49 million to purchase 1.8 million shares of McKesson Europe through exercises of the Put Right by the noncontrolling shareholders.", "Our banks and insurance companies have issued $146 million of standby letters of credit and surety bonds at March 31, 2021.", "redemption value is the Put Amount adjusted for exchange rate fluctuations each period.", "In future periods, unfavorable foreign currency exchange rate fluctuations between the Euro and the U.S. dollar could adversely impact the carrying value of our redeemable noncontrolling interests and require an adjustment to increase the balance of our redeemable noncontrolling interests to its maximum redemption value.", "On April 12, 2021, we received the Stuttgart Court of Appeals\u2019 final ruling confirming the original put value of \u20ac22.99 per share and the annual recurring compensation of \u20ac0.83 per McKesson Europe share.", "Funds necessary for future debt maturities and our other cash requirements are expected to be met by existing cash balances, cash flow from operations, existing credit sources, and other capital market transactions.", "The effect of a hypothetical 50 bp increase in the underlying interest rate on our cash and cash equivalents, net of short-term borrowings and variable rate debt, would have resulted in a favorable impact to earnings in 2021 and 2020 of approximately $17 million and $6 million, respectively.", "The balance of redeemable noncontrolling interests is reported at the greater of its carrying value or its maximum redemption value at each reporting date.", "Additionally,  we  are  obligated  to  pay  an  annual  recurring  compensation  of  \u20ac0.83  per  McKesson  Europe  share  (the  \u201cCompensation  Amount\u201d)  to  the", "Interest rate risk: Our long-term debt bears interest predominately at fixed rates, whereas our short-term borrowings are at variable interest rates.", "Our cash and cash equivalents balances earn interest at variable rates.", "At March 31, 2021 and 2020, we had $6.3 billion and $4.0 billion, respectively, in cash", "Changes in foreign currency exchange rates could have a material adverse impact on our financial results that are reported in U.S. dollars.", "We are also exposed to foreign exchange rate risk related to our foreign subsidiaries, including intercompany loans denominated in non-functional currencies.", "These programs reduce but do not entirely eliminate foreign exchange risk.", "fair value of our foreign exchange contracts by approximately $267 million and $435 million, respectively.", "Foreign exchange risk: We conduct our business worldwide in U.S. dollars and the functional currencies of our foreign subsidiaries, including Euro, British", "We have certain foreign exchange rate risk programs that use foreign currency forward contracts and cross-currency swaps.", "Based on this assessment, our management has concluded that our internal control over financial reporting was effective as of March 31, 2021.", "In our opinion, the financial statements referred to above present fairly, in all material respects, the financial position of the Company as of March 31, 2021 and 2020, and the results of its operations and its cash flows for each of the three years in the period ended March 31, 2021, in conformity with accounting principles generally accepted in the United States of America.", "Also, in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of March 31, 2021, based on criteria established in Internal Control \u2014 Integrated Framework (2013) issued by COSO.", "Our responsibility is to express an opinion on these financial statements and an opinion on the Company\u2019s internal control over financial reporting based  on  our  audits.  We  are  a  public  accounting  firm  registered  with  the  Public  Company  Accounting  Oversight  Board  (United  States)  (\u201cPCAOB\u201d)  and  are required  to  be  independent  with  respect  to  the  Company  in  accordance  with  the  U.S.  federal  securities  laws  and  the  applicable  rules  and  regulations  of  the Securities and Exchange Commission and the PCAOB.", "We conducted our audits in accordance with the standards of the PCAOB.", "Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.", "Our audits of the financial statements included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures to respond to those risks.", "Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements.", "Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk.", "Our audits also included performing such other procedures as we considered necessary in the circumstances.", "We believe that our audits provide a reasonable basis for our opinions.", "The critical audit matters communicated below are matters arising from the current-period audit of the financial statements that were communicated or required to be communicated to the audit committee and that (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments.", "The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.", "The Company also performs an assessment of loss contingencies where a loss is reasonably possible.", "We identified the potential broad settlement of opioid claims as a critical audit matter because of the significant judgment and challenges auditing management\u2019s determination  of  whether  such  loss  is  probable  and  reasonably  estimable.  Specifically,  auditing  management\u2019s  determination  and  disclosure  of  whether  the contingent loss arising from the potential broad settlement of opioid claims is probable, and the related measurement of such loss, is subjective and requires significant judgment given that the potential loss is based upon settlement terms that have not yet been finalized.", "\u2022 We tested the effectiveness of internal controls related to the potential broad settlement of opioid claims, and approval of the accounting treatment and related disclosures based on the most recent facts and circumstances.", "In addition, we inspected responses to inquiry letters sent to both internal and external legal counsel as it relates to the status of discussions with plaintiffs\u2019 counsel and the Company\u2019s intent regarding the framework for a potential broad settlement of opioid claims.", "\u2022 We evaluated management\u2019s analysis of the potential broad settlement of opioid claims, including the methodology used by management to determine the probability of such loss.", "We also evaluated the methodology used by management to estimate the most likely loss to be incurred by the Company as a result of a potential broad settlement of opioid claims.", "\u2022 We performed public domain searches for evidence contrary to management\u2019s analysis.", "\u2022 We evaluated any events subsequent to March 31, 2021 that might impact our evaluation of the potential broad settlement of opioid claims. \u2022 We obtained written representations from executives and internal counsel of the Company. \u2022 We examined proposed terms related to the potential broad settlement framework. \u2022 We evaluated the Company\u2019s related disclosures for consistency with our testing.", "The net amount recognized by management is measured as the largest amount of tax benefit that is greater than 50 percent likely of being realized.", "We identified the Company\u2019s uncertain tax position related to the charge for the potential broad settlement of opioid claims as a critical audit matter because of the challenges in auditing management\u2019s estimate of the amount of income tax benefit that qualifies for recognition.", "Our audit procedures related to the Company's uncertain tax position associated with a potential broad settlement of opioid claims included the following, among others: \u2022 We tested the effectiveness of internal controls related to the Company\u2019s assessment of the technical merits of its tax position, including the Company\u2019s assessment as to the amount of benefit that is more likely than not to be realized. \u2022 With  the  assistance  of  our  tax  specialists,  we  evaluated  the  facts,  evidence  and  the  Company\u2019s  related  income  tax  analysis  for  the  charge  related  to  the potential broad settlement of opioid claims, including assumptions used by management to measure the related recognized and unrecognized tax benefits. \u2022 We inquired of the Company\u2019s internal and external legal counsel to understand the basis for the Company\u2019s conclusion that a portion of the potential broad settlement of opioid claims would be deductible based on the most recent discussions with plaintiffs\u2019 counsel.", "\u2022 We  compared  management's  income  tax  assessment  of  this  matter  to  the  treatment  of  other  recorded  opioid  charges  to  evaluate  the  consistency  of  the Company\u2019s judgments related to the uncertain tax position. \u2022 We evaluated any events subsequent to March 31, 2021 that might impact our evaluation of the Company\u2019s uncertain tax position related to the charge for the potential broad settlement of opioid claims.", "\u2022 We obtained written representations from executives and internal counsel of the Company. \u2022 We examined proposed terms related to the potential broad settlement framework.", "\u2022 We evaluated the Company\u2019s related disclosures for consistency with our testing and also searched for contradictory evidence by reading disclosures from peer companies, who are also party to the potential broad settlement of opioid claims.", "We identified the estimation of the fair value of the McKesson Canada reporting unit used to evaluate the recoverability of goodwill as a critical audit matter because of the challenges auditing significant judgments used in the selection of a discount rate, including the unsystematic risk premium.", "In particular, the fair value estimate is sensitive to the unsystematic risk premium assumption, which is affected by expected risk of changes in the Canadian business and regulatory environments.", "Auditing management\u2019s selected discount rate required a high degree of auditor judgment and an increased extent of effort, including the need to involve more senior members of the team and our fair value specialists.", "Our audit procedures related to the Company\u2019s selection of a discount rate, including consideration of the unsystematic risk premium, for the McKesson Canada reporting unit included the following, among others: \u2022 We tested the effectiveness of internal controls related to management\u2019s goodwill impairment evaluation, including those related to the selection of a discount rate and consideration of an unsystematic risk premium. \u2022 We  evaluated  management\u2019s  ability  to  accurately  forecast  operating  results  for  the  McKesson  Canada  reporting  unit  by  comparing  actual  results  to management\u2019s historical forecasts, in order to consider the reasonableness and adequacy of management\u2019s selected unsystematic risk premium. \u2022 As part of our assessment of the unsystematic risk premium, we evaluated the reasonableness of strategic plans expected to be implemented during the forecast period by comparing the forecasts to:", "\u2022 With the assistance of our fair value specialists, we evaluated the reasonableness of the discount rate, including the unsystematic risk premium, by developing a range of independent estimates, testing the mathematical accuracy of the calculation and comparing to the discount rate selected by management.", "We have served as the Company\u2019s auditor since 1968.", "The Company consolidates VIEs when it is determined that it is the primary beneficiary of the VIE.", "Investments in business entities in which the Company does not have control but has the ability to exercise significant influence over operating and financial policies, are accounted for using the equity method.", "Actual amounts could differ from those estimated amounts.", "These legislative acts are not expected to have a material impact on the Company\u2019s consolidated financial results.", "The Company considers itself to control an entity if it is the majority owner of or has voting control over such entity.", "GAAP requires that the Company make estimates and assumptions that", "If a loss in value has occurred that is deemed to be other-than-temporary, an impairment loss is recorded.", "economic environment, customer credit ratings or bankruptcies, as well as reasonable and supportable forecasts.", "We are exposed to credit losses on accounts receivable balances.", "As a result, the Company\u2019s sales and credit concentration is significant.", "The accounts receivables balances are with individual members of the GPOs, and therefore no significant concentration of credit risk exists.", "This credit risk is mitigated by the size and diversity of the Company\u2019s customer base as well as its geographic dispersion.", "These amounts are equivalent to the Company\u2019s LIFO reserves.", "A LIFO credit is recognized when the net effect of price declines exceeds the impact of price increases on pharmaceutical and non-pharmaceutical products held in inventory.", "The increase was primarily due to charges in 2021 totaling $136 million on certain personal protective equipment and other related products due to inventory impairments and excess inventory within our Medical-Surgical Solutions segment.", "When the net realizable value of a disposal group increases during a period, a gain can be recognized to the extent that it does not increase the value of the disposal group beyond its original carrying value when the disposal group was reclassified as held for sale.", "Depreciation and amortization begins when an asset is placed in service and ready for its intended use.", "The use of alternative assumptions and estimates could affect the fair values and change the impairment determinations.", "Measurement of any impairment loss is based on the excess of the carrying value of the asset group over its estimated fair market value.", "customer in an amount that reflects the consideration to which the entity expects to be entitled for that good or service.", "Revenue is recognized when control of goods is transferred to the customer which occurs upon the Company\u2019s delivery to the customer or upon customer  pick-up.", "The ultimate outcome of any outstanding claims may be different than the Company\u2019s estimate.", "If a derivative is designated as a fair value hedge, the changes in the fair value of the derivative and of the hedged item attributable to the hedged risk are recognized in earnings.", "The cumulative changes in fair value are reclassified to the same line as the hedged item in the Consolidated Statements of Operations when the hedged item affects earnings.", "Noncontrolling interests with redemption features, such as put rights, that are not solely within the Company\u2019s control are considered redeemable noncontrolling interests.", "When a loss is considered probable and reasonably estimable, the Company records a liability in the amount of its best estimate for the ultimate loss.", "When a material loss is reasonably possible or probable, but a reasonable estimate cannot be made, disclosure of the proceeding is provided.", "As discussed above, development of a meaningful estimate of loss or a range of potential loss is complex when the outcome is directly dependent on negotiations with or decisions by third parties, such as regulatory agencies, the court system, and other interested parties.", "Any purchase consideration in excess of the estimated fair values of the net assets acquired is recorded as goodwill.", "Restructuring Charges: Employee severance costs are generally recognized when payments are probable and amounts are reasonably estimable.", "The forward-looking model requires the Company to consider historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount in estimating credit losses.", "The adoption of this amended guidance is not expected to have a material impact on the Company\u2019s consolidated financial statements or disclosures.", "accounting policy has been to disclose any intervening events of the joint venture in the lag period that could materially affect its consolidated financial statements.", "McKesson had the ability to adjust the manner in which certain depreciation or amortization deductions are allocated among Change and McKesson.", "This creates uncertainty over the amount, timing, and probability of the gain recognized.", "Any such change is not expected to have a material impact on the Company\u2019s consolidated financial statements.", "This initiative was substantially complete in 2021 and remaining costs the Company expects to record under this initiative are not material.", "This set of initiatives was substantially complete by the end of 2020 and charges in 2021 were not material.", "Goodwill recognized for business acquisitions is generally not expected to be deductible for tax purposes.", "share-based awards that will ultimately vest primarily based on historical experience.", "The estimated forfeiture rate established upon grant is re-assessed throughout the requisite service period and is adjusted when actual forfeitures occur.", "The actual forfeitures in future reporting periods could be higher or lower than current estimates.", "PSUs have a requisite service period of generally three years.", "Compensation expense for the share-based awards is recognized for the portion of awards ultimately expected to vest.", "The number of vested PSUs is assessed at the end of a", "All  outstanding  PeRSU awards  have  completed  the  performance  period  and  are  now classified  and  accounted  for  as RSUs.", "portion of the awards that is ultimately expected to vest.", "Once the fair value of an employee stock option is determined, current accounting practices do not permit it to be changed, even if the estimates used are different from actual.", "The Company believes this market-based input provides a reasonable estimate of its future stock price movements and is consistent with employee stock option valuation considerations.", "These amounts have not been significant for all the years presented.", "Substantially all its foreign net operating losses have indefinite lives.", "The decrease in unrecognized tax benefits in 2020  compared  to  2019  is  primarily  attributable  to  the  favorable  resolution  of  an  outstanding  California  tax  refund  claim  which  decreased  unrecognized  tax benefits by $91 million.", "2017 Tax Act, the repatriation of cash to the U.S. is generally no longer taxable for federal income tax purposes.", "The Company may remit foreign earnings to the U.S. to the extent it is tax efficient to do so.", "It does not expect the tax impact from remitting these earnings to be material.", "The exercise of the Put Right will reduce the balance of redeemable noncontrolling interests.", "The adoption of this guidance did not have a material impact on the Company\u2019s consolidated statements of operations and cash flows.", "The Company\u2019s lease agreements do not contain any material residual value guarantees or material restrictive covenants.", "Operating lease liabilities are recognized based on the present value of the future lease payments over the lease term, discounted at the Company\u2019s incremental borrowing rate as the implicit rate in the lease is not readily determinable for most of the Company\u2019s leases.", "As a practical expedient, short-term leases with an initial term of 12 months or less are excluded from the Consolidated Balance Sheets and charges from these leases are expensed as incurred.", "Fair value estimates result from a complex series of judgments about future events and uncertainties and rely heavily on estimates and assumptions that have been deemed reasonable by management as of the measurement date.", "The unsystematic risk premium is an input factor used in calculating the discount rate that specifically addresses uncertainty related to the reporting unit\u2019s future cash flow projections.", "The risk of successfully achieving certain business initiatives was the primary factor in the use of a higher discount rate.", "and, from time-to-time, future unsecured and unsubordinated indebtedness outstanding.", "As a result of absorbing this risk, the leases provide the Company with the power to direct the operations of the leased properties and the obligation to absorb losses or the right to receive benefits of the entity.", "Consolidated VIEs do not have a material impact on the Company\u2019s Consolidated Statements of Operations and Cash Flows.", "their economic performance and thus is not considered the primary beneficiary of the entities.", "The pension obligation in Germany is unfunded with the exception of the contractual trust arrangement used to fund pensions of McKesson Europe\u2019s Management Board.", "actuarial  losses  exceeding  10%  of  the  greater  of  the  projected  benefit  obligation  or  the  market  value  of  assets  are  amortized  straight-line  over  the  average remaining future service period of active employees.", "Pension obligations for its unfunded plans are based on the recommendations of independent actuaries.", "The difference between actual inflation and assumed inflation in our U.K. pension plans resulted in a gain of $23 million.", "corporate bonds rated AA or better whose maturities are aligned with the expected benefit payments of its plans.", "Plan assets of the non-U.S. plans are broadly invested in a manner appropriate to the nature and duration of the expected future retirement benefits payable under the plans.", "Assets are properly diversified to avoid excessive reliance on any particular asset, issuer, or group of undertakings so as to avoid accumulations of risk in the portfolio as a whole.", "practical expedient are not leveled within the fair value hierarchy and are included as a reconciling item to total investments.", "Actions taken by other participating employers may lead to adverse changes in the financial condition of a multiemployer benefit plan and the Company\u2019s withdrawal liability and contributions may increase.", "It does not use derivatives for trading or speculative purposes.", "Eligible employees may contribute to the RSP up to 75% of", "In the normal course of business, the Company is exposed to interest rate and foreign currency exchange rate fluctuations.", "These forward contracts and cross-currency swaps are generally used to offset the potential income statement effects from intercompany loans and other obligations denominated in non-functional currencies.", "These programs reduce but do not entirely eliminate foreign currency exchange rate risk.", "To the extent foreign currency-denominated notes designated as net investment hedges are ineffective, changes in carrying value attributable to the change in spot rates are recorded in earnings.", "To the extent cross-currency swaps designated as hedges are ineffective, changes in carrying value attributable to the change in spot rates are recorded in earnings.", "Changes in fair values representing hedge ineffectiveness are recognized in current earnings.", "The settlement loss on the swaps was not material and will be amortized on a straight-line basis as interest expense over the five-year life of the 2025 Notes.", "Gains or losses from these contracts are largely offset by changes in the value of the underlying intercompany obligations.", "Changes in the fair value for contracts not designated as hedges are recorded directly in earnings.", "The carrying value of all other cash equivalents approximates their fair value due to their relatively short-term nature.", "These inputs are considered Level 2 under the fair value measurements and disclosure guidance and may not be representative of actual values that could have been realized or that will be realized in the future.", "If the carrying amount of an asset group is not recoverable, an impairment charge is recorded to reduce the carrying amount by the excess over its fair value.", "repurchase of its customers\u2019 inventory or its customers\u2019 debt in the event these customers are unable to meet their obligations to those financial institutions.", "For the Company\u2019s inventory repurchase agreements, among other requirements, inventories must be in resalable condition and any repurchase would be at a discount.", "The majority of the Company\u2019s customers\u2019 debt guarantees are secured by certain assets of the customer.", "The Company\u2019s long-term debt is also recorded at cost.", "The carrying value and fair value of the Company\u2019s long-term debt was as follows:", "Long-lived Assets The Company utilizes multiple approaches including the DCF model and market approaches for estimating the fair value of intangible assets.", "infringe a third party\u2019s intellectual property rights.", "Where appropriate, obligations for such indemnifications are recorded as liabilities.", "Accrued warranty costs were not material to the Consolidated Balance Sheets.", "Significant developments in those matters are described below.", "Company  is  unable  to  determine  that  a  loss  is  probable,  or  to  reasonably  estimate  the  amount  of  loss  or  a  range  of  loss,  for  a  claim  because  of  the  limited information  available  and  the  potential  effects  of future  events  and  decisions  by third  parties,  such  as  courts  and  regulators,  that  will  determine  the  ultimate resolution of the claim.", "It is not uncommon for claims to remain unresolved over many years.", "The Company reviews loss contingencies at least quarterly to determine whether the likelihood of loss has changed and whether it can make a reasonable estimate of the loss or range of loss.", "When the Company determines that a loss from a claim is probable and reasonably estimable, it records a liability for an estimated amount.", "The Company also provides disclosure when it is reasonably possible that a loss may be incurred or when it is reasonably possible that the amount of a loss will exceed its recorded liability.", "Warranties In the normal course of business, the Company provides certain warranties and indemnification protection for its products and services.", "These two West Virginia plaintiffs are not expected to participate in any broader multistate resolution of opioid-related claims.", "The Cherokee Nation is not expected to participate in any broader multistate resolution of opioid-related claims.", "Those non-participating governmental entities would be entitled to pursue their claims against the Company and other defendants.", "The Company believes that it has valid defenses to the claims pending against it, and it intends to vigorously defend against all such claims if acceptable settlement terms are not achieved.", "The Company believes it has valid legal defenses in these matters and intends to mount a vigorous defense.", "The Company has not concluded a loss is probable in any of these matters; nor is the amount of any loss reasonably estimable.", "An adverse judgment or negotiated resolution in any of these matters could have a material adverse impact on the Company\u2019s financial position, cash flows or liquidity, or results of operations.", "AIG and ACE are seeking declarations that they have no duty to defend or indemnify McKesson in the thousands of lawsuits pending in federal and state courts related to opioids.", "Discussions with attorneys general and other parties continue.", "If the negotiating parties agree on terms under the framework for a broad resolution of claims of", "Plaintiffs\u2019 moved for summary judgment on the same day.", "subpoenas and requests in a cooperative, thorough and timely manner.", "These responses sometimes require time and effort and can result in considerable costs being incurred by the Company.", "Such subpoenas and requests can lead to the assertion of claims or the commencement of civil or criminal legal proceedings against the Company and other members of the health care industry, as well as to settlements of claims against the Company.", "The Company responds to these requests in the ordinary course of business.", "The law adopting the excise tax made clear that the OSA does not apply to sales or distributions occurring after December 31, 2018.", "It is not certain at this point in time what proportion of this estimated liability will be borne by the Company.", "However, it is possible that the ultimate costs of these matters may exceed or be less than the reserves.", "Due to the complex nature of the tax laws, it is not possible to estimate the outcome of these matters.", "improper actions to delay or prevent generic drugs from entering the market.", "The quarterly results of operations are not necessarily indicative of the results that may be expected for the entire year.", "effectiveness of the Company\u2019s \u201cdisclosure controls and procedures\u201d (as such term is defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) as of the end of the period  covered  by  this  report  and  have  concluded  that  our  disclosure  controls  and  procedures  are  effective  based  on  their  evaluation  of  these  controls  and procedures as required by paragraph (b) of Exchange Act Rules 13a-15 or 15d-15.", "Rules 13a-15 or 15d-15 that occurred during our fourth quarter of 2021 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.", "caption  \u201cInvestors  -  Corporate  Governance.\u201d  The  Company\u2019s  Corporate  Governance  Guidelines  and  Charters  for  the  Audit,  Compensation  and  Governance Committees can also be found on our website under the same caption.", "Information  about the Code of Conduct applicable  to all employees, officers  and directors can be found on our website, www.mckesson.com, under the", "Information with respect to this item is incorporated by reference from the discussion under the heading \u201cExecutive Compensation\u201d in our Proxy Statement.", "Such non-employee director award is fully vested on the date of the grant.", "subject to and qualified in their entirety by reference to our amended and restated certificate of incorporation, our amended and restated by- laws  and  the  Delaware  General  Corporation  Law  (\u201cDGCL\u201d).  Copies  of  our  amended  and  restated  certificate  of  incorporation  and  our amended and restated by-laws have been filed with the Securities and Exchange Commission (the \u201cSEC\u201d) and are incorporated by reference herein. 100,000,000 shares are preferred stock, par value $0.01 per share.", "We may amend from time to time our amended and restated certificate of incorporation to increase the number of authorized shares of Common Stock and/or preferred stock.", "Any such amendment would require the approval of the holders of a majority of our shares entitled to vote.", "All of our outstanding shares of Common Stock are fully paid and non- assessable.", "Stock are entitled to receive ratably dividends out of assets legally available therefor at such times and in such amounts as our board of directors may from time to time determine.", "ratably in our assets that are legally available for distribution, after payment of all debts, other liabilities and any liquidation preferences of outstanding preferred stock.", "amended and restated certificate of incorporation does not provide for cumulative voting in the election of directors.", "Upon liquidation, dissolution or winding up of our affairs, the holders of Common Stock are entitled to share", "Holders of our Common Stock have no conversion, redemption, preemptive or similar", "Each outstanding share of Common Stock is entitled to one vote on all matters submitted to a vote of stockholders.", "Anti-Takeover Effects of Provisions of Our Amended and Restated Certificate of Incorporation and Our Amended and Restated By- Laws deemed to have an anti-takeover effect and may delay, deter or prevent a tender offer or takeover attempt that a stockholder might consider in its best interest, including those attempts that might result in a premium over the market price for the shares held by stockholders.", "Our amended and restated by-laws provide that special meetings of holders of Common Stock may be called only by our Chair, Chief Executive Officer or a majority of our board of directors for any purpose at any time.", "Holders of Common Stock owning at least 15% of the outstanding shares of Common Stock for at least one year are permitted to submit a special meeting request in accordance with the procedures described in our amended and restated by-laws.", "In general, notice of intent to nominate a director or raise business at such meetings must be received by us not less than 90 nor more than 120 days prior to the date of the  annual meeting and must contain certain specified  information concerning the person to be nominated or the matters to be brought before the meeting and concerning the stockholder submitting the proposal.", "may be amended by a vote of a majority of our board of directors and by the affirmative vote of a majority of the shares of the corporation entitled  to  vote  thereon.  Our  amended  and  restated  certificate  of  incorporation  and  our  amended  and  restated  by-laws  provide  that  our amended and restated by-laws may be amended by a vote of a majority of our board of directors.", "In addition, our amended and restated by- laws provide that our amended and restated by-laws may be amended by the affirmative vote of a majority of the shares of the corporation entitled to vote thereon.", "Current and former stockholders are deemed to have consented to the personal jurisdiction of the Delaware Courts in connection with any action to enforce that exclusive forum provision and to service of process in any such action.", "We  are  subject  to  the  \u201cbusiness  combination\u201d  statute  of  the  DGCL.  In  general,  such  statute  prohibits  a  publicly  held  Delaware", "The statute could prohibit or delay mergers or other takeover or change in control attempts with respect to us and, accordingly, may discourage attempts to acquire us.", "stock could decrease the amount available for distribution to holders of our Common Stock or could adversely affect the rights and powers, including voting rights, of such holders.", "The issuance of preferred stock could have the effect of delaying or preventing a change in control of us.", "Such limitation does not, however, affect the liability of a director (1) for any breach of the director\u2019s duty of loyalty to us or our stockholders, (2) for acts or omissions not in good faith or that involve intentional misconduct or a knowing violation of law, (3) in respect of certain unlawful dividend payments or stock redemptions or purchases and (4) for any transaction from which the director derives an improper personal benefit.", "The effect of this provision is to eliminate our rights and the rights of our stockholders (through stockholders\u2019 derivative suits) to recover monetary damages against a director for breach of the fiduciary duty of care as a director (including breaches resulting from negligent or grossly negligent behavior) except in the situations described in clauses (1) through (4) above.", "This provision does not limit or eliminate our rights or the rights of our stockholders to seek non-monetary relief such as an injunction or rescission in the event of a breach of a director\u2019s duty of care.", "In addition, our directors and officers have indemnification protection.", "principal amount of 0.625% Notes due 2021 and \u20ac600,000,000 aggregate principal amount of 1.500% Notes due 2025, and on February 12, 2018, we issued \u20ac500,000,000 aggregate principal amount of 1.625% Notes due 2026.", "existing and future unsecured and unsubordinated indebtedness from time to time outstanding.", "EQ Shareowner Services acts as transfer agent and registrar of our Common Stock.", "Our Common Stock is listed on the New York Stock Exchange under the symbol \u201cMCK\u201d.", "On  February  17,  2017,  we  issued  \u00a3450,000,000  aggregate  principal  amount  of  3.125%  Notes  due  2029,  \u20ac600,000,000  aggregate", "Securities\u201d), our senior subordinated debt (\u201cSenior Subordinated Debt Securities\u201d), our subordinated debt (\u201cSubordinated Debt Securities\u201d) or our  junior  subordinated  debt  (\u201cJunior  Subordinated  Debt  Securities\u201d  and,  together  with  the  Senior  Subordinated  Debt  Securities  and  the Subordinated Debt Securities, the \u201cSubordinated Securities\u201d).  The Indenture does not limit the amount of debt securities that we may issue.", "It provides that we may issue debt securities up to the principal amount that we may authorize and may be in any currency or currency unit designated  by  us.  Except  for  the  limitations  on  consolidation,  merger  and  sale  of  all  or  substantially  all  of  our  assets  contained  in  the Indenture, the terms of the Indenture do not contain any covenants or other provisions designed to afford holders of any debt securities protection with respect to our operations, financial condition or transactions involving us.", "any person unless (a) we will be the continuing corporation or (b) the successor corporation or person formed by such consolidation or into which we are merged or to which our assets substantially as an entirety are transferred or leased is a corporation, limited liability company or limited partnership organized or existing under the laws of the United States, any state of the United States or the District of Columbia and, if such entity is not a corporation, a co-obligor of the debt securities is a corporation organized or existing under any such laws, and such successor corporation or person, including such co-obligor, if any, expressly assumes our obligations on the debt securities and under the Indenture.", "In addition, we cannot effect such a transaction unless immediately after giving effect to such transaction, no default or Event of Default under the Indenture shall have occurred and be continuing.", "Subject to certain exceptions, when the person to whom our assets are transferred or leased has assumed our obligations under the debt securities and the Indenture, we shall be discharged from all our obligations under the debt securities and the Indenture, except in limited circumstances.", "unless the transaction or change of control were structured to include a merger or consolidation or transfer or lease of all or substantially all of our assets.", "We cannot consolidate or merge with or into, or transfer or lease all or substantially all of our assets to,", "\u2022 any  other  Event  of  Default  provided  in  the  applicable  resolution  of  our  board  of  directors  or  the  officers\u2019  certificate  or supplemental Indenture under which we issue such series of debt securities.", "The Indenture imposes limitations on suits brought by holders of debt securities against us.", "officer knows of any default by us in the performance, observance or fulfillment of any condition or covenant of the Indenture.", "We and the Trustee may not, however, without the consent of the holder of each outstanding debt security affected thereby:", "The Indenture provides that we and the Trustee may enter into supplemental indentures without the", "value of the assets subject to such transaction, as determined by our Board of Directors, or (b) the present value of the remaining obligations of the lessee for net rental payments during the term of any lease discounted at the rate of interest set forth or implicit in the terms of such lease or, if not practicable to determine such rate, the weighted average interest rate per annum borne by the debt securities of each series outstanding pursuant to the Indenture and subject to limitations on sale and lease-back transaction covenants, compounded semi-annually in either case as determined by our principal accounting or financial officer.", "located,  and  substantially  all  the  operations  of  which  are  conducted,  in  the  United  States  of  America  whose  financial  statements  are consolidated with our financial statements in accordance with accounting principles generally accepted in the United States of America.", "Consolidated  Subsidiaries  incurred  after  the  date  of  issuance  of  the  notes  and  secured  by  liens  not  permitted  by  the  limitation  on  liens provisions, and (2) Attributable Debt of ours and our Consolidated Subsidiaries in respect of every sale and lease-back transaction entered into after the date of the issuance of the notes, other than leases permitted by the limitation on sale and lease-back provisions.", "accordance with accounting principles generally accepted in the United States of America.", "Subsidiaries pursuant to which we or any of our Subsidiaries sells, conveys or otherwise transfers to (1) a Receivables Subsidiary (in the case of a transfer by us or any of our Subsidiaries) or (2) any other person (in the case of a transfer by a Receivables Subsidiary), or grants a security interest in, any accounts receivable (whether now existing or arising in the future) or inventory of us or any of our Subsidiaries, and any assets related thereto including, without limitation, all collateral securing such accounts receivable, all contracts and all guarantees or other  obligations  in  respect  of  such  accounts  receivable  or  inventory,  proceeds  of  such  accounts  receivable  and  other  assets  which  are customarily transferred or in respect of which security interests are customarily granted in connection with asset securitization transactions involving accounts receivable or inventory.", "financing of accounts receivable or inventory (a) no portion of the Indebtedness or any other obligations (contingent or otherwise) of which (1)  is  guaranteed  by  us  or  any  Subsidiary  of  ours  (excluding  guarantees  of  obligations  (other  than  the  principal  of,  and  interest  on, Indebtedness) pursuant to representations, warranties, covenants and indemnities entered into in the ordinary course of business in connection with  a  Qualified  Receivables  Transaction),  (2)  is  recourse  or  obligates  us  or  any  Subsidiary  of  ours  in  any  way  other  than  pursuant  to representations,  warranties,  covenants  and  indemnities  entered  into  in  the  ordinary  course  of  business  in  connection  with  a  Qualified Receivables Transaction or (3) subjects any property or asset of ours or any Subsidiary of ours (other than accounts receivable or inventory and related assets as provided in the definition of \u201cQualified Receivables Transaction\u201d), directly or indirectly, contingently or otherwise, to the satisfaction thereof, other than pursuant to representations, warranties, covenants and indemnities entered into in the ordinary course of business in connection with a Qualified Receivables Transaction, (b) with which neither we nor any Subsidiary of ours has any material contract, agreement, arrangement or understanding other than on terms customary for securitization of receivables or inventory and (c) with which neither we nor any Subsidiary of ours has any obligations to maintain or preserve such Subsidiary\u2019s financial condition or cause such Subsidiary to achieve certain levels of operating results.", "Limitation  on  Liens.  We  covenant  that,  so  long  as  any  of  the  Notes  remain  outstanding,  we  will  not,  and  will  not  permit  any", "Indebtedness which is secured by a lien which would otherwise be subject to the foregoing restrictions; provided that after giving effect thereto the Exempted Debt then outstanding at such time does not exceed 10% of our total assets on a consolidated basis.", "than three years, by us or any Consolidated Subsidiary of any assets are prohibited unless (a) we or such Consolidated Subsidiary would be entitled to incur Indebtedness secured by a lien on the assets to be leased in an amount at least equal to the Attributable Debt in respect of such transaction without equally and ratably securing the notes, or (b) the proceeds of the sale of the assets to be leased are at least equal to their fair market value (as determined by our Board of Directors) and the proceeds are applied to the purchase or acquisition, or, in the case of real property, the construction, of assets or to the retirement of Indebtedness.", "The foregoing limitation will not apply, if at the time we or any Consolidated Subsidiary enters into such sale and lease-back transaction, and after giving effect thereto, Exempted Debt does not exceed 10% of our total assets on a consolidated basis.", "time, or in part, from time to time, at our option, for cash, at a redemption price that includes accrued and unpaid interest and a make-whole premium, as specified in the Indenture and the applicable Officer\u2019s Certificate.", "York  Stock  Exchange  under  the  symbol  \u201cMCK25.\u201d  Our  2026  Notes  are  listed  on  the  New  York  Stock  Exchange  under  the  symbol \u201cMCK26.\u201d Our 2029 Notes are listed on the New York Stock Exchange under the symbol \u201cMCK29.\u201d", "This Statement of Terms and Conditions is intended to meet the requirements of Code Section 409A and any regulations and rules promulgated thereunder.", "In the event of any inconsistency between this Statement of Terms and Conditions and the Plan, the Plan shall govern.", "Capitalized terms not otherwise defined in this Statement of Terms and Conditions shall have the meaning set forth in the Plan.", "With respect to  annual  Restricted  Stock  Unit  Awards  granted  to  Outside  Directors  under  the  Plan,  such  awards  shall  be  subject  to  the  following  terms,  conditions  and restrictions.", "The Administrator administering the Plan has authority to determine the Outside Directors to whom, and the time or", "additional Restricted Stock Units, which will be subject to all of the terms and conditions of the underlying Restricted Stock Unit Award.", "The number of such additional Restricted Stock Units shall be calculated by dividing (a) the aggregate amount or value of the dividends paid with respect to that number of Shares equal to the number of Restricted Stock Units credited as of the record date for such dividend by (b) the Fair Market Value per Share on the payment date for such dividend.", "Any fractional Shares resulting from the accumulation of dividend equivalents shall be paid in cash.", "Dividend equivalents in respect of Restricted Stock Units, if granted in tandem with such Units, will be converted into", "Neither an Outside Director nor any person entitled to exercise an Outside Director\u2019s rights in the event of the Outside", "this Statement of Terms and Conditions, or under a Restricted Stock Unit Agreement, shall be conclusive and binding on all persons.", "is providing the consents herein on a purely voluntary basis.", "Nothing herein contained shall affect an Outside Director\u2019s right, if any, to participate in and receive benefits", "Each Outside Director shall agree to make appropriate arrangements with the Corporation for satisfaction of any applicable federal,", "The Corporation will hold and use the Data only as long as is necessary to implement, administer and manage the", "illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.", "Agreements shall be governed by the laws of the State of Delaware.", "The provisions in this Statement of Terms and Conditions are severable and if any one or more provisions are determined to be", "This Statement of Terms and Conditions and the Restricted Stock Unit Agreements shall be binding upon and inure to the benefit of", "This Statement of Terms and Conditions is intended to meet the requirements of Code Section 409A and any regulations and rules promulgated thereunder.", "In the event of any inconsistency between this Statement of Terms and Conditions and the Plan, the Plan shall govern.", "Capitalized terms not otherwise defined in this Statement of Terms and Conditions shall have the meaning set forth in the Plan.", "With respect to  annual  Restricted  Stock  Unit  Awards  granted  to  Outside  Directors  under  the  Plan,  such  awards  shall  be  subject  to  the  following  terms,  conditions  and restrictions.", "The Administrator administering the Plan has authority to determine the Outside Directors to whom, and the time or", "Neither an Outside Director nor any person entitled to exercise an Outside Director\u2019s rights in the event of the Outside", "this Statement of Terms and Conditions, or under a Restricted Stock Unit Agreement, shall be conclusive and binding on all persons.", "is providing the consents herein on a purely voluntary basis.", "Nothing herein contained shall affect an Outside Director\u2019s right, if any, to participate in and receive benefits", "Each Outside Director shall agree to make appropriate arrangements with the Corporation for satisfaction of any applicable federal,", "The Corporation will hold and use the Data only as long as is necessary to implement, administer and manage the", "illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.", "Agreements shall be governed by the laws of the State of Delaware.", "The provisions in this Statement of Terms and Conditions are severable and if any one or more provisions are determined to be", "This Statement of Terms and Conditions and the Restricted Stock Unit Agreements shall be binding upon and inure to the benefit of", "In the event of any inconsistency between this Statement of Terms and Conditions and the Plan, the Plan shall govern.", "Capitalized terms not otherwise defined in this Statement of Terms and Conditions shall have the meaning set forth in the Plan.", "The Option is also subject to the terms and conditions of the Plan.", "In no event shall the Corporation be required to issue fractional Shares.", "An Option granted under the Plan shall be evidenced by an Option Agreement setting forth the terms and conditions of the", "The Exercise Price of an Option, as specified in the Option Agreement, shall be equal to or greater than the Fair Market Value of", "Period, the Option Period shall end on the date of such termination of employment and the Option shall thereupon not be exercisable to any extent whatsoever.", "Term Disability, the vesting schedule of the Participant\u2019s Option shall be accelerated, the Option shall become fully exercisable and the Option Period shall end on the earlier of (i) three years after the date of the Participant\u2019s termination of employment and (ii) the Expiration Date.", "Retirement, (i) the Option shall be exercisable only to the extent that it was exercisable at the time of such retirement and (ii) the Option Period for that portion of the Option designated as a Non Statutory Stock Option shall end on the earlier of (a) three years after the date of such retirement and (b) the Expiration Date.", "of  the  Participant's  Option,  then  the  Option  shall  continue  to  remain  outstanding  until  the  earlier  of  (i)  such  time  as  the  Participant  subsequently  terminates employment and (ii) the Expiration Date.", "number of Shares as to which the Option is so exercised.", "thereunder shall be transferable by the Participant by operation of law or otherwise, other than by will or the laws of descent and distribution.", "have any of the rights of a stockholder with respect to the Shares subject to an Option except to the extent that a book entry has been entered in the records of the Corporation\u2019s transfer agent with respect to such Shares upon the exercise of an Option.", "Neither a Participant nor any person entitled to exercise a Participant\u2019s rights in the event of the Participant\u2019s death shall", "Stock dividends paid with respect to Restricted Stock during the Restriction Period shall be treated as Restricted Stock which shall be subject to the same restrictions as the original award for the duration of the Restriction Period.", "If the Participant does not have a brokerage account of record, then an appropriate book entry recording the Participant\u2019s interest in the unrestricted Shares shall be entered on the records of the Corporation\u2019s transfer agent.", "Cash dividends paid with respect to Restricted Stock during the Restriction Period shall be credited on behalf of the Participant to a", "Election to Recognize Gross Income in the Year of Grant.", "The Administrator reserves the right to impose a restriction on the sale of Shares that the Participant receives upon", "Neither a Participant nor any person entitled to exercise a Participant\u2019s rights in the event of the Participant\u2019s death shall", "The Administrator reserves the right to impose a restriction on the sale of Shares that the Participant receives upon", "Following the end of the performance period, the Compensation Committee shall determine the extent to which the criteria have been achieved and shall authorize the grant and issuance of Shares in respect of the Performance Stock Unit Award.", "The performance period of a Performance Stock Unit Award shall be greater than one year,", "Unless otherwise determined by the Compensation Committee in its sole discretion, Dividend Equivalents shall not be", "A Participant shall not be permitted to sell, transfer, pledge, assign or encumber all or any portion of a Performance Stock Unit", "Neither a Participant nor any person entitled to exercise a Participant\u2019s rights in the event of the Participant\u2019s death shall", "The Administrator reserves the right to impose a restriction on the sale of Shares that the Participant", "addition, any Award of Restricted Stock or Restricted Stock Units as to which the restrictions have not lapsed shall immediately and automatically be forfeited, Performance Stock Unit Awards shall immediately and automatically be forfeited and any such Shares of Restricted Stock shall be returned to the Corporation and all of the rights of the Participant to such Awards and the underlying Shares shall immediately terminate.", "Any outstanding Option shall immediately and automatically terminate, be forfeited and shall cease to be exercisable, without limitation.", "determination shall be conclusive and binding on all interested persons.", "a manner that is valid and enforceable and that comes closest to the business objectives intended by such invalid or unenforceable provision, without invalidating or rendering unenforceable the remaining provisions of this Section VI.", "under an Award Agreement, shall be conclusive and binding on all interested persons.", "Participation in the Plan shall not create a right to further employment with the Participant\u2019s employer (the", "In making grants to Participants in foreign countries, the Administrator has the full discretion to", "All decisions of the Administrator administering the Plan upon any questions arising under the Plan or", "Nothing herein contained shall affect a Participant\u2019s right to participate in and receive benefits from and in", "Regardless  of any  action  the  Corporation  or  the  Employer  takes  with  respect  to  any  federal,  state  or  local  income  tax,  social", "Calculation of the number of Shares to be withheld shall be made based on the closing price of the Common Stock on the New York Stock Exchange on the date that the amount of tax to be withheld is determined.", "With respect to an Award other than an Option, if adequate arrangements to satisfy the obligations with regard to all Tax-Related Items are not made by the Participant with the Corporation and/or the Employer prior to the relevant taxable event, the Corporation will satisfy such obligations as provided above in clause (3) of this paragraph.", "The Administrator shall be authorized to establish such rules, forms and procedures as it deems necessary to implement the foregoing.", "In accepting the grant, the Participant acknowledges that:", "jurisdiction may have different data privacy laws and protections than the United States.", "In the latter case, the Participant understands and acknowledges that the Corporation\u2019s legal basis for the processing of the Participant\u2019s Data would be compliance with the relevant  laws  or  regulations  or  the  pursuit  by  the  Corporation  of  respective  legitimate  interests  not  outweighed  by  the  Participant\u2019s  interests,  rights  or freedoms.", "When the Corporation no longer needs the Participant\u2019s Data for any of the above purposes, the Participant understands the Corporation will remove it from its systems.", "providing the consents herein on a purely voluntary basis.", "illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.", "If the Participant has received this Statement of Terms and Conditions or any other document related to the Plan translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control.", "The provisions in this Statement of Terms and Conditions are severable and if any one or more provisions are determined to be", "The Participant acknowledges that the Participant is proficient in the English language and, accordingly, understands the provisions of", "The Corporation will hold and use the Data only as long as is necessary to implement, administer and manage the", "Participation in the Plan is voluntary and the Participant is", "In the event of any inconsistency between this Statement of Terms and Conditions and the Plan, the Plan shall govern.", "Capitalized terms not otherwise defined in this Statement of Terms and Conditions shall have the meaning set forth in the Plan.", "The Option is also subject to the terms and conditions of the Plan.", "In no event shall the Corporation be required to issue fractional Shares.", "An Option granted under the Plan shall be evidenced by an Option Agreement setting forth the terms and conditions of the", "The Exercise Price of an Option, as specified in the Option Agreement, shall be equal to or greater than the Fair Market Value of", "Period, the Option Period shall end on the date of such termination of employment and the Option shall thereupon not be exercisable to any extent whatsoever.", "Term Disability, the vesting schedule of the Participant\u2019s Option shall be accelerated, the Option shall become fully exercisable and the Option Period shall end on the earlier of (i) three years after the date of the Participant\u2019s termination of employment and (ii) the Expiration Date.", "Retirement, (i) the Option shall be exercisable only to the extent that it was exercisable at the time of such retirement and (ii) the Option Period for that portion of the Option designated as a Nonstatutory Stock Option shall end on the earlier of (a) three years after the date of such retirement and (b) the Expiration Date.", "of  the  Participant's  Option,  then  the  Option  shall  continue  to  remain  outstanding  until  the  earlier  of  (i)  such  time  as  the  Participant  subsequently  terminates employment and (ii) the Expiration Date.", "number of Shares as to which the Option is so exercised.", "thereunder shall be transferable by the Participant by operation of law or otherwise, other than by will or the laws of descent and distribution.", "have any of the rights of a stockholder with respect to the Shares subject to an Option except to the extent that a book entry has been entered in the records of the Corporation\u2019s transfer agent with respect to such Shares upon the exercise of an Option.", "Neither a Participant nor any person entitled to exercise a Participant\u2019s rights in the event of the Participant\u2019s death shall", "Stock dividends paid with respect to Restricted Stock during the Restriction Period shall be treated as Restricted Stock which shall be subject to the same restrictions as the original award for the duration of the Restriction Period.", "If the Participant does not have a brokerage account of record, then an appropriate book entry recording the Participant\u2019s interest in the unrestricted Shares shall be entered on the records of the Corporation\u2019s transfer agent.", "Cash dividends paid with respect to Restricted Stock during the Restriction Period shall be credited on behalf of the Participant to a", "Election to Recognize Gross Income in the Year of Grant.", "The Administrator reserves the right to impose a restriction on the sale of Shares that the Participant receives upon", "Neither a Participant nor any person entitled to exercise a Participant\u2019s rights in the event of the Participant\u2019s death shall", "The Administrator reserves the right to impose a restriction on the sale of Shares that the Participant receives upon", "The performance period of a Performance Stock Unit Award shall be greater than one year,", "Unless otherwise determined by the Compensation Committee in its sole discretion, Dividend Equivalents shall not be", "A Participant shall not be permitted to sell, transfer, pledge, assign or encumber all or any portion of a Performance Stock Unit", "Neither a Participant nor any person entitled to exercise a Participant\u2019s rights in the event of the Participant\u2019s death shall", "The Administrator reserves the right to impose a restriction on the sale of Shares that the Participant", "addition, any Award of Restricted Stock or Restricted Stock Units as to which the restrictions have not lapsed shall immediately and automatically be forfeited, Performance Stock Unit Awards shall immediately and automatically be forfeited and any such Shares of Restricted Stock shall be returned to the Corporation and all of the rights of the Participant to such Awards and the underlying Shares shall immediately terminate.", "Any outstanding Option shall immediately and automatically terminate, be forfeited and shall cease to be exercisable, without limitation.", "determination shall be conclusive and binding on all interested persons.", "a manner that is valid and enforceable and that comes closest to the business objectives intended by such invalid or unenforceable provision, without invalidating or rendering unenforceable the remaining provisions of this Section VI.", "under an Award Agreement, shall be conclusive and binding on all interested persons.", "Participation in the Plan shall not create a right to further employment with the Participant\u2019s employer (the", "In making grants to Participants in foreign countries, the Administrator has the full discretion to", "All decisions of the Administrator administering the Plan upon any questions arising under the Plan or", "Nothing herein contained shall affect a Participant\u2019s right to participate in and receive benefits from and in", "Regardless  of any  action  the  Corporation  or  the  Employer  takes  with  respect  to  any  federal,  state  or  local  income  tax,  social", "Calculation of the number of Shares to be withheld shall be made based on the closing price of the Common Stock on the New York Stock Exchange on the date that the amount of tax to be withheld is determined.", "With respect to an Award other than an Option, if adequate arrangements to satisfy the obligations with regard to all Tax-Related Items are not made by the Participant with the Corporation and/or the Employer prior to the relevant taxable event, the Corporation will satisfy such obligations as provided above in clause (3) of this paragraph.", "The Administrator shall be authorized to establish such rules, forms and procedures as it deems necessary to implement the foregoing.", "In accepting the grant, the Participant acknowledges that:", "jurisdiction may have different data privacy laws and protections than the United States.", "In the latter case, the Participant understands and acknowledges that the Corporation\u2019s legal basis for the processing of the Participant\u2019s Data would be compliance with the relevant  laws  or  regulations  or  the  pursuit  by  the  Corporation  of  respective  legitimate  interests  not  outweighed  by  the  Participant\u2019s  interests,  rights  or freedoms.", "When the Corporation no longer needs the Participant\u2019s Data for any of the above purposes, the Participant understands the Corporation will remove it from its systems.", "providing the consents herein on a purely voluntary basis.", "illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.", "If the Participant has received this Statement of Terms and Conditions or any other document related to the Plan translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control.", "The provisions in this Statement of Terms and Conditions are severable and if any one or more provisions are determined to be", "The Participant acknowledges that the Participant is proficient in the English language and, accordingly, understands the provisions of", "The Corporation will hold and use the Data only as long as is necessary to implement, administer and manage the", "Participation in the Plan is voluntary and the Participant is", "In the event of any inconsistency between this Statement of Terms and Conditions and the Plan, the Plan shall govern.", "Capitalized terms not otherwise defined in this Statement of Terms and Conditions shall have the meaning set forth in the Plan.", "The Option is also subject to the terms and conditions of the Plan.", "In no event shall the Corporation be required to issue fractional Shares.", "An Option granted under the Plan shall be evidenced by an Option Agreement setting forth the terms and conditions of the", "The Exercise Price of an Option, as specified in the Option Agreement, shall be equal to or greater than the Fair Market Value of", "Period, the Option Period shall end on the date of such termination of employment and the Option shall thereupon not be exercisable to any extent whatsoever.", "Term Disability, the vesting schedule of the Participant\u2019s Option shall be accelerated, the Option shall become fully exercisable and the Option Period shall end on the earlier of (i) three years after the date of the Participant\u2019s termination of employment and (ii) the Expiration Date.", "Retirement, (i) the Option shall be exercisable only to the extent that it was exercisable at the time of such retirement and (ii) the Option Period for that portion of the Option designated as a Non Statutory Stock Option shall end on the earlier of (a) three years after the date of such retirement and (b) the Expiration Date.", "of  the  Participant's  Option,  then  the  Option  shall  continue  to  remain  outstanding  until  the  earlier  of  (i)  such  time  as  the  Participant  subsequently  terminates employment and (ii) the Expiration Date.", "number of Shares as to which the Option is so exercised.", "thereunder shall be transferable by the Participant by operation of law or otherwise, other than by will or the laws of descent and distribution.", "have any of the rights of a stockholder with respect to the Shares subject to an Option except to the extent that a book entry has been entered in the records of the Corporation\u2019s transfer agent with respect to such Shares upon the exercise of an Option.", "Neither a Participant nor any person entitled to exercise a Participant\u2019s rights in the event of the Participant\u2019s death shall", "Stock dividends paid with respect to Restricted Stock during the Restriction Period shall be treated as Restricted Stock which shall be subject to the same restrictions as the original award for the duration of the Restriction Period.", "If the Participant does not have a brokerage account of record, then an appropriate book entry recording the Participant\u2019s interest in the unrestricted Shares shall be entered on the records of the Corporation\u2019s transfer agent.", "Cash dividends paid with respect to Restricted Stock during the Restriction Period shall be credited on behalf of the Participant to a", "Election to Recognize Gross Income in the Year of Grant.", "Neither a Participant nor any person entitled to exercise a Participant\u2019s rights in the event of the Participant\u2019s death shall", "Following the end of the performance period, the Compensation Committee shall determine the extent to which the criteria have been achieved and shall authorize the grant and issuance of Shares in respect of the Performance Stock Unit Award.", "The performance period of a Performance Stock Unit Award shall be greater than one year,", "addition, any Award of Restricted Stock or Restricted Stock Units as to which the restrictions have not lapsed shall immediately and automatically be forfeited, Performance Stock Unit Awards shall immediately and automatically be forfeited and any such Shares of Restricted Stock shall be returned to the Corporation and all of the rights of the Participant to such Awards and the underlying Shares shall immediately terminate.", "Unless otherwise determined by the Compensation Committee in its sole discretion, Dividend Equivalents shall not be", "A Participant shall not be permitted to sell, transfer, pledge, assign or encumber all or any portion of a Performance Stock Unit", "Neither a Participant nor any person entitled to exercise a Participant\u2019s rights in the event of the Participant\u2019s death shall", "Any outstanding Option shall immediately and automatically terminate, be forfeited and shall cease to be exercisable, without limitation.", "determination shall be conclusive and binding on all interested persons.", "a manner that is valid and enforceable and that comes closest to the business objectives intended by such invalid or unenforceable provision, without invalidating or rendering unenforceable the remaining provisions of this Section VI.", "Participation in the Plan shall not create a right to further employment with the Participant\u2019s employer (the", "In making grants to Participants in foreign countries, the Administrator has the full discretion to", "under an Award Agreement, shall be conclusive and binding on all interested persons.", "Calculation of the number of Shares to be withheld shall be made based on the closing price of the Common Stock on the New York Stock Exchange on the date that the amount of tax to be withheld is determined.", "With respect to an Award other than an Option, if adequate arrangements to satisfy the obligations with regard to all Tax-Related Items are not made by the Participant with the Corporation and/or the Employer prior to the relevant taxable event, the Corporation will satisfy such obligations as provided above in clause (3) of this paragraph.", "All decisions of the Administrator administering the Plan upon any questions arising under the Plan or", "Nothing herein contained shall affect a Participant\u2019s right to participate in and receive benefits from and in", "Regardless  of any  action  the  Corporation  or  the  Employer  takes  with  respect  to  any  federal,  state  or  local  income  tax,  social", "The Administrator shall be authorized to establish such rules, forms and procedures as it deems necessary to implement the foregoing.", "In accepting the grant, the Participant acknowledges that:", "jurisdiction may have different data privacy laws and protections than the United States.", "In the latter case, the Participant understands and acknowledges that the Corporation\u2019s legal basis for the processing of the Participant\u2019s Data would be compliance with the relevant  laws  or  regulations  or  the  pursuit  by  the  Corporation  of  respective  legitimate  interests  not  outweighed  by  the  Participant\u2019s  interests,  rights  or freedoms.", "When the Corporation no longer needs the Participant\u2019s Data for any of the above purposes, the Participant understands the Corporation will remove it from its systems.", "providing the consents herein on a purely voluntary basis.", "The Corporation will hold and use the Data only as long as is necessary to implement, administer and manage the", "Participation in the Plan is voluntary and the Participant is", "illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.", "If the Participant has received this Statement of Terms and Conditions or any other document related to the Plan translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control.", "The provisions in this Statement of Terms and Conditions are severable and if any one or more provisions are determined to be", "The Participant acknowledges that the Participant is proficient in the English language and, accordingly, understands the provisions of", "In the event of any inconsistency between this Award Agreement and the Plan, the Plan shall govern.", "Capitalized terms not otherwise defined in this Award Agreement shall have the meaning set forth in the Plan.", "determine the extent to which the performance goals have been achieved, and shall determine the number of PSUs that have been earned.", "Once the Compensation Committee has determined the number of PSUs that have been earned pursuant to the", "Dividend equivalents shall be credited in respect of the One-Year RSU Award.", "The restrictions applicable to the RSU Award shall lapse with respect to 100% of the underlying Shares on the third", "Dividend equivalents shall be credited in respect of the RSU Award granted under this Section III.", "If the Participant ceases to be a bona fide employee of the Corporation or any Affiliate (except as otherwise", "otherwise  forfeited  pursuant  to  the  terms  of  the  Plan  and  this  Award  Agreement  shall  be  paid  to  the  Participant  as  soon  as  reasonably  practicable  after  the restrictions lapse.", "Performance  Stock  Units and  Restricted  Stock  Units,  to  the  extent  the  restrictions  have  not  lapsed,  shall  immediately  and  automatically  be", "determination shall be conclusive and binding on all interested persons.", "a manner that is valid and enforceable and that comes closest to the business objectives intended by such invalid or unenforceable provision, without invalidating or rendering unenforceable the remaining provisions of this Section IV.", "Compensation Committee reserves the right to impose a restriction on the sale of Shares that the Participant receives upon the settlement of the Performance Stock Units and Restricted Stock Units granted hereunder, unless the Participant has satisfied the ownership targets applicable to the Participant as provided in such policy.", "Neither the Participant nor any person entitled to exercise the Participant\u2019s rights in the event of the Participant\u2019s death", "Participation in the Plan shall not create a right to further employment with the Participant\u2019s employer (the", "under this Award Agreement, shall be conclusive and binding on all interested persons.", "Calculation of the number of Shares to be withheld shall be made based on the closing price of the Common Stock on the New York Stock Exchange on the date that the amount of tax to be withheld is determined.", "If adequate arrangements to satisfy the obligations with regard to all Tax-Related Items are not made by the Participant with the Corporation and/or the Employer prior to the relevant taxable event, the Corporation will satisfy such obligations as provided above in clause (iii) of this paragraph.", "The Administrator has the full discretion to deviate from this Award Agreement in order to adjust the Awards", "All decisions of the Administrator administering the Plan upon any questions arising under the Plan or", "Nothing herein contained shall affect the Participant\u2019s right to participate in and receive benefits from and in", "Regardless  of any  action  the  Corporation  or  the  Employer  takes  with  respect  to  any  federal,  state  or  local  income  tax,  social", "The Administrator shall be authorized to establish such rules, forms and procedures as it deems necessary to implement the foregoing.", "In accepting the grant, the Participant acknowledges that:", "providing the consents herein on a purely voluntary basis.", "The Corporation will hold and use the Data only as long as is necessary to implement, administer and manage the", "Participation in the Plan is voluntary and the Participant is", "unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.", "English and if the meaning of the translated version is different than the English version, the English version will control.", "Award, the terms of which are set forth herein and in the Plan.", "The provisions in this Award Agreement are severable and if any one or more provisions are determined to be illegal or otherwise", "Below is a list of documents that are made available to you in connection with this Notice.", "PLEASE BE SURE TO READ THESE DOCUMENTS BECAUSE THEY CONTAIN IMPORTANT INFORMATION SPECIFIC TO THIS GRANT OF RSUs.", "By signing below, I acknowledge that: 1.    I agree to receive copies of the stockholder information, including copies of any annual report, proxy and Form 10-K, from the Investor Resources section of", "Below is a list of documents that are made available to you in connection with this Notice.", "PLEASE BE SURE TO READ THESE DOCUMENTS BECAUSE THEY CONTAIN IMPORTANT INFORMATION SPECIFIC TO THIS GRANT OF RSUs.", "I consent to receiving electronically a copy of the documents set forth above and attachments to this Notice; and 5.", "I accept ALL the terms and conditions as set forth in the Plan and ST&Cs applicable to this grant of RSUs.", "Your  PSUs  will  be  earned  subject  to  the  Company\u2019s  attainment  of  performance  goals  that  have  been  pre-established  by  the  Compensation  Committee  (the \u201cCommittee\u201d) of the Company\u2019s Board of Directors.", "Below is a list of documents that are made available to you in connection with this Notice.", "PLEASE BE SURE TO READ THESE DOCUMENTS BECAUSE THEY CONTAIN IMPORTANT INFORMATION SPECIFIC TO THIS GRANT OF PSUs.", "I consent to receiving electronically a copy of the documents set forth above and attachments to this Notice; and 12.", "I should consult with a tax advisor prior to accepting this grant of PSUs or taking any other action with respect to this grant of PSUs; and 14.", "I accept ALL the terms and conditions as set forth in the Plan and ST&Cs applicable to this grant of PSUs.", "We consent to the incorporation by reference in McKesson Corporation Registration Statement Nos. 333-249817, 333-163642, 333-190847, 333-190848, and 333- 213488 on Form S-8, and Registration Statement No. 333-236808 on Form S-3, of our report dated May 12, 2021, relating to the consolidated financial statements and consolidated financial statement schedule of McKesson Corporation and subsidiaries, and the effectiveness of McKesson Corporation\u2019s internal control over financial reporting appearing in this Annual Report on Form 10-K of McKesson Corporation for the year ended March 31, 2021.", "I have reviewed this annual report on Form 10-K of McKesson Corporation;", "The registrant\u2019s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant\u2019s auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):", "I have reviewed this annual report on Form 10-K of McKesson Corporation;", "The registrant\u2019s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant\u2019s auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):", "Together, we work across the healthcare delivery system to connect pharmacies, providers, payers, and biopharma for next-generation patient access and adherence solutions that help people get the medicine they need to live healthier lives.", "Unless otherwise noted, all references in this document to a particular year shall mean the", "On March 10, 2020, we completed the separation of our interest in the Change Healthcare JV through a split- off transaction.", "This transaction reduced our investment in the Change Healthcare JV to zero.", "Change Healthcare: Our equity ownership interest in Change Healthcare JV, a joint venture, has been accounted for using the equity method of accounting.", "for our innovations and obtain copyright protection for our original works of authorship, when such protection is advantageous.", "Through these efforts, we have developed a portfolio of patents and copyrights in the U.S. and worldwide.", "In addition, we have registered or applied to register certain trademarks and service marks in the U.S. and in foreign countries.", "We cannot guarantee that our intellectual property portfolio will be sufficient to deter misappropriation, theft, or misuse of our technology, nor that we can successfully enjoin infringers.", "We periodically receive notices alleging that our products or services infringe on third party patents and other intellectual property rights.", "While the outcome of any litigation or dispute is inherently uncertain, we do not believe that the resolution of any of these infringement notices would have a material adverse impact on our results of operation.", "These values and behaviors help make McKesson unique.", "We offer financial assistance programs for higher education opportunities that support employees\u2019 career growth at the company.", "To provide compensation that is focused on attracting and retaining talent with the skills and experience necessary for a specific role, our compensation program is built on a set of quantifiable factors defined by our guiding principles of internal fairness, market competitiveness, and pay for performance.", "We operate in several countries and our benefits offerings vary accordingly.", "We offer health and wellness benefits to advance the physical, mental, and social well-being of our people, savings programs to help prepare them for retirement, and flexible work arrangements, among other  benefits  offerings,  when  possible.  In  response  to  the  COVID-19  pandemic,  we  offered  extended  medical  benefits  covering  COVID-19  related  visits, treatment and testing, expanded telehealth options, emergency paid time off (\u201cPTO\u201d), and a platform for employees to donate their regular PTO to co-workers who were  more  impacted  by  COVID-19.", "We have received monetary penalties and/or licensing sanctions pursuant to these requirements and future allegations of noncompliance could result in an inability to obtain, maintain or renew permits, licenses or other regulatory approvals needed for the operation of our businesses.", "As a result of ongoing, advanced discussions with state attorneys general and plaintiffs\u2019 representatives regarding a framework to resolve the claims of governmental entities, and our assessment of certain other opioid-related claims, we have reached a stage at which a broad settlement of opioid claims by governmental entities is probable and recorded a charge of $8.1 billion for the year ended March 31, 2021 within \u201cClaims and litigation charges, net\u201d in our Consolidated Statement of Operations in this Annual Report on Form 10-K.", "Because of the many uncertainties associated with any potential settlement arrangement or other resolution of opioid-related litigation, including the uncertainty of the scope of participation by plaintiffs in any potential settlement, we are not able to reasonably estimate the upper or lower ends of the range of ultimate possible loss for all opioid-related litigation matters.", "The adverse outcome of legal proceedings might also involve significant  expense,  management  time  and  distraction,  and risk  of loss that  can be difficult  to predict  or quantify.  In addition  to this litigation,  legislative  or regulatory measures related to the distribution of controlled substances such as prescription opioids could affect our business in ways that we may not be able to predict.", "For example, some states have passed legislation that could require us to pay taxes or assessments on the distribution of opioid medications in those states and other states have considered similar legislation.", "We are subject to government audits,  investigations  and  oversight  proceedings.  Government  agencies  routinely  review  and  audit  government  contractors  to  determine  whether  they  are complying with contractual and legal requirements.", "If we fail to comply with these requirements, or we fail an audit, we may be subject to various sanctions such as monetary damages, criminal and civil penalties, termination of contracts and suspension or debarment from government contract work.", "These requirements complicate our business and increase our compliance burden and material non-compliance could harm our reputation.", "affecting  Medicare,  Medicaid,  other  government  healthcare  programs,  and  government  contracts.  Our  relationships  with  pharmaceutical  and  medical  surgical product manufacturers and healthcare providers, as well as our provision of products and services to government entities, subject our business to laws, regulation, and government guidance on fraud and abuse.", "Many of these laws are vague or indefinite and have not been interpreted by the courts and, as such, may be interpreted or applied by a prosecutorial, regulatory, or judicial authority in a manner that could require us to make changes in our operations.", "Americans and changed the way healthcare is financed by both governmental and private payers.", "There are also further efforts to broaden healthcare coverage.", "Provincial governments in Canada that provide partial funding for the purchase of pharmaceuticals and independently regulate the sale and reimbursement of drugs have sought to reduce the costs of publicly funded health programs.", "Some European governments  have  implemented  or  are  considering  austerity  measures  to  reduce  healthcare  spending.  These  measures  exert  pressure  on  the  pricing  and reimbursement timelines for pharmaceuticals and may cause our customers to purchase fewer of our products and services or influence us to reduce prices.", "There is substantial uncertainty about the likelihood, timing and results of these health reform efforts.", "We also have record- keeping  and  other  obligations  under  the  E.U.  Falsified  Medicines  Directive.  Pedigree  tracking  laws  such  as  these  increase  our  compliance  burden  and  our pharmaceutical distribution costs.", "For example, under the Health Insurance Portability and Accountability Act of 1996 (\u201cHIPAA\u201d) we must maintain administrative, physical  and  technological  safeguards  to  protect  individually  identifiable  health  information  (\u201cprotected  health  information\u201d)  and  ensure  the  confidentiality, integrity, and availability of electronic protected health information.", "We are subject to significant compliance obligations under privacy laws such as the General Data Protection Regulation (\u201cGDPR\u201d) in the European Union, the Personal Information Protection and Electronic Documents Act (\u201cPIPEDA\u201d) in Canada, and the California Consumer Protection Act (\u201cCCPA\u201d).", "We are subject to privacy  and  data  protection  compliance  audits  or  investigations  by  various  government  agencies.  Failure  to  comply  with  these  laws  subjects  us  to  potential regulatory enforcement activity, fines, private litigation including class actions, and other costs.", "We also have contractual obligations to customers that might be breached if we fail to comply with privacy laws.", "Our efforts to comply with privacy laws complicate our operations and add to our compliance costs.", "storage and hosting of sensitive information, including protected health information and other types of personal information, confidential financial information, proprietary information, and other sensitive information relating to our customers, company and workforce.", "costs.  Environmental  costs  and  accruals,  including  that  related  to  our  legacy  chemical  distribution  operations,  presently  are  not  material  to our  operations  or financial position.", "Our ten largest customers comprised approximately 32%, and CVS was approximately 19%, of total trade accounts receivable at March 31, 2021.", "We also have agreements with GPOs, each of which functions as a purchasing agent on behalf of member  hospitals,  pharmacies  and other healthcare  providers,  as well as with government  entities  and agencies.  The accounts receivable balances are with individual members of the GPOs, and therefore no significant concentration of credit risk exists.", "Substantially all of these revenues and accounts receivable are included in our U.S.", "distribution arrangements with pharmaceutical manufacturers that include an inflation-based compensation component whereby we benefit when the manufacturers increase their prices as we sell our existing inventory at the new higher prices.", "Forward-looking  statements  involve  risks  and  uncertainties  that  could  cause  actual  results  to  differ  materially  from  those  projected,  anticipated,  or  implied.", "Except to the extent required by federal securities laws, we undertake no obligation to publicly release the result of any revisions to any forward-looking statements to reflect events or circumstances after the date the statements are made, or to reflect the occurrence of unanticipated events.", "Some of our distribution arrangements with the manufacturers provides us compensation based on a percentage of our purchases.", "We experience costly and disruptive legal disputes.", "Despite valid defenses that we assert, legal disputes are often costly, time-consuming, distracting to management and disruptive to normal business operations.", "The outcome of legal disputes is difficult to predict.", "Outcomes can occur that are not justified by the evidence or existing law.", "The uncertainty and expense associated with unresolved legal disputes might harm our business and reputation even if the matter is favorably resolved.", "Accordingly, any legal dispute might have a materially adverse impact on our reputation, our business operations and our financial position or results of operations.", "We might experience losses not covered by insurance.", "supplies, the provision of ancillary services, the conduct of our payer businesses and the provision of products that assist clinical decision-making and relate to patient medical histories and treatment plans.", "Although we seek to maintain adequate insurance coverage,  such  as  property  insurance  for  inventory  and  professional  and  general  liability  insurance,  coverages  on  acceptable  terms  might  be  unavailable,  or coverages might not cover our losses.", "We generally seek to limit our contractual exposure, but limitations of liability or indemnity provisions in our contracts may not be enforceable or adequately protect us from liability.", "Uninsured losses might have a materially adverse impact on our business operations and our financial position or results of operations.", "We regularly are named as a defendant in similar, new cases.", "Many of these cases raise novel theories of liability.", "Any proceedings can have unexpected outcomes that are not justified by evidence or existing law.", "It is not uncommon for claims to be resolved over many years.", "Although the Company has valid defenses and is vigorously defending itself, some proceedings have been and others may be resolved by negotiated outcome.", "Our reputation has been and may continue to be impacted by publicity regarding the litigation and related allegations.", "The adverse outcome of legal proceedings might have a materially adverse impact on our business operations and our financial position or results of operations.", "For example, some states have passed legislation that could require us to pay taxes or assessments on the distribution of opioid medications in those states and other states have considered similar legislation.", "Liabilities for taxes or assessments or other costs of compliance under any such laws might have a materially adverse impact on our reputation, business operations, and our financial position or results of operations.", "We are subject to extensive, complex and challenging healthcare and other laws.", "Any noncompliance by us with applicable laws or the failure to maintain, renew or obtain necessary permits and licenses could lead to litigation and might have a materially adverse impact on our business operations and our financial position or results of operations.", "Local, state and federal governments continue to strengthen their position and scrutiny over practices involving or allegedly involving fraud, waste and abuse affecting Medicare, Medicaid and other government healthcare programs.", "Our relationships with pharmaceutical and medical surgical product manufacturers and healthcare providers, as well as our provision of products and services to government entities, subject our business to laws and regulations on fraud and abuse, which among other things: (1) prohibit persons from soliciting, offering, receiving or paying any remuneration in order to induce the referral of a patient for treatment  or  to  induce  the  ordering  or  purchasing  of  items  or  services  that  are  in  any  way  paid  for  by  Medicare,  Medicaid  or  other  government-sponsored healthcare programs; (2) impose many restrictions upon referring physicians and providers of designated health services under Medicare and Medicaid programs; and (3) prohibit the knowing submission of a false or fraudulent claim for payment to, and knowing retention of an overpayment by, a federal healthcare program such  as  Medicare  and  Medicaid.  Many  of  these  laws,  regulations,  and  government  guidance,  including  those  relating  to  marketing  incentives,  are  vague  or indefinite and have not been interpreted by the courts.", "The laws may be interpreted or applied by a prosecutorial, regulatory, or judicial authority in a manner that could require us to make changes in our operations.", "Failures to comply with applicable laws subject us to federal or state government investigations or qui tam actions, and to liability for damages and civil and criminal penalties, including the loss of licenses or our ability to participate in Medicare, Medicaid and other federal and state healthcare programs.", "These sanctions might have a materially adverse impact on our business operations and our financial position or results of operations.", "Noncompliance with these requirements has resulted in monetary penalties and/or licensing sanctions.", "For example, under a January 2017 agreement with the DEA and Department of Justice we paid $150 million to settle potential administrative and civil claims about our practices for reporting suspicious orders of controlled substances and the DEA suspended, on a staggered basis for limited periods of time, our registrations to distribute certain controlled substances from four distribution centers.", "Pedigree tracking laws increase our compliance burden and our pharmaceutical distribution costs.", "Pedigree tracking laws such as these increase our compliance burden and our pharmaceutical distribution costs, and they might have a materially adverse impact on our business operations and our financial position or results of operations.", "Privacy and data protection laws increase our compliance burden.", "example,  under  the  Health  Insurance  Portability  and  Accountability  Act  of  1996  (\u201cHIPAA\u201d)  we  must  maintain  administrative,  physical  and  technological safeguards  to  protect  individually  identifiable  health  information  (\u201cprotected  health  information\u201d)  and  ensure  the  confidentiality,  integrity  and  availability  of electronic protected health information.", "Failure to comply with these laws subjects us to potential regulatory enforcement activity, fines, private litigation including class actions, and other costs.", "We also have contractual obligations to customers that might be breached if we fail to comply with privacy laws.", "Our efforts to comply with privacy laws complicates our operations and adds to our compliance costs.", "A significant privacy breach or failure  to  comply  with  privacy  laws  might  have  a  materially  adverse  impact  on  our  reputation,  business  operations  and  our  financial  position  or  results  of operations.", "Anti-bribery and anti-corruption laws increase our compliance burden.", "Bribery Act unless the organization can establish the defense of having implemented adequate procedures to prevent bribery.", "Our failure to comply with these laws might subject us to civil and criminal penalties that might have a materially adverse impact on our reputation, business operations and our financial position or results of operations.", "We are subject to a variety of privacy and data protection laws that change frequently and have requirements that vary from jurisdiction to jurisdiction.", "We  are  subject  to  laws  prohibiting  improper  payments  and  bribery,  including  the  U.S.  Foreign  Corrupt  Practices  Act,  the  U.K.  Bribery  Act  and  similar", "We might record significant charges from impairment to goodwill, intangibles and other assets or investments.", "In addition, we periodically review our intangible and other long-lived assets for impairment when events or changes in circumstances, such as a divestiture, indicate the carrying value may not be recoverable.", "Factors that may be considered a change in circumstances indicating that  the  carrying  value  of  our  intangible  and  other  long-lived  assets  may  not  be  recoverable  include  slower  growth  rates,  the  loss  of  a  significant  customer, burdensome new laws or divestiture of a business or asset for less than its carrying value.", "There are inherent uncertainties in management\u2019s estimates, judgments and assumptions used in assessing recoverability of goodwill, intangible and other long-lived assets.", "We may be required to record a significant charge to earnings in our consolidated financial statements during the period in which any impairment of our goodwill or intangible and other long-lived assets is determined, which might have a materially adverse impact on our business operations and our financial position or results of operations.", "storage and hosting of sensitive information, including protected health information and other types of personal information, confidential financial information, proprietary information, and other sensitive information relating to our customers, company and workforce.", "If our software and technology services are alleged to have contributed to faulty clinical decisions or injury to patients, we might be subject to claims or litigation by users of our software or services or their patients.", "Any of these types of errors or failures might have a materially adverse impact on our reputation, business operations and our financial position or results of operations.", "We  are  required  under  U.S.  Generally  Accepted  Accounting  Principles  (\u201cGAAP\u201d)  to  test  our  goodwill  for  impairment  annually  or  more  frequently  if", "We might be impeded in providing customers online services and data access.", "Any such problems might have a materially adverse impact on our business operations and our financial position or results of operations.", "Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.", "we may require financing that may not be available on acceptable terms.", "Any of these risks could adversely affect our ability to achieve the anticipated benefits of an acquisition and might have a materially adverse impact on our business operations and our financial position or results of operations.", "Exclusive forum provisions in our Bylaws could limit our stockholders\u2019 ability to choose their preferred judicial forum for disputes with us or our directors, officers or employees.", "Current and former stockholders are deemed to have consented to the personal jurisdiction of the Delaware Courts in connection with any action to enforce that exclusive forum provision and to service of process in any such action.", "To the extent that these provisions of the bylaws limit a current or former stockholder\u2019s ability to select a judicial forum other than the Delaware Courts, they might discourage the specified legal actions, might cause current or former stockholders to incur additional litigation-related expenses and might result in outcomes unfavorable to current or former stockholders.", "A court might determine that these provisions of the bylaws are inapplicable or unenforceable in any particular action, in which case we may incur additional litigation related expenses in such action, and the action may result in outcomes unfavorable to us, which could have a materially adverse impact on our reputation, our business operations and our financial position or results of operations.", "We might be adversely impacted by delays or other difficulties with divestitures.", "After the disposition, we might experience greater dissynergies than expected, and the impact of the divestiture on our revenue or profit might be larger than we expected.", "We might have difficulties with pre-closing conditions such as regulatory and governmental approvals, which could delay or prevent the divestiture.", "We might have financial exposure in a divested business, such as through minority equity ownership, financial  or  performance  guarantees,  indemnities  or  other  obligations,  such  that  conditions  outside  of  our  control  might  negate  the  expected  benefits  of  the disposition.", "Any of these risks could adversely affect our ability to achieve the anticipated benefits of a divestiture and might have a materially adverse impact on our business operations and our financial position or results of operations.", "We might not realize the expected tax treatment from our split-off of Change Healthcare.", "If Change does not honor its obligations to indemnify the Company, or if the Transactions fail to qualify for the intended tax-free treatment for reasons not related to a disqualifying action by Change or SpinCo, the resulting tax to the Company could have a significant adverse effect on our financial position or results of operations.", "outsourced service providers, and we might not realize expected cost savings or other benefits.", "For example, our ability to use outsourcing resources in certain jurisdictions might be limited by legislative action or customer contracts, with the result that the work must be performed at greater expense or we may be subject to sanctions for non-compliance.", "Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.", "We might encounter difficulties attracting and retaining customers to our retail locations due to their unfamiliarity with our brands or our inexperience with local market  preferences.  Competition  from  our  retail  pharmacy  operations  might  strain  relationships  with  our  retail  pharmacy  customers.  Consolidation  of  retail pharmacies with third party payers, expansion of large retail pharmacy networks, reductions in reimbursement rates, shifts in the mix of branded and generic pharmaceutical sales, and exclusion from preferred pharmacy networks can impair our retail pharmacy sales and profitability.", "We might be harmed by large customer purchase reductions, payment defaults or contract non-renewal.", "March 31, 2021, sales to our largest customer represented approximately 21% of our consolidated revenues and approximately 19% of our trade receivables, and those of our ten largest customers combined accounted for approximately 51% of our consolidated revenues and approximately 32% of our trade receivables.", "A material  default  in  payment,  reduction  in  purchases,  or  the  loss  of  business  from  a  large  customer  might  have  a  materially  adverse  impact  on  our  business operations and our financial position or results of operations.", "Our contracts with government entities involve future funding and compliance risks.", "Our government contracts might not be renewed or might be terminated for convenience with little or no prior notice.", "Government contracts typically expose us to higher potential liability than do other types of contracts.", "We are subject to government audits, investigations and oversight proceedings.", "If we fail to comply with these requirements, or we fail an audit, we are subject to various sanctions such as monetary damages, criminal and civil penalties, termination of contracts and suspension or debarment from government contract work.", "These requirements complicate our business and increase our compliance burden.", "We also provide supplies used for vaccine administration in the Federal COVID-19 Response.", "Our participation in such programs exposes us to various uncertainties.", "Because of these risks and uncertainties our operating results may be materially higher or lower than our projections.", "Certain distribution agreements with manufacturers include pharmaceutical price inflation as a component of our compensation, and we cannot  control  the  frequency  or  magnitude  of  pharmaceutical  price  changes.  We  might  be  unable  to  renew  pharmaceutical  distribution  agreements  with manufacturers in a timely and favorable manner.", "Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.", "We  derive  a  significant  portion  of  our  revenue  from,  and  have  a  significant  portion  of  our  accounts  receivable  with,  a  small  number  of  customers.  At", "Our contracts with government entities are subject to risks such as lack of funding and compliance  with unique requirements.", "We might infringe intellectual property rights or our intellectual property protections might be inadequate.", "If a court were to hold that we infringed other\u2019s rights, we might be required to pay substantial damages, develop non-infringing products or services, obtain a license, stop selling or using the infringing products or services, or incur other sanctions.", "We rely on trade secret, patent, copyright and  trademark  laws,  nondisclosure  obligations  and  other  contractual  provisions  and  technical  measures  to  protect  our  proprietary  rights  in  our  products  and solutions.  We  might  initiate  costly  and  time-consuming  litigation  to  protect  our  trade  secrets,  to  enforce  our  patent,  copyright  and  trademark  rights  and  to determine the scope and validity of the proprietary rights of others.", "Our intellectual property protection efforts might be inadequate to protect our rights.", "Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.", "Competition among potential employers might result in increased salaries, benefits or other employee-related costs, or in our failure to recruit and retain employees.", "Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.", "We might be adversely impacted by healthcare reform such as changes in pricing and reimbursement models.", "healthcare industry and related government programs are changing.", "profit margins for us and our customers and impose new legal requirements on healthcare providers.", "the way healthcare is financed by both governmental and private payers.", "drugs have sought to reduce the costs of publicly funded health programs.", "These measures exert pressure on the pricing and reimbursement timelines for pharmaceuticals and may cause our customers to purchase fewer of our products and services or influence us to reduce prices.", "adverse impact on our business operations and our financial position or results of operations.", "Consolidation might increase counter-party credit risk because credit purchases increase for fewer market participants.", "Any of these changes or disruptions might have a materially adverse impact on our business operations and our financial position or results of operations.", "We might be adversely impacted as a result of our distribution of generic pharmaceuticals.", "Generic drug manufacturers often offer a generic version of branded pharmaceuticals while they challenge the validity or enforceability branded pharmaceutical patents.", "The patent holder might assert infringement claims against us for distributing those generic versions and the generic drug manufactures may not fully indemnify us against such claims.", "These risks, as well as changes in the availability,  pricing  volatility,  reimbursement  rates  for  generic  drugs,  or significant  changes  in  the  nature,  frequency  or magnitude  of  generic  pharmaceutical launches, might have a materially adverse impact on our business operations and our financial position or results of operations.", "We might be adversely impacted by an economic slowdown or recession.", "Any economic slowdown or recession might have a materially adverse impact on our business operations and our financial position or results of operations.", "Disruption or other changes in capital and credit markets might impede access to credit and increase borrowing costs for us and our customers and suppliers and might impair the financial soundness of our customers and suppliers.", "activity by financial institutions, or decreased liquidity and increased costs in the commercial paper market, might adversely affect our borrowing ability and cost of borrowing.", "We generally sell our products and services under short-term unsecured credit arrangements.", "An adverse change in general economic conditions or access to capital might cause our customers to reduce their purchases from us, or delay or fail paying amounts owed to us.", "Suppliers might be unable to make payments due to us for fees, returned products or incentives.", "Interest rate increases or changes in capital market conditions might impede our or our customers\u2019 or suppliers\u2019 ability or cost to obtain credit.", "Any of these risks might have a material adverse impact on our business operations and our financial position or results of operations.", "Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.", "We might be adversely impacted by tax legislation or challenges to our tax positions.", "Tax laws might change in ways that adversely affect our tax positions, effective tax rate and cash flow.", "The tax laws are extremely complex and subject to varying interpretations.", "We are subject to tax examinations in various jurisdictions that might assess additional tax liabilities against us.", "Our tax reporting positions might be challenged by relevant tax authorities, we might incur significant expense in our efforts to defend those challenges, and we might be unsuccessful in those efforts.", "Developments in examinations and challenges might materially change our provision for taxes in the affected periods and might differ materially from our historical tax accruals.", "Any of these risks might have a materially adverse impact on our business operations, our cash flows and our financial position or results of operations.", "For example, we might experience volatility in exchange rates and interest rates and changes in laws regulating our U.K. operations.", "Customers might reduce purchases due to the uncertainty caused by Brexit.", "Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.", "We might be adversely impacted by fluctuations in foreign currency exchange rates.", "exchange rates could reduce our revenues, increase our costs or otherwise adversely affect our financial results reported in U.S. dollars.", "For example, we are exposed to transactional currency exchange risk due to our import and export of products that are purchased or sold in currencies other than the U.S. dollar.", "We also  have  currency  exchange  risk  due  to  intercompany  loans  denominated  in  various  currencies.  The  COVID-19  pandemic  has  affected  and  might  increase currency exchange rate volatility.", "We may from time to time enter into foreign currency contracts, foreign currency borrowings or other techniques intended to hedge  a  portion  of our  foreign  currency  exchange  rate  risks.  These  hedging  activities  may  not  completely  offset  the  adverse  financial  effects  of  unfavorable movements in foreign currency exchange rates during the time the hedges are in place.", "Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.", "We are subject to the tax laws in the U.S. at the federal, state and local government levels and to the tax laws of many other jurisdictions in which we operate", "We conduct our business in various currencies,  including  the U.S. dollar, euro, British pound sterling  and Canadian dollar.  Changes in foreign  currency", "Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.", "We might be adversely impacted by changes in accounting standards.", "It is possible that future accounting standards may require changes to the accounting treatment in our consolidated financial statements and may require us to make significant changes to our financial systems.", "Such changes might have a materially adverse impact on our financial position or results of operations.", "Our consolidated financial statements are subject to the application of U.S.", "Disclosure of an environmental proceeding where a governmental agency is a party generally is included only if we expect monetary sanctions in the proceeding to exceed $1 million, unless otherwise material.", "There are no family relationships between any of the executive officers or directors of the Company.", "We declared regular cash dividends of $1.67 and $1.62 per share in the years ended March 31, 2021 and 2020, respectively.", "discretion of the Board and will depend upon our future earnings, financial condition, capital requirements, and other factors.", "Dividends: In  July  2020,  our  quarterly  dividend  was  raised  from  $0.41  to  $0.42  per  common  share  for  dividends  declared  on  or  after  such  date  by  the", "We anticipate that we will continue to pay quarterly cash dividends in the future.", "In accordance with our accounting policy, we allocate any excess of share repurchase price over par value between additional paid-in capital and retained earnings.", "Accordingly, our retained earnings and additional paid-in capital were reduced by $472 million and $70 million, respectively, during 2019.", "In 2019, we retired 5.0 million or $542 million of our treasury shares previously repurchased.", "This discussion and analysis should be read in conjunction with the consolidated financial statements and accompanying financial notes in Item 8 of Part II of this Annual Report on Form 10-K.", "Our fiscal year begins on April 1 and ends on March 31.", "Unless otherwise noted, all references to a particular year shall mean our fiscal year.", "Our organizational structure also includes Corporate, which consists of income and expenses associated with administrative functions and projects, and the results of certain investments.", "We evaluate the performance of our operating segments on a number of measures, including revenues and operating profit before interest expense and income taxes.", "The following summarizes our four reportable segments and the changes made to our reporting structure commencing in the second quarter of 2021.", "\u2022 Coronavirus disease 2019 (\u201cCOVID-19\u201d) impacted our results of operations for the year ended March 31, 2021.", "The recovery from the COVID- 19 pandemic continued to fluctuate throughout our fiscal year.", "\u2022 We expanded our existing contractual relationship with the Centers for Disease Control and Prevention (\u201cCDC\u201d) through an amendment to our existing Vaccines for Children Program contract to support the U.S. government as a centralized distributor of COVID-19 vaccines and ancillary supplies needed to administer vaccines.", "\u2022 In  December  2020,  we  began  distributing  certain  COVID-19  vaccines  under  the  direction  of  the  CDC.  Through  the  end  of  the  fiscal  year,  we  had distributed approximately 100 million of COVID-19 vaccine doses.", "\u2022 Revenues of $238.2 billion, reflects a 3% increase from the prior year primarily in our U.S.", "\u2022 Diluted loss per common share from continuing operations attributable to McKesson Corporation in 2021 of $28.26 reflects the aforementioned items, net of any respective tax impacts, and a lower share count compared to the prior year driven largely by the separation of our investment in Change Healthcare JV on March 10, 2020;", "The full extent to which COVID-19 will impact us depends on many factors and future developments, which are described at the end of this COVID-19 section.", "We continue to evaluate the nature and extent of the impacts COVID-19 has on our business and operations.", "We provided further support including additional emergency leave and an internal paid time off donation platform for employees impacted by COVID-19.", "These responses were initially put in place during our fourth quarter of 2020.", "policies did not have a material effect on our internal control over financial reporting during the year ended March 31, 2021.", "We also took various actions to mitigate the impact of COVID-19 on our results from operations through cost-containment and payroll-related expenses.", "We support the U.S. government as a centralized distributor of COVID-19 vaccines and ancillary supplies needed to administer vaccines.", "We make no decisions on where products are to be distributed nor how the products are allocated between the various provider sites and ultimately administered to the individuals receiving a vaccine.", "We utilize our expertise and capabilities to support the CDC\u2019s efforts to vaccinate everyone in the U.S. who wants to receive a COVID-19 vaccine.", "The Pfizer Vaccine, which is ultra-frozen, is not being distributed by McKesson, although we are providing ancillary supplies needed for its administration.", "custom freezers and refrigerators to safely store and process millions of vaccine doses.", "The capital expenditures we made during 2021 to prepare for vaccine and ancillary supply kit distribution were not material to our financial condition or liquidity.", "In December 2020, we began distributing the Moderna Vaccine in the U.S. and in March 2021, we began distributing the Janssen Vaccine.", "Subsequently, during the first quarter, we had lower pharmaceutical volumes, specialty drug volumes, and patient care visits that negatively impacted our consolidated revenues and income (loss) from continuing operations before income taxes for the year ended March 31, 2021.", "Additionally, increased costs for certain PPE compressed our margins.", "During the year ended March 31, 2021, we recorded charges totaling $136 million in cost of sales on certain PPE and other related products due to inventory impairments and excess inventory in our Medical-Surgical Solutions segment.", "Although market price volatility and changes to anticipated customer demand may require additional write-downs in future periods, we are taking measures to mitigate such risk.", "We collaborated closely with the federal government and other healthcare stakeholders to source more critical PPE to the U.S.", "We have deferred certain employer payroll taxes and continue to monitor the potential impact of other tax legislation changes as result of the CARES Act, including refundable payroll tax credits on certain qualified wages.", "We anticipate changes due to the CARES Act in the timing of certain cash flows, with no material impact to our financial results for the year ended March 31, 2021.", "The CA Act did not have a material impact on our financial condition, results of operations, or liquidity for the year ended March 31, 2021 nor do we currently expect a material impact on our future financial results.", "We are monitoring our customers closely for changes to their timing of payments or ability to pay amounts owed to us as a result of COVID-19 pandemic impacts to their businesses.", "We remain well-capitalized with access to liquidity from our revolving credit facility.", "Long- term debt markets and commercial paper markets, our primary sources of capital after cash flow from operations, have remained open and accessible to us during the COVID-19 pandemic.", "At March 31, 2021, we were in compliance with all debt covenants, and believe we have the ability to continue to meet our debt covenants in the future.", "Our consolidated balance sheets and ability to maintain financial liquidity remains strong.", "We have experienced no material impacts to our liquidity or net", "We face numerous uncertainties in estimating the direct and indirect effects of COVID-19 on our future business operations, financial condition, results of operations, and liquidity.", "Due to several rapidly changing variables related to the COVID-19 pandemic, estimations of future economic trends and the timing of when stability will  return  remains  challenging.  Additionally,  we  periodically  review  our  intangible  and  other  long-lived  assets  for  impairment  when  events  or  changes  in circumstances indicate  the carrying value may not be recoverable.  Key assumptions and estimates  about future values in our impairment assessments can be affected by a variety of factors, including the impacts of the global pandemic on industry and economic trends as well as on our business strategy and internal forecasts.", "We continue to be involved in discussions with the objective of achieving broad resolution of opioid- related claims of states, their political subdivisions and other government entities (\u201cgovernmental entities\u201d).", "We are in ongoing, advanced discussions with state attorneys general and plaintiffs\u2019 representatives regarding a framework under which, in order to resolve the claims of governmental entities, the three largest U.S. pharmaceutical distributors would pay up to approximately $21.0 billion over a period of 18 years, with up to approximately $8.0 billion to be paid by us, of which more than 90% is anticipated to be used to remediate the opioids crisis.", "As a result of that conclusion, and our assessment of certain other opioid- related claims, we recorded a charge of $8.1 billion for the year ended March 31, 2021 within \u201cClaims and litigation charges, net\u201d in our Consolidated Statement of Operations, related to our share of the settlement framework described above, as well as other opioid-related claims.", "Because of the many uncertainties associated with any potential settlement arrangement or other resolution of opioid-related litigation, including the uncertainty of the scope of participation by plaintiffs in any potential settlement, we are not able to reasonably estimate the upper or lower ends of the range of ultimate possible loss for all opioid-related litigation matters.", "We believe that we have valid defenses to the claims pending against us and, absent an acceptable settlement, intend to vigorously defend against all such claims.  An  adverse  judgment  or  negotiated  resolution  in  any  of  these  matters  could  have  a  material  adverse  impact  on  our  financial  position,  cash  flows  or liquidity, or results of operations.", "The law adopting the excise tax made clear that the OSA would apply only to opioid sales on or before December 31, 2018.", "The excise tax applies only to the first sale occurring in New York, and thus may not apply to sales from our distribution centers in New York to New York customers.", "Unless the appellate court\u2019s decision is overturned, the OSA will be reinstated for calendar years 2017 and 2018 (but not beyond those years), and, subject to any further legal challenge, we will have to pay our ratable share of the annual surcharge for those two years.", "During the second quarter of 2021, we reflected an estimated liability of $50 million for the OSA surcharge in our accompanying consolidated financial statements on the assumption that the appellate court\u2019s decision will stand.", "The higher LIFO credits in 2020 compared to 2019 is primarily driven by higher generic deflation.", "\u2022 Claims and litigation charges, net: These charges include adjustments for estimated probable settlements related to our controlled substance monitoring and reporting, and opioid-related claims, as well as any applicable income items or credit adjustments due to subsequent changes in estimates.", "We have reclassified prior period amounts to conform to the current period presentation.", "\u2022 Goodwill impairments charges: We perform an impairment test on goodwill balances annually in the third quarter and more frequently if indicators for potential impairment exist.", "The resulting goodwill impairment charges are reflected within this line item. \u2022 Restructuring, impairment, and related charges: Restructuring charges that are incurred for programs in which we change our operations, the scope of a business undertaken by our business units, or the manner in which that business is conducted as well as long-lived asset impairments.", "\u2022 SDG&A reflects charges of $58 million to remeasure assets and liabilities held for sale to fair value less costs to sell related to the completed contribution of the majority of our German pharmaceutical wholesale business to create a joint venture with WBA in which we have a 30% ownership interest within our International segment.", "As a result, we were required to perform a goodwill impairment test for these reporting units and recorded a goodwill impairment charge in our European RP reporting unit of $69 million during the second quarter of 2021.", "As of the testing date, other risks, expenses, and future developments, such as additional government actions, increased regulatory uncertainty, and material changes in key market assumptions limit our ability to estimate projected cash flows, which could adversely affect the fair value of various reporting units in future periods, including our McKesson Canada reporting unit within our International segment and our RxCrossroads reporting unit within our RxTS segment, where the risk of a material goodwill impairment is higher than other reporting units.", "\u2022 Restructuring, impairment, and related charges, net includes long-lived asset impairment charges of $112 million, primarily for our United Kingdom (\u201cU.K.\u201d)  business  (mainly  pharmacy  licenses)  and  Rexall  Health  retail  business  (\u201cRexall  Health\u201d)  (mainly  customer  relationships)  within  our International segment, and the remaining $156 million primarily represents employee severance and exit-related costs related to our 2019 restructuring initiatives, as further discussed below; and", "\u2022 Total operating expenses includes higher SDG&A due to our business acquisitions and to support business growth, as well as our technology initiatives, partially offset by favorable effects of foreign currency exchange fluctuations.", "\u2022 SDG&A includes opioid-related costs of $114 million, primarily related to litigation expenses, and increased expenses due to our business acquisitions and to support growth, partially offset by a gain from an escrow settlement of $97 million representing certain indemnity and other claims related to our 2017 acquisition of Rexall Health and a credit of $90 million for the derecognition of a liability related to the tax receivable agreement (\u201cTRA\u201d) payable to the shareholders of Change Healthcare, Inc. (\u201cChange\u201d);", "\u2022 Restructuring,  impairment,  and  related  charges,  net  primarily  includes  employee  severance  and  exit-related  costs  of  $352  million  for  our  2019 restructuring initiatives, as further discussed below and long-lived asset impairment charges of $245 million primarily for our U.K. business (mainly pharmacy licenses) within our International segment driven by additional government reimbursement reductions and competitive pressures in the U.K.", "We evaluate goodwill for impairment on an annual basis as of October 1, and at an interim date, if indicators of potential impairment exist.", "This change was not material to our consolidated financial statements as it did not delay, accelerate, or avoid any potential goodwill impairment charge.", "We expect to incur total charges of approximately $180 million to $280 million for this initiative, consisting primarily of exit related costs, accelerated depreciation and amortization of long-lived assets, and asset impairments.", "We expect to incur total charges of approximately $85 million to $90 million, of which $57 million of charges were recorded to date.", "This initiative was substantially complete in 2021 and remaining costs we expect to record under this initiative are not material.", "The relocation was substantially complete in January 2021 and remaining costs we expect to record under this initiative, primarily relating to lease costs, are not material.", "This primarily reflects mark-to-market gains on our investments in certain U.S. growth stage companies in the healthcare industry and realized gains on the exit of some of these investments as further described in Financial Note 17, \u201cFair Value Measurements,\u201d to the accompanying consolidated financial statements  included  in  this  Annual  Report  on  Form  10-K.  In  future  periods,  fair  value  adjustments  recognized  in  our  operating  results  for  these  types  of investments may be adversely impacted by market volatility.", "Other income, net also increased year over year due to pension settlement charges of $122 million recognized in 2020 related to our previously approved termination of the frozen U.S. defined benefit pension plan.", "In connection with the pension plan termination, we purchased annuity contracts from an insurer that will pay and administer the future pension benefits of the remaining participants.", "Excluding the impairment and transaction-related items described below, our proportionate share of loss from our investment in Change Healthcare JV for the years ended March 31, 2020 and 2019 was $119 million and $194 million, respectively, which primarily includes transaction and integration expenses incurred by the joint venture and basis differences between the joint venture and McKesson including amortization of fair value adjustments.", "During the first quarter of 2020 and for the year ended March 31, 2019, we owned approximately 70% of this joint venture.", "The proceeds from the concurrent offering of other securities were also used by Change  to  acquire  certain  securities  of  Change  Healthcare  JV.  As  a  result,  McKesson\u2019s  equity  interest  in  Change  Healthcare  JV  was  reduced  from  70%  to approximately 58.5%, which was used to recognize our proportionate share in net loss from Change Healthcare JV, commencing in the second quarter of 2020.", "As a result of the ownership dilution to 58.5% from 70%, we recognized a dilution loss of approximately $246 million in the second quarter of 2020.", "Additionally, our proportionate share of income or loss from this investment was subsequently reduced as immaterial settlements of stock option exercises occurred after the IPO and further diluted our ownership.", "Equity Earnings and Charges from Investment in Change Healthcare Joint Venture Until the separation of our investment in Change Healthcare JV on March 10, 2020, we accounted for this investment using the equity method of accounting.", "In the second quarter of 2020, we recorded an other-than-temporary-impairment (\u201cOTTI\u201d) charge of $1.2 billion to our investment in Change Healthcare JV,", "Following the Split-off, we do not beneficially own any of Change\u2019s outstanding securities.", "In connection with this transaction, we recognized a net gain for financial reporting purposes of $414 million during the fourth quarter of 2020, which was largely driven by the reversal of a related deferred tax liability.", "The receipt of any payments under the TRA is dependent upon Change benefiting from this depreciation or amortization in future tax return filings, which creates uncertainty over the amount, timing and probability of the gain recognized.", "As such, we accounted for the TRA as a gain contingency, with no receivable recognized as of March 31, 2021 nor 2020.", "Interest expense decreased in 2020 compared to the prior year primarily due to a decrease in the issuance of commercial paper, partially offset by a decrease in interest income from our derivative contracts.", "Our reported income tax (benefit) expense rates were (13.8%), 1.6%, and 58.4% in 2021, 2020, and 2019, respectively.", "after-tax), which was intended to generally be a tax-free split-off for U.S. federal income tax purposes, and unfavorably impacted by charges of $275 million (pre- tax and after-tax) to remeasure assets and liabilities held for sale to fair value less costs to sell related to the completed contribution of the majority of our German pharmaceutical wholesale business to create a joint venture with WBA.", "goodwill of our European RP and European PD reporting units within the International segment, given that these charges are generally not deductible for tax purposes.", "Our income tax expense, deferred tax assets and liabilities, and uncertain tax liabilities reflect management\u2019s best assessment of estimated current and future taxes to be paid.", "We believe that we have made adequate provision for all income tax uncertainties.", "In connection with the exchange offer, on March 9, 2020, we distributed all 176.0 million outstanding shares of common stock of SpinCo to participating", "Income Tax (Benefit) Expense We recorded income tax (benefit) expense of ($695 million), $18 million, and $356 million for the years ended March 31, 2021, 2020, and 2019, respectively.", "Our reported income tax expense rate for 2019 was unfavorably impacted by charges of $1.8 billion (pre-tax and after-tax) to impair the carrying value of", "Significant judgments and estimates are required in determining the consolidated income tax provision and evaluating income tax uncertainties.", "Noncontrolling interests with redemption  features, such as put rights, that are not solely within our control are considered redeemable  noncontrolling  interests.  Redeemable  noncontrolling interests are presented outside of McKesson Corporation stockholders\u2019 equity (deficit) on our consolidated balance sheet.", "Diluted earnings (loss) per common share attributable to McKesson Corporation was $(28.26), $4.95, and $0.17 for the years ended March 31, 2021,  2020,  and  2019,  respectively.  Net  loss  per  diluted  share  for  the  year  ended  March  31,  2021  is  calculated  by  excluding  dilutive  securities  from  the denominator  due to their antidilutive  effects.  Additionally,  our 2021, 2020, and 2019 diluted  earnings (loss) per share  reflect  the cumulative  effects  of share repurchases.", "Weighted-average diluted common shares outstanding is impacted by the exercise and settlement of share-based awards and the cumulative effect of share repurchases, including the impact of shares exchanged as part of the split-off from our investment in Change Healthcare JV, as discussed above.", "(1) Segment operating profit (loss) includes gross profit, net of operating expenses, as well as other income (expense), net, for our reportable segments.", "For retrospective periods presented, operating loss for Other reflects equity earnings and charges from our equity method investment in Change Healthcare JV, which we split-off in the fourth quarter of 2020.", "Pharmaceutical segment includes a charge of $50 million for the year ended March 31, 2021 related to our estimated liability under the OSA.", "(3) Operating loss for our International segment for the years ended March 31, 2021 and 2020 includes charges of $58 million and $275 million, respectively, to remeasure to fair value the assets and liabilities of our German pharmaceutical wholesale business which was contributed to a joint venture with WBA.", "This segment\u2019s operating loss for the years ended March 31, 2021 and 2019 includes goodwill impairment charges of $69 million and $1.8 billion, respectively, as well as long-lived asset impairment charges for the  years ended March 31, 2021,  2020, and 2019  of $115  million,  $112  million,  and $245  million,  respectively, primarily  related to  our retail  pharmacy businesses in Canada and Europe.", "(4) Operating profit for our Medical-Surgical Solutions segment for the year ended March 31, 2021 includes charges totaling $136 million on certain PPE and other related products due to inventory impairments and excess inventory.", "(5) Operating profit for our RxTS segment for the year ended March 31, 2019 includes a gain of $56 million from the divestiture of an equity investment.", "(6) Operating loss for Other for the year ended March 31, 2020 includes an OTTI charge of $1.2 billion and a dilution loss of $246 million related to our investment in Change Healthcare JV, partially offset by a net gain of $414 million related to the completed separation of our interest in Change Healthcare JV during the fourth quarter of 2020.", "(7) Corporate expenses, net for the year ended March 31, 2021 includes a charge of $8.1 billion related to our estimated liability for opioid-related claims, net gains of $133 million  from  our  equity  investments,  and a net  gain  of $131  million  recorded  in  connection  with  insurance  proceeds  received  from  the  settlement  of  the  shareholder derivative action related to our controlled substances monitoring program.", "This was partially offset by a decrease in LIFO credits of $214 million, a charge of $50 million recorded in 2021 related to our estimated liability under the OSA, net impacts from COVID-19, including a less severe cough, cold, and flu season, as well as increased costs for strategic growth initiatives.", "Operating profit and operating profit margin were unfavorably impacted by customer mix and a decrease in net cash proceeds received of $180 million representing our share of antitrust legal settlements.", "recorded to remeasure to fair value the assets and liabilities of our German pharmaceutical wholesale business which was contributed to a joint venture with WBA, of  which  $58  million  and  $275  million  was  reflected  for  the  years  ended  March  31,  2021  and  2020,  respectively.  This  was  partially  offset  by  a  goodwill impairment charge of $69 million recorded in the second quarter of 2021 related to our European retail pharmacy business.", "This was partially offset  by  the  fair  value  remeasurement  charges  in  2020  described  above  and  a  gain  from  an  escrow  settlement  of  $97  million  in  2019  related  to  our  2017 acquisition of Rexall Health.", "Additionally,  operating  profit  was favorable  year over year  due to lower  operating  expenses, including a decrease in our provision for bad debts.", "primary care business and lower restructuring charges, partially offset by the remeasurement of assets and liabilities to fair value related to a divestiture that was completed in 2020 and higher operating expenses, including an increase in our provision for bad debts.", "and existing customers, integration costs incurred in 2019 for our acquisition of RxCrossroads that closed during the fourth quarter of 2018, partially offset by a gain of $56 million from the divestiture of an equity investment in 2019.", "investment in Change Healthcare JV, partially offset by a net gain of $414 million related to the completed separation of our interest in Change Healthcare JV during the fourth quarter of 2020.", "Operating loss for Other also includes our proportionate share of loss from Change Healthcare JV of $119 million and $194 million for the years ended March 31, 2020 and 2019, respectively.", "connection with insurance proceeds received from the settlement of the shareholder derivative action related to our controlled substances monitoring program.", "Corporate expenses, net, for 2020 includes pension settlement charges of $122 million, an opioid claim settlement charge of $82 million, and net settlement gains of $26 million recognized from our derivative contracts.", "claim settlement charge mentioned above, as well as higher costs for technology initiatives, partially offset by net settlement gains recognized in 2020 from our derivative contracts.", "Other Operating  loss  for  Other  for  the  year  ended  March  31,  2020  includes  an  OTTI charge  of  $1.2  billion  and  a  dilution  loss  of  $246  million  related  to  our", "Corporate 2021 vs. 2020 Corporate expenses, net increased for the year ended March 31, 2021 compared to the prior year due to a charge of $8.1 billion related to our estimated", "We conduct our business worldwide in local currencies including Euro, British pound sterling, and Canadian dollar.", "As a result, the comparability of our results reported in U.S. dollars can be affected by changes in foreign currency exchange rates.", "In discussing our operating results, we may use the term \u201cforeign currency exchange fluctuations,\u201d which refers to the effect of changes in foreign currency exchange rates used to convert the local currency results of our operations in foreign countries where the functional currency is not the U.S. dollar.", "We present this information to provide a framework for assessing how our business performed excluding the effect of foreign currency exchange rate fluctuations.", "In computing the foreign currency exchange fluctuations, we translate our current year results of our operations in foreign countries recorded in local currencies into U.S dollars by applying their respective average foreign currency exchange rates of the corresponding prior year periods, and we subsequently compare those results to the previously reported results of the comparable prior year periods reported in U.S. dollars.", "estimate was made and if different estimates that we reasonably could have used in the current period, or changes in the accounting estimate that are reasonably likely to occur from period to period, could have a material impact on our financial condition or results from operations.", "Below are the estimates that we believe are  critical  to  the  understanding  of  our  operating  results  and  financial  condition.  Other  accounting  policies  are  described  in  Financial  Note  1,  \u201cSignificant Accounting  Policies,\u201d  to  the  consolidated  financial  statements  appearing  in  this  Annual  Report  on  Form  10-K.  Because  of  the  uncertainty  inherent  in  such estimates, actual results may differ from these estimates.", "Other customer financing primarily relates to guarantees provided to our customers, or their creditors, regarding the repurchase of inventories.", "We also provide financing to certain customers related to the purchase of pharmacies, which serve as collateral for the loans.", "We estimate the receivables for which we do not  expect  full  collection  based  on  historical  collection  rates  and  specific  knowledge  regarding  the  current  creditworthiness  of  our  customers  and  record  an allowance in our consolidated financial statements for these amounts.", "Management reviews these factors quarterly to determine if any adjustments are needed to the allowance.", "Sales to our largest customer, CVS Health Corporation (\u201cCVS\u201d), accounted for approximately 21% of our total consolidated revenues in 2021 and comprised approximately 19% of total trade accounts receivable at March 31, 2021.", "As a result, our sales and credit concentration is significant.", "The accounts receivables balances are with individual members of the GPOs, and therefore no significant concentration of credit risk exists.", "A material default in payment, a material reduction in purchases from these or any other large customers, or the loss of a large customer or GPO could have a material adverse impact on our financial position, results of operations, and liquidity.", "We believe the reserves maintained and expenses recorded in 2021 are appropriate and consistent in the context of historical methodologies employed, as well as assessment of trends currently available.", "The selected 0.1% hypothetical change does not reflect what could be considered the best or worst-case scenarios.", "Our LIFO valuation amount includes both pharmaceutical and non-pharmaceutical products.", "We recognized LIFO credits of $38 million, $252 million, and $210 million, respectively, in 2021, 2020, and 2019 in our Consolidated Statements of Operations.", "A LIFO charge is recognized when the net effect of price increases on pharmaceutical and non-pharmaceutical products held in inventory exceeds the impact of price declines, including the effect  of branded pharmaceutical  products  that have lost market  exclusivity.  A LIFO credit  is recognized  when the net effect  of price  declines exceeds the impact of price increases on pharmaceutical and non-pharmaceutical products held in inventory.", "Excluding LIFO reserves, our inventory reserves as of March 31, 2021 and 2020 were $263 million and $96 million, respectively.", "The increase was primarily due to 2021 charges totaling $136 million on certain PPE and other related products due to inventory impairments and excess inventory within our Medical-Surgical Solutions segment.", "In 2021, 2020 and, 2019, our provision for bad debts", "At March 31, 2021 and 2020, total inventories, net were $19.2 billion and $16.7 billion, respectively, in our Consolidated Balance Sheets.", "Any purchase consideration in excess of the estimated fair values of the net assets acquired is recorded as goodwill.", "that is a form or variation of the income approach, whereby a forecast of future cash flows attributable to the asset are discounted to present value using a risk- adjusted discount rate.", "We perform an impairment test on goodwill balances annually in the third quarter and more frequently if indicators for potential impairment exist.", "equal to the amount of excess carrying value above the estimated fair value, if any, but not to exceed the amount of goodwill allocated to the reporting unit.", "we estimate fair value by comparing the business to similar businesses, or guideline companies whose securities are actively traded in public markets.", "Under the income approach, we use a discounted cash flow (\u201cDCF\u201d) model in which cash flows anticipated over several periods, plus a terminal value at the end of that time horizon, are discounted to their present value using an appropriate rate that is commensurate with the risk inherent within the reporting unit.", "Goodwill  and  Long-Lived  Assets: As  a  result  of  acquiring  businesses,  we  have  $9.5  billion  and  $9.4  billion  of  goodwill  at  March  31,  2021  and  2020,", "To estimate the fair value of our reporting units, we generally use a combination of the market approach and the income approach.", "Judgments made in determining an estimate of fair value may materially impact our results of operations.", "Included in the estimate of the weighted-average cost of capital is the assumption of an unsystematic risk premium to address incremental uncertainty related to the reporting units\u2019 future cash flow projections.", "An increase in the unsystematic risk premium increases the discount rate.", "Pharmaceutical  Distribution  reporting  units  in  our  International  segment,  exceeded  their  carrying  values.  The  impairment  testing  performed  in  2020  did  not indicate  any  material  impairment  of  goodwill.  The  segment  change  in  the  second  quarter  of  2021  prompted  changes  in  multiple  reporting  units  across  the Company.", "We recorded a goodwill impairment charge of $69 million in 2021 as the estimated fair value of the Europe Retail Pharmacy reporting unit was lower than its reassigned carrying value based on changes in the composition of the Europe Retail Pharmacy reporting unit within the International segment.", "At March 31, 2021, the  balance  of goodwill for the  reporting  units  in Europe  was approximately  nil  and the  remaining  balance  of goodwill  in the International segment primarily relates to one of our reporting units in Canada.", "Other risks, expenses and future developments, such as additional government actions, increased regulatory uncertainty, and material changes in key market assumptions that we were unable to anticipate as of the testing date may require us to further revise the projected cash flows, which could adversely affect the fair value of our other reporting units in future periods.", "We review intangible assets for impairment at an asset group level whenever events or changes in circumstances indicate that the carrying value of the assets may not be recoverable.", "Determination of recoverability of intangible assets is based on the lowest level of identifiable estimated future undiscounted cash flows resulting from use of the asset and its eventual disposition.", "Measurement of any impairment loss is based on the excess of the carrying value of the asset group over its fair value.", "Assumptions and estimates about future values and remaining useful lives of our purchased intangible assets are complex and subjective.", "When the decline in value is deemed to be other than temporary, an impairment is recognized to the extent that the fair value is less than the carrying value of the investment.", "We consider various factors in determining whether a loss in value of an investment is other than temporary including: the length of time and the extent to which the fair value has been below cost, the financial condition of the investees, and our intent and ability to retain the investment for a period of time sufficient to allow for recovery of value.", "Any significant changes in assumptions or judgments in assessing impairments could result in an impairment charge.", "We generally recognize employee severance costs when payments are probable and amounts are estimable.  Costs related  to contracts without future benefit or contract termination  are recognized  at the earlier of the contract termination  or  the  cease-use  dates.  Other  exit-related  costs  are  recognized  as  incurred.  In  connection  with  these  restructuring  actions,  we  also  assess  the recoverability of long-lived assets used in the business, and as a result, we may recognize accelerated depreciation and amortization reflecting shortened useful lives of the underlying assets.", "paid.  We  are  subject  to  income  taxes  in  the  U.S.  and  numerous  foreign  jurisdictions.  Significant  judgments  and  estimates  are  required  in  determining  the consolidated income tax provision and in evaluating income tax uncertainties and include those used to conclude on the tax-free nature of the separation of the Change Healthcare JV and the unrecognized tax position related to opioid-related litigation and claims, which remains unfinalized, and which may differ from the actual amounts of tax benefit recognized.", "We review our tax positions at the end of each quarter and adjust the balances as new information becomes available.", "to recover our deferred tax assets, we consider all available positive and negative evidence including our past operating results, the existence of cumulative net operating losses in the most recent years, and our forecast of future taxable income.", "In estimating future taxable income, we develop assumptions including the amount of future federal, state and foreign pre-tax operating income, the reversal of temporary differences, and the implementation of feasible and prudent tax planning strategies.", "These assumptions require significant judgment about the forecasts of future taxable income and are consistent with the plans and estimates we use to manage the underlying businesses.", "additional taxes and related interest will be due.", "If our current estimate of tax and interest liabilities is less than the ultimate settlement, an additional charge to income tax expense may result.", "If our current estimate of tax and interest liabilities is more than the ultimate settlement, a reduction to income tax expense may be recognized.", "investigations  relating  to  laws  and  regulations  and  other  matters  arising  out  of  the  normal  conduct  of  our  business.  When  a  loss  is  considered  probable  and reasonably estimable, we record a liability in the amount of our best estimate for the ultimate loss.", "When a material loss is reasonably possible or probable but a reasonable estimate cannot be made, disclosure of the proceeding is provided.", "Deferred income taxes arise from temporary differences between the tax and financial statement recognition of revenue and expense.", "Changes in tax laws and rates could also affect recorded deferred tax assets and liabilities in the future.", "We recognize liabilities for tax and related interest for issues in the U.S. and other tax jurisdictions based on our estimate of whether, and the extent to which,", "As discussed above, development of a meaningful estimate of loss or a range of potential loss is complex when the outcome is directly dependent on future negotiations with or decisions by third parties, such as regulatory agencies, the court system and other interested parties.", "As a result of ongoing, advanced discussions with state attorneys general and plaintiffs\u2019 representatives regarding a framework to resolve the claims of governmental  entities,  and  our  assessment  of  certain  other  opioid-related  claims,  we  have  reached  a  stage  at  which  a  broad  settlement  of  opioid  claims  by governmental entities is probable and recorded a charge of $8.1 billion for the year ended March 31, 2021 within \u201cClaims and litigation charges, net\u201d in our Consolidated Statement of Operations in this report.", "Because of the many uncertainties associated with any potential settlement arrangement or other resolution of opioid-related litigation, including the uncertainty of the scope of participation by plaintiffs in any potential settlement, we are not able to reasonably estimate the upper or lower ends of the range of ultimate possible loss for all opioid-related litigation matters.", "While we are not able to predict the outcome or reasonably estimate a range of possible losses in these matters, an adverse judgment or negotiated resolution in any of these matters could have a material adverse effect on our results of operations, consolidated financial position, cash flows or liquidity.", "facilities and commercial paper program, will be sufficient to fund our short-term and long-term capital expenditures, working capital, and other cash requirements.", "We continue to monitor its impact on demand within parts of our business, as well as trends potentially impacting the timing or ability for some of our customers to pay amounts owed to us.", "We remain well-capitalized with access to liquidity from our $4.0 billion revolving credit facility.", "Additionally, long-term debt markets and commercial paper markets, our primary sources of capital after cash flow from operations, have remained open and accessible to us during the COVID-19 pandemic.", "We have seen continued improvement in conditions in the debt markets and commercial paper markets as the Federal Reserve has taken steps to stabilize the markets.", "At March 31, 2021, we were in compliance with all debt covenants, and believe we have the ability to continue to meet our debt covenants in the future.", "Cash flows from operations can be significantly impacted by factors such as the timing of receipts from customers and payments to vendors.", "Operating activities for the year ended March 31, 2021 were affected by net income adjusted for non-cash items, including the pre-tax $8.1 billion (after-tax $6.8 billion) non-cash charge related to our estimated liability for opioid-related claims, an increase in inventory of $2.3 billion and an increase in drafts and accounts payable of $1.3 billion driven by higher inventory stock levels to meet increased volume demand as part of our inventory management, as well as a decrease in receivables of $1.1 billion driven by timing, higher sales recognized at the end of March 2020, and higher collections in our fourth quarter of 2021.", "value remeasurement charges of $58 million related to the contribution of our German pharmaceutical wholesale business to a joint venture with WBA.", "Additionally, we made a cash payment of $114 million from the executive benefit retirement plan in 2020.", "Investing activities for the year ended March 31, 2021 also includes net cash proceeds of $400 million from sales of businesses and investments, including $286 million in exchange for the contribution of our German pharmaceutical wholesale business to a joint venture with WBA.", "Cash used for other financing activities generally includes payments to noncontrolling interests and activity from our finance leases.", "We received cash from long-term debt issuances of $1.1 billion and made repayments on long-term debt of $1.1 billion in 2019.", "The timing of any repurchases and the actual number of shares repurchased will depend on a variety of factors, including our stock price, corporate and regulatory requirements, restrictions under our debt obligations, and other market and economic conditions.", "In accordance with our accounting policy, we allocate any excess of share repurchase price over par value between additional paid-in capital and retained earnings.", "Accordingly, our retained earnings and additional paid-in capital were reduced by $472 million and $70 million during 2019, respectively.", "outstanding shares of SpinCo common stock, which held all of the Company\u2019s interests in the Change Healthcare JV, to participating holders of the Company\u2019s common  stock  in  exchange  for  15.4  million  shares  of  McKesson  stock,  which  are  now  held  as  treasury  stock  on  our  consolidated  balance  sheet.  Following consummation of the exchange offer, on March 10, 2020, SpinCo merged with and into Change and each share of SpinCo common stock was converted into one share of Change common stock, par value $0.001 per share, with cash being paid in lieu of fractional shares of Change common stock.", "give us the ability to meet our financing needs for the foreseeable future.", "However, there can be no assurance that an increase in volatility or disruption in the global capital and credit markets will not impair our liquidity or increase our costs of borrowing.", "As described within the \u201cTrends and Uncertainties\u201d section above,  the  COVID-19  pandemic  continues  to  develop  rapidly.  We  continue  to  monitor  its  impact  on  demand  within  parts  of  our  business,  as  well  as  trends potentially impacting the timing or ability for some of our customers to pay amounts owed to us.", "(2) This ratio describes the relationship and changes within our capital resources, and is computed as total debt divided by the sum of total debt and McKesson stockholders\u2019 equity (deficit), which excludes noncontrolling and redeemable noncontrolling interests and accumulated other comprehensive loss. (3) Ratio is computed as net income (loss) attributable to McKesson Corporation for the last four quarters, divided by a five-quarter average of McKesson stockholders\u2019 equity (deficit), which excludes noncontrolling and redeemable noncontrolling interests.", "In 2019, we retired 5.0 million or $542 million of the Company\u2019s treasury shares previously repurchased.", "In connection with the Split-off, we distributed all 176.0 million", "Deposits with financial institutions are primarily denominated in U.S. dollars and the functional currencies of our foreign subsidiaries, including Euro, British pound sterling, and Canadian dollars.", "We mitigate the risk of our short-term investment portfolio by depositing funds with reputable financial institutions and monitoring risk profiles and investment strategies of money market funds. outside of the U.S., respectively.", "Our primary intent is to utilize this cash for foreign operations for an indefinite period of time.", "Although the vast majority of cash held outside the U.S. is available for repatriation, doing so could subject us to foreign withholding taxes and state income taxes.", "The COVID-19 pandemic has potential to increase the variations in our working capital, which we continue to monitor closely. partially offset by an increase in drafts and accounts payable and a decrease in receivables.", "Our unfavorable return on McKesson\u2019s stockholder\u2019s equity (deficit) as of March 31, 2021 was also driven by net loss for the year.", "Net loss for the year ended March 31, 2021 includes an after-tax non-cash charge of $6.8 billion related to our estimated liability for opioid-related claims, as discussed in \u201cTrends  and  Uncertainties\u201d of  this  Financial  Review  and  Financial  Note  19,  \u201cCommitments  and  Contingent  Liabilities,\u201d  to  the  accompanying  consolidated financial statements included in this Annual Report on Form 10\u2011K.", "Our debt to capital ratio increased for 2020 primarily due to a decrease in stockholders\u2019 equity driven by the Split-off of our interest in Change Healthcare JV and share repurchases.", "We anticipate that we will continue to pay quarterly cash dividends in the future.", "However, the payment and amount of future dividends remain within the discretion of the Board and will depend upon our future earnings, financial condition,  capital  requirements,  and  other  factors.  In  2021,  2020,  and  2019,  we  paid  total  cash  dividends  of  $276  million,  $294  million,  and  $292  million, respectively.  Additionally,  as  required  under  the  Domination  Agreement,  we  are  obligated  to  pay  an  annual  recurring  compensation  amount  of  \u20ac0.83  per McKesson Europe share (effective January 1, 2015) to the noncontrolling shareholders of McKesson Europe.", "Cash equivalents, which are readily convertible to known amounts of cash, are carried at fair value.", "Our cash and cash equivalents balance as of March 31, 2021 and 2020 included approximately $2.3 billion and $1.7 billion of cash held by our subsidiaries", "On  July  29,  2020,  we  raised  our  quarterly  dividend  from  $0.41  to  $0.42  per  common  share  for  dividends  declared  on  or  after  such  date  by  the  Board.", "(3) Includes our estimated benefit payments for the unfunded benefit plans and minimum funding requirements for the pension plans. (4) Primarily represents interest that will become due on our fixed rate long-term debt obligations.", "These obligations primarily relate to inventory purchases and capital commitments. (6) Includes agreements under which we have guaranteed the repurchase of our customers\u2019 inventory and our customers\u2019 debt in the event these customers are unable to meet their obligations to those financial institutions.", "The ultimate amount and timing of any future cash settlements related to these items cannot be predicted with reasonable certainty.", "and are mostly related to our customer contracts and to meet the security requirements for statutory licenses and permits, court and fiduciary obligations, and our workers\u2019 compensation and automotive liability programs.", "The exercise of the Put Right will reduce the balance of redeemable noncontrolling interests.", "During 2021, we paid $49 million to purchase 1.8 million shares of McKesson Europe through exercises of the Put Right by the noncontrolling shareholders.", "Our banks and insurance companies have issued $146 million of standby letters of credit and surety bonds at March 31, 2021.", "redemption value is the Put Amount adjusted for exchange rate fluctuations each period.", "In future periods, unfavorable foreign currency exchange rate fluctuations between the Euro and the U.S. dollar could adversely impact the carrying value of our redeemable noncontrolling interests and require an adjustment to increase the balance of our redeemable noncontrolling interests to its maximum redemption value.", "On April 12, 2021, we received the Stuttgart Court of Appeals\u2019 final ruling confirming the original put value of \u20ac22.99 per share and the annual recurring compensation of \u20ac0.83 per McKesson Europe share.", "Funds necessary for future debt maturities and our other cash requirements are expected to be met by existing cash balances, cash flow from operations, existing credit sources, and other capital market transactions.", "The effect of a hypothetical 50 bp increase in the underlying interest rate on our cash and cash equivalents, net of short-term borrowings and variable rate debt, would have resulted in a favorable impact to earnings in 2021 and 2020 of approximately $17 million and $6 million, respectively.", "The balance of redeemable noncontrolling interests is reported at the greater of its carrying value or its maximum redemption value at each reporting date.", "Additionally,  we  are  obligated  to  pay  an  annual  recurring  compensation  of  \u20ac0.83  per  McKesson  Europe  share  (the  \u201cCompensation  Amount\u201d)  to  the", "Interest rate risk: Our long-term debt bears interest predominately at fixed rates, whereas our short-term borrowings are at variable interest rates.", "Our cash and cash equivalents balances earn interest at variable rates.", "At March 31, 2021 and 2020, we had $6.3 billion and $4.0 billion, respectively, in cash", "Changes in foreign currency exchange rates could have a material adverse impact on our financial results that are reported in U.S. dollars.", "We are also exposed to foreign exchange rate risk related to our foreign subsidiaries, including intercompany loans denominated in non-functional currencies.", "These programs reduce but do not entirely eliminate foreign exchange risk.", "fair value of our foreign exchange contracts by approximately $267 million and $435 million, respectively.", "Foreign exchange risk: We conduct our business worldwide in U.S. dollars and the functional currencies of our foreign subsidiaries, including Euro, British", "We have certain foreign exchange rate risk programs that use foreign currency forward contracts and cross-currency swaps.", "Based on this assessment, our management has concluded that our internal control over financial reporting was effective as of March 31, 2021.", "In our opinion, the financial statements referred to above present fairly, in all material respects, the financial position of the Company as of March 31, 2021 and 2020, and the results of its operations and its cash flows for each of the three years in the period ended March 31, 2021, in conformity with accounting principles generally accepted in the United States of America.", "Also, in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of March 31, 2021, based on criteria established in Internal Control \u2014 Integrated Framework (2013) issued by COSO.", "Our responsibility is to express an opinion on these financial statements and an opinion on the Company\u2019s internal control over financial reporting based  on  our  audits.  We  are  a  public  accounting  firm  registered  with  the  Public  Company  Accounting  Oversight  Board  (United  States)  (\u201cPCAOB\u201d)  and  are required  to  be  independent  with  respect  to  the  Company  in  accordance  with  the  U.S.  federal  securities  laws  and  the  applicable  rules  and  regulations  of  the Securities and Exchange Commission and the PCAOB.", "We conducted our audits in accordance with the standards of the PCAOB.", "Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.", "Our audits of the financial statements included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures to respond to those risks.", "Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements.", "Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk.", "Our audits also included performing such other procedures as we considered necessary in the circumstances.", "We believe that our audits provide a reasonable basis for our opinions.", "The critical audit matters communicated below are matters arising from the current-period audit of the financial statements that were communicated or required to be communicated to the audit committee and that (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments.", "The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.", "The Company also performs an assessment of loss contingencies where a loss is reasonably possible.", "We identified the potential broad settlement of opioid claims as a critical audit matter because of the significant judgment and challenges auditing management\u2019s determination  of  whether  such  loss  is  probable  and  reasonably  estimable.  Specifically,  auditing  management\u2019s  determination  and  disclosure  of  whether  the contingent loss arising from the potential broad settlement of opioid claims is probable, and the related measurement of such loss, is subjective and requires significant judgment given that the potential loss is based upon settlement terms that have not yet been finalized.", "\u2022 We tested the effectiveness of internal controls related to the potential broad settlement of opioid claims, and approval of the accounting treatment and related disclosures based on the most recent facts and circumstances.", "In addition, we inspected responses to inquiry letters sent to both internal and external legal counsel as it relates to the status of discussions with plaintiffs\u2019 counsel and the Company\u2019s intent regarding the framework for a potential broad settlement of opioid claims.", "\u2022 We evaluated management\u2019s analysis of the potential broad settlement of opioid claims, including the methodology used by management to determine the probability of such loss.", "We also evaluated the methodology used by management to estimate the most likely loss to be incurred by the Company as a result of a potential broad settlement of opioid claims.", "\u2022 We performed public domain searches for evidence contrary to management\u2019s analysis.", "\u2022 We evaluated any events subsequent to March 31, 2021 that might impact our evaluation of the potential broad settlement of opioid claims. \u2022 We obtained written representations from executives and internal counsel of the Company. \u2022 We examined proposed terms related to the potential broad settlement framework. \u2022 We evaluated the Company\u2019s related disclosures for consistency with our testing.", "The net amount recognized by management is measured as the largest amount of tax benefit that is greater than 50 percent likely of being realized.", "We identified the Company\u2019s uncertain tax position related to the charge for the potential broad settlement of opioid claims as a critical audit matter because of the challenges in auditing management\u2019s estimate of the amount of income tax benefit that qualifies for recognition.", "Our audit procedures related to the Company's uncertain tax position associated with a potential broad settlement of opioid claims included the following, among others: \u2022 We tested the effectiveness of internal controls related to the Company\u2019s assessment of the technical merits of its tax position, including the Company\u2019s assessment as to the amount of benefit that is more likely than not to be realized. \u2022 With  the  assistance  of  our  tax  specialists,  we  evaluated  the  facts,  evidence  and  the  Company\u2019s  related  income  tax  analysis  for  the  charge  related  to  the potential broad settlement of opioid claims, including assumptions used by management to measure the related recognized and unrecognized tax benefits. \u2022 We inquired of the Company\u2019s internal and external legal counsel to understand the basis for the Company\u2019s conclusion that a portion of the potential broad settlement of opioid claims would be deductible based on the most recent discussions with plaintiffs\u2019 counsel.", "\u2022 We  compared  management's  income  tax  assessment  of  this  matter  to  the  treatment  of  other  recorded  opioid  charges  to  evaluate  the  consistency  of  the Company\u2019s judgments related to the uncertain tax position. \u2022 We evaluated any events subsequent to March 31, 2021 that might impact our evaluation of the Company\u2019s uncertain tax position related to the charge for the potential broad settlement of opioid claims.", "\u2022 We obtained written representations from executives and internal counsel of the Company. \u2022 We examined proposed terms related to the potential broad settlement framework.", "\u2022 We evaluated the Company\u2019s related disclosures for consistency with our testing and also searched for contradictory evidence by reading disclosures from peer companies, who are also party to the potential broad settlement of opioid claims.", "We identified the estimation of the fair value of the McKesson Canada reporting unit used to evaluate the recoverability of goodwill as a critical audit matter because of the challenges auditing significant judgments used in the selection of a discount rate, including the unsystematic risk premium.", "In particular, the fair value estimate is sensitive to the unsystematic risk premium assumption, which is affected by expected risk of changes in the Canadian business and regulatory environments.", "Auditing management\u2019s selected discount rate required a high degree of auditor judgment and an increased extent of effort, including the need to involve more senior members of the team and our fair value specialists.", "Our audit procedures related to the Company\u2019s selection of a discount rate, including consideration of the unsystematic risk premium, for the McKesson Canada reporting unit included the following, among others: \u2022 We tested the effectiveness of internal controls related to management\u2019s goodwill impairment evaluation, including those related to the selection of a discount rate and consideration of an unsystematic risk premium. \u2022 We  evaluated  management\u2019s  ability  to  accurately  forecast  operating  results  for  the  McKesson  Canada  reporting  unit  by  comparing  actual  results  to management\u2019s historical forecasts, in order to consider the reasonableness and adequacy of management\u2019s selected unsystematic risk premium. \u2022 As part of our assessment of the unsystematic risk premium, we evaluated the reasonableness of strategic plans expected to be implemented during the forecast period by comparing the forecasts to:", "\u2022 With the assistance of our fair value specialists, we evaluated the reasonableness of the discount rate, including the unsystematic risk premium, by developing a range of independent estimates, testing the mathematical accuracy of the calculation and comparing to the discount rate selected by management.", "We have served as the Company\u2019s auditor since 1968.", "The Company consolidates VIEs when it is determined that it is the primary beneficiary of the VIE.", "Investments in business entities in which the Company does not have control but has the ability to exercise significant influence over operating and financial policies, are accounted for using the equity method.", "Actual amounts could differ from those estimated amounts.", "These legislative acts are not expected to have a material impact on the Company\u2019s consolidated financial results.", "The Company considers itself to control an entity if it is the majority owner of or has voting control over such entity.", "GAAP requires that the Company make estimates and assumptions that", "If a loss in value has occurred that is deemed to be other-than-temporary, an impairment loss is recorded.", "economic environment, customer credit ratings or bankruptcies, as well as reasonable and supportable forecasts.", "We are exposed to credit losses on accounts receivable balances.", "As a result, the Company\u2019s sales and credit concentration is significant.", "The accounts receivables balances are with individual members of the GPOs, and therefore no significant concentration of credit risk exists.", "This credit risk is mitigated by the size and diversity of the Company\u2019s customer base as well as its geographic dispersion.", "These amounts are equivalent to the Company\u2019s LIFO reserves.", "A LIFO credit is recognized when the net effect of price declines exceeds the impact of price increases on pharmaceutical and non-pharmaceutical products held in inventory.", "The increase was primarily due to charges in 2021 totaling $136 million on certain personal protective equipment and other related products due to inventory impairments and excess inventory within our Medical-Surgical Solutions segment.", "When the net realizable value of a disposal group increases during a period, a gain can be recognized to the extent that it does not increase the value of the disposal group beyond its original carrying value when the disposal group was reclassified as held for sale.", "Depreciation and amortization begins when an asset is placed in service and ready for its intended use.", "The use of alternative assumptions and estimates could affect the fair values and change the impairment determinations.", "Measurement of any impairment loss is based on the excess of the carrying value of the asset group over its estimated fair market value.", "customer in an amount that reflects the consideration to which the entity expects to be entitled for that good or service.", "Revenue is recognized when control of goods is transferred to the customer which occurs upon the Company\u2019s delivery to the customer or upon customer  pick-up.", "The ultimate outcome of any outstanding claims may be different than the Company\u2019s estimate.", "If a derivative is designated as a fair value hedge, the changes in the fair value of the derivative and of the hedged item attributable to the hedged risk are recognized in earnings.", "The cumulative changes in fair value are reclassified to the same line as the hedged item in the Consolidated Statements of Operations when the hedged item affects earnings.", "Noncontrolling interests with redemption features, such as put rights, that are not solely within the Company\u2019s control are considered redeemable noncontrolling interests.", "When a loss is considered probable and reasonably estimable, the Company records a liability in the amount of its best estimate for the ultimate loss.", "When a material loss is reasonably possible or probable, but a reasonable estimate cannot be made, disclosure of the proceeding is provided.", "As discussed above, development of a meaningful estimate of loss or a range of potential loss is complex when the outcome is directly dependent on negotiations with or decisions by third parties, such as regulatory agencies, the court system, and other interested parties.", "Any purchase consideration in excess of the estimated fair values of the net assets acquired is recorded as goodwill.", "Restructuring Charges: Employee severance costs are generally recognized when payments are probable and amounts are reasonably estimable.", "The forward-looking model requires the Company to consider historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount in estimating credit losses.", "The adoption of this amended guidance is not expected to have a material impact on the Company\u2019s consolidated financial statements or disclosures.", "accounting policy has been to disclose any intervening events of the joint venture in the lag period that could materially affect its consolidated financial statements.", "McKesson had the ability to adjust the manner in which certain depreciation or amortization deductions are allocated among Change and McKesson.", "This creates uncertainty over the amount, timing, and probability of the gain recognized.", "Any such change is not expected to have a material impact on the Company\u2019s consolidated financial statements.", "This initiative was substantially complete in 2021 and remaining costs the Company expects to record under this initiative are not material.", "This set of initiatives was substantially complete by the end of 2020 and charges in 2021 were not material.", "Goodwill recognized for business acquisitions is generally not expected to be deductible for tax purposes.", "share-based awards that will ultimately vest primarily based on historical experience.", "The estimated forfeiture rate established upon grant is re-assessed throughout the requisite service period and is adjusted when actual forfeitures occur.", "The actual forfeitures in future reporting periods could be higher or lower than current estimates.", "PSUs have a requisite service period of generally three years.", "Compensation expense for the share-based awards is recognized for the portion of awards ultimately expected to vest.", "The number of vested PSUs is assessed at the end of a", "All  outstanding  PeRSU awards  have  completed  the  performance  period  and  are  now classified  and  accounted  for  as RSUs.", "portion of the awards that is ultimately expected to vest.", "Once the fair value of an employee stock option is determined, current accounting practices do not permit it to be changed, even if the estimates used are different from actual.", "The Company believes this market-based input provides a reasonable estimate of its future stock price movements and is consistent with employee stock option valuation considerations.", "These amounts have not been significant for all the years presented.", "Substantially all its foreign net operating losses have indefinite lives.", "The decrease in unrecognized tax benefits in 2020  compared  to  2019  is  primarily  attributable  to  the  favorable  resolution  of  an  outstanding  California  tax  refund  claim  which  decreased  unrecognized  tax benefits by $91 million.", "2017 Tax Act, the repatriation of cash to the U.S. is generally no longer taxable for federal income tax purposes.", "The Company may remit foreign earnings to the U.S. to the extent it is tax efficient to do so.", "It does not expect the tax impact from remitting these earnings to be material.", "The exercise of the Put Right will reduce the balance of redeemable noncontrolling interests.", "The adoption of this guidance did not have a material impact on the Company\u2019s consolidated statements of operations and cash flows.", "The Company\u2019s lease agreements do not contain any material residual value guarantees or material restrictive covenants.", "Operating lease liabilities are recognized based on the present value of the future lease payments over the lease term, discounted at the Company\u2019s incremental borrowing rate as the implicit rate in the lease is not readily determinable for most of the Company\u2019s leases.", "As a practical expedient, short-term leases with an initial term of 12 months or less are excluded from the Consolidated Balance Sheets and charges from these leases are expensed as incurred.", "Fair value estimates result from a complex series of judgments about future events and uncertainties and rely heavily on estimates and assumptions that have been deemed reasonable by management as of the measurement date.", "The unsystematic risk premium is an input factor used in calculating the discount rate that specifically addresses uncertainty related to the reporting unit\u2019s future cash flow projections.", "The risk of successfully achieving certain business initiatives was the primary factor in the use of a higher discount rate.", "and, from time-to-time, future unsecured and unsubordinated indebtedness outstanding.", "As a result of absorbing this risk, the leases provide the Company with the power to direct the operations of the leased properties and the obligation to absorb losses or the right to receive benefits of the entity.", "Consolidated VIEs do not have a material impact on the Company\u2019s Consolidated Statements of Operations and Cash Flows.", "their economic performance and thus is not considered the primary beneficiary of the entities.", "The pension obligation in Germany is unfunded with the exception of the contractual trust arrangement used to fund pensions of McKesson Europe\u2019s Management Board.", "actuarial  losses  exceeding  10%  of  the  greater  of  the  projected  benefit  obligation  or  the  market  value  of  assets  are  amortized  straight-line  over  the  average remaining future service period of active employees.", "Pension obligations for its unfunded plans are based on the recommendations of independent actuaries.", "The difference between actual inflation and assumed inflation in our U.K. pension plans resulted in a gain of $23 million.", "corporate bonds rated AA or better whose maturities are aligned with the expected benefit payments of its plans.", "Plan assets of the non-U.S. plans are broadly invested in a manner appropriate to the nature and duration of the expected future retirement benefits payable under the plans.", "Assets are properly diversified to avoid excessive reliance on any particular asset, issuer, or group of undertakings so as to avoid accumulations of risk in the portfolio as a whole.", "practical expedient are not leveled within the fair value hierarchy and are included as a reconciling item to total investments.", "Actions taken by other participating employers may lead to adverse changes in the financial condition of a multiemployer benefit plan and the Company\u2019s withdrawal liability and contributions may increase.", "It does not use derivatives for trading or speculative purposes.", "Eligible employees may contribute to the RSP up to 75% of", "In the normal course of business, the Company is exposed to interest rate and foreign currency exchange rate fluctuations.", "These forward contracts and cross-currency swaps are generally used to offset the potential income statement effects from intercompany loans and other obligations denominated in non-functional currencies.", "These programs reduce but do not entirely eliminate foreign currency exchange rate risk.", "To the extent foreign currency-denominated notes designated as net investment hedges are ineffective, changes in carrying value attributable to the change in spot rates are recorded in earnings.", "To the extent cross-currency swaps designated as hedges are ineffective, changes in carrying value attributable to the change in spot rates are recorded in earnings.", "Changes in fair values representing hedge ineffectiveness are recognized in current earnings.", "The settlement loss on the swaps was not material and will be amortized on a straight-line basis as interest expense over the five-year life of the 2025 Notes.", "Gains or losses from these contracts are largely offset by changes in the value of the underlying intercompany obligations.", "Changes in the fair value for contracts not designated as hedges are recorded directly in earnings.", "The carrying value of all other cash equivalents approximates their fair value due to their relatively short-term nature.", "These inputs are considered Level 2 under the fair value measurements and disclosure guidance and may not be representative of actual values that could have been realized or that will be realized in the future.", "If the carrying amount of an asset group is not recoverable, an impairment charge is recorded to reduce the carrying amount by the excess over its fair value.", "repurchase of its customers\u2019 inventory or its customers\u2019 debt in the event these customers are unable to meet their obligations to those financial institutions.", "For the Company\u2019s inventory repurchase agreements, among other requirements, inventories must be in resalable condition and any repurchase would be at a discount.", "The majority of the Company\u2019s customers\u2019 debt guarantees are secured by certain assets of the customer.", "The Company\u2019s long-term debt is also recorded at cost.", "The carrying value and fair value of the Company\u2019s long-term debt was as follows:", "Long-lived Assets The Company utilizes multiple approaches including the DCF model and market approaches for estimating the fair value of intangible assets.", "infringe a third party\u2019s intellectual property rights.", "Where appropriate, obligations for such indemnifications are recorded as liabilities.", "Accrued warranty costs were not material to the Consolidated Balance Sheets.", "Significant developments in those matters are described below.", "Company  is  unable  to  determine  that  a  loss  is  probable,  or  to  reasonably  estimate  the  amount  of  loss  or  a  range  of  loss,  for  a  claim  because  of  the  limited information  available  and  the  potential  effects  of future  events  and  decisions  by third  parties,  such  as  courts  and  regulators,  that  will  determine  the  ultimate resolution of the claim.", "It is not uncommon for claims to remain unresolved over many years.", "The Company reviews loss contingencies at least quarterly to determine whether the likelihood of loss has changed and whether it can make a reasonable estimate of the loss or range of loss.", "When the Company determines that a loss from a claim is probable and reasonably estimable, it records a liability for an estimated amount.", "The Company also provides disclosure when it is reasonably possible that a loss may be incurred or when it is reasonably possible that the amount of a loss will exceed its recorded liability.", "Warranties In the normal course of business, the Company provides certain warranties and indemnification protection for its products and services.", "These two West Virginia plaintiffs are not expected to participate in any broader multistate resolution of opioid-related claims.", "The Cherokee Nation is not expected to participate in any broader multistate resolution of opioid-related claims.", "Those non-participating governmental entities would be entitled to pursue their claims against the Company and other defendants.", "The Company believes that it has valid defenses to the claims pending against it, and it intends to vigorously defend against all such claims if acceptable settlement terms are not achieved.", "The Company believes it has valid legal defenses in these matters and intends to mount a vigorous defense.", "The Company has not concluded a loss is probable in any of these matters; nor is the amount of any loss reasonably estimable.", "An adverse judgment or negotiated resolution in any of these matters could have a material adverse impact on the Company\u2019s financial position, cash flows or liquidity, or results of operations.", "AIG and ACE are seeking declarations that they have no duty to defend or indemnify McKesson in the thousands of lawsuits pending in federal and state courts related to opioids.", "Discussions with attorneys general and other parties continue.", "If the negotiating parties agree on terms under the framework for a broad resolution of claims of", "Plaintiffs\u2019 moved for summary judgment on the same day.", "subpoenas and requests in a cooperative, thorough and timely manner.", "These responses sometimes require time and effort and can result in considerable costs being incurred by the Company.", "Such subpoenas and requests can lead to the assertion of claims or the commencement of civil or criminal legal proceedings against the Company and other members of the health care industry, as well as to settlements of claims against the Company.", "The Company responds to these requests in the ordinary course of business.", "The law adopting the excise tax made clear that the OSA does not apply to sales or distributions occurring after December 31, 2018.", "It is not certain at this point in time what proportion of this estimated liability will be borne by the Company.", "However, it is possible that the ultimate costs of these matters may exceed or be less than the reserves.", "Due to the complex nature of the tax laws, it is not possible to estimate the outcome of these matters.", "improper actions to delay or prevent generic drugs from entering the market.", "The quarterly results of operations are not necessarily indicative of the results that may be expected for the entire year.", "effectiveness of the Company\u2019s \u201cdisclosure controls and procedures\u201d (as such term is defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) as of the end of the period  covered  by  this  report  and  have  concluded  that  our  disclosure  controls  and  procedures  are  effective  based  on  their  evaluation  of  these  controls  and procedures as required by paragraph (b) of Exchange Act Rules 13a-15 or 15d-15.", "Rules 13a-15 or 15d-15 that occurred during our fourth quarter of 2021 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.", "caption  \u201cInvestors  -  Corporate  Governance.\u201d  The  Company\u2019s  Corporate  Governance  Guidelines  and  Charters  for  the  Audit,  Compensation  and  Governance Committees can also be found on our website under the same caption.", "Information  about the Code of Conduct applicable  to all employees, officers  and directors can be found on our website, www.mckesson.com, under the", "Information with respect to this item is incorporated by reference from the discussion under the heading \u201cExecutive Compensation\u201d in our Proxy Statement.", "Such non-employee director award is fully vested on the date of the grant.", "subject to and qualified in their entirety by reference to our amended and restated certificate of incorporation, our amended and restated by- laws  and  the  Delaware  General  Corporation  Law  (\u201cDGCL\u201d).  Copies  of  our  amended  and  restated  certificate  of  incorporation  and  our amended and restated by-laws have been filed with the Securities and Exchange Commission (the \u201cSEC\u201d) and are incorporated by reference herein. 100,000,000 shares are preferred stock, par value $0.01 per share.", "We may amend from time to time our amended and restated certificate of incorporation to increase the number of authorized shares of Common Stock and/or preferred stock.", "Any such amendment would require the approval of the holders of a majority of our shares entitled to vote.", "All of our outstanding shares of Common Stock are fully paid and non- assessable.", "Stock are entitled to receive ratably dividends out of assets legally available therefor at such times and in such amounts as our board of directors may from time to time determine.", "ratably in our assets that are legally available for distribution, after payment of all debts, other liabilities and any liquidation preferences of outstanding preferred stock.", "amended and restated certificate of incorporation does not provide for cumulative voting in the election of directors.", "Upon liquidation, dissolution or winding up of our affairs, the holders of Common Stock are entitled to share", "Holders of our Common Stock have no conversion, redemption, preemptive or similar", "Each outstanding share of Common Stock is entitled to one vote on all matters submitted to a vote of stockholders.", "Anti-Takeover Effects of Provisions of Our Amended and Restated Certificate of Incorporation and Our Amended and Restated By- Laws deemed to have an anti-takeover effect and may delay, deter or prevent a tender offer or takeover attempt that a stockholder might consider in its best interest, including those attempts that might result in a premium over the market price for the shares held by stockholders.", "Our amended and restated by-laws provide that special meetings of holders of Common Stock may be called only by our Chair, Chief Executive Officer or a majority of our board of directors for any purpose at any time.", "Holders of Common Stock owning at least 15% of the outstanding shares of Common Stock for at least one year are permitted to submit a special meeting request in accordance with the procedures described in our amended and restated by-laws.", "In general, notice of intent to nominate a director or raise business at such meetings must be received by us not less than 90 nor more than 120 days prior to the date of the  annual meeting and must contain certain specified  information concerning the person to be nominated or the matters to be brought before the meeting and concerning the stockholder submitting the proposal.", "may be amended by a vote of a majority of our board of directors and by the affirmative vote of a majority of the shares of the corporation entitled  to  vote  thereon.  Our  amended  and  restated  certificate  of  incorporation  and  our  amended  and  restated  by-laws  provide  that  our amended and restated by-laws may be amended by a vote of a majority of our board of directors.", "In addition, our amended and restated by- laws provide that our amended and restated by-laws may be amended by the affirmative vote of a majority of the shares of the corporation entitled to vote thereon.", "Current and former stockholders are deemed to have consented to the personal jurisdiction of the Delaware Courts in connection with any action to enforce that exclusive forum provision and to service of process in any such action.", "We  are  subject  to  the  \u201cbusiness  combination\u201d  statute  of  the  DGCL.  In  general,  such  statute  prohibits  a  publicly  held  Delaware", "The statute could prohibit or delay mergers or other takeover or change in control attempts with respect to us and, accordingly, may discourage attempts to acquire us.", "stock could decrease the amount available for distribution to holders of our Common Stock or could adversely affect the rights and powers, including voting rights, of such holders.", "The issuance of preferred stock could have the effect of delaying or preventing a change in control of us.", "Such limitation does not, however, affect the liability of a director (1) for any breach of the director\u2019s duty of loyalty to us or our stockholders, (2) for acts or omissions not in good faith or that involve intentional misconduct or a knowing violation of law, (3) in respect of certain unlawful dividend payments or stock redemptions or purchases and (4) for any transaction from which the director derives an improper personal benefit.", "The effect of this provision is to eliminate our rights and the rights of our stockholders (through stockholders\u2019 derivative suits) to recover monetary damages against a director for breach of the fiduciary duty of care as a director (including breaches resulting from negligent or grossly negligent behavior) except in the situations described in clauses (1) through (4) above.", "This provision does not limit or eliminate our rights or the rights of our stockholders to seek non-monetary relief such as an injunction or rescission in the event of a breach of a director\u2019s duty of care.", "In addition, our directors and officers have indemnification protection.", "principal amount of 0.625% Notes due 2021 and \u20ac600,000,000 aggregate principal amount of 1.500% Notes due 2025, and on February 12, 2018, we issued \u20ac500,000,000 aggregate principal amount of 1.625% Notes due 2026.", "existing and future unsecured and unsubordinated indebtedness from time to time outstanding.", "EQ Shareowner Services acts as transfer agent and registrar of our Common Stock.", "Our Common Stock is listed on the New York Stock Exchange under the symbol \u201cMCK\u201d.", "On  February  17,  2017,  we  issued  \u00a3450,000,000  aggregate  principal  amount  of  3.125%  Notes  due  2029,  \u20ac600,000,000  aggregate", "Securities\u201d), our senior subordinated debt (\u201cSenior Subordinated Debt Securities\u201d), our subordinated debt (\u201cSubordinated Debt Securities\u201d) or our  junior  subordinated  debt  (\u201cJunior  Subordinated  Debt  Securities\u201d  and,  together  with  the  Senior  Subordinated  Debt  Securities  and  the Subordinated Debt Securities, the \u201cSubordinated Securities\u201d).  The Indenture does not limit the amount of debt securities that we may issue.", "It provides that we may issue debt securities up to the principal amount that we may authorize and may be in any currency or currency unit designated  by  us.  Except  for  the  limitations  on  consolidation,  merger  and  sale  of  all  or  substantially  all  of  our  assets  contained  in  the Indenture, the terms of the Indenture do not contain any covenants or other provisions designed to afford holders of any debt securities protection with respect to our operations, financial condition or transactions involving us.", "any person unless (a) we will be the continuing corporation or (b) the successor corporation or person formed by such consolidation or into which we are merged or to which our assets substantially as an entirety are transferred or leased is a corporation, limited liability company or limited partnership organized or existing under the laws of the United States, any state of the United States or the District of Columbia and, if such entity is not a corporation, a co-obligor of the debt securities is a corporation organized or existing under any such laws, and such successor corporation or person, including such co-obligor, if any, expressly assumes our obligations on the debt securities and under the Indenture.", "In addition, we cannot effect such a transaction unless immediately after giving effect to such transaction, no default or Event of Default under the Indenture shall have occurred and be continuing.", "Subject to certain exceptions, when the person to whom our assets are transferred or leased has assumed our obligations under the debt securities and the Indenture, we shall be discharged from all our obligations under the debt securities and the Indenture, except in limited circumstances.", "unless the transaction or change of control were structured to include a merger or consolidation or transfer or lease of all or substantially all of our assets.", "We cannot consolidate or merge with or into, or transfer or lease all or substantially all of our assets to,", "\u2022 any  other  Event  of  Default  provided  in  the  applicable  resolution  of  our  board  of  directors  or  the  officers\u2019  certificate  or supplemental Indenture under which we issue such series of debt securities.", "The Indenture imposes limitations on suits brought by holders of debt securities against us.", "officer knows of any default by us in the performance, observance or fulfillment of any condition or covenant of the Indenture.", "We and the Trustee may not, however, without the consent of the holder of each outstanding debt security affected thereby:", "The Indenture provides that we and the Trustee may enter into supplemental indentures without the", "value of the assets subject to such transaction, as determined by our Board of Directors, or (b) the present value of the remaining obligations of the lessee for net rental payments during the term of any lease discounted at the rate of interest set forth or implicit in the terms of such lease or, if not practicable to determine such rate, the weighted average interest rate per annum borne by the debt securities of each series outstanding pursuant to the Indenture and subject to limitations on sale and lease-back transaction covenants, compounded semi-annually in either case as determined by our principal accounting or financial officer.", "located,  and  substantially  all  the  operations  of  which  are  conducted,  in  the  United  States  of  America  whose  financial  statements  are consolidated with our financial statements in accordance with accounting principles generally accepted in the United States of America.", "Consolidated  Subsidiaries  incurred  after  the  date  of  issuance  of  the  notes  and  secured  by  liens  not  permitted  by  the  limitation  on  liens provisions, and (2) Attributable Debt of ours and our Consolidated Subsidiaries in respect of every sale and lease-back transaction entered into after the date of the issuance of the notes, other than leases permitted by the limitation on sale and lease-back provisions.", "accordance with accounting principles generally accepted in the United States of America.", "Subsidiaries pursuant to which we or any of our Subsidiaries sells, conveys or otherwise transfers to (1) a Receivables Subsidiary (in the case of a transfer by us or any of our Subsidiaries) or (2) any other person (in the case of a transfer by a Receivables Subsidiary), or grants a security interest in, any accounts receivable (whether now existing or arising in the future) or inventory of us or any of our Subsidiaries, and any assets related thereto including, without limitation, all collateral securing such accounts receivable, all contracts and all guarantees or other  obligations  in  respect  of  such  accounts  receivable  or  inventory,  proceeds  of  such  accounts  receivable  and  other  assets  which  are customarily transferred or in respect of which security interests are customarily granted in connection with asset securitization transactions involving accounts receivable or inventory.", "financing of accounts receivable or inventory (a) no portion of the Indebtedness or any other obligations (contingent or otherwise) of which (1)  is  guaranteed  by  us  or  any  Subsidiary  of  ours  (excluding  guarantees  of  obligations  (other  than  the  principal  of,  and  interest  on, Indebtedness) pursuant to representations, warranties, covenants and indemnities entered into in the ordinary course of business in connection with  a  Qualified  Receivables  Transaction),  (2)  is  recourse  or  obligates  us  or  any  Subsidiary  of  ours  in  any  way  other  than  pursuant  to representations,  warranties,  covenants  and  indemnities  entered  into  in  the  ordinary  course  of  business  in  connection  with  a  Qualified Receivables Transaction or (3) subjects any property or asset of ours or any Subsidiary of ours (other than accounts receivable or inventory and related assets as provided in the definition of \u201cQualified Receivables Transaction\u201d), directly or indirectly, contingently or otherwise, to the satisfaction thereof, other than pursuant to representations, warranties, covenants and indemnities entered into in the ordinary course of business in connection with a Qualified Receivables Transaction, (b) with which neither we nor any Subsidiary of ours has any material contract, agreement, arrangement or understanding other than on terms customary for securitization of receivables or inventory and (c) with which neither we nor any Subsidiary of ours has any obligations to maintain or preserve such Subsidiary\u2019s financial condition or cause such Subsidiary to achieve certain levels of operating results.", "Limitation  on  Liens.  We  covenant  that,  so  long  as  any  of  the  Notes  remain  outstanding,  we  will  not,  and  will  not  permit  any", "Indebtedness which is secured by a lien which would otherwise be subject to the foregoing restrictions; provided that after giving effect thereto the Exempted Debt then outstanding at such time does not exceed 10% of our total assets on a consolidated basis.", "than three years, by us or any Consolidated Subsidiary of any assets are prohibited unless (a) we or such Consolidated Subsidiary would be entitled to incur Indebtedness secured by a lien on the assets to be leased in an amount at least equal to the Attributable Debt in respect of such transaction without equally and ratably securing the notes, or (b) the proceeds of the sale of the assets to be leased are at least equal to their fair market value (as determined by our Board of Directors) and the proceeds are applied to the purchase or acquisition, or, in the case of real property, the construction, of assets or to the retirement of Indebtedness.", "The foregoing limitation will not apply, if at the time we or any Consolidated Subsidiary enters into such sale and lease-back transaction, and after giving effect thereto, Exempted Debt does not exceed 10% of our total assets on a consolidated basis.", "time, or in part, from time to time, at our option, for cash, at a redemption price that includes accrued and unpaid interest and a make-whole premium, as specified in the Indenture and the applicable Officer\u2019s Certificate.", "York  Stock  Exchange  under  the  symbol  \u201cMCK25.\u201d  Our  2026  Notes  are  listed  on  the  New  York  Stock  Exchange  under  the  symbol \u201cMCK26.\u201d Our 2029 Notes are listed on the New York Stock Exchange under the symbol \u201cMCK29.\u201d", "This Statement of Terms and Conditions is intended to meet the requirements of Code Section 409A and any regulations and rules promulgated thereunder.", "In the event of any inconsistency between this Statement of Terms and Conditions and the Plan, the Plan shall govern.", "Capitalized terms not otherwise defined in this Statement of Terms and Conditions shall have the meaning set forth in the Plan.", "With respect to  annual  Restricted  Stock  Unit  Awards  granted  to  Outside  Directors  under  the  Plan,  such  awards  shall  be  subject  to  the  following  terms,  conditions  and restrictions.", "The Administrator administering the Plan has authority to determine the Outside Directors to whom, and the time or", "additional Restricted Stock Units, which will be subject to all of the terms and conditions of the underlying Restricted Stock Unit Award.", "The number of such additional Restricted Stock Units shall be calculated by dividing (a) the aggregate amount or value of the dividends paid with respect to that number of Shares equal to the number of Restricted Stock Units credited as of the record date for such dividend by (b) the Fair Market Value per Share on the payment date for such dividend.", "Any fractional Shares resulting from the accumulation of dividend equivalents shall be paid in cash.", "Dividend equivalents in respect of Restricted Stock Units, if granted in tandem with such Units, will be converted into", "Neither an Outside Director nor any person entitled to exercise an Outside Director\u2019s rights in the event of the Outside", "this Statement of Terms and Conditions, or under a Restricted Stock Unit Agreement, shall be conclusive and binding on all persons.", "is providing the consents herein on a purely voluntary basis.", "Nothing herein contained shall affect an Outside Director\u2019s right, if any, to participate in and receive benefits", "Each Outside Director shall agree to make appropriate arrangements with the Corporation for satisfaction of any applicable federal,", "The Corporation will hold and use the Data only as long as is necessary to implement, administer and manage the", "illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.", "Agreements shall be governed by the laws of the State of Delaware.", "The provisions in this Statement of Terms and Conditions are severable and if any one or more provisions are determined to be", "This Statement of Terms and Conditions and the Restricted Stock Unit Agreements shall be binding upon and inure to the benefit of", "This Statement of Terms and Conditions is intended to meet the requirements of Code Section 409A and any regulations and rules promulgated thereunder.", "In the event of any inconsistency between this Statement of Terms and Conditions and the Plan, the Plan shall govern.", "Capitalized terms not otherwise defined in this Statement of Terms and Conditions shall have the meaning set forth in the Plan.", "With respect to  annual  Restricted  Stock  Unit  Awards  granted  to  Outside  Directors  under  the  Plan,  such  awards  shall  be  subject  to  the  following  terms,  conditions  and restrictions.", "The Administrator administering the Plan has authority to determine the Outside Directors to whom, and the time or", "Neither an Outside Director nor any person entitled to exercise an Outside Director\u2019s rights in the event of the Outside", "this Statement of Terms and Conditions, or under a Restricted Stock Unit Agreement, shall be conclusive and binding on all persons.", "is providing the consents herein on a purely voluntary basis.", "Nothing herein contained shall affect an Outside Director\u2019s right, if any, to participate in and receive benefits", "Each Outside Director shall agree to make appropriate arrangements with the Corporation for satisfaction of any applicable federal,", "The Corporation will hold and use the Data only as long as is necessary to implement, administer and manage the", "illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.", "Agreements shall be governed by the laws of the State of Delaware.", "The provisions in this Statement of Terms and Conditions are severable and if any one or more provisions are determined to be", "This Statement of Terms and Conditions and the Restricted Stock Unit Agreements shall be binding upon and inure to the benefit of", "In the event of any inconsistency between this Statement of Terms and Conditions and the Plan, the Plan shall govern.", "Capitalized terms not otherwise defined in this Statement of Terms and Conditions shall have the meaning set forth in the Plan.", "The Option is also subject to the terms and conditions of the Plan.", "In no event shall the Corporation be required to issue fractional Shares.", "An Option granted under the Plan shall be evidenced by an Option Agreement setting forth the terms and conditions of the", "The Exercise Price of an Option, as specified in the Option Agreement, shall be equal to or greater than the Fair Market Value of", "Period, the Option Period shall end on the date of such termination of employment and the Option shall thereupon not be exercisable to any extent whatsoever.", "Term Disability, the vesting schedule of the Participant\u2019s Option shall be accelerated, the Option shall become fully exercisable and the Option Period shall end on the earlier of (i) three years after the date of the Participant\u2019s termination of employment and (ii) the Expiration Date.", "Retirement, (i) the Option shall be exercisable only to the extent that it was exercisable at the time of such retirement and (ii) the Option Period for that portion of the Option designated as a Non Statutory Stock Option shall end on the earlier of (a) three years after the date of such retirement and (b) the Expiration Date.", "of  the  Participant's  Option,  then  the  Option  shall  continue  to  remain  outstanding  until  the  earlier  of  (i)  such  time  as  the  Participant  subsequently  terminates employment and (ii) the Expiration Date.", "number of Shares as to which the Option is so exercised.", "thereunder shall be transferable by the Participant by operation of law or otherwise, other than by will or the laws of descent and distribution.", "have any of the rights of a stockholder with respect to the Shares subject to an Option except to the extent that a book entry has been entered in the records of the Corporation\u2019s transfer agent with respect to such Shares upon the exercise of an Option.", "Neither a Participant nor any person entitled to exercise a Participant\u2019s rights in the event of the Participant\u2019s death shall", "Stock dividends paid with respect to Restricted Stock during the Restriction Period shall be treated as Restricted Stock which shall be subject to the same restrictions as the original award for the duration of the Restriction Period.", "If the Participant does not have a brokerage account of record, then an appropriate book entry recording the Participant\u2019s interest in the unrestricted Shares shall be entered on the records of the Corporation\u2019s transfer agent.", "Cash dividends paid with respect to Restricted Stock during the Restriction Period shall be credited on behalf of the Participant to a", "Election to Recognize Gross Income in the Year of Grant.", "The Administrator reserves the right to impose a restriction on the sale of Shares that the Participant receives upon", "Neither a Participant nor any person entitled to exercise a Participant\u2019s rights in the event of the Participant\u2019s death shall", "The Administrator reserves the right to impose a restriction on the sale of Shares that the Participant receives upon", "Following the end of the performance period, the Compensation Committee shall determine the extent to which the criteria have been achieved and shall authorize the grant and issuance of Shares in respect of the Performance Stock Unit Award.", "The performance period of a Performance Stock Unit Award shall be greater than one year,", "Unless otherwise determined by the Compensation Committee in its sole discretion, Dividend Equivalents shall not be", "A Participant shall not be permitted to sell, transfer, pledge, assign or encumber all or any portion of a Performance Stock Unit", "Neither a Participant nor any person entitled to exercise a Participant\u2019s rights in the event of the Participant\u2019s death shall", "The Administrator reserves the right to impose a restriction on the sale of Shares that the Participant", "addition, any Award of Restricted Stock or Restricted Stock Units as to which the restrictions have not lapsed shall immediately and automatically be forfeited, Performance Stock Unit Awards shall immediately and automatically be forfeited and any such Shares of Restricted Stock shall be returned to the Corporation and all of the rights of the Participant to such Awards and the underlying Shares shall immediately terminate.", "Any outstanding Option shall immediately and automatically terminate, be forfeited and shall cease to be exercisable, without limitation.", "determination shall be conclusive and binding on all interested persons.", "a manner that is valid and enforceable and that comes closest to the business objectives intended by such invalid or unenforceable provision, without invalidating or rendering unenforceable the remaining provisions of this Section VI.", "under an Award Agreement, shall be conclusive and binding on all interested persons.", "Participation in the Plan shall not create a right to further employment with the Participant\u2019s employer (the", "In making grants to Participants in foreign countries, the Administrator has the full discretion to", "All decisions of the Administrator administering the Plan upon any questions arising under the Plan or", "Nothing herein contained shall affect a Participant\u2019s right to participate in and receive benefits from and in", "Regardless  of any  action  the  Corporation  or  the  Employer  takes  with  respect  to  any  federal,  state  or  local  income  tax,  social", "Calculation of the number of Shares to be withheld shall be made based on the closing price of the Common Stock on the New York Stock Exchange on the date that the amount of tax to be withheld is determined.", "With respect to an Award other than an Option, if adequate arrangements to satisfy the obligations with regard to all Tax-Related Items are not made by the Participant with the Corporation and/or the Employer prior to the relevant taxable event, the Corporation will satisfy such obligations as provided above in clause (3) of this paragraph.", "The Administrator shall be authorized to establish such rules, forms and procedures as it deems necessary to implement the foregoing.", "In accepting the grant, the Participant acknowledges that:", "jurisdiction may have different data privacy laws and protections than the United States.", "In the latter case, the Participant understands and acknowledges that the Corporation\u2019s legal basis for the processing of the Participant\u2019s Data would be compliance with the relevant  laws  or  regulations  or  the  pursuit  by  the  Corporation  of  respective  legitimate  interests  not  outweighed  by  the  Participant\u2019s  interests,  rights  or freedoms.", "When the Corporation no longer needs the Participant\u2019s Data for any of the above purposes, the Participant understands the Corporation will remove it from its systems.", "providing the consents herein on a purely voluntary basis.", "illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.", "If the Participant has received this Statement of Terms and Conditions or any other document related to the Plan translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control.", "The provisions in this Statement of Terms and Conditions are severable and if any one or more provisions are determined to be", "The Participant acknowledges that the Participant is proficient in the English language and, accordingly, understands the provisions of", "The Corporation will hold and use the Data only as long as is necessary to implement, administer and manage the", "Participation in the Plan is voluntary and the Participant is", "In the event of any inconsistency between this Statement of Terms and Conditions and the Plan, the Plan shall govern.", "Capitalized terms not otherwise defined in this Statement of Terms and Conditions shall have the meaning set forth in the Plan.", "The Option is also subject to the terms and conditions of the Plan.", "In no event shall the Corporation be required to issue fractional Shares.", "An Option granted under the Plan shall be evidenced by an Option Agreement setting forth the terms and conditions of the", "The Exercise Price of an Option, as specified in the Option Agreement, shall be equal to or greater than the Fair Market Value of", "Period, the Option Period shall end on the date of such termination of employment and the Option shall thereupon not be exercisable to any extent whatsoever.", "Term Disability, the vesting schedule of the Participant\u2019s Option shall be accelerated, the Option shall become fully exercisable and the Option Period shall end on the earlier of (i) three years after the date of the Participant\u2019s termination of employment and (ii) the Expiration Date.", "Retirement, (i) the Option shall be exercisable only to the extent that it was exercisable at the time of such retirement and (ii) the Option Period for that portion of the Option designated as a Nonstatutory Stock Option shall end on the earlier of (a) three years after the date of such retirement and (b) the Expiration Date.", "of  the  Participant's  Option,  then  the  Option  shall  continue  to  remain  outstanding  until  the  earlier  of  (i)  such  time  as  the  Participant  subsequently  terminates employment and (ii) the Expiration Date.", "number of Shares as to which the Option is so exercised.", "thereunder shall be transferable by the Participant by operation of law or otherwise, other than by will or the laws of descent and distribution.", "have any of the rights of a stockholder with respect to the Shares subject to an Option except to the extent that a book entry has been entered in the records of the Corporation\u2019s transfer agent with respect to such Shares upon the exercise of an Option.", "Neither a Participant nor any person entitled to exercise a Participant\u2019s rights in the event of the Participant\u2019s death shall", "Stock dividends paid with respect to Restricted Stock during the Restriction Period shall be treated as Restricted Stock which shall be subject to the same restrictions as the original award for the duration of the Restriction Period.", "If the Participant does not have a brokerage account of record, then an appropriate book entry recording the Participant\u2019s interest in the unrestricted Shares shall be entered on the records of the Corporation\u2019s transfer agent.", "Cash dividends paid with respect to Restricted Stock during the Restriction Period shall be credited on behalf of the Participant to a", "Election to Recognize Gross Income in the Year of Grant.", "The Administrator reserves the right to impose a restriction on the sale of Shares that the Participant receives upon", "Neither a Participant nor any person entitled to exercise a Participant\u2019s rights in the event of the Participant\u2019s death shall", "The Administrator reserves the right to impose a restriction on the sale of Shares that the Participant receives upon", "The performance period of a Performance Stock Unit Award shall be greater than one year,", "Unless otherwise determined by the Compensation Committee in its sole discretion, Dividend Equivalents shall not be", "A Participant shall not be permitted to sell, transfer, pledge, assign or encumber all or any portion of a Performance Stock Unit", "Neither a Participant nor any person entitled to exercise a Participant\u2019s rights in the event of the Participant\u2019s death shall", "The Administrator reserves the right to impose a restriction on the sale of Shares that the Participant", "addition, any Award of Restricted Stock or Restricted Stock Units as to which the restrictions have not lapsed shall immediately and automatically be forfeited, Performance Stock Unit Awards shall immediately and automatically be forfeited and any such Shares of Restricted Stock shall be returned to the Corporation and all of the rights of the Participant to such Awards and the underlying Shares shall immediately terminate.", "Any outstanding Option shall immediately and automatically terminate, be forfeited and shall cease to be exercisable, without limitation.", "determination shall be conclusive and binding on all interested persons.", "a manner that is valid and enforceable and that comes closest to the business objectives intended by such invalid or unenforceable provision, without invalidating or rendering unenforceable the remaining provisions of this Section VI.", "under an Award Agreement, shall be conclusive and binding on all interested persons.", "Participation in the Plan shall not create a right to further employment with the Participant\u2019s employer (the", "In making grants to Participants in foreign countries, the Administrator has the full discretion to", "All decisions of the Administrator administering the Plan upon any questions arising under the Plan or", "Nothing herein contained shall affect a Participant\u2019s right to participate in and receive benefits from and in", "Regardless  of any  action  the  Corporation  or  the  Employer  takes  with  respect  to  any  federal,  state  or  local  income  tax,  social", "Calculation of the number of Shares to be withheld shall be made based on the closing price of the Common Stock on the New York Stock Exchange on the date that the amount of tax to be withheld is determined.", "With respect to an Award other than an Option, if adequate arrangements to satisfy the obligations with regard to all Tax-Related Items are not made by the Participant with the Corporation and/or the Employer prior to the relevant taxable event, the Corporation will satisfy such obligations as provided above in clause (3) of this paragraph.", "The Administrator shall be authorized to establish such rules, forms and procedures as it deems necessary to implement the foregoing.", "In accepting the grant, the Participant acknowledges that:", "jurisdiction may have different data privacy laws and protections than the United States.", "In the latter case, the Participant understands and acknowledges that the Corporation\u2019s legal basis for the processing of the Participant\u2019s Data would be compliance with the relevant  laws  or  regulations  or  the  pursuit  by  the  Corporation  of  respective  legitimate  interests  not  outweighed  by  the  Participant\u2019s  interests,  rights  or freedoms.", "When the Corporation no longer needs the Participant\u2019s Data for any of the above purposes, the Participant understands the Corporation will remove it from its systems.", "providing the consents herein on a purely voluntary basis.", "illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.", "If the Participant has received this Statement of Terms and Conditions or any other document related to the Plan translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control.", "The provisions in this Statement of Terms and Conditions are severable and if any one or more provisions are determined to be", "The Participant acknowledges that the Participant is proficient in the English language and, accordingly, understands the provisions of", "The Corporation will hold and use the Data only as long as is necessary to implement, administer and manage the", "Participation in the Plan is voluntary and the Participant is", "In the event of any inconsistency between this Statement of Terms and Conditions and the Plan, the Plan shall govern.", "Capitalized terms not otherwise defined in this Statement of Terms and Conditions shall have the meaning set forth in the Plan.", "The Option is also subject to the terms and conditions of the Plan.", "In no event shall the Corporation be required to issue fractional Shares.", "An Option granted under the Plan shall be evidenced by an Option Agreement setting forth the terms and conditions of the", "The Exercise Price of an Option, as specified in the Option Agreement, shall be equal to or greater than the Fair Market Value of", "Period, the Option Period shall end on the date of such termination of employment and the Option shall thereupon not be exercisable to any extent whatsoever.", "Term Disability, the vesting schedule of the Participant\u2019s Option shall be accelerated, the Option shall become fully exercisable and the Option Period shall end on the earlier of (i) three years after the date of the Participant\u2019s termination of employment and (ii) the Expiration Date.", "Retirement, (i) the Option shall be exercisable only to the extent that it was exercisable at the time of such retirement and (ii) the Option Period for that portion of the Option designated as a Non Statutory Stock Option shall end on the earlier of (a) three years after the date of such retirement and (b) the Expiration Date.", "of  the  Participant's  Option,  then  the  Option  shall  continue  to  remain  outstanding  until  the  earlier  of  (i)  such  time  as  the  Participant  subsequently  terminates employment and (ii) the Expiration Date.", "number of Shares as to which the Option is so exercised.", "thereunder shall be transferable by the Participant by operation of law or otherwise, other than by will or the laws of descent and distribution.", "have any of the rights of a stockholder with respect to the Shares subject to an Option except to the extent that a book entry has been entered in the records of the Corporation\u2019s transfer agent with respect to such Shares upon the exercise of an Option.", "Neither a Participant nor any person entitled to exercise a Participant\u2019s rights in the event of the Participant\u2019s death shall", "Stock dividends paid with respect to Restricted Stock during the Restriction Period shall be treated as Restricted Stock which shall be subject to the same restrictions as the original award for the duration of the Restriction Period.", "If the Participant does not have a brokerage account of record, then an appropriate book entry recording the Participant\u2019s interest in the unrestricted Shares shall be entered on the records of the Corporation\u2019s transfer agent.", "Cash dividends paid with respect to Restricted Stock during the Restriction Period shall be credited on behalf of the Participant to a", "Election to Recognize Gross Income in the Year of Grant.", "Neither a Participant nor any person entitled to exercise a Participant\u2019s rights in the event of the Participant\u2019s death shall", "Following the end of the performance period, the Compensation Committee shall determine the extent to which the criteria have been achieved and shall authorize the grant and issuance of Shares in respect of the Performance Stock Unit Award.", "The performance period of a Performance Stock Unit Award shall be greater than one year,", "addition, any Award of Restricted Stock or Restricted Stock Units as to which the restrictions have not lapsed shall immediately and automatically be forfeited, Performance Stock Unit Awards shall immediately and automatically be forfeited and any such Shares of Restricted Stock shall be returned to the Corporation and all of the rights of the Participant to such Awards and the underlying Shares shall immediately terminate.", "Unless otherwise determined by the Compensation Committee in its sole discretion, Dividend Equivalents shall not be", "A Participant shall not be permitted to sell, transfer, pledge, assign or encumber all or any portion of a Performance Stock Unit", "Neither a Participant nor any person entitled to exercise a Participant\u2019s rights in the event of the Participant\u2019s death shall", "Any outstanding Option shall immediately and automatically terminate, be forfeited and shall cease to be exercisable, without limitation.", "determination shall be conclusive and binding on all interested persons.", "a manner that is valid and enforceable and that comes closest to the business objectives intended by such invalid or unenforceable provision, without invalidating or rendering unenforceable the remaining provisions of this Section VI.", "Participation in the Plan shall not create a right to further employment with the Participant\u2019s employer (the", "In making grants to Participants in foreign countries, the Administrator has the full discretion to", "under an Award Agreement, shall be conclusive and binding on all interested persons.", "Calculation of the number of Shares to be withheld shall be made based on the closing price of the Common Stock on the New York Stock Exchange on the date that the amount of tax to be withheld is determined.", "With respect to an Award other than an Option, if adequate arrangements to satisfy the obligations with regard to all Tax-Related Items are not made by the Participant with the Corporation and/or the Employer prior to the relevant taxable event, the Corporation will satisfy such obligations as provided above in clause (3) of this paragraph.", "All decisions of the Administrator administering the Plan upon any questions arising under the Plan or", "Nothing herein contained shall affect a Participant\u2019s right to participate in and receive benefits from and in", "Regardless  of any  action  the  Corporation  or  the  Employer  takes  with  respect  to  any  federal,  state  or  local  income  tax,  social", "The Administrator shall be authorized to establish such rules, forms and procedures as it deems necessary to implement the foregoing.", "In accepting the grant, the Participant acknowledges that:", "jurisdiction may have different data privacy laws and protections than the United States.", "In the latter case, the Participant understands and acknowledges that the Corporation\u2019s legal basis for the processing of the Participant\u2019s Data would be compliance with the relevant  laws  or  regulations  or  the  pursuit  by  the  Corporation  of  respective  legitimate  interests  not  outweighed  by  the  Participant\u2019s  interests,  rights  or freedoms.", "When the Corporation no longer needs the Participant\u2019s Data for any of the above purposes, the Participant understands the Corporation will remove it from its systems.", "providing the consents herein on a purely voluntary basis.", "The Corporation will hold and use the Data only as long as is necessary to implement, administer and manage the", "Participation in the Plan is voluntary and the Participant is", "illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.", "If the Participant has received this Statement of Terms and Conditions or any other document related to the Plan translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control.", "The provisions in this Statement of Terms and Conditions are severable and if any one or more provisions are determined to be", "The Participant acknowledges that the Participant is proficient in the English language and, accordingly, understands the provisions of", "In the event of any inconsistency between this Award Agreement and the Plan, the Plan shall govern.", "Capitalized terms not otherwise defined in this Award Agreement shall have the meaning set forth in the Plan.", "determine the extent to which the performance goals have been achieved, and shall determine the number of PSUs that have been earned.", "Once the Compensation Committee has determined the number of PSUs that have been earned pursuant to the", "Dividend equivalents shall be credited in respect of the One-Year RSU Award.", "The restrictions applicable to the RSU Award shall lapse with respect to 100% of the underlying Shares on the third", "Dividend equivalents shall be credited in respect of the RSU Award granted under this Section III.", "If the Participant ceases to be a bona fide employee of the Corporation or any Affiliate (except as otherwise", "otherwise  forfeited  pursuant  to  the  terms  of  the  Plan  and  this  Award  Agreement  shall  be  paid  to  the  Participant  as  soon  as  reasonably  practicable  after  the restrictions lapse.", "Performance  Stock  Units and  Restricted  Stock  Units,  to  the  extent  the  restrictions  have  not  lapsed,  shall  immediately  and  automatically  be", "determination shall be conclusive and binding on all interested persons.", "a manner that is valid and enforceable and that comes closest to the business objectives intended by such invalid or unenforceable provision, without invalidating or rendering unenforceable the remaining provisions of this Section IV.", "Compensation Committee reserves the right to impose a restriction on the sale of Shares that the Participant receives upon the settlement of the Performance Stock Units and Restricted Stock Units granted hereunder, unless the Participant has satisfied the ownership targets applicable to the Participant as provided in such policy.", "Neither the Participant nor any person entitled to exercise the Participant\u2019s rights in the event of the Participant\u2019s death", "Participation in the Plan shall not create a right to further employment with the Participant\u2019s employer (the", "under this Award Agreement, shall be conclusive and binding on all interested persons.", "Calculation of the number of Shares to be withheld shall be made based on the closing price of the Common Stock on the New York Stock Exchange on the date that the amount of tax to be withheld is determined.", "If adequate arrangements to satisfy the obligations with regard to all Tax-Related Items are not made by the Participant with the Corporation and/or the Employer prior to the relevant taxable event, the Corporation will satisfy such obligations as provided above in clause (iii) of this paragraph.", "The Administrator has the full discretion to deviate from this Award Agreement in order to adjust the Awards", "All decisions of the Administrator administering the Plan upon any questions arising under the Plan or", "Nothing herein contained shall affect the Participant\u2019s right to participate in and receive benefits from and in", "Regardless  of any  action  the  Corporation  or  the  Employer  takes  with  respect  to  any  federal,  state  or  local  income  tax,  social", "The Administrator shall be authorized to establish such rules, forms and procedures as it deems necessary to implement the foregoing.", "In accepting the grant, the Participant acknowledges that:", "providing the consents herein on a purely voluntary basis.", "The Corporation will hold and use the Data only as long as is necessary to implement, administer and manage the", "Participation in the Plan is voluntary and the Participant is", "unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.", "English and if the meaning of the translated version is different than the English version, the English version will control.", "Award, the terms of which are set forth herein and in the Plan.", "The provisions in this Award Agreement are severable and if any one or more provisions are determined to be illegal or otherwise", "Below is a list of documents that are made available to you in connection with this Notice.", "PLEASE BE SURE TO READ THESE DOCUMENTS BECAUSE THEY CONTAIN IMPORTANT INFORMATION SPECIFIC TO THIS GRANT OF RSUs.", "By signing below, I acknowledge that: 1.    I agree to receive copies of the stockholder information, including copies of any annual report, proxy and Form 10-K, from the Investor Resources section of", "Below is a list of documents that are made available to you in connection with this Notice.", "PLEASE BE SURE TO READ THESE DOCUMENTS BECAUSE THEY CONTAIN IMPORTANT INFORMATION SPECIFIC TO THIS GRANT OF RSUs.", "I consent to receiving electronically a copy of the documents set forth above and attachments to this Notice; and 5.", "I accept ALL the terms and conditions as set forth in the Plan and ST&Cs applicable to this grant of RSUs.", "Your  PSUs  will  be  earned  subject  to  the  Company\u2019s  attainment  of  performance  goals  that  have  been  pre-established  by  the  Compensation  Committee  (the \u201cCommittee\u201d) of the Company\u2019s Board of Directors.", "Below is a list of documents that are made available to you in connection with this Notice.", "PLEASE BE SURE TO READ THESE DOCUMENTS BECAUSE THEY CONTAIN IMPORTANT INFORMATION SPECIFIC TO THIS GRANT OF PSUs.", "I consent to receiving electronically a copy of the documents set forth above and attachments to this Notice; and 12.", "I should consult with a tax advisor prior to accepting this grant of PSUs or taking any other action with respect to this grant of PSUs; and 14.", "I accept ALL the terms and conditions as set forth in the Plan and ST&Cs applicable to this grant of PSUs.", "We consent to the incorporation by reference in McKesson Corporation Registration Statement Nos. 333-249817, 333-163642, 333-190847, 333-190848, and 333- 213488 on Form S-8, and Registration Statement No. 333-236808 on Form S-3, of our report dated May 12, 2021, relating to the consolidated financial statements and consolidated financial statement schedule of McKesson Corporation and subsidiaries, and the effectiveness of McKesson Corporation\u2019s internal control over financial reporting appearing in this Annual Report on Form 10-K of McKesson Corporation for the year ended March 31, 2021.", "I have reviewed this annual report on Form 10-K of McKesson Corporation;", "The registrant\u2019s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant\u2019s auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):", "I have reviewed this annual report on Form 10-K of McKesson Corporation;", "The registrant\u2019s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant\u2019s auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):", "Together, we work across the healthcare delivery system to connect pharmacies, providers, payers, and biopharma for next-generation patient access and adherence solutions that help people get the medicine they need to live healthier lives.", "Unless otherwise noted, all references in this document to a particular year shall mean the", "On March 10, 2020, we completed the separation of our interest in the Change Healthcare JV through a split- off transaction.", "This transaction reduced our investment in the Change Healthcare JV to zero.", "Change Healthcare: Our equity ownership interest in Change Healthcare JV, a joint venture, has been accounted for using the equity method of accounting.", "for our innovations and obtain copyright protection for our original works of authorship, when such protection is advantageous.", "Through these efforts, we have developed a portfolio of patents and copyrights in the U.S. and worldwide.", "In addition, we have registered or applied to register certain trademarks and service marks in the U.S. and in foreign countries.", "We cannot guarantee that our intellectual property portfolio will be sufficient to deter misappropriation, theft, or misuse of our technology, nor that we can successfully enjoin infringers.", "We periodically receive notices alleging that our products or services infringe on third party patents and other intellectual property rights.", "While the outcome of any litigation or dispute is inherently uncertain, we do not believe that the resolution of any of these infringement notices would have a material adverse impact on our results of operation.", "These values and behaviors help make McKesson unique.", "We offer financial assistance programs for higher education opportunities that support employees\u2019 career growth at the company.", "To provide compensation that is focused on attracting and retaining talent with the skills and experience necessary for a specific role, our compensation program is built on a set of quantifiable factors defined by our guiding principles of internal fairness, market competitiveness, and pay for performance.", "We operate in several countries and our benefits offerings vary accordingly.", "We offer health and wellness benefits to advance the physical, mental, and social well-being of our people, savings programs to help prepare them for retirement, and flexible work arrangements, among other  benefits  offerings,  when  possible.  In  response  to  the  COVID-19  pandemic,  we  offered  extended  medical  benefits  covering  COVID-19  related  visits, treatment and testing, expanded telehealth options, emergency paid time off (\u201cPTO\u201d), and a platform for employees to donate their regular PTO to co-workers who were  more  impacted  by  COVID-19.", "We have received monetary penalties and/or licensing sanctions pursuant to these requirements and future allegations of noncompliance could result in an inability to obtain, maintain or renew permits, licenses or other regulatory approvals needed for the operation of our businesses.", "As a result of ongoing, advanced discussions with state attorneys general and plaintiffs\u2019 representatives regarding a framework to resolve the claims of governmental entities, and our assessment of certain other opioid-related claims, we have reached a stage at which a broad settlement of opioid claims by governmental entities is probable and recorded a charge of $8.1 billion for the year ended March 31, 2021 within \u201cClaims and litigation charges, net\u201d in our Consolidated Statement of Operations in this Annual Report on Form 10-K.", "Because of the many uncertainties associated with any potential settlement arrangement or other resolution of opioid-related litigation, including the uncertainty of the scope of participation by plaintiffs in any potential settlement, we are not able to reasonably estimate the upper or lower ends of the range of ultimate possible loss for all opioid-related litigation matters.", "The adverse outcome of legal proceedings might also involve significant  expense,  management  time  and  distraction,  and risk  of loss that  can be difficult  to predict  or quantify.  In addition  to this litigation,  legislative  or regulatory measures related to the distribution of controlled substances such as prescription opioids could affect our business in ways that we may not be able to predict.", "For example, some states have passed legislation that could require us to pay taxes or assessments on the distribution of opioid medications in those states and other states have considered similar legislation.", "We are subject to government audits,  investigations  and  oversight  proceedings.  Government  agencies  routinely  review  and  audit  government  contractors  to  determine  whether  they  are complying with contractual and legal requirements.", "If we fail to comply with these requirements, or we fail an audit, we may be subject to various sanctions such as monetary damages, criminal and civil penalties, termination of contracts and suspension or debarment from government contract work.", "These requirements complicate our business and increase our compliance burden and material non-compliance could harm our reputation.", "affecting  Medicare,  Medicaid,  other  government  healthcare  programs,  and  government  contracts.  Our  relationships  with  pharmaceutical  and  medical  surgical product manufacturers and healthcare providers, as well as our provision of products and services to government entities, subject our business to laws, regulation, and government guidance on fraud and abuse.", "Many of these laws are vague or indefinite and have not been interpreted by the courts and, as such, may be interpreted or applied by a prosecutorial, regulatory, or judicial authority in a manner that could require us to make changes in our operations.", "Americans and changed the way healthcare is financed by both governmental and private payers.", "There are also further efforts to broaden healthcare coverage.", "Provincial governments in Canada that provide partial funding for the purchase of pharmaceuticals and independently regulate the sale and reimbursement of drugs have sought to reduce the costs of publicly funded health programs.", "Some European governments  have  implemented  or  are  considering  austerity  measures  to  reduce  healthcare  spending.  These  measures  exert  pressure  on  the  pricing  and reimbursement timelines for pharmaceuticals and may cause our customers to purchase fewer of our products and services or influence us to reduce prices.", "There is substantial uncertainty about the likelihood, timing and results of these health reform efforts.", "We also have record- keeping  and  other  obligations  under  the  E.U.  Falsified  Medicines  Directive.  Pedigree  tracking  laws  such  as  these  increase  our  compliance  burden  and  our pharmaceutical distribution costs.", "For example, under the Health Insurance Portability and Accountability Act of 1996 (\u201cHIPAA\u201d) we must maintain administrative, physical  and  technological  safeguards  to  protect  individually  identifiable  health  information  (\u201cprotected  health  information\u201d)  and  ensure  the  confidentiality, integrity, and availability of electronic protected health information.", "We are subject to significant compliance obligations under privacy laws such as the General Data Protection Regulation (\u201cGDPR\u201d) in the European Union, the Personal Information Protection and Electronic Documents Act (\u201cPIPEDA\u201d) in Canada, and the California Consumer Protection Act (\u201cCCPA\u201d).", "We are subject to privacy  and  data  protection  compliance  audits  or  investigations  by  various  government  agencies.  Failure  to  comply  with  these  laws  subjects  us  to  potential regulatory enforcement activity, fines, private litigation including class actions, and other costs.", "We also have contractual obligations to customers that might be breached if we fail to comply with privacy laws.", "Our efforts to comply with privacy laws complicate our operations and add to our compliance costs.", "storage and hosting of sensitive information, including protected health information and other types of personal information, confidential financial information, proprietary information, and other sensitive information relating to our customers, company and workforce.", "costs.  Environmental  costs  and  accruals,  including  that  related  to  our  legacy  chemical  distribution  operations,  presently  are  not  material  to our  operations  or financial position.", "Our ten largest customers comprised approximately 32%, and CVS was approximately 19%, of total trade accounts receivable at March 31, 2021.", "We also have agreements with GPOs, each of which functions as a purchasing agent on behalf of member  hospitals,  pharmacies  and other healthcare  providers,  as well as with government  entities  and agencies.  The accounts receivable balances are with individual members of the GPOs, and therefore no significant concentration of credit risk exists.", "Substantially all of these revenues and accounts receivable are included in our U.S.", "distribution arrangements with pharmaceutical manufacturers that include an inflation-based compensation component whereby we benefit when the manufacturers increase their prices as we sell our existing inventory at the new higher prices.", "Forward-looking  statements  involve  risks  and  uncertainties  that  could  cause  actual  results  to  differ  materially  from  those  projected,  anticipated,  or  implied.", "Except to the extent required by federal securities laws, we undertake no obligation to publicly release the result of any revisions to any forward-looking statements to reflect events or circumstances after the date the statements are made, or to reflect the occurrence of unanticipated events.", "Some of our distribution arrangements with the manufacturers provides us compensation based on a percentage of our purchases.", "We experience costly and disruptive legal disputes.", "Despite valid defenses that we assert, legal disputes are often costly, time-consuming, distracting to management and disruptive to normal business operations.", "The outcome of legal disputes is difficult to predict.", "Outcomes can occur that are not justified by the evidence or existing law.", "The uncertainty and expense associated with unresolved legal disputes might harm our business and reputation even if the matter is favorably resolved.", "Accordingly, any legal dispute might have a materially adverse impact on our reputation, our business operations and our financial position or results of operations.", "We might experience losses not covered by insurance.", "supplies, the provision of ancillary services, the conduct of our payer businesses and the provision of products that assist clinical decision-making and relate to patient medical histories and treatment plans.", "Although we seek to maintain adequate insurance coverage,  such  as  property  insurance  for  inventory  and  professional  and  general  liability  insurance,  coverages  on  acceptable  terms  might  be  unavailable,  or coverages might not cover our losses.", "We generally seek to limit our contractual exposure, but limitations of liability or indemnity provisions in our contracts may not be enforceable or adequately protect us from liability.", "Uninsured losses might have a materially adverse impact on our business operations and our financial position or results of operations.", "We regularly are named as a defendant in similar, new cases.", "Many of these cases raise novel theories of liability.", "Any proceedings can have unexpected outcomes that are not justified by evidence or existing law.", "It is not uncommon for claims to be resolved over many years.", "Although the Company has valid defenses and is vigorously defending itself, some proceedings have been and others may be resolved by negotiated outcome.", "Our reputation has been and may continue to be impacted by publicity regarding the litigation and related allegations.", "The adverse outcome of legal proceedings might have a materially adverse impact on our business operations and our financial position or results of operations.", "For example, some states have passed legislation that could require us to pay taxes or assessments on the distribution of opioid medications in those states and other states have considered similar legislation.", "Liabilities for taxes or assessments or other costs of compliance under any such laws might have a materially adverse impact on our reputation, business operations, and our financial position or results of operations.", "We are subject to extensive, complex and challenging healthcare and other laws.", "Any noncompliance by us with applicable laws or the failure to maintain, renew or obtain necessary permits and licenses could lead to litigation and might have a materially adverse impact on our business operations and our financial position or results of operations.", "Local, state and federal governments continue to strengthen their position and scrutiny over practices involving or allegedly involving fraud, waste and abuse affecting Medicare, Medicaid and other government healthcare programs.", "Our relationships with pharmaceutical and medical surgical product manufacturers and healthcare providers, as well as our provision of products and services to government entities, subject our business to laws and regulations on fraud and abuse, which among other things: (1) prohibit persons from soliciting, offering, receiving or paying any remuneration in order to induce the referral of a patient for treatment  or  to  induce  the  ordering  or  purchasing  of  items  or  services  that  are  in  any  way  paid  for  by  Medicare,  Medicaid  or  other  government-sponsored healthcare programs; (2) impose many restrictions upon referring physicians and providers of designated health services under Medicare and Medicaid programs; and (3) prohibit the knowing submission of a false or fraudulent claim for payment to, and knowing retention of an overpayment by, a federal healthcare program such  as  Medicare  and  Medicaid.  Many  of  these  laws,  regulations,  and  government  guidance,  including  those  relating  to  marketing  incentives,  are  vague  or indefinite and have not been interpreted by the courts.", "The laws may be interpreted or applied by a prosecutorial, regulatory, or judicial authority in a manner that could require us to make changes in our operations.", "Failures to comply with applicable laws subject us to federal or state government investigations or qui tam actions, and to liability for damages and civil and criminal penalties, including the loss of licenses or our ability to participate in Medicare, Medicaid and other federal and state healthcare programs.", "These sanctions might have a materially adverse impact on our business operations and our financial position or results of operations.", "Noncompliance with these requirements has resulted in monetary penalties and/or licensing sanctions.", "For example, under a January 2017 agreement with the DEA and Department of Justice we paid $150 million to settle potential administrative and civil claims about our practices for reporting suspicious orders of controlled substances and the DEA suspended, on a staggered basis for limited periods of time, our registrations to distribute certain controlled substances from four distribution centers.", "Pedigree tracking laws increase our compliance burden and our pharmaceutical distribution costs.", "Pedigree tracking laws such as these increase our compliance burden and our pharmaceutical distribution costs, and they might have a materially adverse impact on our business operations and our financial position or results of operations.", "Privacy and data protection laws increase our compliance burden.", "example,  under  the  Health  Insurance  Portability  and  Accountability  Act  of  1996  (\u201cHIPAA\u201d)  we  must  maintain  administrative,  physical  and  technological safeguards  to  protect  individually  identifiable  health  information  (\u201cprotected  health  information\u201d)  and  ensure  the  confidentiality,  integrity  and  availability  of electronic protected health information.", "Failure to comply with these laws subjects us to potential regulatory enforcement activity, fines, private litigation including class actions, and other costs.", "We also have contractual obligations to customers that might be breached if we fail to comply with privacy laws.", "Our efforts to comply with privacy laws complicates our operations and adds to our compliance costs.", "A significant privacy breach or failure  to  comply  with  privacy  laws  might  have  a  materially  adverse  impact  on  our  reputation,  business  operations  and  our  financial  position  or  results  of operations.", "Anti-bribery and anti-corruption laws increase our compliance burden.", "Bribery Act unless the organization can establish the defense of having implemented adequate procedures to prevent bribery.", "Our failure to comply with these laws might subject us to civil and criminal penalties that might have a materially adverse impact on our reputation, business operations and our financial position or results of operations.", "We are subject to a variety of privacy and data protection laws that change frequently and have requirements that vary from jurisdiction to jurisdiction.", "We  are  subject  to  laws  prohibiting  improper  payments  and  bribery,  including  the  U.S.  Foreign  Corrupt  Practices  Act,  the  U.K.  Bribery  Act  and  similar", "We might record significant charges from impairment to goodwill, intangibles and other assets or investments.", "In addition, we periodically review our intangible and other long-lived assets for impairment when events or changes in circumstances, such as a divestiture, indicate the carrying value may not be recoverable.", "Factors that may be considered a change in circumstances indicating that  the  carrying  value  of  our  intangible  and  other  long-lived  assets  may  not  be  recoverable  include  slower  growth  rates,  the  loss  of  a  significant  customer, burdensome new laws or divestiture of a business or asset for less than its carrying value.", "There are inherent uncertainties in management\u2019s estimates, judgments and assumptions used in assessing recoverability of goodwill, intangible and other long-lived assets.", "We may be required to record a significant charge to earnings in our consolidated financial statements during the period in which any impairment of our goodwill or intangible and other long-lived assets is determined, which might have a materially adverse impact on our business operations and our financial position or results of operations.", "storage and hosting of sensitive information, including protected health information and other types of personal information, confidential financial information, proprietary information, and other sensitive information relating to our customers, company and workforce.", "If our software and technology services are alleged to have contributed to faulty clinical decisions or injury to patients, we might be subject to claims or litigation by users of our software or services or their patients.", "Any of these types of errors or failures might have a materially adverse impact on our reputation, business operations and our financial position or results of operations.", "We  are  required  under  U.S.  Generally  Accepted  Accounting  Principles  (\u201cGAAP\u201d)  to  test  our  goodwill  for  impairment  annually  or  more  frequently  if", "We might be impeded in providing customers online services and data access.", "Any such problems might have a materially adverse impact on our business operations and our financial position or results of operations.", "Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.", "we may require financing that may not be available on acceptable terms.", "Any of these risks could adversely affect our ability to achieve the anticipated benefits of an acquisition and might have a materially adverse impact on our business operations and our financial position or results of operations.", "Exclusive forum provisions in our Bylaws could limit our stockholders\u2019 ability to choose their preferred judicial forum for disputes with us or our directors, officers or employees.", "Current and former stockholders are deemed to have consented to the personal jurisdiction of the Delaware Courts in connection with any action to enforce that exclusive forum provision and to service of process in any such action.", "To the extent that these provisions of the bylaws limit a current or former stockholder\u2019s ability to select a judicial forum other than the Delaware Courts, they might discourage the specified legal actions, might cause current or former stockholders to incur additional litigation-related expenses and might result in outcomes unfavorable to current or former stockholders.", "A court might determine that these provisions of the bylaws are inapplicable or unenforceable in any particular action, in which case we may incur additional litigation related expenses in such action, and the action may result in outcomes unfavorable to us, which could have a materially adverse impact on our reputation, our business operations and our financial position or results of operations.", "We might be adversely impacted by delays or other difficulties with divestitures.", "After the disposition, we might experience greater dissynergies than expected, and the impact of the divestiture on our revenue or profit might be larger than we expected.", "We might have difficulties with pre-closing conditions such as regulatory and governmental approvals, which could delay or prevent the divestiture.", "We might have financial exposure in a divested business, such as through minority equity ownership, financial  or  performance  guarantees,  indemnities  or  other  obligations,  such  that  conditions  outside  of  our  control  might  negate  the  expected  benefits  of  the disposition.", "Any of these risks could adversely affect our ability to achieve the anticipated benefits of a divestiture and might have a materially adverse impact on our business operations and our financial position or results of operations.", "We might not realize the expected tax treatment from our split-off of Change Healthcare.", "If Change does not honor its obligations to indemnify the Company, or if the Transactions fail to qualify for the intended tax-free treatment for reasons not related to a disqualifying action by Change or SpinCo, the resulting tax to the Company could have a significant adverse effect on our financial position or results of operations.", "outsourced service providers, and we might not realize expected cost savings or other benefits.", "For example, our ability to use outsourcing resources in certain jurisdictions might be limited by legislative action or customer contracts, with the result that the work must be performed at greater expense or we may be subject to sanctions for non-compliance.", "Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.", "We might encounter difficulties attracting and retaining customers to our retail locations due to their unfamiliarity with our brands or our inexperience with local market  preferences.  Competition  from  our  retail  pharmacy  operations  might  strain  relationships  with  our  retail  pharmacy  customers.  Consolidation  of  retail pharmacies with third party payers, expansion of large retail pharmacy networks, reductions in reimbursement rates, shifts in the mix of branded and generic pharmaceutical sales, and exclusion from preferred pharmacy networks can impair our retail pharmacy sales and profitability.", "We might be harmed by large customer purchase reductions, payment defaults or contract non-renewal.", "March 31, 2021, sales to our largest customer represented approximately 21% of our consolidated revenues and approximately 19% of our trade receivables, and those of our ten largest customers combined accounted for approximately 51% of our consolidated revenues and approximately 32% of our trade receivables.", "A material  default  in  payment,  reduction  in  purchases,  or  the  loss  of  business  from  a  large  customer  might  have  a  materially  adverse  impact  on  our  business operations and our financial position or results of operations.", "Our contracts with government entities involve future funding and compliance risks.", "Our government contracts might not be renewed or might be terminated for convenience with little or no prior notice.", "Government contracts typically expose us to higher potential liability than do other types of contracts.", "We are subject to government audits, investigations and oversight proceedings.", "If we fail to comply with these requirements, or we fail an audit, we are subject to various sanctions such as monetary damages, criminal and civil penalties, termination of contracts and suspension or debarment from government contract work.", "These requirements complicate our business and increase our compliance burden.", "We also provide supplies used for vaccine administration in the Federal COVID-19 Response.", "Our participation in such programs exposes us to various uncertainties.", "Because of these risks and uncertainties our operating results may be materially higher or lower than our projections.", "Certain distribution agreements with manufacturers include pharmaceutical price inflation as a component of our compensation, and we cannot  control  the  frequency  or  magnitude  of  pharmaceutical  price  changes.  We  might  be  unable  to  renew  pharmaceutical  distribution  agreements  with manufacturers in a timely and favorable manner.", "Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.", "We  derive  a  significant  portion  of  our  revenue  from,  and  have  a  significant  portion  of  our  accounts  receivable  with,  a  small  number  of  customers.  At", "Our contracts with government entities are subject to risks such as lack of funding and compliance  with unique requirements.", "We might infringe intellectual property rights or our intellectual property protections might be inadequate.", "If a court were to hold that we infringed other\u2019s rights, we might be required to pay substantial damages, develop non-infringing products or services, obtain a license, stop selling or using the infringing products or services, or incur other sanctions.", "We rely on trade secret, patent, copyright and  trademark  laws,  nondisclosure  obligations  and  other  contractual  provisions  and  technical  measures  to  protect  our  proprietary  rights  in  our  products  and solutions.  We  might  initiate  costly  and  time-consuming  litigation  to  protect  our  trade  secrets,  to  enforce  our  patent,  copyright  and  trademark  rights  and  to determine the scope and validity of the proprietary rights of others.", "Our intellectual property protection efforts might be inadequate to protect our rights.", "Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.", "Competition among potential employers might result in increased salaries, benefits or other employee-related costs, or in our failure to recruit and retain employees.", "Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.", "We might be adversely impacted by healthcare reform such as changes in pricing and reimbursement models.", "healthcare industry and related government programs are changing.", "profit margins for us and our customers and impose new legal requirements on healthcare providers.", "the way healthcare is financed by both governmental and private payers.", "drugs have sought to reduce the costs of publicly funded health programs.", "These measures exert pressure on the pricing and reimbursement timelines for pharmaceuticals and may cause our customers to purchase fewer of our products and services or influence us to reduce prices.", "adverse impact on our business operations and our financial position or results of operations.", "Consolidation might increase counter-party credit risk because credit purchases increase for fewer market participants.", "Any of these changes or disruptions might have a materially adverse impact on our business operations and our financial position or results of operations.", "We might be adversely impacted as a result of our distribution of generic pharmaceuticals.", "Generic drug manufacturers often offer a generic version of branded pharmaceuticals while they challenge the validity or enforceability branded pharmaceutical patents.", "The patent holder might assert infringement claims against us for distributing those generic versions and the generic drug manufactures may not fully indemnify us against such claims.", "These risks, as well as changes in the availability,  pricing  volatility,  reimbursement  rates  for  generic  drugs,  or significant  changes  in  the  nature,  frequency  or magnitude  of  generic  pharmaceutical launches, might have a materially adverse impact on our business operations and our financial position or results of operations.", "We might be adversely impacted by an economic slowdown or recession.", "Any economic slowdown or recession might have a materially adverse impact on our business operations and our financial position or results of operations.", "Disruption or other changes in capital and credit markets might impede access to credit and increase borrowing costs for us and our customers and suppliers and might impair the financial soundness of our customers and suppliers.", "activity by financial institutions, or decreased liquidity and increased costs in the commercial paper market, might adversely affect our borrowing ability and cost of borrowing.", "We generally sell our products and services under short-term unsecured credit arrangements.", "An adverse change in general economic conditions or access to capital might cause our customers to reduce their purchases from us, or delay or fail paying amounts owed to us.", "Suppliers might be unable to make payments due to us for fees, returned products or incentives.", "Interest rate increases or changes in capital market conditions might impede our or our customers\u2019 or suppliers\u2019 ability or cost to obtain credit.", "Any of these risks might have a material adverse impact on our business operations and our financial position or results of operations.", "Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.", "We might be adversely impacted by tax legislation or challenges to our tax positions.", "Tax laws might change in ways that adversely affect our tax positions, effective tax rate and cash flow.", "The tax laws are extremely complex and subject to varying interpretations.", "We are subject to tax examinations in various jurisdictions that might assess additional tax liabilities against us.", "Our tax reporting positions might be challenged by relevant tax authorities, we might incur significant expense in our efforts to defend those challenges, and we might be unsuccessful in those efforts.", "Developments in examinations and challenges might materially change our provision for taxes in the affected periods and might differ materially from our historical tax accruals.", "Any of these risks might have a materially adverse impact on our business operations, our cash flows and our financial position or results of operations.", "For example, we might experience volatility in exchange rates and interest rates and changes in laws regulating our U.K. operations.", "Customers might reduce purchases due to the uncertainty caused by Brexit.", "Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.", "We might be adversely impacted by fluctuations in foreign currency exchange rates.", "exchange rates could reduce our revenues, increase our costs or otherwise adversely affect our financial results reported in U.S. dollars.", "For example, we are exposed to transactional currency exchange risk due to our import and export of products that are purchased or sold in currencies other than the U.S. dollar.", "We also  have  currency  exchange  risk  due  to  intercompany  loans  denominated  in  various  currencies.  The  COVID-19  pandemic  has  affected  and  might  increase currency exchange rate volatility.", "We may from time to time enter into foreign currency contracts, foreign currency borrowings or other techniques intended to hedge  a  portion  of our  foreign  currency  exchange  rate  risks.  These  hedging  activities  may  not  completely  offset  the  adverse  financial  effects  of  unfavorable movements in foreign currency exchange rates during the time the hedges are in place.", "Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.", "We are subject to the tax laws in the U.S. at the federal, state and local government levels and to the tax laws of many other jurisdictions in which we operate", "We conduct our business in various currencies,  including  the U.S. dollar, euro, British pound sterling  and Canadian dollar.  Changes in foreign  currency", "Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.", "We might be adversely impacted by changes in accounting standards.", "It is possible that future accounting standards may require changes to the accounting treatment in our consolidated financial statements and may require us to make significant changes to our financial systems.", "Such changes might have a materially adverse impact on our financial position or results of operations.", "Our consolidated financial statements are subject to the application of U.S.", "Disclosure of an environmental proceeding where a governmental agency is a party generally is included only if we expect monetary sanctions in the proceeding to exceed $1 million, unless otherwise material.", "There are no family relationships between any of the executive officers or directors of the Company.", "We declared regular cash dividends of $1.67 and $1.62 per share in the years ended March 31, 2021 and 2020, respectively.", "discretion of the Board and will depend upon our future earnings, financial condition, capital requirements, and other factors.", "Dividends: In  July  2020,  our  quarterly  dividend  was  raised  from  $0.41  to  $0.42  per  common  share  for  dividends  declared  on  or  after  such  date  by  the", "We anticipate that we will continue to pay quarterly cash dividends in the future.", "In accordance with our accounting policy, we allocate any excess of share repurchase price over par value between additional paid-in capital and retained earnings.", "Accordingly, our retained earnings and additional paid-in capital were reduced by $472 million and $70 million, respectively, during 2019.", "In 2019, we retired 5.0 million or $542 million of our treasury shares previously repurchased.", "This discussion and analysis should be read in conjunction with the consolidated financial statements and accompanying financial notes in Item 8 of Part II of this Annual Report on Form 10-K.", "Our fiscal year begins on April 1 and ends on March 31.", "Unless otherwise noted, all references to a particular year shall mean our fiscal year.", "Our organizational structure also includes Corporate, which consists of income and expenses associated with administrative functions and projects, and the results of certain investments.", "We evaluate the performance of our operating segments on a number of measures, including revenues and operating profit before interest expense and income taxes.", "The following summarizes our four reportable segments and the changes made to our reporting structure commencing in the second quarter of 2021.", "\u2022 Coronavirus disease 2019 (\u201cCOVID-19\u201d) impacted our results of operations for the year ended March 31, 2021.", "The recovery from the COVID- 19 pandemic continued to fluctuate throughout our fiscal year.", "\u2022 We expanded our existing contractual relationship with the Centers for Disease Control and Prevention (\u201cCDC\u201d) through an amendment to our existing Vaccines for Children Program contract to support the U.S. government as a centralized distributor of COVID-19 vaccines and ancillary supplies needed to administer vaccines.", "\u2022 In  December  2020,  we  began  distributing  certain  COVID-19  vaccines  under  the  direction  of  the  CDC.  Through  the  end  of  the  fiscal  year,  we  had distributed approximately 100 million of COVID-19 vaccine doses.", "\u2022 Revenues of $238.2 billion, reflects a 3% increase from the prior year primarily in our U.S.", "\u2022 Diluted loss per common share from continuing operations attributable to McKesson Corporation in 2021 of $28.26 reflects the aforementioned items, net of any respective tax impacts, and a lower share count compared to the prior year driven largely by the separation of our investment in Change Healthcare JV on March 10, 2020;", "The full extent to which COVID-19 will impact us depends on many factors and future developments, which are described at the end of this COVID-19 section.", "We continue to evaluate the nature and extent of the impacts COVID-19 has on our business and operations.", "We provided further support including additional emergency leave and an internal paid time off donation platform for employees impacted by COVID-19.", "These responses were initially put in place during our fourth quarter of 2020.", "policies did not have a material effect on our internal control over financial reporting during the year ended March 31, 2021.", "We also took various actions to mitigate the impact of COVID-19 on our results from operations through cost-containment and payroll-related expenses.", "We support the U.S. government as a centralized distributor of COVID-19 vaccines and ancillary supplies needed to administer vaccines.", "We make no decisions on where products are to be distributed nor how the products are allocated between the various provider sites and ultimately administered to the individuals receiving a vaccine.", "We utilize our expertise and capabilities to support the CDC\u2019s efforts to vaccinate everyone in the U.S. who wants to receive a COVID-19 vaccine.", "The Pfizer Vaccine, which is ultra-frozen, is not being distributed by McKesson, although we are providing ancillary supplies needed for its administration.", "custom freezers and refrigerators to safely store and process millions of vaccine doses.", "The capital expenditures we made during 2021 to prepare for vaccine and ancillary supply kit distribution were not material to our financial condition or liquidity.", "In December 2020, we began distributing the Moderna Vaccine in the U.S. and in March 2021, we began distributing the Janssen Vaccine.", "Subsequently, during the first quarter, we had lower pharmaceutical volumes, specialty drug volumes, and patient care visits that negatively impacted our consolidated revenues and income (loss) from continuing operations before income taxes for the year ended March 31, 2021.", "Additionally, increased costs for certain PPE compressed our margins.", "During the year ended March 31, 2021, we recorded charges totaling $136 million in cost of sales on certain PPE and other related products due to inventory impairments and excess inventory in our Medical-Surgical Solutions segment.", "Although market price volatility and changes to anticipated customer demand may require additional write-downs in future periods, we are taking measures to mitigate such risk.", "We collaborated closely with the federal government and other healthcare stakeholders to source more critical PPE to the U.S.", "We have deferred certain employer payroll taxes and continue to monitor the potential impact of other tax legislation changes as result of the CARES Act, including refundable payroll tax credits on certain qualified wages.", "We anticipate changes due to the CARES Act in the timing of certain cash flows, with no material impact to our financial results for the year ended March 31, 2021.", "The CA Act did not have a material impact on our financial condition, results of operations, or liquidity for the year ended March 31, 2021 nor do we currently expect a material impact on our future financial results.", "We are monitoring our customers closely for changes to their timing of payments or ability to pay amounts owed to us as a result of COVID-19 pandemic impacts to their businesses.", "We remain well-capitalized with access to liquidity from our revolving credit facility.", "Long- term debt markets and commercial paper markets, our primary sources of capital after cash flow from operations, have remained open and accessible to us during the COVID-19 pandemic.", "At March 31, 2021, we were in compliance with all debt covenants, and believe we have the ability to continue to meet our debt covenants in the future.", "Our consolidated balance sheets and ability to maintain financial liquidity remains strong.", "We have experienced no material impacts to our liquidity or net", "We face numerous uncertainties in estimating the direct and indirect effects of COVID-19 on our future business operations, financial condition, results of operations, and liquidity.", "Due to several rapidly changing variables related to the COVID-19 pandemic, estimations of future economic trends and the timing of when stability will  return  remains  challenging.  Additionally,  we  periodically  review  our  intangible  and  other  long-lived  assets  for  impairment  when  events  or  changes  in circumstances indicate  the carrying value may not be recoverable.  Key assumptions and estimates  about future values in our impairment assessments can be affected by a variety of factors, including the impacts of the global pandemic on industry and economic trends as well as on our business strategy and internal forecasts.", "We continue to be involved in discussions with the objective of achieving broad resolution of opioid- related claims of states, their political subdivisions and other government entities (\u201cgovernmental entities\u201d).", "We are in ongoing, advanced discussions with state attorneys general and plaintiffs\u2019 representatives regarding a framework under which, in order to resolve the claims of governmental entities, the three largest U.S. pharmaceutical distributors would pay up to approximately $21.0 billion over a period of 18 years, with up to approximately $8.0 billion to be paid by us, of which more than 90% is anticipated to be used to remediate the opioids crisis.", "As a result of that conclusion, and our assessment of certain other opioid- related claims, we recorded a charge of $8.1 billion for the year ended March 31, 2021 within \u201cClaims and litigation charges, net\u201d in our Consolidated Statement of Operations, related to our share of the settlement framework described above, as well as other opioid-related claims.", "Because of the many uncertainties associated with any potential settlement arrangement or other resolution of opioid-related litigation, including the uncertainty of the scope of participation by plaintiffs in any potential settlement, we are not able to reasonably estimate the upper or lower ends of the range of ultimate possible loss for all opioid-related litigation matters.", "We believe that we have valid defenses to the claims pending against us and, absent an acceptable settlement, intend to vigorously defend against all such claims.  An  adverse  judgment  or  negotiated  resolution  in  any  of  these  matters  could  have  a  material  adverse  impact  on  our  financial  position,  cash  flows  or liquidity, or results of operations.", "The law adopting the excise tax made clear that the OSA would apply only to opioid sales on or before December 31, 2018.", "The excise tax applies only to the first sale occurring in New York, and thus may not apply to sales from our distribution centers in New York to New York customers.", "Unless the appellate court\u2019s decision is overturned, the OSA will be reinstated for calendar years 2017 and 2018 (but not beyond those years), and, subject to any further legal challenge, we will have to pay our ratable share of the annual surcharge for those two years.", "During the second quarter of 2021, we reflected an estimated liability of $50 million for the OSA surcharge in our accompanying consolidated financial statements on the assumption that the appellate court\u2019s decision will stand.", "The higher LIFO credits in 2020 compared to 2019 is primarily driven by higher generic deflation.", "\u2022 Claims and litigation charges, net: These charges include adjustments for estimated probable settlements related to our controlled substance monitoring and reporting, and opioid-related claims, as well as any applicable income items or credit adjustments due to subsequent changes in estimates.", "We have reclassified prior period amounts to conform to the current period presentation.", "\u2022 Goodwill impairments charges: We perform an impairment test on goodwill balances annually in the third quarter and more frequently if indicators for potential impairment exist.", "The resulting goodwill impairment charges are reflected within this line item. \u2022 Restructuring, impairment, and related charges: Restructuring charges that are incurred for programs in which we change our operations, the scope of a business undertaken by our business units, or the manner in which that business is conducted as well as long-lived asset impairments.", "\u2022 SDG&A reflects charges of $58 million to remeasure assets and liabilities held for sale to fair value less costs to sell related to the completed contribution of the majority of our German pharmaceutical wholesale business to create a joint venture with WBA in which we have a 30% ownership interest within our International segment.", "As a result, we were required to perform a goodwill impairment test for these reporting units and recorded a goodwill impairment charge in our European RP reporting unit of $69 million during the second quarter of 2021.", "As of the testing date, other risks, expenses, and future developments, such as additional government actions, increased regulatory uncertainty, and material changes in key market assumptions limit our ability to estimate projected cash flows, which could adversely affect the fair value of various reporting units in future periods, including our McKesson Canada reporting unit within our International segment and our RxCrossroads reporting unit within our RxTS segment, where the risk of a material goodwill impairment is higher than other reporting units.", "\u2022 Restructuring, impairment, and related charges, net includes long-lived asset impairment charges of $112 million, primarily for our United Kingdom (\u201cU.K.\u201d)  business  (mainly  pharmacy  licenses)  and  Rexall  Health  retail  business  (\u201cRexall  Health\u201d)  (mainly  customer  relationships)  within  our International segment, and the remaining $156 million primarily represents employee severance and exit-related costs related to our 2019 restructuring initiatives, as further discussed below; and", "\u2022 Total operating expenses includes higher SDG&A due to our business acquisitions and to support business growth, as well as our technology initiatives, partially offset by favorable effects of foreign currency exchange fluctuations.", "\u2022 SDG&A includes opioid-related costs of $114 million, primarily related to litigation expenses, and increased expenses due to our business acquisitions and to support growth, partially offset by a gain from an escrow settlement of $97 million representing certain indemnity and other claims related to our 2017 acquisition of Rexall Health and a credit of $90 million for the derecognition of a liability related to the tax receivable agreement (\u201cTRA\u201d) payable to the shareholders of Change Healthcare, Inc. (\u201cChange\u201d);", "\u2022 Restructuring,  impairment,  and  related  charges,  net  primarily  includes  employee  severance  and  exit-related  costs  of  $352  million  for  our  2019 restructuring initiatives, as further discussed below and long-lived asset impairment charges of $245 million primarily for our U.K. business (mainly pharmacy licenses) within our International segment driven by additional government reimbursement reductions and competitive pressures in the U.K.", "We evaluate goodwill for impairment on an annual basis as of October 1, and at an interim date, if indicators of potential impairment exist.", "This change was not material to our consolidated financial statements as it did not delay, accelerate, or avoid any potential goodwill impairment charge.", "We expect to incur total charges of approximately $180 million to $280 million for this initiative, consisting primarily of exit related costs, accelerated depreciation and amortization of long-lived assets, and asset impairments.", "We expect to incur total charges of approximately $85 million to $90 million, of which $57 million of charges were recorded to date.", "This initiative was substantially complete in 2021 and remaining costs we expect to record under this initiative are not material.", "The relocation was substantially complete in January 2021 and remaining costs we expect to record under this initiative, primarily relating to lease costs, are not material.", "This primarily reflects mark-to-market gains on our investments in certain U.S. growth stage companies in the healthcare industry and realized gains on the exit of some of these investments as further described in Financial Note 17, \u201cFair Value Measurements,\u201d to the accompanying consolidated financial statements  included  in  this  Annual  Report  on  Form  10-K.  In  future  periods,  fair  value  adjustments  recognized  in  our  operating  results  for  these  types  of investments may be adversely impacted by market volatility.", "Other income, net also increased year over year due to pension settlement charges of $122 million recognized in 2020 related to our previously approved termination of the frozen U.S. defined benefit pension plan.", "In connection with the pension plan termination, we purchased annuity contracts from an insurer that will pay and administer the future pension benefits of the remaining participants.", "Excluding the impairment and transaction-related items described below, our proportionate share of loss from our investment in Change Healthcare JV for the years ended March 31, 2020 and 2019 was $119 million and $194 million, respectively, which primarily includes transaction and integration expenses incurred by the joint venture and basis differences between the joint venture and McKesson including amortization of fair value adjustments.", "During the first quarter of 2020 and for the year ended March 31, 2019, we owned approximately 70% of this joint venture.", "The proceeds from the concurrent offering of other securities were also used by Change  to  acquire  certain  securities  of  Change  Healthcare  JV.  As  a  result,  McKesson\u2019s  equity  interest  in  Change  Healthcare  JV  was  reduced  from  70%  to approximately 58.5%, which was used to recognize our proportionate share in net loss from Change Healthcare JV, commencing in the second quarter of 2020.", "As a result of the ownership dilution to 58.5% from 70%, we recognized a dilution loss of approximately $246 million in the second quarter of 2020.", "Additionally, our proportionate share of income or loss from this investment was subsequently reduced as immaterial settlements of stock option exercises occurred after the IPO and further diluted our ownership.", "Equity Earnings and Charges from Investment in Change Healthcare Joint Venture Until the separation of our investment in Change Healthcare JV on March 10, 2020, we accounted for this investment using the equity method of accounting.", "In the second quarter of 2020, we recorded an other-than-temporary-impairment (\u201cOTTI\u201d) charge of $1.2 billion to our investment in Change Healthcare JV,", "Following the Split-off, we do not beneficially own any of Change\u2019s outstanding securities.", "In connection with this transaction, we recognized a net gain for financial reporting purposes of $414 million during the fourth quarter of 2020, which was largely driven by the reversal of a related deferred tax liability.", "The receipt of any payments under the TRA is dependent upon Change benefiting from this depreciation or amortization in future tax return filings, which creates uncertainty over the amount, timing and probability of the gain recognized.", "As such, we accounted for the TRA as a gain contingency, with no receivable recognized as of March 31, 2021 nor 2020.", "Interest expense decreased in 2020 compared to the prior year primarily due to a decrease in the issuance of commercial paper, partially offset by a decrease in interest income from our derivative contracts.", "Our reported income tax (benefit) expense rates were (13.8%), 1.6%, and 58.4% in 2021, 2020, and 2019, respectively.", "after-tax), which was intended to generally be a tax-free split-off for U.S. federal income tax purposes, and unfavorably impacted by charges of $275 million (pre- tax and after-tax) to remeasure assets and liabilities held for sale to fair value less costs to sell related to the completed contribution of the majority of our German pharmaceutical wholesale business to create a joint venture with WBA.", "goodwill of our European RP and European PD reporting units within the International segment, given that these charges are generally not deductible for tax purposes.", "Our income tax expense, deferred tax assets and liabilities, and uncertain tax liabilities reflect management\u2019s best assessment of estimated current and future taxes to be paid.", "We believe that we have made adequate provision for all income tax uncertainties.", "In connection with the exchange offer, on March 9, 2020, we distributed all 176.0 million outstanding shares of common stock of SpinCo to participating", "Income Tax (Benefit) Expense We recorded income tax (benefit) expense of ($695 million), $18 million, and $356 million for the years ended March 31, 2021, 2020, and 2019, respectively.", "Our reported income tax expense rate for 2019 was unfavorably impacted by charges of $1.8 billion (pre-tax and after-tax) to impair the carrying value of", "Significant judgments and estimates are required in determining the consolidated income tax provision and evaluating income tax uncertainties.", "Noncontrolling interests with redemption  features, such as put rights, that are not solely within our control are considered redeemable  noncontrolling  interests.  Redeemable  noncontrolling interests are presented outside of McKesson Corporation stockholders\u2019 equity (deficit) on our consolidated balance sheet.", "Diluted earnings (loss) per common share attributable to McKesson Corporation was $(28.26), $4.95, and $0.17 for the years ended March 31, 2021,  2020,  and  2019,  respectively.  Net  loss  per  diluted  share  for  the  year  ended  March  31,  2021  is  calculated  by  excluding  dilutive  securities  from  the denominator  due to their antidilutive  effects.  Additionally,  our 2021, 2020, and 2019 diluted  earnings (loss) per share  reflect  the cumulative  effects  of share repurchases.", "Weighted-average diluted common shares outstanding is impacted by the exercise and settlement of share-based awards and the cumulative effect of share repurchases, including the impact of shares exchanged as part of the split-off from our investment in Change Healthcare JV, as discussed above.", "(1) Segment operating profit (loss) includes gross profit, net of operating expenses, as well as other income (expense), net, for our reportable segments.", "For retrospective periods presented, operating loss for Other reflects equity earnings and charges from our equity method investment in Change Healthcare JV, which we split-off in the fourth quarter of 2020.", "Pharmaceutical segment includes a charge of $50 million for the year ended March 31, 2021 related to our estimated liability under the OSA.", "(3) Operating loss for our International segment for the years ended March 31, 2021 and 2020 includes charges of $58 million and $275 million, respectively, to remeasure to fair value the assets and liabilities of our German pharmaceutical wholesale business which was contributed to a joint venture with WBA.", "This segment\u2019s operating loss for the years ended March 31, 2021 and 2019 includes goodwill impairment charges of $69 million and $1.8 billion, respectively, as well as long-lived asset impairment charges for the  years ended March 31, 2021,  2020, and 2019  of $115  million,  $112  million,  and $245  million,  respectively, primarily  related to  our retail  pharmacy businesses in Canada and Europe.", "(4) Operating profit for our Medical-Surgical Solutions segment for the year ended March 31, 2021 includes charges totaling $136 million on certain PPE and other related products due to inventory impairments and excess inventory.", "(5) Operating profit for our RxTS segment for the year ended March 31, 2019 includes a gain of $56 million from the divestiture of an equity investment.", "(6) Operating loss for Other for the year ended March 31, 2020 includes an OTTI charge of $1.2 billion and a dilution loss of $246 million related to our investment in Change Healthcare JV, partially offset by a net gain of $414 million related to the completed separation of our interest in Change Healthcare JV during the fourth quarter of 2020.", "(7) Corporate expenses, net for the year ended March 31, 2021 includes a charge of $8.1 billion related to our estimated liability for opioid-related claims, net gains of $133 million  from  our  equity  investments,  and a net  gain  of $131  million  recorded  in  connection  with  insurance  proceeds  received  from  the  settlement  of  the  shareholder derivative action related to our controlled substances monitoring program.", "This was partially offset by a decrease in LIFO credits of $214 million, a charge of $50 million recorded in 2021 related to our estimated liability under the OSA, net impacts from COVID-19, including a less severe cough, cold, and flu season, as well as increased costs for strategic growth initiatives.", "Operating profit and operating profit margin were unfavorably impacted by customer mix and a decrease in net cash proceeds received of $180 million representing our share of antitrust legal settlements.", "recorded to remeasure to fair value the assets and liabilities of our German pharmaceutical wholesale business which was contributed to a joint venture with WBA, of  which  $58  million  and  $275  million  was  reflected  for  the  years  ended  March  31,  2021  and  2020,  respectively.  This  was  partially  offset  by  a  goodwill impairment charge of $69 million recorded in the second quarter of 2021 related to our European retail pharmacy business.", "This was partially offset  by  the  fair  value  remeasurement  charges  in  2020  described  above  and  a  gain  from  an  escrow  settlement  of  $97  million  in  2019  related  to  our  2017 acquisition of Rexall Health.", "Additionally,  operating  profit  was favorable  year over year  due to lower  operating  expenses, including a decrease in our provision for bad debts.", "primary care business and lower restructuring charges, partially offset by the remeasurement of assets and liabilities to fair value related to a divestiture that was completed in 2020 and higher operating expenses, including an increase in our provision for bad debts.", "and existing customers, integration costs incurred in 2019 for our acquisition of RxCrossroads that closed during the fourth quarter of 2018, partially offset by a gain of $56 million from the divestiture of an equity investment in 2019.", "investment in Change Healthcare JV, partially offset by a net gain of $414 million related to the completed separation of our interest in Change Healthcare JV during the fourth quarter of 2020.", "Operating loss for Other also includes our proportionate share of loss from Change Healthcare JV of $119 million and $194 million for the years ended March 31, 2020 and 2019, respectively.", "connection with insurance proceeds received from the settlement of the shareholder derivative action related to our controlled substances monitoring program.", "Corporate expenses, net, for 2020 includes pension settlement charges of $122 million, an opioid claim settlement charge of $82 million, and net settlement gains of $26 million recognized from our derivative contracts.", "claim settlement charge mentioned above, as well as higher costs for technology initiatives, partially offset by net settlement gains recognized in 2020 from our derivative contracts.", "Other Operating  loss  for  Other  for  the  year  ended  March  31,  2020  includes  an  OTTI charge  of  $1.2  billion  and  a  dilution  loss  of  $246  million  related  to  our", "Corporate 2021 vs. 2020 Corporate expenses, net increased for the year ended March 31, 2021 compared to the prior year due to a charge of $8.1 billion related to our estimated", "We conduct our business worldwide in local currencies including Euro, British pound sterling, and Canadian dollar.", "As a result, the comparability of our results reported in U.S. dollars can be affected by changes in foreign currency exchange rates.", "In discussing our operating results, we may use the term \u201cforeign currency exchange fluctuations,\u201d which refers to the effect of changes in foreign currency exchange rates used to convert the local currency results of our operations in foreign countries where the functional currency is not the U.S. dollar.", "We present this information to provide a framework for assessing how our business performed excluding the effect of foreign currency exchange rate fluctuations.", "In computing the foreign currency exchange fluctuations, we translate our current year results of our operations in foreign countries recorded in local currencies into U.S dollars by applying their respective average foreign currency exchange rates of the corresponding prior year periods, and we subsequently compare those results to the previously reported results of the comparable prior year periods reported in U.S. dollars.", "estimate was made and if different estimates that we reasonably could have used in the current period, or changes in the accounting estimate that are reasonably likely to occur from period to period, could have a material impact on our financial condition or results from operations.", "Below are the estimates that we believe are  critical  to  the  understanding  of  our  operating  results  and  financial  condition.  Other  accounting  policies  are  described  in  Financial  Note  1,  \u201cSignificant Accounting  Policies,\u201d  to  the  consolidated  financial  statements  appearing  in  this  Annual  Report  on  Form  10-K.  Because  of  the  uncertainty  inherent  in  such estimates, actual results may differ from these estimates.", "Other customer financing primarily relates to guarantees provided to our customers, or their creditors, regarding the repurchase of inventories.", "We also provide financing to certain customers related to the purchase of pharmacies, which serve as collateral for the loans.", "We estimate the receivables for which we do not  expect  full  collection  based  on  historical  collection  rates  and  specific  knowledge  regarding  the  current  creditworthiness  of  our  customers  and  record  an allowance in our consolidated financial statements for these amounts.", "Management reviews these factors quarterly to determine if any adjustments are needed to the allowance.", "Sales to our largest customer, CVS Health Corporation (\u201cCVS\u201d), accounted for approximately 21% of our total consolidated revenues in 2021 and comprised approximately 19% of total trade accounts receivable at March 31, 2021.", "As a result, our sales and credit concentration is significant.", "The accounts receivables balances are with individual members of the GPOs, and therefore no significant concentration of credit risk exists.", "A material default in payment, a material reduction in purchases from these or any other large customers, or the loss of a large customer or GPO could have a material adverse impact on our financial position, results of operations, and liquidity.", "We believe the reserves maintained and expenses recorded in 2021 are appropriate and consistent in the context of historical methodologies employed, as well as assessment of trends currently available.", "The selected 0.1% hypothetical change does not reflect what could be considered the best or worst-case scenarios.", "Our LIFO valuation amount includes both pharmaceutical and non-pharmaceutical products.", "We recognized LIFO credits of $38 million, $252 million, and $210 million, respectively, in 2021, 2020, and 2019 in our Consolidated Statements of Operations.", "A LIFO charge is recognized when the net effect of price increases on pharmaceutical and non-pharmaceutical products held in inventory exceeds the impact of price declines, including the effect  of branded pharmaceutical  products  that have lost market  exclusivity.  A LIFO credit  is recognized  when the net effect  of price  declines exceeds the impact of price increases on pharmaceutical and non-pharmaceutical products held in inventory.", "Excluding LIFO reserves, our inventory reserves as of March 31, 2021 and 2020 were $263 million and $96 million, respectively.", "The increase was primarily due to 2021 charges totaling $136 million on certain PPE and other related products due to inventory impairments and excess inventory within our Medical-Surgical Solutions segment.", "In 2021, 2020 and, 2019, our provision for bad debts", "At March 31, 2021 and 2020, total inventories, net were $19.2 billion and $16.7 billion, respectively, in our Consolidated Balance Sheets.", "Any purchase consideration in excess of the estimated fair values of the net assets acquired is recorded as goodwill.", "that is a form or variation of the income approach, whereby a forecast of future cash flows attributable to the asset are discounted to present value using a risk- adjusted discount rate.", "We perform an impairment test on goodwill balances annually in the third quarter and more frequently if indicators for potential impairment exist.", "equal to the amount of excess carrying value above the estimated fair value, if any, but not to exceed the amount of goodwill allocated to the reporting unit.", "we estimate fair value by comparing the business to similar businesses, or guideline companies whose securities are actively traded in public markets.", "Under the income approach, we use a discounted cash flow (\u201cDCF\u201d) model in which cash flows anticipated over several periods, plus a terminal value at the end of that time horizon, are discounted to their present value using an appropriate rate that is commensurate with the risk inherent within the reporting unit.", "Goodwill  and  Long-Lived  Assets: As  a  result  of  acquiring  businesses,  we  have  $9.5  billion  and  $9.4  billion  of  goodwill  at  March  31,  2021  and  2020,", "To estimate the fair value of our reporting units, we generally use a combination of the market approach and the income approach.", "Judgments made in determining an estimate of fair value may materially impact our results of operations.", "Included in the estimate of the weighted-average cost of capital is the assumption of an unsystematic risk premium to address incremental uncertainty related to the reporting units\u2019 future cash flow projections.", "An increase in the unsystematic risk premium increases the discount rate.", "Pharmaceutical  Distribution  reporting  units  in  our  International  segment,  exceeded  their  carrying  values.  The  impairment  testing  performed  in  2020  did  not indicate  any  material  impairment  of  goodwill.  The  segment  change  in  the  second  quarter  of  2021  prompted  changes  in  multiple  reporting  units  across  the Company.", "We recorded a goodwill impairment charge of $69 million in 2021 as the estimated fair value of the Europe Retail Pharmacy reporting unit was lower than its reassigned carrying value based on changes in the composition of the Europe Retail Pharmacy reporting unit within the International segment.", "At March 31, 2021, the  balance  of goodwill for the  reporting  units  in Europe  was approximately  nil  and the  remaining  balance  of goodwill  in the International segment primarily relates to one of our reporting units in Canada.", "Other risks, expenses and future developments, such as additional government actions, increased regulatory uncertainty, and material changes in key market assumptions that we were unable to anticipate as of the testing date may require us to further revise the projected cash flows, which could adversely affect the fair value of our other reporting units in future periods.", "We review intangible assets for impairment at an asset group level whenever events or changes in circumstances indicate that the carrying value of the assets may not be recoverable.", "Determination of recoverability of intangible assets is based on the lowest level of identifiable estimated future undiscounted cash flows resulting from use of the asset and its eventual disposition.", "Measurement of any impairment loss is based on the excess of the carrying value of the asset group over its fair value.", "Assumptions and estimates about future values and remaining useful lives of our purchased intangible assets are complex and subjective.", "When the decline in value is deemed to be other than temporary, an impairment is recognized to the extent that the fair value is less than the carrying value of the investment.", "We consider various factors in determining whether a loss in value of an investment is other than temporary including: the length of time and the extent to which the fair value has been below cost, the financial condition of the investees, and our intent and ability to retain the investment for a period of time sufficient to allow for recovery of value.", "Any significant changes in assumptions or judgments in assessing impairments could result in an impairment charge.", "We generally recognize employee severance costs when payments are probable and amounts are estimable.  Costs related  to contracts without future benefit or contract termination  are recognized  at the earlier of the contract termination  or  the  cease-use  dates.  Other  exit-related  costs  are  recognized  as  incurred.  In  connection  with  these  restructuring  actions,  we  also  assess  the recoverability of long-lived assets used in the business, and as a result, we may recognize accelerated depreciation and amortization reflecting shortened useful lives of the underlying assets.", "paid.  We  are  subject  to  income  taxes  in  the  U.S.  and  numerous  foreign  jurisdictions.  Significant  judgments  and  estimates  are  required  in  determining  the consolidated income tax provision and in evaluating income tax uncertainties and include those used to conclude on the tax-free nature of the separation of the Change Healthcare JV and the unrecognized tax position related to opioid-related litigation and claims, which remains unfinalized, and which may differ from the actual amounts of tax benefit recognized.", "We review our tax positions at the end of each quarter and adjust the balances as new information becomes available.", "to recover our deferred tax assets, we consider all available positive and negative evidence including our past operating results, the existence of cumulative net operating losses in the most recent years, and our forecast of future taxable income.", "In estimating future taxable income, we develop assumptions including the amount of future federal, state and foreign pre-tax operating income, the reversal of temporary differences, and the implementation of feasible and prudent tax planning strategies.", "These assumptions require significant judgment about the forecasts of future taxable income and are consistent with the plans and estimates we use to manage the underlying businesses.", "additional taxes and related interest will be due.", "If our current estimate of tax and interest liabilities is less than the ultimate settlement, an additional charge to income tax expense may result.", "If our current estimate of tax and interest liabilities is more than the ultimate settlement, a reduction to income tax expense may be recognized.", "investigations  relating  to  laws  and  regulations  and  other  matters  arising  out  of  the  normal  conduct  of  our  business.  When  a  loss  is  considered  probable  and reasonably estimable, we record a liability in the amount of our best estimate for the ultimate loss.", "When a material loss is reasonably possible or probable but a reasonable estimate cannot be made, disclosure of the proceeding is provided.", "Deferred income taxes arise from temporary differences between the tax and financial statement recognition of revenue and expense.", "Changes in tax laws and rates could also affect recorded deferred tax assets and liabilities in the future.", "We recognize liabilities for tax and related interest for issues in the U.S. and other tax jurisdictions based on our estimate of whether, and the extent to which,", "As discussed above, development of a meaningful estimate of loss or a range of potential loss is complex when the outcome is directly dependent on future negotiations with or decisions by third parties, such as regulatory agencies, the court system and other interested parties.", "As a result of ongoing, advanced discussions with state attorneys general and plaintiffs\u2019 representatives regarding a framework to resolve the claims of governmental  entities,  and  our  assessment  of  certain  other  opioid-related  claims,  we  have  reached  a  stage  at  which  a  broad  settlement  of  opioid  claims  by governmental entities is probable and recorded a charge of $8.1 billion for the year ended March 31, 2021 within \u201cClaims and litigation charges, net\u201d in our Consolidated Statement of Operations in this report.", "Because of the many uncertainties associated with any potential settlement arrangement or other resolution of opioid-related litigation, including the uncertainty of the scope of participation by plaintiffs in any potential settlement, we are not able to reasonably estimate the upper or lower ends of the range of ultimate possible loss for all opioid-related litigation matters.", "While we are not able to predict the outcome or reasonably estimate a range of possible losses in these matters, an adverse judgment or negotiated resolution in any of these matters could have a material adverse effect on our results of operations, consolidated financial position, cash flows or liquidity.", "facilities and commercial paper program, will be sufficient to fund our short-term and long-term capital expenditures, working capital, and other cash requirements.", "We continue to monitor its impact on demand within parts of our business, as well as trends potentially impacting the timing or ability for some of our customers to pay amounts owed to us.", "We remain well-capitalized with access to liquidity from our $4.0 billion revolving credit facility.", "Additionally, long-term debt markets and commercial paper markets, our primary sources of capital after cash flow from operations, have remained open and accessible to us during the COVID-19 pandemic.", "We have seen continued improvement in conditions in the debt markets and commercial paper markets as the Federal Reserve has taken steps to stabilize the markets.", "At March 31, 2021, we were in compliance with all debt covenants, and believe we have the ability to continue to meet our debt covenants in the future.", "Cash flows from operations can be significantly impacted by factors such as the timing of receipts from customers and payments to vendors.", "Operating activities for the year ended March 31, 2021 were affected by net income adjusted for non-cash items, including the pre-tax $8.1 billion (after-tax $6.8 billion) non-cash charge related to our estimated liability for opioid-related claims, an increase in inventory of $2.3 billion and an increase in drafts and accounts payable of $1.3 billion driven by higher inventory stock levels to meet increased volume demand as part of our inventory management, as well as a decrease in receivables of $1.1 billion driven by timing, higher sales recognized at the end of March 2020, and higher collections in our fourth quarter of 2021.", "value remeasurement charges of $58 million related to the contribution of our German pharmaceutical wholesale business to a joint venture with WBA.", "Additionally, we made a cash payment of $114 million from the executive benefit retirement plan in 2020.", "Investing activities for the year ended March 31, 2021 also includes net cash proceeds of $400 million from sales of businesses and investments, including $286 million in exchange for the contribution of our German pharmaceutical wholesale business to a joint venture with WBA.", "Cash used for other financing activities generally includes payments to noncontrolling interests and activity from our finance leases.", "We received cash from long-term debt issuances of $1.1 billion and made repayments on long-term debt of $1.1 billion in 2019.", "The timing of any repurchases and the actual number of shares repurchased will depend on a variety of factors, including our stock price, corporate and regulatory requirements, restrictions under our debt obligations, and other market and economic conditions.", "In accordance with our accounting policy, we allocate any excess of share repurchase price over par value between additional paid-in capital and retained earnings.", "Accordingly, our retained earnings and additional paid-in capital were reduced by $472 million and $70 million during 2019, respectively.", "outstanding shares of SpinCo common stock, which held all of the Company\u2019s interests in the Change Healthcare JV, to participating holders of the Company\u2019s common  stock  in  exchange  for  15.4  million  shares  of  McKesson  stock,  which  are  now  held  as  treasury  stock  on  our  consolidated  balance  sheet.  Following consummation of the exchange offer, on March 10, 2020, SpinCo merged with and into Change and each share of SpinCo common stock was converted into one share of Change common stock, par value $0.001 per share, with cash being paid in lieu of fractional shares of Change common stock.", "give us the ability to meet our financing needs for the foreseeable future.", "However, there can be no assurance that an increase in volatility or disruption in the global capital and credit markets will not impair our liquidity or increase our costs of borrowing.", "As described within the \u201cTrends and Uncertainties\u201d section above,  the  COVID-19  pandemic  continues  to  develop  rapidly.  We  continue  to  monitor  its  impact  on  demand  within  parts  of  our  business,  as  well  as  trends potentially impacting the timing or ability for some of our customers to pay amounts owed to us.", "(2) This ratio describes the relationship and changes within our capital resources, and is computed as total debt divided by the sum of total debt and McKesson stockholders\u2019 equity (deficit), which excludes noncontrolling and redeemable noncontrolling interests and accumulated other comprehensive loss. (3) Ratio is computed as net income (loss) attributable to McKesson Corporation for the last four quarters, divided by a five-quarter average of McKesson stockholders\u2019 equity (deficit), which excludes noncontrolling and redeemable noncontrolling interests.", "In 2019, we retired 5.0 million or $542 million of the Company\u2019s treasury shares previously repurchased.", "In connection with the Split-off, we distributed all 176.0 million", "Deposits with financial institutions are primarily denominated in U.S. dollars and the functional currencies of our foreign subsidiaries, including Euro, British pound sterling, and Canadian dollars.", "We mitigate the risk of our short-term investment portfolio by depositing funds with reputable financial institutions and monitoring risk profiles and investment strategies of money market funds. outside of the U.S., respectively.", "Our primary intent is to utilize this cash for foreign operations for an indefinite period of time.", "Although the vast majority of cash held outside the U.S. is available for repatriation, doing so could subject us to foreign withholding taxes and state income taxes.", "The COVID-19 pandemic has potential to increase the variations in our working capital, which we continue to monitor closely. partially offset by an increase in drafts and accounts payable and a decrease in receivables.", "Our unfavorable return on McKesson\u2019s stockholder\u2019s equity (deficit) as of March 31, 2021 was also driven by net loss for the year.", "Net loss for the year ended March 31, 2021 includes an after-tax non-cash charge of $6.8 billion related to our estimated liability for opioid-related claims, as discussed in \u201cTrends  and  Uncertainties\u201d of  this  Financial  Review  and  Financial  Note  19,  \u201cCommitments  and  Contingent  Liabilities,\u201d  to  the  accompanying  consolidated financial statements included in this Annual Report on Form 10\u2011K.", "Our debt to capital ratio increased for 2020 primarily due to a decrease in stockholders\u2019 equity driven by the Split-off of our interest in Change Healthcare JV and share repurchases.", "We anticipate that we will continue to pay quarterly cash dividends in the future.", "However, the payment and amount of future dividends remain within the discretion of the Board and will depend upon our future earnings, financial condition,  capital  requirements,  and  other  factors.  In  2021,  2020,  and  2019,  we  paid  total  cash  dividends  of  $276  million,  $294  million,  and  $292  million, respectively.  Additionally,  as  required  under  the  Domination  Agreement,  we  are  obligated  to  pay  an  annual  recurring  compensation  amount  of  \u20ac0.83  per McKesson Europe share (effective January 1, 2015) to the noncontrolling shareholders of McKesson Europe.", "Cash equivalents, which are readily convertible to known amounts of cash, are carried at fair value.", "Our cash and cash equivalents balance as of March 31, 2021 and 2020 included approximately $2.3 billion and $1.7 billion of cash held by our subsidiaries", "On  July  29,  2020,  we  raised  our  quarterly  dividend  from  $0.41  to  $0.42  per  common  share  for  dividends  declared  on  or  after  such  date  by  the  Board.", "(3) Includes our estimated benefit payments for the unfunded benefit plans and minimum funding requirements for the pension plans. (4) Primarily represents interest that will become due on our fixed rate long-term debt obligations.", "These obligations primarily relate to inventory purchases and capital commitments. (6) Includes agreements under which we have guaranteed the repurchase of our customers\u2019 inventory and our customers\u2019 debt in the event these customers are unable to meet their obligations to those financial institutions.", "The ultimate amount and timing of any future cash settlements related to these items cannot be predicted with reasonable certainty.", "and are mostly related to our customer contracts and to meet the security requirements for statutory licenses and permits, court and fiduciary obligations, and our workers\u2019 compensation and automotive liability programs.", "The exercise of the Put Right will reduce the balance of redeemable noncontrolling interests.", "During 2021, we paid $49 million to purchase 1.8 million shares of McKesson Europe through exercises of the Put Right by the noncontrolling shareholders.", "Our banks and insurance companies have issued $146 million of standby letters of credit and surety bonds at March 31, 2021.", "redemption value is the Put Amount adjusted for exchange rate fluctuations each period.", "In future periods, unfavorable foreign currency exchange rate fluctuations between the Euro and the U.S. dollar could adversely impact the carrying value of our redeemable noncontrolling interests and require an adjustment to increase the balance of our redeemable noncontrolling interests to its maximum redemption value.", "On April 12, 2021, we received the Stuttgart Court of Appeals\u2019 final ruling confirming the original put value of \u20ac22.99 per share and the annual recurring compensation of \u20ac0.83 per McKesson Europe share.", "Funds necessary for future debt maturities and our other cash requirements are expected to be met by existing cash balances, cash flow from operations, existing credit sources, and other capital market transactions.", "The effect of a hypothetical 50 bp increase in the underlying interest rate on our cash and cash equivalents, net of short-term borrowings and variable rate debt, would have resulted in a favorable impact to earnings in 2021 and 2020 of approximately $17 million and $6 million, respectively.", "The balance of redeemable noncontrolling interests is reported at the greater of its carrying value or its maximum redemption value at each reporting date.", "Additionally,  we  are  obligated  to  pay  an  annual  recurring  compensation  of  \u20ac0.83  per  McKesson  Europe  share  (the  \u201cCompensation  Amount\u201d)  to  the", "Interest rate risk: Our long-term debt bears interest predominately at fixed rates, whereas our short-term borrowings are at variable interest rates.", "Our cash and cash equivalents balances earn interest at variable rates.", "At March 31, 2021 and 2020, we had $6.3 billion and $4.0 billion, respectively, in cash", "Changes in foreign currency exchange rates could have a material adverse impact on our financial results that are reported in U.S. dollars.", "We are also exposed to foreign exchange rate risk related to our foreign subsidiaries, including intercompany loans denominated in non-functional currencies.", "These programs reduce but do not entirely eliminate foreign exchange risk.", "fair value of our foreign exchange contracts by approximately $267 million and $435 million, respectively.", "Foreign exchange risk: We conduct our business worldwide in U.S. dollars and the functional currencies of our foreign subsidiaries, including Euro, British", "We have certain foreign exchange rate risk programs that use foreign currency forward contracts and cross-currency swaps.", "Based on this assessment, our management has concluded that our internal control over financial reporting was effective as of March 31, 2021.", "In our opinion, the financial statements referred to above present fairly, in all material respects, the financial position of the Company as of March 31, 2021 and 2020, and the results of its operations and its cash flows for each of the three years in the period ended March 31, 2021, in conformity with accounting principles generally accepted in the United States of America.", "Also, in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of March 31, 2021, based on criteria established in Internal Control \u2014 Integrated Framework (2013) issued by COSO.", "Our responsibility is to express an opinion on these financial statements and an opinion on the Company\u2019s internal control over financial reporting based  on  our  audits.  We  are  a  public  accounting  firm  registered  with  the  Public  Company  Accounting  Oversight  Board  (United  States)  (\u201cPCAOB\u201d)  and  are required  to  be  independent  with  respect  to  the  Company  in  accordance  with  the  U.S.  federal  securities  laws  and  the  applicable  rules  and  regulations  of  the Securities and Exchange Commission and the PCAOB.", "We conducted our audits in accordance with the standards of the PCAOB.", "Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.", "Our audits of the financial statements included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures to respond to those risks.", "Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements.", "Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk.", "Our audits also included performing such other procedures as we considered necessary in the circumstances.", "We believe that our audits provide a reasonable basis for our opinions.", "The critical audit matters communicated below are matters arising from the current-period audit of the financial statements that were communicated or required to be communicated to the audit committee and that (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments.", "The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.", "The Company also performs an assessment of loss contingencies where a loss is reasonably possible.", "We identified the potential broad settlement of opioid claims as a critical audit matter because of the significant judgment and challenges auditing management\u2019s determination  of  whether  such  loss  is  probable  and  reasonably  estimable.  Specifically,  auditing  management\u2019s  determination  and  disclosure  of  whether  the contingent loss arising from the potential broad settlement of opioid claims is probable, and the related measurement of such loss, is subjective and requires significant judgment given that the potential loss is based upon settlement terms that have not yet been finalized.", "\u2022 We tested the effectiveness of internal controls related to the potential broad settlement of opioid claims, and approval of the accounting treatment and related disclosures based on the most recent facts and circumstances.", "In addition, we inspected responses to inquiry letters sent to both internal and external legal counsel as it relates to the status of discussions with plaintiffs\u2019 counsel and the Company\u2019s intent regarding the framework for a potential broad settlement of opioid claims.", "\u2022 We evaluated management\u2019s analysis of the potential broad settlement of opioid claims, including the methodology used by management to determine the probability of such loss.", "We also evaluated the methodology used by management to estimate the most likely loss to be incurred by the Company as a result of a potential broad settlement of opioid claims.", "\u2022 We performed public domain searches for evidence contrary to management\u2019s analysis.", "\u2022 We evaluated any events subsequent to March 31, 2021 that might impact our evaluation of the potential broad settlement of opioid claims. \u2022 We obtained written representations from executives and internal counsel of the Company. \u2022 We examined proposed terms related to the potential broad settlement framework. \u2022 We evaluated the Company\u2019s related disclosures for consistency with our testing.", "The net amount recognized by management is measured as the largest amount of tax benefit that is greater than 50 percent likely of being realized.", "We identified the Company\u2019s uncertain tax position related to the charge for the potential broad settlement of opioid claims as a critical audit matter because of the challenges in auditing management\u2019s estimate of the amount of income tax benefit that qualifies for recognition.", "Our audit procedures related to the Company's uncertain tax position associated with a potential broad settlement of opioid claims included the following, among others: \u2022 We tested the effectiveness of internal controls related to the Company\u2019s assessment of the technical merits of its tax position, including the Company\u2019s assessment as to the amount of benefit that is more likely than not to be realized. \u2022 With  the  assistance  of  our  tax  specialists,  we  evaluated  the  facts,  evidence  and  the  Company\u2019s  related  income  tax  analysis  for  the  charge  related  to  the potential broad settlement of opioid claims, including assumptions used by management to measure the related recognized and unrecognized tax benefits. \u2022 We inquired of the Company\u2019s internal and external legal counsel to understand the basis for the Company\u2019s conclusion that a portion of the potential broad settlement of opioid claims would be deductible based on the most recent discussions with plaintiffs\u2019 counsel.", "\u2022 We  compared  management's  income  tax  assessment  of  this  matter  to  the  treatment  of  other  recorded  opioid  charges  to  evaluate  the  consistency  of  the Company\u2019s judgments related to the uncertain tax position. \u2022 We evaluated any events subsequent to March 31, 2021 that might impact our evaluation of the Company\u2019s uncertain tax position related to the charge for the potential broad settlement of opioid claims.", "\u2022 We obtained written representations from executives and internal counsel of the Company. \u2022 We examined proposed terms related to the potential broad settlement framework.", "\u2022 We evaluated the Company\u2019s related disclosures for consistency with our testing and also searched for contradictory evidence by reading disclosures from peer companies, who are also party to the potential broad settlement of opioid claims.", "We identified the estimation of the fair value of the McKesson Canada reporting unit used to evaluate the recoverability of goodwill as a critical audit matter because of the challenges auditing significant judgments used in the selection of a discount rate, including the unsystematic risk premium.", "In particular, the fair value estimate is sensitive to the unsystematic risk premium assumption, which is affected by expected risk of changes in the Canadian business and regulatory environments.", "Auditing management\u2019s selected discount rate required a high degree of auditor judgment and an increased extent of effort, including the need to involve more senior members of the team and our fair value specialists.", "Our audit procedures related to the Company\u2019s selection of a discount rate, including consideration of the unsystematic risk premium, for the McKesson Canada reporting unit included the following, among others: \u2022 We tested the effectiveness of internal controls related to management\u2019s goodwill impairment evaluation, including those related to the selection of a discount rate and consideration of an unsystematic risk premium. \u2022 We  evaluated  management\u2019s  ability  to  accurately  forecast  operating  results  for  the  McKesson  Canada  reporting  unit  by  comparing  actual  results  to management\u2019s historical forecasts, in order to consider the reasonableness and adequacy of management\u2019s selected unsystematic risk premium. \u2022 As part of our assessment of the unsystematic risk premium, we evaluated the reasonableness of strategic plans expected to be implemented during the forecast period by comparing the forecasts to:", "\u2022 With the assistance of our fair value specialists, we evaluated the reasonableness of the discount rate, including the unsystematic risk premium, by developing a range of independent estimates, testing the mathematical accuracy of the calculation and comparing to the discount rate selected by management.", "We have served as the Company\u2019s auditor since 1968.", "The Company consolidates VIEs when it is determined that it is the primary beneficiary of the VIE.", "Investments in business entities in which the Company does not have control but has the ability to exercise significant influence over operating and financial policies, are accounted for using the equity method.", "Actual amounts could differ from those estimated amounts.", "These legislative acts are not expected to have a material impact on the Company\u2019s consolidated financial results.", "The Company considers itself to control an entity if it is the majority owner of or has voting control over such entity.", "GAAP requires that the Company make estimates and assumptions that", "If a loss in value has occurred that is deemed to be other-than-temporary, an impairment loss is recorded.", "economic environment, customer credit ratings or bankruptcies, as well as reasonable and supportable forecasts.", "We are exposed to credit losses on accounts receivable balances.", "As a result, the Company\u2019s sales and credit concentration is significant.", "The accounts receivables balances are with individual members of the GPOs, and therefore no significant concentration of credit risk exists.", "This credit risk is mitigated by the size and diversity of the Company\u2019s customer base as well as its geographic dispersion.", "These amounts are equivalent to the Company\u2019s LIFO reserves.", "A LIFO credit is recognized when the net effect of price declines exceeds the impact of price increases on pharmaceutical and non-pharmaceutical products held in inventory.", "The increase was primarily due to charges in 2021 totaling $136 million on certain personal protective equipment and other related products due to inventory impairments and excess inventory within our Medical-Surgical Solutions segment.", "When the net realizable value of a disposal group increases during a period, a gain can be recognized to the extent that it does not increase the value of the disposal group beyond its original carrying value when the disposal group was reclassified as held for sale.", "Depreciation and amortization begins when an asset is placed in service and ready for its intended use.", "The use of alternative assumptions and estimates could affect the fair values and change the impairment determinations.", "Measurement of any impairment loss is based on the excess of the carrying value of the asset group over its estimated fair market value.", "customer in an amount that reflects the consideration to which the entity expects to be entitled for that good or service.", "Revenue is recognized when control of goods is transferred to the customer which occurs upon the Company\u2019s delivery to the customer or upon customer  pick-up.", "The ultimate outcome of any outstanding claims may be different than the Company\u2019s estimate.", "If a derivative is designated as a fair value hedge, the changes in the fair value of the derivative and of the hedged item attributable to the hedged risk are recognized in earnings.", "The cumulative changes in fair value are reclassified to the same line as the hedged item in the Consolidated Statements of Operations when the hedged item affects earnings.", "Noncontrolling interests with redemption features, such as put rights, that are not solely within the Company\u2019s control are considered redeemable noncontrolling interests.", "When a loss is considered probable and reasonably estimable, the Company records a liability in the amount of its best estimate for the ultimate loss.", "When a material loss is reasonably possible or probable, but a reasonable estimate cannot be made, disclosure of the proceeding is provided.", "As discussed above, development of a meaningful estimate of loss or a range of potential loss is complex when the outcome is directly dependent on negotiations with or decisions by third parties, such as regulatory agencies, the court system, and other interested parties.", "Any purchase consideration in excess of the estimated fair values of the net assets acquired is recorded as goodwill.", "Restructuring Charges: Employee severance costs are generally recognized when payments are probable and amounts are reasonably estimable.", "The forward-looking model requires the Company to consider historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount in estimating credit losses.", "The adoption of this amended guidance is not expected to have a material impact on the Company\u2019s consolidated financial statements or disclosures.", "accounting policy has been to disclose any intervening events of the joint venture in the lag period that could materially affect its consolidated financial statements.", "McKesson had the ability to adjust the manner in which certain depreciation or amortization deductions are allocated among Change and McKesson.", "This creates uncertainty over the amount, timing, and probability of the gain recognized.", "Any such change is not expected to have a material impact on the Company\u2019s consolidated financial statements.", "This initiative was substantially complete in 2021 and remaining costs the Company expects to record under this initiative are not material.", "This set of initiatives was substantially complete by the end of 2020 and charges in 2021 were not material.", "Goodwill recognized for business acquisitions is generally not expected to be deductible for tax purposes.", "share-based awards that will ultimately vest primarily based on historical experience.", "The estimated forfeiture rate established upon grant is re-assessed throughout the requisite service period and is adjusted when actual forfeitures occur.", "The actual forfeitures in future reporting periods could be higher or lower than current estimates.", "PSUs have a requisite service period of generally three years.", "Compensation expense for the share-based awards is recognized for the portion of awards ultimately expected to vest.", "The number of vested PSUs is assessed at the end of a", "All  outstanding  PeRSU awards  have  completed  the  performance  period  and  are  now classified  and  accounted  for  as RSUs.", "portion of the awards that is ultimately expected to vest.", "Once the fair value of an employee stock option is determined, current accounting practices do not permit it to be changed, even if the estimates used are different from actual.", "The Company believes this market-based input provides a reasonable estimate of its future stock price movements and is consistent with employee stock option valuation considerations.", "These amounts have not been significant for all the years presented.", "Substantially all its foreign net operating losses have indefinite lives.", "The decrease in unrecognized tax benefits in 2020  compared  to  2019  is  primarily  attributable  to  the  favorable  resolution  of  an  outstanding  California  tax  refund  claim  which  decreased  unrecognized  tax benefits by $91 million.", "2017 Tax Act, the repatriation of cash to the U.S. is generally no longer taxable for federal income tax purposes.", "The Company may remit foreign earnings to the U.S. to the extent it is tax efficient to do so.", "It does not expect the tax impact from remitting these earnings to be material.", "The exercise of the Put Right will reduce the balance of redeemable noncontrolling interests.", "The adoption of this guidance did not have a material impact on the Company\u2019s consolidated statements of operations and cash flows.", "The Company\u2019s lease agreements do not contain any material residual value guarantees or material restrictive covenants.", "Operating lease liabilities are recognized based on the present value of the future lease payments over the lease term, discounted at the Company\u2019s incremental borrowing rate as the implicit rate in the lease is not readily determinable for most of the Company\u2019s leases.", "As a practical expedient, short-term leases with an initial term of 12 months or less are excluded from the Consolidated Balance Sheets and charges from these leases are expensed as incurred.", "Fair value estimates result from a complex series of judgments about future events and uncertainties and rely heavily on estimates and assumptions that have been deemed reasonable by management as of the measurement date.", "The unsystematic risk premium is an input factor used in calculating the discount rate that specifically addresses uncertainty related to the reporting unit\u2019s future cash flow projections.", "The risk of successfully achieving certain business initiatives was the primary factor in the use of a higher discount rate.", "and, from time-to-time, future unsecured and unsubordinated indebtedness outstanding.", "As a result of absorbing this risk, the leases provide the Company with the power to direct the operations of the leased properties and the obligation to absorb losses or the right to receive benefits of the entity.", "Consolidated VIEs do not have a material impact on the Company\u2019s Consolidated Statements of Operations and Cash Flows.", "their economic performance and thus is not considered the primary beneficiary of the entities.", "The pension obligation in Germany is unfunded with the exception of the contractual trust arrangement used to fund pensions of McKesson Europe\u2019s Management Board.", "actuarial  losses  exceeding  10%  of  the  greater  of  the  projected  benefit  obligation  or  the  market  value  of  assets  are  amortized  straight-line  over  the  average remaining future service period of active employees.", "Pension obligations for its unfunded plans are based on the recommendations of independent actuaries.", "The difference between actual inflation and assumed inflation in our U.K. pension plans resulted in a gain of $23 million.", "corporate bonds rated AA or better whose maturities are aligned with the expected benefit payments of its plans.", "Plan assets of the non-U.S. plans are broadly invested in a manner appropriate to the nature and duration of the expected future retirement benefits payable under the plans.", "Assets are properly diversified to avoid excessive reliance on any particular asset, issuer, or group of undertakings so as to avoid accumulations of risk in the portfolio as a whole.", "practical expedient are not leveled within the fair value hierarchy and are included as a reconciling item to total investments.", "Actions taken by other participating employers may lead to adverse changes in the financial condition of a multiemployer benefit plan and the Company\u2019s withdrawal liability and contributions may increase.", "It does not use derivatives for trading or speculative purposes.", "Eligible employees may contribute to the RSP up to 75% of", "In the normal course of business, the Company is exposed to interest rate and foreign currency exchange rate fluctuations.", "These forward contracts and cross-currency swaps are generally used to offset the potential income statement effects from intercompany loans and other obligations denominated in non-functional currencies.", "These programs reduce but do not entirely eliminate foreign currency exchange rate risk.", "To the extent foreign currency-denominated notes designated as net investment hedges are ineffective, changes in carrying value attributable to the change in spot rates are recorded in earnings.", "To the extent cross-currency swaps designated as hedges are ineffective, changes in carrying value attributable to the change in spot rates are recorded in earnings.", "Changes in fair values representing hedge ineffectiveness are recognized in current earnings.", "The settlement loss on the swaps was not material and will be amortized on a straight-line basis as interest expense over the five-year life of the 2025 Notes.", "Gains or losses from these contracts are largely offset by changes in the value of the underlying intercompany obligations.", "Changes in the fair value for contracts not designated as hedges are recorded directly in earnings.", "The carrying value of all other cash equivalents approximates their fair value due to their relatively short-term nature.", "These inputs are considered Level 2 under the fair value measurements and disclosure guidance and may not be representative of actual values that could have been realized or that will be realized in the future.", "If the carrying amount of an asset group is not recoverable, an impairment charge is recorded to reduce the carrying amount by the excess over its fair value.", "repurchase of its customers\u2019 inventory or its customers\u2019 debt in the event these customers are unable to meet their obligations to those financial institutions.", "For the Company\u2019s inventory repurchase agreements, among other requirements, inventories must be in resalable condition and any repurchase would be at a discount.", "The majority of the Company\u2019s customers\u2019 debt guarantees are secured by certain assets of the customer.", "The Company\u2019s long-term debt is also recorded at cost.", "The carrying value and fair value of the Company\u2019s long-term debt was as follows:", "Long-lived Assets The Company utilizes multiple approaches including the DCF model and market approaches for estimating the fair value of intangible assets.", "infringe a third party\u2019s intellectual property rights.", "Where appropriate, obligations for such indemnifications are recorded as liabilities.", "Accrued warranty costs were not material to the Consolidated Balance Sheets.", "Significant developments in those matters are described below.", "Company  is  unable  to  determine  that  a  loss  is  probable,  or  to  reasonably  estimate  the  amount  of  loss  or  a  range  of  loss,  for  a  claim  because  of  the  limited information  available  and  the  potential  effects  of future  events  and  decisions  by third  parties,  such  as  courts  and  regulators,  that  will  determine  the  ultimate resolution of the claim.", "It is not uncommon for claims to remain unresolved over many years.", "The Company reviews loss contingencies at least quarterly to determine whether the likelihood of loss has changed and whether it can make a reasonable estimate of the loss or range of loss.", "When the Company determines that a loss from a claim is probable and reasonably estimable, it records a liability for an estimated amount.", "The Company also provides disclosure when it is reasonably possible that a loss may be incurred or when it is reasonably possible that the amount of a loss will exceed its recorded liability.", "Warranties In the normal course of business, the Company provides certain warranties and indemnification protection for its products and services.", "These two West Virginia plaintiffs are not expected to participate in any broader multistate resolution of opioid-related claims.", "The Cherokee Nation is not expected to participate in any broader multistate resolution of opioid-related claims.", "Those non-participating governmental entities would be entitled to pursue their claims against the Company and other defendants.", "The Company believes that it has valid defenses to the claims pending against it, and it intends to vigorously defend against all such claims if acceptable settlement terms are not achieved.", "The Company believes it has valid legal defenses in these matters and intends to mount a vigorous defense.", "The Company has not concluded a loss is probable in any of these matters; nor is the amount of any loss reasonably estimable.", "An adverse judgment or negotiated resolution in any of these matters could have a material adverse impact on the Company\u2019s financial position, cash flows or liquidity, or results of operations.", "AIG and ACE are seeking declarations that they have no duty to defend or indemnify McKesson in the thousands of lawsuits pending in federal and state courts related to opioids.", "Discussions with attorneys general and other parties continue.", "If the negotiating parties agree on terms under the framework for a broad resolution of claims of", "Plaintiffs\u2019 moved for summary judgment on the same day.", "subpoenas and requests in a cooperative, thorough and timely manner.", "These responses sometimes require time and effort and can result in considerable costs being incurred by the Company.", "Such subpoenas and requests can lead to the assertion of claims or the commencement of civil or criminal legal proceedings against the Company and other members of the health care industry, as well as to settlements of claims against the Company.", "The Company responds to these requests in the ordinary course of business.", "The law adopting the excise tax made clear that the OSA does not apply to sales or distributions occurring after December 31, 2018.", "It is not certain at this point in time what proportion of this estimated liability will be borne by the Company.", "However, it is possible that the ultimate costs of these matters may exceed or be less than the reserves.", "Due to the complex nature of the tax laws, it is not possible to estimate the outcome of these matters.", "improper actions to delay or prevent generic drugs from entering the market.", "The quarterly results of operations are not necessarily indicative of the results that may be expected for the entire year.", "effectiveness of the Company\u2019s \u201cdisclosure controls and procedures\u201d (as such term is defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) as of the end of the period  covered  by  this  report  and  have  concluded  that  our  disclosure  controls  and  procedures  are  effective  based  on  their  evaluation  of  these  controls  and procedures as required by paragraph (b) of Exchange Act Rules 13a-15 or 15d-15.", "Rules 13a-15 or 15d-15 that occurred during our fourth quarter of 2021 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.", "caption  \u201cInvestors  -  Corporate  Governance.\u201d  The  Company\u2019s  Corporate  Governance  Guidelines  and  Charters  for  the  Audit,  Compensation  and  Governance Committees can also be found on our website under the same caption.", "Information  about the Code of Conduct applicable  to all employees, officers  and directors can be found on our website, www.mckesson.com, under the", "Information with respect to this item is incorporated by reference from the discussion under the heading \u201cExecutive Compensation\u201d in our Proxy Statement.", "Such non-employee director award is fully vested on the date of the grant.", "subject to and qualified in their entirety by reference to our amended and restated certificate of incorporation, our amended and restated by- laws  and  the  Delaware  General  Corporation  Law  (\u201cDGCL\u201d).  Copies  of  our  amended  and  restated  certificate  of  incorporation  and  our amended and restated by-laws have been filed with the Securities and Exchange Commission (the \u201cSEC\u201d) and are incorporated by reference herein. 100,000,000 shares are preferred stock, par value $0.01 per share.", "We may amend from time to time our amended and restated certificate of incorporation to increase the number of authorized shares of Common Stock and/or preferred stock.", "Any such amendment would require the approval of the holders of a majority of our shares entitled to vote.", "All of our outstanding shares of Common Stock are fully paid and non- assessable.", "Stock are entitled to receive ratably dividends out of assets legally available therefor at such times and in such amounts as our board of directors may from time to time determine.", "ratably in our assets that are legally available for distribution, after payment of all debts, other liabilities and any liquidation preferences of outstanding preferred stock.", "amended and restated certificate of incorporation does not provide for cumulative voting in the election of directors.", "Upon liquidation, dissolution or winding up of our affairs, the holders of Common Stock are entitled to share", "Holders of our Common Stock have no conversion, redemption, preemptive or similar", "Each outstanding share of Common Stock is entitled to one vote on all matters submitted to a vote of stockholders.", "Anti-Takeover Effects of Provisions of Our Amended and Restated Certificate of Incorporation and Our Amended and Restated By- Laws deemed to have an anti-takeover effect and may delay, deter or prevent a tender offer or takeover attempt that a stockholder might consider in its best interest, including those attempts that might result in a premium over the market price for the shares held by stockholders.", "Our amended and restated by-laws provide that special meetings of holders of Common Stock may be called only by our Chair, Chief Executive Officer or a majority of our board of directors for any purpose at any time.", "Holders of Common Stock owning at least 15% of the outstanding shares of Common Stock for at least one year are permitted to submit a special meeting request in accordance with the procedures described in our amended and restated by-laws.", "In general, notice of intent to nominate a director or raise business at such meetings must be received by us not less than 90 nor more than 120 days prior to the date of the  annual meeting and must contain certain specified  information concerning the person to be nominated or the matters to be brought before the meeting and concerning the stockholder submitting the proposal.", "may be amended by a vote of a majority of our board of directors and by the affirmative vote of a majority of the shares of the corporation entitled  to  vote  thereon.  Our  amended  and  restated  certificate  of  incorporation  and  our  amended  and  restated  by-laws  provide  that  our amended and restated by-laws may be amended by a vote of a majority of our board of directors.", "In addition, our amended and restated by- laws provide that our amended and restated by-laws may be amended by the affirmative vote of a majority of the shares of the corporation entitled to vote thereon.", "Current and former stockholders are deemed to have consented to the personal jurisdiction of the Delaware Courts in connection with any action to enforce that exclusive forum provision and to service of process in any such action.", "We  are  subject  to  the  \u201cbusiness  combination\u201d  statute  of  the  DGCL.  In  general,  such  statute  prohibits  a  publicly  held  Delaware", "The statute could prohibit or delay mergers or other takeover or change in control attempts with respect to us and, accordingly, may discourage attempts to acquire us.", "stock could decrease the amount available for distribution to holders of our Common Stock or could adversely affect the rights and powers, including voting rights, of such holders.", "The issuance of preferred stock could have the effect of delaying or preventing a change in control of us.", "Such limitation does not, however, affect the liability of a director (1) for any breach of the director\u2019s duty of loyalty to us or our stockholders, (2) for acts or omissions not in good faith or that involve intentional misconduct or a knowing violation of law, (3) in respect of certain unlawful dividend payments or stock redemptions or purchases and (4) for any transaction from which the director derives an improper personal benefit.", "The effect of this provision is to eliminate our rights and the rights of our stockholders (through stockholders\u2019 derivative suits) to recover monetary damages against a director for breach of the fiduciary duty of care as a director (including breaches resulting from negligent or grossly negligent behavior) except in the situations described in clauses (1) through (4) above.", "This provision does not limit or eliminate our rights or the rights of our stockholders to seek non-monetary relief such as an injunction or rescission in the event of a breach of a director\u2019s duty of care.", "In addition, our directors and officers have indemnification protection.", "principal amount of 0.625% Notes due 2021 and \u20ac600,000,000 aggregate principal amount of 1.500% Notes due 2025, and on February 12, 2018, we issued \u20ac500,000,000 aggregate principal amount of 1.625% Notes due 2026.", "existing and future unsecured and unsubordinated indebtedness from time to time outstanding.", "EQ Shareowner Services acts as transfer agent and registrar of our Common Stock.", "Our Common Stock is listed on the New York Stock Exchange under the symbol \u201cMCK\u201d.", "On  February  17,  2017,  we  issued  \u00a3450,000,000  aggregate  principal  amount  of  3.125%  Notes  due  2029,  \u20ac600,000,000  aggregate", "Securities\u201d), our senior subordinated debt (\u201cSenior Subordinated Debt Securities\u201d), our subordinated debt (\u201cSubordinated Debt Securities\u201d) or our  junior  subordinated  debt  (\u201cJunior  Subordinated  Debt  Securities\u201d  and,  together  with  the  Senior  Subordinated  Debt  Securities  and  the Subordinated Debt Securities, the \u201cSubordinated Securities\u201d).  The Indenture does not limit the amount of debt securities that we may issue.", "It provides that we may issue debt securities up to the principal amount that we may authorize and may be in any currency or currency unit designated  by  us.  Except  for  the  limitations  on  consolidation,  merger  and  sale  of  all  or  substantially  all  of  our  assets  contained  in  the Indenture, the terms of the Indenture do not contain any covenants or other provisions designed to afford holders of any debt securities protection with respect to our operations, financial condition or transactions involving us.", "any person unless (a) we will be the continuing corporation or (b) the successor corporation or person formed by such consolidation or into which we are merged or to which our assets substantially as an entirety are transferred or leased is a corporation, limited liability company or limited partnership organized or existing under the laws of the United States, any state of the United States or the District of Columbia and, if such entity is not a corporation, a co-obligor of the debt securities is a corporation organized or existing under any such laws, and such successor corporation or person, including such co-obligor, if any, expressly assumes our obligations on the debt securities and under the Indenture.", "In addition, we cannot effect such a transaction unless immediately after giving effect to such transaction, no default or Event of Default under the Indenture shall have occurred and be continuing.", "Subject to certain exceptions, when the person to whom our assets are transferred or leased has assumed our obligations under the debt securities and the Indenture, we shall be discharged from all our obligations under the debt securities and the Indenture, except in limited circumstances.", "unless the transaction or change of control were structured to include a merger or consolidation or transfer or lease of all or substantially all of our assets.", "We cannot consolidate or merge with or into, or transfer or lease all or substantially all of our assets to,", "\u2022 any  other  Event  of  Default  provided  in  the  applicable  resolution  of  our  board  of  directors  or  the  officers\u2019  certificate  or supplemental Indenture under which we issue such series of debt securities.", "The Indenture imposes limitations on suits brought by holders of debt securities against us.", "officer knows of any default by us in the performance, observance or fulfillment of any condition or covenant of the Indenture.", "We and the Trustee may not, however, without the consent of the holder of each outstanding debt security affected thereby:", "The Indenture provides that we and the Trustee may enter into supplemental indentures without the", "value of the assets subject to such transaction, as determined by our Board of Directors, or (b) the present value of the remaining obligations of the lessee for net rental payments during the term of any lease discounted at the rate of interest set forth or implicit in the terms of such lease or, if not practicable to determine such rate, the weighted average interest rate per annum borne by the debt securities of each series outstanding pursuant to the Indenture and subject to limitations on sale and lease-back transaction covenants, compounded semi-annually in either case as determined by our principal accounting or financial officer.", "located,  and  substantially  all  the  operations  of  which  are  conducted,  in  the  United  States  of  America  whose  financial  statements  are consolidated with our financial statements in accordance with accounting principles generally accepted in the United States of America.", "Consolidated  Subsidiaries  incurred  after  the  date  of  issuance  of  the  notes  and  secured  by  liens  not  permitted  by  the  limitation  on  liens provisions, and (2) Attributable Debt of ours and our Consolidated Subsidiaries in respect of every sale and lease-back transaction entered into after the date of the issuance of the notes, other than leases permitted by the limitation on sale and lease-back provisions.", "accordance with accounting principles generally accepted in the United States of America.", "Subsidiaries pursuant to which we or any of our Subsidiaries sells, conveys or otherwise transfers to (1) a Receivables Subsidiary (in the case of a transfer by us or any of our Subsidiaries) or (2) any other person (in the case of a transfer by a Receivables Subsidiary), or grants a security interest in, any accounts receivable (whether now existing or arising in the future) or inventory of us or any of our Subsidiaries, and any assets related thereto including, without limitation, all collateral securing such accounts receivable, all contracts and all guarantees or other  obligations  in  respect  of  such  accounts  receivable  or  inventory,  proceeds  of  such  accounts  receivable  and  other  assets  which  are customarily transferred or in respect of which security interests are customarily granted in connection with asset securitization transactions involving accounts receivable or inventory.", "financing of accounts receivable or inventory (a) no portion of the Indebtedness or any other obligations (contingent or otherwise) of which (1)  is  guaranteed  by  us  or  any  Subsidiary  of  ours  (excluding  guarantees  of  obligations  (other  than  the  principal  of,  and  interest  on, Indebtedness) pursuant to representations, warranties, covenants and indemnities entered into in the ordinary course of business in connection with  a  Qualified  Receivables  Transaction),  (2)  is  recourse  or  obligates  us  or  any  Subsidiary  of  ours  in  any  way  other  than  pursuant  to representations,  warranties,  covenants  and  indemnities  entered  into  in  the  ordinary  course  of  business  in  connection  with  a  Qualified Receivables Transaction or (3) subjects any property or asset of ours or any Subsidiary of ours (other than accounts receivable or inventory and related assets as provided in the definition of \u201cQualified Receivables Transaction\u201d), directly or indirectly, contingently or otherwise, to the satisfaction thereof, other than pursuant to representations, warranties, covenants and indemnities entered into in the ordinary course of business in connection with a Qualified Receivables Transaction, (b) with which neither we nor any Subsidiary of ours has any material contract, agreement, arrangement or understanding other than on terms customary for securitization of receivables or inventory and (c) with which neither we nor any Subsidiary of ours has any obligations to maintain or preserve such Subsidiary\u2019s financial condition or cause such Subsidiary to achieve certain levels of operating results.", "Limitation  on  Liens.  We  covenant  that,  so  long  as  any  of  the  Notes  remain  outstanding,  we  will  not,  and  will  not  permit  any", "Indebtedness which is secured by a lien which would otherwise be subject to the foregoing restrictions; provided that after giving effect thereto the Exempted Debt then outstanding at such time does not exceed 10% of our total assets on a consolidated basis.", "than three years, by us or any Consolidated Subsidiary of any assets are prohibited unless (a) we or such Consolidated Subsidiary would be entitled to incur Indebtedness secured by a lien on the assets to be leased in an amount at least equal to the Attributable Debt in respect of such transaction without equally and ratably securing the notes, or (b) the proceeds of the sale of the assets to be leased are at least equal to their fair market value (as determined by our Board of Directors) and the proceeds are applied to the purchase or acquisition, or, in the case of real property, the construction, of assets or to the retirement of Indebtedness.", "The foregoing limitation will not apply, if at the time we or any Consolidated Subsidiary enters into such sale and lease-back transaction, and after giving effect thereto, Exempted Debt does not exceed 10% of our total assets on a consolidated basis.", "time, or in part, from time to time, at our option, for cash, at a redemption price that includes accrued and unpaid interest and a make-whole premium, as specified in the Indenture and the applicable Officer\u2019s Certificate.", "York  Stock  Exchange  under  the  symbol  \u201cMCK25.\u201d  Our  2026  Notes  are  listed  on  the  New  York  Stock  Exchange  under  the  symbol \u201cMCK26.\u201d Our 2029 Notes are listed on the New York Stock Exchange under the symbol \u201cMCK29.\u201d", "This Statement of Terms and Conditions is intended to meet the requirements of Code Section 409A and any regulations and rules promulgated thereunder.", "In the event of any inconsistency between this Statement of Terms and Conditions and the Plan, the Plan shall govern.", "Capitalized terms not otherwise defined in this Statement of Terms and Conditions shall have the meaning set forth in the Plan.", "With respect to  annual  Restricted  Stock  Unit  Awards  granted  to  Outside  Directors  under  the  Plan,  such  awards  shall  be  subject  to  the  following  terms,  conditions  and restrictions.", "The Administrator administering the Plan has authority to determine the Outside Directors to whom, and the time or", "additional Restricted Stock Units, which will be subject to all of the terms and conditions of the underlying Restricted Stock Unit Award.", "The number of such additional Restricted Stock Units shall be calculated by dividing (a) the aggregate amount or value of the dividends paid with respect to that number of Shares equal to the number of Restricted Stock Units credited as of the record date for such dividend by (b) the Fair Market Value per Share on the payment date for such dividend.", "Any fractional Shares resulting from the accumulation of dividend equivalents shall be paid in cash.", "Dividend equivalents in respect of Restricted Stock Units, if granted in tandem with such Units, will be converted into", "Neither an Outside Director nor any person entitled to exercise an Outside Director\u2019s rights in the event of the Outside", "this Statement of Terms and Conditions, or under a Restricted Stock Unit Agreement, shall be conclusive and binding on all persons.", "is providing the consents herein on a purely voluntary basis.", "Nothing herein contained shall affect an Outside Director\u2019s right, if any, to participate in and receive benefits", "Each Outside Director shall agree to make appropriate arrangements with the Corporation for satisfaction of any applicable federal,", "The Corporation will hold and use the Data only as long as is necessary to implement, administer and manage the", "illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.", "Agreements shall be governed by the laws of the State of Delaware.", "The provisions in this Statement of Terms and Conditions are severable and if any one or more provisions are determined to be", "This Statement of Terms and Conditions and the Restricted Stock Unit Agreements shall be binding upon and inure to the benefit of", "This Statement of Terms and Conditions is intended to meet the requirements of Code Section 409A and any regulations and rules promulgated thereunder.", "In the event of any inconsistency between this Statement of Terms and Conditions and the Plan, the Plan shall govern.", "Capitalized terms not otherwise defined in this Statement of Terms and Conditions shall have the meaning set forth in the Plan.", "With respect to  annual  Restricted  Stock  Unit  Awards  granted  to  Outside  Directors  under  the  Plan,  such  awards  shall  be  subject  to  the  following  terms,  conditions  and restrictions.", "The Administrator administering the Plan has authority to determine the Outside Directors to whom, and the time or", "Neither an Outside Director nor any person entitled to exercise an Outside Director\u2019s rights in the event of the Outside", "this Statement of Terms and Conditions, or under a Restricted Stock Unit Agreement, shall be conclusive and binding on all persons.", "is providing the consents herein on a purely voluntary basis.", "Nothing herein contained shall affect an Outside Director\u2019s right, if any, to participate in and receive benefits", "Each Outside Director shall agree to make appropriate arrangements with the Corporation for satisfaction of any applicable federal,", "The Corporation will hold and use the Data only as long as is necessary to implement, administer and manage the", "illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.", "Agreements shall be governed by the laws of the State of Delaware.", "The provisions in this Statement of Terms and Conditions are severable and if any one or more provisions are determined to be", "This Statement of Terms and Conditions and the Restricted Stock Unit Agreements shall be binding upon and inure to the benefit of", "In the event of any inconsistency between this Statement of Terms and Conditions and the Plan, the Plan shall govern.", "Capitalized terms not otherwise defined in this Statement of Terms and Conditions shall have the meaning set forth in the Plan.", "The Option is also subject to the terms and conditions of the Plan.", "In no event shall the Corporation be required to issue fractional Shares.", "An Option granted under the Plan shall be evidenced by an Option Agreement setting forth the terms and conditions of the", "The Exercise Price of an Option, as specified in the Option Agreement, shall be equal to or greater than the Fair Market Value of", "Period, the Option Period shall end on the date of such termination of employment and the Option shall thereupon not be exercisable to any extent whatsoever.", "Term Disability, the vesting schedule of the Participant\u2019s Option shall be accelerated, the Option shall become fully exercisable and the Option Period shall end on the earlier of (i) three years after the date of the Participant\u2019s termination of employment and (ii) the Expiration Date.", "Retirement, (i) the Option shall be exercisable only to the extent that it was exercisable at the time of such retirement and (ii) the Option Period for that portion of the Option designated as a Non Statutory Stock Option shall end on the earlier of (a) three years after the date of such retirement and (b) the Expiration Date.", "of  the  Participant's  Option,  then  the  Option  shall  continue  to  remain  outstanding  until  the  earlier  of  (i)  such  time  as  the  Participant  subsequently  terminates employment and (ii) the Expiration Date.", "number of Shares as to which the Option is so exercised.", "thereunder shall be transferable by the Participant by operation of law or otherwise, other than by will or the laws of descent and distribution.", "have any of the rights of a stockholder with respect to the Shares subject to an Option except to the extent that a book entry has been entered in the records of the Corporation\u2019s transfer agent with respect to such Shares upon the exercise of an Option.", "Neither a Participant nor any person entitled to exercise a Participant\u2019s rights in the event of the Participant\u2019s death shall", "Stock dividends paid with respect to Restricted Stock during the Restriction Period shall be treated as Restricted Stock which shall be subject to the same restrictions as the original award for the duration of the Restriction Period.", "If the Participant does not have a brokerage account of record, then an appropriate book entry recording the Participant\u2019s interest in the unrestricted Shares shall be entered on the records of the Corporation\u2019s transfer agent.", "Cash dividends paid with respect to Restricted Stock during the Restriction Period shall be credited on behalf of the Participant to a", "Election to Recognize Gross Income in the Year of Grant.", "The Administrator reserves the right to impose a restriction on the sale of Shares that the Participant receives upon", "Neither a Participant nor any person entitled to exercise a Participant\u2019s rights in the event of the Participant\u2019s death shall", "The Administrator reserves the right to impose a restriction on the sale of Shares that the Participant receives upon", "Following the end of the performance period, the Compensation Committee shall determine the extent to which the criteria have been achieved and shall authorize the grant and issuance of Shares in respect of the Performance Stock Unit Award.", "The performance period of a Performance Stock Unit Award shall be greater than one year,", "Unless otherwise determined by the Compensation Committee in its sole discretion, Dividend Equivalents shall not be", "A Participant shall not be permitted to sell, transfer, pledge, assign or encumber all or any portion of a Performance Stock Unit", "Neither a Participant nor any person entitled to exercise a Participant\u2019s rights in the event of the Participant\u2019s death shall", "The Administrator reserves the right to impose a restriction on the sale of Shares that the Participant", "addition, any Award of Restricted Stock or Restricted Stock Units as to which the restrictions have not lapsed shall immediately and automatically be forfeited, Performance Stock Unit Awards shall immediately and automatically be forfeited and any such Shares of Restricted Stock shall be returned to the Corporation and all of the rights of the Participant to such Awards and the underlying Shares shall immediately terminate.", "Any outstanding Option shall immediately and automatically terminate, be forfeited and shall cease to be exercisable, without limitation.", "determination shall be conclusive and binding on all interested persons.", "a manner that is valid and enforceable and that comes closest to the business objectives intended by such invalid or unenforceable provision, without invalidating or rendering unenforceable the remaining provisions of this Section VI.", "under an Award Agreement, shall be conclusive and binding on all interested persons.", "Participation in the Plan shall not create a right to further employment with the Participant\u2019s employer (the", "In making grants to Participants in foreign countries, the Administrator has the full discretion to", "All decisions of the Administrator administering the Plan upon any questions arising under the Plan or", "Nothing herein contained shall affect a Participant\u2019s right to participate in and receive benefits from and in", "Regardless  of any  action  the  Corporation  or  the  Employer  takes  with  respect  to  any  federal,  state  or  local  income  tax,  social", "Calculation of the number of Shares to be withheld shall be made based on the closing price of the Common Stock on the New York Stock Exchange on the date that the amount of tax to be withheld is determined.", "With respect to an Award other than an Option, if adequate arrangements to satisfy the obligations with regard to all Tax-Related Items are not made by the Participant with the Corporation and/or the Employer prior to the relevant taxable event, the Corporation will satisfy such obligations as provided above in clause (3) of this paragraph.", "The Administrator shall be authorized to establish such rules, forms and procedures as it deems necessary to implement the foregoing.", "In accepting the grant, the Participant acknowledges that:", "jurisdiction may have different data privacy laws and protections than the United States.", "In the latter case, the Participant understands and acknowledges that the Corporation\u2019s legal basis for the processing of the Participant\u2019s Data would be compliance with the relevant  laws  or  regulations  or  the  pursuit  by  the  Corporation  of  respective  legitimate  interests  not  outweighed  by  the  Participant\u2019s  interests,  rights  or freedoms.", "When the Corporation no longer needs the Participant\u2019s Data for any of the above purposes, the Participant understands the Corporation will remove it from its systems.", "providing the consents herein on a purely voluntary basis.", "illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.", "If the Participant has received this Statement of Terms and Conditions or any other document related to the Plan translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control.", "The provisions in this Statement of Terms and Conditions are severable and if any one or more provisions are determined to be", "The Participant acknowledges that the Participant is proficient in the English language and, accordingly, understands the provisions of", "The Corporation will hold and use the Data only as long as is necessary to implement, administer and manage the", "Participation in the Plan is voluntary and the Participant is", "In the event of any inconsistency between this Statement of Terms and Conditions and the Plan, the Plan shall govern.", "Capitalized terms not otherwise defined in this Statement of Terms and Conditions shall have the meaning set forth in the Plan.", "The Option is also subject to the terms and conditions of the Plan.", "In no event shall the Corporation be required to issue fractional Shares.", "An Option granted under the Plan shall be evidenced by an Option Agreement setting forth the terms and conditions of the", "The Exercise Price of an Option, as specified in the Option Agreement, shall be equal to or greater than the Fair Market Value of", "Period, the Option Period shall end on the date of such termination of employment and the Option shall thereupon not be exercisable to any extent whatsoever.", "Term Disability, the vesting schedule of the Participant\u2019s Option shall be accelerated, the Option shall become fully exercisable and the Option Period shall end on the earlier of (i) three years after the date of the Participant\u2019s termination of employment and (ii) the Expiration Date.", "Retirement, (i) the Option shall be exercisable only to the extent that it was exercisable at the time of such retirement and (ii) the Option Period for that portion of the Option designated as a Nonstatutory Stock Option shall end on the earlier of (a) three years after the date of such retirement and (b) the Expiration Date.", "of  the  Participant's  Option,  then  the  Option  shall  continue  to  remain  outstanding  until  the  earlier  of  (i)  such  time  as  the  Participant  subsequently  terminates employment and (ii) the Expiration Date.", "number of Shares as to which the Option is so exercised.", "thereunder shall be transferable by the Participant by operation of law or otherwise, other than by will or the laws of descent and distribution.", "have any of the rights of a stockholder with respect to the Shares subject to an Option except to the extent that a book entry has been entered in the records of the Corporation\u2019s transfer agent with respect to such Shares upon the exercise of an Option.", "Neither a Participant nor any person entitled to exercise a Participant\u2019s rights in the event of the Participant\u2019s death shall", "Stock dividends paid with respect to Restricted Stock during the Restriction Period shall be treated as Restricted Stock which shall be subject to the same restrictions as the original award for the duration of the Restriction Period.", "If the Participant does not have a brokerage account of record, then an appropriate book entry recording the Participant\u2019s interest in the unrestricted Shares shall be entered on the records of the Corporation\u2019s transfer agent.", "Cash dividends paid with respect to Restricted Stock during the Restriction Period shall be credited on behalf of the Participant to a", "Election to Recognize Gross Income in the Year of Grant.", "The Administrator reserves the right to impose a restriction on the sale of Shares that the Participant receives upon", "Neither a Participant nor any person entitled to exercise a Participant\u2019s rights in the event of the Participant\u2019s death shall", "The Administrator reserves the right to impose a restriction on the sale of Shares that the Participant receives upon", "The performance period of a Performance Stock Unit Award shall be greater than one year,", "Unless otherwise determined by the Compensation Committee in its sole discretion, Dividend Equivalents shall not be", "A Participant shall not be permitted to sell, transfer, pledge, assign or encumber all or any portion of a Performance Stock Unit", "Neither a Participant nor any person entitled to exercise a Participant\u2019s rights in the event of the Participant\u2019s death shall", "The Administrator reserves the right to impose a restriction on the sale of Shares that the Participant", "addition, any Award of Restricted Stock or Restricted Stock Units as to which the restrictions have not lapsed shall immediately and automatically be forfeited, Performance Stock Unit Awards shall immediately and automatically be forfeited and any such Shares of Restricted Stock shall be returned to the Corporation and all of the rights of the Participant to such Awards and the underlying Shares shall immediately terminate.", "Any outstanding Option shall immediately and automatically terminate, be forfeited and shall cease to be exercisable, without limitation.", "determination shall be conclusive and binding on all interested persons.", "a manner that is valid and enforceable and that comes closest to the business objectives intended by such invalid or unenforceable provision, without invalidating or rendering unenforceable the remaining provisions of this Section VI.", "under an Award Agreement, shall be conclusive and binding on all interested persons.", "Participation in the Plan shall not create a right to further employment with the Participant\u2019s employer (the", "In making grants to Participants in foreign countries, the Administrator has the full discretion to", "All decisions of the Administrator administering the Plan upon any questions arising under the Plan or", "Nothing herein contained shall affect a Participant\u2019s right to participate in and receive benefits from and in", "Regardless  of any  action  the  Corporation  or  the  Employer  takes  with  respect  to  any  federal,  state  or  local  income  tax,  social", "Calculation of the number of Shares to be withheld shall be made based on the closing price of the Common Stock on the New York Stock Exchange on the date that the amount of tax to be withheld is determined.", "With respect to an Award other than an Option, if adequate arrangements to satisfy the obligations with regard to all Tax-Related Items are not made by the Participant with the Corporation and/or the Employer prior to the relevant taxable event, the Corporation will satisfy such obligations as provided above in clause (3) of this paragraph.", "The Administrator shall be authorized to establish such rules, forms and procedures as it deems necessary to implement the foregoing.", "In accepting the grant, the Participant acknowledges that:", "jurisdiction may have different data privacy laws and protections than the United States.", "In the latter case, the Participant understands and acknowledges that the Corporation\u2019s legal basis for the processing of the Participant\u2019s Data would be compliance with the relevant  laws  or  regulations  or  the  pursuit  by  the  Corporation  of  respective  legitimate  interests  not  outweighed  by  the  Participant\u2019s  interests,  rights  or freedoms.", "When the Corporation no longer needs the Participant\u2019s Data for any of the above purposes, the Participant understands the Corporation will remove it from its systems.", "providing the consents herein on a purely voluntary basis.", "illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.", "If the Participant has received this Statement of Terms and Conditions or any other document related to the Plan translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control.", "The provisions in this Statement of Terms and Conditions are severable and if any one or more provisions are determined to be", "The Participant acknowledges that the Participant is proficient in the English language and, accordingly, understands the provisions of", "The Corporation will hold and use the Data only as long as is necessary to implement, administer and manage the", "Participation in the Plan is voluntary and the Participant is", "In the event of any inconsistency between this Statement of Terms and Conditions and the Plan, the Plan shall govern.", "Capitalized terms not otherwise defined in this Statement of Terms and Conditions shall have the meaning set forth in the Plan.", "The Option is also subject to the terms and conditions of the Plan.", "In no event shall the Corporation be required to issue fractional Shares.", "An Option granted under the Plan shall be evidenced by an Option Agreement setting forth the terms and conditions of the", "The Exercise Price of an Option, as specified in the Option Agreement, shall be equal to or greater than the Fair Market Value of", "Period, the Option Period shall end on the date of such termination of employment and the Option shall thereupon not be exercisable to any extent whatsoever.", "Term Disability, the vesting schedule of the Participant\u2019s Option shall be accelerated, the Option shall become fully exercisable and the Option Period shall end on the earlier of (i) three years after the date of the Participant\u2019s termination of employment and (ii) the Expiration Date.", "Retirement, (i) the Option shall be exercisable only to the extent that it was exercisable at the time of such retirement and (ii) the Option Period for that portion of the Option designated as a Non Statutory Stock Option shall end on the earlier of (a) three years after the date of such retirement and (b) the Expiration Date.", "of  the  Participant's  Option,  then  the  Option  shall  continue  to  remain  outstanding  until  the  earlier  of  (i)  such  time  as  the  Participant  subsequently  terminates employment and (ii) the Expiration Date.", "number of Shares as to which the Option is so exercised.", "thereunder shall be transferable by the Participant by operation of law or otherwise, other than by will or the laws of descent and distribution.", "have any of the rights of a stockholder with respect to the Shares subject to an Option except to the extent that a book entry has been entered in the records of the Corporation\u2019s transfer agent with respect to such Shares upon the exercise of an Option.", "Neither a Participant nor any person entitled to exercise a Participant\u2019s rights in the event of the Participant\u2019s death shall", "Stock dividends paid with respect to Restricted Stock during the Restriction Period shall be treated as Restricted Stock which shall be subject to the same restrictions as the original award for the duration of the Restriction Period.", "If the Participant does not have a brokerage account of record, then an appropriate book entry recording the Participant\u2019s interest in the unrestricted Shares shall be entered on the records of the Corporation\u2019s transfer agent.", "Cash dividends paid with respect to Restricted Stock during the Restriction Period shall be credited on behalf of the Participant to a", "Election to Recognize Gross Income in the Year of Grant.", "Neither a Participant nor any person entitled to exercise a Participant\u2019s rights in the event of the Participant\u2019s death shall", "Following the end of the performance period, the Compensation Committee shall determine the extent to which the criteria have been achieved and shall authorize the grant and issuance of Shares in respect of the Performance Stock Unit Award.", "The performance period of a Performance Stock Unit Award shall be greater than one year,", "addition, any Award of Restricted Stock or Restricted Stock Units as to which the restrictions have not lapsed shall immediately and automatically be forfeited, Performance Stock Unit Awards shall immediately and automatically be forfeited and any such Shares of Restricted Stock shall be returned to the Corporation and all of the rights of the Participant to such Awards and the underlying Shares shall immediately terminate.", "Unless otherwise determined by the Compensation Committee in its sole discretion, Dividend Equivalents shall not be", "A Participant shall not be permitted to sell, transfer, pledge, assign or encumber all or any portion of a Performance Stock Unit", "Neither a Participant nor any person entitled to exercise a Participant\u2019s rights in the event of the Participant\u2019s death shall", "Any outstanding Option shall immediately and automatically terminate, be forfeited and shall cease to be exercisable, without limitation.", "determination shall be conclusive and binding on all interested persons.", "a manner that is valid and enforceable and that comes closest to the business objectives intended by such invalid or unenforceable provision, without invalidating or rendering unenforceable the remaining provisions of this Section VI.", "Participation in the Plan shall not create a right to further employment with the Participant\u2019s employer (the", "In making grants to Participants in foreign countries, the Administrator has the full discretion to", "under an Award Agreement, shall be conclusive and binding on all interested persons.", "Calculation of the number of Shares to be withheld shall be made based on the closing price of the Common Stock on the New York Stock Exchange on the date that the amount of tax to be withheld is determined.", "With respect to an Award other than an Option, if adequate arrangements to satisfy the obligations with regard to all Tax-Related Items are not made by the Participant with the Corporation and/or the Employer prior to the relevant taxable event, the Corporation will satisfy such obligations as provided above in clause (3) of this paragraph.", "All decisions of the Administrator administering the Plan upon any questions arising under the Plan or", "Nothing herein contained shall affect a Participant\u2019s right to participate in and receive benefits from and in", "Regardless  of any  action  the  Corporation  or  the  Employer  takes  with  respect  to  any  federal,  state  or  local  income  tax,  social", "The Administrator shall be authorized to establish such rules, forms and procedures as it deems necessary to implement the foregoing.", "In accepting the grant, the Participant acknowledges that:", "jurisdiction may have different data privacy laws and protections than the United States.", "In the latter case, the Participant understands and acknowledges that the Corporation\u2019s legal basis for the processing of the Participant\u2019s Data would be compliance with the relevant  laws  or  regulations  or  the  pursuit  by  the  Corporation  of  respective  legitimate  interests  not  outweighed  by  the  Participant\u2019s  interests,  rights  or freedoms.", "When the Corporation no longer needs the Participant\u2019s Data for any of the above purposes, the Participant understands the Corporation will remove it from its systems.", "providing the consents herein on a purely voluntary basis.", "The Corporation will hold and use the Data only as long as is necessary to implement, administer and manage the", "Participation in the Plan is voluntary and the Participant is", "illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.", "If the Participant has received this Statement of Terms and Conditions or any other document related to the Plan translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control.", "The provisions in this Statement of Terms and Conditions are severable and if any one or more provisions are determined to be", "The Participant acknowledges that the Participant is proficient in the English language and, accordingly, understands the provisions of", "In the event of any inconsistency between this Award Agreement and the Plan, the Plan shall govern.", "Capitalized terms not otherwise defined in this Award Agreement shall have the meaning set forth in the Plan.", "determine the extent to which the performance goals have been achieved, and shall determine the number of PSUs that have been earned.", "Once the Compensation Committee has determined the number of PSUs that have been earned pursuant to the", "Dividend equivalents shall be credited in respect of the One-Year RSU Award.", "The restrictions applicable to the RSU Award shall lapse with respect to 100% of the underlying Shares on the third", "Dividend equivalents shall be credited in respect of the RSU Award granted under this Section III.", "If the Participant ceases to be a bona fide employee of the Corporation or any Affiliate (except as otherwise", "otherwise  forfeited  pursuant  to  the  terms  of  the  Plan  and  this  Award  Agreement  shall  be  paid  to  the  Participant  as  soon  as  reasonably  practicable  after  the restrictions lapse.", "Performance  Stock  Units and  Restricted  Stock  Units,  to  the  extent  the  restrictions  have  not  lapsed,  shall  immediately  and  automatically  be", "determination shall be conclusive and binding on all interested persons.", "a manner that is valid and enforceable and that comes closest to the business objectives intended by such invalid or unenforceable provision, without invalidating or rendering unenforceable the remaining provisions of this Section IV.", "Compensation Committee reserves the right to impose a restriction on the sale of Shares that the Participant receives upon the settlement of the Performance Stock Units and Restricted Stock Units granted hereunder, unless the Participant has satisfied the ownership targets applicable to the Participant as provided in such policy.", "Neither the Participant nor any person entitled to exercise the Participant\u2019s rights in the event of the Participant\u2019s death", "Participation in the Plan shall not create a right to further employment with the Participant\u2019s employer (the", "under this Award Agreement, shall be conclusive and binding on all interested persons.", "Calculation of the number of Shares to be withheld shall be made based on the closing price of the Common Stock on the New York Stock Exchange on the date that the amount of tax to be withheld is determined.", "If adequate arrangements to satisfy the obligations with regard to all Tax-Related Items are not made by the Participant with the Corporation and/or the Employer prior to the relevant taxable event, the Corporation will satisfy such obligations as provided above in clause (iii) of this paragraph.", "The Administrator has the full discretion to deviate from this Award Agreement in order to adjust the Awards", "All decisions of the Administrator administering the Plan upon any questions arising under the Plan or", "Nothing herein contained shall affect the Participant\u2019s right to participate in and receive benefits from and in", "Regardless  of any  action  the  Corporation  or  the  Employer  takes  with  respect  to  any  federal,  state  or  local  income  tax,  social", "The Administrator shall be authorized to establish such rules, forms and procedures as it deems necessary to implement the foregoing.", "In accepting the grant, the Participant acknowledges that:", "providing the consents herein on a purely voluntary basis.", "The Corporation will hold and use the Data only as long as is necessary to implement, administer and manage the", "Participation in the Plan is voluntary and the Participant is", "unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.", "English and if the meaning of the translated version is different than the English version, the English version will control.", "Award, the terms of which are set forth herein and in the Plan.", "The provisions in this Award Agreement are severable and if any one or more provisions are determined to be illegal or otherwise", "Below is a list of documents that are made available to you in connection with this Notice.", "PLEASE BE SURE TO READ THESE DOCUMENTS BECAUSE THEY CONTAIN IMPORTANT INFORMATION SPECIFIC TO THIS GRANT OF RSUs.", "By signing below, I acknowledge that: 1.    I agree to receive copies of the stockholder information, including copies of any annual report, proxy and Form 10-K, from the Investor Resources section of", "Below is a list of documents that are made available to you in connection with this Notice.", "PLEASE BE SURE TO READ THESE DOCUMENTS BECAUSE THEY CONTAIN IMPORTANT INFORMATION SPECIFIC TO THIS GRANT OF RSUs.", "I consent to receiving electronically a copy of the documents set forth above and attachments to this Notice; and 5.", "I accept ALL the terms and conditions as set forth in the Plan and ST&Cs applicable to this grant of RSUs.", "Your  PSUs  will  be  earned  subject  to  the  Company\u2019s  attainment  of  performance  goals  that  have  been  pre-established  by  the  Compensation  Committee  (the \u201cCommittee\u201d) of the Company\u2019s Board of Directors.", "Below is a list of documents that are made available to you in connection with this Notice.", "PLEASE BE SURE TO READ THESE DOCUMENTS BECAUSE THEY CONTAIN IMPORTANT INFORMATION SPECIFIC TO THIS GRANT OF PSUs.", "I consent to receiving electronically a copy of the documents set forth above and attachments to this Notice; and 12.", "I should consult with a tax advisor prior to accepting this grant of PSUs or taking any other action with respect to this grant of PSUs; and 14.", "I accept ALL the terms and conditions as set forth in the Plan and ST&Cs applicable to this grant of PSUs.", "We consent to the incorporation by reference in McKesson Corporation Registration Statement Nos. 333-249817, 333-163642, 333-190847, 333-190848, and 333- 213488 on Form S-8, and Registration Statement No. 333-236808 on Form S-3, of our report dated May 12, 2021, relating to the consolidated financial statements and consolidated financial statement schedule of McKesson Corporation and subsidiaries, and the effectiveness of McKesson Corporation\u2019s internal control over financial reporting appearing in this Annual Report on Form 10-K of McKesson Corporation for the year ended March 31, 2021.", "I have reviewed this annual report on Form 10-K of McKesson Corporation;", "The registrant\u2019s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant\u2019s auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):", "I have reviewed this annual report on Form 10-K of McKesson Corporation;", "The registrant\u2019s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant\u2019s auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):", "Together, we work across the healthcare delivery system to connect pharmacies, providers, payers, and biopharma for next-generation patient access and adherence solutions that help people get the medicine they need to live healthier lives.", "Unless otherwise noted, all references in this document to a particular year shall mean the", "On March 10, 2020, we completed the separation of our interest in the Change Healthcare JV through a split- off transaction.", "This transaction reduced our investment in the Change Healthcare JV to zero.", "Change Healthcare: Our equity ownership interest in Change Healthcare JV, a joint venture, has been accounted for using the equity method of accounting.", "for our innovations and obtain copyright protection for our original works of authorship, when such protection is advantageous.", "Through these efforts, we have developed a portfolio of patents and copyrights in the U.S. and worldwide.", "In addition, we have registered or applied to register certain trademarks and service marks in the U.S. and in foreign countries.", "We cannot guarantee that our intellectual property portfolio will be sufficient to deter misappropriation, theft, or misuse of our technology, nor that we can successfully enjoin infringers.", "We periodically receive notices alleging that our products or services infringe on third party patents and other intellectual property rights.", "While the outcome of any litigation or dispute is inherently uncertain, we do not believe that the resolution of any of these infringement notices would have a material adverse impact on our results of operation.", "These values and behaviors help make McKesson unique.", "We offer financial assistance programs for higher education opportunities that support employees\u2019 career growth at the company.", "To provide compensation that is focused on attracting and retaining talent with the skills and experience necessary for a specific role, our compensation program is built on a set of quantifiable factors defined by our guiding principles of internal fairness, market competitiveness, and pay for performance.", "We operate in several countries and our benefits offerings vary accordingly.", "We offer health and wellness benefits to advance the physical, mental, and social well-being of our people, savings programs to help prepare them for retirement, and flexible work arrangements, among other  benefits  offerings,  when  possible.  In  response  to  the  COVID-19  pandemic,  we  offered  extended  medical  benefits  covering  COVID-19  related  visits, treatment and testing, expanded telehealth options, emergency paid time off (\u201cPTO\u201d), and a platform for employees to donate their regular PTO to co-workers who were  more  impacted  by  COVID-19.", "We have received monetary penalties and/or licensing sanctions pursuant to these requirements and future allegations of noncompliance could result in an inability to obtain, maintain or renew permits, licenses or other regulatory approvals needed for the operation of our businesses.", "As a result of ongoing, advanced discussions with state attorneys general and plaintiffs\u2019 representatives regarding a framework to resolve the claims of governmental entities, and our assessment of certain other opioid-related claims, we have reached a stage at which a broad settlement of opioid claims by governmental entities is probable and recorded a charge of $8.1 billion for the year ended March 31, 2021 within \u201cClaims and litigation charges, net\u201d in our Consolidated Statement of Operations in this Annual Report on Form 10-K.", "Because of the many uncertainties associated with any potential settlement arrangement or other resolution of opioid-related litigation, including the uncertainty of the scope of participation by plaintiffs in any potential settlement, we are not able to reasonably estimate the upper or lower ends of the range of ultimate possible loss for all opioid-related litigation matters.", "The adverse outcome of legal proceedings might also involve significant  expense,  management  time  and  distraction,  and risk  of loss that  can be difficult  to predict  or quantify.  In addition  to this litigation,  legislative  or regulatory measures related to the distribution of controlled substances such as prescription opioids could affect our business in ways that we may not be able to predict.", "For example, some states have passed legislation that could require us to pay taxes or assessments on the distribution of opioid medications in those states and other states have considered similar legislation.", "We are subject to government audits,  investigations  and  oversight  proceedings.  Government  agencies  routinely  review  and  audit  government  contractors  to  determine  whether  they  are complying with contractual and legal requirements.", "If we fail to comply with these requirements, or we fail an audit, we may be subject to various sanctions such as monetary damages, criminal and civil penalties, termination of contracts and suspension or debarment from government contract work.", "These requirements complicate our business and increase our compliance burden and material non-compliance could harm our reputation.", "affecting  Medicare,  Medicaid,  other  government  healthcare  programs,  and  government  contracts.  Our  relationships  with  pharmaceutical  and  medical  surgical product manufacturers and healthcare providers, as well as our provision of products and services to government entities, subject our business to laws, regulation, and government guidance on fraud and abuse.", "Many of these laws are vague or indefinite and have not been interpreted by the courts and, as such, may be interpreted or applied by a prosecutorial, regulatory, or judicial authority in a manner that could require us to make changes in our operations.", "Americans and changed the way healthcare is financed by both governmental and private payers.", "There are also further efforts to broaden healthcare coverage.", "Provincial governments in Canada that provide partial funding for the purchase of pharmaceuticals and independently regulate the sale and reimbursement of drugs have sought to reduce the costs of publicly funded health programs.", "Some European governments  have  implemented  or  are  considering  austerity  measures  to  reduce  healthcare  spending.  These  measures  exert  pressure  on  the  pricing  and reimbursement timelines for pharmaceuticals and may cause our customers to purchase fewer of our products and services or influence us to reduce prices.", "There is substantial uncertainty about the likelihood, timing and results of these health reform efforts.", "We also have record- keeping  and  other  obligations  under  the  E.U.  Falsified  Medicines  Directive.  Pedigree  tracking  laws  such  as  these  increase  our  compliance  burden  and  our pharmaceutical distribution costs.", "For example, under the Health Insurance Portability and Accountability Act of 1996 (\u201cHIPAA\u201d) we must maintain administrative, physical  and  technological  safeguards  to  protect  individually  identifiable  health  information  (\u201cprotected  health  information\u201d)  and  ensure  the  confidentiality, integrity, and availability of electronic protected health information.", "We are subject to significant compliance obligations under privacy laws such as the General Data Protection Regulation (\u201cGDPR\u201d) in the European Union, the Personal Information Protection and Electronic Documents Act (\u201cPIPEDA\u201d) in Canada, and the California Consumer Protection Act (\u201cCCPA\u201d).", "We are subject to privacy  and  data  protection  compliance  audits  or  investigations  by  various  government  agencies.  Failure  to  comply  with  these  laws  subjects  us  to  potential regulatory enforcement activity, fines, private litigation including class actions, and other costs.", "We also have contractual obligations to customers that might be breached if we fail to comply with privacy laws.", "Our efforts to comply with privacy laws complicate our operations and add to our compliance costs.", "storage and hosting of sensitive information, including protected health information and other types of personal information, confidential financial information, proprietary information, and other sensitive information relating to our customers, company and workforce.", "costs.  Environmental  costs  and  accruals,  including  that  related  to  our  legacy  chemical  distribution  operations,  presently  are  not  material  to our  operations  or financial position.", "Our ten largest customers comprised approximately 32%, and CVS was approximately 19%, of total trade accounts receivable at March 31, 2021.", "We also have agreements with GPOs, each of which functions as a purchasing agent on behalf of member  hospitals,  pharmacies  and other healthcare  providers,  as well as with government  entities  and agencies.  The accounts receivable balances are with individual members of the GPOs, and therefore no significant concentration of credit risk exists.", "Substantially all of these revenues and accounts receivable are included in our U.S.", "distribution arrangements with pharmaceutical manufacturers that include an inflation-based compensation component whereby we benefit when the manufacturers increase their prices as we sell our existing inventory at the new higher prices.", "Forward-looking  statements  involve  risks  and  uncertainties  that  could  cause  actual  results  to  differ  materially  from  those  projected,  anticipated,  or  implied.", "Except to the extent required by federal securities laws, we undertake no obligation to publicly release the result of any revisions to any forward-looking statements to reflect events or circumstances after the date the statements are made, or to reflect the occurrence of unanticipated events.", "Some of our distribution arrangements with the manufacturers provides us compensation based on a percentage of our purchases.", "We experience costly and disruptive legal disputes.", "Despite valid defenses that we assert, legal disputes are often costly, time-consuming, distracting to management and disruptive to normal business operations.", "The outcome of legal disputes is difficult to predict.", "Outcomes can occur that are not justified by the evidence or existing law.", "The uncertainty and expense associated with unresolved legal disputes might harm our business and reputation even if the matter is favorably resolved.", "Accordingly, any legal dispute might have a materially adverse impact on our reputation, our business operations and our financial position or results of operations.", "We might experience losses not covered by insurance.", "supplies, the provision of ancillary services, the conduct of our payer businesses and the provision of products that assist clinical decision-making and relate to patient medical histories and treatment plans.", "Although we seek to maintain adequate insurance coverage,  such  as  property  insurance  for  inventory  and  professional  and  general  liability  insurance,  coverages  on  acceptable  terms  might  be  unavailable,  or coverages might not cover our losses.", "We generally seek to limit our contractual exposure, but limitations of liability or indemnity provisions in our contracts may not be enforceable or adequately protect us from liability.", "Uninsured losses might have a materially adverse impact on our business operations and our financial position or results of operations.", "We regularly are named as a defendant in similar, new cases.", "Many of these cases raise novel theories of liability.", "Any proceedings can have unexpected outcomes that are not justified by evidence or existing law.", "It is not uncommon for claims to be resolved over many years.", "Although the Company has valid defenses and is vigorously defending itself, some proceedings have been and others may be resolved by negotiated outcome.", "Our reputation has been and may continue to be impacted by publicity regarding the litigation and related allegations.", "The adverse outcome of legal proceedings might have a materially adverse impact on our business operations and our financial position or results of operations.", "For example, some states have passed legislation that could require us to pay taxes or assessments on the distribution of opioid medications in those states and other states have considered similar legislation.", "Liabilities for taxes or assessments or other costs of compliance under any such laws might have a materially adverse impact on our reputation, business operations, and our financial position or results of operations.", "We are subject to extensive, complex and challenging healthcare and other laws.", "Any noncompliance by us with applicable laws or the failure to maintain, renew or obtain necessary permits and licenses could lead to litigation and might have a materially adverse impact on our business operations and our financial position or results of operations.", "Local, state and federal governments continue to strengthen their position and scrutiny over practices involving or allegedly involving fraud, waste and abuse affecting Medicare, Medicaid and other government healthcare programs.", "Our relationships with pharmaceutical and medical surgical product manufacturers and healthcare providers, as well as our provision of products and services to government entities, subject our business to laws and regulations on fraud and abuse, which among other things: (1) prohibit persons from soliciting, offering, receiving or paying any remuneration in order to induce the referral of a patient for treatment  or  to  induce  the  ordering  or  purchasing  of  items  or  services  that  are  in  any  way  paid  for  by  Medicare,  Medicaid  or  other  government-sponsored healthcare programs; (2) impose many restrictions upon referring physicians and providers of designated health services under Medicare and Medicaid programs; and (3) prohibit the knowing submission of a false or fraudulent claim for payment to, and knowing retention of an overpayment by, a federal healthcare program such  as  Medicare  and  Medicaid.  Many  of  these  laws,  regulations,  and  government  guidance,  including  those  relating  to  marketing  incentives,  are  vague  or indefinite and have not been interpreted by the courts.", "The laws may be interpreted or applied by a prosecutorial, regulatory, or judicial authority in a manner that could require us to make changes in our operations.", "Failures to comply with applicable laws subject us to federal or state government investigations or qui tam actions, and to liability for damages and civil and criminal penalties, including the loss of licenses or our ability to participate in Medicare, Medicaid and other federal and state healthcare programs.", "These sanctions might have a materially adverse impact on our business operations and our financial position or results of operations.", "Noncompliance with these requirements has resulted in monetary penalties and/or licensing sanctions.", "For example, under a January 2017 agreement with the DEA and Department of Justice we paid $150 million to settle potential administrative and civil claims about our practices for reporting suspicious orders of controlled substances and the DEA suspended, on a staggered basis for limited periods of time, our registrations to distribute certain controlled substances from four distribution centers.", "Pedigree tracking laws increase our compliance burden and our pharmaceutical distribution costs.", "Pedigree tracking laws such as these increase our compliance burden and our pharmaceutical distribution costs, and they might have a materially adverse impact on our business operations and our financial position or results of operations.", "Privacy and data protection laws increase our compliance burden.", "example,  under  the  Health  Insurance  Portability  and  Accountability  Act  of  1996  (\u201cHIPAA\u201d)  we  must  maintain  administrative,  physical  and  technological safeguards  to  protect  individually  identifiable  health  information  (\u201cprotected  health  information\u201d)  and  ensure  the  confidentiality,  integrity  and  availability  of electronic protected health information.", "Failure to comply with these laws subjects us to potential regulatory enforcement activity, fines, private litigation including class actions, and other costs.", "We also have contractual obligations to customers that might be breached if we fail to comply with privacy laws.", "Our efforts to comply with privacy laws complicates our operations and adds to our compliance costs.", "A significant privacy breach or failure  to  comply  with  privacy  laws  might  have  a  materially  adverse  impact  on  our  reputation,  business  operations  and  our  financial  position  or  results  of operations.", "Anti-bribery and anti-corruption laws increase our compliance burden.", "Bribery Act unless the organization can establish the defense of having implemented adequate procedures to prevent bribery.", "Our failure to comply with these laws might subject us to civil and criminal penalties that might have a materially adverse impact on our reputation, business operations and our financial position or results of operations.", "We are subject to a variety of privacy and data protection laws that change frequently and have requirements that vary from jurisdiction to jurisdiction.", "We  are  subject  to  laws  prohibiting  improper  payments  and  bribery,  including  the  U.S.  Foreign  Corrupt  Practices  Act,  the  U.K.  Bribery  Act  and  similar", "We might record significant charges from impairment to goodwill, intangibles and other assets or investments.", "In addition, we periodically review our intangible and other long-lived assets for impairment when events or changes in circumstances, such as a divestiture, indicate the carrying value may not be recoverable.", "Factors that may be considered a change in circumstances indicating that  the  carrying  value  of  our  intangible  and  other  long-lived  assets  may  not  be  recoverable  include  slower  growth  rates,  the  loss  of  a  significant  customer, burdensome new laws or divestiture of a business or asset for less than its carrying value.", "There are inherent uncertainties in management\u2019s estimates, judgments and assumptions used in assessing recoverability of goodwill, intangible and other long-lived assets.", "We may be required to record a significant charge to earnings in our consolidated financial statements during the period in which any impairment of our goodwill or intangible and other long-lived assets is determined, which might have a materially adverse impact on our business operations and our financial position or results of operations.", "storage and hosting of sensitive information, including protected health information and other types of personal information, confidential financial information, proprietary information, and other sensitive information relating to our customers, company and workforce.", "If our software and technology services are alleged to have contributed to faulty clinical decisions or injury to patients, we might be subject to claims or litigation by users of our software or services or their patients.", "Any of these types of errors or failures might have a materially adverse impact on our reputation, business operations and our financial position or results of operations.", "We  are  required  under  U.S.  Generally  Accepted  Accounting  Principles  (\u201cGAAP\u201d)  to  test  our  goodwill  for  impairment  annually  or  more  frequently  if", "We might be impeded in providing customers online services and data access.", "Any such problems might have a materially adverse impact on our business operations and our financial position or results of operations.", "Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.", "we may require financing that may not be available on acceptable terms.", "Any of these risks could adversely affect our ability to achieve the anticipated benefits of an acquisition and might have a materially adverse impact on our business operations and our financial position or results of operations.", "Exclusive forum provisions in our Bylaws could limit our stockholders\u2019 ability to choose their preferred judicial forum for disputes with us or our directors, officers or employees.", "Current and former stockholders are deemed to have consented to the personal jurisdiction of the Delaware Courts in connection with any action to enforce that exclusive forum provision and to service of process in any such action.", "To the extent that these provisions of the bylaws limit a current or former stockholder\u2019s ability to select a judicial forum other than the Delaware Courts, they might discourage the specified legal actions, might cause current or former stockholders to incur additional litigation-related expenses and might result in outcomes unfavorable to current or former stockholders.", "A court might determine that these provisions of the bylaws are inapplicable or unenforceable in any particular action, in which case we may incur additional litigation related expenses in such action, and the action may result in outcomes unfavorable to us, which could have a materially adverse impact on our reputation, our business operations and our financial position or results of operations.", "We might be adversely impacted by delays or other difficulties with divestitures.", "After the disposition, we might experience greater dissynergies than expected, and the impact of the divestiture on our revenue or profit might be larger than we expected.", "We might have difficulties with pre-closing conditions such as regulatory and governmental approvals, which could delay or prevent the divestiture.", "We might have financial exposure in a divested business, such as through minority equity ownership, financial  or  performance  guarantees,  indemnities  or  other  obligations,  such  that  conditions  outside  of  our  control  might  negate  the  expected  benefits  of  the disposition.", "Any of these risks could adversely affect our ability to achieve the anticipated benefits of a divestiture and might have a materially adverse impact on our business operations and our financial position or results of operations.", "We might not realize the expected tax treatment from our split-off of Change Healthcare.", "If Change does not honor its obligations to indemnify the Company, or if the Transactions fail to qualify for the intended tax-free treatment for reasons not related to a disqualifying action by Change or SpinCo, the resulting tax to the Company could have a significant adverse effect on our financial position or results of operations.", "outsourced service providers, and we might not realize expected cost savings or other benefits.", "For example, our ability to use outsourcing resources in certain jurisdictions might be limited by legislative action or customer contracts, with the result that the work must be performed at greater expense or we may be subject to sanctions for non-compliance.", "Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.", "We might encounter difficulties attracting and retaining customers to our retail locations due to their unfamiliarity with our brands or our inexperience with local market  preferences.  Competition  from  our  retail  pharmacy  operations  might  strain  relationships  with  our  retail  pharmacy  customers.  Consolidation  of  retail pharmacies with third party payers, expansion of large retail pharmacy networks, reductions in reimbursement rates, shifts in the mix of branded and generic pharmaceutical sales, and exclusion from preferred pharmacy networks can impair our retail pharmacy sales and profitability.", "We might be harmed by large customer purchase reductions, payment defaults or contract non-renewal.", "March 31, 2021, sales to our largest customer represented approximately 21% of our consolidated revenues and approximately 19% of our trade receivables, and those of our ten largest customers combined accounted for approximately 51% of our consolidated revenues and approximately 32% of our trade receivables.", "A material  default  in  payment,  reduction  in  purchases,  or  the  loss  of  business  from  a  large  customer  might  have  a  materially  adverse  impact  on  our  business operations and our financial position or results of operations.", "Our contracts with government entities involve future funding and compliance risks.", "Our government contracts might not be renewed or might be terminated for convenience with little or no prior notice.", "Government contracts typically expose us to higher potential liability than do other types of contracts.", "We are subject to government audits, investigations and oversight proceedings.", "If we fail to comply with these requirements, or we fail an audit, we are subject to various sanctions such as monetary damages, criminal and civil penalties, termination of contracts and suspension or debarment from government contract work.", "These requirements complicate our business and increase our compliance burden.", "We also provide supplies used for vaccine administration in the Federal COVID-19 Response.", "Our participation in such programs exposes us to various uncertainties.", "Because of these risks and uncertainties our operating results may be materially higher or lower than our projections.", "Certain distribution agreements with manufacturers include pharmaceutical price inflation as a component of our compensation, and we cannot  control  the  frequency  or  magnitude  of  pharmaceutical  price  changes.  We  might  be  unable  to  renew  pharmaceutical  distribution  agreements  with manufacturers in a timely and favorable manner.", "Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.", "We  derive  a  significant  portion  of  our  revenue  from,  and  have  a  significant  portion  of  our  accounts  receivable  with,  a  small  number  of  customers.  At", "Our contracts with government entities are subject to risks such as lack of funding and compliance  with unique requirements.", "We might infringe intellectual property rights or our intellectual property protections might be inadequate.", "If a court were to hold that we infringed other\u2019s rights, we might be required to pay substantial damages, develop non-infringing products or services, obtain a license, stop selling or using the infringing products or services, or incur other sanctions.", "We rely on trade secret, patent, copyright and  trademark  laws,  nondisclosure  obligations  and  other  contractual  provisions  and  technical  measures  to  protect  our  proprietary  rights  in  our  products  and solutions.  We  might  initiate  costly  and  time-consuming  litigation  to  protect  our  trade  secrets,  to  enforce  our  patent,  copyright  and  trademark  rights  and  to determine the scope and validity of the proprietary rights of others.", "Our intellectual property protection efforts might be inadequate to protect our rights.", "Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.", "Competition among potential employers might result in increased salaries, benefits or other employee-related costs, or in our failure to recruit and retain employees.", "Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.", "We might be adversely impacted by healthcare reform such as changes in pricing and reimbursement models.", "healthcare industry and related government programs are changing.", "profit margins for us and our customers and impose new legal requirements on healthcare providers.", "the way healthcare is financed by both governmental and private payers.", "drugs have sought to reduce the costs of publicly funded health programs.", "These measures exert pressure on the pricing and reimbursement timelines for pharmaceuticals and may cause our customers to purchase fewer of our products and services or influence us to reduce prices.", "adverse impact on our business operations and our financial position or results of operations.", "Consolidation might increase counter-party credit risk because credit purchases increase for fewer market participants.", "Any of these changes or disruptions might have a materially adverse impact on our business operations and our financial position or results of operations.", "We might be adversely impacted as a result of our distribution of generic pharmaceuticals.", "Generic drug manufacturers often offer a generic version of branded pharmaceuticals while they challenge the validity or enforceability branded pharmaceutical patents.", "The patent holder might assert infringement claims against us for distributing those generic versions and the generic drug manufactures may not fully indemnify us against such claims.", "These risks, as well as changes in the availability,  pricing  volatility,  reimbursement  rates  for  generic  drugs,  or significant  changes  in  the  nature,  frequency  or magnitude  of  generic  pharmaceutical launches, might have a materially adverse impact on our business operations and our financial position or results of operations.", "We might be adversely impacted by an economic slowdown or recession.", "Any economic slowdown or recession might have a materially adverse impact on our business operations and our financial position or results of operations.", "Disruption or other changes in capital and credit markets might impede access to credit and increase borrowing costs for us and our customers and suppliers and might impair the financial soundness of our customers and suppliers.", "activity by financial institutions, or decreased liquidity and increased costs in the commercial paper market, might adversely affect our borrowing ability and cost of borrowing.", "We generally sell our products and services under short-term unsecured credit arrangements.", "An adverse change in general economic conditions or access to capital might cause our customers to reduce their purchases from us, or delay or fail paying amounts owed to us.", "Suppliers might be unable to make payments due to us for fees, returned products or incentives.", "Interest rate increases or changes in capital market conditions might impede our or our customers\u2019 or suppliers\u2019 ability or cost to obtain credit.", "Any of these risks might have a material adverse impact on our business operations and our financial position or results of operations.", "Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.", "We might be adversely impacted by tax legislation or challenges to our tax positions.", "Tax laws might change in ways that adversely affect our tax positions, effective tax rate and cash flow.", "The tax laws are extremely complex and subject to varying interpretations.", "We are subject to tax examinations in various jurisdictions that might assess additional tax liabilities against us.", "Our tax reporting positions might be challenged by relevant tax authorities, we might incur significant expense in our efforts to defend those challenges, and we might be unsuccessful in those efforts.", "Developments in examinations and challenges might materially change our provision for taxes in the affected periods and might differ materially from our historical tax accruals.", "Any of these risks might have a materially adverse impact on our business operations, our cash flows and our financial position or results of operations.", "For example, we might experience volatility in exchange rates and interest rates and changes in laws regulating our U.K. operations.", "Customers might reduce purchases due to the uncertainty caused by Brexit.", "Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.", "We might be adversely impacted by fluctuations in foreign currency exchange rates.", "exchange rates could reduce our revenues, increase our costs or otherwise adversely affect our financial results reported in U.S. dollars.", "For example, we are exposed to transactional currency exchange risk due to our import and export of products that are purchased or sold in currencies other than the U.S. dollar.", "We also  have  currency  exchange  risk  due  to  intercompany  loans  denominated  in  various  currencies.  The  COVID-19  pandemic  has  affected  and  might  increase currency exchange rate volatility.", "We may from time to time enter into foreign currency contracts, foreign currency borrowings or other techniques intended to hedge  a  portion  of our  foreign  currency  exchange  rate  risks.  These  hedging  activities  may  not  completely  offset  the  adverse  financial  effects  of  unfavorable movements in foreign currency exchange rates during the time the hedges are in place.", "Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.", "We are subject to the tax laws in the U.S. at the federal, state and local government levels and to the tax laws of many other jurisdictions in which we operate", "We conduct our business in various currencies,  including  the U.S. dollar, euro, British pound sterling  and Canadian dollar.  Changes in foreign  currency", "Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.", "We might be adversely impacted by changes in accounting standards.", "It is possible that future accounting standards may require changes to the accounting treatment in our consolidated financial statements and may require us to make significant changes to our financial systems.", "Such changes might have a materially adverse impact on our financial position or results of operations.", "Our consolidated financial statements are subject to the application of U.S.", "Disclosure of an environmental proceeding where a governmental agency is a party generally is included only if we expect monetary sanctions in the proceeding to exceed $1 million, unless otherwise material.", "There are no family relationships between any of the executive officers or directors of the Company.", "We declared regular cash dividends of $1.67 and $1.62 per share in the years ended March 31, 2021 and 2020, respectively.", "discretion of the Board and will depend upon our future earnings, financial condition, capital requirements, and other factors.", "Dividends: In  July  2020,  our  quarterly  dividend  was  raised  from  $0.41  to  $0.42  per  common  share  for  dividends  declared  on  or  after  such  date  by  the", "We anticipate that we will continue to pay quarterly cash dividends in the future.", "In accordance with our accounting policy, we allocate any excess of share repurchase price over par value between additional paid-in capital and retained earnings.", "Accordingly, our retained earnings and additional paid-in capital were reduced by $472 million and $70 million, respectively, during 2019.", "In 2019, we retired 5.0 million or $542 million of our treasury shares previously repurchased.", "This discussion and analysis should be read in conjunction with the consolidated financial statements and accompanying financial notes in Item 8 of Part II of this Annual Report on Form 10-K.", "Our fiscal year begins on April 1 and ends on March 31.", "Unless otherwise noted, all references to a particular year shall mean our fiscal year.", "Our organizational structure also includes Corporate, which consists of income and expenses associated with administrative functions and projects, and the results of certain investments.", "We evaluate the performance of our operating segments on a number of measures, including revenues and operating profit before interest expense and income taxes.", "The following summarizes our four reportable segments and the changes made to our reporting structure commencing in the second quarter of 2021.", "\u2022 Coronavirus disease 2019 (\u201cCOVID-19\u201d) impacted our results of operations for the year ended March 31, 2021.", "The recovery from the COVID- 19 pandemic continued to fluctuate throughout our fiscal year.", "\u2022 We expanded our existing contractual relationship with the Centers for Disease Control and Prevention (\u201cCDC\u201d) through an amendment to our existing Vaccines for Children Program contract to support the U.S. government as a centralized distributor of COVID-19 vaccines and ancillary supplies needed to administer vaccines.", "\u2022 In  December  2020,  we  began  distributing  certain  COVID-19  vaccines  under  the  direction  of  the  CDC.  Through  the  end  of  the  fiscal  year,  we  had distributed approximately 100 million of COVID-19 vaccine doses.", "\u2022 Revenues of $238.2 billion, reflects a 3% increase from the prior year primarily in our U.S.", "\u2022 Diluted loss per common share from continuing operations attributable to McKesson Corporation in 2021 of $28.26 reflects the aforementioned items, net of any respective tax impacts, and a lower share count compared to the prior year driven largely by the separation of our investment in Change Healthcare JV on March 10, 2020;", "The full extent to which COVID-19 will impact us depends on many factors and future developments, which are described at the end of this COVID-19 section.", "We continue to evaluate the nature and extent of the impacts COVID-19 has on our business and operations.", "We provided further support including additional emergency leave and an internal paid time off donation platform for employees impacted by COVID-19.", "These responses were initially put in place during our fourth quarter of 2020.", "policies did not have a material effect on our internal control over financial reporting during the year ended March 31, 2021.", "We also took various actions to mitigate the impact of COVID-19 on our results from operations through cost-containment and payroll-related expenses.", "We support the U.S. government as a centralized distributor of COVID-19 vaccines and ancillary supplies needed to administer vaccines.", "We make no decisions on where products are to be distributed nor how the products are allocated between the various provider sites and ultimately administered to the individuals receiving a vaccine.", "We utilize our expertise and capabilities to support the CDC\u2019s efforts to vaccinate everyone in the U.S. who wants to receive a COVID-19 vaccine.", "The Pfizer Vaccine, which is ultra-frozen, is not being distributed by McKesson, although we are providing ancillary supplies needed for its administration.", "custom freezers and refrigerators to safely store and process millions of vaccine doses.", "The capital expenditures we made during 2021 to prepare for vaccine and ancillary supply kit distribution were not material to our financial condition or liquidity.", "In December 2020, we began distributing the Moderna Vaccine in the U.S. and in March 2021, we began distributing the Janssen Vaccine.", "Subsequently, during the first quarter, we had lower pharmaceutical volumes, specialty drug volumes, and patient care visits that negatively impacted our consolidated revenues and income (loss) from continuing operations before income taxes for the year ended March 31, 2021.", "Additionally, increased costs for certain PPE compressed our margins.", "During the year ended March 31, 2021, we recorded charges totaling $136 million in cost of sales on certain PPE and other related products due to inventory impairments and excess inventory in our Medical-Surgical Solutions segment.", "Although market price volatility and changes to anticipated customer demand may require additional write-downs in future periods, we are taking measures to mitigate such risk.", "We collaborated closely with the federal government and other healthcare stakeholders to source more critical PPE to the U.S.", "We have deferred certain employer payroll taxes and continue to monitor the potential impact of other tax legislation changes as result of the CARES Act, including refundable payroll tax credits on certain qualified wages.", "We anticipate changes due to the CARES Act in the timing of certain cash flows, with no material impact to our financial results for the year ended March 31, 2021.", "The CA Act did not have a material impact on our financial condition, results of operations, or liquidity for the year ended March 31, 2021 nor do we currently expect a material impact on our future financial results.", "We are monitoring our customers closely for changes to their timing of payments or ability to pay amounts owed to us as a result of COVID-19 pandemic impacts to their businesses.", "We remain well-capitalized with access to liquidity from our revolving credit facility.", "Long- term debt markets and commercial paper markets, our primary sources of capital after cash flow from operations, have remained open and accessible to us during the COVID-19 pandemic.", "At March 31, 2021, we were in compliance with all debt covenants, and believe we have the ability to continue to meet our debt covenants in the future.", "Our consolidated balance sheets and ability to maintain financial liquidity remains strong.", "We have experienced no material impacts to our liquidity or net", "We face numerous uncertainties in estimating the direct and indirect effects of COVID-19 on our future business operations, financial condition, results of operations, and liquidity.", "Due to several rapidly changing variables related to the COVID-19 pandemic, estimations of future economic trends and the timing of when stability will  return  remains  challenging.  Additionally,  we  periodically  review  our  intangible  and  other  long-lived  assets  for  impairment  when  events  or  changes  in circumstances indicate  the carrying value may not be recoverable.  Key assumptions and estimates  about future values in our impairment assessments can be affected by a variety of factors, including the impacts of the global pandemic on industry and economic trends as well as on our business strategy and internal forecasts.", "We continue to be involved in discussions with the objective of achieving broad resolution of opioid- related claims of states, their political subdivisions and other government entities (\u201cgovernmental entities\u201d).", "We are in ongoing, advanced discussions with state attorneys general and plaintiffs\u2019 representatives regarding a framework under which, in order to resolve the claims of governmental entities, the three largest U.S. pharmaceutical distributors would pay up to approximately $21.0 billion over a period of 18 years, with up to approximately $8.0 billion to be paid by us, of which more than 90% is anticipated to be used to remediate the opioids crisis.", "As a result of that conclusion, and our assessment of certain other opioid- related claims, we recorded a charge of $8.1 billion for the year ended March 31, 2021 within \u201cClaims and litigation charges, net\u201d in our Consolidated Statement of Operations, related to our share of the settlement framework described above, as well as other opioid-related claims.", "Because of the many uncertainties associated with any potential settlement arrangement or other resolution of opioid-related litigation, including the uncertainty of the scope of participation by plaintiffs in any potential settlement, we are not able to reasonably estimate the upper or lower ends of the range of ultimate possible loss for all opioid-related litigation matters.", "We believe that we have valid defenses to the claims pending against us and, absent an acceptable settlement, intend to vigorously defend against all such claims.  An  adverse  judgment  or  negotiated  resolution  in  any  of  these  matters  could  have  a  material  adverse  impact  on  our  financial  position,  cash  flows  or liquidity, or results of operations.", "The law adopting the excise tax made clear that the OSA would apply only to opioid sales on or before December 31, 2018.", "The excise tax applies only to the first sale occurring in New York, and thus may not apply to sales from our distribution centers in New York to New York customers.", "Unless the appellate court\u2019s decision is overturned, the OSA will be reinstated for calendar years 2017 and 2018 (but not beyond those years), and, subject to any further legal challenge, we will have to pay our ratable share of the annual surcharge for those two years.", "During the second quarter of 2021, we reflected an estimated liability of $50 million for the OSA surcharge in our accompanying consolidated financial statements on the assumption that the appellate court\u2019s decision will stand.", "The higher LIFO credits in 2020 compared to 2019 is primarily driven by higher generic deflation.", "\u2022 Claims and litigation charges, net: These charges include adjustments for estimated probable settlements related to our controlled substance monitoring and reporting, and opioid-related claims, as well as any applicable income items or credit adjustments due to subsequent changes in estimates.", "We have reclassified prior period amounts to conform to the current period presentation.", "\u2022 Goodwill impairments charges: We perform an impairment test on goodwill balances annually in the third quarter and more frequently if indicators for potential impairment exist.", "The resulting goodwill impairment charges are reflected within this line item. \u2022 Restructuring, impairment, and related charges: Restructuring charges that are incurred for programs in which we change our operations, the scope of a business undertaken by our business units, or the manner in which that business is conducted as well as long-lived asset impairments.", "\u2022 SDG&A reflects charges of $58 million to remeasure assets and liabilities held for sale to fair value less costs to sell related to the completed contribution of the majority of our German pharmaceutical wholesale business to create a joint venture with WBA in which we have a 30% ownership interest within our International segment.", "As a result, we were required to perform a goodwill impairment test for these reporting units and recorded a goodwill impairment charge in our European RP reporting unit of $69 million during the second quarter of 2021.", "As of the testing date, other risks, expenses, and future developments, such as additional government actions, increased regulatory uncertainty, and material changes in key market assumptions limit our ability to estimate projected cash flows, which could adversely affect the fair value of various reporting units in future periods, including our McKesson Canada reporting unit within our International segment and our RxCrossroads reporting unit within our RxTS segment, where the risk of a material goodwill impairment is higher than other reporting units.", "\u2022 Restructuring, impairment, and related charges, net includes long-lived asset impairment charges of $112 million, primarily for our United Kingdom (\u201cU.K.\u201d)  business  (mainly  pharmacy  licenses)  and  Rexall  Health  retail  business  (\u201cRexall  Health\u201d)  (mainly  customer  relationships)  within  our International segment, and the remaining $156 million primarily represents employee severance and exit-related costs related to our 2019 restructuring initiatives, as further discussed below; and", "\u2022 Total operating expenses includes higher SDG&A due to our business acquisitions and to support business growth, as well as our technology initiatives, partially offset by favorable effects of foreign currency exchange fluctuations.", "\u2022 SDG&A includes opioid-related costs of $114 million, primarily related to litigation expenses, and increased expenses due to our business acquisitions and to support growth, partially offset by a gain from an escrow settlement of $97 million representing certain indemnity and other claims related to our 2017 acquisition of Rexall Health and a credit of $90 million for the derecognition of a liability related to the tax receivable agreement (\u201cTRA\u201d) payable to the shareholders of Change Healthcare, Inc. (\u201cChange\u201d);", "\u2022 Restructuring,  impairment,  and  related  charges,  net  primarily  includes  employee  severance  and  exit-related  costs  of  $352  million  for  our  2019 restructuring initiatives, as further discussed below and long-lived asset impairment charges of $245 million primarily for our U.K. business (mainly pharmacy licenses) within our International segment driven by additional government reimbursement reductions and competitive pressures in the U.K.", "We evaluate goodwill for impairment on an annual basis as of October 1, and at an interim date, if indicators of potential impairment exist.", "This change was not material to our consolidated financial statements as it did not delay, accelerate, or avoid any potential goodwill impairment charge.", "We expect to incur total charges of approximately $180 million to $280 million for this initiative, consisting primarily of exit related costs, accelerated depreciation and amortization of long-lived assets, and asset impairments.", "We expect to incur total charges of approximately $85 million to $90 million, of which $57 million of charges were recorded to date.", "This initiative was substantially complete in 2021 and remaining costs we expect to record under this initiative are not material.", "The relocation was substantially complete in January 2021 and remaining costs we expect to record under this initiative, primarily relating to lease costs, are not material.", "This primarily reflects mark-to-market gains on our investments in certain U.S. growth stage companies in the healthcare industry and realized gains on the exit of some of these investments as further described in Financial Note 17, \u201cFair Value Measurements,\u201d to the accompanying consolidated financial statements  included  in  this  Annual  Report  on  Form  10-K.  In  future  periods,  fair  value  adjustments  recognized  in  our  operating  results  for  these  types  of investments may be adversely impacted by market volatility.", "Other income, net also increased year over year due to pension settlement charges of $122 million recognized in 2020 related to our previously approved termination of the frozen U.S. defined benefit pension plan.", "In connection with the pension plan termination, we purchased annuity contracts from an insurer that will pay and administer the future pension benefits of the remaining participants.", "Excluding the impairment and transaction-related items described below, our proportionate share of loss from our investment in Change Healthcare JV for the years ended March 31, 2020 and 2019 was $119 million and $194 million, respectively, which primarily includes transaction and integration expenses incurred by the joint venture and basis differences between the joint venture and McKesson including amortization of fair value adjustments.", "During the first quarter of 2020 and for the year ended March 31, 2019, we owned approximately 70% of this joint venture.", "The proceeds from the concurrent offering of other securities were also used by Change  to  acquire  certain  securities  of  Change  Healthcare  JV.  As  a  result,  McKesson\u2019s  equity  interest  in  Change  Healthcare  JV  was  reduced  from  70%  to approximately 58.5%, which was used to recognize our proportionate share in net loss from Change Healthcare JV, commencing in the second quarter of 2020.", "As a result of the ownership dilution to 58.5% from 70%, we recognized a dilution loss of approximately $246 million in the second quarter of 2020.", "Additionally, our proportionate share of income or loss from this investment was subsequently reduced as immaterial settlements of stock option exercises occurred after the IPO and further diluted our ownership.", "Equity Earnings and Charges from Investment in Change Healthcare Joint Venture Until the separation of our investment in Change Healthcare JV on March 10, 2020, we accounted for this investment using the equity method of accounting.", "In the second quarter of 2020, we recorded an other-than-temporary-impairment (\u201cOTTI\u201d) charge of $1.2 billion to our investment in Change Healthcare JV,", "Following the Split-off, we do not beneficially own any of Change\u2019s outstanding securities.", "In connection with this transaction, we recognized a net gain for financial reporting purposes of $414 million during the fourth quarter of 2020, which was largely driven by the reversal of a related deferred tax liability.", "The receipt of any payments under the TRA is dependent upon Change benefiting from this depreciation or amortization in future tax return filings, which creates uncertainty over the amount, timing and probability of the gain recognized.", "As such, we accounted for the TRA as a gain contingency, with no receivable recognized as of March 31, 2021 nor 2020.", "Interest expense decreased in 2020 compared to the prior year primarily due to a decrease in the issuance of commercial paper, partially offset by a decrease in interest income from our derivative contracts.", "Our reported income tax (benefit) expense rates were (13.8%), 1.6%, and 58.4% in 2021, 2020, and 2019, respectively.", "after-tax), which was intended to generally be a tax-free split-off for U.S. federal income tax purposes, and unfavorably impacted by charges of $275 million (pre- tax and after-tax) to remeasure assets and liabilities held for sale to fair value less costs to sell related to the completed contribution of the majority of our German pharmaceutical wholesale business to create a joint venture with WBA.", "goodwill of our European RP and European PD reporting units within the International segment, given that these charges are generally not deductible for tax purposes.", "Our income tax expense, deferred tax assets and liabilities, and uncertain tax liabilities reflect management\u2019s best assessment of estimated current and future taxes to be paid.", "We believe that we have made adequate provision for all income tax uncertainties.", "In connection with the exchange offer, on March 9, 2020, we distributed all 176.0 million outstanding shares of common stock of SpinCo to participating", "Income Tax (Benefit) Expense We recorded income tax (benefit) expense of ($695 million), $18 million, and $356 million for the years ended March 31, 2021, 2020, and 2019, respectively.", "Our reported income tax expense rate for 2019 was unfavorably impacted by charges of $1.8 billion (pre-tax and after-tax) to impair the carrying value of", "Significant judgments and estimates are required in determining the consolidated income tax provision and evaluating income tax uncertainties.", "Noncontrolling interests with redemption  features, such as put rights, that are not solely within our control are considered redeemable  noncontrolling  interests.  Redeemable  noncontrolling interests are presented outside of McKesson Corporation stockholders\u2019 equity (deficit) on our consolidated balance sheet.", "Diluted earnings (loss) per common share attributable to McKesson Corporation was $(28.26), $4.95, and $0.17 for the years ended March 31, 2021,  2020,  and  2019,  respectively.  Net  loss  per  diluted  share  for  the  year  ended  March  31,  2021  is  calculated  by  excluding  dilutive  securities  from  the denominator  due to their antidilutive  effects.  Additionally,  our 2021, 2020, and 2019 diluted  earnings (loss) per share  reflect  the cumulative  effects  of share repurchases.", "Weighted-average diluted common shares outstanding is impacted by the exercise and settlement of share-based awards and the cumulative effect of share repurchases, including the impact of shares exchanged as part of the split-off from our investment in Change Healthcare JV, as discussed above.", "(1) Segment operating profit (loss) includes gross profit, net of operating expenses, as well as other income (expense), net, for our reportable segments.", "For retrospective periods presented, operating loss for Other reflects equity earnings and charges from our equity method investment in Change Healthcare JV, which we split-off in the fourth quarter of 2020.", "Pharmaceutical segment includes a charge of $50 million for the year ended March 31, 2021 related to our estimated liability under the OSA.", "(3) Operating loss for our International segment for the years ended March 31, 2021 and 2020 includes charges of $58 million and $275 million, respectively, to remeasure to fair value the assets and liabilities of our German pharmaceutical wholesale business which was contributed to a joint venture with WBA.", "This segment\u2019s operating loss for the years ended March 31, 2021 and 2019 includes goodwill impairment charges of $69 million and $1.8 billion, respectively, as well as long-lived asset impairment charges for the  years ended March 31, 2021,  2020, and 2019  of $115  million,  $112  million,  and $245  million,  respectively, primarily  related to  our retail  pharmacy businesses in Canada and Europe.", "(4) Operating profit for our Medical-Surgical Solutions segment for the year ended March 31, 2021 includes charges totaling $136 million on certain PPE and other related products due to inventory impairments and excess inventory.", "(5) Operating profit for our RxTS segment for the year ended March 31, 2019 includes a gain of $56 million from the divestiture of an equity investment.", "(6) Operating loss for Other for the year ended March 31, 2020 includes an OTTI charge of $1.2 billion and a dilution loss of $246 million related to our investment in Change Healthcare JV, partially offset by a net gain of $414 million related to the completed separation of our interest in Change Healthcare JV during the fourth quarter of 2020.", "(7) Corporate expenses, net for the year ended March 31, 2021 includes a charge of $8.1 billion related to our estimated liability for opioid-related claims, net gains of $133 million  from  our  equity  investments,  and a net  gain  of $131  million  recorded  in  connection  with  insurance  proceeds  received  from  the  settlement  of  the  shareholder derivative action related to our controlled substances monitoring program.", "This was partially offset by a decrease in LIFO credits of $214 million, a charge of $50 million recorded in 2021 related to our estimated liability under the OSA, net impacts from COVID-19, including a less severe cough, cold, and flu season, as well as increased costs for strategic growth initiatives.", "Operating profit and operating profit margin were unfavorably impacted by customer mix and a decrease in net cash proceeds received of $180 million representing our share of antitrust legal settlements.", "recorded to remeasure to fair value the assets and liabilities of our German pharmaceutical wholesale business which was contributed to a joint venture with WBA, of  which  $58  million  and  $275  million  was  reflected  for  the  years  ended  March  31,  2021  and  2020,  respectively.  This  was  partially  offset  by  a  goodwill impairment charge of $69 million recorded in the second quarter of 2021 related to our European retail pharmacy business.", "This was partially offset  by  the  fair  value  remeasurement  charges  in  2020  described  above  and  a  gain  from  an  escrow  settlement  of  $97  million  in  2019  related  to  our  2017 acquisition of Rexall Health.", "Additionally,  operating  profit  was favorable  year over year  due to lower  operating  expenses, including a decrease in our provision for bad debts.", "primary care business and lower restructuring charges, partially offset by the remeasurement of assets and liabilities to fair value related to a divestiture that was completed in 2020 and higher operating expenses, including an increase in our provision for bad debts.", "and existing customers, integration costs incurred in 2019 for our acquisition of RxCrossroads that closed during the fourth quarter of 2018, partially offset by a gain of $56 million from the divestiture of an equity investment in 2019.", "investment in Change Healthcare JV, partially offset by a net gain of $414 million related to the completed separation of our interest in Change Healthcare JV during the fourth quarter of 2020.", "Operating loss for Other also includes our proportionate share of loss from Change Healthcare JV of $119 million and $194 million for the years ended March 31, 2020 and 2019, respectively.", "connection with insurance proceeds received from the settlement of the shareholder derivative action related to our controlled substances monitoring program.", "Corporate expenses, net, for 2020 includes pension settlement charges of $122 million, an opioid claim settlement charge of $82 million, and net settlement gains of $26 million recognized from our derivative contracts.", "claim settlement charge mentioned above, as well as higher costs for technology initiatives, partially offset by net settlement gains recognized in 2020 from our derivative contracts.", "Other Operating  loss  for  Other  for  the  year  ended  March  31,  2020  includes  an  OTTI charge  of  $1.2  billion  and  a  dilution  loss  of  $246  million  related  to  our", "Corporate 2021 vs. 2020 Corporate expenses, net increased for the year ended March 31, 2021 compared to the prior year due to a charge of $8.1 billion related to our estimated", "We conduct our business worldwide in local currencies including Euro, British pound sterling, and Canadian dollar.", "As a result, the comparability of our results reported in U.S. dollars can be affected by changes in foreign currency exchange rates.", "In discussing our operating results, we may use the term \u201cforeign currency exchange fluctuations,\u201d which refers to the effect of changes in foreign currency exchange rates used to convert the local currency results of our operations in foreign countries where the functional currency is not the U.S. dollar.", "We present this information to provide a framework for assessing how our business performed excluding the effect of foreign currency exchange rate fluctuations.", "In computing the foreign currency exchange fluctuations, we translate our current year results of our operations in foreign countries recorded in local currencies into U.S dollars by applying their respective average foreign currency exchange rates of the corresponding prior year periods, and we subsequently compare those results to the previously reported results of the comparable prior year periods reported in U.S. dollars.", "estimate was made and if different estimates that we reasonably could have used in the current period, or changes in the accounting estimate that are reasonably likely to occur from period to period, could have a material impact on our financial condition or results from operations.", "Below are the estimates that we believe are  critical  to  the  understanding  of  our  operating  results  and  financial  condition.  Other  accounting  policies  are  described  in  Financial  Note  1,  \u201cSignificant Accounting  Policies,\u201d  to  the  consolidated  financial  statements  appearing  in  this  Annual  Report  on  Form  10-K.  Because  of  the  uncertainty  inherent  in  such estimates, actual results may differ from these estimates.", "Other customer financing primarily relates to guarantees provided to our customers, or their creditors, regarding the repurchase of inventories.", "We also provide financing to certain customers related to the purchase of pharmacies, which serve as collateral for the loans.", "We estimate the receivables for which we do not  expect  full  collection  based  on  historical  collection  rates  and  specific  knowledge  regarding  the  current  creditworthiness  of  our  customers  and  record  an allowance in our consolidated financial statements for these amounts.", "Management reviews these factors quarterly to determine if any adjustments are needed to the allowance.", "Sales to our largest customer, CVS Health Corporation (\u201cCVS\u201d), accounted for approximately 21% of our total consolidated revenues in 2021 and comprised approximately 19% of total trade accounts receivable at March 31, 2021.", "As a result, our sales and credit concentration is significant.", "The accounts receivables balances are with individual members of the GPOs, and therefore no significant concentration of credit risk exists.", "A material default in payment, a material reduction in purchases from these or any other large customers, or the loss of a large customer or GPO could have a material adverse impact on our financial position, results of operations, and liquidity.", "We believe the reserves maintained and expenses recorded in 2021 are appropriate and consistent in the context of historical methodologies employed, as well as assessment of trends currently available.", "The selected 0.1% hypothetical change does not reflect what could be considered the best or worst-case scenarios.", "Our LIFO valuation amount includes both pharmaceutical and non-pharmaceutical products.", "We recognized LIFO credits of $38 million, $252 million, and $210 million, respectively, in 2021, 2020, and 2019 in our Consolidated Statements of Operations.", "A LIFO charge is recognized when the net effect of price increases on pharmaceutical and non-pharmaceutical products held in inventory exceeds the impact of price declines, including the effect  of branded pharmaceutical  products  that have lost market  exclusivity.  A LIFO credit  is recognized  when the net effect  of price  declines exceeds the impact of price increases on pharmaceutical and non-pharmaceutical products held in inventory.", "Excluding LIFO reserves, our inventory reserves as of March 31, 2021 and 2020 were $263 million and $96 million, respectively.", "The increase was primarily due to 2021 charges totaling $136 million on certain PPE and other related products due to inventory impairments and excess inventory within our Medical-Surgical Solutions segment.", "In 2021, 2020 and, 2019, our provision for bad debts", "At March 31, 2021 and 2020, total inventories, net were $19.2 billion and $16.7 billion, respectively, in our Consolidated Balance Sheets.", "Any purchase consideration in excess of the estimated fair values of the net assets acquired is recorded as goodwill.", "that is a form or variation of the income approach, whereby a forecast of future cash flows attributable to the asset are discounted to present value using a risk- adjusted discount rate.", "We perform an impairment test on goodwill balances annually in the third quarter and more frequently if indicators for potential impairment exist.", "equal to the amount of excess carrying value above the estimated fair value, if any, but not to exceed the amount of goodwill allocated to the reporting unit.", "we estimate fair value by comparing the business to similar businesses, or guideline companies whose securities are actively traded in public markets.", "Under the income approach, we use a discounted cash flow (\u201cDCF\u201d) model in which cash flows anticipated over several periods, plus a terminal value at the end of that time horizon, are discounted to their present value using an appropriate rate that is commensurate with the risk inherent within the reporting unit.", "Goodwill  and  Long-Lived  Assets: As  a  result  of  acquiring  businesses,  we  have  $9.5  billion  and  $9.4  billion  of  goodwill  at  March  31,  2021  and  2020,", "To estimate the fair value of our reporting units, we generally use a combination of the market approach and the income approach.", "Judgments made in determining an estimate of fair value may materially impact our results of operations.", "Included in the estimate of the weighted-average cost of capital is the assumption of an unsystematic risk premium to address incremental uncertainty related to the reporting units\u2019 future cash flow projections.", "An increase in the unsystematic risk premium increases the discount rate.", "Pharmaceutical  Distribution  reporting  units  in  our  International  segment,  exceeded  their  carrying  values.  The  impairment  testing  performed  in  2020  did  not indicate  any  material  impairment  of  goodwill.  The  segment  change  in  the  second  quarter  of  2021  prompted  changes  in  multiple  reporting  units  across  the Company.", "We recorded a goodwill impairment charge of $69 million in 2021 as the estimated fair value of the Europe Retail Pharmacy reporting unit was lower than its reassigned carrying value based on changes in the composition of the Europe Retail Pharmacy reporting unit within the International segment.", "At March 31, 2021, the  balance  of goodwill for the  reporting  units  in Europe  was approximately  nil  and the  remaining  balance  of goodwill  in the International segment primarily relates to one of our reporting units in Canada.", "Other risks, expenses and future developments, such as additional government actions, increased regulatory uncertainty, and material changes in key market assumptions that we were unable to anticipate as of the testing date may require us to further revise the projected cash flows, which could adversely affect the fair value of our other reporting units in future periods.", "We review intangible assets for impairment at an asset group level whenever events or changes in circumstances indicate that the carrying value of the assets may not be recoverable.", "Determination of recoverability of intangible assets is based on the lowest level of identifiable estimated future undiscounted cash flows resulting from use of the asset and its eventual disposition.", "Measurement of any impairment loss is based on the excess of the carrying value of the asset group over its fair value.", "Assumptions and estimates about future values and remaining useful lives of our purchased intangible assets are complex and subjective.", "When the decline in value is deemed to be other than temporary, an impairment is recognized to the extent that the fair value is less than the carrying value of the investment.", "We consider various factors in determining whether a loss in value of an investment is other than temporary including: the length of time and the extent to which the fair value has been below cost, the financial condition of the investees, and our intent and ability to retain the investment for a period of time sufficient to allow for recovery of value.", "Any significant changes in assumptions or judgments in assessing impairments could result in an impairment charge.", "We generally recognize employee severance costs when payments are probable and amounts are estimable.  Costs related  to contracts without future benefit or contract termination  are recognized  at the earlier of the contract termination  or  the  cease-use  dates.  Other  exit-related  costs  are  recognized  as  incurred.  In  connection  with  these  restructuring  actions,  we  also  assess  the recoverability of long-lived assets used in the business, and as a result, we may recognize accelerated depreciation and amortization reflecting shortened useful lives of the underlying assets.", "paid.  We  are  subject  to  income  taxes  in  the  U.S.  and  numerous  foreign  jurisdictions.  Significant  judgments  and  estimates  are  required  in  determining  the consolidated income tax provision and in evaluating income tax uncertainties and include those used to conclude on the tax-free nature of the separation of the Change Healthcare JV and the unrecognized tax position related to opioid-related litigation and claims, which remains unfinalized, and which may differ from the actual amounts of tax benefit recognized.", "We review our tax positions at the end of each quarter and adjust the balances as new information becomes available.", "to recover our deferred tax assets, we consider all available positive and negative evidence including our past operating results, the existence of cumulative net operating losses in the most recent years, and our forecast of future taxable income.", "In estimating future taxable income, we develop assumptions including the amount of future federal, state and foreign pre-tax operating income, the reversal of temporary differences, and the implementation of feasible and prudent tax planning strategies.", "These assumptions require significant judgment about the forecasts of future taxable income and are consistent with the plans and estimates we use to manage the underlying businesses.", "additional taxes and related interest will be due.", "If our current estimate of tax and interest liabilities is less than the ultimate settlement, an additional charge to income tax expense may result.", "If our current estimate of tax and interest liabilities is more than the ultimate settlement, a reduction to income tax expense may be recognized.", "investigations  relating  to  laws  and  regulations  and  other  matters  arising  out  of  the  normal  conduct  of  our  business.  When  a  loss  is  considered  probable  and reasonably estimable, we record a liability in the amount of our best estimate for the ultimate loss.", "When a material loss is reasonably possible or probable but a reasonable estimate cannot be made, disclosure of the proceeding is provided.", "Deferred income taxes arise from temporary differences between the tax and financial statement recognition of revenue and expense.", "Changes in tax laws and rates could also affect recorded deferred tax assets and liabilities in the future.", "We recognize liabilities for tax and related interest for issues in the U.S. and other tax jurisdictions based on our estimate of whether, and the extent to which,", "As discussed above, development of a meaningful estimate of loss or a range of potential loss is complex when the outcome is directly dependent on future negotiations with or decisions by third parties, such as regulatory agencies, the court system and other interested parties.", "As a result of ongoing, advanced discussions with state attorneys general and plaintiffs\u2019 representatives regarding a framework to resolve the claims of governmental  entities,  and  our  assessment  of  certain  other  opioid-related  claims,  we  have  reached  a  stage  at  which  a  broad  settlement  of  opioid  claims  by governmental entities is probable and recorded a charge of $8.1 billion for the year ended March 31, 2021 within \u201cClaims and litigation charges, net\u201d in our Consolidated Statement of Operations in this report.", "Because of the many uncertainties associated with any potential settlement arrangement or other resolution of opioid-related litigation, including the uncertainty of the scope of participation by plaintiffs in any potential settlement, we are not able to reasonably estimate the upper or lower ends of the range of ultimate possible loss for all opioid-related litigation matters.", "While we are not able to predict the outcome or reasonably estimate a range of possible losses in these matters, an adverse judgment or negotiated resolution in any of these matters could have a material adverse effect on our results of operations, consolidated financial position, cash flows or liquidity.", "facilities and commercial paper program, will be sufficient to fund our short-term and long-term capital expenditures, working capital, and other cash requirements.", "We continue to monitor its impact on demand within parts of our business, as well as trends potentially impacting the timing or ability for some of our customers to pay amounts owed to us.", "We remain well-capitalized with access to liquidity from our $4.0 billion revolving credit facility.", "Additionally, long-term debt markets and commercial paper markets, our primary sources of capital after cash flow from operations, have remained open and accessible to us during the COVID-19 pandemic.", "We have seen continued improvement in conditions in the debt markets and commercial paper markets as the Federal Reserve has taken steps to stabilize the markets.", "At March 31, 2021, we were in compliance with all debt covenants, and believe we have the ability to continue to meet our debt covenants in the future.", "Cash flows from operations can be significantly impacted by factors such as the timing of receipts from customers and payments to vendors.", "Operating activities for the year ended March 31, 2021 were affected by net income adjusted for non-cash items, including the pre-tax $8.1 billion (after-tax $6.8 billion) non-cash charge related to our estimated liability for opioid-related claims, an increase in inventory of $2.3 billion and an increase in drafts and accounts payable of $1.3 billion driven by higher inventory stock levels to meet increased volume demand as part of our inventory management, as well as a decrease in receivables of $1.1 billion driven by timing, higher sales recognized at the end of March 2020, and higher collections in our fourth quarter of 2021.", "value remeasurement charges of $58 million related to the contribution of our German pharmaceutical wholesale business to a joint venture with WBA.", "Additionally, we made a cash payment of $114 million from the executive benefit retirement plan in 2020.", "Investing activities for the year ended March 31, 2021 also includes net cash proceeds of $400 million from sales of businesses and investments, including $286 million in exchange for the contribution of our German pharmaceutical wholesale business to a joint venture with WBA.", "Cash used for other financing activities generally includes payments to noncontrolling interests and activity from our finance leases.", "We received cash from long-term debt issuances of $1.1 billion and made repayments on long-term debt of $1.1 billion in 2019.", "The timing of any repurchases and the actual number of shares repurchased will depend on a variety of factors, including our stock price, corporate and regulatory requirements, restrictions under our debt obligations, and other market and economic conditions.", "In accordance with our accounting policy, we allocate any excess of share repurchase price over par value between additional paid-in capital and retained earnings.", "Accordingly, our retained earnings and additional paid-in capital were reduced by $472 million and $70 million during 2019, respectively.", "outstanding shares of SpinCo common stock, which held all of the Company\u2019s interests in the Change Healthcare JV, to participating holders of the Company\u2019s common  stock  in  exchange  for  15.4  million  shares  of  McKesson  stock,  which  are  now  held  as  treasury  stock  on  our  consolidated  balance  sheet.  Following consummation of the exchange offer, on March 10, 2020, SpinCo merged with and into Change and each share of SpinCo common stock was converted into one share of Change common stock, par value $0.001 per share, with cash being paid in lieu of fractional shares of Change common stock.", "give us the ability to meet our financing needs for the foreseeable future.", "However, there can be no assurance that an increase in volatility or disruption in the global capital and credit markets will not impair our liquidity or increase our costs of borrowing.", "As described within the \u201cTrends and Uncertainties\u201d section above,  the  COVID-19  pandemic  continues  to  develop  rapidly.  We  continue  to  monitor  its  impact  on  demand  within  parts  of  our  business,  as  well  as  trends potentially impacting the timing or ability for some of our customers to pay amounts owed to us.", "(2) This ratio describes the relationship and changes within our capital resources, and is computed as total debt divided by the sum of total debt and McKesson stockholders\u2019 equity (deficit), which excludes noncontrolling and redeemable noncontrolling interests and accumulated other comprehensive loss. (3) Ratio is computed as net income (loss) attributable to McKesson Corporation for the last four quarters, divided by a five-quarter average of McKesson stockholders\u2019 equity (deficit), which excludes noncontrolling and redeemable noncontrolling interests.", "In 2019, we retired 5.0 million or $542 million of the Company\u2019s treasury shares previously repurchased.", "In connection with the Split-off, we distributed all 176.0 million", "Deposits with financial institutions are primarily denominated in U.S. dollars and the functional currencies of our foreign subsidiaries, including Euro, British pound sterling, and Canadian dollars.", "We mitigate the risk of our short-term investment portfolio by depositing funds with reputable financial institutions and monitoring risk profiles and investment strategies of money market funds. outside of the U.S., respectively.", "Our primary intent is to utilize this cash for foreign operations for an indefinite period of time.", "Although the vast majority of cash held outside the U.S. is available for repatriation, doing so could subject us to foreign withholding taxes and state income taxes.", "The COVID-19 pandemic has potential to increase the variations in our working capital, which we continue to monitor closely. partially offset by an increase in drafts and accounts payable and a decrease in receivables.", "Our unfavorable return on McKesson\u2019s stockholder\u2019s equity (deficit) as of March 31, 2021 was also driven by net loss for the year.", "Net loss for the year ended March 31, 2021 includes an after-tax non-cash charge of $6.8 billion related to our estimated liability for opioid-related claims, as discussed in \u201cTrends  and  Uncertainties\u201d of  this  Financial  Review  and  Financial  Note  19,  \u201cCommitments  and  Contingent  Liabilities,\u201d  to  the  accompanying  consolidated financial statements included in this Annual Report on Form 10\u2011K.", "Our debt to capital ratio increased for 2020 primarily due to a decrease in stockholders\u2019 equity driven by the Split-off of our interest in Change Healthcare JV and share repurchases.", "We anticipate that we will continue to pay quarterly cash dividends in the future.", "However, the payment and amount of future dividends remain within the discretion of the Board and will depend upon our future earnings, financial condition,  capital  requirements,  and  other  factors.  In  2021,  2020,  and  2019,  we  paid  total  cash  dividends  of  $276  million,  $294  million,  and  $292  million, respectively.  Additionally,  as  required  under  the  Domination  Agreement,  we  are  obligated  to  pay  an  annual  recurring  compensation  amount  of  \u20ac0.83  per McKesson Europe share (effective January 1, 2015) to the noncontrolling shareholders of McKesson Europe.", "Cash equivalents, which are readily convertible to known amounts of cash, are carried at fair value.", "Our cash and cash equivalents balance as of March 31, 2021 and 2020 included approximately $2.3 billion and $1.7 billion of cash held by our subsidiaries", "On  July  29,  2020,  we  raised  our  quarterly  dividend  from  $0.41  to  $0.42  per  common  share  for  dividends  declared  on  or  after  such  date  by  the  Board.", "(3) Includes our estimated benefit payments for the unfunded benefit plans and minimum funding requirements for the pension plans. (4) Primarily represents interest that will become due on our fixed rate long-term debt obligations.", "These obligations primarily relate to inventory purchases and capital commitments. (6) Includes agreements under which we have guaranteed the repurchase of our customers\u2019 inventory and our customers\u2019 debt in the event these customers are unable to meet their obligations to those financial institutions.", "The ultimate amount and timing of any future cash settlements related to these items cannot be predicted with reasonable certainty.", "and are mostly related to our customer contracts and to meet the security requirements for statutory licenses and permits, court and fiduciary obligations, and our workers\u2019 compensation and automotive liability programs.", "The exercise of the Put Right will reduce the balance of redeemable noncontrolling interests.", "During 2021, we paid $49 million to purchase 1.8 million shares of McKesson Europe through exercises of the Put Right by the noncontrolling shareholders.", "Our banks and insurance companies have issued $146 million of standby letters of credit and surety bonds at March 31, 2021.", "redemption value is the Put Amount adjusted for exchange rate fluctuations each period.", "In future periods, unfavorable foreign currency exchange rate fluctuations between the Euro and the U.S. dollar could adversely impact the carrying value of our redeemable noncontrolling interests and require an adjustment to increase the balance of our redeemable noncontrolling interests to its maximum redemption value.", "On April 12, 2021, we received the Stuttgart Court of Appeals\u2019 final ruling confirming the original put value of \u20ac22.99 per share and the annual recurring compensation of \u20ac0.83 per McKesson Europe share.", "Funds necessary for future debt maturities and our other cash requirements are expected to be met by existing cash balances, cash flow from operations, existing credit sources, and other capital market transactions.", "The effect of a hypothetical 50 bp increase in the underlying interest rate on our cash and cash equivalents, net of short-term borrowings and variable rate debt, would have resulted in a favorable impact to earnings in 2021 and 2020 of approximately $17 million and $6 million, respectively.", "The balance of redeemable noncontrolling interests is reported at the greater of its carrying value or its maximum redemption value at each reporting date.", "Additionally,  we  are  obligated  to  pay  an  annual  recurring  compensation  of  \u20ac0.83  per  McKesson  Europe  share  (the  \u201cCompensation  Amount\u201d)  to  the", "Interest rate risk: Our long-term debt bears interest predominately at fixed rates, whereas our short-term borrowings are at variable interest rates.", "Our cash and cash equivalents balances earn interest at variable rates.", "At March 31, 2021 and 2020, we had $6.3 billion and $4.0 billion, respectively, in cash", "Changes in foreign currency exchange rates could have a material adverse impact on our financial results that are reported in U.S. dollars.", "We are also exposed to foreign exchange rate risk related to our foreign subsidiaries, including intercompany loans denominated in non-functional currencies.", "These programs reduce but do not entirely eliminate foreign exchange risk.", "fair value of our foreign exchange contracts by approximately $267 million and $435 million, respectively.", "Foreign exchange risk: We conduct our business worldwide in U.S. dollars and the functional currencies of our foreign subsidiaries, including Euro, British", "We have certain foreign exchange rate risk programs that use foreign currency forward contracts and cross-currency swaps.", "Based on this assessment, our management has concluded that our internal control over financial reporting was effective as of March 31, 2021.", "In our opinion, the financial statements referred to above present fairly, in all material respects, the financial position of the Company as of March 31, 2021 and 2020, and the results of its operations and its cash flows for each of the three years in the period ended March 31, 2021, in conformity with accounting principles generally accepted in the United States of America.", "Also, in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of March 31, 2021, based on criteria established in Internal Control \u2014 Integrated Framework (2013) issued by COSO.", "Our responsibility is to express an opinion on these financial statements and an opinion on the Company\u2019s internal control over financial reporting based  on  our  audits.  We  are  a  public  accounting  firm  registered  with  the  Public  Company  Accounting  Oversight  Board  (United  States)  (\u201cPCAOB\u201d)  and  are required  to  be  independent  with  respect  to  the  Company  in  accordance  with  the  U.S.  federal  securities  laws  and  the  applicable  rules  and  regulations  of  the Securities and Exchange Commission and the PCAOB.", "We conducted our audits in accordance with the standards of the PCAOB.", "Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.", "Our audits of the financial statements included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures to respond to those risks.", "Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements.", "Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk.", "Our audits also included performing such other procedures as we considered necessary in the circumstances.", "We believe that our audits provide a reasonable basis for our opinions.", "The critical audit matters communicated below are matters arising from the current-period audit of the financial statements that were communicated or required to be communicated to the audit committee and that (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments.", "The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.", "The Company also performs an assessment of loss contingencies where a loss is reasonably possible.", "We identified the potential broad settlement of opioid claims as a critical audit matter because of the significant judgment and challenges auditing management\u2019s determination  of  whether  such  loss  is  probable  and  reasonably  estimable.  Specifically,  auditing  management\u2019s  determination  and  disclosure  of  whether  the contingent loss arising from the potential broad settlement of opioid claims is probable, and the related measurement of such loss, is subjective and requires significant judgment given that the potential loss is based upon settlement terms that have not yet been finalized.", "\u2022 We tested the effectiveness of internal controls related to the potential broad settlement of opioid claims, and approval of the accounting treatment and related disclosures based on the most recent facts and circumstances.", "In addition, we inspected responses to inquiry letters sent to both internal and external legal counsel as it relates to the status of discussions with plaintiffs\u2019 counsel and the Company\u2019s intent regarding the framework for a potential broad settlement of opioid claims.", "\u2022 We evaluated management\u2019s analysis of the potential broad settlement of opioid claims, including the methodology used by management to determine the probability of such loss.", "We also evaluated the methodology used by management to estimate the most likely loss to be incurred by the Company as a result of a potential broad settlement of opioid claims.", "\u2022 We performed public domain searches for evidence contrary to management\u2019s analysis.", "\u2022 We evaluated any events subsequent to March 31, 2021 that might impact our evaluation of the potential broad settlement of opioid claims. \u2022 We obtained written representations from executives and internal counsel of the Company. \u2022 We examined proposed terms related to the potential broad settlement framework. \u2022 We evaluated the Company\u2019s related disclosures for consistency with our testing.", "The net amount recognized by management is measured as the largest amount of tax benefit that is greater than 50 percent likely of being realized.", "We identified the Company\u2019s uncertain tax position related to the charge for the potential broad settlement of opioid claims as a critical audit matter because of the challenges in auditing management\u2019s estimate of the amount of income tax benefit that qualifies for recognition.", "Our audit procedures related to the Company's uncertain tax position associated with a potential broad settlement of opioid claims included the following, among others: \u2022 We tested the effectiveness of internal controls related to the Company\u2019s assessment of the technical merits of its tax position, including the Company\u2019s assessment as to the amount of benefit that is more likely than not to be realized. \u2022 With  the  assistance  of  our  tax  specialists,  we  evaluated  the  facts,  evidence  and  the  Company\u2019s  related  income  tax  analysis  for  the  charge  related  to  the potential broad settlement of opioid claims, including assumptions used by management to measure the related recognized and unrecognized tax benefits. \u2022 We inquired of the Company\u2019s internal and external legal counsel to understand the basis for the Company\u2019s conclusion that a portion of the potential broad settlement of opioid claims would be deductible based on the most recent discussions with plaintiffs\u2019 counsel.", "\u2022 We  compared  management's  income  tax  assessment  of  this  matter  to  the  treatment  of  other  recorded  opioid  charges  to  evaluate  the  consistency  of  the Company\u2019s judgments related to the uncertain tax position. \u2022 We evaluated any events subsequent to March 31, 2021 that might impact our evaluation of the Company\u2019s uncertain tax position related to the charge for the potential broad settlement of opioid claims.", "\u2022 We obtained written representations from executives and internal counsel of the Company. \u2022 We examined proposed terms related to the potential broad settlement framework.", "\u2022 We evaluated the Company\u2019s related disclosures for consistency with our testing and also searched for contradictory evidence by reading disclosures from peer companies, who are also party to the potential broad settlement of opioid claims.", "We identified the estimation of the fair value of the McKesson Canada reporting unit used to evaluate the recoverability of goodwill as a critical audit matter because of the challenges auditing significant judgments used in the selection of a discount rate, including the unsystematic risk premium.", "In particular, the fair value estimate is sensitive to the unsystematic risk premium assumption, which is affected by expected risk of changes in the Canadian business and regulatory environments.", "Auditing management\u2019s selected discount rate required a high degree of auditor judgment and an increased extent of effort, including the need to involve more senior members of the team and our fair value specialists.", "Our audit procedures related to the Company\u2019s selection of a discount rate, including consideration of the unsystematic risk premium, for the McKesson Canada reporting unit included the following, among others: \u2022 We tested the effectiveness of internal controls related to management\u2019s goodwill impairment evaluation, including those related to the selection of a discount rate and consideration of an unsystematic risk premium. \u2022 We  evaluated  management\u2019s  ability  to  accurately  forecast  operating  results  for  the  McKesson  Canada  reporting  unit  by  comparing  actual  results  to management\u2019s historical forecasts, in order to consider the reasonableness and adequacy of management\u2019s selected unsystematic risk premium. \u2022 As part of our assessment of the unsystematic risk premium, we evaluated the reasonableness of strategic plans expected to be implemented during the forecast period by comparing the forecasts to:", "\u2022 With the assistance of our fair value specialists, we evaluated the reasonableness of the discount rate, including the unsystematic risk premium, by developing a range of independent estimates, testing the mathematical accuracy of the calculation and comparing to the discount rate selected by management.", "We have served as the Company\u2019s auditor since 1968.", "The Company consolidates VIEs when it is determined that it is the primary beneficiary of the VIE.", "Investments in business entities in which the Company does not have control but has the ability to exercise significant influence over operating and financial policies, are accounted for using the equity method.", "Actual amounts could differ from those estimated amounts.", "These legislative acts are not expected to have a material impact on the Company\u2019s consolidated financial results.", "The Company considers itself to control an entity if it is the majority owner of or has voting control over such entity.", "GAAP requires that the Company make estimates and assumptions that", "If a loss in value has occurred that is deemed to be other-than-temporary, an impairment loss is recorded.", "economic environment, customer credit ratings or bankruptcies, as well as reasonable and supportable forecasts.", "We are exposed to credit losses on accounts receivable balances.", "As a result, the Company\u2019s sales and credit concentration is significant.", "The accounts receivables balances are with individual members of the GPOs, and therefore no significant concentration of credit risk exists.", "This credit risk is mitigated by the size and diversity of the Company\u2019s customer base as well as its geographic dispersion.", "These amounts are equivalent to the Company\u2019s LIFO reserves.", "A LIFO credit is recognized when the net effect of price declines exceeds the impact of price increases on pharmaceutical and non-pharmaceutical products held in inventory.", "The increase was primarily due to charges in 2021 totaling $136 million on certain personal protective equipment and other related products due to inventory impairments and excess inventory within our Medical-Surgical Solutions segment.", "When the net realizable value of a disposal group increases during a period, a gain can be recognized to the extent that it does not increase the value of the disposal group beyond its original carrying value when the disposal group was reclassified as held for sale.", "Depreciation and amortization begins when an asset is placed in service and ready for its intended use.", "The use of alternative assumptions and estimates could affect the fair values and change the impairment determinations.", "Measurement of any impairment loss is based on the excess of the carrying value of the asset group over its estimated fair market value.", "customer in an amount that reflects the consideration to which the entity expects to be entitled for that good or service.", "Revenue is recognized when control of goods is transferred to the customer which occurs upon the Company\u2019s delivery to the customer or upon customer  pick-up.", "The ultimate outcome of any outstanding claims may be different than the Company\u2019s estimate.", "If a derivative is designated as a fair value hedge, the changes in the fair value of the derivative and of the hedged item attributable to the hedged risk are recognized in earnings.", "The cumulative changes in fair value are reclassified to the same line as the hedged item in the Consolidated Statements of Operations when the hedged item affects earnings.", "Noncontrolling interests with redemption features, such as put rights, that are not solely within the Company\u2019s control are considered redeemable noncontrolling interests.", "When a loss is considered probable and reasonably estimable, the Company records a liability in the amount of its best estimate for the ultimate loss.", "When a material loss is reasonably possible or probable, but a reasonable estimate cannot be made, disclosure of the proceeding is provided.", "As discussed above, development of a meaningful estimate of loss or a range of potential loss is complex when the outcome is directly dependent on negotiations with or decisions by third parties, such as regulatory agencies, the court system, and other interested parties.", "Any purchase consideration in excess of the estimated fair values of the net assets acquired is recorded as goodwill.", "Restructuring Charges: Employee severance costs are generally recognized when payments are probable and amounts are reasonably estimable.", "The forward-looking model requires the Company to consider historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount in estimating credit losses.", "The adoption of this amended guidance is not expected to have a material impact on the Company\u2019s consolidated financial statements or disclosures.", "accounting policy has been to disclose any intervening events of the joint venture in the lag period that could materially affect its consolidated financial statements.", "McKesson had the ability to adjust the manner in which certain depreciation or amortization deductions are allocated among Change and McKesson.", "This creates uncertainty over the amount, timing, and probability of the gain recognized.", "Any such change is not expected to have a material impact on the Company\u2019s consolidated financial statements.", "This initiative was substantially complete in 2021 and remaining costs the Company expects to record under this initiative are not material.", "This set of initiatives was substantially complete by the end of 2020 and charges in 2021 were not material.", "Goodwill recognized for business acquisitions is generally not expected to be deductible for tax purposes.", "share-based awards that will ultimately vest primarily based on historical experience.", "The estimated forfeiture rate established upon grant is re-assessed throughout the requisite service period and is adjusted when actual forfeitures occur.", "The actual forfeitures in future reporting periods could be higher or lower than current estimates.", "PSUs have a requisite service period of generally three years.", "Compensation expense for the share-based awards is recognized for the portion of awards ultimately expected to vest.", "The number of vested PSUs is assessed at the end of a", "All  outstanding  PeRSU awards  have  completed  the  performance  period  and  are  now classified  and  accounted  for  as RSUs.", "portion of the awards that is ultimately expected to vest.", "Once the fair value of an employee stock option is determined, current accounting practices do not permit it to be changed, even if the estimates used are different from actual.", "The Company believes this market-based input provides a reasonable estimate of its future stock price movements and is consistent with employee stock option valuation considerations.", "These amounts have not been significant for all the years presented.", "Substantially all its foreign net operating losses have indefinite lives.", "The decrease in unrecognized tax benefits in 2020  compared  to  2019  is  primarily  attributable  to  the  favorable  resolution  of  an  outstanding  California  tax  refund  claim  which  decreased  unrecognized  tax benefits by $91 million.", "2017 Tax Act, the repatriation of cash to the U.S. is generally no longer taxable for federal income tax purposes.", "The Company may remit foreign earnings to the U.S. to the extent it is tax efficient to do so.", "It does not expect the tax impact from remitting these earnings to be material.", "The exercise of the Put Right will reduce the balance of redeemable noncontrolling interests.", "The adoption of this guidance did not have a material impact on the Company\u2019s consolidated statements of operations and cash flows.", "The Company\u2019s lease agreements do not contain any material residual value guarantees or material restrictive covenants.", "Operating lease liabilities are recognized based on the present value of the future lease payments over the lease term, discounted at the Company\u2019s incremental borrowing rate as the implicit rate in the lease is not readily determinable for most of the Company\u2019s leases.", "As a practical expedient, short-term leases with an initial term of 12 months or less are excluded from the Consolidated Balance Sheets and charges from these leases are expensed as incurred.", "Fair value estimates result from a complex series of judgments about future events and uncertainties and rely heavily on estimates and assumptions that have been deemed reasonable by management as of the measurement date.", "The unsystematic risk premium is an input factor used in calculating the discount rate that specifically addresses uncertainty related to the reporting unit\u2019s future cash flow projections.", "The risk of successfully achieving certain business initiatives was the primary factor in the use of a higher discount rate.", "and, from time-to-time, future unsecured and unsubordinated indebtedness outstanding.", "As a result of absorbing this risk, the leases provide the Company with the power to direct the operations of the leased properties and the obligation to absorb losses or the right to receive benefits of the entity.", "Consolidated VIEs do not have a material impact on the Company\u2019s Consolidated Statements of Operations and Cash Flows.", "their economic performance and thus is not considered the primary beneficiary of the entities.", "The pension obligation in Germany is unfunded with the exception of the contractual trust arrangement used to fund pensions of McKesson Europe\u2019s Management Board.", "actuarial  losses  exceeding  10%  of  the  greater  of  the  projected  benefit  obligation  or  the  market  value  of  assets  are  amortized  straight-line  over  the  average remaining future service period of active employees.", "Pension obligations for its unfunded plans are based on the recommendations of independent actuaries.", "The difference between actual inflation and assumed inflation in our U.K. pension plans resulted in a gain of $23 million.", "corporate bonds rated AA or better whose maturities are aligned with the expected benefit payments of its plans.", "Plan assets of the non-U.S. plans are broadly invested in a manner appropriate to the nature and duration of the expected future retirement benefits payable under the plans.", "Assets are properly diversified to avoid excessive reliance on any particular asset, issuer, or group of undertakings so as to avoid accumulations of risk in the portfolio as a whole.", "practical expedient are not leveled within the fair value hierarchy and are included as a reconciling item to total investments.", "Actions taken by other participating employers may lead to adverse changes in the financial condition of a multiemployer benefit plan and the Company\u2019s withdrawal liability and contributions may increase.", "It does not use derivatives for trading or speculative purposes.", "Eligible employees may contribute to the RSP up to 75% of", "In the normal course of business, the Company is exposed to interest rate and foreign currency exchange rate fluctuations.", "These forward contracts and cross-currency swaps are generally used to offset the potential income statement effects from intercompany loans and other obligations denominated in non-functional currencies.", "These programs reduce but do not entirely eliminate foreign currency exchange rate risk.", "To the extent foreign currency-denominated notes designated as net investment hedges are ineffective, changes in carrying value attributable to the change in spot rates are recorded in earnings.", "To the extent cross-currency swaps designated as hedges are ineffective, changes in carrying value attributable to the change in spot rates are recorded in earnings.", "Changes in fair values representing hedge ineffectiveness are recognized in current earnings.", "The settlement loss on the swaps was not material and will be amortized on a straight-line basis as interest expense over the five-year life of the 2025 Notes.", "Gains or losses from these contracts are largely offset by changes in the value of the underlying intercompany obligations.", "Changes in the fair value for contracts not designated as hedges are recorded directly in earnings.", "The carrying value of all other cash equivalents approximates their fair value due to their relatively short-term nature.", "These inputs are considered Level 2 under the fair value measurements and disclosure guidance and may not be representative of actual values that could have been realized or that will be realized in the future.", "If the carrying amount of an asset group is not recoverable, an impairment charge is recorded to reduce the carrying amount by the excess over its fair value.", "repurchase of its customers\u2019 inventory or its customers\u2019 debt in the event these customers are unable to meet their obligations to those financial institutions.", "For the Company\u2019s inventory repurchase agreements, among other requirements, inventories must be in resalable condition and any repurchase would be at a discount.", "The majority of the Company\u2019s customers\u2019 debt guarantees are secured by certain assets of the customer.", "The Company\u2019s long-term debt is also recorded at cost.", "The carrying value and fair value of the Company\u2019s long-term debt was as follows:", "Long-lived Assets The Company utilizes multiple approaches including the DCF model and market approaches for estimating the fair value of intangible assets.", "infringe a third party\u2019s intellectual property rights.", "Where appropriate, obligations for such indemnifications are recorded as liabilities.", "Accrued warranty costs were not material to the Consolidated Balance Sheets.", "Significant developments in those matters are described below.", "Company  is  unable  to  determine  that  a  loss  is  probable,  or  to  reasonably  estimate  the  amount  of  loss  or  a  range  of  loss,  for  a  claim  because  of  the  limited information  available  and  the  potential  effects  of future  events  and  decisions  by third  parties,  such  as  courts  and  regulators,  that  will  determine  the  ultimate resolution of the claim.", "It is not uncommon for claims to remain unresolved over many years.", "The Company reviews loss contingencies at least quarterly to determine whether the likelihood of loss has changed and whether it can make a reasonable estimate of the loss or range of loss.", "When the Company determines that a loss from a claim is probable and reasonably estimable, it records a liability for an estimated amount.", "The Company also provides disclosure when it is reasonably possible that a loss may be incurred or when it is reasonably possible that the amount of a loss will exceed its recorded liability.", "Warranties In the normal course of business, the Company provides certain warranties and indemnification protection for its products and services.", "These two West Virginia plaintiffs are not expected to participate in any broader multistate resolution of opioid-related claims.", "The Cherokee Nation is not expected to participate in any broader multistate resolution of opioid-related claims.", "Those non-participating governmental entities would be entitled to pursue their claims against the Company and other defendants.", "The Company believes that it has valid defenses to the claims pending against it, and it intends to vigorously defend against all such claims if acceptable settlement terms are not achieved.", "The Company believes it has valid legal defenses in these matters and intends to mount a vigorous defense.", "The Company has not concluded a loss is probable in any of these matters; nor is the amount of any loss reasonably estimable.", "An adverse judgment or negotiated resolution in any of these matters could have a material adverse impact on the Company\u2019s financial position, cash flows or liquidity, or results of operations.", "AIG and ACE are seeking declarations that they have no duty to defend or indemnify McKesson in the thousands of lawsuits pending in federal and state courts related to opioids.", "Discussions with attorneys general and other parties continue.", "If the negotiating parties agree on terms under the framework for a broad resolution of claims of", "Plaintiffs\u2019 moved for summary judgment on the same day.", "subpoenas and requests in a cooperative, thorough and timely manner.", "These responses sometimes require time and effort and can result in considerable costs being incurred by the Company.", "Such subpoenas and requests can lead to the assertion of claims or the commencement of civil or criminal legal proceedings against the Company and other members of the health care industry, as well as to settlements of claims against the Company.", "The Company responds to these requests in the ordinary course of business.", "The law adopting the excise tax made clear that the OSA does not apply to sales or distributions occurring after December 31, 2018.", "It is not certain at this point in time what proportion of this estimated liability will be borne by the Company.", "However, it is possible that the ultimate costs of these matters may exceed or be less than the reserves.", "Due to the complex nature of the tax laws, it is not possible to estimate the outcome of these matters.", "improper actions to delay or prevent generic drugs from entering the market.", "The quarterly results of operations are not necessarily indicative of the results that may be expected for the entire year.", "effectiveness of the Company\u2019s \u201cdisclosure controls and procedures\u201d (as such term is defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) as of the end of the period  covered  by  this  report  and  have  concluded  that  our  disclosure  controls  and  procedures  are  effective  based  on  their  evaluation  of  these  controls  and procedures as required by paragraph (b) of Exchange Act Rules 13a-15 or 15d-15.", "Rules 13a-15 or 15d-15 that occurred during our fourth quarter of 2021 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.", "caption  \u201cInvestors  -  Corporate  Governance.\u201d  The  Company\u2019s  Corporate  Governance  Guidelines  and  Charters  for  the  Audit,  Compensation  and  Governance Committees can also be found on our website under the same caption.", "Information  about the Code of Conduct applicable  to all employees, officers  and directors can be found on our website, www.mckesson.com, under the", "Information with respect to this item is incorporated by reference from the discussion under the heading \u201cExecutive Compensation\u201d in our Proxy Statement.", "Such non-employee director award is fully vested on the date of the grant.", "subject to and qualified in their entirety by reference to our amended and restated certificate of incorporation, our amended and restated by- laws  and  the  Delaware  General  Corporation  Law  (\u201cDGCL\u201d).  Copies  of  our  amended  and  restated  certificate  of  incorporation  and  our amended and restated by-laws have been filed with the Securities and Exchange Commission (the \u201cSEC\u201d) and are incorporated by reference herein. 100,000,000 shares are preferred stock, par value $0.01 per share.", "We may amend from time to time our amended and restated certificate of incorporation to increase the number of authorized shares of Common Stock and/or preferred stock.", "Any such amendment would require the approval of the holders of a majority of our shares entitled to vote.", "All of our outstanding shares of Common Stock are fully paid and non- assessable.", "Stock are entitled to receive ratably dividends out of assets legally available therefor at such times and in such amounts as our board of directors may from time to time determine.", "ratably in our assets that are legally available for distribution, after payment of all debts, other liabilities and any liquidation preferences of outstanding preferred stock.", "amended and restated certificate of incorporation does not provide for cumulative voting in the election of directors.", "Upon liquidation, dissolution or winding up of our affairs, the holders of Common Stock are entitled to share", "Holders of our Common Stock have no conversion, redemption, preemptive or similar", "Each outstanding share of Common Stock is entitled to one vote on all matters submitted to a vote of stockholders.", "Anti-Takeover Effects of Provisions of Our Amended and Restated Certificate of Incorporation and Our Amended and Restated By- Laws deemed to have an anti-takeover effect and may delay, deter or prevent a tender offer or takeover attempt that a stockholder might consider in its best interest, including those attempts that might result in a premium over the market price for the shares held by stockholders.", "Our amended and restated by-laws provide that special meetings of holders of Common Stock may be called only by our Chair, Chief Executive Officer or a majority of our board of directors for any purpose at any time.", "Holders of Common Stock owning at least 15% of the outstanding shares of Common Stock for at least one year are permitted to submit a special meeting request in accordance with the procedures described in our amended and restated by-laws.", "In general, notice of intent to nominate a director or raise business at such meetings must be received by us not less than 90 nor more than 120 days prior to the date of the  annual meeting and must contain certain specified  information concerning the person to be nominated or the matters to be brought before the meeting and concerning the stockholder submitting the proposal.", "may be amended by a vote of a majority of our board of directors and by the affirmative vote of a majority of the shares of the corporation entitled  to  vote  thereon.  Our  amended  and  restated  certificate  of  incorporation  and  our  amended  and  restated  by-laws  provide  that  our amended and restated by-laws may be amended by a vote of a majority of our board of directors.", "In addition, our amended and restated by- laws provide that our amended and restated by-laws may be amended by the affirmative vote of a majority of the shares of the corporation entitled to vote thereon.", "Current and former stockholders are deemed to have consented to the personal jurisdiction of the Delaware Courts in connection with any action to enforce that exclusive forum provision and to service of process in any such action.", "We  are  subject  to  the  \u201cbusiness  combination\u201d  statute  of  the  DGCL.  In  general,  such  statute  prohibits  a  publicly  held  Delaware", "The statute could prohibit or delay mergers or other takeover or change in control attempts with respect to us and, accordingly, may discourage attempts to acquire us.", "stock could decrease the amount available for distribution to holders of our Common Stock or could adversely affect the rights and powers, including voting rights, of such holders.", "The issuance of preferred stock could have the effect of delaying or preventing a change in control of us.", "Such limitation does not, however, affect the liability of a director (1) for any breach of the director\u2019s duty of loyalty to us or our stockholders, (2) for acts or omissions not in good faith or that involve intentional misconduct or a knowing violation of law, (3) in respect of certain unlawful dividend payments or stock redemptions or purchases and (4) for any transaction from which the director derives an improper personal benefit.", "The effect of this provision is to eliminate our rights and the rights of our stockholders (through stockholders\u2019 derivative suits) to recover monetary damages against a director for breach of the fiduciary duty of care as a director (including breaches resulting from negligent or grossly negligent behavior) except in the situations described in clauses (1) through (4) above.", "This provision does not limit or eliminate our rights or the rights of our stockholders to seek non-monetary relief such as an injunction or rescission in the event of a breach of a director\u2019s duty of care.", "In addition, our directors and officers have indemnification protection.", "principal amount of 0.625% Notes due 2021 and \u20ac600,000,000 aggregate principal amount of 1.500% Notes due 2025, and on February 12, 2018, we issued \u20ac500,000,000 aggregate principal amount of 1.625% Notes due 2026.", "existing and future unsecured and unsubordinated indebtedness from time to time outstanding.", "EQ Shareowner Services acts as transfer agent and registrar of our Common Stock.", "Our Common Stock is listed on the New York Stock Exchange under the symbol \u201cMCK\u201d.", "On  February  17,  2017,  we  issued  \u00a3450,000,000  aggregate  principal  amount  of  3.125%  Notes  due  2029,  \u20ac600,000,000  aggregate", "Securities\u201d), our senior subordinated debt (\u201cSenior Subordinated Debt Securities\u201d), our subordinated debt (\u201cSubordinated Debt Securities\u201d) or our  junior  subordinated  debt  (\u201cJunior  Subordinated  Debt  Securities\u201d  and,  together  with  the  Senior  Subordinated  Debt  Securities  and  the Subordinated Debt Securities, the \u201cSubordinated Securities\u201d).  The Indenture does not limit the amount of debt securities that we may issue.", "It provides that we may issue debt securities up to the principal amount that we may authorize and may be in any currency or currency unit designated  by  us.  Except  for  the  limitations  on  consolidation,  merger  and  sale  of  all  or  substantially  all  of  our  assets  contained  in  the Indenture, the terms of the Indenture do not contain any covenants or other provisions designed to afford holders of any debt securities protection with respect to our operations, financial condition or transactions involving us.", "any person unless (a) we will be the continuing corporation or (b) the successor corporation or person formed by such consolidation or into which we are merged or to which our assets substantially as an entirety are transferred or leased is a corporation, limited liability company or limited partnership organized or existing under the laws of the United States, any state of the United States or the District of Columbia and, if such entity is not a corporation, a co-obligor of the debt securities is a corporation organized or existing under any such laws, and such successor corporation or person, including such co-obligor, if any, expressly assumes our obligations on the debt securities and under the Indenture.", "In addition, we cannot effect such a transaction unless immediately after giving effect to such transaction, no default or Event of Default under the Indenture shall have occurred and be continuing.", "Subject to certain exceptions, when the person to whom our assets are transferred or leased has assumed our obligations under the debt securities and the Indenture, we shall be discharged from all our obligations under the debt securities and the Indenture, except in limited circumstances.", "unless the transaction or change of control were structured to include a merger or consolidation or transfer or lease of all or substantially all of our assets.", "We cannot consolidate or merge with or into, or transfer or lease all or substantially all of our assets to,", "\u2022 any  other  Event  of  Default  provided  in  the  applicable  resolution  of  our  board  of  directors  or  the  officers\u2019  certificate  or supplemental Indenture under which we issue such series of debt securities.", "The Indenture imposes limitations on suits brought by holders of debt securities against us.", "officer knows of any default by us in the performance, observance or fulfillment of any condition or covenant of the Indenture.", "We and the Trustee may not, however, without the consent of the holder of each outstanding debt security affected thereby:", "The Indenture provides that we and the Trustee may enter into supplemental indentures without the", "value of the assets subject to such transaction, as determined by our Board of Directors, or (b) the present value of the remaining obligations of the lessee for net rental payments during the term of any lease discounted at the rate of interest set forth or implicit in the terms of such lease or, if not practicable to determine such rate, the weighted average interest rate per annum borne by the debt securities of each series outstanding pursuant to the Indenture and subject to limitations on sale and lease-back transaction covenants, compounded semi-annually in either case as determined by our principal accounting or financial officer.", "located,  and  substantially  all  the  operations  of  which  are  conducted,  in  the  United  States  of  America  whose  financial  statements  are consolidated with our financial statements in accordance with accounting principles generally accepted in the United States of America.", "Consolidated  Subsidiaries  incurred  after  the  date  of  issuance  of  the  notes  and  secured  by  liens  not  permitted  by  the  limitation  on  liens provisions, and (2) Attributable Debt of ours and our Consolidated Subsidiaries in respect of every sale and lease-back transaction entered into after the date of the issuance of the notes, other than leases permitted by the limitation on sale and lease-back provisions.", "accordance with accounting principles generally accepted in the United States of America.", "Subsidiaries pursuant to which we or any of our Subsidiaries sells, conveys or otherwise transfers to (1) a Receivables Subsidiary (in the case of a transfer by us or any of our Subsidiaries) or (2) any other person (in the case of a transfer by a Receivables Subsidiary), or grants a security interest in, any accounts receivable (whether now existing or arising in the future) or inventory of us or any of our Subsidiaries, and any assets related thereto including, without limitation, all collateral securing such accounts receivable, all contracts and all guarantees or other  obligations  in  respect  of  such  accounts  receivable  or  inventory,  proceeds  of  such  accounts  receivable  and  other  assets  which  are customarily transferred or in respect of which security interests are customarily granted in connection with asset securitization transactions involving accounts receivable or inventory.", "financing of accounts receivable or inventory (a) no portion of the Indebtedness or any other obligations (contingent or otherwise) of which (1)  is  guaranteed  by  us  or  any  Subsidiary  of  ours  (excluding  guarantees  of  obligations  (other  than  the  principal  of,  and  interest  on, Indebtedness) pursuant to representations, warranties, covenants and indemnities entered into in the ordinary course of business in connection with  a  Qualified  Receivables  Transaction),  (2)  is  recourse  or  obligates  us  or  any  Subsidiary  of  ours  in  any  way  other  than  pursuant  to representations,  warranties,  covenants  and  indemnities  entered  into  in  the  ordinary  course  of  business  in  connection  with  a  Qualified Receivables Transaction or (3) subjects any property or asset of ours or any Subsidiary of ours (other than accounts receivable or inventory and related assets as provided in the definition of \u201cQualified Receivables Transaction\u201d), directly or indirectly, contingently or otherwise, to the satisfaction thereof, other than pursuant to representations, warranties, covenants and indemnities entered into in the ordinary course of business in connection with a Qualified Receivables Transaction, (b) with which neither we nor any Subsidiary of ours has any material contract, agreement, arrangement or understanding other than on terms customary for securitization of receivables or inventory and (c) with which neither we nor any Subsidiary of ours has any obligations to maintain or preserve such Subsidiary\u2019s financial condition or cause such Subsidiary to achieve certain levels of operating results.", "Limitation  on  Liens.  We  covenant  that,  so  long  as  any  of  the  Notes  remain  outstanding,  we  will  not,  and  will  not  permit  any", "Indebtedness which is secured by a lien which would otherwise be subject to the foregoing restrictions; provided that after giving effect thereto the Exempted Debt then outstanding at such time does not exceed 10% of our total assets on a consolidated basis.", "than three years, by us or any Consolidated Subsidiary of any assets are prohibited unless (a) we or such Consolidated Subsidiary would be entitled to incur Indebtedness secured by a lien on the assets to be leased in an amount at least equal to the Attributable Debt in respect of such transaction without equally and ratably securing the notes, or (b) the proceeds of the sale of the assets to be leased are at least equal to their fair market value (as determined by our Board of Directors) and the proceeds are applied to the purchase or acquisition, or, in the case of real property, the construction, of assets or to the retirement of Indebtedness.", "The foregoing limitation will not apply, if at the time we or any Consolidated Subsidiary enters into such sale and lease-back transaction, and after giving effect thereto, Exempted Debt does not exceed 10% of our total assets on a consolidated basis.", "time, or in part, from time to time, at our option, for cash, at a redemption price that includes accrued and unpaid interest and a make-whole premium, as specified in the Indenture and the applicable Officer\u2019s Certificate.", "York  Stock  Exchange  under  the  symbol  \u201cMCK25.\u201d  Our  2026  Notes  are  listed  on  the  New  York  Stock  Exchange  under  the  symbol \u201cMCK26.\u201d Our 2029 Notes are listed on the New York Stock Exchange under the symbol \u201cMCK29.\u201d", "This Statement of Terms and Conditions is intended to meet the requirements of Code Section 409A and any regulations and rules promulgated thereunder.", "In the event of any inconsistency between this Statement of Terms and Conditions and the Plan, the Plan shall govern.", "Capitalized terms not otherwise defined in this Statement of Terms and Conditions shall have the meaning set forth in the Plan.", "With respect to  annual  Restricted  Stock  Unit  Awards  granted  to  Outside  Directors  under  the  Plan,  such  awards  shall  be  subject  to  the  following  terms,  conditions  and restrictions.", "The Administrator administering the Plan has authority to determine the Outside Directors to whom, and the time or", "additional Restricted Stock Units, which will be subject to all of the terms and conditions of the underlying Restricted Stock Unit Award.", "The number of such additional Restricted Stock Units shall be calculated by dividing (a) the aggregate amount or value of the dividends paid with respect to that number of Shares equal to the number of Restricted Stock Units credited as of the record date for such dividend by (b) the Fair Market Value per Share on the payment date for such dividend.", "Any fractional Shares resulting from the accumulation of dividend equivalents shall be paid in cash.", "Dividend equivalents in respect of Restricted Stock Units, if granted in tandem with such Units, will be converted into", "Neither an Outside Director nor any person entitled to exercise an Outside Director\u2019s rights in the event of the Outside", "this Statement of Terms and Conditions, or under a Restricted Stock Unit Agreement, shall be conclusive and binding on all persons.", "is providing the consents herein on a purely voluntary basis.", "Nothing herein contained shall affect an Outside Director\u2019s right, if any, to participate in and receive benefits", "Each Outside Director shall agree to make appropriate arrangements with the Corporation for satisfaction of any applicable federal,", "The Corporation will hold and use the Data only as long as is necessary to implement, administer and manage the", "illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.", "Agreements shall be governed by the laws of the State of Delaware.", "The provisions in this Statement of Terms and Conditions are severable and if any one or more provisions are determined to be", "This Statement of Terms and Conditions and the Restricted Stock Unit Agreements shall be binding upon and inure to the benefit of", "This Statement of Terms and Conditions is intended to meet the requirements of Code Section 409A and any regulations and rules promulgated thereunder.", "In the event of any inconsistency between this Statement of Terms and Conditions and the Plan, the Plan shall govern.", "Capitalized terms not otherwise defined in this Statement of Terms and Conditions shall have the meaning set forth in the Plan.", "With respect to  annual  Restricted  Stock  Unit  Awards  granted  to  Outside  Directors  under  the  Plan,  such  awards  shall  be  subject  to  the  following  terms,  conditions  and restrictions.", "The Administrator administering the Plan has authority to determine the Outside Directors to whom, and the time or", "Neither an Outside Director nor any person entitled to exercise an Outside Director\u2019s rights in the event of the Outside", "this Statement of Terms and Conditions, or under a Restricted Stock Unit Agreement, shall be conclusive and binding on all persons.", "is providing the consents herein on a purely voluntary basis.", "Nothing herein contained shall affect an Outside Director\u2019s right, if any, to participate in and receive benefits", "Each Outside Director shall agree to make appropriate arrangements with the Corporation for satisfaction of any applicable federal,", "The Corporation will hold and use the Data only as long as is necessary to implement, administer and manage the", "illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.", "Agreements shall be governed by the laws of the State of Delaware.", "The provisions in this Statement of Terms and Conditions are severable and if any one or more provisions are determined to be", "This Statement of Terms and Conditions and the Restricted Stock Unit Agreements shall be binding upon and inure to the benefit of", "In the event of any inconsistency between this Statement of Terms and Conditions and the Plan, the Plan shall govern.", "Capitalized terms not otherwise defined in this Statement of Terms and Conditions shall have the meaning set forth in the Plan.", "The Option is also subject to the terms and conditions of the Plan.", "In no event shall the Corporation be required to issue fractional Shares.", "An Option granted under the Plan shall be evidenced by an Option Agreement setting forth the terms and conditions of the", "The Exercise Price of an Option, as specified in the Option Agreement, shall be equal to or greater than the Fair Market Value of", "Period, the Option Period shall end on the date of such termination of employment and the Option shall thereupon not be exercisable to any extent whatsoever.", "Term Disability, the vesting schedule of the Participant\u2019s Option shall be accelerated, the Option shall become fully exercisable and the Option Period shall end on the earlier of (i) three years after the date of the Participant\u2019s termination of employment and (ii) the Expiration Date.", "Retirement, (i) the Option shall be exercisable only to the extent that it was exercisable at the time of such retirement and (ii) the Option Period for that portion of the Option designated as a Non Statutory Stock Option shall end on the earlier of (a) three years after the date of such retirement and (b) the Expiration Date.", "of  the  Participant's  Option,  then  the  Option  shall  continue  to  remain  outstanding  until  the  earlier  of  (i)  such  time  as  the  Participant  subsequently  terminates employment and (ii) the Expiration Date.", "number of Shares as to which the Option is so exercised.", "thereunder shall be transferable by the Participant by operation of law or otherwise, other than by will or the laws of descent and distribution.", "have any of the rights of a stockholder with respect to the Shares subject to an Option except to the extent that a book entry has been entered in the records of the Corporation\u2019s transfer agent with respect to such Shares upon the exercise of an Option.", "Neither a Participant nor any person entitled to exercise a Participant\u2019s rights in the event of the Participant\u2019s death shall", "Stock dividends paid with respect to Restricted Stock during the Restriction Period shall be treated as Restricted Stock which shall be subject to the same restrictions as the original award for the duration of the Restriction Period.", "If the Participant does not have a brokerage account of record, then an appropriate book entry recording the Participant\u2019s interest in the unrestricted Shares shall be entered on the records of the Corporation\u2019s transfer agent.", "Cash dividends paid with respect to Restricted Stock during the Restriction Period shall be credited on behalf of the Participant to a", "Election to Recognize Gross Income in the Year of Grant.", "The Administrator reserves the right to impose a restriction on the sale of Shares that the Participant receives upon", "Neither a Participant nor any person entitled to exercise a Participant\u2019s rights in the event of the Participant\u2019s death shall", "The Administrator reserves the right to impose a restriction on the sale of Shares that the Participant receives upon", "Following the end of the performance period, the Compensation Committee shall determine the extent to which the criteria have been achieved and shall authorize the grant and issuance of Shares in respect of the Performance Stock Unit Award.", "The performance period of a Performance Stock Unit Award shall be greater than one year,", "Unless otherwise determined by the Compensation Committee in its sole discretion, Dividend Equivalents shall not be", "A Participant shall not be permitted to sell, transfer, pledge, assign or encumber all or any portion of a Performance Stock Unit", "Neither a Participant nor any person entitled to exercise a Participant\u2019s rights in the event of the Participant\u2019s death shall", "The Administrator reserves the right to impose a restriction on the sale of Shares that the Participant", "addition, any Award of Restricted Stock or Restricted Stock Units as to which the restrictions have not lapsed shall immediately and automatically be forfeited, Performance Stock Unit Awards shall immediately and automatically be forfeited and any such Shares of Restricted Stock shall be returned to the Corporation and all of the rights of the Participant to such Awards and the underlying Shares shall immediately terminate.", "Any outstanding Option shall immediately and automatically terminate, be forfeited and shall cease to be exercisable, without limitation.", "determination shall be conclusive and binding on all interested persons.", "a manner that is valid and enforceable and that comes closest to the business objectives intended by such invalid or unenforceable provision, without invalidating or rendering unenforceable the remaining provisions of this Section VI.", "under an Award Agreement, shall be conclusive and binding on all interested persons.", "Participation in the Plan shall not create a right to further employment with the Participant\u2019s employer (the", "In making grants to Participants in foreign countries, the Administrator has the full discretion to", "All decisions of the Administrator administering the Plan upon any questions arising under the Plan or", "Nothing herein contained shall affect a Participant\u2019s right to participate in and receive benefits from and in", "Regardless  of any  action  the  Corporation  or  the  Employer  takes  with  respect  to  any  federal,  state  or  local  income  tax,  social", "Calculation of the number of Shares to be withheld shall be made based on the closing price of the Common Stock on the New York Stock Exchange on the date that the amount of tax to be withheld is determined.", "With respect to an Award other than an Option, if adequate arrangements to satisfy the obligations with regard to all Tax-Related Items are not made by the Participant with the Corporation and/or the Employer prior to the relevant taxable event, the Corporation will satisfy such obligations as provided above in clause (3) of this paragraph.", "The Administrator shall be authorized to establish such rules, forms and procedures as it deems necessary to implement the foregoing.", "In accepting the grant, the Participant acknowledges that:", "jurisdiction may have different data privacy laws and protections than the United States.", "In the latter case, the Participant understands and acknowledges that the Corporation\u2019s legal basis for the processing of the Participant\u2019s Data would be compliance with the relevant  laws  or  regulations  or  the  pursuit  by  the  Corporation  of  respective  legitimate  interests  not  outweighed  by  the  Participant\u2019s  interests,  rights  or freedoms.", "When the Corporation no longer needs the Participant\u2019s Data for any of the above purposes, the Participant understands the Corporation will remove it from its systems.", "providing the consents herein on a purely voluntary basis.", "illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.", "If the Participant has received this Statement of Terms and Conditions or any other document related to the Plan translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control.", "The provisions in this Statement of Terms and Conditions are severable and if any one or more provisions are determined to be", "The Participant acknowledges that the Participant is proficient in the English language and, accordingly, understands the provisions of", "The Corporation will hold and use the Data only as long as is necessary to implement, administer and manage the", "Participation in the Plan is voluntary and the Participant is", "In the event of any inconsistency between this Statement of Terms and Conditions and the Plan, the Plan shall govern.", "Capitalized terms not otherwise defined in this Statement of Terms and Conditions shall have the meaning set forth in the Plan.", "The Option is also subject to the terms and conditions of the Plan.", "In no event shall the Corporation be required to issue fractional Shares.", "An Option granted under the Plan shall be evidenced by an Option Agreement setting forth the terms and conditions of the", "The Exercise Price of an Option, as specified in the Option Agreement, shall be equal to or greater than the Fair Market Value of", "Period, the Option Period shall end on the date of such termination of employment and the Option shall thereupon not be exercisable to any extent whatsoever.", "Term Disability, the vesting schedule of the Participant\u2019s Option shall be accelerated, the Option shall become fully exercisable and the Option Period shall end on the earlier of (i) three years after the date of the Participant\u2019s termination of employment and (ii) the Expiration Date.", "Retirement, (i) the Option shall be exercisable only to the extent that it was exercisable at the time of such retirement and (ii) the Option Period for that portion of the Option designated as a Nonstatutory Stock Option shall end on the earlier of (a) three years after the date of such retirement and (b) the Expiration Date.", "of  the  Participant's  Option,  then  the  Option  shall  continue  to  remain  outstanding  until  the  earlier  of  (i)  such  time  as  the  Participant  subsequently  terminates employment and (ii) the Expiration Date.", "number of Shares as to which the Option is so exercised.", "thereunder shall be transferable by the Participant by operation of law or otherwise, other than by will or the laws of descent and distribution.", "have any of the rights of a stockholder with respect to the Shares subject to an Option except to the extent that a book entry has been entered in the records of the Corporation\u2019s transfer agent with respect to such Shares upon the exercise of an Option.", "Neither a Participant nor any person entitled to exercise a Participant\u2019s rights in the event of the Participant\u2019s death shall", "Stock dividends paid with respect to Restricted Stock during the Restriction Period shall be treated as Restricted Stock which shall be subject to the same restrictions as the original award for the duration of the Restriction Period.", "If the Participant does not have a brokerage account of record, then an appropriate book entry recording the Participant\u2019s interest in the unrestricted Shares shall be entered on the records of the Corporation\u2019s transfer agent.", "Cash dividends paid with respect to Restricted Stock during the Restriction Period shall be credited on behalf of the Participant to a", "Election to Recognize Gross Income in the Year of Grant.", "The Administrator reserves the right to impose a restriction on the sale of Shares that the Participant receives upon", "Neither a Participant nor any person entitled to exercise a Participant\u2019s rights in the event of the Participant\u2019s death shall", "The Administrator reserves the right to impose a restriction on the sale of Shares that the Participant receives upon", "The performance period of a Performance Stock Unit Award shall be greater than one year,", "Unless otherwise determined by the Compensation Committee in its sole discretion, Dividend Equivalents shall not be", "A Participant shall not be permitted to sell, transfer, pledge, assign or encumber all or any portion of a Performance Stock Unit", "Neither a Participant nor any person entitled to exercise a Participant\u2019s rights in the event of the Participant\u2019s death shall", "The Administrator reserves the right to impose a restriction on the sale of Shares that the Participant", "addition, any Award of Restricted Stock or Restricted Stock Units as to which the restrictions have not lapsed shall immediately and automatically be forfeited, Performance Stock Unit Awards shall immediately and automatically be forfeited and any such Shares of Restricted Stock shall be returned to the Corporation and all of the rights of the Participant to such Awards and the underlying Shares shall immediately terminate.", "Any outstanding Option shall immediately and automatically terminate, be forfeited and shall cease to be exercisable, without limitation.", "determination shall be conclusive and binding on all interested persons.", "a manner that is valid and enforceable and that comes closest to the business objectives intended by such invalid or unenforceable provision, without invalidating or rendering unenforceable the remaining provisions of this Section VI.", "under an Award Agreement, shall be conclusive and binding on all interested persons.", "Participation in the Plan shall not create a right to further employment with the Participant\u2019s employer (the", "In making grants to Participants in foreign countries, the Administrator has the full discretion to", "All decisions of the Administrator administering the Plan upon any questions arising under the Plan or", "Nothing herein contained shall affect a Participant\u2019s right to participate in and receive benefits from and in", "Regardless  of any  action  the  Corporation  or  the  Employer  takes  with  respect  to  any  federal,  state  or  local  income  tax,  social", "Calculation of the number of Shares to be withheld shall be made based on the closing price of the Common Stock on the New York Stock Exchange on the date that the amount of tax to be withheld is determined.", "With respect to an Award other than an Option, if adequate arrangements to satisfy the obligations with regard to all Tax-Related Items are not made by the Participant with the Corporation and/or the Employer prior to the relevant taxable event, the Corporation will satisfy such obligations as provided above in clause (3) of this paragraph.", "The Administrator shall be authorized to establish such rules, forms and procedures as it deems necessary to implement the foregoing.", "In accepting the grant, the Participant acknowledges that:", "jurisdiction may have different data privacy laws and protections than the United States.", "In the latter case, the Participant understands and acknowledges that the Corporation\u2019s legal basis for the processing of the Participant\u2019s Data would be compliance with the relevant  laws  or  regulations  or  the  pursuit  by  the  Corporation  of  respective  legitimate  interests  not  outweighed  by  the  Participant\u2019s  interests,  rights  or freedoms.", "When the Corporation no longer needs the Participant\u2019s Data for any of the above purposes, the Participant understands the Corporation will remove it from its systems.", "providing the consents herein on a purely voluntary basis.", "illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.", "If the Participant has received this Statement of Terms and Conditions or any other document related to the Plan translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control.", "The provisions in this Statement of Terms and Conditions are severable and if any one or more provisions are determined to be", "The Participant acknowledges that the Participant is proficient in the English language and, accordingly, understands the provisions of", "The Corporation will hold and use the Data only as long as is necessary to implement, administer and manage the", "Participation in the Plan is voluntary and the Participant is", "In the event of any inconsistency between this Statement of Terms and Conditions and the Plan, the Plan shall govern.", "Capitalized terms not otherwise defined in this Statement of Terms and Conditions shall have the meaning set forth in the Plan.", "The Option is also subject to the terms and conditions of the Plan.", "In no event shall the Corporation be required to issue fractional Shares.", "An Option granted under the Plan shall be evidenced by an Option Agreement setting forth the terms and conditions of the", "The Exercise Price of an Option, as specified in the Option Agreement, shall be equal to or greater than the Fair Market Value of", "Period, the Option Period shall end on the date of such termination of employment and the Option shall thereupon not be exercisable to any extent whatsoever.", "Term Disability, the vesting schedule of the Participant\u2019s Option shall be accelerated, the Option shall become fully exercisable and the Option Period shall end on the earlier of (i) three years after the date of the Participant\u2019s termination of employment and (ii) the Expiration Date.", "Retirement, (i) the Option shall be exercisable only to the extent that it was exercisable at the time of such retirement and (ii) the Option Period for that portion of the Option designated as a Non Statutory Stock Option shall end on the earlier of (a) three years after the date of such retirement and (b) the Expiration Date.", "of  the  Participant's  Option,  then  the  Option  shall  continue  to  remain  outstanding  until  the  earlier  of  (i)  such  time  as  the  Participant  subsequently  terminates employment and (ii) the Expiration Date.", "number of Shares as to which the Option is so exercised.", "thereunder shall be transferable by the Participant by operation of law or otherwise, other than by will or the laws of descent and distribution.", "have any of the rights of a stockholder with respect to the Shares subject to an Option except to the extent that a book entry has been entered in the records of the Corporation\u2019s transfer agent with respect to such Shares upon the exercise of an Option.", "Neither a Participant nor any person entitled to exercise a Participant\u2019s rights in the event of the Participant\u2019s death shall", "Stock dividends paid with respect to Restricted Stock during the Restriction Period shall be treated as Restricted Stock which shall be subject to the same restrictions as the original award for the duration of the Restriction Period.", "If the Participant does not have a brokerage account of record, then an appropriate book entry recording the Participant\u2019s interest in the unrestricted Shares shall be entered on the records of the Corporation\u2019s transfer agent.", "Cash dividends paid with respect to Restricted Stock during the Restriction Period shall be credited on behalf of the Participant to a", "Election to Recognize Gross Income in the Year of Grant.", "Neither a Participant nor any person entitled to exercise a Participant\u2019s rights in the event of the Participant\u2019s death shall", "Following the end of the performance period, the Compensation Committee shall determine the extent to which the criteria have been achieved and shall authorize the grant and issuance of Shares in respect of the Performance Stock Unit Award.", "The performance period of a Performance Stock Unit Award shall be greater than one year,", "addition, any Award of Restricted Stock or Restricted Stock Units as to which the restrictions have not lapsed shall immediately and automatically be forfeited, Performance Stock Unit Awards shall immediately and automatically be forfeited and any such Shares of Restricted Stock shall be returned to the Corporation and all of the rights of the Participant to such Awards and the underlying Shares shall immediately terminate.", "Unless otherwise determined by the Compensation Committee in its sole discretion, Dividend Equivalents shall not be", "A Participant shall not be permitted to sell, transfer, pledge, assign or encumber all or any portion of a Performance Stock Unit", "Neither a Participant nor any person entitled to exercise a Participant\u2019s rights in the event of the Participant\u2019s death shall", "Any outstanding Option shall immediately and automatically terminate, be forfeited and shall cease to be exercisable, without limitation.", "determination shall be conclusive and binding on all interested persons.", "a manner that is valid and enforceable and that comes closest to the business objectives intended by such invalid or unenforceable provision, without invalidating or rendering unenforceable the remaining provisions of this Section VI.", "Participation in the Plan shall not create a right to further employment with the Participant\u2019s employer (the", "In making grants to Participants in foreign countries, the Administrator has the full discretion to", "under an Award Agreement, shall be conclusive and binding on all interested persons.", "Calculation of the number of Shares to be withheld shall be made based on the closing price of the Common Stock on the New York Stock Exchange on the date that the amount of tax to be withheld is determined.", "With respect to an Award other than an Option, if adequate arrangements to satisfy the obligations with regard to all Tax-Related Items are not made by the Participant with the Corporation and/or the Employer prior to the relevant taxable event, the Corporation will satisfy such obligations as provided above in clause (3) of this paragraph.", "All decisions of the Administrator administering the Plan upon any questions arising under the Plan or", "Nothing herein contained shall affect a Participant\u2019s right to participate in and receive benefits from and in", "Regardless  of any  action  the  Corporation  or  the  Employer  takes  with  respect  to  any  federal,  state  or  local  income  tax,  social", "The Administrator shall be authorized to establish such rules, forms and procedures as it deems necessary to implement the foregoing.", "In accepting the grant, the Participant acknowledges that:", "jurisdiction may have different data privacy laws and protections than the United States.", "In the latter case, the Participant understands and acknowledges that the Corporation\u2019s legal basis for the processing of the Participant\u2019s Data would be compliance with the relevant  laws  or  regulations  or  the  pursuit  by  the  Corporation  of  respective  legitimate  interests  not  outweighed  by  the  Participant\u2019s  interests,  rights  or freedoms.", "When the Corporation no longer needs the Participant\u2019s Data for any of the above purposes, the Participant understands the Corporation will remove it from its systems.", "providing the consents herein on a purely voluntary basis.", "The Corporation will hold and use the Data only as long as is necessary to implement, administer and manage the", "Participation in the Plan is voluntary and the Participant is", "illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.", "If the Participant has received this Statement of Terms and Conditions or any other document related to the Plan translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control.", "The provisions in this Statement of Terms and Conditions are severable and if any one or more provisions are determined to be", "The Participant acknowledges that the Participant is proficient in the English language and, accordingly, understands the provisions of", "In the event of any inconsistency between this Award Agreement and the Plan, the Plan shall govern.", "Capitalized terms not otherwise defined in this Award Agreement shall have the meaning set forth in the Plan.", "determine the extent to which the performance goals have been achieved, and shall determine the number of PSUs that have been earned.", "Once the Compensation Committee has determined the number of PSUs that have been earned pursuant to the", "Dividend equivalents shall be credited in respect of the One-Year RSU Award.", "The restrictions applicable to the RSU Award shall lapse with respect to 100% of the underlying Shares on the third", "Dividend equivalents shall be credited in respect of the RSU Award granted under this Section III.", "If the Participant ceases to be a bona fide employee of the Corporation or any Affiliate (except as otherwise", "otherwise  forfeited  pursuant  to  the  terms  of  the  Plan  and  this  Award  Agreement  shall  be  paid  to  the  Participant  as  soon  as  reasonably  practicable  after  the restrictions lapse.", "Performance  Stock  Units and  Restricted  Stock  Units,  to  the  extent  the  restrictions  have  not  lapsed,  shall  immediately  and  automatically  be", "determination shall be conclusive and binding on all interested persons.", "a manner that is valid and enforceable and that comes closest to the business objectives intended by such invalid or unenforceable provision, without invalidating or rendering unenforceable the remaining provisions of this Section IV.", "Compensation Committee reserves the right to impose a restriction on the sale of Shares that the Participant receives upon the settlement of the Performance Stock Units and Restricted Stock Units granted hereunder, unless the Participant has satisfied the ownership targets applicable to the Participant as provided in such policy.", "Neither the Participant nor any person entitled to exercise the Participant\u2019s rights in the event of the Participant\u2019s death", "Participation in the Plan shall not create a right to further employment with the Participant\u2019s employer (the", "under this Award Agreement, shall be conclusive and binding on all interested persons.", "Calculation of the number of Shares to be withheld shall be made based on the closing price of the Common Stock on the New York Stock Exchange on the date that the amount of tax to be withheld is determined.", "If adequate arrangements to satisfy the obligations with regard to all Tax-Related Items are not made by the Participant with the Corporation and/or the Employer prior to the relevant taxable event, the Corporation will satisfy such obligations as provided above in clause (iii) of this paragraph.", "The Administrator has the full discretion to deviate from this Award Agreement in order to adjust the Awards", "All decisions of the Administrator administering the Plan upon any questions arising under the Plan or", "Nothing herein contained shall affect the Participant\u2019s right to participate in and receive benefits from and in", "Regardless  of any  action  the  Corporation  or  the  Employer  takes  with  respect  to  any  federal,  state  or  local  income  tax,  social", "The Administrator shall be authorized to establish such rules, forms and procedures as it deems necessary to implement the foregoing.", "In accepting the grant, the Participant acknowledges that:", "providing the consents herein on a purely voluntary basis.", "The Corporation will hold and use the Data only as long as is necessary to implement, administer and manage the", "Participation in the Plan is voluntary and the Participant is", "unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.", "English and if the meaning of the translated version is different than the English version, the English version will control.", "Award, the terms of which are set forth herein and in the Plan.", "The provisions in this Award Agreement are severable and if any one or more provisions are determined to be illegal or otherwise", "Below is a list of documents that are made available to you in connection with this Notice.", "PLEASE BE SURE TO READ THESE DOCUMENTS BECAUSE THEY CONTAIN IMPORTANT INFORMATION SPECIFIC TO THIS GRANT OF RSUs.", "By signing below, I acknowledge that: 1.    I agree to receive copies of the stockholder information, including copies of any annual report, proxy and Form 10-K, from the Investor Resources section of", "Below is a list of documents that are made available to you in connection with this Notice.", "PLEASE BE SURE TO READ THESE DOCUMENTS BECAUSE THEY CONTAIN IMPORTANT INFORMATION SPECIFIC TO THIS GRANT OF RSUs.", "I consent to receiving electronically a copy of the documents set forth above and attachments to this Notice; and 5.", "I accept ALL the terms and conditions as set forth in the Plan and ST&Cs applicable to this grant of RSUs.", "Your  PSUs  will  be  earned  subject  to  the  Company\u2019s  attainment  of  performance  goals  that  have  been  pre-established  by  the  Compensation  Committee  (the \u201cCommittee\u201d) of the Company\u2019s Board of Directors.", "Below is a list of documents that are made available to you in connection with this Notice.", "PLEASE BE SURE TO READ THESE DOCUMENTS BECAUSE THEY CONTAIN IMPORTANT INFORMATION SPECIFIC TO THIS GRANT OF PSUs.", "I consent to receiving electronically a copy of the documents set forth above and attachments to this Notice; and 12.", "I should consult with a tax advisor prior to accepting this grant of PSUs or taking any other action with respect to this grant of PSUs; and 14.", "I accept ALL the terms and conditions as set forth in the Plan and ST&Cs applicable to this grant of PSUs.", "We consent to the incorporation by reference in McKesson Corporation Registration Statement Nos. 333-249817, 333-163642, 333-190847, 333-190848, and 333- 213488 on Form S-8, and Registration Statement No. 333-236808 on Form S-3, of our report dated May 12, 2021, relating to the consolidated financial statements and consolidated financial statement schedule of McKesson Corporation and subsidiaries, and the effectiveness of McKesson Corporation\u2019s internal control over financial reporting appearing in this Annual Report on Form 10-K of McKesson Corporation for the year ended March 31, 2021.", "I have reviewed this annual report on Form 10-K of McKesson Corporation;", "The registrant\u2019s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant\u2019s auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):", "I have reviewed this annual report on Form 10-K of McKesson Corporation;", "The registrant\u2019s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant\u2019s auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):", "Together, we work across the healthcare delivery system to connect pharmacies, providers, payers, and biopharma for next-generation patient access and adherence solutions that help people get the medicine they need to live healthier lives.", "Unless otherwise noted, all references in this document to a particular year shall mean the", "On March 10, 2020, we completed the separation of our interest in the Change Healthcare JV through a split- off transaction.", "This transaction reduced our investment in the Change Healthcare JV to zero.", "Change Healthcare: Our equity ownership interest in Change Healthcare JV, a joint venture, has been accounted for using the equity method of accounting.", "for our innovations and obtain copyright protection for our original works of authorship, when such protection is advantageous.", "Through these efforts, we have developed a portfolio of patents and copyrights in the U.S. and worldwide.", "In addition, we have registered or applied to register certain trademarks and service marks in the U.S. and in foreign countries.", "We cannot guarantee that our intellectual property portfolio will be sufficient to deter misappropriation, theft, or misuse of our technology, nor that we can successfully enjoin infringers.", "We periodically receive notices alleging that our products or services infringe on third party patents and other intellectual property rights.", "While the outcome of any litigation or dispute is inherently uncertain, we do not believe that the resolution of any of these infringement notices would have a material adverse impact on our results of operation.", "These values and behaviors help make McKesson unique.", "We offer financial assistance programs for higher education opportunities that support employees\u2019 career growth at the company.", "To provide compensation that is focused on attracting and retaining talent with the skills and experience necessary for a specific role, our compensation program is built on a set of quantifiable factors defined by our guiding principles of internal fairness, market competitiveness, and pay for performance.", "We operate in several countries and our benefits offerings vary accordingly.", "We offer health and wellness benefits to advance the physical, mental, and social well-being of our people, savings programs to help prepare them for retirement, and flexible work arrangements, among other  benefits  offerings,  when  possible.  In  response  to  the  COVID-19  pandemic,  we  offered  extended  medical  benefits  covering  COVID-19  related  visits, treatment and testing, expanded telehealth options, emergency paid time off (\u201cPTO\u201d), and a platform for employees to donate their regular PTO to co-workers who were  more  impacted  by  COVID-19.", "We have received monetary penalties and/or licensing sanctions pursuant to these requirements and future allegations of noncompliance could result in an inability to obtain, maintain or renew permits, licenses or other regulatory approvals needed for the operation of our businesses.", "As a result of ongoing, advanced discussions with state attorneys general and plaintiffs\u2019 representatives regarding a framework to resolve the claims of governmental entities, and our assessment of certain other opioid-related claims, we have reached a stage at which a broad settlement of opioid claims by governmental entities is probable and recorded a charge of $8.1 billion for the year ended March 31, 2021 within \u201cClaims and litigation charges, net\u201d in our Consolidated Statement of Operations in this Annual Report on Form 10-K.", "Because of the many uncertainties associated with any potential settlement arrangement or other resolution of opioid-related litigation, including the uncertainty of the scope of participation by plaintiffs in any potential settlement, we are not able to reasonably estimate the upper or lower ends of the range of ultimate possible loss for all opioid-related litigation matters.", "The adverse outcome of legal proceedings might also involve significant  expense,  management  time  and  distraction,  and risk  of loss that  can be difficult  to predict  or quantify.  In addition  to this litigation,  legislative  or regulatory measures related to the distribution of controlled substances such as prescription opioids could affect our business in ways that we may not be able to predict.", "For example, some states have passed legislation that could require us to pay taxes or assessments on the distribution of opioid medications in those states and other states have considered similar legislation.", "We are subject to government audits,  investigations  and  oversight  proceedings.  Government  agencies  routinely  review  and  audit  government  contractors  to  determine  whether  they  are complying with contractual and legal requirements.", "If we fail to comply with these requirements, or we fail an audit, we may be subject to various sanctions such as monetary damages, criminal and civil penalties, termination of contracts and suspension or debarment from government contract work.", "These requirements complicate our business and increase our compliance burden and material non-compliance could harm our reputation.", "affecting  Medicare,  Medicaid,  other  government  healthcare  programs,  and  government  contracts.  Our  relationships  with  pharmaceutical  and  medical  surgical product manufacturers and healthcare providers, as well as our provision of products and services to government entities, subject our business to laws, regulation, and government guidance on fraud and abuse.", "Many of these laws are vague or indefinite and have not been interpreted by the courts and, as such, may be interpreted or applied by a prosecutorial, regulatory, or judicial authority in a manner that could require us to make changes in our operations.", "Americans and changed the way healthcare is financed by both governmental and private payers.", "There are also further efforts to broaden healthcare coverage.", "Provincial governments in Canada that provide partial funding for the purchase of pharmaceuticals and independently regulate the sale and reimbursement of drugs have sought to reduce the costs of publicly funded health programs.", "Some European governments  have  implemented  or  are  considering  austerity  measures  to  reduce  healthcare  spending.  These  measures  exert  pressure  on  the  pricing  and reimbursement timelines for pharmaceuticals and may cause our customers to purchase fewer of our products and services or influence us to reduce prices.", "There is substantial uncertainty about the likelihood, timing and results of these health reform efforts.", "We also have record- keeping  and  other  obligations  under  the  E.U.  Falsified  Medicines  Directive.  Pedigree  tracking  laws  such  as  these  increase  our  compliance  burden  and  our pharmaceutical distribution costs.", "For example, under the Health Insurance Portability and Accountability Act of 1996 (\u201cHIPAA\u201d) we must maintain administrative, physical  and  technological  safeguards  to  protect  individually  identifiable  health  information  (\u201cprotected  health  information\u201d)  and  ensure  the  confidentiality, integrity, and availability of electronic protected health information.", "We are subject to significant compliance obligations under privacy laws such as the General Data Protection Regulation (\u201cGDPR\u201d) in the European Union, the Personal Information Protection and Electronic Documents Act (\u201cPIPEDA\u201d) in Canada, and the California Consumer Protection Act (\u201cCCPA\u201d).", "We are subject to privacy  and  data  protection  compliance  audits  or  investigations  by  various  government  agencies.  Failure  to  comply  with  these  laws  subjects  us  to  potential regulatory enforcement activity, fines, private litigation including class actions, and other costs.", "We also have contractual obligations to customers that might be breached if we fail to comply with privacy laws.", "Our efforts to comply with privacy laws complicate our operations and add to our compliance costs.", "storage and hosting of sensitive information, including protected health information and other types of personal information, confidential financial information, proprietary information, and other sensitive information relating to our customers, company and workforce.", "costs.  Environmental  costs  and  accruals,  including  that  related  to  our  legacy  chemical  distribution  operations,  presently  are  not  material  to our  operations  or financial position.", "Our ten largest customers comprised approximately 32%, and CVS was approximately 19%, of total trade accounts receivable at March 31, 2021.", "We also have agreements with GPOs, each of which functions as a purchasing agent on behalf of member  hospitals,  pharmacies  and other healthcare  providers,  as well as with government  entities  and agencies.  The accounts receivable balances are with individual members of the GPOs, and therefore no significant concentration of credit risk exists.", "Substantially all of these revenues and accounts receivable are included in our U.S.", "distribution arrangements with pharmaceutical manufacturers that include an inflation-based compensation component whereby we benefit when the manufacturers increase their prices as we sell our existing inventory at the new higher prices.", "Forward-looking  statements  involve  risks  and  uncertainties  that  could  cause  actual  results  to  differ  materially  from  those  projected,  anticipated,  or  implied.", "Except to the extent required by federal securities laws, we undertake no obligation to publicly release the result of any revisions to any forward-looking statements to reflect events or circumstances after the date the statements are made, or to reflect the occurrence of unanticipated events.", "Some of our distribution arrangements with the manufacturers provides us compensation based on a percentage of our purchases.", "We experience costly and disruptive legal disputes.", "Despite valid defenses that we assert, legal disputes are often costly, time-consuming, distracting to management and disruptive to normal business operations.", "The outcome of legal disputes is difficult to predict.", "Outcomes can occur that are not justified by the evidence or existing law.", "The uncertainty and expense associated with unresolved legal disputes might harm our business and reputation even if the matter is favorably resolved.", "Accordingly, any legal dispute might have a materially adverse impact on our reputation, our business operations and our financial position or results of operations.", "We might experience losses not covered by insurance.", "supplies, the provision of ancillary services, the conduct of our payer businesses and the provision of products that assist clinical decision-making and relate to patient medical histories and treatment plans.", "Although we seek to maintain adequate insurance coverage,  such  as  property  insurance  for  inventory  and  professional  and  general  liability  insurance,  coverages  on  acceptable  terms  might  be  unavailable,  or coverages might not cover our losses.", "We generally seek to limit our contractual exposure, but limitations of liability or indemnity provisions in our contracts may not be enforceable or adequately protect us from liability.", "Uninsured losses might have a materially adverse impact on our business operations and our financial position or results of operations.", "We regularly are named as a defendant in similar, new cases.", "Many of these cases raise novel theories of liability.", "Any proceedings can have unexpected outcomes that are not justified by evidence or existing law.", "It is not uncommon for claims to be resolved over many years.", "Although the Company has valid defenses and is vigorously defending itself, some proceedings have been and others may be resolved by negotiated outcome.", "Our reputation has been and may continue to be impacted by publicity regarding the litigation and related allegations.", "The adverse outcome of legal proceedings might have a materially adverse impact on our business operations and our financial position or results of operations.", "For example, some states have passed legislation that could require us to pay taxes or assessments on the distribution of opioid medications in those states and other states have considered similar legislation.", "Liabilities for taxes or assessments or other costs of compliance under any such laws might have a materially adverse impact on our reputation, business operations, and our financial position or results of operations.", "We are subject to extensive, complex and challenging healthcare and other laws.", "Any noncompliance by us with applicable laws or the failure to maintain, renew or obtain necessary permits and licenses could lead to litigation and might have a materially adverse impact on our business operations and our financial position or results of operations.", "Local, state and federal governments continue to strengthen their position and scrutiny over practices involving or allegedly involving fraud, waste and abuse affecting Medicare, Medicaid and other government healthcare programs.", "Our relationships with pharmaceutical and medical surgical product manufacturers and healthcare providers, as well as our provision of products and services to government entities, subject our business to laws and regulations on fraud and abuse, which among other things: (1) prohibit persons from soliciting, offering, receiving or paying any remuneration in order to induce the referral of a patient for treatment  or  to  induce  the  ordering  or  purchasing  of  items  or  services  that  are  in  any  way  paid  for  by  Medicare,  Medicaid  or  other  government-sponsored healthcare programs; (2) impose many restrictions upon referring physicians and providers of designated health services under Medicare and Medicaid programs; and (3) prohibit the knowing submission of a false or fraudulent claim for payment to, and knowing retention of an overpayment by, a federal healthcare program such  as  Medicare  and  Medicaid.  Many  of  these  laws,  regulations,  and  government  guidance,  including  those  relating  to  marketing  incentives,  are  vague  or indefinite and have not been interpreted by the courts.", "The laws may be interpreted or applied by a prosecutorial, regulatory, or judicial authority in a manner that could require us to make changes in our operations.", "Failures to comply with applicable laws subject us to federal or state government investigations or qui tam actions, and to liability for damages and civil and criminal penalties, including the loss of licenses or our ability to participate in Medicare, Medicaid and other federal and state healthcare programs.", "These sanctions might have a materially adverse impact on our business operations and our financial position or results of operations.", "Noncompliance with these requirements has resulted in monetary penalties and/or licensing sanctions.", "For example, under a January 2017 agreement with the DEA and Department of Justice we paid $150 million to settle potential administrative and civil claims about our practices for reporting suspicious orders of controlled substances and the DEA suspended, on a staggered basis for limited periods of time, our registrations to distribute certain controlled substances from four distribution centers.", "Pedigree tracking laws increase our compliance burden and our pharmaceutical distribution costs.", "Pedigree tracking laws such as these increase our compliance burden and our pharmaceutical distribution costs, and they might have a materially adverse impact on our business operations and our financial position or results of operations.", "Privacy and data protection laws increase our compliance burden.", "example,  under  the  Health  Insurance  Portability  and  Accountability  Act  of  1996  (\u201cHIPAA\u201d)  we  must  maintain  administrative,  physical  and  technological safeguards  to  protect  individually  identifiable  health  information  (\u201cprotected  health  information\u201d)  and  ensure  the  confidentiality,  integrity  and  availability  of electronic protected health information.", "Failure to comply with these laws subjects us to potential regulatory enforcement activity, fines, private litigation including class actions, and other costs.", "We also have contractual obligations to customers that might be breached if we fail to comply with privacy laws.", "Our efforts to comply with privacy laws complicates our operations and adds to our compliance costs.", "A significant privacy breach or failure  to  comply  with  privacy  laws  might  have  a  materially  adverse  impact  on  our  reputation,  business  operations  and  our  financial  position  or  results  of operations.", "Anti-bribery and anti-corruption laws increase our compliance burden.", "Bribery Act unless the organization can establish the defense of having implemented adequate procedures to prevent bribery.", "Our failure to comply with these laws might subject us to civil and criminal penalties that might have a materially adverse impact on our reputation, business operations and our financial position or results of operations.", "We are subject to a variety of privacy and data protection laws that change frequently and have requirements that vary from jurisdiction to jurisdiction.", "We  are  subject  to  laws  prohibiting  improper  payments  and  bribery,  including  the  U.S.  Foreign  Corrupt  Practices  Act,  the  U.K.  Bribery  Act  and  similar", "We might record significant charges from impairment to goodwill, intangibles and other assets or investments.", "In addition, we periodically review our intangible and other long-lived assets for impairment when events or changes in circumstances, such as a divestiture, indicate the carrying value may not be recoverable.", "Factors that may be considered a change in circumstances indicating that  the  carrying  value  of  our  intangible  and  other  long-lived  assets  may  not  be  recoverable  include  slower  growth  rates,  the  loss  of  a  significant  customer, burdensome new laws or divestiture of a business or asset for less than its carrying value.", "There are inherent uncertainties in management\u2019s estimates, judgments and assumptions used in assessing recoverability of goodwill, intangible and other long-lived assets.", "We may be required to record a significant charge to earnings in our consolidated financial statements during the period in which any impairment of our goodwill or intangible and other long-lived assets is determined, which might have a materially adverse impact on our business operations and our financial position or results of operations.", "storage and hosting of sensitive information, including protected health information and other types of personal information, confidential financial information, proprietary information, and other sensitive information relating to our customers, company and workforce.", "If our software and technology services are alleged to have contributed to faulty clinical decisions or injury to patients, we might be subject to claims or litigation by users of our software or services or their patients.", "Any of these types of errors or failures might have a materially adverse impact on our reputation, business operations and our financial position or results of operations.", "We  are  required  under  U.S.  Generally  Accepted  Accounting  Principles  (\u201cGAAP\u201d)  to  test  our  goodwill  for  impairment  annually  or  more  frequently  if", "We might be impeded in providing customers online services and data access.", "Any such problems might have a materially adverse impact on our business operations and our financial position or results of operations.", "Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.", "we may require financing that may not be available on acceptable terms.", "Any of these risks could adversely affect our ability to achieve the anticipated benefits of an acquisition and might have a materially adverse impact on our business operations and our financial position or results of operations.", "Exclusive forum provisions in our Bylaws could limit our stockholders\u2019 ability to choose their preferred judicial forum for disputes with us or our directors, officers or employees.", "Current and former stockholders are deemed to have consented to the personal jurisdiction of the Delaware Courts in connection with any action to enforce that exclusive forum provision and to service of process in any such action.", "To the extent that these provisions of the bylaws limit a current or former stockholder\u2019s ability to select a judicial forum other than the Delaware Courts, they might discourage the specified legal actions, might cause current or former stockholders to incur additional litigation-related expenses and might result in outcomes unfavorable to current or former stockholders.", "A court might determine that these provisions of the bylaws are inapplicable or unenforceable in any particular action, in which case we may incur additional litigation related expenses in such action, and the action may result in outcomes unfavorable to us, which could have a materially adverse impact on our reputation, our business operations and our financial position or results of operations.", "We might be adversely impacted by delays or other difficulties with divestitures.", "After the disposition, we might experience greater dissynergies than expected, and the impact of the divestiture on our revenue or profit might be larger than we expected.", "We might have difficulties with pre-closing conditions such as regulatory and governmental approvals, which could delay or prevent the divestiture.", "We might have financial exposure in a divested business, such as through minority equity ownership, financial  or  performance  guarantees,  indemnities  or  other  obligations,  such  that  conditions  outside  of  our  control  might  negate  the  expected  benefits  of  the disposition.", "Any of these risks could adversely affect our ability to achieve the anticipated benefits of a divestiture and might have a materially adverse impact on our business operations and our financial position or results of operations.", "We might not realize the expected tax treatment from our split-off of Change Healthcare.", "If Change does not honor its obligations to indemnify the Company, or if the Transactions fail to qualify for the intended tax-free treatment for reasons not related to a disqualifying action by Change or SpinCo, the resulting tax to the Company could have a significant adverse effect on our financial position or results of operations.", "outsourced service providers, and we might not realize expected cost savings or other benefits.", "For example, our ability to use outsourcing resources in certain jurisdictions might be limited by legislative action or customer contracts, with the result that the work must be performed at greater expense or we may be subject to sanctions for non-compliance.", "Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.", "We might encounter difficulties attracting and retaining customers to our retail locations due to their unfamiliarity with our brands or our inexperience with local market  preferences.  Competition  from  our  retail  pharmacy  operations  might  strain  relationships  with  our  retail  pharmacy  customers.  Consolidation  of  retail pharmacies with third party payers, expansion of large retail pharmacy networks, reductions in reimbursement rates, shifts in the mix of branded and generic pharmaceutical sales, and exclusion from preferred pharmacy networks can impair our retail pharmacy sales and profitability.", "We might be harmed by large customer purchase reductions, payment defaults or contract non-renewal.", "March 31, 2021, sales to our largest customer represented approximately 21% of our consolidated revenues and approximately 19% of our trade receivables, and those of our ten largest customers combined accounted for approximately 51% of our consolidated revenues and approximately 32% of our trade receivables.", "A material  default  in  payment,  reduction  in  purchases,  or  the  loss  of  business  from  a  large  customer  might  have  a  materially  adverse  impact  on  our  business operations and our financial position or results of operations.", "Our contracts with government entities involve future funding and compliance risks.", "Our government contracts might not be renewed or might be terminated for convenience with little or no prior notice.", "Government contracts typically expose us to higher potential liability than do other types of contracts.", "We are subject to government audits, investigations and oversight proceedings.", "If we fail to comply with these requirements, or we fail an audit, we are subject to various sanctions such as monetary damages, criminal and civil penalties, termination of contracts and suspension or debarment from government contract work.", "These requirements complicate our business and increase our compliance burden.", "We also provide supplies used for vaccine administration in the Federal COVID-19 Response.", "Our participation in such programs exposes us to various uncertainties.", "Because of these risks and uncertainties our operating results may be materially higher or lower than our projections.", "Certain distribution agreements with manufacturers include pharmaceutical price inflation as a component of our compensation, and we cannot  control  the  frequency  or  magnitude  of  pharmaceutical  price  changes.  We  might  be  unable  to  renew  pharmaceutical  distribution  agreements  with manufacturers in a timely and favorable manner.", "Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.", "We  derive  a  significant  portion  of  our  revenue  from,  and  have  a  significant  portion  of  our  accounts  receivable  with,  a  small  number  of  customers.  At", "Our contracts with government entities are subject to risks such as lack of funding and compliance  with unique requirements.", "We might infringe intellectual property rights or our intellectual property protections might be inadequate.", "If a court were to hold that we infringed other\u2019s rights, we might be required to pay substantial damages, develop non-infringing products or services, obtain a license, stop selling or using the infringing products or services, or incur other sanctions.", "We rely on trade secret, patent, copyright and  trademark  laws,  nondisclosure  obligations  and  other  contractual  provisions  and  technical  measures  to  protect  our  proprietary  rights  in  our  products  and solutions.  We  might  initiate  costly  and  time-consuming  litigation  to  protect  our  trade  secrets,  to  enforce  our  patent,  copyright  and  trademark  rights  and  to determine the scope and validity of the proprietary rights of others.", "Our intellectual property protection efforts might be inadequate to protect our rights.", "Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.", "Competition among potential employers might result in increased salaries, benefits or other employee-related costs, or in our failure to recruit and retain employees.", "Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.", "We might be adversely impacted by healthcare reform such as changes in pricing and reimbursement models.", "healthcare industry and related government programs are changing.", "profit margins for us and our customers and impose new legal requirements on healthcare providers.", "the way healthcare is financed by both governmental and private payers.", "drugs have sought to reduce the costs of publicly funded health programs.", "These measures exert pressure on the pricing and reimbursement timelines for pharmaceuticals and may cause our customers to purchase fewer of our products and services or influence us to reduce prices.", "adverse impact on our business operations and our financial position or results of operations.", "Consolidation might increase counter-party credit risk because credit purchases increase for fewer market participants.", "Any of these changes or disruptions might have a materially adverse impact on our business operations and our financial position or results of operations.", "We might be adversely impacted as a result of our distribution of generic pharmaceuticals.", "Generic drug manufacturers often offer a generic version of branded pharmaceuticals while they challenge the validity or enforceability branded pharmaceutical patents.", "The patent holder might assert infringement claims against us for distributing those generic versions and the generic drug manufactures may not fully indemnify us against such claims.", "These risks, as well as changes in the availability,  pricing  volatility,  reimbursement  rates  for  generic  drugs,  or significant  changes  in  the  nature,  frequency  or magnitude  of  generic  pharmaceutical launches, might have a materially adverse impact on our business operations and our financial position or results of operations.", "We might be adversely impacted by an economic slowdown or recession.", "Any economic slowdown or recession might have a materially adverse impact on our business operations and our financial position or results of operations.", "Disruption or other changes in capital and credit markets might impede access to credit and increase borrowing costs for us and our customers and suppliers and might impair the financial soundness of our customers and suppliers.", "activity by financial institutions, or decreased liquidity and increased costs in the commercial paper market, might adversely affect our borrowing ability and cost of borrowing.", "We generally sell our products and services under short-term unsecured credit arrangements.", "An adverse change in general economic conditions or access to capital might cause our customers to reduce their purchases from us, or delay or fail paying amounts owed to us.", "Suppliers might be unable to make payments due to us for fees, returned products or incentives.", "Interest rate increases or changes in capital market conditions might impede our or our customers\u2019 or suppliers\u2019 ability or cost to obtain credit.", "Any of these risks might have a material adverse impact on our business operations and our financial position or results of operations.", "Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.", "We might be adversely impacted by tax legislation or challenges to our tax positions.", "Tax laws might change in ways that adversely affect our tax positions, effective tax rate and cash flow.", "The tax laws are extremely complex and subject to varying interpretations.", "We are subject to tax examinations in various jurisdictions that might assess additional tax liabilities against us.", "Our tax reporting positions might be challenged by relevant tax authorities, we might incur significant expense in our efforts to defend those challenges, and we might be unsuccessful in those efforts.", "Developments in examinations and challenges might materially change our provision for taxes in the affected periods and might differ materially from our historical tax accruals.", "Any of these risks might have a materially adverse impact on our business operations, our cash flows and our financial position or results of operations.", "For example, we might experience volatility in exchange rates and interest rates and changes in laws regulating our U.K. operations.", "Customers might reduce purchases due to the uncertainty caused by Brexit.", "Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.", "We might be adversely impacted by fluctuations in foreign currency exchange rates.", "exchange rates could reduce our revenues, increase our costs or otherwise adversely affect our financial results reported in U.S. dollars.", "For example, we are exposed to transactional currency exchange risk due to our import and export of products that are purchased or sold in currencies other than the U.S. dollar.", "We also  have  currency  exchange  risk  due  to  intercompany  loans  denominated  in  various  currencies.  The  COVID-19  pandemic  has  affected  and  might  increase currency exchange rate volatility.", "We may from time to time enter into foreign currency contracts, foreign currency borrowings or other techniques intended to hedge  a  portion  of our  foreign  currency  exchange  rate  risks.  These  hedging  activities  may  not  completely  offset  the  adverse  financial  effects  of  unfavorable movements in foreign currency exchange rates during the time the hedges are in place.", "Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.", "We are subject to the tax laws in the U.S. at the federal, state and local government levels and to the tax laws of many other jurisdictions in which we operate", "We conduct our business in various currencies,  including  the U.S. dollar, euro, British pound sterling  and Canadian dollar.  Changes in foreign  currency", "Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.", "We might be adversely impacted by changes in accounting standards.", "It is possible that future accounting standards may require changes to the accounting treatment in our consolidated financial statements and may require us to make significant changes to our financial systems.", "Such changes might have a materially adverse impact on our financial position or results of operations.", "Our consolidated financial statements are subject to the application of U.S.", "Disclosure of an environmental proceeding where a governmental agency is a party generally is included only if we expect monetary sanctions in the proceeding to exceed $1 million, unless otherwise material.", "There are no family relationships between any of the executive officers or directors of the Company.", "We declared regular cash dividends of $1.67 and $1.62 per share in the years ended March 31, 2021 and 2020, respectively.", "discretion of the Board and will depend upon our future earnings, financial condition, capital requirements, and other factors.", "Dividends: In  July  2020,  our  quarterly  dividend  was  raised  from  $0.41  to  $0.42  per  common  share  for  dividends  declared  on  or  after  such  date  by  the", "We anticipate that we will continue to pay quarterly cash dividends in the future.", "In accordance with our accounting policy, we allocate any excess of share repurchase price over par value between additional paid-in capital and retained earnings.", "Accordingly, our retained earnings and additional paid-in capital were reduced by $472 million and $70 million, respectively, during 2019.", "In 2019, we retired 5.0 million or $542 million of our treasury shares previously repurchased.", "This discussion and analysis should be read in conjunction with the consolidated financial statements and accompanying financial notes in Item 8 of Part II of this Annual Report on Form 10-K.", "Our fiscal year begins on April 1 and ends on March 31.", "Unless otherwise noted, all references to a particular year shall mean our fiscal year.", "Our organizational structure also includes Corporate, which consists of income and expenses associated with administrative functions and projects, and the results of certain investments.", "We evaluate the performance of our operating segments on a number of measures, including revenues and operating profit before interest expense and income taxes.", "The following summarizes our four reportable segments and the changes made to our reporting structure commencing in the second quarter of 2021.", "\u2022 Coronavirus disease 2019 (\u201cCOVID-19\u201d) impacted our results of operations for the year ended March 31, 2021.", "The recovery from the COVID- 19 pandemic continued to fluctuate throughout our fiscal year.", "\u2022 We expanded our existing contractual relationship with the Centers for Disease Control and Prevention (\u201cCDC\u201d) through an amendment to our existing Vaccines for Children Program contract to support the U.S. government as a centralized distributor of COVID-19 vaccines and ancillary supplies needed to administer vaccines.", "\u2022 In  December  2020,  we  began  distributing  certain  COVID-19  vaccines  under  the  direction  of  the  CDC.  Through  the  end  of  the  fiscal  year,  we  had distributed approximately 100 million of COVID-19 vaccine doses.", "\u2022 Revenues of $238.2 billion, reflects a 3% increase from the prior year primarily in our U.S.", "\u2022 Diluted loss per common share from continuing operations attributable to McKesson Corporation in 2021 of $28.26 reflects the aforementioned items, net of any respective tax impacts, and a lower share count compared to the prior year driven largely by the separation of our investment in Change Healthcare JV on March 10, 2020;", "The full extent to which COVID-19 will impact us depends on many factors and future developments, which are described at the end of this COVID-19 section.", "We continue to evaluate the nature and extent of the impacts COVID-19 has on our business and operations.", "We provided further support including additional emergency leave and an internal paid time off donation platform for employees impacted by COVID-19.", "These responses were initially put in place during our fourth quarter of 2020.", "policies did not have a material effect on our internal control over financial reporting during the year ended March 31, 2021.", "We also took various actions to mitigate the impact of COVID-19 on our results from operations through cost-containment and payroll-related expenses.", "We support the U.S. government as a centralized distributor of COVID-19 vaccines and ancillary supplies needed to administer vaccines.", "We make no decisions on where products are to be distributed nor how the products are allocated between the various provider sites and ultimately administered to the individuals receiving a vaccine.", "We utilize our expertise and capabilities to support the CDC\u2019s efforts to vaccinate everyone in the U.S. who wants to receive a COVID-19 vaccine.", "The Pfizer Vaccine, which is ultra-frozen, is not being distributed by McKesson, although we are providing ancillary supplies needed for its administration.", "custom freezers and refrigerators to safely store and process millions of vaccine doses.", "The capital expenditures we made during 2021 to prepare for vaccine and ancillary supply kit distribution were not material to our financial condition or liquidity.", "In December 2020, we began distributing the Moderna Vaccine in the U.S. and in March 2021, we began distributing the Janssen Vaccine.", "Subsequently, during the first quarter, we had lower pharmaceutical volumes, specialty drug volumes, and patient care visits that negatively impacted our consolidated revenues and income (loss) from continuing operations before income taxes for the year ended March 31, 2021.", "Additionally, increased costs for certain PPE compressed our margins.", "During the year ended March 31, 2021, we recorded charges totaling $136 million in cost of sales on certain PPE and other related products due to inventory impairments and excess inventory in our Medical-Surgical Solutions segment.", "Although market price volatility and changes to anticipated customer demand may require additional write-downs in future periods, we are taking measures to mitigate such risk.", "We collaborated closely with the federal government and other healthcare stakeholders to source more critical PPE to the U.S.", "We have deferred certain employer payroll taxes and continue to monitor the potential impact of other tax legislation changes as result of the CARES Act, including refundable payroll tax credits on certain qualified wages.", "We anticipate changes due to the CARES Act in the timing of certain cash flows, with no material impact to our financial results for the year ended March 31, 2021.", "The CA Act did not have a material impact on our financial condition, results of operations, or liquidity for the year ended March 31, 2021 nor do we currently expect a material impact on our future financial results.", "We are monitoring our customers closely for changes to their timing of payments or ability to pay amounts owed to us as a result of COVID-19 pandemic impacts to their businesses.", "We remain well-capitalized with access to liquidity from our revolving credit facility.", "Long- term debt markets and commercial paper markets, our primary sources of capital after cash flow from operations, have remained open and accessible to us during the COVID-19 pandemic.", "At March 31, 2021, we were in compliance with all debt covenants, and believe we have the ability to continue to meet our debt covenants in the future.", "Our consolidated balance sheets and ability to maintain financial liquidity remains strong.", "We have experienced no material impacts to our liquidity or net", "We face numerous uncertainties in estimating the direct and indirect effects of COVID-19 on our future business operations, financial condition, results of operations, and liquidity.", "Due to several rapidly changing variables related to the COVID-19 pandemic, estimations of future economic trends and the timing of when stability will  return  remains  challenging.  Additionally,  we  periodically  review  our  intangible  and  other  long-lived  assets  for  impairment  when  events  or  changes  in circumstances indicate  the carrying value may not be recoverable.  Key assumptions and estimates  about future values in our impairment assessments can be affected by a variety of factors, including the impacts of the global pandemic on industry and economic trends as well as on our business strategy and internal forecasts.", "We continue to be involved in discussions with the objective of achieving broad resolution of opioid- related claims of states, their political subdivisions and other government entities (\u201cgovernmental entities\u201d).", "We are in ongoing, advanced discussions with state attorneys general and plaintiffs\u2019 representatives regarding a framework under which, in order to resolve the claims of governmental entities, the three largest U.S. pharmaceutical distributors would pay up to approximately $21.0 billion over a period of 18 years, with up to approximately $8.0 billion to be paid by us, of which more than 90% is anticipated to be used to remediate the opioids crisis.", "As a result of that conclusion, and our assessment of certain other opioid- related claims, we recorded a charge of $8.1 billion for the year ended March 31, 2021 within \u201cClaims and litigation charges, net\u201d in our Consolidated Statement of Operations, related to our share of the settlement framework described above, as well as other opioid-related claims.", "Because of the many uncertainties associated with any potential settlement arrangement or other resolution of opioid-related litigation, including the uncertainty of the scope of participation by plaintiffs in any potential settlement, we are not able to reasonably estimate the upper or lower ends of the range of ultimate possible loss for all opioid-related litigation matters.", "We believe that we have valid defenses to the claims pending against us and, absent an acceptable settlement, intend to vigorously defend against all such claims.  An  adverse  judgment  or  negotiated  resolution  in  any  of  these  matters  could  have  a  material  adverse  impact  on  our  financial  position,  cash  flows  or liquidity, or results of operations.", "The law adopting the excise tax made clear that the OSA would apply only to opioid sales on or before December 31, 2018.", "The excise tax applies only to the first sale occurring in New York, and thus may not apply to sales from our distribution centers in New York to New York customers.", "Unless the appellate court\u2019s decision is overturned, the OSA will be reinstated for calendar years 2017 and 2018 (but not beyond those years), and, subject to any further legal challenge, we will have to pay our ratable share of the annual surcharge for those two years.", "During the second quarter of 2021, we reflected an estimated liability of $50 million for the OSA surcharge in our accompanying consolidated financial statements on the assumption that the appellate court\u2019s decision will stand.", "The higher LIFO credits in 2020 compared to 2019 is primarily driven by higher generic deflation.", "\u2022 Claims and litigation charges, net: These charges include adjustments for estimated probable settlements related to our controlled substance monitoring and reporting, and opioid-related claims, as well as any applicable income items or credit adjustments due to subsequent changes in estimates.", "We have reclassified prior period amounts to conform to the current period presentation.", "\u2022 Goodwill impairments charges: We perform an impairment test on goodwill balances annually in the third quarter and more frequently if indicators for potential impairment exist.", "The resulting goodwill impairment charges are reflected within this line item. \u2022 Restructuring, impairment, and related charges: Restructuring charges that are incurred for programs in which we change our operations, the scope of a business undertaken by our business units, or the manner in which that business is conducted as well as long-lived asset impairments.", "\u2022 SDG&A reflects charges of $58 million to remeasure assets and liabilities held for sale to fair value less costs to sell related to the completed contribution of the majority of our German pharmaceutical wholesale business to create a joint venture with WBA in which we have a 30% ownership interest within our International segment.", "As a result, we were required to perform a goodwill impairment test for these reporting units and recorded a goodwill impairment charge in our European RP reporting unit of $69 million during the second quarter of 2021.", "As of the testing date, other risks, expenses, and future developments, such as additional government actions, increased regulatory uncertainty, and material changes in key market assumptions limit our ability to estimate projected cash flows, which could adversely affect the fair value of various reporting units in future periods, including our McKesson Canada reporting unit within our International segment and our RxCrossroads reporting unit within our RxTS segment, where the risk of a material goodwill impairment is higher than other reporting units.", "\u2022 Restructuring, impairment, and related charges, net includes long-lived asset impairment charges of $112 million, primarily for our United Kingdom (\u201cU.K.\u201d)  business  (mainly  pharmacy  licenses)  and  Rexall  Health  retail  business  (\u201cRexall  Health\u201d)  (mainly  customer  relationships)  within  our International segment, and the remaining $156 million primarily represents employee severance and exit-related costs related to our 2019 restructuring initiatives, as further discussed below; and", "\u2022 Total operating expenses includes higher SDG&A due to our business acquisitions and to support business growth, as well as our technology initiatives, partially offset by favorable effects of foreign currency exchange fluctuations.", "\u2022 SDG&A includes opioid-related costs of $114 million, primarily related to litigation expenses, and increased expenses due to our business acquisitions and to support growth, partially offset by a gain from an escrow settlement of $97 million representing certain indemnity and other claims related to our 2017 acquisition of Rexall Health and a credit of $90 million for the derecognition of a liability related to the tax receivable agreement (\u201cTRA\u201d) payable to the shareholders of Change Healthcare, Inc. (\u201cChange\u201d);", "\u2022 Restructuring,  impairment,  and  related  charges,  net  primarily  includes  employee  severance  and  exit-related  costs  of  $352  million  for  our  2019 restructuring initiatives, as further discussed below and long-lived asset impairment charges of $245 million primarily for our U.K. business (mainly pharmacy licenses) within our International segment driven by additional government reimbursement reductions and competitive pressures in the U.K.", "We evaluate goodwill for impairment on an annual basis as of October 1, and at an interim date, if indicators of potential impairment exist.", "This change was not material to our consolidated financial statements as it did not delay, accelerate, or avoid any potential goodwill impairment charge.", "We expect to incur total charges of approximately $180 million to $280 million for this initiative, consisting primarily of exit related costs, accelerated depreciation and amortization of long-lived assets, and asset impairments.", "We expect to incur total charges of approximately $85 million to $90 million, of which $57 million of charges were recorded to date.", "This initiative was substantially complete in 2021 and remaining costs we expect to record under this initiative are not material.", "The relocation was substantially complete in January 2021 and remaining costs we expect to record under this initiative, primarily relating to lease costs, are not material.", "This primarily reflects mark-to-market gains on our investments in certain U.S. growth stage companies in the healthcare industry and realized gains on the exit of some of these investments as further described in Financial Note 17, \u201cFair Value Measurements,\u201d to the accompanying consolidated financial statements  included  in  this  Annual  Report  on  Form  10-K.  In  future  periods,  fair  value  adjustments  recognized  in  our  operating  results  for  these  types  of investments may be adversely impacted by market volatility.", "Other income, net also increased year over year due to pension settlement charges of $122 million recognized in 2020 related to our previously approved termination of the frozen U.S. defined benefit pension plan.", "In connection with the pension plan termination, we purchased annuity contracts from an insurer that will pay and administer the future pension benefits of the remaining participants.", "Excluding the impairment and transaction-related items described below, our proportionate share of loss from our investment in Change Healthcare JV for the years ended March 31, 2020 and 2019 was $119 million and $194 million, respectively, which primarily includes transaction and integration expenses incurred by the joint venture and basis differences between the joint venture and McKesson including amortization of fair value adjustments.", "During the first quarter of 2020 and for the year ended March 31, 2019, we owned approximately 70% of this joint venture.", "The proceeds from the concurrent offering of other securities were also used by Change  to  acquire  certain  securities  of  Change  Healthcare  JV.  As  a  result,  McKesson\u2019s  equity  interest  in  Change  Healthcare  JV  was  reduced  from  70%  to approximately 58.5%, which was used to recognize our proportionate share in net loss from Change Healthcare JV, commencing in the second quarter of 2020.", "As a result of the ownership dilution to 58.5% from 70%, we recognized a dilution loss of approximately $246 million in the second quarter of 2020.", "Additionally, our proportionate share of income or loss from this investment was subsequently reduced as immaterial settlements of stock option exercises occurred after the IPO and further diluted our ownership.", "Equity Earnings and Charges from Investment in Change Healthcare Joint Venture Until the separation of our investment in Change Healthcare JV on March 10, 2020, we accounted for this investment using the equity method of accounting.", "In the second quarter of 2020, we recorded an other-than-temporary-impairment (\u201cOTTI\u201d) charge of $1.2 billion to our investment in Change Healthcare JV,", "Following the Split-off, we do not beneficially own any of Change\u2019s outstanding securities.", "In connection with this transaction, we recognized a net gain for financial reporting purposes of $414 million during the fourth quarter of 2020, which was largely driven by the reversal of a related deferred tax liability.", "The receipt of any payments under the TRA is dependent upon Change benefiting from this depreciation or amortization in future tax return filings, which creates uncertainty over the amount, timing and probability of the gain recognized.", "As such, we accounted for the TRA as a gain contingency, with no receivable recognized as of March 31, 2021 nor 2020.", "Interest expense decreased in 2020 compared to the prior year primarily due to a decrease in the issuance of commercial paper, partially offset by a decrease in interest income from our derivative contracts.", "Our reported income tax (benefit) expense rates were (13.8%), 1.6%, and 58.4% in 2021, 2020, and 2019, respectively.", "after-tax), which was intended to generally be a tax-free split-off for U.S. federal income tax purposes, and unfavorably impacted by charges of $275 million (pre- tax and after-tax) to remeasure assets and liabilities held for sale to fair value less costs to sell related to the completed contribution of the majority of our German pharmaceutical wholesale business to create a joint venture with WBA.", "goodwill of our European RP and European PD reporting units within the International segment, given that these charges are generally not deductible for tax purposes.", "Our income tax expense, deferred tax assets and liabilities, and uncertain tax liabilities reflect management\u2019s best assessment of estimated current and future taxes to be paid.", "We believe that we have made adequate provision for all income tax uncertainties.", "In connection with the exchange offer, on March 9, 2020, we distributed all 176.0 million outstanding shares of common stock of SpinCo to participating", "Income Tax (Benefit) Expense We recorded income tax (benefit) expense of ($695 million), $18 million, and $356 million for the years ended March 31, 2021, 2020, and 2019, respectively.", "Our reported income tax expense rate for 2019 was unfavorably impacted by charges of $1.8 billion (pre-tax and after-tax) to impair the carrying value of", "Significant judgments and estimates are required in determining the consolidated income tax provision and evaluating income tax uncertainties.", "Noncontrolling interests with redemption  features, such as put rights, that are not solely within our control are considered redeemable  noncontrolling  interests.  Redeemable  noncontrolling interests are presented outside of McKesson Corporation stockholders\u2019 equity (deficit) on our consolidated balance sheet.", "Diluted earnings (loss) per common share attributable to McKesson Corporation was $(28.26), $4.95, and $0.17 for the years ended March 31, 2021,  2020,  and  2019,  respectively.  Net  loss  per  diluted  share  for  the  year  ended  March  31,  2021  is  calculated  by  excluding  dilutive  securities  from  the denominator  due to their antidilutive  effects.  Additionally,  our 2021, 2020, and 2019 diluted  earnings (loss) per share  reflect  the cumulative  effects  of share repurchases.", "Weighted-average diluted common shares outstanding is impacted by the exercise and settlement of share-based awards and the cumulative effect of share repurchases, including the impact of shares exchanged as part of the split-off from our investment in Change Healthcare JV, as discussed above.", "(1) Segment operating profit (loss) includes gross profit, net of operating expenses, as well as other income (expense), net, for our reportable segments.", "For retrospective periods presented, operating loss for Other reflects equity earnings and charges from our equity method investment in Change Healthcare JV, which we split-off in the fourth quarter of 2020.", "Pharmaceutical segment includes a charge of $50 million for the year ended March 31, 2021 related to our estimated liability under the OSA.", "(3) Operating loss for our International segment for the years ended March 31, 2021 and 2020 includes charges of $58 million and $275 million, respectively, to remeasure to fair value the assets and liabilities of our German pharmaceutical wholesale business which was contributed to a joint venture with WBA.", "This segment\u2019s operating loss for the years ended March 31, 2021 and 2019 includes goodwill impairment charges of $69 million and $1.8 billion, respectively, as well as long-lived asset impairment charges for the  years ended March 31, 2021,  2020, and 2019  of $115  million,  $112  million,  and $245  million,  respectively, primarily  related to  our retail  pharmacy businesses in Canada and Europe.", "(4) Operating profit for our Medical-Surgical Solutions segment for the year ended March 31, 2021 includes charges totaling $136 million on certain PPE and other related products due to inventory impairments and excess inventory.", "(5) Operating profit for our RxTS segment for the year ended March 31, 2019 includes a gain of $56 million from the divestiture of an equity investment.", "(6) Operating loss for Other for the year ended March 31, 2020 includes an OTTI charge of $1.2 billion and a dilution loss of $246 million related to our investment in Change Healthcare JV, partially offset by a net gain of $414 million related to the completed separation of our interest in Change Healthcare JV during the fourth quarter of 2020.", "(7) Corporate expenses, net for the year ended March 31, 2021 includes a charge of $8.1 billion related to our estimated liability for opioid-related claims, net gains of $133 million  from  our  equity  investments,  and a net  gain  of $131  million  recorded  in  connection  with  insurance  proceeds  received  from  the  settlement  of  the  shareholder derivative action related to our controlled substances monitoring program.", "This was partially offset by a decrease in LIFO credits of $214 million, a charge of $50 million recorded in 2021 related to our estimated liability under the OSA, net impacts from COVID-19, including a less severe cough, cold, and flu season, as well as increased costs for strategic growth initiatives.", "Operating profit and operating profit margin were unfavorably impacted by customer mix and a decrease in net cash proceeds received of $180 million representing our share of antitrust legal settlements.", "recorded to remeasure to fair value the assets and liabilities of our German pharmaceutical wholesale business which was contributed to a joint venture with WBA, of  which  $58  million  and  $275  million  was  reflected  for  the  years  ended  March  31,  2021  and  2020,  respectively.  This  was  partially  offset  by  a  goodwill impairment charge of $69 million recorded in the second quarter of 2021 related to our European retail pharmacy business.", "This was partially offset  by  the  fair  value  remeasurement  charges  in  2020  described  above  and  a  gain  from  an  escrow  settlement  of  $97  million  in  2019  related  to  our  2017 acquisition of Rexall Health.", "Additionally,  operating  profit  was favorable  year over year  due to lower  operating  expenses, including a decrease in our provision for bad debts.", "primary care business and lower restructuring charges, partially offset by the remeasurement of assets and liabilities to fair value related to a divestiture that was completed in 2020 and higher operating expenses, including an increase in our provision for bad debts.", "and existing customers, integration costs incurred in 2019 for our acquisition of RxCrossroads that closed during the fourth quarter of 2018, partially offset by a gain of $56 million from the divestiture of an equity investment in 2019.", "investment in Change Healthcare JV, partially offset by a net gain of $414 million related to the completed separation of our interest in Change Healthcare JV during the fourth quarter of 2020.", "Operating loss for Other also includes our proportionate share of loss from Change Healthcare JV of $119 million and $194 million for the years ended March 31, 2020 and 2019, respectively.", "connection with insurance proceeds received from the settlement of the shareholder derivative action related to our controlled substances monitoring program.", "Corporate expenses, net, for 2020 includes pension settlement charges of $122 million, an opioid claim settlement charge of $82 million, and net settlement gains of $26 million recognized from our derivative contracts.", "claim settlement charge mentioned above, as well as higher costs for technology initiatives, partially offset by net settlement gains recognized in 2020 from our derivative contracts.", "Other Operating  loss  for  Other  for  the  year  ended  March  31,  2020  includes  an  OTTI charge  of  $1.2  billion  and  a  dilution  loss  of  $246  million  related  to  our", "Corporate 2021 vs. 2020 Corporate expenses, net increased for the year ended March 31, 2021 compared to the prior year due to a charge of $8.1 billion related to our estimated", "We conduct our business worldwide in local currencies including Euro, British pound sterling, and Canadian dollar.", "As a result, the comparability of our results reported in U.S. dollars can be affected by changes in foreign currency exchange rates.", "In discussing our operating results, we may use the term \u201cforeign currency exchange fluctuations,\u201d which refers to the effect of changes in foreign currency exchange rates used to convert the local currency results of our operations in foreign countries where the functional currency is not the U.S. dollar.", "We present this information to provide a framework for assessing how our business performed excluding the effect of foreign currency exchange rate fluctuations.", "In computing the foreign currency exchange fluctuations, we translate our current year results of our operations in foreign countries recorded in local currencies into U.S dollars by applying their respective average foreign currency exchange rates of the corresponding prior year periods, and we subsequently compare those results to the previously reported results of the comparable prior year periods reported in U.S. dollars.", "estimate was made and if different estimates that we reasonably could have used in the current period, or changes in the accounting estimate that are reasonably likely to occur from period to period, could have a material impact on our financial condition or results from operations.", "Below are the estimates that we believe are  critical  to  the  understanding  of  our  operating  results  and  financial  condition.  Other  accounting  policies  are  described  in  Financial  Note  1,  \u201cSignificant Accounting  Policies,\u201d  to  the  consolidated  financial  statements  appearing  in  this  Annual  Report  on  Form  10-K.  Because  of  the  uncertainty  inherent  in  such estimates, actual results may differ from these estimates.", "Other customer financing primarily relates to guarantees provided to our customers, or their creditors, regarding the repurchase of inventories.", "We also provide financing to certain customers related to the purchase of pharmacies, which serve as collateral for the loans.", "We estimate the receivables for which we do not  expect  full  collection  based  on  historical  collection  rates  and  specific  knowledge  regarding  the  current  creditworthiness  of  our  customers  and  record  an allowance in our consolidated financial statements for these amounts.", "Management reviews these factors quarterly to determine if any adjustments are needed to the allowance.", "Sales to our largest customer, CVS Health Corporation (\u201cCVS\u201d), accounted for approximately 21% of our total consolidated revenues in 2021 and comprised approximately 19% of total trade accounts receivable at March 31, 2021.", "As a result, our sales and credit concentration is significant.", "The accounts receivables balances are with individual members of the GPOs, and therefore no significant concentration of credit risk exists.", "A material default in payment, a material reduction in purchases from these or any other large customers, or the loss of a large customer or GPO could have a material adverse impact on our financial position, results of operations, and liquidity.", "We believe the reserves maintained and expenses recorded in 2021 are appropriate and consistent in the context of historical methodologies employed, as well as assessment of trends currently available.", "The selected 0.1% hypothetical change does not reflect what could be considered the best or worst-case scenarios.", "Our LIFO valuation amount includes both pharmaceutical and non-pharmaceutical products.", "We recognized LIFO credits of $38 million, $252 million, and $210 million, respectively, in 2021, 2020, and 2019 in our Consolidated Statements of Operations.", "A LIFO charge is recognized when the net effect of price increases on pharmaceutical and non-pharmaceutical products held in inventory exceeds the impact of price declines, including the effect  of branded pharmaceutical  products  that have lost market  exclusivity.  A LIFO credit  is recognized  when the net effect  of price  declines exceeds the impact of price increases on pharmaceutical and non-pharmaceutical products held in inventory.", "Excluding LIFO reserves, our inventory reserves as of March 31, 2021 and 2020 were $263 million and $96 million, respectively.", "The increase was primarily due to 2021 charges totaling $136 million on certain PPE and other related products due to inventory impairments and excess inventory within our Medical-Surgical Solutions segment.", "In 2021, 2020 and, 2019, our provision for bad debts", "At March 31, 2021 and 2020, total inventories, net were $19.2 billion and $16.7 billion, respectively, in our Consolidated Balance Sheets.", "Any purchase consideration in excess of the estimated fair values of the net assets acquired is recorded as goodwill.", "that is a form or variation of the income approach, whereby a forecast of future cash flows attributable to the asset are discounted to present value using a risk- adjusted discount rate.", "We perform an impairment test on goodwill balances annually in the third quarter and more frequently if indicators for potential impairment exist.", "equal to the amount of excess carrying value above the estimated fair value, if any, but not to exceed the amount of goodwill allocated to the reporting unit.", "we estimate fair value by comparing the business to similar businesses, or guideline companies whose securities are actively traded in public markets.", "Under the income approach, we use a discounted cash flow (\u201cDCF\u201d) model in which cash flows anticipated over several periods, plus a terminal value at the end of that time horizon, are discounted to their present value using an appropriate rate that is commensurate with the risk inherent within the reporting unit.", "Goodwill  and  Long-Lived  Assets: As  a  result  of  acquiring  businesses,  we  have  $9.5  billion  and  $9.4  billion  of  goodwill  at  March  31,  2021  and  2020,", "To estimate the fair value of our reporting units, we generally use a combination of the market approach and the income approach.", "Judgments made in determining an estimate of fair value may materially impact our results of operations.", "Included in the estimate of the weighted-average cost of capital is the assumption of an unsystematic risk premium to address incremental uncertainty related to the reporting units\u2019 future cash flow projections.", "An increase in the unsystematic risk premium increases the discount rate.", "Pharmaceutical  Distribution  reporting  units  in  our  International  segment,  exceeded  their  carrying  values.  The  impairment  testing  performed  in  2020  did  not indicate  any  material  impairment  of  goodwill.  The  segment  change  in  the  second  quarter  of  2021  prompted  changes  in  multiple  reporting  units  across  the Company.", "We recorded a goodwill impairment charge of $69 million in 2021 as the estimated fair value of the Europe Retail Pharmacy reporting unit was lower than its reassigned carrying value based on changes in the composition of the Europe Retail Pharmacy reporting unit within the International segment.", "At March 31, 2021, the  balance  of goodwill for the  reporting  units  in Europe  was approximately  nil  and the  remaining  balance  of goodwill  in the International segment primarily relates to one of our reporting units in Canada.", "Other risks, expenses and future developments, such as additional government actions, increased regulatory uncertainty, and material changes in key market assumptions that we were unable to anticipate as of the testing date may require us to further revise the projected cash flows, which could adversely affect the fair value of our other reporting units in future periods.", "We review intangible assets for impairment at an asset group level whenever events or changes in circumstances indicate that the carrying value of the assets may not be recoverable.", "Determination of recoverability of intangible assets is based on the lowest level of identifiable estimated future undiscounted cash flows resulting from use of the asset and its eventual disposition.", "Measurement of any impairment loss is based on the excess of the carrying value of the asset group over its fair value.", "Assumptions and estimates about future values and remaining useful lives of our purchased intangible assets are complex and subjective.", "When the decline in value is deemed to be other than temporary, an impairment is recognized to the extent that the fair value is less than the carrying value of the investment.", "We consider various factors in determining whether a loss in value of an investment is other than temporary including: the length of time and the extent to which the fair value has been below cost, the financial condition of the investees, and our intent and ability to retain the investment for a period of time sufficient to allow for recovery of value.", "Any significant changes in assumptions or judgments in assessing impairments could result in an impairment charge.", "We generally recognize employee severance costs when payments are probable and amounts are estimable.  Costs related  to contracts without future benefit or contract termination  are recognized  at the earlier of the contract termination  or  the  cease-use  dates.  Other  exit-related  costs  are  recognized  as  incurred.  In  connection  with  these  restructuring  actions,  we  also  assess  the recoverability of long-lived assets used in the business, and as a result, we may recognize accelerated depreciation and amortization reflecting shortened useful lives of the underlying assets.", "paid.  We  are  subject  to  income  taxes  in  the  U.S.  and  numerous  foreign  jurisdictions.  Significant  judgments  and  estimates  are  required  in  determining  the consolidated income tax provision and in evaluating income tax uncertainties and include those used to conclude on the tax-free nature of the separation of the Change Healthcare JV and the unrecognized tax position related to opioid-related litigation and claims, which remains unfinalized, and which may differ from the actual amounts of tax benefit recognized.", "We review our tax positions at the end of each quarter and adjust the balances as new information becomes available.", "to recover our deferred tax assets, we consider all available positive and negative evidence including our past operating results, the existence of cumulative net operating losses in the most recent years, and our forecast of future taxable income.", "In estimating future taxable income, we develop assumptions including the amount of future federal, state and foreign pre-tax operating income, the reversal of temporary differences, and the implementation of feasible and prudent tax planning strategies.", "These assumptions require significant judgment about the forecasts of future taxable income and are consistent with the plans and estimates we use to manage the underlying businesses.", "additional taxes and related interest will be due.", "If our current estimate of tax and interest liabilities is less than the ultimate settlement, an additional charge to income tax expense may result.", "If our current estimate of tax and interest liabilities is more than the ultimate settlement, a reduction to income tax expense may be recognized.", "investigations  relating  to  laws  and  regulations  and  other  matters  arising  out  of  the  normal  conduct  of  our  business.  When  a  loss  is  considered  probable  and reasonably estimable, we record a liability in the amount of our best estimate for the ultimate loss.", "When a material loss is reasonably possible or probable but a reasonable estimate cannot be made, disclosure of the proceeding is provided.", "Deferred income taxes arise from temporary differences between the tax and financial statement recognition of revenue and expense.", "Changes in tax laws and rates could also affect recorded deferred tax assets and liabilities in the future.", "We recognize liabilities for tax and related interest for issues in the U.S. and other tax jurisdictions based on our estimate of whether, and the extent to which,", "As discussed above, development of a meaningful estimate of loss or a range of potential loss is complex when the outcome is directly dependent on future negotiations with or decisions by third parties, such as regulatory agencies, the court system and other interested parties.", "As a result of ongoing, advanced discussions with state attorneys general and plaintiffs\u2019 representatives regarding a framework to resolve the claims of governmental  entities,  and  our  assessment  of  certain  other  opioid-related  claims,  we  have  reached  a  stage  at  which  a  broad  settlement  of  opioid  claims  by governmental entities is probable and recorded a charge of $8.1 billion for the year ended March 31, 2021 within \u201cClaims and litigation charges, net\u201d in our Consolidated Statement of Operations in this report.", "Because of the many uncertainties associated with any potential settlement arrangement or other resolution of opioid-related litigation, including the uncertainty of the scope of participation by plaintiffs in any potential settlement, we are not able to reasonably estimate the upper or lower ends of the range of ultimate possible loss for all opioid-related litigation matters.", "While we are not able to predict the outcome or reasonably estimate a range of possible losses in these matters, an adverse judgment or negotiated resolution in any of these matters could have a material adverse effect on our results of operations, consolidated financial position, cash flows or liquidity.", "facilities and commercial paper program, will be sufficient to fund our short-term and long-term capital expenditures, working capital, and other cash requirements.", "We continue to monitor its impact on demand within parts of our business, as well as trends potentially impacting the timing or ability for some of our customers to pay amounts owed to us.", "We remain well-capitalized with access to liquidity from our $4.0 billion revolving credit facility.", "Additionally, long-term debt markets and commercial paper markets, our primary sources of capital after cash flow from operations, have remained open and accessible to us during the COVID-19 pandemic.", "We have seen continued improvement in conditions in the debt markets and commercial paper markets as the Federal Reserve has taken steps to stabilize the markets.", "At March 31, 2021, we were in compliance with all debt covenants, and believe we have the ability to continue to meet our debt covenants in the future.", "Cash flows from operations can be significantly impacted by factors such as the timing of receipts from customers and payments to vendors.", "Operating activities for the year ended March 31, 2021 were affected by net income adjusted for non-cash items, including the pre-tax $8.1 billion (after-tax $6.8 billion) non-cash charge related to our estimated liability for opioid-related claims, an increase in inventory of $2.3 billion and an increase in drafts and accounts payable of $1.3 billion driven by higher inventory stock levels to meet increased volume demand as part of our inventory management, as well as a decrease in receivables of $1.1 billion driven by timing, higher sales recognized at the end of March 2020, and higher collections in our fourth quarter of 2021.", "value remeasurement charges of $58 million related to the contribution of our German pharmaceutical wholesale business to a joint venture with WBA.", "Additionally, we made a cash payment of $114 million from the executive benefit retirement plan in 2020.", "Investing activities for the year ended March 31, 2021 also includes net cash proceeds of $400 million from sales of businesses and investments, including $286 million in exchange for the contribution of our German pharmaceutical wholesale business to a joint venture with WBA.", "Cash used for other financing activities generally includes payments to noncontrolling interests and activity from our finance leases.", "We received cash from long-term debt issuances of $1.1 billion and made repayments on long-term debt of $1.1 billion in 2019.", "The timing of any repurchases and the actual number of shares repurchased will depend on a variety of factors, including our stock price, corporate and regulatory requirements, restrictions under our debt obligations, and other market and economic conditions.", "In accordance with our accounting policy, we allocate any excess of share repurchase price over par value between additional paid-in capital and retained earnings.", "Accordingly, our retained earnings and additional paid-in capital were reduced by $472 million and $70 million during 2019, respectively.", "outstanding shares of SpinCo common stock, which held all of the Company\u2019s interests in the Change Healthcare JV, to participating holders of the Company\u2019s common  stock  in  exchange  for  15.4  million  shares  of  McKesson  stock,  which  are  now  held  as  treasury  stock  on  our  consolidated  balance  sheet.  Following consummation of the exchange offer, on March 10, 2020, SpinCo merged with and into Change and each share of SpinCo common stock was converted into one share of Change common stock, par value $0.001 per share, with cash being paid in lieu of fractional shares of Change common stock.", "give us the ability to meet our financing needs for the foreseeable future.", "However, there can be no assurance that an increase in volatility or disruption in the global capital and credit markets will not impair our liquidity or increase our costs of borrowing.", "As described within the \u201cTrends and Uncertainties\u201d section above,  the  COVID-19  pandemic  continues  to  develop  rapidly.  We  continue  to  monitor  its  impact  on  demand  within  parts  of  our  business,  as  well  as  trends potentially impacting the timing or ability for some of our customers to pay amounts owed to us.", "(2) This ratio describes the relationship and changes within our capital resources, and is computed as total debt divided by the sum of total debt and McKesson stockholders\u2019 equity (deficit), which excludes noncontrolling and redeemable noncontrolling interests and accumulated other comprehensive loss. (3) Ratio is computed as net income (loss) attributable to McKesson Corporation for the last four quarters, divided by a five-quarter average of McKesson stockholders\u2019 equity (deficit), which excludes noncontrolling and redeemable noncontrolling interests.", "In 2019, we retired 5.0 million or $542 million of the Company\u2019s treasury shares previously repurchased.", "In connection with the Split-off, we distributed all 176.0 million", "Deposits with financial institutions are primarily denominated in U.S. dollars and the functional currencies of our foreign subsidiaries, including Euro, British pound sterling, and Canadian dollars.", "We mitigate the risk of our short-term investment portfolio by depositing funds with reputable financial institutions and monitoring risk profiles and investment strategies of money market funds. outside of the U.S., respectively.", "Our primary intent is to utilize this cash for foreign operations for an indefinite period of time.", "Although the vast majority of cash held outside the U.S. is available for repatriation, doing so could subject us to foreign withholding taxes and state income taxes.", "The COVID-19 pandemic has potential to increase the variations in our working capital, which we continue to monitor closely. partially offset by an increase in drafts and accounts payable and a decrease in receivables.", "Our unfavorable return on McKesson\u2019s stockholder\u2019s equity (deficit) as of March 31, 2021 was also driven by net loss for the year.", "Net loss for the year ended March 31, 2021 includes an after-tax non-cash charge of $6.8 billion related to our estimated liability for opioid-related claims, as discussed in \u201cTrends  and  Uncertainties\u201d of  this  Financial  Review  and  Financial  Note  19,  \u201cCommitments  and  Contingent  Liabilities,\u201d  to  the  accompanying  consolidated financial statements included in this Annual Report on Form 10\u2011K.", "Our debt to capital ratio increased for 2020 primarily due to a decrease in stockholders\u2019 equity driven by the Split-off of our interest in Change Healthcare JV and share repurchases.", "We anticipate that we will continue to pay quarterly cash dividends in the future.", "However, the payment and amount of future dividends remain within the discretion of the Board and will depend upon our future earnings, financial condition,  capital  requirements,  and  other  factors.  In  2021,  2020,  and  2019,  we  paid  total  cash  dividends  of  $276  million,  $294  million,  and  $292  million, respectively.  Additionally,  as  required  under  the  Domination  Agreement,  we  are  obligated  to  pay  an  annual  recurring  compensation  amount  of  \u20ac0.83  per McKesson Europe share (effective January 1, 2015) to the noncontrolling shareholders of McKesson Europe.", "Cash equivalents, which are readily convertible to known amounts of cash, are carried at fair value.", "Our cash and cash equivalents balance as of March 31, 2021 and 2020 included approximately $2.3 billion and $1.7 billion of cash held by our subsidiaries", "On  July  29,  2020,  we  raised  our  quarterly  dividend  from  $0.41  to  $0.42  per  common  share  for  dividends  declared  on  or  after  such  date  by  the  Board.", "(3) Includes our estimated benefit payments for the unfunded benefit plans and minimum funding requirements for the pension plans. (4) Primarily represents interest that will become due on our fixed rate long-term debt obligations.", "These obligations primarily relate to inventory purchases and capital commitments. (6) Includes agreements under which we have guaranteed the repurchase of our customers\u2019 inventory and our customers\u2019 debt in the event these customers are unable to meet their obligations to those financial institutions.", "The ultimate amount and timing of any future cash settlements related to these items cannot be predicted with reasonable certainty.", "and are mostly related to our customer contracts and to meet the security requirements for statutory licenses and permits, court and fiduciary obligations, and our workers\u2019 compensation and automotive liability programs.", "The exercise of the Put Right will reduce the balance of redeemable noncontrolling interests.", "During 2021, we paid $49 million to purchase 1.8 million shares of McKesson Europe through exercises of the Put Right by the noncontrolling shareholders.", "Our banks and insurance companies have issued $146 million of standby letters of credit and surety bonds at March 31, 2021.", "redemption value is the Put Amount adjusted for exchange rate fluctuations each period.", "In future periods, unfavorable foreign currency exchange rate fluctuations between the Euro and the U.S. dollar could adversely impact the carrying value of our redeemable noncontrolling interests and require an adjustment to increase the balance of our redeemable noncontrolling interests to its maximum redemption value.", "On April 12, 2021, we received the Stuttgart Court of Appeals\u2019 final ruling confirming the original put value of \u20ac22.99 per share and the annual recurring compensation of \u20ac0.83 per McKesson Europe share.", "Funds necessary for future debt maturities and our other cash requirements are expected to be met by existing cash balances, cash flow from operations, existing credit sources, and other capital market transactions.", "The effect of a hypothetical 50 bp increase in the underlying interest rate on our cash and cash equivalents, net of short-term borrowings and variable rate debt, would have resulted in a favorable impact to earnings in 2021 and 2020 of approximately $17 million and $6 million, respectively.", "The balance of redeemable noncontrolling interests is reported at the greater of its carrying value or its maximum redemption value at each reporting date.", "Additionally,  we  are  obligated  to  pay  an  annual  recurring  compensation  of  \u20ac0.83  per  McKesson  Europe  share  (the  \u201cCompensation  Amount\u201d)  to  the", "Interest rate risk: Our long-term debt bears interest predominately at fixed rates, whereas our short-term borrowings are at variable interest rates.", "Our cash and cash equivalents balances earn interest at variable rates.", "At March 31, 2021 and 2020, we had $6.3 billion and $4.0 billion, respectively, in cash", "Changes in foreign currency exchange rates could have a material adverse impact on our financial results that are reported in U.S. dollars.", "We are also exposed to foreign exchange rate risk related to our foreign subsidiaries, including intercompany loans denominated in non-functional currencies.", "These programs reduce but do not entirely eliminate foreign exchange risk.", "fair value of our foreign exchange contracts by approximately $267 million and $435 million, respectively.", "Foreign exchange risk: We conduct our business worldwide in U.S. dollars and the functional currencies of our foreign subsidiaries, including Euro, British", "We have certain foreign exchange rate risk programs that use foreign currency forward contracts and cross-currency swaps.", "Based on this assessment, our management has concluded that our internal control over financial reporting was effective as of March 31, 2021.", "In our opinion, the financial statements referred to above present fairly, in all material respects, the financial position of the Company as of March 31, 2021 and 2020, and the results of its operations and its cash flows for each of the three years in the period ended March 31, 2021, in conformity with accounting principles generally accepted in the United States of America.", "Also, in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of March 31, 2021, based on criteria established in Internal Control \u2014 Integrated Framework (2013) issued by COSO.", "Our responsibility is to express an opinion on these financial statements and an opinion on the Company\u2019s internal control over financial reporting based  on  our  audits.  We  are  a  public  accounting  firm  registered  with  the  Public  Company  Accounting  Oversight  Board  (United  States)  (\u201cPCAOB\u201d)  and  are required  to  be  independent  with  respect  to  the  Company  in  accordance  with  the  U.S.  federal  securities  laws  and  the  applicable  rules  and  regulations  of  the Securities and Exchange Commission and the PCAOB.", "We conducted our audits in accordance with the standards of the PCAOB.", "Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.", "Our audits of the financial statements included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures to respond to those risks.", "Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements.", "Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk.", "Our audits also included performing such other procedures as we considered necessary in the circumstances.", "We believe that our audits provide a reasonable basis for our opinions.", "The critical audit matters communicated below are matters arising from the current-period audit of the financial statements that were communicated or required to be communicated to the audit committee and that (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments.", "The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.", "The Company also performs an assessment of loss contingencies where a loss is reasonably possible.", "We identified the potential broad settlement of opioid claims as a critical audit matter because of the significant judgment and challenges auditing management\u2019s determination  of  whether  such  loss  is  probable  and  reasonably  estimable.  Specifically,  auditing  management\u2019s  determination  and  disclosure  of  whether  the contingent loss arising from the potential broad settlement of opioid claims is probable, and the related measurement of such loss, is subjective and requires significant judgment given that the potential loss is based upon settlement terms that have not yet been finalized.", "\u2022 We tested the effectiveness of internal controls related to the potential broad settlement of opioid claims, and approval of the accounting treatment and related disclosures based on the most recent facts and circumstances.", "In addition, we inspected responses to inquiry letters sent to both internal and external legal counsel as it relates to the status of discussions with plaintiffs\u2019 counsel and the Company\u2019s intent regarding the framework for a potential broad settlement of opioid claims.", "\u2022 We evaluated management\u2019s analysis of the potential broad settlement of opioid claims, including the methodology used by management to determine the probability of such loss.", "We also evaluated the methodology used by management to estimate the most likely loss to be incurred by the Company as a result of a potential broad settlement of opioid claims.", "\u2022 We performed public domain searches for evidence contrary to management\u2019s analysis.", "\u2022 We evaluated any events subsequent to March 31, 2021 that might impact our evaluation of the potential broad settlement of opioid claims. \u2022 We obtained written representations from executives and internal counsel of the Company. \u2022 We examined proposed terms related to the potential broad settlement framework. \u2022 We evaluated the Company\u2019s related disclosures for consistency with our testing.", "The net amount recognized by management is measured as the largest amount of tax benefit that is greater than 50 percent likely of being realized.", "We identified the Company\u2019s uncertain tax position related to the charge for the potential broad settlement of opioid claims as a critical audit matter because of the challenges in auditing management\u2019s estimate of the amount of income tax benefit that qualifies for recognition.", "Our audit procedures related to the Company's uncertain tax position associated with a potential broad settlement of opioid claims included the following, among others: \u2022 We tested the effectiveness of internal controls related to the Company\u2019s assessment of the technical merits of its tax position, including the Company\u2019s assessment as to the amount of benefit that is more likely than not to be realized. \u2022 With  the  assistance  of  our  tax  specialists,  we  evaluated  the  facts,  evidence  and  the  Company\u2019s  related  income  tax  analysis  for  the  charge  related  to  the potential broad settlement of opioid claims, including assumptions used by management to measure the related recognized and unrecognized tax benefits. \u2022 We inquired of the Company\u2019s internal and external legal counsel to understand the basis for the Company\u2019s conclusion that a portion of the potential broad settlement of opioid claims would be deductible based on the most recent discussions with plaintiffs\u2019 counsel.", "\u2022 We  compared  management's  income  tax  assessment  of  this  matter  to  the  treatment  of  other  recorded  opioid  charges  to  evaluate  the  consistency  of  the Company\u2019s judgments related to the uncertain tax position. \u2022 We evaluated any events subsequent to March 31, 2021 that might impact our evaluation of the Company\u2019s uncertain tax position related to the charge for the potential broad settlement of opioid claims.", "\u2022 We obtained written representations from executives and internal counsel of the Company. \u2022 We examined proposed terms related to the potential broad settlement framework.", "\u2022 We evaluated the Company\u2019s related disclosures for consistency with our testing and also searched for contradictory evidence by reading disclosures from peer companies, who are also party to the potential broad settlement of opioid claims.", "We identified the estimation of the fair value of the McKesson Canada reporting unit used to evaluate the recoverability of goodwill as a critical audit matter because of the challenges auditing significant judgments used in the selection of a discount rate, including the unsystematic risk premium.", "In particular, the fair value estimate is sensitive to the unsystematic risk premium assumption, which is affected by expected risk of changes in the Canadian business and regulatory environments.", "Auditing management\u2019s selected discount rate required a high degree of auditor judgment and an increased extent of effort, including the need to involve more senior members of the team and our fair value specialists.", "Our audit procedures related to the Company\u2019s selection of a discount rate, including consideration of the unsystematic risk premium, for the McKesson Canada reporting unit included the following, among others: \u2022 We tested the effectiveness of internal controls related to management\u2019s goodwill impairment evaluation, including those related to the selection of a discount rate and consideration of an unsystematic risk premium. \u2022 We  evaluated  management\u2019s  ability  to  accurately  forecast  operating  results  for  the  McKesson  Canada  reporting  unit  by  comparing  actual  results  to management\u2019s historical forecasts, in order to consider the reasonableness and adequacy of management\u2019s selected unsystematic risk premium. \u2022 As part of our assessment of the unsystematic risk premium, we evaluated the reasonableness of strategic plans expected to be implemented during the forecast period by comparing the forecasts to:", "\u2022 With the assistance of our fair value specialists, we evaluated the reasonableness of the discount rate, including the unsystematic risk premium, by developing a range of independent estimates, testing the mathematical accuracy of the calculation and comparing to the discount rate selected by management.", "We have served as the Company\u2019s auditor since 1968.", "The Company consolidates VIEs when it is determined that it is the primary beneficiary of the VIE.", "Investments in business entities in which the Company does not have control but has the ability to exercise significant influence over operating and financial policies, are accounted for using the equity method.", "Actual amounts could differ from those estimated amounts.", "These legislative acts are not expected to have a material impact on the Company\u2019s consolidated financial results.", "The Company considers itself to control an entity if it is the majority owner of or has voting control over such entity.", "GAAP requires that the Company make estimates and assumptions that", "If a loss in value has occurred that is deemed to be other-than-temporary, an impairment loss is recorded.", "economic environment, customer credit ratings or bankruptcies, as well as reasonable and supportable forecasts.", "We are exposed to credit losses on accounts receivable balances.", "As a result, the Company\u2019s sales and credit concentration is significant.", "The accounts receivables balances are with individual members of the GPOs, and therefore no significant concentration of credit risk exists.", "This credit risk is mitigated by the size and diversity of the Company\u2019s customer base as well as its geographic dispersion.", "These amounts are equivalent to the Company\u2019s LIFO reserves.", "A LIFO credit is recognized when the net effect of price declines exceeds the impact of price increases on pharmaceutical and non-pharmaceutical products held in inventory.", "The increase was primarily due to charges in 2021 totaling $136 million on certain personal protective equipment and other related products due to inventory impairments and excess inventory within our Medical-Surgical Solutions segment.", "When the net realizable value of a disposal group increases during a period, a gain can be recognized to the extent that it does not increase the value of the disposal group beyond its original carrying value when the disposal group was reclassified as held for sale.", "Depreciation and amortization begins when an asset is placed in service and ready for its intended use.", "The use of alternative assumptions and estimates could affect the fair values and change the impairment determinations.", "Measurement of any impairment loss is based on the excess of the carrying value of the asset group over its estimated fair market value.", "customer in an amount that reflects the consideration to which the entity expects to be entitled for that good or service.", "Revenue is recognized when control of goods is transferred to the customer which occurs upon the Company\u2019s delivery to the customer or upon customer  pick-up.", "The ultimate outcome of any outstanding claims may be different than the Company\u2019s estimate.", "If a derivative is designated as a fair value hedge, the changes in the fair value of the derivative and of the hedged item attributable to the hedged risk are recognized in earnings.", "The cumulative changes in fair value are reclassified to the same line as the hedged item in the Consolidated Statements of Operations when the hedged item affects earnings.", "Noncontrolling interests with redemption features, such as put rights, that are not solely within the Company\u2019s control are considered redeemable noncontrolling interests.", "When a loss is considered probable and reasonably estimable, the Company records a liability in the amount of its best estimate for the ultimate loss.", "When a material loss is reasonably possible or probable, but a reasonable estimate cannot be made, disclosure of the proceeding is provided.", "As discussed above, development of a meaningful estimate of loss or a range of potential loss is complex when the outcome is directly dependent on negotiations with or decisions by third parties, such as regulatory agencies, the court system, and other interested parties.", "Any purchase consideration in excess of the estimated fair values of the net assets acquired is recorded as goodwill.", "Restructuring Charges: Employee severance costs are generally recognized when payments are probable and amounts are reasonably estimable.", "The forward-looking model requires the Company to consider historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount in estimating credit losses.", "The adoption of this amended guidance is not expected to have a material impact on the Company\u2019s consolidated financial statements or disclosures.", "accounting policy has been to disclose any intervening events of the joint venture in the lag period that could materially affect its consolidated financial statements.", "McKesson had the ability to adjust the manner in which certain depreciation or amortization deductions are allocated among Change and McKesson.", "This creates uncertainty over the amount, timing, and probability of the gain recognized.", "Any such change is not expected to have a material impact on the Company\u2019s consolidated financial statements.", "This initiative was substantially complete in 2021 and remaining costs the Company expects to record under this initiative are not material.", "This set of initiatives was substantially complete by the end of 2020 and charges in 2021 were not material.", "Goodwill recognized for business acquisitions is generally not expected to be deductible for tax purposes.", "share-based awards that will ultimately vest primarily based on historical experience.", "The estimated forfeiture rate established upon grant is re-assessed throughout the requisite service period and is adjusted when actual forfeitures occur.", "The actual forfeitures in future reporting periods could be higher or lower than current estimates.", "PSUs have a requisite service period of generally three years.", "Compensation expense for the share-based awards is recognized for the portion of awards ultimately expected to vest.", "The number of vested PSUs is assessed at the end of a", "All  outstanding  PeRSU awards  have  completed  the  performance  period  and  are  now classified  and  accounted  for  as RSUs.", "portion of the awards that is ultimately expected to vest.", "Once the fair value of an employee stock option is determined, current accounting practices do not permit it to be changed, even if the estimates used are different from actual.", "The Company believes this market-based input provides a reasonable estimate of its future stock price movements and is consistent with employee stock option valuation considerations.", "These amounts have not been significant for all the years presented.", "Substantially all its foreign net operating losses have indefinite lives.", "The decrease in unrecognized tax benefits in 2020  compared  to  2019  is  primarily  attributable  to  the  favorable  resolution  of  an  outstanding  California  tax  refund  claim  which  decreased  unrecognized  tax benefits by $91 million.", "2017 Tax Act, the repatriation of cash to the U.S. is generally no longer taxable for federal income tax purposes.", "The Company may remit foreign earnings to the U.S. to the extent it is tax efficient to do so.", "It does not expect the tax impact from remitting these earnings to be material.", "The exercise of the Put Right will reduce the balance of redeemable noncontrolling interests.", "The adoption of this guidance did not have a material impact on the Company\u2019s consolidated statements of operations and cash flows.", "The Company\u2019s lease agreements do not contain any material residual value guarantees or material restrictive covenants.", "Operating lease liabilities are recognized based on the present value of the future lease payments over the lease term, discounted at the Company\u2019s incremental borrowing rate as the implicit rate in the lease is not readily determinable for most of the Company\u2019s leases.", "As a practical expedient, short-term leases with an initial term of 12 months or less are excluded from the Consolidated Balance Sheets and charges from these leases are expensed as incurred.", "Fair value estimates result from a complex series of judgments about future events and uncertainties and rely heavily on estimates and assumptions that have been deemed reasonable by management as of the measurement date.", "The unsystematic risk premium is an input factor used in calculating the discount rate that specifically addresses uncertainty related to the reporting unit\u2019s future cash flow projections.", "The risk of successfully achieving certain business initiatives was the primary factor in the use of a higher discount rate.", "and, from time-to-time, future unsecured and unsubordinated indebtedness outstanding.", "As a result of absorbing this risk, the leases provide the Company with the power to direct the operations of the leased properties and the obligation to absorb losses or the right to receive benefits of the entity.", "Consolidated VIEs do not have a material impact on the Company\u2019s Consolidated Statements of Operations and Cash Flows.", "their economic performance and thus is not considered the primary beneficiary of the entities.", "The pension obligation in Germany is unfunded with the exception of the contractual trust arrangement used to fund pensions of McKesson Europe\u2019s Management Board.", "actuarial  losses  exceeding  10%  of  the  greater  of  the  projected  benefit  obligation  or  the  market  value  of  assets  are  amortized  straight-line  over  the  average remaining future service period of active employees.", "Pension obligations for its unfunded plans are based on the recommendations of independent actuaries.", "The difference between actual inflation and assumed inflation in our U.K. pension plans resulted in a gain of $23 million.", "corporate bonds rated AA or better whose maturities are aligned with the expected benefit payments of its plans.", "Plan assets of the non-U.S. plans are broadly invested in a manner appropriate to the nature and duration of the expected future retirement benefits payable under the plans.", "Assets are properly diversified to avoid excessive reliance on any particular asset, issuer, or group of undertakings so as to avoid accumulations of risk in the portfolio as a whole.", "practical expedient are not leveled within the fair value hierarchy and are included as a reconciling item to total investments.", "Actions taken by other participating employers may lead to adverse changes in the financial condition of a multiemployer benefit plan and the Company\u2019s withdrawal liability and contributions may increase.", "It does not use derivatives for trading or speculative purposes.", "Eligible employees may contribute to the RSP up to 75% of", "In the normal course of business, the Company is exposed to interest rate and foreign currency exchange rate fluctuations.", "These forward contracts and cross-currency swaps are generally used to offset the potential income statement effects from intercompany loans and other obligations denominated in non-functional currencies.", "These programs reduce but do not entirely eliminate foreign currency exchange rate risk.", "To the extent foreign currency-denominated notes designated as net investment hedges are ineffective, changes in carrying value attributable to the change in spot rates are recorded in earnings.", "To the extent cross-currency swaps designated as hedges are ineffective, changes in carrying value attributable to the change in spot rates are recorded in earnings.", "Changes in fair values representing hedge ineffectiveness are recognized in current earnings.", "The settlement loss on the swaps was not material and will be amortized on a straight-line basis as interest expense over the five-year life of the 2025 Notes.", "Gains or losses from these contracts are largely offset by changes in the value of the underlying intercompany obligations.", "Changes in the fair value for contracts not designated as hedges are recorded directly in earnings.", "The carrying value of all other cash equivalents approximates their fair value due to their relatively short-term nature.", "These inputs are considered Level 2 under the fair value measurements and disclosure guidance and may not be representative of actual values that could have been realized or that will be realized in the future.", "If the carrying amount of an asset group is not recoverable, an impairment charge is recorded to reduce the carrying amount by the excess over its fair value.", "repurchase of its customers\u2019 inventory or its customers\u2019 debt in the event these customers are unable to meet their obligations to those financial institutions.", "For the Company\u2019s inventory repurchase agreements, among other requirements, inventories must be in resalable condition and any repurchase would be at a discount.", "The majority of the Company\u2019s customers\u2019 debt guarantees are secured by certain assets of the customer.", "The Company\u2019s long-term debt is also recorded at cost.", "The carrying value and fair value of the Company\u2019s long-term debt was as follows:", "Long-lived Assets The Company utilizes multiple approaches including the DCF model and market approaches for estimating the fair value of intangible assets.", "infringe a third party\u2019s intellectual property rights.", "Where appropriate, obligations for such indemnifications are recorded as liabilities.", "Accrued warranty costs were not material to the Consolidated Balance Sheets.", "Significant developments in those matters are described below.", "Company  is  unable  to  determine  that  a  loss  is  probable,  or  to  reasonably  estimate  the  amount  of  loss  or  a  range  of  loss,  for  a  claim  because  of  the  limited information  available  and  the  potential  effects  of future  events  and  decisions  by third  parties,  such  as  courts  and  regulators,  that  will  determine  the  ultimate resolution of the claim.", "It is not uncommon for claims to remain unresolved over many years.", "The Company reviews loss contingencies at least quarterly to determine whether the likelihood of loss has changed and whether it can make a reasonable estimate of the loss or range of loss.", "When the Company determines that a loss from a claim is probable and reasonably estimable, it records a liability for an estimated amount.", "The Company also provides disclosure when it is reasonably possible that a loss may be incurred or when it is reasonably possible that the amount of a loss will exceed its recorded liability.", "Warranties In the normal course of business, the Company provides certain warranties and indemnification protection for its products and services.", "These two West Virginia plaintiffs are not expected to participate in any broader multistate resolution of opioid-related claims.", "The Cherokee Nation is not expected to participate in any broader multistate resolution of opioid-related claims.", "Those non-participating governmental entities would be entitled to pursue their claims against the Company and other defendants.", "The Company believes that it has valid defenses to the claims pending against it, and it intends to vigorously defend against all such claims if acceptable settlement terms are not achieved.", "The Company believes it has valid legal defenses in these matters and intends to mount a vigorous defense.", "The Company has not concluded a loss is probable in any of these matters; nor is the amount of any loss reasonably estimable.", "An adverse judgment or negotiated resolution in any of these matters could have a material adverse impact on the Company\u2019s financial position, cash flows or liquidity, or results of operations.", "AIG and ACE are seeking declarations that they have no duty to defend or indemnify McKesson in the thousands of lawsuits pending in federal and state courts related to opioids.", "Discussions with attorneys general and other parties continue.", "If the negotiating parties agree on terms under the framework for a broad resolution of claims of", "Plaintiffs\u2019 moved for summary judgment on the same day.", "subpoenas and requests in a cooperative, thorough and timely manner.", "These responses sometimes require time and effort and can result in considerable costs being incurred by the Company.", "Such subpoenas and requests can lead to the assertion of claims or the commencement of civil or criminal legal proceedings against the Company and other members of the health care industry, as well as to settlements of claims against the Company.", "The Company responds to these requests in the ordinary course of business.", "The law adopting the excise tax made clear that the OSA does not apply to sales or distributions occurring after December 31, 2018.", "It is not certain at this point in time what proportion of this estimated liability will be borne by the Company.", "However, it is possible that the ultimate costs of these matters may exceed or be less than the reserves.", "Due to the complex nature of the tax laws, it is not possible to estimate the outcome of these matters.", "improper actions to delay or prevent generic drugs from entering the market.", "The quarterly results of operations are not necessarily indicative of the results that may be expected for the entire year.", "effectiveness of the Company\u2019s \u201cdisclosure controls and procedures\u201d (as such term is defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) as of the end of the period  covered  by  this  report  and  have  concluded  that  our  disclosure  controls  and  procedures  are  effective  based  on  their  evaluation  of  these  controls  and procedures as required by paragraph (b) of Exchange Act Rules 13a-15 or 15d-15.", "Rules 13a-15 or 15d-15 that occurred during our fourth quarter of 2021 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.", "caption  \u201cInvestors  -  Corporate  Governance.\u201d  The  Company\u2019s  Corporate  Governance  Guidelines  and  Charters  for  the  Audit,  Compensation  and  Governance Committees can also be found on our website under the same caption.", "Information  about the Code of Conduct applicable  to all employees, officers  and directors can be found on our website, www.mckesson.com, under the", "Information with respect to this item is incorporated by reference from the discussion under the heading \u201cExecutive Compensation\u201d in our Proxy Statement.", "Such non-employee director award is fully vested on the date of the grant.", "subject to and qualified in their entirety by reference to our amended and restated certificate of incorporation, our amended and restated by- laws  and  the  Delaware  General  Corporation  Law  (\u201cDGCL\u201d).  Copies  of  our  amended  and  restated  certificate  of  incorporation  and  our amended and restated by-laws have been filed with the Securities and Exchange Commission (the \u201cSEC\u201d) and are incorporated by reference herein. 100,000,000 shares are preferred stock, par value $0.01 per share.", "We may amend from time to time our amended and restated certificate of incorporation to increase the number of authorized shares of Common Stock and/or preferred stock.", "Any such amendment would require the approval of the holders of a majority of our shares entitled to vote.", "All of our outstanding shares of Common Stock are fully paid and non- assessable.", "Stock are entitled to receive ratably dividends out of assets legally available therefor at such times and in such amounts as our board of directors may from time to time determine.", "ratably in our assets that are legally available for distribution, after payment of all debts, other liabilities and any liquidation preferences of outstanding preferred stock.", "amended and restated certificate of incorporation does not provide for cumulative voting in the election of directors.", "Upon liquidation, dissolution or winding up of our affairs, the holders of Common Stock are entitled to share", "Holders of our Common Stock have no conversion, redemption, preemptive or similar", "Each outstanding share of Common Stock is entitled to one vote on all matters submitted to a vote of stockholders.", "Anti-Takeover Effects of Provisions of Our Amended and Restated Certificate of Incorporation and Our Amended and Restated By- Laws deemed to have an anti-takeover effect and may delay, deter or prevent a tender offer or takeover attempt that a stockholder might consider in its best interest, including those attempts that might result in a premium over the market price for the shares held by stockholders.", "Our amended and restated by-laws provide that special meetings of holders of Common Stock may be called only by our Chair, Chief Executive Officer or a majority of our board of directors for any purpose at any time.", "Holders of Common Stock owning at least 15% of the outstanding shares of Common Stock for at least one year are permitted to submit a special meeting request in accordance with the procedures described in our amended and restated by-laws.", "In general, notice of intent to nominate a director or raise business at such meetings must be received by us not less than 90 nor more than 120 days prior to the date of the  annual meeting and must contain certain specified  information concerning the person to be nominated or the matters to be brought before the meeting and concerning the stockholder submitting the proposal.", "may be amended by a vote of a majority of our board of directors and by the affirmative vote of a majority of the shares of the corporation entitled  to  vote  thereon.  Our  amended  and  restated  certificate  of  incorporation  and  our  amended  and  restated  by-laws  provide  that  our amended and restated by-laws may be amended by a vote of a majority of our board of directors.", "In addition, our amended and restated by- laws provide that our amended and restated by-laws may be amended by the affirmative vote of a majority of the shares of the corporation entitled to vote thereon.", "Current and former stockholders are deemed to have consented to the personal jurisdiction of the Delaware Courts in connection with any action to enforce that exclusive forum provision and to service of process in any such action.", "We  are  subject  to  the  \u201cbusiness  combination\u201d  statute  of  the  DGCL.  In  general,  such  statute  prohibits  a  publicly  held  Delaware", "The statute could prohibit or delay mergers or other takeover or change in control attempts with respect to us and, accordingly, may discourage attempts to acquire us.", "stock could decrease the amount available for distribution to holders of our Common Stock or could adversely affect the rights and powers, including voting rights, of such holders.", "The issuance of preferred stock could have the effect of delaying or preventing a change in control of us.", "Such limitation does not, however, affect the liability of a director (1) for any breach of the director\u2019s duty of loyalty to us or our stockholders, (2) for acts or omissions not in good faith or that involve intentional misconduct or a knowing violation of law, (3) in respect of certain unlawful dividend payments or stock redemptions or purchases and (4) for any transaction from which the director derives an improper personal benefit.", "The effect of this provision is to eliminate our rights and the rights of our stockholders (through stockholders\u2019 derivative suits) to recover monetary damages against a director for breach of the fiduciary duty of care as a director (including breaches resulting from negligent or grossly negligent behavior) except in the situations described in clauses (1) through (4) above.", "This provision does not limit or eliminate our rights or the rights of our stockholders to seek non-monetary relief such as an injunction or rescission in the event of a breach of a director\u2019s duty of care.", "In addition, our directors and officers have indemnification protection.", "principal amount of 0.625% Notes due 2021 and \u20ac600,000,000 aggregate principal amount of 1.500% Notes due 2025, and on February 12, 2018, we issued \u20ac500,000,000 aggregate principal amount of 1.625% Notes due 2026.", "existing and future unsecured and unsubordinated indebtedness from time to time outstanding.", "EQ Shareowner Services acts as transfer agent and registrar of our Common Stock.", "Our Common Stock is listed on the New York Stock Exchange under the symbol \u201cMCK\u201d.", "On  February  17,  2017,  we  issued  \u00a3450,000,000  aggregate  principal  amount  of  3.125%  Notes  due  2029,  \u20ac600,000,000  aggregate", "Securities\u201d), our senior subordinated debt (\u201cSenior Subordinated Debt Securities\u201d), our subordinated debt (\u201cSubordinated Debt Securities\u201d) or our  junior  subordinated  debt  (\u201cJunior  Subordinated  Debt  Securities\u201d  and,  together  with  the  Senior  Subordinated  Debt  Securities  and  the Subordinated Debt Securities, the \u201cSubordinated Securities\u201d).  The Indenture does not limit the amount of debt securities that we may issue.", "It provides that we may issue debt securities up to the principal amount that we may authorize and may be in any currency or currency unit designated  by  us.  Except  for  the  limitations  on  consolidation,  merger  and  sale  of  all  or  substantially  all  of  our  assets  contained  in  the Indenture, the terms of the Indenture do not contain any covenants or other provisions designed to afford holders of any debt securities protection with respect to our operations, financial condition or transactions involving us.", "any person unless (a) we will be the continuing corporation or (b) the successor corporation or person formed by such consolidation or into which we are merged or to which our assets substantially as an entirety are transferred or leased is a corporation, limited liability company or limited partnership organized or existing under the laws of the United States, any state of the United States or the District of Columbia and, if such entity is not a corporation, a co-obligor of the debt securities is a corporation organized or existing under any such laws, and such successor corporation or person, including such co-obligor, if any, expressly assumes our obligations on the debt securities and under the Indenture.", "In addition, we cannot effect such a transaction unless immediately after giving effect to such transaction, no default or Event of Default under the Indenture shall have occurred and be continuing.", "Subject to certain exceptions, when the person to whom our assets are transferred or leased has assumed our obligations under the debt securities and the Indenture, we shall be discharged from all our obligations under the debt securities and the Indenture, except in limited circumstances.", "unless the transaction or change of control were structured to include a merger or consolidation or transfer or lease of all or substantially all of our assets.", "We cannot consolidate or merge with or into, or transfer or lease all or substantially all of our assets to,", "\u2022 any  other  Event  of  Default  provided  in  the  applicable  resolution  of  our  board  of  directors  or  the  officers\u2019  certificate  or supplemental Indenture under which we issue such series of debt securities.", "The Indenture imposes limitations on suits brought by holders of debt securities against us.", "officer knows of any default by us in the performance, observance or fulfillment of any condition or covenant of the Indenture.", "We and the Trustee may not, however, without the consent of the holder of each outstanding debt security affected thereby:", "The Indenture provides that we and the Trustee may enter into supplemental indentures without the", "value of the assets subject to such transaction, as determined by our Board of Directors, or (b) the present value of the remaining obligations of the lessee for net rental payments during the term of any lease discounted at the rate of interest set forth or implicit in the terms of such lease or, if not practicable to determine such rate, the weighted average interest rate per annum borne by the debt securities of each series outstanding pursuant to the Indenture and subject to limitations on sale and lease-back transaction covenants, compounded semi-annually in either case as determined by our principal accounting or financial officer.", "located,  and  substantially  all  the  operations  of  which  are  conducted,  in  the  United  States  of  America  whose  financial  statements  are consolidated with our financial statements in accordance with accounting principles generally accepted in the United States of America.", "Consolidated  Subsidiaries  incurred  after  the  date  of  issuance  of  the  notes  and  secured  by  liens  not  permitted  by  the  limitation  on  liens provisions, and (2) Attributable Debt of ours and our Consolidated Subsidiaries in respect of every sale and lease-back transaction entered into after the date of the issuance of the notes, other than leases permitted by the limitation on sale and lease-back provisions.", "accordance with accounting principles generally accepted in the United States of America.", "Subsidiaries pursuant to which we or any of our Subsidiaries sells, conveys or otherwise transfers to (1) a Receivables Subsidiary (in the case of a transfer by us or any of our Subsidiaries) or (2) any other person (in the case of a transfer by a Receivables Subsidiary), or grants a security interest in, any accounts receivable (whether now existing or arising in the future) or inventory of us or any of our Subsidiaries, and any assets related thereto including, without limitation, all collateral securing such accounts receivable, all contracts and all guarantees or other  obligations  in  respect  of  such  accounts  receivable  or  inventory,  proceeds  of  such  accounts  receivable  and  other  assets  which  are customarily transferred or in respect of which security interests are customarily granted in connection with asset securitization transactions involving accounts receivable or inventory.", "financing of accounts receivable or inventory (a) no portion of the Indebtedness or any other obligations (contingent or otherwise) of which (1)  is  guaranteed  by  us  or  any  Subsidiary  of  ours  (excluding  guarantees  of  obligations  (other  than  the  principal  of,  and  interest  on, Indebtedness) pursuant to representations, warranties, covenants and indemnities entered into in the ordinary course of business in connection with  a  Qualified  Receivables  Transaction),  (2)  is  recourse  or  obligates  us  or  any  Subsidiary  of  ours  in  any  way  other  than  pursuant  to representations,  warranties,  covenants  and  indemnities  entered  into  in  the  ordinary  course  of  business  in  connection  with  a  Qualified Receivables Transaction or (3) subjects any property or asset of ours or any Subsidiary of ours (other than accounts receivable or inventory and related assets as provided in the definition of \u201cQualified Receivables Transaction\u201d), directly or indirectly, contingently or otherwise, to the satisfaction thereof, other than pursuant to representations, warranties, covenants and indemnities entered into in the ordinary course of business in connection with a Qualified Receivables Transaction, (b) with which neither we nor any Subsidiary of ours has any material contract, agreement, arrangement or understanding other than on terms customary for securitization of receivables or inventory and (c) with which neither we nor any Subsidiary of ours has any obligations to maintain or preserve such Subsidiary\u2019s financial condition or cause such Subsidiary to achieve certain levels of operating results.", "Limitation  on  Liens.  We  covenant  that,  so  long  as  any  of  the  Notes  remain  outstanding,  we  will  not,  and  will  not  permit  any", "Indebtedness which is secured by a lien which would otherwise be subject to the foregoing restrictions; provided that after giving effect thereto the Exempted Debt then outstanding at such time does not exceed 10% of our total assets on a consolidated basis.", "than three years, by us or any Consolidated Subsidiary of any assets are prohibited unless (a) we or such Consolidated Subsidiary would be entitled to incur Indebtedness secured by a lien on the assets to be leased in an amount at least equal to the Attributable Debt in respect of such transaction without equally and ratably securing the notes, or (b) the proceeds of the sale of the assets to be leased are at least equal to their fair market value (as determined by our Board of Directors) and the proceeds are applied to the purchase or acquisition, or, in the case of real property, the construction, of assets or to the retirement of Indebtedness.", "The foregoing limitation will not apply, if at the time we or any Consolidated Subsidiary enters into such sale and lease-back transaction, and after giving effect thereto, Exempted Debt does not exceed 10% of our total assets on a consolidated basis.", "time, or in part, from time to time, at our option, for cash, at a redemption price that includes accrued and unpaid interest and a make-whole premium, as specified in the Indenture and the applicable Officer\u2019s Certificate.", "York  Stock  Exchange  under  the  symbol  \u201cMCK25.\u201d  Our  2026  Notes  are  listed  on  the  New  York  Stock  Exchange  under  the  symbol \u201cMCK26.\u201d Our 2029 Notes are listed on the New York Stock Exchange under the symbol \u201cMCK29.\u201d", "This Statement of Terms and Conditions is intended to meet the requirements of Code Section 409A and any regulations and rules promulgated thereunder.", "In the event of any inconsistency between this Statement of Terms and Conditions and the Plan, the Plan shall govern.", "Capitalized terms not otherwise defined in this Statement of Terms and Conditions shall have the meaning set forth in the Plan.", "With respect to  annual  Restricted  Stock  Unit  Awards  granted  to  Outside  Directors  under  the  Plan,  such  awards  shall  be  subject  to  the  following  terms,  conditions  and restrictions.", "The Administrator administering the Plan has authority to determine the Outside Directors to whom, and the time or", "additional Restricted Stock Units, which will be subject to all of the terms and conditions of the underlying Restricted Stock Unit Award.", "The number of such additional Restricted Stock Units shall be calculated by dividing (a) the aggregate amount or value of the dividends paid with respect to that number of Shares equal to the number of Restricted Stock Units credited as of the record date for such dividend by (b) the Fair Market Value per Share on the payment date for such dividend.", "Any fractional Shares resulting from the accumulation of dividend equivalents shall be paid in cash.", "Dividend equivalents in respect of Restricted Stock Units, if granted in tandem with such Units, will be converted into", "Neither an Outside Director nor any person entitled to exercise an Outside Director\u2019s rights in the event of the Outside", "this Statement of Terms and Conditions, or under a Restricted Stock Unit Agreement, shall be conclusive and binding on all persons.", "is providing the consents herein on a purely voluntary basis.", "Nothing herein contained shall affect an Outside Director\u2019s right, if any, to participate in and receive benefits", "Each Outside Director shall agree to make appropriate arrangements with the Corporation for satisfaction of any applicable federal,", "The Corporation will hold and use the Data only as long as is necessary to implement, administer and manage the", "illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.", "Agreements shall be governed by the laws of the State of Delaware.", "The provisions in this Statement of Terms and Conditions are severable and if any one or more provisions are determined to be", "This Statement of Terms and Conditions and the Restricted Stock Unit Agreements shall be binding upon and inure to the benefit of", "This Statement of Terms and Conditions is intended to meet the requirements of Code Section 409A and any regulations and rules promulgated thereunder.", "In the event of any inconsistency between this Statement of Terms and Conditions and the Plan, the Plan shall govern.", "Capitalized terms not otherwise defined in this Statement of Terms and Conditions shall have the meaning set forth in the Plan.", "With respect to  annual  Restricted  Stock  Unit  Awards  granted  to  Outside  Directors  under  the  Plan,  such  awards  shall  be  subject  to  the  following  terms,  conditions  and restrictions.", "The Administrator administering the Plan has authority to determine the Outside Directors to whom, and the time or", "Neither an Outside Director nor any person entitled to exercise an Outside Director\u2019s rights in the event of the Outside", "this Statement of Terms and Conditions, or under a Restricted Stock Unit Agreement, shall be conclusive and binding on all persons.", "is providing the consents herein on a purely voluntary basis.", "Nothing herein contained shall affect an Outside Director\u2019s right, if any, to participate in and receive benefits", "Each Outside Director shall agree to make appropriate arrangements with the Corporation for satisfaction of any applicable federal,", "The Corporation will hold and use the Data only as long as is necessary to implement, administer and manage the", "illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.", "Agreements shall be governed by the laws of the State of Delaware.", "The provisions in this Statement of Terms and Conditions are severable and if any one or more provisions are determined to be", "This Statement of Terms and Conditions and the Restricted Stock Unit Agreements shall be binding upon and inure to the benefit of", "In the event of any inconsistency between this Statement of Terms and Conditions and the Plan, the Plan shall govern.", "Capitalized terms not otherwise defined in this Statement of Terms and Conditions shall have the meaning set forth in the Plan.", "The Option is also subject to the terms and conditions of the Plan.", "In no event shall the Corporation be required to issue fractional Shares.", "An Option granted under the Plan shall be evidenced by an Option Agreement setting forth the terms and conditions of the", "The Exercise Price of an Option, as specified in the Option Agreement, shall be equal to or greater than the Fair Market Value of", "Period, the Option Period shall end on the date of such termination of employment and the Option shall thereupon not be exercisable to any extent whatsoever.", "Term Disability, the vesting schedule of the Participant\u2019s Option shall be accelerated, the Option shall become fully exercisable and the Option Period shall end on the earlier of (i) three years after the date of the Participant\u2019s termination of employment and (ii) the Expiration Date.", "Retirement, (i) the Option shall be exercisable only to the extent that it was exercisable at the time of such retirement and (ii) the Option Period for that portion of the Option designated as a Non Statutory Stock Option shall end on the earlier of (a) three years after the date of such retirement and (b) the Expiration Date.", "of  the  Participant's  Option,  then  the  Option  shall  continue  to  remain  outstanding  until  the  earlier  of  (i)  such  time  as  the  Participant  subsequently  terminates employment and (ii) the Expiration Date.", "number of Shares as to which the Option is so exercised.", "thereunder shall be transferable by the Participant by operation of law or otherwise, other than by will or the laws of descent and distribution.", "have any of the rights of a stockholder with respect to the Shares subject to an Option except to the extent that a book entry has been entered in the records of the Corporation\u2019s transfer agent with respect to such Shares upon the exercise of an Option.", "Neither a Participant nor any person entitled to exercise a Participant\u2019s rights in the event of the Participant\u2019s death shall", "Stock dividends paid with respect to Restricted Stock during the Restriction Period shall be treated as Restricted Stock which shall be subject to the same restrictions as the original award for the duration of the Restriction Period.", "If the Participant does not have a brokerage account of record, then an appropriate book entry recording the Participant\u2019s interest in the unrestricted Shares shall be entered on the records of the Corporation\u2019s transfer agent.", "Cash dividends paid with respect to Restricted Stock during the Restriction Period shall be credited on behalf of the Participant to a", "Election to Recognize Gross Income in the Year of Grant.", "The Administrator reserves the right to impose a restriction on the sale of Shares that the Participant receives upon", "Neither a Participant nor any person entitled to exercise a Participant\u2019s rights in the event of the Participant\u2019s death shall", "The Administrator reserves the right to impose a restriction on the sale of Shares that the Participant receives upon", "Following the end of the performance period, the Compensation Committee shall determine the extent to which the criteria have been achieved and shall authorize the grant and issuance of Shares in respect of the Performance Stock Unit Award.", "The performance period of a Performance Stock Unit Award shall be greater than one year,", "Unless otherwise determined by the Compensation Committee in its sole discretion, Dividend Equivalents shall not be", "A Participant shall not be permitted to sell, transfer, pledge, assign or encumber all or any portion of a Performance Stock Unit", "Neither a Participant nor any person entitled to exercise a Participant\u2019s rights in the event of the Participant\u2019s death shall", "The Administrator reserves the right to impose a restriction on the sale of Shares that the Participant", "addition, any Award of Restricted Stock or Restricted Stock Units as to which the restrictions have not lapsed shall immediately and automatically be forfeited, Performance Stock Unit Awards shall immediately and automatically be forfeited and any such Shares of Restricted Stock shall be returned to the Corporation and all of the rights of the Participant to such Awards and the underlying Shares shall immediately terminate.", "Any outstanding Option shall immediately and automatically terminate, be forfeited and shall cease to be exercisable, without limitation.", "determination shall be conclusive and binding on all interested persons.", "a manner that is valid and enforceable and that comes closest to the business objectives intended by such invalid or unenforceable provision, without invalidating or rendering unenforceable the remaining provisions of this Section VI.", "under an Award Agreement, shall be conclusive and binding on all interested persons.", "Participation in the Plan shall not create a right to further employment with the Participant\u2019s employer (the", "In making grants to Participants in foreign countries, the Administrator has the full discretion to", "All decisions of the Administrator administering the Plan upon any questions arising under the Plan or", "Nothing herein contained shall affect a Participant\u2019s right to participate in and receive benefits from and in", "Regardless  of any  action  the  Corporation  or  the  Employer  takes  with  respect  to  any  federal,  state  or  local  income  tax,  social", "Calculation of the number of Shares to be withheld shall be made based on the closing price of the Common Stock on the New York Stock Exchange on the date that the amount of tax to be withheld is determined.", "With respect to an Award other than an Option, if adequate arrangements to satisfy the obligations with regard to all Tax-Related Items are not made by the Participant with the Corporation and/or the Employer prior to the relevant taxable event, the Corporation will satisfy such obligations as provided above in clause (3) of this paragraph.", "The Administrator shall be authorized to establish such rules, forms and procedures as it deems necessary to implement the foregoing.", "In accepting the grant, the Participant acknowledges that:", "jurisdiction may have different data privacy laws and protections than the United States.", "In the latter case, the Participant understands and acknowledges that the Corporation\u2019s legal basis for the processing of the Participant\u2019s Data would be compliance with the relevant  laws  or  regulations  or  the  pursuit  by  the  Corporation  of  respective  legitimate  interests  not  outweighed  by  the  Participant\u2019s  interests,  rights  or freedoms.", "When the Corporation no longer needs the Participant\u2019s Data for any of the above purposes, the Participant understands the Corporation will remove it from its systems.", "providing the consents herein on a purely voluntary basis.", "illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.", "If the Participant has received this Statement of Terms and Conditions or any other document related to the Plan translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control.", "The provisions in this Statement of Terms and Conditions are severable and if any one or more provisions are determined to be", "The Participant acknowledges that the Participant is proficient in the English language and, accordingly, understands the provisions of", "The Corporation will hold and use the Data only as long as is necessary to implement, administer and manage the", "Participation in the Plan is voluntary and the Participant is", "In the event of any inconsistency between this Statement of Terms and Conditions and the Plan, the Plan shall govern.", "Capitalized terms not otherwise defined in this Statement of Terms and Conditions shall have the meaning set forth in the Plan.", "The Option is also subject to the terms and conditions of the Plan.", "In no event shall the Corporation be required to issue fractional Shares.", "An Option granted under the Plan shall be evidenced by an Option Agreement setting forth the terms and conditions of the", "The Exercise Price of an Option, as specified in the Option Agreement, shall be equal to or greater than the Fair Market Value of", "Period, the Option Period shall end on the date of such termination of employment and the Option shall thereupon not be exercisable to any extent whatsoever.", "Term Disability, the vesting schedule of the Participant\u2019s Option shall be accelerated, the Option shall become fully exercisable and the Option Period shall end on the earlier of (i) three years after the date of the Participant\u2019s termination of employment and (ii) the Expiration Date.", "Retirement, (i) the Option shall be exercisable only to the extent that it was exercisable at the time of such retirement and (ii) the Option Period for that portion of the Option designated as a Nonstatutory Stock Option shall end on the earlier of (a) three years after the date of such retirement and (b) the Expiration Date.", "of  the  Participant's  Option,  then  the  Option  shall  continue  to  remain  outstanding  until  the  earlier  of  (i)  such  time  as  the  Participant  subsequently  terminates employment and (ii) the Expiration Date.", "number of Shares as to which the Option is so exercised.", "thereunder shall be transferable by the Participant by operation of law or otherwise, other than by will or the laws of descent and distribution.", "have any of the rights of a stockholder with respect to the Shares subject to an Option except to the extent that a book entry has been entered in the records of the Corporation\u2019s transfer agent with respect to such Shares upon the exercise of an Option.", "Neither a Participant nor any person entitled to exercise a Participant\u2019s rights in the event of the Participant\u2019s death shall", "Stock dividends paid with respect to Restricted Stock during the Restriction Period shall be treated as Restricted Stock which shall be subject to the same restrictions as the original award for the duration of the Restriction Period.", "If the Participant does not have a brokerage account of record, then an appropriate book entry recording the Participant\u2019s interest in the unrestricted Shares shall be entered on the records of the Corporation\u2019s transfer agent.", "Cash dividends paid with respect to Restricted Stock during the Restriction Period shall be credited on behalf of the Participant to a", "Election to Recognize Gross Income in the Year of Grant.", "The Administrator reserves the right to impose a restriction on the sale of Shares that the Participant receives upon", "Neither a Participant nor any person entitled to exercise a Participant\u2019s rights in the event of the Participant\u2019s death shall", "The Administrator reserves the right to impose a restriction on the sale of Shares that the Participant receives upon", "The performance period of a Performance Stock Unit Award shall be greater than one year,", "Unless otherwise determined by the Compensation Committee in its sole discretion, Dividend Equivalents shall not be", "A Participant shall not be permitted to sell, transfer, pledge, assign or encumber all or any portion of a Performance Stock Unit", "Neither a Participant nor any person entitled to exercise a Participant\u2019s rights in the event of the Participant\u2019s death shall", "The Administrator reserves the right to impose a restriction on the sale of Shares that the Participant", "addition, any Award of Restricted Stock or Restricted Stock Units as to which the restrictions have not lapsed shall immediately and automatically be forfeited, Performance Stock Unit Awards shall immediately and automatically be forfeited and any such Shares of Restricted Stock shall be returned to the Corporation and all of the rights of the Participant to such Awards and the underlying Shares shall immediately terminate.", "Any outstanding Option shall immediately and automatically terminate, be forfeited and shall cease to be exercisable, without limitation.", "determination shall be conclusive and binding on all interested persons.", "a manner that is valid and enforceable and that comes closest to the business objectives intended by such invalid or unenforceable provision, without invalidating or rendering unenforceable the remaining provisions of this Section VI.", "under an Award Agreement, shall be conclusive and binding on all interested persons.", "Participation in the Plan shall not create a right to further employment with the Participant\u2019s employer (the", "In making grants to Participants in foreign countries, the Administrator has the full discretion to", "All decisions of the Administrator administering the Plan upon any questions arising under the Plan or", "Nothing herein contained shall affect a Participant\u2019s right to participate in and receive benefits from and in", "Regardless  of any  action  the  Corporation  or  the  Employer  takes  with  respect  to  any  federal,  state  or  local  income  tax,  social", "Calculation of the number of Shares to be withheld shall be made based on the closing price of the Common Stock on the New York Stock Exchange on the date that the amount of tax to be withheld is determined.", "With respect to an Award other than an Option, if adequate arrangements to satisfy the obligations with regard to all Tax-Related Items are not made by the Participant with the Corporation and/or the Employer prior to the relevant taxable event, the Corporation will satisfy such obligations as provided above in clause (3) of this paragraph.", "The Administrator shall be authorized to establish such rules, forms and procedures as it deems necessary to implement the foregoing.", "In accepting the grant, the Participant acknowledges that:", "jurisdiction may have different data privacy laws and protections than the United States.", "In the latter case, the Participant understands and acknowledges that the Corporation\u2019s legal basis for the processing of the Participant\u2019s Data would be compliance with the relevant  laws  or  regulations  or  the  pursuit  by  the  Corporation  of  respective  legitimate  interests  not  outweighed  by  the  Participant\u2019s  interests,  rights  or freedoms.", "When the Corporation no longer needs the Participant\u2019s Data for any of the above purposes, the Participant understands the Corporation will remove it from its systems.", "providing the consents herein on a purely voluntary basis.", "illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.", "If the Participant has received this Statement of Terms and Conditions or any other document related to the Plan translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control.", "The provisions in this Statement of Terms and Conditions are severable and if any one or more provisions are determined to be", "The Participant acknowledges that the Participant is proficient in the English language and, accordingly, understands the provisions of", "The Corporation will hold and use the Data only as long as is necessary to implement, administer and manage the", "Participation in the Plan is voluntary and the Participant is", "In the event of any inconsistency between this Statement of Terms and Conditions and the Plan, the Plan shall govern.", "Capitalized terms not otherwise defined in this Statement of Terms and Conditions shall have the meaning set forth in the Plan.", "The Option is also subject to the terms and conditions of the Plan.", "In no event shall the Corporation be required to issue fractional Shares.", "An Option granted under the Plan shall be evidenced by an Option Agreement setting forth the terms and conditions of the", "The Exercise Price of an Option, as specified in the Option Agreement, shall be equal to or greater than the Fair Market Value of", "Period, the Option Period shall end on the date of such termination of employment and the Option shall thereupon not be exercisable to any extent whatsoever.", "Term Disability, the vesting schedule of the Participant\u2019s Option shall be accelerated, the Option shall become fully exercisable and the Option Period shall end on the earlier of (i) three years after the date of the Participant\u2019s termination of employment and (ii) the Expiration Date.", "Retirement, (i) the Option shall be exercisable only to the extent that it was exercisable at the time of such retirement and (ii) the Option Period for that portion of the Option designated as a Non Statutory Stock Option shall end on the earlier of (a) three years after the date of such retirement and (b) the Expiration Date.", "of  the  Participant's  Option,  then  the  Option  shall  continue  to  remain  outstanding  until  the  earlier  of  (i)  such  time  as  the  Participant  subsequently  terminates employment and (ii) the Expiration Date.", "number of Shares as to which the Option is so exercised.", "thereunder shall be transferable by the Participant by operation of law or otherwise, other than by will or the laws of descent and distribution.", "have any of the rights of a stockholder with respect to the Shares subject to an Option except to the extent that a book entry has been entered in the records of the Corporation\u2019s transfer agent with respect to such Shares upon the exercise of an Option.", "Neither a Participant nor any person entitled to exercise a Participant\u2019s rights in the event of the Participant\u2019s death shall", "Stock dividends paid with respect to Restricted Stock during the Restriction Period shall be treated as Restricted Stock which shall be subject to the same restrictions as the original award for the duration of the Restriction Period.", "If the Participant does not have a brokerage account of record, then an appropriate book entry recording the Participant\u2019s interest in the unrestricted Shares shall be entered on the records of the Corporation\u2019s transfer agent.", "Cash dividends paid with respect to Restricted Stock during the Restriction Period shall be credited on behalf of the Participant to a", "Election to Recognize Gross Income in the Year of Grant.", "Neither a Participant nor any person entitled to exercise a Participant\u2019s rights in the event of the Participant\u2019s death shall", "Following the end of the performance period, the Compensation Committee shall determine the extent to which the criteria have been achieved and shall authorize the grant and issuance of Shares in respect of the Performance Stock Unit Award.", "The performance period of a Performance Stock Unit Award shall be greater than one year,", "addition, any Award of Restricted Stock or Restricted Stock Units as to which the restrictions have not lapsed shall immediately and automatically be forfeited, Performance Stock Unit Awards shall immediately and automatically be forfeited and any such Shares of Restricted Stock shall be returned to the Corporation and all of the rights of the Participant to such Awards and the underlying Shares shall immediately terminate.", "Unless otherwise determined by the Compensation Committee in its sole discretion, Dividend Equivalents shall not be", "A Participant shall not be permitted to sell, transfer, pledge, assign or encumber all or any portion of a Performance Stock Unit", "Neither a Participant nor any person entitled to exercise a Participant\u2019s rights in the event of the Participant\u2019s death shall", "Any outstanding Option shall immediately and automatically terminate, be forfeited and shall cease to be exercisable, without limitation.", "determination shall be conclusive and binding on all interested persons.", "a manner that is valid and enforceable and that comes closest to the business objectives intended by such invalid or unenforceable provision, without invalidating or rendering unenforceable the remaining provisions of this Section VI.", "Participation in the Plan shall not create a right to further employment with the Participant\u2019s employer (the", "In making grants to Participants in foreign countries, the Administrator has the full discretion to", "under an Award Agreement, shall be conclusive and binding on all interested persons.", "Calculation of the number of Shares to be withheld shall be made based on the closing price of the Common Stock on the New York Stock Exchange on the date that the amount of tax to be withheld is determined.", "With respect to an Award other than an Option, if adequate arrangements to satisfy the obligations with regard to all Tax-Related Items are not made by the Participant with the Corporation and/or the Employer prior to the relevant taxable event, the Corporation will satisfy such obligations as provided above in clause (3) of this paragraph.", "All decisions of the Administrator administering the Plan upon any questions arising under the Plan or", "Nothing herein contained shall affect a Participant\u2019s right to participate in and receive benefits from and in", "Regardless  of any  action  the  Corporation  or  the  Employer  takes  with  respect  to  any  federal,  state  or  local  income  tax,  social", "The Administrator shall be authorized to establish such rules, forms and procedures as it deems necessary to implement the foregoing.", "In accepting the grant, the Participant acknowledges that:", "jurisdiction may have different data privacy laws and protections than the United States.", "In the latter case, the Participant understands and acknowledges that the Corporation\u2019s legal basis for the processing of the Participant\u2019s Data would be compliance with the relevant  laws  or  regulations  or  the  pursuit  by  the  Corporation  of  respective  legitimate  interests  not  outweighed  by  the  Participant\u2019s  interests,  rights  or freedoms.", "When the Corporation no longer needs the Participant\u2019s Data for any of the above purposes, the Participant understands the Corporation will remove it from its systems.", "providing the consents herein on a purely voluntary basis.", "The Corporation will hold and use the Data only as long as is necessary to implement, administer and manage the", "Participation in the Plan is voluntary and the Participant is", "illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.", "If the Participant has received this Statement of Terms and Conditions or any other document related to the Plan translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control.", "The provisions in this Statement of Terms and Conditions are severable and if any one or more provisions are determined to be", "The Participant acknowledges that the Participant is proficient in the English language and, accordingly, understands the provisions of", "In the event of any inconsistency between this Award Agreement and the Plan, the Plan shall govern.", "Capitalized terms not otherwise defined in this Award Agreement shall have the meaning set forth in the Plan.", "determine the extent to which the performance goals have been achieved, and shall determine the number of PSUs that have been earned.", "Once the Compensation Committee has determined the number of PSUs that have been earned pursuant to the", "Dividend equivalents shall be credited in respect of the One-Year RSU Award.", "The restrictions applicable to the RSU Award shall lapse with respect to 100% of the underlying Shares on the third", "Dividend equivalents shall be credited in respect of the RSU Award granted under this Section III.", "If the Participant ceases to be a bona fide employee of the Corporation or any Affiliate (except as otherwise", "otherwise  forfeited  pursuant  to  the  terms  of  the  Plan  and  this  Award  Agreement  shall  be  paid  to  the  Participant  as  soon  as  reasonably  practicable  after  the restrictions lapse.", "Performance  Stock  Units and  Restricted  Stock  Units,  to  the  extent  the  restrictions  have  not  lapsed,  shall  immediately  and  automatically  be", "determination shall be conclusive and binding on all interested persons.", "a manner that is valid and enforceable and that comes closest to the business objectives intended by such invalid or unenforceable provision, without invalidating or rendering unenforceable the remaining provisions of this Section IV.", "Compensation Committee reserves the right to impose a restriction on the sale of Shares that the Participant receives upon the settlement of the Performance Stock Units and Restricted Stock Units granted hereunder, unless the Participant has satisfied the ownership targets applicable to the Participant as provided in such policy.", "Neither the Participant nor any person entitled to exercise the Participant\u2019s rights in the event of the Participant\u2019s death", "Participation in the Plan shall not create a right to further employment with the Participant\u2019s employer (the", "under this Award Agreement, shall be conclusive and binding on all interested persons.", "Calculation of the number of Shares to be withheld shall be made based on the closing price of the Common Stock on the New York Stock Exchange on the date that the amount of tax to be withheld is determined.", "If adequate arrangements to satisfy the obligations with regard to all Tax-Related Items are not made by the Participant with the Corporation and/or the Employer prior to the relevant taxable event, the Corporation will satisfy such obligations as provided above in clause (iii) of this paragraph.", "The Administrator has the full discretion to deviate from this Award Agreement in order to adjust the Awards", "All decisions of the Administrator administering the Plan upon any questions arising under the Plan or", "Nothing herein contained shall affect the Participant\u2019s right to participate in and receive benefits from and in", "Regardless  of any  action  the  Corporation  or  the  Employer  takes  with  respect  to  any  federal,  state  or  local  income  tax,  social", "The Administrator shall be authorized to establish such rules, forms and procedures as it deems necessary to implement the foregoing.", "In accepting the grant, the Participant acknowledges that:", "providing the consents herein on a purely voluntary basis.", "The Corporation will hold and use the Data only as long as is necessary to implement, administer and manage the", "Participation in the Plan is voluntary and the Participant is", "unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.", "English and if the meaning of the translated version is different than the English version, the English version will control.", "Award, the terms of which are set forth herein and in the Plan.", "The provisions in this Award Agreement are severable and if any one or more provisions are determined to be illegal or otherwise", "Below is a list of documents that are made available to you in connection with this Notice.", "PLEASE BE SURE TO READ THESE DOCUMENTS BECAUSE THEY CONTAIN IMPORTANT INFORMATION SPECIFIC TO THIS GRANT OF RSUs.", "By signing below, I acknowledge that: 1.    I agree to receive copies of the stockholder information, including copies of any annual report, proxy and Form 10-K, from the Investor Resources section of", "Below is a list of documents that are made available to you in connection with this Notice.", "PLEASE BE SURE TO READ THESE DOCUMENTS BECAUSE THEY CONTAIN IMPORTANT INFORMATION SPECIFIC TO THIS GRANT OF RSUs.", "I consent to receiving electronically a copy of the documents set forth above and attachments to this Notice; and 5.", "I accept ALL the terms and conditions as set forth in the Plan and ST&Cs applicable to this grant of RSUs.", "Your  PSUs  will  be  earned  subject  to  the  Company\u2019s  attainment  of  performance  goals  that  have  been  pre-established  by  the  Compensation  Committee  (the \u201cCommittee\u201d) of the Company\u2019s Board of Directors.", "Below is a list of documents that are made available to you in connection with this Notice.", "PLEASE BE SURE TO READ THESE DOCUMENTS BECAUSE THEY CONTAIN IMPORTANT INFORMATION SPECIFIC TO THIS GRANT OF PSUs.", "I consent to receiving electronically a copy of the documents set forth above and attachments to this Notice; and 12.", "I should consult with a tax advisor prior to accepting this grant of PSUs or taking any other action with respect to this grant of PSUs; and 14.", "I accept ALL the terms and conditions as set forth in the Plan and ST&Cs applicable to this grant of PSUs.", "We consent to the incorporation by reference in McKesson Corporation Registration Statement Nos. 333-249817, 333-163642, 333-190847, 333-190848, and 333- 213488 on Form S-8, and Registration Statement No. 333-236808 on Form S-3, of our report dated May 12, 2021, relating to the consolidated financial statements and consolidated financial statement schedule of McKesson Corporation and subsidiaries, and the effectiveness of McKesson Corporation\u2019s internal control over financial reporting appearing in this Annual Report on Form 10-K of McKesson Corporation for the year ended March 31, 2021.", "I have reviewed this annual report on Form 10-K of McKesson Corporation;", "The registrant\u2019s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant\u2019s auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):", "I have reviewed this annual report on Form 10-K of McKesson Corporation;", "The registrant\u2019s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant\u2019s auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):"], "Governance": ["We offer more than 275,000 national brand medical- surgical products as well as McKesson\u2019s own line of high-quality products through a network of distribution centers within the United States (\u201cU.S.\u201d).", "as a Service, to serve our biopharma and life sciences partners and patients.", "Our  U.S.  Pharmaceutical  segment  distributes  branded,  generic,  specialty,  biosimilar  and  over-the-counter  (\u201cOTC\u201d)  pharmaceutical  drugs,  and  other", "We also source generic pharmaceutical drugs through our joint sourcing entity, ClarusONE Sourcing Services LLP (\u201cClarusONE\u201d).", "We invest in technology and other systems at all of our distribution centers to enhance safety, reliability, and product availability.", "For example, we offer McKesson Connect , an internet-based ordering system that provides item look-up and real-time inventory availability as well as ordering, purchasing, third-party reconciliation, and account management functionality.", "We make extensive use of technology as an enabler to ensure customers have the right products at the right time in the right place.", "We provide solutions to our customers including supply management technology, world-class marketing programs, managed care, repackaging products, and services to help them meet their business and quality goals.", "We continue to implement information systems to help achieve greater consistency and accuracy both internally and for our customers.", "operational efficiency, and automation that help independent pharmacists focus on patient care while improving profitability.", "Retail National Accounts: We provide business solutions that help retail national account customers increase revenues and profitability.", "These distribution centers also provide the foundation for a two-tiered distribution network that supports best-in-class direct store delivery.", "performance, increase operational efficiencies, and deliver better patient care.", "Community-based physicians in this business have broad flexibility and discretion to select the products and commitment levels that best meet their practice needs.", "Services in provider solutions include specialty drug distribution, group purchasing organizations (\u201cGPO\u201d) like Onmark\u00ae, technology solutions, practice consulting services, and vaccine distribution, including our exclusive distributor relationship with the Centers for Disease Control and Prevention\u2019s (\u201cCDC\u201d) Vaccines for Children program.", "SKY Packaging enables acute care, long-term care, and institutional pharmacies to provide cost-effective, uniform packaging.", "Our use of the term \u201cspecialty\u201d may not be comparable to that used by other industry participants, including our competitors.", "Our operations in Canada, including Rexall retail pharmacies, support better, safer patient care by delivering vital medicines, supplies, and information technology solutions throughout Canada.", "functions  as  a  vital  link,  using  technology-enabled  management  systems  at  our  regional  wholesale  branches  to  connect  manufacturers  to  retail  pharmacies, supplying medicines and other products sold in pharmacies.", "In addition, we partner with independent pharmacies under local banner programs.", "banners, and more than 400 owned pharmacies under the Rexall brand where we provide patients with greater choice and access, integrated pharmacy care and industry-leading service levels.", "This segment includes our Ontada business, providing software to support the clinical, financial, and operational needs of our oncology practice partners.", "Our European Pharmaceutical Distribution business delivers pharmaceutical and other healthcare-related products to pharmacies across Europe.", "Our more than 250,000 customers include physician offices, surgery centers, post-acute care facilities, hospital reference labs, and  home  health  agencies.  We  distribute  medical-surgical  supplies  (such  as  gloves,  needles,  syringes  and  wound  care  products),  infusion  pumps,  laboratory equipment  and  pharmaceuticals.  Through  a  network  of  distribution  centers  within  the  U.S.,  we  offer  more  than  275,000  products  from  national  brand manufacturers and McKesson\u2019s own high-quality product line.", "Through the right mix of products and services, we help improve efficiencies, profitability and compliance.  We  also  never  lose  focus  on  helping  customers  improve  patient  and  business  outcomes.  We  develop  customized  plans  to  address  the  product, operational, and clinical support needs of our customers, including tackling inventory management, reducing administrative burdens, and training and educating clinical staff.", "We deliver for our customers, so they can deliver and care for their patients.", "pharmaceutical distribution environment in which our U.S.", "Pharmaceutical and International segments operate, we face strong competition from international, national, regional and local full-line, short-line and specialty distributors, service merchandisers, self-warehousing chain drug stores, manufacturers engaged in direct distribution, third-party logistics companies, and large payer organizations.", "Our retail businesses, which primarily operate in our International segment, face competition from various global, national, regional, and local global retailers, including chain and independent pharmacies.", "We consider our largest competitors in distribution, wholesaling, and logistics to be AmerisourceBergen Corporation and Cardinal Health, Inc.", "businesses, which may from time to time decide to develop, for their own internal needs, supply management capabilities that might otherwise be provided by our businesses.", "We believe that our scale and diversity of product and service offerings are our primary competitive advantages.", "operations and market position, but we do not consider any of our businesses to be dependent upon any one patent, copyright, trademark, or trade secret, or any family or families of the same.", "be necessary in the future to seek or renew licenses relating to various aspects of our products and services, we believe, based upon past experience and industry practice,  such  licenses  generally  can  be  obtained  on  commercially  reasonable  terms.  We  believe  our  operations  and  products  and  services  are  not  materially dependent on any single license or other agreement with any third party.", "on improving employee health and wellness, creating opportunities for growth and development, and providing an inclusive workplace where our employees can reach their full potential.", "At March 31, 2021, we had approximately 76,000 employees worldwide, including 17,000 part-time employees and 32,000 employees in the U.S. healthier future is everyone\u2019s business.", "We build successful teams by recruiting, developing, and retaining diverse talent and we recognize our culture of inclusion as an important element that drives long-term shareholder value.", "(1) The data for our metrics is derived from our voluntary, self-identification process as of March 31, 2021 and therefore represents our best estimate at this time. (2) Represents our leadership at the vice president level and above. (3) Represents worldwide employees. (4) Represents U.S. employees only as the data for Canada and Europe is not available.", "I CARE and ILEAD principles, we fulfill our mission of improving care in every setting.", "Our I CARE values (Integrity, Inclusion, Customer-First, Accountability, Respect, Excellence) are foundational to all that we do, and who we are as a company.", "ILEAD (Inspire, Leverage, Execute, Advance, Develop) is our common definition and shared commitment to leadership.", "By embracing this commitment, we bring out the best in ourselves and position McKesson to continue to drive better health \u2013 for our company, our customers, and the patients they serve for years to come.", "We promote leadership behaviors through culture initiatives that offer practical tips on how to debate, decide, and commit, be open and candid, and maintain an enterprise-first mindset when navigating conversations affecting operations within and across our business segments.", "We hold inbound licenses for certain intellectual property that is used internally, and in some cases, utilized in McKesson\u2019s products or services.", "Culture and Leadership: What sets McKesson apart as an exceptional place is our people.", "Our employees understand that together, unified by our global", "where everyone can bring their authentic self to work and feel welcomed and appreciated, and where their perspectives are sought out, heard, and considered.", "Through training, we encourage leaders to embrace diverse perspectives and lead inclusively.", "We  also  seek  employee  feedback  through  an  annual  employee  opinion  survey,  which  assesses  our employees\u2019  levels  of engagement, commitment, and overall satisfaction using industry benchmarks, and we then design action plans to improve those metrics.", "We routinely assess facilities to monitor closely adherence to established security and safety standards.", "If we identify a vulnerability, it is documented, and the facility prepares an action plan.", "Our employees receive specialized training related to their role, work setting, and equipment used in their work environment.", "As our processes evolve, we update relevant safety training modules, which may include new employee training programs.", "The various responses we put in place to mitigate the impact of COVID- 19  on  our  business  operations,  including  telecommuting  and  work-from-home  policies,  restricted  travel,  and  enhanced  safety  measures,  are  intended  to  limit employee exposure to the virus that causes COVID-19 as they perform their jobs while also providing employee support programs and a sense of belonging.", "For additional  information  on  our  response  to  COVID-19  in  the  workplace,  refer  to  the  COVID-19  section  of \u201cTrends  and  Uncertainties\u201d in  \u201cManagement\u2019s Discussion and Analysis of Financial Condition and Results of Operations\u201d in Item 7 of Part II included in this Annual Report on Form 10-K.", "Food and Drug Administration Amendments Act of 2007 requires the FDA to establish standards and identify and validate effective technologies, such as track and trace or authentication technologies, to secure the pharmaceutical supply chain against counterfeit drugs.", "Despite physical, technical, and administrative security measures that we implement in order to, among other things, address regulatory requirements, our technology systems and operations may continue to be subject to cybersecurity incidents.", "The risk of cybersecurity incidents may be increased due to a variety of factors, both internal and external.", "Sales to our largest customer, CVS Health Corporation (\u201cCVS\u201d), accounted for approximately 21% of our total consolidated revenues in 2021.", "In May 2019, we extended our pharmaceutical distribution relationship with CVS to June 2023.", "a supplier could adversely affect our business if alternate sources of supply are unavailable.", "We believe that our relationships with our suppliers are generally sound.", "The ten largest suppliers in 2021 accounted for approximately 50% of our purchases.", "For these manufacturers, a reduction in the frequency and magnitude of price increases, as well as restrictions in the amount of inventory available to us, could have an adverse impact on our gross profit margin.", "Although it is not possible to predict or identify all such risks and uncertainties, they include, but are not limited to, the factors discussed in Item 1A of Part I of this report under \u201cRisk Factors\u201d and in our publicly available SEC filings and press releases.", "Suppliers: We obtain pharmaceutical and other products from manufacturers, none of which accounted for more than 7% of our purchases in 2021.", "practical  to  identify  or  describe  all  risks  and  uncertainties  that  might  materially  impact  our  business  operations,  reputation,  financial  position  or  results  of operations.", "Our business could be materially affected by risks that we have not yet identified or that we currently consider to be immaterial.", "This is not a complete statement of all potential risks and uncertainties.", "For example, pharmacy operations are exposed to risks such as improper filling of prescriptions, mislabeling of prescriptions, inadequacy of warnings, unintentional distribution of counterfeit drugs and expiration of drugs.", "The  discussion  below  identifies  certain  representative  risks  that  might  cause  our  actual  business  results  to  materially  differ  from  our  estimates.  It  is  not", "Certain of our businesses may be required to register for permits and/or licenses with, and comply with operating and security standards of, the DEA, FDA, HHS, CMS, various state boards of pharmacy, state health departments and/or comparable state agencies as well as foreign agencies and certain accrediting bodies, depending upon the type of operations and location of product development, manufacture, distribution, and sale.", "As of March 31, 2021, suspensions at the four distribution centers had all expired  by  their  own  terms.  If  we  are  not  able  to  obtain,  maintain  or  renew  permits,  licenses  or  other  regulatory  approvals  needed  for  the  operation  of  our businesses, it might have a materially adverse impact on our business operations and our financial position or results of operations.", "Food and Drug Administration Amendments Act of 2007 requires the FDA to establish standards and identify and validate effective technologies, such as track  and  trace  or  authentication  technologies,  to  secure  the  pharmaceutical  supply  chain  against  counterfeit  drugs.  We  also  have  record-keeping  and  other obligations under the E.U.", "We are subject to significant compliance obligations under privacy laws such as the General Data Protection Regulation in the  European  Union  (\u201cGDPR\u201d),  the  Personal  Information  Protection  and  Electronic  Documents  Act  (\u201cPIPEDA\u201d)  in  Canada,  and  the  California  Consumer Protection  Act  (\u201cCCPA\u201d).  Some  privacy  laws  prohibit  the  transfer  of  personal  information  to  certain  other  jurisdictions.  We  are  subject  to  privacy  and  data protection compliance audits or investigations by various government agencies.", "We experience cybersecurity incidents that might significantly compromise our technology systems or might result in material data breaches.", "Despite physical, technical, and administrative security measures, our technology systems and operations have been, and likely will continue to be, subject to cyberattacks from sources beyond our control.", "Cybersecurity incidents  include  actual  or  attempted  unauthorized  access,  tampering,  malware  insertion,  ransomware  attacks  or  other  system  integrity  events.  The  risk  of cyberattacks  may be increased  due to a variety of factors, both internal  and external.  A cybersecurity  incident might involve a material  data breach or other material impact to the integrity and operations of our technology systems, which might result in litigation or regulatory action, loss of customers or revenue, and increased expense, any of which might have a materially adverse impact on our business operations, reputation, and our financial position or results of operations.", "We might experience significant problems with information systems or networks.", "If those information systems suffer errors, interruptions, or become unavailable, there might be a materially adverse impact on our business operations, reputation, and our financial position or results of operations.", "Our products or services might not conform to specifications or perform as we intend.", "professionals delivering patient care tend to have heightened sensitivity to system and software errors.", "Errors or failures might damage our reputation and negatively affect future sales.", "We sell and provide services involving complex software and technology that may contain errors, especially when first introduced to market.", "The networks and hosting systems are vulnerable to interruption or damage from sources beyond our control, such as power loss, telecommunications failures, fire, natural disasters, software and hardware failures and cyberattacks.", "If the timely delivery of medical care or other customer business requirements are impaired by data access, network or systems problems, we could be exposed to significant claims and reputational harm.", "We might not realize expected benefits from business process initiatives.", "achieve  our  desired  objectives,  or  unintended  consequences  such  as  distraction  of  our  management  and  employees,  business  disruption,  attrition  beyond  any planned reduction in workforce, inability to attract or retain key personnel and reduced employee productivity.", "We might be unable to successfully complete or integrate acquisitions or other business combinations.", "We may not receive regulatory approvals needed to complete proposed transactions, or such  approvals  may  be  subject  to  delays  or  conditions  that  reduce  transaction  benefits.  Achieving  the  desired  outcomes  of  business  combinations  involves significant  risks  including:  diverting  management\u2019s  attention  from  other  business  operations;  challenges  with  assimilating  the  acquired  businesses,  such  as integration  of  operations  and  systems;  failure  or  delay  in  realizing  operating  synergies;  difficulty  retaining  key  acquired  company  personnel;  unanticipated accounting or financial systems issues with the acquired business, which might affect our internal controls over financial reporting; unanticipated compliance issues in the acquired business; challenges retaining customers of the acquired business; unanticipated expenses or charges to earnings, including depreciation and amortization or potential impairment charges; and risks of known and unknown assumed liabilities in the acquired business.", "We provide remote services that involve hosting customer data and operating software on our own or third party systems.", "Our growth strategy includes consummating acquisitions or other business combinations that either expand or complement our business.", "could delay the achievement of our strategic objectives.", "We might be adversely impacted by outsourcing or similar third-party relationships.", "Third-party services providers might fail to perform as anticipated, or we might experience unanticipated operational difficulties, compliance requirements or increased costs related to outsourced services.", "We may be unsuccessful in retail pharmacy operations or maintaining profitability.", "If our retail pharmacy operations fail to achieve, or are unable to sustain, acceptable net sales and profitability levels, it might have a materially adverse impact on our business operations and our financial position or results of operations.", "We rely on third parties to perform certain business and administrative functions for us.", "We might not adequately develop, implement and monitor these", "Our business strategy included expanding our retail pharmacy operations.", "Our retail pharmacy operations involve numerous risks, such as the following ones.", "For example, our contracts with the U.S. government generally require us to comply with the Federal Acquisition Regulations, Procurement Integrity Act, Buy American Act, Trade Agreements Act, and other laws and regulations.", "The occurrence of any of these risks could harm our reputation and might have a materially adverse impact on our business operations and our financial position or results of operations.", "Our participation in vaccination distribution programs may materially affect our operating results, reputation, and business.", "For example, the novel nature of the SARS-CoV\u20112 virus and the broad scope of the ongoing COVID-19 vaccine distribution program introduce uncertainty about what volumes of products may become available for distribution by us, the effectiveness of vaccines, and the cost of distribution.", "Because of such uncertainties, our operating results may be subject to variability.", "Our participation in such programs also exposes us to various risks, including regulatory compliance, government oversight, dependence on government funding, contractual performance, litigation, security risks, and supply chain challenges.", "Any significant problems with our participation in such programs might have a materially adverse impact on our reputation and our business.", "We might be harmed by changes in our relationships or contracts with suppliers.", "Our competitors might develop non-infringing products or services equivalent or superior to ours.", "We might be unable to successfully recruit and retain qualified employees.", "We compete with many other businesses to attract and retain employees.", "We may experience sudden loss of key personnel due to a variety of causes, such as illness, and must adequately plan for succession of key management roles.", "Employees might not successfully transition into new roles.", "Some of these changes increase our risks and create uncertainties for our business.", "These proposals might result in significant changes in the pharmaceutical value chain as manufacturers, PBM, managed care organizations and other industry stakeholders look to implement new transactional flows and adapt their business models.", "Many of our products and services are designed and intended to function within the structure of current healthcare financing and reimbursement systems.", "We might be adversely impacted by competition and industry consolidation.", "specialty distributors, service merchandisers, self-warehousing chain drug stores, manufacturers engaged in direct distribution, third-party logistics companies and large  payer  organizations.  In  addition,  our  businesses  face  competition  from  various  other  service  providers  and  from  pharmaceutical  and  other  healthcare manufacturers as well as other potential customers, which may from time-to-time decide to develop, for their own internal needs, supply management capabilities that might otherwise be provided by our businesses.", "This concentration reduces our ability to negotiate favorable terms with suppliers and causes us to depend on a smaller number of suppliers.", "Many of our customers, including  healthcare  organizations,  have  consolidated  and  have  greater  power  to  negotiate  favorable  prices.  Consolidation  by  our  customers,  suppliers  and competitors might reduce the number of market participants and give the remaining enterprises greater bargaining power, which might lead to erosion in our profit margin.", "These competitive pressures and industry consolidation might have a materially adverse impact on our business operations and our financial position or results of operations.", "We might be adversely impacted by changes or disruptions in product supply.", "Our inventory might be requisitioned, diverted or allocated by government order such as under emergency, disaster and civil defense declarations.", "For example, government actions in response to the COVID-19 pandemic affect our supply allocation, and those and our own allocation decisions can impact our customer relationships.", "Changes in the healthcare industry\u2019s or our suppliers\u2019 pricing, selling, inventory, distribution or supply policies or practices could significantly reduce our revenues and net income.", "We might experience disruptions in our supply of higher margin pharmaceuticals, including generic pharmaceuticals.", "sourcing joint venture with Walmart, Inc. is unsuccessful or experiences margins declines.", "products and services and the volume of their purchases.", "Our generic  pharmaceuticals  distribution  business  is subject  to  pricing  risks.  We  might  be  adversely  impacted  if  our ClarusONE  generic  pharmaceutical", "Suppliers might increase their prices, reduce their output or change their terms of sale due to limited availability of credit.", "We may have difficulties in sourcing or selling products due to a variety of causes.", "Difficulties in product manufacturing or access to raw materials could result in supplier production shutdowns, product shortages and other supply disruptions.", "The COVID-19 pandemic adversely affects the availability of some products, resulting in product allocation and delivery delays.", "We have operations in the U.K. and the European Union (\u201cE.U.\u201d) and face risks associated with the uncertainty and potential disruptions that might follow the", "These events can disrupt operations for us, our suppliers, our vendors, and our customers.", "For example, in February 2021, a severe winter storm affecting the United  States  temporarily  impacted  our  distribution  business  operations,  primarily  in  Texas.  They  might  affect  consumer  confidence  levels  and  spending.  In response to these events, we might suspend operations, implement extraordinary procedures, seek alternate sources for product supply, or suffer consequences that are unexpected and difficult to mitigate.", "In particular, the rapid and widespread transmission of the SARS-CoV-2 novel coronavirus beginning in late 2019 impacts us in significant ways.", "For example, to mitigate the spread of the COVID-19 disease caused by SARS-CoV-2, we implemented travel restrictions and remote working  arrangements  for  most  of  our  employees  in  order  to  minimize  physical  contact,  and  we  implemented  additional  sanitation  and  personal  protection measures in our warehouse, retail pharmacy and delivery operations.", "These measures might not fully mitigate COVID-19 risks to our workforce and we could experience unusual levels of absenteeism that might impair operations and delay delivery of products.", "The ongoing impacts of the pandemic might cause a general economic slowdown or recession in one or more markets, disruptions and volatility in global capital markets and other broad and adverse effects on the economy, business conditions, commercial activity and the healthcare industry.", "The pandemic might impact our business operation, financial position and results of operation in unpredictable ways that depend on highly uncertain future  developments,  such  as  determining  the  effectiveness  of  current  or  future  government  actions  to  address  the  public  health  or  economic  impacts  of  the pandemic.", "These events and impacts could materially adversely affect our business operations, financial position or results of operation.", "locations,  primarily  throughout  North  America  and  Europe.  Retail  pharmacies  and  most  warehouses  are  typically  owned  or  leased  on  a  long-term  basis.  We consider our operating properties to be in satisfactory condition and adequate to meet our needs for the next several years without making capital expenditures materially higher than historical levels.", "Form 10-K for additional factors relating to these statements and Item 1A - Risk Factors in Part I of this Annual Report on Form 10-K for a list of certain risk factors applicable to our business, financial condition, and results of operations.", "We partner with life sciences companies, manufacturers, providers, pharmacies, governments, and other healthcare organizations to help provide the right medicines, medical products, and healthcare services to the right patients at the right time, safely, and cost-effectively.", "All prior segment information has been recast to reflect our new segment structure and current period presentation.", "We  implemented  a  new  segment  reporting  structure  commencing  with  the  second  quarter  of  2021,  which  resulted  in  four  reportable  segments:  U.S.", "\u2022 International is  a  new  reportable  segment  that  includes  our  operations  in  Europe  and  Canada,  bringing  together  non-U.S.-based  drug  distribution services, specialty pharmacy, retail, and infusion care services.", "\u2022 RxTS is  a  new  reportable  segment  that  brings  together  existing  businesses,  including  CoverMyMeds,  RelayHealth,  RxCrossroads,  and  McKesson Prescription Automation, including Multi-Client Central Fill as a Service, to serve our biopharma and life sciences partners and patients.", "We benefited from demand for COVID-19 tests, favorable contributions from our vaccine and related ancillary supply kit distribution programs as discussed further below, and savings from reduced travel and meetings throughout 2021;", "We have also partnered with the Department of Health and Human Services (\u201cHHS\u201d) and Pfizer to manage the assembly and distribution of the ancillary supplies needed to administer COVID-19 vaccines;", "Pharmaceutical segment driven by market growth; \u2022 Gross profit increased 1% from the prior year primarily in our Medical-Surgical Solutions segment driven by sales of COVID-19 tests; \u2022 Total operating expenses in 2021 includes the following:", "Infection rates varied throughout our fiscal year, peaking in January 2021.", "Our role in the distribution of COVID-19 vaccines in the U.S. as well as the assembly and distribution of related ancillary supply kits is discussed further below.", "McKesson Europe is also playing a role in helping support governments and public health entities in not only distributing COVID-19 vaccines across several European countries, but administering them in pharmacies as well.", "solutions, we are well positioned to respond to the COVID-19 pandemic in the U.S., Canada, and Europe.", "We have worked and continue to work closely with national and local governments, agencies, and industry partners to ensure that available supplies, including personal protective equipment (\u201cPPE\u201d), and medicine reach our customers and patients.", "put in place to mitigate the impact of COVID-19 on our business operations, including telecommuting and work-from-home policies, restricted travel, employee support programs, and enhanced safety measures, are intended to limit employee exposure to the virus that causes COVID-19.", "We expanded employee medical benefits covering COVID-19 related visits, treatments, and testing as well as expanded telehealth options to protect employee safety.", "For employees whose roles require presence at our facilities, we enhanced safety by promoting the practice of social distancing, providing reminders to wash or disinfect hands and avoid unnecessary face touching, making face masks available, placing hand sanitizers within our operating environments, and periodically cleaning and disinfecting our facilities.", "For employees whose roles do not require presence at our facilities, we added technology resources to support their working remotely.", "These steps to protect employee safety have resulted in limited disruption from COVID-19 to our normal business operations, productivity trends, and have not materially impacted our operating expenses or operating margins.", "pharmacy foot traffic as our customers increased supplies on hand in March, which drove unfavorability in our results of operations when comparing 2021 versus 2020.", "We also experienced decreased demand for primary care medical-surgical supplies due to deferrals in elective procedures in hospitals and surgery centers as well as decreased traffic and closures of doctors\u2019 offices, which was partially offset by demand for PPE and COVID-19 tests.", "COVID-19  for  the  second  half  of  our  fiscal  year  was  non-linear  and  tracked  with  patient  mobility.  We  also  saw  increased  demand  for  COVID-19  tests  and continued sales of PPE throughout the year in our Medical-Surgical Solutions segment partially offset by the impacts of social distancing measures which resulted in a less severe cough, cold, and flu season, savings for reduced travel and meetings across the enterprise, as well as improvements of retail pharmacy foot traffic in Europe and Canada.", "The vaccine and related  ancillary  kit distribution  in the U.S. favorably impacted our results in the second half of fiscal 2021 as further discussed below.", "Our Response to COVID-19 in the Workplace During this unprecedented time, we are committed in continuing to supply our customers and protect the safety of our employees.", "During  the  first  quarter  of  2021,  we  experienced  growth  in  pharmaceutical  distribution  and  specialty  drug  volumes  at  a  lower  rate  in  the  U.S.,  while", "In the centralized model, the U.S. government directs us on the distribution of the vaccines and related supplies to point-of-care sites across the country.", "The results of operations related to our vaccine distribution are reflected in our U.S.", "We also have an agreement with Pfizer to assemble and distribute ancillary supply kits needed to administer that particular COVID-19 vaccine.", "We began assembling the ancillary supply kits in September 2020 in preparation for vaccine authorization and subsequent distribution.", "Ancillary supply kits to administer the Pfizer Vaccine are shipped directly to point-of-care sites, and all other ancillary supply kits are shipped to our dedicated vaccine distribution centers.", "The results of operations for the kitting and distribution of ancillary supplies are reflected in our Medical-Surgical Solutions segment.", "These facilities can scale to meet the demand of increasing volumes of vaccines being manufactured.", "We have also set up distribution centers for kitting and inventory management as part of our contract with the HHS.", "We are working with delivery partners to manage the delivery of vaccines and ancillary supply kits from our centralized vaccine distribution centers to point-of-care destinations as directed by the CDC.", "as well as the kitting and distribution of ancillary supplies for COVID-19 vaccines in our Medical-Surgical Solutions segment contributed approximately 20% in segment  revenues  and  segment  operating  profit.  Additionally,  the  distribution  of  COVID-19  vaccines  in  our  U.S.  Pharmaceutical  segment  contributed approximately 2% in segment operating profit for the year ended March 31, 2021.", "During our fourth quarter of 2020, we experienced a temporary increase in demand for pharmaceuticals.", "Certain PPE items held for resale were valued in our inventory at costs that were inflated by earlier COVID-19 pandemic demand levels.", "That inventory valuation, if not supported by market resale prices, may be written down to net realizable value.", "We may also write-off inventory due to decreased customer demand and excess inventory.", "response to supply availability and customer demand patterns for certain products, with varying inventory level impacts depending on the specific product within our portfolio.", "As our supply levels improve, and the federal government evolves guidance on the prioritization of providers or geographic markets, we will continue to adapt our distribution policies.", "We were able to maintain appropriate labor and overall vendor supply levels during the year ended March 31, 2021.", "suppliers,  their  locations,  and  the  extent  to  which  they  are  impacted  by  the  COVID-19  pandemic,  we  are  proactively  working  with  manufacturers,  industry partners, and government agencies to meet the needs of our customers during the pandemic.", "We have assembled a Critical Care Drug Task Force, made up of our procurement  specialists,  clinical  health  systems  pharmacists,  and  supply  chain  professionals,  that  is  focused  on  securing  additional  product  where  available, sourcing back-up products, and protecting our operations across all locations and facilities.", "We are also working with manufacturers through several channels, including  our  ClarusONE  Sourcing  Services  LLP  (\u201cClarusONE\u201d)  and  global  sourcing  teams  in  London,  and  our  leaders  are  actively  engaged  in  addressing potential shortages.", "We have engaged with industry partners and government agencies to gain visibility into supply and demand.", "Additionally, we have a robust Business Continuity and Disaster Recovery Program (\u201cBCRP\u201d) and we have proactively enhanced our BCRP in response to the COVID-19 pandemic to protect the supply  chain  to  minimize  disruption  in  healthcare,  protect  our  customers,  ensure  the  safety  and  security  of  our  employees  and  workplaces,  and  ensure  the continuity of critical business processes.", "supplies and medications to help prevent the spread of the disease and treat those that are ill.", "COVID-19 has put an unprecedented strain on the supply of high- demand PPE, including N95 masks, gloves, as well as disinfecting sprays and wipes.", "The supply chain has improved over the initial impact of pandemic-related demand, and we continue to closely monitor demand by customer type and certain PPE and infection prevention items are still in short supply.", "Our allocation approach has helped us avoid stock outs in many critical product categories, allowing us to provide PPE supplies to many more customers for a much longer time.", "We anticipate these market conditions will remain for the foreseeable future.", "Our efforts to help the supply chain have included sourcing products from new suppliers all over the world, working closely with the federal government to help with the nation\u2019s response and collaborating with partners to source, develop, and deliver new products to market.", "The full extent to which COVID-19 will impact us depends on many factors and future developments, including: the duration and spread of the virus; governmental actions to limit the spread of the virus; potential seasonality of viral outbreaks; potential new strains or variants of the original virus; the amount of COVID-19 vaccines authorized, manufactured, distributed, and administered; the amount of ancillary supply kits assembled and distributed; the  effectiveness  of  COVID-19  vaccines  and  governmental  measures  in  controlling  the  spread  of  the  virus;  and  the  effectiveness  of  treatments  of  infected individuals.", "Impact to our Supply Chain We  also  continue  to  monitor  the  COVID-19  pandemic  impacts  on  our  supply  chain.  Although  the  availability  of  various  products  is  dependent  on  our", "Gross profit was favorably impacted by growth of specialty pharmaceuticals and the contribution from our vaccine distribution programs in our U.S.", "\u2022 Goodwill impairment charges of $1.8 billion in our European Retail Pharmacy (\u201cEuropean RP\u201d) and European Pharmaceutical Distribution (\u201cEuropean PD\u201d) reporting units within the International segment.", "This initiative primarily led us to rationalize our office space in North America.", "Where we determine to cease using office space, we plan to exit the portion of the facility no longer used.", "We also may retain and repurpose certain other office locations.", "transformational changes in technologies and business processes, operational efficiencies, and cost savings.", "centralization of certain functions and outsourcing through an expanded arrangement with a third-party vendor to achieve operational efficiency.", "The  initiative  consisted  of  multiple  growth  priorities  and  plans  to  optimize  our  operating  models  and  cost  structures  primarily  through  centralization,  cost management, and outsourcing of certain administrative functions.", "As part of the growth initiative, we committed to implement certain actions including a reduction in workforce, facility consolidation, and store closures.", "This set of initiatives was substantially complete by the end of 2020. $115 million, $112 million, and $245 million, respectively, primarily related to our retail pharmacy businesses in Canada and Europe within our International segment.", "During  the  first  quarter  of  2021,  we  committed  to  an  initiative  within  the  U.K.,  which  is  included  in  our  International  segment,  to  further  drive", "In the fourth quarter of 2019, we committed to certain programs to continue our operating model and cost optimization efforts.", "On April 25, 2018, we announced a strategic growth initiative intended to drive long-term incremental profit growth and to increase operational efficiency.", "pharmaceutical price increases, growth in specialty pharmaceuticals, and higher volumes from retail national account customers, partially offset by branded to generic  drug  conversions.  Revenues  for  this  segment  were  unfavorably  impacted  by  fluctuations  in  demand  for  pharmaceuticals  in  retail  pharmacies  and institutional healthcare providers due to COVID-19 largely during the onset of the pandemic in late March 2020 and during our first quarter of 2021 combined with the loss of certain customers.", "exchange fluctuations, revenues for this segment decreased 9% primarily due to the contribution of our German pharmaceutical wholesale business to a joint venture with WBA and to a lesser extent, the exit of unprofitable customers in our Canadian business.", "Revenues for this segment were also unfavorably impacted by lower volumes from the adverse impacts from COVID-19 in our pharmaceutical distribution and retail pharmacy businesses within Europe.", "exchange fluctuations, revenues for this segment increased 4% primarily due to market growth in our European pharmaceutical distribution and retail pharmacy businesses.", "2020 vs. 2019 Medical-Surgical Solutions revenues for the year ended March 31, 2020 increased 9% compared to the prior year primarily due to market growth in our", "The impacts from COVID-19 in our pharmaceutical distribution and retail pharmacy businesses within Europe also caused unfavorability in our segment results year over year.", "demand for COVID-19 tests and PPE, as well as the contribution from kitting and distribution of ancillary supplies for COVID-19 vaccines.", "This was partially offset by inventory charges on certain PPE and other related products, unfavorability in our primary care business due to customer closures largely during the first quarter  of 2021, and a  less severe  cough, cold, and flu  season.", "2020 vs. 2019 Operating profit increased for the year ended March 31, 2020 compared to the prior year primarily due to market growth in our specialty business.", "2020 vs. 2019 Operating profit and operating profit margin increased for the year ended March 31, 2020 compared to prior year primarily due to market growth in our", "We monitor our operations and adopt strategies responsive to changes in the economic and political environment in each of the countries in which we operate.", "Our foreign operations represented approximately 15%, 17%, and 18% of our consolidated revenues in 2021, 2020, and 2019, respectively.", "We also have agreements with GPOs, each of which functions as a purchasing agent on behalf of member hospitals, pharmacies and other healthcare providers, as well as with government entities and agencies.", "and updated if unusual circumstances or trends are present.", "LIFO method presumes that the most recent inventory purchases are the first items sold and the inventory cost under LIFO approximates market.", "The majority of the cost of domestic inventories is determined using the LIFO method.", "If we had used the moving average method of inventory valuation, inventories would have been approximately $406 million and $444 million higher than the amounts reported at March 31, 2021 and 2020, respectively.", "such, our LIFO inventory is valued at the lower of LIFO or market.", "Inventories: Inventories  consist of merchandise  held  for resale.  We report  inventories  at the lower of cost or net realizable  value, except  for inventories", "We believe that the moving average inventory costing method provides a reasonable estimation of the current cost of replacing inventory (i.e., \u201cmarket\u201d).", "Shifts in market trends and conditions, changes in customer preferences due to the introduction of generic drugs or new pharmaceutical products or the loss of one or more significant customers are factors that could affect the value of our inventories.", "We write down inventories which are considered excess and obsolete as a result of these reviews.", "These factors could make our estimates of inventory valuation differ from actual results.", "In addition, we compare the aggregate of the reporting units\u2019 fair values to our market capitalization as further corroboration of the fair values.", "They can be affected by a variety of factors, including external factors such as industry and economic trends, and internal factors such as changes in our business strategy and our internal forecasts.", "Management makes certain judgments and estimates in its assessment including but not limited to: identifying if circumstances indicate a decline in value is other than temporary, expectations about the business operations of investees, as well as industry, financial, and market factors.", "On March 9, 2020, we completed the Split-off of our interest in the Change Healthcare JV.", "Our businesses require substantial investments in working capital that are susceptible to large variations during the year as a result of inventory purchase patterns and seasonal demands.", "Our  redeemable  noncontrolling  interests  primarily  relate  to  our  consolidated  subsidiary,  McKesson  Europe.  Under  the  Domination  Agreement,  the", "However, our risk management programs are designed such  that  the  potential  loss  in  value  of  these  risk  management  portfolios  described  above  would  be  largely  offset  by  changes  in  the  value  of  the  underlying exposure.", "With the participation of the Chief Executive Officer and the Chief Financial Officer, our management conducted an assessment of the effectiveness of our internal control over financial  reporting based on the framework and criteria  established in Internal Control\u2014Integrated Framework (2013), issued by the Committee of Sponsoring Organizations of the Treadway Commission.", "Under the market approach, fair value is estimated by comparing the business to similar businesses, or guideline companies whose securities are actively traded in public markets.", "The severity,  magnitude  and  duration,  as  well  as  the  economic  consequences  of  the  coronavirus  diseases  2019  (\u201cCOVID-19\u201d)  pandemic,  are  uncertain,  rapidly changing, and difficult to predict.", "The majority of the cost of domestic inventories is determined using the LIFO method.", "Goodwill testing requires a complex series of assumptions and judgments by management in projecting future operating results, selecting guideline companies for comparisons and assessing risks.", "Revenues generated from the distribution of pharmaceutical and medical products represent the majority of the Company\u2019s revenues.", "customer, is responsible for fulfilling the promise to its customer, has latitude in establishing prices, and controls the relationship with the customer.", "Shipping and handling costs associated with outbound freight after control over a product has transferred to a customer are accounted for as fulfillment costs.", "International segment, to further drive transformational changes in technologies and business processes, operational efficiencies, and cost savings.", "continues to implement centralization of certain functions and outsourcing through an expanded arrangement with a third-party vendor to achieve operational efficiency.", "Irving, Texas to improve efficiency, collaboration, and cost competitiveness.", "PSUs are conditional upon the attainment of market and performance objectives over a specified period.", "As a practical expedient, the Company does not separate lease components from non-lease components such as common area maintenance, utilities, and repairs and maintenance.", "The Company\u2019s most significant relationships are with oncology and other specialty practices.", "Level 2 - significant other observable market-based inputs.", "Level 3 - significant unobservable inputs for which little or no market data exists and requires considerable assumptions that are significant to the fair value", "measurement due to the significance of unobservable inputs developed using company-specific information.", "It has received the same warranties from its suppliers, which customarily are the manufacturers of the products.", "Pharma Belgium NV is also part of the investigation.", "Stockholders (the \u201cProxy Statement\u201d) under the heading \u201cElection of Directors.\u201d Information about our Executive Officers is incorporated by reference from the discussion in Part I of this report under the heading \u201cInformation about our Executive Officers.\u201d Information about our Audit Committee, including the members of the  committee  and  our  Audit  Committee  Financial  Expert,  is  incorporated  by  reference  from  the  discussion  under  Item  1  of  our  Proxy  Statement  under  the headings \u201cThe Board, Committees and Meetings,\u201d and \u201cAudit Committee Report.\u201d", "We offer more than 275,000 national brand medical- surgical products as well as McKesson\u2019s own line of high-quality products through a network of distribution centers within the United States (\u201cU.S.\u201d).", "as a Service, to serve our biopharma and life sciences partners and patients.", "Our  U.S.  Pharmaceutical  segment  distributes  branded,  generic,  specialty,  biosimilar  and  over-the-counter  (\u201cOTC\u201d)  pharmaceutical  drugs,  and  other", "We also source generic pharmaceutical drugs through our joint sourcing entity, ClarusONE Sourcing Services LLP (\u201cClarusONE\u201d).", "We invest in technology and other systems at all of our distribution centers to enhance safety, reliability, and product availability.", "For example, we offer McKesson Connect , an internet-based ordering system that provides item look-up and real-time inventory availability as well as ordering, purchasing, third-party reconciliation, and account management functionality.", "We make extensive use of technology as an enabler to ensure customers have the right products at the right time in the right place.", "We provide solutions to our customers including supply management technology, world-class marketing programs, managed care, repackaging products, and services to help them meet their business and quality goals.", "We continue to implement information systems to help achieve greater consistency and accuracy both internally and for our customers.", "operational efficiency, and automation that help independent pharmacists focus on patient care while improving profitability.", "Retail National Accounts: We provide business solutions that help retail national account customers increase revenues and profitability.", "These distribution centers also provide the foundation for a two-tiered distribution network that supports best-in-class direct store delivery.", "performance, increase operational efficiencies, and deliver better patient care.", "Community-based physicians in this business have broad flexibility and discretion to select the products and commitment levels that best meet their practice needs.", "Services in provider solutions include specialty drug distribution, group purchasing organizations (\u201cGPO\u201d) like Onmark\u00ae, technology solutions, practice consulting services, and vaccine distribution, including our exclusive distributor relationship with the Centers for Disease Control and Prevention\u2019s (\u201cCDC\u201d) Vaccines for Children program.", "SKY Packaging enables acute care, long-term care, and institutional pharmacies to provide cost-effective, uniform packaging.", "Our use of the term \u201cspecialty\u201d may not be comparable to that used by other industry participants, including our competitors.", "Our operations in Canada, including Rexall retail pharmacies, support better, safer patient care by delivering vital medicines, supplies, and information technology solutions throughout Canada.", "functions  as  a  vital  link,  using  technology-enabled  management  systems  at  our  regional  wholesale  branches  to  connect  manufacturers  to  retail  pharmacies, supplying medicines and other products sold in pharmacies.", "In addition, we partner with independent pharmacies under local banner programs.", "banners, and more than 400 owned pharmacies under the Rexall brand where we provide patients with greater choice and access, integrated pharmacy care and industry-leading service levels.", "This segment includes our Ontada business, providing software to support the clinical, financial, and operational needs of our oncology practice partners.", "Our European Pharmaceutical Distribution business delivers pharmaceutical and other healthcare-related products to pharmacies across Europe.", "Our more than 250,000 customers include physician offices, surgery centers, post-acute care facilities, hospital reference labs, and  home  health  agencies.  We  distribute  medical-surgical  supplies  (such  as  gloves,  needles,  syringes  and  wound  care  products),  infusion  pumps,  laboratory equipment  and  pharmaceuticals.  Through  a  network  of  distribution  centers  within  the  U.S.,  we  offer  more  than  275,000  products  from  national  brand manufacturers and McKesson\u2019s own high-quality product line.", "Through the right mix of products and services, we help improve efficiencies, profitability and compliance.  We  also  never  lose  focus  on  helping  customers  improve  patient  and  business  outcomes.  We  develop  customized  plans  to  address  the  product, operational, and clinical support needs of our customers, including tackling inventory management, reducing administrative burdens, and training and educating clinical staff.", "We deliver for our customers, so they can deliver and care for their patients.", "pharmaceutical distribution environment in which our U.S.", "Pharmaceutical and International segments operate, we face strong competition from international, national, regional and local full-line, short-line and specialty distributors, service merchandisers, self-warehousing chain drug stores, manufacturers engaged in direct distribution, third-party logistics companies, and large payer organizations.", "Our retail businesses, which primarily operate in our International segment, face competition from various global, national, regional, and local global retailers, including chain and independent pharmacies.", "We consider our largest competitors in distribution, wholesaling, and logistics to be AmerisourceBergen Corporation and Cardinal Health, Inc.", "businesses, which may from time to time decide to develop, for their own internal needs, supply management capabilities that might otherwise be provided by our businesses.", "We believe that our scale and diversity of product and service offerings are our primary competitive advantages.", "operations and market position, but we do not consider any of our businesses to be dependent upon any one patent, copyright, trademark, or trade secret, or any family or families of the same.", "be necessary in the future to seek or renew licenses relating to various aspects of our products and services, we believe, based upon past experience and industry practice,  such  licenses  generally  can  be  obtained  on  commercially  reasonable  terms.  We  believe  our  operations  and  products  and  services  are  not  materially dependent on any single license or other agreement with any third party.", "on improving employee health and wellness, creating opportunities for growth and development, and providing an inclusive workplace where our employees can reach their full potential.", "At March 31, 2021, we had approximately 76,000 employees worldwide, including 17,000 part-time employees and 32,000 employees in the U.S. healthier future is everyone\u2019s business.", "We build successful teams by recruiting, developing, and retaining diverse talent and we recognize our culture of inclusion as an important element that drives long-term shareholder value.", "(1) The data for our metrics is derived from our voluntary, self-identification process as of March 31, 2021 and therefore represents our best estimate at this time. (2) Represents our leadership at the vice president level and above. (3) Represents worldwide employees. (4) Represents U.S. employees only as the data for Canada and Europe is not available.", "I CARE and ILEAD principles, we fulfill our mission of improving care in every setting.", "Our I CARE values (Integrity, Inclusion, Customer-First, Accountability, Respect, Excellence) are foundational to all that we do, and who we are as a company.", "ILEAD (Inspire, Leverage, Execute, Advance, Develop) is our common definition and shared commitment to leadership.", "By embracing this commitment, we bring out the best in ourselves and position McKesson to continue to drive better health \u2013 for our company, our customers, and the patients they serve for years to come.", "We promote leadership behaviors through culture initiatives that offer practical tips on how to debate, decide, and commit, be open and candid, and maintain an enterprise-first mindset when navigating conversations affecting operations within and across our business segments.", "We hold inbound licenses for certain intellectual property that is used internally, and in some cases, utilized in McKesson\u2019s products or services.", "Culture and Leadership: What sets McKesson apart as an exceptional place is our people.", "Our employees understand that together, unified by our global", "where everyone can bring their authentic self to work and feel welcomed and appreciated, and where their perspectives are sought out, heard, and considered.", "Through training, we encourage leaders to embrace diverse perspectives and lead inclusively.", "We  also  seek  employee  feedback  through  an  annual  employee  opinion  survey,  which  assesses  our employees\u2019  levels  of engagement, commitment, and overall satisfaction using industry benchmarks, and we then design action plans to improve those metrics.", "We routinely assess facilities to monitor closely adherence to established security and safety standards.", "If we identify a vulnerability, it is documented, and the facility prepares an action plan.", "Our employees receive specialized training related to their role, work setting, and equipment used in their work environment.", "As our processes evolve, we update relevant safety training modules, which may include new employee training programs.", "The various responses we put in place to mitigate the impact of COVID- 19  on  our  business  operations,  including  telecommuting  and  work-from-home  policies,  restricted  travel,  and  enhanced  safety  measures,  are  intended  to  limit employee exposure to the virus that causes COVID-19 as they perform their jobs while also providing employee support programs and a sense of belonging.", "For additional  information  on  our  response  to  COVID-19  in  the  workplace,  refer  to  the  COVID-19  section  of \u201cTrends  and  Uncertainties\u201d in  \u201cManagement\u2019s Discussion and Analysis of Financial Condition and Results of Operations\u201d in Item 7 of Part II included in this Annual Report on Form 10-K.", "Food and Drug Administration Amendments Act of 2007 requires the FDA to establish standards and identify and validate effective technologies, such as track and trace or authentication technologies, to secure the pharmaceutical supply chain against counterfeit drugs.", "Despite physical, technical, and administrative security measures that we implement in order to, among other things, address regulatory requirements, our technology systems and operations may continue to be subject to cybersecurity incidents.", "The risk of cybersecurity incidents may be increased due to a variety of factors, both internal and external.", "Sales to our largest customer, CVS Health Corporation (\u201cCVS\u201d), accounted for approximately 21% of our total consolidated revenues in 2021.", "In May 2019, we extended our pharmaceutical distribution relationship with CVS to June 2023.", "a supplier could adversely affect our business if alternate sources of supply are unavailable.", "We believe that our relationships with our suppliers are generally sound.", "The ten largest suppliers in 2021 accounted for approximately 50% of our purchases.", "For these manufacturers, a reduction in the frequency and magnitude of price increases, as well as restrictions in the amount of inventory available to us, could have an adverse impact on our gross profit margin.", "Although it is not possible to predict or identify all such risks and uncertainties, they include, but are not limited to, the factors discussed in Item 1A of Part I of this report under \u201cRisk Factors\u201d and in our publicly available SEC filings and press releases.", "Suppliers: We obtain pharmaceutical and other products from manufacturers, none of which accounted for more than 7% of our purchases in 2021.", "practical  to  identify  or  describe  all  risks  and  uncertainties  that  might  materially  impact  our  business  operations,  reputation,  financial  position  or  results  of operations.", "Our business could be materially affected by risks that we have not yet identified or that we currently consider to be immaterial.", "This is not a complete statement of all potential risks and uncertainties.", "For example, pharmacy operations are exposed to risks such as improper filling of prescriptions, mislabeling of prescriptions, inadequacy of warnings, unintentional distribution of counterfeit drugs and expiration of drugs.", "The  discussion  below  identifies  certain  representative  risks  that  might  cause  our  actual  business  results  to  materially  differ  from  our  estimates.  It  is  not", "Certain of our businesses may be required to register for permits and/or licenses with, and comply with operating and security standards of, the DEA, FDA, HHS, CMS, various state boards of pharmacy, state health departments and/or comparable state agencies as well as foreign agencies and certain accrediting bodies, depending upon the type of operations and location of product development, manufacture, distribution, and sale.", "As of March 31, 2021, suspensions at the four distribution centers had all expired  by  their  own  terms.  If  we  are  not  able  to  obtain,  maintain  or  renew  permits,  licenses  or  other  regulatory  approvals  needed  for  the  operation  of  our businesses, it might have a materially adverse impact on our business operations and our financial position or results of operations.", "Food and Drug Administration Amendments Act of 2007 requires the FDA to establish standards and identify and validate effective technologies, such as track  and  trace  or  authentication  technologies,  to  secure  the  pharmaceutical  supply  chain  against  counterfeit  drugs.  We  also  have  record-keeping  and  other obligations under the E.U.", "We are subject to significant compliance obligations under privacy laws such as the General Data Protection Regulation in the  European  Union  (\u201cGDPR\u201d),  the  Personal  Information  Protection  and  Electronic  Documents  Act  (\u201cPIPEDA\u201d)  in  Canada,  and  the  California  Consumer Protection  Act  (\u201cCCPA\u201d).  Some  privacy  laws  prohibit  the  transfer  of  personal  information  to  certain  other  jurisdictions.  We  are  subject  to  privacy  and  data protection compliance audits or investigations by various government agencies.", "We experience cybersecurity incidents that might significantly compromise our technology systems or might result in material data breaches.", "Despite physical, technical, and administrative security measures, our technology systems and operations have been, and likely will continue to be, subject to cyberattacks from sources beyond our control.", "Cybersecurity incidents  include  actual  or  attempted  unauthorized  access,  tampering,  malware  insertion,  ransomware  attacks  or  other  system  integrity  events.  The  risk  of cyberattacks  may be increased  due to a variety of factors, both internal  and external.  A cybersecurity  incident might involve a material  data breach or other material impact to the integrity and operations of our technology systems, which might result in litigation or regulatory action, loss of customers or revenue, and increased expense, any of which might have a materially adverse impact on our business operations, reputation, and our financial position or results of operations.", "We might experience significant problems with information systems or networks.", "If those information systems suffer errors, interruptions, or become unavailable, there might be a materially adverse impact on our business operations, reputation, and our financial position or results of operations.", "Our products or services might not conform to specifications or perform as we intend.", "professionals delivering patient care tend to have heightened sensitivity to system and software errors.", "Errors or failures might damage our reputation and negatively affect future sales.", "We sell and provide services involving complex software and technology that may contain errors, especially when first introduced to market.", "The networks and hosting systems are vulnerable to interruption or damage from sources beyond our control, such as power loss, telecommunications failures, fire, natural disasters, software and hardware failures and cyberattacks.", "If the timely delivery of medical care or other customer business requirements are impaired by data access, network or systems problems, we could be exposed to significant claims and reputational harm.", "We might not realize expected benefits from business process initiatives.", "achieve  our  desired  objectives,  or  unintended  consequences  such  as  distraction  of  our  management  and  employees,  business  disruption,  attrition  beyond  any planned reduction in workforce, inability to attract or retain key personnel and reduced employee productivity.", "We might be unable to successfully complete or integrate acquisitions or other business combinations.", "We may not receive regulatory approvals needed to complete proposed transactions, or such  approvals  may  be  subject  to  delays  or  conditions  that  reduce  transaction  benefits.  Achieving  the  desired  outcomes  of  business  combinations  involves significant  risks  including:  diverting  management\u2019s  attention  from  other  business  operations;  challenges  with  assimilating  the  acquired  businesses,  such  as integration  of  operations  and  systems;  failure  or  delay  in  realizing  operating  synergies;  difficulty  retaining  key  acquired  company  personnel;  unanticipated accounting or financial systems issues with the acquired business, which might affect our internal controls over financial reporting; unanticipated compliance issues in the acquired business; challenges retaining customers of the acquired business; unanticipated expenses or charges to earnings, including depreciation and amortization or potential impairment charges; and risks of known and unknown assumed liabilities in the acquired business.", "We provide remote services that involve hosting customer data and operating software on our own or third party systems.", "Our growth strategy includes consummating acquisitions or other business combinations that either expand or complement our business.", "could delay the achievement of our strategic objectives.", "We might be adversely impacted by outsourcing or similar third-party relationships.", "Third-party services providers might fail to perform as anticipated, or we might experience unanticipated operational difficulties, compliance requirements or increased costs related to outsourced services.", "We may be unsuccessful in retail pharmacy operations or maintaining profitability.", "If our retail pharmacy operations fail to achieve, or are unable to sustain, acceptable net sales and profitability levels, it might have a materially adverse impact on our business operations and our financial position or results of operations.", "We rely on third parties to perform certain business and administrative functions for us.", "We might not adequately develop, implement and monitor these", "Our business strategy included expanding our retail pharmacy operations.", "Our retail pharmacy operations involve numerous risks, such as the following ones.", "For example, our contracts with the U.S. government generally require us to comply with the Federal Acquisition Regulations, Procurement Integrity Act, Buy American Act, Trade Agreements Act, and other laws and regulations.", "The occurrence of any of these risks could harm our reputation and might have a materially adverse impact on our business operations and our financial position or results of operations.", "Our participation in vaccination distribution programs may materially affect our operating results, reputation, and business.", "For example, the novel nature of the SARS-CoV\u20112 virus and the broad scope of the ongoing COVID-19 vaccine distribution program introduce uncertainty about what volumes of products may become available for distribution by us, the effectiveness of vaccines, and the cost of distribution.", "Because of such uncertainties, our operating results may be subject to variability.", "Our participation in such programs also exposes us to various risks, including regulatory compliance, government oversight, dependence on government funding, contractual performance, litigation, security risks, and supply chain challenges.", "Any significant problems with our participation in such programs might have a materially adverse impact on our reputation and our business.", "We might be harmed by changes in our relationships or contracts with suppliers.", "Our competitors might develop non-infringing products or services equivalent or superior to ours.", "We might be unable to successfully recruit and retain qualified employees.", "We compete with many other businesses to attract and retain employees.", "We may experience sudden loss of key personnel due to a variety of causes, such as illness, and must adequately plan for succession of key management roles.", "Employees might not successfully transition into new roles.", "Some of these changes increase our risks and create uncertainties for our business.", "These proposals might result in significant changes in the pharmaceutical value chain as manufacturers, PBM, managed care organizations and other industry stakeholders look to implement new transactional flows and adapt their business models.", "Many of our products and services are designed and intended to function within the structure of current healthcare financing and reimbursement systems.", "We might be adversely impacted by competition and industry consolidation.", "specialty distributors, service merchandisers, self-warehousing chain drug stores, manufacturers engaged in direct distribution, third-party logistics companies and large  payer  organizations.  In  addition,  our  businesses  face  competition  from  various  other  service  providers  and  from  pharmaceutical  and  other  healthcare manufacturers as well as other potential customers, which may from time-to-time decide to develop, for their own internal needs, supply management capabilities that might otherwise be provided by our businesses.", "This concentration reduces our ability to negotiate favorable terms with suppliers and causes us to depend on a smaller number of suppliers.", "Many of our customers, including  healthcare  organizations,  have  consolidated  and  have  greater  power  to  negotiate  favorable  prices.  Consolidation  by  our  customers,  suppliers  and competitors might reduce the number of market participants and give the remaining enterprises greater bargaining power, which might lead to erosion in our profit margin.", "These competitive pressures and industry consolidation might have a materially adverse impact on our business operations and our financial position or results of operations.", "We might be adversely impacted by changes or disruptions in product supply.", "Our inventory might be requisitioned, diverted or allocated by government order such as under emergency, disaster and civil defense declarations.", "For example, government actions in response to the COVID-19 pandemic affect our supply allocation, and those and our own allocation decisions can impact our customer relationships.", "Changes in the healthcare industry\u2019s or our suppliers\u2019 pricing, selling, inventory, distribution or supply policies or practices could significantly reduce our revenues and net income.", "We might experience disruptions in our supply of higher margin pharmaceuticals, including generic pharmaceuticals.", "sourcing joint venture with Walmart, Inc. is unsuccessful or experiences margins declines.", "products and services and the volume of their purchases.", "Our generic  pharmaceuticals  distribution  business  is subject  to  pricing  risks.  We  might  be  adversely  impacted  if  our ClarusONE  generic  pharmaceutical", "Suppliers might increase their prices, reduce their output or change their terms of sale due to limited availability of credit.", "We may have difficulties in sourcing or selling products due to a variety of causes.", "Difficulties in product manufacturing or access to raw materials could result in supplier production shutdowns, product shortages and other supply disruptions.", "The COVID-19 pandemic adversely affects the availability of some products, resulting in product allocation and delivery delays.", "We have operations in the U.K. and the European Union (\u201cE.U.\u201d) and face risks associated with the uncertainty and potential disruptions that might follow the", "These events can disrupt operations for us, our suppliers, our vendors, and our customers.", "For example, in February 2021, a severe winter storm affecting the United  States  temporarily  impacted  our  distribution  business  operations,  primarily  in  Texas.  They  might  affect  consumer  confidence  levels  and  spending.  In response to these events, we might suspend operations, implement extraordinary procedures, seek alternate sources for product supply, or suffer consequences that are unexpected and difficult to mitigate.", "In particular, the rapid and widespread transmission of the SARS-CoV-2 novel coronavirus beginning in late 2019 impacts us in significant ways.", "For example, to mitigate the spread of the COVID-19 disease caused by SARS-CoV-2, we implemented travel restrictions and remote working  arrangements  for  most  of  our  employees  in  order  to  minimize  physical  contact,  and  we  implemented  additional  sanitation  and  personal  protection measures in our warehouse, retail pharmacy and delivery operations.", "These measures might not fully mitigate COVID-19 risks to our workforce and we could experience unusual levels of absenteeism that might impair operations and delay delivery of products.", "The ongoing impacts of the pandemic might cause a general economic slowdown or recession in one or more markets, disruptions and volatility in global capital markets and other broad and adverse effects on the economy, business conditions, commercial activity and the healthcare industry.", "The pandemic might impact our business operation, financial position and results of operation in unpredictable ways that depend on highly uncertain future  developments,  such  as  determining  the  effectiveness  of  current  or  future  government  actions  to  address  the  public  health  or  economic  impacts  of  the pandemic.", "These events and impacts could materially adversely affect our business operations, financial position or results of operation.", "locations,  primarily  throughout  North  America  and  Europe.  Retail  pharmacies  and  most  warehouses  are  typically  owned  or  leased  on  a  long-term  basis.  We consider our operating properties to be in satisfactory condition and adequate to meet our needs for the next several years without making capital expenditures materially higher than historical levels.", "Form 10-K for additional factors relating to these statements and Item 1A - Risk Factors in Part I of this Annual Report on Form 10-K for a list of certain risk factors applicable to our business, financial condition, and results of operations.", "We partner with life sciences companies, manufacturers, providers, pharmacies, governments, and other healthcare organizations to help provide the right medicines, medical products, and healthcare services to the right patients at the right time, safely, and cost-effectively.", "All prior segment information has been recast to reflect our new segment structure and current period presentation.", "We  implemented  a  new  segment  reporting  structure  commencing  with  the  second  quarter  of  2021,  which  resulted  in  four  reportable  segments:  U.S.", "\u2022 International is  a  new  reportable  segment  that  includes  our  operations  in  Europe  and  Canada,  bringing  together  non-U.S.-based  drug  distribution services, specialty pharmacy, retail, and infusion care services.", "\u2022 RxTS is  a  new  reportable  segment  that  brings  together  existing  businesses,  including  CoverMyMeds,  RelayHealth,  RxCrossroads,  and  McKesson Prescription Automation, including Multi-Client Central Fill as a Service, to serve our biopharma and life sciences partners and patients.", "We benefited from demand for COVID-19 tests, favorable contributions from our vaccine and related ancillary supply kit distribution programs as discussed further below, and savings from reduced travel and meetings throughout 2021;", "We have also partnered with the Department of Health and Human Services (\u201cHHS\u201d) and Pfizer to manage the assembly and distribution of the ancillary supplies needed to administer COVID-19 vaccines;", "Pharmaceutical segment driven by market growth; \u2022 Gross profit increased 1% from the prior year primarily in our Medical-Surgical Solutions segment driven by sales of COVID-19 tests; \u2022 Total operating expenses in 2021 includes the following:", "Infection rates varied throughout our fiscal year, peaking in January 2021.", "Our role in the distribution of COVID-19 vaccines in the U.S. as well as the assembly and distribution of related ancillary supply kits is discussed further below.", "McKesson Europe is also playing a role in helping support governments and public health entities in not only distributing COVID-19 vaccines across several European countries, but administering them in pharmacies as well.", "solutions, we are well positioned to respond to the COVID-19 pandemic in the U.S., Canada, and Europe.", "We have worked and continue to work closely with national and local governments, agencies, and industry partners to ensure that available supplies, including personal protective equipment (\u201cPPE\u201d), and medicine reach our customers and patients.", "put in place to mitigate the impact of COVID-19 on our business operations, including telecommuting and work-from-home policies, restricted travel, employee support programs, and enhanced safety measures, are intended to limit employee exposure to the virus that causes COVID-19.", "We expanded employee medical benefits covering COVID-19 related visits, treatments, and testing as well as expanded telehealth options to protect employee safety.", "For employees whose roles require presence at our facilities, we enhanced safety by promoting the practice of social distancing, providing reminders to wash or disinfect hands and avoid unnecessary face touching, making face masks available, placing hand sanitizers within our operating environments, and periodically cleaning and disinfecting our facilities.", "For employees whose roles do not require presence at our facilities, we added technology resources to support their working remotely.", "These steps to protect employee safety have resulted in limited disruption from COVID-19 to our normal business operations, productivity trends, and have not materially impacted our operating expenses or operating margins.", "pharmacy foot traffic as our customers increased supplies on hand in March, which drove unfavorability in our results of operations when comparing 2021 versus 2020.", "We also experienced decreased demand for primary care medical-surgical supplies due to deferrals in elective procedures in hospitals and surgery centers as well as decreased traffic and closures of doctors\u2019 offices, which was partially offset by demand for PPE and COVID-19 tests.", "COVID-19  for  the  second  half  of  our  fiscal  year  was  non-linear  and  tracked  with  patient  mobility.  We  also  saw  increased  demand  for  COVID-19  tests  and continued sales of PPE throughout the year in our Medical-Surgical Solutions segment partially offset by the impacts of social distancing measures which resulted in a less severe cough, cold, and flu season, savings for reduced travel and meetings across the enterprise, as well as improvements of retail pharmacy foot traffic in Europe and Canada.", "The vaccine and related  ancillary  kit distribution  in the U.S. favorably impacted our results in the second half of fiscal 2021 as further discussed below.", "Our Response to COVID-19 in the Workplace During this unprecedented time, we are committed in continuing to supply our customers and protect the safety of our employees.", "During  the  first  quarter  of  2021,  we  experienced  growth  in  pharmaceutical  distribution  and  specialty  drug  volumes  at  a  lower  rate  in  the  U.S.,  while", "In the centralized model, the U.S. government directs us on the distribution of the vaccines and related supplies to point-of-care sites across the country.", "The results of operations related to our vaccine distribution are reflected in our U.S.", "We also have an agreement with Pfizer to assemble and distribute ancillary supply kits needed to administer that particular COVID-19 vaccine.", "We began assembling the ancillary supply kits in September 2020 in preparation for vaccine authorization and subsequent distribution.", "Ancillary supply kits to administer the Pfizer Vaccine are shipped directly to point-of-care sites, and all other ancillary supply kits are shipped to our dedicated vaccine distribution centers.", "The results of operations for the kitting and distribution of ancillary supplies are reflected in our Medical-Surgical Solutions segment.", "These facilities can scale to meet the demand of increasing volumes of vaccines being manufactured.", "We have also set up distribution centers for kitting and inventory management as part of our contract with the HHS.", "We are working with delivery partners to manage the delivery of vaccines and ancillary supply kits from our centralized vaccine distribution centers to point-of-care destinations as directed by the CDC.", "as well as the kitting and distribution of ancillary supplies for COVID-19 vaccines in our Medical-Surgical Solutions segment contributed approximately 20% in segment  revenues  and  segment  operating  profit.  Additionally,  the  distribution  of  COVID-19  vaccines  in  our  U.S.  Pharmaceutical  segment  contributed approximately 2% in segment operating profit for the year ended March 31, 2021.", "During our fourth quarter of 2020, we experienced a temporary increase in demand for pharmaceuticals.", "Certain PPE items held for resale were valued in our inventory at costs that were inflated by earlier COVID-19 pandemic demand levels.", "That inventory valuation, if not supported by market resale prices, may be written down to net realizable value.", "We may also write-off inventory due to decreased customer demand and excess inventory.", "response to supply availability and customer demand patterns for certain products, with varying inventory level impacts depending on the specific product within our portfolio.", "As our supply levels improve, and the federal government evolves guidance on the prioritization of providers or geographic markets, we will continue to adapt our distribution policies.", "We were able to maintain appropriate labor and overall vendor supply levels during the year ended March 31, 2021.", "suppliers,  their  locations,  and  the  extent  to  which  they  are  impacted  by  the  COVID-19  pandemic,  we  are  proactively  working  with  manufacturers,  industry partners, and government agencies to meet the needs of our customers during the pandemic.", "We have assembled a Critical Care Drug Task Force, made up of our procurement  specialists,  clinical  health  systems  pharmacists,  and  supply  chain  professionals,  that  is  focused  on  securing  additional  product  where  available, sourcing back-up products, and protecting our operations across all locations and facilities.", "We are also working with manufacturers through several channels, including  our  ClarusONE  Sourcing  Services  LLP  (\u201cClarusONE\u201d)  and  global  sourcing  teams  in  London,  and  our  leaders  are  actively  engaged  in  addressing potential shortages.", "We have engaged with industry partners and government agencies to gain visibility into supply and demand.", "Additionally, we have a robust Business Continuity and Disaster Recovery Program (\u201cBCRP\u201d) and we have proactively enhanced our BCRP in response to the COVID-19 pandemic to protect the supply  chain  to  minimize  disruption  in  healthcare,  protect  our  customers,  ensure  the  safety  and  security  of  our  employees  and  workplaces,  and  ensure  the continuity of critical business processes.", "supplies and medications to help prevent the spread of the disease and treat those that are ill.", "COVID-19 has put an unprecedented strain on the supply of high- demand PPE, including N95 masks, gloves, as well as disinfecting sprays and wipes.", "The supply chain has improved over the initial impact of pandemic-related demand, and we continue to closely monitor demand by customer type and certain PPE and infection prevention items are still in short supply.", "Our allocation approach has helped us avoid stock outs in many critical product categories, allowing us to provide PPE supplies to many more customers for a much longer time.", "We anticipate these market conditions will remain for the foreseeable future.", "Our efforts to help the supply chain have included sourcing products from new suppliers all over the world, working closely with the federal government to help with the nation\u2019s response and collaborating with partners to source, develop, and deliver new products to market.", "The full extent to which COVID-19 will impact us depends on many factors and future developments, including: the duration and spread of the virus; governmental actions to limit the spread of the virus; potential seasonality of viral outbreaks; potential new strains or variants of the original virus; the amount of COVID-19 vaccines authorized, manufactured, distributed, and administered; the amount of ancillary supply kits assembled and distributed; the  effectiveness  of  COVID-19  vaccines  and  governmental  measures  in  controlling  the  spread  of  the  virus;  and  the  effectiveness  of  treatments  of  infected individuals.", "Impact to our Supply Chain We  also  continue  to  monitor  the  COVID-19  pandemic  impacts  on  our  supply  chain.  Although  the  availability  of  various  products  is  dependent  on  our", "Gross profit was favorably impacted by growth of specialty pharmaceuticals and the contribution from our vaccine distribution programs in our U.S.", "\u2022 Goodwill impairment charges of $1.8 billion in our European Retail Pharmacy (\u201cEuropean RP\u201d) and European Pharmaceutical Distribution (\u201cEuropean PD\u201d) reporting units within the International segment.", "This initiative primarily led us to rationalize our office space in North America.", "Where we determine to cease using office space, we plan to exit the portion of the facility no longer used.", "We also may retain and repurpose certain other office locations.", "transformational changes in technologies and business processes, operational efficiencies, and cost savings.", "centralization of certain functions and outsourcing through an expanded arrangement with a third-party vendor to achieve operational efficiency.", "The  initiative  consisted  of  multiple  growth  priorities  and  plans  to  optimize  our  operating  models  and  cost  structures  primarily  through  centralization,  cost management, and outsourcing of certain administrative functions.", "As part of the growth initiative, we committed to implement certain actions including a reduction in workforce, facility consolidation, and store closures.", "This set of initiatives was substantially complete by the end of 2020. $115 million, $112 million, and $245 million, respectively, primarily related to our retail pharmacy businesses in Canada and Europe within our International segment.", "During  the  first  quarter  of  2021,  we  committed  to  an  initiative  within  the  U.K.,  which  is  included  in  our  International  segment,  to  further  drive", "In the fourth quarter of 2019, we committed to certain programs to continue our operating model and cost optimization efforts.", "On April 25, 2018, we announced a strategic growth initiative intended to drive long-term incremental profit growth and to increase operational efficiency.", "pharmaceutical price increases, growth in specialty pharmaceuticals, and higher volumes from retail national account customers, partially offset by branded to generic  drug  conversions.  Revenues  for  this  segment  were  unfavorably  impacted  by  fluctuations  in  demand  for  pharmaceuticals  in  retail  pharmacies  and institutional healthcare providers due to COVID-19 largely during the onset of the pandemic in late March 2020 and during our first quarter of 2021 combined with the loss of certain customers.", "exchange fluctuations, revenues for this segment decreased 9% primarily due to the contribution of our German pharmaceutical wholesale business to a joint venture with WBA and to a lesser extent, the exit of unprofitable customers in our Canadian business.", "Revenues for this segment were also unfavorably impacted by lower volumes from the adverse impacts from COVID-19 in our pharmaceutical distribution and retail pharmacy businesses within Europe.", "exchange fluctuations, revenues for this segment increased 4% primarily due to market growth in our European pharmaceutical distribution and retail pharmacy businesses.", "2020 vs. 2019 Medical-Surgical Solutions revenues for the year ended March 31, 2020 increased 9% compared to the prior year primarily due to market growth in our", "The impacts from COVID-19 in our pharmaceutical distribution and retail pharmacy businesses within Europe also caused unfavorability in our segment results year over year.", "demand for COVID-19 tests and PPE, as well as the contribution from kitting and distribution of ancillary supplies for COVID-19 vaccines.", "This was partially offset by inventory charges on certain PPE and other related products, unfavorability in our primary care business due to customer closures largely during the first quarter  of 2021, and a  less severe  cough, cold, and flu  season.", "2020 vs. 2019 Operating profit increased for the year ended March 31, 2020 compared to the prior year primarily due to market growth in our specialty business.", "2020 vs. 2019 Operating profit and operating profit margin increased for the year ended March 31, 2020 compared to prior year primarily due to market growth in our", "We monitor our operations and adopt strategies responsive to changes in the economic and political environment in each of the countries in which we operate.", "Our foreign operations represented approximately 15%, 17%, and 18% of our consolidated revenues in 2021, 2020, and 2019, respectively.", "We also have agreements with GPOs, each of which functions as a purchasing agent on behalf of member hospitals, pharmacies and other healthcare providers, as well as with government entities and agencies.", "and updated if unusual circumstances or trends are present.", "LIFO method presumes that the most recent inventory purchases are the first items sold and the inventory cost under LIFO approximates market.", "The majority of the cost of domestic inventories is determined using the LIFO method.", "If we had used the moving average method of inventory valuation, inventories would have been approximately $406 million and $444 million higher than the amounts reported at March 31, 2021 and 2020, respectively.", "such, our LIFO inventory is valued at the lower of LIFO or market.", "Inventories: Inventories  consist of merchandise  held  for resale.  We report  inventories  at the lower of cost or net realizable  value, except  for inventories", "We believe that the moving average inventory costing method provides a reasonable estimation of the current cost of replacing inventory (i.e., \u201cmarket\u201d).", "Shifts in market trends and conditions, changes in customer preferences due to the introduction of generic drugs or new pharmaceutical products or the loss of one or more significant customers are factors that could affect the value of our inventories.", "We write down inventories which are considered excess and obsolete as a result of these reviews.", "These factors could make our estimates of inventory valuation differ from actual results.", "In addition, we compare the aggregate of the reporting units\u2019 fair values to our market capitalization as further corroboration of the fair values.", "They can be affected by a variety of factors, including external factors such as industry and economic trends, and internal factors such as changes in our business strategy and our internal forecasts.", "Management makes certain judgments and estimates in its assessment including but not limited to: identifying if circumstances indicate a decline in value is other than temporary, expectations about the business operations of investees, as well as industry, financial, and market factors.", "On March 9, 2020, we completed the Split-off of our interest in the Change Healthcare JV.", "Our businesses require substantial investments in working capital that are susceptible to large variations during the year as a result of inventory purchase patterns and seasonal demands.", "Our  redeemable  noncontrolling  interests  primarily  relate  to  our  consolidated  subsidiary,  McKesson  Europe.  Under  the  Domination  Agreement,  the", "However, our risk management programs are designed such  that  the  potential  loss  in  value  of  these  risk  management  portfolios  described  above  would  be  largely  offset  by  changes  in  the  value  of  the  underlying exposure.", "With the participation of the Chief Executive Officer and the Chief Financial Officer, our management conducted an assessment of the effectiveness of our internal control over financial  reporting based on the framework and criteria  established in Internal Control\u2014Integrated Framework (2013), issued by the Committee of Sponsoring Organizations of the Treadway Commission.", "Under the market approach, fair value is estimated by comparing the business to similar businesses, or guideline companies whose securities are actively traded in public markets.", "The severity,  magnitude  and  duration,  as  well  as  the  economic  consequences  of  the  coronavirus  diseases  2019  (\u201cCOVID-19\u201d)  pandemic,  are  uncertain,  rapidly changing, and difficult to predict.", "The majority of the cost of domestic inventories is determined using the LIFO method.", "Goodwill testing requires a complex series of assumptions and judgments by management in projecting future operating results, selecting guideline companies for comparisons and assessing risks.", "Revenues generated from the distribution of pharmaceutical and medical products represent the majority of the Company\u2019s revenues.", "customer, is responsible for fulfilling the promise to its customer, has latitude in establishing prices, and controls the relationship with the customer.", "Shipping and handling costs associated with outbound freight after control over a product has transferred to a customer are accounted for as fulfillment costs.", "International segment, to further drive transformational changes in technologies and business processes, operational efficiencies, and cost savings.", "continues to implement centralization of certain functions and outsourcing through an expanded arrangement with a third-party vendor to achieve operational efficiency.", "Irving, Texas to improve efficiency, collaboration, and cost competitiveness.", "PSUs are conditional upon the attainment of market and performance objectives over a specified period.", "As a practical expedient, the Company does not separate lease components from non-lease components such as common area maintenance, utilities, and repairs and maintenance.", "The Company\u2019s most significant relationships are with oncology and other specialty practices.", "Level 2 - significant other observable market-based inputs.", "Level 3 - significant unobservable inputs for which little or no market data exists and requires considerable assumptions that are significant to the fair value", "measurement due to the significance of unobservable inputs developed using company-specific information.", "It has received the same warranties from its suppliers, which customarily are the manufacturers of the products.", "Pharma Belgium NV is also part of the investigation.", "Stockholders (the \u201cProxy Statement\u201d) under the heading \u201cElection of Directors.\u201d Information about our Executive Officers is incorporated by reference from the discussion in Part I of this report under the heading \u201cInformation about our Executive Officers.\u201d Information about our Audit Committee, including the members of the  committee  and  our  Audit  Committee  Financial  Expert,  is  incorporated  by  reference  from  the  discussion  under  Item  1  of  our  Proxy  Statement  under  the headings \u201cThe Board, Committees and Meetings,\u201d and \u201cAudit Committee Report.\u201d", "We offer more than 275,000 national brand medical- surgical products as well as McKesson\u2019s own line of high-quality products through a network of distribution centers within the United States (\u201cU.S.\u201d).", "as a Service, to serve our biopharma and life sciences partners and patients.", "Our  U.S.  Pharmaceutical  segment  distributes  branded,  generic,  specialty,  biosimilar  and  over-the-counter  (\u201cOTC\u201d)  pharmaceutical  drugs,  and  other", "We also source generic pharmaceutical drugs through our joint sourcing entity, ClarusONE Sourcing Services LLP (\u201cClarusONE\u201d).", "We invest in technology and other systems at all of our distribution centers to enhance safety, reliability, and product availability.", "For example, we offer McKesson Connect , an internet-based ordering system that provides item look-up and real-time inventory availability as well as ordering, purchasing, third-party reconciliation, and account management functionality.", "We make extensive use of technology as an enabler to ensure customers have the right products at the right time in the right place.", "We provide solutions to our customers including supply management technology, world-class marketing programs, managed care, repackaging products, and services to help them meet their business and quality goals.", "We continue to implement information systems to help achieve greater consistency and accuracy both internally and for our customers.", "operational efficiency, and automation that help independent pharmacists focus on patient care while improving profitability.", "Retail National Accounts: We provide business solutions that help retail national account customers increase revenues and profitability.", "These distribution centers also provide the foundation for a two-tiered distribution network that supports best-in-class direct store delivery.", "performance, increase operational efficiencies, and deliver better patient care.", "Community-based physicians in this business have broad flexibility and discretion to select the products and commitment levels that best meet their practice needs.", "Services in provider solutions include specialty drug distribution, group purchasing organizations (\u201cGPO\u201d) like Onmark\u00ae, technology solutions, practice consulting services, and vaccine distribution, including our exclusive distributor relationship with the Centers for Disease Control and Prevention\u2019s (\u201cCDC\u201d) Vaccines for Children program.", "SKY Packaging enables acute care, long-term care, and institutional pharmacies to provide cost-effective, uniform packaging.", "Our use of the term \u201cspecialty\u201d may not be comparable to that used by other industry participants, including our competitors.", "Our operations in Canada, including Rexall retail pharmacies, support better, safer patient care by delivering vital medicines, supplies, and information technology solutions throughout Canada.", "functions  as  a  vital  link,  using  technology-enabled  management  systems  at  our  regional  wholesale  branches  to  connect  manufacturers  to  retail  pharmacies, supplying medicines and other products sold in pharmacies.", "In addition, we partner with independent pharmacies under local banner programs.", "banners, and more than 400 owned pharmacies under the Rexall brand where we provide patients with greater choice and access, integrated pharmacy care and industry-leading service levels.", "This segment includes our Ontada business, providing software to support the clinical, financial, and operational needs of our oncology practice partners.", "Our European Pharmaceutical Distribution business delivers pharmaceutical and other healthcare-related products to pharmacies across Europe.", "Our more than 250,000 customers include physician offices, surgery centers, post-acute care facilities, hospital reference labs, and  home  health  agencies.  We  distribute  medical-surgical  supplies  (such  as  gloves,  needles,  syringes  and  wound  care  products),  infusion  pumps,  laboratory equipment  and  pharmaceuticals.  Through  a  network  of  distribution  centers  within  the  U.S.,  we  offer  more  than  275,000  products  from  national  brand manufacturers and McKesson\u2019s own high-quality product line.", "Through the right mix of products and services, we help improve efficiencies, profitability and compliance.  We  also  never  lose  focus  on  helping  customers  improve  patient  and  business  outcomes.  We  develop  customized  plans  to  address  the  product, operational, and clinical support needs of our customers, including tackling inventory management, reducing administrative burdens, and training and educating clinical staff.", "We deliver for our customers, so they can deliver and care for their patients.", "pharmaceutical distribution environment in which our U.S.", "Pharmaceutical and International segments operate, we face strong competition from international, national, regional and local full-line, short-line and specialty distributors, service merchandisers, self-warehousing chain drug stores, manufacturers engaged in direct distribution, third-party logistics companies, and large payer organizations.", "Our retail businesses, which primarily operate in our International segment, face competition from various global, national, regional, and local global retailers, including chain and independent pharmacies.", "We consider our largest competitors in distribution, wholesaling, and logistics to be AmerisourceBergen Corporation and Cardinal Health, Inc.", "businesses, which may from time to time decide to develop, for their own internal needs, supply management capabilities that might otherwise be provided by our businesses.", "We believe that our scale and diversity of product and service offerings are our primary competitive advantages.", "operations and market position, but we do not consider any of our businesses to be dependent upon any one patent, copyright, trademark, or trade secret, or any family or families of the same.", "be necessary in the future to seek or renew licenses relating to various aspects of our products and services, we believe, based upon past experience and industry practice,  such  licenses  generally  can  be  obtained  on  commercially  reasonable  terms.  We  believe  our  operations  and  products  and  services  are  not  materially dependent on any single license or other agreement with any third party.", "on improving employee health and wellness, creating opportunities for growth and development, and providing an inclusive workplace where our employees can reach their full potential.", "At March 31, 2021, we had approximately 76,000 employees worldwide, including 17,000 part-time employees and 32,000 employees in the U.S. healthier future is everyone\u2019s business.", "We build successful teams by recruiting, developing, and retaining diverse talent and we recognize our culture of inclusion as an important element that drives long-term shareholder value.", "(1) The data for our metrics is derived from our voluntary, self-identification process as of March 31, 2021 and therefore represents our best estimate at this time. (2) Represents our leadership at the vice president level and above. (3) Represents worldwide employees. (4) Represents U.S. employees only as the data for Canada and Europe is not available.", "I CARE and ILEAD principles, we fulfill our mission of improving care in every setting.", "Our I CARE values (Integrity, Inclusion, Customer-First, Accountability, Respect, Excellence) are foundational to all that we do, and who we are as a company.", "ILEAD (Inspire, Leverage, Execute, Advance, Develop) is our common definition and shared commitment to leadership.", "By embracing this commitment, we bring out the best in ourselves and position McKesson to continue to drive better health \u2013 for our company, our customers, and the patients they serve for years to come.", "We promote leadership behaviors through culture initiatives that offer practical tips on how to debate, decide, and commit, be open and candid, and maintain an enterprise-first mindset when navigating conversations affecting operations within and across our business segments.", "We hold inbound licenses for certain intellectual property that is used internally, and in some cases, utilized in McKesson\u2019s products or services.", "Culture and Leadership: What sets McKesson apart as an exceptional place is our people.", "Our employees understand that together, unified by our global", "where everyone can bring their authentic self to work and feel welcomed and appreciated, and where their perspectives are sought out, heard, and considered.", "Through training, we encourage leaders to embrace diverse perspectives and lead inclusively.", "We  also  seek  employee  feedback  through  an  annual  employee  opinion  survey,  which  assesses  our employees\u2019  levels  of engagement, commitment, and overall satisfaction using industry benchmarks, and we then design action plans to improve those metrics.", "We routinely assess facilities to monitor closely adherence to established security and safety standards.", "If we identify a vulnerability, it is documented, and the facility prepares an action plan.", "Our employees receive specialized training related to their role, work setting, and equipment used in their work environment.", "As our processes evolve, we update relevant safety training modules, which may include new employee training programs.", "The various responses we put in place to mitigate the impact of COVID- 19  on  our  business  operations,  including  telecommuting  and  work-from-home  policies,  restricted  travel,  and  enhanced  safety  measures,  are  intended  to  limit employee exposure to the virus that causes COVID-19 as they perform their jobs while also providing employee support programs and a sense of belonging.", "For additional  information  on  our  response  to  COVID-19  in  the  workplace,  refer  to  the  COVID-19  section  of \u201cTrends  and  Uncertainties\u201d in  \u201cManagement\u2019s Discussion and Analysis of Financial Condition and Results of Operations\u201d in Item 7 of Part II included in this Annual Report on Form 10-K.", "Food and Drug Administration Amendments Act of 2007 requires the FDA to establish standards and identify and validate effective technologies, such as track and trace or authentication technologies, to secure the pharmaceutical supply chain against counterfeit drugs.", "Despite physical, technical, and administrative security measures that we implement in order to, among other things, address regulatory requirements, our technology systems and operations may continue to be subject to cybersecurity incidents.", "The risk of cybersecurity incidents may be increased due to a variety of factors, both internal and external.", "Sales to our largest customer, CVS Health Corporation (\u201cCVS\u201d), accounted for approximately 21% of our total consolidated revenues in 2021.", "In May 2019, we extended our pharmaceutical distribution relationship with CVS to June 2023.", "a supplier could adversely affect our business if alternate sources of supply are unavailable.", "We believe that our relationships with our suppliers are generally sound.", "The ten largest suppliers in 2021 accounted for approximately 50% of our purchases.", "For these manufacturers, a reduction in the frequency and magnitude of price increases, as well as restrictions in the amount of inventory available to us, could have an adverse impact on our gross profit margin.", "Although it is not possible to predict or identify all such risks and uncertainties, they include, but are not limited to, the factors discussed in Item 1A of Part I of this report under \u201cRisk Factors\u201d and in our publicly available SEC filings and press releases.", "Suppliers: We obtain pharmaceutical and other products from manufacturers, none of which accounted for more than 7% of our purchases in 2021.", "practical  to  identify  or  describe  all  risks  and  uncertainties  that  might  materially  impact  our  business  operations,  reputation,  financial  position  or  results  of operations.", "Our business could be materially affected by risks that we have not yet identified or that we currently consider to be immaterial.", "This is not a complete statement of all potential risks and uncertainties.", "For example, pharmacy operations are exposed to risks such as improper filling of prescriptions, mislabeling of prescriptions, inadequacy of warnings, unintentional distribution of counterfeit drugs and expiration of drugs.", "The  discussion  below  identifies  certain  representative  risks  that  might  cause  our  actual  business  results  to  materially  differ  from  our  estimates.  It  is  not", "Certain of our businesses may be required to register for permits and/or licenses with, and comply with operating and security standards of, the DEA, FDA, HHS, CMS, various state boards of pharmacy, state health departments and/or comparable state agencies as well as foreign agencies and certain accrediting bodies, depending upon the type of operations and location of product development, manufacture, distribution, and sale.", "As of March 31, 2021, suspensions at the four distribution centers had all expired  by  their  own  terms.  If  we  are  not  able  to  obtain,  maintain  or  renew  permits,  licenses  or  other  regulatory  approvals  needed  for  the  operation  of  our businesses, it might have a materially adverse impact on our business operations and our financial position or results of operations.", "Food and Drug Administration Amendments Act of 2007 requires the FDA to establish standards and identify and validate effective technologies, such as track  and  trace  or  authentication  technologies,  to  secure  the  pharmaceutical  supply  chain  against  counterfeit  drugs.  We  also  have  record-keeping  and  other obligations under the E.U.", "We are subject to significant compliance obligations under privacy laws such as the General Data Protection Regulation in the  European  Union  (\u201cGDPR\u201d),  the  Personal  Information  Protection  and  Electronic  Documents  Act  (\u201cPIPEDA\u201d)  in  Canada,  and  the  California  Consumer Protection  Act  (\u201cCCPA\u201d).  Some  privacy  laws  prohibit  the  transfer  of  personal  information  to  certain  other  jurisdictions.  We  are  subject  to  privacy  and  data protection compliance audits or investigations by various government agencies.", "We experience cybersecurity incidents that might significantly compromise our technology systems or might result in material data breaches.", "Despite physical, technical, and administrative security measures, our technology systems and operations have been, and likely will continue to be, subject to cyberattacks from sources beyond our control.", "Cybersecurity incidents  include  actual  or  attempted  unauthorized  access,  tampering,  malware  insertion,  ransomware  attacks  or  other  system  integrity  events.  The  risk  of cyberattacks  may be increased  due to a variety of factors, both internal  and external.  A cybersecurity  incident might involve a material  data breach or other material impact to the integrity and operations of our technology systems, which might result in litigation or regulatory action, loss of customers or revenue, and increased expense, any of which might have a materially adverse impact on our business operations, reputation, and our financial position or results of operations.", "We might experience significant problems with information systems or networks.", "If those information systems suffer errors, interruptions, or become unavailable, there might be a materially adverse impact on our business operations, reputation, and our financial position or results of operations.", "Our products or services might not conform to specifications or perform as we intend.", "professionals delivering patient care tend to have heightened sensitivity to system and software errors.", "Errors or failures might damage our reputation and negatively affect future sales.", "We sell and provide services involving complex software and technology that may contain errors, especially when first introduced to market.", "The networks and hosting systems are vulnerable to interruption or damage from sources beyond our control, such as power loss, telecommunications failures, fire, natural disasters, software and hardware failures and cyberattacks.", "If the timely delivery of medical care or other customer business requirements are impaired by data access, network or systems problems, we could be exposed to significant claims and reputational harm.", "We might not realize expected benefits from business process initiatives.", "achieve  our  desired  objectives,  or  unintended  consequences  such  as  distraction  of  our  management  and  employees,  business  disruption,  attrition  beyond  any planned reduction in workforce, inability to attract or retain key personnel and reduced employee productivity.", "We might be unable to successfully complete or integrate acquisitions or other business combinations.", "We may not receive regulatory approvals needed to complete proposed transactions, or such  approvals  may  be  subject  to  delays  or  conditions  that  reduce  transaction  benefits.  Achieving  the  desired  outcomes  of  business  combinations  involves significant  risks  including:  diverting  management\u2019s  attention  from  other  business  operations;  challenges  with  assimilating  the  acquired  businesses,  such  as integration  of  operations  and  systems;  failure  or  delay  in  realizing  operating  synergies;  difficulty  retaining  key  acquired  company  personnel;  unanticipated accounting or financial systems issues with the acquired business, which might affect our internal controls over financial reporting; unanticipated compliance issues in the acquired business; challenges retaining customers of the acquired business; unanticipated expenses or charges to earnings, including depreciation and amortization or potential impairment charges; and risks of known and unknown assumed liabilities in the acquired business.", "We provide remote services that involve hosting customer data and operating software on our own or third party systems.", "Our growth strategy includes consummating acquisitions or other business combinations that either expand or complement our business.", "could delay the achievement of our strategic objectives.", "We might be adversely impacted by outsourcing or similar third-party relationships.", "Third-party services providers might fail to perform as anticipated, or we might experience unanticipated operational difficulties, compliance requirements or increased costs related to outsourced services.", "We may be unsuccessful in retail pharmacy operations or maintaining profitability.", "If our retail pharmacy operations fail to achieve, or are unable to sustain, acceptable net sales and profitability levels, it might have a materially adverse impact on our business operations and our financial position or results of operations.", "We rely on third parties to perform certain business and administrative functions for us.", "We might not adequately develop, implement and monitor these", "Our business strategy included expanding our retail pharmacy operations.", "Our retail pharmacy operations involve numerous risks, such as the following ones.", "For example, our contracts with the U.S. government generally require us to comply with the Federal Acquisition Regulations, Procurement Integrity Act, Buy American Act, Trade Agreements Act, and other laws and regulations.", "The occurrence of any of these risks could harm our reputation and might have a materially adverse impact on our business operations and our financial position or results of operations.", "Our participation in vaccination distribution programs may materially affect our operating results, reputation, and business.", "For example, the novel nature of the SARS-CoV\u20112 virus and the broad scope of the ongoing COVID-19 vaccine distribution program introduce uncertainty about what volumes of products may become available for distribution by us, the effectiveness of vaccines, and the cost of distribution.", "Because of such uncertainties, our operating results may be subject to variability.", "Our participation in such programs also exposes us to various risks, including regulatory compliance, government oversight, dependence on government funding, contractual performance, litigation, security risks, and supply chain challenges.", "Any significant problems with our participation in such programs might have a materially adverse impact on our reputation and our business.", "We might be harmed by changes in our relationships or contracts with suppliers.", "Our competitors might develop non-infringing products or services equivalent or superior to ours.", "We might be unable to successfully recruit and retain qualified employees.", "We compete with many other businesses to attract and retain employees.", "We may experience sudden loss of key personnel due to a variety of causes, such as illness, and must adequately plan for succession of key management roles.", "Employees might not successfully transition into new roles.", "Some of these changes increase our risks and create uncertainties for our business.", "These proposals might result in significant changes in the pharmaceutical value chain as manufacturers, PBM, managed care organizations and other industry stakeholders look to implement new transactional flows and adapt their business models.", "Many of our products and services are designed and intended to function within the structure of current healthcare financing and reimbursement systems.", "We might be adversely impacted by competition and industry consolidation.", "specialty distributors, service merchandisers, self-warehousing chain drug stores, manufacturers engaged in direct distribution, third-party logistics companies and large  payer  organizations.  In  addition,  our  businesses  face  competition  from  various  other  service  providers  and  from  pharmaceutical  and  other  healthcare manufacturers as well as other potential customers, which may from time-to-time decide to develop, for their own internal needs, supply management capabilities that might otherwise be provided by our businesses.", "This concentration reduces our ability to negotiate favorable terms with suppliers and causes us to depend on a smaller number of suppliers.", "Many of our customers, including  healthcare  organizations,  have  consolidated  and  have  greater  power  to  negotiate  favorable  prices.  Consolidation  by  our  customers,  suppliers  and competitors might reduce the number of market participants and give the remaining enterprises greater bargaining power, which might lead to erosion in our profit margin.", "These competitive pressures and industry consolidation might have a materially adverse impact on our business operations and our financial position or results of operations.", "We might be adversely impacted by changes or disruptions in product supply.", "Our inventory might be requisitioned, diverted or allocated by government order such as under emergency, disaster and civil defense declarations.", "For example, government actions in response to the COVID-19 pandemic affect our supply allocation, and those and our own allocation decisions can impact our customer relationships.", "Changes in the healthcare industry\u2019s or our suppliers\u2019 pricing, selling, inventory, distribution or supply policies or practices could significantly reduce our revenues and net income.", "We might experience disruptions in our supply of higher margin pharmaceuticals, including generic pharmaceuticals.", "sourcing joint venture with Walmart, Inc. is unsuccessful or experiences margins declines.", "products and services and the volume of their purchases.", "Our generic  pharmaceuticals  distribution  business  is subject  to  pricing  risks.  We  might  be  adversely  impacted  if  our ClarusONE  generic  pharmaceutical", "Suppliers might increase their prices, reduce their output or change their terms of sale due to limited availability of credit.", "We may have difficulties in sourcing or selling products due to a variety of causes.", "Difficulties in product manufacturing or access to raw materials could result in supplier production shutdowns, product shortages and other supply disruptions.", "The COVID-19 pandemic adversely affects the availability of some products, resulting in product allocation and delivery delays.", "We have operations in the U.K. and the European Union (\u201cE.U.\u201d) and face risks associated with the uncertainty and potential disruptions that might follow the", "These events can disrupt operations for us, our suppliers, our vendors, and our customers.", "For example, in February 2021, a severe winter storm affecting the United  States  temporarily  impacted  our  distribution  business  operations,  primarily  in  Texas.  They  might  affect  consumer  confidence  levels  and  spending.  In response to these events, we might suspend operations, implement extraordinary procedures, seek alternate sources for product supply, or suffer consequences that are unexpected and difficult to mitigate.", "In particular, the rapid and widespread transmission of the SARS-CoV-2 novel coronavirus beginning in late 2019 impacts us in significant ways.", "For example, to mitigate the spread of the COVID-19 disease caused by SARS-CoV-2, we implemented travel restrictions and remote working  arrangements  for  most  of  our  employees  in  order  to  minimize  physical  contact,  and  we  implemented  additional  sanitation  and  personal  protection measures in our warehouse, retail pharmacy and delivery operations.", "These measures might not fully mitigate COVID-19 risks to our workforce and we could experience unusual levels of absenteeism that might impair operations and delay delivery of products.", "The ongoing impacts of the pandemic might cause a general economic slowdown or recession in one or more markets, disruptions and volatility in global capital markets and other broad and adverse effects on the economy, business conditions, commercial activity and the healthcare industry.", "The pandemic might impact our business operation, financial position and results of operation in unpredictable ways that depend on highly uncertain future  developments,  such  as  determining  the  effectiveness  of  current  or  future  government  actions  to  address  the  public  health  or  economic  impacts  of  the pandemic.", "These events and impacts could materially adversely affect our business operations, financial position or results of operation.", "locations,  primarily  throughout  North  America  and  Europe.  Retail  pharmacies  and  most  warehouses  are  typically  owned  or  leased  on  a  long-term  basis.  We consider our operating properties to be in satisfactory condition and adequate to meet our needs for the next several years without making capital expenditures materially higher than historical levels.", "Form 10-K for additional factors relating to these statements and Item 1A - Risk Factors in Part I of this Annual Report on Form 10-K for a list of certain risk factors applicable to our business, financial condition, and results of operations.", "We partner with life sciences companies, manufacturers, providers, pharmacies, governments, and other healthcare organizations to help provide the right medicines, medical products, and healthcare services to the right patients at the right time, safely, and cost-effectively.", "All prior segment information has been recast to reflect our new segment structure and current period presentation.", "We  implemented  a  new  segment  reporting  structure  commencing  with  the  second  quarter  of  2021,  which  resulted  in  four  reportable  segments:  U.S.", "\u2022 International is  a  new  reportable  segment  that  includes  our  operations  in  Europe  and  Canada,  bringing  together  non-U.S.-based  drug  distribution services, specialty pharmacy, retail, and infusion care services.", "\u2022 RxTS is  a  new  reportable  segment  that  brings  together  existing  businesses,  including  CoverMyMeds,  RelayHealth,  RxCrossroads,  and  McKesson Prescription Automation, including Multi-Client Central Fill as a Service, to serve our biopharma and life sciences partners and patients.", "We benefited from demand for COVID-19 tests, favorable contributions from our vaccine and related ancillary supply kit distribution programs as discussed further below, and savings from reduced travel and meetings throughout 2021;", "We have also partnered with the Department of Health and Human Services (\u201cHHS\u201d) and Pfizer to manage the assembly and distribution of the ancillary supplies needed to administer COVID-19 vaccines;", "Pharmaceutical segment driven by market growth; \u2022 Gross profit increased 1% from the prior year primarily in our Medical-Surgical Solutions segment driven by sales of COVID-19 tests; \u2022 Total operating expenses in 2021 includes the following:", "Infection rates varied throughout our fiscal year, peaking in January 2021.", "Our role in the distribution of COVID-19 vaccines in the U.S. as well as the assembly and distribution of related ancillary supply kits is discussed further below.", "McKesson Europe is also playing a role in helping support governments and public health entities in not only distributing COVID-19 vaccines across several European countries, but administering them in pharmacies as well.", "solutions, we are well positioned to respond to the COVID-19 pandemic in the U.S., Canada, and Europe.", "We have worked and continue to work closely with national and local governments, agencies, and industry partners to ensure that available supplies, including personal protective equipment (\u201cPPE\u201d), and medicine reach our customers and patients.", "put in place to mitigate the impact of COVID-19 on our business operations, including telecommuting and work-from-home policies, restricted travel, employee support programs, and enhanced safety measures, are intended to limit employee exposure to the virus that causes COVID-19.", "We expanded employee medical benefits covering COVID-19 related visits, treatments, and testing as well as expanded telehealth options to protect employee safety.", "For employees whose roles require presence at our facilities, we enhanced safety by promoting the practice of social distancing, providing reminders to wash or disinfect hands and avoid unnecessary face touching, making face masks available, placing hand sanitizers within our operating environments, and periodically cleaning and disinfecting our facilities.", "For employees whose roles do not require presence at our facilities, we added technology resources to support their working remotely.", "These steps to protect employee safety have resulted in limited disruption from COVID-19 to our normal business operations, productivity trends, and have not materially impacted our operating expenses or operating margins.", "pharmacy foot traffic as our customers increased supplies on hand in March, which drove unfavorability in our results of operations when comparing 2021 versus 2020.", "We also experienced decreased demand for primary care medical-surgical supplies due to deferrals in elective procedures in hospitals and surgery centers as well as decreased traffic and closures of doctors\u2019 offices, which was partially offset by demand for PPE and COVID-19 tests.", "COVID-19  for  the  second  half  of  our  fiscal  year  was  non-linear  and  tracked  with  patient  mobility.  We  also  saw  increased  demand  for  COVID-19  tests  and continued sales of PPE throughout the year in our Medical-Surgical Solutions segment partially offset by the impacts of social distancing measures which resulted in a less severe cough, cold, and flu season, savings for reduced travel and meetings across the enterprise, as well as improvements of retail pharmacy foot traffic in Europe and Canada.", "The vaccine and related  ancillary  kit distribution  in the U.S. favorably impacted our results in the second half of fiscal 2021 as further discussed below.", "Our Response to COVID-19 in the Workplace During this unprecedented time, we are committed in continuing to supply our customers and protect the safety of our employees.", "During  the  first  quarter  of  2021,  we  experienced  growth  in  pharmaceutical  distribution  and  specialty  drug  volumes  at  a  lower  rate  in  the  U.S.,  while", "In the centralized model, the U.S. government directs us on the distribution of the vaccines and related supplies to point-of-care sites across the country.", "The results of operations related to our vaccine distribution are reflected in our U.S.", "We also have an agreement with Pfizer to assemble and distribute ancillary supply kits needed to administer that particular COVID-19 vaccine.", "We began assembling the ancillary supply kits in September 2020 in preparation for vaccine authorization and subsequent distribution.", "Ancillary supply kits to administer the Pfizer Vaccine are shipped directly to point-of-care sites, and all other ancillary supply kits are shipped to our dedicated vaccine distribution centers.", "The results of operations for the kitting and distribution of ancillary supplies are reflected in our Medical-Surgical Solutions segment.", "These facilities can scale to meet the demand of increasing volumes of vaccines being manufactured.", "We have also set up distribution centers for kitting and inventory management as part of our contract with the HHS.", "We are working with delivery partners to manage the delivery of vaccines and ancillary supply kits from our centralized vaccine distribution centers to point-of-care destinations as directed by the CDC.", "as well as the kitting and distribution of ancillary supplies for COVID-19 vaccines in our Medical-Surgical Solutions segment contributed approximately 20% in segment  revenues  and  segment  operating  profit.  Additionally,  the  distribution  of  COVID-19  vaccines  in  our  U.S.  Pharmaceutical  segment  contributed approximately 2% in segment operating profit for the year ended March 31, 2021.", "During our fourth quarter of 2020, we experienced a temporary increase in demand for pharmaceuticals.", "Certain PPE items held for resale were valued in our inventory at costs that were inflated by earlier COVID-19 pandemic demand levels.", "That inventory valuation, if not supported by market resale prices, may be written down to net realizable value.", "We may also write-off inventory due to decreased customer demand and excess inventory.", "response to supply availability and customer demand patterns for certain products, with varying inventory level impacts depending on the specific product within our portfolio.", "As our supply levels improve, and the federal government evolves guidance on the prioritization of providers or geographic markets, we will continue to adapt our distribution policies.", "We were able to maintain appropriate labor and overall vendor supply levels during the year ended March 31, 2021.", "suppliers,  their  locations,  and  the  extent  to  which  they  are  impacted  by  the  COVID-19  pandemic,  we  are  proactively  working  with  manufacturers,  industry partners, and government agencies to meet the needs of our customers during the pandemic.", "We have assembled a Critical Care Drug Task Force, made up of our procurement  specialists,  clinical  health  systems  pharmacists,  and  supply  chain  professionals,  that  is  focused  on  securing  additional  product  where  available, sourcing back-up products, and protecting our operations across all locations and facilities.", "We are also working with manufacturers through several channels, including  our  ClarusONE  Sourcing  Services  LLP  (\u201cClarusONE\u201d)  and  global  sourcing  teams  in  London,  and  our  leaders  are  actively  engaged  in  addressing potential shortages.", "We have engaged with industry partners and government agencies to gain visibility into supply and demand.", "Additionally, we have a robust Business Continuity and Disaster Recovery Program (\u201cBCRP\u201d) and we have proactively enhanced our BCRP in response to the COVID-19 pandemic to protect the supply  chain  to  minimize  disruption  in  healthcare,  protect  our  customers,  ensure  the  safety  and  security  of  our  employees  and  workplaces,  and  ensure  the continuity of critical business processes.", "supplies and medications to help prevent the spread of the disease and treat those that are ill.", "COVID-19 has put an unprecedented strain on the supply of high- demand PPE, including N95 masks, gloves, as well as disinfecting sprays and wipes.", "The supply chain has improved over the initial impact of pandemic-related demand, and we continue to closely monitor demand by customer type and certain PPE and infection prevention items are still in short supply.", "Our allocation approach has helped us avoid stock outs in many critical product categories, allowing us to provide PPE supplies to many more customers for a much longer time.", "We anticipate these market conditions will remain for the foreseeable future.", "Our efforts to help the supply chain have included sourcing products from new suppliers all over the world, working closely with the federal government to help with the nation\u2019s response and collaborating with partners to source, develop, and deliver new products to market.", "The full extent to which COVID-19 will impact us depends on many factors and future developments, including: the duration and spread of the virus; governmental actions to limit the spread of the virus; potential seasonality of viral outbreaks; potential new strains or variants of the original virus; the amount of COVID-19 vaccines authorized, manufactured, distributed, and administered; the amount of ancillary supply kits assembled and distributed; the  effectiveness  of  COVID-19  vaccines  and  governmental  measures  in  controlling  the  spread  of  the  virus;  and  the  effectiveness  of  treatments  of  infected individuals.", "Impact to our Supply Chain We  also  continue  to  monitor  the  COVID-19  pandemic  impacts  on  our  supply  chain.  Although  the  availability  of  various  products  is  dependent  on  our", "Gross profit was favorably impacted by growth of specialty pharmaceuticals and the contribution from our vaccine distribution programs in our U.S.", "\u2022 Goodwill impairment charges of $1.8 billion in our European Retail Pharmacy (\u201cEuropean RP\u201d) and European Pharmaceutical Distribution (\u201cEuropean PD\u201d) reporting units within the International segment.", "This initiative primarily led us to rationalize our office space in North America.", "Where we determine to cease using office space, we plan to exit the portion of the facility no longer used.", "We also may retain and repurpose certain other office locations.", "transformational changes in technologies and business processes, operational efficiencies, and cost savings.", "centralization of certain functions and outsourcing through an expanded arrangement with a third-party vendor to achieve operational efficiency.", "The  initiative  consisted  of  multiple  growth  priorities  and  plans  to  optimize  our  operating  models  and  cost  structures  primarily  through  centralization,  cost management, and outsourcing of certain administrative functions.", "As part of the growth initiative, we committed to implement certain actions including a reduction in workforce, facility consolidation, and store closures.", "This set of initiatives was substantially complete by the end of 2020. $115 million, $112 million, and $245 million, respectively, primarily related to our retail pharmacy businesses in Canada and Europe within our International segment.", "During  the  first  quarter  of  2021,  we  committed  to  an  initiative  within  the  U.K.,  which  is  included  in  our  International  segment,  to  further  drive", "In the fourth quarter of 2019, we committed to certain programs to continue our operating model and cost optimization efforts.", "On April 25, 2018, we announced a strategic growth initiative intended to drive long-term incremental profit growth and to increase operational efficiency.", "pharmaceutical price increases, growth in specialty pharmaceuticals, and higher volumes from retail national account customers, partially offset by branded to generic  drug  conversions.  Revenues  for  this  segment  were  unfavorably  impacted  by  fluctuations  in  demand  for  pharmaceuticals  in  retail  pharmacies  and institutional healthcare providers due to COVID-19 largely during the onset of the pandemic in late March 2020 and during our first quarter of 2021 combined with the loss of certain customers.", "exchange fluctuations, revenues for this segment decreased 9% primarily due to the contribution of our German pharmaceutical wholesale business to a joint venture with WBA and to a lesser extent, the exit of unprofitable customers in our Canadian business.", "Revenues for this segment were also unfavorably impacted by lower volumes from the adverse impacts from COVID-19 in our pharmaceutical distribution and retail pharmacy businesses within Europe.", "exchange fluctuations, revenues for this segment increased 4% primarily due to market growth in our European pharmaceutical distribution and retail pharmacy businesses.", "2020 vs. 2019 Medical-Surgical Solutions revenues for the year ended March 31, 2020 increased 9% compared to the prior year primarily due to market growth in our", "The impacts from COVID-19 in our pharmaceutical distribution and retail pharmacy businesses within Europe also caused unfavorability in our segment results year over year.", "demand for COVID-19 tests and PPE, as well as the contribution from kitting and distribution of ancillary supplies for COVID-19 vaccines.", "This was partially offset by inventory charges on certain PPE and other related products, unfavorability in our primary care business due to customer closures largely during the first quarter  of 2021, and a  less severe  cough, cold, and flu  season.", "2020 vs. 2019 Operating profit increased for the year ended March 31, 2020 compared to the prior year primarily due to market growth in our specialty business.", "2020 vs. 2019 Operating profit and operating profit margin increased for the year ended March 31, 2020 compared to prior year primarily due to market growth in our", "We monitor our operations and adopt strategies responsive to changes in the economic and political environment in each of the countries in which we operate.", "Our foreign operations represented approximately 15%, 17%, and 18% of our consolidated revenues in 2021, 2020, and 2019, respectively.", "We also have agreements with GPOs, each of which functions as a purchasing agent on behalf of member hospitals, pharmacies and other healthcare providers, as well as with government entities and agencies.", "and updated if unusual circumstances or trends are present.", "LIFO method presumes that the most recent inventory purchases are the first items sold and the inventory cost under LIFO approximates market.", "The majority of the cost of domestic inventories is determined using the LIFO method.", "If we had used the moving average method of inventory valuation, inventories would have been approximately $406 million and $444 million higher than the amounts reported at March 31, 2021 and 2020, respectively.", "such, our LIFO inventory is valued at the lower of LIFO or market.", "Inventories: Inventories  consist of merchandise  held  for resale.  We report  inventories  at the lower of cost or net realizable  value, except  for inventories", "We believe that the moving average inventory costing method provides a reasonable estimation of the current cost of replacing inventory (i.e., \u201cmarket\u201d).", "Shifts in market trends and conditions, changes in customer preferences due to the introduction of generic drugs or new pharmaceutical products or the loss of one or more significant customers are factors that could affect the value of our inventories.", "We write down inventories which are considered excess and obsolete as a result of these reviews.", "These factors could make our estimates of inventory valuation differ from actual results.", "In addition, we compare the aggregate of the reporting units\u2019 fair values to our market capitalization as further corroboration of the fair values.", "They can be affected by a variety of factors, including external factors such as industry and economic trends, and internal factors such as changes in our business strategy and our internal forecasts.", "Management makes certain judgments and estimates in its assessment including but not limited to: identifying if circumstances indicate a decline in value is other than temporary, expectations about the business operations of investees, as well as industry, financial, and market factors.", "On March 9, 2020, we completed the Split-off of our interest in the Change Healthcare JV.", "Our businesses require substantial investments in working capital that are susceptible to large variations during the year as a result of inventory purchase patterns and seasonal demands.", "Our  redeemable  noncontrolling  interests  primarily  relate  to  our  consolidated  subsidiary,  McKesson  Europe.  Under  the  Domination  Agreement,  the", "However, our risk management programs are designed such  that  the  potential  loss  in  value  of  these  risk  management  portfolios  described  above  would  be  largely  offset  by  changes  in  the  value  of  the  underlying exposure.", "With the participation of the Chief Executive Officer and the Chief Financial Officer, our management conducted an assessment of the effectiveness of our internal control over financial  reporting based on the framework and criteria  established in Internal Control\u2014Integrated Framework (2013), issued by the Committee of Sponsoring Organizations of the Treadway Commission.", "Under the market approach, fair value is estimated by comparing the business to similar businesses, or guideline companies whose securities are actively traded in public markets.", "The severity,  magnitude  and  duration,  as  well  as  the  economic  consequences  of  the  coronavirus  diseases  2019  (\u201cCOVID-19\u201d)  pandemic,  are  uncertain,  rapidly changing, and difficult to predict.", "The majority of the cost of domestic inventories is determined using the LIFO method.", "Goodwill testing requires a complex series of assumptions and judgments by management in projecting future operating results, selecting guideline companies for comparisons and assessing risks.", "Revenues generated from the distribution of pharmaceutical and medical products represent the majority of the Company\u2019s revenues.", "customer, is responsible for fulfilling the promise to its customer, has latitude in establishing prices, and controls the relationship with the customer.", "Shipping and handling costs associated with outbound freight after control over a product has transferred to a customer are accounted for as fulfillment costs.", "International segment, to further drive transformational changes in technologies and business processes, operational efficiencies, and cost savings.", "continues to implement centralization of certain functions and outsourcing through an expanded arrangement with a third-party vendor to achieve operational efficiency.", "Irving, Texas to improve efficiency, collaboration, and cost competitiveness.", "PSUs are conditional upon the attainment of market and performance objectives over a specified period.", "As a practical expedient, the Company does not separate lease components from non-lease components such as common area maintenance, utilities, and repairs and maintenance.", "The Company\u2019s most significant relationships are with oncology and other specialty practices.", "Level 2 - significant other observable market-based inputs.", "Level 3 - significant unobservable inputs for which little or no market data exists and requires considerable assumptions that are significant to the fair value", "measurement due to the significance of unobservable inputs developed using company-specific information.", "It has received the same warranties from its suppliers, which customarily are the manufacturers of the products.", "Pharma Belgium NV is also part of the investigation.", "Stockholders (the \u201cProxy Statement\u201d) under the heading \u201cElection of Directors.\u201d Information about our Executive Officers is incorporated by reference from the discussion in Part I of this report under the heading \u201cInformation about our Executive Officers.\u201d Information about our Audit Committee, including the members of the  committee  and  our  Audit  Committee  Financial  Expert,  is  incorporated  by  reference  from  the  discussion  under  Item  1  of  our  Proxy  Statement  under  the headings \u201cThe Board, Committees and Meetings,\u201d and \u201cAudit Committee Report.\u201d", "We offer more than 275,000 national brand medical- surgical products as well as McKesson\u2019s own line of high-quality products through a network of distribution centers within the United States (\u201cU.S.\u201d).", "as a Service, to serve our biopharma and life sciences partners and patients.", "Our  U.S.  Pharmaceutical  segment  distributes  branded,  generic,  specialty,  biosimilar  and  over-the-counter  (\u201cOTC\u201d)  pharmaceutical  drugs,  and  other", "We also source generic pharmaceutical drugs through our joint sourcing entity, ClarusONE Sourcing Services LLP (\u201cClarusONE\u201d).", "We invest in technology and other systems at all of our distribution centers to enhance safety, reliability, and product availability.", "For example, we offer McKesson Connect , an internet-based ordering system that provides item look-up and real-time inventory availability as well as ordering, purchasing, third-party reconciliation, and account management functionality.", "We make extensive use of technology as an enabler to ensure customers have the right products at the right time in the right place.", "We provide solutions to our customers including supply management technology, world-class marketing programs, managed care, repackaging products, and services to help them meet their business and quality goals.", "We continue to implement information systems to help achieve greater consistency and accuracy both internally and for our customers.", "operational efficiency, and automation that help independent pharmacists focus on patient care while improving profitability.", "Retail National Accounts: We provide business solutions that help retail national account customers increase revenues and profitability.", "These distribution centers also provide the foundation for a two-tiered distribution network that supports best-in-class direct store delivery.", "performance, increase operational efficiencies, and deliver better patient care.", "Community-based physicians in this business have broad flexibility and discretion to select the products and commitment levels that best meet their practice needs.", "Services in provider solutions include specialty drug distribution, group purchasing organizations (\u201cGPO\u201d) like Onmark\u00ae, technology solutions, practice consulting services, and vaccine distribution, including our exclusive distributor relationship with the Centers for Disease Control and Prevention\u2019s (\u201cCDC\u201d) Vaccines for Children program.", "SKY Packaging enables acute care, long-term care, and institutional pharmacies to provide cost-effective, uniform packaging.", "Our use of the term \u201cspecialty\u201d may not be comparable to that used by other industry participants, including our competitors.", "Our operations in Canada, including Rexall retail pharmacies, support better, safer patient care by delivering vital medicines, supplies, and information technology solutions throughout Canada.", "functions  as  a  vital  link,  using  technology-enabled  management  systems  at  our  regional  wholesale  branches  to  connect  manufacturers  to  retail  pharmacies, supplying medicines and other products sold in pharmacies.", "In addition, we partner with independent pharmacies under local banner programs.", "banners, and more than 400 owned pharmacies under the Rexall brand where we provide patients with greater choice and access, integrated pharmacy care and industry-leading service levels.", "This segment includes our Ontada business, providing software to support the clinical, financial, and operational needs of our oncology practice partners.", "Our European Pharmaceutical Distribution business delivers pharmaceutical and other healthcare-related products to pharmacies across Europe.", "Our more than 250,000 customers include physician offices, surgery centers, post-acute care facilities, hospital reference labs, and  home  health  agencies.  We  distribute  medical-surgical  supplies  (such  as  gloves,  needles,  syringes  and  wound  care  products),  infusion  pumps,  laboratory equipment  and  pharmaceuticals.  Through  a  network  of  distribution  centers  within  the  U.S.,  we  offer  more  than  275,000  products  from  national  brand manufacturers and McKesson\u2019s own high-quality product line.", "Through the right mix of products and services, we help improve efficiencies, profitability and compliance.  We  also  never  lose  focus  on  helping  customers  improve  patient  and  business  outcomes.  We  develop  customized  plans  to  address  the  product, operational, and clinical support needs of our customers, including tackling inventory management, reducing administrative burdens, and training and educating clinical staff.", "We deliver for our customers, so they can deliver and care for their patients.", "pharmaceutical distribution environment in which our U.S.", "Pharmaceutical and International segments operate, we face strong competition from international, national, regional and local full-line, short-line and specialty distributors, service merchandisers, self-warehousing chain drug stores, manufacturers engaged in direct distribution, third-party logistics companies, and large payer organizations.", "Our retail businesses, which primarily operate in our International segment, face competition from various global, national, regional, and local global retailers, including chain and independent pharmacies.", "We consider our largest competitors in distribution, wholesaling, and logistics to be AmerisourceBergen Corporation and Cardinal Health, Inc.", "businesses, which may from time to time decide to develop, for their own internal needs, supply management capabilities that might otherwise be provided by our businesses.", "We believe that our scale and diversity of product and service offerings are our primary competitive advantages.", "operations and market position, but we do not consider any of our businesses to be dependent upon any one patent, copyright, trademark, or trade secret, or any family or families of the same.", "be necessary in the future to seek or renew licenses relating to various aspects of our products and services, we believe, based upon past experience and industry practice,  such  licenses  generally  can  be  obtained  on  commercially  reasonable  terms.  We  believe  our  operations  and  products  and  services  are  not  materially dependent on any single license or other agreement with any third party.", "on improving employee health and wellness, creating opportunities for growth and development, and providing an inclusive workplace where our employees can reach their full potential.", "At March 31, 2021, we had approximately 76,000 employees worldwide, including 17,000 part-time employees and 32,000 employees in the U.S. healthier future is everyone\u2019s business.", "We build successful teams by recruiting, developing, and retaining diverse talent and we recognize our culture of inclusion as an important element that drives long-term shareholder value.", "(1) The data for our metrics is derived from our voluntary, self-identification process as of March 31, 2021 and therefore represents our best estimate at this time. (2) Represents our leadership at the vice president level and above. (3) Represents worldwide employees. (4) Represents U.S. employees only as the data for Canada and Europe is not available.", "I CARE and ILEAD principles, we fulfill our mission of improving care in every setting.", "Our I CARE values (Integrity, Inclusion, Customer-First, Accountability, Respect, Excellence) are foundational to all that we do, and who we are as a company.", "ILEAD (Inspire, Leverage, Execute, Advance, Develop) is our common definition and shared commitment to leadership.", "By embracing this commitment, we bring out the best in ourselves and position McKesson to continue to drive better health \u2013 for our company, our customers, and the patients they serve for years to come.", "We promote leadership behaviors through culture initiatives that offer practical tips on how to debate, decide, and commit, be open and candid, and maintain an enterprise-first mindset when navigating conversations affecting operations within and across our business segments.", "We hold inbound licenses for certain intellectual property that is used internally, and in some cases, utilized in McKesson\u2019s products or services.", "Culture and Leadership: What sets McKesson apart as an exceptional place is our people.", "Our employees understand that together, unified by our global", "where everyone can bring their authentic self to work and feel welcomed and appreciated, and where their perspectives are sought out, heard, and considered.", "Through training, we encourage leaders to embrace diverse perspectives and lead inclusively.", "We  also  seek  employee  feedback  through  an  annual  employee  opinion  survey,  which  assesses  our employees\u2019  levels  of engagement, commitment, and overall satisfaction using industry benchmarks, and we then design action plans to improve those metrics.", "We routinely assess facilities to monitor closely adherence to established security and safety standards.", "If we identify a vulnerability, it is documented, and the facility prepares an action plan.", "Our employees receive specialized training related to their role, work setting, and equipment used in their work environment.", "As our processes evolve, we update relevant safety training modules, which may include new employee training programs.", "The various responses we put in place to mitigate the impact of COVID- 19  on  our  business  operations,  including  telecommuting  and  work-from-home  policies,  restricted  travel,  and  enhanced  safety  measures,  are  intended  to  limit employee exposure to the virus that causes COVID-19 as they perform their jobs while also providing employee support programs and a sense of belonging.", "For additional  information  on  our  response  to  COVID-19  in  the  workplace,  refer  to  the  COVID-19  section  of \u201cTrends  and  Uncertainties\u201d in  \u201cManagement\u2019s Discussion and Analysis of Financial Condition and Results of Operations\u201d in Item 7 of Part II included in this Annual Report on Form 10-K.", "Food and Drug Administration Amendments Act of 2007 requires the FDA to establish standards and identify and validate effective technologies, such as track and trace or authentication technologies, to secure the pharmaceutical supply chain against counterfeit drugs.", "Despite physical, technical, and administrative security measures that we implement in order to, among other things, address regulatory requirements, our technology systems and operations may continue to be subject to cybersecurity incidents.", "The risk of cybersecurity incidents may be increased due to a variety of factors, both internal and external.", "Sales to our largest customer, CVS Health Corporation (\u201cCVS\u201d), accounted for approximately 21% of our total consolidated revenues in 2021.", "In May 2019, we extended our pharmaceutical distribution relationship with CVS to June 2023.", "a supplier could adversely affect our business if alternate sources of supply are unavailable.", "We believe that our relationships with our suppliers are generally sound.", "The ten largest suppliers in 2021 accounted for approximately 50% of our purchases.", "For these manufacturers, a reduction in the frequency and magnitude of price increases, as well as restrictions in the amount of inventory available to us, could have an adverse impact on our gross profit margin.", "Although it is not possible to predict or identify all such risks and uncertainties, they include, but are not limited to, the factors discussed in Item 1A of Part I of this report under \u201cRisk Factors\u201d and in our publicly available SEC filings and press releases.", "Suppliers: We obtain pharmaceutical and other products from manufacturers, none of which accounted for more than 7% of our purchases in 2021.", "practical  to  identify  or  describe  all  risks  and  uncertainties  that  might  materially  impact  our  business  operations,  reputation,  financial  position  or  results  of operations.", "Our business could be materially affected by risks that we have not yet identified or that we currently consider to be immaterial.", "This is not a complete statement of all potential risks and uncertainties.", "For example, pharmacy operations are exposed to risks such as improper filling of prescriptions, mislabeling of prescriptions, inadequacy of warnings, unintentional distribution of counterfeit drugs and expiration of drugs.", "The  discussion  below  identifies  certain  representative  risks  that  might  cause  our  actual  business  results  to  materially  differ  from  our  estimates.  It  is  not", "Certain of our businesses may be required to register for permits and/or licenses with, and comply with operating and security standards of, the DEA, FDA, HHS, CMS, various state boards of pharmacy, state health departments and/or comparable state agencies as well as foreign agencies and certain accrediting bodies, depending upon the type of operations and location of product development, manufacture, distribution, and sale.", "As of March 31, 2021, suspensions at the four distribution centers had all expired  by  their  own  terms.  If  we  are  not  able  to  obtain,  maintain  or  renew  permits,  licenses  or  other  regulatory  approvals  needed  for  the  operation  of  our businesses, it might have a materially adverse impact on our business operations and our financial position or results of operations.", "Food and Drug Administration Amendments Act of 2007 requires the FDA to establish standards and identify and validate effective technologies, such as track  and  trace  or  authentication  technologies,  to  secure  the  pharmaceutical  supply  chain  against  counterfeit  drugs.  We  also  have  record-keeping  and  other obligations under the E.U.", "We are subject to significant compliance obligations under privacy laws such as the General Data Protection Regulation in the  European  Union  (\u201cGDPR\u201d),  the  Personal  Information  Protection  and  Electronic  Documents  Act  (\u201cPIPEDA\u201d)  in  Canada,  and  the  California  Consumer Protection  Act  (\u201cCCPA\u201d).  Some  privacy  laws  prohibit  the  transfer  of  personal  information  to  certain  other  jurisdictions.  We  are  subject  to  privacy  and  data protection compliance audits or investigations by various government agencies.", "We experience cybersecurity incidents that might significantly compromise our technology systems or might result in material data breaches.", "Despite physical, technical, and administrative security measures, our technology systems and operations have been, and likely will continue to be, subject to cyberattacks from sources beyond our control.", "Cybersecurity incidents  include  actual  or  attempted  unauthorized  access,  tampering,  malware  insertion,  ransomware  attacks  or  other  system  integrity  events.  The  risk  of cyberattacks  may be increased  due to a variety of factors, both internal  and external.  A cybersecurity  incident might involve a material  data breach or other material impact to the integrity and operations of our technology systems, which might result in litigation or regulatory action, loss of customers or revenue, and increased expense, any of which might have a materially adverse impact on our business operations, reputation, and our financial position or results of operations.", "We might experience significant problems with information systems or networks.", "If those information systems suffer errors, interruptions, or become unavailable, there might be a materially adverse impact on our business operations, reputation, and our financial position or results of operations.", "Our products or services might not conform to specifications or perform as we intend.", "professionals delivering patient care tend to have heightened sensitivity to system and software errors.", "Errors or failures might damage our reputation and negatively affect future sales.", "We sell and provide services involving complex software and technology that may contain errors, especially when first introduced to market.", "The networks and hosting systems are vulnerable to interruption or damage from sources beyond our control, such as power loss, telecommunications failures, fire, natural disasters, software and hardware failures and cyberattacks.", "If the timely delivery of medical care or other customer business requirements are impaired by data access, network or systems problems, we could be exposed to significant claims and reputational harm.", "We might not realize expected benefits from business process initiatives.", "achieve  our  desired  objectives,  or  unintended  consequences  such  as  distraction  of  our  management  and  employees,  business  disruption,  attrition  beyond  any planned reduction in workforce, inability to attract or retain key personnel and reduced employee productivity.", "We might be unable to successfully complete or integrate acquisitions or other business combinations.", "We may not receive regulatory approvals needed to complete proposed transactions, or such  approvals  may  be  subject  to  delays  or  conditions  that  reduce  transaction  benefits.  Achieving  the  desired  outcomes  of  business  combinations  involves significant  risks  including:  diverting  management\u2019s  attention  from  other  business  operations;  challenges  with  assimilating  the  acquired  businesses,  such  as integration  of  operations  and  systems;  failure  or  delay  in  realizing  operating  synergies;  difficulty  retaining  key  acquired  company  personnel;  unanticipated accounting or financial systems issues with the acquired business, which might affect our internal controls over financial reporting; unanticipated compliance issues in the acquired business; challenges retaining customers of the acquired business; unanticipated expenses or charges to earnings, including depreciation and amortization or potential impairment charges; and risks of known and unknown assumed liabilities in the acquired business.", "We provide remote services that involve hosting customer data and operating software on our own or third party systems.", "Our growth strategy includes consummating acquisitions or other business combinations that either expand or complement our business.", "could delay the achievement of our strategic objectives.", "We might be adversely impacted by outsourcing or similar third-party relationships.", "Third-party services providers might fail to perform as anticipated, or we might experience unanticipated operational difficulties, compliance requirements or increased costs related to outsourced services.", "We may be unsuccessful in retail pharmacy operations or maintaining profitability.", "If our retail pharmacy operations fail to achieve, or are unable to sustain, acceptable net sales and profitability levels, it might have a materially adverse impact on our business operations and our financial position or results of operations.", "We rely on third parties to perform certain business and administrative functions for us.", "We might not adequately develop, implement and monitor these", "Our business strategy included expanding our retail pharmacy operations.", "Our retail pharmacy operations involve numerous risks, such as the following ones.", "For example, our contracts with the U.S. government generally require us to comply with the Federal Acquisition Regulations, Procurement Integrity Act, Buy American Act, Trade Agreements Act, and other laws and regulations.", "The occurrence of any of these risks could harm our reputation and might have a materially adverse impact on our business operations and our financial position or results of operations.", "Our participation in vaccination distribution programs may materially affect our operating results, reputation, and business.", "For example, the novel nature of the SARS-CoV\u20112 virus and the broad scope of the ongoing COVID-19 vaccine distribution program introduce uncertainty about what volumes of products may become available for distribution by us, the effectiveness of vaccines, and the cost of distribution.", "Because of such uncertainties, our operating results may be subject to variability.", "Our participation in such programs also exposes us to various risks, including regulatory compliance, government oversight, dependence on government funding, contractual performance, litigation, security risks, and supply chain challenges.", "Any significant problems with our participation in such programs might have a materially adverse impact on our reputation and our business.", "We might be harmed by changes in our relationships or contracts with suppliers.", "Our competitors might develop non-infringing products or services equivalent or superior to ours.", "We might be unable to successfully recruit and retain qualified employees.", "We compete with many other businesses to attract and retain employees.", "We may experience sudden loss of key personnel due to a variety of causes, such as illness, and must adequately plan for succession of key management roles.", "Employees might not successfully transition into new roles.", "Some of these changes increase our risks and create uncertainties for our business.", "These proposals might result in significant changes in the pharmaceutical value chain as manufacturers, PBM, managed care organizations and other industry stakeholders look to implement new transactional flows and adapt their business models.", "Many of our products and services are designed and intended to function within the structure of current healthcare financing and reimbursement systems.", "We might be adversely impacted by competition and industry consolidation.", "specialty distributors, service merchandisers, self-warehousing chain drug stores, manufacturers engaged in direct distribution, third-party logistics companies and large  payer  organizations.  In  addition,  our  businesses  face  competition  from  various  other  service  providers  and  from  pharmaceutical  and  other  healthcare manufacturers as well as other potential customers, which may from time-to-time decide to develop, for their own internal needs, supply management capabilities that might otherwise be provided by our businesses.", "This concentration reduces our ability to negotiate favorable terms with suppliers and causes us to depend on a smaller number of suppliers.", "Many of our customers, including  healthcare  organizations,  have  consolidated  and  have  greater  power  to  negotiate  favorable  prices.  Consolidation  by  our  customers,  suppliers  and competitors might reduce the number of market participants and give the remaining enterprises greater bargaining power, which might lead to erosion in our profit margin.", "These competitive pressures and industry consolidation might have a materially adverse impact on our business operations and our financial position or results of operations.", "We might be adversely impacted by changes or disruptions in product supply.", "Our inventory might be requisitioned, diverted or allocated by government order such as under emergency, disaster and civil defense declarations.", "For example, government actions in response to the COVID-19 pandemic affect our supply allocation, and those and our own allocation decisions can impact our customer relationships.", "Changes in the healthcare industry\u2019s or our suppliers\u2019 pricing, selling, inventory, distribution or supply policies or practices could significantly reduce our revenues and net income.", "We might experience disruptions in our supply of higher margin pharmaceuticals, including generic pharmaceuticals.", "sourcing joint venture with Walmart, Inc. is unsuccessful or experiences margins declines.", "products and services and the volume of their purchases.", "Our generic  pharmaceuticals  distribution  business  is subject  to  pricing  risks.  We  might  be  adversely  impacted  if  our ClarusONE  generic  pharmaceutical", "Suppliers might increase their prices, reduce their output or change their terms of sale due to limited availability of credit.", "We may have difficulties in sourcing or selling products due to a variety of causes.", "Difficulties in product manufacturing or access to raw materials could result in supplier production shutdowns, product shortages and other supply disruptions.", "The COVID-19 pandemic adversely affects the availability of some products, resulting in product allocation and delivery delays.", "We have operations in the U.K. and the European Union (\u201cE.U.\u201d) and face risks associated with the uncertainty and potential disruptions that might follow the", "These events can disrupt operations for us, our suppliers, our vendors, and our customers.", "For example, in February 2021, a severe winter storm affecting the United  States  temporarily  impacted  our  distribution  business  operations,  primarily  in  Texas.  They  might  affect  consumer  confidence  levels  and  spending.  In response to these events, we might suspend operations, implement extraordinary procedures, seek alternate sources for product supply, or suffer consequences that are unexpected and difficult to mitigate.", "In particular, the rapid and widespread transmission of the SARS-CoV-2 novel coronavirus beginning in late 2019 impacts us in significant ways.", "For example, to mitigate the spread of the COVID-19 disease caused by SARS-CoV-2, we implemented travel restrictions and remote working  arrangements  for  most  of  our  employees  in  order  to  minimize  physical  contact,  and  we  implemented  additional  sanitation  and  personal  protection measures in our warehouse, retail pharmacy and delivery operations.", "These measures might not fully mitigate COVID-19 risks to our workforce and we could experience unusual levels of absenteeism that might impair operations and delay delivery of products.", "The ongoing impacts of the pandemic might cause a general economic slowdown or recession in one or more markets, disruptions and volatility in global capital markets and other broad and adverse effects on the economy, business conditions, commercial activity and the healthcare industry.", "The pandemic might impact our business operation, financial position and results of operation in unpredictable ways that depend on highly uncertain future  developments,  such  as  determining  the  effectiveness  of  current  or  future  government  actions  to  address  the  public  health  or  economic  impacts  of  the pandemic.", "These events and impacts could materially adversely affect our business operations, financial position or results of operation.", "locations,  primarily  throughout  North  America  and  Europe.  Retail  pharmacies  and  most  warehouses  are  typically  owned  or  leased  on  a  long-term  basis.  We consider our operating properties to be in satisfactory condition and adequate to meet our needs for the next several years without making capital expenditures materially higher than historical levels.", "Form 10-K for additional factors relating to these statements and Item 1A - Risk Factors in Part I of this Annual Report on Form 10-K for a list of certain risk factors applicable to our business, financial condition, and results of operations.", "We partner with life sciences companies, manufacturers, providers, pharmacies, governments, and other healthcare organizations to help provide the right medicines, medical products, and healthcare services to the right patients at the right time, safely, and cost-effectively.", "All prior segment information has been recast to reflect our new segment structure and current period presentation.", "We  implemented  a  new  segment  reporting  structure  commencing  with  the  second  quarter  of  2021,  which  resulted  in  four  reportable  segments:  U.S.", "\u2022 International is  a  new  reportable  segment  that  includes  our  operations  in  Europe  and  Canada,  bringing  together  non-U.S.-based  drug  distribution services, specialty pharmacy, retail, and infusion care services.", "\u2022 RxTS is  a  new  reportable  segment  that  brings  together  existing  businesses,  including  CoverMyMeds,  RelayHealth,  RxCrossroads,  and  McKesson Prescription Automation, including Multi-Client Central Fill as a Service, to serve our biopharma and life sciences partners and patients.", "We benefited from demand for COVID-19 tests, favorable contributions from our vaccine and related ancillary supply kit distribution programs as discussed further below, and savings from reduced travel and meetings throughout 2021;", "We have also partnered with the Department of Health and Human Services (\u201cHHS\u201d) and Pfizer to manage the assembly and distribution of the ancillary supplies needed to administer COVID-19 vaccines;", "Pharmaceutical segment driven by market growth; \u2022 Gross profit increased 1% from the prior year primarily in our Medical-Surgical Solutions segment driven by sales of COVID-19 tests; \u2022 Total operating expenses in 2021 includes the following:", "Infection rates varied throughout our fiscal year, peaking in January 2021.", "Our role in the distribution of COVID-19 vaccines in the U.S. as well as the assembly and distribution of related ancillary supply kits is discussed further below.", "McKesson Europe is also playing a role in helping support governments and public health entities in not only distributing COVID-19 vaccines across several European countries, but administering them in pharmacies as well.", "solutions, we are well positioned to respond to the COVID-19 pandemic in the U.S., Canada, and Europe.", "We have worked and continue to work closely with national and local governments, agencies, and industry partners to ensure that available supplies, including personal protective equipment (\u201cPPE\u201d), and medicine reach our customers and patients.", "put in place to mitigate the impact of COVID-19 on our business operations, including telecommuting and work-from-home policies, restricted travel, employee support programs, and enhanced safety measures, are intended to limit employee exposure to the virus that causes COVID-19.", "We expanded employee medical benefits covering COVID-19 related visits, treatments, and testing as well as expanded telehealth options to protect employee safety.", "For employees whose roles require presence at our facilities, we enhanced safety by promoting the practice of social distancing, providing reminders to wash or disinfect hands and avoid unnecessary face touching, making face masks available, placing hand sanitizers within our operating environments, and periodically cleaning and disinfecting our facilities.", "For employees whose roles do not require presence at our facilities, we added technology resources to support their working remotely.", "These steps to protect employee safety have resulted in limited disruption from COVID-19 to our normal business operations, productivity trends, and have not materially impacted our operating expenses or operating margins.", "pharmacy foot traffic as our customers increased supplies on hand in March, which drove unfavorability in our results of operations when comparing 2021 versus 2020.", "We also experienced decreased demand for primary care medical-surgical supplies due to deferrals in elective procedures in hospitals and surgery centers as well as decreased traffic and closures of doctors\u2019 offices, which was partially offset by demand for PPE and COVID-19 tests.", "COVID-19  for  the  second  half  of  our  fiscal  year  was  non-linear  and  tracked  with  patient  mobility.  We  also  saw  increased  demand  for  COVID-19  tests  and continued sales of PPE throughout the year in our Medical-Surgical Solutions segment partially offset by the impacts of social distancing measures which resulted in a less severe cough, cold, and flu season, savings for reduced travel and meetings across the enterprise, as well as improvements of retail pharmacy foot traffic in Europe and Canada.", "The vaccine and related  ancillary  kit distribution  in the U.S. favorably impacted our results in the second half of fiscal 2021 as further discussed below.", "Our Response to COVID-19 in the Workplace During this unprecedented time, we are committed in continuing to supply our customers and protect the safety of our employees.", "During  the  first  quarter  of  2021,  we  experienced  growth  in  pharmaceutical  distribution  and  specialty  drug  volumes  at  a  lower  rate  in  the  U.S.,  while", "In the centralized model, the U.S. government directs us on the distribution of the vaccines and related supplies to point-of-care sites across the country.", "The results of operations related to our vaccine distribution are reflected in our U.S.", "We also have an agreement with Pfizer to assemble and distribute ancillary supply kits needed to administer that particular COVID-19 vaccine.", "We began assembling the ancillary supply kits in September 2020 in preparation for vaccine authorization and subsequent distribution.", "Ancillary supply kits to administer the Pfizer Vaccine are shipped directly to point-of-care sites, and all other ancillary supply kits are shipped to our dedicated vaccine distribution centers.", "The results of operations for the kitting and distribution of ancillary supplies are reflected in our Medical-Surgical Solutions segment.", "These facilities can scale to meet the demand of increasing volumes of vaccines being manufactured.", "We have also set up distribution centers for kitting and inventory management as part of our contract with the HHS.", "We are working with delivery partners to manage the delivery of vaccines and ancillary supply kits from our centralized vaccine distribution centers to point-of-care destinations as directed by the CDC.", "as well as the kitting and distribution of ancillary supplies for COVID-19 vaccines in our Medical-Surgical Solutions segment contributed approximately 20% in segment  revenues  and  segment  operating  profit.  Additionally,  the  distribution  of  COVID-19  vaccines  in  our  U.S.  Pharmaceutical  segment  contributed approximately 2% in segment operating profit for the year ended March 31, 2021.", "During our fourth quarter of 2020, we experienced a temporary increase in demand for pharmaceuticals.", "Certain PPE items held for resale were valued in our inventory at costs that were inflated by earlier COVID-19 pandemic demand levels.", "That inventory valuation, if not supported by market resale prices, may be written down to net realizable value.", "We may also write-off inventory due to decreased customer demand and excess inventory.", "response to supply availability and customer demand patterns for certain products, with varying inventory level impacts depending on the specific product within our portfolio.", "As our supply levels improve, and the federal government evolves guidance on the prioritization of providers or geographic markets, we will continue to adapt our distribution policies.", "We were able to maintain appropriate labor and overall vendor supply levels during the year ended March 31, 2021.", "suppliers,  their  locations,  and  the  extent  to  which  they  are  impacted  by  the  COVID-19  pandemic,  we  are  proactively  working  with  manufacturers,  industry partners, and government agencies to meet the needs of our customers during the pandemic.", "We have assembled a Critical Care Drug Task Force, made up of our procurement  specialists,  clinical  health  systems  pharmacists,  and  supply  chain  professionals,  that  is  focused  on  securing  additional  product  where  available, sourcing back-up products, and protecting our operations across all locations and facilities.", "We are also working with manufacturers through several channels, including  our  ClarusONE  Sourcing  Services  LLP  (\u201cClarusONE\u201d)  and  global  sourcing  teams  in  London,  and  our  leaders  are  actively  engaged  in  addressing potential shortages.", "We have engaged with industry partners and government agencies to gain visibility into supply and demand.", "Additionally, we have a robust Business Continuity and Disaster Recovery Program (\u201cBCRP\u201d) and we have proactively enhanced our BCRP in response to the COVID-19 pandemic to protect the supply  chain  to  minimize  disruption  in  healthcare,  protect  our  customers,  ensure  the  safety  and  security  of  our  employees  and  workplaces,  and  ensure  the continuity of critical business processes.", "supplies and medications to help prevent the spread of the disease and treat those that are ill.", "COVID-19 has put an unprecedented strain on the supply of high- demand PPE, including N95 masks, gloves, as well as disinfecting sprays and wipes.", "The supply chain has improved over the initial impact of pandemic-related demand, and we continue to closely monitor demand by customer type and certain PPE and infection prevention items are still in short supply.", "Our allocation approach has helped us avoid stock outs in many critical product categories, allowing us to provide PPE supplies to many more customers for a much longer time.", "We anticipate these market conditions will remain for the foreseeable future.", "Our efforts to help the supply chain have included sourcing products from new suppliers all over the world, working closely with the federal government to help with the nation\u2019s response and collaborating with partners to source, develop, and deliver new products to market.", "The full extent to which COVID-19 will impact us depends on many factors and future developments, including: the duration and spread of the virus; governmental actions to limit the spread of the virus; potential seasonality of viral outbreaks; potential new strains or variants of the original virus; the amount of COVID-19 vaccines authorized, manufactured, distributed, and administered; the amount of ancillary supply kits assembled and distributed; the  effectiveness  of  COVID-19  vaccines  and  governmental  measures  in  controlling  the  spread  of  the  virus;  and  the  effectiveness  of  treatments  of  infected individuals.", "Impact to our Supply Chain We  also  continue  to  monitor  the  COVID-19  pandemic  impacts  on  our  supply  chain.  Although  the  availability  of  various  products  is  dependent  on  our", "Gross profit was favorably impacted by growth of specialty pharmaceuticals and the contribution from our vaccine distribution programs in our U.S.", "\u2022 Goodwill impairment charges of $1.8 billion in our European Retail Pharmacy (\u201cEuropean RP\u201d) and European Pharmaceutical Distribution (\u201cEuropean PD\u201d) reporting units within the International segment.", "This initiative primarily led us to rationalize our office space in North America.", "Where we determine to cease using office space, we plan to exit the portion of the facility no longer used.", "We also may retain and repurpose certain other office locations.", "transformational changes in technologies and business processes, operational efficiencies, and cost savings.", "centralization of certain functions and outsourcing through an expanded arrangement with a third-party vendor to achieve operational efficiency.", "The  initiative  consisted  of  multiple  growth  priorities  and  plans  to  optimize  our  operating  models  and  cost  structures  primarily  through  centralization,  cost management, and outsourcing of certain administrative functions.", "As part of the growth initiative, we committed to implement certain actions including a reduction in workforce, facility consolidation, and store closures.", "This set of initiatives was substantially complete by the end of 2020. $115 million, $112 million, and $245 million, respectively, primarily related to our retail pharmacy businesses in Canada and Europe within our International segment.", "During  the  first  quarter  of  2021,  we  committed  to  an  initiative  within  the  U.K.,  which  is  included  in  our  International  segment,  to  further  drive", "In the fourth quarter of 2019, we committed to certain programs to continue our operating model and cost optimization efforts.", "On April 25, 2018, we announced a strategic growth initiative intended to drive long-term incremental profit growth and to increase operational efficiency.", "pharmaceutical price increases, growth in specialty pharmaceuticals, and higher volumes from retail national account customers, partially offset by branded to generic  drug  conversions.  Revenues  for  this  segment  were  unfavorably  impacted  by  fluctuations  in  demand  for  pharmaceuticals  in  retail  pharmacies  and institutional healthcare providers due to COVID-19 largely during the onset of the pandemic in late March 2020 and during our first quarter of 2021 combined with the loss of certain customers.", "exchange fluctuations, revenues for this segment decreased 9% primarily due to the contribution of our German pharmaceutical wholesale business to a joint venture with WBA and to a lesser extent, the exit of unprofitable customers in our Canadian business.", "Revenues for this segment were also unfavorably impacted by lower volumes from the adverse impacts from COVID-19 in our pharmaceutical distribution and retail pharmacy businesses within Europe.", "exchange fluctuations, revenues for this segment increased 4% primarily due to market growth in our European pharmaceutical distribution and retail pharmacy businesses.", "2020 vs. 2019 Medical-Surgical Solutions revenues for the year ended March 31, 2020 increased 9% compared to the prior year primarily due to market growth in our", "The impacts from COVID-19 in our pharmaceutical distribution and retail pharmacy businesses within Europe also caused unfavorability in our segment results year over year.", "demand for COVID-19 tests and PPE, as well as the contribution from kitting and distribution of ancillary supplies for COVID-19 vaccines.", "This was partially offset by inventory charges on certain PPE and other related products, unfavorability in our primary care business due to customer closures largely during the first quarter  of 2021, and a  less severe  cough, cold, and flu  season.", "2020 vs. 2019 Operating profit increased for the year ended March 31, 2020 compared to the prior year primarily due to market growth in our specialty business.", "2020 vs. 2019 Operating profit and operating profit margin increased for the year ended March 31, 2020 compared to prior year primarily due to market growth in our", "We monitor our operations and adopt strategies responsive to changes in the economic and political environment in each of the countries in which we operate.", "Our foreign operations represented approximately 15%, 17%, and 18% of our consolidated revenues in 2021, 2020, and 2019, respectively.", "We also have agreements with GPOs, each of which functions as a purchasing agent on behalf of member hospitals, pharmacies and other healthcare providers, as well as with government entities and agencies.", "and updated if unusual circumstances or trends are present.", "LIFO method presumes that the most recent inventory purchases are the first items sold and the inventory cost under LIFO approximates market.", "The majority of the cost of domestic inventories is determined using the LIFO method.", "If we had used the moving average method of inventory valuation, inventories would have been approximately $406 million and $444 million higher than the amounts reported at March 31, 2021 and 2020, respectively.", "such, our LIFO inventory is valued at the lower of LIFO or market.", "Inventories: Inventories  consist of merchandise  held  for resale.  We report  inventories  at the lower of cost or net realizable  value, except  for inventories", "We believe that the moving average inventory costing method provides a reasonable estimation of the current cost of replacing inventory (i.e., \u201cmarket\u201d).", "Shifts in market trends and conditions, changes in customer preferences due to the introduction of generic drugs or new pharmaceutical products or the loss of one or more significant customers are factors that could affect the value of our inventories.", "We write down inventories which are considered excess and obsolete as a result of these reviews.", "These factors could make our estimates of inventory valuation differ from actual results.", "In addition, we compare the aggregate of the reporting units\u2019 fair values to our market capitalization as further corroboration of the fair values.", "They can be affected by a variety of factors, including external factors such as industry and economic trends, and internal factors such as changes in our business strategy and our internal forecasts.", "Management makes certain judgments and estimates in its assessment including but not limited to: identifying if circumstances indicate a decline in value is other than temporary, expectations about the business operations of investees, as well as industry, financial, and market factors.", "On March 9, 2020, we completed the Split-off of our interest in the Change Healthcare JV.", "Our businesses require substantial investments in working capital that are susceptible to large variations during the year as a result of inventory purchase patterns and seasonal demands.", "Our  redeemable  noncontrolling  interests  primarily  relate  to  our  consolidated  subsidiary,  McKesson  Europe.  Under  the  Domination  Agreement,  the", "However, our risk management programs are designed such  that  the  potential  loss  in  value  of  these  risk  management  portfolios  described  above  would  be  largely  offset  by  changes  in  the  value  of  the  underlying exposure.", "With the participation of the Chief Executive Officer and the Chief Financial Officer, our management conducted an assessment of the effectiveness of our internal control over financial  reporting based on the framework and criteria  established in Internal Control\u2014Integrated Framework (2013), issued by the Committee of Sponsoring Organizations of the Treadway Commission.", "Under the market approach, fair value is estimated by comparing the business to similar businesses, or guideline companies whose securities are actively traded in public markets.", "The severity,  magnitude  and  duration,  as  well  as  the  economic  consequences  of  the  coronavirus  diseases  2019  (\u201cCOVID-19\u201d)  pandemic,  are  uncertain,  rapidly changing, and difficult to predict.", "The majority of the cost of domestic inventories is determined using the LIFO method.", "Goodwill testing requires a complex series of assumptions and judgments by management in projecting future operating results, selecting guideline companies for comparisons and assessing risks.", "Revenues generated from the distribution of pharmaceutical and medical products represent the majority of the Company\u2019s revenues.", "customer, is responsible for fulfilling the promise to its customer, has latitude in establishing prices, and controls the relationship with the customer.", "Shipping and handling costs associated with outbound freight after control over a product has transferred to a customer are accounted for as fulfillment costs.", "International segment, to further drive transformational changes in technologies and business processes, operational efficiencies, and cost savings.", "continues to implement centralization of certain functions and outsourcing through an expanded arrangement with a third-party vendor to achieve operational efficiency.", "Irving, Texas to improve efficiency, collaboration, and cost competitiveness.", "PSUs are conditional upon the attainment of market and performance objectives over a specified period.", "As a practical expedient, the Company does not separate lease components from non-lease components such as common area maintenance, utilities, and repairs and maintenance.", "The Company\u2019s most significant relationships are with oncology and other specialty practices.", "Level 2 - significant other observable market-based inputs.", "Level 3 - significant unobservable inputs for which little or no market data exists and requires considerable assumptions that are significant to the fair value", "measurement due to the significance of unobservable inputs developed using company-specific information.", "It has received the same warranties from its suppliers, which customarily are the manufacturers of the products.", "Pharma Belgium NV is also part of the investigation.", "Stockholders (the \u201cProxy Statement\u201d) under the heading \u201cElection of Directors.\u201d Information about our Executive Officers is incorporated by reference from the discussion in Part I of this report under the heading \u201cInformation about our Executive Officers.\u201d Information about our Audit Committee, including the members of the  committee  and  our  Audit  Committee  Financial  Expert,  is  incorporated  by  reference  from  the  discussion  under  Item  1  of  our  Proxy  Statement  under  the headings \u201cThe Board, Committees and Meetings,\u201d and \u201cAudit Committee Report.\u201d", "We offer more than 275,000 national brand medical- surgical products as well as McKesson\u2019s own line of high-quality products through a network of distribution centers within the United States (\u201cU.S.\u201d).", "as a Service, to serve our biopharma and life sciences partners and patients.", "Our  U.S.  Pharmaceutical  segment  distributes  branded,  generic,  specialty,  biosimilar  and  over-the-counter  (\u201cOTC\u201d)  pharmaceutical  drugs,  and  other", "We also source generic pharmaceutical drugs through our joint sourcing entity, ClarusONE Sourcing Services LLP (\u201cClarusONE\u201d).", "We invest in technology and other systems at all of our distribution centers to enhance safety, reliability, and product availability.", "For example, we offer McKesson Connect , an internet-based ordering system that provides item look-up and real-time inventory availability as well as ordering, purchasing, third-party reconciliation, and account management functionality.", "We make extensive use of technology as an enabler to ensure customers have the right products at the right time in the right place.", "We provide solutions to our customers including supply management technology, world-class marketing programs, managed care, repackaging products, and services to help them meet their business and quality goals.", "We continue to implement information systems to help achieve greater consistency and accuracy both internally and for our customers.", "operational efficiency, and automation that help independent pharmacists focus on patient care while improving profitability.", "Retail National Accounts: We provide business solutions that help retail national account customers increase revenues and profitability.", "These distribution centers also provide the foundation for a two-tiered distribution network that supports best-in-class direct store delivery.", "performance, increase operational efficiencies, and deliver better patient care.", "Community-based physicians in this business have broad flexibility and discretion to select the products and commitment levels that best meet their practice needs.", "Services in provider solutions include specialty drug distribution, group purchasing organizations (\u201cGPO\u201d) like Onmark\u00ae, technology solutions, practice consulting services, and vaccine distribution, including our exclusive distributor relationship with the Centers for Disease Control and Prevention\u2019s (\u201cCDC\u201d) Vaccines for Children program.", "SKY Packaging enables acute care, long-term care, and institutional pharmacies to provide cost-effective, uniform packaging.", "Our use of the term \u201cspecialty\u201d may not be comparable to that used by other industry participants, including our competitors.", "Our operations in Canada, including Rexall retail pharmacies, support better, safer patient care by delivering vital medicines, supplies, and information technology solutions throughout Canada.", "functions  as  a  vital  link,  using  technology-enabled  management  systems  at  our  regional  wholesale  branches  to  connect  manufacturers  to  retail  pharmacies, supplying medicines and other products sold in pharmacies.", "In addition, we partner with independent pharmacies under local banner programs.", "banners, and more than 400 owned pharmacies under the Rexall brand where we provide patients with greater choice and access, integrated pharmacy care and industry-leading service levels.", "This segment includes our Ontada business, providing software to support the clinical, financial, and operational needs of our oncology practice partners.", "Our European Pharmaceutical Distribution business delivers pharmaceutical and other healthcare-related products to pharmacies across Europe.", "Our more than 250,000 customers include physician offices, surgery centers, post-acute care facilities, hospital reference labs, and  home  health  agencies.  We  distribute  medical-surgical  supplies  (such  as  gloves,  needles,  syringes  and  wound  care  products),  infusion  pumps,  laboratory equipment  and  pharmaceuticals.  Through  a  network  of  distribution  centers  within  the  U.S.,  we  offer  more  than  275,000  products  from  national  brand manufacturers and McKesson\u2019s own high-quality product line.", "Through the right mix of products and services, we help improve efficiencies, profitability and compliance.  We  also  never  lose  focus  on  helping  customers  improve  patient  and  business  outcomes.  We  develop  customized  plans  to  address  the  product, operational, and clinical support needs of our customers, including tackling inventory management, reducing administrative burdens, and training and educating clinical staff.", "We deliver for our customers, so they can deliver and care for their patients.", "pharmaceutical distribution environment in which our U.S.", "Pharmaceutical and International segments operate, we face strong competition from international, national, regional and local full-line, short-line and specialty distributors, service merchandisers, self-warehousing chain drug stores, manufacturers engaged in direct distribution, third-party logistics companies, and large payer organizations.", "Our retail businesses, which primarily operate in our International segment, face competition from various global, national, regional, and local global retailers, including chain and independent pharmacies.", "We consider our largest competitors in distribution, wholesaling, and logistics to be AmerisourceBergen Corporation and Cardinal Health, Inc.", "businesses, which may from time to time decide to develop, for their own internal needs, supply management capabilities that might otherwise be provided by our businesses.", "We believe that our scale and diversity of product and service offerings are our primary competitive advantages.", "operations and market position, but we do not consider any of our businesses to be dependent upon any one patent, copyright, trademark, or trade secret, or any family or families of the same.", "be necessary in the future to seek or renew licenses relating to various aspects of our products and services, we believe, based upon past experience and industry practice,  such  licenses  generally  can  be  obtained  on  commercially  reasonable  terms.  We  believe  our  operations  and  products  and  services  are  not  materially dependent on any single license or other agreement with any third party.", "on improving employee health and wellness, creating opportunities for growth and development, and providing an inclusive workplace where our employees can reach their full potential.", "At March 31, 2021, we had approximately 76,000 employees worldwide, including 17,000 part-time employees and 32,000 employees in the U.S. healthier future is everyone\u2019s business.", "We build successful teams by recruiting, developing, and retaining diverse talent and we recognize our culture of inclusion as an important element that drives long-term shareholder value.", "(1) The data for our metrics is derived from our voluntary, self-identification process as of March 31, 2021 and therefore represents our best estimate at this time. (2) Represents our leadership at the vice president level and above. (3) Represents worldwide employees. (4) Represents U.S. employees only as the data for Canada and Europe is not available.", "I CARE and ILEAD principles, we fulfill our mission of improving care in every setting.", "Our I CARE values (Integrity, Inclusion, Customer-First, Accountability, Respect, Excellence) are foundational to all that we do, and who we are as a company.", "ILEAD (Inspire, Leverage, Execute, Advance, Develop) is our common definition and shared commitment to leadership.", "By embracing this commitment, we bring out the best in ourselves and position McKesson to continue to drive better health \u2013 for our company, our customers, and the patients they serve for years to come.", "We promote leadership behaviors through culture initiatives that offer practical tips on how to debate, decide, and commit, be open and candid, and maintain an enterprise-first mindset when navigating conversations affecting operations within and across our business segments.", "We hold inbound licenses for certain intellectual property that is used internally, and in some cases, utilized in McKesson\u2019s products or services.", "Culture and Leadership: What sets McKesson apart as an exceptional place is our people.", "Our employees understand that together, unified by our global", "where everyone can bring their authentic self to work and feel welcomed and appreciated, and where their perspectives are sought out, heard, and considered.", "Through training, we encourage leaders to embrace diverse perspectives and lead inclusively.", "We  also  seek  employee  feedback  through  an  annual  employee  opinion  survey,  which  assesses  our employees\u2019  levels  of engagement, commitment, and overall satisfaction using industry benchmarks, and we then design action plans to improve those metrics.", "We routinely assess facilities to monitor closely adherence to established security and safety standards.", "If we identify a vulnerability, it is documented, and the facility prepares an action plan.", "Our employees receive specialized training related to their role, work setting, and equipment used in their work environment.", "As our processes evolve, we update relevant safety training modules, which may include new employee training programs.", "The various responses we put in place to mitigate the impact of COVID- 19  on  our  business  operations,  including  telecommuting  and  work-from-home  policies,  restricted  travel,  and  enhanced  safety  measures,  are  intended  to  limit employee exposure to the virus that causes COVID-19 as they perform their jobs while also providing employee support programs and a sense of belonging.", "For additional  information  on  our  response  to  COVID-19  in  the  workplace,  refer  to  the  COVID-19  section  of \u201cTrends  and  Uncertainties\u201d in  \u201cManagement\u2019s Discussion and Analysis of Financial Condition and Results of Operations\u201d in Item 7 of Part II included in this Annual Report on Form 10-K.", "Food and Drug Administration Amendments Act of 2007 requires the FDA to establish standards and identify and validate effective technologies, such as track and trace or authentication technologies, to secure the pharmaceutical supply chain against counterfeit drugs.", "Despite physical, technical, and administrative security measures that we implement in order to, among other things, address regulatory requirements, our technology systems and operations may continue to be subject to cybersecurity incidents.", "The risk of cybersecurity incidents may be increased due to a variety of factors, both internal and external.", "Sales to our largest customer, CVS Health Corporation (\u201cCVS\u201d), accounted for approximately 21% of our total consolidated revenues in 2021.", "In May 2019, we extended our pharmaceutical distribution relationship with CVS to June 2023.", "a supplier could adversely affect our business if alternate sources of supply are unavailable.", "We believe that our relationships with our suppliers are generally sound.", "The ten largest suppliers in 2021 accounted for approximately 50% of our purchases.", "For these manufacturers, a reduction in the frequency and magnitude of price increases, as well as restrictions in the amount of inventory available to us, could have an adverse impact on our gross profit margin.", "Although it is not possible to predict or identify all such risks and uncertainties, they include, but are not limited to, the factors discussed in Item 1A of Part I of this report under \u201cRisk Factors\u201d and in our publicly available SEC filings and press releases.", "Suppliers: We obtain pharmaceutical and other products from manufacturers, none of which accounted for more than 7% of our purchases in 2021.", "practical  to  identify  or  describe  all  risks  and  uncertainties  that  might  materially  impact  our  business  operations,  reputation,  financial  position  or  results  of operations.", "Our business could be materially affected by risks that we have not yet identified or that we currently consider to be immaterial.", "This is not a complete statement of all potential risks and uncertainties.", "For example, pharmacy operations are exposed to risks such as improper filling of prescriptions, mislabeling of prescriptions, inadequacy of warnings, unintentional distribution of counterfeit drugs and expiration of drugs.", "The  discussion  below  identifies  certain  representative  risks  that  might  cause  our  actual  business  results  to  materially  differ  from  our  estimates.  It  is  not", "Certain of our businesses may be required to register for permits and/or licenses with, and comply with operating and security standards of, the DEA, FDA, HHS, CMS, various state boards of pharmacy, state health departments and/or comparable state agencies as well as foreign agencies and certain accrediting bodies, depending upon the type of operations and location of product development, manufacture, distribution, and sale.", "As of March 31, 2021, suspensions at the four distribution centers had all expired  by  their  own  terms.  If  we  are  not  able  to  obtain,  maintain  or  renew  permits,  licenses  or  other  regulatory  approvals  needed  for  the  operation  of  our businesses, it might have a materially adverse impact on our business operations and our financial position or results of operations.", "Food and Drug Administration Amendments Act of 2007 requires the FDA to establish standards and identify and validate effective technologies, such as track  and  trace  or  authentication  technologies,  to  secure  the  pharmaceutical  supply  chain  against  counterfeit  drugs.  We  also  have  record-keeping  and  other obligations under the E.U.", "We are subject to significant compliance obligations under privacy laws such as the General Data Protection Regulation in the  European  Union  (\u201cGDPR\u201d),  the  Personal  Information  Protection  and  Electronic  Documents  Act  (\u201cPIPEDA\u201d)  in  Canada,  and  the  California  Consumer Protection  Act  (\u201cCCPA\u201d).  Some  privacy  laws  prohibit  the  transfer  of  personal  information  to  certain  other  jurisdictions.  We  are  subject  to  privacy  and  data protection compliance audits or investigations by various government agencies.", "We experience cybersecurity incidents that might significantly compromise our technology systems or might result in material data breaches.", "Despite physical, technical, and administrative security measures, our technology systems and operations have been, and likely will continue to be, subject to cyberattacks from sources beyond our control.", "Cybersecurity incidents  include  actual  or  attempted  unauthorized  access,  tampering,  malware  insertion,  ransomware  attacks  or  other  system  integrity  events.  The  risk  of cyberattacks  may be increased  due to a variety of factors, both internal  and external.  A cybersecurity  incident might involve a material  data breach or other material impact to the integrity and operations of our technology systems, which might result in litigation or regulatory action, loss of customers or revenue, and increased expense, any of which might have a materially adverse impact on our business operations, reputation, and our financial position or results of operations.", "We might experience significant problems with information systems or networks.", "If those information systems suffer errors, interruptions, or become unavailable, there might be a materially adverse impact on our business operations, reputation, and our financial position or results of operations.", "Our products or services might not conform to specifications or perform as we intend.", "professionals delivering patient care tend to have heightened sensitivity to system and software errors.", "Errors or failures might damage our reputation and negatively affect future sales.", "We sell and provide services involving complex software and technology that may contain errors, especially when first introduced to market.", "The networks and hosting systems are vulnerable to interruption or damage from sources beyond our control, such as power loss, telecommunications failures, fire, natural disasters, software and hardware failures and cyberattacks.", "If the timely delivery of medical care or other customer business requirements are impaired by data access, network or systems problems, we could be exposed to significant claims and reputational harm.", "We might not realize expected benefits from business process initiatives.", "achieve  our  desired  objectives,  or  unintended  consequences  such  as  distraction  of  our  management  and  employees,  business  disruption,  attrition  beyond  any planned reduction in workforce, inability to attract or retain key personnel and reduced employee productivity.", "We might be unable to successfully complete or integrate acquisitions or other business combinations.", "We may not receive regulatory approvals needed to complete proposed transactions, or such  approvals  may  be  subject  to  delays  or  conditions  that  reduce  transaction  benefits.  Achieving  the  desired  outcomes  of  business  combinations  involves significant  risks  including:  diverting  management\u2019s  attention  from  other  business  operations;  challenges  with  assimilating  the  acquired  businesses,  such  as integration  of  operations  and  systems;  failure  or  delay  in  realizing  operating  synergies;  difficulty  retaining  key  acquired  company  personnel;  unanticipated accounting or financial systems issues with the acquired business, which might affect our internal controls over financial reporting; unanticipated compliance issues in the acquired business; challenges retaining customers of the acquired business; unanticipated expenses or charges to earnings, including depreciation and amortization or potential impairment charges; and risks of known and unknown assumed liabilities in the acquired business.", "We provide remote services that involve hosting customer data and operating software on our own or third party systems.", "Our growth strategy includes consummating acquisitions or other business combinations that either expand or complement our business.", "could delay the achievement of our strategic objectives.", "We might be adversely impacted by outsourcing or similar third-party relationships.", "Third-party services providers might fail to perform as anticipated, or we might experience unanticipated operational difficulties, compliance requirements or increased costs related to outsourced services.", "We may be unsuccessful in retail pharmacy operations or maintaining profitability.", "If our retail pharmacy operations fail to achieve, or are unable to sustain, acceptable net sales and profitability levels, it might have a materially adverse impact on our business operations and our financial position or results of operations.", "We rely on third parties to perform certain business and administrative functions for us.", "We might not adequately develop, implement and monitor these", "Our business strategy included expanding our retail pharmacy operations.", "Our retail pharmacy operations involve numerous risks, such as the following ones.", "For example, our contracts with the U.S. government generally require us to comply with the Federal Acquisition Regulations, Procurement Integrity Act, Buy American Act, Trade Agreements Act, and other laws and regulations.", "The occurrence of any of these risks could harm our reputation and might have a materially adverse impact on our business operations and our financial position or results of operations.", "Our participation in vaccination distribution programs may materially affect our operating results, reputation, and business.", "For example, the novel nature of the SARS-CoV\u20112 virus and the broad scope of the ongoing COVID-19 vaccine distribution program introduce uncertainty about what volumes of products may become available for distribution by us, the effectiveness of vaccines, and the cost of distribution.", "Because of such uncertainties, our operating results may be subject to variability.", "Our participation in such programs also exposes us to various risks, including regulatory compliance, government oversight, dependence on government funding, contractual performance, litigation, security risks, and supply chain challenges.", "Any significant problems with our participation in such programs might have a materially adverse impact on our reputation and our business.", "We might be harmed by changes in our relationships or contracts with suppliers.", "Our competitors might develop non-infringing products or services equivalent or superior to ours.", "We might be unable to successfully recruit and retain qualified employees.", "We compete with many other businesses to attract and retain employees.", "We may experience sudden loss of key personnel due to a variety of causes, such as illness, and must adequately plan for succession of key management roles.", "Employees might not successfully transition into new roles.", "Some of these changes increase our risks and create uncertainties for our business.", "These proposals might result in significant changes in the pharmaceutical value chain as manufacturers, PBM, managed care organizations and other industry stakeholders look to implement new transactional flows and adapt their business models.", "Many of our products and services are designed and intended to function within the structure of current healthcare financing and reimbursement systems.", "We might be adversely impacted by competition and industry consolidation.", "specialty distributors, service merchandisers, self-warehousing chain drug stores, manufacturers engaged in direct distribution, third-party logistics companies and large  payer  organizations.  In  addition,  our  businesses  face  competition  from  various  other  service  providers  and  from  pharmaceutical  and  other  healthcare manufacturers as well as other potential customers, which may from time-to-time decide to develop, for their own internal needs, supply management capabilities that might otherwise be provided by our businesses.", "This concentration reduces our ability to negotiate favorable terms with suppliers and causes us to depend on a smaller number of suppliers.", "Many of our customers, including  healthcare  organizations,  have  consolidated  and  have  greater  power  to  negotiate  favorable  prices.  Consolidation  by  our  customers,  suppliers  and competitors might reduce the number of market participants and give the remaining enterprises greater bargaining power, which might lead to erosion in our profit margin.", "These competitive pressures and industry consolidation might have a materially adverse impact on our business operations and our financial position or results of operations.", "We might be adversely impacted by changes or disruptions in product supply.", "Our inventory might be requisitioned, diverted or allocated by government order such as under emergency, disaster and civil defense declarations.", "For example, government actions in response to the COVID-19 pandemic affect our supply allocation, and those and our own allocation decisions can impact our customer relationships.", "Changes in the healthcare industry\u2019s or our suppliers\u2019 pricing, selling, inventory, distribution or supply policies or practices could significantly reduce our revenues and net income.", "We might experience disruptions in our supply of higher margin pharmaceuticals, including generic pharmaceuticals.", "sourcing joint venture with Walmart, Inc. is unsuccessful or experiences margins declines.", "products and services and the volume of their purchases.", "Our generic  pharmaceuticals  distribution  business  is subject  to  pricing  risks.  We  might  be  adversely  impacted  if  our ClarusONE  generic  pharmaceutical", "Suppliers might increase their prices, reduce their output or change their terms of sale due to limited availability of credit.", "We may have difficulties in sourcing or selling products due to a variety of causes.", "Difficulties in product manufacturing or access to raw materials could result in supplier production shutdowns, product shortages and other supply disruptions.", "The COVID-19 pandemic adversely affects the availability of some products, resulting in product allocation and delivery delays.", "We have operations in the U.K. and the European Union (\u201cE.U.\u201d) and face risks associated with the uncertainty and potential disruptions that might follow the", "These events can disrupt operations for us, our suppliers, our vendors, and our customers.", "For example, in February 2021, a severe winter storm affecting the United  States  temporarily  impacted  our  distribution  business  operations,  primarily  in  Texas.  They  might  affect  consumer  confidence  levels  and  spending.  In response to these events, we might suspend operations, implement extraordinary procedures, seek alternate sources for product supply, or suffer consequences that are unexpected and difficult to mitigate.", "In particular, the rapid and widespread transmission of the SARS-CoV-2 novel coronavirus beginning in late 2019 impacts us in significant ways.", "For example, to mitigate the spread of the COVID-19 disease caused by SARS-CoV-2, we implemented travel restrictions and remote working  arrangements  for  most  of  our  employees  in  order  to  minimize  physical  contact,  and  we  implemented  additional  sanitation  and  personal  protection measures in our warehouse, retail pharmacy and delivery operations.", "These measures might not fully mitigate COVID-19 risks to our workforce and we could experience unusual levels of absenteeism that might impair operations and delay delivery of products.", "The ongoing impacts of the pandemic might cause a general economic slowdown or recession in one or more markets, disruptions and volatility in global capital markets and other broad and adverse effects on the economy, business conditions, commercial activity and the healthcare industry.", "The pandemic might impact our business operation, financial position and results of operation in unpredictable ways that depend on highly uncertain future  developments,  such  as  determining  the  effectiveness  of  current  or  future  government  actions  to  address  the  public  health  or  economic  impacts  of  the pandemic.", "These events and impacts could materially adversely affect our business operations, financial position or results of operation.", "locations,  primarily  throughout  North  America  and  Europe.  Retail  pharmacies  and  most  warehouses  are  typically  owned  or  leased  on  a  long-term  basis.  We consider our operating properties to be in satisfactory condition and adequate to meet our needs for the next several years without making capital expenditures materially higher than historical levels.", "Form 10-K for additional factors relating to these statements and Item 1A - Risk Factors in Part I of this Annual Report on Form 10-K for a list of certain risk factors applicable to our business, financial condition, and results of operations.", "We partner with life sciences companies, manufacturers, providers, pharmacies, governments, and other healthcare organizations to help provide the right medicines, medical products, and healthcare services to the right patients at the right time, safely, and cost-effectively.", "All prior segment information has been recast to reflect our new segment structure and current period presentation.", "We  implemented  a  new  segment  reporting  structure  commencing  with  the  second  quarter  of  2021,  which  resulted  in  four  reportable  segments:  U.S.", "\u2022 International is  a  new  reportable  segment  that  includes  our  operations  in  Europe  and  Canada,  bringing  together  non-U.S.-based  drug  distribution services, specialty pharmacy, retail, and infusion care services.", "\u2022 RxTS is  a  new  reportable  segment  that  brings  together  existing  businesses,  including  CoverMyMeds,  RelayHealth,  RxCrossroads,  and  McKesson Prescription Automation, including Multi-Client Central Fill as a Service, to serve our biopharma and life sciences partners and patients.", "We benefited from demand for COVID-19 tests, favorable contributions from our vaccine and related ancillary supply kit distribution programs as discussed further below, and savings from reduced travel and meetings throughout 2021;", "We have also partnered with the Department of Health and Human Services (\u201cHHS\u201d) and Pfizer to manage the assembly and distribution of the ancillary supplies needed to administer COVID-19 vaccines;", "Pharmaceutical segment driven by market growth; \u2022 Gross profit increased 1% from the prior year primarily in our Medical-Surgical Solutions segment driven by sales of COVID-19 tests; \u2022 Total operating expenses in 2021 includes the following:", "Infection rates varied throughout our fiscal year, peaking in January 2021.", "Our role in the distribution of COVID-19 vaccines in the U.S. as well as the assembly and distribution of related ancillary supply kits is discussed further below.", "McKesson Europe is also playing a role in helping support governments and public health entities in not only distributing COVID-19 vaccines across several European countries, but administering them in pharmacies as well.", "solutions, we are well positioned to respond to the COVID-19 pandemic in the U.S., Canada, and Europe.", "We have worked and continue to work closely with national and local governments, agencies, and industry partners to ensure that available supplies, including personal protective equipment (\u201cPPE\u201d), and medicine reach our customers and patients.", "put in place to mitigate the impact of COVID-19 on our business operations, including telecommuting and work-from-home policies, restricted travel, employee support programs, and enhanced safety measures, are intended to limit employee exposure to the virus that causes COVID-19.", "We expanded employee medical benefits covering COVID-19 related visits, treatments, and testing as well as expanded telehealth options to protect employee safety.", "For employees whose roles require presence at our facilities, we enhanced safety by promoting the practice of social distancing, providing reminders to wash or disinfect hands and avoid unnecessary face touching, making face masks available, placing hand sanitizers within our operating environments, and periodically cleaning and disinfecting our facilities.", "For employees whose roles do not require presence at our facilities, we added technology resources to support their working remotely.", "These steps to protect employee safety have resulted in limited disruption from COVID-19 to our normal business operations, productivity trends, and have not materially impacted our operating expenses or operating margins.", "pharmacy foot traffic as our customers increased supplies on hand in March, which drove unfavorability in our results of operations when comparing 2021 versus 2020.", "We also experienced decreased demand for primary care medical-surgical supplies due to deferrals in elective procedures in hospitals and surgery centers as well as decreased traffic and closures of doctors\u2019 offices, which was partially offset by demand for PPE and COVID-19 tests.", "COVID-19  for  the  second  half  of  our  fiscal  year  was  non-linear  and  tracked  with  patient  mobility.  We  also  saw  increased  demand  for  COVID-19  tests  and continued sales of PPE throughout the year in our Medical-Surgical Solutions segment partially offset by the impacts of social distancing measures which resulted in a less severe cough, cold, and flu season, savings for reduced travel and meetings across the enterprise, as well as improvements of retail pharmacy foot traffic in Europe and Canada.", "The vaccine and related  ancillary  kit distribution  in the U.S. favorably impacted our results in the second half of fiscal 2021 as further discussed below.", "Our Response to COVID-19 in the Workplace During this unprecedented time, we are committed in continuing to supply our customers and protect the safety of our employees.", "During  the  first  quarter  of  2021,  we  experienced  growth  in  pharmaceutical  distribution  and  specialty  drug  volumes  at  a  lower  rate  in  the  U.S.,  while", "In the centralized model, the U.S. government directs us on the distribution of the vaccines and related supplies to point-of-care sites across the country.", "The results of operations related to our vaccine distribution are reflected in our U.S.", "We also have an agreement with Pfizer to assemble and distribute ancillary supply kits needed to administer that particular COVID-19 vaccine.", "We began assembling the ancillary supply kits in September 2020 in preparation for vaccine authorization and subsequent distribution.", "Ancillary supply kits to administer the Pfizer Vaccine are shipped directly to point-of-care sites, and all other ancillary supply kits are shipped to our dedicated vaccine distribution centers.", "The results of operations for the kitting and distribution of ancillary supplies are reflected in our Medical-Surgical Solutions segment.", "These facilities can scale to meet the demand of increasing volumes of vaccines being manufactured.", "We have also set up distribution centers for kitting and inventory management as part of our contract with the HHS.", "We are working with delivery partners to manage the delivery of vaccines and ancillary supply kits from our centralized vaccine distribution centers to point-of-care destinations as directed by the CDC.", "as well as the kitting and distribution of ancillary supplies for COVID-19 vaccines in our Medical-Surgical Solutions segment contributed approximately 20% in segment  revenues  and  segment  operating  profit.  Additionally,  the  distribution  of  COVID-19  vaccines  in  our  U.S.  Pharmaceutical  segment  contributed approximately 2% in segment operating profit for the year ended March 31, 2021.", "During our fourth quarter of 2020, we experienced a temporary increase in demand for pharmaceuticals.", "Certain PPE items held for resale were valued in our inventory at costs that were inflated by earlier COVID-19 pandemic demand levels.", "That inventory valuation, if not supported by market resale prices, may be written down to net realizable value.", "We may also write-off inventory due to decreased customer demand and excess inventory.", "response to supply availability and customer demand patterns for certain products, with varying inventory level impacts depending on the specific product within our portfolio.", "As our supply levels improve, and the federal government evolves guidance on the prioritization of providers or geographic markets, we will continue to adapt our distribution policies.", "We were able to maintain appropriate labor and overall vendor supply levels during the year ended March 31, 2021.", "suppliers,  their  locations,  and  the  extent  to  which  they  are  impacted  by  the  COVID-19  pandemic,  we  are  proactively  working  with  manufacturers,  industry partners, and government agencies to meet the needs of our customers during the pandemic.", "We have assembled a Critical Care Drug Task Force, made up of our procurement  specialists,  clinical  health  systems  pharmacists,  and  supply  chain  professionals,  that  is  focused  on  securing  additional  product  where  available, sourcing back-up products, and protecting our operations across all locations and facilities.", "We are also working with manufacturers through several channels, including  our  ClarusONE  Sourcing  Services  LLP  (\u201cClarusONE\u201d)  and  global  sourcing  teams  in  London,  and  our  leaders  are  actively  engaged  in  addressing potential shortages.", "We have engaged with industry partners and government agencies to gain visibility into supply and demand.", "Additionally, we have a robust Business Continuity and Disaster Recovery Program (\u201cBCRP\u201d) and we have proactively enhanced our BCRP in response to the COVID-19 pandemic to protect the supply  chain  to  minimize  disruption  in  healthcare,  protect  our  customers,  ensure  the  safety  and  security  of  our  employees  and  workplaces,  and  ensure  the continuity of critical business processes.", "supplies and medications to help prevent the spread of the disease and treat those that are ill.", "COVID-19 has put an unprecedented strain on the supply of high- demand PPE, including N95 masks, gloves, as well as disinfecting sprays and wipes.", "The supply chain has improved over the initial impact of pandemic-related demand, and we continue to closely monitor demand by customer type and certain PPE and infection prevention items are still in short supply.", "Our allocation approach has helped us avoid stock outs in many critical product categories, allowing us to provide PPE supplies to many more customers for a much longer time.", "We anticipate these market conditions will remain for the foreseeable future.", "Our efforts to help the supply chain have included sourcing products from new suppliers all over the world, working closely with the federal government to help with the nation\u2019s response and collaborating with partners to source, develop, and deliver new products to market.", "The full extent to which COVID-19 will impact us depends on many factors and future developments, including: the duration and spread of the virus; governmental actions to limit the spread of the virus; potential seasonality of viral outbreaks; potential new strains or variants of the original virus; the amount of COVID-19 vaccines authorized, manufactured, distributed, and administered; the amount of ancillary supply kits assembled and distributed; the  effectiveness  of  COVID-19  vaccines  and  governmental  measures  in  controlling  the  spread  of  the  virus;  and  the  effectiveness  of  treatments  of  infected individuals.", "Impact to our Supply Chain We  also  continue  to  monitor  the  COVID-19  pandemic  impacts  on  our  supply  chain.  Although  the  availability  of  various  products  is  dependent  on  our", "Gross profit was favorably impacted by growth of specialty pharmaceuticals and the contribution from our vaccine distribution programs in our U.S.", "\u2022 Goodwill impairment charges of $1.8 billion in our European Retail Pharmacy (\u201cEuropean RP\u201d) and European Pharmaceutical Distribution (\u201cEuropean PD\u201d) reporting units within the International segment.", "This initiative primarily led us to rationalize our office space in North America.", "Where we determine to cease using office space, we plan to exit the portion of the facility no longer used.", "We also may retain and repurpose certain other office locations.", "transformational changes in technologies and business processes, operational efficiencies, and cost savings.", "centralization of certain functions and outsourcing through an expanded arrangement with a third-party vendor to achieve operational efficiency.", "The  initiative  consisted  of  multiple  growth  priorities  and  plans  to  optimize  our  operating  models  and  cost  structures  primarily  through  centralization,  cost management, and outsourcing of certain administrative functions.", "As part of the growth initiative, we committed to implement certain actions including a reduction in workforce, facility consolidation, and store closures.", "This set of initiatives was substantially complete by the end of 2020. $115 million, $112 million, and $245 million, respectively, primarily related to our retail pharmacy businesses in Canada and Europe within our International segment.", "During  the  first  quarter  of  2021,  we  committed  to  an  initiative  within  the  U.K.,  which  is  included  in  our  International  segment,  to  further  drive", "In the fourth quarter of 2019, we committed to certain programs to continue our operating model and cost optimization efforts.", "On April 25, 2018, we announced a strategic growth initiative intended to drive long-term incremental profit growth and to increase operational efficiency.", "pharmaceutical price increases, growth in specialty pharmaceuticals, and higher volumes from retail national account customers, partially offset by branded to generic  drug  conversions.  Revenues  for  this  segment  were  unfavorably  impacted  by  fluctuations  in  demand  for  pharmaceuticals  in  retail  pharmacies  and institutional healthcare providers due to COVID-19 largely during the onset of the pandemic in late March 2020 and during our first quarter of 2021 combined with the loss of certain customers.", "exchange fluctuations, revenues for this segment decreased 9% primarily due to the contribution of our German pharmaceutical wholesale business to a joint venture with WBA and to a lesser extent, the exit of unprofitable customers in our Canadian business.", "Revenues for this segment were also unfavorably impacted by lower volumes from the adverse impacts from COVID-19 in our pharmaceutical distribution and retail pharmacy businesses within Europe.", "exchange fluctuations, revenues for this segment increased 4% primarily due to market growth in our European pharmaceutical distribution and retail pharmacy businesses.", "2020 vs. 2019 Medical-Surgical Solutions revenues for the year ended March 31, 2020 increased 9% compared to the prior year primarily due to market growth in our", "The impacts from COVID-19 in our pharmaceutical distribution and retail pharmacy businesses within Europe also caused unfavorability in our segment results year over year.", "demand for COVID-19 tests and PPE, as well as the contribution from kitting and distribution of ancillary supplies for COVID-19 vaccines.", "This was partially offset by inventory charges on certain PPE and other related products, unfavorability in our primary care business due to customer closures largely during the first quarter  of 2021, and a  less severe  cough, cold, and flu  season.", "2020 vs. 2019 Operating profit increased for the year ended March 31, 2020 compared to the prior year primarily due to market growth in our specialty business.", "2020 vs. 2019 Operating profit and operating profit margin increased for the year ended March 31, 2020 compared to prior year primarily due to market growth in our", "We monitor our operations and adopt strategies responsive to changes in the economic and political environment in each of the countries in which we operate.", "Our foreign operations represented approximately 15%, 17%, and 18% of our consolidated revenues in 2021, 2020, and 2019, respectively.", "We also have agreements with GPOs, each of which functions as a purchasing agent on behalf of member hospitals, pharmacies and other healthcare providers, as well as with government entities and agencies.", "and updated if unusual circumstances or trends are present.", "LIFO method presumes that the most recent inventory purchases are the first items sold and the inventory cost under LIFO approximates market.", "The majority of the cost of domestic inventories is determined using the LIFO method.", "If we had used the moving average method of inventory valuation, inventories would have been approximately $406 million and $444 million higher than the amounts reported at March 31, 2021 and 2020, respectively.", "such, our LIFO inventory is valued at the lower of LIFO or market.", "Inventories: Inventories  consist of merchandise  held  for resale.  We report  inventories  at the lower of cost or net realizable  value, except  for inventories", "We believe that the moving average inventory costing method provides a reasonable estimation of the current cost of replacing inventory (i.e., \u201cmarket\u201d).", "Shifts in market trends and conditions, changes in customer preferences due to the introduction of generic drugs or new pharmaceutical products or the loss of one or more significant customers are factors that could affect the value of our inventories.", "We write down inventories which are considered excess and obsolete as a result of these reviews.", "These factors could make our estimates of inventory valuation differ from actual results.", "In addition, we compare the aggregate of the reporting units\u2019 fair values to our market capitalization as further corroboration of the fair values.", "They can be affected by a variety of factors, including external factors such as industry and economic trends, and internal factors such as changes in our business strategy and our internal forecasts.", "Management makes certain judgments and estimates in its assessment including but not limited to: identifying if circumstances indicate a decline in value is other than temporary, expectations about the business operations of investees, as well as industry, financial, and market factors.", "On March 9, 2020, we completed the Split-off of our interest in the Change Healthcare JV.", "Our businesses require substantial investments in working capital that are susceptible to large variations during the year as a result of inventory purchase patterns and seasonal demands.", "Our  redeemable  noncontrolling  interests  primarily  relate  to  our  consolidated  subsidiary,  McKesson  Europe.  Under  the  Domination  Agreement,  the", "However, our risk management programs are designed such  that  the  potential  loss  in  value  of  these  risk  management  portfolios  described  above  would  be  largely  offset  by  changes  in  the  value  of  the  underlying exposure.", "With the participation of the Chief Executive Officer and the Chief Financial Officer, our management conducted an assessment of the effectiveness of our internal control over financial  reporting based on the framework and criteria  established in Internal Control\u2014Integrated Framework (2013), issued by the Committee of Sponsoring Organizations of the Treadway Commission.", "Under the market approach, fair value is estimated by comparing the business to similar businesses, or guideline companies whose securities are actively traded in public markets.", "The severity,  magnitude  and  duration,  as  well  as  the  economic  consequences  of  the  coronavirus  diseases  2019  (\u201cCOVID-19\u201d)  pandemic,  are  uncertain,  rapidly changing, and difficult to predict.", "The majority of the cost of domestic inventories is determined using the LIFO method.", "Goodwill testing requires a complex series of assumptions and judgments by management in projecting future operating results, selecting guideline companies for comparisons and assessing risks.", "Revenues generated from the distribution of pharmaceutical and medical products represent the majority of the Company\u2019s revenues.", "customer, is responsible for fulfilling the promise to its customer, has latitude in establishing prices, and controls the relationship with the customer.", "Shipping and handling costs associated with outbound freight after control over a product has transferred to a customer are accounted for as fulfillment costs.", "International segment, to further drive transformational changes in technologies and business processes, operational efficiencies, and cost savings.", "continues to implement centralization of certain functions and outsourcing through an expanded arrangement with a third-party vendor to achieve operational efficiency.", "Irving, Texas to improve efficiency, collaboration, and cost competitiveness.", "PSUs are conditional upon the attainment of market and performance objectives over a specified period.", "As a practical expedient, the Company does not separate lease components from non-lease components such as common area maintenance, utilities, and repairs and maintenance.", "The Company\u2019s most significant relationships are with oncology and other specialty practices.", "Level 2 - significant other observable market-based inputs.", "Level 3 - significant unobservable inputs for which little or no market data exists and requires considerable assumptions that are significant to the fair value", "measurement due to the significance of unobservable inputs developed using company-specific information.", "It has received the same warranties from its suppliers, which customarily are the manufacturers of the products.", "Pharma Belgium NV is also part of the investigation.", "Stockholders (the \u201cProxy Statement\u201d) under the heading \u201cElection of Directors.\u201d Information about our Executive Officers is incorporated by reference from the discussion in Part I of this report under the heading \u201cInformation about our Executive Officers.\u201d Information about our Audit Committee, including the members of the  committee  and  our  Audit  Committee  Financial  Expert,  is  incorporated  by  reference  from  the  discussion  under  Item  1  of  our  Proxy  Statement  under  the headings \u201cThe Board, Committees and Meetings,\u201d and \u201cAudit Committee Report.\u201d", "We offer more than 275,000 national brand medical- surgical products as well as McKesson\u2019s own line of high-quality products through a network of distribution centers within the United States (\u201cU.S.\u201d).", "as a Service, to serve our biopharma and life sciences partners and patients.", "Our  U.S.  Pharmaceutical  segment  distributes  branded,  generic,  specialty,  biosimilar  and  over-the-counter  (\u201cOTC\u201d)  pharmaceutical  drugs,  and  other", "We also source generic pharmaceutical drugs through our joint sourcing entity, ClarusONE Sourcing Services LLP (\u201cClarusONE\u201d).", "We invest in technology and other systems at all of our distribution centers to enhance safety, reliability, and product availability.", "For example, we offer McKesson Connect , an internet-based ordering system that provides item look-up and real-time inventory availability as well as ordering, purchasing, third-party reconciliation, and account management functionality.", "We make extensive use of technology as an enabler to ensure customers have the right products at the right time in the right place.", "We provide solutions to our customers including supply management technology, world-class marketing programs, managed care, repackaging products, and services to help them meet their business and quality goals.", "We continue to implement information systems to help achieve greater consistency and accuracy both internally and for our customers.", "operational efficiency, and automation that help independent pharmacists focus on patient care while improving profitability.", "Retail National Accounts: We provide business solutions that help retail national account customers increase revenues and profitability.", "These distribution centers also provide the foundation for a two-tiered distribution network that supports best-in-class direct store delivery.", "performance, increase operational efficiencies, and deliver better patient care.", "Community-based physicians in this business have broad flexibility and discretion to select the products and commitment levels that best meet their practice needs.", "Services in provider solutions include specialty drug distribution, group purchasing organizations (\u201cGPO\u201d) like Onmark\u00ae, technology solutions, practice consulting services, and vaccine distribution, including our exclusive distributor relationship with the Centers for Disease Control and Prevention\u2019s (\u201cCDC\u201d) Vaccines for Children program.", "SKY Packaging enables acute care, long-term care, and institutional pharmacies to provide cost-effective, uniform packaging.", "Our use of the term \u201cspecialty\u201d may not be comparable to that used by other industry participants, including our competitors.", "Our operations in Canada, including Rexall retail pharmacies, support better, safer patient care by delivering vital medicines, supplies, and information technology solutions throughout Canada.", "functions  as  a  vital  link,  using  technology-enabled  management  systems  at  our  regional  wholesale  branches  to  connect  manufacturers  to  retail  pharmacies, supplying medicines and other products sold in pharmacies.", "In addition, we partner with independent pharmacies under local banner programs.", "banners, and more than 400 owned pharmacies under the Rexall brand where we provide patients with greater choice and access, integrated pharmacy care and industry-leading service levels.", "This segment includes our Ontada business, providing software to support the clinical, financial, and operational needs of our oncology practice partners.", "Our European Pharmaceutical Distribution business delivers pharmaceutical and other healthcare-related products to pharmacies across Europe.", "Our more than 250,000 customers include physician offices, surgery centers, post-acute care facilities, hospital reference labs, and  home  health  agencies.  We  distribute  medical-surgical  supplies  (such  as  gloves,  needles,  syringes  and  wound  care  products),  infusion  pumps,  laboratory equipment  and  pharmaceuticals.  Through  a  network  of  distribution  centers  within  the  U.S.,  we  offer  more  than  275,000  products  from  national  brand manufacturers and McKesson\u2019s own high-quality product line.", "Through the right mix of products and services, we help improve efficiencies, profitability and compliance.  We  also  never  lose  focus  on  helping  customers  improve  patient  and  business  outcomes.  We  develop  customized  plans  to  address  the  product, operational, and clinical support needs of our customers, including tackling inventory management, reducing administrative burdens, and training and educating clinical staff.", "We deliver for our customers, so they can deliver and care for their patients.", "pharmaceutical distribution environment in which our U.S.", "Pharmaceutical and International segments operate, we face strong competition from international, national, regional and local full-line, short-line and specialty distributors, service merchandisers, self-warehousing chain drug stores, manufacturers engaged in direct distribution, third-party logistics companies, and large payer organizations.", "Our retail businesses, which primarily operate in our International segment, face competition from various global, national, regional, and local global retailers, including chain and independent pharmacies.", "We consider our largest competitors in distribution, wholesaling, and logistics to be AmerisourceBergen Corporation and Cardinal Health, Inc.", "businesses, which may from time to time decide to develop, for their own internal needs, supply management capabilities that might otherwise be provided by our businesses.", "We believe that our scale and diversity of product and service offerings are our primary competitive advantages.", "operations and market position, but we do not consider any of our businesses to be dependent upon any one patent, copyright, trademark, or trade secret, or any family or families of the same.", "be necessary in the future to seek or renew licenses relating to various aspects of our products and services, we believe, based upon past experience and industry practice,  such  licenses  generally  can  be  obtained  on  commercially  reasonable  terms.  We  believe  our  operations  and  products  and  services  are  not  materially dependent on any single license or other agreement with any third party.", "on improving employee health and wellness, creating opportunities for growth and development, and providing an inclusive workplace where our employees can reach their full potential.", "At March 31, 2021, we had approximately 76,000 employees worldwide, including 17,000 part-time employees and 32,000 employees in the U.S. healthier future is everyone\u2019s business.", "We build successful teams by recruiting, developing, and retaining diverse talent and we recognize our culture of inclusion as an important element that drives long-term shareholder value.", "(1) The data for our metrics is derived from our voluntary, self-identification process as of March 31, 2021 and therefore represents our best estimate at this time. (2) Represents our leadership at the vice president level and above. (3) Represents worldwide employees. (4) Represents U.S. employees only as the data for Canada and Europe is not available.", "I CARE and ILEAD principles, we fulfill our mission of improving care in every setting.", "Our I CARE values (Integrity, Inclusion, Customer-First, Accountability, Respect, Excellence) are foundational to all that we do, and who we are as a company.", "ILEAD (Inspire, Leverage, Execute, Advance, Develop) is our common definition and shared commitment to leadership.", "By embracing this commitment, we bring out the best in ourselves and position McKesson to continue to drive better health \u2013 for our company, our customers, and the patients they serve for years to come.", "We promote leadership behaviors through culture initiatives that offer practical tips on how to debate, decide, and commit, be open and candid, and maintain an enterprise-first mindset when navigating conversations affecting operations within and across our business segments.", "We hold inbound licenses for certain intellectual property that is used internally, and in some cases, utilized in McKesson\u2019s products or services.", "Culture and Leadership: What sets McKesson apart as an exceptional place is our people.", "Our employees understand that together, unified by our global", "where everyone can bring their authentic self to work and feel welcomed and appreciated, and where their perspectives are sought out, heard, and considered.", "Through training, we encourage leaders to embrace diverse perspectives and lead inclusively.", "We  also  seek  employee  feedback  through  an  annual  employee  opinion  survey,  which  assesses  our employees\u2019  levels  of engagement, commitment, and overall satisfaction using industry benchmarks, and we then design action plans to improve those metrics.", "We routinely assess facilities to monitor closely adherence to established security and safety standards.", "If we identify a vulnerability, it is documented, and the facility prepares an action plan.", "Our employees receive specialized training related to their role, work setting, and equipment used in their work environment.", "As our processes evolve, we update relevant safety training modules, which may include new employee training programs.", "The various responses we put in place to mitigate the impact of COVID- 19  on  our  business  operations,  including  telecommuting  and  work-from-home  policies,  restricted  travel,  and  enhanced  safety  measures,  are  intended  to  limit employee exposure to the virus that causes COVID-19 as they perform their jobs while also providing employee support programs and a sense of belonging.", "For additional  information  on  our  response  to  COVID-19  in  the  workplace,  refer  to  the  COVID-19  section  of \u201cTrends  and  Uncertainties\u201d in  \u201cManagement\u2019s Discussion and Analysis of Financial Condition and Results of Operations\u201d in Item 7 of Part II included in this Annual Report on Form 10-K.", "Food and Drug Administration Amendments Act of 2007 requires the FDA to establish standards and identify and validate effective technologies, such as track and trace or authentication technologies, to secure the pharmaceutical supply chain against counterfeit drugs.", "Despite physical, technical, and administrative security measures that we implement in order to, among other things, address regulatory requirements, our technology systems and operations may continue to be subject to cybersecurity incidents.", "The risk of cybersecurity incidents may be increased due to a variety of factors, both internal and external.", "Sales to our largest customer, CVS Health Corporation (\u201cCVS\u201d), accounted for approximately 21% of our total consolidated revenues in 2021.", "In May 2019, we extended our pharmaceutical distribution relationship with CVS to June 2023.", "a supplier could adversely affect our business if alternate sources of supply are unavailable.", "We believe that our relationships with our suppliers are generally sound.", "The ten largest suppliers in 2021 accounted for approximately 50% of our purchases.", "For these manufacturers, a reduction in the frequency and magnitude of price increases, as well as restrictions in the amount of inventory available to us, could have an adverse impact on our gross profit margin.", "Although it is not possible to predict or identify all such risks and uncertainties, they include, but are not limited to, the factors discussed in Item 1A of Part I of this report under \u201cRisk Factors\u201d and in our publicly available SEC filings and press releases.", "Suppliers: We obtain pharmaceutical and other products from manufacturers, none of which accounted for more than 7% of our purchases in 2021.", "practical  to  identify  or  describe  all  risks  and  uncertainties  that  might  materially  impact  our  business  operations,  reputation,  financial  position  or  results  of operations.", "Our business could be materially affected by risks that we have not yet identified or that we currently consider to be immaterial.", "This is not a complete statement of all potential risks and uncertainties.", "For example, pharmacy operations are exposed to risks such as improper filling of prescriptions, mislabeling of prescriptions, inadequacy of warnings, unintentional distribution of counterfeit drugs and expiration of drugs.", "The  discussion  below  identifies  certain  representative  risks  that  might  cause  our  actual  business  results  to  materially  differ  from  our  estimates.  It  is  not", "Certain of our businesses may be required to register for permits and/or licenses with, and comply with operating and security standards of, the DEA, FDA, HHS, CMS, various state boards of pharmacy, state health departments and/or comparable state agencies as well as foreign agencies and certain accrediting bodies, depending upon the type of operations and location of product development, manufacture, distribution, and sale.", "As of March 31, 2021, suspensions at the four distribution centers had all expired  by  their  own  terms.  If  we  are  not  able  to  obtain,  maintain  or  renew  permits,  licenses  or  other  regulatory  approvals  needed  for  the  operation  of  our businesses, it might have a materially adverse impact on our business operations and our financial position or results of operations.", "Food and Drug Administration Amendments Act of 2007 requires the FDA to establish standards and identify and validate effective technologies, such as track  and  trace  or  authentication  technologies,  to  secure  the  pharmaceutical  supply  chain  against  counterfeit  drugs.  We  also  have  record-keeping  and  other obligations under the E.U.", "We are subject to significant compliance obligations under privacy laws such as the General Data Protection Regulation in the  European  Union  (\u201cGDPR\u201d),  the  Personal  Information  Protection  and  Electronic  Documents  Act  (\u201cPIPEDA\u201d)  in  Canada,  and  the  California  Consumer Protection  Act  (\u201cCCPA\u201d).  Some  privacy  laws  prohibit  the  transfer  of  personal  information  to  certain  other  jurisdictions.  We  are  subject  to  privacy  and  data protection compliance audits or investigations by various government agencies.", "We experience cybersecurity incidents that might significantly compromise our technology systems or might result in material data breaches.", "Despite physical, technical, and administrative security measures, our technology systems and operations have been, and likely will continue to be, subject to cyberattacks from sources beyond our control.", "Cybersecurity incidents  include  actual  or  attempted  unauthorized  access,  tampering,  malware  insertion,  ransomware  attacks  or  other  system  integrity  events.  The  risk  of cyberattacks  may be increased  due to a variety of factors, both internal  and external.  A cybersecurity  incident might involve a material  data breach or other material impact to the integrity and operations of our technology systems, which might result in litigation or regulatory action, loss of customers or revenue, and increased expense, any of which might have a materially adverse impact on our business operations, reputation, and our financial position or results of operations.", "We might experience significant problems with information systems or networks.", "If those information systems suffer errors, interruptions, or become unavailable, there might be a materially adverse impact on our business operations, reputation, and our financial position or results of operations.", "Our products or services might not conform to specifications or perform as we intend.", "professionals delivering patient care tend to have heightened sensitivity to system and software errors.", "Errors or failures might damage our reputation and negatively affect future sales.", "We sell and provide services involving complex software and technology that may contain errors, especially when first introduced to market.", "The networks and hosting systems are vulnerable to interruption or damage from sources beyond our control, such as power loss, telecommunications failures, fire, natural disasters, software and hardware failures and cyberattacks.", "If the timely delivery of medical care or other customer business requirements are impaired by data access, network or systems problems, we could be exposed to significant claims and reputational harm.", "We might not realize expected benefits from business process initiatives.", "achieve  our  desired  objectives,  or  unintended  consequences  such  as  distraction  of  our  management  and  employees,  business  disruption,  attrition  beyond  any planned reduction in workforce, inability to attract or retain key personnel and reduced employee productivity.", "We might be unable to successfully complete or integrate acquisitions or other business combinations.", "We may not receive regulatory approvals needed to complete proposed transactions, or such  approvals  may  be  subject  to  delays  or  conditions  that  reduce  transaction  benefits.  Achieving  the  desired  outcomes  of  business  combinations  involves significant  risks  including:  diverting  management\u2019s  attention  from  other  business  operations;  challenges  with  assimilating  the  acquired  businesses,  such  as integration  of  operations  and  systems;  failure  or  delay  in  realizing  operating  synergies;  difficulty  retaining  key  acquired  company  personnel;  unanticipated accounting or financial systems issues with the acquired business, which might affect our internal controls over financial reporting; unanticipated compliance issues in the acquired business; challenges retaining customers of the acquired business; unanticipated expenses or charges to earnings, including depreciation and amortization or potential impairment charges; and risks of known and unknown assumed liabilities in the acquired business.", "We provide remote services that involve hosting customer data and operating software on our own or third party systems.", "Our growth strategy includes consummating acquisitions or other business combinations that either expand or complement our business.", "could delay the achievement of our strategic objectives.", "We might be adversely impacted by outsourcing or similar third-party relationships.", "Third-party services providers might fail to perform as anticipated, or we might experience unanticipated operational difficulties, compliance requirements or increased costs related to outsourced services.", "We may be unsuccessful in retail pharmacy operations or maintaining profitability.", "If our retail pharmacy operations fail to achieve, or are unable to sustain, acceptable net sales and profitability levels, it might have a materially adverse impact on our business operations and our financial position or results of operations.", "We rely on third parties to perform certain business and administrative functions for us.", "We might not adequately develop, implement and monitor these", "Our business strategy included expanding our retail pharmacy operations.", "Our retail pharmacy operations involve numerous risks, such as the following ones.", "For example, our contracts with the U.S. government generally require us to comply with the Federal Acquisition Regulations, Procurement Integrity Act, Buy American Act, Trade Agreements Act, and other laws and regulations.", "The occurrence of any of these risks could harm our reputation and might have a materially adverse impact on our business operations and our financial position or results of operations.", "Our participation in vaccination distribution programs may materially affect our operating results, reputation, and business.", "For example, the novel nature of the SARS-CoV\u20112 virus and the broad scope of the ongoing COVID-19 vaccine distribution program introduce uncertainty about what volumes of products may become available for distribution by us, the effectiveness of vaccines, and the cost of distribution.", "Because of such uncertainties, our operating results may be subject to variability.", "Our participation in such programs also exposes us to various risks, including regulatory compliance, government oversight, dependence on government funding, contractual performance, litigation, security risks, and supply chain challenges.", "Any significant problems with our participation in such programs might have a materially adverse impact on our reputation and our business.", "We might be harmed by changes in our relationships or contracts with suppliers.", "Our competitors might develop non-infringing products or services equivalent or superior to ours.", "We might be unable to successfully recruit and retain qualified employees.", "We compete with many other businesses to attract and retain employees.", "We may experience sudden loss of key personnel due to a variety of causes, such as illness, and must adequately plan for succession of key management roles.", "Employees might not successfully transition into new roles.", "Some of these changes increase our risks and create uncertainties for our business.", "These proposals might result in significant changes in the pharmaceutical value chain as manufacturers, PBM, managed care organizations and other industry stakeholders look to implement new transactional flows and adapt their business models.", "Many of our products and services are designed and intended to function within the structure of current healthcare financing and reimbursement systems.", "We might be adversely impacted by competition and industry consolidation.", "specialty distributors, service merchandisers, self-warehousing chain drug stores, manufacturers engaged in direct distribution, third-party logistics companies and large  payer  organizations.  In  addition,  our  businesses  face  competition  from  various  other  service  providers  and  from  pharmaceutical  and  other  healthcare manufacturers as well as other potential customers, which may from time-to-time decide to develop, for their own internal needs, supply management capabilities that might otherwise be provided by our businesses.", "This concentration reduces our ability to negotiate favorable terms with suppliers and causes us to depend on a smaller number of suppliers.", "Many of our customers, including  healthcare  organizations,  have  consolidated  and  have  greater  power  to  negotiate  favorable  prices.  Consolidation  by  our  customers,  suppliers  and competitors might reduce the number of market participants and give the remaining enterprises greater bargaining power, which might lead to erosion in our profit margin.", "These competitive pressures and industry consolidation might have a materially adverse impact on our business operations and our financial position or results of operations.", "We might be adversely impacted by changes or disruptions in product supply.", "Our inventory might be requisitioned, diverted or allocated by government order such as under emergency, disaster and civil defense declarations.", "For example, government actions in response to the COVID-19 pandemic affect our supply allocation, and those and our own allocation decisions can impact our customer relationships.", "Changes in the healthcare industry\u2019s or our suppliers\u2019 pricing, selling, inventory, distribution or supply policies or practices could significantly reduce our revenues and net income.", "We might experience disruptions in our supply of higher margin pharmaceuticals, including generic pharmaceuticals.", "sourcing joint venture with Walmart, Inc. is unsuccessful or experiences margins declines.", "products and services and the volume of their purchases.", "Our generic  pharmaceuticals  distribution  business  is subject  to  pricing  risks.  We  might  be  adversely  impacted  if  our ClarusONE  generic  pharmaceutical", "Suppliers might increase their prices, reduce their output or change their terms of sale due to limited availability of credit.", "We may have difficulties in sourcing or selling products due to a variety of causes.", "Difficulties in product manufacturing or access to raw materials could result in supplier production shutdowns, product shortages and other supply disruptions.", "The COVID-19 pandemic adversely affects the availability of some products, resulting in product allocation and delivery delays.", "We have operations in the U.K. and the European Union (\u201cE.U.\u201d) and face risks associated with the uncertainty and potential disruptions that might follow the", "These events can disrupt operations for us, our suppliers, our vendors, and our customers.", "For example, in February 2021, a severe winter storm affecting the United  States  temporarily  impacted  our  distribution  business  operations,  primarily  in  Texas.  They  might  affect  consumer  confidence  levels  and  spending.  In response to these events, we might suspend operations, implement extraordinary procedures, seek alternate sources for product supply, or suffer consequences that are unexpected and difficult to mitigate.", "In particular, the rapid and widespread transmission of the SARS-CoV-2 novel coronavirus beginning in late 2019 impacts us in significant ways.", "For example, to mitigate the spread of the COVID-19 disease caused by SARS-CoV-2, we implemented travel restrictions and remote working  arrangements  for  most  of  our  employees  in  order  to  minimize  physical  contact,  and  we  implemented  additional  sanitation  and  personal  protection measures in our warehouse, retail pharmacy and delivery operations.", "These measures might not fully mitigate COVID-19 risks to our workforce and we could experience unusual levels of absenteeism that might impair operations and delay delivery of products.", "The ongoing impacts of the pandemic might cause a general economic slowdown or recession in one or more markets, disruptions and volatility in global capital markets and other broad and adverse effects on the economy, business conditions, commercial activity and the healthcare industry.", "The pandemic might impact our business operation, financial position and results of operation in unpredictable ways that depend on highly uncertain future  developments,  such  as  determining  the  effectiveness  of  current  or  future  government  actions  to  address  the  public  health  or  economic  impacts  of  the pandemic.", "These events and impacts could materially adversely affect our business operations, financial position or results of operation.", "locations,  primarily  throughout  North  America  and  Europe.  Retail  pharmacies  and  most  warehouses  are  typically  owned  or  leased  on  a  long-term  basis.  We consider our operating properties to be in satisfactory condition and adequate to meet our needs for the next several years without making capital expenditures materially higher than historical levels.", "Form 10-K for additional factors relating to these statements and Item 1A - Risk Factors in Part I of this Annual Report on Form 10-K for a list of certain risk factors applicable to our business, financial condition, and results of operations.", "We partner with life sciences companies, manufacturers, providers, pharmacies, governments, and other healthcare organizations to help provide the right medicines, medical products, and healthcare services to the right patients at the right time, safely, and cost-effectively.", "All prior segment information has been recast to reflect our new segment structure and current period presentation.", "We  implemented  a  new  segment  reporting  structure  commencing  with  the  second  quarter  of  2021,  which  resulted  in  four  reportable  segments:  U.S.", "\u2022 International is  a  new  reportable  segment  that  includes  our  operations  in  Europe  and  Canada,  bringing  together  non-U.S.-based  drug  distribution services, specialty pharmacy, retail, and infusion care services.", "\u2022 RxTS is  a  new  reportable  segment  that  brings  together  existing  businesses,  including  CoverMyMeds,  RelayHealth,  RxCrossroads,  and  McKesson Prescription Automation, including Multi-Client Central Fill as a Service, to serve our biopharma and life sciences partners and patients.", "We benefited from demand for COVID-19 tests, favorable contributions from our vaccine and related ancillary supply kit distribution programs as discussed further below, and savings from reduced travel and meetings throughout 2021;", "We have also partnered with the Department of Health and Human Services (\u201cHHS\u201d) and Pfizer to manage the assembly and distribution of the ancillary supplies needed to administer COVID-19 vaccines;", "Pharmaceutical segment driven by market growth; \u2022 Gross profit increased 1% from the prior year primarily in our Medical-Surgical Solutions segment driven by sales of COVID-19 tests; \u2022 Total operating expenses in 2021 includes the following:", "Infection rates varied throughout our fiscal year, peaking in January 2021.", "Our role in the distribution of COVID-19 vaccines in the U.S. as well as the assembly and distribution of related ancillary supply kits is discussed further below.", "McKesson Europe is also playing a role in helping support governments and public health entities in not only distributing COVID-19 vaccines across several European countries, but administering them in pharmacies as well.", "solutions, we are well positioned to respond to the COVID-19 pandemic in the U.S., Canada, and Europe.", "We have worked and continue to work closely with national and local governments, agencies, and industry partners to ensure that available supplies, including personal protective equipment (\u201cPPE\u201d), and medicine reach our customers and patients.", "put in place to mitigate the impact of COVID-19 on our business operations, including telecommuting and work-from-home policies, restricted travel, employee support programs, and enhanced safety measures, are intended to limit employee exposure to the virus that causes COVID-19.", "We expanded employee medical benefits covering COVID-19 related visits, treatments, and testing as well as expanded telehealth options to protect employee safety.", "For employees whose roles require presence at our facilities, we enhanced safety by promoting the practice of social distancing, providing reminders to wash or disinfect hands and avoid unnecessary face touching, making face masks available, placing hand sanitizers within our operating environments, and periodically cleaning and disinfecting our facilities.", "For employees whose roles do not require presence at our facilities, we added technology resources to support their working remotely.", "These steps to protect employee safety have resulted in limited disruption from COVID-19 to our normal business operations, productivity trends, and have not materially impacted our operating expenses or operating margins.", "pharmacy foot traffic as our customers increased supplies on hand in March, which drove unfavorability in our results of operations when comparing 2021 versus 2020.", "We also experienced decreased demand for primary care medical-surgical supplies due to deferrals in elective procedures in hospitals and surgery centers as well as decreased traffic and closures of doctors\u2019 offices, which was partially offset by demand for PPE and COVID-19 tests.", "COVID-19  for  the  second  half  of  our  fiscal  year  was  non-linear  and  tracked  with  patient  mobility.  We  also  saw  increased  demand  for  COVID-19  tests  and continued sales of PPE throughout the year in our Medical-Surgical Solutions segment partially offset by the impacts of social distancing measures which resulted in a less severe cough, cold, and flu season, savings for reduced travel and meetings across the enterprise, as well as improvements of retail pharmacy foot traffic in Europe and Canada.", "The vaccine and related  ancillary  kit distribution  in the U.S. favorably impacted our results in the second half of fiscal 2021 as further discussed below.", "Our Response to COVID-19 in the Workplace During this unprecedented time, we are committed in continuing to supply our customers and protect the safety of our employees.", "During  the  first  quarter  of  2021,  we  experienced  growth  in  pharmaceutical  distribution  and  specialty  drug  volumes  at  a  lower  rate  in  the  U.S.,  while", "In the centralized model, the U.S. government directs us on the distribution of the vaccines and related supplies to point-of-care sites across the country.", "The results of operations related to our vaccine distribution are reflected in our U.S.", "We also have an agreement with Pfizer to assemble and distribute ancillary supply kits needed to administer that particular COVID-19 vaccine.", "We began assembling the ancillary supply kits in September 2020 in preparation for vaccine authorization and subsequent distribution.", "Ancillary supply kits to administer the Pfizer Vaccine are shipped directly to point-of-care sites, and all other ancillary supply kits are shipped to our dedicated vaccine distribution centers.", "The results of operations for the kitting and distribution of ancillary supplies are reflected in our Medical-Surgical Solutions segment.", "These facilities can scale to meet the demand of increasing volumes of vaccines being manufactured.", "We have also set up distribution centers for kitting and inventory management as part of our contract with the HHS.", "We are working with delivery partners to manage the delivery of vaccines and ancillary supply kits from our centralized vaccine distribution centers to point-of-care destinations as directed by the CDC.", "as well as the kitting and distribution of ancillary supplies for COVID-19 vaccines in our Medical-Surgical Solutions segment contributed approximately 20% in segment  revenues  and  segment  operating  profit.  Additionally,  the  distribution  of  COVID-19  vaccines  in  our  U.S.  Pharmaceutical  segment  contributed approximately 2% in segment operating profit for the year ended March 31, 2021.", "During our fourth quarter of 2020, we experienced a temporary increase in demand for pharmaceuticals.", "Certain PPE items held for resale were valued in our inventory at costs that were inflated by earlier COVID-19 pandemic demand levels.", "That inventory valuation, if not supported by market resale prices, may be written down to net realizable value.", "We may also write-off inventory due to decreased customer demand and excess inventory.", "response to supply availability and customer demand patterns for certain products, with varying inventory level impacts depending on the specific product within our portfolio.", "As our supply levels improve, and the federal government evolves guidance on the prioritization of providers or geographic markets, we will continue to adapt our distribution policies.", "We were able to maintain appropriate labor and overall vendor supply levels during the year ended March 31, 2021.", "suppliers,  their  locations,  and  the  extent  to  which  they  are  impacted  by  the  COVID-19  pandemic,  we  are  proactively  working  with  manufacturers,  industry partners, and government agencies to meet the needs of our customers during the pandemic.", "We have assembled a Critical Care Drug Task Force, made up of our procurement  specialists,  clinical  health  systems  pharmacists,  and  supply  chain  professionals,  that  is  focused  on  securing  additional  product  where  available, sourcing back-up products, and protecting our operations across all locations and facilities.", "We are also working with manufacturers through several channels, including  our  ClarusONE  Sourcing  Services  LLP  (\u201cClarusONE\u201d)  and  global  sourcing  teams  in  London,  and  our  leaders  are  actively  engaged  in  addressing potential shortages.", "We have engaged with industry partners and government agencies to gain visibility into supply and demand.", "Additionally, we have a robust Business Continuity and Disaster Recovery Program (\u201cBCRP\u201d) and we have proactively enhanced our BCRP in response to the COVID-19 pandemic to protect the supply  chain  to  minimize  disruption  in  healthcare,  protect  our  customers,  ensure  the  safety  and  security  of  our  employees  and  workplaces,  and  ensure  the continuity of critical business processes.", "supplies and medications to help prevent the spread of the disease and treat those that are ill.", "COVID-19 has put an unprecedented strain on the supply of high- demand PPE, including N95 masks, gloves, as well as disinfecting sprays and wipes.", "The supply chain has improved over the initial impact of pandemic-related demand, and we continue to closely monitor demand by customer type and certain PPE and infection prevention items are still in short supply.", "Our allocation approach has helped us avoid stock outs in many critical product categories, allowing us to provide PPE supplies to many more customers for a much longer time.", "We anticipate these market conditions will remain for the foreseeable future.", "Our efforts to help the supply chain have included sourcing products from new suppliers all over the world, working closely with the federal government to help with the nation\u2019s response and collaborating with partners to source, develop, and deliver new products to market.", "The full extent to which COVID-19 will impact us depends on many factors and future developments, including: the duration and spread of the virus; governmental actions to limit the spread of the virus; potential seasonality of viral outbreaks; potential new strains or variants of the original virus; the amount of COVID-19 vaccines authorized, manufactured, distributed, and administered; the amount of ancillary supply kits assembled and distributed; the  effectiveness  of  COVID-19  vaccines  and  governmental  measures  in  controlling  the  spread  of  the  virus;  and  the  effectiveness  of  treatments  of  infected individuals.", "Impact to our Supply Chain We  also  continue  to  monitor  the  COVID-19  pandemic  impacts  on  our  supply  chain.  Although  the  availability  of  various  products  is  dependent  on  our", "Gross profit was favorably impacted by growth of specialty pharmaceuticals and the contribution from our vaccine distribution programs in our U.S.", "\u2022 Goodwill impairment charges of $1.8 billion in our European Retail Pharmacy (\u201cEuropean RP\u201d) and European Pharmaceutical Distribution (\u201cEuropean PD\u201d) reporting units within the International segment.", "This initiative primarily led us to rationalize our office space in North America.", "Where we determine to cease using office space, we plan to exit the portion of the facility no longer used.", "We also may retain and repurpose certain other office locations.", "transformational changes in technologies and business processes, operational efficiencies, and cost savings.", "centralization of certain functions and outsourcing through an expanded arrangement with a third-party vendor to achieve operational efficiency.", "The  initiative  consisted  of  multiple  growth  priorities  and  plans  to  optimize  our  operating  models  and  cost  structures  primarily  through  centralization,  cost management, and outsourcing of certain administrative functions.", "As part of the growth initiative, we committed to implement certain actions including a reduction in workforce, facility consolidation, and store closures.", "This set of initiatives was substantially complete by the end of 2020. $115 million, $112 million, and $245 million, respectively, primarily related to our retail pharmacy businesses in Canada and Europe within our International segment.", "During  the  first  quarter  of  2021,  we  committed  to  an  initiative  within  the  U.K.,  which  is  included  in  our  International  segment,  to  further  drive", "In the fourth quarter of 2019, we committed to certain programs to continue our operating model and cost optimization efforts.", "On April 25, 2018, we announced a strategic growth initiative intended to drive long-term incremental profit growth and to increase operational efficiency.", "pharmaceutical price increases, growth in specialty pharmaceuticals, and higher volumes from retail national account customers, partially offset by branded to generic  drug  conversions.  Revenues  for  this  segment  were  unfavorably  impacted  by  fluctuations  in  demand  for  pharmaceuticals  in  retail  pharmacies  and institutional healthcare providers due to COVID-19 largely during the onset of the pandemic in late March 2020 and during our first quarter of 2021 combined with the loss of certain customers.", "exchange fluctuations, revenues for this segment decreased 9% primarily due to the contribution of our German pharmaceutical wholesale business to a joint venture with WBA and to a lesser extent, the exit of unprofitable customers in our Canadian business.", "Revenues for this segment were also unfavorably impacted by lower volumes from the adverse impacts from COVID-19 in our pharmaceutical distribution and retail pharmacy businesses within Europe.", "exchange fluctuations, revenues for this segment increased 4% primarily due to market growth in our European pharmaceutical distribution and retail pharmacy businesses.", "2020 vs. 2019 Medical-Surgical Solutions revenues for the year ended March 31, 2020 increased 9% compared to the prior year primarily due to market growth in our", "The impacts from COVID-19 in our pharmaceutical distribution and retail pharmacy businesses within Europe also caused unfavorability in our segment results year over year.", "demand for COVID-19 tests and PPE, as well as the contribution from kitting and distribution of ancillary supplies for COVID-19 vaccines.", "This was partially offset by inventory charges on certain PPE and other related products, unfavorability in our primary care business due to customer closures largely during the first quarter  of 2021, and a  less severe  cough, cold, and flu  season.", "2020 vs. 2019 Operating profit increased for the year ended March 31, 2020 compared to the prior year primarily due to market growth in our specialty business.", "2020 vs. 2019 Operating profit and operating profit margin increased for the year ended March 31, 2020 compared to prior year primarily due to market growth in our", "We monitor our operations and adopt strategies responsive to changes in the economic and political environment in each of the countries in which we operate.", "Our foreign operations represented approximately 15%, 17%, and 18% of our consolidated revenues in 2021, 2020, and 2019, respectively.", "We also have agreements with GPOs, each of which functions as a purchasing agent on behalf of member hospitals, pharmacies and other healthcare providers, as well as with government entities and agencies.", "and updated if unusual circumstances or trends are present.", "LIFO method presumes that the most recent inventory purchases are the first items sold and the inventory cost under LIFO approximates market.", "The majority of the cost of domestic inventories is determined using the LIFO method.", "If we had used the moving average method of inventory valuation, inventories would have been approximately $406 million and $444 million higher than the amounts reported at March 31, 2021 and 2020, respectively.", "such, our LIFO inventory is valued at the lower of LIFO or market.", "Inventories: Inventories  consist of merchandise  held  for resale.  We report  inventories  at the lower of cost or net realizable  value, except  for inventories", "We believe that the moving average inventory costing method provides a reasonable estimation of the current cost of replacing inventory (i.e., \u201cmarket\u201d).", "Shifts in market trends and conditions, changes in customer preferences due to the introduction of generic drugs or new pharmaceutical products or the loss of one or more significant customers are factors that could affect the value of our inventories.", "We write down inventories which are considered excess and obsolete as a result of these reviews.", "These factors could make our estimates of inventory valuation differ from actual results.", "In addition, we compare the aggregate of the reporting units\u2019 fair values to our market capitalization as further corroboration of the fair values.", "They can be affected by a variety of factors, including external factors such as industry and economic trends, and internal factors such as changes in our business strategy and our internal forecasts.", "Management makes certain judgments and estimates in its assessment including but not limited to: identifying if circumstances indicate a decline in value is other than temporary, expectations about the business operations of investees, as well as industry, financial, and market factors.", "On March 9, 2020, we completed the Split-off of our interest in the Change Healthcare JV.", "Our businesses require substantial investments in working capital that are susceptible to large variations during the year as a result of inventory purchase patterns and seasonal demands.", "Our  redeemable  noncontrolling  interests  primarily  relate  to  our  consolidated  subsidiary,  McKesson  Europe.  Under  the  Domination  Agreement,  the", "However, our risk management programs are designed such  that  the  potential  loss  in  value  of  these  risk  management  portfolios  described  above  would  be  largely  offset  by  changes  in  the  value  of  the  underlying exposure.", "With the participation of the Chief Executive Officer and the Chief Financial Officer, our management conducted an assessment of the effectiveness of our internal control over financial  reporting based on the framework and criteria  established in Internal Control\u2014Integrated Framework (2013), issued by the Committee of Sponsoring Organizations of the Treadway Commission.", "Under the market approach, fair value is estimated by comparing the business to similar businesses, or guideline companies whose securities are actively traded in public markets.", "The severity,  magnitude  and  duration,  as  well  as  the  economic  consequences  of  the  coronavirus  diseases  2019  (\u201cCOVID-19\u201d)  pandemic,  are  uncertain,  rapidly changing, and difficult to predict.", "The majority of the cost of domestic inventories is determined using the LIFO method.", "Goodwill testing requires a complex series of assumptions and judgments by management in projecting future operating results, selecting guideline companies for comparisons and assessing risks.", "Revenues generated from the distribution of pharmaceutical and medical products represent the majority of the Company\u2019s revenues.", "customer, is responsible for fulfilling the promise to its customer, has latitude in establishing prices, and controls the relationship with the customer.", "Shipping and handling costs associated with outbound freight after control over a product has transferred to a customer are accounted for as fulfillment costs.", "International segment, to further drive transformational changes in technologies and business processes, operational efficiencies, and cost savings.", "continues to implement centralization of certain functions and outsourcing through an expanded arrangement with a third-party vendor to achieve operational efficiency.", "Irving, Texas to improve efficiency, collaboration, and cost competitiveness.", "PSUs are conditional upon the attainment of market and performance objectives over a specified period.", "As a practical expedient, the Company does not separate lease components from non-lease components such as common area maintenance, utilities, and repairs and maintenance.", "The Company\u2019s most significant relationships are with oncology and other specialty practices.", "Level 2 - significant other observable market-based inputs.", "Level 3 - significant unobservable inputs for which little or no market data exists and requires considerable assumptions that are significant to the fair value", "measurement due to the significance of unobservable inputs developed using company-specific information.", "It has received the same warranties from its suppliers, which customarily are the manufacturers of the products.", "Pharma Belgium NV is also part of the investigation.", "Stockholders (the \u201cProxy Statement\u201d) under the heading \u201cElection of Directors.\u201d Information about our Executive Officers is incorporated by reference from the discussion in Part I of this report under the heading \u201cInformation about our Executive Officers.\u201d Information about our Audit Committee, including the members of the  committee  and  our  Audit  Committee  Financial  Expert,  is  incorporated  by  reference  from  the  discussion  under  Item  1  of  our  Proxy  Statement  under  the headings \u201cThe Board, Committees and Meetings,\u201d and \u201cAudit Committee Report.\u201d", "We offer more than 275,000 national brand medical- surgical products as well as McKesson\u2019s own line of high-quality products through a network of distribution centers within the United States (\u201cU.S.\u201d).", "as a Service, to serve our biopharma and life sciences partners and patients.", "Our  U.S.  Pharmaceutical  segment  distributes  branded,  generic,  specialty,  biosimilar  and  over-the-counter  (\u201cOTC\u201d)  pharmaceutical  drugs,  and  other", "We also source generic pharmaceutical drugs through our joint sourcing entity, ClarusONE Sourcing Services LLP (\u201cClarusONE\u201d).", "We invest in technology and other systems at all of our distribution centers to enhance safety, reliability, and product availability.", "For example, we offer McKesson Connect , an internet-based ordering system that provides item look-up and real-time inventory availability as well as ordering, purchasing, third-party reconciliation, and account management functionality.", "We make extensive use of technology as an enabler to ensure customers have the right products at the right time in the right place.", "We provide solutions to our customers including supply management technology, world-class marketing programs, managed care, repackaging products, and services to help them meet their business and quality goals.", "We continue to implement information systems to help achieve greater consistency and accuracy both internally and for our customers.", "operational efficiency, and automation that help independent pharmacists focus on patient care while improving profitability.", "Retail National Accounts: We provide business solutions that help retail national account customers increase revenues and profitability.", "These distribution centers also provide the foundation for a two-tiered distribution network that supports best-in-class direct store delivery.", "performance, increase operational efficiencies, and deliver better patient care.", "Community-based physicians in this business have broad flexibility and discretion to select the products and commitment levels that best meet their practice needs.", "Services in provider solutions include specialty drug distribution, group purchasing organizations (\u201cGPO\u201d) like Onmark\u00ae, technology solutions, practice consulting services, and vaccine distribution, including our exclusive distributor relationship with the Centers for Disease Control and Prevention\u2019s (\u201cCDC\u201d) Vaccines for Children program.", "SKY Packaging enables acute care, long-term care, and institutional pharmacies to provide cost-effective, uniform packaging.", "Our use of the term \u201cspecialty\u201d may not be comparable to that used by other industry participants, including our competitors.", "Our operations in Canada, including Rexall retail pharmacies, support better, safer patient care by delivering vital medicines, supplies, and information technology solutions throughout Canada.", "functions  as  a  vital  link,  using  technology-enabled  management  systems  at  our  regional  wholesale  branches  to  connect  manufacturers  to  retail  pharmacies, supplying medicines and other products sold in pharmacies.", "In addition, we partner with independent pharmacies under local banner programs.", "banners, and more than 400 owned pharmacies under the Rexall brand where we provide patients with greater choice and access, integrated pharmacy care and industry-leading service levels.", "This segment includes our Ontada business, providing software to support the clinical, financial, and operational needs of our oncology practice partners.", "Our European Pharmaceutical Distribution business delivers pharmaceutical and other healthcare-related products to pharmacies across Europe.", "Our more than 250,000 customers include physician offices, surgery centers, post-acute care facilities, hospital reference labs, and  home  health  agencies.  We  distribute  medical-surgical  supplies  (such  as  gloves,  needles,  syringes  and  wound  care  products),  infusion  pumps,  laboratory equipment  and  pharmaceuticals.  Through  a  network  of  distribution  centers  within  the  U.S.,  we  offer  more  than  275,000  products  from  national  brand manufacturers and McKesson\u2019s own high-quality product line.", "Through the right mix of products and services, we help improve efficiencies, profitability and compliance.  We  also  never  lose  focus  on  helping  customers  improve  patient  and  business  outcomes.  We  develop  customized  plans  to  address  the  product, operational, and clinical support needs of our customers, including tackling inventory management, reducing administrative burdens, and training and educating clinical staff.", "We deliver for our customers, so they can deliver and care for their patients.", "pharmaceutical distribution environment in which our U.S.", "Pharmaceutical and International segments operate, we face strong competition from international, national, regional and local full-line, short-line and specialty distributors, service merchandisers, self-warehousing chain drug stores, manufacturers engaged in direct distribution, third-party logistics companies, and large payer organizations.", "Our retail businesses, which primarily operate in our International segment, face competition from various global, national, regional, and local global retailers, including chain and independent pharmacies.", "We consider our largest competitors in distribution, wholesaling, and logistics to be AmerisourceBergen Corporation and Cardinal Health, Inc.", "businesses, which may from time to time decide to develop, for their own internal needs, supply management capabilities that might otherwise be provided by our businesses.", "We believe that our scale and diversity of product and service offerings are our primary competitive advantages.", "operations and market position, but we do not consider any of our businesses to be dependent upon any one patent, copyright, trademark, or trade secret, or any family or families of the same.", "be necessary in the future to seek or renew licenses relating to various aspects of our products and services, we believe, based upon past experience and industry practice,  such  licenses  generally  can  be  obtained  on  commercially  reasonable  terms.  We  believe  our  operations  and  products  and  services  are  not  materially dependent on any single license or other agreement with any third party.", "on improving employee health and wellness, creating opportunities for growth and development, and providing an inclusive workplace where our employees can reach their full potential.", "At March 31, 2021, we had approximately 76,000 employees worldwide, including 17,000 part-time employees and 32,000 employees in the U.S. healthier future is everyone\u2019s business.", "We build successful teams by recruiting, developing, and retaining diverse talent and we recognize our culture of inclusion as an important element that drives long-term shareholder value.", "(1) The data for our metrics is derived from our voluntary, self-identification process as of March 31, 2021 and therefore represents our best estimate at this time. (2) Represents our leadership at the vice president level and above. (3) Represents worldwide employees. (4) Represents U.S. employees only as the data for Canada and Europe is not available.", "I CARE and ILEAD principles, we fulfill our mission of improving care in every setting.", "Our I CARE values (Integrity, Inclusion, Customer-First, Accountability, Respect, Excellence) are foundational to all that we do, and who we are as a company.", "ILEAD (Inspire, Leverage, Execute, Advance, Develop) is our common definition and shared commitment to leadership.", "By embracing this commitment, we bring out the best in ourselves and position McKesson to continue to drive better health \u2013 for our company, our customers, and the patients they serve for years to come.", "We promote leadership behaviors through culture initiatives that offer practical tips on how to debate, decide, and commit, be open and candid, and maintain an enterprise-first mindset when navigating conversations affecting operations within and across our business segments.", "We hold inbound licenses for certain intellectual property that is used internally, and in some cases, utilized in McKesson\u2019s products or services.", "Culture and Leadership: What sets McKesson apart as an exceptional place is our people.", "Our employees understand that together, unified by our global", "where everyone can bring their authentic self to work and feel welcomed and appreciated, and where their perspectives are sought out, heard, and considered.", "Through training, we encourage leaders to embrace diverse perspectives and lead inclusively.", "We  also  seek  employee  feedback  through  an  annual  employee  opinion  survey,  which  assesses  our employees\u2019  levels  of engagement, commitment, and overall satisfaction using industry benchmarks, and we then design action plans to improve those metrics.", "We routinely assess facilities to monitor closely adherence to established security and safety standards.", "If we identify a vulnerability, it is documented, and the facility prepares an action plan.", "Our employees receive specialized training related to their role, work setting, and equipment used in their work environment.", "As our processes evolve, we update relevant safety training modules, which may include new employee training programs.", "The various responses we put in place to mitigate the impact of COVID- 19  on  our  business  operations,  including  telecommuting  and  work-from-home  policies,  restricted  travel,  and  enhanced  safety  measures,  are  intended  to  limit employee exposure to the virus that causes COVID-19 as they perform their jobs while also providing employee support programs and a sense of belonging.", "For additional  information  on  our  response  to  COVID-19  in  the  workplace,  refer  to  the  COVID-19  section  of \u201cTrends  and  Uncertainties\u201d in  \u201cManagement\u2019s Discussion and Analysis of Financial Condition and Results of Operations\u201d in Item 7 of Part II included in this Annual Report on Form 10-K.", "Food and Drug Administration Amendments Act of 2007 requires the FDA to establish standards and identify and validate effective technologies, such as track and trace or authentication technologies, to secure the pharmaceutical supply chain against counterfeit drugs.", "Despite physical, technical, and administrative security measures that we implement in order to, among other things, address regulatory requirements, our technology systems and operations may continue to be subject to cybersecurity incidents.", "The risk of cybersecurity incidents may be increased due to a variety of factors, both internal and external.", "Sales to our largest customer, CVS Health Corporation (\u201cCVS\u201d), accounted for approximately 21% of our total consolidated revenues in 2021.", "In May 2019, we extended our pharmaceutical distribution relationship with CVS to June 2023.", "a supplier could adversely affect our business if alternate sources of supply are unavailable.", "We believe that our relationships with our suppliers are generally sound.", "The ten largest suppliers in 2021 accounted for approximately 50% of our purchases.", "For these manufacturers, a reduction in the frequency and magnitude of price increases, as well as restrictions in the amount of inventory available to us, could have an adverse impact on our gross profit margin.", "Although it is not possible to predict or identify all such risks and uncertainties, they include, but are not limited to, the factors discussed in Item 1A of Part I of this report under \u201cRisk Factors\u201d and in our publicly available SEC filings and press releases.", "Suppliers: We obtain pharmaceutical and other products from manufacturers, none of which accounted for more than 7% of our purchases in 2021.", "practical  to  identify  or  describe  all  risks  and  uncertainties  that  might  materially  impact  our  business  operations,  reputation,  financial  position  or  results  of operations.", "Our business could be materially affected by risks that we have not yet identified or that we currently consider to be immaterial.", "This is not a complete statement of all potential risks and uncertainties.", "For example, pharmacy operations are exposed to risks such as improper filling of prescriptions, mislabeling of prescriptions, inadequacy of warnings, unintentional distribution of counterfeit drugs and expiration of drugs.", "The  discussion  below  identifies  certain  representative  risks  that  might  cause  our  actual  business  results  to  materially  differ  from  our  estimates.  It  is  not", "Certain of our businesses may be required to register for permits and/or licenses with, and comply with operating and security standards of, the DEA, FDA, HHS, CMS, various state boards of pharmacy, state health departments and/or comparable state agencies as well as foreign agencies and certain accrediting bodies, depending upon the type of operations and location of product development, manufacture, distribution, and sale.", "As of March 31, 2021, suspensions at the four distribution centers had all expired  by  their  own  terms.  If  we  are  not  able  to  obtain,  maintain  or  renew  permits,  licenses  or  other  regulatory  approvals  needed  for  the  operation  of  our businesses, it might have a materially adverse impact on our business operations and our financial position or results of operations.", "Food and Drug Administration Amendments Act of 2007 requires the FDA to establish standards and identify and validate effective technologies, such as track  and  trace  or  authentication  technologies,  to  secure  the  pharmaceutical  supply  chain  against  counterfeit  drugs.  We  also  have  record-keeping  and  other obligations under the E.U.", "We are subject to significant compliance obligations under privacy laws such as the General Data Protection Regulation in the  European  Union  (\u201cGDPR\u201d),  the  Personal  Information  Protection  and  Electronic  Documents  Act  (\u201cPIPEDA\u201d)  in  Canada,  and  the  California  Consumer Protection  Act  (\u201cCCPA\u201d).  Some  privacy  laws  prohibit  the  transfer  of  personal  information  to  certain  other  jurisdictions.  We  are  subject  to  privacy  and  data protection compliance audits or investigations by various government agencies.", "We experience cybersecurity incidents that might significantly compromise our technology systems or might result in material data breaches.", "Despite physical, technical, and administrative security measures, our technology systems and operations have been, and likely will continue to be, subject to cyberattacks from sources beyond our control.", "Cybersecurity incidents  include  actual  or  attempted  unauthorized  access,  tampering,  malware  insertion,  ransomware  attacks  or  other  system  integrity  events.  The  risk  of cyberattacks  may be increased  due to a variety of factors, both internal  and external.  A cybersecurity  incident might involve a material  data breach or other material impact to the integrity and operations of our technology systems, which might result in litigation or regulatory action, loss of customers or revenue, and increased expense, any of which might have a materially adverse impact on our business operations, reputation, and our financial position or results of operations.", "We might experience significant problems with information systems or networks.", "If those information systems suffer errors, interruptions, or become unavailable, there might be a materially adverse impact on our business operations, reputation, and our financial position or results of operations.", "Our products or services might not conform to specifications or perform as we intend.", "professionals delivering patient care tend to have heightened sensitivity to system and software errors.", "Errors or failures might damage our reputation and negatively affect future sales.", "We sell and provide services involving complex software and technology that may contain errors, especially when first introduced to market.", "The networks and hosting systems are vulnerable to interruption or damage from sources beyond our control, such as power loss, telecommunications failures, fire, natural disasters, software and hardware failures and cyberattacks.", "If the timely delivery of medical care or other customer business requirements are impaired by data access, network or systems problems, we could be exposed to significant claims and reputational harm.", "We might not realize expected benefits from business process initiatives.", "achieve  our  desired  objectives,  or  unintended  consequences  such  as  distraction  of  our  management  and  employees,  business  disruption,  attrition  beyond  any planned reduction in workforce, inability to attract or retain key personnel and reduced employee productivity.", "We might be unable to successfully complete or integrate acquisitions or other business combinations.", "We may not receive regulatory approvals needed to complete proposed transactions, or such  approvals  may  be  subject  to  delays  or  conditions  that  reduce  transaction  benefits.  Achieving  the  desired  outcomes  of  business  combinations  involves significant  risks  including:  diverting  management\u2019s  attention  from  other  business  operations;  challenges  with  assimilating  the  acquired  businesses,  such  as integration  of  operations  and  systems;  failure  or  delay  in  realizing  operating  synergies;  difficulty  retaining  key  acquired  company  personnel;  unanticipated accounting or financial systems issues with the acquired business, which might affect our internal controls over financial reporting; unanticipated compliance issues in the acquired business; challenges retaining customers of the acquired business; unanticipated expenses or charges to earnings, including depreciation and amortization or potential impairment charges; and risks of known and unknown assumed liabilities in the acquired business.", "We provide remote services that involve hosting customer data and operating software on our own or third party systems.", "Our growth strategy includes consummating acquisitions or other business combinations that either expand or complement our business.", "could delay the achievement of our strategic objectives.", "We might be adversely impacted by outsourcing or similar third-party relationships.", "Third-party services providers might fail to perform as anticipated, or we might experience unanticipated operational difficulties, compliance requirements or increased costs related to outsourced services.", "We may be unsuccessful in retail pharmacy operations or maintaining profitability.", "If our retail pharmacy operations fail to achieve, or are unable to sustain, acceptable net sales and profitability levels, it might have a materially adverse impact on our business operations and our financial position or results of operations.", "We rely on third parties to perform certain business and administrative functions for us.", "We might not adequately develop, implement and monitor these", "Our business strategy included expanding our retail pharmacy operations.", "Our retail pharmacy operations involve numerous risks, such as the following ones.", "For example, our contracts with the U.S. government generally require us to comply with the Federal Acquisition Regulations, Procurement Integrity Act, Buy American Act, Trade Agreements Act, and other laws and regulations.", "The occurrence of any of these risks could harm our reputation and might have a materially adverse impact on our business operations and our financial position or results of operations.", "Our participation in vaccination distribution programs may materially affect our operating results, reputation, and business.", "For example, the novel nature of the SARS-CoV\u20112 virus and the broad scope of the ongoing COVID-19 vaccine distribution program introduce uncertainty about what volumes of products may become available for distribution by us, the effectiveness of vaccines, and the cost of distribution.", "Because of such uncertainties, our operating results may be subject to variability.", "Our participation in such programs also exposes us to various risks, including regulatory compliance, government oversight, dependence on government funding, contractual performance, litigation, security risks, and supply chain challenges.", "Any significant problems with our participation in such programs might have a materially adverse impact on our reputation and our business.", "We might be harmed by changes in our relationships or contracts with suppliers.", "Our competitors might develop non-infringing products or services equivalent or superior to ours.", "We might be unable to successfully recruit and retain qualified employees.", "We compete with many other businesses to attract and retain employees.", "We may experience sudden loss of key personnel due to a variety of causes, such as illness, and must adequately plan for succession of key management roles.", "Employees might not successfully transition into new roles.", "Some of these changes increase our risks and create uncertainties for our business.", "These proposals might result in significant changes in the pharmaceutical value chain as manufacturers, PBM, managed care organizations and other industry stakeholders look to implement new transactional flows and adapt their business models.", "Many of our products and services are designed and intended to function within the structure of current healthcare financing and reimbursement systems.", "We might be adversely impacted by competition and industry consolidation.", "specialty distributors, service merchandisers, self-warehousing chain drug stores, manufacturers engaged in direct distribution, third-party logistics companies and large  payer  organizations.  In  addition,  our  businesses  face  competition  from  various  other  service  providers  and  from  pharmaceutical  and  other  healthcare manufacturers as well as other potential customers, which may from time-to-time decide to develop, for their own internal needs, supply management capabilities that might otherwise be provided by our businesses.", "This concentration reduces our ability to negotiate favorable terms with suppliers and causes us to depend on a smaller number of suppliers.", "Many of our customers, including  healthcare  organizations,  have  consolidated  and  have  greater  power  to  negotiate  favorable  prices.  Consolidation  by  our  customers,  suppliers  and competitors might reduce the number of market participants and give the remaining enterprises greater bargaining power, which might lead to erosion in our profit margin.", "These competitive pressures and industry consolidation might have a materially adverse impact on our business operations and our financial position or results of operations.", "We might be adversely impacted by changes or disruptions in product supply.", "Our inventory might be requisitioned, diverted or allocated by government order such as under emergency, disaster and civil defense declarations.", "For example, government actions in response to the COVID-19 pandemic affect our supply allocation, and those and our own allocation decisions can impact our customer relationships.", "Changes in the healthcare industry\u2019s or our suppliers\u2019 pricing, selling, inventory, distribution or supply policies or practices could significantly reduce our revenues and net income.", "We might experience disruptions in our supply of higher margin pharmaceuticals, including generic pharmaceuticals.", "sourcing joint venture with Walmart, Inc. is unsuccessful or experiences margins declines.", "products and services and the volume of their purchases.", "Our generic  pharmaceuticals  distribution  business  is subject  to  pricing  risks.  We  might  be  adversely  impacted  if  our ClarusONE  generic  pharmaceutical", "Suppliers might increase their prices, reduce their output or change their terms of sale due to limited availability of credit.", "We may have difficulties in sourcing or selling products due to a variety of causes.", "Difficulties in product manufacturing or access to raw materials could result in supplier production shutdowns, product shortages and other supply disruptions.", "The COVID-19 pandemic adversely affects the availability of some products, resulting in product allocation and delivery delays.", "We have operations in the U.K. and the European Union (\u201cE.U.\u201d) and face risks associated with the uncertainty and potential disruptions that might follow the", "These events can disrupt operations for us, our suppliers, our vendors, and our customers.", "For example, in February 2021, a severe winter storm affecting the United  States  temporarily  impacted  our  distribution  business  operations,  primarily  in  Texas.  They  might  affect  consumer  confidence  levels  and  spending.  In response to these events, we might suspend operations, implement extraordinary procedures, seek alternate sources for product supply, or suffer consequences that are unexpected and difficult to mitigate.", "In particular, the rapid and widespread transmission of the SARS-CoV-2 novel coronavirus beginning in late 2019 impacts us in significant ways.", "For example, to mitigate the spread of the COVID-19 disease caused by SARS-CoV-2, we implemented travel restrictions and remote working  arrangements  for  most  of  our  employees  in  order  to  minimize  physical  contact,  and  we  implemented  additional  sanitation  and  personal  protection measures in our warehouse, retail pharmacy and delivery operations.", "These measures might not fully mitigate COVID-19 risks to our workforce and we could experience unusual levels of absenteeism that might impair operations and delay delivery of products.", "The ongoing impacts of the pandemic might cause a general economic slowdown or recession in one or more markets, disruptions and volatility in global capital markets and other broad and adverse effects on the economy, business conditions, commercial activity and the healthcare industry.", "The pandemic might impact our business operation, financial position and results of operation in unpredictable ways that depend on highly uncertain future  developments,  such  as  determining  the  effectiveness  of  current  or  future  government  actions  to  address  the  public  health  or  economic  impacts  of  the pandemic.", "These events and impacts could materially adversely affect our business operations, financial position or results of operation.", "locations,  primarily  throughout  North  America  and  Europe.  Retail  pharmacies  and  most  warehouses  are  typically  owned  or  leased  on  a  long-term  basis.  We consider our operating properties to be in satisfactory condition and adequate to meet our needs for the next several years without making capital expenditures materially higher than historical levels.", "Form 10-K for additional factors relating to these statements and Item 1A - Risk Factors in Part I of this Annual Report on Form 10-K for a list of certain risk factors applicable to our business, financial condition, and results of operations.", "We partner with life sciences companies, manufacturers, providers, pharmacies, governments, and other healthcare organizations to help provide the right medicines, medical products, and healthcare services to the right patients at the right time, safely, and cost-effectively.", "All prior segment information has been recast to reflect our new segment structure and current period presentation.", "We  implemented  a  new  segment  reporting  structure  commencing  with  the  second  quarter  of  2021,  which  resulted  in  four  reportable  segments:  U.S.", "\u2022 International is  a  new  reportable  segment  that  includes  our  operations  in  Europe  and  Canada,  bringing  together  non-U.S.-based  drug  distribution services, specialty pharmacy, retail, and infusion care services.", "\u2022 RxTS is  a  new  reportable  segment  that  brings  together  existing  businesses,  including  CoverMyMeds,  RelayHealth,  RxCrossroads,  and  McKesson Prescription Automation, including Multi-Client Central Fill as a Service, to serve our biopharma and life sciences partners and patients.", "We benefited from demand for COVID-19 tests, favorable contributions from our vaccine and related ancillary supply kit distribution programs as discussed further below, and savings from reduced travel and meetings throughout 2021;", "We have also partnered with the Department of Health and Human Services (\u201cHHS\u201d) and Pfizer to manage the assembly and distribution of the ancillary supplies needed to administer COVID-19 vaccines;", "Pharmaceutical segment driven by market growth; \u2022 Gross profit increased 1% from the prior year primarily in our Medical-Surgical Solutions segment driven by sales of COVID-19 tests; \u2022 Total operating expenses in 2021 includes the following:", "Infection rates varied throughout our fiscal year, peaking in January 2021.", "Our role in the distribution of COVID-19 vaccines in the U.S. as well as the assembly and distribution of related ancillary supply kits is discussed further below.", "McKesson Europe is also playing a role in helping support governments and public health entities in not only distributing COVID-19 vaccines across several European countries, but administering them in pharmacies as well.", "solutions, we are well positioned to respond to the COVID-19 pandemic in the U.S., Canada, and Europe.", "We have worked and continue to work closely with national and local governments, agencies, and industry partners to ensure that available supplies, including personal protective equipment (\u201cPPE\u201d), and medicine reach our customers and patients.", "put in place to mitigate the impact of COVID-19 on our business operations, including telecommuting and work-from-home policies, restricted travel, employee support programs, and enhanced safety measures, are intended to limit employee exposure to the virus that causes COVID-19.", "We expanded employee medical benefits covering COVID-19 related visits, treatments, and testing as well as expanded telehealth options to protect employee safety.", "For employees whose roles require presence at our facilities, we enhanced safety by promoting the practice of social distancing, providing reminders to wash or disinfect hands and avoid unnecessary face touching, making face masks available, placing hand sanitizers within our operating environments, and periodically cleaning and disinfecting our facilities.", "For employees whose roles do not require presence at our facilities, we added technology resources to support their working remotely.", "These steps to protect employee safety have resulted in limited disruption from COVID-19 to our normal business operations, productivity trends, and have not materially impacted our operating expenses or operating margins.", "pharmacy foot traffic as our customers increased supplies on hand in March, which drove unfavorability in our results of operations when comparing 2021 versus 2020.", "We also experienced decreased demand for primary care medical-surgical supplies due to deferrals in elective procedures in hospitals and surgery centers as well as decreased traffic and closures of doctors\u2019 offices, which was partially offset by demand for PPE and COVID-19 tests.", "COVID-19  for  the  second  half  of  our  fiscal  year  was  non-linear  and  tracked  with  patient  mobility.  We  also  saw  increased  demand  for  COVID-19  tests  and continued sales of PPE throughout the year in our Medical-Surgical Solutions segment partially offset by the impacts of social distancing measures which resulted in a less severe cough, cold, and flu season, savings for reduced travel and meetings across the enterprise, as well as improvements of retail pharmacy foot traffic in Europe and Canada.", "The vaccine and related  ancillary  kit distribution  in the U.S. favorably impacted our results in the second half of fiscal 2021 as further discussed below.", "Our Response to COVID-19 in the Workplace During this unprecedented time, we are committed in continuing to supply our customers and protect the safety of our employees.", "During  the  first  quarter  of  2021,  we  experienced  growth  in  pharmaceutical  distribution  and  specialty  drug  volumes  at  a  lower  rate  in  the  U.S.,  while", "In the centralized model, the U.S. government directs us on the distribution of the vaccines and related supplies to point-of-care sites across the country.", "The results of operations related to our vaccine distribution are reflected in our U.S.", "We also have an agreement with Pfizer to assemble and distribute ancillary supply kits needed to administer that particular COVID-19 vaccine.", "We began assembling the ancillary supply kits in September 2020 in preparation for vaccine authorization and subsequent distribution.", "Ancillary supply kits to administer the Pfizer Vaccine are shipped directly to point-of-care sites, and all other ancillary supply kits are shipped to our dedicated vaccine distribution centers.", "The results of operations for the kitting and distribution of ancillary supplies are reflected in our Medical-Surgical Solutions segment.", "These facilities can scale to meet the demand of increasing volumes of vaccines being manufactured.", "We have also set up distribution centers for kitting and inventory management as part of our contract with the HHS.", "We are working with delivery partners to manage the delivery of vaccines and ancillary supply kits from our centralized vaccine distribution centers to point-of-care destinations as directed by the CDC.", "as well as the kitting and distribution of ancillary supplies for COVID-19 vaccines in our Medical-Surgical Solutions segment contributed approximately 20% in segment  revenues  and  segment  operating  profit.  Additionally,  the  distribution  of  COVID-19  vaccines  in  our  U.S.  Pharmaceutical  segment  contributed approximately 2% in segment operating profit for the year ended March 31, 2021.", "During our fourth quarter of 2020, we experienced a temporary increase in demand for pharmaceuticals.", "Certain PPE items held for resale were valued in our inventory at costs that were inflated by earlier COVID-19 pandemic demand levels.", "That inventory valuation, if not supported by market resale prices, may be written down to net realizable value.", "We may also write-off inventory due to decreased customer demand and excess inventory.", "response to supply availability and customer demand patterns for certain products, with varying inventory level impacts depending on the specific product within our portfolio.", "As our supply levels improve, and the federal government evolves guidance on the prioritization of providers or geographic markets, we will continue to adapt our distribution policies.", "We were able to maintain appropriate labor and overall vendor supply levels during the year ended March 31, 2021.", "suppliers,  their  locations,  and  the  extent  to  which  they  are  impacted  by  the  COVID-19  pandemic,  we  are  proactively  working  with  manufacturers,  industry partners, and government agencies to meet the needs of our customers during the pandemic.", "We have assembled a Critical Care Drug Task Force, made up of our procurement  specialists,  clinical  health  systems  pharmacists,  and  supply  chain  professionals,  that  is  focused  on  securing  additional  product  where  available, sourcing back-up products, and protecting our operations across all locations and facilities.", "We are also working with manufacturers through several channels, including  our  ClarusONE  Sourcing  Services  LLP  (\u201cClarusONE\u201d)  and  global  sourcing  teams  in  London,  and  our  leaders  are  actively  engaged  in  addressing potential shortages.", "We have engaged with industry partners and government agencies to gain visibility into supply and demand.", "Additionally, we have a robust Business Continuity and Disaster Recovery Program (\u201cBCRP\u201d) and we have proactively enhanced our BCRP in response to the COVID-19 pandemic to protect the supply  chain  to  minimize  disruption  in  healthcare,  protect  our  customers,  ensure  the  safety  and  security  of  our  employees  and  workplaces,  and  ensure  the continuity of critical business processes.", "supplies and medications to help prevent the spread of the disease and treat those that are ill.", "COVID-19 has put an unprecedented strain on the supply of high- demand PPE, including N95 masks, gloves, as well as disinfecting sprays and wipes.", "The supply chain has improved over the initial impact of pandemic-related demand, and we continue to closely monitor demand by customer type and certain PPE and infection prevention items are still in short supply.", "Our allocation approach has helped us avoid stock outs in many critical product categories, allowing us to provide PPE supplies to many more customers for a much longer time.", "We anticipate these market conditions will remain for the foreseeable future.", "Our efforts to help the supply chain have included sourcing products from new suppliers all over the world, working closely with the federal government to help with the nation\u2019s response and collaborating with partners to source, develop, and deliver new products to market.", "The full extent to which COVID-19 will impact us depends on many factors and future developments, including: the duration and spread of the virus; governmental actions to limit the spread of the virus; potential seasonality of viral outbreaks; potential new strains or variants of the original virus; the amount of COVID-19 vaccines authorized, manufactured, distributed, and administered; the amount of ancillary supply kits assembled and distributed; the  effectiveness  of  COVID-19  vaccines  and  governmental  measures  in  controlling  the  spread  of  the  virus;  and  the  effectiveness  of  treatments  of  infected individuals.", "Impact to our Supply Chain We  also  continue  to  monitor  the  COVID-19  pandemic  impacts  on  our  supply  chain.  Although  the  availability  of  various  products  is  dependent  on  our", "Gross profit was favorably impacted by growth of specialty pharmaceuticals and the contribution from our vaccine distribution programs in our U.S.", "\u2022 Goodwill impairment charges of $1.8 billion in our European Retail Pharmacy (\u201cEuropean RP\u201d) and European Pharmaceutical Distribution (\u201cEuropean PD\u201d) reporting units within the International segment.", "This initiative primarily led us to rationalize our office space in North America.", "Where we determine to cease using office space, we plan to exit the portion of the facility no longer used.", "We also may retain and repurpose certain other office locations.", "transformational changes in technologies and business processes, operational efficiencies, and cost savings.", "centralization of certain functions and outsourcing through an expanded arrangement with a third-party vendor to achieve operational efficiency.", "The  initiative  consisted  of  multiple  growth  priorities  and  plans  to  optimize  our  operating  models  and  cost  structures  primarily  through  centralization,  cost management, and outsourcing of certain administrative functions.", "As part of the growth initiative, we committed to implement certain actions including a reduction in workforce, facility consolidation, and store closures.", "This set of initiatives was substantially complete by the end of 2020. $115 million, $112 million, and $245 million, respectively, primarily related to our retail pharmacy businesses in Canada and Europe within our International segment.", "During  the  first  quarter  of  2021,  we  committed  to  an  initiative  within  the  U.K.,  which  is  included  in  our  International  segment,  to  further  drive", "In the fourth quarter of 2019, we committed to certain programs to continue our operating model and cost optimization efforts.", "On April 25, 2018, we announced a strategic growth initiative intended to drive long-term incremental profit growth and to increase operational efficiency.", "pharmaceutical price increases, growth in specialty pharmaceuticals, and higher volumes from retail national account customers, partially offset by branded to generic  drug  conversions.  Revenues  for  this  segment  were  unfavorably  impacted  by  fluctuations  in  demand  for  pharmaceuticals  in  retail  pharmacies  and institutional healthcare providers due to COVID-19 largely during the onset of the pandemic in late March 2020 and during our first quarter of 2021 combined with the loss of certain customers.", "exchange fluctuations, revenues for this segment decreased 9% primarily due to the contribution of our German pharmaceutical wholesale business to a joint venture with WBA and to a lesser extent, the exit of unprofitable customers in our Canadian business.", "Revenues for this segment were also unfavorably impacted by lower volumes from the adverse impacts from COVID-19 in our pharmaceutical distribution and retail pharmacy businesses within Europe.", "exchange fluctuations, revenues for this segment increased 4% primarily due to market growth in our European pharmaceutical distribution and retail pharmacy businesses.", "2020 vs. 2019 Medical-Surgical Solutions revenues for the year ended March 31, 2020 increased 9% compared to the prior year primarily due to market growth in our", "The impacts from COVID-19 in our pharmaceutical distribution and retail pharmacy businesses within Europe also caused unfavorability in our segment results year over year.", "demand for COVID-19 tests and PPE, as well as the contribution from kitting and distribution of ancillary supplies for COVID-19 vaccines.", "This was partially offset by inventory charges on certain PPE and other related products, unfavorability in our primary care business due to customer closures largely during the first quarter  of 2021, and a  less severe  cough, cold, and flu  season.", "2020 vs. 2019 Operating profit increased for the year ended March 31, 2020 compared to the prior year primarily due to market growth in our specialty business.", "2020 vs. 2019 Operating profit and operating profit margin increased for the year ended March 31, 2020 compared to prior year primarily due to market growth in our", "We monitor our operations and adopt strategies responsive to changes in the economic and political environment in each of the countries in which we operate.", "Our foreign operations represented approximately 15%, 17%, and 18% of our consolidated revenues in 2021, 2020, and 2019, respectively.", "We also have agreements with GPOs, each of which functions as a purchasing agent on behalf of member hospitals, pharmacies and other healthcare providers, as well as with government entities and agencies.", "and updated if unusual circumstances or trends are present.", "LIFO method presumes that the most recent inventory purchases are the first items sold and the inventory cost under LIFO approximates market.", "The majority of the cost of domestic inventories is determined using the LIFO method.", "If we had used the moving average method of inventory valuation, inventories would have been approximately $406 million and $444 million higher than the amounts reported at March 31, 2021 and 2020, respectively.", "such, our LIFO inventory is valued at the lower of LIFO or market.", "Inventories: Inventories  consist of merchandise  held  for resale.  We report  inventories  at the lower of cost or net realizable  value, except  for inventories", "We believe that the moving average inventory costing method provides a reasonable estimation of the current cost of replacing inventory (i.e., \u201cmarket\u201d).", "Shifts in market trends and conditions, changes in customer preferences due to the introduction of generic drugs or new pharmaceutical products or the loss of one or more significant customers are factors that could affect the value of our inventories.", "We write down inventories which are considered excess and obsolete as a result of these reviews.", "These factors could make our estimates of inventory valuation differ from actual results.", "In addition, we compare the aggregate of the reporting units\u2019 fair values to our market capitalization as further corroboration of the fair values.", "They can be affected by a variety of factors, including external factors such as industry and economic trends, and internal factors such as changes in our business strategy and our internal forecasts.", "Management makes certain judgments and estimates in its assessment including but not limited to: identifying if circumstances indicate a decline in value is other than temporary, expectations about the business operations of investees, as well as industry, financial, and market factors.", "On March 9, 2020, we completed the Split-off of our interest in the Change Healthcare JV.", "Our businesses require substantial investments in working capital that are susceptible to large variations during the year as a result of inventory purchase patterns and seasonal demands.", "Our  redeemable  noncontrolling  interests  primarily  relate  to  our  consolidated  subsidiary,  McKesson  Europe.  Under  the  Domination  Agreement,  the", "However, our risk management programs are designed such  that  the  potential  loss  in  value  of  these  risk  management  portfolios  described  above  would  be  largely  offset  by  changes  in  the  value  of  the  underlying exposure.", "With the participation of the Chief Executive Officer and the Chief Financial Officer, our management conducted an assessment of the effectiveness of our internal control over financial  reporting based on the framework and criteria  established in Internal Control\u2014Integrated Framework (2013), issued by the Committee of Sponsoring Organizations of the Treadway Commission.", "Under the market approach, fair value is estimated by comparing the business to similar businesses, or guideline companies whose securities are actively traded in public markets.", "The severity,  magnitude  and  duration,  as  well  as  the  economic  consequences  of  the  coronavirus  diseases  2019  (\u201cCOVID-19\u201d)  pandemic,  are  uncertain,  rapidly changing, and difficult to predict.", "The majority of the cost of domestic inventories is determined using the LIFO method.", "Goodwill testing requires a complex series of assumptions and judgments by management in projecting future operating results, selecting guideline companies for comparisons and assessing risks.", "Revenues generated from the distribution of pharmaceutical and medical products represent the majority of the Company\u2019s revenues.", "customer, is responsible for fulfilling the promise to its customer, has latitude in establishing prices, and controls the relationship with the customer.", "Shipping and handling costs associated with outbound freight after control over a product has transferred to a customer are accounted for as fulfillment costs.", "International segment, to further drive transformational changes in technologies and business processes, operational efficiencies, and cost savings.", "continues to implement centralization of certain functions and outsourcing through an expanded arrangement with a third-party vendor to achieve operational efficiency.", "Irving, Texas to improve efficiency, collaboration, and cost competitiveness.", "PSUs are conditional upon the attainment of market and performance objectives over a specified period.", "As a practical expedient, the Company does not separate lease components from non-lease components such as common area maintenance, utilities, and repairs and maintenance.", "The Company\u2019s most significant relationships are with oncology and other specialty practices.", "Level 2 - significant other observable market-based inputs.", "Level 3 - significant unobservable inputs for which little or no market data exists and requires considerable assumptions that are significant to the fair value", "measurement due to the significance of unobservable inputs developed using company-specific information.", "It has received the same warranties from its suppliers, which customarily are the manufacturers of the products.", "Pharma Belgium NV is also part of the investigation.", "Stockholders (the \u201cProxy Statement\u201d) under the heading \u201cElection of Directors.\u201d Information about our Executive Officers is incorporated by reference from the discussion in Part I of this report under the heading \u201cInformation about our Executive Officers.\u201d Information about our Audit Committee, including the members of the  committee  and  our  Audit  Committee  Financial  Expert,  is  incorporated  by  reference  from  the  discussion  under  Item  1  of  our  Proxy  Statement  under  the headings \u201cThe Board, Committees and Meetings,\u201d and \u201cAudit Committee Report.\u201d", "We offer more than 275,000 national brand medical- surgical products as well as McKesson\u2019s own line of high-quality products through a network of distribution centers within the United States (\u201cU.S.\u201d).", "as a Service, to serve our biopharma and life sciences partners and patients.", "Our  U.S.  Pharmaceutical  segment  distributes  branded,  generic,  specialty,  biosimilar  and  over-the-counter  (\u201cOTC\u201d)  pharmaceutical  drugs,  and  other", "We also source generic pharmaceutical drugs through our joint sourcing entity, ClarusONE Sourcing Services LLP (\u201cClarusONE\u201d).", "We invest in technology and other systems at all of our distribution centers to enhance safety, reliability, and product availability.", "For example, we offer McKesson Connect , an internet-based ordering system that provides item look-up and real-time inventory availability as well as ordering, purchasing, third-party reconciliation, and account management functionality.", "We make extensive use of technology as an enabler to ensure customers have the right products at the right time in the right place.", "We provide solutions to our customers including supply management technology, world-class marketing programs, managed care, repackaging products, and services to help them meet their business and quality goals.", "We continue to implement information systems to help achieve greater consistency and accuracy both internally and for our customers.", "operational efficiency, and automation that help independent pharmacists focus on patient care while improving profitability.", "Retail National Accounts: We provide business solutions that help retail national account customers increase revenues and profitability.", "These distribution centers also provide the foundation for a two-tiered distribution network that supports best-in-class direct store delivery.", "performance, increase operational efficiencies, and deliver better patient care.", "Community-based physicians in this business have broad flexibility and discretion to select the products and commitment levels that best meet their practice needs.", "Services in provider solutions include specialty drug distribution, group purchasing organizations (\u201cGPO\u201d) like Onmark\u00ae, technology solutions, practice consulting services, and vaccine distribution, including our exclusive distributor relationship with the Centers for Disease Control and Prevention\u2019s (\u201cCDC\u201d) Vaccines for Children program.", "SKY Packaging enables acute care, long-term care, and institutional pharmacies to provide cost-effective, uniform packaging.", "Our use of the term \u201cspecialty\u201d may not be comparable to that used by other industry participants, including our competitors.", "Our operations in Canada, including Rexall retail pharmacies, support better, safer patient care by delivering vital medicines, supplies, and information technology solutions throughout Canada.", "functions  as  a  vital  link,  using  technology-enabled  management  systems  at  our  regional  wholesale  branches  to  connect  manufacturers  to  retail  pharmacies, supplying medicines and other products sold in pharmacies.", "In addition, we partner with independent pharmacies under local banner programs.", "banners, and more than 400 owned pharmacies under the Rexall brand where we provide patients with greater choice and access, integrated pharmacy care and industry-leading service levels.", "This segment includes our Ontada business, providing software to support the clinical, financial, and operational needs of our oncology practice partners.", "Our European Pharmaceutical Distribution business delivers pharmaceutical and other healthcare-related products to pharmacies across Europe.", "Our more than 250,000 customers include physician offices, surgery centers, post-acute care facilities, hospital reference labs, and  home  health  agencies.  We  distribute  medical-surgical  supplies  (such  as  gloves,  needles,  syringes  and  wound  care  products),  infusion  pumps,  laboratory equipment  and  pharmaceuticals.  Through  a  network  of  distribution  centers  within  the  U.S.,  we  offer  more  than  275,000  products  from  national  brand manufacturers and McKesson\u2019s own high-quality product line.", "Through the right mix of products and services, we help improve efficiencies, profitability and compliance.  We  also  never  lose  focus  on  helping  customers  improve  patient  and  business  outcomes.  We  develop  customized  plans  to  address  the  product, operational, and clinical support needs of our customers, including tackling inventory management, reducing administrative burdens, and training and educating clinical staff.", "We deliver for our customers, so they can deliver and care for their patients.", "pharmaceutical distribution environment in which our U.S.", "Pharmaceutical and International segments operate, we face strong competition from international, national, regional and local full-line, short-line and specialty distributors, service merchandisers, self-warehousing chain drug stores, manufacturers engaged in direct distribution, third-party logistics companies, and large payer organizations.", "Our retail businesses, which primarily operate in our International segment, face competition from various global, national, regional, and local global retailers, including chain and independent pharmacies.", "We consider our largest competitors in distribution, wholesaling, and logistics to be AmerisourceBergen Corporation and Cardinal Health, Inc.", "businesses, which may from time to time decide to develop, for their own internal needs, supply management capabilities that might otherwise be provided by our businesses.", "We believe that our scale and diversity of product and service offerings are our primary competitive advantages.", "operations and market position, but we do not consider any of our businesses to be dependent upon any one patent, copyright, trademark, or trade secret, or any family or families of the same.", "be necessary in the future to seek or renew licenses relating to various aspects of our products and services, we believe, based upon past experience and industry practice,  such  licenses  generally  can  be  obtained  on  commercially  reasonable  terms.  We  believe  our  operations  and  products  and  services  are  not  materially dependent on any single license or other agreement with any third party.", "on improving employee health and wellness, creating opportunities for growth and development, and providing an inclusive workplace where our employees can reach their full potential.", "At March 31, 2021, we had approximately 76,000 employees worldwide, including 17,000 part-time employees and 32,000 employees in the U.S. healthier future is everyone\u2019s business.", "We build successful teams by recruiting, developing, and retaining diverse talent and we recognize our culture of inclusion as an important element that drives long-term shareholder value.", "(1) The data for our metrics is derived from our voluntary, self-identification process as of March 31, 2021 and therefore represents our best estimate at this time. (2) Represents our leadership at the vice president level and above. (3) Represents worldwide employees. (4) Represents U.S. employees only as the data for Canada and Europe is not available.", "I CARE and ILEAD principles, we fulfill our mission of improving care in every setting.", "Our I CARE values (Integrity, Inclusion, Customer-First, Accountability, Respect, Excellence) are foundational to all that we do, and who we are as a company.", "ILEAD (Inspire, Leverage, Execute, Advance, Develop) is our common definition and shared commitment to leadership.", "By embracing this commitment, we bring out the best in ourselves and position McKesson to continue to drive better health \u2013 for our company, our customers, and the patients they serve for years to come.", "We promote leadership behaviors through culture initiatives that offer practical tips on how to debate, decide, and commit, be open and candid, and maintain an enterprise-first mindset when navigating conversations affecting operations within and across our business segments.", "We hold inbound licenses for certain intellectual property that is used internally, and in some cases, utilized in McKesson\u2019s products or services.", "Culture and Leadership: What sets McKesson apart as an exceptional place is our people.", "Our employees understand that together, unified by our global", "where everyone can bring their authentic self to work and feel welcomed and appreciated, and where their perspectives are sought out, heard, and considered.", "Through training, we encourage leaders to embrace diverse perspectives and lead inclusively.", "We  also  seek  employee  feedback  through  an  annual  employee  opinion  survey,  which  assesses  our employees\u2019  levels  of engagement, commitment, and overall satisfaction using industry benchmarks, and we then design action plans to improve those metrics.", "We routinely assess facilities to monitor closely adherence to established security and safety standards.", "If we identify a vulnerability, it is documented, and the facility prepares an action plan.", "Our employees receive specialized training related to their role, work setting, and equipment used in their work environment.", "As our processes evolve, we update relevant safety training modules, which may include new employee training programs.", "The various responses we put in place to mitigate the impact of COVID- 19  on  our  business  operations,  including  telecommuting  and  work-from-home  policies,  restricted  travel,  and  enhanced  safety  measures,  are  intended  to  limit employee exposure to the virus that causes COVID-19 as they perform their jobs while also providing employee support programs and a sense of belonging.", "For additional  information  on  our  response  to  COVID-19  in  the  workplace,  refer  to  the  COVID-19  section  of \u201cTrends  and  Uncertainties\u201d in  \u201cManagement\u2019s Discussion and Analysis of Financial Condition and Results of Operations\u201d in Item 7 of Part II included in this Annual Report on Form 10-K.", "Food and Drug Administration Amendments Act of 2007 requires the FDA to establish standards and identify and validate effective technologies, such as track and trace or authentication technologies, to secure the pharmaceutical supply chain against counterfeit drugs.", "Despite physical, technical, and administrative security measures that we implement in order to, among other things, address regulatory requirements, our technology systems and operations may continue to be subject to cybersecurity incidents.", "The risk of cybersecurity incidents may be increased due to a variety of factors, both internal and external.", "Sales to our largest customer, CVS Health Corporation (\u201cCVS\u201d), accounted for approximately 21% of our total consolidated revenues in 2021.", "In May 2019, we extended our pharmaceutical distribution relationship with CVS to June 2023.", "a supplier could adversely affect our business if alternate sources of supply are unavailable.", "We believe that our relationships with our suppliers are generally sound.", "The ten largest suppliers in 2021 accounted for approximately 50% of our purchases.", "For these manufacturers, a reduction in the frequency and magnitude of price increases, as well as restrictions in the amount of inventory available to us, could have an adverse impact on our gross profit margin.", "Although it is not possible to predict or identify all such risks and uncertainties, they include, but are not limited to, the factors discussed in Item 1A of Part I of this report under \u201cRisk Factors\u201d and in our publicly available SEC filings and press releases.", "Suppliers: We obtain pharmaceutical and other products from manufacturers, none of which accounted for more than 7% of our purchases in 2021.", "practical  to  identify  or  describe  all  risks  and  uncertainties  that  might  materially  impact  our  business  operations,  reputation,  financial  position  or  results  of operations.", "Our business could be materially affected by risks that we have not yet identified or that we currently consider to be immaterial.", "This is not a complete statement of all potential risks and uncertainties.", "For example, pharmacy operations are exposed to risks such as improper filling of prescriptions, mislabeling of prescriptions, inadequacy of warnings, unintentional distribution of counterfeit drugs and expiration of drugs.", "The  discussion  below  identifies  certain  representative  risks  that  might  cause  our  actual  business  results  to  materially  differ  from  our  estimates.  It  is  not", "Certain of our businesses may be required to register for permits and/or licenses with, and comply with operating and security standards of, the DEA, FDA, HHS, CMS, various state boards of pharmacy, state health departments and/or comparable state agencies as well as foreign agencies and certain accrediting bodies, depending upon the type of operations and location of product development, manufacture, distribution, and sale.", "As of March 31, 2021, suspensions at the four distribution centers had all expired  by  their  own  terms.  If  we  are  not  able  to  obtain,  maintain  or  renew  permits,  licenses  or  other  regulatory  approvals  needed  for  the  operation  of  our businesses, it might have a materially adverse impact on our business operations and our financial position or results of operations.", "Food and Drug Administration Amendments Act of 2007 requires the FDA to establish standards and identify and validate effective technologies, such as track  and  trace  or  authentication  technologies,  to  secure  the  pharmaceutical  supply  chain  against  counterfeit  drugs.  We  also  have  record-keeping  and  other obligations under the E.U.", "We are subject to significant compliance obligations under privacy laws such as the General Data Protection Regulation in the  European  Union  (\u201cGDPR\u201d),  the  Personal  Information  Protection  and  Electronic  Documents  Act  (\u201cPIPEDA\u201d)  in  Canada,  and  the  California  Consumer Protection  Act  (\u201cCCPA\u201d).  Some  privacy  laws  prohibit  the  transfer  of  personal  information  to  certain  other  jurisdictions.  We  are  subject  to  privacy  and  data protection compliance audits or investigations by various government agencies.", "We experience cybersecurity incidents that might significantly compromise our technology systems or might result in material data breaches.", "Despite physical, technical, and administrative security measures, our technology systems and operations have been, and likely will continue to be, subject to cyberattacks from sources beyond our control.", "Cybersecurity incidents  include  actual  or  attempted  unauthorized  access,  tampering,  malware  insertion,  ransomware  attacks  or  other  system  integrity  events.  The  risk  of cyberattacks  may be increased  due to a variety of factors, both internal  and external.  A cybersecurity  incident might involve a material  data breach or other material impact to the integrity and operations of our technology systems, which might result in litigation or regulatory action, loss of customers or revenue, and increased expense, any of which might have a materially adverse impact on our business operations, reputation, and our financial position or results of operations.", "We might experience significant problems with information systems or networks.", "If those information systems suffer errors, interruptions, or become unavailable, there might be a materially adverse impact on our business operations, reputation, and our financial position or results of operations.", "Our products or services might not conform to specifications or perform as we intend.", "professionals delivering patient care tend to have heightened sensitivity to system and software errors.", "Errors or failures might damage our reputation and negatively affect future sales.", "We sell and provide services involving complex software and technology that may contain errors, especially when first introduced to market.", "The networks and hosting systems are vulnerable to interruption or damage from sources beyond our control, such as power loss, telecommunications failures, fire, natural disasters, software and hardware failures and cyberattacks.", "If the timely delivery of medical care or other customer business requirements are impaired by data access, network or systems problems, we could be exposed to significant claims and reputational harm.", "We might not realize expected benefits from business process initiatives.", "achieve  our  desired  objectives,  or  unintended  consequences  such  as  distraction  of  our  management  and  employees,  business  disruption,  attrition  beyond  any planned reduction in workforce, inability to attract or retain key personnel and reduced employee productivity.", "We might be unable to successfully complete or integrate acquisitions or other business combinations.", "We may not receive regulatory approvals needed to complete proposed transactions, or such  approvals  may  be  subject  to  delays  or  conditions  that  reduce  transaction  benefits.  Achieving  the  desired  outcomes  of  business  combinations  involves significant  risks  including:  diverting  management\u2019s  attention  from  other  business  operations;  challenges  with  assimilating  the  acquired  businesses,  such  as integration  of  operations  and  systems;  failure  or  delay  in  realizing  operating  synergies;  difficulty  retaining  key  acquired  company  personnel;  unanticipated accounting or financial systems issues with the acquired business, which might affect our internal controls over financial reporting; unanticipated compliance issues in the acquired business; challenges retaining customers of the acquired business; unanticipated expenses or charges to earnings, including depreciation and amortization or potential impairment charges; and risks of known and unknown assumed liabilities in the acquired business.", "We provide remote services that involve hosting customer data and operating software on our own or third party systems.", "Our growth strategy includes consummating acquisitions or other business combinations that either expand or complement our business.", "could delay the achievement of our strategic objectives.", "We might be adversely impacted by outsourcing or similar third-party relationships.", "Third-party services providers might fail to perform as anticipated, or we might experience unanticipated operational difficulties, compliance requirements or increased costs related to outsourced services.", "We may be unsuccessful in retail pharmacy operations or maintaining profitability.", "If our retail pharmacy operations fail to achieve, or are unable to sustain, acceptable net sales and profitability levels, it might have a materially adverse impact on our business operations and our financial position or results of operations.", "We rely on third parties to perform certain business and administrative functions for us.", "We might not adequately develop, implement and monitor these", "Our business strategy included expanding our retail pharmacy operations.", "Our retail pharmacy operations involve numerous risks, such as the following ones.", "For example, our contracts with the U.S. government generally require us to comply with the Federal Acquisition Regulations, Procurement Integrity Act, Buy American Act, Trade Agreements Act, and other laws and regulations.", "The occurrence of any of these risks could harm our reputation and might have a materially adverse impact on our business operations and our financial position or results of operations.", "Our participation in vaccination distribution programs may materially affect our operating results, reputation, and business.", "For example, the novel nature of the SARS-CoV\u20112 virus and the broad scope of the ongoing COVID-19 vaccine distribution program introduce uncertainty about what volumes of products may become available for distribution by us, the effectiveness of vaccines, and the cost of distribution.", "Because of such uncertainties, our operating results may be subject to variability.", "Our participation in such programs also exposes us to various risks, including regulatory compliance, government oversight, dependence on government funding, contractual performance, litigation, security risks, and supply chain challenges.", "Any significant problems with our participation in such programs might have a materially adverse impact on our reputation and our business.", "We might be harmed by changes in our relationships or contracts with suppliers.", "Our competitors might develop non-infringing products or services equivalent or superior to ours.", "We might be unable to successfully recruit and retain qualified employees.", "We compete with many other businesses to attract and retain employees.", "We may experience sudden loss of key personnel due to a variety of causes, such as illness, and must adequately plan for succession of key management roles.", "Employees might not successfully transition into new roles.", "Some of these changes increase our risks and create uncertainties for our business.", "These proposals might result in significant changes in the pharmaceutical value chain as manufacturers, PBM, managed care organizations and other industry stakeholders look to implement new transactional flows and adapt their business models.", "Many of our products and services are designed and intended to function within the structure of current healthcare financing and reimbursement systems.", "We might be adversely impacted by competition and industry consolidation.", "specialty distributors, service merchandisers, self-warehousing chain drug stores, manufacturers engaged in direct distribution, third-party logistics companies and large  payer  organizations.  In  addition,  our  businesses  face  competition  from  various  other  service  providers  and  from  pharmaceutical  and  other  healthcare manufacturers as well as other potential customers, which may from time-to-time decide to develop, for their own internal needs, supply management capabilities that might otherwise be provided by our businesses.", "This concentration reduces our ability to negotiate favorable terms with suppliers and causes us to depend on a smaller number of suppliers.", "Many of our customers, including  healthcare  organizations,  have  consolidated  and  have  greater  power  to  negotiate  favorable  prices.  Consolidation  by  our  customers,  suppliers  and competitors might reduce the number of market participants and give the remaining enterprises greater bargaining power, which might lead to erosion in our profit margin.", "These competitive pressures and industry consolidation might have a materially adverse impact on our business operations and our financial position or results of operations.", "We might be adversely impacted by changes or disruptions in product supply.", "Our inventory might be requisitioned, diverted or allocated by government order such as under emergency, disaster and civil defense declarations.", "For example, government actions in response to the COVID-19 pandemic affect our supply allocation, and those and our own allocation decisions can impact our customer relationships.", "Changes in the healthcare industry\u2019s or our suppliers\u2019 pricing, selling, inventory, distribution or supply policies or practices could significantly reduce our revenues and net income.", "We might experience disruptions in our supply of higher margin pharmaceuticals, including generic pharmaceuticals.", "sourcing joint venture with Walmart, Inc. is unsuccessful or experiences margins declines.", "products and services and the volume of their purchases.", "Our generic  pharmaceuticals  distribution  business  is subject  to  pricing  risks.  We  might  be  adversely  impacted  if  our ClarusONE  generic  pharmaceutical", "Suppliers might increase their prices, reduce their output or change their terms of sale due to limited availability of credit.", "We may have difficulties in sourcing or selling products due to a variety of causes.", "Difficulties in product manufacturing or access to raw materials could result in supplier production shutdowns, product shortages and other supply disruptions.", "The COVID-19 pandemic adversely affects the availability of some products, resulting in product allocation and delivery delays.", "We have operations in the U.K. and the European Union (\u201cE.U.\u201d) and face risks associated with the uncertainty and potential disruptions that might follow the", "These events can disrupt operations for us, our suppliers, our vendors, and our customers.", "For example, in February 2021, a severe winter storm affecting the United  States  temporarily  impacted  our  distribution  business  operations,  primarily  in  Texas.  They  might  affect  consumer  confidence  levels  and  spending.  In response to these events, we might suspend operations, implement extraordinary procedures, seek alternate sources for product supply, or suffer consequences that are unexpected and difficult to mitigate.", "In particular, the rapid and widespread transmission of the SARS-CoV-2 novel coronavirus beginning in late 2019 impacts us in significant ways.", "For example, to mitigate the spread of the COVID-19 disease caused by SARS-CoV-2, we implemented travel restrictions and remote working  arrangements  for  most  of  our  employees  in  order  to  minimize  physical  contact,  and  we  implemented  additional  sanitation  and  personal  protection measures in our warehouse, retail pharmacy and delivery operations.", "These measures might not fully mitigate COVID-19 risks to our workforce and we could experience unusual levels of absenteeism that might impair operations and delay delivery of products.", "The ongoing impacts of the pandemic might cause a general economic slowdown or recession in one or more markets, disruptions and volatility in global capital markets and other broad and adverse effects on the economy, business conditions, commercial activity and the healthcare industry.", "The pandemic might impact our business operation, financial position and results of operation in unpredictable ways that depend on highly uncertain future  developments,  such  as  determining  the  effectiveness  of  current  or  future  government  actions  to  address  the  public  health  or  economic  impacts  of  the pandemic.", "These events and impacts could materially adversely affect our business operations, financial position or results of operation.", "locations,  primarily  throughout  North  America  and  Europe.  Retail  pharmacies  and  most  warehouses  are  typically  owned  or  leased  on  a  long-term  basis.  We consider our operating properties to be in satisfactory condition and adequate to meet our needs for the next several years without making capital expenditures materially higher than historical levels.", "Form 10-K for additional factors relating to these statements and Item 1A - Risk Factors in Part I of this Annual Report on Form 10-K for a list of certain risk factors applicable to our business, financial condition, and results of operations.", "We partner with life sciences companies, manufacturers, providers, pharmacies, governments, and other healthcare organizations to help provide the right medicines, medical products, and healthcare services to the right patients at the right time, safely, and cost-effectively.", "All prior segment information has been recast to reflect our new segment structure and current period presentation.", "We  implemented  a  new  segment  reporting  structure  commencing  with  the  second  quarter  of  2021,  which  resulted  in  four  reportable  segments:  U.S.", "\u2022 International is  a  new  reportable  segment  that  includes  our  operations  in  Europe  and  Canada,  bringing  together  non-U.S.-based  drug  distribution services, specialty pharmacy, retail, and infusion care services.", "\u2022 RxTS is  a  new  reportable  segment  that  brings  together  existing  businesses,  including  CoverMyMeds,  RelayHealth,  RxCrossroads,  and  McKesson Prescription Automation, including Multi-Client Central Fill as a Service, to serve our biopharma and life sciences partners and patients.", "We benefited from demand for COVID-19 tests, favorable contributions from our vaccine and related ancillary supply kit distribution programs as discussed further below, and savings from reduced travel and meetings throughout 2021;", "We have also partnered with the Department of Health and Human Services (\u201cHHS\u201d) and Pfizer to manage the assembly and distribution of the ancillary supplies needed to administer COVID-19 vaccines;", "Pharmaceutical segment driven by market growth; \u2022 Gross profit increased 1% from the prior year primarily in our Medical-Surgical Solutions segment driven by sales of COVID-19 tests; \u2022 Total operating expenses in 2021 includes the following:", "Infection rates varied throughout our fiscal year, peaking in January 2021.", "Our role in the distribution of COVID-19 vaccines in the U.S. as well as the assembly and distribution of related ancillary supply kits is discussed further below.", "McKesson Europe is also playing a role in helping support governments and public health entities in not only distributing COVID-19 vaccines across several European countries, but administering them in pharmacies as well.", "solutions, we are well positioned to respond to the COVID-19 pandemic in the U.S., Canada, and Europe.", "We have worked and continue to work closely with national and local governments, agencies, and industry partners to ensure that available supplies, including personal protective equipment (\u201cPPE\u201d), and medicine reach our customers and patients.", "put in place to mitigate the impact of COVID-19 on our business operations, including telecommuting and work-from-home policies, restricted travel, employee support programs, and enhanced safety measures, are intended to limit employee exposure to the virus that causes COVID-19.", "We expanded employee medical benefits covering COVID-19 related visits, treatments, and testing as well as expanded telehealth options to protect employee safety.", "For employees whose roles require presence at our facilities, we enhanced safety by promoting the practice of social distancing, providing reminders to wash or disinfect hands and avoid unnecessary face touching, making face masks available, placing hand sanitizers within our operating environments, and periodically cleaning and disinfecting our facilities.", "For employees whose roles do not require presence at our facilities, we added technology resources to support their working remotely.", "These steps to protect employee safety have resulted in limited disruption from COVID-19 to our normal business operations, productivity trends, and have not materially impacted our operating expenses or operating margins.", "pharmacy foot traffic as our customers increased supplies on hand in March, which drove unfavorability in our results of operations when comparing 2021 versus 2020.", "We also experienced decreased demand for primary care medical-surgical supplies due to deferrals in elective procedures in hospitals and surgery centers as well as decreased traffic and closures of doctors\u2019 offices, which was partially offset by demand for PPE and COVID-19 tests.", "COVID-19  for  the  second  half  of  our  fiscal  year  was  non-linear  and  tracked  with  patient  mobility.  We  also  saw  increased  demand  for  COVID-19  tests  and continued sales of PPE throughout the year in our Medical-Surgical Solutions segment partially offset by the impacts of social distancing measures which resulted in a less severe cough, cold, and flu season, savings for reduced travel and meetings across the enterprise, as well as improvements of retail pharmacy foot traffic in Europe and Canada.", "The vaccine and related  ancillary  kit distribution  in the U.S. favorably impacted our results in the second half of fiscal 2021 as further discussed below.", "Our Response to COVID-19 in the Workplace During this unprecedented time, we are committed in continuing to supply our customers and protect the safety of our employees.", "During  the  first  quarter  of  2021,  we  experienced  growth  in  pharmaceutical  distribution  and  specialty  drug  volumes  at  a  lower  rate  in  the  U.S.,  while", "In the centralized model, the U.S. government directs us on the distribution of the vaccines and related supplies to point-of-care sites across the country.", "The results of operations related to our vaccine distribution are reflected in our U.S.", "We also have an agreement with Pfizer to assemble and distribute ancillary supply kits needed to administer that particular COVID-19 vaccine.", "We began assembling the ancillary supply kits in September 2020 in preparation for vaccine authorization and subsequent distribution.", "Ancillary supply kits to administer the Pfizer Vaccine are shipped directly to point-of-care sites, and all other ancillary supply kits are shipped to our dedicated vaccine distribution centers.", "The results of operations for the kitting and distribution of ancillary supplies are reflected in our Medical-Surgical Solutions segment.", "These facilities can scale to meet the demand of increasing volumes of vaccines being manufactured.", "We have also set up distribution centers for kitting and inventory management as part of our contract with the HHS.", "We are working with delivery partners to manage the delivery of vaccines and ancillary supply kits from our centralized vaccine distribution centers to point-of-care destinations as directed by the CDC.", "as well as the kitting and distribution of ancillary supplies for COVID-19 vaccines in our Medical-Surgical Solutions segment contributed approximately 20% in segment  revenues  and  segment  operating  profit.  Additionally,  the  distribution  of  COVID-19  vaccines  in  our  U.S.  Pharmaceutical  segment  contributed approximately 2% in segment operating profit for the year ended March 31, 2021.", "During our fourth quarter of 2020, we experienced a temporary increase in demand for pharmaceuticals.", "Certain PPE items held for resale were valued in our inventory at costs that were inflated by earlier COVID-19 pandemic demand levels.", "That inventory valuation, if not supported by market resale prices, may be written down to net realizable value.", "We may also write-off inventory due to decreased customer demand and excess inventory.", "response to supply availability and customer demand patterns for certain products, with varying inventory level impacts depending on the specific product within our portfolio.", "As our supply levels improve, and the federal government evolves guidance on the prioritization of providers or geographic markets, we will continue to adapt our distribution policies.", "We were able to maintain appropriate labor and overall vendor supply levels during the year ended March 31, 2021.", "suppliers,  their  locations,  and  the  extent  to  which  they  are  impacted  by  the  COVID-19  pandemic,  we  are  proactively  working  with  manufacturers,  industry partners, and government agencies to meet the needs of our customers during the pandemic.", "We have assembled a Critical Care Drug Task Force, made up of our procurement  specialists,  clinical  health  systems  pharmacists,  and  supply  chain  professionals,  that  is  focused  on  securing  additional  product  where  available, sourcing back-up products, and protecting our operations across all locations and facilities.", "We are also working with manufacturers through several channels, including  our  ClarusONE  Sourcing  Services  LLP  (\u201cClarusONE\u201d)  and  global  sourcing  teams  in  London,  and  our  leaders  are  actively  engaged  in  addressing potential shortages.", "We have engaged with industry partners and government agencies to gain visibility into supply and demand.", "Additionally, we have a robust Business Continuity and Disaster Recovery Program (\u201cBCRP\u201d) and we have proactively enhanced our BCRP in response to the COVID-19 pandemic to protect the supply  chain  to  minimize  disruption  in  healthcare,  protect  our  customers,  ensure  the  safety  and  security  of  our  employees  and  workplaces,  and  ensure  the continuity of critical business processes.", "supplies and medications to help prevent the spread of the disease and treat those that are ill.", "COVID-19 has put an unprecedented strain on the supply of high- demand PPE, including N95 masks, gloves, as well as disinfecting sprays and wipes.", "The supply chain has improved over the initial impact of pandemic-related demand, and we continue to closely monitor demand by customer type and certain PPE and infection prevention items are still in short supply.", "Our allocation approach has helped us avoid stock outs in many critical product categories, allowing us to provide PPE supplies to many more customers for a much longer time.", "We anticipate these market conditions will remain for the foreseeable future.", "Our efforts to help the supply chain have included sourcing products from new suppliers all over the world, working closely with the federal government to help with the nation\u2019s response and collaborating with partners to source, develop, and deliver new products to market.", "The full extent to which COVID-19 will impact us depends on many factors and future developments, including: the duration and spread of the virus; governmental actions to limit the spread of the virus; potential seasonality of viral outbreaks; potential new strains or variants of the original virus; the amount of COVID-19 vaccines authorized, manufactured, distributed, and administered; the amount of ancillary supply kits assembled and distributed; the  effectiveness  of  COVID-19  vaccines  and  governmental  measures  in  controlling  the  spread  of  the  virus;  and  the  effectiveness  of  treatments  of  infected individuals.", "Impact to our Supply Chain We  also  continue  to  monitor  the  COVID-19  pandemic  impacts  on  our  supply  chain.  Although  the  availability  of  various  products  is  dependent  on  our", "Gross profit was favorably impacted by growth of specialty pharmaceuticals and the contribution from our vaccine distribution programs in our U.S.", "\u2022 Goodwill impairment charges of $1.8 billion in our European Retail Pharmacy (\u201cEuropean RP\u201d) and European Pharmaceutical Distribution (\u201cEuropean PD\u201d) reporting units within the International segment.", "This initiative primarily led us to rationalize our office space in North America.", "Where we determine to cease using office space, we plan to exit the portion of the facility no longer used.", "We also may retain and repurpose certain other office locations.", "transformational changes in technologies and business processes, operational efficiencies, and cost savings.", "centralization of certain functions and outsourcing through an expanded arrangement with a third-party vendor to achieve operational efficiency.", "The  initiative  consisted  of  multiple  growth  priorities  and  plans  to  optimize  our  operating  models  and  cost  structures  primarily  through  centralization,  cost management, and outsourcing of certain administrative functions.", "As part of the growth initiative, we committed to implement certain actions including a reduction in workforce, facility consolidation, and store closures.", "This set of initiatives was substantially complete by the end of 2020. $115 million, $112 million, and $245 million, respectively, primarily related to our retail pharmacy businesses in Canada and Europe within our International segment.", "During  the  first  quarter  of  2021,  we  committed  to  an  initiative  within  the  U.K.,  which  is  included  in  our  International  segment,  to  further  drive", "In the fourth quarter of 2019, we committed to certain programs to continue our operating model and cost optimization efforts.", "On April 25, 2018, we announced a strategic growth initiative intended to drive long-term incremental profit growth and to increase operational efficiency.", "pharmaceutical price increases, growth in specialty pharmaceuticals, and higher volumes from retail national account customers, partially offset by branded to generic  drug  conversions.  Revenues  for  this  segment  were  unfavorably  impacted  by  fluctuations  in  demand  for  pharmaceuticals  in  retail  pharmacies  and institutional healthcare providers due to COVID-19 largely during the onset of the pandemic in late March 2020 and during our first quarter of 2021 combined with the loss of certain customers.", "exchange fluctuations, revenues for this segment decreased 9% primarily due to the contribution of our German pharmaceutical wholesale business to a joint venture with WBA and to a lesser extent, the exit of unprofitable customers in our Canadian business.", "Revenues for this segment were also unfavorably impacted by lower volumes from the adverse impacts from COVID-19 in our pharmaceutical distribution and retail pharmacy businesses within Europe.", "exchange fluctuations, revenues for this segment increased 4% primarily due to market growth in our European pharmaceutical distribution and retail pharmacy businesses.", "2020 vs. 2019 Medical-Surgical Solutions revenues for the year ended March 31, 2020 increased 9% compared to the prior year primarily due to market growth in our", "The impacts from COVID-19 in our pharmaceutical distribution and retail pharmacy businesses within Europe also caused unfavorability in our segment results year over year.", "demand for COVID-19 tests and PPE, as well as the contribution from kitting and distribution of ancillary supplies for COVID-19 vaccines.", "This was partially offset by inventory charges on certain PPE and other related products, unfavorability in our primary care business due to customer closures largely during the first quarter  of 2021, and a  less severe  cough, cold, and flu  season.", "2020 vs. 2019 Operating profit increased for the year ended March 31, 2020 compared to the prior year primarily due to market growth in our specialty business.", "2020 vs. 2019 Operating profit and operating profit margin increased for the year ended March 31, 2020 compared to prior year primarily due to market growth in our", "We monitor our operations and adopt strategies responsive to changes in the economic and political environment in each of the countries in which we operate.", "Our foreign operations represented approximately 15%, 17%, and 18% of our consolidated revenues in 2021, 2020, and 2019, respectively.", "We also have agreements with GPOs, each of which functions as a purchasing agent on behalf of member hospitals, pharmacies and other healthcare providers, as well as with government entities and agencies.", "and updated if unusual circumstances or trends are present.", "LIFO method presumes that the most recent inventory purchases are the first items sold and the inventory cost under LIFO approximates market.", "The majority of the cost of domestic inventories is determined using the LIFO method.", "If we had used the moving average method of inventory valuation, inventories would have been approximately $406 million and $444 million higher than the amounts reported at March 31, 2021 and 2020, respectively.", "such, our LIFO inventory is valued at the lower of LIFO or market.", "Inventories: Inventories  consist of merchandise  held  for resale.  We report  inventories  at the lower of cost or net realizable  value, except  for inventories", "We believe that the moving average inventory costing method provides a reasonable estimation of the current cost of replacing inventory (i.e., \u201cmarket\u201d).", "Shifts in market trends and conditions, changes in customer preferences due to the introduction of generic drugs or new pharmaceutical products or the loss of one or more significant customers are factors that could affect the value of our inventories.", "We write down inventories which are considered excess and obsolete as a result of these reviews.", "These factors could make our estimates of inventory valuation differ from actual results.", "In addition, we compare the aggregate of the reporting units\u2019 fair values to our market capitalization as further corroboration of the fair values.", "They can be affected by a variety of factors, including external factors such as industry and economic trends, and internal factors such as changes in our business strategy and our internal forecasts.", "Management makes certain judgments and estimates in its assessment including but not limited to: identifying if circumstances indicate a decline in value is other than temporary, expectations about the business operations of investees, as well as industry, financial, and market factors.", "On March 9, 2020, we completed the Split-off of our interest in the Change Healthcare JV.", "Our businesses require substantial investments in working capital that are susceptible to large variations during the year as a result of inventory purchase patterns and seasonal demands.", "Our  redeemable  noncontrolling  interests  primarily  relate  to  our  consolidated  subsidiary,  McKesson  Europe.  Under  the  Domination  Agreement,  the", "However, our risk management programs are designed such  that  the  potential  loss  in  value  of  these  risk  management  portfolios  described  above  would  be  largely  offset  by  changes  in  the  value  of  the  underlying exposure.", "With the participation of the Chief Executive Officer and the Chief Financial Officer, our management conducted an assessment of the effectiveness of our internal control over financial  reporting based on the framework and criteria  established in Internal Control\u2014Integrated Framework (2013), issued by the Committee of Sponsoring Organizations of the Treadway Commission.", "Under the market approach, fair value is estimated by comparing the business to similar businesses, or guideline companies whose securities are actively traded in public markets.", "The severity,  magnitude  and  duration,  as  well  as  the  economic  consequences  of  the  coronavirus  diseases  2019  (\u201cCOVID-19\u201d)  pandemic,  are  uncertain,  rapidly changing, and difficult to predict.", "The majority of the cost of domestic inventories is determined using the LIFO method.", "Goodwill testing requires a complex series of assumptions and judgments by management in projecting future operating results, selecting guideline companies for comparisons and assessing risks.", "Revenues generated from the distribution of pharmaceutical and medical products represent the majority of the Company\u2019s revenues.", "customer, is responsible for fulfilling the promise to its customer, has latitude in establishing prices, and controls the relationship with the customer.", "Shipping and handling costs associated with outbound freight after control over a product has transferred to a customer are accounted for as fulfillment costs.", "International segment, to further drive transformational changes in technologies and business processes, operational efficiencies, and cost savings.", "continues to implement centralization of certain functions and outsourcing through an expanded arrangement with a third-party vendor to achieve operational efficiency.", "Irving, Texas to improve efficiency, collaboration, and cost competitiveness.", "PSUs are conditional upon the attainment of market and performance objectives over a specified period.", "As a practical expedient, the Company does not separate lease components from non-lease components such as common area maintenance, utilities, and repairs and maintenance.", "The Company\u2019s most significant relationships are with oncology and other specialty practices.", "Level 2 - significant other observable market-based inputs.", "Level 3 - significant unobservable inputs for which little or no market data exists and requires considerable assumptions that are significant to the fair value", "measurement due to the significance of unobservable inputs developed using company-specific information.", "It has received the same warranties from its suppliers, which customarily are the manufacturers of the products.", "Pharma Belgium NV is also part of the investigation.", "Stockholders (the \u201cProxy Statement\u201d) under the heading \u201cElection of Directors.\u201d Information about our Executive Officers is incorporated by reference from the discussion in Part I of this report under the heading \u201cInformation about our Executive Officers.\u201d Information about our Audit Committee, including the members of the  committee  and  our  Audit  Committee  Financial  Expert,  is  incorporated  by  reference  from  the  discussion  under  Item  1  of  our  Proxy  Statement  under  the headings \u201cThe Board, Committees and Meetings,\u201d and \u201cAudit Committee Report.\u201d", "We offer more than 275,000 national brand medical- surgical products as well as McKesson\u2019s own line of high-quality products through a network of distribution centers within the United States (\u201cU.S.\u201d).", "as a Service, to serve our biopharma and life sciences partners and patients.", "Our  U.S.  Pharmaceutical  segment  distributes  branded,  generic,  specialty,  biosimilar  and  over-the-counter  (\u201cOTC\u201d)  pharmaceutical  drugs,  and  other", "We also source generic pharmaceutical drugs through our joint sourcing entity, ClarusONE Sourcing Services LLP (\u201cClarusONE\u201d).", "We invest in technology and other systems at all of our distribution centers to enhance safety, reliability, and product availability.", "For example, we offer McKesson Connect , an internet-based ordering system that provides item look-up and real-time inventory availability as well as ordering, purchasing, third-party reconciliation, and account management functionality.", "We make extensive use of technology as an enabler to ensure customers have the right products at the right time in the right place.", "We provide solutions to our customers including supply management technology, world-class marketing programs, managed care, repackaging products, and services to help them meet their business and quality goals.", "We continue to implement information systems to help achieve greater consistency and accuracy both internally and for our customers.", "operational efficiency, and automation that help independent pharmacists focus on patient care while improving profitability.", "Retail National Accounts: We provide business solutions that help retail national account customers increase revenues and profitability.", "These distribution centers also provide the foundation for a two-tiered distribution network that supports best-in-class direct store delivery.", "performance, increase operational efficiencies, and deliver better patient care.", "Community-based physicians in this business have broad flexibility and discretion to select the products and commitment levels that best meet their practice needs.", "Services in provider solutions include specialty drug distribution, group purchasing organizations (\u201cGPO\u201d) like Onmark\u00ae, technology solutions, practice consulting services, and vaccine distribution, including our exclusive distributor relationship with the Centers for Disease Control and Prevention\u2019s (\u201cCDC\u201d) Vaccines for Children program.", "SKY Packaging enables acute care, long-term care, and institutional pharmacies to provide cost-effective, uniform packaging.", "Our use of the term \u201cspecialty\u201d may not be comparable to that used by other industry participants, including our competitors.", "Our operations in Canada, including Rexall retail pharmacies, support better, safer patient care by delivering vital medicines, supplies, and information technology solutions throughout Canada.", "functions  as  a  vital  link,  using  technology-enabled  management  systems  at  our  regional  wholesale  branches  to  connect  manufacturers  to  retail  pharmacies, supplying medicines and other products sold in pharmacies.", "In addition, we partner with independent pharmacies under local banner programs.", "banners, and more than 400 owned pharmacies under the Rexall brand where we provide patients with greater choice and access, integrated pharmacy care and industry-leading service levels.", "This segment includes our Ontada business, providing software to support the clinical, financial, and operational needs of our oncology practice partners.", "Our European Pharmaceutical Distribution business delivers pharmaceutical and other healthcare-related products to pharmacies across Europe.", "Our more than 250,000 customers include physician offices, surgery centers, post-acute care facilities, hospital reference labs, and  home  health  agencies.  We  distribute  medical-surgical  supplies  (such  as  gloves,  needles,  syringes  and  wound  care  products),  infusion  pumps,  laboratory equipment  and  pharmaceuticals.  Through  a  network  of  distribution  centers  within  the  U.S.,  we  offer  more  than  275,000  products  from  national  brand manufacturers and McKesson\u2019s own high-quality product line.", "Through the right mix of products and services, we help improve efficiencies, profitability and compliance.  We  also  never  lose  focus  on  helping  customers  improve  patient  and  business  outcomes.  We  develop  customized  plans  to  address  the  product, operational, and clinical support needs of our customers, including tackling inventory management, reducing administrative burdens, and training and educating clinical staff.", "We deliver for our customers, so they can deliver and care for their patients.", "pharmaceutical distribution environment in which our U.S.", "Pharmaceutical and International segments operate, we face strong competition from international, national, regional and local full-line, short-line and specialty distributors, service merchandisers, self-warehousing chain drug stores, manufacturers engaged in direct distribution, third-party logistics companies, and large payer organizations.", "Our retail businesses, which primarily operate in our International segment, face competition from various global, national, regional, and local global retailers, including chain and independent pharmacies.", "We consider our largest competitors in distribution, wholesaling, and logistics to be AmerisourceBergen Corporation and Cardinal Health, Inc.", "businesses, which may from time to time decide to develop, for their own internal needs, supply management capabilities that might otherwise be provided by our businesses.", "We believe that our scale and diversity of product and service offerings are our primary competitive advantages.", "operations and market position, but we do not consider any of our businesses to be dependent upon any one patent, copyright, trademark, or trade secret, or any family or families of the same.", "be necessary in the future to seek or renew licenses relating to various aspects of our products and services, we believe, based upon past experience and industry practice,  such  licenses  generally  can  be  obtained  on  commercially  reasonable  terms.  We  believe  our  operations  and  products  and  services  are  not  materially dependent on any single license or other agreement with any third party.", "on improving employee health and wellness, creating opportunities for growth and development, and providing an inclusive workplace where our employees can reach their full potential.", "At March 31, 2021, we had approximately 76,000 employees worldwide, including 17,000 part-time employees and 32,000 employees in the U.S. healthier future is everyone\u2019s business.", "We build successful teams by recruiting, developing, and retaining diverse talent and we recognize our culture of inclusion as an important element that drives long-term shareholder value.", "(1) The data for our metrics is derived from our voluntary, self-identification process as of March 31, 2021 and therefore represents our best estimate at this time. (2) Represents our leadership at the vice president level and above. (3) Represents worldwide employees. (4) Represents U.S. employees only as the data for Canada and Europe is not available.", "I CARE and ILEAD principles, we fulfill our mission of improving care in every setting.", "Our I CARE values (Integrity, Inclusion, Customer-First, Accountability, Respect, Excellence) are foundational to all that we do, and who we are as a company.", "ILEAD (Inspire, Leverage, Execute, Advance, Develop) is our common definition and shared commitment to leadership.", "By embracing this commitment, we bring out the best in ourselves and position McKesson to continue to drive better health \u2013 for our company, our customers, and the patients they serve for years to come.", "We promote leadership behaviors through culture initiatives that offer practical tips on how to debate, decide, and commit, be open and candid, and maintain an enterprise-first mindset when navigating conversations affecting operations within and across our business segments.", "We hold inbound licenses for certain intellectual property that is used internally, and in some cases, utilized in McKesson\u2019s products or services.", "Culture and Leadership: What sets McKesson apart as an exceptional place is our people.", "Our employees understand that together, unified by our global", "where everyone can bring their authentic self to work and feel welcomed and appreciated, and where their perspectives are sought out, heard, and considered.", "Through training, we encourage leaders to embrace diverse perspectives and lead inclusively.", "We  also  seek  employee  feedback  through  an  annual  employee  opinion  survey,  which  assesses  our employees\u2019  levels  of engagement, commitment, and overall satisfaction using industry benchmarks, and we then design action plans to improve those metrics.", "We routinely assess facilities to monitor closely adherence to established security and safety standards.", "If we identify a vulnerability, it is documented, and the facility prepares an action plan.", "Our employees receive specialized training related to their role, work setting, and equipment used in their work environment.", "As our processes evolve, we update relevant safety training modules, which may include new employee training programs.", "The various responses we put in place to mitigate the impact of COVID- 19  on  our  business  operations,  including  telecommuting  and  work-from-home  policies,  restricted  travel,  and  enhanced  safety  measures,  are  intended  to  limit employee exposure to the virus that causes COVID-19 as they perform their jobs while also providing employee support programs and a sense of belonging.", "For additional  information  on  our  response  to  COVID-19  in  the  workplace,  refer  to  the  COVID-19  section  of \u201cTrends  and  Uncertainties\u201d in  \u201cManagement\u2019s Discussion and Analysis of Financial Condition and Results of Operations\u201d in Item 7 of Part II included in this Annual Report on Form 10-K.", "Food and Drug Administration Amendments Act of 2007 requires the FDA to establish standards and identify and validate effective technologies, such as track and trace or authentication technologies, to secure the pharmaceutical supply chain against counterfeit drugs.", "Despite physical, technical, and administrative security measures that we implement in order to, among other things, address regulatory requirements, our technology systems and operations may continue to be subject to cybersecurity incidents.", "The risk of cybersecurity incidents may be increased due to a variety of factors, both internal and external.", "Sales to our largest customer, CVS Health Corporation (\u201cCVS\u201d), accounted for approximately 21% of our total consolidated revenues in 2021.", "In May 2019, we extended our pharmaceutical distribution relationship with CVS to June 2023.", "a supplier could adversely affect our business if alternate sources of supply are unavailable.", "We believe that our relationships with our suppliers are generally sound.", "The ten largest suppliers in 2021 accounted for approximately 50% of our purchases.", "For these manufacturers, a reduction in the frequency and magnitude of price increases, as well as restrictions in the amount of inventory available to us, could have an adverse impact on our gross profit margin.", "Although it is not possible to predict or identify all such risks and uncertainties, they include, but are not limited to, the factors discussed in Item 1A of Part I of this report under \u201cRisk Factors\u201d and in our publicly available SEC filings and press releases.", "Suppliers: We obtain pharmaceutical and other products from manufacturers, none of which accounted for more than 7% of our purchases in 2021.", "practical  to  identify  or  describe  all  risks  and  uncertainties  that  might  materially  impact  our  business  operations,  reputation,  financial  position  or  results  of operations.", "Our business could be materially affected by risks that we have not yet identified or that we currently consider to be immaterial.", "This is not a complete statement of all potential risks and uncertainties.", "For example, pharmacy operations are exposed to risks such as improper filling of prescriptions, mislabeling of prescriptions, inadequacy of warnings, unintentional distribution of counterfeit drugs and expiration of drugs.", "The  discussion  below  identifies  certain  representative  risks  that  might  cause  our  actual  business  results  to  materially  differ  from  our  estimates.  It  is  not", "Certain of our businesses may be required to register for permits and/or licenses with, and comply with operating and security standards of, the DEA, FDA, HHS, CMS, various state boards of pharmacy, state health departments and/or comparable state agencies as well as foreign agencies and certain accrediting bodies, depending upon the type of operations and location of product development, manufacture, distribution, and sale.", "As of March 31, 2021, suspensions at the four distribution centers had all expired  by  their  own  terms.  If  we  are  not  able  to  obtain,  maintain  or  renew  permits,  licenses  or  other  regulatory  approvals  needed  for  the  operation  of  our businesses, it might have a materially adverse impact on our business operations and our financial position or results of operations.", "Food and Drug Administration Amendments Act of 2007 requires the FDA to establish standards and identify and validate effective technologies, such as track  and  trace  or  authentication  technologies,  to  secure  the  pharmaceutical  supply  chain  against  counterfeit  drugs.  We  also  have  record-keeping  and  other obligations under the E.U.", "We are subject to significant compliance obligations under privacy laws such as the General Data Protection Regulation in the  European  Union  (\u201cGDPR\u201d),  the  Personal  Information  Protection  and  Electronic  Documents  Act  (\u201cPIPEDA\u201d)  in  Canada,  and  the  California  Consumer Protection  Act  (\u201cCCPA\u201d).  Some  privacy  laws  prohibit  the  transfer  of  personal  information  to  certain  other  jurisdictions.  We  are  subject  to  privacy  and  data protection compliance audits or investigations by various government agencies.", "We experience cybersecurity incidents that might significantly compromise our technology systems or might result in material data breaches.", "Despite physical, technical, and administrative security measures, our technology systems and operations have been, and likely will continue to be, subject to cyberattacks from sources beyond our control.", "Cybersecurity incidents  include  actual  or  attempted  unauthorized  access,  tampering,  malware  insertion,  ransomware  attacks  or  other  system  integrity  events.  The  risk  of cyberattacks  may be increased  due to a variety of factors, both internal  and external.  A cybersecurity  incident might involve a material  data breach or other material impact to the integrity and operations of our technology systems, which might result in litigation or regulatory action, loss of customers or revenue, and increased expense, any of which might have a materially adverse impact on our business operations, reputation, and our financial position or results of operations.", "We might experience significant problems with information systems or networks.", "If those information systems suffer errors, interruptions, or become unavailable, there might be a materially adverse impact on our business operations, reputation, and our financial position or results of operations.", "Our products or services might not conform to specifications or perform as we intend.", "professionals delivering patient care tend to have heightened sensitivity to system and software errors.", "Errors or failures might damage our reputation and negatively affect future sales.", "We sell and provide services involving complex software and technology that may contain errors, especially when first introduced to market.", "The networks and hosting systems are vulnerable to interruption or damage from sources beyond our control, such as power loss, telecommunications failures, fire, natural disasters, software and hardware failures and cyberattacks.", "If the timely delivery of medical care or other customer business requirements are impaired by data access, network or systems problems, we could be exposed to significant claims and reputational harm.", "We might not realize expected benefits from business process initiatives.", "achieve  our  desired  objectives,  or  unintended  consequences  such  as  distraction  of  our  management  and  employees,  business  disruption,  attrition  beyond  any planned reduction in workforce, inability to attract or retain key personnel and reduced employee productivity.", "We might be unable to successfully complete or integrate acquisitions or other business combinations.", "We may not receive regulatory approvals needed to complete proposed transactions, or such  approvals  may  be  subject  to  delays  or  conditions  that  reduce  transaction  benefits.  Achieving  the  desired  outcomes  of  business  combinations  involves significant  risks  including:  diverting  management\u2019s  attention  from  other  business  operations;  challenges  with  assimilating  the  acquired  businesses,  such  as integration  of  operations  and  systems;  failure  or  delay  in  realizing  operating  synergies;  difficulty  retaining  key  acquired  company  personnel;  unanticipated accounting or financial systems issues with the acquired business, which might affect our internal controls over financial reporting; unanticipated compliance issues in the acquired business; challenges retaining customers of the acquired business; unanticipated expenses or charges to earnings, including depreciation and amortization or potential impairment charges; and risks of known and unknown assumed liabilities in the acquired business.", "We provide remote services that involve hosting customer data and operating software on our own or third party systems.", "Our growth strategy includes consummating acquisitions or other business combinations that either expand or complement our business.", "could delay the achievement of our strategic objectives.", "We might be adversely impacted by outsourcing or similar third-party relationships.", "Third-party services providers might fail to perform as anticipated, or we might experience unanticipated operational difficulties, compliance requirements or increased costs related to outsourced services.", "We may be unsuccessful in retail pharmacy operations or maintaining profitability.", "If our retail pharmacy operations fail to achieve, or are unable to sustain, acceptable net sales and profitability levels, it might have a materially adverse impact on our business operations and our financial position or results of operations.", "We rely on third parties to perform certain business and administrative functions for us.", "We might not adequately develop, implement and monitor these", "Our business strategy included expanding our retail pharmacy operations.", "Our retail pharmacy operations involve numerous risks, such as the following ones.", "For example, our contracts with the U.S. government generally require us to comply with the Federal Acquisition Regulations, Procurement Integrity Act, Buy American Act, Trade Agreements Act, and other laws and regulations.", "The occurrence of any of these risks could harm our reputation and might have a materially adverse impact on our business operations and our financial position or results of operations.", "Our participation in vaccination distribution programs may materially affect our operating results, reputation, and business.", "For example, the novel nature of the SARS-CoV\u20112 virus and the broad scope of the ongoing COVID-19 vaccine distribution program introduce uncertainty about what volumes of products may become available for distribution by us, the effectiveness of vaccines, and the cost of distribution.", "Because of such uncertainties, our operating results may be subject to variability.", "Our participation in such programs also exposes us to various risks, including regulatory compliance, government oversight, dependence on government funding, contractual performance, litigation, security risks, and supply chain challenges.", "Any significant problems with our participation in such programs might have a materially adverse impact on our reputation and our business.", "We might be harmed by changes in our relationships or contracts with suppliers.", "Our competitors might develop non-infringing products or services equivalent or superior to ours.", "We might be unable to successfully recruit and retain qualified employees.", "We compete with many other businesses to attract and retain employees.", "We may experience sudden loss of key personnel due to a variety of causes, such as illness, and must adequately plan for succession of key management roles.", "Employees might not successfully transition into new roles.", "Some of these changes increase our risks and create uncertainties for our business.", "These proposals might result in significant changes in the pharmaceutical value chain as manufacturers, PBM, managed care organizations and other industry stakeholders look to implement new transactional flows and adapt their business models.", "Many of our products and services are designed and intended to function within the structure of current healthcare financing and reimbursement systems.", "We might be adversely impacted by competition and industry consolidation.", "specialty distributors, service merchandisers, self-warehousing chain drug stores, manufacturers engaged in direct distribution, third-party logistics companies and large  payer  organizations.  In  addition,  our  businesses  face  competition  from  various  other  service  providers  and  from  pharmaceutical  and  other  healthcare manufacturers as well as other potential customers, which may from time-to-time decide to develop, for their own internal needs, supply management capabilities that might otherwise be provided by our businesses.", "This concentration reduces our ability to negotiate favorable terms with suppliers and causes us to depend on a smaller number of suppliers.", "Many of our customers, including  healthcare  organizations,  have  consolidated  and  have  greater  power  to  negotiate  favorable  prices.  Consolidation  by  our  customers,  suppliers  and competitors might reduce the number of market participants and give the remaining enterprises greater bargaining power, which might lead to erosion in our profit margin.", "These competitive pressures and industry consolidation might have a materially adverse impact on our business operations and our financial position or results of operations.", "We might be adversely impacted by changes or disruptions in product supply.", "Our inventory might be requisitioned, diverted or allocated by government order such as under emergency, disaster and civil defense declarations.", "For example, government actions in response to the COVID-19 pandemic affect our supply allocation, and those and our own allocation decisions can impact our customer relationships.", "Changes in the healthcare industry\u2019s or our suppliers\u2019 pricing, selling, inventory, distribution or supply policies or practices could significantly reduce our revenues and net income.", "We might experience disruptions in our supply of higher margin pharmaceuticals, including generic pharmaceuticals.", "sourcing joint venture with Walmart, Inc. is unsuccessful or experiences margins declines.", "products and services and the volume of their purchases.", "Our generic  pharmaceuticals  distribution  business  is subject  to  pricing  risks.  We  might  be  adversely  impacted  if  our ClarusONE  generic  pharmaceutical", "Suppliers might increase their prices, reduce their output or change their terms of sale due to limited availability of credit.", "We may have difficulties in sourcing or selling products due to a variety of causes.", "Difficulties in product manufacturing or access to raw materials could result in supplier production shutdowns, product shortages and other supply disruptions.", "The COVID-19 pandemic adversely affects the availability of some products, resulting in product allocation and delivery delays.", "We have operations in the U.K. and the European Union (\u201cE.U.\u201d) and face risks associated with the uncertainty and potential disruptions that might follow the", "These events can disrupt operations for us, our suppliers, our vendors, and our customers.", "For example, in February 2021, a severe winter storm affecting the United  States  temporarily  impacted  our  distribution  business  operations,  primarily  in  Texas.  They  might  affect  consumer  confidence  levels  and  spending.  In response to these events, we might suspend operations, implement extraordinary procedures, seek alternate sources for product supply, or suffer consequences that are unexpected and difficult to mitigate.", "In particular, the rapid and widespread transmission of the SARS-CoV-2 novel coronavirus beginning in late 2019 impacts us in significant ways.", "For example, to mitigate the spread of the COVID-19 disease caused by SARS-CoV-2, we implemented travel restrictions and remote working  arrangements  for  most  of  our  employees  in  order  to  minimize  physical  contact,  and  we  implemented  additional  sanitation  and  personal  protection measures in our warehouse, retail pharmacy and delivery operations.", "These measures might not fully mitigate COVID-19 risks to our workforce and we could experience unusual levels of absenteeism that might impair operations and delay delivery of products.", "The ongoing impacts of the pandemic might cause a general economic slowdown or recession in one or more markets, disruptions and volatility in global capital markets and other broad and adverse effects on the economy, business conditions, commercial activity and the healthcare industry.", "The pandemic might impact our business operation, financial position and results of operation in unpredictable ways that depend on highly uncertain future  developments,  such  as  determining  the  effectiveness  of  current  or  future  government  actions  to  address  the  public  health  or  economic  impacts  of  the pandemic.", "These events and impacts could materially adversely affect our business operations, financial position or results of operation.", "locations,  primarily  throughout  North  America  and  Europe.  Retail  pharmacies  and  most  warehouses  are  typically  owned  or  leased  on  a  long-term  basis.  We consider our operating properties to be in satisfactory condition and adequate to meet our needs for the next several years without making capital expenditures materially higher than historical levels.", "Form 10-K for additional factors relating to these statements and Item 1A - Risk Factors in Part I of this Annual Report on Form 10-K for a list of certain risk factors applicable to our business, financial condition, and results of operations.", "We partner with life sciences companies, manufacturers, providers, pharmacies, governments, and other healthcare organizations to help provide the right medicines, medical products, and healthcare services to the right patients at the right time, safely, and cost-effectively.", "All prior segment information has been recast to reflect our new segment structure and current period presentation.", "We  implemented  a  new  segment  reporting  structure  commencing  with  the  second  quarter  of  2021,  which  resulted  in  four  reportable  segments:  U.S.", "\u2022 International is  a  new  reportable  segment  that  includes  our  operations  in  Europe  and  Canada,  bringing  together  non-U.S.-based  drug  distribution services, specialty pharmacy, retail, and infusion care services.", "\u2022 RxTS is  a  new  reportable  segment  that  brings  together  existing  businesses,  including  CoverMyMeds,  RelayHealth,  RxCrossroads,  and  McKesson Prescription Automation, including Multi-Client Central Fill as a Service, to serve our biopharma and life sciences partners and patients.", "We benefited from demand for COVID-19 tests, favorable contributions from our vaccine and related ancillary supply kit distribution programs as discussed further below, and savings from reduced travel and meetings throughout 2021;", "We have also partnered with the Department of Health and Human Services (\u201cHHS\u201d) and Pfizer to manage the assembly and distribution of the ancillary supplies needed to administer COVID-19 vaccines;", "Pharmaceutical segment driven by market growth; \u2022 Gross profit increased 1% from the prior year primarily in our Medical-Surgical Solutions segment driven by sales of COVID-19 tests; \u2022 Total operating expenses in 2021 includes the following:", "Infection rates varied throughout our fiscal year, peaking in January 2021.", "Our role in the distribution of COVID-19 vaccines in the U.S. as well as the assembly and distribution of related ancillary supply kits is discussed further below.", "McKesson Europe is also playing a role in helping support governments and public health entities in not only distributing COVID-19 vaccines across several European countries, but administering them in pharmacies as well.", "solutions, we are well positioned to respond to the COVID-19 pandemic in the U.S., Canada, and Europe.", "We have worked and continue to work closely with national and local governments, agencies, and industry partners to ensure that available supplies, including personal protective equipment (\u201cPPE\u201d), and medicine reach our customers and patients.", "put in place to mitigate the impact of COVID-19 on our business operations, including telecommuting and work-from-home policies, restricted travel, employee support programs, and enhanced safety measures, are intended to limit employee exposure to the virus that causes COVID-19.", "We expanded employee medical benefits covering COVID-19 related visits, treatments, and testing as well as expanded telehealth options to protect employee safety.", "For employees whose roles require presence at our facilities, we enhanced safety by promoting the practice of social distancing, providing reminders to wash or disinfect hands and avoid unnecessary face touching, making face masks available, placing hand sanitizers within our operating environments, and periodically cleaning and disinfecting our facilities.", "For employees whose roles do not require presence at our facilities, we added technology resources to support their working remotely.", "These steps to protect employee safety have resulted in limited disruption from COVID-19 to our normal business operations, productivity trends, and have not materially impacted our operating expenses or operating margins.", "pharmacy foot traffic as our customers increased supplies on hand in March, which drove unfavorability in our results of operations when comparing 2021 versus 2020.", "We also experienced decreased demand for primary care medical-surgical supplies due to deferrals in elective procedures in hospitals and surgery centers as well as decreased traffic and closures of doctors\u2019 offices, which was partially offset by demand for PPE and COVID-19 tests.", "COVID-19  for  the  second  half  of  our  fiscal  year  was  non-linear  and  tracked  with  patient  mobility.  We  also  saw  increased  demand  for  COVID-19  tests  and continued sales of PPE throughout the year in our Medical-Surgical Solutions segment partially offset by the impacts of social distancing measures which resulted in a less severe cough, cold, and flu season, savings for reduced travel and meetings across the enterprise, as well as improvements of retail pharmacy foot traffic in Europe and Canada.", "The vaccine and related  ancillary  kit distribution  in the U.S. favorably impacted our results in the second half of fiscal 2021 as further discussed below.", "Our Response to COVID-19 in the Workplace During this unprecedented time, we are committed in continuing to supply our customers and protect the safety of our employees.", "During  the  first  quarter  of  2021,  we  experienced  growth  in  pharmaceutical  distribution  and  specialty  drug  volumes  at  a  lower  rate  in  the  U.S.,  while", "In the centralized model, the U.S. government directs us on the distribution of the vaccines and related supplies to point-of-care sites across the country.", "The results of operations related to our vaccine distribution are reflected in our U.S.", "We also have an agreement with Pfizer to assemble and distribute ancillary supply kits needed to administer that particular COVID-19 vaccine.", "We began assembling the ancillary supply kits in September 2020 in preparation for vaccine authorization and subsequent distribution.", "Ancillary supply kits to administer the Pfizer Vaccine are shipped directly to point-of-care sites, and all other ancillary supply kits are shipped to our dedicated vaccine distribution centers.", "The results of operations for the kitting and distribution of ancillary supplies are reflected in our Medical-Surgical Solutions segment.", "These facilities can scale to meet the demand of increasing volumes of vaccines being manufactured.", "We have also set up distribution centers for kitting and inventory management as part of our contract with the HHS.", "We are working with delivery partners to manage the delivery of vaccines and ancillary supply kits from our centralized vaccine distribution centers to point-of-care destinations as directed by the CDC.", "as well as the kitting and distribution of ancillary supplies for COVID-19 vaccines in our Medical-Surgical Solutions segment contributed approximately 20% in segment  revenues  and  segment  operating  profit.  Additionally,  the  distribution  of  COVID-19  vaccines  in  our  U.S.  Pharmaceutical  segment  contributed approximately 2% in segment operating profit for the year ended March 31, 2021.", "During our fourth quarter of 2020, we experienced a temporary increase in demand for pharmaceuticals.", "Certain PPE items held for resale were valued in our inventory at costs that were inflated by earlier COVID-19 pandemic demand levels.", "That inventory valuation, if not supported by market resale prices, may be written down to net realizable value.", "We may also write-off inventory due to decreased customer demand and excess inventory.", "response to supply availability and customer demand patterns for certain products, with varying inventory level impacts depending on the specific product within our portfolio.", "As our supply levels improve, and the federal government evolves guidance on the prioritization of providers or geographic markets, we will continue to adapt our distribution policies.", "We were able to maintain appropriate labor and overall vendor supply levels during the year ended March 31, 2021.", "suppliers,  their  locations,  and  the  extent  to  which  they  are  impacted  by  the  COVID-19  pandemic,  we  are  proactively  working  with  manufacturers,  industry partners, and government agencies to meet the needs of our customers during the pandemic.", "We have assembled a Critical Care Drug Task Force, made up of our procurement  specialists,  clinical  health  systems  pharmacists,  and  supply  chain  professionals,  that  is  focused  on  securing  additional  product  where  available, sourcing back-up products, and protecting our operations across all locations and facilities.", "We are also working with manufacturers through several channels, including  our  ClarusONE  Sourcing  Services  LLP  (\u201cClarusONE\u201d)  and  global  sourcing  teams  in  London,  and  our  leaders  are  actively  engaged  in  addressing potential shortages.", "We have engaged with industry partners and government agencies to gain visibility into supply and demand.", "Additionally, we have a robust Business Continuity and Disaster Recovery Program (\u201cBCRP\u201d) and we have proactively enhanced our BCRP in response to the COVID-19 pandemic to protect the supply  chain  to  minimize  disruption  in  healthcare,  protect  our  customers,  ensure  the  safety  and  security  of  our  employees  and  workplaces,  and  ensure  the continuity of critical business processes.", "supplies and medications to help prevent the spread of the disease and treat those that are ill.", "COVID-19 has put an unprecedented strain on the supply of high- demand PPE, including N95 masks, gloves, as well as disinfecting sprays and wipes.", "The supply chain has improved over the initial impact of pandemic-related demand, and we continue to closely monitor demand by customer type and certain PPE and infection prevention items are still in short supply.", "Our allocation approach has helped us avoid stock outs in many critical product categories, allowing us to provide PPE supplies to many more customers for a much longer time.", "We anticipate these market conditions will remain for the foreseeable future.", "Our efforts to help the supply chain have included sourcing products from new suppliers all over the world, working closely with the federal government to help with the nation\u2019s response and collaborating with partners to source, develop, and deliver new products to market.", "The full extent to which COVID-19 will impact us depends on many factors and future developments, including: the duration and spread of the virus; governmental actions to limit the spread of the virus; potential seasonality of viral outbreaks; potential new strains or variants of the original virus; the amount of COVID-19 vaccines authorized, manufactured, distributed, and administered; the amount of ancillary supply kits assembled and distributed; the  effectiveness  of  COVID-19  vaccines  and  governmental  measures  in  controlling  the  spread  of  the  virus;  and  the  effectiveness  of  treatments  of  infected individuals.", "Impact to our Supply Chain We  also  continue  to  monitor  the  COVID-19  pandemic  impacts  on  our  supply  chain.  Although  the  availability  of  various  products  is  dependent  on  our", "Gross profit was favorably impacted by growth of specialty pharmaceuticals and the contribution from our vaccine distribution programs in our U.S.", "\u2022 Goodwill impairment charges of $1.8 billion in our European Retail Pharmacy (\u201cEuropean RP\u201d) and European Pharmaceutical Distribution (\u201cEuropean PD\u201d) reporting units within the International segment.", "This initiative primarily led us to rationalize our office space in North America.", "Where we determine to cease using office space, we plan to exit the portion of the facility no longer used.", "We also may retain and repurpose certain other office locations.", "transformational changes in technologies and business processes, operational efficiencies, and cost savings.", "centralization of certain functions and outsourcing through an expanded arrangement with a third-party vendor to achieve operational efficiency.", "The  initiative  consisted  of  multiple  growth  priorities  and  plans  to  optimize  our  operating  models  and  cost  structures  primarily  through  centralization,  cost management, and outsourcing of certain administrative functions.", "As part of the growth initiative, we committed to implement certain actions including a reduction in workforce, facility consolidation, and store closures.", "This set of initiatives was substantially complete by the end of 2020. $115 million, $112 million, and $245 million, respectively, primarily related to our retail pharmacy businesses in Canada and Europe within our International segment.", "During  the  first  quarter  of  2021,  we  committed  to  an  initiative  within  the  U.K.,  which  is  included  in  our  International  segment,  to  further  drive", "In the fourth quarter of 2019, we committed to certain programs to continue our operating model and cost optimization efforts.", "On April 25, 2018, we announced a strategic growth initiative intended to drive long-term incremental profit growth and to increase operational efficiency.", "pharmaceutical price increases, growth in specialty pharmaceuticals, and higher volumes from retail national account customers, partially offset by branded to generic  drug  conversions.  Revenues  for  this  segment  were  unfavorably  impacted  by  fluctuations  in  demand  for  pharmaceuticals  in  retail  pharmacies  and institutional healthcare providers due to COVID-19 largely during the onset of the pandemic in late March 2020 and during our first quarter of 2021 combined with the loss of certain customers.", "exchange fluctuations, revenues for this segment decreased 9% primarily due to the contribution of our German pharmaceutical wholesale business to a joint venture with WBA and to a lesser extent, the exit of unprofitable customers in our Canadian business.", "Revenues for this segment were also unfavorably impacted by lower volumes from the adverse impacts from COVID-19 in our pharmaceutical distribution and retail pharmacy businesses within Europe.", "exchange fluctuations, revenues for this segment increased 4% primarily due to market growth in our European pharmaceutical distribution and retail pharmacy businesses.", "2020 vs. 2019 Medical-Surgical Solutions revenues for the year ended March 31, 2020 increased 9% compared to the prior year primarily due to market growth in our", "The impacts from COVID-19 in our pharmaceutical distribution and retail pharmacy businesses within Europe also caused unfavorability in our segment results year over year.", "demand for COVID-19 tests and PPE, as well as the contribution from kitting and distribution of ancillary supplies for COVID-19 vaccines.", "This was partially offset by inventory charges on certain PPE and other related products, unfavorability in our primary care business due to customer closures largely during the first quarter  of 2021, and a  less severe  cough, cold, and flu  season.", "2020 vs. 2019 Operating profit increased for the year ended March 31, 2020 compared to the prior year primarily due to market growth in our specialty business.", "2020 vs. 2019 Operating profit and operating profit margin increased for the year ended March 31, 2020 compared to prior year primarily due to market growth in our", "We monitor our operations and adopt strategies responsive to changes in the economic and political environment in each of the countries in which we operate.", "Our foreign operations represented approximately 15%, 17%, and 18% of our consolidated revenues in 2021, 2020, and 2019, respectively.", "We also have agreements with GPOs, each of which functions as a purchasing agent on behalf of member hospitals, pharmacies and other healthcare providers, as well as with government entities and agencies.", "and updated if unusual circumstances or trends are present.", "LIFO method presumes that the most recent inventory purchases are the first items sold and the inventory cost under LIFO approximates market.", "The majority of the cost of domestic inventories is determined using the LIFO method.", "If we had used the moving average method of inventory valuation, inventories would have been approximately $406 million and $444 million higher than the amounts reported at March 31, 2021 and 2020, respectively.", "such, our LIFO inventory is valued at the lower of LIFO or market.", "Inventories: Inventories  consist of merchandise  held  for resale.  We report  inventories  at the lower of cost or net realizable  value, except  for inventories", "We believe that the moving average inventory costing method provides a reasonable estimation of the current cost of replacing inventory (i.e., \u201cmarket\u201d).", "Shifts in market trends and conditions, changes in customer preferences due to the introduction of generic drugs or new pharmaceutical products or the loss of one or more significant customers are factors that could affect the value of our inventories.", "We write down inventories which are considered excess and obsolete as a result of these reviews.", "These factors could make our estimates of inventory valuation differ from actual results.", "In addition, we compare the aggregate of the reporting units\u2019 fair values to our market capitalization as further corroboration of the fair values.", "They can be affected by a variety of factors, including external factors such as industry and economic trends, and internal factors such as changes in our business strategy and our internal forecasts.", "Management makes certain judgments and estimates in its assessment including but not limited to: identifying if circumstances indicate a decline in value is other than temporary, expectations about the business operations of investees, as well as industry, financial, and market factors.", "On March 9, 2020, we completed the Split-off of our interest in the Change Healthcare JV.", "Our businesses require substantial investments in working capital that are susceptible to large variations during the year as a result of inventory purchase patterns and seasonal demands.", "Our  redeemable  noncontrolling  interests  primarily  relate  to  our  consolidated  subsidiary,  McKesson  Europe.  Under  the  Domination  Agreement,  the", "However, our risk management programs are designed such  that  the  potential  loss  in  value  of  these  risk  management  portfolios  described  above  would  be  largely  offset  by  changes  in  the  value  of  the  underlying exposure.", "With the participation of the Chief Executive Officer and the Chief Financial Officer, our management conducted an assessment of the effectiveness of our internal control over financial  reporting based on the framework and criteria  established in Internal Control\u2014Integrated Framework (2013), issued by the Committee of Sponsoring Organizations of the Treadway Commission.", "Under the market approach, fair value is estimated by comparing the business to similar businesses, or guideline companies whose securities are actively traded in public markets.", "The severity,  magnitude  and  duration,  as  well  as  the  economic  consequences  of  the  coronavirus  diseases  2019  (\u201cCOVID-19\u201d)  pandemic,  are  uncertain,  rapidly changing, and difficult to predict.", "The majority of the cost of domestic inventories is determined using the LIFO method.", "Goodwill testing requires a complex series of assumptions and judgments by management in projecting future operating results, selecting guideline companies for comparisons and assessing risks.", "Revenues generated from the distribution of pharmaceutical and medical products represent the majority of the Company\u2019s revenues.", "customer, is responsible for fulfilling the promise to its customer, has latitude in establishing prices, and controls the relationship with the customer.", "Shipping and handling costs associated with outbound freight after control over a product has transferred to a customer are accounted for as fulfillment costs.", "International segment, to further drive transformational changes in technologies and business processes, operational efficiencies, and cost savings.", "continues to implement centralization of certain functions and outsourcing through an expanded arrangement with a third-party vendor to achieve operational efficiency.", "Irving, Texas to improve efficiency, collaboration, and cost competitiveness.", "PSUs are conditional upon the attainment of market and performance objectives over a specified period.", "As a practical expedient, the Company does not separate lease components from non-lease components such as common area maintenance, utilities, and repairs and maintenance.", "The Company\u2019s most significant relationships are with oncology and other specialty practices.", "Level 2 - significant other observable market-based inputs.", "Level 3 - significant unobservable inputs for which little or no market data exists and requires considerable assumptions that are significant to the fair value", "measurement due to the significance of unobservable inputs developed using company-specific information.", "It has received the same warranties from its suppliers, which customarily are the manufacturers of the products.", "Pharma Belgium NV is also part of the investigation.", "Stockholders (the \u201cProxy Statement\u201d) under the heading \u201cElection of Directors.\u201d Information about our Executive Officers is incorporated by reference from the discussion in Part I of this report under the heading \u201cInformation about our Executive Officers.\u201d Information about our Audit Committee, including the members of the  committee  and  our  Audit  Committee  Financial  Expert,  is  incorporated  by  reference  from  the  discussion  under  Item  1  of  our  Proxy  Statement  under  the headings \u201cThe Board, Committees and Meetings,\u201d and \u201cAudit Committee Report.\u201d", "We offer more than 275,000 national brand medical- surgical products as well as McKesson\u2019s own line of high-quality products through a network of distribution centers within the United States (\u201cU.S.\u201d).", "as a Service, to serve our biopharma and life sciences partners and patients.", "Our  U.S.  Pharmaceutical  segment  distributes  branded,  generic,  specialty,  biosimilar  and  over-the-counter  (\u201cOTC\u201d)  pharmaceutical  drugs,  and  other", "We also source generic pharmaceutical drugs through our joint sourcing entity, ClarusONE Sourcing Services LLP (\u201cClarusONE\u201d).", "We invest in technology and other systems at all of our distribution centers to enhance safety, reliability, and product availability.", "For example, we offer McKesson Connect , an internet-based ordering system that provides item look-up and real-time inventory availability as well as ordering, purchasing, third-party reconciliation, and account management functionality.", "We make extensive use of technology as an enabler to ensure customers have the right products at the right time in the right place.", "We provide solutions to our customers including supply management technology, world-class marketing programs, managed care, repackaging products, and services to help them meet their business and quality goals.", "We continue to implement information systems to help achieve greater consistency and accuracy both internally and for our customers.", "operational efficiency, and automation that help independent pharmacists focus on patient care while improving profitability.", "Retail National Accounts: We provide business solutions that help retail national account customers increase revenues and profitability.", "These distribution centers also provide the foundation for a two-tiered distribution network that supports best-in-class direct store delivery.", "performance, increase operational efficiencies, and deliver better patient care.", "Community-based physicians in this business have broad flexibility and discretion to select the products and commitment levels that best meet their practice needs.", "Services in provider solutions include specialty drug distribution, group purchasing organizations (\u201cGPO\u201d) like Onmark\u00ae, technology solutions, practice consulting services, and vaccine distribution, including our exclusive distributor relationship with the Centers for Disease Control and Prevention\u2019s (\u201cCDC\u201d) Vaccines for Children program.", "SKY Packaging enables acute care, long-term care, and institutional pharmacies to provide cost-effective, uniform packaging.", "Our use of the term \u201cspecialty\u201d may not be comparable to that used by other industry participants, including our competitors.", "Our operations in Canada, including Rexall retail pharmacies, support better, safer patient care by delivering vital medicines, supplies, and information technology solutions throughout Canada.", "functions  as  a  vital  link,  using  technology-enabled  management  systems  at  our  regional  wholesale  branches  to  connect  manufacturers  to  retail  pharmacies, supplying medicines and other products sold in pharmacies.", "In addition, we partner with independent pharmacies under local banner programs.", "banners, and more than 400 owned pharmacies under the Rexall brand where we provide patients with greater choice and access, integrated pharmacy care and industry-leading service levels.", "This segment includes our Ontada business, providing software to support the clinical, financial, and operational needs of our oncology practice partners.", "Our European Pharmaceutical Distribution business delivers pharmaceutical and other healthcare-related products to pharmacies across Europe.", "Our more than 250,000 customers include physician offices, surgery centers, post-acute care facilities, hospital reference labs, and  home  health  agencies.  We  distribute  medical-surgical  supplies  (such  as  gloves,  needles,  syringes  and  wound  care  products),  infusion  pumps,  laboratory equipment  and  pharmaceuticals.  Through  a  network  of  distribution  centers  within  the  U.S.,  we  offer  more  than  275,000  products  from  national  brand manufacturers and McKesson\u2019s own high-quality product line.", "Through the right mix of products and services, we help improve efficiencies, profitability and compliance.  We  also  never  lose  focus  on  helping  customers  improve  patient  and  business  outcomes.  We  develop  customized  plans  to  address  the  product, operational, and clinical support needs of our customers, including tackling inventory management, reducing administrative burdens, and training and educating clinical staff.", "We deliver for our customers, so they can deliver and care for their patients.", "pharmaceutical distribution environment in which our U.S.", "Pharmaceutical and International segments operate, we face strong competition from international, national, regional and local full-line, short-line and specialty distributors, service merchandisers, self-warehousing chain drug stores, manufacturers engaged in direct distribution, third-party logistics companies, and large payer organizations.", "Our retail businesses, which primarily operate in our International segment, face competition from various global, national, regional, and local global retailers, including chain and independent pharmacies.", "We consider our largest competitors in distribution, wholesaling, and logistics to be AmerisourceBergen Corporation and Cardinal Health, Inc.", "businesses, which may from time to time decide to develop, for their own internal needs, supply management capabilities that might otherwise be provided by our businesses.", "We believe that our scale and diversity of product and service offerings are our primary competitive advantages.", "operations and market position, but we do not consider any of our businesses to be dependent upon any one patent, copyright, trademark, or trade secret, or any family or families of the same.", "be necessary in the future to seek or renew licenses relating to various aspects of our products and services, we believe, based upon past experience and industry practice,  such  licenses  generally  can  be  obtained  on  commercially  reasonable  terms.  We  believe  our  operations  and  products  and  services  are  not  materially dependent on any single license or other agreement with any third party.", "on improving employee health and wellness, creating opportunities for growth and development, and providing an inclusive workplace where our employees can reach their full potential.", "At March 31, 2021, we had approximately 76,000 employees worldwide, including 17,000 part-time employees and 32,000 employees in the U.S. healthier future is everyone\u2019s business.", "We build successful teams by recruiting, developing, and retaining diverse talent and we recognize our culture of inclusion as an important element that drives long-term shareholder value.", "(1) The data for our metrics is derived from our voluntary, self-identification process as of March 31, 2021 and therefore represents our best estimate at this time. (2) Represents our leadership at the vice president level and above. (3) Represents worldwide employees. (4) Represents U.S. employees only as the data for Canada and Europe is not available.", "I CARE and ILEAD principles, we fulfill our mission of improving care in every setting.", "Our I CARE values (Integrity, Inclusion, Customer-First, Accountability, Respect, Excellence) are foundational to all that we do, and who we are as a company.", "ILEAD (Inspire, Leverage, Execute, Advance, Develop) is our common definition and shared commitment to leadership.", "By embracing this commitment, we bring out the best in ourselves and position McKesson to continue to drive better health \u2013 for our company, our customers, and the patients they serve for years to come.", "We promote leadership behaviors through culture initiatives that offer practical tips on how to debate, decide, and commit, be open and candid, and maintain an enterprise-first mindset when navigating conversations affecting operations within and across our business segments.", "We hold inbound licenses for certain intellectual property that is used internally, and in some cases, utilized in McKesson\u2019s products or services.", "Culture and Leadership: What sets McKesson apart as an exceptional place is our people.", "Our employees understand that together, unified by our global", "where everyone can bring their authentic self to work and feel welcomed and appreciated, and where their perspectives are sought out, heard, and considered.", "Through training, we encourage leaders to embrace diverse perspectives and lead inclusively.", "We  also  seek  employee  feedback  through  an  annual  employee  opinion  survey,  which  assesses  our employees\u2019  levels  of engagement, commitment, and overall satisfaction using industry benchmarks, and we then design action plans to improve those metrics.", "We routinely assess facilities to monitor closely adherence to established security and safety standards.", "If we identify a vulnerability, it is documented, and the facility prepares an action plan.", "Our employees receive specialized training related to their role, work setting, and equipment used in their work environment.", "As our processes evolve, we update relevant safety training modules, which may include new employee training programs.", "The various responses we put in place to mitigate the impact of COVID- 19  on  our  business  operations,  including  telecommuting  and  work-from-home  policies,  restricted  travel,  and  enhanced  safety  measures,  are  intended  to  limit employee exposure to the virus that causes COVID-19 as they perform their jobs while also providing employee support programs and a sense of belonging.", "For additional  information  on  our  response  to  COVID-19  in  the  workplace,  refer  to  the  COVID-19  section  of \u201cTrends  and  Uncertainties\u201d in  \u201cManagement\u2019s Discussion and Analysis of Financial Condition and Results of Operations\u201d in Item 7 of Part II included in this Annual Report on Form 10-K.", "Food and Drug Administration Amendments Act of 2007 requires the FDA to establish standards and identify and validate effective technologies, such as track and trace or authentication technologies, to secure the pharmaceutical supply chain against counterfeit drugs.", "Despite physical, technical, and administrative security measures that we implement in order to, among other things, address regulatory requirements, our technology systems and operations may continue to be subject to cybersecurity incidents.", "The risk of cybersecurity incidents may be increased due to a variety of factors, both internal and external.", "Sales to our largest customer, CVS Health Corporation (\u201cCVS\u201d), accounted for approximately 21% of our total consolidated revenues in 2021.", "In May 2019, we extended our pharmaceutical distribution relationship with CVS to June 2023.", "a supplier could adversely affect our business if alternate sources of supply are unavailable.", "We believe that our relationships with our suppliers are generally sound.", "The ten largest suppliers in 2021 accounted for approximately 50% of our purchases.", "For these manufacturers, a reduction in the frequency and magnitude of price increases, as well as restrictions in the amount of inventory available to us, could have an adverse impact on our gross profit margin.", "Although it is not possible to predict or identify all such risks and uncertainties, they include, but are not limited to, the factors discussed in Item 1A of Part I of this report under \u201cRisk Factors\u201d and in our publicly available SEC filings and press releases.", "Suppliers: We obtain pharmaceutical and other products from manufacturers, none of which accounted for more than 7% of our purchases in 2021.", "practical  to  identify  or  describe  all  risks  and  uncertainties  that  might  materially  impact  our  business  operations,  reputation,  financial  position  or  results  of operations.", "Our business could be materially affected by risks that we have not yet identified or that we currently consider to be immaterial.", "This is not a complete statement of all potential risks and uncertainties.", "For example, pharmacy operations are exposed to risks such as improper filling of prescriptions, mislabeling of prescriptions, inadequacy of warnings, unintentional distribution of counterfeit drugs and expiration of drugs.", "The  discussion  below  identifies  certain  representative  risks  that  might  cause  our  actual  business  results  to  materially  differ  from  our  estimates.  It  is  not", "Certain of our businesses may be required to register for permits and/or licenses with, and comply with operating and security standards of, the DEA, FDA, HHS, CMS, various state boards of pharmacy, state health departments and/or comparable state agencies as well as foreign agencies and certain accrediting bodies, depending upon the type of operations and location of product development, manufacture, distribution, and sale.", "As of March 31, 2021, suspensions at the four distribution centers had all expired  by  their  own  terms.  If  we  are  not  able  to  obtain,  maintain  or  renew  permits,  licenses  or  other  regulatory  approvals  needed  for  the  operation  of  our businesses, it might have a materially adverse impact on our business operations and our financial position or results of operations.", "Food and Drug Administration Amendments Act of 2007 requires the FDA to establish standards and identify and validate effective technologies, such as track  and  trace  or  authentication  technologies,  to  secure  the  pharmaceutical  supply  chain  against  counterfeit  drugs.  We  also  have  record-keeping  and  other obligations under the E.U.", "We are subject to significant compliance obligations under privacy laws such as the General Data Protection Regulation in the  European  Union  (\u201cGDPR\u201d),  the  Personal  Information  Protection  and  Electronic  Documents  Act  (\u201cPIPEDA\u201d)  in  Canada,  and  the  California  Consumer Protection  Act  (\u201cCCPA\u201d).  Some  privacy  laws  prohibit  the  transfer  of  personal  information  to  certain  other  jurisdictions.  We  are  subject  to  privacy  and  data protection compliance audits or investigations by various government agencies.", "We experience cybersecurity incidents that might significantly compromise our technology systems or might result in material data breaches.", "Despite physical, technical, and administrative security measures, our technology systems and operations have been, and likely will continue to be, subject to cyberattacks from sources beyond our control.", "Cybersecurity incidents  include  actual  or  attempted  unauthorized  access,  tampering,  malware  insertion,  ransomware  attacks  or  other  system  integrity  events.  The  risk  of cyberattacks  may be increased  due to a variety of factors, both internal  and external.  A cybersecurity  incident might involve a material  data breach or other material impact to the integrity and operations of our technology systems, which might result in litigation or regulatory action, loss of customers or revenue, and increased expense, any of which might have a materially adverse impact on our business operations, reputation, and our financial position or results of operations.", "We might experience significant problems with information systems or networks.", "If those information systems suffer errors, interruptions, or become unavailable, there might be a materially adverse impact on our business operations, reputation, and our financial position or results of operations.", "Our products or services might not conform to specifications or perform as we intend.", "professionals delivering patient care tend to have heightened sensitivity to system and software errors.", "Errors or failures might damage our reputation and negatively affect future sales.", "We sell and provide services involving complex software and technology that may contain errors, especially when first introduced to market.", "The networks and hosting systems are vulnerable to interruption or damage from sources beyond our control, such as power loss, telecommunications failures, fire, natural disasters, software and hardware failures and cyberattacks.", "If the timely delivery of medical care or other customer business requirements are impaired by data access, network or systems problems, we could be exposed to significant claims and reputational harm.", "We might not realize expected benefits from business process initiatives.", "achieve  our  desired  objectives,  or  unintended  consequences  such  as  distraction  of  our  management  and  employees,  business  disruption,  attrition  beyond  any planned reduction in workforce, inability to attract or retain key personnel and reduced employee productivity.", "We might be unable to successfully complete or integrate acquisitions or other business combinations.", "We may not receive regulatory approvals needed to complete proposed transactions, or such  approvals  may  be  subject  to  delays  or  conditions  that  reduce  transaction  benefits.  Achieving  the  desired  outcomes  of  business  combinations  involves significant  risks  including:  diverting  management\u2019s  attention  from  other  business  operations;  challenges  with  assimilating  the  acquired  businesses,  such  as integration  of  operations  and  systems;  failure  or  delay  in  realizing  operating  synergies;  difficulty  retaining  key  acquired  company  personnel;  unanticipated accounting or financial systems issues with the acquired business, which might affect our internal controls over financial reporting; unanticipated compliance issues in the acquired business; challenges retaining customers of the acquired business; unanticipated expenses or charges to earnings, including depreciation and amortization or potential impairment charges; and risks of known and unknown assumed liabilities in the acquired business.", "We provide remote services that involve hosting customer data and operating software on our own or third party systems.", "Our growth strategy includes consummating acquisitions or other business combinations that either expand or complement our business.", "could delay the achievement of our strategic objectives.", "We might be adversely impacted by outsourcing or similar third-party relationships.", "Third-party services providers might fail to perform as anticipated, or we might experience unanticipated operational difficulties, compliance requirements or increased costs related to outsourced services.", "We may be unsuccessful in retail pharmacy operations or maintaining profitability.", "If our retail pharmacy operations fail to achieve, or are unable to sustain, acceptable net sales and profitability levels, it might have a materially adverse impact on our business operations and our financial position or results of operations.", "We rely on third parties to perform certain business and administrative functions for us.", "We might not adequately develop, implement and monitor these", "Our business strategy included expanding our retail pharmacy operations.", "Our retail pharmacy operations involve numerous risks, such as the following ones.", "For example, our contracts with the U.S. government generally require us to comply with the Federal Acquisition Regulations, Procurement Integrity Act, Buy American Act, Trade Agreements Act, and other laws and regulations.", "The occurrence of any of these risks could harm our reputation and might have a materially adverse impact on our business operations and our financial position or results of operations.", "Our participation in vaccination distribution programs may materially affect our operating results, reputation, and business.", "For example, the novel nature of the SARS-CoV\u20112 virus and the broad scope of the ongoing COVID-19 vaccine distribution program introduce uncertainty about what volumes of products may become available for distribution by us, the effectiveness of vaccines, and the cost of distribution.", "Because of such uncertainties, our operating results may be subject to variability.", "Our participation in such programs also exposes us to various risks, including regulatory compliance, government oversight, dependence on government funding, contractual performance, litigation, security risks, and supply chain challenges.", "Any significant problems with our participation in such programs might have a materially adverse impact on our reputation and our business.", "We might be harmed by changes in our relationships or contracts with suppliers.", "Our competitors might develop non-infringing products or services equivalent or superior to ours.", "We might be unable to successfully recruit and retain qualified employees.", "We compete with many other businesses to attract and retain employees.", "We may experience sudden loss of key personnel due to a variety of causes, such as illness, and must adequately plan for succession of key management roles.", "Employees might not successfully transition into new roles.", "Some of these changes increase our risks and create uncertainties for our business.", "These proposals might result in significant changes in the pharmaceutical value chain as manufacturers, PBM, managed care organizations and other industry stakeholders look to implement new transactional flows and adapt their business models.", "Many of our products and services are designed and intended to function within the structure of current healthcare financing and reimbursement systems.", "We might be adversely impacted by competition and industry consolidation.", "specialty distributors, service merchandisers, self-warehousing chain drug stores, manufacturers engaged in direct distribution, third-party logistics companies and large  payer  organizations.  In  addition,  our  businesses  face  competition  from  various  other  service  providers  and  from  pharmaceutical  and  other  healthcare manufacturers as well as other potential customers, which may from time-to-time decide to develop, for their own internal needs, supply management capabilities that might otherwise be provided by our businesses.", "This concentration reduces our ability to negotiate favorable terms with suppliers and causes us to depend on a smaller number of suppliers.", "Many of our customers, including  healthcare  organizations,  have  consolidated  and  have  greater  power  to  negotiate  favorable  prices.  Consolidation  by  our  customers,  suppliers  and competitors might reduce the number of market participants and give the remaining enterprises greater bargaining power, which might lead to erosion in our profit margin.", "These competitive pressures and industry consolidation might have a materially adverse impact on our business operations and our financial position or results of operations.", "We might be adversely impacted by changes or disruptions in product supply.", "Our inventory might be requisitioned, diverted or allocated by government order such as under emergency, disaster and civil defense declarations.", "For example, government actions in response to the COVID-19 pandemic affect our supply allocation, and those and our own allocation decisions can impact our customer relationships.", "Changes in the healthcare industry\u2019s or our suppliers\u2019 pricing, selling, inventory, distribution or supply policies or practices could significantly reduce our revenues and net income.", "We might experience disruptions in our supply of higher margin pharmaceuticals, including generic pharmaceuticals.", "sourcing joint venture with Walmart, Inc. is unsuccessful or experiences margins declines.", "products and services and the volume of their purchases.", "Our generic  pharmaceuticals  distribution  business  is subject  to  pricing  risks.  We  might  be  adversely  impacted  if  our ClarusONE  generic  pharmaceutical", "Suppliers might increase their prices, reduce their output or change their terms of sale due to limited availability of credit.", "We may have difficulties in sourcing or selling products due to a variety of causes.", "Difficulties in product manufacturing or access to raw materials could result in supplier production shutdowns, product shortages and other supply disruptions.", "The COVID-19 pandemic adversely affects the availability of some products, resulting in product allocation and delivery delays.", "We have operations in the U.K. and the European Union (\u201cE.U.\u201d) and face risks associated with the uncertainty and potential disruptions that might follow the", "These events can disrupt operations for us, our suppliers, our vendors, and our customers.", "For example, in February 2021, a severe winter storm affecting the United  States  temporarily  impacted  our  distribution  business  operations,  primarily  in  Texas.  They  might  affect  consumer  confidence  levels  and  spending.  In response to these events, we might suspend operations, implement extraordinary procedures, seek alternate sources for product supply, or suffer consequences that are unexpected and difficult to mitigate.", "In particular, the rapid and widespread transmission of the SARS-CoV-2 novel coronavirus beginning in late 2019 impacts us in significant ways.", "For example, to mitigate the spread of the COVID-19 disease caused by SARS-CoV-2, we implemented travel restrictions and remote working  arrangements  for  most  of  our  employees  in  order  to  minimize  physical  contact,  and  we  implemented  additional  sanitation  and  personal  protection measures in our warehouse, retail pharmacy and delivery operations.", "These measures might not fully mitigate COVID-19 risks to our workforce and we could experience unusual levels of absenteeism that might impair operations and delay delivery of products.", "The ongoing impacts of the pandemic might cause a general economic slowdown or recession in one or more markets, disruptions and volatility in global capital markets and other broad and adverse effects on the economy, business conditions, commercial activity and the healthcare industry.", "The pandemic might impact our business operation, financial position and results of operation in unpredictable ways that depend on highly uncertain future  developments,  such  as  determining  the  effectiveness  of  current  or  future  government  actions  to  address  the  public  health  or  economic  impacts  of  the pandemic.", "These events and impacts could materially adversely affect our business operations, financial position or results of operation.", "locations,  primarily  throughout  North  America  and  Europe.  Retail  pharmacies  and  most  warehouses  are  typically  owned  or  leased  on  a  long-term  basis.  We consider our operating properties to be in satisfactory condition and adequate to meet our needs for the next several years without making capital expenditures materially higher than historical levels.", "Form 10-K for additional factors relating to these statements and Item 1A - Risk Factors in Part I of this Annual Report on Form 10-K for a list of certain risk factors applicable to our business, financial condition, and results of operations.", "We partner with life sciences companies, manufacturers, providers, pharmacies, governments, and other healthcare organizations to help provide the right medicines, medical products, and healthcare services to the right patients at the right time, safely, and cost-effectively.", "All prior segment information has been recast to reflect our new segment structure and current period presentation.", "We  implemented  a  new  segment  reporting  structure  commencing  with  the  second  quarter  of  2021,  which  resulted  in  four  reportable  segments:  U.S.", "\u2022 International is  a  new  reportable  segment  that  includes  our  operations  in  Europe  and  Canada,  bringing  together  non-U.S.-based  drug  distribution services, specialty pharmacy, retail, and infusion care services.", "\u2022 RxTS is  a  new  reportable  segment  that  brings  together  existing  businesses,  including  CoverMyMeds,  RelayHealth,  RxCrossroads,  and  McKesson Prescription Automation, including Multi-Client Central Fill as a Service, to serve our biopharma and life sciences partners and patients.", "We benefited from demand for COVID-19 tests, favorable contributions from our vaccine and related ancillary supply kit distribution programs as discussed further below, and savings from reduced travel and meetings throughout 2021;", "We have also partnered with the Department of Health and Human Services (\u201cHHS\u201d) and Pfizer to manage the assembly and distribution of the ancillary supplies needed to administer COVID-19 vaccines;", "Pharmaceutical segment driven by market growth; \u2022 Gross profit increased 1% from the prior year primarily in our Medical-Surgical Solutions segment driven by sales of COVID-19 tests; \u2022 Total operating expenses in 2021 includes the following:", "Infection rates varied throughout our fiscal year, peaking in January 2021.", "Our role in the distribution of COVID-19 vaccines in the U.S. as well as the assembly and distribution of related ancillary supply kits is discussed further below.", "McKesson Europe is also playing a role in helping support governments and public health entities in not only distributing COVID-19 vaccines across several European countries, but administering them in pharmacies as well.", "solutions, we are well positioned to respond to the COVID-19 pandemic in the U.S., Canada, and Europe.", "We have worked and continue to work closely with national and local governments, agencies, and industry partners to ensure that available supplies, including personal protective equipment (\u201cPPE\u201d), and medicine reach our customers and patients.", "put in place to mitigate the impact of COVID-19 on our business operations, including telecommuting and work-from-home policies, restricted travel, employee support programs, and enhanced safety measures, are intended to limit employee exposure to the virus that causes COVID-19.", "We expanded employee medical benefits covering COVID-19 related visits, treatments, and testing as well as expanded telehealth options to protect employee safety.", "For employees whose roles require presence at our facilities, we enhanced safety by promoting the practice of social distancing, providing reminders to wash or disinfect hands and avoid unnecessary face touching, making face masks available, placing hand sanitizers within our operating environments, and periodically cleaning and disinfecting our facilities.", "For employees whose roles do not require presence at our facilities, we added technology resources to support their working remotely.", "These steps to protect employee safety have resulted in limited disruption from COVID-19 to our normal business operations, productivity trends, and have not materially impacted our operating expenses or operating margins.", "pharmacy foot traffic as our customers increased supplies on hand in March, which drove unfavorability in our results of operations when comparing 2021 versus 2020.", "We also experienced decreased demand for primary care medical-surgical supplies due to deferrals in elective procedures in hospitals and surgery centers as well as decreased traffic and closures of doctors\u2019 offices, which was partially offset by demand for PPE and COVID-19 tests.", "COVID-19  for  the  second  half  of  our  fiscal  year  was  non-linear  and  tracked  with  patient  mobility.  We  also  saw  increased  demand  for  COVID-19  tests  and continued sales of PPE throughout the year in our Medical-Surgical Solutions segment partially offset by the impacts of social distancing measures which resulted in a less severe cough, cold, and flu season, savings for reduced travel and meetings across the enterprise, as well as improvements of retail pharmacy foot traffic in Europe and Canada.", "The vaccine and related  ancillary  kit distribution  in the U.S. favorably impacted our results in the second half of fiscal 2021 as further discussed below.", "Our Response to COVID-19 in the Workplace During this unprecedented time, we are committed in continuing to supply our customers and protect the safety of our employees.", "During  the  first  quarter  of  2021,  we  experienced  growth  in  pharmaceutical  distribution  and  specialty  drug  volumes  at  a  lower  rate  in  the  U.S.,  while", "In the centralized model, the U.S. government directs us on the distribution of the vaccines and related supplies to point-of-care sites across the country.", "The results of operations related to our vaccine distribution are reflected in our U.S.", "We also have an agreement with Pfizer to assemble and distribute ancillary supply kits needed to administer that particular COVID-19 vaccine.", "We began assembling the ancillary supply kits in September 2020 in preparation for vaccine authorization and subsequent distribution.", "Ancillary supply kits to administer the Pfizer Vaccine are shipped directly to point-of-care sites, and all other ancillary supply kits are shipped to our dedicated vaccine distribution centers.", "The results of operations for the kitting and distribution of ancillary supplies are reflected in our Medical-Surgical Solutions segment.", "These facilities can scale to meet the demand of increasing volumes of vaccines being manufactured.", "We have also set up distribution centers for kitting and inventory management as part of our contract with the HHS.", "We are working with delivery partners to manage the delivery of vaccines and ancillary supply kits from our centralized vaccine distribution centers to point-of-care destinations as directed by the CDC.", "as well as the kitting and distribution of ancillary supplies for COVID-19 vaccines in our Medical-Surgical Solutions segment contributed approximately 20% in segment  revenues  and  segment  operating  profit.  Additionally,  the  distribution  of  COVID-19  vaccines  in  our  U.S.  Pharmaceutical  segment  contributed approximately 2% in segment operating profit for the year ended March 31, 2021.", "During our fourth quarter of 2020, we experienced a temporary increase in demand for pharmaceuticals.", "Certain PPE items held for resale were valued in our inventory at costs that were inflated by earlier COVID-19 pandemic demand levels.", "That inventory valuation, if not supported by market resale prices, may be written down to net realizable value.", "We may also write-off inventory due to decreased customer demand and excess inventory.", "response to supply availability and customer demand patterns for certain products, with varying inventory level impacts depending on the specific product within our portfolio.", "As our supply levels improve, and the federal government evolves guidance on the prioritization of providers or geographic markets, we will continue to adapt our distribution policies.", "We were able to maintain appropriate labor and overall vendor supply levels during the year ended March 31, 2021.", "suppliers,  their  locations,  and  the  extent  to  which  they  are  impacted  by  the  COVID-19  pandemic,  we  are  proactively  working  with  manufacturers,  industry partners, and government agencies to meet the needs of our customers during the pandemic.", "We have assembled a Critical Care Drug Task Force, made up of our procurement  specialists,  clinical  health  systems  pharmacists,  and  supply  chain  professionals,  that  is  focused  on  securing  additional  product  where  available, sourcing back-up products, and protecting our operations across all locations and facilities.", "We are also working with manufacturers through several channels, including  our  ClarusONE  Sourcing  Services  LLP  (\u201cClarusONE\u201d)  and  global  sourcing  teams  in  London,  and  our  leaders  are  actively  engaged  in  addressing potential shortages.", "We have engaged with industry partners and government agencies to gain visibility into supply and demand.", "Additionally, we have a robust Business Continuity and Disaster Recovery Program (\u201cBCRP\u201d) and we have proactively enhanced our BCRP in response to the COVID-19 pandemic to protect the supply  chain  to  minimize  disruption  in  healthcare,  protect  our  customers,  ensure  the  safety  and  security  of  our  employees  and  workplaces,  and  ensure  the continuity of critical business processes.", "supplies and medications to help prevent the spread of the disease and treat those that are ill.", "COVID-19 has put an unprecedented strain on the supply of high- demand PPE, including N95 masks, gloves, as well as disinfecting sprays and wipes.", "The supply chain has improved over the initial impact of pandemic-related demand, and we continue to closely monitor demand by customer type and certain PPE and infection prevention items are still in short supply.", "Our allocation approach has helped us avoid stock outs in many critical product categories, allowing us to provide PPE supplies to many more customers for a much longer time.", "We anticipate these market conditions will remain for the foreseeable future.", "Our efforts to help the supply chain have included sourcing products from new suppliers all over the world, working closely with the federal government to help with the nation\u2019s response and collaborating with partners to source, develop, and deliver new products to market.", "The full extent to which COVID-19 will impact us depends on many factors and future developments, including: the duration and spread of the virus; governmental actions to limit the spread of the virus; potential seasonality of viral outbreaks; potential new strains or variants of the original virus; the amount of COVID-19 vaccines authorized, manufactured, distributed, and administered; the amount of ancillary supply kits assembled and distributed; the  effectiveness  of  COVID-19  vaccines  and  governmental  measures  in  controlling  the  spread  of  the  virus;  and  the  effectiveness  of  treatments  of  infected individuals.", "Impact to our Supply Chain We  also  continue  to  monitor  the  COVID-19  pandemic  impacts  on  our  supply  chain.  Although  the  availability  of  various  products  is  dependent  on  our", "Gross profit was favorably impacted by growth of specialty pharmaceuticals and the contribution from our vaccine distribution programs in our U.S.", "\u2022 Goodwill impairment charges of $1.8 billion in our European Retail Pharmacy (\u201cEuropean RP\u201d) and European Pharmaceutical Distribution (\u201cEuropean PD\u201d) reporting units within the International segment.", "This initiative primarily led us to rationalize our office space in North America.", "Where we determine to cease using office space, we plan to exit the portion of the facility no longer used.", "We also may retain and repurpose certain other office locations.", "transformational changes in technologies and business processes, operational efficiencies, and cost savings.", "centralization of certain functions and outsourcing through an expanded arrangement with a third-party vendor to achieve operational efficiency.", "The  initiative  consisted  of  multiple  growth  priorities  and  plans  to  optimize  our  operating  models  and  cost  structures  primarily  through  centralization,  cost management, and outsourcing of certain administrative functions.", "As part of the growth initiative, we committed to implement certain actions including a reduction in workforce, facility consolidation, and store closures.", "This set of initiatives was substantially complete by the end of 2020. $115 million, $112 million, and $245 million, respectively, primarily related to our retail pharmacy businesses in Canada and Europe within our International segment.", "During  the  first  quarter  of  2021,  we  committed  to  an  initiative  within  the  U.K.,  which  is  included  in  our  International  segment,  to  further  drive", "In the fourth quarter of 2019, we committed to certain programs to continue our operating model and cost optimization efforts.", "On April 25, 2018, we announced a strategic growth initiative intended to drive long-term incremental profit growth and to increase operational efficiency.", "pharmaceutical price increases, growth in specialty pharmaceuticals, and higher volumes from retail national account customers, partially offset by branded to generic  drug  conversions.  Revenues  for  this  segment  were  unfavorably  impacted  by  fluctuations  in  demand  for  pharmaceuticals  in  retail  pharmacies  and institutional healthcare providers due to COVID-19 largely during the onset of the pandemic in late March 2020 and during our first quarter of 2021 combined with the loss of certain customers.", "exchange fluctuations, revenues for this segment decreased 9% primarily due to the contribution of our German pharmaceutical wholesale business to a joint venture with WBA and to a lesser extent, the exit of unprofitable customers in our Canadian business.", "Revenues for this segment were also unfavorably impacted by lower volumes from the adverse impacts from COVID-19 in our pharmaceutical distribution and retail pharmacy businesses within Europe.", "exchange fluctuations, revenues for this segment increased 4% primarily due to market growth in our European pharmaceutical distribution and retail pharmacy businesses.", "2020 vs. 2019 Medical-Surgical Solutions revenues for the year ended March 31, 2020 increased 9% compared to the prior year primarily due to market growth in our", "The impacts from COVID-19 in our pharmaceutical distribution and retail pharmacy businesses within Europe also caused unfavorability in our segment results year over year.", "demand for COVID-19 tests and PPE, as well as the contribution from kitting and distribution of ancillary supplies for COVID-19 vaccines.", "This was partially offset by inventory charges on certain PPE and other related products, unfavorability in our primary care business due to customer closures largely during the first quarter  of 2021, and a  less severe  cough, cold, and flu  season.", "2020 vs. 2019 Operating profit increased for the year ended March 31, 2020 compared to the prior year primarily due to market growth in our specialty business.", "2020 vs. 2019 Operating profit and operating profit margin increased for the year ended March 31, 2020 compared to prior year primarily due to market growth in our", "We monitor our operations and adopt strategies responsive to changes in the economic and political environment in each of the countries in which we operate.", "Our foreign operations represented approximately 15%, 17%, and 18% of our consolidated revenues in 2021, 2020, and 2019, respectively.", "We also have agreements with GPOs, each of which functions as a purchasing agent on behalf of member hospitals, pharmacies and other healthcare providers, as well as with government entities and agencies.", "and updated if unusual circumstances or trends are present.", "LIFO method presumes that the most recent inventory purchases are the first items sold and the inventory cost under LIFO approximates market.", "The majority of the cost of domestic inventories is determined using the LIFO method.", "If we had used the moving average method of inventory valuation, inventories would have been approximately $406 million and $444 million higher than the amounts reported at March 31, 2021 and 2020, respectively.", "such, our LIFO inventory is valued at the lower of LIFO or market.", "Inventories: Inventories  consist of merchandise  held  for resale.  We report  inventories  at the lower of cost or net realizable  value, except  for inventories", "We believe that the moving average inventory costing method provides a reasonable estimation of the current cost of replacing inventory (i.e., \u201cmarket\u201d).", "Shifts in market trends and conditions, changes in customer preferences due to the introduction of generic drugs or new pharmaceutical products or the loss of one or more significant customers are factors that could affect the value of our inventories.", "We write down inventories which are considered excess and obsolete as a result of these reviews.", "These factors could make our estimates of inventory valuation differ from actual results.", "In addition, we compare the aggregate of the reporting units\u2019 fair values to our market capitalization as further corroboration of the fair values.", "They can be affected by a variety of factors, including external factors such as industry and economic trends, and internal factors such as changes in our business strategy and our internal forecasts.", "Management makes certain judgments and estimates in its assessment including but not limited to: identifying if circumstances indicate a decline in value is other than temporary, expectations about the business operations of investees, as well as industry, financial, and market factors.", "On March 9, 2020, we completed the Split-off of our interest in the Change Healthcare JV.", "Our businesses require substantial investments in working capital that are susceptible to large variations during the year as a result of inventory purchase patterns and seasonal demands.", "Our  redeemable  noncontrolling  interests  primarily  relate  to  our  consolidated  subsidiary,  McKesson  Europe.  Under  the  Domination  Agreement,  the", "However, our risk management programs are designed such  that  the  potential  loss  in  value  of  these  risk  management  portfolios  described  above  would  be  largely  offset  by  changes  in  the  value  of  the  underlying exposure.", "With the participation of the Chief Executive Officer and the Chief Financial Officer, our management conducted an assessment of the effectiveness of our internal control over financial  reporting based on the framework and criteria  established in Internal Control\u2014Integrated Framework (2013), issued by the Committee of Sponsoring Organizations of the Treadway Commission.", "Under the market approach, fair value is estimated by comparing the business to similar businesses, or guideline companies whose securities are actively traded in public markets.", "The severity,  magnitude  and  duration,  as  well  as  the  economic  consequences  of  the  coronavirus  diseases  2019  (\u201cCOVID-19\u201d)  pandemic,  are  uncertain,  rapidly changing, and difficult to predict.", "The majority of the cost of domestic inventories is determined using the LIFO method.", "Goodwill testing requires a complex series of assumptions and judgments by management in projecting future operating results, selecting guideline companies for comparisons and assessing risks.", "Revenues generated from the distribution of pharmaceutical and medical products represent the majority of the Company\u2019s revenues.", "customer, is responsible for fulfilling the promise to its customer, has latitude in establishing prices, and controls the relationship with the customer.", "Shipping and handling costs associated with outbound freight after control over a product has transferred to a customer are accounted for as fulfillment costs.", "International segment, to further drive transformational changes in technologies and business processes, operational efficiencies, and cost savings.", "continues to implement centralization of certain functions and outsourcing through an expanded arrangement with a third-party vendor to achieve operational efficiency.", "Irving, Texas to improve efficiency, collaboration, and cost competitiveness.", "PSUs are conditional upon the attainment of market and performance objectives over a specified period.", "As a practical expedient, the Company does not separate lease components from non-lease components such as common area maintenance, utilities, and repairs and maintenance.", "The Company\u2019s most significant relationships are with oncology and other specialty practices.", "Level 2 - significant other observable market-based inputs.", "Level 3 - significant unobservable inputs for which little or no market data exists and requires considerable assumptions that are significant to the fair value", "measurement due to the significance of unobservable inputs developed using company-specific information.", "It has received the same warranties from its suppliers, which customarily are the manufacturers of the products.", "Pharma Belgium NV is also part of the investigation.", "Stockholders (the \u201cProxy Statement\u201d) under the heading \u201cElection of Directors.\u201d Information about our Executive Officers is incorporated by reference from the discussion in Part I of this report under the heading \u201cInformation about our Executive Officers.\u201d Information about our Audit Committee, including the members of the  committee  and  our  Audit  Committee  Financial  Expert,  is  incorporated  by  reference  from  the  discussion  under  Item  1  of  our  Proxy  Statement  under  the headings \u201cThe Board, Committees and Meetings,\u201d and \u201cAudit Committee Report.\u201d", "We offer more than 275,000 national brand medical- surgical products as well as McKesson\u2019s own line of high-quality products through a network of distribution centers within the United States (\u201cU.S.\u201d).", "as a Service, to serve our biopharma and life sciences partners and patients.", "Our  U.S.  Pharmaceutical  segment  distributes  branded,  generic,  specialty,  biosimilar  and  over-the-counter  (\u201cOTC\u201d)  pharmaceutical  drugs,  and  other", "We also source generic pharmaceutical drugs through our joint sourcing entity, ClarusONE Sourcing Services LLP (\u201cClarusONE\u201d).", "We invest in technology and other systems at all of our distribution centers to enhance safety, reliability, and product availability.", "For example, we offer McKesson Connect , an internet-based ordering system that provides item look-up and real-time inventory availability as well as ordering, purchasing, third-party reconciliation, and account management functionality.", "We make extensive use of technology as an enabler to ensure customers have the right products at the right time in the right place.", "We provide solutions to our customers including supply management technology, world-class marketing programs, managed care, repackaging products, and services to help them meet their business and quality goals.", "We continue to implement information systems to help achieve greater consistency and accuracy both internally and for our customers.", "operational efficiency, and automation that help independent pharmacists focus on patient care while improving profitability.", "Retail National Accounts: We provide business solutions that help retail national account customers increase revenues and profitability.", "These distribution centers also provide the foundation for a two-tiered distribution network that supports best-in-class direct store delivery.", "performance, increase operational efficiencies, and deliver better patient care.", "Community-based physicians in this business have broad flexibility and discretion to select the products and commitment levels that best meet their practice needs.", "Services in provider solutions include specialty drug distribution, group purchasing organizations (\u201cGPO\u201d) like Onmark\u00ae, technology solutions, practice consulting services, and vaccine distribution, including our exclusive distributor relationship with the Centers for Disease Control and Prevention\u2019s (\u201cCDC\u201d) Vaccines for Children program.", "SKY Packaging enables acute care, long-term care, and institutional pharmacies to provide cost-effective, uniform packaging.", "Our use of the term \u201cspecialty\u201d may not be comparable to that used by other industry participants, including our competitors.", "Our operations in Canada, including Rexall retail pharmacies, support better, safer patient care by delivering vital medicines, supplies, and information technology solutions throughout Canada.", "functions  as  a  vital  link,  using  technology-enabled  management  systems  at  our  regional  wholesale  branches  to  connect  manufacturers  to  retail  pharmacies, supplying medicines and other products sold in pharmacies.", "In addition, we partner with independent pharmacies under local banner programs.", "banners, and more than 400 owned pharmacies under the Rexall brand where we provide patients with greater choice and access, integrated pharmacy care and industry-leading service levels.", "This segment includes our Ontada business, providing software to support the clinical, financial, and operational needs of our oncology practice partners.", "Our European Pharmaceutical Distribution business delivers pharmaceutical and other healthcare-related products to pharmacies across Europe.", "Our more than 250,000 customers include physician offices, surgery centers, post-acute care facilities, hospital reference labs, and  home  health  agencies.  We  distribute  medical-surgical  supplies  (such  as  gloves,  needles,  syringes  and  wound  care  products),  infusion  pumps,  laboratory equipment  and  pharmaceuticals.  Through  a  network  of  distribution  centers  within  the  U.S.,  we  offer  more  than  275,000  products  from  national  brand manufacturers and McKesson\u2019s own high-quality product line.", "Through the right mix of products and services, we help improve efficiencies, profitability and compliance.  We  also  never  lose  focus  on  helping  customers  improve  patient  and  business  outcomes.  We  develop  customized  plans  to  address  the  product, operational, and clinical support needs of our customers, including tackling inventory management, reducing administrative burdens, and training and educating clinical staff.", "We deliver for our customers, so they can deliver and care for their patients.", "pharmaceutical distribution environment in which our U.S.", "Pharmaceutical and International segments operate, we face strong competition from international, national, regional and local full-line, short-line and specialty distributors, service merchandisers, self-warehousing chain drug stores, manufacturers engaged in direct distribution, third-party logistics companies, and large payer organizations.", "Our retail businesses, which primarily operate in our International segment, face competition from various global, national, regional, and local global retailers, including chain and independent pharmacies.", "We consider our largest competitors in distribution, wholesaling, and logistics to be AmerisourceBergen Corporation and Cardinal Health, Inc.", "businesses, which may from time to time decide to develop, for their own internal needs, supply management capabilities that might otherwise be provided by our businesses.", "We believe that our scale and diversity of product and service offerings are our primary competitive advantages.", "operations and market position, but we do not consider any of our businesses to be dependent upon any one patent, copyright, trademark, or trade secret, or any family or families of the same.", "be necessary in the future to seek or renew licenses relating to various aspects of our products and services, we believe, based upon past experience and industry practice,  such  licenses  generally  can  be  obtained  on  commercially  reasonable  terms.  We  believe  our  operations  and  products  and  services  are  not  materially dependent on any single license or other agreement with any third party.", "on improving employee health and wellness, creating opportunities for growth and development, and providing an inclusive workplace where our employees can reach their full potential.", "At March 31, 2021, we had approximately 76,000 employees worldwide, including 17,000 part-time employees and 32,000 employees in the U.S. healthier future is everyone\u2019s business.", "We build successful teams by recruiting, developing, and retaining diverse talent and we recognize our culture of inclusion as an important element that drives long-term shareholder value.", "(1) The data for our metrics is derived from our voluntary, self-identification process as of March 31, 2021 and therefore represents our best estimate at this time. (2) Represents our leadership at the vice president level and above. (3) Represents worldwide employees. (4) Represents U.S. employees only as the data for Canada and Europe is not available.", "I CARE and ILEAD principles, we fulfill our mission of improving care in every setting.", "Our I CARE values (Integrity, Inclusion, Customer-First, Accountability, Respect, Excellence) are foundational to all that we do, and who we are as a company.", "ILEAD (Inspire, Leverage, Execute, Advance, Develop) is our common definition and shared commitment to leadership.", "By embracing this commitment, we bring out the best in ourselves and position McKesson to continue to drive better health \u2013 for our company, our customers, and the patients they serve for years to come.", "We promote leadership behaviors through culture initiatives that offer practical tips on how to debate, decide, and commit, be open and candid, and maintain an enterprise-first mindset when navigating conversations affecting operations within and across our business segments.", "We hold inbound licenses for certain intellectual property that is used internally, and in some cases, utilized in McKesson\u2019s products or services.", "Culture and Leadership: What sets McKesson apart as an exceptional place is our people.", "Our employees understand that together, unified by our global", "where everyone can bring their authentic self to work and feel welcomed and appreciated, and where their perspectives are sought out, heard, and considered.", "Through training, we encourage leaders to embrace diverse perspectives and lead inclusively.", "We  also  seek  employee  feedback  through  an  annual  employee  opinion  survey,  which  assesses  our employees\u2019  levels  of engagement, commitment, and overall satisfaction using industry benchmarks, and we then design action plans to improve those metrics.", "We routinely assess facilities to monitor closely adherence to established security and safety standards.", "If we identify a vulnerability, it is documented, and the facility prepares an action plan.", "Our employees receive specialized training related to their role, work setting, and equipment used in their work environment.", "As our processes evolve, we update relevant safety training modules, which may include new employee training programs.", "The various responses we put in place to mitigate the impact of COVID- 19  on  our  business  operations,  including  telecommuting  and  work-from-home  policies,  restricted  travel,  and  enhanced  safety  measures,  are  intended  to  limit employee exposure to the virus that causes COVID-19 as they perform their jobs while also providing employee support programs and a sense of belonging.", "For additional  information  on  our  response  to  COVID-19  in  the  workplace,  refer  to  the  COVID-19  section  of \u201cTrends  and  Uncertainties\u201d in  \u201cManagement\u2019s Discussion and Analysis of Financial Condition and Results of Operations\u201d in Item 7 of Part II included in this Annual Report on Form 10-K.", "Food and Drug Administration Amendments Act of 2007 requires the FDA to establish standards and identify and validate effective technologies, such as track and trace or authentication technologies, to secure the pharmaceutical supply chain against counterfeit drugs.", "Despite physical, technical, and administrative security measures that we implement in order to, among other things, address regulatory requirements, our technology systems and operations may continue to be subject to cybersecurity incidents.", "The risk of cybersecurity incidents may be increased due to a variety of factors, both internal and external.", "Sales to our largest customer, CVS Health Corporation (\u201cCVS\u201d), accounted for approximately 21% of our total consolidated revenues in 2021.", "In May 2019, we extended our pharmaceutical distribution relationship with CVS to June 2023.", "a supplier could adversely affect our business if alternate sources of supply are unavailable.", "We believe that our relationships with our suppliers are generally sound.", "The ten largest suppliers in 2021 accounted for approximately 50% of our purchases.", "For these manufacturers, a reduction in the frequency and magnitude of price increases, as well as restrictions in the amount of inventory available to us, could have an adverse impact on our gross profit margin.", "Although it is not possible to predict or identify all such risks and uncertainties, they include, but are not limited to, the factors discussed in Item 1A of Part I of this report under \u201cRisk Factors\u201d and in our publicly available SEC filings and press releases.", "Suppliers: We obtain pharmaceutical and other products from manufacturers, none of which accounted for more than 7% of our purchases in 2021.", "practical  to  identify  or  describe  all  risks  and  uncertainties  that  might  materially  impact  our  business  operations,  reputation,  financial  position  or  results  of operations.", "Our business could be materially affected by risks that we have not yet identified or that we currently consider to be immaterial.", "This is not a complete statement of all potential risks and uncertainties.", "For example, pharmacy operations are exposed to risks such as improper filling of prescriptions, mislabeling of prescriptions, inadequacy of warnings, unintentional distribution of counterfeit drugs and expiration of drugs.", "The  discussion  below  identifies  certain  representative  risks  that  might  cause  our  actual  business  results  to  materially  differ  from  our  estimates.  It  is  not", "Certain of our businesses may be required to register for permits and/or licenses with, and comply with operating and security standards of, the DEA, FDA, HHS, CMS, various state boards of pharmacy, state health departments and/or comparable state agencies as well as foreign agencies and certain accrediting bodies, depending upon the type of operations and location of product development, manufacture, distribution, and sale.", "As of March 31, 2021, suspensions at the four distribution centers had all expired  by  their  own  terms.  If  we  are  not  able  to  obtain,  maintain  or  renew  permits,  licenses  or  other  regulatory  approvals  needed  for  the  operation  of  our businesses, it might have a materially adverse impact on our business operations and our financial position or results of operations.", "Food and Drug Administration Amendments Act of 2007 requires the FDA to establish standards and identify and validate effective technologies, such as track  and  trace  or  authentication  technologies,  to  secure  the  pharmaceutical  supply  chain  against  counterfeit  drugs.  We  also  have  record-keeping  and  other obligations under the E.U.", "We are subject to significant compliance obligations under privacy laws such as the General Data Protection Regulation in the  European  Union  (\u201cGDPR\u201d),  the  Personal  Information  Protection  and  Electronic  Documents  Act  (\u201cPIPEDA\u201d)  in  Canada,  and  the  California  Consumer Protection  Act  (\u201cCCPA\u201d).  Some  privacy  laws  prohibit  the  transfer  of  personal  information  to  certain  other  jurisdictions.  We  are  subject  to  privacy  and  data protection compliance audits or investigations by various government agencies.", "We experience cybersecurity incidents that might significantly compromise our technology systems or might result in material data breaches.", "Despite physical, technical, and administrative security measures, our technology systems and operations have been, and likely will continue to be, subject to cyberattacks from sources beyond our control.", "Cybersecurity incidents  include  actual  or  attempted  unauthorized  access,  tampering,  malware  insertion,  ransomware  attacks  or  other  system  integrity  events.  The  risk  of cyberattacks  may be increased  due to a variety of factors, both internal  and external.  A cybersecurity  incident might involve a material  data breach or other material impact to the integrity and operations of our technology systems, which might result in litigation or regulatory action, loss of customers or revenue, and increased expense, any of which might have a materially adverse impact on our business operations, reputation, and our financial position or results of operations.", "We might experience significant problems with information systems or networks.", "If those information systems suffer errors, interruptions, or become unavailable, there might be a materially adverse impact on our business operations, reputation, and our financial position or results of operations.", "Our products or services might not conform to specifications or perform as we intend.", "professionals delivering patient care tend to have heightened sensitivity to system and software errors.", "Errors or failures might damage our reputation and negatively affect future sales.", "We sell and provide services involving complex software and technology that may contain errors, especially when first introduced to market.", "The networks and hosting systems are vulnerable to interruption or damage from sources beyond our control, such as power loss, telecommunications failures, fire, natural disasters, software and hardware failures and cyberattacks.", "If the timely delivery of medical care or other customer business requirements are impaired by data access, network or systems problems, we could be exposed to significant claims and reputational harm.", "We might not realize expected benefits from business process initiatives.", "achieve  our  desired  objectives,  or  unintended  consequences  such  as  distraction  of  our  management  and  employees,  business  disruption,  attrition  beyond  any planned reduction in workforce, inability to attract or retain key personnel and reduced employee productivity.", "We might be unable to successfully complete or integrate acquisitions or other business combinations.", "We may not receive regulatory approvals needed to complete proposed transactions, or such  approvals  may  be  subject  to  delays  or  conditions  that  reduce  transaction  benefits.  Achieving  the  desired  outcomes  of  business  combinations  involves significant  risks  including:  diverting  management\u2019s  attention  from  other  business  operations;  challenges  with  assimilating  the  acquired  businesses,  such  as integration  of  operations  and  systems;  failure  or  delay  in  realizing  operating  synergies;  difficulty  retaining  key  acquired  company  personnel;  unanticipated accounting or financial systems issues with the acquired business, which might affect our internal controls over financial reporting; unanticipated compliance issues in the acquired business; challenges retaining customers of the acquired business; unanticipated expenses or charges to earnings, including depreciation and amortization or potential impairment charges; and risks of known and unknown assumed liabilities in the acquired business.", "We provide remote services that involve hosting customer data and operating software on our own or third party systems.", "Our growth strategy includes consummating acquisitions or other business combinations that either expand or complement our business.", "could delay the achievement of our strategic objectives.", "We might be adversely impacted by outsourcing or similar third-party relationships.", "Third-party services providers might fail to perform as anticipated, or we might experience unanticipated operational difficulties, compliance requirements or increased costs related to outsourced services.", "We may be unsuccessful in retail pharmacy operations or maintaining profitability.", "If our retail pharmacy operations fail to achieve, or are unable to sustain, acceptable net sales and profitability levels, it might have a materially adverse impact on our business operations and our financial position or results of operations.", "We rely on third parties to perform certain business and administrative functions for us.", "We might not adequately develop, implement and monitor these", "Our business strategy included expanding our retail pharmacy operations.", "Our retail pharmacy operations involve numerous risks, such as the following ones.", "For example, our contracts with the U.S. government generally require us to comply with the Federal Acquisition Regulations, Procurement Integrity Act, Buy American Act, Trade Agreements Act, and other laws and regulations.", "The occurrence of any of these risks could harm our reputation and might have a materially adverse impact on our business operations and our financial position or results of operations.", "Our participation in vaccination distribution programs may materially affect our operating results, reputation, and business.", "For example, the novel nature of the SARS-CoV\u20112 virus and the broad scope of the ongoing COVID-19 vaccine distribution program introduce uncertainty about what volumes of products may become available for distribution by us, the effectiveness of vaccines, and the cost of distribution.", "Because of such uncertainties, our operating results may be subject to variability.", "Our participation in such programs also exposes us to various risks, including regulatory compliance, government oversight, dependence on government funding, contractual performance, litigation, security risks, and supply chain challenges.", "Any significant problems with our participation in such programs might have a materially adverse impact on our reputation and our business.", "We might be harmed by changes in our relationships or contracts with suppliers.", "Our competitors might develop non-infringing products or services equivalent or superior to ours.", "We might be unable to successfully recruit and retain qualified employees.", "We compete with many other businesses to attract and retain employees.", "We may experience sudden loss of key personnel due to a variety of causes, such as illness, and must adequately plan for succession of key management roles.", "Employees might not successfully transition into new roles.", "Some of these changes increase our risks and create uncertainties for our business.", "These proposals might result in significant changes in the pharmaceutical value chain as manufacturers, PBM, managed care organizations and other industry stakeholders look to implement new transactional flows and adapt their business models.", "Many of our products and services are designed and intended to function within the structure of current healthcare financing and reimbursement systems.", "We might be adversely impacted by competition and industry consolidation.", "specialty distributors, service merchandisers, self-warehousing chain drug stores, manufacturers engaged in direct distribution, third-party logistics companies and large  payer  organizations.  In  addition,  our  businesses  face  competition  from  various  other  service  providers  and  from  pharmaceutical  and  other  healthcare manufacturers as well as other potential customers, which may from time-to-time decide to develop, for their own internal needs, supply management capabilities that might otherwise be provided by our businesses.", "This concentration reduces our ability to negotiate favorable terms with suppliers and causes us to depend on a smaller number of suppliers.", "Many of our customers, including  healthcare  organizations,  have  consolidated  and  have  greater  power  to  negotiate  favorable  prices.  Consolidation  by  our  customers,  suppliers  and competitors might reduce the number of market participants and give the remaining enterprises greater bargaining power, which might lead to erosion in our profit margin.", "These competitive pressures and industry consolidation might have a materially adverse impact on our business operations and our financial position or results of operations.", "We might be adversely impacted by changes or disruptions in product supply.", "Our inventory might be requisitioned, diverted or allocated by government order such as under emergency, disaster and civil defense declarations.", "For example, government actions in response to the COVID-19 pandemic affect our supply allocation, and those and our own allocation decisions can impact our customer relationships.", "Changes in the healthcare industry\u2019s or our suppliers\u2019 pricing, selling, inventory, distribution or supply policies or practices could significantly reduce our revenues and net income.", "We might experience disruptions in our supply of higher margin pharmaceuticals, including generic pharmaceuticals.", "sourcing joint venture with Walmart, Inc. is unsuccessful or experiences margins declines.", "products and services and the volume of their purchases.", "Our generic  pharmaceuticals  distribution  business  is subject  to  pricing  risks.  We  might  be  adversely  impacted  if  our ClarusONE  generic  pharmaceutical", "Suppliers might increase their prices, reduce their output or change their terms of sale due to limited availability of credit.", "We may have difficulties in sourcing or selling products due to a variety of causes.", "Difficulties in product manufacturing or access to raw materials could result in supplier production shutdowns, product shortages and other supply disruptions.", "The COVID-19 pandemic adversely affects the availability of some products, resulting in product allocation and delivery delays.", "We have operations in the U.K. and the European Union (\u201cE.U.\u201d) and face risks associated with the uncertainty and potential disruptions that might follow the", "These events can disrupt operations for us, our suppliers, our vendors, and our customers.", "For example, in February 2021, a severe winter storm affecting the United  States  temporarily  impacted  our  distribution  business  operations,  primarily  in  Texas.  They  might  affect  consumer  confidence  levels  and  spending.  In response to these events, we might suspend operations, implement extraordinary procedures, seek alternate sources for product supply, or suffer consequences that are unexpected and difficult to mitigate.", "In particular, the rapid and widespread transmission of the SARS-CoV-2 novel coronavirus beginning in late 2019 impacts us in significant ways.", "For example, to mitigate the spread of the COVID-19 disease caused by SARS-CoV-2, we implemented travel restrictions and remote working  arrangements  for  most  of  our  employees  in  order  to  minimize  physical  contact,  and  we  implemented  additional  sanitation  and  personal  protection measures in our warehouse, retail pharmacy and delivery operations.", "These measures might not fully mitigate COVID-19 risks to our workforce and we could experience unusual levels of absenteeism that might impair operations and delay delivery of products.", "The ongoing impacts of the pandemic might cause a general economic slowdown or recession in one or more markets, disruptions and volatility in global capital markets and other broad and adverse effects on the economy, business conditions, commercial activity and the healthcare industry.", "The pandemic might impact our business operation, financial position and results of operation in unpredictable ways that depend on highly uncertain future  developments,  such  as  determining  the  effectiveness  of  current  or  future  government  actions  to  address  the  public  health  or  economic  impacts  of  the pandemic.", "These events and impacts could materially adversely affect our business operations, financial position or results of operation.", "locations,  primarily  throughout  North  America  and  Europe.  Retail  pharmacies  and  most  warehouses  are  typically  owned  or  leased  on  a  long-term  basis.  We consider our operating properties to be in satisfactory condition and adequate to meet our needs for the next several years without making capital expenditures materially higher than historical levels.", "Form 10-K for additional factors relating to these statements and Item 1A - Risk Factors in Part I of this Annual Report on Form 10-K for a list of certain risk factors applicable to our business, financial condition, and results of operations.", "We partner with life sciences companies, manufacturers, providers, pharmacies, governments, and other healthcare organizations to help provide the right medicines, medical products, and healthcare services to the right patients at the right time, safely, and cost-effectively.", "All prior segment information has been recast to reflect our new segment structure and current period presentation.", "We  implemented  a  new  segment  reporting  structure  commencing  with  the  second  quarter  of  2021,  which  resulted  in  four  reportable  segments:  U.S.", "\u2022 International is  a  new  reportable  segment  that  includes  our  operations  in  Europe  and  Canada,  bringing  together  non-U.S.-based  drug  distribution services, specialty pharmacy, retail, and infusion care services.", "\u2022 RxTS is  a  new  reportable  segment  that  brings  together  existing  businesses,  including  CoverMyMeds,  RelayHealth,  RxCrossroads,  and  McKesson Prescription Automation, including Multi-Client Central Fill as a Service, to serve our biopharma and life sciences partners and patients.", "We benefited from demand for COVID-19 tests, favorable contributions from our vaccine and related ancillary supply kit distribution programs as discussed further below, and savings from reduced travel and meetings throughout 2021;", "We have also partnered with the Department of Health and Human Services (\u201cHHS\u201d) and Pfizer to manage the assembly and distribution of the ancillary supplies needed to administer COVID-19 vaccines;", "Pharmaceutical segment driven by market growth; \u2022 Gross profit increased 1% from the prior year primarily in our Medical-Surgical Solutions segment driven by sales of COVID-19 tests; \u2022 Total operating expenses in 2021 includes the following:", "Infection rates varied throughout our fiscal year, peaking in January 2021.", "Our role in the distribution of COVID-19 vaccines in the U.S. as well as the assembly and distribution of related ancillary supply kits is discussed further below.", "McKesson Europe is also playing a role in helping support governments and public health entities in not only distributing COVID-19 vaccines across several European countries, but administering them in pharmacies as well.", "solutions, we are well positioned to respond to the COVID-19 pandemic in the U.S., Canada, and Europe.", "We have worked and continue to work closely with national and local governments, agencies, and industry partners to ensure that available supplies, including personal protective equipment (\u201cPPE\u201d), and medicine reach our customers and patients.", "put in place to mitigate the impact of COVID-19 on our business operations, including telecommuting and work-from-home policies, restricted travel, employee support programs, and enhanced safety measures, are intended to limit employee exposure to the virus that causes COVID-19.", "We expanded employee medical benefits covering COVID-19 related visits, treatments, and testing as well as expanded telehealth options to protect employee safety.", "For employees whose roles require presence at our facilities, we enhanced safety by promoting the practice of social distancing, providing reminders to wash or disinfect hands and avoid unnecessary face touching, making face masks available, placing hand sanitizers within our operating environments, and periodically cleaning and disinfecting our facilities.", "For employees whose roles do not require presence at our facilities, we added technology resources to support their working remotely.", "These steps to protect employee safety have resulted in limited disruption from COVID-19 to our normal business operations, productivity trends, and have not materially impacted our operating expenses or operating margins.", "pharmacy foot traffic as our customers increased supplies on hand in March, which drove unfavorability in our results of operations when comparing 2021 versus 2020.", "We also experienced decreased demand for primary care medical-surgical supplies due to deferrals in elective procedures in hospitals and surgery centers as well as decreased traffic and closures of doctors\u2019 offices, which was partially offset by demand for PPE and COVID-19 tests.", "COVID-19  for  the  second  half  of  our  fiscal  year  was  non-linear  and  tracked  with  patient  mobility.  We  also  saw  increased  demand  for  COVID-19  tests  and continued sales of PPE throughout the year in our Medical-Surgical Solutions segment partially offset by the impacts of social distancing measures which resulted in a less severe cough, cold, and flu season, savings for reduced travel and meetings across the enterprise, as well as improvements of retail pharmacy foot traffic in Europe and Canada.", "The vaccine and related  ancillary  kit distribution  in the U.S. favorably impacted our results in the second half of fiscal 2021 as further discussed below.", "Our Response to COVID-19 in the Workplace During this unprecedented time, we are committed in continuing to supply our customers and protect the safety of our employees.", "During  the  first  quarter  of  2021,  we  experienced  growth  in  pharmaceutical  distribution  and  specialty  drug  volumes  at  a  lower  rate  in  the  U.S.,  while", "In the centralized model, the U.S. government directs us on the distribution of the vaccines and related supplies to point-of-care sites across the country.", "The results of operations related to our vaccine distribution are reflected in our U.S.", "We also have an agreement with Pfizer to assemble and distribute ancillary supply kits needed to administer that particular COVID-19 vaccine.", "We began assembling the ancillary supply kits in September 2020 in preparation for vaccine authorization and subsequent distribution.", "Ancillary supply kits to administer the Pfizer Vaccine are shipped directly to point-of-care sites, and all other ancillary supply kits are shipped to our dedicated vaccine distribution centers.", "The results of operations for the kitting and distribution of ancillary supplies are reflected in our Medical-Surgical Solutions segment.", "These facilities can scale to meet the demand of increasing volumes of vaccines being manufactured.", "We have also set up distribution centers for kitting and inventory management as part of our contract with the HHS.", "We are working with delivery partners to manage the delivery of vaccines and ancillary supply kits from our centralized vaccine distribution centers to point-of-care destinations as directed by the CDC.", "as well as the kitting and distribution of ancillary supplies for COVID-19 vaccines in our Medical-Surgical Solutions segment contributed approximately 20% in segment  revenues  and  segment  operating  profit.  Additionally,  the  distribution  of  COVID-19  vaccines  in  our  U.S.  Pharmaceutical  segment  contributed approximately 2% in segment operating profit for the year ended March 31, 2021.", "During our fourth quarter of 2020, we experienced a temporary increase in demand for pharmaceuticals.", "Certain PPE items held for resale were valued in our inventory at costs that were inflated by earlier COVID-19 pandemic demand levels.", "That inventory valuation, if not supported by market resale prices, may be written down to net realizable value.", "We may also write-off inventory due to decreased customer demand and excess inventory.", "response to supply availability and customer demand patterns for certain products, with varying inventory level impacts depending on the specific product within our portfolio.", "As our supply levels improve, and the federal government evolves guidance on the prioritization of providers or geographic markets, we will continue to adapt our distribution policies.", "We were able to maintain appropriate labor and overall vendor supply levels during the year ended March 31, 2021.", "suppliers,  their  locations,  and  the  extent  to  which  they  are  impacted  by  the  COVID-19  pandemic,  we  are  proactively  working  with  manufacturers,  industry partners, and government agencies to meet the needs of our customers during the pandemic.", "We have assembled a Critical Care Drug Task Force, made up of our procurement  specialists,  clinical  health  systems  pharmacists,  and  supply  chain  professionals,  that  is  focused  on  securing  additional  product  where  available, sourcing back-up products, and protecting our operations across all locations and facilities.", "We are also working with manufacturers through several channels, including  our  ClarusONE  Sourcing  Services  LLP  (\u201cClarusONE\u201d)  and  global  sourcing  teams  in  London,  and  our  leaders  are  actively  engaged  in  addressing potential shortages.", "We have engaged with industry partners and government agencies to gain visibility into supply and demand.", "Additionally, we have a robust Business Continuity and Disaster Recovery Program (\u201cBCRP\u201d) and we have proactively enhanced our BCRP in response to the COVID-19 pandemic to protect the supply  chain  to  minimize  disruption  in  healthcare,  protect  our  customers,  ensure  the  safety  and  security  of  our  employees  and  workplaces,  and  ensure  the continuity of critical business processes.", "supplies and medications to help prevent the spread of the disease and treat those that are ill.", "COVID-19 has put an unprecedented strain on the supply of high- demand PPE, including N95 masks, gloves, as well as disinfecting sprays and wipes.", "The supply chain has improved over the initial impact of pandemic-related demand, and we continue to closely monitor demand by customer type and certain PPE and infection prevention items are still in short supply.", "Our allocation approach has helped us avoid stock outs in many critical product categories, allowing us to provide PPE supplies to many more customers for a much longer time.", "We anticipate these market conditions will remain for the foreseeable future.", "Our efforts to help the supply chain have included sourcing products from new suppliers all over the world, working closely with the federal government to help with the nation\u2019s response and collaborating with partners to source, develop, and deliver new products to market.", "The full extent to which COVID-19 will impact us depends on many factors and future developments, including: the duration and spread of the virus; governmental actions to limit the spread of the virus; potential seasonality of viral outbreaks; potential new strains or variants of the original virus; the amount of COVID-19 vaccines authorized, manufactured, distributed, and administered; the amount of ancillary supply kits assembled and distributed; the  effectiveness  of  COVID-19  vaccines  and  governmental  measures  in  controlling  the  spread  of  the  virus;  and  the  effectiveness  of  treatments  of  infected individuals.", "Impact to our Supply Chain We  also  continue  to  monitor  the  COVID-19  pandemic  impacts  on  our  supply  chain.  Although  the  availability  of  various  products  is  dependent  on  our", "Gross profit was favorably impacted by growth of specialty pharmaceuticals and the contribution from our vaccine distribution programs in our U.S.", "\u2022 Goodwill impairment charges of $1.8 billion in our European Retail Pharmacy (\u201cEuropean RP\u201d) and European Pharmaceutical Distribution (\u201cEuropean PD\u201d) reporting units within the International segment.", "This initiative primarily led us to rationalize our office space in North America.", "Where we determine to cease using office space, we plan to exit the portion of the facility no longer used.", "We also may retain and repurpose certain other office locations.", "transformational changes in technologies and business processes, operational efficiencies, and cost savings.", "centralization of certain functions and outsourcing through an expanded arrangement with a third-party vendor to achieve operational efficiency.", "The  initiative  consisted  of  multiple  growth  priorities  and  plans  to  optimize  our  operating  models  and  cost  structures  primarily  through  centralization,  cost management, and outsourcing of certain administrative functions.", "As part of the growth initiative, we committed to implement certain actions including a reduction in workforce, facility consolidation, and store closures.", "This set of initiatives was substantially complete by the end of 2020. $115 million, $112 million, and $245 million, respectively, primarily related to our retail pharmacy businesses in Canada and Europe within our International segment.", "During  the  first  quarter  of  2021,  we  committed  to  an  initiative  within  the  U.K.,  which  is  included  in  our  International  segment,  to  further  drive", "In the fourth quarter of 2019, we committed to certain programs to continue our operating model and cost optimization efforts.", "On April 25, 2018, we announced a strategic growth initiative intended to drive long-term incremental profit growth and to increase operational efficiency.", "pharmaceutical price increases, growth in specialty pharmaceuticals, and higher volumes from retail national account customers, partially offset by branded to generic  drug  conversions.  Revenues  for  this  segment  were  unfavorably  impacted  by  fluctuations  in  demand  for  pharmaceuticals  in  retail  pharmacies  and institutional healthcare providers due to COVID-19 largely during the onset of the pandemic in late March 2020 and during our first quarter of 2021 combined with the loss of certain customers.", "exchange fluctuations, revenues for this segment decreased 9% primarily due to the contribution of our German pharmaceutical wholesale business to a joint venture with WBA and to a lesser extent, the exit of unprofitable customers in our Canadian business.", "Revenues for this segment were also unfavorably impacted by lower volumes from the adverse impacts from COVID-19 in our pharmaceutical distribution and retail pharmacy businesses within Europe.", "exchange fluctuations, revenues for this segment increased 4% primarily due to market growth in our European pharmaceutical distribution and retail pharmacy businesses.", "2020 vs. 2019 Medical-Surgical Solutions revenues for the year ended March 31, 2020 increased 9% compared to the prior year primarily due to market growth in our", "The impacts from COVID-19 in our pharmaceutical distribution and retail pharmacy businesses within Europe also caused unfavorability in our segment results year over year.", "demand for COVID-19 tests and PPE, as well as the contribution from kitting and distribution of ancillary supplies for COVID-19 vaccines.", "This was partially offset by inventory charges on certain PPE and other related products, unfavorability in our primary care business due to customer closures largely during the first quarter  of 2021, and a  less severe  cough, cold, and flu  season.", "2020 vs. 2019 Operating profit increased for the year ended March 31, 2020 compared to the prior year primarily due to market growth in our specialty business.", "2020 vs. 2019 Operating profit and operating profit margin increased for the year ended March 31, 2020 compared to prior year primarily due to market growth in our", "We monitor our operations and adopt strategies responsive to changes in the economic and political environment in each of the countries in which we operate.", "Our foreign operations represented approximately 15%, 17%, and 18% of our consolidated revenues in 2021, 2020, and 2019, respectively.", "We also have agreements with GPOs, each of which functions as a purchasing agent on behalf of member hospitals, pharmacies and other healthcare providers, as well as with government entities and agencies.", "and updated if unusual circumstances or trends are present.", "LIFO method presumes that the most recent inventory purchases are the first items sold and the inventory cost under LIFO approximates market.", "The majority of the cost of domestic inventories is determined using the LIFO method.", "If we had used the moving average method of inventory valuation, inventories would have been approximately $406 million and $444 million higher than the amounts reported at March 31, 2021 and 2020, respectively.", "such, our LIFO inventory is valued at the lower of LIFO or market.", "Inventories: Inventories  consist of merchandise  held  for resale.  We report  inventories  at the lower of cost or net realizable  value, except  for inventories", "We believe that the moving average inventory costing method provides a reasonable estimation of the current cost of replacing inventory (i.e., \u201cmarket\u201d).", "Shifts in market trends and conditions, changes in customer preferences due to the introduction of generic drugs or new pharmaceutical products or the loss of one or more significant customers are factors that could affect the value of our inventories.", "We write down inventories which are considered excess and obsolete as a result of these reviews.", "These factors could make our estimates of inventory valuation differ from actual results.", "In addition, we compare the aggregate of the reporting units\u2019 fair values to our market capitalization as further corroboration of the fair values.", "They can be affected by a variety of factors, including external factors such as industry and economic trends, and internal factors such as changes in our business strategy and our internal forecasts.", "Management makes certain judgments and estimates in its assessment including but not limited to: identifying if circumstances indicate a decline in value is other than temporary, expectations about the business operations of investees, as well as industry, financial, and market factors.", "On March 9, 2020, we completed the Split-off of our interest in the Change Healthcare JV.", "Our businesses require substantial investments in working capital that are susceptible to large variations during the year as a result of inventory purchase patterns and seasonal demands.", "Our  redeemable  noncontrolling  interests  primarily  relate  to  our  consolidated  subsidiary,  McKesson  Europe.  Under  the  Domination  Agreement,  the", "However, our risk management programs are designed such  that  the  potential  loss  in  value  of  these  risk  management  portfolios  described  above  would  be  largely  offset  by  changes  in  the  value  of  the  underlying exposure.", "With the participation of the Chief Executive Officer and the Chief Financial Officer, our management conducted an assessment of the effectiveness of our internal control over financial  reporting based on the framework and criteria  established in Internal Control\u2014Integrated Framework (2013), issued by the Committee of Sponsoring Organizations of the Treadway Commission.", "Under the market approach, fair value is estimated by comparing the business to similar businesses, or guideline companies whose securities are actively traded in public markets.", "The severity,  magnitude  and  duration,  as  well  as  the  economic  consequences  of  the  coronavirus  diseases  2019  (\u201cCOVID-19\u201d)  pandemic,  are  uncertain,  rapidly changing, and difficult to predict.", "The majority of the cost of domestic inventories is determined using the LIFO method.", "Goodwill testing requires a complex series of assumptions and judgments by management in projecting future operating results, selecting guideline companies for comparisons and assessing risks.", "Revenues generated from the distribution of pharmaceutical and medical products represent the majority of the Company\u2019s revenues.", "customer, is responsible for fulfilling the promise to its customer, has latitude in establishing prices, and controls the relationship with the customer.", "Shipping and handling costs associated with outbound freight after control over a product has transferred to a customer are accounted for as fulfillment costs.", "International segment, to further drive transformational changes in technologies and business processes, operational efficiencies, and cost savings.", "continues to implement centralization of certain functions and outsourcing through an expanded arrangement with a third-party vendor to achieve operational efficiency.", "Irving, Texas to improve efficiency, collaboration, and cost competitiveness.", "PSUs are conditional upon the attainment of market and performance objectives over a specified period.", "As a practical expedient, the Company does not separate lease components from non-lease components such as common area maintenance, utilities, and repairs and maintenance.", "The Company\u2019s most significant relationships are with oncology and other specialty practices.", "Level 2 - significant other observable market-based inputs.", "Level 3 - significant unobservable inputs for which little or no market data exists and requires considerable assumptions that are significant to the fair value", "measurement due to the significance of unobservable inputs developed using company-specific information.", "It has received the same warranties from its suppliers, which customarily are the manufacturers of the products.", "Pharma Belgium NV is also part of the investigation.", "Stockholders (the \u201cProxy Statement\u201d) under the heading \u201cElection of Directors.\u201d Information about our Executive Officers is incorporated by reference from the discussion in Part I of this report under the heading \u201cInformation about our Executive Officers.\u201d Information about our Audit Committee, including the members of the  committee  and  our  Audit  Committee  Financial  Expert,  is  incorporated  by  reference  from  the  discussion  under  Item  1  of  our  Proxy  Statement  under  the headings \u201cThe Board, Committees and Meetings,\u201d and \u201cAudit Committee Report.\u201d"]}